ENSG00000167323,STIM1,nf-κb signaling pathway activation,oncogenic driver,cell growth regulation,calcium homeostasis disruption,store-operated calcium entry (soce),cancer cell survival enhancement
ENSG00000144935,TRPC1,calcium influx,aberrant activation,oncogene potential,tumor progression,cell migration,signaling pathway regulation
ENSG00000089250,NOS1,nitric oxide production,tumor microenvironment modulation,angiogenesis promotion,cell migration enhancement,protein-protein interaction,s-nitrosylation target
ENSG00000058668,ATP2B4,calcium homeostasis disruption,cell migration,metabolic reprogramming,angiogenesis promotion,cancer cell metabolism alteration,protein-protein interaction
ENSG00000069431,ABCC9,cellular metabolism regulation,ion homeostasis maintenance,oncogenic potential,therapeutic target,drug resistance association,signaling pathway interaction
ENSG00000187486,KCNJ11,metabolic reprogramming,cellular metabolism regulation,genetic mutations associated,dysregulation implicated,therapeutic target potential,cell proliferation enhancement
ENSG00000084754,HADHA,mitochondrial enzyme,fatty acid metabolism,metabolic disorder,energy production,lipid biosynthesis,tumor cell growth
ENSG00000138029,HADHB,mitochondrial dysfunction,oxidative stress induction,energy metabolism regulation,cell proliferation enhancement,signaling pathway activation,tumor progression promotion
ENSG00000197265,GTF2E2,dna repair,transcription regulation,chromatin remodeling,cellular proliferation,genome stability,rna polymerase recruitment
ENSG00000153767,GTF2E1,transcription regulation,cellular proliferation,oncogene,cell cycle regulation,genomic instability,therapeutic target
ENSG00000140307,GTF2A2,transcription initiation,rna polymerase recruitment,genomic instability,tumor suppressor function,cell proliferation enhancement,oncogenic potential
ENSG00000165417,GTF2A1,transcriptional regulation,gene expression alteration,oncogenesis through aberrant growth regulation,cellular response manipulation,target for therapeutic intervention,genetic dysregulation affecting transcriptional activity
ENSG00000162738,VANGL2,planar cell polarity,epithelial-to-mesenchymal transition,oncogene activation,tumor progression,signaling pathway regulation,cell migration
ENSG00000274287,SCRIB,loss of function mutations,tumor suppressor activity,cell polarity regulation,wnt signaling pathway modulation,epithelial-to-mesenchymal transition (emt) inhibition,mitotic spindle orientation maintenance
ENSG00000004975,DVL2,wnt pathway activation,akt/mtor signaling interaction,cell proliferation regulation,dishevelled protein function,signaling pathway modulation,tumorigenesis promotion
ENSG00000102981,PARD6A,regulation of cell polarity,mitotic spindle orientation,cytokinesis control,oncogenic potential,wnt signaling pathway,tumor progression
ENSG00000177885,GRB2,oncogenic signaling,cell proliferation,metabolic regulation,protein-protein interactions,signaling pathway activation,tumor progression
ENSG00000109458,GAB1,pi3k/akt pathway,constitutive activation,oncogenesis,cell proliferation,metabolic regulation,signal transduction
ENSG00000146648,EGFR,oncogenic driver,constitutive activation,cell proliferation,signal transduction,epidermal growth factor binding,therapeutic target
ENSG00000138798,EGF,cell proliferation,tumor growth promotion,metastasis facilitation,angiogenesis induction,receptor activation,signaling pathway modulation
ENSG00000121879,PIK3CA,pi3k/akt pathway,oncogene,constitutive activation,gain of function mutations,tumor progression,therapeutic target
ENSG00000145675,PIK3R1,loss of regulatory function,aberrant pi3k activation,akt inhibition,cell growth regulation,signaling pathway modulation,genomic instability
ENSG00000197122,SRC,cellular proliferation,oncogene function,tyrosine kinase activation,signal transduction,integrin signaling,tumor invasion
ENSG00000089159,PXN,cell adhesion disruption,oncogenic progression,pi3k/akt signaling,tumor cell migration,focal adhesion complex,src family kinase activation
ENSG00000137392,CLPS,proteolytic activity,oncogenesis,overexpression,extracellular matrix degradation,tumor invasion,metastasis
ENSG00000175535,PNLIP,lipid metabolism,cell membrane trafficking,tumor growth promotion,apoptosis resistance,prognostic biomarker,genetic regulation
ENSG00000078369,GNB1,g protein activation,heterotrimeric g proteins,cell surface receptor signaling,constitutive activation,metabolic reprogramming,tumor progression
ENSG00000127928,GNGT1,g protein signaling,aberrant activation,loss-of-function mutations,cell proliferation,therapeutic target,genetic alterations
ENSG00000198515,CNGA1,cancer-related signaling pathway modulation,cell proliferation regulation,mutation-driven oncogenesis,apoptosis resistance,genomic instability,sensor protein dysfunction
ENSG00000070729,CNGB1,calcium signaling pathway regulation,transcriptional regulation,epigenetic modification,cellular differentiation modulation,visual transduction dysfunction,chromatin remodeling
ENSG00000257365,FNTB,amplified gene,oncogenic function,fatty acid biosynthesis,cell membrane composition,tumor growth promotion,cancer progression marker
ENSG00000168522,FNTA,long-chain fatty acid biosynthesis,fatty acid elongase activity,cellular metabolism reprogramming,anabolic pathway enhancement,tumor growth promotion,therapeutic resistance association
ENSG00000113522,RAD50,genomic instability,dna repair pathway,homologous recombination,mrn complex component,double-strand break repair,oncogenic mutations
ENSG00000020922,MRE11,genomic instability,apoptosis evasion,dna damage response,tumor suppressor function,nhej pathway,mrn complex
ENSG00000182481,KPNA2,cell proliferation,transcriptional regulation,nuclear transport,oncogenic transformation,chemo-resistance,tumor suppressor inhibition
ENSG00000104320,NBN,genomic instability,mrn complex formation,dna repair mechanisms,tumor susceptibility,homologous recombination,chromosomal segregation
ENSG00000172977,KAT5,genomic instability,histone acetylation,chromatin remodeling,oncogene maintenance,cell cycle progression,dna repair mechanism
ENSG00000149311,ATM,dna damage response,genomic instability,tumor suppressor function,apoptosis regulation,cell cycle checkpoint activation,histone modification
ENSG00000009954,BAZ1B,chromatin remodeling,dna repair mechanism,genomic instability,epigenetic regulation,cell cycle control,transcriptional activation
ENSG00000153147,SMARCA5,chromatin remodeling,oncogenic transcriptional programs,genomic instability,cell growth regulation,transcriptional modulation,chromatin structure alteration
ENSG00000103275,UBE2I,genomic instability,oncogene,cell proliferation,ubiquitination,sumoylation,therapeutic target
ENSG00000116030,SUMO1,genomic instability,aberrant protein modification,cell cycle regulation,tumorigenesis,apoptosis inhibition,protein-protein interaction
ENSG00000169139,UBE2V2,protein degradation,ubiquitination pathway,oncometabolite regulation,tumor suppression,somatic mutations,ancillary ubiquitin ligase
ENSG00000177889,UBE2N,ubiquitin-conjugating enzyme,genetic instability,dna damage response,cell proliferation,protein stability regulation,oncogenic signaling pathways
ENSG00000138376,BARD1,double-strand break repair,genome stability maintenance,tumor suppressor function,brca1 interaction,e3 ubiquitin ligase activity,cell cycle regulation
ENSG00000012048,BRCA1,genomic instability,dna repair deficiency,tumor suppressor function,cell cycle regulation,apoptosis modulation,protein-protein interaction
ENSG00000188612,SUMO2,cellular modification,chromatin regulation,dna repair,apoptosis modulation,cancer driver mutation,tumor suppressor function
ENSG00000225589,MDC1,genomic instability,chromatin remodeling,dna repair,transcriptional regulation,atm kinase activation,cell cycle checkpoint
ENSG00000128731,HERC2,ubiquitin-protein ligase activity,tumor suppressor function,dna damage response regulation,genomic instability prevention,cell cycle regulation modulation,proteasomal degradation pathway regulation
ENSG00000164053,ATRIP,genomic instability,dna damage response,cell cycle checkpoint,homologous recombination repair,atr/atrip complex regulation,oncogenic pathway activation
ENSG00000175054,ATR,dna damage checkpoint,genomic instability,checkpoint activation,replicative stress sensor,therapeutic target,genome integrity maintenance
ENSG00000111602,TIMELESS,cell cycle regulation,chromatin remodeling,dna replication,genomic instability,oncogenesis,proliferation 
ENSG00000075131,TIPIN,genomic instability,cell cycle regulation,oncogenesis,cell proliferation,dna repair pathway,g2/m checkpoint modulation
ENSG00000163605,PPP4R2,histone h2a dephosphorylation,chromatin remodeling,aberrant gene transcription,apoptosis suppression,tumor suppressor function,loss-of-function mutations
ENSG00000149923,PPP4C,pi3k/akt pathway interaction,dephosphorylation regulation,cancer biomarker potential,oncogene role,cell cycle progression regulation,dna repair dysregulation
ENSG00000108384,RAD51C,genomic instability,homologous recombination repair,dna double-strand breaks,cell cycle regulation,apoptosis regulation,tumor suppressor
ENSG00000126215,XRCC3,genomic instability,homologous recombination,dna repair mechanism,mutations leading to tumorigenesis,proliferation and survival pathways,cancer driver gene
ENSG00000197774,EME2,chromatin remodeling,nuclear envelope regulation,transcriptional modulation,oncogenic processes,protein-protein interactions,tumor suppressor pathways
ENSG00000172732,MUS81,genomic instability,dna damage response,chromosomal alteration,telomere maintenance,homologous recombination,structure-selective endonuclease
ENSG00000154920,EME1,genomic instability,dna replication,dna repair mechanism,genome maintenance,tumorigenesis,oncogenic process
ENSG00000139618,BRCA2,genomic instability,tumor suppressor function,loss of function mutations,dna repair pathway activation,chromosomal instability,tumor initiation
ENSG00000051180,RAD51,genomic instability,tumor suppressor function,dna repair mechanism,oncogenesis,prognostic marker,tumor progression
ENSG00000175595,ERCC4,genomic instability,regulation of cell cycle,dna repair pathway,nucleotide excision repair,tumor suppressor function,cell cycle maintenance
ENSG00000012061,ERCC1,genomic instability,dna damage response,impaired repair mechanisms,therapeutic target,biomarker for treatment response,cancer predisposition
ENSG00000073050,XRCC1,dna damage response,genetic instability,oncogenic potential,tumor suppressor function,ber pathway interaction,cell survival enhancement
ENSG00000005156,LIG3,genomic instability,dna repair,tumor suppressor inhibition,apoptosis regulation,cell cycle progression,base excision repair pathway
ENSG00000196419,XRCC6,dna repair,genomic instability,telomere maintenance,cancer driver,apoptosis regulation,dna damage response
ENSG00000079246,XRCC5,genomic instability,dna repair deficiency,tumor suppressor function,nhej pathway dysfunction,cancer susceptibility gene,protein-protein interaction
ENSG00000152422,XRCC4,dna double-strand breaks,genomic instability,ionizing radiation sensitivity,malignant transformation,tumorigenesis promoter,dna repair pathway interaction
ENSG00000174405,LIG4,genomic instability,dna repair pathway,tumor suppressor activity,nhej-mediated dna repair,double-strand break repair,cancer predisposition
ENSG00000049860,HEXB,lipid degradation,cellular membrane integrity,glycosphingolipid metabolism,metabolic regulation,genetic deficiency disorder,rare genetic disorder
ENSG00000213614,HEXA,lysosomal function,gm2 ganglioside accumulation,neurodegeneration,lysosomal storage disorder,lysosomal enzyme deficiency,cellular toxicity
ENSG00000151348,EXT2,heparan sulfate modification,tumor microenvironment modulation,angiogenesis promotion,metastasis facilitation,glycosyltransferase complex component,cell-cell adhesion regulation
ENSG00000182197,EXT1,tumor suppressor,genome instability,cell adhesion disruption,dna damage response,proliferation regulation,glycosylation pathway alteration
ENSG00000115904,SOS1,ras activation,constitutive signaling,gain of function mutations,tumor progression,immune evasion,signaling cascade
ENSG00000170312,CDK1,mitotic kinase,cell cycle regulation,apoptosis suppression,genomic instability,oncogenic driver,therapeutic target
ENSG00000134057,CCNB1,cell cycle regulation,aneuploidy induction,oncogene overexpression,cyclin b1 protein accumulation,genomic instability,protein interaction networks
ENSG00000165494,PCF11,genomic instability,tumor suppressor function,transcriptional regulation,chromatin remodeling,oncogenic interaction,dna repair process
ENSG00000172409,CLP1,clp1 mrna binding,cellular transcription regulation,tumor-suppressive functions,translational control,oncogenic processes,genomic instability
ENSG00000187079,TEAD1,tea domain transcription factor,transcriptional regulation,cell proliferation,oncogenic processes,epithelial-to-mesenchymal transition,tumor progression
ENSG00000137693,YAP1,tead interaction,transcriptional coactivator,hippo signaling pathway,constitutive activation,tumor progression,oncogenic driver
ENSG00000074219,TEAD2,tea/atts family transcription factor,tumor suppressor activity loss,oncogenic transformation driver,cell growth regulation dysregulation,hippo-yap pathway interaction,transcriptional activator/repressor function
ENSG00000007866,TEAD3,hippo signaling pathway,transcriptional regulation,cellular proliferation,tumorigenesis promotion,overexpression in tumors,chromatin remodeling
ENSG00000197905,TEAD4,epithelial-to-mesenchymal transition (emt),oncogene,transcription factor,cell proliferation,hippo pathway interaction,tumor progression
ENSG00000132964,CDK8,mediator complex regulation,e3 ubiquitin ligase activity,transcriptional modulation,oncogenic transformation,therapeutic target,genetic signature
ENSG00000112237,CCNC,cak complex,constitutive activation,cell cycle regulation,tumor suppressor dysfunction,cyclin-dependent kinase phosphorylation,g1/s transition
ENSG00000101665,SMAD7,tumor suppressor function,constitutive tgf-β activation,cellular growth inhibition,oncogenic pathway regulation,protein-protein interaction,genomic loss or downregulation
ENSG00000157450,RNF111,protein degradation,tumor suppressor regulation,oncogenic pathway interaction,cell cycle progression,apoptosis regulation,genomic instability
ENSG00000284792,PTEN,pi3k/akt signaling pathway regulation,tumor suppressor function,loss-of-function mutations,cell cycle regulation,apoptosis induction,dna repair interaction
ENSG00000141510,TP53,tumor suppressor function,genomic instability,loss of function mutation,cell cycle arrest,apoptosis induction,dna repair regulation
ENSG00000165699,TSC1,mtor pathway regulation,tumor suppressor function,loss of function mutations,cell growth promotion,autophagy inhibition,genomic instability
ENSG00000103197,TSC2,tumor suppressor function,mtor pathway regulation,oncogenesis,cell proliferation inhibition,gain of function mutations,therapeutic target
ENSG00000284194,SCO2,mitochondrial dysfunction,energy metabolism reprogramming,cell growth promotion,dna damage induction,oncogenic pathway activation,electron transport chain disruption
ENSG00000048392,RRM2B,dna replication,cell proliferation,potentiation of ribonucleotide reductase activity,oncogene function,increased genomic instability,therapeutic target
ENSG00000135423,GLS2,glutaminase activity,metabolic reprogramming,warburg effect,dna damage repair,cell proliferation enhancement,cancer prognosis indicator
ENSG00000146674,IGFBP3,igf regulation,tumor suppression,angiogenesis inhibition,cell proliferation inhibition,gene expression regulation,blood vessel formation
ENSG00000141682,PMAIP1,pro-apoptotic function,cellular stress response,mitochondrial regulation,apoptosis modulation,tumorigenesis association,stress pathway interaction
ENSG00000015475,BID,apoptosis regulation,pro-apoptotic function,extrinsic pathway involvement,mitochondrial outer membrane permeabilization,tumor growth promotion,cancer cell survival enhancement
ENSG00000120471,TP53AIP1,regulation of p53 pathway,loss of tumor suppressor function,impaired apoptosis,cell cycle dysregulation,genomic instability,therapeutic target
ENSG00000197050,ZNF420,zinc finger transcription factor,regulation of cell proliferation,dna sequence binding,cell survival modulation,oncogenesis involvement,genomic regulation
ENSG00000115107,STEAP3,proton-atpase activation,tumor progression,cell migration and invasion,oncogene potential,therapeutic target,ph regulation
ENSG00000104765,BNIP3L,apoptosis regulation,mitochondrial dynamics,tumor suppression,cell growth inhibition,metabolic regulation,hypoxia response
ENSG00000170855,TRIAP1,genomic stability maintenance,tumor suppressor function,dna replication regulation,chromosomal instability,oncogenic driver mutation,genome integrity maintenance
ENSG00000042286,AIFM2,genomic instability,apoptosis regulation,autophagy modulation,mitochondrial dysfunction,oncogene function,tumor progression driver
ENSG00000164938,TP53INP1,tumor suppressor,dna damage response,cell cycle regulation,genomic stability,apoptosis induction,cancer predisposition
ENSG00000120868,APAF1,apoptosis induction,mitochondrial regulation,programmed cell death pathway,tumor growth promotion,therapeutic target potential,caspase activation
ENSG00000177595,PIDD1,apoptosis induction,tumor suppression,dna damage response,cell cycle regulation,genomic stability maintenance,pro-apoptotic function
ENSG00000169372,CRADD,apoptosis regulation,dna damage response,caspase activation,cell death signaling,tumor suppression,genetic instability
ENSG00000091106,NLRC4,immune recognition,cytokine regulation,tumor immunity,inflammasome activation,anti-tumor response,pro-inflammatory signaling
ENSG00000138794,CASP6,apoptosis regulation,tumor suppressor function,cancer mutations,cell death dysregulation,protease activity,programmed cell death
ENSG00000003400,CASP10,apoptosis regulator,cell death induction,extrinsic pathway activation,cancer association,therapeutic target,protein-protein interactions
ENSG00000104419,NDRG1,tumor suppressor function,dna binding and phosphatase activity,pi3k/akt pathway inhibition,cancer development suppression,transcriptional regulation by p53/e2f-1,dysregulated expression in cancer
ENSG00000281449,BCL2L14,apoptosis inhibition,anti-apoptotic function,cell cycle regulation,tumorigenesis,therapeutic target,cellular interaction
ENSG00000089685,BIRC5,apoptosis inhibition,cell proliferation promotion,mitotic progression regulation,chemotherapy resistance,tumor suppressor interaction,microtubule stabilization
ENSG00000113916,BCL6,oncogenic transformation,transcriptional repression,cell growth regulation,chromatin modification,germinal center formation,apoptosis inhibition
ENSG00000161642,ZNF385A,tumor suppressor function,transcriptional regulation,cell growth regulation,apoptosis induction,genomic stability maintenance,epigenetic regulation
ENSG00000116017,ARID3A,chromatin remodeling,transcriptional regulation,oncogenic mutations,cell cycle progression,apoptosis suppression,genomic instability
ENSG00000165891,E2F7,tumor suppressor function,cell cycle regulation,gene repression,chromatin modification,histone methylation,cancer development
ENSG00000129173,E2F8,tumor suppressor,genomic stability,cell cycle regulation,apoptosis promotion,oncogene repression,cellular quiescence
ENSG00000116717,GADD45A,dna damage response,cellular stress,cell cycle regulation,p53 pathway interaction,tumor suppressor function,apoptosis induction
ENSG00000087586,AURKA,cell cycle progression,gene amplification,kinase activation,mitotic checkpoint,oncogene overexpression,tumor suppressor inactivation
ENSG00000132646,PCNA,cell cycle regulation,genomic integrity maintenance,tumor growth promotion,genomic instability driver,cell proliferation enhancement,prognostic marker
ENSG00000087088,BAX,apoptosis regulation,mitochondrial outer membrane permeabilization,pro-apoptotic function,tumor suppressor activity,cancer association,cell death promotion
ENSG00000175793,SFN,apoptosis regulation,cell cycle progression,oncogenic pathway inhibition,tumor suppression,protein-protein interaction,dna damage response
ENSG00000145632,PLK2,cell proliferation,mitotic entry,centrosome maturation,apoptosis resistance,oncogenic transformation,cancer prognosis
ENSG00000173846,PLK3,cell cycle regulation,mitosis initiation,apoptosis resistance,overexpression associations,tumor progression,therapeutic target
ENSG00000102760,RGCC,ribosome biogenesis,regulator complex component,cellular growth regulation,cancer driver mutation,proliferation promotion,survival pathway enhancement
ENSG00000118495,PLAGL1,cell cycle regulation,apoptosis induction,dna repair,tumor suppression,cancer cell proliferation inhibition,zinc finger domain interaction
ENSG00000115966,ATF2,apoptosis regulation,chromatin remodeling,dna damage response,oncogene activation,transcriptional regulation,tumor progression
ENSG00000177606,JUN,ap-1 complex activation,constitutive activation,cell proliferation enhancement,transcriptional regulation,cell survival promotion,oncogenic transformation
ENSG00000170345,FOS,cellular proliferation,transcriptional regulation,oncogenic transformation,cell cycle progression,apoptosis inhibition,tumor initiation
ENSG00000122512,PMS2,genetic instability,dna mismatch repair,oncosuppressor function,cancer predisposition,tumor suppressor pathway,mutational hotspot
ENSG00000076242,MLH1,dna damage response,tumor suppressor,microsatellite instability,genomic stability maintenance,dna mismatch repair,loss-of-function mutations
ENSG00000158169,FANCC,genomic instability,dna repair mechanism,interstrand crosslink repair,oncogene regulation,tumor suppressor function,cancer predisposition
ENSG00000134574,DDB2,nucleotide excision repair pathway,genomic instability,dna damage response,mutations in cancer,tumor suppressor function,impaired dna repair
ENSG00000057657,PRDM1,immune evasion,tumor suppressor function,epigenetic regulation,e3 ubiquitin ligase activity,cellular differentiation,protein degradation
ENSG00000135679,MDM2,oncoprotein activity,p53 degradation,tumor suppressor inhibition,cell cycle regulation disruption,metastasis promotion,therapeutic resistance
ENSG00000198625,MDM4,p53 inhibition,cell cycle regulation,tumor suppressor evasion,dna damage response modulation,protein degradation regulation,anti-apoptotic function
ENSG00000113328,CCNG1,pp2a inhibition,oncogenic signaling,cell proliferation,apoptosis suppression,tumor resistance,genomic instability
ENSG00000064393,HIPK2,cell cycle regulation,apoptosis induction,tumor suppressor function,p53 interaction,dna repair modulation,genomic instability prevention
ENSG00000127445,PIN1,protein isomerization,oncogenesis,tumor growth,cell cycle regulation,protein kinase activation,phosphorylation-dependent recognition
ENSG00000163349,HIPK1,tumor suppressor,dna damage response,apoptosis induction,cell cycle regulation,protein-protein interaction,post-translational modification
ENSG00000149136,SSRP1,chromatin remodeling,histone acetylation inhibition,gene regulation at transcriptional level,transcriptional control complex,rna polymerase ii regulation,cellular regulatory mechanism
ENSG00000092201,SUPT16H,chromatin remodeling,genomic instability,tumor suppression,cell cycle progression,dna repair mechanisms,transcriptional regulation
ENSG00000101266,CSNK2A1,oncogenic signaling pathway,microrna regulation,cell cycle regulation,protein kinase activation,tumor progression,pan-cancer target
ENSG00000070770,CSNK2A2,cellular regulation,phosphorylation events,transcriptional modulation,cancer development,cell proliferation,survival pathway
ENSG00000088325,TPX2,cell cycle regulation,genomic instability,microtubule polymerization,mitotic progression,oncogenic protein,spindle formation
ENSG00000188976,NOC2L,wnt/pcp pathway regulation,golgi apparatus localization,metastasis promotion,oncogenic mutations,tumor progression,cell adhesion modulation
ENSG00000176749,CDK5R1,cell proliferation,oncogene activation,regulatory subunit,tumor metastasis,cell survival,apoptosis inhibition
ENSG00000164885,CDK5,neuronal development,constitutive activation,oncogenic processes,cell proliferation,therapeutic target,apoptosis regulation
ENSG00000152192,POU4F1,chromatin remodeling,cell proliferation regulation,transcription factor function,pou domain binding,neuronal cell differentiation,genetic instability
ENSG00000151615,POU4F2,loss-of-function mutations,cell cycle regulation,transcription factor function,neural development,tumor suppressor potential,genomic instability
ENSG00000172530,BANP,tumor suppressor function,genomic stability maintenance,apoptosis induction,cell cycle regulation,dna damage response,chromosomal instability prevention
ENSG00000025293,PHF20,histone modification regulation,chromatin remodeling,genomic instability,oncogenic potential,protein-protein interactions,dna damage response
ENSG00000185513,L3MBTL1,histone regulation,genome stability maintenance,tumor suppressor function,chromatin modification defects,cell cycle progression deregulation,epigenetic silencing prevention
ENSG00000238134,EHMT2,lysine-specific methylation,chromatin remodeling,genome stability regulation,cellular differentiation suppression,histone modification enzyme activity,epigenetic regulator function
ENSG00000181090,EHMT1,histone methylation,epigenetic regulation,tumor progression,cancer stem cell maintenance,genome stability maintenance,therapeutic target
ENSG00000137203,TFAP2A,tfap2a-mediated gene expression regulation,cell cycle progression,tumor-promoting activity,pioneer factor function,transcriptional dysregulation,genomic instability
ENSG00000124795,DEK,genomic instability,transcriptional regulation,cell proliferation enhancement,tumor promotion,apoptosis resistance,poor prognosis
ENSG00000087510,TFAP2C,cellular differentiation,transcriptional regulation,epithelial-to-mesenchymal transition,oncogene regulation,tumor progression,chromatin remodeling
ENSG00000186153,WWOX,tumor suppressor,cell growth regulation,apoptosis induction,p53 pathway interaction,nf-κb pathway regulation,metabolic regulation
ENSG00000008196,TFAP2B,dna binding,oncogenic properties,transcriptional regulation,cell growth,interaction with co-factors,cellular processes modulation
ENSG00000127337,YEATS4,epigenetic regulation,chromatin remodeling,transcriptional modulation,oncogenic potential,histone mark recognition,gene expression regulation
ENSG00000091831,ESR1,estrogen signaling pathway,constitutive activation,oncogenesis,cell proliferation,tumor progression,therapeutic target
ENSG00000156802,ATAD2,chromatin remodeling,autophagy regulation,apoptosis suppression,cell proliferation,transcriptional activation,histone modification
ENSG00000112715,VEGFA,angiogenic factor,constitutive activation,gain of function mutations,tumor progression,therapeutic target,angiogenesis regulation
ENSG00000163235,TGFA,cell proliferation,angiogenesis promotion,metastasis facilitation,tumor progression,signaling pathway modulation,oncogenic protein interaction
ENSG00000124762,CDKN1A,cell cycle regulation,tumor suppressor function,dna damage response,cell proliferation inhibition,senescence induction,apoptosis promotion
ENSG00000159216,RUNX1,hematopoiesis regulation,tumor suppressor function,loss-of-function mutation,apoptosis regulation,dna binding activity,transcriptional modulation
ENSG00000078900,TP73,apoptosis regulation,gene regulation,tumor suppressor function,cell cycle progression,cancer predisposition,dna damage response
ENSG00000179588,ZFPM1,cell growth regulation,transcriptional regulation,dm domain family,cell proliferation,apoptosis evasion,oncogenesis
ENSG00000102145,GATA1,leukemogenesis,tumor suppressor function,transcriptional regulation,cell cycle progression,apoptosis modulation,gene expression control
ENSG00000143387,CTSK,lysosomal degradation,oncogenic signaling,epithelial-to-mesenchymal transition,tumor aggressiveness,cell invasion,metastatic progression
ENSG00000197641,SERPINB13,protease regulation,tumor suppression,gene expression modulation,prognostic marker,cell invasion inhibition,metastasis modulation
ENSG00000110092,CCND1,cell cycle regulation,oncogenic transformation,tumor progression,cancer therapy target,genomic amplification,protein-protein interactions
ENSG00000135446,CDK4,cell cycle progression,oncogene activation,phosphorylation regulation,tumor suppressor evasion,cyclin binding protein,apoptosis suppression
ENSG00000173153,ESRRA,overexpression,constitutive activation,therapeutic target,transcriptional regulation,oncogenesis,cell proliferation
ENSG00000109819,PPARGC1A,cellular metabolism,tumor progression,hypoxia response,transcriptional regulation,mitochondrial biogenesis,therapeutic target
ENSG00000122691,TWIST1,oncogenic driver,tumor suppressor inhibition,epithelial-to-mesenchymal transition,cell proliferation regulation,transcription factor activation,metastasis promotion
ENSG00000124813,RUNX2,transcription factor regulation,constitutive activation,gain of function mutations,cell cycle modulation,tumor progression,epithelial-to-mesenchymal transition
ENSG00000109705,NKX3-2,transcription factor,tumor suppressor,cell growth inhibition,downstream target regulation,epigenetic silencing,loss-of-function mutation
ENSG00000120149,MSX2,transcriptional regulation,tumor suppressor suppression,cell proliferation promotion,oncogenic pathway activation,cell growth enhancement,apoptosis inhibition
ENSG00000141646,SMAD4,tumor suppressor function,loss-of-function mutations,tgf-β signaling pathway,regulation of cell growth,apoptosis regulation,cell differentiation regulation
ENSG00000170365,SMAD1,tgf-β/bmp signaling,epithelial-to-mesenchymal transition (emt),aberrant gene expression,cell migration and invasion,cancer stem cell maintenance,wnt/β-catenin pathway modulation
ENSG00000020633,RUNX3,tumor suppressor function,gene expression regulation,cell cycle control,loss-of-function mutations,transcriptional repression,apoptosis modulation
ENSG00000166949,SMAD3,transcriptional regulation,constitutive activation,tumor progression,oncogenic processes,cell proliferation,signaling pathway
ENSG00000198176,TFDP1,cell cycle regulation,dysregulated transcription factors,oncogenic potential,e2f interactions,tumor suppressor function loss,gene expression modulation
ENSG00000169016,E2F6,tumor suppression,g1/s phase transition regulation,cell cycle control,apoptosis promotion,transcriptional regulation,dna repair inhibition
ENSG00000114126,TFDP2,cell cycle regulation,genomic instability,oncogenesis,protein-protein interactions,transcriptional regulation,tumor suppressor dysfunction
ENSG00000174197,MGA,transcriptional regulation,cell growth regulation,tumor progression,oncogenic potential,genomic amplification,apoptosis inhibition
ENSG00000125952,MAX,transcription factor regulation,cell cycle progression,apoptosis modulation,oncogene or tumor suppressor,tumorigenesis association,cellular proliferation
ENSG00000213246,SUPT4H1,chromatin remodeling,constitutive activation,gain of function mutations,oncogene amplification,transcriptional regulation,therapeutic target
ENSG00000196235,SUPT5H,oncogene,increased cell proliferation,rna metabolism regulation,alternative splicing regulation,cancer biomarker,prognostic indicator
ENSG00000103363,ELOB,apoptosis regulation,tnf receptor interaction,nf-κb activation,cell cycle progression,inflammatory response modulation,signaling pathway dysregulation
ENSG00000154582,ELOC,protein degradation,cell cycle regulation,apoptosis modulation,tumor suppressor function,oncogenic process promotion,cellular quality control
ENSG00000125651,GTF2F1,transcriptional regulation,oncogenic function,cell proliferation,gene expression enhancement,stress response adaptation,prognostic marker
ENSG00000188342,GTF2F2,transcriptional regulation,oncogenic process,cancer initiation,tumor cell proliferation,dna methylation,histone acetylation
ENSG00000114503,NCBP2,mrna export,oncogene expression,cell proliferation,apoptosis regulation,nuclear-cytoplasmic transport,protein-protein interactions
ENSG00000136937,NCBP1,nuclear cap-binding complex regulation,mrna export enhancement,oncogenic signaling,cancer driver gene,epithelial-to-mesenchymal transition facilitation,cell cycle progression promotion
ENSG00000224748,TAP1,tumor antigen presentation,immune evasion,antigen processing,cell surface protein expression,mhc class i downregulation,tumor progression
ENSG00000223481,TAP2,impaired antigen presentation,immune evasion mechanisms,antigen processing pathways,tumor progression factors,peptide transport functions,protein-protein interactions
ENSG00000166126,AMN,tumor progression,oncogene potential,cell proliferation,angiogenesis and metastasis,pro-tumorigenic microenvironment,wnt/β-catenin signaling pathway interaction
ENSG00000107611,CUBN,vitamin b12 metabolism,renal reabsorption,tumor progression,cellular interaction,protein expression regulation,genetic disorder association
ENSG00000146085,MMUT,genomic instability,cell cycle regulation,apoptosis modulation,chromatin remodeling,transcriptional regulation,tumor suppressor function
ENSG00000151611,MMAA,cell proliferation regulation,cancer progression marker,neurotransmitter metabolism,prognostic value,angiogenic signaling modulation,tumor cell invasion
ENSG00000117560,FASLG,faslg-fas interaction,apoptosis regulation,t-cell activation,immune homeostasis modulation,autimmune disease association,chromosomal localization
ENSG00000026103,FAS,apoptosis regulation,tumor progression modulation,immune response modulation,tumor suppressor function,cancer immunotherapy target,cell death pathway dysregulation
ENSG00000156735,BAG4,cellular survival,apoptosis regulation,protein-protein interaction,tumor progression,therapeutic target,genomic overexpression
ENSG00000067182,TNFRSF1A,tumor growth modulation,aberrant nf-κb activation,immune regulation disruption,apoptosis inhibition,cell migration enhancement,therapeutic target candidate
ENSG00000230108,TNF,tumor necrosis factor,pro-inflammatory cytokine,cytotoxic effects,cell death regulation,oncogenic processes,inflammation promoter
ENSG00000106052,TAX1BP1,cellular regulation,tumor suppressor function,loss-of-function mutations,dna damage response,cancer cell resistance,therapeutic target
ENSG00000118503,TNFAIP3,nf-kappa b signaling inhibition,tumor suppressor function,immune checkpoint regulation,inflammation modulation,cell proliferation enhancement,proteasome regulation
ENSG00000104689,TNFRSF10A,apoptosis regulation,tumor suppressor function,trail receptor activation,cancer cell death,genetic deletion/mutation,cell survival impairment
ENSG00000173530,TNFRSF10D,apoptosis regulation,cell death pathway,oncogenic potential,tumor modulation,lymphocyte development,signal transduction
ENSG00000120889,TNFRSF10B,apoptosis regulation,tumor resistance,immune modulation,death domain function,tumor suppressor potential,cancer association
ENSG00000134259,NGF,angiogenesis promotion,tumor growth facilitation,immune modulation,cell migration stimulation,proteolytic enzyme activation,therapeutic target
ENSG00000064300,NGFR,neurotrophin signaling pathway,cell surface receptor activation,overexpression in cancers,tumor growth enhancement,metastatic potential increase,prognostic indicator reduction
ENSG00000184216,IRAK1,inflammation,immune suppression,gain of function mutations,tumor growth,metastasis,therapeutic target
ENSG00000172936,MYD88,aberrant signaling,tumor progression,cell survival,proliferation,nf-kb activation,immune evasion
ENSG00000109320,NFKB1,nf-kappa b activation,tumor progression,oncogene regulation,genomic instability,immune evasion,apoptosis resistance
ENSG00000173039,RELA,nf-κb transcription factor,transcriptional regulation,cell proliferation,survival signaling,inflammation pathway,immune evasion
ENSG00000119048,UBE2B,ubiquitination pathway,oncogenic pathways,protein degradation regulation,cell cycle progression,nf-κb signaling cascade,aberrant protein function
ENSG00000070950,RAD18,dna repair,genetic instability,tumor suppressor,fanconi anemia/breast cancer c pathway,translesion synthesis,dna damage response
ENSG00000114742,WDR48,tumor suppression,protein degradation regulation,genome stability maintenance,cancer driver gene candidate,therapeutic target potential,cell cycle regulation interaction
ENSG00000162607,USP1,genomic instability,dna repair regulation,cell cycle dysregulation,therapeutic resistance,apoptosis evasion,tumor progression
ENSG00000009413,REV3L,genomic instability,mutagenesis,dna damage repair,tumor progression,therapeutic target,cancer genomic profiling
ENSG00000116670,MAD2L2,cell cycle regulation,mitosis progression,oncogene function,chromosomal instability,genomic mutation accumulation,therapeutic target identification
ENSG00000163743,RCHY1,chromo barrel domain,histone recognition,epigenetic regulation,cell cycle progression,oncogenic properties,protein-protein interactions
ENSG00000170734,POLH,translesion synthesis,genomic instability,interstrand crosslink repair,oncogenesis,genome stability,dna replication
ENSG00000121060,TRIM25,cell cycle regulation,oncoprotein degradation,tumor suppression,protein modification,cell signaling modulation,therapeutic target
ENSG00000156587,UBE2L6,ubiquitin-conjugating enzyme activity,tumor suppressor degradation,pi3k/akt signaling activation,cell cycle regulation,protein stability modulation,oncogenic pathway activation
ENSG00000182179,UBA7,ubiquitin-activating enzyme,proteasome activation,cell cycle regulation,apoptosis suppression,genomic instability,oncogene maintenance
ENSG00000187608,ISG15,protein degradation regulation,tumor microenvironment modulation,antitumor therapy target,biomarker potential,clinical outcome correlation,ubiquitin-proteasome pathway component
ENSG00000184900,SUMO3,sumoylation regulation,tumor progression,protein interaction modulation,cellular pathway modulation,post-translational modification,apoptosis regulation
ENSG00000131944,FAAP24,dna repair mechanism,genomic instability,tumor development,cancer progression,nuclear protein function,fanconi anemia pathway
ENSG00000187790,FANCM,genomic instability,dna repair defect,chromosomal instability,tumor progression,therapeutic resistance,epigenetic alteration
ENSG00000169689,CENPX,microtubule dynamics,chromosomal instability,aneuploidy,cell division regulation,genome integrity maintenance,mitotic spindle assembly
ENSG00000175279,CENPS,genomic instability,aneuploidy,chromosomal segregation,cell cycle disruption,tumor progression,kinetochore regulation
ENSG00000140525,FANCI,genomic instability,dna repair pathway,homologous recombination,replication fork stability,atm/atr interaction,brca1/2 interaction
ENSG00000144554,FANCD2,interstrand dna crosslink repair,genomic instability,dna damage response,homologous recombination repair,tumor suppression,genome stability
ENSG00000175198,PCCA,protein degradation regulation,gene amplification,tumor progression,metabolic reprogramming,oncogenic potential,aberrant protein accumulation
ENSG00000114054,PCCB,tumor progression,constitutive activation,pro-oncogenic protein processing,cell signaling dysregulation,metalloprotease activity,therapeutic target
ENSG00000275300,MCCC2,metabolic regulation,cellular proliferation,tumor suppression,oxidative stress regulation,metabolic homeostasis disruption,biomarker potential
ENSG00000078070,MCCC1,mitochondrial function,altered metabolic flux,gene expression regulation,oxidative stress induction,cell cycle dysregulation,apoptosis inhibition
ENSG00000175505,CLCF1,cell proliferation,immune evasion,tumor metastasis,stat3 pathway activation,growth factor regulation,cell survival promotion
ENSG00000006016,CRLF1,oncogene activation,jak/stat pathway activation,tumor microenvironment modulation,inflammation regulation,angiogenesis promotion,genetic co-occurrence mutations
ENSG00000130175,PRKCSH,cellular signaling regulation,regulatory subunit interaction,tumor growth promotion,dna repair modulation,apoptosis inhibition,protein kinase activation
ENSG00000089597,GANAB,protein glycosylation regulation,cell surface modification,tumor aggressiveness driver,oncogenic signaling pathways activation,cell adhesion and migration modulation,therapeutic target for pan-cancer treatment
ENSG00000179218,CALR,jak-stat pathway activation,calreticulin overexpression,cell proliferation enhancement,signal transduction modulation,protein folding regulation,er stress response
ENSG00000283777,CANX,cellular trafficking,misfolded protein accumulation,oncogenesis,protein folding regulation,cell cycle modulation,therapeutic target
ENSG00000182185,RAD51B,genomic instability,homologous recombination,oncogenic mutations,cell cycle regulation,dna repair,tumorigenesis
ENSG00000243678,NME2,metastasis promotion,tumor resistance,cell migration regulation,cell proliferation modulation,dna repair interaction,therapeutic target
ENSG00000239672,NME1,pi3k/akt signaling pathway activation,tumor growth promotion,dna repair regulation,cell proliferation enhancement,oncogenic mutation association,therapeutic target potential
ENSG00000157500,APPL1,oncogene,cell survival pathway,apoptosis modulation,autophagy regulation,transcription factor interaction,signal transduction
ENSG00000187323,DCC,tumor suppressor,cell migration regulation,axon guidance,neural development regulation,genetic instability response,prognostic marker
ENSG00000179222,MAGED1,oncogene activity,cell migration and invasion,tumor progression,promoter of apoptosis,diagnostic marker potential,molecular interaction partner
ENSG00000113763,UNC5A,cell migration regulation,metastasis promotion,tumor progression,cell adhesion modulation,signaling pathway interaction,glycosphingolipid binding
ENSG00000221823,PPP3R1,protein phosphatase regulation,calcium-dependent signaling,tumor progression,apoptosis inhibition,cancer pathogenesis,cell cycle regulation
ENSG00000120910,PPP3CC,calcium-dependent signaling,cancer-related processes,cell cycle progression,catalytic activity,cell proliferation,drug resistance
ENSG00000171791,BCL2,apoptosis suppression,autophagy regulation,cell survival enhancement,mitochondrial interaction,oncogenic process promotion,therapeutic target
ENSG00000002330,BAD,apoptosis regulation,tumor suppressor,pro-apoptotic protein activation,cell survival modulation,mitochondrial outer membrane permeabilization,genomic instability
ENSG00000030110,BAK1,apoptosis regulation,pro-apoptotic protein,cell survival evasion,mitochondrial outer membrane permeabilization,tumor suppressor function,dysregulation in cancer
ENSG00000172115,CYCS,mitochondrial dysfunction,metabolic reprogramming,oncogenic processes,apoptosis resistance,cytochrome c release,energy metabolism
ENSG00000101966,XIAP,inhibitor of apoptosis,oncogene activation,tumor growth promotion,apoptosis resistance,cancer cell survival,cellular proliferation
ENSG00000164305,CASP3,caspase activation,apoptosis regulation,cell death evasion,promoter hypermethylation,proteolytic processing,tumor suppressor dysfunction
ENSG00000165806,CASP7,apoptotic execution,cysteine-aspartic acid protease activity,caspase activation cascade,pro-apoptotic signaling,tumor progression driver,genetic instability
ENSG00000132906,CASP9,apoptosis regulation,altered protein activity,dysregulation of caspase-3,oncogenic outcomes,cell survival pathway,tumor development
ENSG00000184047,DIABLO,apoptosis regulation,inhibitor of apoptosis proteins (iaps) inhibition,caspase activation promotion,cell survival enhancement,tumorigenesis promotion,therapeutic target identification
ENSG00000169598,DFFB,apoptosis regulation,dna fragmentation,nuclear endonuclease activity,cell death modulation,tumor suppressor interaction,genomic stability maintenance
ENSG00000160049,DFFA,apoptosis resistance,tumor development,transcriptional regulation,dna fragmentation,cell cycle progression,programmed cell death
ENSG00000114030,KPNA1,nuclear localization signals (nls),constitutive activation,gain-of-function mutations,cell cycle progression,tumor growth,protein transport
ENSG00000108424,KPNB1,nuclear transport regulation,p53 transcriptional regulation,cancer cell proliferation,transcription factor import,cell cycle progression modulation,genome stability maintenance
ENSG00000180370,PAK2,cellular migration,phosphorylation activity,signaling pathway activation,oncogenic function,therapeutic target,genomic amplification
ENSG00000071205,ARHGAP10,cellular regulation,tumor suppressor function,cytoskeleton dynamics,epithelial-to-mesenchymal transition (emt),cell migration and invasion,biomarker potential
ENSG00000137275,RIPK1,nf-κb activation,cellular stress response,necroptosis regulation,tumor promotion,inflammation regulation,apoptosis modulation
ENSG00000129465,RIPK3,necroptotic pathway,necroptosis regulation,gain of function mutations,cancer immunosurveillance,tumor progression,programmed cell death
ENSG00000131979,GCH1,bh4 biosynthesis,cancer progression,cell proliferation,metabolic reprogramming,neurotransmitter synthesis,protein kinase regulation
ENSG00000137880,GCHFR,cellular redox balance,glutathione metabolism,dysregulation in cancer,cancer biomarker,altered metabolic profiles,rapid cell growth
ENSG00000244687,UBE2V1,protein regulation,ubiquitin-conjugating enzyme activity,genomic stability maintenance,tumor progression facilitation,cell survival promotion,regulatory mechanism modulation
ENSG00000175104,TRAF6,nf-κb pathway,constitutive activation,gain of function mutations,tumor growth,therapeutic target,immune evasion
ENSG00000134070,IRAK2,pro-inflammatory cytokine production,constitutive activation,gain of function mutations,oncogenic protein interaction,cell proliferation and survival,immune response modulation
ENSG00000113070,HBEGF,protein overexpression,tumor growth promotion,angiogenesis regulation,cell migration facilitation,pi3k/akt pathway involvement,oncogenic signaling
ENSG00000198898,CAPZA2,metastasis,cell migration,actin cytoskeleton regulation,cancer cell invasion,signaling pathway interaction,rho-associated kinase pathway
ENSG00000077549,CAPZB,cytoplasmic protein,actin filament dynamics,cytoskeletal regulation,motility and invasion,protein-protein interactions,oncogene
ENSG00000177938,CAPZA3,cytoskeleton regulation,cell migration,constitutive activation,tumor progression,therapeutic target,protein-protein interactions
ENSG00000116489,CAPZA1,actin filament regulation,dysregulated expression,tumor suppression,tissue motility regulation,cell growth modulation,protein-protein interaction
ENSG00000114745,GORASP1,golgi apparatus,cell membrane trafficking,overexpression in cancers,promotes cell proliferation,interaction with pi3k/akt pathway,epithelial-to-mesenchymal transition
ENSG00000167110,GOLGA2,nuclear transport regulation,cell cycle regulation,oncogenic transformation,apoptosis evasion,genomic instability induction,transcriptional control modification
ENSG00000106799,TGFBR1,oncogene,tumor progression,aberrant signaling,cell cycle regulation,apoptosis suppression,metastasis promotion
ENSG00000088832,FKBP1A,oncogene potential,cyclin-dependent kinase inhibition,signaling pathway regulation,steroid hormone receptor interaction,cell cycle progression modulation,protein-protein interaction mediator
ENSG00000113319,RASGRF2,ras activation,gene amplification,tumor progression,oncogenic driver,mitogen-activated protein kinase pathway,cancer prognosis
ENSG00000058335,RASGRF1,ras activation,oncogenic signaling,gain of function mutations,cell proliferation,mapk/erk pathway,pi3k/akt pathway
ENSG00000120251,GRIA2,altered cellular signaling,cancer cell proliferation,cell migration and invasion,glutamate receptor function,mapk/erk pathway interaction,pi3k/akt pathway regulation
ENSG00000155511,GRIA1,ampa-type glutamate receptor,ionotropic receptor activation,cell proliferation enhancement,synaptic plasticity modulation,cancer progression contribution,biomarker potential
ENSG00000105397,TYK2,cytokine signaling pathway,oncogenic potential,tumor immune evasion,non-receptor tyrosine kinase activity,jak/stat signaling activation,immune regulation
ENSG00000142166,IFNAR1,immune evasion,antitumor response,tumorigenesis,cell survival,inflammation regulation,gene expression regulation
ENSG00000162851,TFB2M,chromatin remodeling,oncogenic pathway promotion,genomic instability,transcriptional regulation,cell cycle regulation,multifaceted function
ENSG00000099821,POLRMT,mitochondrial gene expression,regulation of cell growth,cellular metabolism,oncogenesis,pi3k/akt pathway interaction,therapeutic target
ENSG00000128191,DGCR8,microrna biogenesis,constitutive activation,oncogenic transformation,tumor suppressor suppression,genetic/epigenetic modifications,cellular proliferation
ENSG00000113360,DROSHA,microrna processing,oncogenic mirnas,overexpression,tumor progression,genomic instability,cell proliferation
ENSG00000116918,TSNAX,chromatin remodeling,cell cycle regulation,tumor suppressor,protein-protein interactions,cytoskeletal dynamics,mitotic checkpoint
ENSG00000211460,TSN,constitutive activation,tumor progression,therapeutic target,genomic profiling,akt pathway activation,cellular contraction regulation
ENSG00000076108,BAZ2A,epigenetic regulation,tumor-promoting function,chromatin remodeling,cancer cell transformation,cell cycle progression,dna replication
ENSG00000119772,DNMT3A,gain of function mutations,epigenetic regulation,genomic stability disruption,cell cycle dysregulation,tumor suppressor silencing,dna methylation dysfunction
ENSG00000142182,DNMT3L,genomic regulation,methylation silencing,tumor suppressor gene silencing,epigenetic modification,dna integrity maintenance,oncogenic process promotion
ENSG00000088305,DNMT3B,de novo methylation,tumor suppressor gene silencing,aberrant expression,chromatin modification,genomic instability,epigenetic regulation
ENSG00000055130,CUL1,ubiquitination regulation,cell cycle progression,oncogenic mutations,tumor suppressor function loss,protein degradation dysregulation,transcriptional regulation disruption
ENSG00000111530,CAND1,cancer-relevant regulation,dna damage response,genomic instability,cell proliferation enhancement,apoptosis inhibition,tumor suppressor protein degradation
ENSG00000072274,TFRC,iron regulation,tumor growth promotion,oncogenic processes support,cell division enhancement,metastasis facilitation,signaling pathway interaction
ENSG00000010704,HFE,iron regulation,tumor promotion,oxidative stress,dna damage,cell proliferation,iron overload
ENSG00000091513,TF,transcriptional regulation,oncogenic activity,tumor progression,cell proliferation,apoptosis modulation,dna binding protein
ENSG00000225312,HSD17B8,androgen receptor activation,steroid hormone regulation,tumor growth promotion,metastasis enhancement,oncogenic function,therapeutic target
ENSG00000145439,CBR4,chromatin regulation,tumor suppressor function,transcriptional control,cell cycle regulation,dna repair mechanism,genome stability
ENSG00000157456,CCNB2,mitotic progression,oncogene activation,g2/m phase transition,cell cycle dysregulation,tumor growth promotion,therapeutic target
ENSG00000100241,SBF1,genomic instability,polyadenylation regulation,tumor suppressor function,transcriptional elongation regulation,cellular response disruption,genome integrity maintenance
ENSG00000087053,MTMR2,pi3k/akt signaling pathway regulation,cellular autophagy regulation,tumor progression promotion,oncogenic process facilitation,genetic overexpression,prognostic biomarker potential
ENSG00000003987,MTMR7,phosphatidylinositol 3-kinase (pi3k) pathway activation,dephosphorylation of phosphoinositides,regulation of cell metabolism and survival,tumorigenesis and oncogenesis,potential biomarker for cancer diagnosis,association with chemotherapy resistance and prognosis
ENSG00000104643,MTMR9,cellular autophagy,mitochondrial function regulation,tumor suppressor activity,dephosphorylation regulation,oncogenic signaling suppression,metabolic pathway regulation
ENSG00000051382,PIK3CB,pi3k/akt pathway,tumor suppressor activity,limited oncogenic potential,genomic instability,protein-protein interaction,cellular proliferation
ENSG00000105647,PIK3R2,pi3k/akt/mtor pathway,constitutive activation,loss of regulatory function,tumor progression,therapeutic target,cellular regulation
ENSG00000171608,PIK3CD,cellular growth regulation,cancer driver mutations,pi3k/akt signaling pathway interaction,dysregulated expression,survival and proliferation enhancement,therapeutic target potential
ENSG00000117461,PIK3R3,pi3k/akt signaling,regulatory subunit dysfunction,cellular proliferation regulation,tumor suppressor interaction,gene expression modulation,genomic stability disruption
ENSG00000141506,PIK3R5,pi3k/akt signaling,oncogenesis,growth regulation,cell proliferation,metabolic regulation,tumor progression
ENSG00000105851,PIK3CG,pi3k/akt/mtor signaling pathway,distinct regulatory mechanism,hematopoietic cell development,therapeutic resistance,protein-protein interaction regulation,subcellular localization control
ENSG00000169499,PLEKHA2,apoptosis regulation,cell cycle progression,metastasis suppression,oncogenic process,tumor suppressor function,cellular membrane trafficking
ENSG00000163629,PTPN13,loss of function mutations,cellular signaling modulation,rtk pathway regulation,oncogenic process promotion,genome instability regulation,tumor suppressor interaction
ENSG00000107679,PLEKHA1,cell migration,pi3k signaling pathway,oncogenic properties,cytoskeletal regulation,kinase activation,membrane trafficking
ENSG00000139505,MTMR6,pi3k/akt pathway regulation,constitutive activation,loss-of-function mutations,oncogenic processes promotion,cell growth regulation,metabolic pathway modulation
ENSG00000133812,SBF2,microtubule stabilization,cancer driver mutation,mitotic checkpoint regulation,genomic instability,cell cycle progression,tumor suppressor function
ENSG00000171100,MTM1,regulatory mechanism,tumor suppressor function,pi3k/akt pathway regulation,cellular homeostasis maintenance,dephosphorylation activity,genomic integrity preservation
ENSG00000150712,MTMR12,mtmr12 gene product phosphatase activity,cell migration regulator,cell signaling pathway interaction,oncogenic growth promoter,autophagy regulation,lipid metabolism modulation
ENSG00000033327,GAB2,pi3k/akt/mtor signaling,constitutive activation,oncogenic driver,cell proliferation,survival pathway,signaling adapter
ENSG00000150995,ITPR1,ip3r1-dependent calcium signaling,calcium channel regulation,cell proliferation modulation,tumor growth promotion,genetic amplification,cancer progression driver
,MRVI1,regulatory pathway disruption,oncogenic activation,cell proliferation enhancement,apoptosis resistance,therapeutic target potential,microphthalmia-associated transcription factor interaction
ENSG00000111679,PTPN6,oncogenic function,tumor suppressor,cell proliferation regulation,signaling pathway regulation,immune system modulation,gene expression regulation
ENSG00000261371,PECAM1,cell-cell adhesion,tumor progression,metastasis,immune response regulation,angiogenesis,therapeutic target
ENSG00000179295,PTPN11,constitutive activation of ras/mapk signaling,driver gene,genomic amplification,non-receptor tyrosine phosphatase activity,oncogenic mutations,signal transduction regulation
ENSG00000160712,IL6R,il-6 signaling pathway,oncogenic transformation,tumor growth promotion,immune suppression,pro-inflammatory response,signal transduction
ENSG00000136244,IL6,pleiotropic cytokine,tumor progression,metastasis,apoptosis resistance,signaling pathway modulation,inflammation and immune response mediator
ENSG00000115415,STAT1,tumor suppressor function,immune response regulation,cell growth inhibition,apoptosis induction,genetic instability contribution,phosphorylation-dependent activation
ENSG00000168610,STAT3,constitutive activation,jak/stat signaling pathway,oncogenic transformation,cell survival and proliferation,tumorigenesis and metastasis,aberrant transcriptional regulation
ENSG00000128052,KDR,vegfr2 activation,angiogenesis regulation,endothelial cell migration,proliferation promotion,tumor growth support,anti-angiogenic target
ENSG00000113905,HRG,transcriptional regulation,amplification,oncogenic activity,tumor progression,therapeutic target,cell differentiation
ENSG00000122194,PLG,tumor progression,metastasis,extracellular matrix degradation,angiogenesis,cancer cell dissemination,immune evasion
ENSG00000182718,ANXA2,cell proliferation,protein binding,phospholipid interaction,tumor progression,oncogenic potential,poor prognosis predictor
ENSG00000197747,S100A10,calcium signaling,cell differentiation regulation,cytoplasmic localization,epithelial-to-mesenchymal transition,metastasis promotion,prognostic marker
ENSG00000276838,SERPINF2,angiogenic regulation,vascular endothelial growth factor binding,proliferation inhibition,migratory suppression,tumor growth modulation,overexpression signature
ENSG00000122861,PLAU,tumor progression,extracellular matrix degradation,cell migration,angiogenesis,oncogenic potential,signaling pathway activation
ENSG00000011422,PLAUR,enhanced proteolysis,metastatic potential,cell migration regulation,tumor progression,therapeutic target,biomarker value
ENSG00000165240,ATP7A,cellular copper homeostasis,oncogenic processes,protein-protein interactions,cell survival pathways,tumor progression,genomic instability
ENSG00000120509,PDZD11,cell adhesion regulation,epithelial-to-mesenchymal transition,oncogene activity,cell migration regulation,signaling pathway modulation,cancer progression facilitation
ENSG00000103249,CLCN7,chloride channel regulation,intracellular ph regulation,cell proliferation enhancement,metabolic reprogramming,oncogenic processes,cell survival promotion
ENSG00000081087,OSTM1,tumor suppressor function,cell migration regulation,cell-cell interaction modulation,adhesion complex component,metastasis promoter,cancer progression suppression
ENSG00000136810,TXN,redox regulation,cell survival pathways,metastasis promotion,oncogenesis contributor,stat3 interaction,nf-κb interaction
ENSG00000265972,TXNIP,oxidative stress,tumor suppressor,apoptosis inhibition,glycolytic switch,cancer cell survival,loss of function mutation
ENSG00000162711,NLRP3,inflammasome activation,cytokine processing,pyroptosis induction,pro-inflammatory signaling,cellular stress response,immune system modulation
ENSG00000103313,MEFV,nf-κb signaling pathway,inflammation regulation,autoinflammatory disease association,tumor growth promotion,metastasis facilitation,apoptosis inhibition
ENSG00000140368,PSTPIP1,pyrin inflammasome regulation,innate immune response modulation,cell death regulation,autoinflammatory disease association,protein-protein interaction,immunological dysfunction
ENSG00000103490,PYCARD,inflammasome activation,autophagic regulation,cell proliferation modulation,pro-inflammatory cytokine release,apoptosis regulation,mitochondrial function modulation
ENSG00000135346,CGA,regulation of protein activity,disruption of emt,hydroxylation of gamma-carboxyglutamic acid residues,tumor development and progression,cancer metastasis,gene expression alterations
ENSG00000104826,LHB,glycoprotein hormone regulation,pituitary gland function,reproductive system development,ovulation stimulation,hormone production regulation,cancer cell growth promotion
ENSG00000126895,AVPR2,cellular proliferation,vasopressin signaling,receptor activation,tumor progression,poor prognosis,cellular migration
ENSG00000101200,AVP,cellular growth regulation,apoptosis evasion,dna damage repair,pro-survival signaling pathways,therapeutic resistance,cancer cell survival
ENSG00000115263,GCG,glucose metabolism alteration,tumor growth promotion,anabolic process activation,resistance to therapy,overexpression in cancer cells,poorly understood mechanisms
ENSG00000215644,GCGR,glucagon signaling,tumor progression,cancer cell proliferation,cell survival enhancement,signaling pathway activation,pka activation
ENSG00000122679,RAMP3,gpcr regulation,mitogenic response,tumor progression,pro-tumorigenic microenvironment,biomarker potential,therapeutic target
ENSG00000004948,CALCR,oncogenic signaling,tumor progression,chemotherapy resistance,g-protein coupled receptor,bone metastasis,cell proliferation
ENSG00000132329,RAMP1,constitutive activation,cell proliferation,receptor modification,intracellular signaling,calcium sensing,g protein interaction
ENSG00000134200,TSHB,tumor growth,cell proliferation,thyroid hormone regulation,pi3k/akt pathway activation,mapk/erk signaling modulation,oncogenic pathway interaction
ENSG00000179600,GPHB5,cellular adhesion disruption,oncogenic mutation,enhanced tumor progression,metastasis facilitation,epithelial-to-mesenchymal transition regulation,therapeutic target candidate
ENSG00000149735,GPHA2,tumor progression,cell adhesion modulation,metastasis facilitation,overexpression in cancer,immune response regulation,cell signaling regulation
ENSG00000064989,CALCRL,growth factor regulation,receptor activation,tumor progression,cell migration modulation,metastasis promotion,therapeutic target
ENSG00000131477,RAMP2,gpcr activation,tumor progression,cell proliferation,metastasis,oncogenic signaling,co-receptor function
ENSG00000065325,GLP2R,tumor metabolism,overexpression,proliferation,survival signal,cell growth regulation,glucose uptake enhancement
ENSG00000131808,FSHB,hormone regulation,reproductive axis dysregulation,oncogenic processes,tumor progression,cell proliferation,growth factor signaling
ENSG00000138448,ITGAV,integrin signaling pathway,metastasis,tumor invasion,cell adhesion,angiogenesis,cancer cell migration
ENSG00000082781,ITGB5,cancer progression,integrin activation,cell adhesion regulation,extracellular matrix interaction,tumor cell migration,metastatic potential
ENSG00000103496,STX4,endocytosis regulation,cancer cell migration,therapeutic target,genomic instability,cellular trafficking disruption,tumor growth promotion
ENSG00000265808,SEC22B,cellular stress response,golgi apparatus dysfunction,oncogene function,tumor cell proliferation,cancer driver gene,pi3k/akt pathway interaction
ENSG00000106571,GLI3,gli transcription factor,hedgehog signaling pathway,constitutive activation,neoplastic transformation,tumor metastasis,gene overexpression
ENSG00000185920,PTCH1,hedgehog signaling pathway,tumor suppressor function,constitutive activation,loss-of-function mutations,cell proliferation,metastasis
ENSG00000111087,GLI1,hedgehog pathway,oncogene,transcriptional regulation,cell proliferation,apoptosis resistance,epithelial-to-mesenchymal transition (emt)
ENSG00000074047,GLI2,constitutive activation,transcription factor function,oncogenic mutations,tumor progression,hedgehog pathway dysregulation,wnt/β-catenin pathway interaction
ENSG00000107882,SUFU,hedgehog signaling pathway,dysregulated activity,tumor suppression,gli transcription factor regulation,constitutive activation,oncogenic process
ENSG00000133961,NUMB,notch signaling pathway,tumor suppressor function,apoptosis regulation,cell differentiation,cell proliferation inhibition,genomic stability maintenance
ENSG00000078747,ITCH,oncogenic function,ubiquitin ligase activity,tumor progression,apoptosis regulation,cell proliferation,protein stability modulation
ENSG00000011198,ABHD5,fatty acid regulation,lipid metabolism,cell signaling regulation,tumor progression,genomic instability,metabolic reprogramming
ENSG00000166819,PLIN1,metabolic reprogramming,tumor growth,metastasis promotion,lipid biosynthesis regulation,cancer cell biology modulation,transcriptional regulation
ENSG00000079435,LIPE,fatty acid metabolism regulation,tumor progression,cell survival enhancement,apoptosis resistance,lipid metabolism dysregulation,hormone-sensitive lipase function
ENSG00000170323,FABP4,fatty acid transport,lipid metabolism regulation,tumor progression facilitation,metastasis promotion,therapeutic target identification,inflammation modulation
ENSG00000153822,KCNJ16,aberrant ion flow regulation,cell proliferation regulation,oncogenic behavior promotion,signaling pathway interaction,cancer-related mutations,genetic alteration significance
ENSG00000157551,KCNJ15,hypoxia response,cellular proliferation,ion channel regulation,apoptosis regulation,metabolic adaptation,cancer driver gene
ENSG00000177807,KCNJ10,ion channel function,cellular homeostasis regulation,apoptosis modulation,tumor growth promotion,oncogenic mutations,electrical activity regulation
ENSG00000161921,CXCL16,chemoattractant function,immunosuppressive role,tumor progression,metastasis promotion,angiogenesis facilitation,prognostic biomarker
ENSG00000172215,CXCR6,cell migration,chemokine receptor signaling,tumor progression,metastatic potential,immune suppressive cells recruitment,oncogenic processes promotion
ENSG00000197405,C5AR1,pro-inflammatory response,tumor progression,immune evasion,angiogenesis promotion,oncogene upregulation,signaling pathway modulation
ENSG00000106804,C5,complement activation,anaphylatoxin function,inflammation promotion,immune response,pathogen elimination,multifunctional protein
ENSG00000006210,CX3CL1,chemokine signaling,tumor progression,angiogenesis,cell migration,immune cell interaction,cancer metastasis
ENSG00000168329,CX3CR1,chemotaxis,invasion,immune evasion,tumor progression,cell migration,signal transduction
ENSG00000179002,TAS1R2,taste receptor signaling,pi3k/akt pathway modulation,oncogenesis promotion,cell growth regulation,apoptosis inhibition,cell cycle progression
ENSG00000169962,TAS1R3,g-protein coupled signaling,sweet taste receptor function,tumor progression,chemoresistance modulation,cellular response regulation,genomic instability
ENSG00000173662,TAS1R1,aberrant signaling pathway,cell proliferation,mutation hotspot,tumor progression,poor prognosis,glycogen synthase kinase 3 activation
ENSG00000136928,GABBR2,tumor progression,metastasis,cell proliferation,apoptosis regulation,immune evasion,neurotransmission
ENSG00000204681,GABBR1,gaba signaling,tumor microenvironment modulation,cell proliferation regulation,therapeutic target identification,neurotransmitter regulation,synaptic plasticity disruption
ENSG00000243646,IL10RB,tumor microenvironment modulation,immunosuppression promotion,oncogenesis facilitation,angiogenesis regulation,metastasis enhancement,chemotherapy resistance
ENSG00000104064,GABPB1,transcription factor,c/ebp family member,cell proliferation regulation,apoptosis modulation,oncogenic potential,therapeutic target
ENSG00000154727,GABPA,gata1 interaction,transcriptional regulation,post-translational modification,hematopoietic malignancies,cell proliferation inhibition,apoptosis suppression
ENSG00000083312,TNPO1,nuclear import,chromatin remodeling,transcriptional regulation,oncogenic process,cell cycle progression,tumor suppressor interaction
ENSG00000117245,KIF17,cellular transport regulation,mitotic spindle assembly,oncogene function,pi3k/akt pathway interaction,protein-protein interactions,genomic instability
ENSG00000243955,GSTA1,oxidative stress modulation,detoxification mechanism,tumor suppression,treatment resistance modification,antioxidant defense,cytoplasmic localization
ENSG00000244067,GSTA2,oxidative stress regulation,detoxification mechanism,cellular redox balance,tumor initiation,chemotherapy resistance,biomarker potential
ENSG00000001084,GCLC,glutathione synthesis,dna damage repair,genomic instability,cellular redox balance,antioxidant function,chemotherapy resistance
ENSG00000023909,GCLM,glutathione synthesis,redox balance regulation,oncogenic potential,cell survival promotion,protein interaction,dna damage repair facilitation
ENSG00000254647,INS,insulin regulation,cancer cell proliferation,cell growth promotion,tumor angiogenesis,genetic variation association,hormone signaling pathway
ENSG00000171105,INSR,cell proliferation,signaling pathway dysregulation,tumor growth promotion,glycogen synthesis regulation,lipid metabolism modulation,receptor tyrosine kinase activation
ENSG00000173208,ABCD2,lipid transport regulation,transcriptional regulation,tumor growth promotion,dysregulation in cancer,cancer metabolism alteration,genomic instability association
ENSG00000101986,ABCD1,fatty acid transport,mitochondrial function,metabolic regulation,lipid metabolism,energy production,nervous system damage
ENSG00000117528,ABCD3,multidrug resistance,cellular efflux pump,cholesterol transport,cell membrane transport,cell proliferation regulation,oncogene overexpression
ENSG00000138075,ABCG5,steroid export,cholesterol regulation,xenobiotic efflux,cell membrane transport,lipid homeostasis,tumor biology
ENSG00000143921,ABCG8,cholesterol efflux,cellular lipid metabolism,lipid transporter activity,autophagy regulation,tumor microenvironment modulation,protein-protein interactions
ENSG00000160716,CHRNB2,cell cycle regulation,apoptosis modulation,protein kinase activation,signaling pathway activation,growth factor receptor interaction,tumor progression
ENSG00000101204,CHRNA4,nicotinic acetylcholine receptor function,aberrant expression,gain of function mutations,tumor growth promotion,therapeutic target,signaling pathway interaction
ENSG00000080644,CHRNA3,oncogenesis,tumor progression,cell proliferation,signaling pathway modulation,therapeutic target,neurotransmitter regulation
ENSG00000117971,CHRNB4,nicotinic receptor signaling pathway,oncogene activation,cell proliferation regulation,therapeutic target potential,genomic amplification,signaling pathway interaction
ENSG00000111206,FOXM1,transcriptional regulation,cell proliferation enhancement,dna replication facilitation,oncogenic driver,poor prognosis association,therapeutic target
ENSG00000166851,PLK1,genomic instability,aneuploidy,tumor progression,dna damage response,cell proliferation,therapeutic target
ENSG00000117724,CENPF,centrosome structure,chromosome segregation,cell cycle regulation,genomic instability,tumor progression,cancer prognosis
ENSG00000115353,TACR1,g protein-coupled receptor activation,neuropeptide ligand interaction,tumor growth promotion,metastasis facilitation,immune modulation disruption,cancer therapeutic target
ENSG00000006128,TAC1,tumor progression,metastasis driver,immune evasion,neurotransmitter modulation,cell proliferation enhancer,angiogenesis promoter
ENSG00000075073,TACR2,cancer progression,tumor growth,receptor activation,angiogenesis modulation,cell survival signaling,gene amplification
ENSG00000180914,OXTR,oncogenic properties,g protein-coupled receptor function,cell proliferation regulation,metastasis promotion,immune response modulation,downstream signaling pathway activation
ENSG00000101405,OXT,cell proliferation,oncogenesis,neuroendocrine regulation,stress response,social bonding,g protein-coupled receptor activation
ENSG00000147571,CRH,aberrant hpa axis activation,tumor growth promotion,immune evasion modulation,cell adhesion regulation,signaling pathway interaction,stress response dysregulation
ENSG00000145708,CRHBP,crh signaling,angiogenesis promotion,metastasis enhancement,tumor progression,stress response regulation,pro-tumorigenic protein
ENSG00000123146,ADGRE5,erk/mapk pathway,cell adhesion,tumor progression,immune evasion,genomic instability,protein-protein interactions
ENSG00000196352,CD55,tumor immune evasion,immunosuppressive molecule expression,cell signaling pathways,complement regulation,tumor cell survival,poor prognosis marker
ENSG00000100211,CBY1,mitochondrial function,glycolysis regulation,cell signaling modulation,autophagy regulation,oncogenesis promotion,cell proliferation enhancement
ENSG00000168036,CTNNB1,wnt/beta-catenin signaling pathway,constitutive activation,oncogenic driver,cell proliferation,apoptosis resistance,tumorigenesis facilitation
ENSG00000178585,CTNNBIP1,wnt/β-catenin signaling,constitutive activation,gain of function mutations,tumor progression,cell proliferation regulation,nuclear accumulation
ENSG00000100888,CHD8,epigenetic regulation,chromatin remodeling,tumor suppression,genome instability,mutation hotspot,oncogene activation
ENSG00000180398,MCFD2,iron regulation,cell growth promotion,tumor progression facilitation,metastasis enhancement,therapeutic target,transcriptional regulation
ENSG00000074695,LMAN1,erad pathway activation,protein misfolding,stress response induction,oncogenic potential,pi3k/akt interaction,cell survival promotion
ENSG00000170348,TMED10,oligosaccharyltransferase activity,protein n-glycosylation,tumor progression,cell cycle regulation,apoptosis modulation,ubiquitination regulation
ENSG00000086598,TMED2,retrograde transport,protein trafficking,cell proliferation,signaling pathway regulation,constitutive activation,cancer driver gene
ENSG00000010610,CD4,immunomodulation,tumor microenvironment,co-receptor function,t helper cell activation,immune checkpoint,cell surface receptor
ENSG00000182866,LCK,t-cell receptor signaling,oncogenic potential,non-receptor tyrosine kinase activity,tumor growth promotion,cell proliferation regulation,aberrant t-cell activation
ENSG00000115839,RAB3GAP1,ras/rab signaling activation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000118873,RAB3GAP2,gtpase regulation,tumor suppressor function,cell surface receptor regulation,endocytic pathway disruption,pi3k/akt signaling interaction,oncogenic mutation
ENSG00000148053,NTRK2,receptor tyrosine kinase activity,oncogenic driver,constitutive activation,downstream signaling pathway,gene fusion events,therapeutic target
ENSG00000176697,BDNF,neurotrophic signaling,cell proliferation,oncogenesis,metastasis promotion,chemotherapy resistance,angiogenesis
ENSG00000225950,NTF4,wnt signaling inhibition,tumor suppressor role,cell differentiation regulation,pi3k/akt pathway modulation,genomic instability prevention,therapeutic target candidate
ENSG00000100385,IL2RB,immune evasion,t-cell suppression,cellular proliferation,signaling pathway,receptor activation,genetic mutations
ENSG00000162434,JAK1,janus kinase signaling,constitutive activation,growth factor regulation,cellular proliferation,immune evasion,protein kinase activation
ENSG00000105639,JAK3,aberrant signaling pathway,cytokine receptor interaction,growth factor regulation,cell proliferation driver,stat protein activation,t-cell signaling
ENSG00000147168,IL2RG,cell signaling pathway,immunodeficiency,leukemia involvement,t-cell development,cell activation,proliferation
ENSG00000120899,PTK2B,pi3k/akt pathway,kinase activity,cell adhesion,tumor progression,therapeutic target,cell migration
ENSG00000105246,EBI3,il-27 complex,immune regulation,tumor suppression,cytokine signaling pathway,cell proliferation inhibition,molecular interaction
ENSG00000197272,IL27,jak/stat signaling pathway,anti-tumor cytokine,immunomodulation,cell proliferation inhibition,apoptosis induction,cancer immunotherapy
ENSG00000110400,NECTIN1,cell-cell adhesion,tumor progression,metastasis promotion,angiogenesis regulation,prognostic marker,cancer driver gene
ENSG00000177707,NECTIN3,cell adhesion,cell migration,tumor progression,oncogene activation,metastasis facilitation,therapeutic target
ENSG00000143217,NECTIN4,cell-cell adhesion disruption,oncogene activation,metastasis promotion,angiogenesis facilitation,cellular signaling regulation,therapeutic target identification
ENSG00000130202,NECTIN2,adherens junctions formation,cell-cell adhesion,tumor progression facilitation,oncogenic signaling modulation,migratory enhancement,epithelial tissue interaction
ENSG00000073008,PVR,tumor progression,tim-3 interaction,immune suppression,cell adhesion and migration,pro-tumorigenic microenvironment,oncogenic mutation
ENSG00000113302,IL12B,immune cell activation,tumor suppression,cytokine signaling,oncogenesis,cell proliferation regulation,immune evasion
ENSG00000168811,IL12A,immunomodulation,cancer immunosurveillance,th1 cell differentiation,tumor suppression,cell proliferation regulation,immune response activation
ENSG00000096996,IL12RB1,tumor immunosuppression,immunogenic cell death,cytokine receptor signaling,immune evasion mechanisms,cellular differentiation blockade,genetic alterations in cancer
ENSG00000081985,IL12RB2,immunomodulation,cellular immunity suppression,prognostic marker,therapeutic target,tumor progression,signal transduction
ENSG00000096968,JAK2,jak/stat signaling,constitutive activation,gain of function mutations,cell proliferation,therapeutic target,genomic profiling
ENSG00000137462,TLR2,tlr signaling,immune activation,inflammation modulation,cancer microenvironment,pro-inflammatory cytokine production,immunosuppression regulation
ENSG00000174125,TLR1,innate immunity modulation,inflammation regulation,immune response activation,microbial component recognition,pro-inflammatory cytokine production,tumor progression promotion
ENSG00000174130,TLR6,pattern recognition,innate immunity activation,immune evasion,tumor microenvironment modulation,nf-κb regulation,inflammation induction
ENSG00000168214,RBPJ,notch signaling pathway,constitutive activation,oncogenic driver,transcriptional regulator,cell proliferation,tumor suppression
ENSG00000100603,SNW1,general transcriptional coactivator complex interaction,oncogene expression,protein sumoylation,tumor progression,gene regulatory mechanism disruption,transcription factor interaction
ENSG00000148400,NOTCH1,notch signaling pathway,aberrant activation,gain of function mutations,tumor growth promotion,apoptosis evasion,cell cycle progression
ENSG00000100644,HIF1A,tumor hypoxia,hypoxic adaptation,metabolic reprogramming,angiogenesis stimulation,apoptosis inhibition,genetic instability
ENSG00000101384,JAG1,angiogenesis regulation,cell adhesion modulation,notch pathway activation,tumorigenesis promotion,cancer cell invasion,context-dependent role
ENSG00000184916,JAG2,notch signaling pathway,oncogene activation,cell proliferation,tumor metastasis,poor prognosis,aggressive tumor behavior
ENSG00000110395,CBL,e3 ubiquitin-protein ligase function,proto-oncogene regulation,tumor suppressor activity,receptor tyrosine kinase binding,cell signaling pathway regulation,apoptosis suppression
ENSG00000149294,NCAM1,tumor progression,metastasis promotion,immune evasion,tumor-promoting signaling,cell adhesion modulation,cancer biomarker
ENSG00000130287,NCAN,pi3k/akt pathway,oncogene,cell proliferation,tumor progression,epithelial-to-mesenchymal transition (emt),poor prognosis
ENSG00000134871,COL4A2,basement membrane composition,tumor progression,metastasis,cell adhesion regulation,extracellular matrix alteration,prognostic marker
ENSG00000187498,COL4A1,basement membrane assembly,cell invasion,tumor progression,metastasis,angiogenesis,tumor suppressor
ENSG00000206435,HLA-C,immunogenicity,major histocompatibility complex (mhc) class i,antigen presentation,t-cell activation,cancer immunity,genetic diversity
ENSG00000273686,B2M,antigen presentation,tumor evasion,immune suppression,cell survival,proliferation regulation,prognostic marker
ENSG00000274739,KIR2DS5,tumor microenvironment,immune evasion,cell adhesion,cytokine production regulation,nk cell activation,therapeutic target
ENSG00000011600,TYROBP,immune evasion,tumor progression,cell adhesion regulation,stress response regulation,receptor interaction,adaptor molecule function
ENSG00000258227,CLEC5A,immune modulation,tumor microenvironment regulation,innate immune response activation,pathogen recognition,prognostic marker,therapeutic target
ENSG00000096264,NCR2,immune modulation,tumor recognition,natural killer cell function,cancer immune evasion,ligand binding,apoptosis signaling
ENSG00000101307,SIRPB1,immune evasion,tumor progression,metastasis,immunosuppression,cell adhesion,phagocytosis
ENSG00000124731,TREM1,trem1/trem2 signaling,myeloid cell activation,cytokine production,tumor immunosuppression,tumor-promoting macrophages,immune evasion
ENSG00000095970,TREM2,tumor immune evasion,microglial function modulation,phagocytic regulation,immune response activation,oncogenic interaction,inflammatory process regulation
ENSG00000186407,CD300E,immunosuppression,immune evasion,tumor immune microenvironment,cell surface receptor,natural killer cell regulation,anti-tumor immunity modulation
ENSG00000178789,CD300LB,pi3k pathway interaction,immune evasion mechanisms,oncogenic process contributor,transmembrane receptor function,cytokine production regulation,phagocytosis modulation
ENSG00000100351,GRAP2,immune regulation,signaling pathway modulation,t-cell receptor signaling,cellular adaptation,adaptor protein function,genetic interaction
ENSG00000043462,LCP2,transcription regulation,cell proliferation,downstream effector,tumor progression,oxidative stress modulation,signaling pathway interaction
ENSG00000136158,SPRY2,loss of function mutations,tumor suppressor activity,rtk signaling inhibition,cell proliferation regulation,angiogenesis inhibition,metastasis suppression
ENSG00000153071,DAB2,tumor suppressor,cell migration regulation,cell polarity maintenance,pi3k/akt pathway modulation,oncogenesis prevention,metastasis inhibition
ENSG00000081479,LRP2,tumor suppressor function,cell growth regulation,signaling pathway modulation,nutrient uptake disruption,chemoresistance,endocytic receptor activity
ENSG00000124333,VAMP7,cell proliferation,protein-protein interactions,vesicular transport regulation,exocytosis modulation,tumor microenvironment interaction,cancer cell migration
ENSG00000173744,AGFG1,oncogenic signaling,cell proliferation,tumor progression,apoptosis inhibition,signaling pathway activation,genomic instability
ENSG00000078053,AMPH,endocytic regulation,tumorigenesis promotion,negative regulator function,dynamin interaction disruption,phosphorylation site mutation,cell proliferation enhancement
ENSG00000136717,BIN1,mitochondrial dynamics,tumor suppressor function,chromatin remodeling,dna repair regulation,mitochondrial localization,cancer cell metabolism
ENSG00000161011,SQSTM1,autophagy regulation,cellular homeostasis disruption,oncogenic signaling modulation,tumor growth promotion,therapeutic target,signaling pathway dysregulation
ENSG00000198909,MAP3K3,mapk/erk signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cellular proliferation
ENSG00000187840,EIF4EBP1,mtor-dependent translation,tumor suppressor activity,constitutive activation,protein synthesis regulation,phosphorylation inhibition,cellular growth modulation
ENSG00000151247,EIF4E,cap-dependent translation,constitutive activation,gain of function mutations,mrna binding,oncogenic transformation,tumor progression
ENSG00000134250,NOTCH2,notch signaling pathway,aberrant activation,gain of function mutations,cell proliferation,tumor progression,therapeutic target
ENSG00000137496,IL18BP,pro-inflammatory cytokine regulation,anti-tumor activity,immune modulation,tumor growth promotion,metastasis facilitation,inflammatory pathway inhibition
ENSG00000150782,IL18,immune modulation,tumor progression,cytokine signaling,pro-inflammatory responses,angiogenesis promotion,oncogenic functions
ENSG00000115604,IL18R1,immune checkpoint regulation,tumor microenvironment modulation,apoptosis resistance,cancer stem cell maintenance,metastasis promotion,nf-κb pathway activation
ENSG00000164136,IL15,cancer-promoting cytokine,growth factor signaling,immune response modulation,apoptosis suppression,tumor microenvironment regulation,angiogenesis promotion
ENSG00000134470,IL15RA,oncogenesis,tumor progression,immune evasion,cellular proliferation,signaling pathway regulation,genomic instability
ENSG00000126456,IRF3,ifn-mediated antitumor response,cell cycle regulation,apoptosis induction,immune modulation,epigenetic control,protein-protein interaction
ENSG00000185507,IRF7,ifn signaling pathway,transcriptional regulation,cell proliferation inhibition,antiviral defense,apoptosis induction,tumor suppression
ENSG00000005339,CREBBP,chromatin remodeling,histone acetylation,transcriptional regulation,gene expression modulation,protein-protein interactions,oncogenesis promotion
ENSG00000074181,NOTCH3,notch signaling pathway,oncogenic transformation,cell proliferation,cell survival,aberrant activation,tumor progression
ENSG00000163435,ELF3,oncosuppressor function,cell cycle regulation,apoptosis induction,transcriptional regulation,epigenetic modulation,tumor suppressor activity
ENSG00000018236,CNTN1,cell adhesion molecule,oncogenic process,cell proliferation,metastasis driver,gene expression regulation,protein-protein interaction
ENSG00000110492,MDK,tumor progression,immunosuppression,cell migration,angiogenesis,signaling pathway activation,overexpression
ENSG00000198719,DLL1,notch signaling activation,cell proliferation promotion,tumor progression facilitation,immune suppression,amplification or overexpression,self-renewal maintenance
ENSG00000065978,YBX1,transcription regulation,cell cycle progression,apoptosis inhibition,metastasis promotion,drug resistance,angiogenesis promotion
ENSG00000164683,HEY1,hey1 transcription factor,oncogenic function,overexpression in cancer,cell proliferation regulation,metastasis promotion,epithelial-to-mesenchymal transition (emt)
ENSG00000160973,FOXH1,wnt/β-catenin pathway modulation,tumor suppressor function loss,cell cycle regulation,transcriptional modulation,oncogenic pathway activation,genetic alterations
ENSG00000175550,DRAP1,genome integrity maintenance,fanconi anemia pathway regulation,dna repair facilitation,cell cycle checkpoint modulation,tumor suppressor potential,genomic instability prevention
ENSG00000064309,CDON,notch signaling pathway,overexpression,cell proliferation,tumor progression,epithelial-to-mesenchymal transition,genomic amplification
ENSG00000144857,BOC,cellular morphology regulation,cytoskeleton organization disruption,microtubule dynamics modulation,signaling pathway regulation,tumorigenesis association,therapeutic target
ENSG00000110944,IL23A,chronic inflammation,tumor-promoting microenvironment,immunosuppressive activity,cell proliferation,angiogenesis,pro-inflammatory cytokines
ENSG00000162594,IL23R,pro-inflammatory cytokines,immune evasion mechanisms,chronic inflammation,tumor progression,immunosuppressive environment,genetic alterations
ENSG00000138378,STAT4,stat transcription factor,immunomodulation,tumor growth promotion,cell proliferation enhancement,metastasis facilitation,cancer prognosis marker
ENSG00000113889,KNG1,angiogenesis facilitation,endogenous regulator,vascular homeostasis regulation,oncogene interaction,signaling pathway modulation,tumor progression promotion
ENSG00000108561,C1QBP,p53 regulation,cell adhesion,overexpression,oncogenic signaling,tumor suppressor inhibition,multifunctional protein
ENSG00000185010,F8,coagulation pathway,genetic disorder,bleeding risk,blood clotting factor,tumor progression,metastasis
ENSG00000110799,VWF,tumor progression,tumor metastasis,vascular adhesion,cell adhesion protein,glycoprotein function,protein multimerization
ENSG00000101981,F9,carboxylation activation,thrombin processing,vitamin k-dependent modification,protein activation regulation,hemostasis disruption,tumor progression facilitation
ENSG00000143278,F13B,coagulation cascade disruption,fibrinogen deposition,tumor progression facilitation,cell migration enhancement,angiogenesis promotion,apoptosis resistance
ENSG00000124491,F13A1,angiogenesis promotion,coagulation cascade involvement,fibrin clot formation,inflammation regulation,metastasis facilitation,tumor growth promotion
ENSG00000115718,PROC,oncogene activation,aberrant protein processing,proteolytic activity dysregulation,tumor progression facilitation,therapeutic target candidate,cellular signaling pathway modulation
ENSG00000101000,PROCR,tumor progression,tumor angiogenesis,endothelial cell marker,growth factor interaction,signaling pathway modulation,poor prognosis
ENSG00000154589,LY96,tumor cell proliferation,apoptosis modulation,toll-like receptor signaling,immune response regulation,biomarker potential,genomic alterations
ENSG00000136869,TLR4,immune evasion,pattern recognition receptor,pro-inflammatory signaling,tumor microenvironment modulation,angiogenesis promotion,cancer progression driver
ENSG00000163220,S100A9,inflammatory response,calcium signaling,protease regulation,epithelial-to-mesenchymal transition (emt),tumor progression,cell proliferation 
ENSG00000143546,S100A8,inflammatory response,tumor progression,cell cycle regulation,apoptosis inhibition,protein kinase activation,metastasis promotion
ENSG00000130522,JUND,transcriptional regulation,cell survival,oncogenesis,tumor progression,apoptosis resistance,gene expression dysregulation
ENSG00000125740,FOSB,ap-1 complex formation,constitutive activation,oncogenic transcription,cell survival promotion,gene amplification,mapk/erk pathway interaction
ENSG00000242335,CFB,genomic instability,oncogenic activity,cell proliferation,angiogenesis promotion,immune evasion,therapeutic target
ENSG00000125730,C3,tumor microenvironment modulation,tumor progression,prognostic biomarker,immune evasion,cancer diagnosis,complement system activation
ENSG00000104879,CKM,cellular energetics,isoenzyme regulation,energy metabolism,tumor progression,protein-protein interactions,cell proliferation
ENSG00000166165,CKB,tumor-promoting activity,angiogenic modulation,cellular signaling disruption,metastasis facilitation,protein degradation enhancement,cancer progression association
ENSG00000117592,PRDX6,oxidative stress regulation,antioxidant activity,cell proliferation promotion,apoptosis inhibition,metastasis facilitation,redox homeostasis maintenance
ENSG00000084207,GSTP1,gstp1,glutathione s-transferase activity,detoxification pathway,overexpression in tumors,nf-κb signaling interaction,epigenetic regulation
ENSG00000185122,HSF1,enhanced cell proliferation,constitutive activation,genomic instability,heat shock response,increased apoptosis resistance,protein misfolding
ENSG00000230989,HSBP1,cell cycle regulation,apoptosis modulation,tumor-suppressor/oncogene duality,transcriptional regulation,chromatin remodeling,protein-protein interaction
ENSG00000108953,YWHAE,oncogenic driver,cell proliferation,apoptosis regulation,tumor suppression,epithelial-to-mesenchymal transition,protein-protein interaction
ENSG00000158941,CCAR2,tumor progression,therapeutic target,pi3k/akt pathway,oncogenic function,gene expression regulation,transcriptional modulation
ENSG00000096717,SIRT1,epigenetic regulation,cellular metabolism,chromatin remodeling,transcriptional activation,oncogenic signaling,protein deacetylation
ENSG00000125968,ID1,cell proliferation,oncogenic role,apoptosis inhibition,epithelial-to-mesenchymal transition,tumor progression,overexpression marker
ENSG00000157557,ETS2,cell proliferation regulation,gene expression regulation,tumor suppressor activity,apoptosis induction,mutation-driven oncogenesis,angiogenesis promotion
ENSG00000105722,ERF,tumor progression,genomic profiling,oncogenic transformation,cell proliferation,apoptosis regulation,transcriptional regulation
ENSG00000197442,MAP3K5,cancer driver gene,mapkkk activity,cell survival regulation,jnk/p38 pathway activation,tumor progression enhancement,transcriptional regulation alteration
ENSG00000147883,CDKN2B,cell cycle regulation,tumor suppressor function,cyclin-dependent kinase inhibition,genomic stability maintenance,apoptosis modulation,tumorigenesis promotion
ENSG00000172216,CEBPB,transcription factor regulation,cellular proliferation,oncogenic potential,chromatin remodeling,gene expression modulation,immune response suppression
ENSG00000198178,CLEC4C,lectin receptor function,tumor cell growth regulation,immune surveillance,biomarker potential,surface protein expression,cellular response modulation
ENSG00000158869,FCER1G,cell signaling pathway modulation,oncogenic process contribution,tumor progression promotion,metastasis enhancement,cancer-related gene expression alteration,allergic response mediation
ENSG00000166523,CLEC4E,innate immune response,immune cell activation,cancer immunotherapy target,dendritic cell function,tumor recognition,pathogen binding protein
ENSG00000006062,MAP3K14,nf-κb pathway activation,oncogene function,cell signaling regulation,immune response modulation,proliferation promotion,survival pathways
ENSG00000213341,CHUK,nf-κb signaling pathway,constitutive activation of ikk,tumor progression through nf-κb activation,immune evasion mechanisms,oncogenic cell proliferation,dysregulation of inflammatory responses
ENSG00000077150,NFKB2,nf-kappa b signaling,constitutive activation,oncogenesis,tumor suppression,epigenetic regulation,gene expression modulation
ENSG00000104856,RELB,oncogenic regulation,cell migration,cell adhesion,tumor progression,metastasis,angiogenesis
ENSG00000172175,MALT1,nf-κb signaling pathway,gain of function mutations,paracaspase activity,tumor progression,oncogenic processes,therapeutic target
ENSG00000064012,CASP8,apoptosis regulation,loss of function mutations,oncogenic transformation,disrupted cell death,pro-survival signaling,tumor suppressor dysfunction
ENSG00000090659,CD209,immune modulation,oncogene overexpression,immunosuppressive microenvironment,tumor progression,metastasis promotion,poor prognosis
ENSG00000108622,ICAM2,tumor progression,cell adhesion disruption,pro-inflammatory signaling,immune evasion mechanisms,angiogenesis regulation,glycosylation modification
ENSG00000075218,GTSE1,tumor suppressor interaction,apoptosis regulation,oncogene activity,cell cycle progression,microtubule stability,transcriptional regulation
ENSG00000117399,CDC20,genomic instability,tumor formation,cell proliferation,apoptosis resistance,therapeutic target,cell cycle regulation
ENSG00000164109,MAD2L1,spindle checkpoint activation,genomic instability driver,mitotic progression regulator,apoptosis modulation,chromosomal instability promoter,cell cycle checkpoint control
ENSG00000136997,MYC,tumor suppressor dysfunction,constitutive activation,transcriptional regulation,cell cycle progression,apoptosis evasion,gene amplification
ENSG00000123374,CDK2,oncogenic driver,cell cycle progression,proliferation regulation,cyclin interaction,genomic instability,therapeutic target
ENSG00000105173,CCNE1,oncogenesis,cell cycle progression,protein overexpression,amplification mutations,cdk2 interaction,tumor aggressiveness
ENSG00000112312,GMNN,chromatin assembly,genomic instability,cell proliferation,oncogenesis,cell cycle progression,dna replication
ENSG00000167513,CDT1,cell cycle regulation,dna replication initiation,chromatin loading,oncogene overexpression,g1-s checkpoint dysregulation,transcriptional elongation
ENSG00000006634,DBF4,genomic instability,constitutive activation,dna replication regulation,cell cycle progression,aberrant protein interaction,tumor suppression deficiency
ENSG00000097046,CDC7,dna replication,cell cycle progression,chromosomal stability,oncogene activation,cell proliferation,genomic instability
ENSG00000133101,CCNA1,mitotic regulation,cell cycle progression,proliferation enhancement,chromosomal instability,tumor growth promotion,genomic instability
ENSG00000145386,CCNA2,cell cycle deregulation,cancer proliferation,tumor initiation,therapeutic target,dna replication,prognostic marker
ENSG00000139289,PHLDA1,cell cycle regulation,cyclin d1 accumulation,gene amplification,tumor proliferation,proliferation driver,survival factor
ENSG00000288307,CTDNEP1,transcriptional regulation,phosphatase activity,rna polymerase ii regulation,tumorigenesis,cellular metabolism,metabolic reprogramming
ENSG00000205423,CNEP1R1,wnt/β-catenin pathway,transcriptional regulation,coactivator function,cell proliferation,oncogenic processes,therapeutic target
ENSG00000135476,ESPL1,aneuploidy,chromosomal instability,mitotic spindle assembly,protein-protein interaction,cell proliferation,genomic stability
ENSG00000164611,PTTG1,chromosomal instability,cell cycle disruption,mitotic checkpoint regulation,oncogenic protein-protein interactions,angiogenesis facilitation,tumor cell proliferation 
ENSG00000129933,MAU2,genomic instability,dna repair deficiency,homologous recombination,non-homologous end joining,oncogenic interaction,tumor progression
ENSG00000164190,NIPBL,genomic instability,chromatin modification,co-hesin loading complex,dna damage response,cell cycle regulation,aneuploidy
ENSG00000112029,FBXO5,ubiquitination regulation,tumor suppressor function,cyclin degradation,dna repair mechanism,cell cycle progression regulation,genome stability maintenance
ENSG00000073712,FERMT2,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,oncogenic signaling pathway activation,p53 regulation inhibition,cancer cell migration enhancement,signaling molecule interaction
ENSG00000162458,FBLIM1,regulation of epithelial-to-mesenchymal transition,loss-of-function mutations,disrupted cell adhesion,tumor aggressiveness,metastasis promotion,cell migration regulation
ENSG00000150093,ITGB1,metastasis driver,epithelial-to-mesenchymal transition (emt),cell adhesion modulation,signaling pathway interaction,apoptosis regulation,tumor progression facilitator
ENSG00000166333,ILK,cell adhesion,cell migration,oncogenic signaling,tumor aggressiveness,akt pathway modulation,apoptosis resistance
ENSG00000197702,PARVA,p53 regulation,cell growth modulation,e3 ubiquitin ligase activity,protein degradation,tumor suppressor interaction,cell survival pathway
ENSG00000129675,ARHGEF6,gef activity,rho gtpase activation,cell migration,cell proliferation,genomic instability,oncogenic signaling
ENSG00000188677,PARVB,oncogenic function,tumor progression,cell migration,cell adhesion regulation,signaling pathway modulation,overexpression in cancer
ENSG00000148484,RSU1,alternative splicing regulation,oncogenic pathway activation,tumor progression marker,cellular proliferation enhancement,splice variant production,wnt/β-catenin pathway interaction
ENSG00000169756,LIMS1,epithelial-to-mesenchymal transition,oncogene,cell migration,tumor progression,protein-protein interactions,dna damage response
ENSG00000072110,ACTN1,cytoplasmic structure disruption,cell migration enhancement,cancer progression association,tumor invasiveness,protein-protein interactions,cytoskeleton regulation
ENSG00000091409,ITGA6,integrin signaling pathway,tumor progression,cancer cell migration,adhesion molecule interaction,ligand binding,prognostic marker
ENSG00000132470,ITGB4,constitutive activation,cell adhesion disruption,epithelial-to-mesenchymal transition (emt) promotion,increased migratory capacity,metastasis facilitation,therapeutic target
ENSG00000196776,CD47,oncogene,tumor escape,immune evasion,prognostic marker,therapeutic target,cancer metastasis
ENSG00000198053,SIRPA,myeloid cell regulation,immune system modulation,cell adhesion regulation,tumor progression,prognostic marker,therapeutic target
ENSG00000089012,SIRPG,immune evasion,metastasis promotion,tumor growth facilitation,phagocytosis inhibition,cancer cell survival enhancement,prognostic marker
ENSG00000161270,NPHS1,cellular migration,regulatory mechanism,cellular adhesion,epithelial-to-mesenchymal transition (emt),genomic aberration,kidney disease
ENSG00000183853,KIRREL1,cell-cell adhesion disruption,genomic instability,tumor suppressor function,epithelial expression,metastatic potential,aggressive tumor phenotype
ENSG00000118898,PPL,cell-cell adhesion,desmosomal plaque,tumor suppressor,genomic stability,cell proliferation,epithelial integrity
ENSG00000167880,EVPL,tumor progression,cell proliferation,gene expression,protein interaction,apoptosis regulation,metastasis promotion
ENSG00000189337,KAZN,chromatin remodeling,genomic instability,epigenetic regulation,transcriptional modulation,cellular proliferation,tumor progression
ENSG00000167754,KLK5,extracellular matrix regulation,oncogenic activity,proteolytic activity,cell surface protein regulation,tumor progression,metastasis facilitation
ENSG00000133710,SPINK5,serine protease regulation,barrier maintenance,skin and mucosal function,kallikrein inhibition,proteolytic dysregulation,tissue homeostasis disruption
ENSG00000186474,KLK12,extracellular matrix degradation,cell proliferation,tumor progression,metastasis promoter,prognostic marker,pi3k/akt interaction
ENSG00000178172,SPINK6,pi3k/akt pathway,constitutive activation,gain of function mutations,tumor progression,cell survival,epithelial-to-mesenchymal transition (emt)
ENSG00000167759,KLK13,tumor progression,proteolytic activity,epithelial-to-mesenchymal transition (emt),cell migration,invasiveness,aggressive phenotype
ENSG00000129437,KLK14,oncogene,tumor progression,metastasis facilitation,extracellular matrix degradation,protease activation,cell invasion enhancement
ENSG00000204909,SPINK9,pi3k/akt pathway regulation,oncogenic properties,tumor growth promotion,emt modulation,biomarker candidate,protein-protein interaction
ENSG00000077782,FGFR1,fgfr1 signaling pathway,constitutive activation,amplification mutations,tumor progression,oncogenic driver,genomic instability
ENSG00000011201,ANOS1,calcium-activated chloride channel,cell migration,oncogene potential,epithelial-to-mesenchymal transition,apoptosis regulation,tumor progression
ENSG00000165029,ABCA1,cholesterol efflux regulation,lipid metabolism modulation,cell survival enhancement,tumor microenvironment modification,chemotherapy resistance promotion,lipid-protein interaction
ENSG00000118137,APOA1,anti-tumor effects,gene expression regulation,pi3k/akt pathway inhibition,lipid metabolism regulation,tumor suppressor activity,protein-protein interactions
ENSG00000132855,ANGPTL3,lipid metabolism regulation,tumor progression,therapeutic target,cell proliferation,metastasis promotion,angiogenesis modulation
ENSG00000130173,ANGPTL8,tumor progression,angiogenesis,lipid metabolism regulation,energy homeostasis modulation,therapeutic target,metastasis promotion
ENSG00000126261,UBA2,protein degradation regulation,ubiquitin transfer mechanism,oncogenic pathway activation,cellular stress response modulation,therapeutic target identification,genomic instability regulation
ENSG00000142230,SAE1,ubiquitin ligase regulation,chaperone activity,gain of function mutations,cancer cell proliferation,tumor growth,therapeutic target
ENSG00000112576,CCND3,ccn2 signaling pathway,cell cycle dysregulation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000069956,MAPK6,inflammation response,mapk pathway regulation,cell signaling modulation,tumor cell proliferation,apoptosis evasion,stress response
ENSG00000005884,ITGA3,cell adhesion molecules,tumor progression,cancer metastasis,angiogenesis promotion,transmembrane receptor interaction,transcriptional regulation
ENSG00000135424,ITGA7,integrin subunit,cell adhesion,tumor invasion,metastasis,pi3k/akt signaling,angiogenesis
ENSG00000164171,ITGA2,tumor progression,cell adhesion molecule,metastasis promoter,pi3k/akt pathway activation,angiogenesis facilitation,cell migration regulator
ENSG00000213949,ITGA1,integrin-mediated cell adhesion,cell migration and invasion,oncogenic properties,tumor progression and metastasis,epithelial-to-mesenchymal transition,growth factor interactions
ENSG00000182220,ATP6AP2,ion channel regulation,tumor metabolism,oncogenic properties,cell signaling pathways,metabolic reprogramming,therapeutic resistance
ENSG00000143839,REN,renin-angiotensin system,cell proliferation,angiogenesis,tumor metastasis,mutation hotspot,signaling pathway activation
ENSG00000117481,NSUN4,small nucleolar rna biogenesis,oncogenic pathway activation,tumor progression driver,ribosomal protein misfolding,gene expression alteration,cell proliferation enhancement
ENSG00000122085,MTERF4,mitochondrial regulation,genetic instability,ribosome biogenesis,cellular metabolism,tumor progression,apoptosis resistance
ENSG00000259207,ITGB3,cell adhesion,growth factor signaling,protein-protein interaction,tumor progression,metastasis,therapeutic target
ENSG00000005961,ITGA2B,cell adhesion,integrin signaling,metastasis promotion,platelet function regulation,thrombus formation,tumor progression
ENSG00000130164,LDLR,angiogenesis promotion,cell migration enhancement,immunosuppression induction,lipid metabolism dysregulation,metastasis facilitation,oncogenic signaling pathway interaction
ENSG00000169174,PCSK9,tumor progression,oncogenic signaling pathway activation,cell proliferation enhancement,metastasis promotion,lipid metabolism regulation,cholesterol clearance modulation
,TMEM173,antitumor immunity,cytosolic sensing,immune evasion,tumor-promoting activity,viral defense mechanism,aberrant expression
ENSG00000183735,TBK1,nf-κb activation,adaptor molecule function,innate immune regulation,tumor progression,cancer immunosuppression,cellular stress signaling
ENSG00000139193,CD27,tumor immune evasion,immune activation,germinal center reaction,regulatory t cell interaction,myeloid-derived suppressor cell interaction,poor prognosis biomarker
ENSG00000125726,CD70,co-stimulation,immune regulation,t-cell activation,metastasis promotion,immunosuppression,tumor progression
ENSG00000135960,EDAR,signaling pathway regulation,cell growth promotion,apoptosis inhibition,tumor progression enhancement,epithelial differentiation disruption,cancer association
ENSG00000158813,EDA,cellular processes,epithelial tissue maintenance,gene expression regulation,tumor initiation,cell differentiation,developmental disorders
ENSG00000131080,EDA2R,pan-cancer target,oncogenic pathway,cell proliferation enhancement,tumor initiation,genomic instability,protein-protein interaction
ENSG00000120337,TNFSF18,nf-κb activation,apoptosis regulation,oncogene function,tumor progression,immune evasion,cancer cell proliferation
ENSG00000186891,TNFRSF18,apoptosis regulation,immunomodulation,cell death pathways,tumor progression influence,cancer immune evasion,nf-κb pathway interaction
ENSG00000186827,TNFRSF4,ox40/ox40l interaction,immunomodulation,tumor microenvironment remodeling,t-cell activation and proliferation,nf-κb/mapk/erk signaling pathway,immunosuppression and resistance to immunotherapy
ENSG00000117586,TNFSF4,tumor necrosis factor superfamily,t cell activation,proliferation,immunomodulation,oncogenesis,overexpression
ENSG00000215788,TNFRSF25,apoptosis regulation,tumor necrosis factor receptor signaling,immune modulation,cellular proliferation regulation,inflammation regulation,cancer immunoediting
ENSG00000181634,TNFSF15,angiogenesis promotion,immune evasion facilitation,tumor growth enhancement,metastasis facilitation,overexpression commonality,cancer-related immune modulation
ENSG00000106952,TNFSF8,apoptosis regulation,cell proliferation,immune modulation,inflammation signaling,proliferative signaling,tumor progression
ENSG00000120949,TNFRSF8,nf-κb activation,cell proliferation,oncogenesis,immune response regulation,apoptosis inhibition,signaling pathway interaction
ENSG00000125657,TNFSF9,apoptosis induction,immunomodulation,tumor cell regulation,myeloid-derived suppressor cells modulation,cancer immunotherapy target,pan-cancer downregulation
ENSG00000049249,TNFRSF9,immunoregulation,immune evasion,tumor growth promotion,regulatory t cell expansion,survival pathway activation,poor prognosis marker
ENSG00000101213,PTK6,tyrosine kinase activation,cell signaling regulation,oncogene overexpression,tumor progression enhancement,therapeutic target identification,signaling pathway modulation
ENSG00000121774,KHDRBS1,alternative pre-mrna splicing,cell proliferation,oncogenesis,spliceosome complex,gene expression regulation,dysregulated expression
ENSG00000186635,ARAP1,gef activation,cell migration,tumor invasion,metastasis promotion,pi3k/akt interaction,signaling regulation
ENSG00000142208,AKT1,pi3k/akt/mtor pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cell survival
ENSG00000115325,DOK1,rtk signaling complex,tumor suppressor gene,oncogenic process,cell proliferation,cell survival,tumorigenesis
ENSG00000196396,PTPN1,tumor suppressor,dephosphorylation activity,loss-of-function mutations,cell proliferation,angiogenesis promotion,poor prognosis marker
ENSG00000178078,STAP2,dysregulation of cell cycle control,tumor suppressor activity,modulator of immune responses,interaction with pi3k/akt/mtor pathways,driver gene in tumorigenesis,therapeutic target for cancer treatment
ENSG00000184557,SOCS3,cell growth regulation,immune response modulation,tumor suppressor function,jak/stat pathway interaction,oncogene potential,epithelial-to-mesenchymal transition induction
ENSG00000143127,ITGA10,cell adhesion,oncogenic transformation,metastasis,tumor progression,cell migration,extracellular matrix interaction
ENSG00000275931,GP6,cell adhesion regulation,gene overexpression,angiogenesis promotion,oncogenic signaling,cell migration facilitation,tumor progression enhancement
ENSG00000132155,RAF1,mapk/erk pathway,gain of function mutations,therapeutic target,cell proliferation,survival signaling,signaling pathway activation
ENSG00000164924,YWHAZ,oncogenic signaling,tumor suppressor dysfunction,cell cycle regulation,anti-apoptotic function,phosphorylation regulation,protein kinase activation
ENSG00000162493,PDPN,oncogenic potential,glycoprotein function,cell migration,overexpression,growth factor interaction,signaling pathway modulation
ENSG00000165682,CLEC1B,immune regulation,tumor microenvironment modulation,cell adhesion regulation,macrophage activation,oncogenic expression,metastasis promotion
ENSG00000197461,PDGFA,cell proliferation,oncogenic driver,angiogenesis promotion,metastatic potential,tumor progression facilitation,growth factor signaling pathway
ENSG00000100311,PDGFB,pdgf signaling pathway,constitutive activation,gain of function mutations,tumor progression,angiogenesis promoter,therapeutic target
ENSG00000169896,ITGAM,cell adhesion,leukocyte migration,tumor progression,metastasis,cancer cell invasion,signal transduction
ENSG00000160255,ITGB2,adhesion molecule regulation,angiogenesis promotion,immune evasion mechanisms,metastasis facilitation,oncogene co-expression,tumor progression enhancement
ENSG00000154721,JAM2,tumor progression,metastasis promotion,cell adhesion regulation,oncogenic mutations,signal transduction,cancer metastasis
ENSG00000166086,JAM3,cellular interaction disruption,metastasis promotion,invasion facilitation,adhesion regulation,signaling pathway modulation,tumor aggressiveness enhancement
ENSG00000115232,ITGA4,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),integrin activation,leukocyte migration facilitation,metastasis promotion,tumor cell invasion
ENSG00000005844,ITGAL,cell adhesion signaling,immune cell activation,tumor metastasis,immunomodulation,signal transduction pathway,cancer immunosuppression
ENSG00000140678,ITGAX,integrin-mediated adhesion,tumor progression,cell migration,oncogenic signaling,immune evasion,angiogenesis
ENSG00000117091,CD48,immunomodulation,cell surface molecule,immune cell activation,tumor microenvironment,immune evasion,adhesion and migration
ENSG00000122223,CD244,tumor immunity,immune evasion,cell activation,oncogenic function,signaling pathways,t-cell regulation
ENSG00000116815,CD58,adhesion molecule,immune evasion,cell surface protein,tumor progression,immune suppression,oncogene overexpression
ENSG00000116824,CD2,adhesive interactions,cell activation,immune evasion,leukemia-related genes,malignancy progression,t-cell development
ENSG00000161638,ITGA5,tumor metastasis,cell adhesion,cell migration,transmembrane receptor,prognostic marker,gene expression regulation
ENSG00000160593,JAML,disruption of tight junctions,enhanced cell migration,vascular permeability,tumor progression,prognostic marker,signaling pathway regulator
ENSG00000154639,CXADR,cellular adhesion,epithelial-to-mesenchymal transition (emt),protein-protein interaction,tumor progression,metastasis regulation,cancer prognosis
ENSG00000240972,MIF,pro-inflammatory cytokine,oncogene activation,constitutive activation of signaling pathways,angiogenesis promotion,metastasis facilitation,chemotherapy resistance
ENSG00000019582,CD74,tumor progression,proliferation,metastasis,cell signaling,molecular interaction,tumor microenvironment
ENSG00000120156,TEK,tie2 receptor tyrosine kinase,angiogenesis regulation,lymphangiogenesis stimulation,vegfr interaction,endothelial cell activation,mitogenic signaling pathway
ENSG00000154188,ANGPT1,angiogenesis promotion,tumor growth support,vascular remodeling regulation,immune suppression facilitation,endothelial cell interaction,hematopoietic progenitor cell regulation
ENSG00000091879,ANGPT2,angiogenesis,tumor progression,metastasis,immune modulation,vascular remodeling,oncogenic signaling
ENSG00000101280,ANGPT4,tumor growth,angiogenesis promotion,vegfr regulation,cell proliferation enhancement,pi3k/akt pathway modulation,prognostic marker
ENSG00000168918,INPP5D,pi3k/akt signaling,loss-of-function mutations,negative regulator,cell growth regulation,cell survival enhancement,oncogenic process
ENSG00000124181,PLCG1,signaling pathway activation,phospholipase activity,tyrosine kinase receptor interaction,cell proliferation promotion,cancer driver mutation,protein-protein interaction
ENSG00000172270,BSG,cell migration,tumor progression,growth factor regulation,angiogenesis stimulation,protein-protein interaction,adhesion molecule function
ENSG00000100023,PPIL2,cell proliferation,apoptosis regulation,protein folding,molecular chaperone function,tumor aggressiveness,poor prognosis marker
ENSG00000105974,CAV1,pi3k/akt/mtor regulation,tumor suppressor function,cell proliferation inhibition,signal transduction modulation,caveolae structure maintenance,cholesterol transport regulation
ENSG00000196262,PPIA,cellular regulation,protein stability,potential biomarker,tumor suppressor interaction,cancer progression,biological function
ENSG00000155465,SLC7A7,mtor pathway regulation,amino acid transport,tumor progression,genomic profiling,therapeutic target,cellular growth
ENSG00000168003,SLC3A2,tumor metabolism,cellular proliferation,nutrient uptake regulation,transport protein function,cancer prognosis marker,chemotherapy response modulation
ENSG00000092068,SLC7A8,mtor signaling pathway,amino acid transport,cell growth regulation,protein synthesis,oncogenic process,therapeutic target
ENSG00000021488,SLC7A9,amino acid transport,tumor progression,cancer metabolism,oncogenic driver,therapeutic target,genomic amplification
ENSG00000151012,SLC7A11,amino acid transport,cellular metabolism reprogramming,anabolic process promotion,therapeutic target resistance,tumor growth support,metabolic adaptation enhancement
ENSG00000103257,SLC7A5,enhanced amino acid uptake,increased cell proliferation,promotes oncogenic signaling,angiogenesis regulation,co-localizes with pi3k/akt/mtor pathway components,resistance to apoptosis
ENSG00000130876,SLC7A10,amino acid transport,cell proliferation,tumor progression,chemotherapy resistance,cancer cell survival,anabolic processes
ENSG00000103064,SLC7A6,glutamine metabolism,metabolic reprogramming,aberrant amino acid transport,cell survival enhancement,tumor adaptation,chemotherapy resistance
ENSG00000136750,GAD2,glutamate decarboxylation,gaba neurotransmission,tumor progression,cell proliferation,chemotherapy resistance,oncogenic potential
ENSG00000128683,GAD1,gaba synthesis,neurotransmitter regulation,synaptic plasticity,tumor progression,metastasis promotion,cancer biology relevance
ENSG00000186090,HTR3D,tumor growth,apoptosis regulation,cell proliferation enhancement,tumor aggressiveness promotion,angiogenesis facilitation,signaling pathway interaction
ENSG00000166736,HTR3A,cell proliferation,oncogenic driver,tumor progression,neurotransmission regulation,ligand-gated ion channel,signaling pathway interaction
ENSG00000186038,HTR3E,angiogenesis,metastasis promotion,tumor microenvironment modulation,immune evasion mechanisms,pro-angiogenic factor regulation,cell proliferation enhancement
ENSG00000149305,HTR3B,serotonin signaling pathway,amplification/overexpression,cell proliferation/survival,tumor progression/metastasis,immune response modulation,therapeutic target
ENSG00000178084,HTR3C,neurotransmission regulation,tumor progression,cell survival enhancement,metastatic potential,gene expression regulation,signaling pathway modulation
ENSG00000175387,SMAD2,tgf-β signaling pathway,gain of function mutations,transcriptional regulation,tumor progression,apoptosis inhibition,cell differentiation disruption
ENSG00000177628,GBA,lysosomal dysfunction,autophagy disruption,cellular metabolism alteration,oncogenesis promotion,epigenetic modification involvement,dna damage repair pathway interaction
ENSG00000197746,PSAP,redox regulation,selenocysteine biosynthesis,protein synthesis regulation,cell survival mechanism,antioxidant defense,oxidative stress response
ENSG00000112799,LY86,tumor surveillance,natural killer cell function,immune regulatory molecule,immune checkpoint modulation,cancer immunotherapy target,tumor immunity regulation
ENSG00000134061,CD180,tnf-related interactions,costimulatory molecule,tumor progression,immunomodulation,cell proliferation regulation,activated t lymphocyte expression
ENSG00000118004,COLEC11,complement activation,cell adhesion,cell migration,tumor progression,protein interaction,cancer prognosis
ENSG00000127241,MASP1,complement activation,serine protease activity,tumor progression,metastasis promotion,cell growth regulation,inflammation modulation
ENSG00000169562,GJB1,gap junctional intercellular communication disruption,tumor progression enhancement,cellular adhesion loss,intercellular signaling impairment,metabolic dysfunction promotion,epithelial to mesenchymal transition facilitation
ENSG00000165474,GJB2,gap junctions,cellular adhesion disruption,oncogenic function,tumor progression,intercellular communication disruption,loss-of-function mutations
ENSG00000152661,GJA1,gap junction function,tumor progression,cell migration,metastasis promotion,pro-tumorigenic microenvironment,oncogene interaction
ENSG00000277401,TJP1,tight junction disruption,cell polarity loss,epithelial barrier breach,wnt/β-catenin pathway interaction,protein complex stabilization,cancer cell invasion
ENSG00000069869,NEDD4,pi3k/akt pathway modulation,tumor suppressor function loss,cell proliferation regulation,protein stability regulation,ubiquitin-protein ligase activity,e3 ubiquitin ligase function
ENSG00000138032,PPM1B,pp2a regulation,oncogenic pathway modulation,tumor suppressor function,cell growth regulation,phosphatase activity modulation,protein-protein interaction 
ENSG00000136068,FLNB,cell migration,cytoskeletal dynamics,mechanotransduction,oncogenic behavior,therapeutic target,genetic alterations
ENSG00000137033,IL33,alarmin function,immunoregulation,oncogenesis,tumor microenvironment modification,angiogenesis promotion,immune checkpoint suppression
ENSG00000115602,IL1RL1,immune evasion,inflammation regulation,th2 cell differentiation,mast cell activation,tumor growth promotion,decoy receptor function
ENSG00000125571,IL37,tumor microenvironment modulation,inflammation regulation,oncogenesis promotion,therapeutic target,immune suppression,anti-inflammatory cytokine
ENSG00000100368,CSF2RB,gm-csfr signaling pathway,receptor activation,myeloid cell development,cell proliferation regulation,survival pathways,signaling dysregulation
ENSG00000198223,CSF2RA,angiogenesis,cancer progression,immune evasion,myeloid cell proliferation,tumor metastasis,growth factor signaling
ENSG00000164400,CSF2,aberrant expression,angiogenesis promotion,immune suppression,epithelial-to-mesenchymal transition (emt),constitutive activation mutations,immune evasion
ENSG00000091181,IL5RA,cell proliferation,oncogenic signaling,signaling pathway dysregulation,immune evasion,eosinophil activation,cytokine receptor interaction
ENSG00000113525,IL5,cell proliferation,immune system regulation,tumor growth promotion,metastasis facilitation,therapeutic target,inflammation regulation
,TEC,cellular signaling,non-receptor tyrosine kinase,tec family kinases,cell growth regulation,immune system modulation,hematopoietic development
ENSG00000141968,VAV1,rhoa/rac activation,tumor progression,cell migration and adhesion,oncogenic signaling pathways,guanine nucleotide exchange factor (gef),pan-cancer biology
ENSG00000095585,BLNK,tyrosine kinase regulation,signaling pathway modulation,cell proliferation regulation,immune cell interaction,apoptosis suppression,tumor metastasis facilitation
ENSG00000077238,IL4R,il-4/stat6 pathway,gain of function mutations,cell proliferation,immune evasion,tumor progression,therapeutic target
ENSG00000131724,IL13RA1,stat6 pathway activation,cell proliferation regulation,immune evasion mechanisms,tumor progression facilitation,oncogene interaction,angiogenesis promotion
ENSG00000169194,IL13,tumor growth promotion,oncogenic signaling,metastasis facilitation,immune evasion support,angiogenesis regulation,pro-tumorigenic microenvironment creation
ENSG00000123496,IL13RA2,jak/stat pathway,tumor progression,cell proliferation,cytokine receptor function,signaling pathway interaction,immune evasion
ENSG00000168685,IL7R,il-7/stat5 pathway,constitutive activation,jak/stat signaling,immune evasion,tumor microenvironment modulation,oncogene cooperation
ENSG00000127616,SMARCA4,chromatin remodeling,genomic instability,gene expression regulation,cell cycle progression,dna repair,tumor suppression
ENSG00000185658,BRWD1,chromatin regulation,genetic instability,dna damage response,cell cycle modulation,protein-protein interactions,transcriptional regulation
ENSG00000164485,IL22RA2,immune evasion,enhanced angiogenesis,tumor growth promotion,suppressed anti-tumor immunity,il-22 signaling pathway,epithelial homeostasis disruption
ENSG00000127318,IL22,tumor growth promotion,cancer cell survival enhancement,inflammation regulation,immune response modulation,angiogenesis support,epithelial barrier function maintenance
ENSG00000185436,IFNLR1,interferon signaling pathway,immune evasion,cancer cell survival,tumor growth regulation,innate immune response,genetic polymorphism
ENSG00000172349,IL16,tumor-suppressive effects,immune regulation,cytokine signaling pathway,apoptosis induction,cell proliferation inhibition,angiogenesis inhibition
ENSG00000008517,IL32,nf-κb pathway activation,aberrant expression,pro-inflammatory cytokine production,apoptosis resistance,tumor progression,angiogenesis promotion
ENSG00000196415,PRTN3,proteolysis regulation,tumor progression,apoptosis modulation,immune response modulation,oncogenic protein interaction,cell survival promotion
ENSG00000122025,FLT3,constitutive activation,gain of function mutations,oncogenic driver,leukemogenesis,proliferation and survival signaling,therapeutic target
ENSG00000090554,FLT3LG,angiogenesis promotion,immune evasion,cell proliferation enhancement,tumor metastasis facilitation,oncogene activation,signaling pathway regulation
ENSG00000108342,CSF3,granulopoiesis,cytokine signaling,myeloid lineage,proliferation regulation,oncogenic transformation,hematopoietic disorder
ENSG00000119535,CSF3R,constitutive activation,oncogenic driver mutations,cell proliferation enhancement,survival advantage promotion,hematopoietic cell regulation,receptor overexpression
ENSG00000084652,TXLNA,telomere maintenance,telomerase regulation,chromatin remodeling,cell cycle progression,genetic instability,oncogenic potential
ENSG00000106089,STX1A,vesicle transport regulation,overexpression,tumor progression facilitation,cell migration enhancement,prognostic marker,therapeutic target
ENSG00000112964,GHR,gh receptor overexpression,constitutive activation,jak/stat signaling,tumor progression,metabolic regulation,cell proliferation
ENSG00000113494,PRLR,cellular proliferation,tumor progression,signal transduction pathway,cancer-promoting factor,growth regulation,metastasis promotion
ENSG00000131323,TRAF3,nf-κb signaling pathway,e3 ubiquitin ligase activity,loss of function mutation,cancer development,immune evasion,cell survival regulation
ENSG00000028137,TNFRSF1B,nf-κb pathway regulation,apoptosis inhibition,tumor progression modulation,cancer cell proliferation,inflammation regulation,p53 interaction
ENSG00000102245,CD40LG,tumor progression,angiogenesis regulation,immune evasion,cancer immunotherapy target,cell activation signaling,t cell modulation
ENSG00000101017,CD40,cell activation,immune modulation,nf-κb signaling,tumor immunity,t-cell proliferation,dendritic cell maturation
ENSG00000159958,TNFRSF13C,baff-mediated signaling,tumor necrosis factor receptor superfamily member 13c,death domain-containing protein,b-cell development regulator,apoptosis inhibitor,oncogenic driver gene
ENSG00000102524,TNFSF13B,tnf-13b signaling,immune evasion,tumor microenvironment regulation,angiogenesis promotion,cell survival enhancement,oncogenic process contribution
ENSG00000076641,PAG1,cellular growth regulation,phospholipid metabolism alteration,lipid kinase regulation,tumor cell proliferation,protein dephosphorylation dysregulation,apoptosis evasion 
ENSG00000103653,CSK,oncogene,cell proliferation,signal transduction,tumor growth,src kinase regulation,apoptosis evasion
ENSG00000134242,PTPN22,cellular regulation,tumor progression,apoptosis inhibition,immunoregulation dysfunction,signaling pathway interaction,autoimmune disease association
ENSG00000213658,LAT,t-cell activation,dysregulated immune responses,cancer immunotherapy target,tumor immune evasion,immunomodulation,leukocyte signaling
ENSG00000082074,FYB1,fyn-binding protein activity,cytosolic adaptor function,oncogenic transformation,cell cycle progression,apoptosis inhibition,pi3k/akt/mtor pathway interaction
ENSG00000158092,NCK1,adaptor protein function,cell proliferation,pi3k pathway modulation,oncogenic process enhancement,signaling pathway regulation,protein-protein interaction
ENSG00000135341,MAP3K7,nf-κb signaling pathway,oncogenic,tumor progression,map kinase activation,cell survival regulation,inflammatory response
ENSG00000055208,TAB2,tgf-beta signaling pathway,nf-κb activation,cell proliferation regulation,apoptosis regulation,inflammation modulation,oncogenic processes
ENSG00000163600,ICOS,t-cell activation,immune modulation,germinal center reaction,cancer immunity,antibody production regulation,cellular response modulation
ENSG00000160223,ICOSLG,t-cell activation,promoting tumor growth,immune regulation,nf-κb pathway,t-cell proliferation,immunotherapy target
ENSG00000157873,TNFRSF14,aberrant signaling,anti-tumor immunity suppression,cancer immune evasion,immune cell regulation,lymphotoxin-alpha interaction,nf-κb activation
ENSG00000186265,BTLA,immune evasion,t cell regulation,oncogenesis promotion,immunosuppression,signaling attenuation,cell activation modulation
ENSG00000121594,CD80,antigen presentation,impaired t-cell activation,tumor immune evasion,pi3k/akt signaling interaction,immune surveillance disruption,cell surface expression
ENSG00000178562,CD28,co-stimulatory signaling,immune evasion,tumor microenvironment modulation,regulatory t-cell induction,cell proliferation enhancement,immunosuppression facilitation
ENSG00000114013,CD86,immune evasion,tumor microenvironment modulation,adaptive immune suppression,regulatory t-cell expansion,dendritic cell maturation inhibition,immunosuppressive environment creation
ENSG00000100906,NFKBIA,nf-κb signaling pathway,constitutive activation of nf-κb,loss of iκbα function,oncogenic processes,uncontrolled cell proliferation,apoptosis suppression
ENSG00000141367,CLTC,genomic instability,cellular proliferation,resistance to therapy,microtubule dynamics,cytoplasmic localization,cell cycle regulation
ENSG00000122705,CLTA,angiogenesis,tetraspanin complex,cell adhesion molecule,oncogenic driver,tumor progression,signaling pathway modulation
ENSG00000242574,HLA-DMB,antigen presentation,immune evasion,protein interaction,tumor suppression,t-cell activation,mhc class ii expression
ENSG00000204257,HLA-DMA,antigen presentation,immune modulation,tumor microenvironment regulation,immunogenicity modulation,cancer-associated antigens presentation,antigen processing and presentation pathway
ENSG00000153283,CD96,cell surface molecule,immunoglobulin superfamily member,tumor progression regulator,metastasis promoter,biomarker for disease progression,immune evasion mechanism
ENSG00000139626,ITGB7,tumor progression,cell adhesion,immune evasion,metastasis facilitation,intraepithelial lymphocyte interaction,tumor microenvironment modulation
ENSG00000206493,HLA-E,immune evasion,tumor progression,overexpression in cancer,nk cell suppression,therapeutic target,genomic profiling
ENSG00000039068,CDH1,cadherin function disruption,cell-cell adhesion loss,epithelial-to-mesenchymal transition (emt),reduced expression levels,wnt/β-catenin pathway dysregulation,oncogenic transcriptional repression
ENSG00000139187,KLRG1,immune regulation,cell adhesion,tumor immunology,biomarker potential,immune evasion,cancer immunotherapy
ENSG00000150637,CD226,immune activation,cell adhesion molecule,t cell modulation,immune evasion,cancer prognosis,immunotherapeutic target
ENSG00000091972,CD200,tumor immune evasion,macrophage regulation,immune suppression,tumor microenvironment modulation,oncogenic transformation,cancer cell proliferation
ENSG00000163606,CD200R1,immune evasion,tumor progression,protein expression regulation,myeloid cell modulation,anti-tumor immunity suppression,cancer immunotherapy
ENSG00000235346,HLA-G,immune evasion,tumor-associated antigen,immunosuppression,promoter methylation,epigenetic regulation,soluble factor interaction
ENSG00000275583,KIR2DS2,potassium ion channel regulation,cellular homeostasis maintenance,oncogenic process promotion,cell signaling modulation,cell growth enhancement,genetic alterations implicated
ENSG00000069493,CLEC2D,cell adhesion modulation,immune response dysregulation,pi3k/akt signaling,tumor progression enhancement,metastasis facilitation,cancer aggressiveness marker
ENSG00000111796,KLRB1,tumor immune evasion,immunosuppressive microenvironment,nk cell activation,cytotoxic activity,immune regulation,cell surface receptor function
ENSG00000158125,XDH,dual function,oxidative stress regulation,cell proliferation promotion,angiogenesis facilitation,prognostic marker,therapeutic target
ENSG00000124557,BTN1A1,tumor progression,immune regulation,oncogenesis,signaling pathway modulation,therapeutic target,cancer cell migration
ENSG00000115221,ITGB6,integrin-mediated adhesion,oncogenic signaling pathway,tumor aggressiveness,cell migration,adhesion molecule regulation,genomic instability
ENSG00000105329,TGFB1,tumor suppressor,tgf-beta signaling pathway,cell growth inhibition,apoptosis promotion,metastasis promoter,angiogenesis regulator
ENSG00000090006,LTBP4,tgf-β signaling regulation,metastasis facilitation,immune evasion mechanism,cell adhesion disruption,basement membrane remodeling,angiogenesis promotion
ENSG00000077943,ITGA8,cell adhesion,integrin function,tumor progression,metastasis promotion,cell migration enhancement,protein interaction modulation
ENSG00000105855,ITGB8,angiogenesis promotion,oncogenic properties,cell adhesion regulation,metastasis facilitation,tumor growth support,protein-protein interaction
ENSG00000064692,SNCAIP,tumor growth progression,serine protease inhibition,cellular signaling modulation,genomic instability,apoptosis resistance,dna damage response
ENSG00000185345,PRKN,mitochondrial dynamics,autophagy regulation,e3 ubiquitin ligase activity,mitophagy modulation,tumor suppressor function,genetic mutations associated
ENSG00000145335,SNCA,alpha-synuclein overexpression,pi3k/akt pathway interaction,neurotransmitter regulation dysfunction,transcription factor modulation,protein aggregation induction,cell proliferation enhancement
ENSG00000124486,USP9X,pi3k/akt pathway regulation,oncogenic protein stabilization,deubiquitinating enzyme activity,tumor suppressor degradation,apoptosis modulation,cell cycle regulation
ENSG00000137642,SORL1,enhanced mapk/erk signaling,overexpression,cell growth regulation,apoptosis suppression,endocytic pathway activation,tumor progression biomarker
ENSG00000142192,APP,protein degradation,wnt/β-catenin signaling,cell growth regulation,amyloid-beta production,apoptosis modulation,cell adhesion
ENSG00000145782,ATG12,autophagy pathway,constitutive expression,tumor microenvironment,cellular homeostasis,genetic instability,molecular regulation
ENSG00000197548,ATG7,autophagy promotion,cell survival enhancement,genetic instability,pi3k/akt pathway modulation,tumor progression facilitation,protein degradation regulation
ENSG00000152348,ATG10,autophagy regulation,oncogenic potential,mitochondrial dysfunction,protein degradation impairment,genetic instability promotion,tumor suppressor gene dysfunction
ENSG00000057663,ATG5,autophagy regulation,oncogenic function,overexpression,tumor progression,chemotherapy resistance,cell survival
ENSG00000176194,CIDEA,lipid metabolism alteration,apoptosis resistance,autophagy regulation,cell proliferation enhancement,tumor progression facilitation,oncogenic potential
ENSG00000187288,CIDEC,mitochondrial regulation,apoptosis induction,tumor progression,cell survival,protein-protein interactions,tissue remodeling
ENSG00000113721,PDGFRB,angiogenesis,constitutive activation,gain of function mutations,pi3k/akt pathway,tumor progression,therapeutic target
ENSG00000134853,PDGFRA,receptor tyrosine kinase activity,ligand-independent activation,pi3k/akt pathway activation,cell proliferation promotion,tumor progression association,therapeutic target potential
ENSG00000163513,TGFBR2,tumor suppressor function,loss of function mutations,tgf-β signaling pathway,cell proliferation,aberrant signaling,cancer therapy resistance
ENSG00000166913,YWHAB,regulation of cell cycle progression,interaction with pi3k/akt pathway,overexpression in various cancers,collaboration with other oncogenes,modulation of transcription factor activity,poor prognosis and increased tumorigenesis
ENSG00000126934,MAP2K2,mek/erk signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,ras/raf interaction
ENSG00000169032,MAP2K1,erk signaling pathway,constitutive activation,gain of function mutations,oncogene,cancer driver gene,tumor progression
ENSG00000141068,KSR1,mapk signaling,cell proliferation,oncogenic transformation,scaffold protein function,mitogen-activated protein kinases,aberrant expression
ENSG00000075413,MARK3,genomic instability,tumor suppressor function,aberrant microtubule dynamics,oncogene properties,cell cycle regulation,dualistic behavior
ENSG00000136807,CDK9,transcriptional activation,oncogenic transformation,chemotherapy resistance,cell proliferation,rna polymerase ii regulation,cyclin-dependent kinase activity
ENSG00000129315,CCNT1,regulation of rna polymerase ii-dependent transcription,positive regulation of cell proliferation,cell cycle progression,dna replication and repair,oncogenic processes,tumor growth and survival suppression
ENSG00000165898,ISCA2,metabolic reprogramming,cellular energy production,tumor metabolism,genomic instability,mitochondrial function,altered cellular homeostasis
ENSG00000135070,ISCA1,mitochondrial dysfunction,iron-sulfur cluster assembly,cell proliferation,tumorigenesis,genomic instability,apoptosis regulation
ENSG00000160703,NLRX1,mitochondrial function,immune surveillance,tumor suppressor,oncogenic transformation,mitophagy regulation,cell growth modulation
ENSG00000088888,MAVS,tumor suppressor,apoptosis induction,immune evasion,pro-inflammatory gene regulation,signaling pathway modulation,angiogenesis promotion
ENSG00000169855,ROBO1,tumor suppressor function,metastasis inhibition,rho gtpase regulation,apoptosis induction,epithelial-to-mesenchymal transition regulation,gene expression alteration
ENSG00000145147,SLIT2,tumor suppressor,epigenetic silencing,cell migration regulation,apoptosis induction,cell adhesion modulation,cancer cell invasion suppression
ENSG00000185652,NTF3,ntf3-trkc interaction,cell proliferation enhancement,angiogenesis promotion,apoptosis evasion,oncogenic potential,pi3k/akt pathway modulation
ENSG00000179841,AKAP5,oncogene,tumor suppressor interaction,signaling pathway modulation,cell proliferation regulation,pka anchoring protein,cancer progression facilitation
ENSG00000154134,ROBO3,tumor suppressor,slit/robo signaling,axon guidance regulation,chemotaxis modulation,pi3k/akt pathway interaction,metastasis inhibition
ENSG00000000971,CFH,complement system regulation,oncogenic role,tumor cell protection,angiogenesis promotion,protein interaction,cell survival enhancement
ENSG00000177455,CD19,b cell development,tumor marker,surface receptor function,mutation associations,co-receptor activity,b cell proliferation
ENSG00000110651,CD81,tumor progression,cell adhesion regulation,metastasis promotion,prognostic marker,signal transduction modulation,oncogenic processes
ENSG00000149131,SERPING1,complement system regulation,pro-tumorigenic microenvironment,anti-inflammatory properties,anticoagulant functions,mutations associated with cancer,inflammation and tumor progression
ENSG00000182326,C1S,complement activation,dysregulated pathways,protein-protein interactions,immunoglobulin binding,post-translational modifications,cellular regulation
ENSG00000288512,C1R,complement system dysregulation,immune evasion mechanisms,tumor growth promotion,metastasis facilitation,cell survival signaling,inflammatory response modulation
ENSG00000178772,CPN2,protein misfolding,chaperone function,tumor suppressor activity,cellular stress response,proteolytic regulation,quality control mechanism
ENSG00000120054,CPN1,pyruvate dehydrogenase complex activation,aerobic glycolysis,oncogenic metabolism,tumor progression,mitochondrial dysfunction,cellular respiration regulation
ENSG00000198910,L1CAM,cell adhesion disruption,metastatic potential,prognostic biomarker,tumor suppressor function,signaling pathway modulation,oncogenic transformation
ENSG00000099250,NRP1,angiogenic regulation,vegf signaling pathway,cell migration and invasion,tumor progression,metastasis promotion,cancer prognosis marker
ENSG00000144668,ITGA9,integrin-mediated adhesion,cell migration regulation,tumor progression facilitation,adhesion molecule overexpression,protein-protein interaction,metastatic potential enhancement
ENSG00000102882,MAPK3,mitogen-activated protein kinase signaling,cellular stress response,pro-inflammatory cytokine regulation,tumor progression,epithelial-to-mesenchymal transition,angiogenesis promoter
ENSG00000100030,MAPK1,raf-mek-erk pathway,constitutive activation,gain of function mutations,cell proliferation,signaling pathway regulation,mitogen-activated protein kinase activity
ENSG00000039537,C6,t-cell activation,cell surface glycoprotein,immune system regulation,oncogene activation,proliferation promotion,survival enhancement
ENSG00000179115,FARSA,regulation of mrna stability,cellular proliferation,rna-binding protein function,cell cycle regulation,protein-protein interactions,tumorigenesis
ENSG00000116120,FARSB,translation initiation,phenylalanine incorporation,tumor progression,amino acid metabolism,cancer biology,coding mutations
ENSG00000244734,HBB,hypoxia response,tumor aggressiveness,cancer stem cells,angiogenesis,metastasis promotion,gene expression dysregulation
ENSG00000206172,HBA1,alpha-globin subunit function,adult hemoglobin formation,rbc maturation,oxygen transport regulation,hemoglobinopathies,genetic mutations
ENSG00000188536,HBA2,alpha-globin subunit,redundant function,hemoglobin production,adaptation to hypoxia,tumor microenvironment,low oxygen adaptation
ENSG00000108854,SMURF2,tgf-β pathway regulation,ubiquitin ligase function,cell proliferation promotion,oncogene involvement,smad protein interaction,protein degradation mechanism
ENSG00000284126,SMURF1,tumor suppression/oncogenesis,ubiquitination regulation,tgf-? signaling pathway,protein degradation,cell growth modulation,pan-cancer involvement
ENSG00000049759,NEDD4L,e3 ubiquitin ligase activity,cellular regulation,tumor progression,protein degradation,oncogene regulation,pi3k/akt signaling
ENSG00000103266,STUB1,apoptosis regulation,endoplasmic reticulum stress response,tumor suppressor function,protein folding modulation,cell death pathways,hsp70 interaction
ENSG00000130725,UBE2M,ubiquitin-conjugating enzyme,protein degradation pathway,oncogenic protein regulation,tumor suppressor degradation,cell cycle regulation,therapeutic target
ENSG00000285246,NEDD8,cell cycle regulation,transcriptional regulation,oncogenic processes,ubiquitination pathway,cancer development,neddylation process
ENSG00000155827,RNF20,ubiquitin ligase function,histone modification,chromatin regulation,transcriptional activation,cancer prognosis,dna repair
ENSG00000103549,RNF40,oncogenic activity,tumor progression,cell cycle regulation,apoptosis modulation,protein degradation,e3 ubiquitin ligase function
ENSG00000111816,FRK,gain of function mutations,non-receptor tyrosine kinase activity,phosphorylation-dependent signaling,tumor growth promotion,genomic stability regulation,therapeutic target
ENSG00000233948,TRIM27,ubiquitin ligase activity,cell cycle regulation,oncogenic signaling,apoptosis regulation,genomic instability,therapeutic target
ENSG00000137809,ITGA11,cell adhesion,constitutive expression,dysregulation,extracellular matrix interaction,gene expression,metastasis
ENSG00000156886,ITGAD,t-cell activation,promotes tumor progression,regulates immune response,modulates synapse formation,immunosuppressive microenvironment,adhesion molecule function
ENSG00000083457,ITGAE,tumor progression,immune evasion,cell adhesion,metastasis,therapeutic target,cancer progression
ENSG00000142798,HSPG2,tumor microenvironment modulation,cell adhesion regulation,angiogenesis facilitation,oncogenic potential,extracellular matrix interaction,signal transduction modulation
ENSG00000288299,LDHA,warburg effect,altered metabolism,glycolytic shift,proliferation and survival,tumor microenvironment modification,cellular adaptation
ENSG00000111716,LDHB,metabolic reprogramming,glycolytic shift,tumor growth promotion,warburg effect regulation,prognostic marker,cellular metabolism modulation
ENSG00000163541,SUCLG1,mitochondrial function,energy metabolism regulation,cellular respiration modulation,succinyl-coa synthesis,tumor suppressor potential,genetic instability association
ENSG00000172340,SUCLG2,tca cycle regulation,glycolytic shift,oncogenic mutations,amplicon formation,hypoxic adaptation,tumor suppressor interaction
ENSG00000136143,SUCLA2,tricarboxylic acid cycle,energy metabolism,cellular respiration,cell proliferation,cell survival,tumor progression
ENSG00000102265,TIMP1,tumor progression,inflammation regulation,angiogenesis modulation,cell invasion inhibition,proteolytic balance control,stress response modulation
ENSG00000100985,MMP9,tumor progression,extracellular matrix degradation,angiogenesis promotion,growth factor activation,metastasis facilitation,therapeutic target
ENSG00000157227,MMP14,tumor progression,tumor initiation,metastasis,cancer biology,ecm degradation,cell migration
ENSG00000035862,TIMP2,tumor suppression,cell proliferation,dual functionality,matrix metalloproteinase regulation,apoptosis inhibition,extracellular matrix remodeling
ENSG00000102054,RBBP7,dna repair mechanisms,chromatin remodeling,genomic instability,cell cycle regulation,transcriptional regulation,oncogene activity
ENSG00000128708,HAT1,epigenetic regulation,chromatin remodeling,histone modification,cell proliferation,transcriptional regulation,tumor suppressor
ENSG00000135903,PAX3,oncogene,tumor progression,epithelial-to-mesenchymal transition (emt),transcription factor activation,cell proliferation and differentiation regulation,metastasis and invasion
ENSG00000084676,NCOA1,transcriptional regulation,aberrant activation,genomic instability,cell proliferation,oncogene cooperation,apoptosis suppression
ENSG00000163930,BAP1,genomic instability,tumor suppressor function,dna repair mechanism,cell cycle regulation,chromatin remodeling,ubiquitin modification
ENSG00000172534,HCFC1,transcriptional coactivator,cell cycle regulation,oncogenic process,cell proliferation,survival enhancement,metastasis promotion
ENSG00000100324,TAB1,nf-?b activation,tgf-?-activated binding protein,oncogenic signaling pathway,cell proliferation enhancement,metastasis facilitation,protein-protein interaction
ENSG00000145604,SKP2,cell cycle progression,cyclin-dependent kinase inhibitor degradation,oncogenic driver,cell proliferation promotion,transcriptional regulation modulation,tumor growth facilitation
ENSG00000070010,UFD1,ubiquitin-proteasome pathway,protein quality control,dna repair mechanisms,tumor suppressor regulation,genome stability maintenance,oncogenic protein accumulation
ENSG00000165280,VCP,oncogenic mutations,proteostasis dysregulation,mitotic progression,dna repair dysfunction,tumor growth promotion,autophagy disruption
ENSG00000180667,YOD1,lysine dehydrogenase activity,redox balance maintenance,oxidative stress response,tumor progression promotion,therapeutic target,metastasis enhancement
ENSG00000019995,ZRANB1,oncogenic activation,tumor progression,chromatin remodeling,transcriptional regulation,cell cycle disruption,genomic instability
ENSG00000134982,APC,cell cycle regulation,wnt signaling pathway,tumor suppression,epithelial-to-mesenchymal transition,beta-catenin interaction,genomic stability maintenance
ENSG00000066427,ATXN3,histone acetyltransferase activity,chromatin remodeling,protein-protein interaction,cell cycle regulation,apoptosis evasion,tumor growth promotion
ENSG00000124356,STAMBP,chromatin regulation,protein degradation regulation,ubiquitin-proteasome pathway regulation,tumor progression driver,oncogenic transformation associated,therapeutic target
ENSG00000136738,STAM,cell signaling pathway regulation,endocytic pathway modulation,tumor growth promotion,metastasis facilitation,poor prognosis biomarker,therapeutic target
ENSG00000140538,NTRK3,chimeric protein formation,constitutive kinase activity,cell proliferation regulation,tumor growth promotion,angiogenesis induction,oncogenic signaling pathway activation
ENSG00000105426,PTPRS,dephosphorylation regulation,signaling pathway modulation,cell growth promotion,cell survival enhancement,oncogenic process contribution,tumor progression facilitation
ENSG00000106366,SERPINE1,proteolytic regulation,tumor progression,angiogenesis inhibition,cell migration,cell invasion,apoptosis suppression
ENSG00000109072,VTN,angiogenesis,cell adhesion,endothelial cell interaction,factor viii carrier,platelet plug formation,tumor progression
ENSG00000173402,DAG1,disrupted lipid metabolism,tumor suppressor function,cell membrane regulation,pi3k/akt pathway interaction,oncogenic mutation,regulatory dysfunction
ENSG00000188157,AGRN,nmj formation,constitutive activation,cell adhesion regulation,tumor progression,genomic instability,synaptic transmission regulation
ENSG00000142867,BCL10,nf-κb signaling pathway,aberrant activation,mutations leading to overexpression,enhanced cell survival and proliferation,carma1-bcl10-malt1 complex formation,dysregulation in cancer pathogenesis
ENSG00000187122,SLIT1,cell adhesion regulation,tumor suppressor function,robo receptor modulation,angiogenesis inhibition,metastasis suppression,cell migration regulation
ENSG00000188559,RALGAPA2,ras-activation,gain-of-function mutations,oncogene regulation,signal transduction modulation,cell growth promotion,tumor progression driver
ENSG00000170471,RALGAPB,cell proliferation,metastasis promotion,downstream signaling regulation,protein-protein interaction,gtpase activity modulation,genomic instability
ENSG00000173230,GOLGB1,oncogenic potential,golgi apparatus modification,cell growth regulation,signaling pathway modulation,tumor progression,stress response regulation
ENSG00000182827,ACBD3,fatty acid metabolism,cellular stress response,tumor suppressor function,pparα regulation,cancer metastasis,genomic instability
ENSG00000100099,HPS4,cellular proliferation,transcriptional regulation,oncogenic potential,chromatin remodeling,apoptosis evasion,cell cycle progression
ENSG00000107521,HPS1,gain of function mutations,cell cycle regulation,dna repair,tumor suppressor role,mitochondrial dynamics,protein kinase modulation
ENSG00000163083,INHBB,tumor progression,cell proliferation inhibition,tgf-β pathway regulation,oncogenesis association,protein-protein interaction,signal transduction alteration
ENSG00000122641,INHBA,tumor suppressor,hypoxia-inducible factor regulation,transcriptional activation,cell differentiation,growth inhibition,cell proliferation inhibition
ENSG00000108950,FAM20A,oncogenic signaling,cell proliferation regulation,tumorigenesis association,phosphorylation activity,biomarker potential,interactions with other proteins
ENSG00000177706,FAM20C,cellular proliferation,signaling pathway dysregulation,tumor progression,phosphatase activity,genomic instability,oncogene expression
ENSG00000143799,PARP1,genomic instability,oncogene activation,therapeutic target,dna repair mechanism,apoptosis regulation,cell cycle progression
ENSG00000002016,RAD52,homologous recombination,genomic instability,cellular resistance,dna repair mechanism,oncogenic mutations,tumor progression
ENSG00000163961,RNF168,dna damage response,ubiquitination,tumor suppressor function,genomic instability,cell cycle regulation,apoptosis regulation
ENSG00000067066,SP100,nuclear localization,chromatin regulation,cell cycle progression,transcriptional modulation,oncogenic function,protein-protein interactions
ENSG00000139372,TDG,dna repair,genotoxic stress protection,tumorigenesis,oncogenic processes,cell survival,dna damage response
ENSG00000165392,WRN,telomere regulation,genomic instability,dna repair mechanism,p53 interaction,cell cycle checkpoint activation,apoptosis induction
ENSG00000154767,XPC,genome instability,dna repair deficiency,mutational burden,cancer susceptibility,transcriptional regulation,protein-protein interaction
ENSG00000187098,MITF,cell survival,transcriptional regulation,tumor progression,oncogene function,metastasis promotion,pi3k/akt pathway interaction
ENSG00000172845,SP3,tumor progression,transcriptional regulation,oncogene upregulation,cell proliferation,cell survival,metastasis promotion
ENSG00000067369,TP53BP1,dna double-strand break repair,genomic stability maintenance,non-homologous end joining,tumor suppressor interaction,chromosomal instability,oncogenic transformation
ENSG00000147889,CDKN2A,genomic instability,tumor suppressor function,loss of heterozygosity,p53 pathway activation,cell cycle regulation,malignant transformation
ENSG00000177374,HIC1,genomic instability,tumor suppressor function,epigenetic silencing,transcriptional regulation,apoptosis suppression,cancer cell proliferation
ENSG00000183770,FOXL2,tumor suppressor function,transcriptional regulation,cellular differentiation,proliferation control,ovarian cancer association,genomic instability
ENSG00000100201,DDX17,cell cycle regulation,oncogenic processes,tumor development,chromatin modulation,biomarker potential,rna metabolism regulation
ENSG00000182568,SATB1,global chromatin organizer,oncogenic transcription factor,chromatin remodeling complex interaction,cell proliferation promoter,metastasis enhancer,gene expression regulator
ENSG00000178691,SUZ12,polycomb repressive complex 2 (prc2) component,epigenetic silencer,chromatin remodeling,histone modification (h3k27me3),oncogene/tumor suppressor,cell growth regulation
ENSG00000068024,HDAC4,cell cycle regulation,histone deacetylation,gene transcription repression,tumor suppressor function,metastasis promotion,prognostic marker
ENSG00000116478,HDAC1,epigenetic regulation,histone deacetylation,transcriptional silencing,oncogenesis,chromatin compaction,therapeutic target
ENSG00000196591,HDAC2,histone deacetylation,epigenetic regulation,tumor suppressor function,apoptosis modulation,senescence induction,chromatin remodeling
ENSG00000170004,CHD3,chromatin remodeling,epigenetic regulation,tumor suppressor function,genomic instability,cell cycle regulation,chromatin modification
ENSG00000092199,HNRNPC,spliceosome regulation,aberrant splicing events,cell survival pathways,apoptosis evasion,pro-survival signaling,genomic instability
ENSG00000055044,NOP58,non-coding rna-binding protein,pre-mrna splicing regulator,nuclear architecture modulator,oncogenic function driver,cell proliferation promoter,signaling pathway regulator
ENSG00000198900,TOP1,dna unwinding,cell cycle regulation,oncogenic potential,chemosensitivity,genomic instability,tumor progression
ENSG00000131747,TOP2A,dna damage,genomic instability,cell proliferation,transcription regulation,tumor progression,therapeutic target
ENSG00000077097,TOP2B,genomic instability,aneuploidy,cell proliferation,topoisomerase function,dna replication,genome stability
ENSG00000143379,SETDB1,histone modification,epigenetic regulation,heterochromatin formation,oncogene expression,cell cycle progression,therapeutic target
ENSG00000171681,ATF7IP,transcriptional regulation,oncogenic processes,cell growth promotion,genome instability,cancer-associated mutations,tumor suppressor function
ENSG00000100462,PRMT5,arginine methylation,chromatin regulation,oncogenic driver,cell proliferation,apoptosis inhibition,tumor suppressor regulation
ENSG00000116455,WDR77,cell cycle regulation,transcriptional modulation,dna damage response,oncogenic potential,tumor suppressor activity,chromatin remodeling
ENSG00000158828,PINK1,mitochondrial function,mitophagy regulation,tumor suppressor activity,metabolic reprogramming,oxidative stress response,cellular energy metabolism
ENSG00000178568,ERBB4,oncogenic activity,constitutive activation,protein kinase activation,growth factor signaling,tumor progression,autophosphorylation
ENSG00000189056,RELN,cell migration,tumor progression,cell adhesion,signaling pathway activation,oncogenesis,neurodevelopmental gene expression
ENSG00000147852,VLDLR,tumor progression,metabolic regulation,endocytosis pathway,lipid metabolism,cell signaling,oncogenic potential
ENSG00000141505,ASGR1,wnt/β-catenin pathway,aberrant expression,cell proliferation,glycoprotein endocytosis,tumor aggressiveness,cancer prognosis
ENSG00000161944,ASGR2,asgr2 subunit,anti-tumor properties,cellular recognition,glycoprotein endocytosis,protein quality control,tumor suppression
ENSG00000120738,EGR1,overexpression,transcriptional regulation,cell proliferation,apoptosis suppression,tumor progression,therapeutic target
ENSG00000101115,SALL4,tumor suppressor gene regulation,oncogenesis,cell proliferation,stem cell maintenance,metastasis,prognostic marker
ENSG00000179632,MAF1,p53 pathway regulation,transcriptional repression,dna damage response,cellular survival,tumor suppressor interaction,genetic regulatory network
ENSG00000160007,ARHGAP35,rho gtpase regulation,oncogenic signaling pathway disruption,tumor suppressor function,cell proliferation enhancement,aberrant activation of effectors,gene expression profile changes
ENSG00000145715,RASA1,genetic predisposition,ras protein activation,oncogenic mutations,cell proliferation regulation,apoptosis suppression,tumor suppressor interaction
ENSG00000285460,BCAR1,src activation,oncogenic processes,cell proliferation,apoptosis resistance,genomic instability,signaling pathway modulation
ENSG00000143171,RXRG,retinoic acid regulation,tumor suppressor,oncogene activation,nuclear receptor signaling,cell differentiation,cancer driver gene
ENSG00000172819,RARG,tumor suppression,cellular differentiation regulation,apoptosis induction,cell cycle regulation,therapeutic target,transcriptional modulation
ENSG00000186350,RXRA,apoptosis evasion,cell differentiation,chromatin remodeling,dna repair,metastasis promotion,transcriptional regulation
ENSG00000131759,RARA,rar-alpha activation,cell differentiation,transcription factor activity,pml-rara fusion protein,epithelial-to-mesenchymal transition,chromosomal rearrangement
ENSG00000231321,RXRB,metabolic reprogramming,cell growth regulation,tumor suppressive function,transcriptional regulation,stem cell self-renewal regulation,gene expression modulation
ENSG00000077092,RARB,regulatory function,tumor suppressor activity,transcriptional regulation,apoptosis induction,cell proliferation suppression,genetic instability
ENSG00000112033,PPARD,metabolic reprogramming,inflammation regulation,cell proliferation inhibition,tumor suppression,oncogenic function,genomic instability
ENSG00000118257,NRP2,vegf signaling pathway,angiogenesis promoter,metastasis regulator,oncogene function,cell migration facilitator,tumor growth driver
ENSG00000102755,FLT1,angiogenesis promotion,vegf-a signaling pathway activation,constitutive receptor activation,tumor-induced vascularization,immunosuppression induction,therapeutic target identification
ENSG00000049130,KITLG,tumor-promoting ligand,aberrant signaling pathway activation,cell proliferation enhancement,immune system dysregulation,oncogenic protein-protein interactions,signaling cascade modulation
ENSG00000157404,KIT,oncogenic driver,constitutive activation,receptor tyrosine kinase activity,downstream signaling pathways,kinase inhibitor target,cell proliferation regulator
ENSG00000154229,PRKCA,oncogene activation,cell proliferation,pi3k/akt pathway interaction,protein kinase activity,cell survival regulation,tumor progression promotion
ENSG00000060656,PTPRU,tumor suppressor,constitutive activation,loss of phosphatase activity,enhanced cell proliferation,cell signaling regulation,genomic alterations
ENSG00000141027,NCOR1,corepressor function,tumor suppressor role,aberrant expression mutations,cellular regulation disruption,transcriptional repression,nuclear receptor interaction
ENSG00000131746,TNS4,tumor suppressor inhibition,cell survival promotion,epithelial-to-mesenchymal transition,cancer cell growth facilitation,metastasis promotion,transcriptional regulation disruption
ENSG00000105976,MET,cancer progression,therapeutic target,oncogenic signaling,aberrant activation,cell proliferation,metastasis promotion
ENSG00000144749,LRIG1,rtk regulation,tumor suppression,gpcr interaction,signaling pathway modulation,angiogenesis inhibition,therapeutic target
ENSG00000135473,PAN2,gain of function mutations,polyadenylated transcript degradation,tumor progression,cell proliferation enhancement,apoptosis resistance,therapeutic target
ENSG00000152520,PAN3,cell proliferation,oncogene overexpression,nuclear localization,mrna regulation,cancer progression,therapeutic target
ENSG00000009830,POMT2,glycosylation,cell-cell adhesion disruption,extracellular matrix degradation,tumor suppressor dysfunction,muscular dystrophy association,cancer-related glycosylation
ENSG00000130714,POMT1,n-glycosylation disruption,glycoprotein alterations,cell signaling modulation,aberrant protein modifications,mass spectrometry detectable,tumor initiation role
ENSG00000171155,C1GALT1C1,protein glycosylation,chaperone function,tumor progression,post-translational modification,glycoprotein regulation,cancer association
ENSG00000106392,C1GALT1,epithelial cell function disruption,cell proliferation enhancement,tumor progression contribution,glycosylation pattern alteration,signaling pathway activation,genomic instability promotion
ENSG00000165688,PMPCA,oncogenic activity,tumor growth promotion,cell cycle regulation,apoptosis evasion,chemoresistance,protein-protein interactions
ENSG00000105819,PMPCB,cell growth regulation,genomic instability,oncogenic processes,tumor progression,cell proliferation enhancement,protein interaction modulation
ENSG00000118217,ATF6,chronic cell stress,er stress regulation,cell survival enhancement,oncogenesis facilitation,transcriptional induction,tumor adaptation
ENSG00000044574,HSPA5,oncogenic chaperone,constitutive overexpression,tumor progression,cell survival,metastasis initiation,therapeutic resistance
ENSG00000172071,EIF2AK3,er stress response,integrated stress pathway,tumor suppressor activity,protein synthesis regulation,cellular survival mechanism,cancer driver mutation
ENSG00000178607,ERN1,autophagic regulation,pi3k/akt pathway modulation,cell survival promotion,tumor progression driver,genetic mutation association,metabolic reprogramming
ENSG00000196455,PIK3R4,pi3k/akt pathway regulation,dysregulation of signaling,interaction with oncogenes,modulation of cell growth,impact on cellular metabolism,regulatory function in cancer
ENSG00000078142,PIK3C3,regulatory subunit,constitutive activation,tumor progression,oncogenic mutations,pi3k/akt pathway,cell proliferation
ENSG00000149476,TKFC,genomic instability,cellular proliferation,dna replication,apoptosis regulation,tumor progression,genetic interaction
ENSG00000115267,IFIH1,antiviral response,innate immunity,viral recognition,interferon signaling,cellular responses,antitumor immune evasion
ENSG00000172757,CFL1,actin dynamics regulation,cell cycle progression enhancement,oncogene upregulation,emt facilitation,tumor-initiating cell association,cytoskeleton modulation
ENSG00000106683,LIMK1,cellular invasion,cancer metastasis,actin cytoskeleton regulation,cell migration,protein-protein interactions,microtubule stabilization
ENSG00000163218,PGLYRP4,pentraxin family,innate immunity,microbial pathogen recognition,tumor microenvironment modulation,immune evasion,apoptosis resistance
ENSG00000159527,PGLYRP3,tumor-promoting inflammation,overexpression in cancers,regulation of immune responses,interaction with complement components,role in nf-κb signaling pathway,potential biomarker for early detection
ENSG00000132170,PPARG,tumor suppression,cell cycle regulation,apoptosis induction,anti-angiogenic effects,metabolic regulation,dna methylation modification
ENSG00000138079,SLC3A1,amplification,cell membrane transport,energy metabolism regulation,oncogenic transformation,protein synthesis enhancement,tumor progression facilitation
ENSG00000165617,DACT1,wnt/β-catenin signaling,transcriptional repression,epithelial-to-mesenchymal transition (emt),apoptosis regulation,pro-survival pathway activation,tumor suppressor function
ENSG00000103126,AXIN1,wnt/β-catenin pathway disruption,constitutive activation of tcf/lef transcription factors,loss-of-function mutations,oncogenic gene expression,cell proliferation regulation,adhesion and polarity regulation
ENSG00000082701,GSK3B,glycogen metabolism disruption,apoptosis inhibition,wnt signaling pathway modulation,tumor suppressor function,cell growth regulation,protein kinase activation
ENSG00000067057,PFKP,cellular respiration,glycolytic pathway,atp production,carbohydrate metabolism,catabolic process,energy regulation
ENSG00000141959,PFKL,altered metabolism,enhanced glycolysis,increased energy production,tumor aggressiveness,prognostic significance,metabolic reprogramming
ENSG00000152556,PFKM,glycolysis regulation,metabolic reprogramming,energy metabolism,cancer cell proliferation,therapeutic target,glucose metabolism
ENSG00000084734,GCKR,regulation of glucose metabolism,interaction with pi3k/akt pathway,metabolic reprogramming,altered energy metabolism,cancer cell growth,glycolytic shift
ENSG00000106633,GCK,glycolytic pathway,gain of function mutations,glucose metabolism regulation,tumor progression,therapeutic target,aberrant expression
ENSG00000029534,ANK1,actin cytoskeleton regulation,signaling pathway modulation,cytoskeletal anchoring,mutation-driven oncogenesis,cell adhesion disruption,survival pathway interaction
ENSG00000091129,NRCAM,neuronal growth cone motility,cell adhesion molecule,axon guidance,neurite outgrowth,synaptogenesis,extracellular matrix interaction
ENSG00000184144,CNTN2,neurodevelopmental function,cell-cell adhesion,tumor progression,metastasis,therapeutic target,oncogenic signaling
ENSG00000134121,CHL1,epithelial-to-mesenchymal transition,cell adhesion molecule function,prognostic marker,tumor progression,migration and invasion,axon guidance regulation
ENSG00000163531,NFASC,neurodevelopmental regulation,cell adhesion molecule function,tumor progression,immune evasion mechanisms,metastatic potential,signaling pathway interaction
ENSG00000077279,DCX,disrupted microtubule dynamics,cytoskeletal protein function,neuronal migration regulation,epigenetic modifications,genetic alterations,tumor aggressiveness predictor
ENSG00000137575,SDCBP,chromatin remodeling,oncogenic transformation,cell cycle progression,transcriptional activation,apoptosis resistance,pi3k/akt pathway interaction
ENSG00000164050,PLXNB1,angiogenesis promotion,cell adhesion disruption,metastasis facilitation,oncogene activation,tumor progression enhancement,biomarker identification
ENSG00000141736,ERBB2,oncogene,receptor tyrosine kinase activation,cell proliferation,constitutive activation,growth-promoting signals,overexpression
ENSG00000137076,TLN1,tumor suppressor activity,cell adhesion regulation,cell migration modulation,metastatic potential enhancement,protein-protein interactions,transcriptional regulation
ENSG00000186111,PIP5K1C,pip2 synthesis,cell proliferation,tumor progression,therapeutic target,signaling regulation,genomic alterations
ENSG00000004399,PLXND1,angiogenic signaling,tumor growth promotion,vascular niche modulation,vegfa pathway interaction,pi3k/akt pathway activation,gene overexpression
ENSG00000170381,SEMA3E,tumor progression,cell migration regulation,angiogenesis promotion,immune evasion facilitation,metastasis suppression downregulation,cell adhesion modulation
ENSG00000196189,SEMA4A,tumor progression,angiogenesis promotion,cell-cell communication disruption,plexin receptor interaction,immune response modulation,tumor suppressor potential
ENSG00000262418,PTPRC,cellular adhesion,immune response modulation,oncogenic processes,tumorigenesis driver,receptor signaling regulation,chemokine and cytokine signaling
ENSG00000187764,SEMA4D,sema4d,cell migration,vegf secretion,immune suppression,tumor progression,angiogenesis
ENSG00000137101,CD72,cell surface receptor,tumor suppression,oncogenic process modulation,b cell development regulation,immune response regulation,mutation associated cancer
ENSG00000136040,PLXNC1,vegf signaling pathway disruption,cell adhesion and migration regulation,angiogenesis promotion,tumor progression driver,therapeutic target candidate,genomic instability mediator
ENSG00000138623,SEMA7A,tumor progression,immune evasion,metastasis promotion,therapeutic target,cell signaling regulation,gene expression dysregulation
ENSG00000010810,FYN,fyn kinase activity,oncogenic signaling,non-receptor tyrosine kinase,tumor progression,immune cell modulation,cell proliferation 
ENSG00000185008,ROBO2,slit family receptor,axon guidance,epithelial maintenance,tumor suppressor function,pi3k/akt pathway regulation,cell cycle inhibition
ENSG00000151748,SAV1,wnt/beta-catenin pathway activation,cell cycle regulation disruption,genomic instability promotion,tumor growth facilitation,therapeutic target identification,protein-protein interaction alterations
ENSG00000104375,STK3,apoptosis regulation,tumor suppressor function,cell signaling pathway regulation,mst2/stk3 complex formation,cancer progression association,dna damage response
ENSG00000101109,STK4,tumor suppressor function,apoptosis induction,cell cycle regulation,dna damage response,hippo pathway regulation,pi3k/akt pathway modulation
ENSG00000119139,TJP2,cell-cell adhesion disruption,epithelial integrity loss,potential tumor suppressor,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition (emt),cancer cell metastasis enhancement
ENSG00000018408,WWTR1,cell proliferation,hippo signaling pathway,oncogenic activation,transcriptional regulation,g2/m cell cycle progression,tumor suppressor inactivation
ENSG00000075340,ADD2,cell adhesion disruption,epithelial-to-mesenchymal transition,cytoskeletal regulation,tumor progression,signaling pathway activation,protein-protein interaction
ENSG00000087274,ADD1,calmodulin-binding protein activity,promotes tumor growth,epigenetic regulation,protein-protein interactions,cell signaling pathways,tumor progression
ENSG00000148700,ADD3,oncogenic function,tumor progression,cell motility regulation,protein-protein interaction,cytoplasmic localization,genomic instability
ENSG00000160862,AZGP1,angiogenesis regulation,cell migration facilitation,epithelial-to-mesenchymal transition,heparan sulfate proteoglycan interaction,proteolytic activity enhancement,vascular permeability modulation
ENSG00000159763,PIP,pi3k signaling pathway,oncogenesis,tumor progression,cell growth regulation,apoptosis resistance,therapeutic target
ENSG00000136802,LRRC8A,ion channel function,mechanotransduction regulation,cell migration promotion,metastasis facilitation,pi3k/akt pathway interaction,therapeutic target
ENSG00000197147,LRRC8B,apoptosis evasion,cellular homeostasis disruption,cellular swelling regulation,oncogenic driver mutation,tumor progression facilitation,genomic instability promotion
ENSG00000171017,LRRC8E,ion channel regulation,oncogenic mutations,cell proliferation,pro-survival signaling,tumor progression,therapeutic target
ENSG00000171492,LRRC8D,ion channel regulation,tumor progression,cell migration,cell invasion,protein-protein interaction,adhesion molecule function
ENSG00000171488,LRRC8C,mechanosensitive channel regulation,cell proliferation modulation,tumorigenesis association,dysregulated expression levels,cellular mechanics alteration,cancer cell migration influence
ENSG00000158402,CDC25C,g2/m phase transition,cell cycle regulation,cyclin-dependent kinase activation,tumor progression,dna damage response,protein-protein interaction
ENSG00000144867,SRPRB,lipid metabolism regulation,tumor suppressor interaction,pi3k/akt pathway modulation,cell growth regulation,apoptosis inhibition,therapeutic resistance induction
ENSG00000182934,SRPRA,protein targeting,cellular protein regulation,gene expression dysregulation,misfolded protein accumulation,oncogenic pathway activation,tumor suppressor function disruption
ENSG00000009950,MLXIPL,glucose metabolism regulation,insulin signaling activation,transcriptional regulation,tumor growth promotion,cell proliferation enhancement,energy metabolism modulation
ENSG00000108788,MLX,wnt/β-catenin signaling,transcriptional regulation,coactivator function,cell proliferation,oncogenesis,genomic amplification 
ENSG00000141526,SLC16A3,mct activity,warburg effect,cell proliferation,energy metabolism,glycolysis regulation,lactate export enhancement
ENSG00000281917,SLC16A1,metabolic adaptation,tumor growth promotion,chemoresistance,glycolytic shift,energy supply facilitation,hypoxia adaptation
ENSG00000149269,PAK1,cell migration regulation,oncogenic signaling,pi3k/akt pathway interaction,tumor progression driver,therapeutic target,cytoskeleton reorganization
ENSG00000186575,NF2,tumor suppressor,cell growth regulation,rho gtpase signaling inhibition,oncogenic pathway inhibition,neurofibromatosis 2 association,cancer treatment target
ENSG00000196924,FLNA,cellular dynamics,actin filament cross-linking,cell migration regulation,tumor progression,metastasis promotion,cancer cell invasion
ENSG00000123143,PKN1,aberrant activation,cell migration,cell proliferation,genomic instability,post-translational modifications,serine/threonine kinase activity
ENSG00000122966,CIT,metabolic regulation,cell growth promotion,oncogenesis contribution,glycolytic enhancement,energy metabolism regulation,ph level regulation
ENSG00000111276,CDKN1B,cell cycle regulation,tumor suppressor,apoptosis resistance,cyclin-dependent kinase inhibition,epigenetic silencing,dna methylation
ENSG00000001626,CFTR,cancer associated protein,epithelial ion regulation,genetic alteration,chloride channel dysfunction,pancreatic adenocarcinoma association,regulatory pathway interaction
ENSG00000047932,GOPC,oncogene activation,protein trafficking regulation,cell growth promotion,tumor progression facilitation,golgi apparatus involvement,cellular homeostasis disruption
ENSG00000159593,NAE1,chromatin maintenance,tumor suppressor function,histone chaperone activity,epigenetic regulation,dna repair mechanisms,genome instability
ENSG00000144744,UBA3,neddylation pathway,protein stabilization,cell cycle regulation,genome stability,apoptosis evasion,therapeutic target
ENSG00000184182,UBE2F,genomic stability regulation,tumor suppressor function,dna damage repair,protein degradation regulation,cell cycle progression control,cancer prognosis association
ENSG00000158290,CUL4B,ubiquitination regulation,cancer progression,genomic instability,oncogenic process promotion,apoptosis resistance,cell cycle control
ENSG00000139842,CUL4A,ubiquitin-proteasome pathway,tumor suppressor function,dna damage response,transcriptional control,cell cycle regulation,oncogene activation
ENSG00000100387,RBX1,scf complex regulation,proteasome degradation pathway,mitotic checkpoint control,tumor suppressor protein inhibition,dna repair pathway interaction,oncoprotein accumulation
ENSG00000112659,CUL9,ubiquitin-proteasome pathway,cellular degradation,e3 ligase complex,oncogenic pathways,tumor progression,p53 regulation
ENSG00000116678,LEPR,oncogenic signaling,angiogenesis promotion,emt induction,apoptosis suppression,hormone regulation,cell proliferation enhancement
ENSG00000099800,TIMM13,mitochondrial assembly,cytochrome c oxidase interaction,cellular metabolism regulation,apoptosis modulation,genetic expression regulation,signaling pathway interaction
ENSG00000150779,TIMM8B,mitochondrial dysfunction,glycolytic shift,oncogenic mutations,genomic instability,cell proliferation regulation,metabolic reprogramming
ENSG00000126953,TIMM8A,mitochondrial dysfunction,energy metabolism reprogramming,loss-of-function mutations,apoptosis modulation,therapeutic target,genomic profiling
ENSG00000134809,TIMM10,mitochondrial translation,tumor progression,metabolic regulation,cell survival,biomarker potential,energy metabolism alteration
ENSG00000100575,TIMM9,mitochondrial function regulation,oncogenic adaptation,enhanced glycolysis,genomic instability protection,cellular metabolism reprogramming,tumor cell survival enhancement
ENSG00000111880,RNGTT,chromatin regulation,histone methylation,cell cycle progression,transcriptional control,epigenetic modifications,oncogenic function
ENSG00000101654,RNMT,transcriptional regulation,genetic instability,rna processing,tumor suppressor interaction,cancer-related mrna stability,oncogenic pathway activation
ENSG00000133226,SRRM1,alternative splicing regulation,splicing factor activity,rna processing modulation,tumor progression influence,genomic instability contribution,therapeutic target potential
ENSG00000167978,SRRM2,alternative splicing,tumor progression,oncogenic mrnas regulation,spliceosomal interaction,transcriptional regulation,protein kinase activation
,EPRS,translation regulation,stress response activation,protein synthesis modulation,cellular homeostasis maintenance,translation initiation control,tumor suppressor function
ENSG00000167264,DUS2,dephosphorylation,mapk signaling pathway regulation,tumor suppressor function,cell survival promotion,therapeutic target potential,genomic instability association
ENSG00000160193,WDR4,spliceosome component,genomic stability maintenance,aberrant splicing prevention,oncogene dysregulation,tumor progression driver,cancer-associated mutations
ENSG00000037897,METTL1,m6a modification,oncogenic function,tumor progression,metabolic regulation,rna processing,protein interaction
ENSG00000213339,QTRT1,alternative splicing regulation,oncogene function,cell proliferation promotion,pi3k/akt pathway modulation,therapeutic target,rna stability regulator
ENSG00000151576,QTRT2,trna degradation,anabolic metabolism,cell proliferation enhancement,cancer driver gene candidate,mtor pathway regulation,protein localization
ENSG00000089195,TRMT6,translational regulation,trna modification,dna damage response,cell proliferation,oncogene,metabolic reprogramming
ENSG00000166166,TRMT61A,trna modification,oncogenic properties,cell proliferation,aberrant translation,genomic instability,cellular transformation
ENSG00000163964,PIGX,regulation of cell surface receptors,constitutive activation of pi3k/akt,gain of function mutations,oncogenesis,cell proliferation,metabolic reprogramming
ENSG00000143315,PIGM,glycosylphosphatidylinositol (gpi) anchors,tumor progression,cell adhesion disruption,metastasis facilitation,protein-protein interaction modulation,pi3k/akt pathway regulation
ENSG00000151665,PIGF,angiogenesis promotion,tumor progression facilitation,metastasis contribution,vascular permeability increase,cell survival enhancement,protein-protein interaction modulation
ENSG00000165282,PIGO,pi3k/akt/mtor pathway,oncogene/tumor suppressor,cell signaling regulation,protein anchoring disruption,membrane trafficking modulation,cell growth regulation
ENSG00000174227,PIGG,aberrant expression,apoptosis evasion,cellular proliferation,genetic instability,phosphorylation signaling,tumor initiation
ENSG00000156976,EIF4A2,mrna translation regulation,oncogene activation,cell cycle progression,tumor growth promotion,therapeutic target,genetic dysregulation
ENSG00000161960,EIF4A1,mrna translation regulation,cell growth and proliferation enhancement,oncogenic transformation promotion,tumor progression facilitation,therapeutic target,genomic amplification
ENSG00000080815,PSEN1,gamma-secretase activity,amyloid precursor protein cleavage,cell proliferation,notch signaling regulation,presenilin function disruption,familial alzheimer's disease
ENSG00000162736,NCSTN,notch signaling pathway,cell fate determination,gain of function mutations,tumor progression,tumorigenesis,therapeutic target
ENSG00000186298,PPP1CC,constitutive activation,regulatory phosphorylation,cell cycle regulation,dephosphorylation activity,oncogenic transformation,signaling pathway modulation
ENSG00000087074,PPP1R15A,cell cycle regulation,apoptosis suppression,metabolic regulation,stress response modulation,protein phosphatase regulation,oncogenesis promotion
ENSG00000168288,MMADHC,protein degradation regulation,cell cycle control,e3 ubiquitin ligase activity,ring finger domain,genomic stability maintenance,tumor suppressor function
ENSG00000132763,MMACHC,homocysteine regulation,methionine metabolism,genetic disorders,cellular response modulation,tumorigenesis association,methylmalonic acidemia link
ENSG00000203618,GP1BB,aberrant expression,angiogenesis,cell adhesion,genetic alteration,metastasis,tumor progression
ENSG00000185245,GP1BA,platelet adhesion regulation,glycoprotein complex formation,thrombin binding sites,platelet signaling pathway,glycoprotein ib-v-ix complex,phosphatidylinositol 3-kinase (pi3k) inhibition
ENSG00000232957,HLA-DOA,antigen presentation,immune regulation,tumor evasion,immune suppressive,mhc class ii complex,antigen processing
ENSG00000243612,HLA-DOB,antigen presentation,immune evasion,mhc class i pathway,tumor immunogenicity,cellular recognition,genetic mutations
ENSG00000146232,NFKBIE,nf-?b signaling pathway,cellular survival,tumor progression,inflammatory response modulation,kinase activation inhibitor,none
ENSG00000162924,REL,constitutive activation,oncogenic transformation,transcriptional regulation,apoptosis resistance,inflammatory signaling,immune evasion
ENSG00000196781,TLE1,wnt/β-catenin pathway modulation,transcriptional corepressor activity,cell growth regulation,proliferation induction,tumor suppressor gene repression,biomarker potential
ENSG00000116266,STXBP3,snare complex regulation,gene amplification,mitochondrial dysfunction,cancer cell migration,cell cycle progression,tumor suppression
ENSG00000147614,ATP6V0D2,ph homeostasis disruption,lysosomal dysfunction,cellular proliferation,metastasis promotion,tumor microenvironment modulation,genomic instability
ENSG00000159720,ATP6V0D1,proton pumping activity,cellular ph regulation,tumor microenvironment modulation,acidic ph maintenance,cancer cell survival enhancement,therapeutic target for cancer treatment
ENSG00000115942,ORC2,origin recognition complex (orc) binding,genomic instability,dna replication initiation,cell cycle progression,chromatin modification,aneuploidy promotion
ENSG00000125885,MCM8,dna replication licensing,genomic instability,homologous recombination repair,transcriptional regulation,cell cycle progression,tumorigenesis
ENSG00000172116,CD8B,t-cell receptor activation,immune recognition,tumor suppression,antigen presentation,major histocompatibility complex interaction,cytotoxic t cell activation
ENSG00000153563,CD8A,cell surface receptor interaction,immune surveillance evasion,tumor antigen presentation,cytotoxic activity modulation,antigen-presenting cell recognition,adaptive immune response regulation
ENSG00000198851,CD3E,immunosuppression,t cell dysfunction,oncogenic transformation,tumor progression,immune evasion,signaling pathway modulation
ENSG00000160654,CD3G,tcr complex,gain of function mutations,zap70/lck activation,t-cell receptor signaling,oncogenic transformation,cell proliferation
ENSG00000167286,CD3D,t-cell receptor signaling,immunoglobulin superfamily interaction,t-lymphocyte development,t-cell function regulation,cell surface receptor assembly,therapeutic target for immunotherapy
ENSG00000138674,SEC31A,cellular export,protein homeostasis regulation,tumor progression,oncogene potential,pi3k/akt pathway interaction,vesicle coat component
ENSG00000157020,SEC13,oncogenic process,genomic instability,cellular stress response,protein secretion,chromosomal alterations,cancer progression
ENSG00000134539,KLRD1,immune surveillance,mhc class i interaction,cell adhesion regulation,cancer immunoevasion,tumor microenvironment modulation,leukocyte receptor function
ENSG00000205809,KLRC2,klrc2-mhc interaction,natural killer cell activation,tumor immunoevasion,cancer progression,immune surveillance evasion,tumor suppressor function
ENSG00000136854,STXBP1,regulation of membrane fusion,association with mtor pathway,constitutive activation,dysregulation in cancer,cell proliferation and survival pathways,therapeutic target
ENSG00000168283,BMI1,polycomb repressive complex 1 interaction,oncogene function,cell cycle regulation,cancer stem cell maintenance,apoptosis inhibition,proliferation promotion
ENSG00000141582,CBX4,chromatin regulation,dna repair,transcriptional repression,tumor suppressor silencing,oncogene activation,angiogenesis promotion
ENSG00000080824,HSP90AA1,hsp90 client proteins stabilization,oncogenic protein stabilization,chemotherapy resistance,tumor growth promotion,therapeutic target,protein folding facilitation
ENSG00000077800,FKBP6,mtor pathway regulation,gene expression modulation,t-cell receptor interaction,immunosuppression regulation,cancer-related pathways disruption,autophagy inhibition
ENSG00000123607,TTC21B,microtubule dynamics,cellular trafficking,retrograde motor transport,oncogenic processes,tumorigenesis,aberrant expression
ENSG00000118965,WDR35,er stress response,genetic mutations,tumor growth progression,biomarkers for cancer diagnosis and treatment,cellular survival regulation,pi3k/akt signaling pathway modulation
ENSG00000169398,PTK2,cell migration,focal adhesion kinase,hyperactivation,integrin interaction,oncogenic transformation,phosphorylation activity
ENSG00000204103,MAFB,transcription factor regulation,cell differentiation disruption,oncogenic activity,cell proliferation enhancement,survival pathway activation,tumor metastasis facilitation
ENSG00000220205,VAMP2,vesicle-associated membrane protein 2,tumor progression,membrane fusion,cell migration,exocytosis regulation,growth factor signaling
ENSG00000167986,DDB1,genomic instability,dna damage tolerance,oncogenic driver,transcription regulation,cell cycle progression,dna repair pathway
ENSG00000112115,IL17A,gain-of-function mutations,constitutive activation,tumor progression,immunosuppression,oncogenesis,cell proliferation
ENSG00000112116,IL17F,tumor progression,inflammatory cytokine,pro-inflammatory signaling,angiogenesis promotion,immune suppression,poor prognosis marker
ENSG00000088247,KHSRP,alternative splicing regulation,oncogenic potential,tumor suppressor function,rna-binding protein interactions,microrna regulation,genomic instability
ENSG00000185630,PBX1,transcriptional regulation,oncogene activity,cell proliferation,transcription factor binding,tumorigenesis,developmental gene expression
ENSG00000160199,PKNOX1,transcription factor activation,oncogene function,tumor progression,apoptosis inhibition,nf-κb signaling pathway,cell proliferation regulation
ENSG00000082458,DLG3,cell proliferation regulation,tumor suppressor function,synaptic plasticity regulation,ion channel modulation,apoptosis induction,pi3k/akt pathway interaction
ENSG00000132535,DLG4,neurodevelopmental abnormalities,tumor suppressor function,synaptic adhesion,cell proliferation regulation,signaling pathway modulation,genomic instability
ENSG00000158477,CD1A,immune surveillance,dysregulation,tumor progression,biomarker,t-cell activation,signaling pathway regulation
ENSG00000158485,CD1B,antigen presentation,immune evasion,oncogenic transformation,tumor progression,antigen-specific t-cell activation,lipid antigen presentation
ENSG00000158473,CD1D,impaired antigen presentation,tumor microenvironment,immune dysregulation,lipid antigen presentation,invariant nkt cell function,antigen presenting cell dysfunction
ENSG00000158481,CD1C,antigen presentation,immune modulation,oncogenic potential,prognostic marker,tumor immunology,therapeutic target
ENSG00000175097,RAG2,immune cell development,v(d)j recombination,tumor-infiltrating lymphocytes,dysregulated expression,immune modulation,oncogenic transformation
ENSG00000166349,RAG1,immunodeficiency,v(d)j recombination,lymphocyte development,dna cleavage,non-homologous end joining (nhej),cancer predisposition
ENSG00000107566,ERLIN1,erlin 1 mutations,tumor progression,traf2 regulation,ubiquitination modulation,cell signaling pathway,cancer driver gene
ENSG00000147475,ERLIN2,erbb2 interaction,cell polarity regulation,cancer-promoting signaling,protein-protein interactions,mitotic maintenance,tumor growth modulation
ENSG00000140836,ZFHX3,cell cycle regulation,tumor suppression,apoptosis regulation,angiogenesis inhibition,mutation association,tumor suppressor function
ENSG00000167770,OTUB1,oncogenic potential,proteasomal inhibition,genome stability maintenance,tumor progression facilitation,immune evasion modulation,cell survival promotion
ENSG00000133135,RNF128,ubiquitination regulation,cell cycle control,genomic stability maintenance,tumor suppressor function,protein degradation modulation,dna repair pathway interaction
ENSG00000072506,HSD17B10,mitochondrial function,dysregulation in cancer,energy metabolism alteration,apoptosis suppression,cell proliferation enhancement,genetic mutations impact
ENSG00000174173,TRMT10C,mitochondrial protein modification,tumor progression,oncogenic mutations,energy metabolism regulation,cellular homeostasis maintenance,protein-protein interactions
ENSG00000198026,ZNF335,transcriptional regulation,cellular proliferation,oncogenic properties,dna-binding activity,apoptosis regulation,cell cycle progression
ENSG00000113300,CNOT6,cellular regulation,oncogene activation,metabolic regulation,tumor progression,transcriptional control,mrna degradation
ENSG00000185002,RFX6,transcriptional regulation,oncogenic pathways,cell cycle regulation,apoptosis disruption,metastasis promotion,drug resistance involvement
ENSG00000134352,IL6ST,il6/stat3 pathway,constitutive activation,oncogenic signaling,tumor growth promotion,immunomodulation disruption,prognostic marker
ENSG00000166266,CUL5,tumor suppressor regulation,apoptosis suppression,proteasomal degradation,oncogenic promotion,cell cycle regulation,cancer progression
ENSG00000036257,CUL3,aberrant protein degradation,adaptor protein function,cancer driver gene,cell cycle regulation,genomic instability,nf-kb pathway activation
ENSG00000108094,CUL2,ubiquitin-proteasome pathway,cell cycle regulation,oncogenic processes,cell proliferation,apoptosis regulation,genomic instability
ENSG00000215021,PHB2,oncogenic function,apoptosis regulation,cell cycle progression,p53 interaction,ubiquitin-proteasome degradation,dna repair pathway
ENSG00000167085,PHB,cell cycle regulation,apoptosis regulation,chromatin remodeling,histone modification,protein degradation regulation,tumorigenesis
ENSG00000100401,RANGAP1,ran gtpase cycle,genomic instability,cell proliferation,dna repair,mitotic spindle assembly,nuclear transport
ENSG00000137100,DCTN3,microtubule stability,mitotic progression,cellular homeostasis,tumorigenicity,oncogenic interaction,cancer prognosis
ENSG00000175203,DCTN2,microtubule stabilization,cell migration,cytoplasmic dynein interaction,prognostic marker,apoptosis evasion,genomic amplification
ENSG00000205755,CRLF2,aberrant signaling,constitutive activation,jak/stat pathway,oncogenesis,cell proliferation,tumor progression
ENSG00000145623,OSMR,oncostatin m receptor,cell proliferation,jak/stat pathway,metastasis,angiogenesis,oncogenic process
ENSG00000048649,RSF1,chromatin remodeling,oncogenic transformation,transcriptional regulation,tumor progression,dna repair,genomic instability
ENSG00000137752,CASP1,inflammasome activation,gain of function mutations,tumor growth,apoptosis regulation,pro-inflammatory cytokine activation,cell migration
ENSG00000025434,NR1H3,tumor suppression,gene regulation,cell differentiation,lipid metabolism,transcriptional regulation,oncosuppressor
ENSG00000131408,NR1H2,metabolic regulation,constitutive activation,cellular proliferation,apoptosis resistance,tumor progression,inflammatory response modulation
ENSG00000142655,PEX14,peroxisomal biogenesis,lipid metabolism regulation,cellular proliferation promotion,reactive oxygen species production,autophagy dysregulation,zellweger spectrum disorder
ENSG00000162928,PEX13,genetic instability,peroxisomal dysfunction,cellular import regulation,protein-protein interactions,tumor suppressor function,epigenetic regulation
ENSG00000176884,GRIN1,glutamate-gated ion channel activation,aberrant signaling cascade,cell growth regulation,neurotransmission modulation,signaling pathway interaction,oncogenic transformation
ENSG00000273079,GRIN2B,neurotransmission regulation,excitatory neurotransmission dysregulation,tumor progression facilitation,cell survival promotion,therapeutic target potential,synaptic plasticity disruption
ENSG00000106299,WASL,actin cytoskeleton remodeling,cell migration enhancement,oncogenic process promotion,tumor progression association,signaling pathway modulation,rho gtpase interaction
ENSG00000205726,ITSN1,endocytosis regulation,cell migration facilitation,cytoskeleton organization,oncogenic driver,tumor progression,receptor recycling
ENSG00000027697,IFNGR1,cell surface receptor,cytokine signaling,immune response modulation,inflammation regulation,cell proliferation control,antitumor immunity
ENSG00000262795,IFNGR2,immune evasion,tumor progression,cell proliferation,genetic alterations,receptor activation,immunosuppression
ENSG00000134852,CLOCK,cell cycle progression,apoptosis modulation,dna repair regulation,circadian rhythm disruption,oncogene activation,tumor promotion
ENSG00000029153,ARNTL2,transcriptional regulation,tumorigenesis,cell cycle regulation,oncogene,circadian rhythm disruption,dna damage response
ENSG00000057468,MSH4,genomic stability,dna mismatch repair,meiotic recombination,mismatch error correction,homologous pairing,genome integrity
ENSG00000237333,MSH5,mutation hotspot,tumor suppressor,genomic instability,homologous recombination,dna repair pathway,chromosomal instability
ENSG00000119684,MLH3,mismatch repair,genomic instability,microsatellite instability,tumor suppressor function,dna damage response,cancer predisposition
ENSG00000168495,POLR3D,transcriptional regulation,nuclear localization,rna polymerase iii interaction,cellular growth modulation,chromatin remodeling involvement,mutational associations
ENSG00000058600,POLR3E,rna polymerase iii transcription,ribosome biogenesis,aberrant gene expression,tumor growth promotion,cell survival enhancement,gene regulatory interaction
ENSG00000100413,POLR3H,rna polymerase activity,transcriptional regulation,cell proliferation,genomic instability,neurological disorders,tumorigenesis
ENSG00000241258,CRCP,regulation of cellular processes,modulation of signaling pathways,protein degradation and processing,tumor development,cancer progression,apoptosis regulation
ENSG00000165168,CYBB,nox complex activation,oxidative stress,genomic instability,dna mutation,epigenetic regulation,inflammatory response
ENSG00000051523,CYBA,protein interaction,immunodeficiency,nadph oxidase activity,tumor progression,angiogenesis,upregulation
ENSG00000083123,BCKDHB,disrupted metabolic regulation,loss-of-function mutation,cell growth promotion,mtor pathway activation,mitochondrial dysfunction,genetic instability
ENSG00000248098,BCKDHA,cellular adaptation,energy regulation,metabolic homeostasis disruption,oxidative stress enhancement,tumor metabolism alteration,cellular redox imbalance
ENSG00000168906,MAT2A,epigenetic regulation,hypoxia adaptation,cell survival pathways,oncogenic potential,methylation enzymes,redox balance modulation
ENSG00000038274,MAT2B,tumor progression,cell proliferation,angiogenesis regulation,gene amplification,hypoxia response modulation,metabolic reprogramming
ENSG00000140505,CYP1A2,dna damage,reactive oxygen species,cellular stress response,oncogenesis,apoptosis regulation,gene expression profiling
ENSG00000127948,POR,heme biosynthesis pathway,overexpression and amplification,cell proliferation and survival,promoter hypermethylation and transcriptional activity,pi3k/akt signaling pathway interaction,cancer cell growth and metabolism support
ENSG00000165841,CYP2C19,drug metabolism,oxidation reactions,pharmacokinetic variability,polymorphic variants,therapeutic response,chemotherapy resistance
ENSG00000163114,PDHA2,pyruvate conversion,cellular metabolism,energy production regulation,subunit interaction,metabolic pathway modulation,protein complex assembly
ENSG00000168291,PDHB,pyruvate metabolism,metabolic reprogramming,oncogenic signaling,tumor progression,therapeutic target,substrate-level phosphorylation
ENSG00000131828,PDHA1,metabolic reprogramming,glycolytic switch,pyruvate accumulation,oncogenic transformation,therapeutic target,genomic instability
ENSG00000117118,SDHB,mitochondrial dysfunction,aerobic glycolysis,pseudohypoxia-inducible factor alpha,loss-of-function mutations,tumor suppressor function,energy metabolism alterations
ENSG00000073578,SDHA,mitochondrial electron transport chain,loss of function mutations,oncogenic ras/mapk signaling,activation of pi3k/akt/mtor axis,cellular metabolism regulation,apoptosis suppression
ENSG00000164951,PDP1,genomic stability,tumor suppressor,dna repair regulation,telomere maintenance,cell survival regulation,apoptosis modulation
ENSG00000090857,PDPR,regulatory role,metabolic regulation,cellular response modulation,oncogene activation,tumor progression,genomic instability
ENSG00000105568,PPP2R1A,cell cycle regulation,gene mutation,promoter region interaction,tumor suppressor function,apoptosis inhibition,cancer prognosis
ENSG00000113575,PPP2CA,tumor suppressor,cell cycle regulation,genomic stability,dephosphorylation,pi3k/akt pathway modulation,therapeutic target
ENSG00000112818,MEP1A,genomic instability,aberrant activation,dna replication,cell proliferation,growth factor regulation,nucleosome remodeling
ENSG00000141434,MEP1B,pi3k/akt pathway modulation,calcium homeostasis regulation,phosphoinositide metabolism alteration,oncogenic growth promotion,cell proliferation enhancement,apoptosis resistance induction
ENSG00000105675,ATP4A,gastric acid secretion,proton pump activation,cell survival promotion,oncogenic signaling,tumor progression driver,apoptosis resistance
ENSG00000288359,ATP4B,gain of function mutations,invasive potential,tumor progression,cellular ph regulation,ion transport,metastasis
ENSG00000143437,ARNT,transcriptional regulation,dimerization partner,cell cycle regulation,xenobiotic metabolism,oncogene/tumor suppressor function,signaling pathway interaction
ENSG00000116016,EPAS1,hypoxia adaptation,transcriptional regulation,oncogenic activation,tumor progression,angiogenesis promotion,metabolic reprogramming
ENSG00000169245,CXCL10,cancer promotion,immune evasion,tumor microenvironment,angiogenesis,chemoattractant function,pro-inflammatory cytokine
ENSG00000186810,CXCR3,chemokine receptor function,immune cell recruitment,tumor progression,angiogenesis,immunosuppression,cell migration
ENSG00000186469,GNG2,g protein activation,cell proliferation,signaling pathway regulation,oncogenic process,tumor progression,therapeutic target
ENSG00000181104,F2R,g protein-coupled receptor activation,proteolytic activation,cell migration promotion,tumor growth stimulation,oncogenic signaling pathway engagement,apoptosis modulation
ENSG00000164220,F2RL2,f2rl2 mutations,par1 activation,protease-activated receptor 1,tumor growth promotion,coagulation regulation,thrombin stimulation
ENSG00000070886,EPHA8,angiogenic signaling,ephrin-b2 interaction,gain of function mutations,tumor progression,prognostic marker,receptor tyrosine kinase activity
ENSG00000184349,EFNA5,aberrant expression,angiogenesis promotion,cell proliferation enhancement,epithelial-to-mesenchymal transition regulation,ligand interaction,oncogene potential
ENSG00000033800,PIAS1,ubiquitin ligase activity,regulation of stat1,modulation of jak/stat pathway,tumor suppressor activity,oncogene potential,post-translational regulation
ENSG00000035403,VCL,cellular morphology disruption,tumor progression,cancer driver gene,metastasis suppression,cell adhesion regulation,therapeutic target
ENSG00000072401,UBE2D1,cell cycle regulation,ubiquitination process,protein degradation,p53 pathway modulation,oncogenic properties,therapeutic target
ENSG00000118513,MYB,transcriptional regulation,oncogene activation,constitutive activation,cell proliferation,apoptosis suppression,dna repair modulation
ENSG00000113580,NR3C1,loss-of-function mutations,glucocorticoid signaling disruption,dysregulated transcription regulation,cell growth promotion,tumor suppressor function,possible therapeutic target
ENSG00000140396,NCOA2,nuclear receptor coactivation,transcriptional regulation,cell proliferation enhancement,chromatin remodeling,oncogenic driver,genomic instability
ENSG00000164161,HHIP,shh signaling pathway regulation,tumor suppressor function,cell proliferation inhibition,glycoprotein modification,protein-protein interaction modulation,wnt/shh canonical pathway inhibition
ENSG00000163501,IHH,hedgehog signaling,oncogenesis,gain of function mutations,tumor progression,cell proliferation,developmental regulation
ENSG00000115170,ACVR1,transforming growth factor-beta signaling pathway,activin a stimulation,gain of function mutations,tumor metastasis,epithelial-to-mesenchymal transition (emt),angiogenesis
ENSG00000198648,STK39,hippo signaling pathway activation,protein kinase activity,cell division regulation,genomic instability modulation,therapeutic target identification,signaling pathway interaction
ENSG00000065675,PRKCQ,kinase activity,cell survival,signaling pathway,apoptosis regulation,tumor progression,therapeutic target
ENSG00000106070,GRB10,insulin signaling inhibitor,pi3k/akt pathway inhibition,tumor suppressor function loss,mapk/erk pathway regulation,cell growth regulator,genomic deletion hotspot
ENSG00000101096,NFATC2,calcium signaling pathway,transcriptional regulation,oncogenic transformation,cell proliferation,immune response modulation,therapeutic target
ENSG00000049768,FOXP3,immune modulation,epigenetic regulation,tumor suppression,oncogenesis,proliferation inhibition,tumor progression
ENSG00000086758,HUWE1,ubiquitin ligase activity,cell cycle regulation,apoptosis inhibition,tumor suppressor regulation,p53 modulation,cancer driver gene 
ENSG00000107968,MAP3K8,dlk activation,oncogenic transformation,tumor progression,cell cycle regulation,apoptosis evasion,jnk signaling pathway
ENSG00000120063,GNA13,oncogene,g-protein signaling,cell migration,rhoa interaction,metabolic regulation,cell proliferation
ENSG00000146535,GNA12,g-protein subunit activation,constitutive activation,oncogenic mutations,tumor progression,therapeutic target,signaling pathway regulation
ENSG00000130396,AFDN,emt regulation,cell-cell adhesion disruption,protein-protein interaction,tumor progression modulation,cancer prognosis correlation,metastasis facilitation
ENSG00000197943,PLCG2,oncogenic process,constitutive activation,signal transduction,cell proliferation,tumor progression,amplification
ENSG00000254087,LYN,constitutive activation,genomic alterations,cellular proliferation,apoptosis inhibition,signaling pathway modulation,hematopoietic malignancy
ENSG00000180210,F2,tumor progression,angiogenesis promotion,cell proliferation enhancement,metastasis facilitation,proteolytic activation,thrombosis association
ENSG00000171720,HDAC3,tumor suppressor function,histone modification,transcriptional regulation,chromatin compaction,gene expression control,cell cycle regulation
ENSG00000164331,ANKRA2,chromosomal instability,genomic maintenance failure,aneuploidy promoter,cell cycle regulation,dna replication modulation,oncogenic function
ENSG00000164867,NOS3,nadph oxidase activity,cell proliferation inhibition,protein kinase activation,tumor progression promotion,molecular interaction regulation,apothosis induction
ENSG00000135966,TGFBRAP1,tgf-β receptor regulation,loss of function mutations,constitutive activation,epithelial-to-mesenchymal transition (emt),cell migration and invasion,smad protein interaction
ENSG00000124145,SDC4,epithelial-to-mesenchymal transition (emt),overexpression,growth factor interaction,cell adhesion regulation,signaling pathway modulation,tumor progression
ENSG00000274233,CCL5,tumor progression,immune suppression,angiogenesis promotion,chemotaxis induction,metastasis facilitation,epithelial-to-mesenchymal transition
ENSG00000148737,TCF7L2,wnt/β-catenin pathway,transcriptional regulation,cell proliferation,oncogenic processes,cancer progression,therapeutic target
ENSG00000139549,DHH,aberrant signaling,cell proliferation,overexpression,poor prognosis,tumor aggressiveness,tissue patterning
ENSG00000175592,FOSL1,fos family transcription factor,oncogene,tumor progression,transcriptional regulator,apoptosis inhibition,epithelial-to-mesenchymal transition
ENSG00000180340,FZD2,wnt/β-catenin signaling,cell proliferation,tumor progression,oncogenic driver,cancer stem cell maintenance,receptor activation
ENSG00000114251,WNT5A,canonical wnt pathway,cell proliferation enhancement,oncogenic activation,protein-protein interaction,tumor suppressor activity,signal transduction modulation
ENSG00000028528,SNX1,pi3k/akt pathway,tumor progression,cell growth regulation,endosomal trafficking regulation,oncogene interaction,therapeutic target
ENSG00000205302,SNX2,endosomal recycling pathway,constitutive activation,gain of function mutations,cell migration,therapeutic target,genomic instability
ENSG00000080503,SMARCA2,swi/snf complex,chromatin remodeling,tumor suppressor function,apoptosis regulation,proliferation inhibition,gene expression modulation
ENSG00000245848,CEBPA,tumor suppressor,cellular differentiation regulation,cell cycle regulation,epigenetic modification,genomic instability,anti-proliferative response
ENSG00000075426,FOSL2,transcription factor regulation,cell cycle progression,angiogenesis modulation,metastasis facilitation,cell proliferation enhancement,oncogenic driver status
ENSG00000090776,EFNB1,enhanced cell migration,pi3k/akt activation,oncogenic signaling,poor prognosis,tumor progression,aberrant regulation
ENSG00000154928,EPHB1,receptor tyrosine kinase function,angiogenesis regulation,tumor progression,metastasis promotion,oncogene role,cell migration disruption
ENSG00000174808,BTC,epithelial-to-mesenchymal transition,metastasis promoter,tumor progression,angiogenesis facilitator,cancer stem cell maintenance,chemotherapy resistance
ENSG00000100811,YY1,gene regulation,transcriptional control,tumor suppression,oncogenesis,cancer metastasis,cell growth promotion
ENSG00000115594,IL1R1,inflammation,immune evasion,tumor growth,metastasis,angiogenesis,cell proliferation
ENSG00000136689,IL1RN,tumor suppression,inflammation regulation,il-1 modulation,immune response modulation,oncogenesis promotion,anti-tumor activity
ENSG00000130427,EPO,tumor progression,angiogenesis promotion,anti-apoptotic properties,erythropoiesis regulation,cell proliferation enhancement,promotion of uncontrolled erythropoiesis
ENSG00000187266,EPOR,constitutive activation,gain of function mutations,tumor progression,erythropoietin signaling,hematological malignancy,cell growth regulation
ENSG00000198400,NTRK1,neurotrophic signaling pathways,constitutive activation,gain of function mutations,oncogenic fusion,tumor progression,therapeutic target
ENSG00000168040,FADD,apoptosis regulation,tumor progression,oncogenesis,survival advantage,cancer cell survival,nf-kb pathway activation
ENSG00000169242,EFNA1,angiogenesis,oncogene activation,microtubule dynamics,tumor progression,cell migration,chemoresistance
ENSG00000142627,EPHA2,oncogenic driver,receptor tyrosine kinase activation,tumor growth regulation,angiogenesis promotion,cell migration enhancement,therapeutic target candidate
ENSG00000151693,ASAP2,rho gtpase activation,tumor progression,cell migration regulation,actin cytoskeleton remodeling,protein-protein interaction,metastasis promotion
ENSG00000128917,DLL4,notch signaling pathway,angiogenesis regulation,tumor vasculature formation,cell proliferation promotion,apoptosis resistance,embryonic development role
ENSG00000235396,NOTCH4,tumor growth,therapeutic target,cell proliferation,pathway hyperactivation,epithelial homeostasis regulation,transcriptional modulation
ENSG00000081059,TCF7,wnt/tcf7 pathway,constitutive activation,oncogene activity,cell proliferation,transcriptional regulation,cancer driver gene
ENSG00000127191,TRAF2,signaling pathway regulation,apoptosis inhibition,cell proliferation promotion,tumor progression facilitation,immune response modulation,protein-protein interaction
ENSG00000128602,SMO,hedgehog pathway activation,constitutive signaling,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000141480,ARRB2,g-protein signaling,cell growth regulation,tumor suppressor/tumor promoter,metastasis regulation,apoptosis modulation,signal transduction pathway
ENSG00000196367,TRRAP,genome instability,chromatin modification,dna repair,histone regulation,tumor suppressor function,genomic stability maintenance
ENSG00000108773,KAT2A,histone acetylation,tumor suppressor activity,transcriptional coactivator function,cell cycle regulation,apoptosis modulation,chromatin remodeling
ENSG00000196411,EPHB4,tumor progression,angiogenesis promotion,cell proliferation enhancement,signaling pathway modulation,metastatic potential,regulatory function alteration
ENSG00000125266,EFNB2,cell adhesion disruption,ephrin receptor interactions,metastatic spread promotion,tumor progression facilitation,oncogenic pathway regulation,biomarker potential
ENSG00000175354,PTPN2,phosphatase activity,signal transduction regulation,tumor suppressor function,immunomodulatory effects,cell growth regulation,protein interaction
ENSG00000177425,PAWR,tumor suppressor,apoptosis regulation,cell cycle modulation,protein interaction,cancer driver,oncogenic pathway regulation
ENSG00000067606,PRKCZ,pkc signaling pathway,dysregulated protein kinase activity,cell proliferation enhancement,tumor progression facilitation,genomic instability contribution,apoptosis inhibition
ENSG00000116809,ZBTB17,tumor suppression,transcriptional regulation,cell cycle progression,apoptosis modulation,oncogene repression,pancreatic cancer association
ENSG00000140968,IRF8,tumor suppressor function,immune evasion,cellular proliferation,oncogenic processes,genetic instability,apoptosis resistance
ENSG00000160867,FGFR4,fgfr pathway,constitutive activation,gain-of-function mutations,tumor progression,angiogenesis,therapeutic target
ENSG00000138685,FGF2,angiogenesis promotion,tumor growth enhancement,cell survival pathway activation,metastasis facilitation,mapk/erk pathway activation,fgf-2/fgfr interaction
ENSG00000068078,FGFR3,pi3k/akt pathway,constitutive activation,gain of function mutations,tumor progression,genomic instability,dna damage response
ENSG00000066468,FGFR2,constitutive activation,fgf/fgfr signaling pathway,tumor progression,angiogenesis promotion,mutation hotspot,ras-mapk pathway activation
ENSG00000171223,JUNB,ap-1 dependent pathways,constitutive activation,cooperates with oncogenes,dimerization with jun proteins,oncogenic processes,transcriptional regulation
ENSG00000100393,EP300,transcriptional coactivator,histone acetylation,oncogenic activity,chromatin remodeling,cell proliferation,transcription factor binding
ENSG00000099942,CRKL,pi3k/akt pathway interaction,aberrant activation,cell migration regulation,oncogene overexpression,poor prognosis indicator,metastasis promotion
ENSG00000107263,RAPGEF1,r-ras activation,gene amplification,mitogenic signaling,cell proliferation,kinase regulation,tumor aggressiveness
ENSG00000157193,LRP8,cellular proliferation,tumor suppressor function,signaling pathway regulation,wnt/β-catenin interaction,notch signaling modulation,emt induction
ENSG00000164093,PITX2,cell growth regulation,transcriptional modulation,oncogenic driver,tumor progression,gene expression regulation,developmental maintenance
ENSG00000140992,PDPK1,cellular regulation,akt signaling pathway,constitutive activation,gain of function mutations,oncogenic process,therapeutic target
ENSG00000121067,SPOP,loss of tumor suppressor function,e3 ubiquitin ligase activity,chromatin remodeling,oncogenic transcription factor regulation,genome instability,cell proliferation enhancement
ENSG00000281324,LRP6,wnt/β-catenin pathway,ligand-dependent activation,tumor suppressor function,cell proliferation regulation,apoptosis inhibition,signaling complex formation 
ENSG00000107984,DKK1,wnt/β-catenin pathway inhibition,oncogene activation,tumor progression enhancement,metastasis facilitation,cell survival promotion,therapeutic resistance association
ENSG00000116288,PARK7,apoptosis regulation,antioxidant function,mitochondrial protection,oxidative stress response,tumor suppression,cell survival modulation
ENSG00000063660,GPC1,tumor progression,metastatic potential,growth factor binding,cell adhesion modulation,angiogenesis regulation,transcriptional modulation
ENSG00000241186,TDGF1,cell proliferation,enhanced cell survival,wnt/β-catenin pathway,oncogenic transformation,protein interaction,tumorigenesis
ENSG00000138795,LEF1,transcription factor activation,wnt/β-catenin signaling pathway,constitutive activation,oncogene,cell proliferation regulation,tumor progression
ENSG00000119630,PGF,angiogenesis,proliferation,receptor binding,growth factor signaling,tumor progression,mutation
ENSG00000071564,TCF3,oncogene/tumor suppressor,cell growth regulation,transcriptional regulation,cell differentiation,apoptosis modulation,chromatin remodeling interaction
ENSG00000129152,MYOD1,myod1,oncogene,myogenic differentiation factor,cell proliferation,aggressive tumors,poor prognosis
ENSG00000157168,NRG1,erbb receptor activation,cell-to-cell communication,signaling pathway modulation,pi3k/akt pathway activation,oncogenic transformation promotion,tumor growth and metastasis facilitation
ENSG00000123349,PFDN5,cellular growth regulation,protein-protein interactions,membrane trafficking,oncogenic potential,signaling pathway modulation,tumorigenesis
ENSG00000153317,ASAP1,oncogenic signaling,tyrosine kinase regulation,cell proliferation enhancement,abl kinase interaction,cancer cell survival promotion,therapeutic target candidate
ENSG00000113578,FGF1,tumor growth promotion,angiogenesis,metastasis facilitation,cell proliferation regulation,receptor binding,signaling pathway modulation
ENSG00000075388,FGF4,fgf pathway activation,oncogene overexpression,cell proliferation enhancement,tumor development,embryonic development regulation,chemotherapy resistance
ENSG00000162344,FGF19,wnt/β-catenin signaling pathway,tumor suppression,oncogenic reprogramming,growth factor regulation,metabolic reprogramming,therapeutic target
ENSG00000123416,TUBA1B,microtubule dynamics,mitotic spindle formation,oncogene overexpression,genomic instability,therapeutic target,microtubule stability
ENSG00000112245,PTP4A1,ptp family member,dephosphorylation activity,cell proliferation promotion,oncoprotein expression,mapk/erk pathway modulation,cancer tissue overexpression
ENSG00000121858,TNFSF10,apoptosis induction,tumor cell sensitivity,death receptor interaction,cancer cell survival,gene expression regulation,multifunctional protein
ENSG00000139567,ACVRL1,tgf-β pathway activation,constitutive activation mutations,angiogenic regulation,cellular proliferation enhancement,endothelial function dysregulation,genomic instability
ENSG00000157764,BRAF,gain of function mutations,constitutive activation,cell proliferation,mapk signaling pathway,oncogenic driver,therapeutic target
ENSG00000166579,NDEL1,microtubule dynamics,genomic instability,tumor progression,mitotic spindle assembly,cell cycle regulation,therapeutic target
ENSG00000013810,TACC3,cell cycle regulation,mitotic spindle assembly,microtubule dynamics,oncogene overexpression,tumor aggressiveness,genomic instability
ENSG00000119383,PTPA,regulation of pi3k/akt pathway,dephosphorylation of proteins,cellular proliferation and survival,signaling network modulation,tumor suppressive function loss,potential therapeutic target
ENSG00000121989,ACVR2A,tumor suppressor function,aberrant tgf-beta signaling,cancer progression,cell proliferation regulation,dysregulated expression,genomic instability
ENSG00000133794,ARNTL,circadian rhythm regulation,transcriptional modulation,tumor suppression,environmental stress response,hypoxia adaptation,cellular proliferation
ENSG00000065526,SPEN,histone methylation modulation,chromatin regulation,epigenetic modification,gene expression control,cellular proliferation driver,cancer hallmark alteration
ENSG00000150455,TIRAP,toll-like receptor signaling,innate immunity modulation,myd88 recruitment,immune evasion mechanism,cytokine regulation,adaptor protein function
ENSG00000167393,PPP2R3B,cancer driver,signal transduction pathway,apoptosis regulation,cell cycle control,phosphatase activity modulation,oncogenic process
ENSG00000064490,RFXANK,genomic instability,regulatory factor x (rfx) family member,transcriptional regulation of nf-κb pathway,homologous recombination (hr) dna repair,apoptosis regulation,cell cycle progression
ENSG00000170558,CDH2,epithelial-to-mesenchymal transition,cell adhesion molecule,tumor progression,metastasis,signaling pathway modulation,cancer driver gene
ENSG00000150760,DOCK1,rac activation,cell migration,cytoskeletal reorganization,tumor progression,oncogenic signaling,metastasis
ENSG00000155849,ELMO1,cell migration,microenvironment interaction,rac1 gtpase activation,cancer progression,immune response modulation,tumor invasion
ENSG00000169439,SDC2,cell adhesion disruption,tumor progression enhancement,metastasis facilitation,growth factor interaction,matrix degradation,adhesion molecule regulation
ENSG00000178999,AURKB,genomic instability,chromosomal abnormalities,constitutive activation,mitotic spindle formation,aneuploidy,cell cycle progression
ENSG00000173535,TNFRSF10C,apoptosis inhibition,chemotherapy resistance,immune modulation,programmed cell death regulation,survival advantage,tumor progression
ENSG00000112592,TBP,transcription initiation,tata box binding,genetic regulation,cellular proliferation,dna binding activity,chromatin remodeling
ENSG00000066336,SPI1,cell proliferation,transcriptional regulation,oncogene activation,tumor progression,hematopoiesis regulation,immune response modulation
ENSG00000147443,DOK2,oncogenic activation,adapter protein function,cell cycle regulation,pi3k/akt/mtor pathway,metastatic potential enhancement,tumor suppressor dysregulation
ENSG00000198561,CTNND1,epithelial-to-mesenchymal transition (emt),oncogenic driver,disrupted adhesion,cell migration regulation,wnt/β-catenin pathway interaction,tumor suppressor function
ENSG00000167193,CRK,adaptor molecule regulation,cancer cell invasion,cell migration,metastasis promotion,non-receptor tyrosine kinase activity,signaling pathway modulation
ENSG00000108840,HDAC5,chromatin remodeling,epigenetic regulation,gene expression modulation,tumor suppressor function,corepressor/coactivator activity,cellular differentiation
ENSG00000101199,ARFGAP1,regulation of golgi apparatus function,altered protein trafficking,enhanced tumor growth,tumor metastasis,golgi apparatus dysfunction,apoptosis regulation
ENSG00000105438,KDELR1,protein chaperone function,regulation of protein folding,cellular homeostasis maintenance,tumor progression enhancement,cell proliferation promotion,retrograde transport mediation
ENSG00000094631,HDAC6,tumor progression,therapeutic target,cell survival,chromatin remodeling,protein deacetylation,autophagy regulation
ENSG00000114423,CBLB,cellular regulation,tumor suppressor function,oncogene regulation,signaling pathway modulation,egfr interaction,ubiquitin ligase activity
ENSG00000157240,FZD1,wnt/β-catenin signaling pathway,tumor progression,cell proliferation,signaling receptor,cancer driver gene candidate,gene expression regulation
ENSG00000154342,WNT3A,wnt/β-catenin signaling pathway,constitutive activation,gain of function mutations,tumor progression,embryonic development,cell proliferation
ENSG00000163517,HDAC11,aberrant activity,tumor suppression,histone modification regulation,cell cycle progression modulation,apoptosis dysregulation,immune response modulation
ENSG00000172179,PRL,prolactin signaling pathway,cell proliferation regulation,epithelial-to-mesenchymal transition (emt),apoptosis inhibition,growth factor regulation,hormone-dependent tumorigenesis
ENSG00000179094,PER1,cell cycle regulation,tumor suppression,circadian rhythm disruption,apoptosis induction,circadian clock regulation,cancer cell growth inhibition
ENSG00000135144,DTX1,oncogenic transformation,transcriptional regulation,chromatin remodeling,cell cycle progression,apoptosis regulation,tumor suppressor function
ENSG00000182944,EWSR1,oncogene,chromosomal translocations,transcriptional regulation,cell growth and survival,rna processing,molecular diagnostics
ENSG00000100485,SOS2,mapk signaling pathway,constitutive activation,gain of function mutations,oncogenic driver,therapeutic target,cell proliferation
ENSG00000110330,BIRC2,apoptosis regulation,oncogenic activity,cell survival promotion,tumor progression facilitation,therapeutic target potential,protein-protein interaction
ENSG00000023445,BIRC3,apoptosis regulation,inflammation modulation,tumor growth promotion,immune evasion facilitation,nf-κb pathway activation,cell survival enhancement
ENSG00000164327,RICTOR,mtorc2 activation,pi3k/akt pathway regulation,akt kinase activation,cell growth promotion,metabolic regulation,cell survival enhancement
ENSG00000105810,CDK6,cell cycle progression,gene amplification,oncogenic driver,proliferation regulation,apoptosis resistance,tumor growth promotion
ENSG00000134516,DOCK2,rho gtpase activation,tumor progression,metastasis driver,protein-protein interaction,cell migration regulation,gef activity
ENSG00000166167,BTRC,beta-transducin repeat-containing protein,e3 ubiquitin ligase complex,protein degradation regulation,oncoprotein stabilization,tumor suppressor dysregulation,therapeutic target
ENSG00000126767,ELK1,transcriptional regulation,cell proliferation,oncogenic signaling,genomic instability,therapeutic target,protein-protein interaction
ENSG00000112658,SRF,carg element binding,oncogenic transformation,transcriptional regulation,cell proliferation,gene expression modulation,cell migration and invasion
ENSG00000113658,SMAD5,tgf-β signaling,inhibitory smad function,tumor suppression,cell growth regulation,molecular repression,anti-oncogenic role
ENSG00000105698,USF2,transcriptional regulation,cell proliferation,oncogenesis,apoptosis regulation,tumor progression,genomic instability
ENSG00000101138,CSTF1,pre-mrna processing,cleavage stimulation factor,poly(a) signal recognition,tumorigenesis disruption,cancer-related mutations,genomic instability
ENSG00000131462,TUBG1,microtubule stabilization,cell division regulation,tumor suppressor function,chromosomal instability,genomic alteration,dysregulated expression
ENSG00000101004,NINL,microtubule regulation,tumor aggressiveness,genomic instability,cancer cell survival,proliferation signaling pathway,biomarker
ENSG00000120693,SMAD9,tgf-?-mediated signaling pathway,inhibitory smad function,tumor suppressor role,loss-of-function mutations,cell proliferation regulation,apoptosis modulation
ENSG00000158517,NCF1,nadph oxidase activation,ros production,dna damage,genomic instability,cell survival,oncogenic signaling
ENSG00000116701,NCF2,nadph oxidase complex,oxidative stress regulation,protein-protein interactions,cellular redox balance,cancer cell survival,growth factor signaling
ENSG00000137267,TUBB2A,microtubule dynamics,anti-apoptotic effects,cell proliferation enhancement,metastatic potential increase,epigenetic modification involvement,kinase interaction
ENSG00000173273,TNKS,aberrant activation,cell proliferation,constitutive activation,immune evasion,oncogenesis,protein phosphorylation
ENSG00000147601,TERF1,telomere maintenance,genome instability,chromosomal fusion,dna binding protein,tumor progression,therapeutic target
ENSG00000095739,BAMBI,tumor suppressor,tgf-β signaling pathway inhibition,cell proliferation regulation,smad-dependent pathway modulation,smad-independent pathway regulation,pseudoreceptor function
ENSG00000136754,ABI1,rho gtpase activation,tumor suppressor function,negative regulation of cell growth,cell adhesion modulation,pi3k/akt pathway regulation,metastasis promotion
ENSG00000107643,MAPK8,cellular stress response,tumor progression,apoptosis regulation,transcription factor activation,cancer driver gene,protein kinase activity
ENSG00000136827,TOR1A,mtorc1 regulation,autophagy dysregulation,cell proliferation enhancement,metabolic reprogramming,protein kinase activation,growth factor signaling integration
ENSG00000108821,COL1A1,ecm component,tumor growth promotion,cell adhesion facilitation,metastasis enhancement,chemotherapy resistance,radiation therapy resistance
ENSG00000164692,COL1A2,tumor progression,fibrosis,cell adhesion,angiogenesis promotion,desmoplastic reaction,oncogenic mutation 
ENSG00000161800,RACGAP1,cell signaling pathway,cell proliferation,cell migration,cell adhesion,small gtpase regulation,gap activity
ENSG00000137807,KIF23,microtubule-binding protein,constitutive activation,cell cycle regulation,chromosomal instability,aneuploidy,multinucleation
ENSG00000078902,TOLLIP,immune regulation,toll-like receptor signaling pathway,dysregulated in multiple cancers,apoptosis regulation,inflammatory response modulation,tumor cell growth enhancement
ENSG00000117748,RPA2,replication protein complex,dna repair pathways,genomic instability,poor prognosis marker,tumor suppressor function,cell cycle regulation
ENSG00000132383,RPA1,genomic instability,tumor progression,dna replication repair,genome maintenance,cell cycle regulation,protein-protein interaction
ENSG00000069702,TGFBR3,tgf-β signaling,tumor suppressor potential,dysregulated gene expression,cell growth regulation,metastasis promotion,prognostic marker variability
ENSG00000186871,ERCC6L,endonuclease activity,genomic stability,nucleotide excision repair,transcriptional regulation,dna damage response,tumor suppressor function
ENSG00000142319,SLC6A3,dopamine transport regulation,cell growth promotion,oncogenic mutations,tumor aggressiveness,signaling cascade modulation,metastatic potential
ENSG00000169083,AR,constitutive activation,oncogenic transcription,gain of function mutations,cell proliferation,prognostic marker,therapeutic target
ENSG00000196712,NF1,ras/mapk pathway deregulation,tumor suppressor function loss,cancer driver mutations,cell proliferation enhancement,signaling pathway regulation,genetic predisposition
ENSG00000136002,ARHGEF4,rho/rock pathway,constitutive activation,guanylate exchange factor,tumor progression,prognostic marker,resistance to therapy
ENSG00000126214,KLC1,microtubule-based transport,mitotic spindle assembly,cell division regulation,tumor progression facilitation,oncogenic protein transport,therapeutic target for cancer treatment
ENSG00000008294,SPAG9,cell cycle regulation,g2/m phase transition,dna repair mechanisms,transcriptional control,oncogenesis,cell growth promotion
ENSG00000169429,CXCL8,tumor promotion,angiogenesis,chemotaxis,immune evasion,inflammation,oncogenic growth
ENSG00000180871,CXCR2,g protein coupled receptor,chemokine signaling pathway,tumor growth promotion,angiogenesis facilitation,metastasis enhancement,immune cell recruitment 
ENSG00000115590,IL1R2,cancer suppressor,immune modulation,inflammation regulation,tumor growth inhibition,cell survival reduction,signal transduction pathway interaction
ENSG00000115008,IL1A,pro-inflammatory cytokine,tumor growth promotion,immune evasion induction,angiogenesis enhancement,metastasis facilitation,tumor microenvironment modulation
ENSG00000104312,RIPK2,necroptosis regulation,inflammation modulation,cell death pathway dysregulation,tumor progression driver,therapeutic target,genomic instability
ENSG00000167207,NOD2,innate immune function,chronic inflammation,immune surveillance impairment,nf-κb pathway activation,pro-inflammatory cytokine production,genomic instability
ENSG00000114315,HES1,transcription factor regulation,oncogene/tumor suppressor,stem cell maintenance,cell differentiation inhibition,notch signaling interaction,nuclear localization
ENSG00000044524,EPHA3,cellular adhesion,cell migration,receptor tyrosine kinase activity,tumor progression,oncogenic function,epithelial-to-mesenchymal transition (emt)
ENSG00000010017,RANBP9,cell cycle regulation,chromosomal instability,mitotic progression,protein-protein interactions,oncogene activation,tumor aggressiveness
ENSG00000156052,GNAQ,mapk/erk pathway,constitutive activation,gain of function mutations,tumor growth and metastasis,cell proliferation and survival,genomic profiling
ENSG00000105443,CYTH2,oncogenic driver,rhoa activation,cell cycle regulation,guanine nucleotide exchange factor,cancer cell proliferation,signaling pathway modulation
ENSG00000275338,RAB11FIP3,rab gtpase-activating protein,recycling endosome pathway,tumor suppressor function,mutations and deletions,cellular homeostasis,oncogenic protein degradation
ENSG00000103769,RAB11A,endocytic recycling,cell migration,therapeutic target,oncogenic driver,autophagy modulation,membrane trafficking regulation
ENSG00000140464,PML,tumor suppressor function,cell cycle regulation,apoptosis promotion,genomic stability maintenance,dna damage response,transcriptional regulation
ENSG00000205250,E2F4,cell cycle regulation,gain of function mutations,oncogene activation,apoptosis suppression,genomic instability,transcriptional regulation
ENSG00000074706,IPCEF1,cell migration,actin cytoskeleton regulation,tumor progression,metastasis,cancer cell invasion,oncogenic pathway interaction
ENSG00000078043,PIAS2,stat1/stat2 inhibition,transcriptional regulation,tumor suppressor function,protein-protein interactions,cell signaling disruption,oncogenic effects
ENSG00000130779,CLIP1,microtubule stability,chemoresistance,oncogenesis,mitotic spindle assembly,microtubule dynamics,therapeutic target
ENSG00000007168,PAFAH1B1,microtubule dynamics,cellular growth regulation,cytoplasmic microtubules organization,tumor progression,gene amplification,cell division control
ENSG00000125931,CITED1,transcriptional activation,cell growth regulation,apoptosis inhibition,gene expression modulation,tumor suppressor interaction,mitotic checkpoint control
ENSG00000109971,HSPA8,protein folding regulation,cellular homeostasis maintenance,constitutive activation,metabolic regulation,cell survival enhancement,tumorigenesis promotion
,SEPT1,septin organization,mitotic regulation,tumor progression,oncogenic potential,cell cycle dysregulation,protein filament assembly
ENSG00000136280,CCM2,cellular ubiquitination,cancer driver mutation,dna repair dysregulation,cell cycle checkpoint disruption,protein-protein interaction,genomic instability
ENSG00000118689,FOXO3,apoptosis regulation,cell growth suppression,insulin signaling modulation,tumor suppressor function,transcriptional regulation,metabolic regulation
ENSG00000070778,PTPN21,dephosphorylation,cell signaling pathways,oncogenic signaling,tumorigenesis,immune regulation,metastasis 
ENSG00000075651,PLD1,phospholipid metabolism,signaling pathway regulation,cell proliferation enhancement,metastasis promotion,protein interaction modulation,tumor growth facilitation
ENSG00000145242,EPHA5,eph-ephrin signaling pathway,cell surface receptor,tumor suppressor function,oncogenic potential,angiogenesis inhibition,epithelial-to-mesenchymal transition (emt) regulation
ENSG00000152284,TCF7L1,wnt/β-catenin signaling,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cellular proliferation
ENSG00000059728,MXD1,cell cycle regulation,transcriptional repression,tumor suppression,oncogenic gene regulation,chromatin remodeling,histone modification
ENSG00000107295,SH3GL2,endocytic pathway regulation,tumor suppressor function,cell growth modulation,oncogenic signaling,metabolic regulation,cellular homeostasis maintenance
ENSG00000147010,SH3KBP1,pi3k/akt pathway activation,cell proliferation promotion,tumor progression facilitation,akt interaction enhancement,endocytosis regulation,oncogenic signaling modulation
ENSG00000160999,SH2B2,pi3k/akt signaling,regulation of immune cell function,protein-protein interaction,oncogenic processes,tumor growth regulation,jak/stat pathway modulation
ENSG00000178188,SH2B1,oncogene activation,cell proliferation,immune system modulation,genomic instability,scaffolding protein function,loss of function mutations
ENSG00000196655,TRAPPC4,er-to-golgi transport,autophagy regulation,tumor progression marker,cell proliferation enhancement,akt/pi3k interaction,gene amplification event
ENSG00000196498,NCOR2,tumor progression,co-repressor function,transcriptional repression,wnt signaling regulation,nuclear receptor interaction,tumor suppressor gene modulation
ENSG00000101144,BMP7,tgf-β superfamily,cell proliferation regulation,emt inhibition,angiogenesis suppression,wnt/β-catenin pathway activation,biomarker and therapeutic target
ENSG00000171243,SOSTDC1,wnt/β-catenin signaling pathway,oncogenic function,tumor suppressor loss,cell proliferation enhancement,genetic instability promotion,pi3k/akt pathway activation
ENSG00000248333,CDK11B,cell cycle regulation,cyclin-dependent kinase activation,mitotic entry,g1/s transition,pi3k/akt pathway interaction,protein phosphorylation regulation
ENSG00000184937,WT1,gain of function mutations,loss of heterozygosity,tumor suppressor activity,genomic instability,cell cycle regulation,apoptosis regulation
ENSG00000169047,IRS1,constitutive activation,oncogenic driver,tumor progression,metabolic regulation,protein-protein interaction,genomic instability
ENSG00000071051,NCK2,oncogene activation,cell migration,adapter protein function,signal transduction regulation,tumor suppressor interaction,cancer progression promotion
ENSG00000069399,BCL3,nf-kappab signaling pathway,constitutive activation,oncogene function,mutation gain,tumor progression,transcriptional regulation
ENSG00000037280,FLT4,vegfr-3 signaling,lymphangiogenesis promotion,angiopoiesis regulation,tumor progression,metastatic enhancement,cell proliferation enhancement
ENSG00000150630,VEGFC,lymphangiogenesis,angiogenesis promotion,tumor growth enhancement,metastasis facilitation,vascular permeability regulation,prognostic biomarker
ENSG00000124882,EREG,egf signaling,oncogenic driver,epithelial growth stimulation,cell proliferation,angiogenesis promotion,inflammation regulation
ENSG00000131558,EXOC4,cellular metabolism,tumor growth enhancement,oncogenic mutations,chemoresistance mechanism,protein secretion regulation,er structure modification
ENSG00000180104,EXOC3,exocytic regulation,tumor driver mutations,cell surface targeting,growth factor signaling,hormone secretion,oncogenic signaling
ENSG00000151725,CENPU,genomic instability,aneuploidy,mitotic checkpoint regulation,kinetochore assembly,chromosome segregation,tumor suppressor function
ENSG00000160691,SHC1,cell proliferation,signaling pathway regulation,aberrant expression,tumor progression,receptor interaction,oncogenic transformation
ENSG00000105701,FKBP8,tumor suppressor regulation,oncogenic activity,cellular proliferation,protein folding modulation,signal transduction regulation,immunophilin family function
ENSG00000185591,SP1,oncogene,tumor progression,transcriptional regulation,cell growth and differentiation,metastasis and angiogenesis,chemotherapy resistance
ENSG00000269335,IKBKG,nf-κb activation,inflammation promotion,oncogenic signaling,cell survival enhancement,tumor progression,loss-of-function mutation
ENSG00000145431,PDGFC,angiogenesis,cell proliferation,mitogen activity,tumor progression,metastasis promotion,embryonic development
ENSG00000141052,MYOCD,oncogene,transcriptional coactivator,cell growth regulation,signal transduction modulation,cancer cell proliferation,apoptosis inhibition
ENSG00000177565,TBL1XR1,transcriptional co-repressor,cell proliferation,oncogenic processes,tumor suppressor gene suppression,cancer prognosis biomarker,apoptosis regulation
ENSG00000101849,TBL1X,transcriptional regulation,tumor suppressor function,oncogene regulation,gene expression modulation,genomic stability maintenance,cellular differentiation
ENSG00000123159,GIPC1,cell signaling modulation,tumor progression promoter,protein-protein interaction,oncogenic pathway activation,cell proliferation enhancer,adaptor protein function
ENSG00000058272,PPP1R12A,pi3k/akt signaling pathway modification,genetic instability induction,oncogenic protein stabilization,cell survival enhancement,tumor progression facilitation,metabolic adaptation modulation
ENSG00000213639,PPP1CB,oncogene activation,cell cycle regulation,apoptosis resistance,protein phosphatase activity,substrate phosphorylation,cell proliferation
ENSG00000132604,TERF2,telomere maintenance,genomic instability,dna damage repair,cell proliferation,oncogenic processes,telomerase regulation
ENSG00000099956,SMARCB1,chromatin remodeling,swi/snf complex,tumor suppressor function,genomic instability,cell cycle regulation,apoptosis disruption
ENSG00000116604,MEF2D,oncogene activation,transcriptional regulation,cell proliferation,survival pathways,epigenetic modification,tumor progression
ENSG00000099991,CABIN1,cancer driver,protein degradation regulation,tumor suppressor function,cell cycle regulation,genomic instability,apoptosis modulation
ENSG00000162337,LRP5,wnt signaling pathway,constitutive activation,osteoblast differentiation,oncogenic transformation,cancer progression,genomic instability
ENSG00000165197,VEGFD,angiogenesis,lymphangiogenesis,tumor progression,metastasis facilitation,growth factor signaling,receptor-ligand interaction
ENSG00000147526,TACC1,microtubule dynamics regulation,oncogene function,mitotic progression facilitation,chromosomal instability driver,aneuploidy contributor,cancer prognosis marker
ENSG00000100592,DAAM1,planar cell polarity signaling,cell adhesion disruption,epithelial-to-mesenchymal transition,tumor progression,metastasis enhancement,poor prognosis marker
ENSG00000073584,SMARCE1,swi/snf complex,chromatin remodeling,tumor suppressor,genome stability,cell cycle progression,dna repair pathway
ENSG00000073282,TP63,tp63-p53 axis,cell cycle regulation,ectodermal development,oncogenic transformation,tumor suppression,epithelial differentiation
ENSG00000278114,MUC20,cellular proliferation,tumor growth,molecular interaction,glycoprotein expression,tumor metastasis,cancer development
ENSG00000106991,ENG,tgf-beta signaling,loss of function mutations,angiogenesis,tumor progression,immune evasion,vascular endothelial growth factor (vegf) regulation
ENSG00000115884,SDC1,pi3k/akt pathway signaling,oncogene expression,cell adhesion dysregulation,metastasis promotion,tumor progression,stemness maintenance
ENSG00000111664,GNB3,gpcr regulation,constitutive activation,gain of function mutations,tumor progression,metastatic potential,signaling pathway modulation
ENSG00000167083,GNGT2,cell proliferation,g-protein coupled receptors interaction,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000178573,MAF,transcription factor regulation,oncogenic processes,cell proliferation,constitutive activation,apoptosis resistance,cellular differentiation
ENSG00000119335,SET,epigenetic regulation,histone methylation,chromatin remodeling,genomic instability,oncogene activation,tumor suppressor interaction
ENSG00000173801,JUP,adherens junction regulation,gene expression regulation,tumor suppressor function,mitotic checkpoint disruption,cell migration promotion,epithelial-to-mesenchymal transition (emt) facilitation
ENSG00000096696,DSP,cytoskeletal regulation,cell membrane integrity,protein-protein interactions,tumor progression modulation,adhesion molecule,cellular architecture disruption
ENSG00000137834,SMAD6,tgf-β signaling attenuation,tumor suppressor function,smad family member interaction,cancer metastasis regulation,molecular pathway modulation,biological process regulation
ENSG00000183207,RUVBL2,chromatin remodeling,cell proliferation,kinase regulation,genome instability,cell cycle progression,tumor growth promoter
ENSG00000173511,VEGFB,angiogenesis promotion,receptor tyrosine kinase activation,tumor aggressiveness,neovascularization enhancement,vascular permeability regulation,growth factor interaction
ENSG00000150907,FOXO1,loss of function mutations,tumor suppressor activity,apoptosis regulation,cell cycle arrest,genomic instability,transcriptional regulation
ENSG00000184371,CSF1,macrophage recruitment,tumor progression,aberrant activation,cell proliferation,metastasis promotion,pro-tumorigenic microenvironment
ENSG00000182578,CSF1R,stat3 pathway,constitutive activation,gain of function mutations,tumor progression,oncogenic driver,macrophage recruitment
ENSG00000166888,STAT6,stat6 signaling pathway,constitutive activation,gain of function mutations,cell proliferation,transcriptional regulation,immune evasion
ENSG00000173193,PARP14,protein modification,transcriptional regulation,cell survival,tumor progression,metastasis,dna repair
ENSG00000137265,IRF4,constitutive activation,cellular proliferation,tumor progression,immune evasion,transcriptional regulation,oncogenic signaling
ENSG00000050748,MAPK9,jnk pathway activation,cell death regulation,tumor progression,pro-survival factor,cellular stress response,kinase domain interaction
ENSG00000072736,NFATC3,tumor progression,transcriptional regulation,oncogenic signaling,cell proliferation,apoptosis evasion,genomic amplification
ENSG00000163956,LRPAP1,ldlr regulation,endocytic process,lipid metabolism,cancer risk modifier,proliferation enhancement,cell survival
ENSG00000169856,ONECUT1,transcription factor,oncogene activity,tumor progression,cell proliferation,therapeutic target,notch pathway interaction
ENSG00000276971,TRPV6,cancer metabolism,calcium uptake,oncogene,tumor progression,cell proliferation,gain-of-function mutation
ENSG00000109332,UBE2D3,oncogenic potential,ubiquitination process,protein degradation regulation,cell cycle progression,apoptosis modulation,therapeutic target
ENSG00000137841,PLCB2,signaling pathway disruption,cell growth promotion,oncogenic mutation,calcium mobilization regulation,gene expression modulation,protein kinase activation
ENSG00000163932,PRKCD,apoptosis regulation,cell cycle regulation,oncogene/tumor suppressor,pi3k/akt signaling interaction,tumorigenesis driver,protein kinase activity
ENSG00000116106,EPHA4,ephrin signaling pathway,oncogene activation,tumor aggressiveness,cell migration regulation,biomarker expression,signal transduction modulation
ENSG00000118260,CREB1,oncogenic transcription factor,aberrant activation,enhanced cell proliferation,angiogenesis,transcriptional regulation,cell survival pathway
ENSG00000204628,RACK1,signaling pathway regulation,oncogenic process promotion,cell signaling modulation,multifunctional protein activity,protein interaction regulation,gene expression regulation
ENSG00000115306,SPTBN1,cancer driver,constitutive activation,cytoskeleton regulation,epithelial-to-mesenchymal transition (emt),oncogenic signaling pathway,tumor progression
ENSG00000177302,TOP3A,genomic instability,dna replication,oncogene overexpression,chromosomal abnormalities,cell division regulation,cancer progression facilitation
ENSG00000197299,BLM,genomic instability,replication fork stabilization,mismatch repair,genetic mutations,dna helicase function,tumor suppressor
ENSG00000162772,ATF3,tumor suppressor function,apoptosis regulation,cell cycle regulation,genomic stability maintenance,transcriptional modulation,oncogenic potential
ENSG00000108262,GIT1,gef activation,rho gtpase regulation,cell migration,oncogenic signaling,tumor progression,metastatic potential
ENSG00000102606,ARHGEF7,rho gtpase regulation,cancer progression,molecular interactions,tumor growth,therapeutic target,cell migration regulation
ENSG00000138039,LHCGR,ligand-independent activation,aberrant signaling,oncogenic processes,tumor progression,therapeutic target,biomarker potential
ENSG00000284901,RUVBL1,histone modification,chromatin remodeling,cell cycle regulation,dna replication,tumor suppression,genomic stability
ENSG00000183337,BCOR,chromatin modification,oncogenesis,transcriptional regulation,tumor suppression,cell proliferation,genetic reprogramming
ENSG00000171450,CDK5R2,cell cycle regulation,cell proliferation,oncogenic processes,protein kinase activation,chromatin remodeling,microtubule stability
ENSG00000121022,COPS5,cell cycle regulation,protein degradation,tumor suppressor,oncogenic process,cell proliferation,genetic instability
ENSG00000154473,BUB3,chromosomal instability,spindle checkpoint regulation,tumor suppressor function,cell cycle regulation,mitotic error correction,genomic stability maintenance
ENSG00000169679,BUB1,genomic instability,spindle checkpoint regulation,cell proliferation,mitotic progression,kinase activation,gain-of-function mutations
ENSG00000164342,TLR3,innate immune activation,viral recognition,type i interferon production,immune evasion mechanisms,tumor-associated inflammation,adaptor protein recruitment
ENSG00000127666,TICAM1,tumor growth promotion,inflammatory microenvironment modulation,immune response regulation,nf-κb activation,mapk pathway interaction,tlr signaling association
ENSG00000171552,BCL2L1,apoptosis regulation,oncogene function,cell survival promotion,genomic instability maintenance,pi3k/akt pathway interaction,tumor progression facilitation
ENSG00000069966,GNB5,heterotrimeric g-protein signaling,gain of function mutations,tumor progression,therapeutic target,cell proliferation regulation,signaling pathway modulation
ENSG00000131788,PIAS3,stat3 regulation,transcriptional inhibitor,cell cycle regulation,apoptosis modulation,immune response regulation,genetic instability
ENSG00000282130,NSMCE3,nuclear export pathway,alternative splicing,mrna stability regulation,tumor progression,cancer driver gene,therapeutic target
ENSG00000101412,E2F1,tumor suppressor,apoptosis regulation,cell cycle progression,transcription factor activity,dna damage response,cancer driver gene candidate
ENSG00000170962,PDGFD,angiogenesis promotion,cell proliferation enhancement,receptor activation,metastasis facilitation,tumor growth promotion,emt regulation
ENSG00000134954,ETS1,transcription factor regulation,oncogenic pathway activation,cell cycle dysregulation,apoptosis inhibition,angiogenesis promotion,epigenetic modification
ENSG00000161888,SPC24,chromatin remodeling,genomic instability,aneuploidy disruption,sister chromatid cohesion loss,tumor suppressor function alteration,cancer driver gene potential
ENSG00000080986,NDC80,chromosomal instability,aneuploidy,chromosome missegregation,kinetochore function,microtubule attachment,cancer therapy target
ENSG00000185737,NRG3,tumor growth,cell proliferation,oncogenic signaling,erbb receptor interaction,overexpression mutations,pi3k/akt pathway activation
ENSG00000182957,SPATA13,enhanced cell proliferation,overexpression in cancer,cell surface expression regulation,tumor progression facilitation,therapeutic target,pi3k/akt pathway activation
ENSG00000112062,MAPK14,p38 mapk pathway,cell survival,apoptosis suppression,tumor progression,signaling cascade,pro-survival signals
ENSG00000131196,NFATC1,tumor progression,transcriptional regulation,cell proliferation,oncogenic signaling,genetic mutations,therapeutic resistance
ENSG00000081189,MEF2C,cellular proliferation,oncogenesis,transcriptional regulation,epigenetic modification,post-translational modification,tumor progression
ENSG00000170289,CNGB3,ion channel dysfunction,stress signal modulation,cellular response disruption,cancer driver mutation,therapeutic target,emt regulation
ENSG00000144191,CNGA3,constitutive activation,cell proliferation,tumor progression,aberrant expression,mutation-driven oncogenesis,signaling pathway modulation
ENSG00000105221,AKT2,pi3k/akt pathway,constitutive activation,oncogenic driver,protein kinase activation,cell survival enhancement,metabolic regulation
ENSG00000135547,HEY2,transcriptional repression,cell proliferation inhibition,epithelial-to-mesenchymal transition (emt),cancer stem cell self-renewal,co-expression with hes1,prognostic value
ENSG00000133216,EPHB2,tumor angiogenesis,receptor tyrosine kinase activity,cell migration regulation,oncogenic pathway activation,ligand interaction modulation,metastasis promotion
ENSG00000157933,SKI,transcriptional coactivator,tgf-β pathway modulation,proto-oncogene function,dna-binding affinity enhancement,phosphorylation-mediated regulation,p16ink4a suppression
ENSG00000150593,PDCD4,apoptosis regulation,cell cycle control,oncogenic transformation,tumor suppressor function,uncontrolled growth promotion,metastatic potential
ENSG00000196961,AP2A1,regulation of endocytosis,oncogenic processes,cell membrane trafficking,clathrin-dependent machinery,predictive biomarker,signaling pathway modulation
ENSG00000161203,AP2M1,endocytic pathway,cell proliferation,tumor suppressor/oncogene,receptor internalization,protein-protein interaction,clathrin-mediated endocytosis
ENSG00000147044,CASK,cell adhesion disruption,aberrant signaling pathway activation,neuronal function regulation,oncogene/tumor suppressor duality,protein-protein interaction,synaptic plasticity modulation
ENSG00000158458,NRG2,tumor progression,receptor activation,pi3k/akt signaling,cell survival,immune modulation,cell proliferation 
ENSG00000188130,MAPK12,cancer driver,signaling pathway regulation,cell proliferation promotion,oncogene function,tumor suppressor activity,gene amplification association
ENSG00000101400,SNTA1,pi3k/akt interaction,tumor progression,cell signaling regulation,oncogenic activation,muscle development,neuronal function
ENSG00000186625,KATNA1,microtubule disassembly,cellular structure disruption,oncogenic transformation,tumor progression,therapeutic target,genomic instability
ENSG00000125538,IL1B,pro-inflammatory cytokine,immune suppression,tumor growth promotion,angiogenesis induction,metastasis facilitation,oncogenic signaling
ENSG00000097007,ABL1,abl1 kinase activity,chronic myeloid leukemia (cml),tyrosine phosphorylation regulation,cell proliferation enhancement,oncogene activation,signaling pathway dysregulation
ENSG00000187555,USP7,deubiquitinating enzyme function,protein stability regulation,oncogene activation,tumor suppressor protein regulation,cell cycle progression promotion,therapeutic target potential
ENSG00000206279,DAXX,genomic instability,dna repair defect,tumor suppressor function,chromatin remodeling,epigenetic regulation,loss of function mutation
ENSG00000061273,HDAC7,chromatin remodeling,histone deacetylation,transcriptional regulation,tumor suppressor activity,oncogene potential,metastasis promotion
ENSG00000130726,TRIM28,chromatin structure,transcriptional regulation,oncogenic transformation,tumor suppressor gene regulation,cellular proliferation regulation,dna repair dysregulation
ENSG00000144485,HES6,notch signaling pathway,oncogene,tumor progression,cell cycle regulation,apoptosis inhibition,genomic instability 
ENSG00000123124,WWP1,e3 ubiquitin ligase activity,tumor suppressor gene,protein degradation regulation,cell signaling pathway modulation,oncoprotein targeting,cell cycle regulation
ENSG00000138755,CXCL9,tumor progression,immune evasion,chemokine signaling,cell migration,angiogenesis,tumor microenvironment
ENSG00000179348,GATA2,transcription factor regulation,zinc finger dna binding,cellular growth modulation,oncogene or tumor suppressor,constitutive activation potential,hematopoiesis and immune function
ENSG00000164362,TERT,telomere maintenance,oncogene expression,genomic instability,senescence evasion,therapeutic target,cellular immortalization
ENSG00000044115,CTNNA1,disrupted cell adhesion,regulation of transcription,oncogene potential,wnt/β-catenin pathway interaction,signal transduction,cell growth regulation
ENSG00000068903,SIRT2,dna damage response,genomic instability,oncogenic potential,tumor suppressor activity,protein deacetylation,cellular homeostasis
ENSG00000253293,HOXA10,transcriptional regulation,cell fate determination,promoter binding activity,tumor progression,epithelial-to-mesenchymal transition (emt),growth factor signaling
ENSG00000121671,CRY2,cell cycle regulation,cell proliferation,circadian rhythm disruption,dna damage response,oncogene activation,photoreceptor function
ENSG00000072803,FBXW11,ubiquitin-proteasome pathway,g2/m cell cycle regulation,wnt/β-catenin signaling pathway,cell cycle control,oncogenic potential,tumor progression
ENSG00000184481,FOXO4,transcriptional regulation,tumor suppressor function,constitutive activation,cell cycle arrest,apoptosis induction,oncogenic signaling inhibition
ENSG00000160014,CALM3,calcium-dependent signaling pathway,dysregulation of cellular behavior,cell proliferation regulation,oncogenic transformation,apoptosis inhibition,tumor growth promotion
ENSG00000172020,GAP43,cellular migration,actin cytoskeleton regulation,oncogenic mutations,metastatic potential,pi3k/akt pathway modulation,growth factor signaling
ENSG00000113712,CSNK1A1,wnt/β-catenin pathway activation,cell cycle regulation,apoptosis suppression,metastasis promotion,substrate phosphorylation,tumor progression driver
ENSG00000100567,PSMA3,proteasomal degradation,regulation of cell cycle,disruption of protein quality control,immune evasion mechanisms,none,none
ENSG00000126561,STAT5A,transcription factor activation,cancer cell proliferation,metastasis regulation,apoptosis evasion,tumor suppressor function,signal transduction pathway modulation
ENSG00000092820,EZR,epithelial-to-mesenchymal transition (emt),cell migration,cell invasion,oncogenic signaling,protein-protein interaction,tumor metastasis
ENSG00000065717,TLE2,wnt/β-catenin pathway regulation,transcriptional repression,cell cycle progression,corepressor function,notch signaling modulation,tumor suppression role
ENSG00000120798,NR2C1,transcriptional regulation,chromatin remodeling,tumor suppressor function,dysregulation associated with cancer,cell cycle regulation,oncogenic signaling pathway inhibition
ENSG00000075711,DLG1,regulatory dysfunction,cell-cell adhesion disruption,synaptic plasticity modulation,neuronal function regulation,tumor growth promotion,protein interaction alterations
ENSG00000253729,PRKDC,genomic instability,gene expression regulation,cancer development,cell proliferation,protein kinase activation,tumor suppression deficiency
ENSG00000152457,DCLRE1C,dna repair mechanism,genomic instability,tumorigenesis,oncogenic processes,cellular homeostasis,genetic alterations
ENSG00000288401,CTTN,rho gtpase pathway,pi3k/akt signaling,tumor invasion,cytoskeleton modulation,oncogenic protein,cancer cell migration
ENSG00000131910,NR0B2,nuclear receptor,transcription factor,cell proliferation,signaling pathway regulation,tumor suppressor function,cancer progression
ENSG00000185950,IRS2,akt/mtor pathway activation,constitutive insulin/igf-1 signaling,insulin receptor interaction,oncogenic transformation,cell proliferation promotion,genomic instability
ENSG00000140044,JDP2,transcription factor regulation,cell cycle progression,apoptosis regulation,tumor suppressor regulation,genetic mutations,cancer cell proliferation
ENSG00000124440,HIF3A,hypoxia response,angiogenesis promotion,transcriptional regulation,apoptosis evasion,metabolic reprogramming,tumor adaptation
ENSG00000169071,ROR2,receptor tyrosine kinase activity,transmembrane receptor function,wnt/pcp signaling pathway,cell migration regulation,oncogenic process activation,tumor growth promotion
ENSG00000143384,MCL1,apoptosis inhibition,anti-apoptotic function,cell survival promotion,tumor progression facilitation,pro-survival signaling,genetic amplification 
ENSG00000079841,RIMS1,altered cellular signaling,cancer progression,cell proliferation,cellular plasticity,exocytosis regulation,protein-protein interaction
ENSG00000198722,UNC13B,neurotransmitter release modulation,cellular signaling regulation,calcium channel regulation,tumor growth promotion,apoptosis resistance,therapeutic target
ENSG00000140009,ESR2,estrogen signaling,oncogene activation,transcriptional regulation,cell proliferation,biomarker potential,endocrine therapy resistance
ENSG00000131981,LGALS3,angiogenesis induction,apoptosis inhibition,cell migration facilitation,emt promotion,fibrosis induction,metastasis facilitation
ENSG00000147099,HDAC8,transcriptional regulation,constitutive activation,chromatin remodeling,oncogenesis,cell cycle regulation,apoptosis repression
ENSG00000198952,SMG5,aberrant regulation,defective transcript stability,e3 ubiquitin ligase activity,genomic integrity maintenance,nmd pathway disruption,protein degradation enhancement
ENSG00000056558,TRAF1,nf-κb activation,promoter methylation,tumor progression,metastasis facilitation,cell survival enhancement,immune evasion modulation
ENSG00000138964,PARVG,protein stability regulation,tumor suppressor interaction,cell cycle regulation,dna damage response,oncogenic pathway involvement,cancer driver gene
ENSG00000198901,PRC1,microtubule regulation,cytokinesis completion,aneuploidy driver,cell cycle regulation,genomic instability,tumor progression mediator
ENSG00000140350,ANP32A,oncogenic signaling,chromatin remodeling,histone modification regulation,transcriptional regulation,genome stability maintenance,protein-protein interaction
ENSG00000182636,NDN,transcriptional regulation,cellular differentiation,apoptosis evasion,tumor progression,metastatic potential,protein-protein interactions
ENSG00000160633,SAFB,chromatin regulation,dna damage repair,tumor suppressor function,gene expression modulation,oncogenic process promotion,cell cycle progression regulation
ENSG00000089220,PEBP1,pi3k/akt interaction,cell survival enhancement,cytosolic phosphatase activity,apoptosis regulation,proliferation promotion,tumor progression
ENSG00000281766,RYBP,transcriptional corepressor,genomic instability,tumor suppression,cell proliferation regulation,epigenetic regulation,apoptosis regulation
ENSG00000027869,SH2D2A,t-cell signaling,sh2 domain binding,immune regulation,oncogenesis,immune evasion,tumor immunosuppression
ENSG00000169967,MAP3K2,mapk pathway regulation,oncogene/tumor suppressor function,constitutive activation mutations,cell proliferation enhancement,signal transduction modulation,protein kinase activity
ENSG00000065618,COL17A1,oncogenic overexpression,cell adhesion disruption,tumor progression promotion,biomarker potential,protein interaction modulation,epithelial-stromal interface disruption
ENSG00000139687,RB1,cell cycle regulation,tumor suppressor function,genomic stability,apoptosis regulation,cancer initiation,therapeutic target
ENSG00000118971,CCND2,cell cycle regulation,oncogenic activation,cell proliferation,tumor growth,cdk4 complex formation,prb phosphorylation
ENSG00000160791,CCR5,cellular invasion,chemokine binding,g protein-coupled receptor,immune modulation,metastasis promotion,oncogenic signaling pathway
ENSG00000197386,HTT,cellular regulation,neurodegenerative disease,autosomal dominant inheritance,tumor progression,cell growth modulation,synaptic plasticity disruption
ENSG00000106211,HSPB1,heat shock protein function,cellular homeostasis regulation,protein folding and aggregation regulation,cell survival enhancement,tumor suppressor or oncogene activity,molecular chaperone interaction
ENSG00000014216,CAPN1,calcium-dependent proteolysis,proteolytic activity,cell proliferation regulation,survival pathway modulation,tumor suppressor functions,lysosomal membrane permeabilization
ENSG00000126247,CAPNS1,ion channel regulation,oncogenic potential,apoptosis resistance,tumor growth enhancement,cell proliferation increase,cancer biomarker candidate
ENSG00000184500,PROS1,protein activation,thrombin generation,blood coagulation regulation,tumor progression modulation,cancer-associated thrombosis,genetic predisposition
ENSG00000110711,AIP,tumor suppressor function,cell cycle regulation,apoptosis induction,endocrine gland tumor formation,genomic instability,loss of heterozygosity 
ENSG00000162909,CAPN2,calcium-dependent protease,tumor progression,cell migration,oncogenic pathway activation,protein cleavage regulation,genomic instability
ENSG00000141655,TNFRSF11A,nf-κb activation,rankl signaling pathway,cell proliferation enhancement,immune system regulation,osteoclast differentiation,therapeutic target
ENSG00000120659,TNFSF11,rankl/rank pathway,tumor-promoting effects,osteoclast differentiation,cell survival and proliferation,metastasis regulation,immune system modulation
ENSG00000171476,HOPX,tumor suppressor function,pi3k/akt pathway inhibition,apoptosis induction,cell differentiation regulation,prognostic marker potential,genomic instability response
ENSG00000259384,GH1,cell proliferation,angiogenesis promotion,metabolic regulation,growth stimulation,oncogenic signaling pathway activation,tumor progression enhancement
ENSG00000110934,BIN2,endocytic trafficking,autophagy regulation,membrane dynamics,oncogene activation,cancer cell survival,therapeutic target
ENSG00000048052,HDAC9,oncogenic potential,cell proliferation promotion,metabolic reprogramming,pi3k/akt/mtor pathway modulation,transcriptional regulation,protein-protein interaction
ENSG00000198821,CD247,impaired t-cell signaling,tumor escape mechanisms,immune dysfunction,prognostic biomarker candidate,apoptosis regulation,cellular interaction pathways
ENSG00000204217,BMPR2,tgf-β signaling pathway,constitutive activation,gain of function mutations,vascular remodeling,cell proliferation,apoptosis inhibition
ENSG00000107779,BMPR1A,bmp signaling pathway,tumor suppressor function,constitutive activation,loss-of-function mutations,cell differentiation regulation,epithelial-to-mesenchymal transition
ENSG00000140443,IGF1R,igf1r signaling pathway,receptor tyrosine kinase activity,tumor progression,cell proliferation,insulin-like growth factor binding,metastasis promotion
ENSG00000136603,SKIL,chromatin remodeling,oncogene function,cell cycle regulation,dna repair modulation,protein kinase activation,transcriptional regulation
ENSG00000168398,BDKRB2,constitutive activation,oncogenic signaling,gain of function mutations,tumor progression,therapeutic target,angiogenesis modulation
ENSG00000170581,STAT2,transcription factor function,interferon signaling pathway,tumor suppressor activity,apoptosis promotion,cell cycle regulation,immune response modulation
ENSG00000159692,CTBP1,transcriptional co-repressor,wnt/β-catenin signaling pathway,epithelial-to-mesenchymal transition (emt),cell proliferation enhancement,therapeutic target potential,genomic instability contributor
ENSG00000285109,GATA4,wnt signaling pathway,transcription factor activity,cell proliferation,epithelial-to-mesenchymal transition,transcriptional regulation,gene expression modulation
ENSG00000183072,NKX2-5,cell proliferation,transcriptional regulation,tumor suppression,metastatic potential,apoptosis inhibition,chromosomal rearrangement
ENSG00000003402,CFLAR,apoptosis regulation,cancer development,oncogene role,cell survival,proteolytic regulation,tumor progression
ENSG00000111348,ARHGDIB,rhogdi activity inhibition,oncogenic signaling,small gtpase regulation,cell migration promotion,metastasis enhancement,tumor growth acceleration
ENSG00000067560,RHOA,rho gtpase activity,tumor progression,cell migration,metastasis promotion,cancer cell survival,cell cycle regulation
ENSG00000141456,PELP1,transcriptional regulation,apoptosis evasion,cell cycle progression,oncogenesis promotion,prognostic marker,co-regulator interaction
ENSG00000163599,CTLA4,immunosuppression,tumor evasion,checkpoint blockade therapy,cancer immunotherapy target,immune regulation,t cell activation
ENSG00000065361,ERBB3,receptor tyrosine kinase,cell proliferation,oncogenic signaling,pi3k/akt pathway,ligand-independent activation,tumor progression
ENSG00000196132,MYT1,transcriptional regulation,chromatin remodeling complex interaction,tumor growth promotion,apoptosis inhibition,cell cycle progression,oncogenic transcription factor
ENSG00000186951,PPARA,ppar activation pathway,lipid metabolism regulation,fatty acid oxidation induction,transcriptional regulation,apoptosis inhibition,tumor promotion
ENSG00000185291,IL3RA,tumor suppressor function,dysregulated cytokine signaling,immune evasion,altered cellular proliferation,hematopoiesis regulation,genomic instability susceptibility
ENSG00000174697,LEP,cell proliferation,stat3 activation,pi3k/akt pathway,epithelial-to-mesenchymal transition (emt),immune evasion,tumor growth
ENSG00000101773,RBBP8,genomic stability maintenance,apoptosis regulation,tumor suppressor function,dna replication regulation,mutation hotspot identification,cell cycle progression
ENSG00000135218,CD36,lipid metabolism,fatty acid uptake,cell adhesion,tumor growth,metastasis promotion,therapeutic target
ENSG00000128245,YWHAH,oncogene,tumor suppressor regulation,pi3k/akt pathway interaction,cell proliferation enhancement,apoptosis suppression,signaling pathway modulation
ENSG00000159110,IFNAR2,immune evasion,type i interferon signaling pathway,stat1 activation,jak1 interaction,antiviral response impairment,apoptosis inhibition
ENSG00000080839,RBL1,e2f transcription factor regulation,cell cycle progression inhibition,tumor suppressor function loss,genomic instability contribution,oncogenesis facilitation,cell growth regulation
ENSG00000116044,NFE2L2,nuclear translocation,transcriptional regulation,oxidative stress response,cellular adaptation,antioxidant protein activation,chemo-resistance
ENSG00000079999,KEAP1,keap1-nrf2 pathway dysregulation,nrf2 activation,loss of function mutations,therapeutic target,tumor progression,protein ubiquitination
ENSG00000164690,SHH,pathway activation,tumor growth,cell proliferation,angiogenesis,stem cell maintenance,signal transduction
ENSG00000144891,AGTR1,at1r activation,cell proliferation,angiogenesis promotion,epithelial-to-mesenchymal transition (emt),tumor progression,therapeutic target
ENSG00000121966,CXCR4,chemokine receptor function,overexpression/mutation,enhanced cell migration/invasion,tumor progression/recruitment,therapeutic target/anti-cancer treatment resistance,immunosuppression/t-regulatory cells recruitment
ENSG00000134480,CCNH,oncogenic potential,cell cycle regulation,transcriptional control,proliferation enhancement,cell growth promotion,tumor progression
ENSG00000134058,CDK7,cak complex activation,cell cycle regulation,cancer driver gene,therapeutic target,oncogenesis,tumor progression
ENSG00000123908,AGO2,ago2 function in risc,mirna-mediated gene regulation,oncogenic processes,tumor growth and metastasis,cell cycle progression and metabolic reprogramming,potential therapeutic target
ENSG00000100697,DICER1,microrna biogenesis,rna processing regulation,tumor suppressor function,oncogenic mirna accumulation,genetic mutations,cellular homeostasis disruption
ENSG00000016490,CLCA1,calcium signaling,cell proliferation,chloride channel regulation,invasive potential,migration regulator,tumor promoter
ENSG00000164078,MST1R,cell proliferation,receptor tyrosine kinase activation,aberrant signaling pathway,epithelial-to-mesenchymal transition (emt),angiogenesis promotion,tumor progression
ENSG00000168028,RPSA,cell proliferation,translation regulation,ribosomal subunit protein,tumor progression,apoptosis inhibition,cell cycle modulation
ENSG00000151914,DST,wnt/pcp signaling pathway,oncogenic function,cell migration,tumor progression,planar cell polarity,segment polarity protein
ENSG00000178209,PLEC,cell migration,cancer progression,metastasis regulation,tumor microenvironment,adherens junctions,plasma membrane association
ENSG00000136238,RAC1,cell migration,constitutive activation,oncogenic signaling,epithelial-to-mesenchymal transition (emt),metastasis,therapeutic target
ENSG00000112851,ERBIN,cell-cell adhesion disruption,tumor progression facilitation,signaling pathway dysregulation,oncogenic potential,tissue-specific expression,epithelial integrity maintenance
ENSG00000026025,VIM,tumor progression,epithelial-to-mesenchymal transition,cell migration,oncogenesis,biomarker for cancer,protein-protein interaction
ENSG00000177697,CD151,tumor metastasis,cell adhesion disruption,oncogenic properties,integrin modulation,metastatic progression,cancer-related signaling
ENSG00000176105,YES1,oncogenic driver,cell proliferation,transcription regulation,protein-protein interactions,apoptosis inhibition,dna repair regulation
ENSG00000134308,YWHAQ,signaling complex assembly,apoptosis regulation,oncogene overexpression,tumor progression promotion,prognostic marker,cell cycle modulation
ENSG00000242372,EIF6,oncogene overexpression,cell proliferation,protein synthesis regulation,translational control,translation initiation complex,growth factor signaling
ENSG00000166813,KIF7,chromosome segregation,mitotic spindle assembly,cell cycle regulation,aneuploidy,tumor progression,protein-protein interaction
ENSG00000117425,PTCH2,hedgehog signaling pathway,constitutive activation,gain of function mutations,tumor cell proliferation,oncogenic processes,smoothened regulation
ENSG00000173020,GRK2,gpcr signaling regulation,dysregulated kinase activity,tumor progression promotion,cellular migration facilitation,cancer stem cell maintenance,apoptosis evasion
ENSG00000157540,DYRK1A,cell proliferation,dual specificity kinase,oncogenesis,pi3k/akt pathway,tumor suppressor interaction,mapk/erk pathway activation
ENSG00000163482,STK36,wnt signaling pathway,aberrant activation,chromosomal instability,cell proliferation,genomic stability,centrosome regulation
ENSG00000235568,NFAM1,cell cycle regulation,transcriptional regulation,oncogene function,apoptosis suppression,genomic instability,tumor suppressor interaction
ENSG00000115085,ZAP70,t-cell receptor signaling,non-receptor tyrosine kinase,cell proliferation enhancement,oncogene activation,metastasis promotion,immune response modulation
ENSG00000165025,SYK,b-cell receptor signaling,gain of function mutations,tumor progression,immune evasion,therapeutic target,protein kinase activation
ENSG00000111859,NEDD9,oncogenic activity,scaffolding protein function,tumor growth promotion,angiogenesis regulation,cell survival signaling,protein-protein interactions
ENSG00000115935,WIPF1,cell migration,constitutive activation,actin cytoskeleton dynamics,cancer progression,metastasis,signaling pathway regulation
ENSG00000116473,RAP1A,mapk signaling pathway,constitutive activity,oncogenic driver,cell cycle regulation,gtpase activity,protein-protein interactions
ENSG00000068831,RASGRP2,ras protein activation,oncogenic signaling,cell proliferation,downstream effector,pkc pathway regulation,tumor progression
ENSG00000110448,CD5,tumor microenvironment,oncogenic pathway,constitutive activation,gain of function mutations,cell surface protein,signal transduction
ENSG00000155926,SLA,slit-robo signaling pathway,cell migration regulation,tumor progression modulation,oncogenic transformation,dysregulation in metastasis,robo receptor interaction
ENSG00000113263,ITK,t-cell signaling,non-receptor tyrosine kinase activity,gene mutations,tumor cell growth,migratory behavior,oncogene regulation
ENSG00000160856,FCRL3,t-cell regulation,immune evasion,oncogenic processes,cell signaling modulation,tumor microenvironment modulation,genetic alterations
ENSG00000154016,GRAP,signal transduction,adaptor protein function,scaffolding protein,cell migration,oncogene/tumor suppressor potential,signaling complex assembly
ENSG00000141293,SKAP1,actin cytoskeleton regulation,cell migration,metastasis,tumor progression,oncogenic driver,epithelial-to-mesenchymal transition
ENSG00000172575,RASGRP1,gain of function mutations,cellular signaling pathway,ras activation,tumor progression,therapeutic target,gtpase regulation
ENSG00000079805,DNM2,mitochondrial dynamics,cell survival and metabolism,constitutive activation,overexpression and dysregulation,cell migration and invasion,therapeutic target
ENSG00000198286,CARD11,nf-κb signaling pathway,aberrant activation,tumor growth promotion,anti-apoptotic function,cell proliferation enhancement,kinase regulation
ENSG00000139436,GIT2,cell signaling regulation,oncogenic mutations,cell migration modulation,pi3k/akt pathway interaction,tumor progression facilitation,adhesion molecule regulation
ENSG00000125753,VASP,cell adhesion,cell migration,oncogenic potential,tumor progression,angiogenesis,metastasis
ENSG00000154380,ENAH,tumor progression,cell migration,resistance to apoptosis,cancer stem cell maintenance,angiogenesis regulation,dysregulation of cytoskeleton
ENSG00000196405,EVL,cell migration,invasion,epithelial-to-mesenchymal transition,cytoskeletal organization,oncogenic behavior,signaling pathway regulation
ENSG00000232575,TUBB,microtubule dynamics,cell proliferation,tumor growth,microtubule assembly,apoptosis resistance,genomic instability
ENSG00000070159,PTPN3,oncogenic process,cell proliferation,survival enhancement,tumor suppression,signaling regulation,dephosphorylation activity
ENSG00000108861,DUSP3,mapk signaling regulation,oncogene/tumor suppressor function,constitutive activation,cell proliferation/survival,protein phosphatase activity,cellular homeostasis disruption
ENSG00000163519,TRAT1,constitutive activation,oncogene,mutations,overexpression,dna damage response,transcription regulation
ENSG00000127947,PTPN12,loss-of-function mutations,gain-of-function alterations,cell proliferation enhancement,oncogenic signaling pathways activation,tumor suppressor function,stat3 phosphorylation promotion
ENSG00000074966,TXK,oncogenic activation,pi3k/akt pathway,serine/threonine kinase function,cell proliferation,tumor progression,therapeutic target
ENSG00000185499,MUC1,overexpression in cancer,oncogenesis,pi3k/akt pathway interaction,tumor progression,therapeutic target,prognostic marker
ENSG00000015285,WAS,actin cytoskeleton dynamics,t-cell modulation,immune response regulation,cell migration regulation,thrombocytopenia association,oncogenic transformation
ENSG00000005020,SKAP2,immune response modulation,cell migration regulation,tumor progression enhancement,apoptosis inhibition,dna repair regulation,protein-protein interaction
ENSG00000115053,NCL,translational regulation,tumor progression,cell cycle regulation,apoptosis evasion,protein-protein interaction,ribosome biogenesis
ENSG00000109103,UNC119,endocytic pathway regulation,oncogene overexpression,cell membrane interaction,synaptic vesicle recycling,tumor cell proliferation,therapeutic target candidate
ENSG00000101082,SLA2,cell migration,actin cytoskeleton regulation,tumor progression,metastasis promotion,cancer-associated protein overexpression,poor prognosis
ENSG00000095370,SH2D3C,cancer-promoting activity,cell survival and migration,signaling pathway regulation,tyrosine kinase interaction,phosphatase activation,gene overexpression
ENSG00000107338,SHB,oncogenic signaling pathway,gain of function mutations,cell proliferation regulation,protein tyrosine kinase interaction,signal transduction modulation,transcription factor regulation
ENSG00000127824,TUBA4A,cellular structure regulation,gene expression alteration,microtubule destabilization,tumor progression driver,tubulin mutations,rna polymerase interaction
ENSG00000134215,VAV3,cell migration,receptor tyrosine kinase activation,metastasis,prognostic marker,cell proliferation,signaling pathway activation
ENSG00000023892,DEF6,tumor suppressor function,cell cycle regulation,transcriptional control,oncogenic protein interaction,metastasis inhibition,apoptosis modulation
ENSG00000198087,CD2AP,cell adhesion disruption,cytoskeletal remodeling,egfr pathway activation,tumor progression facilitation,apoptosis resistance enhancement,metastasis promotion
ENSG00000122188,LAX1,nuclear receptor regulation,oncogene activation,cell growth promotion,tumor progression,therapeutic target,genomic profiling
ENSG00000080031,PTPRH,ptprh mutations,loss of function mutation,tumor suppressor regulation,hyperactivation of pten,cell proliferation promotion,metastasis facilitation
ENSG00000113594,LIFR,oncogenic processes,constitutive activation,cell proliferation,stat3 activation,angiogenesis,overexpression
ENSG00000198793,MTOR,mtor pathway,constitutive activation,gain of function mutations,tumor development,therapeutic target,cell proliferation
ENSG00000099985,OSM,angiogenesis promotion,cell survival regulation,immune evasion mechanism,tumor progression factor,extracellular matrix remodeling,cytokine signaling pathway
ENSG00000276536,HRAS,mapk/erk pathway activation,gain-of-function mutations,constitutive signaling,ras-raf-mek-erk cascade,tumor progression,oncogene overexpression
ENSG00000121853,GHSR,g protein-coupled receptor,constitutive activation,cell proliferation,metabolic regulation,tumor growth,angiogenesis
ENSG00000124089,MC3R,energy balance regulation,metabolic regulation,g protein-coupled receptor function,hypothalamic expression,melanocortin signaling pathway,reproductive function modulation
ENSG00000184845,DRD1,gpcr activation,oncogenic driver,cell migration,neurotransmitter modulation,signaling pathway interaction,genomic mutation
ENSG00000147246,HTR2C,cellular growth modulation,stress response regulation,receptor signaling pathway,cancer-related genetic alterations,inflammation regulation,tumor microenvironment interaction
ENSG00000114353,GNAI2,cellular proliferation,signaling pathway regulation,oncogenic activation,cell survival modulation,protein-protein interaction,tumor progression regulator
ENSG00000157017,GHRL,cell proliferation,metabolic regulation,tumor progression,oncogene activation,angiogenesis promotion,immune response suppression
ENSG00000123901,GPR83,g-protein coupled receptor,cell proliferation,signaling cascade,oncogenic transformation,tumorigenesis,immune regulation
ENSG00000162009,SSTR5,tumor progression inhibition,g protein-coupled receptor,hormone secretion regulation,cell growth modulation,cancer therapy target,physiological response modulation
ENSG00000137486,ARRB1,gpcr regulation,tumor suppressor function,loss of function mutations,cell proliferation inhibition,metastasis suppression,pi3k/akt pathway interaction
ENSG00000165119,HNRNPK,alternative splicing,apoptosis regulation,cellular proliferation,genomic instability,oncogene expression,rna processing
ENSG00000070190,DAPP1,cell migration modulation,cytoskeletal organization disruption,metastasis promotion,epithelial-to-mesenchymal transition regulation,pi3k/akt pathway interaction,transcription factor modulation
ENSG00000101336,HCK,cellular proliferation,non-receptor tyrosine kinase,immune cell regulation,oncogenic transformation,tumor progression,aberrant signaling
ENSG00000182022,CHST15,glycosaminoglycan biosynthesis,tumor microenvironment modification,cell-cell interaction regulation,apoptosis modulation,biomarker identification,cancer progression promotion
ENSG00000160293,VAV2,gtpase activation,oncogenic signaling,tumor progression,cell proliferation,cytoskeleton reorganization,gef activity
ENSG00000105369,CD79A,b-cell receptor signaling,dysregulated expression,tumor progression,immune evasion,cell proliferation regulation,oncogenic transformation
ENSG00000007312,CD79B,bcr signaling pathway,constitutive activation,gain of function mutations,tumor progression,immunoglobulin-alpha subunit,b-cell receptor complex
ENSG00000086730,LAT2,cellular metabolism,glutamine uptake,tumor progression,oncogenic function,protein-protein interaction,cancer cell growth
ENSG00000010671,BTK,nf-κb pathway activation,gain of function mutations,constitutive activation,therapeutic target,oncogenic signaling pathway,cancer cell survival
ENSG00000166908,PIP4K2C,pi3k/akt/mtor pathway,lipid signaling regulation,cancer cell proliferation,akt activation,metastasis promotion,tumor progression
ENSG00000276293,PIP4K2B,pi3p/pi5p regulation,dysregulation of cellular processes,enhanced cell proliferation,oncogenic pathway activation,resistance to therapy,aberrant signaling pathways
,IGHM,abnormal antibody production,adcc regulation,b-cell malignancy,chromosome 14q32.33 location,dysregulated expression,fc receptor interaction
ENSG00000012124,CD22,tumor progression,oncogene,cell surface receptor,immunotherapeutic target,apoptosis regulation,proliferation promotion
ENSG00000143398,PIP5K1A,pi3k/akt signaling pathway,phosphoinositide metabolism,gain of function mutations,tumor progression,therapeutic target,cell proliferation
ENSG00000072135,PTPN18,src kinase inhibition,tumor suppression,tyrosine dephosphorylation,cell growth regulation,oncogenic signaling modulation,tumor suppressor interaction
ENSG00000035720,STAP1,calcium channel regulation,dysregulated expression,cellular homeostasis modulation,therapeutic target,signaling pathway regulation,oncogenic mechanism
ENSG00000107242,PIP5K1B,cellular signaling,phospholipid metabolism,tumor progression,metastasis promotion,cell migration facilitation,oncogenic signaling
ENSG00000184304,PRKD1,cellular proliferation,signaling pathway activation,mutation-driven oncogenesis,cell survival regulation,protein kinase activation,dna damage response
ENSG00000072694,FCGR2B,immunoglobulin superfamily member,overexpression and mutation,aberrant b-cell receptor signaling,tumor growth and invasion,resistance to chemotherapy and immunotherapy,antibody production regulation
ENSG00000285369,BLK,cell growth regulation,oncogenesis,signaling pathway modulation,apoptosis inhibition,tumor progression,hematopoiesis
ENSG00000166501,PRKCB,cellular proliferation,mitogen-activated protein kinase activation,protein phosphorylation,serine/threonine kinase activation,tumor progression,constitutive activation
ENSG00000263001,GTF2I,genetic instability,gene expression regulation,transcriptional control,tumor suppressor function,cell proliferation regulation,dna repair pathway interaction
ENSG00000120088,CRHR1,hpa axis modulation,stress response regulation,g protein-coupled receptor activation,tumor progression promotion,immune system modulation,therapeutic target potential
ENSG00000087460,GNAS,constitutive activation,gain of function mutations,cell proliferation,tumor progression,therapeutic target,genomic profiling
ENSG00000088256,GNA11,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cell proliferation,signal transduction pathway
ENSG00000087258,GNAO1,g-protein signaling,constitutive activation,gain of function mutations,oncogenic transformation,mapk/erk pathway,cell proliferation
ENSG00000198055,GRK6,g-protein coupled receptor modulation,pi3k/akt signaling pathway interaction,cell survival and growth enhancement,tumor progression facilitation,cell migration and invasion regulation,gpcr activity modification 
ENSG00000127955,GNAI1,g-protein mediated signaling,cancer related mutations,signaling pathway modulation,tumor suppressor function,cell growth regulation,adenylyl cyclase interaction
ENSG00000159069,FBXW5,oncogenesis,substrate recognition,tumor suppressor function,tight transcriptional regulation,cell cycle progression,genomic instability
ENSG00000070061,ELP1,transcriptional regulation,chromatin modification,oncogenic processes,cell proliferation,apoptosis resistance,therapeutic target
ENSG00000119414,PPP6C,cell cycle regulation,gene amplification,protein phosphatase activity,mutation hotspot,dna damage response pathway,apoptosis resistance
ENSG00000198001,IRAK4,constitutive activation,gain of function mutations,immune evasion,inflammation regulation,protein-protein interactions,tumor suppression
ENSG00000196083,IL1RAP,pro-invasive signaling,tumor growth promotion,inflammatory pathway dysregulation,immune evasion mechanism,apoptosis resistance,cancer stem cell maintenance
ENSG00000157625,TAB3,nf-κb activation,constitutive activation,tumor progression,immune evasion,cell proliferation,oncogenic processes
ENSG00000197329,PELI1,immune evasion,signaling pathway modulation,oncogenic potential,adaptor protein function,cell survival regulation,inflammation response manipulation
ENSG00000232960,CSNK2B,ck2 complex activation,constitutive phosphorylation,enhanced proliferation,protein kinase regulation,transcriptional modulation,cell cycle progression
ENSG00000082898,XPO1,nuclear export receptor,constitutive activation,oncogenic protein transport,tumor growth promotion,apoptosis resistance,viral hijacking
ENSG00000132341,RAN,microtubule dynamics,chromosomal instability,genomic instability,cell division regulation,oncogenic transformation,dna replication interaction
ENSG00000108829,LRRC59,pi3k/akt pathway interaction,tumor suppressor function,cell-cell adhesion modulation,proliferation regulation,potential biomarker,cancer tumorigenesis association
ENSG00000172500,FIBP,extracellular matrix remodeling,tumor progression,cell adhesion modulation,metastasis promotion,angiogenesis facilitation,immune evasion mechanisms
ENSG00000176170,SPHK1,pi3k/akt activation,cell survival,sphingolipid metabolism,oncogenic transformation,tumor progression,metastasis
ENSG00000230514,AGER,tumor progression,cell survival,inflammation regulation,angiogenesis promotion,receptor activation,poor prognosis marker
ENSG00000147065,MSN,myelin regulation,tumor suppressor interaction,cell proliferation modulation,oncogenic potential,gene transcription regulation,apoptosis inhibition
ENSG00000067900,ROCK1,tumor progression,gain of function mutations,cell migration,cytoskeleton remodeling,therapeutic target,oncogenic processes
ENSG00000173757,STAT5B,stat5/stat1 pathway,constitutive activation,gain of function mutations,oncogenic transformation,therapeutic resistance,prognostic biomarker
ENSG00000108443,RPS6KB1,mtor pathway activation,histone modification,gain of function mutations,tumor growth promotion,therapeutic target,protein synthesis enhancement
ENSG00000123609,NMI,nucleotide metabolism regulation,cellular signaling modulation,protein-protein interaction,phosphotransferase activity,tumor progression facilitation,genomic instability contribution
ENSG00000136156,ITM2B,cell adhesion modulation,cancer association,metastasis regulation,erk/mapk pathway interaction,oncogene potential,protein modification involvement
ENSG00000134460,IL2RA,immune checkpoint regulation,t-cell modulation,il-2 signaling pathway,cancer immune evasion,cell proliferation regulation,genetic polymorphism
ENSG00000127831,VIL1,cell adhesion disruption,cytoskeletal organization,growth factor signaling,increased cell migration,oncogenic interaction,tumor progression facilitation
ENSG00000182511,FES,cell proliferation,signaling pathway regulation,transmembrane receptor,oncogenic processes,cell migration,jak/stat activation
ENSG00000120833,SOCS2,jak/stat pathway regulation,tumor suppressor function,constitutive activation,oncogenic processes,cell proliferation,negative regulator
ENSG00000153094,BCL2L11,apoptosis regulator,mitochondrial pathway,tumor suppressor function,cellular homeostasis,oncogenic potential,pro-apoptotic activity
ENSG00000196628,TCF4,transcription factor regulation,epithelial-to-mesenchymal transition,cell proliferation promotion,oncogenic activation,chromatin remodeling complex,genomic instability
ENSG00000184502,GAST,gastric acid secretion,cell growth regulation,oncogenic driver,angiogenesis promotion,wnt/β-catenin pathway interaction,metastasis facilitation
ENSG00000124151,NCOA3,oncogenic activity,coactivator function,transcriptional regulation,chromatin remodeling,cell proliferation,protein-protein interaction
ENSG00000197157,SND1,mitochondrial function regulation,tumor progression association,pi3k/akt pathway modulation,cell growth promotion,gene expression regulation,oncogenic potential
ENSG00000113520,IL4,stat6 activation,immune modulation,tumor growth promotion,metastasis facilitation,angiogenesis induction,cytokine signaling pathway
ENSG00000185338,SOCS1,negative regulation,tumor suppressor function,loss-of-function mutations,enhanced tumor progression,cell signaling modulation,oncogenic pathway activation
,HIST3H3,epigenetic regulation,chromatin remodeling,histone modification,tumor suppressor regulation,cancer cell proliferation,genome instability
ENSG00000124766,SOX4,transcriptional regulation,oncogenesis,cell proliferation,metastasis promotion,angiogenesis regulation,chromatin modification
ENSG00000065559,MAP2K4,mapk/erk signaling pathway,gain of function mutations,cell proliferation,tumor progression,protein kinase activation,cancer driver gene
ENSG00000087095,NLK,nlk's dual role,wnt/β-catenin pathway regulation,nf-κb pathway modulation,mapk/erk signaling activation,cell proliferation promotion,tumor suppressor function
ENSG00000104432,IL7,cancer-promoting immune response,tumor growth promotion,immune evasion facilitation,cell proliferation enhancement,apoptosis resistance,pro-tumorigenic microenvironment
ENSG00000013561,RNF14,proteasomal degradation regulation,cell cycle progression modulation,oncogenic signaling pathway interaction,ubiquitination regulation,apoptosis inhibition,tumor suppressor regulation
ENSG00000172531,PPP1CA,cell cycle regulation,phosphatase activity,oncogenic pathway modulation,tumor growth promotion,metastasis facilitation,protein-lipid interaction
ENSG00000167333,TRIM68,cellular regulation,disruption of cell cycle,genetic alterations,modulation of signaling pathways,oncogenic potential,transcriptional regulation
ENSG00000105401,CDC37,hsp90 interaction,cell cycle regulation,molecular chaperone function,protein kinase stabilization,oncogenesis,therapeutic resistance
ENSG00000184895,SRY,transcriptional regulation,cell proliferation,germ cell development,genetic instability,apoptosis inhibition,sex determination
,AES,epigenetic regulation,chromatin remodeling,gene expression modulation,cellular metabolism,protein-protein interaction,dna damage response
ENSG00000114166,KAT2B,histone acetylation,gene regulation,promotes cell survival,tumor progression,transcriptional activation,epigenetic regulation
ENSG00000151729,SLC25A4,mitochondrial localization,tumor suppression,cellular energy metabolism,pyrimidine synthesis,urea cycle disruption,oncogenesis promotion
ENSG00000108654,DDX5,cellular responses,oncogene/tumor suppressor,transcriptional regulation,rna metabolism,signaling pathways,protein interactions
ENSG00000160310,PRMT2,arginine methylation,chromatin regulation,cell proliferation,protein-protein interaction,tumor progression,methyltransferase activity
ENSG00000063978,RNF4,dna damage response,cell cycle regulation,ubiquitination pathway,transcription factor activation,oncogenic signaling,tumor suppression
ENSG00000165671,NSD1,histone modification,epigenetic regulation,oncogenic complexes,chromatin remodeling,cell proliferation,transcriptional regulation
ENSG00000186976,EFCAB6,translation initiation,oncogene,tumorigenesis,protein synthesis,cell growth regulation,mtor signaling pathway
ENSG00000197321,SVIL,cytoskeleton regulation,tumor suppressor function,cell migration inhibition,metastasis modulation,pi3k/akt pathway interaction,mapk/erk signaling regulation
ENSG00000108175,ZMIZ1,oncogene overexpression,cell proliferation,transcriptional activation,tumor metastasis,protein degradation regulation,p53 pathway interaction
ENSG00000144747,TMF1,genomic instability,cell cycle regulation,oncogenic transformation,tumor growth,aberrant gene expression,transcriptional control
ENSG00000115641,FHL2,transcriptional regulation,cell proliferation,oncogenic processes,tumor suppressor gene suppression,therapeutic target,genomic instability
ENSG00000101224,CDC25B,constitutive activation,oncogenesis,cell proliferation,tumor growth,apoptosis regulation,cell cycle regulation
ENSG00000101158,NELFCD,transcriptional coactivator,rna polymerase ii regulation,cell cycle progression,apoptosis inhibition,tumorigenesis promotion,oncogene overexpression
ENSG00000109685,NSD2,epigenetic regulation,histone methylation,chromatin modification,oncogene activation,tumor suppressor silencing,genomic amplification
ENSG00000129514,FOXA1,oncogene activation,transcriptional regulation,cell proliferation enhancement,metastasis promotion,epithelial-to-mesenchymal transition,genomic instability induction
ENSG00000107077,KDM4C,h3k9 demethylation,epigenetic regulation,histone modification,tumor progression,cell proliferation,genomic instability
ENSG00000115548,KDM3A,chromatin regulation,histone demethylation,gene expression modulation,cell proliferation promotion,tumorigenesis driver,therapeutic target
ENSG00000100105,PATZ1,transcriptional regulation,tumor suppressor gene suppression,cell cycle progression,nuclear localization,oncogenic pathway promotion,apoptosis inhibition
ENSG00000170606,HSPA4,hsp70 family member,oncogene potential,tumor progression facilitation,apoptosis regulation,proliferative drive enhancement,molecular chaperone function
ENSG00000107262,BAG1,apoptosis inhibition,cell cycle regulation,multifunctional protein,protein-protein interactions,tumor progression resistance,therapeutic target
ENSG00000078725,BRINP1,genomic stability maintenance,tumor progression promotion,dna damage response regulation,cell cycle checkpoint control,chromatin remodeling interaction,epigenetic modification regulation
ENSG00000185247,MAGEA11,chromatin remodeling,cell cycle regulation,tumor progression,epigenetic reactivation,genomic instability,oncoprotein expression
ENSG00000146587,RBAK,necroptosis induction,apoptosis regulation,oncogenesis promotion,cell death pathways,tumor suppressor interaction,genomic instability
ENSG00000135940,COX5B,mitochondrial respiration,electron transport chain,cellular respiration,energy metabolism,cell survival,cancer progression
ENSG00000122515,ZMIZ2,p53 regulation,oncogene activation,apoptosis inhibition,cell cycle progression,tumor progression,genomic instability
ENSG00000136504,KAT7,histone acetylation,chromatin remodeling,tumor suppressor loss,transcriptional regulation,oncogenic protein interaction,genomic instability
ENSG00000110768,GTF2H1,genomic instability,nucleotide excision repair,dna repair deficiency,tumor suppressor function,oncogenic mutation,basal transcription regulation
ENSG00000266412,NCOA4,tumor growth promotion,epigenetic regulation,transcriptional coactivation,nuclear receptor interaction,cell cycle regulation,apoptosis inhibition
ENSG00000140682,TGFB1I1,tgf-β signaling pathway,epithelial-to-mesenchymal transition (emt),tumor suppressor or oncogene,cell proliferation and differentiation regulation,immune evasion mechanisms,tumor microenvironment modulation
ENSG00000164045,CDC25A,phosphatase activity,cell cycle regulation,g2/m phase transition,cyclin-dependent kinase activation,tumor progression,oncogene
ENSG00000134248,LAMTOR5,mtor activation,cell growth regulation,autophagy dysregulation,protein synthesis modulation,cancer driver gene,genetic mutations
ENSG00000124664,SPDEF,tumor suppression,epithelial-to-mesenchymal transition (emt),cell adhesion regulation,chromatin remodeling,gene expression modulation,histone mark modification
ENSG00000147140,NONO,rna processing regulation,gene expression modulation,cell cycle progression,alternative splicing,oncogenic driver,tumor suppressor function
ENSG00000177426,TGIF1,tgf-β signaling pathway,transcriptional regulator,cell growth regulation,chromatin remodeling,genomic instability,oncogene/tumor suppressor
ENSG00000169375,SIN3A,chromatin remodeling,epigenetic regulation,tumor progression,metastasis,therapeutic target,gene expression
ENSG00000132437,DDC,catecholamine synthesis,growth factor regulation,tumor metabolism,metabolic reprogramming,enzyme activity alteration,cancer cell survival
ENSG00000126457,PRMT1,methyltransferase activity,arginine methylation,cell cycle regulation,apo-5opptosis signaling,transcriptional control,histone modification
ENSG00000105229,PIAS4,tumor suppressor,apoptosis regulation,dna repair mechanism,cell cycle regulation,protein inhibition,transcriptional repression
ENSG00000146278,PNRC1,epigenetic regulation,chromatin remodeling,histone modification,cell proliferation,tumor progression,genomic instability
ENSG00000168066,SF1,steroid hormone biosynthesis,transcription factor activity,cell proliferation regulation,tumor growth promotion,genomic instability contribution,metastasis facilitation
ENSG00000117450,PRDX1,antioxidant defense mechanism,cell growth regulation,protein-protein interaction,post-translational modification,redox signaling pathway,tumor progression support
ENSG00000110031,LPXN,cell adhesion disruption,epithelial-to-mesenchymal transition regulation,cell migration facilitation,tumor progression promotion,therapeutic target potential,protein-protein interaction mediation
ENSG00000273173,SNURF,aberrant splicing,alternative splicing regulation,cell growth regulation,gene expression modification,oncogenesis driver,splicing factor interaction
ENSG00000106546,AHR,cellular stress response,xenobiotic metabolism,transcriptional regulation,tumor progression,apoptosis modulation,environmental carcinogen responsiveness
ENSG00000167657,DAPK3,apoptosis regulation,tumor suppressor,protein-protein interaction,cell cycle control,dna repair mechanisms,signaling pathway modulation
ENSG00000169750,RAC3,pi3k/akt/mtor pathway,constitutive activation,gain of function mutations,cell proliferation,apoptosis suppression,therapeutic target
ENSG00000137992,DBT,biotin synthesis pathway,cell proliferation,dna repair mechanisms,metabolic regulation,oncogenesis,redox balance
ENSG00000177463,NR2C2,tumor suppressor function,transcriptional regulation,cell differentiation inhibition,anti-tumorigenic response,gene expression modulation,nuclear receptor interaction
ENSG00000148180,GSN,tumor progression,cell migration,actin cytoskeleton regulation,therapeutic target,protein-protein interaction,apoptosis suppression
ENSG00000083799,CYLD,nf-κb pathway regulation,tumor suppressor function,protein degradation regulation,jnk signaling modulation,cell survival inhibition,ubiquitin-mediated protein modification
ENSG00000131100,ATP6V1E1,proton transport regulation,ph-dependent regulation,therapeutic target,tumor microenvironment,metastatic potential,resistance to therapy
ENSG00000082512,TRAF5,nf-κb signaling pathway,oncogene activation,constitutive activation,cell proliferation,metastasis,tumor progression
ENSG00000260548,IRS4,cellular signaling,constitutive activation,metabolic reprogramming,tumor progression,angiogenesis,oncogenic driver
ENSG00000172572,PDE3A,cancer-promoting activity,enhanced cell proliferation,regulation of second messengers,signaling pathway modulation,oncogenic properties,epigenetic regulation
ENSG00000132693,CRP,tumor promotion,inflammation regulation,angiogenesis stimulation,poor prognosis marker,multifunctional protein,nf-κb pathway interaction
ENSG00000163399,ATP1A1,na+/k+-atpase regulation,cellular ion balance,oncogenic signaling,therapeutic target,overexpression in tumors,signaling pathway modulation
ENSG00000165409,TSHR,tshr overexpression,constitutive activation,aberrant signaling pathways,cell proliferation enhancement,metastasis promotion,therapeutic target
ENSG00000065135,GNAI3,cellular signal transduction,g-protein coupled signaling,heterotrimeric g protein complex,oncogenic pathway regulation,tumor progression modulation,pi3k/akt/mtor pathway interaction
ENSG00000170820,FSHR,g protein-coupled receptor,constitutive activation,oncogenic signaling,cell proliferation,metastasis,tumor aggressiveness
ENSG00000239697,TNFSF12,apoptosis induction,tumor suppression,cell death regulation,immune system modulation,tumor cell proliferation inhibition,cancer immunotherapy target
ENSG00000006327,TNFRSF12A,osteoclast differentiation,tumor progression,constitutive activation,metastasis,signaling pathway regulation,apoptosis modulation
ENSG00000177575,CD163,tumor-associated macrophages,tumor progression,immune evasion,protein interaction,angiogenesis,immunosuppression
ENSG00000198681,MAGEA1,tumor antigen,x-chromosome inactivation,oncogene activation,cancer-testis antigens,epigenetic regulation,cell proliferation
ENSG00000138433,CIR1,cellular redox regulation,copper homeostasis disruption,dysregulated expression,post-translational modification,cell growth modulation,therapeutic target
ENSG00000022267,FHL1,chromatin remodeling,deregulated expression,cellular proliferation,oncogenesis,transcriptional modulation,tumor progression
ENSG00000184384,MAML2,notch signaling pathway,constitutive activation,chromatin remodeling,transcriptional regulation,cell proliferation,gene fusion
ENSG00000196782,MAML3,notch signaling pathway,oncogenic mutations,cell proliferation,transcriptional coactivator,tumor suppressor loss,notch target gene expression
ENSG00000164105,SAP30,chromatin remodeling,transcriptional regulation,histone modification,transcription factor interaction,oncogenic regulation,tumor suppressor role
ENSG00000283780,MAML1,notch signaling pathway,transcriptional coactivator,cell proliferation regulation,oncogene activation,cell fate decision,therapeutic resistance
ENSG00000109670,FBXW7,tumor suppressor function,cancer driver mutation,proteasome regulation,transcription factor regulation,genomic instability,cell cycle regulation
ENSG00000113558,SKP1,scf complex regulation,ubiquitination pathway,cell cycle progression,protein degradation regulation,tumor suppressor interaction,f-box protein binding
ENSG00000231115,RING1,histone modification,demethylase activity,genome regulation,tumor suppressor silencing,oncogenic function,epigenetic control
ENSG00000223654,FLOT1,cellular trafficking,signal transduction,oncogenic signaling,tumor progression,protein-protein interaction,cancer biomarker
ENSG00000132589,FLOT2,cell membrane trafficking,receptor tyrosine kinase activation,tumor progression,biomarker for diagnosis,cancer cell migration,membrane fluidity regulation
ENSG00000281877,RPS6KA1,mtor signaling pathway,phosphorylation activity,aberrant activation,cell proliferation,survival pathways,tumor progression
ENSG00000071242,RPS6KA2,cellular activation,gain of function mutations,oncogenesis,phosphorylation,protein kinase activation,tumor progression
ENSG00000165458,INPPL1,pi3k regulation,tumor suppressor activity,cell signaling pathway modulation,metabolic regulation,growth factor receptor interaction,genomic instability
ENSG00000169891,REPS2,rho gtpase activation,cell migration regulation,tumor progression,cell cycle control,cytoskeleton rearrangement,metastatic potential
ENSG00000142273,CBLC,ion channel regulation,cellular proliferation,tumor progression,therapeutic target,protein-protein interactions,transcriptional regulation
ENSG00000143333,RGS16,gpcr regulation,negative regulator,oncogenic pathway,signal transduction,cell proliferation,tumorigenesis
ENSG00000168374,ARF4,adp-ribosylation factor,cell migration,multinucleation,oncogenic process,tumor progression,vesicle trafficking
ENSG00000111057,KRT18,tumor progression,cellular differentiation,epithelial integrity,biomarker potential,histone release,cancer mutations
ENSG00000149480,MTA2,chromatin remodeling,transcriptional regulation,oncogenic pathway activation,cell proliferation,metastasis promotion,epigenetic regulation
ENSG00000136044,APPL2,pi3k/akt pathway activation,oncogenic signaling,scaffolding protein function,tumor progression facilitation,cell migration enhancement,metabolic regulation
ENSG00000034152,MAP2K3,oncogene activation,apoptosis evasion,cell proliferation signaling,kinase activation,cell survival pathways,tumor growth support
ENSG00000127946,HIP1,egfr recycling,mapk/erk signaling,pi3k/akt pathway activation,tumor progression promotion,endocytic regulation dysfunction,vesicular transport facilitation
ENSG00000166225,FRS2,oncogenic activation,constitutive signaling,receptor tyrosine kinase interaction,cell proliferation,therapeutic target,signaling pathway regulation
ENSG00000138193,PLCE1,pi3k/akt signaling,oncogene function,epigenetic regulation,cell migration promotion,tumor growth enhancement,metastasis facilitation
ENSG00000105971,CAV2,lipid metabolism regulation,caveolae formation modulation,tumor suppressor function,cell migration enhancement,signaling pathway interaction,cancer development influence
ENSG00000140600,SH3GL3,pi3k/akt pathway regulation,tumor suppressor function,endosomal recycling regulation,escrt machinery interaction,cell growth modulation,metabolic regulation
ENSG00000106976,DNM1,mitochondrial fission,dysregulated cell signaling,mitochondrial dysfunction,autophagy regulation,tumor progression,endocytosis
ENSG00000156508,EEF1A1,translation elongation factor regulation,protein synthesis enhancement,oncogenic protein overexpression,tumorigenesis promotion,cell cycle progression modulation,mrna translation regulation
ENSG00000109917,ZPR1,genomic instability,oncogenic protein interaction,tumor suppressor inhibition,cell cycle progression,dna repair regulation,nuclear protein localization
ENSG00000166484,MAPK7,mapk signaling pathway,cell proliferation,pro-survival functions,gain of function mutations,tumor progression,therapeutic target
ENSG00000153233,PTPRR,receptor tyrosine phosphatase,epithelial-to-mesenchymal transition,cell adhesion and migration,microrna regulation,tumor progression and metastasis,dysregulated signaling pathways
ENSG00000017797,RALBP1,oncogenic processes,vesicle trafficking,cell migration,tumor progression,therapeutic target,protein-protein interaction
ENSG00000144118,RALB,ral-gds interaction,mapk/erk pathway regulation,gtpase activity,cancer cell migration,tumor progression,prognostic marker
ENSG00000108946,PRKAR1A,pi3k/akt pathway,constitutive activation,dysregulated regulation,cell survival,tumor progression,multifunctional role
ENSG00000061938,TNK2,pi3k/akt interaction,oncogenic pathway activation,tumor progression driver,genomic instability contributor,therapeutic resistance mediator,cell signaling regulation
ENSG00000070831,CDC42,constitutive activation,gain of function mutations,cell migration regulation,oncogenic signaling,tumor progression,therapeutic target
ENSG00000133056,PIK3C2B,pi3k signaling,oncogenic processes,cellular response regulation,cell growth promotion,genomic instability,tumor progression
ENSG00000144730,IL17RD,il-17 signaling pathway,oncogenic function,receptor component,tumor growth promotion,metastasis facilitation,angiogenesis regulation
ENSG00000116285,ERRFI1,tumor suppressor,egfr signaling inhibition,phosphorylation regulation,cell proliferation regulation,cell differentiation regulation,oncogene repression
ENSG00000174238,PITPNA,phosphoinositide regulation,cell membrane dynamics,cytoskeletal organization,cell migration promotion,oncogenic phenotype enhancement,lipid metabolic regulation
ENSG00000065243,PKN2,pi3k/akt pathway activation,cell proliferation enhancement,serine/threonine kinase activity,oncogenic signaling,growth factor receptor interaction,cell survival promotion
ENSG00000129219,PLD2,oncogenic transformation,signaling pathway activation,phospholipid metabolism regulation,cell growth promotion,tumor progression facilitation,therapeutic target identification
ENSG00000140575,IQGAP1,cytoskeleton remodeling,cell adhesion disruption,rho gtpase activation,oncogenic signaling,metastasis promotion,scaffolding protein function
ENSG00000288293,CC2D1A,tumor suppressor,ubiquitin ligase activity loss,oncogenic transformation,cell cycle regulation disruption,protein degradation pathway disruption,poor prognosis association
ENSG00000133703,KRAS,constitutive activation,gain of function mutations,tumor progression,oncogenic signaling pathway,protein post-translational modification,cell proliferation enhancement
ENSG00000095015,MAP3K1,mapk pathway dysregulation,constitutive activation,gain of function mutations,cell proliferation enhancement,oncogenic activity,therapeutic target
ENSG00000115290,GRB14,cell growth regulation,scaffolding protein function,tumor progression,prognostic marker,signaling pathway modulation,phosphorylation regulation
ENSG00000160271,RALGDS,oncogenic activation,cell migration,tumor progression,aberrant expression,gtpase regulation,signaling modulation
ENSG00000141738,GRB7,cell proliferation,oncogenic driver,signaling network regulation,tumor progression,therapeutic target,cell migration suppression
ENSG00000144566,RAB5A,constitutive activation,oncogenic signaling pathway,endocytic trafficking dysregulation,tumor progression promotion,protein-protein interaction,cancer cell survival enhancement
ENSG00000174791,RIN1,cellular migration,tumor progression,oncogenic potential,signaling regulation,pi3k/akt interaction,gtpase activation
ENSG00000137218,FRS3,dysregulated metabolism,altered cell signaling,oncogenic transformation,enhanced cell proliferation,increased metastatic potential,therapeutic target
ENSG00000188313,PLSCR1,cellular regulation,dysregulated expression,metastasis,pi3k/akt pathway interaction,promotes oncogenic processes,tumor progression
ENSG00000128422,KRT17,cellular structure disruption,cancer cell migration,epithelial-to-mesenchymal transition,keratin network formation,oncogene overexpression,protein-protein interaction
ENSG00000170421,KRT8,epithelial cell integrity,cell adhesion changes,cytoskeletal alterations,epithelial-to-mesenchymal transition (emt) markers,cell morphology alterations,protein expression dysregulation
ENSG00000137764,MAP2K5,mapk signaling,constitutive activation,gain of function mutations,cell proliferation,oncogenesis,therapeutic target
ENSG00000163558,PRKCI,constitutive activation,genomic instability,therapeutic target,cell survival regulation,pi3k/akt pathway modulation,dna damage response
ENSG00000135480,KRT7,keratin family membership,epithelial cell stability,type i intermediate filament protein,cell proliferation promotion,emt regulation,tumor diagnostic marker
ENSG00000125743,SNRPD2,spliceosome regulation,altered splicing patterns,genomic instability,cellular proliferation,tumor progression,therapeutic target
ENSG00000204842,ATXN2,rna granules formation,oncogenic transformation,polyglutamine repeat expansion,cell proliferation regulation,mtor signaling pathway,therapeutic target
ENSG00000076201,PTPN23,dephosphorylation activity,regulatory role in cell signaling,inhibition of oncogenic pathways,cellular proliferation regulation,tumor suppressor function,oncogenic pathway modulation
ENSG00000145901,TNIP1,nf-κb activation,ubiquitin-proteasome system regulation,tumor progression,oncogenic process,cell survival regulation,inflammatory response modulation
ENSG00000076984,MAP2K7,aberrant activation,amplification,cell proliferation,jnk pathway,migration enhancement,pro-oncogenic transcription factor regulation
ENSG00000085511,MAP3K4,jnk pathway activation,cellular proliferation,oncogenic transformation,tumor progression,apoptosis resistance,stress response regulation
ENSG00000158711,ELK4,transcription factor regulation,gene amplification,oncogenic properties,cell proliferation,signaling pathway interaction,epigenetic modification
ENSG00000283060,ID3,cellular regulation,transcriptional regulator,tumor progression,proliferation promotion,apoptosis inhibition,genomic profiling
ENSG00000115738,ID2,cell proliferation,tumor progression,apoptosis resistance,transcriptional regulation,oncogene activation,angiogenesis facilitation
ENSG00000111145,ELK3,tumor suppressor function,transcriptional regulation,cell cycle progression,apoptosis regulation,angiogenesis modulation,oncogenic potential
ENSG00000172201,ID4,cellular proliferation,transcriptional repressor,oncogene activation,cell cycle progression,signaling pathway modulation,tumor initiation and progression
ENSG00000103479,RBL2,tumor suppressor function,cell cycle regulation,apoptosis induction,e2f protein binding,genomic integrity maintenance,cancer progression inhibition
ENSG00000196092,PAX5,transcription factor,cell growth promotion,tumor progression,apoptosis inhibition,b cell differentiation,genomic regulation
ENSG00000159352,PSMD4,oncogene activation,proteasome regulation,apoptosis suppression,tumor progression,dna repair enhancement,ubiquitin-proteasome pathway
ENSG00000166794,PPIB,protein folding regulation,cell proliferation enhancement,apoptosis inhibition,drug resistance promotion,pi3k/akt pathway interaction,protein homeostasis modulation
ENSG00000164615,CAMLG,cell cycle regulation,signal transduction,calcium-dependent signaling,apoptosis modulation,metastasis promotion,therapeutic target
ENSG00000170027,YWHAG,tyrosine kinase regulation,apoptosis inhibition,cell cycle modulation,g-protein coupled receptor interaction,pi3k/akt pathway activation,oncogenic transformation driver
ENSG00000136098,NEK3,cell cycle regulation,mitotic checkpoint,dna repair mechanism,genomic instability,cancer initiation,therapeutic target
ENSG00000151090,THRB,thyroid hormone regulation,nuclear receptor function,constitutive activation,cell proliferation,gene expression regulation,tumor suppressor function
ENSG00000151849,CENPJ,centriole biogenesis,oncogenic process,tumor growth,microtubule instability,cell proliferation regulation,therapeutic target
ENSG00000007264,MATK,oncogenic activity,cell survival promotion,immune response modulation,tumor progression driver,tyrosine kinase activation,growth factor regulation
ENSG00000000938,FGR,fyn-associated kinase activity,oncogenic transformation,tyrosine phosphorylation regulation,cell proliferation enhancement,tumor progression facilitation,immunosuppressive environment modulation
ENSG00000166068,SPRED1,mapk/erk signaling pathway disruption,constitutive activation,tyrosine kinase regulation failure,oncogenic driver mutation,cell proliferation promotion,tumor suppressor loss-of-function
ENSG00000198369,SPRED2,constitutive activation,loss of function mutations,ras/mapk pathway inhibition,tumor suppressor function,oncogenic driver,cell proliferation regulation
ENSG00000197323,TRIM33,tumor suppressor function,transcriptional regulation,oncogene repression,genomic stability maintenance,cell cycle regulation,epigenetic modification
ENSG00000114520,SNX4,aberrant expression,cell surface receptor recycling,endosomal trafficking regulation,oncogenic process driver,prognostic marker,resistance to targeted therapy
ENSG00000129515,SNX6,sorting nexin function,cell surface protein regulation,membrane trafficking,endosomal sorting,proliferation enhancement,tumor progression
ENSG00000111424,VDR,vitamin d responsive,nuclear receptor function,transcriptional regulation,cell proliferation,apoptosis resistance,epithelial origin
ENSG00000163877,SNIP1,cell cycle regulation,loss of function mutations,transcriptional co-repressor,apoptosis inhibition,p53 signaling pathway,oncogenic driver
ENSG00000100614,PPM1A,dephosphorylation,protein kinase regulation,oncogenesis,metastasis promotion,tumor suppressor function loss,signaling pathway dysregulation
ENSG00000132953,XPO4,mirna regulation,tumor suppressor inhibition,protein transport regulation,cell proliferation promotion,apoptosis inhibition,genomic instability facilitation
ENSG00000102974,CTCF,chromatin remodeling,tumor suppressor function,genome organization regulation,dysregulated gene expression,cancer-related signaling pathways,wnt/β-catenin pathway interaction
ENSG00000126883,NUP214,nuclear pore complex integrity,chromatin remodeling,transcriptional regulation,oncogenic fusion,cell cycle disruption,tumor growth promotion
ENSG00000166887,VPS39,endosomal trafficking,constitutive activation,escrt-iii complex,cell migration and invasion,survival pathway regulation,tumor progression facilitation
ENSG00000157077,ZFYVE9,endosomal trafficking,pi3k/akt pathway interaction,tumor progression,promoter of oncogenesis,growth and survival regulation,mutation-driven tumorigenesis
ENSG00000272886,DCP1A,cellular metabolism,oncogenic processes,nucleotide pool regulation,dna repair mechanisms,tumor growth promotion,cell proliferation enhancement
ENSG00000066136,NFYC,tumor suppressor function loss,transcription factor activity,cell cycle regulation,apoptosis inhibition,oncogenic signaling,dna damage response
ENSG00000120837,NFYB,transcription factor regulation,cell cycle progression,dna repair modulation,gain of function mutations,tumor progression,therapeutic target
ENSG00000169554,ZEB2,transcription factor activity,epithelial-to-mesenchymal transition (emt),oncogenic driver,tumor metastasis,angiogenesis promotion,immune evasion
ENSG00000006125,AP2B1,ap-2 complex,tumor suppressor activity,membrane trafficking,receptor internalization,cancer progression,cytoplasmic signaling
ENSG00000125971,DYNLRB1,mrna regulation,ccr4-not complex,cell growth,transcriptional regulation,oncogene expression,tumor suppression
ENSG00000023734,STRAP,tgf-beta signaling pathway,protein-protein interaction,cell proliferation suppression,epithelial-to-mesenchymal transition,apoptosis inhibition,chemotherapy resistance
ENSG00000130177,CDC16,genomic instability,protein quality control,cellular stress response,ubiquitin-proteasome pathway,oncogenesis,tumor suppressor
ENSG00000176396,EID2,hypoxia response,transcriptional regulation,mitochondrial function,iron homeostasis,cell growth modulation,hif1a degradation pathway
ENSG00000004897,CDC27,spindle checkpoint regulation,cell cycle regulation,chromosome segregation,mitosis regulation,oncogene regulation,therapeutic target
ENSG00000078399,HOXA9,leukemia initiation,transcriptional regulation,oncogene activation,self-renewal promotion,hematopoiesis disruption,genomic amplification
ENSG00000221914,PPP2R2A,dephosphorylation,apoptosis regulation,cell cycle progression,metastatic suppression,tumor suppressor function,phosphatase activity
ENSG00000108984,MAP2K6,mapk signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,signaling cascades
ENSG00000133740,E2F5,cell cycle regulation,oncogene activation,apoptosis evasion,angiogenesis promotion,cell proliferation enhancement,tumor progression
ENSG00000119699,TGFB3,tgf-β signaling pathway,tumor suppression,cellular proliferation,immune evasion,metastasis promotion,oncogene function
ENSG00000114302,PRKAR2A,camp-dependent signaling pathway,oncogenic mutation,tumor suppressor downregulation,cell growth promotion,genetic instability,protein kinase activation
ENSG00000188191,PRKAR1B,regulation of pka activity,tumor suppressor function,pi3k/akt pathway interaction,poor prognosis association,therapeutic target,genomic profiling significance
ENSG00000170604,IRF2BP1,transcriptional regulation,cell cycle progression,apoptosis modulation,tumor suppressor function,dna damage response,genomic instability
ENSG00000101076,HNF4A,metabolic regulation,transcriptional regulation,cellular differentiation,pancreatic development,hepatocyte differentiation,gene expression
ENSG00000125398,SOX9,transcription factor activation,oncogenic function,tumor progression,epithelial-to-mesenchymal transition,wnt/β-catenin pathway interaction,cell proliferation enhancement
ENSG00000105325,FZR1,genome instability,cell cycle regulation,chromosome separation,tumorigenesis,oncogenic potential,ubiquitin ligase function
ENSG00000026508,CD44,cellular adhesion,oncogene activation,metastatic potential,stem cell marker,signaling pathway modulation,cancer stem cell marker
ENSG00000084623,EIF3I,pi3k/akt pathway regulation,protein synthesis dysregulation,cell growth promotion,tumor progression driver,therapeutic target potential,genomic mutation hotspot
ENSG00000118046,STK11, metabolic reprogramming,loss of tumor suppressor function,enhanced cell proliferation,resistance to apoptosis,cellular energy metabolism,genetic instability 
ENSG00000144589,STK11IP,ampk pathway regulation,gene amplification,tumor growth promotion,cell proliferation enhancement,energy metabolism regulation,mitochondrial dysfunction association
ENSG00000001167,NFYA,oncogenic regulation,transcriptional activation,cell cycle progression,apoptosis regulation,dna repair pathways,genome stability maintenance
ENSG00000148516,ZEB1,emt promoter,transcription factor activity,cell migration regulation,metastasis facilitation,prognostic marker,therapeutic target
ENSG00000168589,DYNLRB2,enhanced cell proliferation,stabilization of oncogenic mrnas,disruption of normal mrna regulation,regulation of mrna deadenylation,therapeutic target,constitutive activation
ENSG00000124789,NUP153,npc assembly,cellular transport disruption,tumor suppressor interaction alteration,subcellular localization change,cancer aggressiveness marker,nuclear pore complex dysfunction
ENSG00000181191,PJA1,wnt/β-catenin pathway,gain of function mutations,cell proliferation,tumor progression,oncogenic protein interaction,signaling pathway dysregulation
ENSG00000039319,ZFYVE16,rhogap activity,small gtpase regulation,endosomal trafficking,autophagy dysregulation,tumor progression,cell migration modulation
ENSG00000184221,OLIG1,tumor suppressor function,dna binding,gene silencing,cell proliferation inhibition,pro-survival pathway inhibition,co-repressor complex recruitment
ENSG00000168556,ING2,tumor suppressor,tumor progression inhibition,cell cycle regulation,dna damage response,genomic instability prevention,apoptosis induction
ENSG00000169783,LINGO1,cell proliferation suppression,tumor progression,cell migration enhancement,transcription factor regulation,oncogene overexpression,signaling pathway interaction
ENSG00000134243,SORT1,lipid metabolism regulation,cholesterol homeostasis,tumor progression enhancement,metastasis promotion,pi3k/akt pathway interaction,cell proliferation facilitation
ENSG00000185634,SHC4,shc family member,pi3k/akt signaling,oncogenic adaptor protein,tumor progression,cell growth regulation,metabolic modulation
ENSG00000073969,NSF,cellular trafficking,vesicle fusion regulation,mitochondrial function,protein secretion regulation,cancer progression contributor,tumor microenvironment manipulation
ENSG00000174804,FZD4,wnt signaling pathway,constitutive activation,gain of function mutations,cell proliferation,oncogenic processes,tumor progression
ENSG00000126583,PRKCG,pkc gamma activation,signaling pathway modulation,cell proliferation regulation,apoptosis resistance,protein kinase interaction,therapeutic target
ENSG00000125084,WNT1,wnt signaling,constitutive activation,gain of function mutations,oncogenesis,cell proliferation,metastasis
ENSG00000188763,FZD9,tumor-promoting effect,aberrant activation,altered expression,wnt signaling pathway,canonical wnt/β-catenin pathway,embryonic development
ENSG00000105989,WNT2,wnt/β-catenin pathway,oncogenic mutations,cell proliferation,signaling cascade regulation,tumorigenesis driver,developmental process involvement
ENSG00000164930,FZD6,wnt signaling pathway,tumor progression,cell proliferation,oncogenesis,genetic mutations,therapeutic target
ENSG00000104332,SFRP1,wnt signaling pathway inhibition,tumor suppressor function,cell proliferation suppression,metastasis prevention,β-catenin-dependent transcription regulation,oncogene downregulation
ENSG00000182968,SOX1,transcription factor activity,cell proliferation regulation,dna sequence binding,epithelial-to-mesenchymal transition regulation,cancer tumorigenesis promotion,anti-apoptotic function
ENSG00000107404,DVL1,wnt signaling pathway,cell proliferation,oncogenic transformation,tumor progression,therapeutic target,genomic instability 
ENSG00000155760,FZD7,wnt signaling pathway,constitutive activation,gain of function mutations,tumor progression,cell proliferation,metastasis
ENSG00000277626,WNT3,canonical wnt signaling pathway,constitutive activation,gain of function mutations,oncogenesis,tumor progression,epithelial-to-mesenchymal transition
ENSG00000155252,PI4K2A,cell migration,mitotic regulation,mtor pathway modulation,microtubule dynamics,anti-apoptotic function,tumor progression
ENSG00000104290,FZD3,wnt/β-catenin pathway,oligomerization,gain of function mutations,tumor progression,cell signaling regulation,transmembrane receptor
ENSG00000116128,BCL9,wnt/β-catenin signaling pathway,transcriptional coactivator,oncogenic mutations,tumor progression,beta-catenin stabilization,wnt signaling activation
ENSG00000162552,WNT4,wnt pathway activation,aberrant signaling,tumor growth promotion,metastasis regulation,genetic dysregulation,epithelial-to-mesenchymal transition
ENSG00000123384,LRP1,wnt/β-catenin signaling,cell growth regulation,tumor progression,endocytosis and recycling,co-receptor function,cancer cell survival
ENSG00000154764,WNT7A,wnt/β-catenin pathway,aberrant activation,tumor initiation,cell proliferation,stem cell self-renewal,oncogenic processes
ENSG00000163251,FZD5,wnt signaling,canonical wnt/β-catenin cascade,tumor progression,oncogene overexpression,cell growth regulation,transcriptional regulation
ENSG00000185483,ROR1,overexpression,aberrant activation,tumor suppressor function loss,epithelial-to-mesenchymal transition,wnt/β-catenin pathway interaction,therapeutic target
ENSG00000150764,DIXDC1,wnt/β-catenin signaling pathway,cell proliferation regulation,oncogenic process,protein-protein interaction,tumor aggressiveness regulation,signaling modulation
ENSG00000096384,HSP90AB1,hsp90 client proteins,oncogenic signaling pathways,cell survival mechanisms,protein folding regulation,therapeutic target,cancer progression
ENSG00000104365,IKBKB,nf-κb activation,constitutive activation,tumor progression,oncogenic driver,cell proliferation,immune evasion
ENSG00000282905,NFKBIB,nf-kappab inhibition,transcriptional regulation,cell proliferation,inflammation response,tumor suppression,gene expression control
ENSG00000145703,IQGAP2,pi3k/akt pathway,cell migration,protein scaffolding,tumor progression,metastasis regulator,cytoplasmic signaling
ENSG00000161057,PSMC2,protein degradation,cellular process regulation,cancer progression,therapeutic target,genomic instability,oncogenic signaling
ENSG00000102871,TRADD,nf-κb activation,apoptosis regulation,tumor progression,t cell regulation,inflammation response,cell survival pathway
ENSG00000102753,KPNA3,nuclear localization signals,cell cycle regulation,protein import machinery,therapeutic target,oncogenic processes,genomic instability
ENSG00000100804,PSMB5,proteasomal degradation,ubiquitinated proteins,apoptosis regulation,cell cycle progression,protein homeostasis,tumor microenvironment
ENSG00000185104,FAF1,genomic instability,tumor suppressor function,dna damage response,cell cycle regulation,protein-protein interactions,ubiquitin ligase activity
ENSG00000100764,PSMC1,cellular homeostasis maintenance,protein degradation,transcriptional regulation,apoptosis dysregulation,tumor suppressor function potential,cell cycle progression alteration
ENSG00000137054,POLR1E,ribosomal dna transcription,cell growth enhancement,overexpression,transcriptional regulation,proliferation factor,tumor suppressor interaction
ENSG00000171453,POLR1C,ribosomal rna transcription,chromatin regulation,epigenetic modifications,genomic instability,cell proliferation,dna repair mechanisms
ENSG00000053918,KCNQ1,tumor suppressor,cell proliferation regulation,genomic instability,chromosomal abnormalities,cardiac repolarization regulation,voltage-gated potassium channel activity
ENSG00000110700,RPS13,ribosome subunit,rna accumulation,cell growth regulation,apoptosis resistance,cell cycle deregulation,metabolic dysregulation
ENSG00000089009,RPL6,ribosomal subunit composition,cell cycle regulation,apoptosis resistance,protein synthesis enhancement,gene expression modulation,oncogenic mutations
ENSG00000263528,IKBKE,nf-kappa b activation,tumor growth promotion,oncogenesis,cell survival enhancement,inflammation regulation,protein kinase activity
ENSG00000136560,TANK,nf-?b activation,apoptosis regulation,immune evasion,tumor progression,pro-inflammatory cytokines expression,cell survival pathway modulation
ENSG00000096060,FKBP5,protein folding regulation,tumor progression,apoptosis inhibition,therapeutic target,genomic stability modulation,cancer cell survival
ENSG00000176046,NUPR1,tumor progression,stem cell maintenance,anti-apoptotic signaling,cell survival enhancement,prognostic marker,chemo/radio-resistance
ENSG00000074266,EED,epigenetic regulator,oncogene,histone modification,tumor suppressor regulation,cell proliferation,metastasis
ENSG00000103056,SMPD3,apoptosis regulation,cell membrane modification,oncogenic activity,sphingomyelin metabolism,ceramide production,tumor promotion
ENSG00000025800,KPNA6,nuclear transport regulation,oncogenic signaling pathway,cell cycle progression,transcriptional regulation,protein-protein interaction,therapeutic target
ENSG00000075391,RASAL2,tumor suppression,loss of function mutations,oncogene regulation,cell proliferation,signaling pathway inhibition,epigenetic silencing
ENSG00000138757,G3BP2,rna-binding activity,dna damage response,viral infection responses,apoptosis regulation,cell cycle progression,tumor suppression defects
ENSG00000168884,TNIP2,nf-κb signaling pathway,tumor suppressor function,anti-inflammatory response,tumor progression,immune evasion,cell proliferation inhibition
ENSG00000173163,COMMD1,cellular signaling modulation,gain-of-function mutations,tumor suppressor function,apoptosis regulation,dna repair regulation,pi3k/akt/mtor pathway interaction
ENSG00000173692,PSMD1,cellular homeostasis disruption,dna repair mechanism alteration,genomic instability association,oncogenic protein accumulation,protein degradation modulation,tumor progression facilitation
ENSG00000197170,PSMD12,cellular degradation,proteolytic regulation,oncoprotein stabilization,tumor suppression,genome maintenance,cell cycle control
ENSG00000163636,PSMD6,protein degradation pathway,ubiquitin-proteasome system,cancer cell survival,therapeutic target,oncogenic signaling,cell cycle progression
ENSG00000076604,TRAF4,nf-κb pathway,oncogene activation,cell proliferation,metastasis promotion,cell adhesion regulation,tumor suppressor interaction
ENSG00000142534,RPS11,ribosomal subunit biogenesis,constitutive expression,cell proliferation,oncogenic transformation,cell cycle regulation,apoptosis resistance
ENSG00000173473,SMARCC1,chromatin remodeling,transcriptional regulation,genome stability,dna repair,tumor suppression,nurd complex interaction
ENSG00000185627,PSMD13,protein degradation,ubiquitin-proteasome pathway,tumor suppressor function,proteasome subunit regulation,cell cycle regulation,therapeutic target
ENSG00000108344,PSMD3,protein degradation,cell cycle regulation,tumor suppressor function,ubiquitin-proteasome pathway,oncogenic transformation,cell proliferation enhancement
ENSG00000184432,COPB2,protein folding regulation,secretory pathway facilitation,cellular stress response,chaperone function enhancement,protein assembly modulation,signaling pathway regulation
ENSG00000141030,COPS3,protein degradation regulation,cellular homeostasis disruption,tumor suppressor function loss,cancer predisposition,ubiquitination and de-neddylation,csn complex dysregulation
ENSG00000124602,UNC5CL,netrin signaling,tumor suppression,cancer metastasis,cell death pathways,dna repair mechanisms,axon guidance
ENSG00000139613,SMARCC2,chromatin remodeling,genomic instability,dna repair,cell cycle regulation,tumor suppressor function,swi/snf complex dysfunction
ENSG00000104881,PPP1R13L,pp1 regulation,tumor suppression,oncogenic signaling,cell cycle dysregulation,anti-apoptotic activity,protein interaction
ENSG00000105127,AKAP8,gene regulation,multifunctionality,scaffold protein function,dysregulated in cancer,cell cycle regulation,transcriptional control
ENSG00000136518,ACTL6A,chromatin remodeling,transcriptional regulation,cell proliferation,metastasis promotion,epigenetic modification,gene expression alteration
ENSG00000161016,RPL8,cellular proliferation,protein synthesis,translational efficiency,ribosomal subunit interaction,apoptosis inhibition,tumor progression
ENSG00000105202,FBL,ribosome biogenesis,cell proliferation,oncogenic protein interaction,dna repair,replication maintenance,cancer therapeutic target
ENSG00000156482,RPL30,overexpressed,ribosomal protein function,protein synthesis regulation,oncogenic process modulation,tumor progression contribution,therapeutic target potential
ENSG00000174444,RPL4,ribosome biogenesis,protein synthesis dysregulation,cellular metabolism alteration,tumor growth promotion,cancer-related protein interactions,apoptosis evasion
ENSG00000133884,DPF2,dephosphorylation,transcription factor activation,cell cycle regulation,apoptosis resistance,dna damage response modulation,mapk/erk pathway modulation
ENSG00000131653,TRAF7,nf-κb activation,oncogenic transformation,scaffold protein function,tnf receptor regulation,cell proliferation,inflammatory response modulation
ENSG00000148396,SEC16A,er morphology regulation,oncogenic potential,cellular secretion modulation,tumor growth promotion,pi3k/akt pathway interaction,protein trafficking regulation
ENSG00000100991,TRPC4AP,pi3k/akt pathway interaction,cell proliferation regulation,oncogenic process promotion,tumor progression contribution,therapeutic target potential,signaling pathway modulation
ENSG00000126777,KTN1,microtubule interaction,overexpression,cell proliferation,protein transport facilitation,tumor progression,therapeutic target
ENSG00000101255,TRIB3,apoptosis regulation,inhibition of akt phosphorylation,insulin signaling pathway disruption,metastasis promotion,oncogene involvement,tumor progression enhancement
ENSG00000125995,ROMO1,mitochondrial function,energy metabolism regulation,cellular proliferation,ros production,genomic instability,tumor progression
ENSG00000123091,RNF11,pi3k/akt pathway regulation,e3 ubiquitin ligase activity,oncogenic process promoter,cell growth regulator,ubiquitination modulation,proteasomal degradation regulation
ENSG00000103035,PSMD7,protein degradation dysfunction,ubiquitin-proteasome pathway disruption,cellular homeostasis loss,aberrant protein accumulation,apoptosis resistance,proliferation promotion
ENSG00000165916,PSMC3,protein degradation,ubiquitin-proteasome pathway,cellular homeostasis,protein regulation,tumor progression,gene amplification
ENSG00000068654,POLR1A,genomic instability,tumor progression,cell proliferation,metastasis,ribosome biogenesis,oncogenic transformation
ENSG00000071994,PDCD2,tumor suppressor,apoptosis regulation,cell proliferation modulation,mitochondrial-mediated cell death,nf-κb signaling pathway modulation,chemotherapy resistance mechanism
ENSG00000143256,PFDN2,protein folding regulation,cell cycle progression modulation,ubiquitin-proteasome system modulation,tumor growth promotion,metastasis facilitation,therapeutic target identification
ENSG00000171444,MCC,mismatch repair,tumor suppressor,genomic instability,microsatellite instability,epigenetic silencing,dna damage response
ENSG00000138095,LRPPRC,mtorc1 activation,constitutive pathway activation,gain-of-function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000085760,MTIF2,mitochondrial translation regulation,dysregulation of cellular metabolism,growth factor signaling pathway,protein synthesis regulation,cancer cell proliferation,regulatory mechanisms
ENSG00000036672,USP2,cell cycle regulation,deubiquitinating enzyme,oncogene activation,protein stabilization,tumor growth promotion,ubiquitin-proteasome pathway
ENSG00000106144,CASP2,gain of function mutations,constitutive activation,apoptosis regulation,cell survival and proliferation,dna damage response pathways,tumor progression
ENSG00000168067,MAP4K2,pi3k/akt pathway interaction,oncogenic mutations,cell survival regulation,cell proliferation enhancement,therapeutic target,tumorigenesis regulator
ENSG00000102226,USP11,regulation of tumor suppressor proteins,tumor-promoting deubiquitination activity,cell survival and growth enhancement,p53 stabilization and maintenance,apoptosis inhibition and dna repair regulation,cancer therapy resistance
ENSG00000090863,GLG1,glycolytic regulation,metabolic adaptation,oncogenic activation,tumor progression,energy metabolism regulation,cell survival enhancement
ENSG00000090060,PAPOLA,b cell activation,apoptosis regulation,cell proliferation,immune modulation,oncogenic interaction,tumor growth modulation
ENSG00000186184,POLR1D,increased rrna production,enhanced cell proliferation,ribosome biogenesis,mutational hotspot,oncogenic driver,genomic instability
ENSG00000135002,RFK,energy metabolism regulation,mitochondrial function,oncogenic potential,cell proliferation enhancement,cancer aggressiveness marker,bioenergetic dysregulation
ENSG00000175166,PSMD2,proteasome degradation,ubiquitin-dependent proteolysis,protein stabilization,cell cycle progression,oncoprotein regulation,dna damage response
ENSG00000215301,DDX3X,rna helicase function,oncogenic activity,proliferation promotion,apoptosis evasion,genomic instability,transcriptional regulation
ENSG00000119401,TRIM32,tumor suppressor function,cell cycle regulation,dna damage response,oncogenic pathway interaction,loss-of-function mutations,cancer cell behavior modulation
ENSG00000166508,MCM7,genomic instability,dna replication initiation,cell cycle regulation,oncogenic potential,prognostic marker,cancer aggressiveness
ENSG00000100297,MCM5,genomic instability,dna replication regulation,cell cycle progression,tumor growth promotion,cancer risk factor,therapeutic target
ENSG00000163481,RNF25,e3 ubiquitin ligase,cell cycle regulation,dna damage response,protein degradation,ubiquitination pathway,tumor suppressor gene
ENSG00000162551,ALPL,bone mineralization,phosphate homeostasis,tumor progression,metabolic regulation,cell signaling,prognostic biomarker
ENSG00000163882,POLR2H,rna polymerase ii complex,transcriptional regulation,cellular proliferation,oncogenesis,genomic instability,chromatin remodeling
ENSG00000177700,POLR2L,transcriptional regulation,nucleotide addition,genetic instability,cancer predisposition,cellular transformation,elongation factor 
ENSG00000125630,POLR1B,ribosomal rna synthesis,oncogenic protein interaction,cell proliferation enhancement,poor prognosis biomarker,transcriptional regulation,genomic amplification
ENSG00000136485,DCAF7,cul4-ring e3 ubiquitin ligase complex,cell cycle regulation,protein degradation pathway,transcription factor regulation,dna repair mechanism,oncogenic driver
ENSG00000072518,MARK2,cell cycle regulation,microtubule dynamics,pi3k/akt pathway interaction,oncogenic processes,centrosome regulation,mitotic spindle formation
ENSG00000100784,RPS6KA5,mapk/erk pathway hyperactivation,constitutive activation,increased cell proliferation,oncogenic signaling,cell survival regulation,protein phosphorylation
ENSG00000144802,NFKBIZ,nf-κb regulation,constitutive activation,tumor growth,angiogenesis promotion,cell proliferation enhancement,apoptosis inhibition
ENSG00000017427,IGF1,cell proliferation,tumor growth,signaling pathway activation,therapeutic target,angiogenesis promotion,receptor binding
ENSG00000090020,SLC9A1,nhe1 overexpression,sodium influx regulation,cell proliferation promotion,pi3k/akt signaling interaction,tumor progression enhancement,oncogenic process facilitation
ENSG00000169252,ADRB2,beta-2 adrenergic receptor,g-protein coupled receptor,pi3k/akt signaling pathway,cell proliferation and survival,tumor progression and metastasis,therapeutic resistance
ENSG00000131095,GFAP,astrocyte differentiation,intermediate filament structure,glioma progression,cellular adhesion regulation,angiogenesis promotion,tumor microenvironment modulation
ENSG00000100412,ACO2,metabolic reprogramming,tumor growth promotion,therapeutic target,cellular energy production,glycolytic metabolism enhancement,apoptosis induction
ENSG00000099995,SF3A1,alternative splicing regulation,oncogenic properties,cell growth modulation,genome instability driver,tumor suppressor regulation,premature termination codon mutation
ENSG00000012504,NR1H4,bile acid regulation,cell proliferation enhancement,fxr pathway disruption,lipid metabolism dysregulation,nuclear receptor activity,tumor progression modulation
ENSG00000125503,PPP1R12C,oncogenic pathway modulation,tumor progression association,biomarker potential,signaling pathway interaction,protein phosphatase regulation,pp1 regulatory subunit
ENSG00000138802,SEC24B,sec24b mutations,tumor progression,protein trafficking regulation,cancer driver gene,angiogenesis regulation,er-to-golgi transport
ENSG00000123240,OPTN,autophagy regulation,mitochondrial localization,endocytosis modulation,cellular survival pathway,tumor cell adaptation,genetic alterations
ENSG00000124733,MEA1,genomic instability,aneuploidy,cell cycle progression,spindle checkpoint dysfunction,genome ploidy,overexpression
ENSG00000270647,TAF15,tumor suppressor function loss,transcriptional dysregulation,oncogenic transformation driver,cell proliferation enhancer,apoptosis resistance mediator,genomic instability contributor
ENSG00000241945,PWP2,regulatory rna metabolism,cell proliferation,molecular interactions,nuclear protein localization,tumor progression,oncogenic regulation
ENSG00000140279,DUOX2,redox imbalance,oxidative stress,gene expression alteration,tumor suppressor downregulation,cell proliferation enhancement,multifunctional enzyme activity
ENSG00000072062,PRKACA,constitutive activation,gain of function mutations,tumor progression,therapeutic target,apoptosis resistance,oncogenic pathway activation
ENSG00000107485,GATA3,transcriptional regulation,epithelial differentiation,oncogene activation,tumor progression,therapeutic target,genomic instability
ENSG00000186652,PRG2,inflammation,tumor progression,angiogenesis,metastasis,pro-inflammatory mediator production,chemotherapy resistance
ENSG00000069329,VPS35,endosomal sorting,retromer complex regulation,protein degradation pathway,tumor growth promotion,genetic alterations,oncogenic mechanism
ENSG00000141543,EIF4A3,oncogene activation,mrna translation regulation,tumor progression driver,mutation hotspot,loss of function mutations,translational control pathways
ENSG00000121481,RNF2,polycomb repressive complex 1 formation,chromatin remodeling,ubiquitin ligase activity,oncogenic process,tumor progression,epigenetic regulation
,H3F3A,histone regulation,cancer genomic instability,cellular proliferation,chromatin modification,tumor suppression,dna repair
,H3F3B,histone variant,chromatin remodeling,genomic regulation,nucleosome assembly,histone modification,epigenetic dysregulation
ENSG00000179583,CIITA,antigen presentation,immune regulation,transcriptional activation,mhc class ii expression,tumor immune evasion,adaptive immunity
ENSG00000115840,SLC25A12,mitochondrial dysfunction,tumor metabolism,oncogenic mutations,energy production alteration,fatty acid oxidation modulation,metabolic reprogramming
ENSG00000135047,CTSL,proteolytic activity,tumor progression,metastasis,proteasome regulation,growth factor processing,oncogenic protein interaction
ENSG00000143507,DUSP10,mapk pathway inhibition,dephosphorylation activity,tumor suppression,cell cycle regulation,oncogenic transformation,proteolytic activity
ENSG00000100721,TCL1A,chromatin remodeling,oncogenic interactions,cell cycle regulation,apoptosis inhibition,tumor promotion,genomic instability
ENSG00000112578,BYSL,microtubule stability,cell proliferation,cell division,protein folding,therapeutic target,cancer progression
ENSG00000178104,PDE4DIP,camp regulation,genomic instability,proliferation promotion,survival enhancement,tumor progression modulation,none
ENSG00000170315,UBB,ubiquitination process,protein regulation,cell cycle progression,dna repair,tumor suppressor,oncogenic driver
ENSG00000177971,IMP3,cell migration,tumor progression,metastasis driver,oncogene,adhesion molecule,prognostic biomarker
ENSG00000133026,MYH10,cytoskeleton regulation,tumor progression,cell migration,extracellular matrix remodeling,oncogene activation,metastatic potential
ENSG00000108771,DHX58,rna helicase activity,regulation of transcription,immune response modulation,genomic instability contribution,cell cycle regulation disruption,tumorigenesis promotion
ENSG00000105270,CLIP3,cytoskeletal regulation,actin dynamics modulation,metastasis promotion,cellular migration facilitation,tumor invasion enhancement,therapeutic target identification
ENSG00000010318,PHF7,chromatin remodeling,histone modification recognition,transcriptional regulation,tumor suppressor regulation,genomic stability maintenance,cell cycle progression control
ENSG00000269190,FBXO17,protein degradation,cell cycle progression,chromatin remodeling,histone modification,tumorigenesis,genome instability
ENSG00000111642,CHD4,chromatin remodeling,oncogenic driver,epigenetic regulation,cell proliferation,dna repair,genomic instability
ENSG00000056097,ZFR,rna-binding protein,cell cycle regulation,post-transcriptional regulation,apoptosis resistance,dna repair modulation,tumor suppressor inactivation
ENSG00000100142,POLR2F,transcriptional regulation,oncogenesis,cell proliferation,chromatin remodeling,gene expression,rna synthesis
ENSG00000185787,MORF4L1,genomic instability,tumor suppression,cell cycle regulation,chromatin remodeling,transcriptional regulation,dna damage response
ENSG00000071243,ING3,tumor suppressor function,genomic stability maintenance,histone modification regulation,dna repair mechanisms,cell cycle progression regulation,apoptosis modulation
ENSG00000122026,RPL21,ribosomal regulation,cancer cell growth,proliferation modulation,protein synthesis regulation,ribosome biogenesis,tumor aggressiveness
ENSG00000184990,SIVA1,apoptosis regulation,dna damage response,cell cycle arrest,tumor suppressor,oncogenic transformation,cancer cell proliferation
ENSG00000070495,JMJD6,histone demethylase activity,dna damage response,genomic instability,homologous recombination repair,epigenetic regulation,cancer susceptibility
ENSG00000142405,NLRP12,innate immunity regulation,aberrant expression,oncogenesis promotion,cell proliferation enhancement,survival signaling pathway activation,inflammatory response modulation
ENSG00000144524,COPS7B,ubiquitin-mediated degradation,cell cycle progression,oncogenic pathway activation,tumor growth promotion,metastasis enhancement,protein-protein interactions
ENSG00000132970,WASF3,cell adhesion disruption,tumor progression promotion,cancer cell migration enhancement,wasp family interaction,pan-cancer overexpression,prognostic marker
ENSG00000108107,RPL28,ribosome biogenesis,oncogene activation,constitutive activation,cell proliferation,protein synthesis,tumor suppressor interaction
ENSG00000109339,MAPK10,cell proliferation,oncogenesis,tumor progression,cell migration,protein kinase activation,apoptosis regulation
ENSG00000071082,RPL31,ribosomal protein overexpression,cell proliferation,tumor growth,therapeutic target,oncogene,protein synthesis regulation
ENSG00000082153,BZW1,transcriptional regulation,cell cycle progression,dna damage response,oncogenic transformation,metastasis promotion,prognostic marker
ENSG00000004838,ZMYND10,chromatin remodeling,oncogenic pathway regulation,dna repair,cell cycle progression,tumor suppressor function,epigenetic regulation
ENSG00000173267,SNCG,tumor suppressor modulation,oncogene overexpression,pi3k/akt pathway activation,cell survival enhancement,metastatic potential regulation,prognostic biomarker status
ENSG00000128604,IRF5,tumor immunosuppression,cancer cell survival,transcriptional regulation,immune evasion mechanisms,inflammation modulation,dna damage repair
ENSG00000130303,BST2,immune modulation,cell fusion,syncytia formation,viral replication control,tumor progression,immune evasion
ENSG00000274185,LILRA4,toll-like receptor signaling,decoy receptor function,immune modulation,inflammation suppression,cancer progression,prognostic marker
ENSG00000091592,NLRP1,inflammasome activation,caspase-1 activation,pro-inflammatory cytokine production,tumor promotion,metastasis facilitation,chemotherapy resistance
ENSG00000197444,OGDHL,alpha-ketoglutarate metabolism pathway,glycolysis regulation,glutaminolysis promotion,metabolic reprogramming,genomic instability association,therapeutic target potential
ENSG00000178462,TUBAL3,microtubule stabilization,overexpression,cell proliferation enhancement,poor prognosis indicator,chemosensitivity reduction,microtubule assembly regulation
ENSG00000106615,RHEB,mtor activation,cell proliferation,oncogenic process,constitutive activation,nutrient sensing,hypoxia-inducible factor 1 alpha (hif-1α)
ENSG00000112685,EXOC2,oncogenic regulation,exocytic vesicle trafficking,constitutive activation,tumor progression,metastatic potential,epithelial-to-mesenchymal transition
ENSG00000006451,RALA,oncogenic driver,cell proliferation,signaling pathway activation,cytoskeleton regulation,membrane trafficking,tumor progression
ENSG00000116954,RRAGC,rab gtpase activation,mtor pathway regulation,cell proliferation enhancement,oncogenic potential,nutrient sensing dysregulation,tumor growth promotion
ENSG00000248746,ACTN3,cell adhesion,gain of function mutations,cell migration,therapeutic target,prognostic marker,signaling pathway activation
ENSG00000166200,COPS2,ubiquitin-proteasome pathway,cell cycle regulation,tumor growth,proliferation regulation,protein degradation,genetic instability
ENSG00000060138,YBX3,nuclear localization,transcription regulation,dna-binding protein,oncogenic processes,cellular proliferation,epithelial-to-mesenchymal transition
ENSG00000092445,TYRO3,receptor tyrosine kinase activity,tumor progression,tam receptor family member,cell proliferation and survival signaling pathway regulation,mutations associated with cancer prognosis,poor prognosis marker
ENSG00000107874,CUEDC2,protein ubiquitination,cell growth regulation,genomic instability,apoptosis modulation,therapeutic target,metabolic regulation
ENSG00000069667,RORA,nuclear receptor activity,constitutive activation,oncogenic driver,cell proliferation regulation,transcriptional regulation,circadian rhythm disruption
ENSG00000087191,PSMC5,proteasome complex,cellular degradation,oncogenesis,apoptosis regulation,ubiquitin-proteasome pathway,tumor progression
ENSG00000213928,IRF9,antitumor activity,immune regulation,apoptosis induction,cell proliferation suppression,type i interferon regulation,tumor immunosuppression
ENSG00000138814,PPP3CA,genomic instability,regulation of transcriptional control,apoptosis regulation,nf-κb signaling modulation,ca2+/calmodulin-dependent activation,calcineurin activity
ENSG00000169288,MRPL1,mitochondrial ribosomal protein,tumor growth promotion,cell proliferation regulation,metabolic adaptation enhancement,protein synthesis regulation,poor prognosis indicator
ENSG00000149273,RPS3,enhanced protein synthesis,oncogenic processes,cell proliferation,genomic instability,epigenetic regulation,pi3k/akt pathway interaction
ENSG00000144028,SNRNP200,altered splicing patterns,cancer-associated mutations,gene regulation disruption,protein interaction dysregulation,tumorigenesis involvement,spliceosome component
ENSG00000066044,ELAVL1,rna binding,post-transcriptional regulation,tumor growth promotion,metastasis facilitation,chemoresistance enhancement,signaling pathway interaction
ENSG00000125347,IRF1,interferon-mediated signaling,tumor suppressor function,oncogene potential,cell cycle regulation,apoptosis modulation,transcriptional regulation
ENSG00000107201,DDX58,genomic instability,gain of function mutations,rna helicase activity,oncogenesis,antiviral response,innate immune regulation
ENSG00000136153,LMO7,transcriptional coactivator,cell cycle regulation,epithelial-to-mesenchymal transition (emt),signaling pathway modulation,growth factor regulation,genetic and epigenetic alterations
ENSG00000082014,SMARCD3,chromatin remodeling,cell growth regulation,dna damage response,transcriptional regulation,tumor suppressor function,loss of heterozygosity
ENSG00000178307,TMEM11,cellular regulation,genomic instability,oncogenesis,tumor progression,cell cycle regulation,dna repair mechanism
ENSG00000087077,TRIP6,actin cytoskeleton regulation,cell migration,epithelial-to-mesenchymal transition (emt),microtubule interaction,oncogene overexpression,rho gtpase signaling pathway
ENSG00000103423,DNAJA3,mitochondrial chaperone,heat shock protein 90 interaction,protein folding regulation,cellular homeostasis maintenance,oxidative stress prevention,aberrant protein aggregation
ENSG00000197561,ELANE,tumor progression,genomic instability,proteolytic activity,cell migration,cancer predisposition,protein degradation
ENSG00000158578,ALAS2,heme biosynthesis regulation,ros production,oncogenic process,cell proliferation enhancement,iron homeostasis deregulation,protein interaction with other genes
ENSG00000132703,APCS,wnt signaling pathway regulation,cell adhesion modulation,focal adhesion formation,cytoplasmic dynein regulation,integrin interaction,genomic instability
ENSG00000165471,MBL2,immunomodulation,complement system activation,cancer progression,immune evasion,therapeutic target,tumor growth regulation
ENSG00000050405,LIMA1,cellular proliferation,transcriptional regulation,chromatin remodeling,tissue development,genomic instability,oncogenesis
ENSG00000153201,RANBP2,genomic instability,cellular proliferation,chromatin remodeling,oncogene activation,nuclear-cytoplasmic transport,mitotic regulation
ENSG00000173599,PC,altered expression,cellular adhesion modulation,collagen processing regulation,epithelial-to-mesenchymal transition,tumor progression enhancement,dysregulation association
ENSG00000011304,PTBP1,tumor progression,alternative splicing,oncogene,epigenetic modification,microrna processing,chromatin interaction
ENSG00000105963,ADAP1,pi3k/akt pathway activation,oncogenic signaling,t-cell regulation,overexpression in tumors,immune evasion mechanisms,cell proliferation promotion
ENSG00000100316,RPL3,protein synthesis regulation,ribosomal biogenesis,oncogenic function,tumor growth promotion,mrna stabilization,signaling pathway modulation
ENSG00000262406,MMP12,tumor progression,extracellular matrix degradation,angiogenesis,cell invasion and migration,proteolytic activity,signaling molecule interaction
ENSG00000102119,EMD,loss-of-function mutations,tumor suppressor function,genomic instability,nuclear envelope integrity,nuclear structure regulation,dysregulation of cell cycle progression
ENSG00000115661,STK16,spindle checkpoint regulation,cell cycle progression,mitosis,pi3k/akt pathway modulation,tumor progression,oncogenic potential
ENSG00000198668,CALM1,tumor growth regulation,cellular signaling modulation,intracellular calcium regulation,oncogenic pathway activation,metastasis promotion,tumorigenesis driver
ENSG00000172183,ISG20,oncogenic mutations,tumor progression,cell cycle regulation,apoptosis inhibition,protein turnover modulation,genome stability maintenance
ENSG00000179562,GCC1,amino acid regulation,cell proliferation,gene expression,metabolic regulation,mutations impact,translation machinery
ENSG00000128272,ATF4,tumor progression,metabolic regulation,cell survival,stress response,integrated stress response,transcription factor activation
ENSG00000275796,NLRP2,tumor suppression,apoptosis regulation,inflammation modulation,immune response regulation,cell proliferation inhibition,nf-κb pathway interaction
ENSG00000132530,XAF1,apoptosis regulation,tumor suppression,p53 modulation,anti-apoptotic protein inhibition,cell survival balance,genetic instability
ENSG00000083444,PLOD1,collagen cross-linking,extracellular matrix remodeling,cell migration and invasion,therapeutic resistance,protein-protein interaction,transcriptional regulation
ENSG00000221869,CEBPD,tumor promoter,cell proliferation,apoptosis inhibition,transcriptional regulator,cell differentiation,oncogenic function
ENSG00000084463,WBP11,microtubule regulation,cell growth promotion,signaling pathway modulation,oncogenic process facilitation,ww domain interaction,therapeutic target potential
ENSG00000120217,CD274,immune checkpoint regulation,tumor immune evasion,genetic alterations,molecular heterogeneity,immunosuppressive microenvironment,therapeutic target
ENSG00000276977,PDCD1,immune evasion,checkpoints inhibitors,oncogenic mutations,therapeutic targets,checkpoint blockade,tumor microenvironment modulation
ENSG00000089022,MAPKAPK5,p38 mapk pathway,cellular growth regulation,cytoplasmic localization,oncogenic transformation,signaling pathway activation,protein kinase activity
ENSG00000185386,MAPK11,mapk signaling pathway,gain of function mutations,oncogenic transformation,tumor progression,metastatic potential,protein kinase activation
ENSG00000106462,EZH2,histone modification,oncogenic pathway activation,epigenetic regulation,cell proliferation,tumor suppressor silencing,prognostic marker
ENSG00000034713,GABARAPL2,autophagy regulation,tumor progression,cellular survival,protein degradation,genomic instability,cell signaling
ENSG00000234846,NEU1,cellular degradation,lysosomal enzyme function,glycoconjugate hydrolysis,tumor microenvironment modulation,immune response regulation,metabolic pathway interaction
ENSG00000198911,SREBF2,constitutive activation,lipid metabolism regulation,transcriptional regulation,cell proliferation,oncogenic driver,tumor progression
ENSG00000184381,PLA2G6,cellular lipid metabolism,calcium-independent phospholipase a2 activity,tumor progression,cell proliferation,survival signaling pathway,inflammatory response modulation
ENSG00000132522,GPS2,cell migration,epithelial-to-mesenchymal transition,immune modulation,tumor progression,gtpase regulation,cancer stem cell maintenance
ENSG00000156265,MAP3K7CL,inflammation regulation,tumor progression,cancer prognosis,cell survival modulation,signaling pathway regulation,protein-protein interaction
ENSG00000162889,MAPKAPK2,cellular responses,mapk signaling pathway,phosphorylation activity,protein kinase activation,transcriptional regulation,tumor progression
ENSG00000129167,TPH1,pi3k/akt pathway modulation,oncogene activation,cell cycle progression regulation,tumor invasion enhancement,signaling pathway interaction,neurotransmitter biosynthesis alteration
ENSG00000110906,KCTD10,pi3k/akt signaling,cell cycle regulation,tumor suppressor function,oncogene activation,genomic instability,protein-protein interactions
ENSG00000143878,RHOB,protein kinase regulation,gtp-binding protein,oncogenic signaling,cell migration promotion,tumor progression facilitation,pro-survival pathway activation
ENSG00000043591,ADRB1,cellular proliferation,oncogene activation,g-protein coupled signaling,therapeutic target,epigenetic regulation,tumor growth
ENSG00000136541,ERMN,cell adhesion,tumor suppressor function,cell migration,invasion mechanisms,protein interactions,cytoskeleton dynamics
ENSG00000107164,FUBP3,pi3k/akt pathway activation,transcriptional regulation,oncogene activation,tumor suppressor repression,cell proliferation promotion,epigenetic regulation
ENSG00000129083,COPB1,retrograde transport,golgi apparatus,endoplasmic reticulum,tumor suppressor function,cell growth regulation,apoptosis suppression
ENSG00000140859,KIFC3,microtubule-based transport,centrosome duplication,cell cycle progression,chromosomal instability,oncogenesis,tumor suppression
ENSG00000079462,PAFAH1B3,microtubule dynamics regulation,mitotic spindle assembly disruption,aneuploidy promotion,chromosomal instability enhancement,genomic integrity compromise,cellular homeostasis disruption
ENSG00000072201,LNX1,protein degradation regulation,tumor suppressor inhibition,oncogenic protein stabilization,cellular proliferation enhancement,metastatic potential promotion,cancer association
ENSG00000178952,TUFM,mitochondrial translation,cellular metabolism,oncogenic potential,protein synthesis efficiency,cancer progression,metastasis driver
ENSG00000130165,ELOF1,protein synthesis regulation,tumor progression promotion,anti-apoptotic function,mutations leading to overexpression,hypoxia adaptation facilitation,cell proliferation enhancement
ENSG00000239732,TLR9,tlr9 activation,innate immune response,genomic dna recognition,cytokine production,immune modulation,therapeutic target
ENSG00000052723,SIKE1,microrna biogenesis regulation,tumor immune evasion mechanism,immunosuppressive tumor microenvironment,protein-protein interaction,cancer cell evasion,immune surveillance impairment
ENSG00000100453,GZMB,apoptosis regulation,cytotoxic granule component,extrinsic apoptosis pathway,granzyme activity,immune microenvironment modulation,pro-apoptotic function
ENSG00000174106,LEMD3,cell cycle regulation,chromatin remodeling,oncogenesis,nuclear structure maintenance,genomic instability,dna damage response
ENSG00000152492,CCDC50,genomic instability,tumor suppressor,mitotic checkpoint regulation,aneuploidy induction,spindle assembly disruption,chromosomal missegregation
ENSG00000225921,NOL7,ribosomal rna regulation,nucleolar stress response,cell proliferation enhancement,oncogenic properties,protein-protein interactions,cancer cell adaptation
ENSG00000145907,G3BP1,oncogenic reprogramming,constitutive activation,tumor progression,metabolic regulation,apoptosis resistance,stress granule formation
ENSG00000117335,CD46,complement regulator,immune evasion,cell adhesion,tumor progression,angiogenesis,signaling pathway activation
ENSG00000137309,HMGA1,cell proliferation regulation,chromatin remodeling,epithelial-to-mesenchymal transition (emt),oncogene activation,apoptosis inhibition,survival pathway modulation
ENSG00000130340,SNX9,pi3k/akt pathway regulation,endocytic trafficking modulation,oncogenic protein overexpression,tumor cell proliferation,cancer biomarker,genetic amplification
ENSG00000079739,PGM1,glycogen metabolism,enzyme deficiency,glycogen storage disease,ribose-5-phosphate regulation,glycolysis inhibition,metabolic pathway alteration
ENSG00000272804,KRTAP10-7,cellular structure,epithelial integrity,cancer susceptibility,cellular function regulation,protein complex formation,tissue maintenance 
ENSG00000164346,NSA2,histone deacetylation,chromatin remodeling,tumor suppressor suppression,cell growth promotion,dna damage repair modulation,cancer epigenetics
ENSG00000111640,GAPDH,multifunctional,transcriptional regulation,cellular metabolism,oncogenic potential,protein-protein interactions,cellular growth promotion
ENSG00000085978,ATG16L1,autophagy pathway,oncogenesis,autophagosome formation,cellular survival,tumor progression,therapeutic target
ENSG00000100290,BIK,apoptosis regulation,pro-apoptotic function,anti-apoptotic inhibition,cancer resistance,therapeutic target,cell survival regulation
ENSG00000140379,BCL2A1,apoptosis regulation,anti-apoptotic function,mitochondrial outer membrane permeabilization,oncogenic potential,tumor suppressor role,cell survival promotion
ENSG00000143556,S100A7,tumor progression,oncogenic processes,epithelial cell regulation,cell proliferation,apoptosis regulation,metastasis promotion
ENSG00000073861,TBX21,disrupted immune surveillance,oncogenic mutations,t-cell development regulation,cell differentiation,gene expression modulation,tumor immunosuppression
ENSG00000148798,INA,cellular regulation,signaling pathway modulation,protein-protein interaction,mutational alterations,tumorigenesis contribution,cell growth dysregulation
ENSG00000124214,STAU1,cellular stress response,p53 regulation,oncogenic signaling,cell proliferation,tumor progression,rna-binding protein
ENSG00000115524,SF3B1,spliceosome regulation,altered splicing patterns,gain of function mutations,genomic instability,therapeutic target,rna processing
ENSG00000173327,MAP3K11,nf-κb activation,apoptosis regulation,pro-survival signaling,tumor driver gene,cancer cell proliferation,kinase activity dysregulation
ENSG00000115946,PNO1,pi3k/akt pathway,aberrant activation,gain of function mutations,tumor progression,protein-protein interaction,genomic instability
ENSG00000120616,EPC1,er chaperone,unfolded protein response,cellular stress,protein folding,tumor progression,therapeutic target
ENSG00000117115,PADI2,histone modification,cancer-associated gene,cell migration,protein deimination,tumor progression,apoptosis regulation
ENSG00000143631,FLG,cellular barrier regulation,epithelial integrity maintenance,inflammation modulation,skin tissue repair,tissue permeability regulation,genetic predisposition
ENSG00000084674,APOB,cholesterol metabolism,oncogenic potential,tumor progression,metabolic reprogramming,cellular signaling pathways,lipid assembly
ENSG00000175197,DDIT3,transcription factor regulation,apoptosis resistance,metabolic reprogramming,tumor progression,endoplasmic reticulum stress response,cellular adaptation
ENSG00000136450,SRSF1,alternative splicing,aberrant protein structure,oncogenic function,tumor suppressor role,cell proliferation regulation,gene expression regulation
ENSG00000141570,CBX8,chromatin remodeling,epigenetic regulation,tumor progression,aneuploidy,genomic instability,apoptosis suppression
ENSG00000008988,RPS20,oncogenic mutations,enhanced translation efficiency,altered metabolism,cell cycle regulation,apoptosis modulation,therapeutic target
ENSG00000128973,CLN6,lysosomal transport,autophagic dysfunction,cell survival,protein degradation,tumor progression,therapeutic target
ENSG00000058262,SEC61A1,er protein translocation,protein folding regulation,cell cycle regulation,tumor suppression,chaperone activity,er stress response
ENSG00000130811,EIF3G,oncogene upregulation,translation initiation regulation,cell proliferation enhancement,tumor suppression inhibition,apoptosis modulation,protein interaction
ENSG00000162601,MYSM1,heterochromatin formation,epigenetic regulation,dysregulation of chromatin,chromatin compaction,histone methylation,pan-cancer involvement
ENSG00000166598,HSP90B1,chaperone function,regulated cell growth,pi3k/akt/mtor pathway,cellular homeostasis,oncogenic protein stability,genomic profiling
ENSG00000167987,VPS37C,escrt-0 regulation,tumor progression,genomic instability,cancer cell signaling,cellular homeostasis regulation,protein degradation pathway dysfunction
ENSG00000121807,CCR2,tumor-associated macrophage recruitment,monocyte chemotaxis,immune cell homing,g protein-coupled receptor signaling,protein kinase c activation,cell migration regulation
ENSG00000120438,TCP1,protein folding,cell survival,signaling pathway regulation,misfolded protein accumulation,oncogenic process promotion,therapeutic target
ENSG00000171435,KSR2,erk1/2 pathway activation,oncogenic process promotion,scaffolding function,cell proliferation enhancement,tumor progression facilitation,potential cancer driver gene status
ENSG00000113595,TRIM23,apoptosis regulation,cell cycle progression,e3 ubiquitin ligase activity,oncogenic potential,protein-protein interactions,tumor progression
ENSG00000120896,SORBS3,pi3k/akt pathway interaction,tumor progression facilitation,cell adhesion modulation,oncogenic process promotion,cancer driver potential,prognostic marker status
ENSG00000170482,SLC23A1,nutrient uptake enhancement,pi3k/akt pathway interaction,cell survival promotion,cell proliferation facilitation,metabolic reprogramming,tumor progression driver
ENSG00000104812,GYS1,glycogen biosynthesis,glycolytic pathway activation,oncogene activation,tumor progression,metabolic reprogramming,therapeutic target
ENSG00000150459,SAP18,pi3k/akt pathway,oncogenic properties,protein-protein interactions,cell survival and proliferation,signal transduction modulation,tumorigenesis
ENSG00000188529,SRSF10,altered splicing regulation,alternative splice sites recognition,tumor growth promotion,apoptosis suppression,cell cycle regulation disruption,therapeutic target identification
ENSG00000013364,MVP,oncogene overexpression,drug resistance mechanism,cell cycle regulation,tumor progression,therapeutic target,vault complex formation
ENSG00000162664,ZNF326,transcription factor regulation,oncogene activation,cell cycle regulation,apoptosis suppression,epithelial-to-mesenchymal transition,tumor metastasis
ENSG00000168310,IRF2,tumor suppressor/oncogene switch,tumor progression,dysregulation,cell cycle regulation,apoptosis resistance,biomarker for disease diagnosis and prognosis
ENSG00000142541,RPL13A,ribosomal translation regulation,cell proliferation enhancement,tumor progression contribution,protein synthesis deregulation,genomic instability association,oncogenic pathway modulation
ENSG00000214753,HNRNPUL2,heterogeneous nuclear ribonucleoprotein u-like 2,alternative splicing regulation,oncogene function,aberrant isoform production,cancer driver mutation,cell proliferation enhancement
ENSG00000088833,NSFL1C,proteasome function,dna damage response,tumor suppression,genomic instability,cancer progression,cellular degradation
ENSG00000150991,UBC,protein stabilization,cellular homeostasis,ubiquitination regulation,oncogenic driver,tumor progression,genomic instability
ENSG00000164118,CEP44,microtubule regulation,centrosome organization,cilia formation,oncogenic signaling pathways,tumor growth and progression,genomic instability
ENSG00000047315,POLR2B,aberrant rna synthesis,oncogenic transformation,tumor progression,cell cycle regulation,transcriptional dysregulation,therapeutic target
ENSG00000164111,ANXA5,cell signaling,tumor suppressor function,apoptosis regulation,calcium-dependent binding,phospholipid interaction,membrane trafficking
ENSG00000008438,PGLYRP1,inflammation regulation,nf-κb signaling pathway interaction,tumor suppressor gene suppression,oncogene activation,immunoreceptor function,cancer immunotherapy target
ENSG00000163257,DCAF16,cancer driver gene,tumor suppressor function,ubiquitination regulation,cell cycle progression,dna repair mechanisms,oncogenic processes
ENSG00000130939,UBE4B,oncogenic processes,cell proliferation,ubiquitination regulation,tumor suppressor protein modification,chromatin remodeling,transcriptional regulation
ENSG00000010278,CD9,tumor progression,cell adhesion regulation,signaling pathway modulation,epithelial-to-mesenchymal transition (emt),aberrant gene expression,therapeutic target
ENSG00000169403,PTAFR,cellular proliferation,tumor progression,oncogene interaction,metastasis,receptor activation,signaling pathway modulation
ENSG00000240583,AQP1,cellular hydration,osmotic regulation,angiogenesis facilitation,tumor progression driver,prognostic marker,cancer cell migration
ENSG00000109906,ZBTB16,tumor suppression,cell cycle regulation,genomic stability maintenance,apoptosis promotion,oncogene repression,hematopoietic stem cell self-renewal
ENSG00000164877,MICALL2,clathrin-coated vesicle formation,endocytosis regulator,oncogenic signaling pathway,cell growth regulation,survival factor,genomic instability
ENSG00000077522,ACTN2,cell migration,cytoskeletal protein,oncogene,tumor progression,metastasis promoter,prognostic marker
ENSG00000231408,LTA,nf-κb signaling pathway,constitutive overexpression,immunomodulation,oncogenic processes,tumor progression,therapeutic target
ENSG00000053372,MRTO4,mtor signaling pathway,cell growth regulation,oncogenic mutations,protein kinase activation,cell proliferation,metabolic regulation
ENSG00000134107,BHLHE40,apoptosis regulation,transcriptional repressor function,tumor progression modulation,metastasis inhibition,cancer-related transcription factor,cell growth regulation
ENSG00000188747,NOXA1,apoptosis regulation,mitochondrial outer membrane permeabilization,cancer cell resistance,tumor progression,pro-apoptotic function,cell survival modulation
ENSG00000168135,KCNJ4,tumor suppressor function,cellular adaptation,insulin secretion regulation,apoptosis regulation,metabolic reprogramming,ion channel function
ENSG00000116711,PLA2G4A,phospholipase activity,pro-inflammatory mediator production,tumor growth promotion,angiogenesis regulation,cell signaling modulation,lysophospholipid production
ENSG00000055332,EIF2AK2,integrated stress response,tumor growth promotion,selective translation regulation,autophagy modulation,protein kinase activation,pi3k/akt/mtor pathway interaction
ENSG00000129673,AANAT,melatonin regulation,circadian rhythm,cell proliferation,oncogenic pathway,redox state modulation,tumor microenvironment modification
ENSG00000181789,COPG1,ubiquitination regulation,tumor suppressive activity,protein degradation regulation,cell cycle progression,genomic stability maintenance,oncogenic accumulation
ENSG00000130222,GADD45G,cell cycle regulation,apoptosis induction,tumor suppression,dna repair mechanisms,transcriptional regulation,stress response modulation
ENSG00000160339,FCN2,ficolin binding,oncogenesis,cell proliferation,pi3k/akt signaling,immune evasion,tumor progression
ENSG00000163661,PTX3,angiogenesis,complement activation,inflammation response,immune modulation,tumorigenesis promotion,acute phase reaction
ENSG00000136709,WDR33,oncogene,cell cycle regulation,tumor progression,dna repair modulation,proliferation enhancement,scaffold protein function
ENSG00000101596,SMCHD1,genomic instability,epigenetic regulation,chromatin remodeling,tumor suppressor function,aneuploidy driver,transcriptional regulation
ENSG00000138764,CCNG2,genomic instability,pp2a phosphatase complex,cyclin-dependent kinase activity,tumor progression,cell cycle regulation,dna repair pathways
ENSG00000172809,RPL38,cellular proliferation,translation efficiency regulation,oncogenic processes contribution,therapeutic target potential,ribosomal subunit component,protein synthesis enhancement
ENSG00000170634,ACYP2,genomic instability,cancer cell survival,dna repair pathways,nuclear matrix association,gene expression regulation,prognostic marker
ENSG00000110169,HPX,angiogenesis promotion,anti-inflammatory function,biomarker potential,cell growth regulation,free heme scavenging,tumor progression enhancement
ENSG00000005022,SLC25A5,mitochondrial metabolism,tumor progression,glycolysis activation,lipogenesis regulation,glucose transporter function,dysregulated expression
ENSG00000263465,SRSF8,alternative splicing,rna processing,cancer progression,genomic instability,protein kinase activation,cellular transformation
ENSG00000007952,NOX1,oxidative stress induction,reactive oxygen species production,angiogenesis promotion,cell proliferation enhancement,metastasis facilitation,pi3k/akt/mtor pathway activation
ENSG00000106538,RARRES2,tumor suppressor,cellular differentiation,apoptosis regulation,retinoic acid signaling,epithelial-to-mesenchymal transition,transcriptional modulation
ENSG00000178028,DMAP1,genomic instability,dna repair mechanisms,tumor suppressor function,protein-dna interactions,cellular transcription regulation,rna metabolism
ENSG00000144635,DYNC1LI1,microtubule dynamics,cell migration,chromosome segregation,cellular trafficking,oncogenic mutations,tumor progression
ENSG00000149534,MS4A2,complement activation,cd21 receptor,b cell development,immune regulation,tumor progression,therapeutic target
ENSG00000145649,GZMA,granule membrane protein 2,cytotoxic granules,natural killer cell function,cell killing mechanism,immune surveillance,tumor cell recognition
ENSG00000173641,HSPB7,heat shock response,apoptosis regulation,cell cycle modulation,therapeutic target,tumor progression,stress response
ENSG00000156711,MAPK13,p38 mapk activation,oncogenic mutations,cell proliferation regulation,stress response signaling,cancer progression,therapeutic target
ENSG00000065328,MCM10,genomic instability,oncogene,cell proliferation,s-phase progression,dna replication,protein interaction
ENSG00000108578,BLMH,homologous recombination repair,genomic stability maintenance,double-strand break repair,homology-directed repair,dna helicase activity,chromosomal instability prevention
ENSG00000112874,NUDT12,ndp kinase activity,genomic stability maintenance,tumor suppressor properties,cellular metabolism regulation,dna repair mechanism disruption,protein-protein interactions
ENSG00000091732,ZC3HC1,oncogenic signaling pathway regulation,protein interaction regulation,cell cycle progression facilitation,g2/m checkpoint inhibition,apoptosis suppression,tumor growth promotion
ENSG00000213465,ARL2,microtubule dynamics regulation,gtp-binding protein activity,pi3k/akt signaling pathway modulation,cancer progression facilitation,cell proliferation promotion,protein interaction with other oncogenes
ENSG00000152795,HNRNPDL,pre-mrna splicing,aberrant splicing,tumorigenesis,gene regulation,cancer progression,therapeutic target
ENSG00000092067,CEBPE,transcriptional regulation,cell differentiation,apoptosis regulation,tumor suppressor activity,cellular proliferation,genomic instability
ENSG00000138326,RPS24,ribosomal assembly,oncogenic process,cell proliferation,tumorigenesis,therapeutic target,genomic instability
ENSG00000213923,CSNK1E,wnt/β-catenin signaling,genomic instability,cell proliferation,apoptosis regulation,tumor progression,protein phosphorylation
ENSG00000186847,KRT14,keratin filaments,intermediate filament network,cell morphology changes,oncogenic processes,prognostic marker,therapeutic target
ENSG00000158773,USF1,genomic instability,transcriptional regulation,oncogenesis,pan-cancer context,cell proliferation,transcription factor activity
ENSG00000116251,RPL22,ribosomal biogenesis,cellular proliferation,translation initiation,mutation driver,tumor suppression,protein synthesis regulation
ENSG00000169760,NLGN1,neuronal cell adhesion,synaptic transmission regulation,epithelial-to-mesenchymal transition,cell migration facilitation,tumor progression involvement,cellular adhesion modulation
ENSG00000163512,AZI2,gene regulation,transcriptional repression,oncogenic properties,cell proliferation,survival factor,protein-protein interaction
,QARS,glutaminyl-trna synthetase function,oncogene/tumor suppressor activity,protein synthesis regulation,cell growth promotion,metabolic pathway involvement,pi3k/akt signaling interaction
ENSG00000175899,A2M,protease inhibition,tumor progression,cellular regulation,apoptosis modulation,protein interaction,metastasis promotion
ENSG00000169220,RGS14,regulation of gpcr signaling,dysregulation of rgs14,impact on cell migration,constitutive activation of survival pathways,g-protein interaction,cell proliferation modulation
ENSG00000262845,KRT40,cell proliferation,tumor suppression,oncoprotein function,epithelial cell differentiation,squamous cell carcinoma association,keratin filament assembly
ENSG00000105383,CD33,transmembrane glycoprotein,immune modulation,myeloid cell development,hematological malignancies,signaling pathway regulation,therapeutic target
ENSG00000122566,HNRNPA2B1,pre-mrna processing,regulation of oncogenic transcripts,alternative splicing,mrna export,interaction with transcription factors and chromatin-modifying complexes,epigenetic regulation of gene expression
ENSG00000134419,RPS15A,ribosomal protein,cellular proliferation,protein synthesis efficiency,translation initiation,cancer prognosis marker,therapeutic target
ENSG00000104884,ERCC2,dna repair,genomic instability,nucleotide excision repair,dna damage response,mutation sensitivity,genetic predisposition
ENSG00000075856,SART3,alternative splicing regulation,aberrant expression,chromatin remodeling,tumor progression,oncogene regulation,splice site recognition
ENSG00000147082,CCNB3,mitotic regulation,cyclin-dependent kinase activation,g2/m phase transition,cell proliferation promotion,chromosome segregation,cell cycle progression
ENSG00000090924,PLEKHG2,cell proliferation,oncogenesis,tumor progression,epithelial-to-mesenchymal transition (emt),metastasis,apoptosis resistance
ENSG00000162511,LAPTM5,lysosomal regulation,tumor promoter,cell cycle regulation,apoptosis inhibition,oncogenesis,overexpression marker
ENSG00000099204,ABLIM1,cell migration,invasive potential,rho gtpase activation,focal adhesion kinase regulation,cytoskeletal remodeling,prognostic marker
ENSG00000159200,RCAN1,calcineurin regulation,nfat transcription factors,cell proliferation enhancement,metastasis promotion,oncogene activation,genetic instability
ENSG00000117632,STMN1,microtubule stabilization,cell proliferation,apoptosis resistance,tumor progression,fragile microtubules,signaling pathway regulation
ENSG00000163694,RBM47,alternative splicing,cellular homeostasis disruption,genomic instability,oncogene regulation,tumor suppressor regulation,rna-binding protein interactions
ENSG00000084093,REST,transcriptional regulation,tumor suppressor function,cell cycle regulation,neurogenesis repression,oncogene silencing,dna damage response
ENSG00000180772,AGTR2,angiogenesis promotion,cell proliferation regulation,oncogenic signaling pathway,tumor metastasis facilitation,receptor overexpression,growth factor interaction
ENSG00000156709,AIFM1,apoptosis dysregulation,mitochondrial function,dna damage response,therapeutic target,metabolic regulation,genomic instability
ENSG00000143033,MTF2,mtf2 overexpression,oncogenic transcriptional programs,mtor pathway regulation,transcriptional regulation,cellular growth modulation,chromatin remodeling
ENSG00000009724,MASP2,lectin pathway activation,innate immune response,angiogenesis promotion,inflammatory response modulation,tumor growth enhancement,oncogenic potential
ENSG00000085265,FCN1,immune evasion,complement system activation,cell surface binding,tumorigenesis,cancer progression,protein-carbohydrate interaction
ENSG00000171566,PLRG1,rtk signaling regulation,oncogenic pathway modulation,cell growth regulation,protein-protein interaction,tumorigenesis association,cancer driver gene status
ENSG00000126581,BECN1,autophagy regulation,genetic instability,cellular homeostasis,oncogenic transformation,tumor progression,cancer development
ENSG00000138642,HERC6,ubiquitination regulation,cell cycle control,transcriptional regulation,protein quality control,tumor suppressor function,oncogene potential
ENSG00000138641,HERC3,protein regulation,ubiquitination pathway,tumor suppression,cellular homeostasis,apoptosis regulation,oncogenic stabilization
ENSG00000168090,COPS6,genomic instability,cell cycle regulation,proteasomal degradation,oncogenesis,tumor progression,protein degradation pathway
ENSG00000142937,RPS8,ribosomal assembly,cell proliferation,translation initiation,oncoprotein interaction,protein synthesis enhancement,cancer cell survival
ENSG00000127152,BCL11B,gene regulation,transcriptional activation,epigenetic modification,cell proliferation,hematopoiesis disruption,cancer driver
ENSG00000159140,SON,genomic instability,tumor suppressor function,rna polymerase ii regulation,chromatin organization,cellular growth regulation,dna repair mechanism
ENSG00000074317,SNCB,regulation of synaptic vesicles,aberrant expression,post-translational modifications,cellular signaling modulation,tumor cell behavior regulation,stress response management
ENSG00000101444,AHCY,methylation regulation,sah/sam balance,cellular proliferation,epigenetic regulation,prognostic marker,genomic instability
ENSG00000062725,APPBP2,cellular proliferation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,protein-protein interactions
ENSG00000089094,KDM2B,epigenetic regulation,chromatin remodeling,histone modification,oncogenesis,tumor progression,cell proliferation
ENSG00000205542,TMSB4X,chromatin remodeling,transcriptional regulation,histone binding,oncogene expression,cell proliferation,apoptosis suppression
ENSG00000166037,CEP57,centriole duplication,microtubule dynamics,cellular proliferation,oncogenic potential,cancer mutations,spindle assembly
ENSG00000180209,MYLPF,cell cycle regulation,muscle contraction regulation,gain of function mutations,oncogene activation,cell proliferation enhancement,tumor progression
ENSG00000163565,IFI16,apoptosis regulation,chromatin remodeling,dna damage response,histone modification,immune modulation,tumor suppression
ENSG00000167460,TPM4,cell migration,cancer progression,tumor invasion,smooth muscle contraction,actin binding protein,cytoplasmic regulation
ENSG00000198814,GK,glycolytic enzyme,gain-of-function mutations,oncogenic process,metabolic reprogramming,energy metabolism,therapeutic target
ENSG00000123358,NR4A1,nr4a1,nuclear receptor regulation,cellular proliferation,apoptosis evasion,tumor growth promotion,metabolic regulation
ENSG00000214944,ARHGEF28,rho gtpase activation,oncogenic transformation,cell proliferation enhancement,metastasis promotion,downstream effector recruitment,aggressive disease phenotype
ENSG00000197647,ZNF433,dna binding,transcriptional regulation,cell proliferation,chromatin modification,oncogenic transformation,tumor suppression
ENSG00000012779,ALOX5,leukotriene synthesis,inflammation regulation,tumor growth promotion,angiogenesis enhancement,metastasis facilitation,proliferation induction
ENSG00000116688,MFN2,mitochondrial fusion,oncogenic properties,tumor progression,cell proliferation regulation,metabolic reprogramming,therapeutic target candidate
ENSG00000121957,GPSM2,rhoa/rac1 activation,cancer progression,metastasis promotion,cell migration regulation,gef activity,tumor aggressiveness
ENSG00000106263,EIF3B,oncogenesis,proliferation enhancement,protein synthesis regulation,tumor progression modulation,therapeutic target,genomic instability
ENSG00000100028,SNRPD3,genomic instability,oncogene overexpression,tumor progression,splicing regulation,aberrant gene expression,cancer driver status
ENSG00000019549,SNAI2,cellular invasion,transcriptional regulation,epithelial-to-mesenchymal transition (emt),oncogenic potential,tumor aggressiveness,therapeutic resistance
ENSG00000198932,GPRASP1,cell proliferation,receptor tyrosine kinase activation,scaffolding function,adapter protein interactions,tumor progression,signal transduction
ENSG00000169567,HINT1,tumor suppressor,apoptosis regulation,dna repair mechanism,cell proliferation inhibition,metastasis suppression,therapeutic target
ENSG00000166483,WEE1,dna damage response,cell cycle regulation,genomic stability maintenance,cancer stem cell maintenance,chemosensitivity modulation,protein kinase activation
ENSG00000151846,PABPC3,mrna processing,regulatory function,tumor progression,cell proliferation,protein-protein interaction,genomic instability
ENSG00000102010,BMX,non-receptor tyrosine kinase,constitutive activation,cell proliferation,oncogenic transformation,signaling pathway regulation,therapeutic target
ENSG00000159176,CSRP1,cytoskeletal regulation,oncogene activation,cell migration promotion,apoptosis evasion,cell proliferation enhancement,rho gtpase interaction
ENSG00000125691,RPL23,ribosome biogenesis,cell proliferation,enhanced translation,aberrant protein synthesis,cancer driver gene,protein overexpression
ENSG00000236014,VPS52,vps52 expression,tumor progression,protein trafficking,cellular homeostasis,breast cancer,chromosome 2p13.1
ENSG00000127837,AAMP,genomic instability,homologous recombination repair,dna damage response,apoptosis regulation,microtubule dynamics regulation,tumor progression biomarker
ENSG00000127483,HP1BP3,chromatin remodeling,heterochromatin formation,genomic instability,transcriptional repression,cell cycle regulation,dna repair
ENSG00000072210,ALDH3A2,differential expression,tumor suppressor activity,cell proliferation enhancement,migration and invasion capability,lipid metabolism regulation,oxidative stress response
ENSG00000196218,RYR1,calcium channel regulation,cell proliferation enhancement,oncogenic signaling,poor prognosis marker,calcium signaling pathway,cancer progression promotion
ENSG00000130402,ACTN4,cytoskeletal remodeling,cell adhesion regulation,oncogenic transformation,tumor metastasis,therapeutic target,genomic instability
ENSG00000162191,UBXN1,deubiquitination,apoptosis regulation,tumor suppressor interaction,cell cycle progression,protein-protein interaction modulation,therapeutic target
ENSG00000122359,ANXA11,cellular signaling pathway modification,oncogenic driver,overexpressed protein,tumor progression facilitation,metastasis promotion,chemotherapy resistance enhancement
ENSG00000138180,CEP55,midbody ring component,genomic instability,aneuploidy induction,mitotic checkpoint regulation,cell cycle progression,prognostic marker
ENSG00000102081,FMR1,fragile x syndrome,mental retardation protein,mrna regulation,neurodevelopmental disorder,cgg repeat expansion,autism spectrum disorder
ENSG00000128228,SDF2L1,sphingosine-1-phosphate regulation,pi3k/akt pathway interaction,cell proliferation enhancement,tumor progression facilitation,wnt/β-catenin pathway modulation,genomic instability contribution
ENSG00000114841,DNAH1,cilia dysfunction,cell cycle regulation,apoptosis modulation,intraflagellar transport,mitotic spindle organization,proliferation control
ENSG00000143851,PTPN7,loss of function mutations,tumor suppressor activity,dephosphorylation activity,oncogenic signaling pathway regulation,cell cycle regulation,apoptosis regulation
ENSG00000173889,PHC3,epigenetic regulation,histone modification,chromatin remodeling,tumor suppressor function,oncogene potential,histone h3 lysine 4 trimethylation (h3k4me3)
ENSG00000139211,AMIGO2,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),metastatic progression,angiogenesis promotion,upstream regulation of snail1,cell migration facilitation
ENSG00000141837,CACNA1A,neuronal calcium channel regulation,voltage-gated calcium channel function,cell migration and invasion,apoptosis modulation,angiogenesis regulation,immune response modification
ENSG00000182774,RPS17,ribosome biogenesis,cell proliferation,gain of function mutations,oncogenic pathway,translation regulation,protein synthesis
ENSG00000177663,IL17RA,inflammatory response,angiogenesis,immune evasion,cell proliferation,apoptosis suppression,signaling pathway regulation
ENSG00000082516,GEMIN5,tumor suppression,mutation/loss of function,impaired rna processing,aberrant cell growth,disrupted cell cycle regulation,dna damage response
ENSG00000078114,NEBL,genomic instability,aneuploidy,tumorigenesis,dna repair,cell division,microtubule dynamics
ENSG00000183386,FHL3,cell signaling,transcription regulation,oncogenic processes,cancer driver gene,protein-protein interactions,cell proliferation
ENSG00000125977,EIF2S2,translational regulation,cancer-associated mutations,cell survival,protein synthesis modulation,stress response adaptation,growth factor independence
ENSG00000002834,LASP1,tumor progression,multifunctional protein,cancer biomarker,actin cytoskeleton regulation,oncogenic processes,cell migration and invasion
ENSG00000136861,CDK5RAP2,mitotic regulation,oncogene activation,chromosomal instability,cell cycle control,microtubule dynamics,centrosome function
ENSG00000116641,DOCK7,rho gtpase regulation,constitutive activation,tumor progression,metastasis promotion,cell migration enhancement,oncogenic processes disruption
ENSG00000128609,NDUFA5,mitochondrial respiratory chain,impaired oxidative phosphorylation,glycolytic shift,tumor progression,energy metabolism,cancer driver gene
ENSG00000284983,DEFA1,antimicrobial activity,apoptosis induction,immune system modulation,cell membrane disruption,anticancer properties,innate immunity regulation
ENSG00000285176,DEFA1B,tumor suppressor function,antimicrobial activity,cell cycle regulation,apoptosis induction,angiogenesis inhibition,biomarker potential
ENSG00000132356,PRKAA1,metabolic regulation,energy stress response,tumor suppression,cellular proliferation,apoptosis regulation,genetic instability
ENSG00000155561,NUP205,nuclear pore function,genomic instability,cell cycle regulation,transcriptional regulation,protein-rna transport,cancer susceptibility
ENSG00000204308,RNF5,ubiquitination,protein degradation,oncogene stabilization,nf-κb pathway regulation,cancer progression,poor prognosis
ENSG00000164307,ERAP1,antigen processing,impaired immune response,tumor progression,overexpression,immune evasion,serine protease activity
ENSG00000147274,RBMX,rna binding regulation,oncogenic properties,cell cycle progression,genomic stability maintenance,transcriptional regulation interaction,tumor development influence
ENSG00000240505,TNFRSF13B,nf-κb pathway activation,tumor promotion,immune evasion,cell proliferation regulation,angiogenesis facilitation,pro-inflammatory signaling
ENSG00000121068,TBX2,oncogenic transcription factor,tumor progression,cell cycle regulation,gene silencing,proliferation enhancement,tissue patterning alteration
ENSG00000168438,CDC40,mitotic checkpoint regulation,tumor progression,cytokinesis regulation,chromosomal instability,cell cycle control,spindle assembly
ENSG00000175467,SART1,alternative splicing,rna helicase activity,pre-mrna processing,splicing factor regulation,cancer biology implication,genetic variation impact
ENSG00000132153,DHX30,rna-dna helicase activity,genomic stability,dna repair deficiency,tumor suppressor function,microsatellite instability,cellular metabolism regulation
ENSG00000182287,AP1S2,tumor progression,cell proliferation,cargo transport regulation,oncogenic signaling,metastasis facilitation,microenvironment interaction
ENSG00000030066,NUP160,nuclear pore complexes,chromatin remodeling,genomic instability,cell cycle progression,dna repair,oncogenic transcription
ENSG00000124831,LRRFIP1,protein regulation,tumor suppressor/tumor promoter,cell survival/proliferation modulation,mapk/erk pathway interaction,leucine-rich repeat domain,rna binding protein
ENSG00000080603,SRCAP,chromatin remodeling,cancer driver,histone modification,cell cycle progression,gene expression modulation,protein-protein interaction
ENSG00000145247,OCIAD2,pi3k/akt/mtor pathway regulation,oncogene upregulation,protein degradation regulation,tumor progression promotion,apoptosis evasion,biomarker potential
ENSG00000165259,HDX,histone modification,chromatin remodeling,tumor suppression inhibition,oncogenic potential,cellular response modulation,protein-protein interaction
ENSG00000100726,TELO2,telomere maintenance,oncogenic protein interaction,dna repair stimulation,cell proliferation enhancement,genomic instability association,tumor suppressor function disruption
ENSG00000100345,MYH9,cellular adhesion defects,chromosomal instability,cytoskeleton maintenance,impaired mitosis,oncogenic mutations,tumor aggressiveness
ENSG00000167578,RAB4B,endocytic recycling,cell signaling pathway,oncogenic process,tumor progression,protein expression regulation,cancer cell survival
ENSG00000186832,KRT16,intermediate filament assembly,tumor progression,cell proliferation,altered cellular behavior,aberrant expression,cancer cell heterogeneity
ENSG00000168961,LGALS9,tumor progression,metastasis promotion,angiogenesis regulation,biomarker potential,immune modulation,prognostic value
ENSG00000055955,ITIH4,metastasis promotion,angiogenesis regulation,tumor progression,protease inhibition,cell adhesion modulation,immune evasion
ENSG00000122565,CBX3,genomic instability,epigenetic silencing,histone modifications,transcriptional repression,oncogenesis,chromatin remodeling
ENSG00000135443,KRT85,intermediate filaments,cancer-related mutations,epithelial integrity,cell polarity disruption,oncogenic potential,signaling pathway modulation
ENSG00000285152,RNF31,protein degradation regulation,ubiquitin-mediated proteasomal degradation,oncogenic protein stability,tumor suppressor regulation,cell cycle progression control,therapeutic target potential
ENSG00000173915,ATP5MD,mitochondrial dysfunction,tumor energy metabolism,epigenetic alterations,genomic instability,energy-intensive processes,dysregulation of atp production
ENSG00000278161,TFPT,amplification,cell proliferation,immune evasion,oncogenesis,tumor progression,transcriptional regulation 
ENSG00000185883,ATP6V0C,altered expression,proton transport regulation,tumor progression,therapeutic target,lysosomal acidification,dysregulation
ENSG00000197771,MCMBP,microtubule-based transport,oncogene activation,overexpression mutations,cell migration regulation,therapeutic target,signaling pathway modulation
ENSG00000145041,DCAF1,dna damage response,tumor suppression,genomic stability,cell cycle regulation,ubiquitination pathway,protein degradation
ENSG00000284881,DEFB1,microbial defense,epithelial barrier function,immune system modulation,antimicrobial peptide,innate immunity activation,cellular stress response
ENSG00000137673,MMP7,tumor invasion,extracellular matrix degradation,angiogenesis promotion,cell migration enhancement,cancer progression facilitation,biomarker for cancer diagnosis
ENSG00000152240,HAUS1,centrosome regulation,genomic instability,cilia dysfunction,cell cycle disruption,tumor progression,oncogenic mutation
ENSG00000173674,EIF1AX,protein synthesis regulation,cell growth promotion,oncogenic protein production,global translation alterations,therapeutic target candidate,stress response modulation
ENSG00000108528,SLC25A11,metabolic reprogramming,cellular proliferation,mitochondrial function,glycolytic shift,apoptosis regulation,cell signaling pathway
ENSG00000206075,SERPINB5,apoptosis regulation,tumor suppressor function,cell survival promotion,metastasis association,therapeutic target,protease inhibitor activity
ENSG00000241837,ATP5PO,mitochondrial function,energy homeostasis,glycolytic shift,tumor growth,cell survival,protein interaction
ENSG00000114107,CEP70,microtubule regulation,centrosome integrity,mitotic progression,tumor suppression loss,cell division dysregulation,cancer cell migration
ENSG00000186660,ZFP91,transcriptional regulation,cell differentiation,apoptosis modulation,dna repair,oncogenic interaction,tumorigenesis regulator
ENSG00000108883,EFTUD2,spliceosome regulation,dysregulated splicing,antisense transcription,gene expression regulation,genomic instability,chromosomal abnormalities
ENSG00000137497,NUMA1,centrosomal protein,microtubule regulation,chromosome stability,aneuploidy prevention,genomic instability,mitotic spindle assembly
ENSG00000115875,SRSF7,alternative splicing,cellular machinery disruption,genome instability,oncogenic processes,pre-mrna splicing,splice site recognition
ENSG00000123268,ATF1,overexpression,oncogene activation,transcriptional regulation,cell survival promotion,tumor growth enhancement,metastasis facilitation
ENSG00000100280,AP1B1,receptor trafficking,oncogenesis,cell surface receptors,vesicle biogenesis,protein-protein interactions,cellular signaling pathways
ENSG00000198431,TXNRD1,tumor suppressor,oxidative stress regulation,cell proliferation regulation,oncogenic signaling pathway interaction,redox homeostasis maintenance,genomic instability promotion
ENSG00000023330,ALAS1,heme synthesis,metabolic regulation,cell proliferation,glycolysis enhancement,oncogenic properties,dna damage
ENSG00000104611,SH2D4A,tumor suppressor function,aberrant t-cell activation,gene mutations/deletions,immune homeostasis disruption,cell proliferation enhancement,survival pathway modulation
ENSG00000170677,SOCS6,stat3 pathway inhibition,tumor suppressor activity,cytokine signaling regulation,cell proliferation inhibition,metastasis suppression,protein-protein interaction modulation
ENSG00000133112,TPT1,tumor promotion,protein regulation,molecular chaperone function,cellular adaptation,therapeutic target,genomic instability
ENSG00000067225,PKM,glycolytic pathway,warburg effect,glycolysis regulation,oncogenic adaptation,metabolic reprogramming,cell survival signaling
,HIST1H2AE,histone regulation,chromatin packaging,gene expression modulation,epigenetic modification,transcriptional regulation,genomic stability maintenance
,HIST1H2AB,histone regulation,epigenetic modification,transcriptional control,cell cycle progression,chromatin remodeling,genomic instability
ENSG00000196136,SERPINA3,protease regulation,tumor growth,transcriptional regulator,cell survival,metastasis,tumor invasion
ENSG00000158859,ADAMTS4,matrix degradation,cell migration,extracellular matrix remodeling,proteoglycan loss,tumor progression,metastasis promotion
ENSG00000112559,MDFI,metal-responsive transcription factor,genomic instability,therapy resistance,oxidative stress response,antioxidant defense,detoxification regulation
ENSG00000126778,SIX1,transcription factor regulation,tumor progression,epithelial-to-mesenchymal transition,oncogene activation,cancer stem cell maintenance,chromatin remodeling
ENSG00000104408,EIF3E,regulation of oncogenes,aberrant protein synthesis,tumor progression,cell proliferation,mrna translation,translation initiation complex
ENSG00000185745,IFIT1,tumor suppressor function,pi3k/akt pathway modulation,interferon-induced protein,cell proliferation regulation,antiviral activity,apoptosis induction
ENSG00000057149,SERPINB3,anti-apoptotic function,tumor growth promotion,protease inhibition,cell survival regulation,metastasis enhancement,therapeutic target
ENSG00000174123,TLR10,tumor microenvironment modulation,immune receptor function,innate immune response activation,chronic inflammation induction,cancer cell behavior influence,potential therapeutic target
ENSG00000124875,CXCL6,tumor-promoting chemokine,immune cell recruitment,oncogenic properties,angiogenesis regulation,cell migration promotion,pro-inflammatory signaling
ENSG00000144674,GOLGA4,protein modification,cellular signaling pathway,tumor suppressor loss,oncogene amplification,golgi apparatus disruption,cell proliferation regulation
ENSG00000254772,EEF1G,protein synthesis regulation,translation initiation complex,cellular growth promotion,aberrant protein expression,cell cycle progression,genomic instability
ENSG00000109061,MYH1,constitutive activation,oncogene overexpression,metastasis promotion,apoptosis resistance,cell proliferation,rho gtpase activation
ENSG00000163902,RPN1,dna repair defects,genomic instability,cell cycle dysregulation,oncoprotein accumulation,protein quality control impairment,tumor suppressor interaction
ENSG00000110497,AMBRA1,tumor suppressor,autophagy regulation,apoptosis induction,genomic stability maintenance,mitochondrial quality control,cancer cell inhibition
ENSG00000163739,CXCL1,oncogene,tumor promotion,immune cell recruitment,metastasis facilitation,pro-inflammatory signaling,microenvironment manipulation
ENSG00000162896,PIGR,epithelial cell surface,transmembrane protein,immunoglobulin transport,tumor microenvironment modulation,growth factor regulation,cancer progression
ENSG00000158856,DMTN,genomic methylation regulation,epigenetic maintenance,cellular transformation,methylation aberrance,imprinting loss,tumor suppressor activation
ENSG00000029363,BCLAF1,cell cycle regulation,apoptosis modulation,transcriptional regulation,genome stability,tumor suppression,protein-protein interaction
ENSG00000143621,ILF2,tumor microenvironment alteration,inflammation-mediated tumorigenesis,immune cell activation,cancer-promoting cytokine,epigenetic regulation,transcriptional regulation
ENSG00000125970,RALY,alternative splicing,oncogenic protein production,aberrant rna-binding,tumor suppressor loss,cell proliferation enhancement,metastasis promotion
ENSG00000117036,ETV3,oncogene,transcriptional regulation,cellular proliferation,tumor progression,angiogenesis,immune evasion
ENSG00000198890,PRMT6,histone modification,epigenetic regulation,tumor suppressor activity,dna repair mechanism,cell cycle regulation,protein-protein interaction
ENSG00000135363,LMO2,transcriptional regulation,leukemogenesis,cell cycle progression,apoptosis suppression,t-cell development,oncogenic potential
ENSG00000167552,TUBA1A,microtubule stability,cellular architecture,mitotic spindle formation,microtubule dynamics,prediction of drug resistance,aberrant cell proliferation
ENSG00000118515,SGK1,mitochondrial regulation,protein kinase activation,cell survival promotion,oncogenesis,cell migration,apoptosis inhibition
ENSG00000115009,CCL20,tumor microenvironment modification,immune suppression enhancement,cell recruitment facilitation,pro-tumorigenic signaling,cancer progression promotion,cell migration regulation
ENSG00000038427,VCAN,extracellular matrix component,cell adhesion molecule,cell migration facilitation,tumor progression promotion,poor prognosis indicator,metastasis enhancement
ENSG00000185722,ANKFY1,nuclear receptor coactivator,pi3k/akt pathway regulation,oncogenic protein expression,cell proliferation enhancement,tumor suppressor interaction modulation,cancer therapeutic target
ENSG00000175906,ARL4D,cell membrane trafficking,gtpase activity,oncogene activation,tumor progression,pi3k/akt interaction,ras-like gtp-binding protein
ENSG00000168488,ATXN2L,chromatin regulation,dna repair mechanism,genomic instability,cell cycle progression,oncogene activity,transcriptional modulation
ENSG00000168264,IRF2BP2,transcriptional regulation,tumor growth,chromatin modification,cell proliferation,oncogenic processes,genomic instability
ENSG00000087365,SF3B2,pre-mrna splicing,aberrant splicing patterns,tumor growth,oncogenic processes,cellular proliferation,genetic instability
ENSG00000135046,ANXA1,regulatory protein,cell membrane trafficking,pi3k/akt pathway regulation,anti-inflammatory responses,tumor progression promoter,therapeutic target candidate
ENSG00000143761,ARF1,constitutive activation,cell membrane trafficking,ras superfamily member,epidermal growth factor receptor recycling,growth factor signaling,proliferation enhancer
ENSG00000116661,FBXO2,tumor suppressor degradation,oncogenic mutations,poor prognosis,pi3k/akt pathway regulation,emt regulation,ubiquitination and proteasomal degradation
ENSG00000140332,TLE3,tumor suppressor gene regulation,dysregulated expression,oncogenic activity,cell proliferation regulation,metastatic potential,chromatin remodeling
ENSG00000100448,CTSG,pi3k/akt pathway,constitutive activation,cell surface receptor interaction,protein degradation,tumor progression,therapeutic target
ENSG00000276409,CCL14,tumor microenvironment,immune suppression,cell migration,angiogenesis promotion,therapeutic target,gene dysregulation
ENSG00000204065,TCEAL5,cell cycle regulation,dna-binding activity,oncogene function,candidate driver gene,transcriptional regulation,cell proliferation
ENSG00000111641,NOP2,genomic instability,dna repair regulation,tumor progression,cell proliferation enhancement,chemoresistance promotion,oncogenic mutations
ENSG00000108518,PFN1,actin polymerization,cell migration,cytoskeletal dynamics,cancer cell motility,metastasis promotion,tumor progression
ENSG00000127334,DYRK2,oncogenic,pi3k/akt pathway regulation,cell proliferation enhancement,apoptosis inhibition,angiogenesis promotion,tumor progression
ENSG00000153048,CARHSP1,calcium signaling pathway,t-cell proliferation,immune response regulation,cancer cell survival,apoptosis inhibition,proliferation enhancement
ENSG00000153879,CEBPG,emt regulation,transcriptional regulator,cell growth modulation,apoptosis suppression,oncogenic driver,epithelial-to-mesenchymal transition
ENSG00000183421,RIPK4,regulation of apoptosis,necroptosis modulation,inflammation regulation,cell survival promotion,tumorigenesis association,nf-κb signaling interaction
ENSG00000169100,SLC25A6,mitochondrial carrier protein,cellular energy homeostasis,apoptosis regulation,autophagy modulation,oncogenic potential,mitochondrial dysfunction
ENSG00000080561,MID2,microtubule regulation,cell division disruption,tumor maintenance,oncogenic transformation,therapeutic target,cancer progression
ENSG00000167768,KRT1,epithelial integrity maintenance,oncogenic potential,cell growth regulation,cytoarchitectural disruption,emt induction,tumor progression enhancement
ENSG00000111786,SRSF9,spliceosome component,mutations in cancer,aberrant splicing patterns,dna repair disruption,cancer driver gene,transcriptional control
ENSG00000103710,RASL12,ras signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,gtpase activity
ENSG00000179409,GEMIN4,rna processing,snrna biogenesis,tumor suppression,protein interaction,multiple gene expression,rnp assembly
ENSG00000164056,SPRY1,ras/mapk pathway inhibition,tumor suppressor function,cell proliferation regulation,epithelial-to-mesenchymal transition (emt),metastasis regulation,growth factor receptor interaction
ENSG00000164754,RAD21,chromatin organization,cohesin complex component,dna repair regulation,genomic instability driver,transcriptional regulation mediator,tumor suppressor function
ENSG00000083290,ULK2,autophagy regulation,post-translational modification,cellular survival,tumor suppressor function,oncogenic potential,cancer cell metabolism
ENSG00000175224,ATG13,autophagy regulation,gain of function mutations,tumor suppressor,cellular homeostasis,therapeutic target,resistance to treatment
ENSG00000180549,FUT7,cell adhesion,immune modulation,tumor progression,metastasis promotion,oncogenic potential,cell proliferation enhancement
ENSG00000284832,POLR2A,rna polymerase activity,transcriptional regulation,oncogenic pathway activation,chromatin modification,protein-protein interaction,epigenetic regulation
ENSG00000113719,ERGIC1,cellular trafficking,oncogenic potential,cell proliferation,protein maturation,metastasis promotion,secretion regulation
ENSG00000153157,SYCP2L,mitotic regulation,chromosome stability,tumor suppression,cell cycle control,dna repair mechanism,genomic integrity maintenance
ENSG00000167996,FTH1,iron sequestration,hypoxia response modulation,cellular iron regulation,tumor progression,ferritin overexpression,protein kinase activation
ENSG00000063244,U2AF2,splice site recognition,dysregulated expression,splicing factor complex,pre-mrna processing,oncogenic splicing,gene regulation alteration
ENSG00000008128,CDK11A,cancer driver gene,genomic instability,cell cycle dysregulation,oncogene activation,cell proliferation enhancement,apoptosis suppression
ENSG00000163660,CCNL1,cell cycle regulation,oncogene activation,genomic instability,cell proliferation enhancement,pi3k/akt pathway interaction,tumor aggressiveness
ENSG00000122779,TRIM24,transcriptional regulation,chromatin remodeling,oncogenic coactivator,histone modification,cancer cell proliferation,aggressive tumor behavior
ENSG00000183048,SLC25A10,mitochondrial transport,cell metabolism regulation,glycolysis promotion,oncogenic process driver,therapeutic target,prognostic marker
ENSG00000011451,WIZ,cell cycle regulation,transcriptional control,e3 ubiquitin ligase activity,wd40 repeat protein family,cellular process regulation,tumorigenesis contribution
ENSG00000280962,DUSP16,dephosphorylation,downregulated expression,genomic instability,mapk signaling pathway,oncogenic processes,tumor suppression
ENSG00000132780,NASP,nucleosome assembly,chromatin remodeling,oncogenic potential,gain-of-function mutations,cell proliferation,transcriptional regulation
ENSG00000100065,CARD10,apoptosis regulation,tumor suppression,nf-κb inhibition,oncogenic potential,protein-protein interactions,cell survival pathways
ENSG00000113141,IK,nf-κb signaling,cell proliferation,oncogenesis,immune response regulation,chromatin modification,phosphorylation
ENSG00000130119,GNL3L,tumor suppressor potential,cell cycle regulation,genomic stability maintenance,microtubule dynamics modulation,gene expression regulation,oncogene or tumor suppressor
ENSG00000143632,ACTA1,cellular disruption,tumor progression,metastasis,cancer stem cell maintenance,apoptosis suppression,therapeutic target
ENSG00000075618,FSCN1,actin cytoskeleton reorganization,cell migration promotion,focal adhesion stability enhancement,metastasis facilitation,prognostic marker overexpression,cancer cell motility increase
ENSG00000185359,HGS,hgf-mediated signaling,cell migration and invasion,oncogenic driver,tumor metastasis,therapeutic target,focal adhesions disruption
ENSG00000204673,AKT1S1,akt/pkb signaling pathway,pro-survival pathways,genomic instability,cell growth regulation,oncogenesis promotion,metabolic regulation
ENSG00000198682,PAPSS2,glycosaminoglycan biosynthesis,paps synthesis pathway,tumor progression enhancement,metastasis promotion,therapeutic target,cell surface modification
ENSG00000196730,DAPK1,tumor suppressor,apoptosis induction,cell cycle regulation,protein kinase activity,membrane trafficking,mapk/erk pathway interaction
ENSG00000125775,SDCBP2,cell migration,tumor progression,epithelial-to-mesenchymal transition (emt),signaling pathway regulation,gene amplification,prognostic marker
ENSG00000012223,LTF,angiogenesis,antimicrobial activity,epithelial-to-mesenchymal transition (emt),iron metabolism regulation,macrophage polarization,multifunctional protein
ENSG00000088986,DYNLL1,microtubule-based transport,chromosomal instability,aneuploidy,genomic alterations,cyclin-dependent kinase regulation,spindle assembly
ENSG00000105357,MYH14,amplification,cancer progression,cell migration,cytoplasmic localization,invasive potential,metastasis driver
ENSG00000184922,FMNL1,pan-cancer association,oncogenic cell migration,constitutive activation,aberrant expression,prognostic marker,therapeutic target
ENSG00000174516,PELI3,pi3k/akt signaling,oncogenic protein interaction,e3 ubiquitin ligase activity,cell proliferation regulation,tumor progression,immune evasion mechanism
ENSG00000125845,BMP2,bone morphogenetic protein activation,tgf-β signaling pathway,cell differentiation,osteogenic gene expression,tumor growth promotion,metastasis enhancement
ENSG00000132357,CARD6,proteasome regulation,immune modulation,tumor suppressor function,amplification in cancers,antigen presentation regulation,oncogenic potential
ENSG00000134970,TMED7,erad regulation,enhanced cell proliferation,impaired protein homeostasis,oncogenic transformation,protein trafficking regulation,upr activation
ENSG00000102076,OPN1LW,visual transduction,g-protein coupled receptor,cell growth regulation,tumor progression,therapeutic target,signaling pathway modulation
ENSG00000126351,THRA,thyroid hormone signaling,cell proliferation,gene regulation,nuclear receptor activity,oncogene activation,epigenetic alterations
ENSG00000129654,FOXJ1,transcription factor regulation,constitutive activation,chromatin remodeling,oncogene upregulation,cell proliferation enhancement,tumor suppressor downregulation
ENSG00000277594,DDX52,p53 modulation,mrna processing,tumor progression,cellular homeostasis,translation initiation,dna repair
ENSG00000132676,DAP3,mitochondrial metabolism,apoptosis regulation,tumor aggressiveness,oncogenic process,poor prognosis,energy production enhancement
ENSG00000158560,DYNC1I1,genomic instability,chromosome segregation,mitotic spindle formation,cell migration regulation,protein interaction modulation,oncogenic activity enhancement
ENSG00000083750,RRAGB,aberrant activation,cellular metabolism,mtorc1 signaling,autophagy regulation,tumor progression,oncogenic transformation
ENSG00000025039,RRAGD,regulation of rab gtpases,dysregulation of cellular pathways,tumor progression,cellular metabolism modulation,protein-protein interaction,oncogenic potential
ENSG00000137601,NEK1,chromosomal instability,centrosome amplification,mitotic spindle formation,kinase activity increase,cell proliferation enhancement,cancer driver gene status
ENSG00000118058,KMT2A,histone methylation,akt pathway activation,chromatin remodeling,tumor suppressor gene mutation,dna damage response,epigenetic regulation
ENSG00000133895,MEN1,tumor suppressor function,loss of function mutations,cell proliferation regulation,genetic instability,regulatory protein interaction,transcriptional control
ENSG00000150687,PRSS23,type i transmembrane serine protease,cell proliferation regulation,tumor progression,protein processing degradation,cell migration modulation,therapeutic target
ENSG00000108679,LGALS3BP,cell adhesion,tumor progression,metastasis promotion,immune response modulation,epithelial-to-mesenchymal transition regulation,oncogene interaction
ENSG00000174807,CD248,angiogenic regulation,tumor stroma interaction,vascular endothelial growth factor signaling,lymphangiogenesis facilitation,metastatic potential increase,therapeutic target for cancer
ENSG00000129521,EGLN3,hypoxia response,tumor suppressor function,prolyl hydroxylation,oncogenic pathway activation,angiogenesis regulation,cell proliferation inhibition
ENSG00000171314,PGAM1,glycolysis,warburg effect,tumor growth,cell metabolism,aerobic glycolysis,metabolic reprogramming
ENSG00000002587,HS3ST1,heparan sulfate biosynthesis,oncogenic properties,cell surface modification,tumor growth regulation,signaling molecule interaction,glycosaminoglycan modification
ENSG00000128340,RAC2,cell migration regulation,constitutive activation,gtpase activity regulation,rho gtpase interaction,tumor progression enhancement,therapeutic target identification
ENSG00000136848,DAB2IP,cellular adhesion,pi3k/akt pathway regulation,tumor suppressor function,protein-protein interactions,rho gtpase family modulation,cell migration regulation
ENSG00000198791,CNOT7,ccr4-not complex,rna degradation,transcription regulation,nonsense-mediated decay,apoptosis inhibition,tumor suppression
ENSG00000132938,MTUS2,tumor suppressor function,microtubule regulation,centrosome organization,mitotic spindle control,cell cycle regulation,oncogenic potential
ENSG00000172005,MAL,cadherin-mediated interactions,epithelial-to-mesenchymal transition,cell adhesion regulation,tumor progression facilitation,glycoprotein function,transmembrane protein localization
ENSG00000089154,GCN1,mtor pathway regulation,autophagy dysregulation,protein synthesis modulation,tumor suppressor function,therapeutic target,genomic instability
ENSG00000173546,CSPG4,tumor progression,overexpression,cell migration,cell adhesion,constitutive activation,therapeutic target
ENSG00000167526,RPL13,oncogenic signaling,tumor progression,cell growth regulation,ribosomal function disruption,protein synthesis dysregulation,biomarker potential
ENSG00000137504,CREBZF,p53 modulation,cell cycle regulation,coactivator function,transcriptional control,tumor suppressor dysregulation,apoptosis disruption
ENSG00000104635,SLC39A14,tumor progression,iron metabolism,reactive oxygen species (ros) signaling,cellular proliferation,prognostic marker,therapeutic target
ENSG00000145425,RPS3A,translation initiation,ribosomal protein regulation,mtor pathway activation,cell proliferation enhancement,genomic instability maintenance,poor prognosis biomarker
ENSG00000120370,GORAB,cell membrane organization,constitutive activation,gain of function mutations,tumor progression,therapeutic target,vesicle transport
ENSG00000124216,SNAI1,epithelial-to-mesenchymal transition,transcription factor activation,metastasis promotion,tumor progression,cell migration enhancement,apoptosis suppression
ENSG00000284161,EEF2K,mtor pathway regulation,protein synthesis regulation,cell proliferation,survival and autophagy regulation,oncogenic mutations,therapeutic target
ENSG00000167658,EEF2,translation regulation,cell proliferation,protein synthesis,cell cycle progression,genomic instability,mutation hotspot
ENSG00000124588,NQO2,cellular defense mechanism,dna repair,cell cycle regulation,apoptosis,oxidative stress,pi3k/akt pathway interaction
ENSG00000136011,STAB2,tumor progression,cell migration,cytoplasmic localization,actin filament stabilization,genomic instability,cancer metastasis
ENSG00000164022,AIMP1,cellular proliferation,oncogenic properties,tumor progression,protein synthesis regulation,cell migration and survival enhancement,genetic material protection
ENSG00000165629,ATP5F1C,mitochondrial energy production,cellular growth promotion,oncogenic driver,energy metabolism regulation,subunit interaction,prognostic marker
ENSG00000134884,ARGLU1,metabolic reprogramming,glutamine metabolism regulation,tumor cell proliferation,amidotransferase activity,cell survival enhancement,chemotherapy resistance
ENSG00000276111,SDCCAG8,genomic instability,mitotic regulation,dna repair pathway,cell cycle control,tumor suppressor function,cohesin complex interaction
ENSG00000065534,MYLK,mlc phosphorylation,actomyosin contractility,tumor progression,motility and invasiveness,cancer metastasis,rho kinase pathway interaction
ENSG00000106049,HIBADH,oncogenic potential,elevated expression levels,cell growth promotion,energy production facilitation,metabolic enzyme interaction,tumor progression promotion
ENSG00000151746,BICD1,microtubule dynamics,cytoskeleton regulation,tumor growth promotion,cell migration regulation,microtubule plus-end tracking complex,cell division modulation
ENSG00000176490,DIRAS1,oncogenic gtpase activity,pi3k/akt pathway activation,tumor progression driver,rhoa interaction,cell proliferation regulation,poor prognosis marker
ENSG00000114942,EEF1B2,translation regulation,oncogenic driver,cell proliferation,tumor growth,protein synthesis,mrna stability
ENSG00000047849,MAP4,microtubule stability,cell cycle progression,cell proliferation,spindle assembly checkpoint,signaling pathway modulation,protein-protein interaction
ENSG00000198612,COPS8,protein degradation pathway alteration,tumor progression,cell cycle regulation,apoptosis evasion,ubiquitin-proteasome pathway interaction,cancer association
ENSG00000239789,MRPS17,mitochondrial function,tumor suppressor activity,energy metabolism regulation,cancer cell proliferation,protein synthesis regulation,mitochondrial ribosome assembly
ENSG00000137806,NDUFAF1,mitochondrial complex i assembly,energy metabolism regulation,tumor suppressor function,mitochondrial dynamics regulation,metabolic reprogramming,oxidative phosphorylation efficiency decline
ENSG00000243414,TICAM2,innate immune response regulator,tumor microenvironment modulation,signaling pathway activation,immunosuppressive adaptation,metabolic reprogramming,gene expression dysregulation
ENSG00000160710,ADAR,alternative splicing,cellular proliferation,mirna regulation,oncogenic signaling,post-transcriptional modification,rna editing
ENSG00000129562,DAD1,genomic stability,tumor suppressor function,dna repair mechanism,cell cycle regulation,apoptosis induction,tumorigenesis driver
ENSG00000160753,RUSC1,tumor suppressor/oncogene,genomic instability,transcriptional regulation,cell growth/survival promotion,chromatin remodeling,dna repair pathway interaction
ENSG00000090376,IRAK3,nf-kappab activation,toll-like receptor signaling,constitutive activation,tumor progression,immune evasion,genomic instability
ENSG00000124444,ZNF576,gene regulation,dna binding activity,zinc finger protein,cell growth regulation,transcriptional regulation,genomic stability
ENSG00000086991,NOX4,oxidative stress,dna damage,genomic instability,cell proliferation,therapeutic target,protein interaction
ENSG00000114739,ACVR2B,cell growth regulation,tgf-β signaling pathway,epithelial-to-mesenchymal transition (emt),cell migration,oncogene activation,tumor progression
ENSG00000198836,OPA1,mitochondrial dynamics,tumor development,cell proliferation,energy metabolism regulation,cancer biology involvement,oncogenic transformation
ENSG00000180879,SSR4,gpcr regulation,tumor progression,cell proliferation,dysregulation,aberrant activation,signaling output
ENSG00000153944,MSI2,cellular proliferation,regulatory element disruption,translational control,rna stability regulation,tumor progression,oncogenic driver
ENSG00000100266,PACSIN2,cell migration,cytoskeleton reorganization,metastasis promotion,autophagy regulation,overexpression in tumors,protein-protein interactions
ENSG00000046651,OFD1,cilia dysfunction,cell proliferation regulation,tumor progression,apoptosis inhibition,genetic disorder association,embryonic development disruption
ENSG00000113140,SPARC,tumor progression,cell migration,extracellular matrix interaction,angiogenesis promotion,poor prognosis marker,therapeutic target
ENSG00000154174,TOMM70,mitochondrial function,mitochondrial biogenesis,energy metabolism,cancer cell growth,proliferation regulation,apoptosis modulation
ENSG00000077264,PAK3,oncogene activation,cancer cell proliferation,gtpase-activated signaling,cell migration promotion,prognostic marker,therapeutic target
ENSG00000142731,PLK4,centriole duplication,aneuploidy,chromosomal instability,cell cycle regulation,genomic stability,mitotic checkpoint
ENSG00000147403,RPL10,ribosome biogenesis,constitutive activation,gain of function mutations,tumor progression,therapeutic target,oncogenic driver
ENSG00000054118,THRAP3,chromatin regulation,transcriptional modulation,cell proliferation enhancement,apoptosis inhibition,dna repair suppression,tumor suppressor interaction
ENSG00000182195,LDOC1,wnt pathway regulation,tumor suppressor function,cell proliferation regulation,nuclear localization,genome stability maintenance,oncogenic pathway interaction
ENSG00000128016,ZFP36,tumor suppression,mrna regulation,cell proliferation inhibition,inflammation modulation,cancer initiation prevention,oncogenic pathway regulation
ENSG00000235941,HSPA1A,cellular homeostasis,oncogenic process,tumor progression,protein chaperone function,apoptosis regulation,signaling pathway modulation
ENSG00000121691,CAT,oxidative stress mitigation,redox regulation,tumor promotion,chemotherapy resistance,cancer cell survival,apoptosis inhibition
ENSG00000189091,SF3B3,spliceosome complex,aberrant splicing patterns,rna processing regulation,cellular proliferation,oncogenic activity,tumor suppressor dysfunction
ENSG00000142657,PGD,metabolic reprogramming,oncogene activation,protein-protein interaction,tumor growth promotion,nucleotide synthesis enhancement,oxidative stress reduction
ENSG00000136783,NIPSNAP3A,cellular trafficking regulation,oncogenic mutations,enhanced cell proliferation,vesicle fusion facilitation,neurotransmitter release modulation,snare complex interaction
ENSG00000262993,KRT31,cellular adhesion disruption,epithelial cell integrity loss,cancer diagnosis marker,tumor progression influence,keratin expression alteration,intermediate filament role
ENSG00000004700,RECQL,genomic instability,homologous recombination,oncogenic potential,dna replication,mutations driving tumorigenesis,replication fork stability
ENSG00000180198,RCC1,genomic instability,cell cycle dysregulation,chromatin remodeling,cyclin-dependent kinase activation,dna replication initiation,oncogenic mutations
ENSG00000175602,CCDC85B,g-protein signaling,cell growth regulation,multifaceted function,cell cycle progression,g-protein coupled receptor signaling,tumor progression
ENSG00000176896,TCEANC,tumor immune evasion,apoptosis suppression,cell signaling pathway modulation,immune response regulation,oncogenesis promotion,tumor cell survival enhancement
ENSG00000117020,AKT3,mtor signaling,constitutive activation,phosphorylation of targets,oncogenic pathway involvement,cell survival enhancement,serine/threonine kinase activity
ENSG00000091436,MAP3K20,p38 mapk signaling,apoptosis suppression,emt promotion,cell proliferation enhancement,stress response pathway activation,oncogene overexpression
ENSG00000115109,EPB41L5,oncogene activation,tumor progression,metastasis facilitation,cell migration regulation,signaling pathway modulation,transmembrane receptor function
ENSG00000165138,ANKS6,chromosomal instability,mitotic spindle regulation,cellular proliferation,oncogenic activation,centrosome function,ankyrin repeat-containing protein family
ENSG00000113448,PDE4D,camp degradation,oncogene regulation,tumor progression modulation,inflammation regulation,cell growth modulation,second messenger regulation
ENSG00000143190,POU2F1,pou domain transcription factor,transcriptional regulation,wnt/β-catenin pathway modulation,cell proliferation enhancement,chromatin remodeling,oncogenic transformation
ENSG00000169871,TRIM56,nf-κb signaling pathway,tumor suppression,oncogenesis regulation,ubiquitin ligase activity,cell proliferation regulation,anti-tumorigenic properties
ENSG00000136826,KLF4,transcription factor regulation,epithelial-to-mesenchymal transition (emt),oncogenic potential,cell differentiation suppression,tumor progression facilitation,metastasis enhancement
ENSG00000167601,AXL,tumor progression,phosphorylation activation,receptor tyrosine kinase activity,pi3k/akt pathway interaction,oncogenic signaling,therapeutic target
ENSG00000149948,HMGA2,oncogenic activity,transcriptional regulator,cell proliferation,tumor progression,apoptosis inhibition,epigenetic regulation
ENSG00000132842,AP3B1,ap-3 complex regulation,oncogenic function,protein sorting and trafficking,tumor progression,cell growth and survival regulation,gene expression regulation
ENSG00000099804,CDC34,ubiquitination pathway,cell cycle regulation,proteasome dysfunction,oncogenic driver,cell proliferation enhancer,protein degradation disruptor
ENSG00000108055,SMC3,chromosomal instability,genome integrity maintenance,dna repair regulation,tumor progression facilitation,co-hesin complex interaction,breast cancer susceptibility gene
ENSG00000173894,CBX2,histone modification,chromatin compaction,tumor suppressor function,apoptosis evasion,metastasis suppression,gene silencing
ENSG00000174175,SELP,increased tumor aggressiveness,cell adhesion facilitation,altered cell behavior,adhesive properties modulation,tumor progression enhancement,therapeutic target
ENSG00000090487,SPG21,genomic instability,splicing regulation,cell cycle progression,aberrant splice variants,oncogenic properties,cellular stress response
ENSG00000254726,MEX3A,tumor suppression,rna regulation,mrna binding,cell proliferation inhibition,oncogenic mrna repression,cancer dysregulation
ENSG00000112511,PHF1,genetic instability,chromatin remodeling,histone modification recognition,tumor suppressor function,dna damage response,epigenetic regulation
ENSG00000135999,EPC2,epithelial-to-mesenchymal transition,cell-cell interaction,tumor progression,metastasis,adhesion molecule function,migratory capacity
ENSG00000167088,SNRPD1,spliceosome regulation,rna processing alteration,cellular proliferation enhancement,tumor suppressor gene dysregulation,alternative splicing modulation,gene expression alteration
ENSG00000120215,MLANA,cellular stress response,compromised melanin generation,indirect tumorigenesis link,melanosome biogenesis defect,skin pigmentation vulnerability,tumor progression influence
ENSG00000171132,PRKCE,protein kinase activation,cellular differentiation,cell growth regulation,tumor progression,metastasis promotion,immune evasion 
ENSG00000171490,RSL1D1,ribosome biogenesis,oncogenic potential,therapeutic target,prognostic marker,cell proliferation,protein interaction
ENSG00000135631,RAB11FIP5,recycling endosomes regulation,cell growth regulation,tumor progression driver,protein sorting regulation,oncogenic signaling pathway interaction,endocytic trafficking modulation
ENSG00000135930,EIF4E2,cellular proliferation,translation initiation,tumor progression,poor prognosis,therapeutic target,genomic instability
ENSG00000102580,DNAJC3,protein folding regulation,cell cycle progression modulation,therapeutic target,tumor growth promotion,oncogenesis facilitation,chemoresistance development
ENSG00000149532,CPSF7,pre-mrna 3'-end processing,protein-protein interaction,aberrant gene expression,tumor development,transcriptional regulation,mrna stability
ENSG00000149016,TUT1,rna modification,cell growth regulation,oncogenic micrornas regulation,mir-17~92 cluster modulation,interaction with rna-binding proteins,cancer-associated overexpression
ENSG00000134452,FBH1,genomic instability,tumor suppressor function,dna replication regulation,homologous recombination repair,cell survival advantage,therapeutic target candidate
ENSG00000138835,RGS3,g-protein regulation,signaling pathway modulation,cellular homeostasis maintenance,tumor progression involvement,cancer metastasis association,oncogenic process contribution
ENSG00000120690,ELF1,cell cycle regulation,transcriptional regulation,apoptosis inhibition,tumor progression,genomic instability,oncogenic transcription factor
ENSG00000111196,MAGOHB,translation regulation,gene overexpression,cell proliferation,oncogenic processes,metastasis promotion,protein interaction modulation
ENSG00000010803,SCMH1,chromatin remodeling,cohesin complex,epigenetic instability,loss-of-function mutations,transcriptional regulation,chromosomal instability
ENSG00000101126,ADNP,oncogenic driver,wnt/β-catenin signaling,cellular proliferation,transcriptional regulation,genomic instability,protein-protein interaction
ENSG00000164978,NUDT2,genomic instability,tumor progression,promoter hypermethylation,transcriptional regulation,oncogenesis,protein interaction
ENSG00000182712,CMC4,cell proliferation,tumor progression,genomic instability,cancer therapy resistance,macrophage regulation,colony-stimulating factor 1 signaling
ENSG00000033030,ZCCHC8,zinc finger protein interaction,regulation of gene expression,mrna processing and export,oncogene activation,cell signaling pathway modulation,tumor suppressor regulation
ENSG00000127914,AKAP9,tumor suppressor function loss,signaling pathway dysregulation,cell proliferation enhancement,genomic instability promotion,protein kinase modulation,mitotic checkpoint disruption
ENSG00000169900,PYDC1,dual role in cancer,cell migration enhancement,oncogenic processes promotion,tumor suppressor function loss,cell proliferation regulation,protein interaction modulation
ENSG00000166197,NOLC1,nucleolar regulation,oncogenic function,pi3k/akt pathway activation,cell proliferation enhancement,tumor progression,metastasis facilitation
ENSG00000164047,CAMP,aberrant expression,oncogenic process,tumor marker,cell growth regulation,cancer progression,therapeutic target
ENSG00000167965,MLST8,mtor pathway regulation,constitutive activation,oncogenic mutations,tumor progression driver,therapeutic target,genomic amplification
ENSG00000265241,RBM8A,alternative splicing regulation,rna-binding motif protein function,spliceosome interaction,gene expression modulation,cancer biomarker potential,prognostic significance
ENSG00000137161,CNPY3,cellular proliferation,genomic instability,apoptosis suppression,transcriptional regulation,cytoplasmic localization,tumor suppressor function
ENSG00000204099,NEU4,sialidase activity,glycoprotein modification,tumor metastasis,cell signaling regulation,immune evasion mechanisms,cancer aggressiveness
ENSG00000149554,CHEK1,dna damage response pathway,tumor suppressor function,genomic stability maintenance,p53 activation,cell cycle regulation,apoptosis induction
ENSG00000105483,CARD8,pro-inflammatory signaling,caspase activation,apoptosis inhibition,nf-κb pathway regulation,tumor progression,therapeutic target
ENSG00000135100,HNF1A,genetic regulation,transcription factor activity,cellular growth modulation,glucose metabolism alteration,insulin resistance induction,dna binding specificity
ENSG00000109062,SLC9A3R1,pi3k/akt pathway,regulatory protein interaction,tumor progression,therapeutic target,biomarker,apoptosis regulation
ENSG00000103154,NECAB2,cellular regulation,tumor suppressor function,metalloprotease regulation,cell cycle modulation,apoptosis induction,protein interaction
ENSG00000102878,HSF4,constitutive activation,oncogene function,cell survival enhancement,dna repair induction,therapeutic target,heat shock protein regulation
ENSG00000148187,MRRF,mitochondrial ribosome recycling,altered cellular metabolism,cellular translation regulation,cancer cell adaptation,protein synthesis dysregulation,tumor proliferation enhancement
ENSG00000011478,QPCTL,lipid processing,serine hydrolase activity,oncogenic mutations,cellular proliferation,inflammation regulation,bioactive lipid metabolism
ENSG00000213619,NDUFS3,mitochondrial dysfunction,glycolytic shift,rapid cell division,electron transport chain,cellular respiration,atp production impairment
ENSG00000139180,NDUFA9,mitochondrial electron transport chain,energy metabolism disruption,tumor growth promotion,aerobic glycolysis shift,aerobic glycolysis signature,therapeutic resistance
ENSG00000263012,KRT33B,cancer-associated mutations,epithelial cell damage,type i keratin protein,cellular structure integrity,mechanical support,regulatory partner
ENSG00000186432,KPNA4,nuclear transport regulation,cell cycle progression,transcriptional regulation,oncogenic protein interaction,chromatin remodeling,cancer progression marker
ENSG00000163161,ERCC3,genomic instability,dna repair pathway,nucleotide excision repair,transcription regulation,cell cycle progression,genetic mutations
ENSG00000275023,MLLT6,chromatin regulation,oncogenic overexpression,histone modification,cell proliferation,apoptosis inhibition,genomic instability
ENSG00000135018,UBQLN1,cell proliferation,autophagy modulation,protein degradation regulation,tumor progression,overexpression association,metastasis promotion
ENSG00000102034,ELF4,translation regulation,rna binding protein,oncogenic mrnas stabilization,cell growth promotion,apoptosis evasion,protein-protein interactions
ENSG00000101182,PSMA7,proteasomal degradation,cellular proliferation,tumorigenesis modulation,ubiquitin-proteasome interaction,apoptosis suppression,oncogene regulation
ENSG00000079387,SENP1,deubiquitination,cell cycle regulation,oncogene/tumor suppressor,protein stability modulation,cell growth promotion,dna damage response
ENSG00000101871,MID1,genomic instability,cell cycle regulation,protein ubiquitination,oncogenic transformation,tumor growth,metastasis
ENSG00000173581,CCDC106,microtubule dynamics,gene expression regulation,cell proliferation promotion,tumor suppressor function loss,genomic instability induction,cancer cell survival enhancement
ENSG00000146223,RPL7L1,cell proliferation regulation,ribosome biogenesis,oncogene overexpression,apoptosis evasion,prognostic marker,therapeutic target
ENSG00000015171,ZMYND11,chromatin remodeling,epigenetic regulation,oncogenesis,aggressive tumor behavior,therapeutic target,genomic instability
ENSG00000142611,PRDM16,histone h3 lysine 4 methylation,chromatin remodeling,transcriptional regulation,oncogene activation,epithelial-to-mesenchymal transition,cell differentiation
ENSG00000173372,C1QA,complement system,autoimmune disease,immune regulation,tissue damage,inflammation response,proteolytic activation
ENSG00000184009,ACTG1,high-risk allele mutations,cell proliferation,cytoskeletal dynamics regulation,signaling pathway modulation,tumor progression,genetic conservation
,WDYHV1,hypothetical protein,cell signaling,gene regulation,protein-protein interactions,sequence similarity,uncertain role
ENSG00000244405,ETV5,transcriptional regulation,cell proliferation,oncogenic potential,tumor progression,apoptosis evasion,stem cell-like properties
ENSG00000051108,HERPUD1,ubiquitin-proteasome pathway,protein degradation,tumor suppressor,oncogenic properties,cell cycle regulation,apoptosis
ENSG00000157349,DDX19B,mrna export regulation,cellular proliferation,gene expression regulation,aberrant function mutations,tumor progression,transcriptional modulation
ENSG00000143870,PDIA6,protein folding regulation,oncogene activation,cell proliferation enhancement,cancer progression facilitation,chemotherapy resistance contribution,therapeutic target opportunity
ENSG00000135108,FBXO21,regulation of protein degradation,cell cycle regulation,cki targeting,scf complex interaction,ubiquitin-proteasome pathway modulation,cancer cell proliferation
ENSG00000143373,ZNF687,transcriptional regulation,zinc finger domains,dna binding,tumorigenesis,cell proliferation,apoptosis
ENSG00000276146,LILRB2,modulation of immune response,mhc-i binding,oncogenic process,immune evasion,dysregulation,poor prognosis indicator
ENSG00000103942,HOMER2,transcriptional regulation,chromatin remodeling,oncogenic process,tumor progression,signaling pathway modulation,cell growth promotion
ENSG00000149930,TAOK2,genomic instability,cell cycle regulation,anti-apoptotic,dna repair mechanisms,signaling pathway modulation,oncogenic mutations
ENSG00000126775,ATG14,autophagy initiation complex,cellular adaptation,oncogenic regulation,metabolic reprogramming,therapeutic target,cancer cell survival
ENSG00000003756,RBM5,oncogenic mrna splicing,tumor suppressor function,alternative splicing regulation,cell growth regulation,mrna stability,nuclear export inhibition
ENSG00000148450,MSRB2,protein repair,oxidative damage,apoptosis regulation,protein misfolding,cell proliferation,dna repair
ENSG00000274081,PUF60,cell cycle regulation,tumor suppression,rna-binding protein,nucleus localization,translation inhibition,cancer association
ENSG00000236149,ABCF1,genomic instability,oncogene,dna damage repair,homologous recombination repair,telomere length regulation,chromatin remodeling
ENSG00000128564,VGF,overexpression,tumor progression,cell proliferation,survival promotion,poor prognosis marker,secreted protein
ENSG00000205356,TECPR1,autophagy regulation,aberrant gene expression,tumor progression,cell survival enhancement,therapeutic target,genomic instability
ENSG00000157954,WIPI2,regulation of autophagy,phosphorylation-dependent regulation,wd repeat-containing protein family,autophagosome formation,mitochondrial maintenance,oncogenic/tumor suppressive function
ENSG00000196363,WDR5,mll complex,histone modification,epigenetic regulation,tumor suppressor dysfunction,chromatin remodeling,acute myeloid leukemia stem cell maintenance
ENSG00000163464,CXCR1,chemokine receptor,ligand interaction,tumor progression,angiogenesis,cell migration,inflammation
ENSG00000114354,TFG,microtubule dynamics,genomic instability,cell cycle regulation,oncogene/tumor suppressor,pi3k/akt pathway interaction,spindle formation
ENSG00000213316,LTC4S,inflammation,immune evasion,cell proliferation,angiogenesis,metabolic regulation,tumor progression
ENSG00000119487,MAPKAP1,cellular proliferation,transcriptional regulation,oncogene activation,signaling pathway modulation,protein-protein interaction,apoptosis resistance
ENSG00000187678,SPRY4,receptor tyrosine kinase regulation,tumor suppressor activity,cell growth inhibition,oncogenesis prevention,signaling pathway modulation,epigenetic dysregulation
ENSG00000160208,RRP1B,ribonuclease regulation,cell cycle modulation,oncogenic potential,aberrant expression,rna degradation,protein interaction
ENSG00000040341,STAU2,alternative splicing regulation,cellular growth regulation,oncogenic process promotion,gene expression modulation,spliceosome interaction,tumor-promoting mutations
ENSG00000114439,BBX,cellular differentiation,transcriptional regulation,cancer stem cells,oncogene or tumor suppressor,epithelial-to-mesenchymal transition (emt),prognostic marker
ENSG00000181143,MUC16,immune evasion,cell proliferation,oncofetal antigen,tumor progression,glycosylation,oligomerization
ENSG00000100097,LGALS1,tumor progression,immune evasion,angiogenesis promotion,cell adhesion modulation,epithelial-to-mesenchymal transition (emt),poor prognosis biomarker
ENSG00000144331,ZNF385B,tumor suppressor function,loss of heterozygosity,transcriptional regulation,chromatin modification,cell cycle regulation,apoptosis modulation
ENSG00000204843,DCTN1,microtubule regulation,cytoskeletal dynamics,axon degeneration,mitotic checkpoint regulation,tumor progression,genomic instability
ENSG00000108298,RPL19,ribosome assembly,mutations associated with oncogenesis,cell proliferation,metabolic reprogramming,survival pathways activation,genomic instability
ENSG00000179526,SHARPIN,ubiquitin-proteasome pathway regulation,tumor suppressor function,cell cycle progression inhibition,apoptosis regulation,autophagy modulation,nf-κb signaling inhibition
ENSG00000125826,RBCK1,ubiquitination pathway regulation,cell cycle progression modulation,apoptosis evasion,genomic instability,protein degradation regulation,tumor suppressor function suppression
ENSG00000160360,GPSM1,gpcr signaling,protein-protein interactions,tumor progression,cell migration,adhesion molecules,signaling pathway regulation
ENSG00000033122,LRRC7,tumor progression,cell adhesion,dna repair regulation,apoptosis modulation,genomic instability,cell migration
ENSG00000075292,ZNF638,krab domain,transcriptional repressor,cell proliferation regulation,tumor growth promotion,poor prognosis marker,pancreatic cancer association
ENSG00000180318,ALX1,homeobox transcription factor,tumor suppressor regulation,cellular differentiation,oncogenic expression,tissue patterning,genomic instability
ENSG00000117408,IPO13,genomic instability,tumor suppressor function,dna damage response,g2/m checkpoint regulation,cell cycle control disruption,genome integrity maintenance
ENSG00000070961,ATP2B1,calcium transport regulation,intracellular signaling,oncogenic pathway activation,tumor progression,apoptosis evasion,metastasis facilitation
ENSG00000198730,CTR9,transcriptional regulation,oncogenic activation,genomic instability,cell proliferation,therapeutic target,genetic alteration
ENSG00000265681,RPL17,disrupted protein synthesis,increased cell proliferation,tumor progression,ribosomal subunit function,overexpression in cancer,cell survival enhancement
ENSG00000134909,ARHGAP32,rho gtpase regulation,constitutive activation of rhoa,loss-of-function mutations,oncogenic transformation,cell migration and invasion,pi3k/akt signaling pathway modulation
ENSG00000105392,CRX,transcription factor regulation,tumor suppressor activity,cell cycle modulation,dna repair regulation,genomic stability maintenance,proliferation control
ENSG00000108798,ABI3,constitutive activation,oncogenic processes,cell proliferation,tumor growth,transcriptional regulation,apoptosis suppression
ENSG00000117984,CTSD,protein degradation,oncogenic signaling,tumor invasion,metastasis promotion,immune evasion,apoptosis regulation
ENSG00000065548,ZC3H15,tumor suppressor function,rna processing regulation,spliceosome formation,gene expression regulation,protein-protein interactions,cancer prognostic marker
ENSG00000185624,P4HB,disulfide bond formation,chaperone function,mitochondrial association,tumor progression,growth factor regulation,apoptosis resistance
ENSG00000101347,SAMHD1,deoxynucleoside triphosphatase activity,retroviral restriction,dntp pool regulation,oncogenic potential,negative regulator,mutational hotspot
ENSG00000204397,CARD16,oncogene function,immune evasion,tumor progression,cell proliferation,complement regulation,protein-protein interaction
ENSG00000089289,IGBP1,regulates cell growth,modulator of protein activity,interacts with dna repair proteins,implicated in genomic instability,involved in cell cycle regulation,potential target for therapeutic interventions
ENSG00000038382,TRIO,rho gtpase activation,cell migration regulation,gef activity regulation,cytoskeleton organization,oncogenic signaling pathway,pancreatic cancer metastasis
ENSG00000241123,KRTAP10-5,cell proliferation,tumor invasion,metastasis,oncoprotein overexpression,prognostic marker,epithelial cell differentiation
ENSG00000184060,ADAP2,adaptor protein function,actin dynamics regulation,cell migration enhancement,integrin-mediated signaling,oncogenesis promotion,focal adhesion complex formation
ENSG00000135441,BLOC1S1,lysosomal regulation,trafficking regulation,proteolytic dysfunction,autophagy impairment,endocytic pathway interaction,tumor progression driver
ENSG00000099622,CIRBP,apoptosis regulation,cell cycle control,oncogenic signaling,tumor progression,genomic instability,regulatory protein interactions
ENSG00000164548,TRA2A,rna binding,cell cycle regulation,apoptosis regulation,tumor progression,cancer driver gene,oncogenic process
ENSG00000122068,FYTTD1,akt activation,cell growth regulation,cell survival enhancement,fermi domain interaction,metastasis promotion,oncogenic function
ENSG00000014164,ZC3H3,overexpression,cell cycle regulation,chromatin modification,nucleus localization,transcriptional regulation,antitumor response
ENSG00000173120,KDM2A,histone modification regulation,tumor suppressor function,genome instability prevention,cell cycle regulation,epigenetic regulator,oncogenic driver
ENSG00000185129,PURA,oncogenic regulation,rna processing modulation,cellular growth promotion,transcriptional activation,tumor progression driver,gene expression regulation
ENSG00000167196,FBXO22,scf complex regulation,p53 modulation,protein stability control,oncogene activation,cell cycle regulation,tumor initiation
ENSG00000167985,SDHAF2,energy production regulation,mitochondrial dysfunction,oncogenic process promotion,cell survival enhancement,therapeutic target identification,genomic instability driver
ENSG00000139946,PELI2,oncogene,tumor progression,nf-κb signaling,jak/stat pathway,immune evasion,metastasis driver
ENSG00000188846,RPL14,ribosome biogenesis,protein synthesis enhancement,cell growth promotion,oncogenic processes,mtor signaling interaction,cancer genomic alterations
ENSG00000187554,TLR5,immune modulation,nf-κb signaling pathway,inflammation regulation,antitumor immunity,tumor microenvironment,prognostic marker
ENSG00000156398,SFXN2,genetic instability,gain of function mutations,oxidative stress,tumor growth,apoptosis regulation,cell cycle modulation
ENSG00000121390,PSPC1,cell cycle regulation,dna replication,pre-replicative complex,cell proliferation,tumor growth,therapeutic target
ENSG00000152402,GUCY1A2,cgmp signaling,vegf regulation,tumor angiogenesis,cell proliferation,smooth muscle relaxation,platelet activation
ENSG00000181847,TIGIT,immune suppression,tumor immune evasion,adoptive immunity regulation,innate immunity modulation,cell proliferation inhibition,protein kinase activation
ENSG00000164338,UTP15,rnp complex biogenesis,pre-mrna splicing regulation,genomic stability disruption,cellular transformation,gene expression modulation,oncogenic transcript generation
ENSG00000156515,HK1,glycolytic metabolism,warburg effect,promotes cell proliferation,enhances glucose uptake,contributes to oncogenic processes,key player in tumorigenesis
ENSG00000131203,IDO1,immunosuppression,immune evasion,metastasis,cancer growth,tumor microenvironment,antitumor immunity
ENSG00000129474,AJUBA,cell cycle regulation,mitotic checkpoint control,genomic instability,dna repair mechanisms,oncogenic properties,therapeutic target
ENSG00000043093,DCUN1D1,protein degradation,ubiquitination regulation,cell proliferation,tumor progression,oncogenic process,cancer association
ENSG00000172867,KRT2,structural protein integrity,mechanical stress resistance,cell signaling regulation,epithelial cell structure maintenance,genetic mutations impact,tumor suppressor role
ENSG00000147364,FBXO25,genome instability,tumor suppressor function,protein degradation regulation,cancer cell proliferation,apoptosis inhibition,cell cycle progression
ENSG00000135914,HTR2B,constitutive activation,angiogenesis promotion,tumor progression,g protein-coupled receptor function,inflammatory response modulation,cell proliferation enhancement
ENSG00000150753,CCT5,oncogenic function,chaperone activity,cancer cell proliferation,tumor microenvironment regulation,apoptosis inhibition,cell cycle progression
ENSG00000185479,KRT6B,cellular structure maintenance,epithelial cell proliferation,tumor aggressiveness marker,signaling pathway modulation,keratin intermediate filament formation,oncofetal protein expression
ENSG00000158019,BABAM2,cellular regulation,gain of function mutations,dna repair,cell cycle control,oncogenic processes,tumor progression
ENSG00000165660,ABRAXAS2,genomic instability,homologous recombination,brca1-associated protein complex,genomic rearrangement,cancer predisposition,therapeutic target
ENSG00000074590,NUAK1,ampk signaling pathway,cell survival,pro-apoptotic inhibition,energy metabolism regulation,stress response,tumor progression
ENSG00000144848,ATG3,autophagosome formation,oncogenic signaling,cellular homeostasis,tumor progression,metastasis,chemotherapy resistance
ENSG00000141542,RAB40B,endocytic regulation,oncogenic interaction,autophagy dysregulation,cell migration regulation,signaling pathway modulation,metastatic potential enhancement
ENSG00000128591,FLNC,actin cytoskeleton remodeling,constitutive activation,metastatic potential,cell migration and invasion,tumor progression,therapeutic target
ENSG00000158022,TRIM63,overexpression,tumor suppressor loss,cell cycle regulation,apoptosis modulation,signaling pathway regulation,e3 ubiquitin ligase activity
ENSG00000082146,STRADB,c-met signaling inhibition,constitutive activation,tumor suppressor function,cell migration regulation,phosphatase activity modulation,protein-protein interaction
ENSG00000119326,CTNNAL1,wnt/β-catenin signaling,constitutive activation,cell adhesion disruption,oncogenic driver,tumor progression,therapeutic target
ENSG00000166164,BRD7,chromatin remodeling,transcriptional regulation,tumor suppressor function,chromosomal instability,gene expression dysregulation,histone modification
ENSG00000105323,HNRNPUL1,heterogeneous nuclear ribonucleoprotein,aberrant rna processing,tumor progression,gene expression regulation,rna stability modulation,protein-protein interactions
ENSG00000079385,CEACAM1,cell adhesion regulation,cytokine regulation,tumor promotion,immune modulation,apoptosis regulation,molecular interaction
ENSG00000213578,CPLX3,neurotransmitter release regulation,cellular proliferation promotion,overexpression in cancer,tumor metastasis facilitation,snare complex interaction,cellular signaling pathway modulation
ENSG00000006468,ETV1,etv1 regulation,proliferation regulation,emt induction,gene expression modulation,cell differentiation regulation,tumorigenesis driver
ENSG00000157554,ERG,transcriptional regulation,oncogene function,chromosomal translocations,cell cycle regulation,apoptosis evasion,angiogenesis promotion
ENSG00000117595,IRF6,cellular regulation,tumor progression,epithelial-to-mesenchymal transition,aberrant gene expression,apoptosis inhibition,protein-protein interactions
ENSG00000151929,BAG3,apoptosis resistance,cell migration,chaperone function,co-chaperone interaction,metastasis regulation,tumor progression
ENSG00000183785,TUBA8,microtubule dynamics,aberrant mitotic spindles,cell cycle regulation,chromosomal instability,protein degradation pathway,mitotic spindle checkpoint
ENSG00000023287,RB1CC1,tumor suppressor function,e3 ubiquitin ligase activity,cell cycle regulation,apoptosis modulation,protein-protein interaction,cancer therapy target
ENSG00000165527,ARF6,gtpase activation,signaling pathway regulation,cell proliferation enhancement,oncogenic function,cytoskeletal modulation,tumor progression facilitation
ENSG00000138834,MAPK8IP3,apoptosis regulation,cell growth modulation,scaffolding protein function,cell survival promotion,oncogenic processes enhancement,tumor progression facilitation
ENSG00000099783,HNRNPM,pre-mrna splicing,alternative splicing regulation,oncogenic processes promotion,tumorigenesis facilitation,cell growth enhancement,gene expression modulation
ENSG00000109255,NMU,cancer-promoting signaling,tumor progression,metastasis regulation,cell proliferation enhancement,neurotransmitter function,phosphorylation activation
ENSG00000131051,RBM39,genomic instability,oncogenic splicing,cell proliferation,apoptosis regulation,dna repair interaction,metastatic potential
ENSG00000177138,FAM9B,cell signaling pathway,tumor progression regulator,cell migration facilitator,transcriptional co-activator,protein-protein interaction,cancer cell proliferation enhancer
ENSG00000167641,PPP1R14A,cell cycle progression,apoptosis modulation,tumor growth promotion,genomic instability,oncogenic driver,protein phosphatase regulation
ENSG00000172243,CLEC7A,immunomodulation,myeloid cell interaction,tumor microenvironment modulation,pathogen recognition,immune suppression,signaling pathway regulation
ENSG00000162385,MAGOH,mrna regulation,genomic stability,protein expression,cellular homeostasis,tumor suppression,cancer therapy target
ENSG00000100836,PABPN1,rna-binding activity,cell growth regulation,translational control,oncogene activation,prognostic marker,nuclear localization signal
ENSG00000135766,EGLN1,hypoxia response,tumor growth,metastasis promotion,transcriptional regulation,protein degradation,signaling pathway activation
ENSG00000106100,NOD1,chronic inflammation,dual function tumor suppressor/oncogene,immune response activation,nf-κb/mapk signaling pathway,peptidoglycan recognition,pro-inflammatory cytokine production
ENSG00000167553,TUBA1C,microtubule stability,cell proliferation,genomic instability,oncogenic transformation,tumor progression,dysregulated protein kinase activity
ENSG00000129084,PSMA1,ubiquitin-proteasome pathway,protein degradation regulation,tumor suppressor interaction,oncogenic contribution,cell survival promotion,therapeutic target
ENSG00000171703,TCEA2,transcriptional regulation,epithelial-to-mesenchymal transition,cell proliferation enhancement,apoptosis suppression,angiogenesis promotion,wnt/β-catenin pathway interaction
ENSG00000158796,DEDD,dna repair mechanism,genome stability maintenance,cell survival enhancement,proliferation regulation,tumor suppressor function,genetic alterations
ENSG00000160570,DEDD2,rna binding regulation,tumor suppressor modulation,cell proliferation influence,metabolic regulation influence,genetic instability association,cancer progression contribution
ENSG00000091136,LAMB1,basement membrane formation,cell adhesion modulation,cell migration regulation,extracellular matrix interaction,prognostic marker,tumor progression promotion
ENSG00000197619,ZNF615,tumor suppressor,regulation of gene expression,genomic stability maintenance,cellular proliferation control,epithelial-to-mesenchymal transition regulation,chromatin remodeling interaction
ENSG00000107562,CXCL12,tumor microenvironment modulation,homing and migration regulation,immune cell recruitment promotion,angiogenesis facilitation,emt regulation,metastasis promotion
ENSG00000169925,BRD3,transcriptional regulation,chromatin remodeling,oncogenic mutations,protein-protein interactions,cell growth regulation,epigenetic dysregulation
ENSG00000132275,RRP8,ribosome biogenesis,oncogenic processes,rna-binding protein function,cellular metabolism regulation,tumorigenesis promotion,therapeutic target
ENSG00000140853,NLRC5,tumor suppressor,immune surveillance regulation,mhc class i pathway activation,t-cell activation inhibition,cancer cell proliferation enhancement,oncogene potential
ENSG00000108848,LUC7L3,rna helicase complex,oncogenic processes,transcription regulation,cell growth regulation,tumor progression,biomarker
ENSG00000136436,CALCOCO2,tumor-promoting,oncogene,autophagy regulation,protein degradation,cell survival promotion,mutated in cancers
ENSG00000170448,NFXL1,chromatin remodeling,tumor progression,transcriptional regulation,nf-κb signaling pathway,gene expression regulation,cancer progression
ENSG00000135111,TBX3,oncogene,cell proliferation,apoptosis inhibition,wnt/β-catenin pathway interaction,tumorigenesis driver,stem cell maintenance regulation
ENSG00000275730,LILRB4,immunosuppression,tumor progression,immune evasion,natural killer cell inhibition,pan-cancer association,cancer immunology
ENSG00000213024,NUP62,npc component,chromatin-associated protein,dna damage response,genomic instability,tumor aggressiveness,cell signaling pathway 
ENSG00000125864,BFSP1,epithelial integrity,cell adhesion complex,epithelial-to-mesenchymal transition,tumor progression,cancer initiation,disrupted cellular interactions
ENSG00000285049,CPSF1,mrna processing,aberrant splicing,cancer driver gene,mtor pathway regulation,cleavage and polyadenylation,cell proliferation regulation
ENSG00000188878,FBF1,fbf1 protein regulation,tumor suppressor modulation,chromatin remodeling,oncogenic function,gene expression regulation,transcriptional modulation
ENSG00000162989,KCNJ3,cell membrane potential regulation,gene expression modulation,ion channel function mutation,tumor progression promotion,oncogenic signaling activation,genomic instability susceptibility
ENSG00000157542,KCNJ6,potassium channel regulation,cell proliferation enhancement,oncogenic mutations,cellular metabolism disruption,therapeutic target identification,cellular excitability modulation
,HIST1H1B,histone regulation,chromatin structure,nucleosome organization,dna repair mechanisms,transcriptional regulation,tumorigenesis
,HIST3H2BB,chromatin remodeling,histone modifications,epigenetic reprogramming,transcriptional regulation,cell cycle progression,tumor development
ENSG00000140740,UQCRC2,electron transport chain disruption,mitochondrial dysfunction,mitochondrial membrane protein,cellular respiration regulation,tumor growth promotion,therapeutic target
ENSG00000282853,ECH1,mitochondrial localization,fatty acid beta-oxidation,metabolic reprogramming,cell survival enhancement,tumor progression support,oncogenic function
ENSG00000188042,ARL4C,cell migration,golgi apparatus function,vesicle trafficking,oncogenic process,tumor progression,metastasis
ENSG00000174137,FAM53A,oncogene activation,tumor progression,apoptosis resistance,cell proliferation regulation,protein interaction,therapeutic target
ENSG00000169714,CNBP,cellular proliferation,transcriptional regulation,tumor progression,emerging oncogene,pi3k/akt pathway modulation,epigenetic regulation
ENSG00000165732,DDX21,rna helicase,genomic stability regulation,dna damage response,alternative splicing regulation,oncogenesis involvement,therapeutic target potential
ENSG00000143476,DTL,collagen binding,cell adhesion,epithelial-to-mesenchymal transition,receptor tyrosine kinase activation,tumor progression,metastasis
,WDR34,centrosome regulation,microtubule dynamics,protein-protein interactions,cell division,oncogenic processes,cellular polarity
ENSG00000130826,DKC1,ribosome biogenesis,pseudouridine synthase activity,telomere maintenance,cell cycle regulation,apoptosis inhibition,oncogene activation
ENSG00000083642,PDS5B,chromatin remodeling,genomic instability,cell cycle regulation,cohesin dynamics,epigenetic regulation,tumor suppressor 
ENSG00000165637,VDAC2,mitochondrial regulation,glycolytic reprogramming,apoptosis inhibition,energetic metabolism modulation,cell death evasion,mitochondrial interaction
ENSG00000137942,FNBP1L,cell migration,aberrant regulation,actin filament formation,dna repair dysregulation,genome instability,transcriptional regulation
ENSG00000068366,ACSL4,fatty acid metabolism,oncogenic process,tumor growth promotion,metabolic reprogramming,pro-inflammatory eicosanoids,therapeutic target
ENSG00000164062,APEH,lipid metabolism regulation,tumor suppressor function,inflammation modulation,lysophospholipid degradation,protein-protein interaction,genomic instability marker
ENSG00000182149,IST1,t-cell development,immune response modulation,tumor progression enhancement,migratory and invasive capabilities,prognostic marker,poor survival outcome
ENSG00000185187,SIGIRR,tumor suppressor,immune signaling regulation,inflammatory response modulation,cell survival and proliferation,il-1 and il-18 pathway interference,genomic instability susceptibility
ENSG00000138385,SSB,dna replication,genomic instability,helicase interaction,protein regulation,tumor progression,poor prognosis
ENSG00000173156,RHOD,constitutive activation,gtpase activity,increased cell proliferation,oncogenic signaling cascades,tumor invasion,therapeutic target
ENSG00000239306,RBM14,ribonucleic acid regulation,cell survival promotion,genomic instability contribution,tumor progression association,protein-protein interaction modulation,p53 pathway regulation
ENSG00000185615,PDIA2,er protein folding,cancer cell survival,molecular chaperone function,cellular response modulation,dysregulation in cancer,tumor-promoting activity
ENSG00000277334,NCR1,immunosurveillance,tumor immunity,nk cell activation,apoptosis regulation,cytotoxic granule protein,inflammation modulation
ENSG00000145912,NHP2,ribosome biogenesis,aberrant expression,cell growth promotion,tumor progression,ribosomal rna synthesis,oncogenic effects
ENSG00000023902,PLEKHO1,cellular migration,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway regulation,gene expression modulation,cellular polarity maintenance,signaling pathway interaction
ENSG00000092621,PHGDH,glycolytic reprogramming,oncogenic metabolism,cancer cell proliferation,nadph production,serine biosynthesis pathway,metabolic adaptation
ENSG00000125686,MED1,transcription regulation,oncogene activation,tumor promotion,poor prognosis,therapeutic target,gene amplification
ENSG00000138279,ANXA7,calcium signaling,cell proliferation suppression,tumor suppressor function,protein transport regulation,metastatic potential inhibition,cancer cell growth inhibition
ENSG00000143624,INTS3,integrator complex,splicing regulation,5' end processing,transcriptional regulation,genomic instability,cell growth control
ENSG00000241794,SPRR2A,cell proliferation,oncogenesis,epithelial-to-mesenchymal transition,cell migration,protein interaction,tumor progression
ENSG00000187522,HSPA14,proteotoxic stress regulation,metabolic reprogramming,cell survival enhancement,tumor progression facilitation,protein folding and degradation,chk1/p53 interaction
ENSG00000106245,BUD31,chromatin regulation,oncogenic transformation,epigenetic modulation,transcriptional regulation,cell growth regulation,tumorigenesis
ENSG00000100225,FBXO7,tumor suppressor function,ubiquitin-proteasome pathway dysregulation,apoptosis evasion,cell cycle progression,protein degradation impairment,dna damage response disruption
ENSG00000107833,NPM3,chromatin remodeling,cell cycle regulation,tumor suppression,p53 interaction,ribosome biogenesis,nucleolar organization
ENSG00000153406,NMRAL1,genomic instability,aneuploidy,cell division error,mitotic checkpoint regulation,chromosomal segregation,proliferation enhancement
ENSG00000154277,UCHL1,protein degradation,apoptosis resistance,cell proliferation,tumor suppressor function,ubiquitin-proteasome system regulation,metastasis promotion
ENSG00000083896,YTHDC1,m6a rna modification,tumor suppressor regulation,oncogene modulation,mrna stability regulation,translation efficiency influence,nuclear localization
ENSG00000151623,NR3C2,glucocorticoid receptor activation,transcriptional regulation,cell proliferation modulation,tumor suppressor activity,apoptosis induction,genomic instability
ENSG00000165516,KLHDC2,chromatin remodeling,genomic instability,cell cycle regulation,dna repair mechanisms,tumor suppressor function,pi3k/akt pathway modulation
ENSG00000106554,CHCHD3,mitochondrial membrane integrity,cellular respiration regulation,oncogene activation,glycolytic shift,apoptosis resistance,metabolic reprogramming
ENSG00000280680,HHAT,histone modification regulation,constitutive overexpression,dna repair impairment,cell cycle dysregulation,genome instability promotion,tumor suppressor inactivation
ENSG00000058404,CAMK2B,protein kinase activation,tumor progression,cell proliferation,signaling pathway regulation,mitosis regulation,microtubule dynamics
ENSG00000138646,HERC5,cell cycle regulation,ubiquitin ligase activity,tumor suppressor degradation,oncogene expression,proliferation enhancement,apoptosis inhibition
ENSG00000158445,KCNB1,ion channel regulation,cellular excitability,constitutive activation,oncogenic process,apoptosis inhibition,metastasis promotion
ENSG00000175497,DPP10,tumor suppressor function,cellular adhesion regulation,epithelial-to-mesenchymal transition,metastasis promotion,protein-protein interaction,cancer progression regulation
ENSG00000127314,RAP1B,cell proliferation,signaling pathway regulation,guanine nucleotide-binding activity,cell cycle progression,protein kinase activation,oncogenic transformation
ENSG00000115806,GORASP2,enhanced cell proliferation,aberrant membrane trafficking,growth factor receptor recycling,cellular motility regulation,oncogenic pathway activation,protein-protein interaction
ENSG00000278129,ZNF8,transcriptional regulation,chromatin remodeling,oncogenesis,apoptosis inhibition,gene expression modulation,cancer progression
ENSG00000137171,KLC4,genomic instability,mitotic checkpoint control,tumor suppression,aneuploidy,cell cycle regulation,microtubule-based transport
ENSG00000108312,UBTF,transcriptional regulation,chromatin remodeling,cell cycle progression,gene overexpression,dna repair evasion,apoptosis evasion
ENSG00000163060,TEKT4,tec family kinases,cell adhesion regulation,cytoplasmic protein kinase activation,focal adhesion complexes interaction,oncogenic processes promotion,tumor cell migration
ENSG00000167858,TEKT1,pentose phosphate pathway,altered redox balance,metabolic reprogramming,cancer cell survival,therapeutic target,gene mutation
ENSG00000198382,UVRAG,autophagy regulation,tumor suppressor function,mitochondrial stability,autophagosome formation,dna damage repair,cell survival pathway activation
ENSG00000125676,THOC2,transcriptional regulation,oncogenesis,chromatin remodeling,cell proliferation,gene expression,mrna export
ENSG00000187741,FANCA,genomic instability,dna repair deficiency,homologous recombination repair,tumor suppressor function,cell cycle checkpoint regulation,apoptosis induction
ENSG00000113368,LMNB1,chromatin structure regulation,epithelial-to-mesenchymal transition (emt),nuclear organization,mitotic spindle formation,cell proliferation promotion,chromosomal instability
ENSG00000113645,WWC1,centromere formation,aneuploidy,genomic instability,kinetochore assembly,cell cycle regulation,cancer progression
ENSG00000070371,CLTCL1,oncogenic signaling pathways,transcriptional coactivation,cell cycle regulation,therapeutic target,genetic amplification,protein-protein interactions
ENSG00000181481,RNF135,ubiquitination,tumor progression,oncogenesis,protein degradation,cell cycle regulation,dna damage repair
ENSG00000120457,KCNJ5,potassium channel regulation,gain of function mutations,cellular excitability,potassium ion balance,oncogenesis,cellular responses
ENSG00000124171,PARD6B,cell polarity disruption,wnt/β-catenin pathway activation,oncogenic signaling,cell migration promotion,tumor progression facilitation,poor prognosis marker
ENSG00000161940,BCL6B,transcriptional regulator,apoptosis regulation,inflammation modulation,immune response modification,tumor suppressor gene suppression,oncogene activation
ENSG00000160679,CHTOP,histone modification,chromatin regulation,gene transcription,apoptosis modulation,cell cycle progression,therapeutic target
ENSG00000101844,ATG4A,autophagy regulation,cysteine protease activity,tumor growth promotion,cell survival enhancement,prognostic marker,autophagosome formation
ENSG00000189403,HMGB1,pro-inflammatory cytokine regulation,transcriptional regulation,cell proliferation,oncogene function,metastasis facilitation,tumor microenvironment interaction
ENSG00000172236,TPSAB1,t-cell surface antigen regulation,immune modulation,oncogene activation,therapeutic target,cancer immune microenvironment modification,protein localization and interaction
ENSG00000119138,KLF9,transcriptional regulation,dual function,cell cycle progression,apoptosis modulation,tumor suppressor,transcriptional repressor
ENSG00000171346,KRT15,cancer-related adhesion,tumor progression,biomarker potential,epithelial cell stability,type ii keratin protein,cytostructural integrity
ENSG00000111321,LTBR,tumor progression,immune suppression,oncogenic signaling,cell proliferation,survival pathway activation,genomic instability
ENSG00000196664,TLR7,toll-like receptor signaling,viral recognition,innate immune response,type i interferon production,cytokine release,epithelial cell activation
ENSG00000180182,MED14,transcriptional regulation,oncogenic potential,cell growth regulation,t-box transcription factor activation,subunit of mediator complex,gene expression alteration
ENSG00000142856,ITGB3BP,integrin regulation,cell adhesion modulation,tumor progression facilitation,gene expression regulation,metastatic potential enhancement,cytoskeletal interaction modification
ENSG00000170776,AKAP13,tumor suppressor/oncogene duality,cell signaling regulation,substrate for pkb/akt phosphorylation,scaffold protein functions,cell migration promotion,gene transcription modulation
ENSG00000101460,MAP1LC3A,autophagic flux,cell survival,chemosensitivity,protein regulation,tumor growth,cell proliferation
ENSG00000146701,MDH2,mitochondrial enzyme,metabolic reprogramming,cell survival enhancement,apoptosis evasion,genomic instability promotion,therapeutic target
ENSG00000143970,ASXL2,epigenetic regulation,chromatin modification,histone methyltransferase activity,gene expression dysregulation,dna repair machinery interaction,genomic instability
ENSG00000274651,PRPF31,aberrant splicing,cellular behavior modulation,mutational burden increase,oncogenic mutation promotion,pre-mrna processing regulation,spliceosome assembly dysfunction
ENSG00000090621,PABPC4,mrna translation regulation,oncogene overexpression,cell proliferation enhancement,tumor progression facilitation,therapeutic target potential,cancer stem cell maintenance
ENSG00000141522,ARHGDIA,cell migration,overexpression,gtpase regulation,tumor progression,metastasis promoter,cancer driver gene
ENSG00000168421,RHOH,rho gtpase activity,cell migration,oncogenic potential,aberrant activation,tumor progression,cytoskeletal regulation
ENSG00000182670,TTC3,genomic instability,cancer cell adaptation,dna damage response,cell cycle regulation,apoptosis modulation,tumor suppressor function
ENSG00000103351,CLUAP1,cell surface receptor regulation,downstream signaling pathway activation,protein-protein interaction,clathrin-coated vesicle formation,tumorigenesis association,poor prognosis indicator
ENSG00000105492,SIGLEC6,immune system modulation,tumor microenvironment remodeling,sialoglycoconjugate binding,leukocyte activation,immune effector cell regulation,cancer progression and metastasis
ENSG00000116663,FBXO6,phosphorylation-dependent targeting,ubiquitination pathway,cell cycle regulation,tumor suppressor function,dna repair mechanism,signaling pathway modulation
ENSG00000099817,POLR2E,constitutive activation,enhanced transcriptional activity,oncogenic process,cell proliferation,therapeutic target,transcriptional regulation
ENSG00000189043,NDUFA4,mitochondrial function,oncogenic metabolism,cellular proliferation,prognostic biomarker,therapeutic target,electron transport chain
ENSG00000165588,OTX2,homeodomain-containing transcription factor,oncogene activation,dna sequence binding,transcriptional regulation,tumor progression,epigenetic regulation
ENSG00000108604,SMARCD2,chromatin remodeling,dna binding,genome stability regulation,cell proliferation regulation,apoptosis resistance,oncogenic pathway activation
ENSG00000140743,CDR2,genomic instability,oncogenic process,genome stability maintenance,cell cycle progression,transcriptional regulation,dna damage response
ENSG00000184743,ATL3,lipid metabolism regulation,oncogenic lipid alterations,cell membrane transport,cellular lipotoxicity modulation,cell proliferation enhancement,tumorigenesis pathway interaction
ENSG00000172346,CSDC2,epigenetic regulation,cell proliferation,transcriptional regulation,prognostic marker,tumor progression,therapeutic target
ENSG00000119929,CUTC,e3 ubiquitin ligase activity,ubiquitination pathway,cellular signaling regulation,tumor progression,protein degradation modulation,oncogenic protein accumulation
ENSG00000105829,BET1,copi-coated vesicle formation,vesicular transport regulation,lipid metabolism modulation,oncogenic pathway interaction,tumor progression enhancement,overexpression association
ENSG00000179262,RAD23A,ubiquitin-proteasome pathway,impaired protein degradation,genomic instability,dna damage response,oncogenic processes,protein quality control
ENSG00000231555,HSPA1B,chaperone function,apoptosis resistance,cell survival enhancement,metastasis facilitation,cell cycle regulation,tumor growth promotion
ENSG00000121892,PDS5A,genomic instability,sister chromatid cohesion regulation,dna repair pathway dysregulation,oncogenic potential,therapeutic target,genome maintenance
ENSG00000149187,CELF1,celf1-mediated splicing regulation,oncogenesis enhancement,cell growth promotion,survival pathway activation,tumor suppressor gene modulation,alternative rna processing
ENSG00000135250,SRPK2,alternative splicing regulation,cell proliferation enhancement,metastasis promotion,signaling pathway activation,therapeutic target identification,gene expression modulation
ENSG00000102038,SMARCA1,chromatin remodeling,tumor suppressor function,apoptosis regulation,oncogene activation,dna damage recognition,transcriptional regulation
ENSG00000182199,SHMT2,one-carbon metabolism,nucleotide synthesis,tumor progression,glycolytic pathway,lipogenic pathway,poor prognosis
ENSG00000188554,NBR1,protein degradation regulation,dna damage response,coactivator function,cell cycle progression regulation,tumor suppressor protein interaction,autophagy regulation
ENSG00000170296,GABARAP,autophagy regulation,oncogene/tumor suppressor function,cellular homeostasis modulation,tumor progression association,therapeutic target potential,autophagosome formation facilitation
ENSG00000137947,GTF2B,transcriptional regulation,genomic instability,chromatin remodeling,developmental disorder,cell proliferation,dna repair pathway
,HIST1H2BD,chromatin regulation,histone dimerization,post-translational modifications,oncogenic processes,gene expression regulation,epigenetic alterations
ENSG00000273575,KIR2DL4,tumor suppressor function,cell volume regulation,voltage-gated potassium channel,cell proliferation inhibition,oncogenesis prevention,genomic instability suppression
ENSG00000115165,CYTIP,mtor pathway activation,cell proliferation enhancement,oncogenic process facilitation,cell survival promotion,protein-protein interaction regulation,cancer cell growth support
ENSG00000143376,SNX27,endosomal trafficking,cancer cell proliferation,protein recycling regulation,oncogenic partner,tumor suppressor role,overexpression association
ENSG00000143549,TPM3,oncogenic transformation,tumor progression,gene expression regulation,cell migration,transcriptional activity modulation,cytoskeletal organization
ENSG00000137767,SQOR,mitochondrial metabolism,redox balance regulation,tumor progression modulation,energy production regulation,cancer metabolic reprogramming,dysregulation-induced oncogenesis
ENSG00000143553,SNAPIN,cellular regulation,cancer progression,protein interaction,membrane fusion events,tumor growth promotion,therapeutic target
ENSG00000124228,DDX27,cellular response,transcriptional regulation,genome integrity,oncogenic processes,cancer cell proliferation,protein-rna interactions
ENSG00000237344,PBX2,transcriptional regulator,oncogene activation,hematopoiesis regulation,cell proliferation,metastasis promotion,poor prognosis marker
ENSG00000106785,TRIM14,cellular proliferation,immune modulation,oncogene/tumor suppressor,transcriptional regulation,protein-protein interaction,biomarker potential
ENSG00000112081,SRSF3,regulation of alternative splicing,overexpression in cancer,epithelial-to-mesenchymal transition (emt) regulation,oncogenic splice variants modulation,tumor progression promotion,cancer prognosis association
ENSG00000072134,EPN2,sphingolipid metabolism,cell migration,tumor progression,resistance to therapy,cell proliferation,survival pathway
ENSG00000121653,MAPK8IP1,mitogen-activated protein kinase pathway,cell growth regulation,stress response,apoptosis modulation,tumor progression,protein-protein interaction
ENSG00000173933,RBM4,cellular regulation,rna processing,multifunctional protein,scaffold protein function,transcriptional regulation,oncogene/tumor suppressor
ENSG00000274853,MRM1,trna and rrna processing,altered expression levels,disrupted cellular processes,enhanced cell proliferation,tumorigenic potential,prognostic marker
ENSG00000138768,USO1,protein stabilization,regulatory complex formation,tumor suppression,aberrant protein accumulation,golgi apparatus regulation,cellular homeostasis
ENSG00000070756,PABPC1,oncogene,mrna regulation,cell proliferation,protein-protein interaction,metastasis,translation stability
ENSG00000100968,NFATC4,transcriptional regulation,t-cell activation,cell proliferation,oncogenic processes,apoptosis inhibition,immune system development
ENSG00000149548,CCDC15,cell cycle regulation,chromosomal instability,aberrant localization,oncogenic function,genomic integrity,microtubule dynamics
ENSG00000140319,SRP14,nascent polypeptide targeting,endoplasmic reticulum membrane translocation,oncogene overexpression,cell proliferation,transcriptional regulation,apoptosis inhibition
ENSG00000139197,PEX5,lipid biosynthesis,cellular metabolism,protein import regulation,oncogenic process,autophagy regulation,peroxisomal function
ENSG00000164251,F2RL1,par4 pathway,metastasis promotion,protease interaction,tumor growth facilitation,therapeutic target,coagulation regulation
ENSG00000152086,TUBA3E,microtubule stability,tumor suppressor function,chromosomal instability,cellular transformation,cancer driver mutations,mitotic spindle formation
ENSG00000163156,SCNM1,smn complex assembly,rna splicing regulation,tumor progression,metastasis,oncogenic processes,dysregulated expression
ENSG00000136147,PHF11,histone recognition,chromatin remodeling,oncogenic driver,epigenetic regulation,cell cycle regulation,genomic instability
ENSG00000185651,UBE2L3,ubiquitination pathway,dysregulated protein degradation,oncogene/tumor suppressor function,genome instability,cell cycle regulation,protein homeostasis modulation
,HIST1H2AH,chromatin remodeling,epigenetic regulation,histone modification,dna packaging,cellular transformation,tumor progression
ENSG00000277956,MAPT,tau protein aggregation,dysregulation of microtubules,cell proliferation enhancement,genomic instability promotion,autophagy modulation,cyclin-dependent kinase interaction
ENSG00000131773,KHDRBS3,spliceosome regulation,oncogenic signaling,cell proliferation enhancement,mrna stability modulation,tumor progression facilitation,genomic instability promotion
ENSG00000055118,KCNH2,delayed repolarization,cardiac ion channel dysfunction,ventricular arrhythmia,ion transport regulation,electrophysiological disorder,cardiac electrophysiology
ENSG00000114738,MAPKAPK3,mapk signaling pathway,phosphorylation-dependent activation,cell proliferation regulation,transcription factor phosphorylation,apoptosis inhibition,protein kinase function
ENSG00000136891,TEX10,transcription regulation,chromatin remodeling,cell proliferation,malignant transformation,elevated expression,promoter interaction
ENSG00000125166,GOT2,dna repair deficiency,oxidative stress regulation,signaling pathway modulation,apoptosis suppression,tumor progression facilitation,therapeutic target potential
ENSG00000116459,ATP5PB,mitochondrial function,dysregulated energy metabolism,altered cellular proliferation,oncogenic signaling pathway interaction,gene expression regulation,mitochondrial dynamics disruption
ENSG00000152256,PDK1,akt signaling pathway,phosphorylation activity,gain of function mutations,oncogenic potential,cell proliferation,metabolic regulation
ENSG00000116977,LGALS8,tumor progression,cell signaling modulation,immunosuppression,cancer stem cell regulation,cell adhesion modification,apoptosis evasion
ENSG00000149968,MMP3,tumor progression,matrix degradation,oncogenesis,cell migration,angiogenesis,therapeutic target
ENSG00000140564,FURIN,oncogenic regulation,protein processing,tumor progression,angiogenesis promoter,cell surface receptor activation,trans-golgi network localization
ENSG00000095139,ARCN1,cellular transport regulation,oncogene activation,downstream signaling pathway modulation,cancer cell survival enhancement,tumor progression facilitation,therapeutic target identification
ENSG00000166091,CMTM5,tumor suppression,cell proliferation inhibition,apoptosis regulation,immune response modulation,protein-protein interaction,cancer driver gene potential
ENSG00000104894,CD37,cell surface antigen,immune cell activation,proliferation regulator,tumor microenvironment modifier,malignancy associated protein,gene expression regulator
ENSG00000231543,C2,tumor microenvironment,immune evasion,genetic variants,cellular activation,protein-protease interactions,complement cascade regulation
ENSG00000129460,NGDN,cell surface receptor,wnt signaling pathway modulation,cell polarity maintenance,cytoplasmic adaptor interaction,tumor microenvironment disruption,aberrant cell growth regulation
ENSG00000106803,SEC61B,oncogenic process,cell proliferation,protein translocation,endoplasmic reticulum membrane,secretory protein maturation,er stress regulation
ENSG00000163479,SSR2,mitochondrial function regulation,gain-of-function mutation,tumor progression,cell survival enhancement,p53 interaction,brca1 interaction
ENSG00000107872,FBXL15,tumor suppressor activity,cell cycle regulation,ubiquitination and degradation,dna repair,p53 stabilization,gene expression regulation
ENSG00000102786,INTS6,genomic instability,telomere maintenance,oncogenesis,genome stability,cell cycle regulation,cancer driver gene
ENSG00000169599,NFU1,mitochondrial protein,iron-sulfur cluster assembly,oxidative stress induction,dna damage promotion,cellular proliferation,mitochondrial dysfunction
ENSG00000111615,KRR1,nuclear rna export factor,alternative splicing regulation,tumor growth promotion,gene expression regulation,mrna transport disruption,oncogenic mrnas upregulation
ENSG00000102554,KLF5,transcriptional regulation,cellular proliferation,oncogenic potential,tumor suppressive functions,subcellular localization,cytoplasmic/nuclear interactions
ENSG00000147224,PRPS1,purine biosynthesis,mtor signaling,cell proliferation,nucleotide production,oncogenic activation,cell growth
ENSG00000134138,MEIS2,oncogenic activity,transcriptional regulation,tumor cell proliferation,cell differentiation suppression,epigenetic modification,homeobox protein interaction
ENSG00000105193,RPS16,ribosomal biogenesis,oncogenic mutation,overexpression leading to tumor growth,aberrant protein synthesis,genomic instability,therapeutic target for cancer treatment
ENSG00000126945,HNRNPH2,rna processing regulation,alternative splicing facilitation,genomic instability promotion,cell proliferation enhancement,oncogene transcriptional regulation,signaling pathway modulation
ENSG00000122692,SMU1,transcriptional regulation,oncogenic transcription factors,chromatin remodeling,cell cycle progression,apoptosis modulation,tumor suppressor interaction
ENSG00000169344,UMOD,oncogenic properties,overexpression,cell proliferation enhancement,apoptosis resistance,metastatic potential increase,signaling pathway modulation
ENSG00000108061,SHOC2,cellular proliferation,gain of function mutations,constitutive activation,tumor progression,signaling modulation,protein-protein interaction
ENSG00000145741,BTF3,overexpression,transcriptional regulation,oncogenic potential,cell proliferation,apoptosis regulation,prognostic marker
ENSG00000197785,ATAD3A,chromatin remodeling,dna replication,genomic instability,oncogenic pathways,tumor suppressor genes,therapeutic target
,SEPT4,tumor progression,aberrant septin filament formation,cytokinesis regulation,cell migration modulation,cancer driver gene candidate,septin filament organization
ENSG00000108671,PSMD11,altered expression,protein degradation pathway,oncogenic protein accumulation,cell cycle regulation,apoptosis inhibition,tumor suppressor protein inhibition
ENSG00000004487,KDM1A,histone demethylation,transcriptional regulation,chromatin compaction,tumor progression,cell proliferation inhibition,oncogenic potential
ENSG00000104756,KCTD9,wnt/β-catenin signaling pathway,loss of function mutations,tumor progression,cell cycle regulation,apoptosis modulation,tumor suppressor gene
ENSG00000104687,GSR,oxidative stress modulation,detoxification enzyme,cancer cell resilience,therapeutic target modulation,post-translational modification regulation,cellular protection mechanism
ENSG00000153395,LPCAT1,lipid biosynthesis,overexpression,cell proliferation,metastasis,pi3k/akt interaction,genomic instability
ENSG00000277586,NEFL,tumor microenvironment disruption,cellular plasticity,cytoskeletal dynamics regulation,protein-protein interactions modulation,apoptosis evasion,tumorigenesis promotion
ENSG00000124507,PACSIN1,membrane trafficking regulation,oncogenic potential,vesicle fusion modulation,cellular proliferation enhancement,tumor progression facilitation,cancer biomarker status
ENSG00000115317,HTRA2,mitochondrial localization,serine protease activity,regulation of apoptosis,cellular stress response,potential biomarker,tumor suppressor or oncogene
ENSG00000282947,HNRNPL,alternative splicing,cell proliferation regulation,tumor progression promotion,rna binding protein function,dysregulated expression,pro-oncogenic gene regulation
ENSG00000132849,PATJ,regulation of cell polarity,alteration of adhesion molecules,cytoskeleton reorganization,aggressive tumor behavior,cell migration promotion,oncogenesis association
ENSG00000167081,PBX3,homeodomain-containing transcription factor,chromatin remodeling,apoptosis regulation,tumor growth promotion,oncogene role,stem cell maintenance
ENSG00000068028,RASSF1,tumor suppressor,epigenetic silencing,promoter methylation,cell cycle regulation,apoptosis modulation,microtubule stability regulation
ENSG00000139546,TARBP2,risc complex,microrna processing,oncogenic processes,genomic instability,therapeutic target,cell proliferation
ENSG00000114388,NPRL2,protein degradation,cellular proliferation,signaling pathway regulation,tumor progression,aberrant protein expression,oncogenic transformation
ENSG00000106327,TFR2,iron regulation,dysregulation of cellular uptake,cell surface expression,transmembrane protein interaction,tumor progression,therapeutic target
ENSG00000088002,SULT2B1,steroid hormone metabolism,estrogen regulation,protein-protein interaction,tissue distribution,enzyme regulation,gene expression control
ENSG00000164114,MAP9,microtubule dynamics regulation,cell cycle progression promotion,mitotic spindle formation facilitation,prognostic marker potential,therapeutic target possibility,intracellular transport modulation
ENSG00000096088,PGC,genomic instability,tumor suppression,cell cycle regulation,transcriptional control,dna repair,mitosis regulation
ENSG00000177468,OLIG3,cell cycle regulation,oncogenic driver,transcription factor activity,glioma association,cell proliferation promotion,downstream pathway activation
,SEPT9,cellular migration,tumor growth,oncogenic signaling pathway,pi3k/akt interaction,cytoskeletal regulation,metastasis promotion
ENSG00000143614,GATAD2B,oncogenic properties,tumor growth promotion,chromatin remodeling,transcriptional coactivation,cellular proliferation,metastasis facilitation
ENSG00000151923,TIAL1,microrna regulation,tumor suppressor regulation,stress granule assembly,cell proliferation enhancement,oncogenic mutation,genomic instability
ENSG00000112146,FBXO9,protein ubiquitination,e3 ligase activity,cell cycle regulation,tumor suppressor degradation,apoptosis modulation,cancer oncogene
ENSG00000197540,GZMM,genomic instability,apoptosis regulation,dna repair mechanism,cell proliferation control,tumor progression,tumor suppression
ENSG00000124469,CEACAM8,carcinoma-associated,cell adhesion molecule,tumor progression,immune evasion,prognostic marker,signaling pathway modulation
ENSG00000137776,SLTM,cellular adhesion,tumor progression,cell migration regulation,secreted protein function,protein-protein interaction,cancer metastasis
ENSG00000075702,WDR62,chromosomal instability,aneuploidy,tumor suppressor function,spindle checkpoint regulation,microtubule dynamics regulation,centrosome duplication control
ENSG00000090273,NUDC,genomic instability,cell cycle regulation,oncogenesis,tumor progression,protein-protein interactions,dna repair
ENSG00000125257,ABCC4,drug resistance mechanism,multidrug transporter,chemotherapy evasion,cancer cell survival,efflux pump function,cellular detoxification
ENSG00000087087,SRRT,chromatin remodeling,epigenetic regulation,tumor progression,swi/snf complex component,histone modification,transcriptional regulation
ENSG00000275176,ACACA,fatty acid biosynthesis,constitutive activation,lipid metabolic reprogramming,metabolic adaptation,tumor growth promotion,enzymatic activity dysregulation
ENSG00000168397,ATG4B,autophagy regulation,tumor suppressor function,cell growth inhibition,protein processing,oncogenesis prevention,genomic instability
ENSG00000160214,RRP1,altered mrna stability,aberrant rna degradation,tumor suppressor function,oncogene potential,cell cycle regulation,apoptosis modulation
ENSG00000135503,ACVR1B,epithelial-to-mesenchymal transition (emt),cell proliferation,tumor growth,signaling pathway regulation,tgf-?-superfamily signaling,oncogenic processes
ENSG00000114867,EIF4G1,translation initiation factor,cellular growth regulation,protein synthesis enhancement,oncogenic protein interaction,tumor suppressor interaction,signaling pathway modulation
ENSG00000189369,GSPT2,telomere maintenance,translation regulation,cancer risk factor,cell survival pathway,telomerase regulation,protein complex member
ENSG00000149428,HYOU1,er chaperone activity,endoplasmic reticulum stress,protein folding regulation,cell survival promotion,oncogenic mutations,glycoprotein assembly
ENSG00000181026,AEN,cellular stress response,protein degradation,unfolded protein response,atp-dependent chaperone,oncogenic process,tumor progression
ENSG00000162734,PEA15,apoptosis resistance,cell survival,gene expression regulation,metastasis promotion,oncogenic transformation,protein-protein interaction
ENSG00000089234,BRAP,epigenetic regulation,chromatin remodeling,tumor suppressor function,gene expression regulation,apoptosis inhibition,cell cycle progression
ENSG00000157601,MX1,transcriptional repression,tumor suppression,inflammatory response inhibition,cell growth modulation,apoptosis promotion,genomic regulation
ENSG00000132313,MRPL35,mitochondrial protein regulation,metabolic reprogramming,glycolytic shift,tumor metabolism alterations,cellular energetics adaptation,genomic instability marker
ENSG00000092969,TGFB2,tgf-β pathway,cell signaling,protein-protein interaction,epithelial-to-mesenchymal transition,genomic instability,cellular proliferation
ENSG00000277359,RPS9,regulatory mechanisms,translation initiation complex,ribosomal protein overexpression,cell proliferation enhancement,protein synthesis regulation,therapeutic target potential
ENSG00000100138,SNU13,alternative splicing,oncogene activation,tumor suppressor regulation,apoptosis evasion,cell cycle progression,prognostic biomarker
ENSG00000100650,SRSF5,cellular proliferation,alternative splicing regulation,oncogenic properties,mutational alterations,splicing factor complex interaction,apoptosis modulation
ENSG00000133878,DUSP26,mapk/erk pathway,tumor suppressor/oncogene,dephosphorylation activity,cancer cell survival,chemoresistance,cellular context-dependent function
ENSG00000077312,SNRPA,rna splicing regulation,snrnp component,pre-mrna processing,oncogenic transformation,alternative splice variants,tumorigenesis 
ENSG00000198099,ADH4,alcohol metabolism,cellular redox balance,oxidative stress modulation,chemoresistance modulation,cancer cell proliferation,tumor microenvironment
ENSG00000143106,PSMA5,proteasomal degradation,cell cycle regulation,apoptosis inhibition,tumor growth promotion,angiogenesis facilitation,protein aggregation modulation
ENSG00000107816,LZTS2,cell cycle regulation,gene expression inhibition,tumor suppressor function,chromosomal instability,binding partners interaction,genomic alterations
ENSG00000165169,DYNLT3,microtubule dynamics,cytoplasmic dynein regulation,cell division regulation,mitotic spindle assembly,cytokinesis disruption,retrograde transport
ENSG00000197114,ZGPAT,epigenetic regulation,transcriptional regulation,chromatin remodeling,tumor suppression,cell cycle progression,apoptosis resistance
ENSG00000124535,WRNIP1,genomic instability,tumor suppressor gene repression,dna damage response pathway activation,genomic profiling,oncogenic signaling pathway modulation,therapeutic target
ENSG00000169813,HNRNPF,alternative splicing regulation,cell growth promotion,oncogenic process enhancement,rna processing modulation,tumor metastasis facilitation,cancer cell proliferation
,AARS,constitutive activation,oncogenic mutations,cellular proliferation,protein synthesis regulation,dna repair modulation,heat shock response activation
ENSG00000160216,AGPAT3,lipid biosynthesis,adipogenesis,tumor progression,metabolic regulation,cancer prognosis,biomarker
ENSG00000006744,ELAC2,genomic stability regulation,rna degradation pathway,p53 pathway interaction,oncogenic potential,dna repair mechanism,cell cycle modulation
ENSG00000008083,JARID2,chromatin remodeling,oncogene function,epigenetic regulation,cell cycle progression,dna repair modulation,genomic instability
ENSG00000160584,SIK3,cellular proliferation regulation,tumor suppressor function,apoptosis induction,cell cycle regulation,protein kinase activity,p53 interaction
ENSG00000183010,PYCR1,gluconeogenesis pathway,metabolic regulation,elevated activity,gain of function mutations,tumor progression,energy homeostasis
ENSG00000137818,RPLP1,translation regulation,cell proliferation,ribosomal subunit,protein synthesis dysregulation,metastasis promotion,therapeutic target
ENSG00000114125,RNF7,e3 ubiquitin ligase activity,protein degradation regulation,tumor suppressor modulation,cell cycle regulation,apoptosis induction,immune response regulation
ENSG00000037474,NSUN2,trna methylation,cell proliferation,methyltransferase activity,oncogene,genetic instability,tumor progression
ENSG00000159189,C1QC,complement activation,immune regulation,phagocytosis promotion,inflammation modulation,antibody-antigen binding,cell surface marking
ENSG00000167208,SNX20,regulation of membrane trafficking,pi3k/akt pathway modulation,cell surface receptor dynamics regulation,tumor suppressor or oncogene,molecular chaperone for egfr and her2,signaling pathways involved in proliferation and survival
ENSG00000176624,MEX3C,tumor suppressor regulation,oncogenic function,cell proliferation regulation,apoptosis resistance,microrna regulation,gene expression modulation
ENSG00000131721,RHOXF2,epigenetic regulation,transcriptional activation,chromatin remodeling,cell cycle progression,oncogenic transformation,cytoskeletal organization
ENSG00000276452,LILRB1,immune regulation,tumor evasion,mhc class i interaction,inhibitory receptor function,immune cell modulation,dendritic cell expression
ENSG00000071626,DAZAP1,cellular regulation,tumor suppressor function,transcriptional repressor,oncogene modulation,apoptosis regulation,genomic instability
ENSG00000196470,SIAH1,protein degradation regulation,transcriptional control,tumor growth promotion,p53 interaction,cell cycle modulation,apoptosis inhibition
ENSG00000084774,CAD,tumor growth,cell proliferation,promising biomarker,collagen degradation,tissue invasion,acid-base regulation
ENSG00000135829,DHX9,rna processing,tumor progression,oncogene regulation,poor prognosis,cancer metastasis,prognostic biomarker
ENSG00000153187,HNRNPU,rna processing,transcription regulation,tumor progression,cell proliferation,multifunctional protein,oncogenic functions
ENSG00000077235,GTF3C1,altered transcriptional regulation,rna polymerase iii-mediated transcription,cell proliferation,tumor suppressor function loss,cancer driver mutations,chromatin remodeling
ENSG00000071054,MAP4K4,cell proliferation,tumor progression,metastasis regulation,signal transduction,stress response activation,apoptosis inhibition
ENSG00000012232,EXTL3,cell growth regulation,genomic stability maintenance,oncogene overexpression,tumorigenesis promotion,angiogenesis regulation,poor prognosis marker
ENSG00000145088,EAF2,chromatin remodeling,genomic instability,cell cycle progression,transcriptional regulation,tumor progression,therapeutic target
ENSG00000121310,ECHDC2,metabolic reprogramming,gain of function mutations,fatty acid biosynthesis,anabolic metabolism,therapeutic target,cellular energy metabolism
ENSG00000141564,RPTOR,mtor signaling pathway,aberrant activation,tumor progression,therapeutic target,cell growth regulation,protein kinase activity
ENSG00000101306,MYLK2,cell migration,overexpression,cancer progression,epithelial-to-mesenchymal transition,metastasis promoter,tumor proliferation
ENSG00000197102,DYNC1H1,microtubule transport,dysregulated expression,tumor progression,mitotic spindle assembly,cell division regulation,cytoplasmic dynein complex
ENSG00000101557,USP14,deubiquitination,regulation of proteasome function,maintenance of cellular homeostasis,cell survival enhancement,therapeutic resistance promotion,apoptosis inhibition
ENSG00000281320,DYRK1B,oncogenic driver,protein kinase activation,cell proliferation,metastasis promotion,mapk/erk pathway interaction,genetic mutations
ENSG00000120756,PLS1,oncogenic activity,tumor progression,metastasis resistance,signaling pathway modulation,prognostic marker,therapeutic target
ENSG00000176171,BNIP3,hypoxic response,mitochondrial regulation,cell survival,apoptosis induction,angiogenesis promotion,tumor suppressor function
ENSG00000049449,RCN1,chaperone activity,protein homeostasis,oncogenic process,metastatic potential,cell proliferation,protein stability degradation
ENSG00000128045,RASL11B,cell cycle regulation,constitutive activation,gain of function mutations,protein-protein interactions,apoptosis regulation,oncogenic signaling
ENSG00000186716,BCR,bcr-abl fusion,constitutive tyrosine kinase activity,chronic myeloid leukemia,targeted therapy resistance,cell proliferation and survival,b-cell antigen receptor signaling pathway
ENSG00000151694,ADAM17,tumor microenvironment modification,growth factor processing,signaling pathway modulation,cell surface protein cleavage,angiogenesis promotion,metastasis facilitation
ENSG00000064607,SUGP2,cell proliferation regulation,oncogenic driver,tumor progression promotion,apoptosis evasion mechanism,transcriptional regulation,protein-protein interaction
ENSG00000162728,KCNJ9,altered channel function,aberrant ion transport,cellular homeostasis disruption,oncogenic processes promotion,tumor progression facilitation,ion channel modulation
ENSG00000276825,DRD4,dopamine receptor regulation,oncogene activation,cell proliferation enhancement,epithelial-to-mesenchymal transition,pi3k/akt pathway activation,neurotransmitter signaling modulation
ENSG00000155366,RHOC,cellular migration,constitutive activation,amplification mutations,metastasis promotion,cytoplasmic signaling,cell invasion
ENSG00000111913,RIPOR2,lysosomal dysfunction,aberrant protein trafficking,cellular homeostasis regulation,metabolic regulation,cancer progression,tumor cell survival
ENSG00000196839,ADA,genomic stability,adenosine regulation,immune evasion,purine metabolism,tumor microenvironment,dna repair
ENSG00000151150,ANK3,loss or gain of function mutations,tumor progression,cellular metabolic regulation,ion channel regulation,cell proliferation,therapeutic target
ENSG00000119402,FBXW2,cell cycle progression,tumor suppressor function,loss of cell cycle arrest,mutation associated,oncogene activity,transcription regulation
ENSG00000169057,MECP2,epigenetic regulator,tumor promoter,cell proliferation,apoptosis inhibition,methylation pattern disruption,prognostic marker
ENSG00000151466,SCLT1,emt regulation,cell migration,adhesion molecule regulation,oncogene function,therapeutic target,protein-protein interaction
ENSG00000132694,ARHGEF11,rhoa activation,gtpase regulation,oncogenic signaling,tumor aggressiveness,cell migration,apoptosis resistance
ENSG00000166670,MMP10,ecm degradation,tumor progression,cancer cell invasion,angiogenesis,pro-inflammatory signaling,growth factor regulation
ENSG00000178031,ADAMTSL1,proteolytic activity,cell adhesion modulation,oncogenesis promotion,cell growth enhancement,therapeutic target,genomic instability
ENSG00000173914,RBM4B,genomic amplification,oncogenic expression,rna-binding protein function,cell cycle regulation,apoptosis inhibition,tumor progression
ENSG00000170485,NPAS2,transcription regulation,cell cycle modulation,tumor promoter,oncogenic transformation,genomic instability,protein-protein interaction
ENSG00000081154,PCNP,cell adhesion regulation,dysregulated metalloprotease activity,oncogenic processes promotion,tumor progression enhancement,cell growth and survival promotion,hb-egf processing involvement
ENSG00000149084,HSD17B12,cellular interaction,promotes cell growth,akt signaling pathway,cancer progression,lipid metabolism regulation,tumor promoter
ENSG00000092841,MYL6,actomyosin contractility,apoptosis regulation,cell proliferation,cell invasion,genetic amplification,tumor metastasis
ENSG00000115073,ACTR1B,signaling pathway aberration,transcriptional regulation disruption,oncogenic signaling activation,coactivator complex interaction,tumor progression promotion,genomic instability contribution
ENSG00000100823,APEX1,genomic instability,base excision repair,dna repair enzyme,apurinic/apyrimidinic endonuclease activity,dna damage response,ber pathway dysfunction
ENSG00000188229,TUBB4B,microtubule dynamics,tumor growth and progression,cellular structure disruption,apoptosis resistance,cell proliferation enhancement,cell migration alteration
ENSG00000104267,CA2,tumor progression,co2 transport,metabolic adaptation,ph regulation,acid-base balance,proton pumping
ENSG00000113013,HSPA9,mitochondrial chaperone,tumor growth promotion,energy metabolism regulation,cellular homeostasis maintenance,hif-1α stabilization,ros production enhancement
ENSG00000166441,RPL27A,ribosome assembly,dysregulated protein synthesis,tumorigenesis,cancer driver mutations,autophagic regulation,apoptotic evasion
ENSG00000053501,USE1,protein degradation regulation,oncogenic protein accumulation,cellular stress response modulation,tumor progression influence,therapeutic target,genomic stability maintenance
ENSG00000072501,SMC1A,genomic instability,chromosomal segregation,cohesin complex,anaphase regulation,aneuploidy driver,dna damage response
ENSG00000281459,PADI1,cancer-associated protein modification,citrullination of arginine residues,regulation of protein function,cell signaling modulation,tumor-promoting effects,immune response modulation
ENSG00000182446,NPLOC4,nuclear transport regulation,cell cycle disruption,genomic instability,transcriptional dysregulation,tumor progression,therapeutic target
ENSG00000070087,PFN2,actin cytoskeleton regulation,cell migration,apoptosis regulation,metabolic reprogramming,tumor aggressiveness,protein-protein interactions
ENSG00000134899,ERCC5,genomic instability,defective dna repair,increased mutational burden,tumor suppressor function,loss of heterozygosity,genome maintenance
ENSG00000081181,ARG2,arginine metabolism,nitric oxide depletion,hypoxia response,cell proliferation inhibition,tumor progression facilitation,biomarker identification
ENSG00000215182,MUC5AC,tumor progression,epithelial barrier disruption,oncogene activation,angiogenesis facilitation,metastasis enhancement,stem cell maintenance
ENSG00000122852,SFTPA1,lung tissue maintenance,tumor suppression,cellular differentiation,cell growth regulation,pulmonary surfactant regulation,genetic predisposition
ENSG00000154447,SH3RF1,oncogene overexpression,pi3k/akt pathway interaction,tumor growth promotion,poor prognosis association,dna damage response regulation,cell cycle progression dysregulation
ENSG00000161509,GRIN2C,nmda receptor,neurotransmission regulation,tumor progression,cell proliferation enhancement,migration facilitation,cancer stem cell regulation
ENSG00000044090,CUL7,tumor suppression,cell cycle regulation,apoptosis induction,dna damage response,transcriptional control modulation,proteasome-dependent degradation
ENSG00000104321,TRPA1,overexpression,pain signaling modulation,calcium channel regulation,inflammation mediation,cell proliferation enhancement,therapeutic target
ENSG00000198034,RPS4X,ribosome biogenesis,oncogenic function,cellular proliferation,translational regulation,protein synthesis initiation,tumor progression
ENSG00000111669,TPI1,glycolytic regulation,cellular metabolism,cancer biomarker,prognostic indicator,therapeutic target,redox balance
ENSG00000139722,VPS37B,constitutive activation,tumor progression,genomic instability,cell proliferation,endosomal sorting,escrt complex dysfunction
ENSG00000144381,HSPD1,mitochondrial chaperone,protein folding and assembly,cell survival and proliferation,oncogenesis and metastasis,thermal and oxidative stress protection,heat shock protein interaction
ENSG00000196482,ESRRG,er transcriptional regulation,estrogen response element binding,oncogenic function,tumor progression,metastatic potential,therapeutic target
ENSG00000169297,NR0B1,steroidogenesis regulation,tumor suppression,transcriptional repression,nuclear localization,oncogene inhibition,apoptosis promotion
ENSG00000186468,RPS23,ribosome biogenesis,tumor suppressor function,cell cycle regulation,anti-apoptotic activity,protein synthesis enhancement,tumorigenic potential
ENSG00000169564,PCBP1,rna-binding protein,poly(c) binding,tumor suppressor/oncogene,cell cycle regulation,apoptosis pathway,mrna stability
ENSG00000171345,KRT19,cell polarity disruption,epithelial cell integrity loss,oncogene overexpression,metastatic potential enhancement,tumor progression marker,cell growth promotion
ENSG00000182809,CRIP2,cellular regulation,oncogenic properties,cell survival enhancement,protein-protein interaction,mrna stability modulation,growth promotion
ENSG00000204536,CCHCR1,chromatin remodeling,histone chaperoning,cell proliferation,genomic instability,cell cycle regulation,dna replication repair
ENSG00000092208,GEMIN2,cell cycle inhibition,microrna regulation,g1-s transition,tumor suppressor,genome instability,cell proliferation
ENSG00000163737,PF4,angiogenic signaling,upregulation in cancer,thrombosis regulation,metastasis promotion,protein-protein interaction,chemokine function
ENSG00000106948,AKNA,genomic instability,chromatin remodeling,sister chromatid cohesion,dna repair deficiency,transcriptional activation,proliferation enhancement
ENSG00000198931,APRT,purine metabolism,tumor growth,dna repair mechanisms,cellular energy metabolism,nucleotide synthesis pathways,therapeutic target
ENSG00000154310,TNIK,oncogene,aberrant signaling,cell proliferation,genomic instability,transcriptional regulation,wnt signaling pathway
ENSG00000188739,RBM34,cell cycle regulation,transcriptional regulation,oncogene function,rna binding protein,tumor growth promotion,apoptosis inhibition
ENSG00000178184,PARD6G,planar cell polarity signaling,cancer driver mutation,gene amplification,mitotic spindle formation,dysregulated cell adhesion,cell migration and invasion
ENSG00000139218,SCAF11,genomic instability,dna damage response,tumor suppressor,nucleotide excision repair,base excision repair,histone modification
ENSG00000183741,CBX6,chromatin modification,epigenetic regulation,polycomb repressive complex 1,genomic stability,tumor suppressor silencing,cell cycle progression
ENSG00000125901,MRPS26,mitochondrial biogenesis,mitochondrial translation,tumor suppressor,metabolic reprogramming,cellular respiration,protein synthesis regulation
ENSG00000138100,TRIM54,mitochondrial localization,tumor suppressor activity,anti-proliferative effects,apoptosis promotion,protein degradation regulation,none
ENSG00000082805,ERC1,r-loop degradation,genomic stability maintenance,endonuclease activity,dna damage prevention,tumor suppression,genome instability promotion
ENSG00000168439,STIP1,oncogenic protein regulation,hsp70/hsc70 interaction,cellular growth modulation,tumor suppressor regulation,co-chaperone function,protein folding facilitation
ENSG00000115816,CEBPZ,cell cycle regulation,tumor suppressor function,apoptosis modulation,transcriptional regulation,genetic instability,signaling pathway interaction
ENSG00000146007,ZMAT2,chromatin remodeling,transcriptional regulation,cell cycle regulation,dna damage response,apoptosis inhibition,tumor progression driver
ENSG00000171860,C3AR1,complement regulation,immune modulation,tumor microenvironment,signaling pathway interaction,gene expression changes,biomarker potential
ENSG00000273562,NAP1L4,histone modification,chromatin remodeling,cell proliferation,oncogenesis,transcriptional regulation,cell cycle progression
ENSG00000230624,DDX39B,transcription regulation,dna repair,cell cycle progression,apoptosis evasion,oncogenic suppression,epigenetic modification
ENSG00000130706,ADRM1,androgen receptor regulation,zinc finger domain,c4hc3-type zinc finger,hormone-dependent cancer,prostate cancer,breast cancer
ENSG00000160213,CSTB,lysosomal function,tumor suppressor activity,genomic instability,protease inhibition,cellular homeostasis,dna repair mechanism
ENSG00000104852,SNRNP70,spliceosome regulation,aneuploidy,chromosomal instability,microrna processing alteration,tumor suppressor function,loss of heterozygosity
ENSG00000101916,TLR8,innate immunity regulation,immunosuppressive environment creation,viral rna recognition,inflammatory response induction,tumor microenvironment modulation,oncogene or tumor suppressor potential
ENSG00000100129,EIF3L,critical regulator of protein synthesis,tumor progression driver,resistance to targeted therapies,oncogene activation,cell proliferation enhancer,genomic instability inducer
ENSG00000146676,PURB,protein stability regulation,oncogenic protein regulation,signaling pathway modulation,tumorigenesis association,co-chaperone interaction,cellular quality control
ENSG00000086061,DNAJA1,mitochondrial function regulation,apoptosis resistance,chaperone activity,proliferation promotion,cell survival enhancement,tumor progression facilitation
ENSG00000215271,HOMEZ,hox family member,transcriptional regulation,cellular differentiation,stem cell self-renewal,tumor progression,metastasis
ENSG00000109606,DHX15,rna processing,dna damage repair,genomic instability,oncogene regulation,cell proliferation,signaling pathway modulation
ENSG00000177105,RHOG,rho/rock pathway activation,cell growth promotion,pro-oncogenic properties,metastasis facilitation,cell adhesion regulation,proliferation enhancement
ENSG00000142409,ZNF787,transcriptional regulation,cancer-associated,cell cycle progression,apoptosis inhibition,dna repair suppression,tumor proliferation
ENSG00000172301,COPRS,cell growth regulation,protein degradation regulation,nf-κb signaling pathway interaction,cancer driver mutations,cell proliferation promotion,ubiquitin-proteasome pathway component 
ENSG00000101350,KIF3B,cell cycle regulation,microtubule-based processes,oncogenic mutations,genomic instability,cell proliferation,constitutive expression
ENSG00000167792,NDUFV1,mitochondrial function,tumor suppressor gene,metabolic reprogramming,electron transport chain,reduced atp production,increased ros levels
ENSG00000082175,PGR,regulatory role in gene expression,aberrant cellular behavior,tumor growth promotion,dysregulated interaction,cellular differentiation inhibition,metastatic potential enhancement
ENSG00000168286,THAP11,transcriptional regulation,oncogenic activity,cell proliferation enhancement,apoptosis suppression,dna repair modulation,epigenetic modification
ENSG00000167967,E4F1,oncogenic transformation,transcriptional regulation,cellular proliferation,epigenetic modulation,metastatic potential,tumor suppressor suppression
ENSG00000117650,NEK2,cell cycle regulation,chromatin remodeling,histone phosphorylation,genetic instability,oncogenic pathway activation,therapeutic target
ENSG00000076003,MCM6,genomic instability,cell cycle regulation,dna replication,cell proliferation,oncogenesis,therapeutic target
ENSG00000101197,BIRC7,inhibitor of apoptosis,apoptosis inhibition,cell survival enhancement,genomic instability,cell growth promotion,tumor progression resistance
ENSG00000228267,C4B,complement system activation,immune evasion,cell proliferation regulation,tumor progression modulation,glycosylation modification,protein-protein interactions
ENSG00000233312,C4B_2,tumor progression,immune suppression,complement system activation,gene overexpression,immunosuppressive microenvironment,cancer prognosis
ENSG00000146063,TRIM41,tumor suppressor function,regulation of cell proliferation,transcription factor interaction,oncogene inhibition,cancer prognosis,antiviral defense
ENSG00000104388,RAB2A,rab gtpase activity,aberrant activation,cellular proliferation,tumor growth promotion,oncogenic signaling,membrane trafficking regulation
ENSG00000139990,DCAF5,cul4-ring e3 ubiquitin ligase complex,cell cycle progression,chromatin modification,dna damage response,genomic stability,oncogenic mutations
ENSG00000136111,TBC1D4,endosomal-lysosomal dysfunction,oncogene activation,autophagy regulation,cell growth promotion,metastasis facilitation,gap activity inhibition
ENSG00000140299,BNIP2,mitochondrial function,anti-apoptotic properties,tumor progression,growth inhibition,apoptosis regulation,mitochondrial integrity
ENSG00000142864,SERBP1,tumor progression,oncogenic processes,overexpression,cell migration,splicing regulation,alternative splicing
ENSG00000229314,ORM1,oncogenic driver,cell migration regulation,tumor progression facilitation,adhesion molecule interaction,inflammation modulation,immune evasion support
ENSG00000285258,ATXN7,histone acetyltransferase complex,chromatin regulation,epigenetic marks,oncogene potential,prognostic marker,tumor suppressor interaction
ENSG00000111581,NUP107,nuclear pore complex,genomic stability,cell cycle regulation,dna repair,transcriptional control,tumorigenesis facilitation
ENSG00000187754,SSX7,tumor suppressor interaction,brca1/2 pathway inhibition,oncogenic potential,protein-protein interaction,cell proliferation regulation,synovial sarcoma association
ENSG00000163736,PPBP,cell migration,promotes tumor aggressiveness,overexpressed in cancer,protein folding regulation,signaling pathway activation,metastasis promotion
ENSG00000188404,SELL,cell adhesion,tumor progression,chemoresistance,immune evasion,cell migration,genomic instability
ENSG00000152234,ATP5F1A,mitochondrial function,energy metabolism regulation,cellular proliferation enhancement,metabolic adaptation,oncogenic signaling pathway involvement,tumor growth promotion
ENSG00000162302,RPS6KA4,ribosomal protein synthesis,mtor pathway activation,cell proliferation enhancement,tumor progression promotion,protein kinase activation,signaling pathway modulation
ENSG00000141551,CSNK1D,phosphorylation regulation,oncogene activation,cell proliferation enhancement,therapeutic target identification,signaling pathway modulation,tumor growth inhibition
ENSG00000177733,HNRNPA0,rna-binding protein,pre-mrna splicing,hnrnp complex formation,au-rich element recognition,mrna stability regulation,tumor progression
ENSG00000132182,NUP210,nuclear pore complex assembly,aberrant nucleocytoplasmic transport,rapid cell proliferation,increased metastatic potential,chemosensitivity reduction,genomic instability maintenance
ENSG00000065154,OAT,amino acid transport,cell proliferation,oncogene overexpression,tumor aggressiveness,sodium-dependent transport,amino acid homeostasis
ENSG00000180228,PRKRA,cellular regulation,oncogenic processes,interferon signaling,apoptosis resistance,kinase activation,tumor progression
ENSG00000177169,ULK1,apoptosis induction,autophagic regulation,cell death promotion,oncogenic potential,protein kinase activation,tumor suppression
ENSG00000049540,ELN,elastase inhibition,cell growth regulation,apoptosis evasion,tumor progression modulation,signaling pathway interaction,proteolytic activity regulation
ENSG00000087303,NID2,basement membrane degradation,tumor cell invasion,ecm remodeling,prognostic biomarker,migratory capacity,glycoprotein function
ENSG00000165861,ZFYVE1,pi3k/akt interaction,tumor aggressiveness,protein degradation,endosomal trafficking,lipid metabolism,dna repair
ENSG00000139880,CDH24,adhesion molecule disruption,cell migration facilitation,prognostic marker,therapeutic target,tumor progression enhancement,metastasis promotion
ENSG00000118705,RPN2,proteasome activation,ubiquitin-dependent degradation,cell cycle regulation,apoptosis modulation,tumor suppressor protein degradation,oncogenesis promotion
ENSG00000163939,PBRM1,baf complex disruption,chromatin remodeling,dna repair deficiency,genomic instability,loss-of-function mutations,swi/snf pathway dysfunction
ENSG00000100220,RTCB,cellular growth,genomic stability,nucleotide biosynthesis,dna replication,oncogenesis,metabolic regulation
ENSG00000186010,NDUFA13,mitochondrial function,dysregulated energy metabolism,impaired respiratory chain,electron transfer deficiency,rapid cell growth,cancer progression driver
ENSG00000240694,PNMA2,pi3k/akt pathway,constitutive activation,oncogenic processes,cell proliferation,survival,metastasis
ENSG00000090054,SPTLC1,ceramide regulation,gene mutation,neurodegenerative disorder,cell growth modulation,sphingolipid biosynthesis,tumor progression
ENSG00000095627,TDRD1,microrna regulation,tumor progression marker,nuclear localization,ago2 interaction,rna stability modulation,methylated arginine recognition
ENSG00000099937,SERPIND1,cellular invasion,angiogenesis regulation,tumor growth promotion,apoptosis evasion,autocrine signaling,protease inhibition
ENSG00000081913,PHLPP1,dephosphorylation mechanism,negative regulator,tumor suppressor,cell growth inhibition,akt pathway modulation,genomic instability
ENSG00000121410,A1BG,cellular regulation,gene expression modulation,apoptosis regulation,cell signaling,transcriptional regulation,protein interaction
ENSG00000108839,ALOX12,angiogenesis promotion,cancer progression,eicosanoid production,immune evasion,inflammatory response,metastasis facilitation
ENSG00000164265,SCGB3A2,antimicrobial function,epithelial integrity maintenance,tumor suppression,poor prognosis marker,downregulated expression,cancer-related downregulation
ENSG00000019169,MARCO,immunomodulation,tumor progression,promotes immune evasion,phagocytosis regulation,receptor protein function,immune suppression
ENSG00000056998,GYG2,protein modification,cell proliferation,tumor progression,signaling pathway,oncogenic transformation,genetic instability
ENSG00000074800,ENO1,glycolysis promotion,oncogene activation,multifunctional enzyme,warburg effect facilitation,prognostic biomarker,metabolic regulation enhancement
ENSG00000167004,PDIA3,tumor progression,cell proliferation,metastasis promotion,apoptosis evasion,cell survival enhancement,therapeutic target
ENSG00000171621,SPSB1,spliceosomal protein,rna processing,cell proliferation,oncogene/tumor suppressor potential,genomic profiling,regulatory mechanisms
ENSG00000111802,TDP2,dna repair,genome stability,apoptosis induction,top2 cleavage complex resolution,cellular response to dna damage,nucleus and cytoplasm localization 
ENSG00000133142,TCEAL4,apoptosis regulation,cell cycle regulation,dna repair mechanisms,oncogene or tumor suppressor,prognostic biomarker,tumor suppression
ENSG00000174255,ZNF80,transcriptional regulation,chromatin remodeling,tumor suppressor function,gene expression modulation,cell cycle regulation,apoptosis dysregulation
ENSG00000147604,RPL7,oncogenic process,ribosome function,cellular proliferation,tumor growth,poor prognosis,translation regulation
ENSG00000135625,EGR4,cell cycle regulation,tumor suppressor,dna repair,apoptosis induction,transcriptional regulation,gene expression modulation
ENSG00000263163,SLC27A3,cell membrane synthesis,fatty acid transport,lipid metabolism regulation,tumor growth promotion,metastasis facilitation,energy production enhancement
ENSG00000101856,PGRMC1,cellular regulation,steroid hormone receptor interaction,oncogenic pathway activation,tumor progression,angiogenesis promotion,immune response modulation
ENSG00000145012,LPP,phosphoinositide binding,oncogenic function,tumor progression,cell survival regulation,metabolic regulation,protein-protein interaction
ENSG00000153208,MERTK,aberrant expression,cell death regulation,immunomodulation,oncogenic signaling,receptor tyrosine kinase activity,tumorigenesis driver
ENSG00000105197,TIMM50,mitochondrial biogenesis,mitochondrial protein import,tumor progression biomarker,oncogenic potential,dna damage response,cellular energy metabolism
ENSG00000170759,KIF5B,genomic instability,co-amplification with nut gene,fusion protein,cell cycle regulation,mitotic spindle formation,kinesin activity
ENSG00000105372,RPS19,cellular protein synthesis,chromatin regulation,tumor suppression,wnt/β-catenin pathway,transcriptional modulation,ribosomal function
ENSG00000067082,KLF6,tumor suppressor,transcriptional regulator,genome stability maintenance,epigenetic modification,cell cycle regulation,apoptosis modulation
ENSG00000110107,PRPF19,spliceosome assembly,rna processing,cancer driver gene,tumor suppressor dysfunction,cell cycle regulation disruption,apoptosis evasion
ENSG00000205937,RNPS1,histone modification regulation,chromatin remodeling activity,epithelial-to-mesenchymal transition,cancer stem cell maintenance,oncogenic protein interaction,tumor progression enhancement
ENSG00000114316,USP4,oncogenic role,tumor progression,therapeutic target,cell proliferation,protein degradation regulation,ubiquitination modification
ENSG00000162999,DUSP19,tumor suppressor function,mapk/erk pathway regulation,cell proliferation inhibition,erk2 dephosphorylation,prognostic marker potential,therapeutic target candidate
ENSG00000106344,RBM28,rna binding protein,nuclear pore complex regulation,mrna export regulation,cellular proliferation enhancement,oncogene regulation dysregulation,gene expression modulation
ENSG00000108651,UTP6,pre-mrna splicing regulation,cellular transformation,spliceosome assembly,genome stability disruption,protein-protein interactions,aberrant gene expression
ENSG00000056736,IL17RB,il-17/il-17r signaling pathway,pro-inflammatory cytokine production,tumor cell growth,survival and metastasis,immune response modulation,nf-κb/mapk signaling cascade
ENSG00000285433,DEFB4B,aberrant expression,antibacterial activity,apoptosis regulation,antitumor activity,epithelial cell expression,tumor progression marker
ENSG00000285181,DEFB4A,antimicrobial peptides,immune modulation,innate immunity,apoptosis regulation,tumor cell lysis,nf-κb regulation
ENSG00000131437,KIF3A,microtubule-based transport,mitotic spindle formation,chromosome segregation,centrosome organization,tumorigenesis,cancer progression
ENSG00000172943,PHF8,histone demethylation,epigenetic regulation,chromatin remodeling,transcriptional activation,cancer aggressiveness,tumor suppressor inhibition
ENSG00000008118,CAMK1G,protein kinase activation,cell proliferation,calcium-dependent signaling,cancer progression,tumor initiation,genomic instability
ENSG00000157916,RER1,autophagy regulation,cellular trafficking modulation,retrograde transport facilitation,endosomal pathway involvement,tumor biology contribution,growth signaling modulation
ENSG00000145016,RUBCN,mitochondrial regulation,autophagy modulation,oncogene interaction,tumor progression,cell survival enhancement,genomic amplification
ENSG00000197451,HNRNPAB,oncogenic function,cell proliferation,rna processing regulation,tumor progression,protein-protein interaction,genetic mutation
ENSG00000163931,TKT,glycolytic reprogramming,enhanced glucose metabolism,redox balance regulation,oncogenic transformation,hypoxia adaptation,nucleotide biosynthesis
ENSG00000121741,ZMYM2,tumor suppressor function,transcriptional repressor activity,chromatin remodeling,cell proliferation regulation,apoptosis modulation,oncogenic pathway activation
,HIST2H2AB,chromatin remodeling,tumor suppressor function,genomic instability,epigenetic regulation,cell cycle progression,transcriptional control
ENSG00000177189,RPS6KA3,oncogenic kinase,constitutive activation,cell proliferation,metastasis,downstream signaling pathway,serine/threonine phosphorylation
ENSG00000212935,KRTAP10-3,keratin-associated protein,skin and hair biology,hair cortex structural integrity,limited pan-cancer association,cellular mechanical properties regulation,not directly implicated in oncogenic processes
ENSG00000277377,SERPINA1,tumor suppressive function,apoptosis regulation,immune evasion mechanisms,protease inhibition,cell proliferation enhancement,dual oncogenic role
ENSG00000197694,SPTAN1,cell adhesion dysregulation,cytoskeletal reorganization,metastatic potential,oncogenic processes,protein-protein interactions,tumorigenic mechanisms
ENSG00000131504,DIAPH1,constitutive activation,cell proliferation,tumor progression,mitotic spindle regulation,microtubule stabilization,therapeutic target
ENSG00000128739,SNRPN,alternative splicing regulation,epigenetic gene silencing,rna processing disruption,cell growth and proliferation regulation,snrnp complex assembly,x-inactivation center regulation
ENSG00000105854,PON2,oncogenic properties,cellular antioxidant function,cell survival promotion,tumor progression association,prognostic marker,chemotherapy resistance
ENSG00000189266,PNRC2,chromatin remodeling,cell proliferation,epigenetic regulation,pi3k/akt pathway,transcriptional activation,nuclear receptor interaction
ENSG00000134014,ELP3,transcription regulation,oncogenic potential,poor prognosis marker,genetic instability,chromatin remodeling,cell cycle regulation
ENSG00000125944,HNRNPR,gene regulation,rna processing,transcriptional regulation,cell cycle progression,oncogenesis,post-transcriptional gene silencing
ENSG00000163815,CLEC3B,cell surface recognition,immune response modulation,tumor aggressiveness,apoptotic cell recognition,metastatic progression,prognostic marker
ENSG00000186395,KRT10,cytoskeletal regulation,epithelial cell integrity,cell proliferation promotion,emt suppression,prognostic biomarker,oncogenic signaling interaction
ENSG00000169018,FEM1B,regulation of cell proliferation,apoptosis inhibition,genome stability maintenance,tumor suppressor function,cell cycle regulation,dna repair pathway interaction
ENSG00000173812,EIF1,translational regulation,start codon recognition,cell growth promotion,tumor progression driver,protein synthesis enhancement,oncogenic mechanism
ENSG00000078804,TP53INP2,genomic instability,cell cycle regulation,tumor suppressor function,poor prognosis indicator,apoptosis dysregulation,dna repair mechanism disruption
ENSG00000128573,FOXP2,transcription factor,epithelial-to-mesenchymal transition,cell migration,tumor progression,oncogenic potential,regulatory protein interactions
ENSG00000096080,MRPS18A,mitochondrial biogenesis,cellular metabolism,oncogenic potential,cell proliferation,protein-protein interaction,regulatory mechanism
ENSG00000131507,NDFIP1,protein degradation,ubiquitin ligase interaction,cell signaling modulation,tumor suppressor regulation,oncogenic potential,metastasis promotion
ENSG00000119725,ZNF410,transcription factor regulation,overexpression in cancer,poor prognosis marker,tumor progression regulator,signaling pathway modulation,stemness and emt regulator
ENSG00000062524,LTK,cell signaling pathway,tumor progression,immune response modulation,protein-protein interaction,gene amplification,cell proliferation 
ENSG00000177674,AGTRAP,ras signaling,tumor suppressor function,cellular homeostasis regulation,angiotensin ii type 2 receptor interaction,mutation-associated oncogenesis,tumor growth inhibition
ENSG00000127743,IL17B,tumor suppressor function,dual oncogene/tumor suppressor role,immune modulation,cell proliferation regulation,apoptosis inhibition,mutation/alteration in cancer
ENSG00000142945,KIF2C,cell division regulation,genomic instability,oncogenic potential,mitotic checkpoint disruption,cell cycle dysregulation,microtubule dynamics modulation
ENSG00000147679,UTP23,rna processing,constitutive activation,aberrant splicing patterns,tumor progression,genomic instability,cellular responses to dna damage
ENSG00000185825,BCAP31,oncogenic activity,cell signaling regulation,tumor growth promotion,metastasis facilitation,protein-protein interaction,adaptor function
ENSG00000109107,ALDOC,oncogene,aldehyde dehydrogenase activity,cellular metabolism regulation,stress response modulation,chemoresistance induction,tumor progression promotion
ENSG00000149925,ALDOA,glycolytic reprogramming,oncogene activation,glycolysis enhancement,cell proliferation promotion,tumor aggressiveness enhancer,biological pathway interaction
ENSG00000115825,PRKD3,cell signaling,constitutive activation,gain of function mutations,tumor progression,metastasis regulation,protein kinase activation
ENSG00000147130,ZMYM3,chromatin remodeling,transcriptional regulation,oncogenic transformation,epithelial-to-mesenchymal transition,tumor progression,therapeutic target
ENSG00000163132,MSX1,tumor suppressor,cell cycle regulation,embryonic development,transcriptional regulation,cancer prevention,genetic instability
ENSG00000276618,RAD17,genomic instability,double-strand break repair,interstrand crosslink repair,dna replication,genome maintenance,oncogenic mutations
ENSG00000132254,ARFIP2,arfip2,oncogene,cell surface transport regulation,membrane trafficking facilitation,egfr recycling promotion,poor prognosis association
ENSG00000159111,MRPL10,mitochondrial ribosome function,enhanced cell proliferation,aberrant expression levels,cellular metabolism regulation,apoptosis resistance,protein-protein interactions
ENSG00000163221,S100A12,angiogenesis promotion,metastasis facilitation,inflammatory response modulation,oxidative stress induction,cell cycle regulation disruption,tumor progression enhancement
ENSG00000181788,SIAH2,ubiquitination regulation,apoptosis modulation,transcriptional regulation,cell cycle control,tumor suppressor/oncogene switch,substrate interactions
ENSG00000111247,RAD51AP1,genomic instability,tumor suppressor function,dna repair pathway interaction,biomarker for treatment response,cancer therapy resistance,apoptosis regulation
ENSG00000197498,RPF2,translation initiation,altered translation regulation,ribosome association,aberrant protein synthesis,cancer driver mutation,therapeutic target
ENSG00000117395,EBNA1BP2,ebna1bp2,oncogene activation,epstein-barr virus association,transcriptional regulation,cell cycle progression,apoptosis inhibition
ENSG00000143742,SRP9,protein synthesis regulation,tumor progression promotion,misfolded protein accumulation,aberrant protein secretion,protein homeostasis maintenance,oncogenic process contribution
ENSG00000142168,SOD1,redox regulation,oxidative stress response,mitochondrial dysfunction,protein misfolding,cancer cell survival,genomic instability
ENSG00000152214,RIT2,regulation of cell growth,gtpase activity,signaling pathway activation,oncogenic properties,cell proliferation,metastasis promotion
ENSG00000120800,UTP20,altered pre-mrna splicing,enhanced cell proliferation,genomic instability,increased genomic mutations,oncogene activation,rna processing regulation
ENSG00000011007,ELOA,rna helicase function,gene expression regulation,tumor suppressor potential,phosphorylation-dependent regulation,dna replication regulation,cancer mutation hotspot
ENSG00000140988,RPS2,translation initiation,mtor pathway activation,cell proliferation enhancement,metabolic reprogramming,protein synthesis promotion,ribosomal subunit composition
ENSG00000067596,DHX8,genomic instability,gene mutation,tumor progression,dna repair,apoptosis regulation,cancer driver gene
ENSG00000176783,RUFY1,autophagic regulation,cell cycle progression,cancer driver,oncogenic protein,tumor progression,cell growth regulation
ENSG00000107625,DDX50,ddx50 regulation,rna helicase activity,cell proliferation,transcriptional modulation,oncogene function,cell cycle progression
ENSG00000137804,NUSAP1,microtubule regulation,oncogenic potential,cell division facilitation,mitotic activity promotion,chromosome stability maintenance,prognostic marker status
ENSG00000131018,SYNE1,cellular adhesion,cytoplasmic structure modulation,focal adhesion regulation,mitotic spindle assembly,protein interaction network,tumor cell migration
ENSG00000141644,MBD1,oncogene,transcriptional repressor,epigenetic regulation,tumor growth,apoptosis regulation,genome instability
ENSG00000115234,SNX17,endosomal sorting,cell signaling,metastatic regulation,tumor progression,protein-protein interactions,ubiquitin recognition
ENSG00000278741,ABR,drug efflux,multidrug resistance,cell cycle regulation,apoptosis inhibition,genomic instability,prognostic marker
ENSG00000165006,UBAP1,impaired protein degradation pathway,cell growth regulation,gene dysregulation,tumor progression,protein accumulation,therapeutic target
ENSG00000102908,NFAT5,osmoprotection,cell growth regulation,constitutive activation,tumor progression,transcriptional activation,ion transport regulation
ENSG00000169692,AGPAT2,phosphatidic acid synthesis,lysophosphatidic acid conversion,glycerophospholipid biosynthesis,cellular membrane structure,adipocyte differentiation,lipodystrophy pathogenesis
ENSG00000196581,AJAP1,tumor suppressor,cell adhesion regulation,epithelial-to-mesenchymal transition,wnt/β-catenin pathway modulation,metastasis suppression,polarity maintenance
ENSG00000108700,CCL8,chemokine function,immune suppression,tumor metastasis,cell migration,adhesion regulation,tumor microenvironment modulation
ENSG00000175183,CSRP2,pi3k/akt signaling,tumor progression,cell proliferation,oncogenic driver,therapeutic target,genomic instability
,H2AFY,genomic instability,epigenetic alterations,chromatin remodeling,protein-protein interactions,tumor suppressor dysfunction,dna damage response
ENSG00000130830,MPP1,cell adhesion disruption,actin cytoskeleton regulation,tumor progression,tumor cell migration,prognostic marker,metastatic potential
ENSG00000230456,DDR1,cell migration,receptor tyrosine kinase activation,collagen interaction,tumor progression,prognostic marker,therapeutic target
ENSG00000150594,ADRA2A,adrenergic signaling,cellular proliferation,angiogenesis promotion,metastasis facilitation,receptor activation,downstream pathway modulation
ENSG00000104327,CALB1,calcium homeostasis,cellular signaling,oncogenic properties,tumor progression,metastasis marker,protein-protein interaction
ENSG00000079332,SAR1A,copii vesicle formation,constitutive activation,cell signaling disruption,protein secretion regulation,golgi apparatus dysfunction,oncogenic mutation
ENSG00000274442,PRPF8,aberrant splicing,oncogene function,tumor progression,cell proliferation,therapeutic target,genomic instability
ENSG00000196154,S100A4,tumor progression,metastatic progression,cell migration,extracellular matrix degradation,oncogenic outcomes,metastasis-associated gene
ENSG00000073803,MAP3K13,proliferation regulation,apoptosis evasion,tumor suppressor function,cell survival enhancement,therapeutic resistance modulation,oncogenic activation
ENSG00000130656,HBZ,cellular transformation,chromatin remodeling,gene expression regulation,histone modification interaction,oncogenesis promotion,tumor microenvironment modulation
ENSG00000100410,PHF5A,chromatin remodeling,oncogene activation,tumor progression,cell proliferation,apoptosis inhibition,transcriptional regulation
ENSG00000102531,FNDC3A,cell adhesion,tumor progression,metastasis promoter,cell migration,invasive properties,prognostic biomarker
ENSG00000164506,STXBP5,er stress regulation,cancer cell survival,apoptosis resistance,vesicle trafficking regulation,calcium ion release modulation,onco-proliferation enhancement
ENSG00000076944,STXBP2,aberrant regulation,enhanced cell proliferation,oncogenic processes,pi3k/akt pathway alterations,snare complex dysregulation,tumor progression
ENSG00000198258,UBL5,ubiquitination regulation,cellular process modulation,oncoprotein interaction,tumor progression modulation,therapeutic target potential,chemosensitivity regulation
ENSG00000102879,CORO1A,actin filament regulation,apoptosis regulation,cytoplasmic localization,cancer cell proliferation,genome stability maintenance,cell migration facilitation
ENSG00000120948,TARDBP,genomic instability,cytoplasmic mislocalization,tdp-43-tar interaction,proliferation regulation,apoptosis resistance,transcriptional dysregulation
ENSG00000148337,CIZ1,ccn-dependent transcriptional coactivator function,cell proliferation regulation,transcription factor interaction,chromatin remodeling complex assembly,apoptosis modulation,cancer progression facilitation
ENSG00000103507,BCKDK,cellular energy regulation,dysregulated protein-protein interactions,energy metabolic reprogramming,amino acid metabolism alterations,cancer cell survival promotion,mitochondrial dysfunction
ENSG00000104903,LYL1,t-cell activation,cell adhesion disruption,oncogenic transcription factor,cell migration facilitation,proliferation regulation,metastatic progression
ENSG00000141127,PRPSAP2,nucleotide metabolism,cell proliferation,genomic instability,purine synthesis,regulatory complex,cellular signaling
ENSG00000163938,GNL3,ciliogenesis regulation,wnt signaling activation,cell proliferation promotion,centrosome duplication control,oncogenic process involvement,tumorigenesis association
ENSG00000111907,TPD52L1,tp53 interaction,cell cycle regulation,apoptosis modulation,genomic stability maintenance,oncogenic pathway activation,microtubule dynamics regulation
ENSG00000108433,GOSR2,membrane trafficking,golgi apparatus regulation,cell proliferation,apoptosis resistance,tumor progression,cancer driver gene potential
ENSG00000269858,EGLN2,hypoxia-inducible factor,constitutive activation,gain of function mutations,tumor progression,metastasis,prolyl hydroxylation
ENSG00000142794,NBPF3,dna damage recognition,cell cycle regulation,chromatin remodeling,genomic stability,tumor suppression,senescence modulation
ENSG00000126752,SSX1,transcription factor activity,tumor progression,oncogene cooperation,cell proliferation,apoptosis regulation,genomic amplification
ENSG00000196998,WDR45,genomic instability,cell cycle regulation,protein-protein interactions,haploinsufficiency,loss of function mutations,tumor suppressor
ENSG00000182901,RGS7,g-protein coupled receptor signaling,genomic instability,oncogene or tumor suppressor,cell proliferation regulation,protein kinase regulation,genomic stability maintenance
ENSG00000145191,EIF2B5,cellular response,constitutive activation,protein synthesis regulation,tumor progression,oncogene interaction,dna damage response
ENSG00000130037,KCNA5,potassium channel regulation,cellular proliferation,signaling pathway modulation,ion channel function,therapeutic target,oncogenic processes
ENSG00000169504,CLIC4,cellular proliferation,chloride channel activity,enhanced migration,apoptosis inhibition,tumor progression,frequent amplification
ENSG00000125898,FAM110A,genetic instability,oncogenic process,cell cycle control,apoptosis evasion,dna repair pathway,ubiquitin-proteasome system
ENSG00000174891,RSRC1,cop9 signalosome regulation,cell cycle progression,ubiquitin-proteasome pathway,protein degradation regulation,senescence prevention,cancer susceptibility
ENSG00000133574,GIMAP4,apoptosis regulation,cell growth modulation,immune response control,lymphocyte development regulation,oncogenic process contribution,tumor progression
ENSG00000119408,NEK6,cell cycle regulation,constitutive activation,oncogenic driver,genomic instability,therapeutic target,protein kinase activation
ENSG00000133818,RRAS2,constitutive activation,gtp-binding protein,oncogenic driver,tumor progression,cell proliferation enhancement,signaling pathway regulation
ENSG00000170748,RBMXL2,p53 pathway regulation,cellular proliferation modulation,genome stability maintenance,tumor suppressor function alteration,rna processing regulation,protein-protein interaction
ENSG00000153914,SREK1,cellular proliferation,tumor growth,metastasis driver,biomarker potential,stress response modulation,map kinase pathway interaction
ENSG00000166634,SERPINB12,oncogenic regulation,proteolytic activity enhancement,tumor progression facilitation,cell proliferation promotion,apoptosis evasion,genomic instability modulation
ENSG00000105281,SLC1A5,oncogenic role,tumor progression,cell proliferation,nutrient uptake,metabolic regulation,signaling pathway interaction
ENSG00000123405,NFE2,oxidative stress response,tumor-suppressive function,antioxidant defense,transcriptional regulation,dna damage response,cell survival mechanism
ENSG00000110057,UNC93B1,immune surveillance,effector function,toll-like receptor activation,antiviral response,cancer immunosuppression,tumor progression
ENSG00000099901,RANBP1,genome stability,dna damage response,cell proliferation,oncogenic processes,signaling pathway regulation,tumor metastasis
ENSG00000100714,MTHFD1,one carbon metabolism disruption,oncogenic process promotion,nucleotide synthesis regulation,foliar synthesis essentiality,dna repair alteration,methylation pathway modulation
ENSG00000107537,PHYH,peroxisomal function,phytanic acid breakdown,enzymatic regulation,lipid metabolism,genetic deficiency,cellular accumulation
ENSG00000099624,ATP5F1D,mitochondrial dysfunction,altered energy metabolism,disrupted signaling pathways,aberrant cell growth control,tumor suppressor function,genomic instability
ENSG00000157087,ATP2B2,calcium transport,oncogenesis,cell signaling,cellular proliferation,metabolic regulation,protein expression
ENSG00000161647,MPP3,cell signaling regulation,receptor tyrosine kinase activation,tumor progression,cell survival promotion,tyrosine phosphatase activity enhancement,oncogenic process involvement
ENSG00000069275,NUCKS1,cell cycle regulation,cdk activation,dna replication,apoptosis resistance,oncogenic driver,tumor suppressor dysfunction
ENSG00000089775,ZBTB25,apoptosis resistance,cancer development,cell growth regulation,cellular homeostasis disruption,gene expression dysregulation,oncogenic pathway modulation
ENSG00000162231,NXF1,cell cycle regulation,mrna export regulation,therapeutic target,oncogene / tumor suppressor dual function,nuclear pore complex interaction,gene expression modulation
ENSG00000145979,TBC1D7,rab gtpase regulation,membrane trafficking,oncogenic mutations,cell proliferation,growth control disruption,none
ENSG00000134686,PHC2,chromatin remodeling,histone modification,genomic stability,tumor suppressor function,cell cycle regulation,apoptosis induction
ENSG00000063177,RPL18,ribosome biogenesis,elongation phase of translation,proliferation regulation,cell survival modulation,tumor growth influence,genetic mutations
ENSG00000197111,PCBP2,mrna stabilization,tumor progression,cell cycle regulation,apoptosis inhibition,post-transcriptional regulation,rna-binding protein function
ENSG00000105141,CASP14,apoptosis regulation,caspase activation,inflammation response modulation,programmed cell death pathway involvement,tumor suppressor function,cellular survival enhancement
ENSG00000275700,AATF,apoptosis inhibition,cell proliferation enhancement,oncogene activation,metastasis facilitation,transcriptional regulation,protein-protein interaction
ENSG00000136929,HEMGN,histone modification regulation,chromatin structure stability,gene expression regulation,genome integrity maintenance,tumorigenesis implication,cancer-related process modulation
ENSG00000160299,PCNT,centriole duplication,genomic instability,aneuploidy,chromosomal abnormalities,cell cycle regulation,oncogenic potential
ENSG00000163468,CCT3,protein folding and assembly,mitochondrial function,cellular stress response,protein synthesis regulation,misfolding associated with cancer,tumorigenesis driver
ENSG00000131626,PPFIA1,cell adhesion disruption,oncosuppressor function,loss-of-function mutations,cell migration enhancement,cancer progression,protein interaction regulation
ENSG00000112640,PPP2R5D,constitutive activation,gain of function mutations,protein kinase regulation,signal transduction pathway,tumor suppressor inhibition,oncogenic transformation
ENSG00000123136,DDX39A,gene regulation,rna stability regulation,transcriptional regulation,cell proliferation enhancement,oncogenic signaling pathway activation,therapeutic target
ENSG00000163702,IL17RC,il-17 signaling pathway,enhanced tumorigenesis,promotes cell proliferation,angiogenesis regulation,tumor metastasis,oncogenic process activation
ENSG00000134545,KLRC1,nk cell activation,tumor suppressor function,immune surveillance,cell proliferation regulation,mapk/erk pathway activation,cytotoxic response enhancement
ENSG00000147378,FATE1,wnt/β-catenin pathway,constitutive activation,oncogene function,cell proliferation,epithelial expression,tumor progression
,H1FX,histone modification,tumor progression,genomic instability,chromatin compaction,epigenetic regulation,cancer cell proliferation
ENSG00000101882,NKAP,genomic instability,epigenetic regulation,chromatin remodeling,therapeutic target,oncogene activation,cell proliferation
ENSG00000008735,MAPK8IP2,pi3k/akt pathway modulation,tumor progression enhancement,cancer cell survival facilitation,therapeutic resistance promotion,signaling pathway regulation,dna repair mechanism interaction
ENSG00000119599,DCAF4,cancer driver genes,tumor suppression,ubiquitin ligase complex,cell cycle regulation,transcriptional regulation,dna damage response
ENSG00000168542,COL3A1,type iii collagen overexpression,tumor microenvironment remodeling,cell migration enhancement,angiogenesis promotion,poor prognosis indicator,multifaceted signaling interactions
ENSG00000083720,OXCT1,mitochondrial metabolism,energy production,alpha-ketoacid oxidation,branched-chain amino acid catabolism,cell growth promotion,therapeutic target
ENSG00000075415,SLC25A3,mitochondrial function,cellular metabolism,tumor progression,aerobic glycolysis,warburg effect,energy metabolism
ENSG00000138442,WDR12,regulation of ribosome biogenesis,cell proliferation regulation,oncogene function,genetic interactions,tumor progression,therapeutic target
ENSG00000138160,KIF11,mitotic checkpoint regulation,overexpression,microtubule stabilization,cell division,chromosomal segregation,genomic amplification
ENSG00000017260,ATP2C1,pi3k/akt pathway activation,gene mutation impact,ca2+ homeostasis regulation,tumor progression driver,cell proliferation enhancement,metastasis facilitation
ENSG00000176887,SOX11,transcriptional regulation,oncogene activation,chromatin remodeling,epigenetic modifications,cell cycle regulation,protein-protein interactions
ENSG00000175216,CKAP5,microtubule dynamics,cytoskeletal regulation,apoptosis evasion,cell cycle progression,tumor progression,oncogenic driver
ENSG00000120158,RCL1,rho gtpase activation,epithelial-to-mesenchymal transition,constitutive activation,cell proliferation,signaling pathway modulation,tumor progression
ENSG00000111605,CPSF6,genomic instability,cell cycle regulation,oncogene activation,dna repair dysfunction,tumor development,rna processing
ENSG00000214022,REPIN1,pi3k/akt pathway activation,cell growth regulation,protein kinase activity,tumor progression,epithelial-to-mesenchymal transition,cell migration enhancement
ENSG00000175390,EIF3F,genomic instability,cell growth modulation,translation regulation,tumor progression,protein synthesis enhancement,therapeutic target
ENSG00000164934,DCAF13,cell cycle regulation,ubiquitination process,protein degradation,tumor suppressor regulation,dna repair mechanisms,oncogene modulation
ENSG00000197635,DPP4,tumor growth,metastasis promotion,immune evasion mechanism,tumor microenvironment modulation,cancer development facilitation,therapeutic target identification
ENSG00000171385,KCND3,cardiac myocyte repolarization,gene expression regulation,proliferation modulation,mutation association,tumor suppressor interaction,signaling pathway modulation
ENSG00000134365,CFHR4,complement regulation,tumor microenvironment,autoimmunity,pro-tumorigenic environment,cell signaling pathway modulation,genomic instability
ENSG00000150768,DLAT,mitochondrial metabolism,cell proliferation,tumor progression,glycolytic shift,energy production regulation,cell survival enhancement
ENSG00000078018,MAP2,microtubule regulation,growth factor signaling,cell proliferation enhancement,oncogenic protein interaction,tumor progression facilitation,apoptosis suppression
ENSG00000183765,CHEK2,dna damage response pathway,cell cycle regulation,genomic stability maintenance,tumor suppression,apoptosis regulation,protein-protein interaction
ENSG00000244038,DDOST,protein misfolding,n-linked glycosylation patterns,oligosaccharyltransferase complex,cell proliferation and survival,tumorigenesis and metastasis,er function disruption
ENSG00000064547,LPAR2,oncogenic activity,increased tumor aggressiveness,pro-tumorigenic microenvironment,cell proliferation,signaling pathway activation,genomic amplification
ENSG00000182134,TDRKH,chromatin remodeling,cellular proliferation,genomic instability,tumor suppressor function,histone modification regulation,transcriptional regulation
ENSG00000140382,HMG20A,chromatin remodeling,tumor suppressor function,dna repair mechanisms,genomic instability,cell cycle progression regulation,transcriptional activation
ENSG00000066322,ELOVL1,fatty acid biosynthesis,cell proliferation,apoptosis inhibition,chemoresistance,protein interaction,membrane structure
ENSG00000174827,PDZK1,pi3k/akt pathway modulation,ion channel regulation,oncogenic activity,tumor progression facilitation,emt regulation,cell survival promotion
ENSG00000280987,MATR3,rna splicing regulation,nuclear localization,cell growth promotion,apoptosis inhibition,oncogenic protein expression,genomic instability
ENSG00000143006,DMRTB1,disruption of normal regulation,oncogenesis,cell growth modulation,transcriptional regulation,genomic instability,chromatin remodeling
ENSG00000174547,MRPL11,mitochondrial regulation,mitochondrial dynamics regulation,chemosensitivity alteration,tumor cell metabolism modulation,mitochondrial biogenesis regulation,mitochondrial dna maintenance
ENSG00000100916,BRMS1L,emt suppression,cellular adhesion regulation,tumor suppressor function,protein-protein interactions,metastasis suppression,cancer prognosis impact
ENSG00000143537,ADAM15,tumor progression,cell adhesion modulation,metastasis facilitation,signaling pathway modulation,inflammation regulation,angiogenesis promotion
ENSG00000117139,KDM5B,gene expression regulation,epigenetic machinery,tumor suppressor genes repression,chromatin remodeling,histone modification,oncogenic driver gene
ENSG00000148572,NRBF2,alternative splicing,apoptosis regulation,cell cycle progression,dna repair regulation,nuclear rna-binding protein,tumor suppressor gene
,HIST1H2BB,chromatin organization,gene regulation,histone modifications,epigenetic regulation,dysregulation,packaging
ENSG00000174437,ATP2A2,calcium regulation,tumorigenesis,proliferation,metabolic regulation,dna damage response,cell cycle progression
ENSG00000119285,HEATR1,chromosome instability,genomic deregulation,mitotic checkpoint regulation,tumor suppressor function,centrosome duplication,protein folding regulation
ENSG00000171953,ATPAF2,chromatin remodeling,homologous recombination repair (hrr),dna double-strand breaks,cell cycle regulation,epigenetic modifications,oncogenic processes
ENSG00000163625,WDFY3,ubiquitin-proteasome regulation,tumor progression,oncogenic protein stabilization,cell proliferation modulation,cancer development association,therapeutic target
ENSG00000139112,GABARAPL1,autophagosome regulation,cellular homeostasis maintenance,apoptosis inhibition,mtorc1 signaling pathway modulation,tumor growth promotion/inhibition,protein-protein interaction
ENSG00000113790,EHHADH,fatty acid beta-oxidation,mitochondrial enzyme,oncogenic metabolism,cell proliferation,metabolic reprogramming,therapeutic target
ENSG00000215375,MYL5,myosin contraction regulation,cell migration promotion,epithelial-to-mesenchymal transition (emt) modulation,oncogenic driver,metastasis facilitation,motor protein complex formation
ENSG00000108819,PPP1R9B,pp1 regulation,oncogene activation,tumor suppressor inhibition,cell cycle progression,signal transduction pathway,chemotherapy resistance
ENSG00000145349,CAMK2D,calcium-mediated signaling pathway,neurotransmitter release regulation,protein phosphorylation,cellular growth regulation,signaling cascade modulation,synaptic plasticity
ENSG00000004142,POLDIP2,genomic instability,tumor suppressor function,dna replication regulation,double-strand break repair,genome stability maintenance,oncogenic mutation
ENSG00000124193,SRSF6,alternative splicing,mutation,cell proliferation,tumor progression,biomarker,splicing factor regulation
ENSG00000108852,MPP2,lysosomal dysfunction,cellular growth promotion,glycosylation regulation,oncogenic potential,protein interaction,genomic instability
ENSG00000116584,ARHGEF2,rho gtpase signaling pathway,rac1 activation,cdc42 exchange factor function,tumor progression,cancer cell migration,genomic instability
ENSG00000104969,SGTA,glucose transporter regulation,metabolic adaptation,endoplasmic reticulum chaperone,cell proliferation enhancement,protein folding facilitation,tumor metastasis promotion
ENSG00000175029,CTBP2,transcriptional regulation,oncogenic signaling,tumor suppressor gene suppression,constitutive activation,protein-protein interaction,cell proliferation enhancement
ENSG00000178035,IMPDH2,purine biosynthesis,oncogenic transformation,cell proliferation,guanine nucleotide synthesis,survival resistance to chemotherapy,tumor suppressor interaction
ENSG00000076928,ARHGEF1,activation of small gtpases,cancer progression,cytoplasmic localization,disruption of tumor suppressors,oncogenic signaling pathways,regulation of cell proliferation
ENSG00000007314,SCN4A,ion channel regulation,proliferation and survival enhancement,cellular excitability modulation,tumorigenesis association,therapeutic target potential,neurological disorder link
ENSG00000103222,ABCC1,atp-binding cassette transporters,chemoresistance,drug efflux,multidrug resistance,cancer prognosis,therapeutic target
ENSG00000169727,GPS1,gtpase regulation,oncogenic pathway activation,gef activity,cell proliferation enhancement,apoptosis inhibition,tumor progression driver
ENSG00000100664,EIF5,translation initiation regulation,oncogenic protein synthesis,cell proliferation modulation,translational control disruption,tumor growth promotion,cancer driver gene candidate
ENSG00000115694,STK25,mitotic regulation,cell division abnormality,constitutive activation,therapeutic target,cell survival enhancement,protein kinase activation
ENSG00000108106,UBE2S,nf-κb signaling pathway,oncogenic driver,overexpression,cell stemness,transcriptional regulation,ubiquitin-conjugating enzyme
ENSG00000174989,FBXW8,tumor suppressor function,gene regulation,cell cycle progression,protein degradation,genetic instability,apoptosis induction
ENSG00000166135,HIF1AN,hypoxia response,ubiquitination regulation,tumor metabolism,angiogenic factor suppression,cellular proliferation enhancement,post-translational modification
ENSG00000164946,FREM1,cellular adhesion regulation,tumor suppressor function,epithelial-to-mesenchymal transition inhibition,cell migration regulation,biomarker potential,gene expression modulation
ENSG00000256235,SMIM3,regulatory rna function,pre-mrna splicing modulation,cellular proliferation,apoptosis resistance,genomic instability,non-coding gene expression
ENSG00000213585,VDAC1,apoptosis regulation,cellular energy metabolism,mitochondrial function,oncogene upregulation,tumor cell survival,ion channel activity
ENSG00000168496,FEN1,genomic instability,cell cycle regulation,dna repair mechanisms,oncogenic mutations,cancer progression,replication errors
ENSG00000165934,CPSF2,aberrant expression,enhanced mrna processing,tumorigenesis,poly(a) tail modification,post-transcriptional regulation,cancer prognosis
ENSG00000115355,CCDC88A,microtubule dynamics regulation,oncogenic signaling pathway activation,treatment resistance contribution,tumorigenesis promotion,cell proliferation enhancement,biomarker identification
ENSG00000166681,BEX3,epithelial-to-mesenchymal transition,cell proliferation,gene overexpression,amplification,transcriptional regulation,cell survival
ENSG00000113810,SMC4,genomic instability,chromatin remodeling,sister chromatid cohesion,dna repair mechanisms,oncogene activation,transcriptional regulation
ENSG00000175581,MRPL48,mitochondrial translation,mitochondrial stability,cell proliferation,cancer progression,prognostic marker,energy metabolism
ENSG00000021776,AQR,tumor progression,metastasis facilitation,water channel function,cell migration regulation,protein interaction,oncogenic process involvement
ENSG00000155974,GRIP1,gpcr regulation,pi3k/akt pathway modulation,oncogenic transformation,scaffolding protein function,cell proliferation enhancement,tumor growth promotion
,SPERT,genomic instability,tumor suppressor function,cellular proliferation regulation,loss of function mutations,cancer initiation prevention,transcriptional response suppression
ENSG00000132716,DCAF8,ubiquitination pathway,tumor suppressor degradation,cellular proliferation,oncogenic process,genetic instability,therapeutic target
ENSG00000205846,CLEC6A,immune recognition,innate immune response,cell surface expression,tumor progression modulation,cancer development association,transmembrane receptor
ENSG00000166527,CLEC4D,tumor immunology,immune response modulation,nf-κb pathway activation,cancer prognosis marker,dendritic cell expression,macrophage interaction
ENSG00000160201,U2AF1,gain-of-function mutation,pre-mrna splicing regulation,aberrant gene expression,tumor progression,therapeutic target,genomic profiling
ENSG00000137154,RPS6,mtor pathway regulation,phosphorylation and protein synthesis,oncogenic transformation,cell cycle progression,tumor growth promotion,therapeutic target
ENSG00000015153,YAF2,hippo-yap pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000125457,MIF4GD,transcriptional regulation,nuclear receptor interaction,cell proliferation,tumorigenesis,oncogene,gene expression
ENSG00000129988,LBP,lipopolysaccharide binding,innate immune system activation,tumor microenvironment modulation,cancer stem cell interaction,metastasis promotion,pro-inflammatory cytokine production
ENSG00000123131,PRDX4,oxidative stress regulation,tumor suppressor function,metabolic reprogramming,cell survival enhancement,antioxidant enzyme activity,redox balance modulation
ENSG00000142748,FCN3,tumor progression,immune evasion,cell surface receptor interaction,innate immune response,cancer biomarker potential,pathogen recognition protein
ENSG00000140632,GLYR1,redox balance regulation,cell proliferation promotion,chemotherapy resistance,radiation sensitivity,oncogenic driver,apoptosis evasion
ENSG00000135404,CD63,tumor progression,cell adhesion modulation,cell migration facilitation,immune evasion mechanism,membrane trafficking regulation,oncogenic protein interactions
ENSG00000112742,TTK,genomic instability,oncogene mutation,cell cycle regulation,dna replication error,prognostic marker,cancer driver kinase
ENSG00000105404,RABAC1,autophagy regulation,membrane trafficking,rab gtpase activity,cytoplasmic localization,protein-protein interactions,cancer cell survival
ENSG00000161265,U2AF1L4,splice site recognition,dysregulated splicing,genome instability,aberrant pre-mrna processing,cancer development,cancer-related mutations
ENSG00000130816,DNMT1,dna methylation regulation,tumor suppressor gene silencing,epigenetic instability,cancer driver mutation,oncogene activation,dna methyltransferase activity
ENSG00000162946,DISC1,genomic instability,aneuploidy,cell division regulation,microtubule stability,transcriptional modulation,cancer initiation
ENSG00000100813,ACIN1,apoptosis regulation,oncogenic potential,protein interaction,cell survival enhancement,tumor suppressor stabilization,therapeutic resistance modulation
ENSG00000123395,ATG101,autophagy regulation,growth promotion,metabolic reprogramming,tumor progression,therapeutic target,protein kinase function
ENSG00000151651,ADAM8,tumor microenvironment regulation,cancer progression,proteolytic activity,cell adhesion modulation,tumor cell invasion,metastatic suppression
ENSG00000100227,POLDIP3,genomic instability,apoptosis regulation,cell proliferation,dna repair machinery,replication processivity,cell cycle checkpoint
ENSG00000147416,ATP6V1B2,lysosomal acidification,proton pumping,cell proliferation,tumor progression,therapeutic target,mitochondrial dysfunction
ENSG00000262327,AGK,lipid metabolism regulation,glycolipid synthesis promoter,cancer metabolic reprogramming,energy homeostasis regulator,oncogenic lipid accumulation,protein-protein interaction enhancer
ENSG00000165283,STOML2,enhanced pi3k activity,membrane trafficking regulation,oncogenic progression driver,cell migration enhancement,tumor promoter expression,gene amplification
ENSG00000239713,APOBEC3G,apobec mutagenesis,cytidine deaminase activity,dna mutation hotspot,genome instability,immune system activation,oncogenic mutation driver
ENSG00000155363,MOV10,rna helicase activity,regulatory function,transcriptional regulation,mirna biogenesis,tumor suppressor modulation,cancer susceptibility
ENSG00000102738,MRPS31,mitochondrial translation,mitochondrial function,cellular metabolism,protein synthesis regulation,tumor cell adaptation,cancer associated gene
ENSG00000100450,GZMH,metabolic rewiring,cellular energy metabolism,enhanced glycolysis,mitochondrial enzyme,glycemic regulation,tumor growth
ENSG00000115414,FN1,cell adhesion,cell migration,angiogenesis,oncogenic signaling,tumor invasion,therapeutic target
ENSG00000143842,SOX13,oncogene activity,cell proliferation regulation,transcription factor function,gene expression modulation,stem cell maintenance promotion,poor prognosis association
ENSG00000124253,PCK1,gluconeogenesis regulation,glycolytic shift,cell proliferation,metabolic adaptation,therapeutic target,oncogenic driver
ENSG00000164587,RPS14,ribosomal function,mitochondrial dysfunction,tumor suppressor,gene amplification,ribosome stability,protein translation
ENSG00000040199,PHLPP2,akt inhibition,phosphatase activity,tumor suppressor function,pi3k/akt/mtor pathway regulation,cellular senescence induction,gain of function mutations
ENSG00000148660,CAMK2G,camkii holoenzyme complex,calcium-dependent signal transduction,oncogenic transformation,pro-survival signaling pathway,cell cycle regulation disruption,tumor proliferation enhancement
ENSG00000134759,ELP2,tumor suppressor function,rna processing regulation,spliceosome component,oncogenesis prevention,gene expression modulation,genomic stability maintenance
ENSG00000143412,ANXA9,tumor suppressor,apoptosis regulation,cell cycle arrest,angiogenesis inhibition,wnt/β-catenin pathway regulation,prognostic marker
ENSG00000170542,SERPINB9,apoptosis inhibition,tumor suppression,cancer progression regulation,cell proliferation control,protease inhibitor function,genetic instability modulation
ENSG00000262145,ATP23,abc transporter function,tumor progression,chemotherapy resistance,oxidative stress regulation,mitochondrial function modulation,upregulated expression levels
ENSG00000005810,MYCBP2,myc protein interaction,transcriptional coactivation,cell proliferation enhancement,apoptosis resistance,oncogene cooperation,coactivator domain interaction
ENSG00000203690,TCP10,hsp90 modulation,cellular stress response,tumor suppressor function,protein quality control regulation,cancer-related expression alteration,apo-1 signaling pathway interaction
ENSG00000147509,RGS20,regulation of g-protein coupled receptor signaling pathways,modulation of cell proliferation,negative regulation of galpha subunit activity,enhancement of intrinsic gtpase activity,dampening of downstream signaling events,maintenance of proper cellular responses
ENSG00000067048,DDX3Y,cell cycle regulation,apoptosis evasion,metabolic reprogramming,transcriptional regulation,translation initiation,protein-protein interaction
,HIST1H3A,chromatin remodeling,tumor suppressor,epigenetic regulation,histone modification,gene expression regulation,nucleosome packaging
,HIST1H3B,nucleosome formation,chromatin remodeling,epigenetic modifications,cell cycle regulation,apoptosis evasion,tumor suppressor dysfunction
,HIST1H3C,histone modification,chromatin structure,epigenetic regulation,cell cycle progression,genomic stability,transcriptional repression
,HIST1H3I,histone modification,chromatin remodeling,epigenetic regulation,dna packaging,nucleosome assembly,transcriptional regulation
,HIST1H3H,epigenetic regulation,cell cycle regulation,histone modification,chromatin remodeling,tumor suppressor dysfunction,genome instability
,HIST1H3G,epigenetic regulation,histone modification,chromatin remodeling,genomic instability,tumor progression,cell cycle regulation
,HIST1H3F,chromatin remodeling,histone modification,oncogenic processes,tumor growth,gene regulation,epigenetic regulation
,HIST1H3E,histone modification,chromatin regulation,epigenetic mark,transcriptional regulation,tumorigenesis,oncogenic transformation
,HIST1H3J,histone modification,epigenetic regulation,chromatin structure,dna packaging,oncogenic processes,therapeutic target
,HIST1H3D,histone modification,epigenetic regulation,chromatin structure,transcriptional regulation,post-translational modifications,tumor progression
ENSG00000100422,CERK,cell surface receptor,cancer-promoting signals,protein-protein interactions,tumor growth regulation,signaling pathway modulation,mutation hotspot
ENSG00000129195,PIMREG,transcriptional regulation,cellular proliferation,oncogenic processes,tumorigenesis,genetic regulation,cancer biology
ENSG00000137745,MMP13,tumor progression,prognostic marker,cell migration,metastasis,extracellular matrix degradation,pi3k/akt pathway activation
ENSG00000172059,KLF11,transcription factor activity,cell growth regulation,apoptosis suppression,cell cycle progression,dna-binding protein interaction,co-regulatory complex formation
ENSG00000135316,SYNCRIP,rna binding,post-transcriptional regulation,tumorigenesis,cell proliferation,metastasis,oncogenesis
ENSG00000095002,MSH2,dna mismatch repair,microsatellite instability,tumor suppressor function,genomic stability maintenance,oncogenesis promotion,cancer predisposition risk
ENSG00000067191,CACNB1,calcium channel regulation,oncogenic signaling,cell proliferation,therapeutic target,voltage-gated channels,cancer progression
ENSG00000196504,PRPF40A,alternative splicing,tumor suppressor dysregulation,oncogene expression regulation,metastasis facilitation,cell proliferation enhancement,genetic instability induction
,HIST1H2BC,chromatin organization,histone modification,genomic instability,epigenetic regulation,cell proliferation,tumor progression
,HIST1H2BE,histone modification,chromatin regulation,cell cycle progression,genome stability maintenance,transcription regulation,tumor suppression
,HIST1H2BG,histone modification,chromatin regulation,gene expression regulation,cell proliferation,apoptosis evasion,dna binding protein
,HIST1H2BF,histone modification,abrupt gene expression regulation,cell proliferation,oncogenic process,epigenetic regulation,genomic instability
,HIST1H2BI,chromatin remodeling,histone modification,epigenetic regulation,gene expression regulation,nucleosome assembly,protein-protein interaction
ENSG00000100083,GGA1,endocytic trafficking regulation,g protein-coupled receptor-associated sorting,oncogenic process modulation,cellular proliferation enhancement,signaling pathway interaction,genomic instability promotion
ENSG00000125445,MRPS7,mitochondrial function regulation,oncogenesis,tumor progression,cellular respiration regulation,energy metabolism disruption,signaling pathway interaction
ENSG00000116560,SFPQ,alternative splicing regulation,cancer progression driver,gene expression regulation,nuclear protein function,oncogenic rna modulation,transcriptional activation
ENSG00000173482,PTPRM,tumor suppressor function,cell migration regulation,focal adhesion disruption,loss-of-function mutations,protein-protein interactions,oncogenic progression
ENSG00000164610,RP9,rnase p complex activation,cell proliferation promotion,tumor progression facilitation,metastasis association,genomic instability contribution,poor prognosis indicator
ENSG00000173545,ZNF622,transcriptional regulation,cell cycle progression,apoptosis,chromatin remodeling,tumor suppressor function,tumorigenesis
ENSG00000105393,BABAM1,autophagy regulation,cellular trafficking,vesicle regulation,oncogenic mutation,tumor progression,proteomic interaction
ENSG00000100354,TNRC6B,mirisc complex,microrna-targeted mrna degradation,rna-mediated silencing,gene regulation,ubiquitin ligase activity,protein-protein interaction
ENSG00000124160,NCOA5,erα interaction,chromatin remodeling,nuclear receptor coactivation,transcriptional regulation,oncogenic processes,cell survival and growth
ENSG00000198755,RPL10A,ribosome assembly,cellular proliferation,epigenetic regulation,protein synthesis modulation,cancer progression contribution,aberrant metabolism
ENSG00000102931,ARL2BP,arf1 regulation,golgi apparatus disassembly prevention,cell cycle progression modulation,oncogenic process promotion,tumor cell proliferation facilitation,metastasis enhancement
ENSG00000121058,COIL,cellular localization,cajal body formation,rna metabolism,cell cycle regulation,tumor progression,putative oncogene
ENSG00000160789,LMNA,nuclear matrix disruption,chromatin organization dysfunction,cell cycle regulation impairment,pancytopenia-related myelodysplastic syndromes,genetic instability induction,transcription factor interaction
ENSG00000135083,CCNJL,calcium channel regulation,oncogenic mutations,tumor progression,cellular proliferation,signaling pathway dysregulation,upregulated expression
ENSG00000142186,SCYL1,pi3k/akt pathway modulation,constitutive activation mutations,oncogenic driver,cell cycle regulation,dna repair mechanisms,tumor growth promotion
ENSG00000119403,PHF19,chromatin remodeling,oncogenic function,epigenetic regulation,dna repair mechanisms,transcriptional regulation,gene expression modulation
ENSG00000038945,MSR1,macrophage scavenger receptor,lipid metabolism regulator,foam cell formation,immune system modulator,tumor microenvironment modifier,atherosclerosis associated
ENSG00000226033,STK19,co-activation,cell cycle regulation,mitosis regulation,serine/threonine kinase activity,tumor progression,oncogene amplification
ENSG00000198856,OSTC,osteoclast regulation,tumor invasion,metastasis promotion,bmp/tgf-β interaction,bone remodeling disruption,cancer progression facilitation
ENSG00000107937,GTPBP4,aberrant gtp metabolism,enhanced cell proliferation,gtp-binding protein regulation,mutations driving oncogenesis,potential therapeutic target,protein-protein interaction modulation
ENSG00000184408,KCND2,regulation of cellular excitability,voltage-gated potassium channel,oncogenesis,cell proliferation,cancer therapy target,signaling pathway modulation
ENSG00000100346,CACNA1I,calcium channel regulation,promotes cell proliferation,survival signaling pathways,estrogen receptor interaction,cell migration modulation,aberrant splicing events
ENSG00000110429,FBXO3,tumor suppressor activity,cancer-related mutations,cell cycle regulation,scf complex interaction,dna damage response,ubiquitination pathway
ENSG00000198830,HMGN2,chromatin remodeling,nucleosome positioning,transcription regulation,cell cycle progression,apoptosis inhibition,oncogenic driver
ENSG00000183751,TBL3,genomic instability,cell cycle regulation,chromosome segregation,dna damage response,oncogenic mutations,tumor suppression
ENSG00000092847,AGO1,microrna-mediated regulation,post-transcriptional gene silencing,rna-induced silencing complex (risc) component,epigenetic regulation,tumor progression,target mrna modulation
ENSG00000247077,PGAM5,glycolytic reprogramming,mitochondrial localization,energy metabolism regulation,cell proliferation enhancement,signaling pathway modulation,tumor aggressiveness promotion
ENSG00000134086,VHL,loss of function mutation,tumor suppressor function,e3 ubiquitin ligase activity,hypoxia-inducible factor regulation,angiogenesis promotion,oncogenic processes
ENSG00000132109,TRIM21,immune evasion,tumor suppressor,polyubiquitination,pi3k/akt pathway,nf-κb signaling,epigenetic regulation
ENSG00000167283,ATP5MG,mitochondrial biogenesis,tumor growth,genomic instability,cell proliferation,oncogene function,energy metabolism
ENSG00000088992,TESC,apoptosis regulation,cell cycle progression,oncogene/tumor suppressor role,dna repair modulation,gene transcription regulation,protein stability changes
ENSG00000124126,PREX1,gef function,rac gtpase activation,pi3k/akt pathway modulation,tumor metastasis,cell proliferation enhancement,oncogenic driver
ENSG00000197769,MAP1LC3C,autophagy regulation,cancer-associated mutations,cellular waste accumulation,tumor progression,signaling pathway interaction,mitochondrial dysfunction
ENSG00000111445,RFC5,dna replication regulation,genomic stability maintenance,base excision repair pathway,oncogenic process contribution,cell cycle regulation disruption,tumor progression facilitation
ENSG00000104413,ESRP1,alternative splicing,tumor suppressor/oncogene,pro-oncogenic isoforms,cell proliferation regulation,apoptosis regulation,signaling pathway interaction
ENSG00000100503,NIN,genomic instability,dna damage response,base excision repair,mismatch repair,mutations in gene,tumor progression
ENSG00000093010,COMT,tumor promotion,metabolic regulation,neurotransmitter degradation,therapeutic target,genetic variation,oncogenesis
ENSG00000273772,SMN2,snrnp assembly,gene splicing,dysregulated expression,tumor progression,cellular homeostasis,rna processing
ENSG00000172062,SMN1,genomic instability,protein-protein interactions,spliceosomal complex assembly,rna processing regulation,tumor development influence
ENSG00000156299,TIAM1,cell migration,rac1 activation,guanine nucleotide exchange factor,tumor invasion,metastasis-inducing protein,rho gtpase regulation
ENSG00000197381,ADARB1,rna editing,cellular proliferation,tumor progression,oncogene/tumor suppressor role,signaling pathway regulation,genomic instability
ENSG00000124207,CSE1L,cellular export mechanism,protein-protein interaction,tumor growth promotion,therapeutic target,cell cycle regulation,protein stability modulation
ENSG00000167863,ATP5PD,energy metabolism alteration,cellular adaptation,tumor progression facilitation,therapeutic target potential,prognostic marker,apoptosis modulation
ENSG00000136527,TRA2B,alternative splicing regulation,oncogenic splice variants,cancer-specific expression,splice enhancer recognition,cellular growth promotion,protein function alteration
ENSG00000114391,RPL24,protein synthesis regulation,cell proliferation promotion,ribosome assembly facilitation,tumor growth facilitation,cell survival enhancement,gene expression regulation
ENSG00000111752,PHC1,polycomb group protein,chromatin remodeling,histone modification,gene silencing,tumor suppressor,oncogene function
ENSG00000144713,RPL32,ribosomal function,oncogenic mutations,cell cycle regulation,apoptosis evasion,rna processing interaction,poor prognosis marker
ENSG00000131263,RLIM,chromatin remodeling,oncogenic regulation,tumor suppressor function,transcriptional regulation,ubiquitin ligase activity,cell cycle control
ENSG00000079785,DDX1,genomic instability,dna helicase activity,r-loop resolution,chromatin remodeling,oncogene activation,transcriptional dysregulation
ENSG00000241553,ARPC4,arp2/3 complex regulation,tumor progression,cell migration enhancement,oncogenic process involvement,pi3k/akt pathway interaction,g1/s phase transition dysregulation
ENSG00000163644,PPM1K,pi3k/akt pathway interaction,dephosphorylation activity,apoptosis regulation,cell cycle progression,protein kinase activation,tumor suppression function
ENSG00000100519,PSMC6,proteasome regulatory particle,ubiquitin-proteasome pathway,aberrant protein accumulation,tumor progression,transcriptional regulation,epigenetic modification
ENSG00000152291,TGOLN2,er homeostasis maintenance,proteostasis regulation,tumor progression facilitation,er-associated degradation pathway interaction,metastatic potential enhancement,protein trafficking facilitation
ENSG00000088179,PTPN4,regulation of immune responses,src family kinase inhibition,cell adhesion modulation,tumor suppressive function,oncogenic transformation promotion,prognostic marker
ENSG00000108349,CASC3,pp2a regulation,cell cycle progression,dna damage response,oncogene activation,tumor growth promotion,genomic instability
ENSG00000124614,RPS10,ribosome assembly,translation initiation,oncogenic potential,tumor progression,therapeutic target,genomic amplification
ENSG00000114446,IFT57,cancer driver gene,tumor suppressor function,cellular invasion,genome stability regulation,ciliary assembly maintenance,protein-protein interactions
ENSG00000081320,STK17B,cell cycle regulation,serine/threonine kinase activity,tumor progression,phosphorylation of targets,oncogenic signal promotion,genomic instability
,HIST1H1C,chromatin regulation,epigenetic alteration,histone modification,genomic instability,transcriptional regulation,cell cycle progression
ENSG00000005007,UPF1,nmd pathway,tumor suppression,mrna decay regulation,cellular stress response,genomic instability,protein translation control
ENSG00000125388,GRK4,g protein-coupled receptor phosphorylation,cell proliferation regulation,oncogenic signaling pathways,biomarker potential,kinase activation,protein-protein interactions
ENSG00000093144,ECHDC1,mitochondrial fatty acid oxidation pathway,energy metabolism regulation,tumor growth promotion,watson-lewit effect modulation,cancer cell survival enhancement,mitochondrial protein interaction
ENSG00000166855,CLPX,proteostasis regulation,cell cycle progression,ubiquitin-proteasome pathway,dna damage response,apoptosis induction,tumor suppressor function
ENSG00000141867,BRD4,cell proliferation,transcriptional activation,oncogenic driver,chromatin remodeling,protein-protein interactions,tumor progression
ENSG00000110958,PTGES3,pro-inflammatory mediator,tumor growth promotion,cell proliferation,angiogenesis,immune evasion,genomic amplification
ENSG00000119950,MXI1,cellular repressor,tumor suppression,transcriptional regulation,apoptosis induction,angiogenesis inhibition,cell cycle control
ENSG00000172232,AZU1,chromatin remodeling,oncogenic transcription regulation,tumor progression,protein-protein interaction,mitotic checkpoint control,dna damage response
ENSG00000107859,PITX3,cell cycle regulation,epithelial-to-mesenchymal transition,oncogene activity,transcription factor interaction,cellular proliferation,tumor progression
ENSG00000105538,RASIP1,rap1 activation,loss of function mutations,cell migration regulation,tumor invasion,integrin modulation,cancer progression
ENSG00000213516,RBMXL1,rrm-mediated rna interaction,oncogenic splicing regulation,nuclear protein function,alternative splicing modulation,rna processing dysregulation,tumor aggressiveness marker
ENSG00000285301,BOP1,cyclin b1 regulation,anaphase-promoting complex (apc) modulation,cell cycle regulation,protein degradation,tumor growth promotion,genetic instability
ENSG00000137193,PIM1,cell cycle regulation,oncogenic signaling,tumor progression,apoptosis resistance,therapeutic target,genomic amplification
ENSG00000086504,MRPL28,mitochondrial protein synthesis,energy metabolism regulation,tumor suppressor dysfunction,cellular metabolic shift,glycolysis promotion,antioxidant defense disruption
ENSG00000281763,DHX36,rna processing,dna repair mechanism,cellular response regulation,tumor suppression,cancer susceptibility,genetic instability
ENSG00000165209,STRBP,cellular metabolism regulation,dna damage response,genomic instability,metabolic reprogramming,oncogenic signaling modulation,polyamine biosynthesis regulation
ENSG00000171560,FGA,cellular degradation,tumor progression,metastasis facilitation,cancer cell migration,proliferation regulation,cell surface expression
ENSG00000185515,BRCC3,genomic instability,tumor suppressor function,dna repair mechanisms,homologous recombination,ubiquitination regulation,protein-protein interactions
ENSG00000174243,DDX23,rna helicase activity,pre-mrna splicing regulation,mrna export modulation,translation control,tumor suppressor interaction,oncogene association
ENSG00000179271,GADD45GIP1,p53 interaction,tumor suppressor function,cell cycle regulation,apoptosis modulation,pi3k/akt pathway interaction,loss of function mutations
ENSG00000099875,MKNK2,protein synthesis regulation,cell growth promotion,oncogenic process involvement,translation initiation factor activation,cancer cell survival enhancement,tumor progression facilitation
,HIST2H2BE,histone modification,tumor suppressor function,chromatin structure regulation,nucleosome formation,epigenetic regulation,dna packaging
ENSG00000137270,GCM1,transcription factor activity,cell proliferation regulation,growth factor modulation,apoptosis regulation,tumor suppressor function,oncogene activity
ENSG00000101695,RNF125,apoptosis regulation,cell cycle inhibition,dna repair modulation,ubiquitin ligase function,protein degradation,genetic instability induction
ENSG00000170248,PDCD6IP,tumor suppressor function,apoptosis regulation,cell proliferation control,immune response modulation,signaling pathway interaction,cancer progression
ENSG00000127511,SIN3B,chromatin remodeling,oncogene activation,transcriptional regulation,histone modification,cell cycle progression,tumor suppressor gene silencing
ENSG00000089280,FUS,rna processing,genomic instability,transcriptional regulation,oncogene activation,dna repair mechanisms,cell growth promotion
,HIST1H1D,chromatin regulation,histone modification,cell proliferation,gene expression,oncogenic processes,epigenetic landscape
ENSG00000173272,MZT2A,pi3k/akt pathway,chromatin regulation,polycomb complex member,cell cycle regulation,oncogene overexpression,tumorigenesis driver
ENSG00000166130,IKBIP,nf-κb signaling pathway,protein interactions,kinase regulation,cell proliferation,apoptosis modulation,immune response dysregulation
ENSG00000169710,FASN,de novo fatty acid synthesis,fatty acid elongation,oncogenic potential,lipid metabolism regulation,tumor growth promotion,therapeutic target
ENSG00000100109,TFIP11,transcriptional regulation,nucleolar localization,ribonucleoprotein interaction,splicing machinery regulation,cancer gene expression,cellular proliferation
ENSG00000074201,CLNS1A,cellular homeostasis,chloride channel regulation,cell proliferation,subcellular localization,ion balance modulation,pi3k/akt pathway interaction
ENSG00000000003,TSPAN6,tumor progression,tetraspanin family member,cell adhesion regulation,metastasis promotion,biomarker potential,prognostic marker
ENSG00000189067,LITAF,inflammation,immune response,tnf-alpha activation,nf-κb regulation,apoptosis resistance,cell proliferation
ENSG00000273594,EEF1D,translation elongation factor regulation,gene amplification,oncogene activation,cell growth promotion,tumor progression facilitation,poor prognosis association
ENSG00000102030,NAA10,protein regulation,cell cycle progression,tumor suppressor,apoptosis regulation,genomic stability,oncogene activation
ENSG00000172399,MYOZ2,myosin family member,cell growth regulation,sarcomeric protein interaction,oncogenic potential,enhanced cell proliferation,aberrant expression patterns
ENSG00000133398,MED10,transcriptional regulation,chromatin remodeling,histone modification,cell growth regulation,tumorigenesis,oncogenic signaling
ENSG00000163811,WDR43,cellular turnover regulation,protein degradation,genomic stability maintenance,oncogenic transformation prevention,dna damage response impairment,tumor suppressor role
ENSG00000143321,HDGF,pi3k/akt pathway activation,cell proliferation promotion,oncogene potential,angiogenesis facilitation,protein interaction with hspgs,apoptosis regulation
ENSG00000180628,PCGF5,polycomb group function,chromatin remodeling,tumor progression,cell cycle regulation,dna repair,transcriptional repression
ENSG00000198642,KLHL9,oncogenic regulation,tumor suppressor function,cancer progression,cell cycle regulation,aurora kinase interaction,c-myc modulation
ENSG00000097033,SH3GLB1,oncogenic transformation,rho gtpase regulation,cell proliferation,metastasis,membrane trafficking regulation,tumor progression
ENSG00000176444,CLK2,regulation of rna processing,oncogenic processes,cell proliferation,dysregulation in cancer,protein phosphorylation,overexpression
ENSG00000196975,ANXA4,cell adhesion,apoptosis regulation,cytoskeletal organization,signaling pathway modulation,tumor progression,genomic amplification
ENSG00000280908,PADI4,tumor progression,citrullination activity,post-translational modification,regulatory role in gene expression,altered cellular microenvironment,therapeutic target
ENSG00000125735,TNFSF14,tumor microenvironment modulation,immune checkpoint activation,promoter hypomethylation,cell proliferation enhancement,cancer-associated fibroblast interaction,antitumor immunity suppression
ENSG00000198373,WWP2,tumor suppressor function,ubiquitin ligase activity,protein degradation regulation,oncogenic protein targeting,cell cycle regulation,mdm2 interaction
ENSG00000137941,TTLL7,genomic stability maintenance,microtubule dynamics regulation,chromosomal instability,dna damage repair interaction,cell division regulation,tumor suppressor function
ENSG00000143164,DCAF6,e3 ubiquitin ligase complex,cell cycle regulation,tumor suppressor inhibition,oncogene activation,protein degradation,ubiquitination pathway
ENSG00000060688,SNRNP40,alteration of splicing patterns,alternative protein isoforms,transcriptional regulation,oncogenic processes,genomic instability,rna-protein interactions
ENSG00000143815,LBR,chromatin remodeling,genomic instability,dna repair disruption,apoptosis suppression,cell cycle progression,transcriptional regulation
ENSG00000115289,PCGF1,chromatin remodeling,ezh2 interaction,histone methylation,oncogenesis,epigenetic regulation,tumor suppression
ENSG00000131473,ACLY,sphingolipid metabolism,cellular proliferation,apoptosis regulation,tumor progression,therapeutic target,protein-protein interactions
ENSG00000174996,KLC2,microtubule dynamics,cell migration,tumor progression,cancer metastasis,mitotic regulation,apoptosis modulation
ENSG00000183943,PRKX,tumor progression,cell proliferation,apoptosis regulation,oncogene activation,protein kinase activity,cell signaling pathway
ENSG00000132382,MYBBP1A,myb interaction,transcriptional regulation,cell proliferation inhibition,oncogenic repression,tumor suppressor function,genomic instability
ENSG00000134318,ROCK2,cell cycle regulation,tumor metastasis,constitutive activation,oncogene,protein kinase activation,cytoplasmic localization
ENSG00000055917,PUM2,tumor suppressor,post-transcriptional regulation,mrna degradation,cell cycle regulation,apoptosis modulation,oncogene targeting
ENSG00000107863,ARHGAP21,rhogtpase regulation,tumor suppression,cell migration inhibition,oncogenic pathway modulation,cell invasion regulation,cancer progression involvement
ENSG00000109111,SUPT6H,chromatin remodeling,genomic instability,cell proliferation,transcriptional regulation,dna repair,oncogene activation
ENSG00000186197,EDARADD,notch signaling,dysregulation,cell proliferation,oncogenic process,tumor progression,therapeutic target
ENSG00000187796,CARD9,innate immune response,tumor progression,immune evasion,dysregulation of gene function,pattern recognition receptor,carbohydrate recognition domain
ENSG00000170142,UBE2E1,p53 regulation,ubiquitination pathway,cell cycle progression,oncogenic potential,tumor suppressor degradation,protein degradation regulation
ENSG00000132334,PTPRE,tyrosine phosphatase activation,cell signaling regulation,oncogenic pathway modulation,tumor progression association,cell proliferation influence,receptor tyrosine kinase interaction
ENSG00000028839,TBPL1,transcriptional regulation,cell cycle progression,apoptosis modulation,tumor growth promotion,genetic instability,cancer predisposition
ENSG00000163904,SENP2,sumo-deconjugation,protein regulation,cell cycle progression,transcriptional regulation,tumor suppression,therapeutic target
ENSG00000131469,RPL27,ribosomal synthesis regulation,tumorigenesis association,oncogenic transformation facilitation,cell proliferation enhancement,chemotherapy resistance,protein synthesis involvement
ENSG00000167005,NUDT21,genomic instability,dna repair mechanism,nuclear dna excision repair (ner) pathway,mutations leading to cancer development,chromatin remodeling,protein-protein interactions
ENSG00000102098,SCML2,chromatin remodeling,transcriptional repression,tumor suppressor function,apoptosis suppression,cell cycle progression,oncogenic process
ENSG00000130935,NOL11,dna damage response,homologous recombination repair,cellular proliferation,transcriptional regulation,pi3k/akt pathway activation,chromatin remodeling
ENSG00000251322,SHANK3,postsynaptic density assembly,scaffold protein function,cell migration regulation,neuronal signaling modulation,synaptic plasticity enhancement,adhesion molecule interaction
ENSG00000108448,TRIM16L,tumor suppressor function,cell cycle regulation,transcriptional regulation,apoptosis induction,protein-protein interactions,genomic instability
ENSG00000133661,SFTPD,tumor suppressor function,apoptosis induction,immune system regulation,inflammation modulation,cell proliferation inhibition,protein-protein interaction
ENSG00000125124,BBS2,primary cilium dysfunction,cancer stem cell marker,centrosome separation regulation,genomic instability driver,tumor suppressor interaction,cell cycle regulation
ENSG00000131467,PSME3,ubiquitin-proteasome pathway,proteasomal activation,enhanced proteolytic activity,tumor aggressiveness,apoptosis modulation,autophagy regulation
ENSG00000183496,MEX3B,microrna regulation,cellular differentiation suppression,tumor suppressor function,oncogene upregulation,gene expression regulation,apoptosis inhibition
ENSG00000102837,OLFM4,tumor suppressor,epithelial-mesenchymal transition,cell adhesion disruption,cell proliferation inhibition,apoptosis promotion,genomic instability
ENSG00000105245,NUMBL,genomic instability,overexpression,oncogene,aneuploidy,cell cycle regulation,chromosomal segregation
ENSG00000101210,EEF1A2,translation regulation,oncogene activation,cell proliferation enhancement,signal transduction modulation,protein synthesis promotion,tumorigenic potential
ENSG00000181163,NPM1,nucleolar localization,aberrant expression,chromosomal translocations,cell proliferation,oncogenic transformation,epigenetic modifications
ENSG00000071655,MBD3,nurd complex,chromatin remodeling,tumor suppressor function,dna methylation regulation,genomic instability prevention,oncogenic transcriptional repression
ENSG00000187778,MCRS1,lactate transport,tumor ph regulation,immunosuppression,metastasis promotion,tumor aggressiveness,glycolytic reprogramming
ENSG00000164104,HMGB2,tumor progression,genomic instability,cell proliferation,epithelial-to-mesenchymal transition (emt),chromatin remodeling,transcriptional regulation
ENSG00000266472,MRPS21,mitochondrial ribosome function,dysregulated expression,tumor progression,cell survival enhancement,metabolic regulation,electron transport chain modulation
ENSG00000063046,EIF4B,translation initiation factor,oncogene activation,mrna translation regulation,cell cycle progression,protein synthesis enhancement,cancer driver gene
ENSG00000135945,REV1,genomic instability,mutation frequency,error-prone replication,dna damage bypass,translesion synthesis,polymerase activity
ENSG00000130758,MAP3K10,jnk activation,oncogenic potential,stress-induced response,cell proliferation,apoptosis inhibition,pi3k/akt pathway interaction
ENSG00000171873,ADRA1D,angiogenesis promotion,cell migration enhancement,g protein-coupled receptor function,metastasis facilitation,neurotransmitter regulation disruption,vasoconstriction modulation
ENSG00000170525,PFKFB3,glycolytic pathway regulation,tumor metabolism alteration,oncogenesis promotion,gene overexpression,metabolic reprogramming,lactate production enhancement
ENSG00000119041,GTF3C3,rna polymerase iii,transcriptional regulation,gene expression alteration,chromatin remodeling,oncogenesis,therapeutic target
ENSG00000196557,CACNA1H,calcium channel regulation,cellular excitability modulation,voltage-gated ion channel,neurotransmitter release,cancer cell migration,metastatic progression
ENSG00000100941,PNN,pi3k/akt pathway regulation,tumor suppressor function,protease inhibition,cell adhesion modulation,metastasis suppression,extracellular matrix localization
ENSG00000198363,ASPH,genomic instability,dna repair,chromosomal instability,cell cycle regulation,apoptosis regulation,oncogenic process
,ASNA1,ubiquitination activity loss,cell proliferation enhancement,dna damage response disruption,genomic instability promotion,protein degradation pathway dysregulation,tumor suppressor function loss
ENSG00000096063,SRPK1,alternative splicing,cell proliferation,oncogenic transformation,phosphorylation activity,splicing factor interaction,tumor progression
ENSG00000104081,BMF,apoptosis regulation,tumor suppressor function,cell death modulation,bcl-2 family interaction,mitochondrial outer membrane permeabilization,pro-apoptotic factor activation
ENSG00000139921,TMX1,transcription factor function,cell differentiation suppression,oncogene role,tumor progression facilitation,therapeutic target potential,chromatin remodeling involvement
,HIST1H2BM,histone modification,chromatin structure regulation,epigenetic alterations,tumor growth promotion,cell cycle regulation,gene expression modulation
ENSG00000115484,CCT4,protein folding regulation,genomic instability,therapeutic target,cellular stress response,apoptosis modulation,tumor progression
ENSG00000112365,ZBTB24,transcription factor regulation,genome stability maintenance,dna repair regulation,oncogenic pathway activation,epithelial-to-mesenchymal transition promotion,tumor growth and metastasis facilitation
ENSG00000131876,SNRPA1,rna splicing regulation,cell survival promotion,protein-protein interaction,genomic instability modulation,tumor progression enhancement,epigenetic regulation influence
ENSG00000149452,SLC22A8,transporter activity,ion balance regulation,cellular proliferation,prognostic marker,therapeutic target,cancer progression
ENSG00000107957,SH3PXD2A,mitochondrial localization,cancer metastasis,cell migration,oncogenic driver,downstream signaling pathway,tumor progression
ENSG00000215474,SKOR2,cell proliferation enhancement,pi3k/akt pathway interaction,dna repair regulation,tumor progression contribution,therapeutic target potential,genomic instability promotion
ENSG00000160224,AIRE,autoimmune regulator function,immune tolerance modulation,tumor microenvironment interaction,central tolerance induction,genomic instability promotion,oncogenic potential indication
ENSG00000134371,CDC73,tumor suppressor function,loss of parafibromin activity,hyperparathyroidism-jaw tumor syndrome association,cell proliferation enhancement,apoptosis regulation,rna polymerase ii interaction
ENSG00000135521,LTV1,oncogene regulation,cell proliferation inhibition,transcriptional regulation,tumor suppressor function,protein stability regulation,cancer predisposition
ENSG00000062038,CDH3,epithelial-to-mesenchymal transition,cell adhesion molecule,tumor progression,metastasis,loss-of-function mutations,reduced cell adhesion
ENSG00000168763,CNNM3,cnmp degradation,oncogenic function,cell proliferation regulation,smooth muscle contraction regulation,vascular tone regulation,tumor growth promotion
ENSG00000149792,MRPL49,mitochondrial translation regulation,cell proliferation enhancement,oncogenic role,apoptosis suppression,dna damage response modification,ribosomal protein function
ENSG00000010030,ETV7,genomic instability,transcriptional regulation,tumor suppressor function,cellular responses to dna damage,apoptosis modulation,therapeutic target
ENSG00000179639,FCER1A,fcεri receptor complex,allergic response activation,mast cell degranulation,pro-survival pathway activation,tumor progression facilitation,immunoglobulin epsilon receptor signaling
ENSG00000244537,KRTAP4-2,cellular adhesion,cytoskeleton structure,cell morphology,keratin-associated protein,protein-protein interactions,cellular motility
ENSG00000185650,ZFP36L1,tumor suppressor,mrna regulation,cell survival,au-rich element binding,pro-apoptotic mrna instability,oncogenesis promotion
ENSG00000151702,FLI1,genetic regulation,dna binding,transcriptional activation,cell proliferation,oncogenic potential,tumor progression
ENSG00000079277,MKNK1,protein synthesis regulation,cell growth promotion,oncogene potential,constitutive activation,mrna translation enhancement,eif2b phosphorylation
ENSG00000159023,EPB41,cell membrane integrity,mutation-induced oncogenesis,tumor cell migration,spectrin-protein interaction,cell signaling dysregulation,hematopoietic regulation
ENSG00000047579,DTNBP1,microtubule regulation,cell division disruption,cytoplasmic aggregation,endoplasmic reticulum stress response,tumor progression enhancement,therapeutic target potential
ENSG00000161970,RPL26,ribosomal protein function,cell growth regulation,protein synthesis regulation,tumorigenesis contribution,genetic mutations impact,cellular proliferation modulation
ENSG00000108669,CYTH1,nucleotide metabolism,tumor growth,cell proliferation,survival signaling,apoptosis evasion,protein interaction
ENSG00000129245,FXR2,cellular proliferation,oncogenic mrna regulation,rna binding and splicing,tumorigenesis,metastasis regulation,cancer prognosis
ENSG00000184363,PKP3,cell adhesion disruption,dual role in oncogenesis,epithelial-to-mesenchymal transition,gene expression regulation,metastasis facilitation,pi3k/akt signaling pathway interaction
ENSG00000120437,ACAT2,fatty acid biosynthesis,lipid metabolism regulation,tumor growth promotion,cholesterol synthesis,cellular proliferation enhancement,oncogenic function
ENSG00000075785,RAB7A,endocytic trafficking,cell migration,apoptosis regulation,tumor progression,immune evasion,metastasis facilitation
ENSG00000108064,TFAM,tumor suppressor function,mitochondrial dna maintenance,energy metabolism regulation,glycolytic shift induction,cellular proliferation promotion,dna replication regulation
ENSG00000007392,LUC7L,rna-binding protein,splicing regulation,alternative splicing,testicular expression,cancer association,rna recognition motifs
ENSG00000133243,BTBD2,chromatin remodeling,dna repair mechanisms,genomic instability,cell cycle regulation,apoptosis evasion,transcriptional dysregulation
ENSG00000143622,RIT1,constitutive activation,guanine nucleotide exchange factor,regulatory dysfunction,cell proliferation regulation,rap1 signaling pathway modulation,tumor growth promotion
ENSG00000133835,HSD17B4,hormone metabolism,estrogen synthesis,cell survival pathways,tumor progression,steroid hormone regulation,therapeutic target
ENSG00000148335,NTMT1,cellular proliferation,chromatin remodeling,apoptosis regulation,metastasis promotion,post-translational modification,oncogenic driver
ENSG00000106397,PLOD3,collagen cross-linking,tumor stiffness,extracellular matrix regulation,cell migration enhancement,protein modification enzyme,molecular chaperone activity
ENSG00000088205,DDX18,transcriptional regulation,chromatin remodeling,oncogenic gene expression,cell proliferation,tumor suppressor modulation,nuclear localization
ENSG00000089818,NECAP1,actin cytoskeleton regulation,cell migration,metastasis promotion,cancer driver gene,tumor aggressiveness,prognostic biomarker
ENSG00000156697,UTP14A,spliceosomal regulation,tumor progression,oncogenic potential,transcriptional regulation,cell cycle regulation,rna processing
ENSG00000130255,RPL36,ribosomal subunit component,cellular proliferation,rna translation regulation,tumor suppressor function,proliferation marker,genomic instability
ENSG00000164675,IQUB,chromatin remodeling,histone modification,apoptosis regulation,cell cycle progression,tumor suppressor regulation,genomic instability
ENSG00000138443,ABI2,abl tyrosine kinase activation,scaffold protein function,constitutive overexpression,cell signaling modulation,oncogenic processes promotion,therapeutic target
ENSG00000112282,MED23,oncogene regulation,transcriptional dysregulation,cell proliferation enhancement,tumor progression facilitation,mediator complex interaction,protein kinase activation
ENSG00000243943,ZNF512,transcriptional regulation,oncogene,chromatin remodeling,histone modification,cell proliferation,apoptosis resistance
ENSG00000122180,MYOG,transcriptional regulation,oncogene function,tumor progression,cell proliferation,metastasis,signaling pathway modulation
ENSG00000140463,BBS4,cellular trafficking regulation,ciliary function,genetic disorder association,intracellular signaling pathway,kidney dysfunction,metastasis promotion
ENSG00000167306,MYO5B,cellular trafficking,oncogenic driver,actin cytoskeleton dysregulation,metastasis promotion,cancer cell proliferation,genetic mutations
ENSG00000105501,SIGLEC5,cell adhesion modulation,immune evasion,tumor progression,oncogene overexpression,metastasis promotion,immune microenvironment modulation
ENSG00000198646,NCOA6,transcriptional coactivator,oncogenic properties,cellular proliferation,gene expression regulation,tumorigenesis promotion,therapeutic target
ENSG00000231370,PRRC2A,polycomb repressive complex,chromatin remodeling,epigenetic regulation,tumor suppressor silencing,cell proliferation,therapeutic target
ENSG00000081277,PKP1,disrupted cell-cell adhesion,overexpressed or mutated,tumor aggressiveness increased,enhanced invasion and metastasis,interaction with pi3k/akt pathway,regulation of tight junctions and adherens junctions
ENSG00000145908,ZNF300,oncogene,tumor progression,cell proliferation,transcriptional regulation,zinc finger protein,dna binding
ENSG00000169020,ATP5ME,mitochondrial dysfunction,energy metabolism alteration,oncogenic process promotion,poor prognosis marker,cancer energy demand increase,cellular growth enhancement
ENSG00000125484,GTF3C4,genomic instability,cellular transformation,transcriptional regulation,tumor progression,apoptosis evasion,cancer driver gene
ENSG00000128951,DUT,oncogene,dna replication,cell proliferation,apoptosis resistance,genomic instability,therapeutic target
ENSG00000185532,PRKG1,cellular signaling pathway,protein kinase activity,cancer progression,mitogenic response,tumor cell proliferation,smooth muscle contraction regulation
ENSG00000141385,AFG3L2,protein degradation,genome stability,cell survival,dna damage repair,mitochondrial regulation,apoptosis regulation
ENSG00000169045,HNRNPH1,rna processing,splicing factor regulation,chromatin modification,cellular proliferation,gene expression modulation,tumor progression driver
ENSG00000177600,RPLP2,enhanced cell proliferation,cellular regulation,dysregulation in tumorigenesis,modulated oncogenic pathways,protein synthesis regulation,ribosomal subunit assembly
ENSG00000067715,SYT1,overexpression,membrane fusion regulation,oncogenic interaction,cell survival enhancement,tumor progression facilitation,cancer therapeutic target
ENSG00000273761,DDX24,oncogenic driver,cell proliferation enhancement,rna regulation dysregulation,apoptosis inhibition,cell cycle progression promotion,transcriptional modulation
ENSG00000143226,FCGR2A,antibody-dependent cellular cytotoxicity,immunomodulation,immune evasion,cell growth regulation,signaling pathway modulation,phagocytosis
ENSG00000110876,SELPLG,tumor progression,metastasis promotion,cancer prognosis,cell adhesion regulation,gene interaction,platelet activation
ENSG00000143442,POGZ,chromatin regulation,oncogenic driver,genomic instability,dna repair mechanisms,therapeutic target,prognostic marker
ENSG00000100600,LGMN,microtubule dynamics,apoptosis regulation,tumor development,cellular growth,protein-protein interaction,mitotic regulation
ENSG00000154556,SORBS2,gain of function mutations,cytoplasmic protein interactions,protein kinase activation,focal adhesion complex involvement,tumor progression driver,genomic alterations
ENSG00000109171,SLAIN2,cell cycle regulation,genetic instability,tumor suppressor function,dna damage repair,transcriptional regulation,nuclear localization
ENSG00000130956,HABP4,dna/rna binding,cell proliferation,metastasis regulator,apoptosis modulator,multifunctional protein,gene expression regulator
ENSG00000123700,KCNJ2,cell proliferation,signaling pathway activation,tumor suppressor interaction,oncogenic process contribution,downstream signaling modulation,kcnj2 overexpression
ENSG00000115268,RPS15,ribosome biogenesis,translational upregulation,oncogenic protein expression,cell cycle progression,protein synthesis regulation,genomic instability
ENSG00000183495,EP400,chromatin remodeling,transcriptional regulation,histone modification,chromosomal instability,oncogene activation,tumor suppressor silencing
ENSG00000057608,GDI2,gdp-dissociation inhibitor function,regulation of rhoa/rac1 activity,oncogenic potential,tumorigenesis modulation,cellular signaling regulation,metastasis promotion
ENSG00000094880,CDC23,genomic instability,cell cycle regulation,anaphase-promoting complex,chromosome segregation,oncogenic processes,protein degradation
ENSG00000073350,LLGL2,wnt signaling pathway,epithelial-to-mesenchymal transition,tumor suppressor function,cell adhesion regulation,protein-protein interactions,cytoskeletal organization
ENSG00000096433,ITPR3,aberrant calcium signaling,cell proliferation,intracellular regulation,oncogenic process,store-operated calcium entry (soce),tumorigenesis
ENSG00000137815,RTF1,genomic instability,transcriptional regulation,cell cycle progression,tumor suppression,dna repair pathway,genetic mutations
ENSG00000050130,JKAMP,cell migration regulation,tight junction maintenance,epithelial cell adhesion,gene expression regulation,cell proliferation control,protein-protein interaction
ENSG00000182952,HMGN4,chromatin remodeling,cell proliferation,transcriptional regulation,tumor progression,biomarker potential,oncogenic pathway
ENSG00000164134,NAA15,ribosome biogenesis,rna processing,nucleolar function,tumor growth,cellular metabolism impairment,oncogenic process
ENSG00000244234,GMCL2,dna methylation,cell cycle regulation,promoter silencing,tumor suppressor function,genomic stability maintenance,oncogenic pathway interaction
ENSG00000103569,AQP9,metabolic reprogramming,tumor progression,oncogenic signaling,cell migration,water transport,glycerol facilitation
ENSG00000134001,EIF2S1,isr pathway activation,cellular stress response,protein synthesis regulation,oncogenic mutations,tumor adaptation,genomic instability
ENSG00000117707,PROX1,transcription factor regulation,cell proliferation enhancement,apoptosis suppression,angiogenesis promotion,epithelial-to-mesenchymal transition,poor prognosis biomarker
ENSG00000124198,ARFGEF2,pi3k/akt pathway interaction,gene amplification,loss of function mutation,oncogenic transformation,tumor suppressor dysfunction,cell membrane trafficking
ENSG00000121211,MND1,chromosome segregation,kinetochore assembly,chromosomal instability,aneuploidy,cell division regulation,genomic stability maintenance
ENSG00000123562,MORF4L2,transcriptional regulation,cell proliferation,epithelial differentiation,mutations leading to loss/gain of function,nuclear protein function,gene expression modulation
ENSG00000108395,TRIM37,p53 pathway regulation,tumor suppressor function,apoptosis induction,cell proliferation inhibition,genomic stability maintenance,antiviral defense modulation
ENSG00000116750,UCHL5,genome stability,tumor suppressor function,deubiquitinating enzyme activity,histone modification regulation,cell cycle progression,genomic instability prevention
ENSG00000170144,HNRNPA3,regulatory role,constitutive activation,aberrant splicing,oncogenic transcripts,cell proliferation,rna processing
ENSG00000106305,AIMP2,protein synthesis regulation,aminoacylation complex assembly,oncogenic mutations,cell proliferation enhancement,cancer metabolic adaptation,possible oncogene
ENSG00000138398,PPIG,protein folding regulation,tumor progression influence,oncogenic pathway interaction,biomarker potential,mutational driver,cell cycle regulation
ENSG00000152936,LMNTD1,nuclear transport regulation,cellular proliferation,chromosomal instability,genomic instability,cell survival enhancement,oncogenic protein translocation
ENSG00000196408,NOXO1,ros production,cellular redox regulation,tumor growth promotion,metastasis facilitation,therapeutic resistance,signaling pathway dysregulation
ENSG00000182196,ARL6IP4,cell migration,signaling pathway regulation,tumorigenesis,cell proliferation,survival mechanisms,aberrant activation
ENSG00000153207,AHCTF1,chromatin remodeling,transcriptional regulation,genomic instability,dna repair mechanisms,cell cycle regulation,protein-protein interactions
ENSG00000128487,SPECC1,cell adhesion regulation,mutation implicated,oncogenic properties,epithelial-to-mesenchymal transition,signaling pathway interaction,tumor progression
ENSG00000079819,EPB41L2,genomic instability,cell cycle regulation,oncogenic interaction,tumor progression,apoptosis evasion,protein-protein interaction
ENSG00000175634,RPS6KB2,mtor pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cell proliferation
ENSG00000285317,DNAJC8,protein chaperone function,protein degradation regulation,autophagy modulation,oncogenic driver,cell growth promotion,metastatic potential
ENSG00000172465,TCEAL1,oncogenic transformation,transcriptional regulation,cell proliferation,apoptosis resistance,tumor progression,biomarker potential
ENSG00000105364,MRPL4,mitochondrial translation,metabolic reprogramming,cell proliferation,enhanced survival,altered metabolism,biomarker significance
ENSG00000139154,AEBP2,tumor suppressor,overexpression,cell proliferation,angiogenesis,metastasis,transcriptional regulation
ENSG00000196547,MAN2A2,glycoprotein synthesis,constitutive activation,overexpression,metastatic properties,tumor growth,immune response modulation
ENSG00000148925,BTBD10,tumor suppressor,chromatin remodeling,epigenetic regulation,genomic instability,histone modification,transcriptional regulation
ENSG00000114416,FXR1,genomic instability,dna repair regulation,rna binding protein,tumor progression,cell survival regulation,pi3k/akt signaling interaction
ENSG00000112232,KHDRBS2,gene regulation,oncogene activity,tumor suppressor function,pre-mrna processing,cellular growth,protein-rna interaction
ENSG00000158615,PPP1R15B,er stress response,apoptosis regulation,tumor suppressor function,cancer development,dna damage repair,cell cycle arrest modulation
ENSG00000143819,EPHX1,oxidative stress,genomic instability,apoptosis regulation,cell cycle modulation,toxic metabolite formation,detoxification mechanism
ENSG00000126522,ASL,asparagine depletion,glutamine metabolism regulation,tumor-selective killing,immune modulation,amino acid regulation,metabolic vulnerability targeting
ENSG00000197958,RPL12,cellular proliferation,anti-apoptotic function,translation regulation,genomic instability,dna damage response,tumor progression
ENSG00000142676,RPL11,ribosome biogenesis,p53 inhibition,cell proliferation,oncogene activation,protein synthesis regulation,tumor suppressor interaction
ENSG00000135604,STX11,mtor pathway modulation,cell cycle regulation disruption,apoptosis inhibition,membrane fusion dysfunction,vesicle trafficking impairment,genomic instability mediator
ENSG00000112079,STK38,akt signaling pathway,constitutive activation,cell proliferation,oncogenesis,tumor progression,genetic mutations
ENSG00000144597,EAF1,chromatin remodeling,transcriptional coactivator,oncogene overexpression,aggressive tumor behavior,epigenetic regulation,histone modification
ENSG00000168939,SPRY3,erk/mapk pathway,receptor tyrosine kinase inhibition,tumor suppressor function loss,oncogenic transformation,cellular proliferation enhancement,angiogenesis promotion
ENSG00000138594,TMOD3,microtubule dynamics,cell proliferation,tumor growth,poor prognosis,protein-protein interaction,mitotic spindle assembly
ENSG00000063245,EPN1,cancer-promoting activity,actin cytoskeleton regulation,tumor progression,cell migration,metastasis facilitation,prognostic marker
ENSG00000182247,UBE2E2,cell cycle progression,protein degradation,tumor suppression,oncogene potential,biomarker identification,genome stability regulation
ENSG00000161542,PRPSAP1,prs-prpsap1 complex,regulatory subunit,nucleotide synthesis,purine biosynthesis pathway,oncogenesis,potential therapeutic target
ENSG00000249709,ZNF564,gene regulation,transcriptional modulation,cell growth promotion,nuclear localization,zinc finger domain,oncogene function
ENSG00000187766,KRTAP10-8,tumor marker,epithelial regulation,cell differentiation,growth regulation,dysregulation markers,upregulated expression
ENSG00000111249,CUX2,transcriptional regulation,cell cycle progression,dna repair,epigenetic modifications,tumor suppressor/ oncogene,chromatin remodeling
ENSG00000198945,L3MBTL3,epigenetic regulation,tumor suppressor function,chromatin remodeling,genomic instability,histone recognition,methylated histones
ENSG00000165731,RET,ret activation,heterodimerization with other rtks,apoptosis resistance,cell proliferation enhancement,signaling pathway deregulation,tumor development promotion
ENSG00000124191,TOX2,transcription factor regulation,epithelial-to-mesenchymal transition (emt),oncogene activation,cell growth and survival,cancer cell metastasis,gene expression modulation
ENSG00000143569,UBAP2L,protein degradation,escrt machinery,cell growth,survival,tumorigenesis,cancer progression
ENSG00000101811,CSTF2,rna processing,oncogenic potential,cell proliferation,survival pathways,tumor progression,genomic instability
ENSG00000126016,AMOT,hippo signaling pathway regulation,cell proliferation inhibition,tumor suppressor function,protein-protein interaction,gene expression regulation,apoptosis induction
ENSG00000148843,PDCD11,apoptosis regulation,immune modulation,cellular survival pathways,tumorigenesis involvement,protein-protein interaction,genetic instability
ENSG00000100842,EFS,rna-binding protein,cell growth regulation,translation initiation,constitutive activation,tumor progression,therapeutic target
ENSG00000170819,BFSP2,intermediate filament structure,cell growth regulation,cytoskeleton stability,cell adhesion modulation,tumor progression association,genomic instability marker
ENSG00000111077,TNS2,tumor suppressor,cell growth inhibition,apoptosis promotion,cancer type association,signaling pathway regulation,genomic mutation
ENSG00000168301,KCTD6,wnt signaling regulation,tumor suppressor function,β-catenin interaction,cell proliferation regulation,genetic mutations,protein-protein interactions
ENSG00000145919,BOD1,regulation of transcription,cell growth regulation,tumor suppressor regulation,oncogene modulation,cellular differentiation,genomic instability
ENSG00000163159,VPS72,lysosome biogenesis,escrt-0 complex member,endosomal trafficking regulation,cell signaling modulator,oncogenic pathway regulator,multivesicular body sorting
ENSG00000143153,ATP1B1,na+/k+ -atpase regulation,cell growth modulation,ion transport dysregulation,cell cycle progression,apoptosis evasion,drug resistance contribution
ENSG00000101343,CRNKL1,wnt/β-catenin signaling,positive regulation,axin2 interaction,oncogenic driver,cell proliferation,tumor aggressiveness
ENSG00000163823,CCR1,immune evasion,chemokine receptor,tumor microenvironment modulation,cell migration regulation,stat3 activation,metastasis promotion
ENSG00000102007,PLP2,tumor progression,cell migration,oncogenic kinase activation,cell proliferation,metastasis,genomic instability
ENSG00000166848,TERF2IP,telomere maintenance,telomerase activity,gene regulation,chromatin remodeling,anti-apoptotic function,cancer cell proliferation
ENSG00000185619,PCGF3,chromatin regulation,e3 ubiquitin ligase activity,genome instability,oncogene activation,polycomb repressive complex 1,tumor suppressor gene silencing
ENSG00000140416,TPM1,microfilament regulation,tumor progression,microtubule modulation,cell migration,actin cytoskeleton regulation,cancer metastasis
ENSG00000157110,RBPMS,enhanced mrna stability,rna processing regulation,cell proliferation,oncogenic function,tumor suppressor activity,regulatory protein interaction
ENSG00000148303,RPL7A,ribosome biogenesis,oncogenic mutations,cellular metabolism,protein translation regulation,tumor progression,cancer therapy resistance
ENSG00000129354,AP1M2,cell cycle regulation,apoptosis resistance,signaling pathway modulation,tumor progression,therapeutic target,protein-protein interaction
ENSG00000124422,USP22,oncogenic properties,deubiquitinating activity,cell proliferation,regulatory interaction,transcriptional regulation,tumorigenesis
ENSG00000123415,SMUG1,genomic instability,uracil-dna glycosylase function,base excision repair pathway,dna damage repair,cancer driver mutation,chemotherapy resistance
ENSG00000018510,AGPS,sphingosine-1-phosphate signaling,upregulated expression,cell proliferation,tumor progression,therapeutic target,biosynthetic pathway
ENSG00000135413,LACRT,warburg effect,regulation of glycolysis,tumor growth promotion,metabolic adaptation,cell proliferation enhancement,lactate production regulation
ENSG00000182255,KCNA4,potassium channel regulation,oncogenic potential,cellular excitability disruption,tumor progression enhancement,synaptic transmission modulation,cardiovascular function alteration
ENSG00000099381,SETD1A,h3k4me3 regulation,epigenetic regulation,chromatin modification,cancer cell proliferation,gene expression modulation,histone lysine methylation
ENSG00000197879,MYO1C,cytoplasmic transport,oncogenic signaling pathway,cell proliferation,metastasis promotion,tumor progression,prognostic marker
ENSG00000161634,DCD,aneuploidy,centrosome binding,cell cycle regulation,chromosomal instability,genomic instability,oncogene activation
ENSG00000070081,NUCB2,tumor progression,cell proliferation,metastasis regulation,prognostic marker,oncogenic function,cell survival enhancement
ENSG00000211455,STK38L,oncogenic pathway activation,tumor growth promotion,apoptosis inhibition,cell cycle dysregulation,therapeutic target,protein kinase activity
ENSG00000149599,DUSP15,mapk pathway regulation,gain of function mutations,constitutive activation,cell proliferation promotion,tumor progression,therapeutic target
ENSG00000262814,MRPL12,mitochondrial function,protein synthesis,cell growth regulation,energy metabolism,tumor progression,therapeutic target
ENSG00000155508,CNOT8,mrna degradation,ccr4-not complex,cancer-associated mutations,regulatory rna stability,cellular transformation,metastasis and tumorigenesis
ENSG00000239886,KRTAP9-2,hair growth,pseudogene function,epithelial maintenance,skin development,keratin-associated protein,cell proliferation
ENSG00000107175,CREB3,chaperone-mediated autophagy,cellular differentiation,transcriptional regulation,protein quality control,glucose metabolism,lipid biosynthesis
ENSG00000103264,FBXO31,cell cycle regulation,genomic instability,gene expression,protein degradation,apoptosis modulation,tumor aggressiveness
ENSG00000277936,MRPL45,mitochondrial ribosome function,disrupted cellular metabolism,altered cellular respiration,enhanced cell proliferation,oncogenic mutation,therapeutic target
ENSG00000240682,ISY1,chromatin regulation,transcriptional modulation,genomic stability,telomerase activity,oncogenic processes,tumor suppressor interaction
ENSG00000086065,CHMP5,chromatin remodeling,escrt machinery regulation,ubiquitinated protein degradation,cell growth modulation,oncogenic mutations,tumor suppression modulation
ENSG00000116752,BCAS2,cell cycle regulation,nuclear localization,cyclin-dependent kinase interaction,tumor suppressor function,oncogene properties,dna replication regulation
ENSG00000130159,ECSIT,mitochondrial function,fatty acid metabolism regulation,tumor suppressor function loss,cell growth promotion,oncogenic transformation driver,genetic instability enhancer
ENSG00000182872,RBM10,chromatin remodeling,dysregulated splicing,alternative splicing regulation,transcription factor modulation,tumor progression facilitation,oncogene function
ENSG00000137077,CCL21,chemokine signaling,tumor metastasis,immune response modulation,cell migration regulation,lymphangiogenesis promotion,angiogenesis enhancement
ENSG00000143337,TOR1AIP1,pi3k/akt pathway,microtubule stability,cell division regulation,tumor suppressor function,oncogenic process inhibition,protein degradation regulation
ENSG00000198873,GRK5,gpcr desensitization,oncogenic signaling pathway activation,metastasis promotion,tumor growth enhancement,cancer cell migration facilitation,gtpase-activating protein activity
ENSG00000006638,TBXA2R,thromboxane a2 receptor activation,cell adhesion modulation,g-protein coupled signaling,tumor progression facilitation,metastasis promotion,pro-tumorigenic pathway enhancement
,H1F0,histone modifications,chromatin remodeling,epigenetic dysregulation,gene silencing,cell cycle regulation,genomic instability
,SEPT5,cell proliferation,cancer stem cell maintenance,epithelial-to-mesenchymal transition,protein-protein interaction,gtp-binding activity,cytoplasmic localization
ENSG00000182899,RPL35A,ribosomal protein function,protein synthesis regulation,cell proliferation enhancement,apoptosis resistance,metastatic potential increase,oncogene potential
ENSG00000085872,CHERP,cell cycle regulation,haploinsufficiency,tumor suppression,somatic mutations,spliceosome assembly,nuclear localization
ENSG00000069011,PITX1,transcription factor regulation,epithelial-to-mesenchymal transition,cell proliferation regulation,cancer progression association,tumor growth modulation,genomic instability maintenance
ENSG00000187164,SHTN1,transcriptional regulation,chromatin remodeling,nuclear localization,epigenetic regulation,gene expression modulation,tumorigenesis
ENSG00000090432,MUL1,mitochondrial dysfunction,tumor suppressor function,apoptosis regulation,protein degradation,metabolic reprogramming,cellular homeostasis
ENSG00000155256,ZFYVE27,autophagy dysregulation,endocytosis regulation,oncogenic transformation,cellular growth promotion,genetic mutation hotspot,protein-protein interactions
ENSG00000136167,LCP1,lipid metabolism regulation,cellular stress response modulation,oncogenic lipid synthesis promotion,cancer cell proliferation support,tumor progression facilitation,therapeutic target for cancer treatment
ENSG00000176619,LMNB2,dna repair,nuclear lamina structure,chromatin organization,transcriptional regulation,cell cycle regulation,oncogenic driver
ENSG00000072121,ZFYVE26,oncogenic process,cell proliferation,therapeutic target,tumor progression,ubiquitin ligase activity,escrt regulation
ENSG00000197757,HOXC6,oncogenic process,transcriptional regulation,cell proliferation,tissue patterning,apoptosis resistance,embryonic development
ENSG00000103202,NME4,cellular maintenance,dna repair,apoptosis regulation,tumor suppression,protein interaction,genomic stability
ENSG00000117601,SERPINC1,tumor microenvironment regulation,proteolytic cascade modulation,oncogenesis suppression,therapeutic target potential,dysregulation contribution,genomic instability maintenance
ENSG00000138796,HADH,fatty acid breakdown,metabolic reprogramming,mitochondrial function,oxidative stress response,tumor metabolism,protein interaction
ENSG00000182117,NOP10,ribosome biogenesis,cell growth regulation,protein synthesis regulation,biomarker potential,therapeutic target,nuclear protein
ENSG00000142949,PTPRF,cell signaling regulation,tumor progression modulation,dephosphorylation activity,oncogenic processes promotion,cell migration enhancement,signaling pathway interaction
ENSG00000095794,CREM,transcriptional regulation,cell cycle progression,apoptosis modulation,tumor progression,constitutive activation,signaling pathway interaction
ENSG00000055950,MRPL43,mitochondrial function,cellular metabolism,apoptosis regulation,tumorigenesis association,ribosomal subunit composition,cellular respiration modulation
ENSG00000004864,SLC25A13,mitochondrial function regulation,energy metabolism alterations,glycolysis enhancement,cell growth promotion,oncogenic driver mutation,therapeutic target
ENSG00000281244,ADAMTS13,von willebrand factor cleavage,tumor suppressor activity,cell proliferation inhibition,angiogenesis regulation,platelet aggregation modulation,pi3k/akt/mtor pathway interaction
ENSG00000102921,N4BP1,tumor suppression,loss-of-function mutations,ubiquitin ligase inhibition,cell cycle regulation,apoptosis modulation,transcriptional regulation
ENSG00000112530,PACRG,cell cycle regulation,dna repair mechanism,oncogenic mutations,ubiquitin-proteasome pathway,therapeutic target,tumorigenesis driver
ENSG00000109534,GAR1,trna charging activity,genomic instability,cancer progression,cellular metabolism,dna repair mechanism,oncogenic function
ENSG00000145920,CPLX2,neurotransmitter regulation,cell proliferation enhancement,apoptosis resistance,tumor progression facilitation,biomarker identification,protein-protein interaction
ENSG00000115241,PPM1G,cell cycle regulation,dephosphorylation of p53,regulation of atm/chk2 pathway,oncogenic mutations,antitumor suppressor function,genomic instability maintenance
ENSG00000104381,GDAP1,mitochondrial transport regulation,tumor suppressor function,cell proliferation regulation,axonal integrity maintenance,cell migration inhibition,oncogenic transformation
,HIST1H1E,chromatin remodeling,histone modification,transcriptional regulation,cellular proliferation,genomic instability,epigenetic regulation
ENSG00000112096,SOD2,mitochondrial antioxidant defense,redox regulation,tumor progression,oxidative stress,dna damage,genomic instability
ENSG00000229524,BAG6,protein quality control regulation,tumor suppressor modulation,pi3k/akt pathway activation,aberrant protein accumulation,poor prognosis association,multifaceted role in cancer
,TARS,trna charging mechanism,oncogene activation,protein synthesis regulation,metabolic reprogramming,tumor progression facilitation,therapeutic target identification
ENSG00000112305,SMAP1,arf6 activation,endocytosis regulation,cancer stem cell modulation,tumor progression facilitation,cell membrane dynamics,protein sorting regulation
ENSG00000148908,RGS10,oncogenic pathway modulation,aberrant gpcr signaling,gtpase-activating protein function,cell growth promotion,mitogen-activated protein kinase activation,cancer driver gene mutation
ENSG00000142875,PRKACB,pi3k/akt pathway,constitutive activation,gain of function mutations,tumor progression,altered gene expression therapeutic target,genomic profiling
ENSG00000165512,ZNF22,tumor suppressor,transcriptional regulation,krab domain interaction,cell growth regulation,oncogene/tumor suppressor dual-function,genome-wide expression profiling
ENSG00000065183,WDR3,tumor progression,gain of function mutations,cell cycle regulation,oncogene activation,protein degradation regulation,transcriptional regulation
ENSG00000119314,PTBP3,alternative splicing,splice site mutations,tumor suppressor regulation,oncogene modulation,aberrant protein isoforms,prognostic marker
ENSG00000152217,SETBP1,histone modification regulation,oncogene activation,constitutive activation,cell proliferation enhancement,chromatin remodeling,mll family interaction
ENSG00000131652,THOC6,genome stability maintenance,transcription regulation disruption,cytoskeleton association,cell cycle progression regulation,protein modification phosphorylation,ribosome biogenesis control
ENSG00000129159,KCNC1,cellular excitability,constitutive activation,gain of function mutations,oncogenic signaling,potassium channel regulation,transcriptional regulation
ENSG00000166407,LMO1,transcriptional regulation,oncogenic function,cell proliferation,tumor progression,transcription factor interaction,prognostic marker
ENSG00000106080,FKBP14,protein folding regulation,cell survival enhancement,tumor progression facilitation,apoptosis resistance,stress response regulation,protein degradation modulation
ENSG00000145491,ROPN1L,genomic instability,microtubule dynamics regulation,g2/m phase transition inhibition,cell cycle regulation,dna repair regulation,tumor suppressor function
ENSG00000180353,HCLS1,cellular immune response,oncogenic potential,metastatic progression,cancer cell survival,antigen presentation,tumor immunology
ENSG00000048462,TNFRSF17,nf-kb signaling pathway,constitutive activation,transmembrane receptor function,tumor suppressor mutation potential,cell survival and proliferation,cancer pathogenesis
ENSG00000110713,NUP98,nuclear transport disruption,oncogenic fusion proteins,cellular proliferation,aberrant localization,chromatin remodeling,tumor initiation
ENSG00000168062,BATF2,gene regulation,cell proliferation,immune suppression,transcriptional modulation,prognostic marker,therapeutic target
ENSG00000171863,RPS7,cell cycle progression,oncogenic transformation,protein synthesis regulation,tumor growth promotion,apoptosis inhibition,signaling pathway interaction
ENSG00000136155,SCEL,chromatin organization,transcriptional regulation,nuclear matrix protein,genomic instability,biomarker for diagnosis,tumorigenesis
ENSG00000159166,LAD1,glycosylation regulation,cell adhesion modulation,oncogenic signaling pathway,tumor progression driver,metabolic reprogramming,therapeutic target candidate
ENSG00000004139,SARM1,necroptosis regulation,cellular energy metabolism,apoptosis modulation,axonal degeneration,inflammatory signaling pathway activation,cell survival promotion
ENSG00000138081,FBXO11,tumor suppressor,ubiquitination regulation,cell cycle control,genomic stability maintenance,proteasomal degradation,cancer driver mutation
ENSG00000112983,BRD8,oncogene activation,chromatin remodeling,super-enhancer assembly,transcriptional regulation,cell proliferation enhancement,apoptosis suppression
ENSG00000143013,LMO4,cellular proliferation,oncogenic transformation,transcriptional regulation,signaling pathway modulation,angiogenesis promotion,metastatic potential
ENSG00000104177,MYEF2,wnt/β-catenin pathway activation,transcriptional coactivator function,oncogene potential,cell proliferation regulation,dna repair modulation,tumor suppressor interaction
ENSG00000089157,RPLP0,overexpression,enhanced cell growth,cell division regulation,apoptosis resistance,protein synthesis modulation,tumorigenesis promotion
ENSG00000175866,BAIAP2,rho gtpase regulation,tumor progression,cell migration,signaling pathway modulation,prognostic marker,cell adhesion disruption
ENSG00000161405,IKZF3,tumor suppressor,transcriptional regulation,genomic stability maintenance,apoptosis induction,cell cycle arrest,dna repair mechanisms
ENSG00000137831,UACA,epithelial integrity,oncogene activation,cell proliferation,migration facilitation,metastasis enhancement,signaling pathway modulation
ENSG00000137133,HINT2,tumor suppressor function,genome stability maintenance,oncogene suppression,chromatin remodeling,transcription regulation,dna repair facilitation
ENSG00000161955,TNFSF13,tl1a/tnfrsf13b signaling axis,immune evasion,tumor progression,autoimmune disease association,t-cell suppression,proliferation inhibition
ENSG00000065989,PDE4A,nf-kappa b signaling,camp regulation,oncogenic driver,tumor growth promotion,metastasis enhancer,cancer progression marker
ENSG00000155438,NIFK,transcriptional regulation,constitutive activation,apoptosis inhibition,cell cycle progression,genomic instability,tumor suppressor activity
ENSG00000144283,PKP4,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,oncogenesis,multifunctional protein,tumor progression,resistance to chemotherapy
ENSG00000071282,LMCD1,lipid metabolism regulation,fatty acid synthesis modulation,cellular energy homeostasis maintenance,limited role in cancer,potential impact on tumor growth,speculative connection to cell survival and proliferation
ENSG00000197728,RPS26,ribosomal protein synthesis,cellular proliferation,protein translation regulation,tumor development,gene expression alteration,metabolic reprogramming
ENSG00000166477,LEO1,genome maintenance,dna repair regulation,sister chromatid cohesion,kinetochores formation,tumor suppressor gene,cell cycle regulation
ENSG00000239264,TXNDC5,cellular metabolism regulation,protein interaction modulation,tumor progression facilitation,thioredoxin activity enhancement,cell survival promotion,antioxidant function maintenance
ENSG00000174903,RAB1B,er-to-ga transport,apoptosis resistance,autophagy regulation,cell proliferation enhancement,intracellular signaling modulation,protein secretion alteration
ENSG00000174720,LARP7,alternative splicing regulation,tumor progression,oncogene,rna-binding protein,microrna regulation,cell proliferation
ENSG00000101558,VAPA,oncogenic potential,cell survival,protein-protein interactions,cell migration,adhesion regulation,tumor progression
ENSG00000189058,APOD,apod overexpression,biomarker potential,cell survival enhancement,lipid metabolism regulation,neuronal development role,transcriptional regulation modulation
ENSG00000105640,RPL18A,ribosomal protein assembly,cell proliferation enhancement,oncogenic potential,protein synthesis regulation,tumorigenesis association,therapeutic target
ENSG00000130734,ATG4D,autophagy regulation,tumor adaptation,cell survival promotion,protein degradation regulation,map1s interaction,cancer progression driver
ENSG00000171772,SYCE1,genomic instability,oncogene,synaptonemal complex formation,cell proliferation,dna repair modulation,meiotic recombination
ENSG00000131943,C19orf12,transcriptional regulation,cell cycle control,oncogenic potential,dna binding activity,zinc finger motif,cellular proliferation
ENSG00000163568,AIM2,immune surveillance evasion,inflammasome activation,cell growth promotion,metastasis facilitation,pd-l1 regulation,pro-inflammatory cytokine production
ENSG00000100395,L3MBTL2,chromatin regulation,tumor suppression,histone modification,cell cycle regulation,gene silencing,oncogenic processes
ENSG00000135372,NAT10,histone modification,gene transcription regulation,tumor progression,promotes oncogenesis,nucleotide biosynthesis regulation,cancer cell proliferation
ENSG00000229117,RPL41,ribosome composition,protein synthesis regulation,cell growth promotion,tumorigenesis driver,cancer cell adaptation,oncogenic potential
ENSG00000183134,PTGDR2,pgd2/ptgdr2 pathway,prostaglandin receptor function,tumor growth promotion,cell proliferation regulation,angiogenesis modulation,inflammatory response regulation
ENSG00000168229,PTGDR,tumor progression,promotes cell proliferation,dysregulated expression,potential therapeutic target,involved in oncogenesis,regulates cell growth and metabolism
ENSG00000130312,MRPL34,ribosomal assembly,oncogenic transformation,cellular proliferation,protein synthesis regulation,metabolic alteration,cellular growth regulation
ENSG00000160551,TAOK1,pi3k/akt pathway regulation,oncogenic properties enhancement,tumor progression promotion,cell survival and growth regulation,mapk/erk signaling modulation,metastasis facilitation
ENSG00000171262,FAM98B,chromosomal instability,aberrant expression,tumor progression,microtubule stability,cell division regulation,aneuploidy
ENSG00000132950,ZMYM5,oncogenic activation,transcriptional regulation,cell cycle progression,apoptosis evasion,wnt/β-catenin signaling,p53 pathway modulation
ENSG00000107104,KANK1,cell adhesion disruption,cytoplasmic organization,focal adhesion regulation,metastasis promotion,oncogene interaction,tumor suppressor modulation
ENSG00000168092,PAFAH1B2,microtubule dynamics,axonal transport dysregulation,cell division defects,proliferation enhancement,cytoskeletal rearrangements,cancer cell motility
ENSG00000177432,NAP1L5,genomic instability,chromatin remodeling,transcriptional regulation,proliferation promotion,apolypotis inhibition,gene expression modulation
ENSG00000133704,IPO8,cell growth regulation,pi3k/akt signaling activation,overexpression in cancer,tumor progression,protein-protein interaction,therapeutic target
ENSG00000196507,TCEAL3,cell growth regulation,apoptosis modulation,cell cycle control,dna damage response,oncogenic potential,tumor suppressor function
ENSG00000049167,ERCC8,genomic instability,transcriptional regulation,cell cycle regulation,dna repair deficiency,oncogenic mutations,tumor suppressor
ENSG00000076924,XAB2,genomic instability,rna processing,alternative splicing,tumor progression,cell survival,prognostic marker
ENSG00000115275,MOGS,glycoprotein synthesis,cellular homeostasis,n-glycosylation,protein quality control,tumor cell behavior,cancer progression
ENSG00000077420,APBB1IP,pi3k/akt pathway regulation,oncogenic properties,protein-protein interactions,cell signaling modulation,tumor progression facilitation,therapeutic target potential
ENSG00000100353,EIF3D,anabolic processes,pi3k/akt interaction,translation initiation factor regulation,cell proliferation enhancement,oncogenic activation,catabolic pathway suppression
ENSG00000146425,DYNLT1,cellular transport,mitotic regulation,oncogenesis,microtubule stability,genomic instability,cell cycle progression
ENSG00000143575,HAX1,apoptosis regulation,genomic instability,tumor progression,biomarker potential,cell cycle modulation,mitochondrial function
ENSG00000183087,GAS6,oncogenic driver,tumor progression,cell survival promotion,angiogenesis regulation,apoptosis inhibition,metastasis enhancement
ENSG00000130226,DPP6,cell-cell adhesion disruption,calcium influx regulation,cell signaling pathway interaction,potassium channel component,tumor cell proliferation,overexpression associated tumor aggressiveness
ENSG00000089199,CHGB,calcium homeostasis,cellular signaling,metastatic progression,prognostic marker,tumor microenvironment,calcium-dependent regulation
ENSG00000164736,SOX17,epithelial-to-mesenchymal transition,transcription factor activation,cell migration and invasion,poor prognosis biomarker,cancer stem cell maintenance,endoderm lineage specification
ENSG00000104671,DCTN6,dynein cytoplasmic 1,heavy chain regulation,microtubule stability modulation,protein transport alterations,cell growth regulation,invasion and migration promotion
ENSG00000124788,ATXN1,polyglutamine-repeat expansion,ribonucleoprotein assembly dysfunction,cellular stress response activation,tumor suppressor function,apoptosis regulation,protein aggregation
ENSG00000147421,HMBOX1,genomic instability,chromosomal fragility,tumor suppressor function,homologous recombination repair,dna damage response,transcriptional regulation
ENSG00000138363,ATIC,bh4 biosynthesis,tumor progression,metabolic dysregulation,oxidative stress,cellular metabolism alterations,mitochondrial dysfunction
ENSG00000129824,RPS4Y1,ribosomal protein synthesis,genomic instability,cell cycle regulation,tumor suppressor function,apoptosis modulation,dna damage response
ENSG00000112306,RPS12,ribosome assembly,protein synthesis enhancement,tumor growth promotion,enhanced cell proliferation,therapeutic target,genomic amplification
ENSG00000136888,ATP6V1G1,v-atpase activity,tumor microenvironment modification,proton secretion regulation,tumor progression facilitation,oncogenic role,cellular ph homeostasis disruption
ENSG00000160685,ZBTB7B,tumor suppressor,transcription factor,cell proliferation inhibition,apoptosis promotion,epigenetic regulation,gene expression repression
ENSG00000100239,PPP6R2,dephosphorylation regulation,tumor suppressor,cell cycle progression,apoptosis regulation,p53 regulation,pkc regulation
ENSG00000163918,RFC4,dna replication initiation,genomic instability,homologous recombination,chromosomal rearrangements,cell proliferation,oncogenic interactions
ENSG00000138074,SLC5A6,tumor progression,oncogenic process,cellular metabolism,sodium/myo-inositol transport,glucose uptake regulation,lactate production promotion
ENSG00000108256,NUFIP2,transcriptional regulation,cell cycle progression,oncogenic transcription factor,apoptosis suppression,tumor growth facilitation,gene expression program modulation
ENSG00000184905,TCEAL2,tumor suppressor function,cell growth regulation,cell survival enhancement,apoptosis regulation,protein-protein interaction,cancer prognosis marker
ENSG00000034510,TMSB10,cellular response modulation,oncogenic signaling pathway,dna damage repair,thymosin beta 10 activity,g2/m phase regulation,tumor microenvironment modulation
ENSG00000020426,MNAT1,genomic amplification,oncogenic processes,cell proliferation,cell survival,protein-protein interaction,aneuploidy
ENSG00000105402,NAPA,nuclear pore complex regulation,tumor progression,oncogenic protein-protein interaction,genome stability maintenance,cell cycle regulation,cancer cell proliferation
ENSG00000277564,RBFOX2,alternative splicing regulation,tumor suppressor function,cancer stem cell maintenance,epithelial-to-mesenchymal transition,cellular proliferation regulation,gene expression modulation
ENSG00000130005,GAMT,mtor pathway regulation,glycine metabolism dysregulation,cell proliferation modulation,tumor cell growth promotion,creatine analogs production,therapeutic target for cancer
ENSG00000143155,TIPRL,nf-kappab activation,cell proliferation regulation,apoptosis modulation,tumor suppressor function,genomic instability induction,tir domain-containing adaptor protein
ENSG00000122218,COPA,erad dysfunction,genetic instability,cellular stress response,immunodeficiency disorders,protein homeostasis,tumor suppressor
ENSG00000227746,C4A,complement activation,immune evasion,tumor progression,inflammation regulation,protein-protein interaction,cellular proliferation
ENSG00000142765,SYTL1,cellular trafficking regulation,signaling pathway modulation,oncogenic processes activation,protein-protein interaction,endocytic recycling regulation,tumor progression enhancement
ENSG00000069974,RAB27A,tumor progression,genomic instability,vesicle trafficking regulation,cell migration promotion,metastasis facilitation,therapeutic target
ENSG00000003096,KLHL13,cancer driver gene,cell cycle regulation,dna damage response,e3 ubiquitin ligase function,genome stability maintenance,oncogenic transformation
ENSG00000174748,RPL15,ribosome biogenesis,aberrant translation,cellular proliferation,oncogenic transformation,genomic instability,translational regulation
ENSG00000140983,RHOT2,rho gtpase regulation,cancer driver mutation,cell proliferation pathway,gtpase activating function,tumorigenesis association,genomic instability
,H2AFY2,chromatin remodeling,oncogenic role,cell cycle regulation,epithelial-to-mesenchymal transition,histone variant,genomic instability
ENSG00000127329,PTPRB,cell adhesion regulation,constitutive activation,tumor progression,signaling pathway modulation,receptor tyrosine phosphatase function,potential tumor suppressor
ENSG00000080608,PUM3,tumor suppressor function,post-transcriptional regulation,genomic stability maintenance,apoptosis promotion,cell cycle regulation,oncogenic potential
ENSG00000096746,HNRNPH3,alternative splicing regulation,rna binding activity,cell proliferation promotion,tumor progression association,oncogenic process involvement,prognostic marker status
ENSG00000107796,ACTA2,tgf-β signaling pathway,epithelial-to-mesenchymal transition (emt),smooth muscle contraction,chemoresistance,radiation resistance,cancer-associated fibroblasts (cafs)
ENSG00000128989,ARPP19,oncogene activation,cell proliferation regulation,pi3k/akt pathway interaction,genomic instability driver,tumor growth promotion,signaling pathway dysregulation
ENSG00000117751,PPP1R8,pp1 regulation,cell cycle progression,tumorigenesis,apoptosis modulation,signaling pathway interaction,cancer therapeutics
ENSG00000039123,MTREX,mitochondrial ribosomal protein,cellular energy production,protein synthesis regulation,mitochondrial translation regulation,oncogenic pathway interaction,cell growth regulation
ENSG00000165264,NDUFB6,mitochondrial dysfunction,electron transport chain disruption,metabolic reprogramming,increased ros production,cellular respiration impairment,oncogenic potential
ENSG00000197471,SPN,cell adhesion disruption,epithelial-to-mesenchymal transition,podocyte dysfunction,tumor aggressiveness,metastatic potential,biomarker significance
ENSG00000105058,FAM32A,cell cycle regulation,ubiquitin ligase activity,tumor suppressor interaction,apoptosis inhibition,cancer proliferation,genomic instability
ENSG00000117505,DR1,transcriptional repressor,cell cycle progression,apoptosis regulation,tumor suppressor function,dna binding,corepressor recruitment
ENSG00000106018,VIPR2,cell proliferation,tumor progression,mapk/erk pathway,angiogenesis regulation,g-protein coupled receptor family,vasoactive intestinal peptide signaling
ENSG00000103024,NME3,dna repair,oncogene function,cell proliferation,nuclear protein regulation,prognostic marker,metastasis promotion
ENSG00000109270,LAMTOR3,mtor pathway regulation,amino acid sensing,regulation of autophagy,lysosome function,cell growth control,ragulator complex interaction
ENSG00000106992,AK1,cellular metabolism,energy regulation,adenine nucleotide pool management,glycolysis enhancement,cancer cell growth,oncogenic protein interaction
ENSG00000173369,C1QB,complement activation,immune evasion,inflammation,cell survival,proliferation regulation,tumor progression
ENSG00000156885,COX6A2,mitochondrial function,anti-apoptotic,genomic instability,energy metabolism,cell proliferation,tumor progression
ENSG00000070610,GBA2,gba2 mutations,substrate accumulation,cell cycle regulation,dna damage repair,lysosomal dysfunction,epigenetic modulation
ENSG00000175084,DES,cellular structure,disrupted filament organization,tumor progression,cancer cell migration,aberrant cell growth,stress fiber formation
ENSG00000155876,RRAGA,ras signaling pathway,gain of function mutations,cell proliferation regulation,metabolic regulation,post-translational modifications,tumor progression
ENSG00000148331,ASB6,protein degradation pathway,cell cycle regulation,tumor suppressor function,genomic stability regulation,loss-of-function mutations,e3 ubiquitin ligase interaction
ENSG00000183431,SF3A3,splice site recognition,pre-mrna splicing,gene regulation disruption,oncogene expression modulation,aberrant transcript formation,tumor development promotion
ENSG00000242220,TCP10L,microtubule assembly,cell division disruption,genetic instability,therapeutic resistance,oncogenesis,microtubule dynamics
ENSG00000184164,CRELD2,cell adhesion disruption,tumor cell migration,metastasis promotion,overexpression association,chromosomal location,transcriptional regulation
ENSG00000143947,RPS27A,ribosomal protein synthesis,cell proliferation,protein overproduction,tumorigenesis,cellular growth enhancement,oncogenic potential
ENSG00000157483,MYO1E,cancer progression,actin cytoskeleton regulation,cell migration and invasion,protein-protein interaction,plasma membrane localization,tumor metastasis
ENSG00000066248,NGEF,cell migration,focal adhesions,cytoskeletal dynamics,cell polarity,oncogenic properties,tumor progression
ENSG00000125868,DSTN,cell adhesion disruption,cytokeletal remodeling,dystonin regulation,filamin a interaction,tumor suppressor function,genomic instability
ENSG00000277356,KIR2DL1,ion channel regulation,cellular homeostasis,potassium ion flux,cellular survival pathways,apoptosis modulation,cell motility
ENSG00000099797,TECR,antigen presentation,cell activation,immune response modulation,t cell receptor function,mhc interaction,adaptive immunity regulation
ENSG00000123737,EXOSC9,rna processing,exosome complex,cellular proliferation,therapeutic target,pi3k/akt pathway interaction,cell survival modulation
ENSG00000282019,GPI,glycosylphosphatidylinositol anchor attachment,tumor progression,cell signaling,adhesion,oncogenic transformation,cell membrane regulation
ENSG00000168710,AHCYL1,genomic instability,tumor suppressor function,dual role in oncogenesis,apoptosis regulation,cancer driver mutations,cell cycle modulation
ENSG00000130254,SAFB2,homologous recombination repair,genomic instability,rna metabolism disruption,dna damage response modulation,tumor suppressor function,cell cycle regulation interaction
ENSG00000139343,SNRPF,altered splicing patterns,enhanced oncogene expression,tumor progression,cellular environment modulation,pre-mrna processing,cancer development initiation
ENSG00000062716,VMP1,autophagic regulation,membrane trafficking,oncogenic transformation,tumor progression,cellular homeostasis,protein degradation
ENSG00000104147,OIP5,pi(4,5)p2 regulation,golgi apparatus localization,dual specificity phosphatase,pi3k/akt pathway activation,cell signaling dysregulation
ENSG00000168509,HJV,iron regulation,tumor cell growth,proliferation,bmp signaling,hypoxia-inducible factor (hif),labile plasma iron
ENSG00000153162,BMP6,tumor suppression,epithelial-to-mesenchymal transition (emt),angiogenesis promotion,metastasis regulation,mitogen-activated protein kinase activation,tissue repair modulation
ENSG00000186687,LYRM7,mitochondrial regulation,energy metabolism modulation,oncogenic function promotion,cellular redox balance regulation,pi3k/akt pathway interaction,protein-protein interaction hotspot
ENSG00000134222,PSRC1,loss-of-function mutations,e3 ubiquitin ligase regulation,cell cycle progression,tumor suppressor regulation,cancer driver gene,ubiquitination pathway
ENSG00000213689,TREX1,genomic instability,tumor progression,dna repair,apoptosis regulation,cancer-related mutations,biomarker significance
ENSG00000120885,CLU,apoptosis inhibition,cell adhesion molecule,cell proliferation,dna repair facilitation,metastasis promotion,oncogenic protein interaction
ENSG00000138639,ARHGAP24,rho gtpase regulation,tumor progression,actin cytoskeleton dynamics,epithelial-to-mesenchymal transition (emt),cell migration,chemotherapy resistance
ENSG00000149091,DGKZ,pkc activation,cell proliferation,tumor suppression,protein kinase regulation,lipid signaling,dna repair
ENSG00000187325,TAF9B,transcriptional regulation,genome instability,oncogene expression,tumor suppressor gene suppression,chromatin remodeling,epigenetic modifications
ENSG00000102900,NUP93,altered npc dynamics,genome instability,chromatin regulation,cell growth deregulation,nucleocytoplasmic transport disruption,transcriptional dysregulation
ENSG00000143248,RGS5,heterotrimeric g-protein regulation,gtpase-activating protein function,cell proliferation modulation,tumor progression influence,rhoa/rac1 pathway interaction,transcription factor regulation
ENSG00000164916,FOXK1,genomic instability,transcriptional regulation,cell cycle progression,tumor progression,apoptosis suppression,dna damage response
ENSG00000028277,POU2F2,transcription factor activity,oncogenic mutations,cell cycle regulation,apoptosis inhibition,tumor suppressor function,genomic instability
ENSG00000183763,TRAIP,tumor suppressor activity,cell cycle regulation,apoptosis modulation,p53 interaction,brca1 regulation,oncogenic potential
ENSG00000100307,CBX7,chromatin remodeling,histone modification,cell cycle progression,oncogene activation,tumor suppressor silencing,gene expression regulation
ENSG00000065054,SLC9A3R2,na+/h+ exchanger regulation,cellular proliferation,ph homeostasis regulation,oncogenic signaling pathway activation,tumor progression factor,genomic dysregulation
ENSG00000166925,TSC22D4,tumor suppressor function,cell cycle regulation,apoptosis modulation,transcriptional regulation,gene expression control,cancer progression prevention
ENSG00000109079,TNFAIP1,nf-kappab pathway,apoptosis inhibition,tumor progression,oncogenic functions,dna damage response,pro-survival factor
ENSG00000178567,EPM2AIP1,glucan phosphatase regulation,glycogen metabolism disruption,tumor suppressor function,oncogenic protein expression,proliferation and metastasis promotion,cancer progression role
ENSG00000198242,RPL23A,ribosomal dysfunction,disrupted protein synthesis,cell survival enhancement,tumor progression facilitation,genomic alterations,apoptosis evasion
ENSG00000162409,PRKAA2,ampk activation,energy homeostasis regulation,tumor suppression,cellular metabolism modulation,mtor pathway inhibition,anticancer target
ENSG00000198467,TPM2,tumor progression,cell migration,prognostic marker,cytoskeleton regulation,epithelial-to-mesenchymal transition,microtubule dynamics
ENSG00000110777,POU2AF1,altered splicing patterns,apoptosis inhibition,cell cycle progression,dna damage response disruption,gene expression regulation,transcriptional dysregulation
,HIST1H2BA,histone modification,chromatin remodeling,epigenetic regulation,gene expression,cell cycle progression,dna repair
ENSG00000270885,RASL10B,ras superfamily,small gtpase,gain-of-function mutations,tumor progression,cell proliferation,activation of oncogenic pathways
ENSG00000164244,PRRC1,transcriptional regulation,scaffold protein activity,oncogenic potential,tumor growth promotion,adaptor function,metastasis facilitation
ENSG00000269404,SPIB,transcriptional activation,tumor progression,genomic instability,epigenetic regulation,cellular plasticity,oncogenic driver
ENSG00000237103,NCR3,nkr cell activation,tumor suppression,immune surveillance,nk-cell cytotoxicity,apoptosis regulation,cell signaling
ENSG00000188211,NCR3LG1,immune evasion,mitochondrial membrane modification,apoptosis inhibition,cancer-associated fibroblast interactions,cytokine regulation,kinase-independent signaling
ENSG00000115364,MRPL19,mitochondrial function,redox regulation,energy metabolism,cell proliferation,ribosomal assembly,translation initiation
ENSG00000156374,PCGF6,polycomb repressive complex formation,chromatin remodeling,epigenetic regulation,oncogenic potential,histone modification,cell cycle regulation
ENSG00000224379,TCF19,transcriptional regulation,promoter activation,wnt signaling pathway,cell proliferation,genomic instability,tumor suppressor
,HIST2H2AC,epigenetic regulation,chromatin structure,dna packaging,genomic stability,oncogenic transformation,histone modification
,ADSS,metabolic reprogramming,cellular metabolism regulation,enzyme activity,adenosine derivative sulfation and desulfation,oncogenic process contribution,tumor progression influence
ENSG00000180818,HOXC10,hox transcription factor,cellular differentiation,transcriptional regulation,tumor suppressor/oncogene duality,apoptosis evasion,cell cycle progression
ENSG00000104695,PPP2CB,pp2a tumor suppressor,hyper-phosphorylation of p53,loss-of-function mutations,dysregulation of cell cycle,regulation of pi3k/akt pathway,tumor progression and suppression
ENSG00000069248,NUP133,nuclear pore complex regulation,tumor progression,cell proliferation enhancement,nucleocytoplasmic trafficking dysregulation,chromosomal instability promotion,antibody target
ENSG00000163874,ZC3H12A,tumor suppressor,chromatin regulation,apoptosis regulation,cell cycle progression,dna repair regulation,genetic instability
ENSG00000109475,RPL34,oncogene,protein synthesis regulation,cell proliferation enhancement,tumor growth promotion,ribosomal subunit composition alteration,cancer driver gene
ENSG00000164163,ABCE1,oncogene potential,cellular proliferation,rna-binding capabilities,translation regulation,protein synthesis enhancement,cancer cell growth promotion
ENSG00000187051,RPS19BP1,ribosomal assembly,tumor suppressor activity,cell growth regulation,protein-protein interactions,ribosome biogenesis,translational regulation
ENSG00000138778,CENPE,genomic instability,aneuploidy,mitotic checkpoint regulation,chromosome segregation,kinetochore protein interaction,oncogenic overexpression
ENSG00000135451,TROAP,p53 stabilization,transcriptional co-regulator function,oncogenic activity promotion,cell proliferation regulation,apoptosis modulation,metastasis facilitation
ENSG00000154553,PDLIM3,actin cytoskeleton regulation,cell adhesion modulation,oncogenic driver,prognostic marker,signaling pathway regulation,tumor growth promotion
ENSG00000185303,SFTPA2,overexpression,tumor progression,epithelial-to-mesenchymal transition (emt),angiogenesis,cell differentiation,apoptosis resistance
ENSG00000196465,MYL6B,myosin activity,tumor progression,cell proliferation,cytoskeleton regulation,smooth muscle contraction,signaling pathway modulation
ENSG00000147166,ITGB1BP2,cell adhesion regulation,integrin interaction,molecular signaling,tumor progression,therapeutic target,cell migration
ENSG00000171858,RPS21,cell cycle regulation,chromatin remodeling,oncogenic mrna expression,protein synthesis dysregulation,aberrant cell proliferation,tumor suppressor function
ENSG00000149557,FEZ1,regulation of microtubule dynamics,modulation of cell migration and invasion,constitutive expression in cancer,oncogenic properties promotion,interaction with other signaling pathways,epithelial-to-mesenchymal transition regulation
ENSG00000111725,PRKAB1,cellular energy homeostasis,ampk activation,mtor pathway inhibition,autophagy induction,metabolic regulation,cell growth control
ENSG00000196700,ZNF512B,epigenetic regulation,oncogenic properties,cell cycle progression,apoptosis suppression,transcriptome reprogramming,protein-dna interaction
ENSG00000100897,DCAF11,genomic instability,tumor progression,cul4-ring ubiquitin ligase regulation,dna repair pathway modulation,p53 signaling network regulation,apoptosis inhibition
ENSG00000134283,PPHLN1,cellular regulation,microtubule stability,oncogenic mutations,centrosomal function,protein-protein interaction,cytoskeletal remodeling
ENSG00000162613,FUBP1,tumor suppressor,oncogene activation,cell cycle regulation,transcriptional control,dna damage response,genomic instability
ENSG00000153140,CETN3,cell cycle regulation,g2/m phase progression,centrosome assembly,genomic stability maintenance,apoptosis resistance,cell proliferation enhancement
ENSG00000178950,GAK,cdk regulation,cell cycle progression,oncogene mutations,apoptosis inhibition,protein kinase activation,tumor growth promotion
ENSG00000159516,SPRR2G,cell adhesion disruption,cell migration enhancement,metastasis promotion,apoptosis inhibition,oncogenic signaling,tumor aggressiveness marker
ENSG00000138071,ACTR2,cell cycle regulation,dna damage response,tumor suppressor function,genomic stability,g2/m phase transition,actin cytoskeleton remodeling
ENSG00000105063,PPP6R1,cellular regulation,disruption of homeostasis,phosphatase activity disruption,oncogenic signaling enhancement,therapeutic target consideration,cancer development implication
ENSG00000125485,DDX31,dna repair,constitutive activation,gain of function mutations,tumor progression,oncogene overexpression,microrna regulation
ENSG00000179059,ZFP42,transcription factor activity,zinc finger protein domain,dna binding,cell proliferation,tumor suppressor regulation,epigenetic modulation
ENSG00000137843,PAK6,cellular proliferation,constitutive activation,cancer progression,signaling pathway modulation,kinase activity regulation,apoptosis inhibition
ENSG00000008394,MGST1,antioxidant activity,cellular detoxification,enzymatic conjugation,oxidative stress response,redox balance maintenance,therapeutic target
ENSG00000140990,NDUFB10,mitochondrial function,mitochondrial energy metabolism,tumor progression,cellular reprogramming,oncogenic mutations,antioxidant defense
ENSG00000160307,S100B,cancer metastasis,cellular proliferation,pi3k/akt signaling,cellular differentiation,protein-protein interaction,tumor growth
ENSG00000171773,NXNL1,genomic instability,dna repair mechanism,cell cycle regulation,transcriptional regulation,protein-protein interaction,chromatin remodeling
ENSG00000284571,FLII,transcription regulation,oncogenic function,epithelial-to-mesenchymal transition (emt),cell proliferation,metastasis promotion,poor prognosis indicator
ENSG00000135387,CAPRIN1,translation regulation,rna binding protein,oncogene activation,cell proliferation enhancement,tumor progression facilitation,pi3k/akt pathway modulation
ENSG00000070808,CAMK2A,calcium influx regulation,cell survival enhancement,oncogenic transcription factors activation,neuronal excitability dysregulation,signaling pathway intersection,protein kinase activity
ENSG00000162641,AKNAD1,genomic instability,cell proliferation,pi3k/akt signaling,oncogene function,dna repair mechanisms,tumor suppression
ENSG00000125835,SNRPB,spliceosome regulation,dysregulation of rna processing,constitutive activation of alternative splicing,tumor progression,cancer driver gene,genomic instability
ENSG00000183684,ALYREF,regulation of rna export,oncogenic potential,cell proliferation promotion,genomic instability,enhanced cellular fitness,dna repair regulation
ENSG00000152689,RASGRP3,rap gtpases activation,guanine nucleotide exchange factor,cell adhesion regulation,cell proliferation enhancement,tumor growth promotion,hematopoietic cell expression
ENSG00000170653,ATF7,chromatin remodeling,transcriptional regulation,apoptosis evasion,cell proliferation driver,tumor suppressor function,genome stability maintenance
ENSG00000062582,MRPS24,mitochondrial function disruption,apoptosis inhibition,genomic instability,oncogenic mutations,protein-protein interaction,cancer progression
ENSG00000135535,CD164,cell surface antigen,immune cell interaction,tumor progression,metastasis,adhesion regulation,signaling molecule
ENSG00000183011,NAA38,histone regulation,transcriptional regulation,chromatin modification,gene expression modulation,nuclear function,molecular interaction
ENSG00000110090,CPT1A,metabolic regulation,fatty acid oxidation,mitochondrial function,cell growth,insulin signaling,oncogenesis
ENSG00000140320,BAHD1,fatty acid biosynthesis,lipid metabolism,cell proliferation,acyl-coa-dependent enzymes,tumor progression,therapeutic target
ENSG00000259956,RBM15B,disrupted rna processing,tumor-promoting mrna expression,cellular response modulation,apoptosis regulation,immune function dysregulation,oncogenic transformation
ENSG00000169862,CTNND2,wnt/β-catenin pathway activation,tumor progression,epithelial-to-mesenchymal transition (emt),cell adhesion,oncogenic signaling,cellular migration
ENSG00000136463,TACO1,nf-κb pathway regulation,genomic instability,tumor progression,cell proliferation,metastasis promotion,chemoresistance mechanism
ENSG00000149591,TAGLN,actin filament regulation,cytoskeletal reorganization,smooth muscle differentiation,tumor progression,cell migration,oncogenic potential
ENSG00000235307,BRD2,chromatin remodeling,transcriptional regulation,bet domain protein,bromodomain binding,acetylated histone recognition,cell cycle progression
ENSG00000132305,IMMT,mitochondrial dynamics,apoptosis regulation,autophagy modulation,tumor metabolism adaptation,prognostic marker potential,interactome hub gene
ENSG00000170549,IRX1,tumor suppressor,regulatory mechanism,transcriptional repressor,cell cycle regulation,apoptosis,genomic instability
ENSG00000204071,TCEAL6,tumor suppressor activity loss,t-cell acute lymphoblastic leukemia 6 family,transcription factor regulation,cell proliferation promotion,metastatic potential enhancement,oncogenic protein overexpression
ENSG00000145216,FIP1L1,transcriptional regulation,chromatin remodeling,oncogenic protein interaction,epigenetic alteration,tumor progression,therapeutic target
ENSG00000163631,ALB,transport function,metabolic regulation,immune modulation,protein binding,hormone transport,osmotic pressure maintenance
ENSG00000169129,AFAP1L2,cell migration,pi3k/akt pathway,metastasis,oncogene role,src kinase interaction,rho gtpase regulation
ENSG00000128283,CDC42EP1,gtpase regulation,cell migration,rac/cdc42 signaling pathway,oncogene activity,tumor progression,genomic amplification
ENSG00000132002,DNAJB1,chaperone activity,p53 regulation,tumor suppressor interaction,metastasis promotion,cell migration enhancement,therapeutic target potential
ENSG00000120742,SERP1,apoptosis inhibition,cancer biomarker,cell survival promotion,constitutive expression,oncogene potential,protease inhibition
ENSG00000221983,UBA52,ubiquitination,protein degradation,cellular regulation,tumor microenvironment,cancer progression,genomic instability 
ENSG00000166226,CCT2,chaperone function,protein folding regulation,tumor suppressor activity,oncogenic mutations,cell cycle progression modulation,stress response activation
ENSG00000278644,PCGF2,chromatin compaction,epigenetic regulation,histone h2a ubiquitination,oncogenic processes,polycomb repressive complex 1 (prc1),potential biomarker
ENSG00000100347,SAMM50,mitochondrial function regulation,tumor progression marker,oncogenic role in cancer cells,cellular metabolism modulation,protein integration into outer membrane,mitochondrial dynamics regulation
ENSG00000167515,TRAPPC2L,oncogenic pathway activation,cell proliferation regulation,vesicle-mediated transport disruption,protein-protein interaction modulation,tumor progression association,therapeutic target potential
ENSG00000170145,SIK2,cellular energy regulation,tumor suppressor function,glucose metabolism regulation,mitochondrial biogenesis modulation,ampk pathway activation,energy stress response
ENSG00000205403,CFI,complement regulation,immune modulation,regulatory function,tumor microenvironment,genetic mutations,proteolytic activity
ENSG00000112877,CEP72,centrosomal regulation,genomic instability,microtubule stabilization,cell cycle progression,cytokinesis disruption,oncogenic protein interaction
ENSG00000141101,NOB1,genomic instability,dna replication regulation,cell cycle progression,tumor suppressor function,constitutive activation,cell proliferation promotion
ENSG00000113761,ZNF346,transcriptional regulation,cellular proliferation,tumor suppressor function,apoptosis regulation,prognostic biomarker,genomic instability
ENSG00000105053,VRK3,dna repair mechanism,cellular regulation,tumor aggressiveness,apoptosis modulation,brca1 interaction,atm interaction
,WARS,genetic mutations,aminoacylation process,cellular homeostasis,protein synthesis regulation,tumor suppression mechanism,amino acid incorporation
ENSG00000187601,MAGEH1,tumor suppressor,cell cycle regulation,transcriptional regulation,apoptosis induction,epigenetic silencing,loss of function
ENSG00000111361,EIF2B1,cellular stress response,regulation of protein synthesis,demyelination,neurological disorders,tumor progression,oncogenic processes
ENSG00000109381,ELF2,transcriptional regulation,wnt/β-catenin pathway,cell proliferation,tumor development,gene expression,signaling pathway
ENSG00000064726,BTBD1,transcriptional regulator,chromatin remodeling,co-repressor function,epigenetic alteration,genetic instability,oncogene regulation
ENSG00000146731,CCT6A,protein folding regulation,dysregulated protein stability,chaperone complex formation,tumor suppressor function,cellular integrity maintenance,genetic instability
ENSG00000112782,CLIC5,tumor progression,cell proliferation,apoptosis modulation,pi3k/akt/mtor pathway regulation,chloride ion transport,multifunctional protein
ENSG00000105705,SUGP1,genomic instability,dna damage response evasion,gene regulation,cell cycle progression,chromatin remodeling,nuclear protein interaction
ENSG00000075945,KIFAP3,microtubule dynamics,chromosomal instability,cell division regulation,tumor growth promotion,genomic stability maintenance,mitotic spindle assembly
ENSG00000090520,DNAJB11,cellular chaperoning,protein regulation,tumor suppression,oncogenic transformation,apoptosis modulation,cell cycle control
ENSG00000136146,MED4,transcriptional regulation,oncogene activation,tumor suppressor suppression,cell growth promotion,metabolic regulation,genomic instability
ENSG00000117906,RCN2,er stress response,cell surface molecule,metastasis facilitation,protein folding regulation,calcium homeostasis modulation,cancer cell adhesion
ENSG00000071127,WDR1,genomic instability,chromosomal instability,aneuploidy,cell cycle regulation,tumor suppressor function,protein degradation
ENSG00000179776,CDH5,ve-cadherin function,metastasis,tumor invasion,cell migration,vascular integrity,oncogenesis
ENSG00000011243,AKAP8L,pi3k/akt pathway interaction,tumor suppressor or oncogene,cell cycle regulation,apoptosis modulation,pka anchoring protein,mapk pathway interaction
ENSG00000116544,DLGAP3,cell-cell interactions,signaling pathway regulation,tumor progression,genome stability maintenance,prognostic biomarker,aneuploidy prevention
ENSG00000107854,TNKS2,wnt signaling,telomere maintenance,pseudokinase function,genomic stability,oncogenic regulation,cell proliferation
ENSG00000086827,ZW10,kinetochore regulation,genomic instability,chromosome segregation,aneuploidy induction,spindle checkpoint disruption,tumor progression promotion
ENSG00000156304,SCAF4,genomic instability,dna damage response,cell cycle regulation,oncogenic mutations,tumor suppressor function loss,protein-protein interactions
ENSG00000137168,PPIL1,cell cycle regulation,protein degradation,apoptosis modulation,cancer tumorigenesis,biomarker discovery,mutational hotspot
ENSG00000136935,GOLGA1,golgi apparatus function,cellular proliferation regulation,protein modification and transport,oncogenesis association,tumor suppressor interaction,cancer related expression
ENSG00000049245,VAMP3,exocytosis regulation,cell-cell adhesion modulation,pi3k/akt pathway involvement,tumor progression association,biomarker potential,metastasis facilitation
ENSG00000128596,CCDC136,cell cycle regulation,dysregulation,oncogene,protein interaction,mitosis regulation,tumorigenesis
ENSG00000006837,CDKL3,cytoplasmic poly(a)-specific ribonuclease activity,mrna stability regulation,tumor progression,oncogenic potential,transcriptional regulation,cell cycle progression
ENSG00000196793,ZNF239,tumor suppression,loss-of-function mutations,transcriptional regulation,cell cycle regulation,apoptosis modulation,chromatin remodeling
ENSG00000182923,CEP63,genomic stability,centrosome regulation,cell division,mitosis regulator,tumor progression,cancer driver gene
ENSG00000162408,NOL9,ribosome assembly,nucleolar function,cell proliferation regulation,dna damage response,apoptosis modulation,oncogenic pathway interaction
ENSG00000088930,XRN2,cellular regulation,microrna processing,rna degradation,cell growth inhibition,tumor progression,cancer driver gene
ENSG00000159461,AMFR,cancer-promoting factor,cell migration enhancement,epithelial-to-mesenchymal transition (emt),hmga2 ligand interaction,nf-κb/stat3 activation,transcriptional regulation
ENSG00000099246,RAB18,regulation of membrane trafficking,cell proliferation and survival,cytoskeletal organization,pi3k/akt pathway regulation,gene overexpression and mutation,oncogenic processes promotion
ENSG00000113569,NUP155,genomic instability,chromatin remodeling,nuclear pore complex disruption,tumor progression,cancer predisposition,oncogenic mutations
ENSG00000072364,AFF4,oncogenic fusion protein,chromatin modification,cell proliferation regulation,therapeutic target,apoptosis inhibition,multifunctional protein
ENSG00000198265,HELZ,chromatin remodeling,transcriptional coactivator,cell cycle progression,genomic instability,apoptosis inhibition,oncogenic driver
ENSG00000004478,FKBP4,protein regulation,tumor suppressor interaction,cell cycle regulation,dna damage response,apoptosis inhibition,chaperone function
ENSG00000151239,TWF1,actin filament regulation,cell division modulation,cytoskeletal organization,protein-protein interactions,tumor progression,genetic alterations
ENSG00000124659,TBCC,rab gtpase regulation,genomic stability maintenance,dna damage prevention,oncogene mutation,cell survival promotion,tumor suppressor activity
ENSG00000079337,RAPGEF3,ras/raf pathway,cell migration,tumor progression,guanine nucleotide exchange factor (gef),protein-protein interaction,poor prognosis
ENSG00000172315,TP53RK,cell cycle regulation,apoptosis modulation,p53 interaction,oncogenic activity,tumor suppressor function,genomic instability
ENSG00000101361,NOP56,ribosome biogenesis,cell growth regulation,nucleolar protein function,protein-protein interactions,cell cycle progression,apoptosis regulation
ENSG00000155008,APOOL,apoptotic pathway regulation,tumor suppressor function,programmed cell death inhibition,cell survival enhancement,cancer progression facilitation,genomic instability promotion
ENSG00000157106,SMG1,tumor suppression,oncogenesis promotion,cell growth regulation,translation control,genomic maintenance,nmd pathway activation
ENSG00000143811,PYCR2,pyruvate metabolism,gluconeogenesis regulation,energy homeostasis modulation,cellular proliferation support,metabolic reprogramming,oncogenic transformation
ENSG00000136448,NMT1,tumor suppressor function,pi3k/akt pathway modulation,genomic instability,oncogenic transcription factor activation,cell proliferation enhancement,dna repair mechanism interaction
ENSG00000067829,IDH3G,mitochondrial dysfunction,gain of function mutations,metabolic reprogramming,cell proliferation,dna methylation,epigenetic regulation
ENSG00000125249,RAP2A,constitutive activation,cell cycle regulation,oncogenic processes,increased cell proliferation,tumor progression,gtpase activity
ENSG00000113758,DBN1,protein degradation,genomic instability,tumor suppressor,ubiquitin-proteasome pathway,cell cycle regulation,oncogene mutation
ENSG00000105398,SULT2A1,metabolic regulation,tumor suppressor function,carcinogen detoxification,cellular homeostasis modulation,protein interaction,genomic alteration
ENSG00000126856,PRDM7,chromatin regulation,transcriptional regulation,epigenetic control,tumor suppressor/oncogene,cell cycle progression,apoptosis modulation
ENSG00000152465,NMT2,n-terminal myristoylation,cell signaling pathways,cell proliferation,cancer driver mutations,post-translational modification,tumor progression
ENSG00000153814,JAZF1,loss of tumor suppressor function,oncogene activation,cell cycle regulation,dna replication,pi3k/akt/mtor interaction,transcriptional regulation
ENSG00000213463,SYNJ2BP,pi(4,5)p2 regulation,cell proliferation regulation,protein kinase activation,cell migration promotion,cancer prognosis marker
ENSG00000113356,POLR3G,genomic instability,aberrant expression,cellular proliferation,protein synthesis regulation,tumor progression,oncogenic potential
ENSG00000132664,POLR3F,rna polymerase iii activity,rdna transcriptional regulation,genome stability maintenance,cell cycle progression,dna replication,telomere shortening
ENSG00000136271,DDX56,cellular regulation,alternative splicing,rna processing,oncogenesis,gene expression regulation,protein-protein interactions
ENSG00000145824,CXCL14,chemokine activity,angiogenesis modulation,immune response regulation,tumor growth promotion,cell migration,inflammation
ENSG00000172893,DHCR7,cholesterol biosynthesis,oncogene overexpression,cell proliferation,cell survival,protein-protein interaction,transcriptional regulation
ENSG00000149485,FADS1,fatty acid biosynthesis,lipid metabolism regulation,cell proliferation enhancement,tumor progression facilitation,angiogenesis promotion,gene regulation modulation
ENSG00000171109,MFN1,mitochondrial fusion,mitochondrial morphology,autophagy regulation,cell survival,apoptosis resistance,oncogenesis
ENSG00000163110,PDLIM5,cellular adhesion,constitutive activation,cytoplasmic localization,gain of function mutations,oncogenic signaling,pi3k/akt pathway
ENSG00000282972,GNG4,g protein signaling pathway,cancer cell proliferation,cell cycle dysregulation,oncogenic mutation,tumor growth promotion,gα subunit activation
ENSG00000153922,CHD1,chromatin remodeling,genomic instability,tumor progression,therapeutic target,transcriptional regulation,cell proliferation
ENSG00000136045,PWP1,dna damage response,gene mutation,genomic instability,dna repair pathway,cellular transformation,tumor progression
ENSG00000197043,ANXA6,cell membrane trafficking,oncogenesis,tumor progression,apoptosis regulation,protein-protein interaction,metastasis promotion
ENSG00000126107,HECTD3,ubiquitination regulation,tumor progression,pi3k/akt signaling pathway,cell proliferation,apoptosis regulation,proteasome degradation
ENSG00000108468,CBX1,histone modification regulation,chromatin compaction,epigenetic regulation,polycomb group protein interaction,tumor suppressor/oncogene duality,chromatin remodeling
ENSG00000141380,SS18,chromatin remodeling,tumor suppressor loss,gene fusion partner,coactivator function,cohesin complex disruption,sister chromatid cohesion
ENSG00000196072,BLOC1S2,autophagy regulation,pi3k/akt pathway interaction,prognostic biomarker potential,oncogenic phenotype promotion,cell survival enhancement,tumorigenesis involvement
ENSG00000162244,RPL29,ribosome assembly,enhanced translation,oncogenic protein production,tumor growth promotion,cell cycle regulation disruption,therapeutic target
ENSG00000162521,RBBP4,chromatin remodeling,oncogenesis,histone incorporation,cell cycle regulation,dna repair,transcriptional regulation
ENSG00000169035,KLK7,proteolytic activity,tumor progression,metastasis facilitation,extracellular matrix degradation,signaling pathway modulation,oncogenic potential
ENSG00000165912,PACSIN3,cell cycle regulation,oncogenic interactions,tumor progression,apoptosis resistance,microtubule dynamics,endocytosis facilitation
ENSG00000064218,DMRT3,oncogenic regulation,overexpression,cell cycle modulation,apoptosis suppression,transcriptional regulation,genomic instability
ENSG00000106605,BLVRA,calcium channel regulation,cell proliferation,oncogenesis,apoptosis regulation,tumor progression,promiscuous interaction
ENSG00000181852,RNF41,protein degradation,cell cycle regulation,ubiquitination pathway,tumor suppressor function,oncogenic driver,proteasomal targeting
ENSG00000087245,MMP2,tumor invasion,extracellular matrix remodeling,cell migration,inflammation modulation,oncogenic potential,therapeutic target
ENSG00000099910,KLHL22,regulation of protein degradation,cell cycle progression,substrate recognition component,ubiquitination and degradation,tumorigenesis,stress response regulation
ENSG00000172482,AGXT,cellular metabolism regulation,oxidative stress modulation,tumor progression association,glyoxalate detoxification,metabolic reprogramming,therapeutic target candidate
ENSG00000107581,EIF3A,deregulation of protein synthesis,oncogenic processes,tumor progression,therapeutic target,cell growth and proliferation,biomarker for cancer diagnosis or prognosis
ENSG00000122406,RPL5,tumorigenesis,cell proliferation,genomic instability,dna damage response,cell cycle regulation,protein synthesis regulation
ENSG00000196616,ADH1B,tumor progression,cell proliferation,dna damage,oncogenesis,signaling pathway activation,metabolic regulation
ENSG00000188428,BLOC1S5,endosome regulation,protein-protein interaction modulation,cell growth regulation,melanogenic enzyme transport,tumorigenesis association,cellular homeostasis disruption
ENSG00000118113,MMP8,proteolytic activity,tumor progression,metastasis promotion,therapeutic target,cancer metastasis,extracellular matrix degradation
ENSG00000173821,RNF213,microtubule stabilization,mitosis and meiosis regulation,cell proliferation enhancement,dna damage response,genomic instability maintenance,cell cycle regulation interaction
ENSG00000158864,NDUFS2,mitochondrial dysfunction,energy metabolism regulation,electron transport chain disruption,tumor cell adaptation,cellular proliferation promotion,metabolic reprogramming
ENSG00000166090,IL25,tumor progression,pro-inflammatory signaling,immune evasion,oncogenesis,cell proliferation,therapeutic target
ENSG00000136931,NR5A1,steroidogenesis regulation,transcriptional activation,androgen receptor signaling,cell proliferation induction,co-regulator interaction,hormone synthesis regulation
ENSG00000148346,LCN2,iron regulation,tumor progression,inflammation,angiogenesis,epithelial-to-mesenchymal transition (emt),biomarker signaling
ENSG00000181555,SETD2,h3k36me3 mark regulation,loss-of-function mutations,tumor suppressor function,genomic instability,chromatin remodeling,prognostic marker
ENSG00000164466,SFXN1,mitochondrial function,redox balance disruption,tumor suppressor,cellular signaling pathway regulation,mitochondrial biogenesis dysregulation,cancer cell metabolism enhancement
ENSG00000078668,VDAC3,mitochondrial regulation,tumor progression,constitutive activation,metabolic reprogramming,apoptosis inhibition,autophagy dysregulation
ENSG00000177542,SLC25A22,mitochondrial carrier protein,coenzyme a transport,metabolic regulation,energy production dysregulation,rapid cell growth promotion,cancer metabolic reprogramming
ENSG00000080293,SCTR,serotonin signaling pathway,gain of function mutations,genomic instability,apoptosis dysregulation,cell migration and invasion,therapeutic target
ENSG00000133773,CCDC59,ciliary dysfunction,tumor suppression,oncogenic signaling,cellular motility,protein-protein interactions,microtubule regulation
ENSG00000170956,CEACAM3,cell adhesion receptor,immune system modulation,tumor progression association,inflammatory response regulation,receptor-ligand interaction,cell surface expression
ENSG00000068308,OTUD5,pi3k/akt pathway modulation,gain of function mutations,tumor progression driver,cell survival enhancement,protein stability regulation,ubiquitin-proteasome system dysregulation
ENSG00000134245,WNT2B,canonical wnt signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000106789,CORO2A,cellular protrusion,actin cytoskeleton dynamics,oncogenesis,cell migration,therapeutic target,gain of function mutations
ENSG00000116329,OPRD1,opioid receptor activation,cell proliferation enhancement,tumor progression facilitation,apoptosis suppression,autophagy induction,pi3k/akt pathway interaction
ENSG00000166313,APBB1,protein-protein interactions,transcriptional regulation,cell adhesion,endocytosis,wnt/β-catenin signaling pathway,tumorigenesis
ENSG00000137409,MTCH1,mitochondrial regulation,oncogenic mutations,apoptosis inhibition,mitophagy modulation,cell survival promotion,therapeutic target
ENSG00000172638,EFEMP2,tumor progression,angiogenesis,extracellular matrix,cell migration,metastasis,oncogene activation
ENSG00000144791,LIMD1,tumor suppressor,dna repair regulation,genomic stability maintenance,cell proliferation inhibition,apoptosis promotion,alternative splicing modulation
ENSG00000111667,USP5,chromatin remodeling,histone modifications,deubiquitinating enzyme activity,oncogenic protein stabilization,dna repair and damage response,potential therapeutic target
ENSG00000075142,SRI,amino acid metabolism regulation,metabolic reprogramming,oncogenic pathway interaction,cellular redox balance,tumor progression driver,therapeutic target
ENSG00000111652,COPS7A,csn complex dysregulation,cullin-ring ubiquitin ligases activation,oncogenic role,cell cycle regulation,protein degradation pathway,ubiquitination regulation
ENSG00000116218,NPHS2,podocyte integrity,cell migration,oncogenesis,cell proliferation regulation,protein interaction,signaling pathway modulation
ENSG00000083845,RPS5,protein synthesis regulation,translation initiation,oncogene activation,cell growth modulation,chemo-resistance,poor prognosis
ENSG00000136872,ALDOB,cellular metabolism,oncogenesis,glycolysis regulation,energy production alteration,tumor progression,warburg effect
ENSG00000109133,TMEM33,tumor progression,constitutive activation,cell survival,apoptosis inhibition,oncogenic process,biomarker expression
ENSG00000101057,MYBL2,cell cycle regulation,transcription factor activity,dna replication,apoptosis evasion,chromatin remodeling,overexpression
ENSG00000100029,PES1,ribosome biogenesis,constitutive expression,gain of function mutations,tumor progression,cell proliferation,genomic instability
ENSG00000102158,MAGT1,cellular magnesium regulation,oncogenic signaling pathway interaction,chemosensitivity modulation,tumor progression facilitation,co-activator/co-repressor function,metabolic adaptation support
ENSG00000160305,DIP2A,chromatin remodeling,gene expression regulation,oncogenic transformation,tumor progression,therapeutic target,epithelial-to-mesenchymal transition
ENSG00000068305,MEF2A,transcriptional regulation,cellular proliferation,genomic instability,apoptosis modulation,tumorigenesis association,oncogene interaction
ENSG00000076382,SPAG5,cell cycle regulation,centrosome function,mitotic spindle formation,oncogenic signaling,tumor progression,protein overexpression
ENSG00000101146,RAE1,mitotic spindle checkpoint regulation,oncogenic function,cellular stress response,apoptosis inhibition,chromosome segregation accuracy,tumor suppressor activity
ENSG00000124713,GNMT,cellular methylation,dna synthesis regulation,genomic instability,homocysteine metabolism,metabolic regulation,protein stability
ENSG00000147669,POLR2K,transcriptional regulation,mrna synthesis,subunit of rna polymerase ii,enhanced cell proliferation,genomic instability,therapeutic target
ENSG00000124688,MAD2L1BP,genomic instability,tumor suppressor function,spindle assembly checkpoint regulation,cell cycle dysregulation,protein ubiquitination,e3 ligase activity
ENSG00000071539,TRIP13,genomic instability,dna damage response,homologous recombination repair,tumor suppressor function loss,oncogenic mutations,prognostic marker
ENSG00000120875,DUSP4,mapk pathway regulation,cell cycle arrest,tumor suppression,oncogenic signaling,angiogenesis promotion,epigenetic silencing
ENSG00000002822,MAD1L1,mitotic checkpoint regulation,genomic stability maintenance,cell cycle progression inhibition,apoptosis suppression,tumor promotion,therapeutic target
ENSG00000111726,CMAS,lipid metabolism,cellular processes,vitamin k regulation,thioester formation,phospholipase activity,lysophosphatidylcholine generation
ENSG00000166432,ZMAT1,dna damage response,tumor suppression,e3 ubiquitin ligase activity,cell cycle regulation,g2/m phase transition,cancer-related mutations
ENSG00000171497,PPID,mitochondrial dynamics,altered energy metabolism,cellular proliferation,tumor growth,biomarker for prognosis,interaction with pi3k/akt
ENSG00000139874,SSTR1,pi3k/akt pathway,constitutive activation,hormone regulation,tumor progression,cell proliferation,g-protein coupled receptor
ENSG00000197535,MYO5A,actin dynamics,intracellular transport,tumor progression,metastasis facilitation,cellular homeostasis regulation,protein interaction
ENSG00000196642,RABL6,gtpase regulation,cell trafficking,oncogenic transformation,constitutive activation,pi3k/akt interaction,tumor progression
ENSG00000188603,CLN3,lysosomal function,impaired cellular metabolism,increased oxidative stress,regulation of cell growth,oncogenesis,cellular homeostasis
ENSG00000134824,FADS2,lipid metabolism regulation,fatty acid desaturation,cell membrane fluidity modulation,cancer cell proliferation,therapeutic target,genetic alterations
ENSG00000184160,ADRA2C,adra2c overexpression,pi3k/akt pathway interaction,cell proliferation promotion,tumor progression facilitation,apoptosis inhibition,oncogenic signaling activation
ENSG00000134046,MBD2,tumor suppression,genomic stability,dna methylation regulation,chromatin modification,apoptosis regulation,cancer progression prevention
ENSG00000145220,LYAR,tumor suppressor function,chromatin remodeling,transcriptional regulation,cell cycle inhibition,apoptosis modulation,cancer-related expression changes
ENSG00000171861,MRM3,drug efflux pump,multidrug resistance,chemotherapy treatment,redox regulation,detoxification mechanism,abc transporter superfamily
ENSG00000113851,CRBN,cancer evasion mechanism,protein degradation regulation,immunogenic unresponsiveness,nedd8 pathway regulation,dna damage response,protein accumulation
ENSG00000077514,POLD3,genomic instability,dna repair,oncogenic mutations,cell proliferation,therapeutic target,protein interaction
ENSG00000125967,NECAB3,protein lipidation regulation,tumor progression,cell proliferation enhancement,oncogenic protein interaction,poor prognosis biomarker,overexpression
ENSG00000137674,MMP20,tumor progression,extracellular matrix remodeling,cell migration and invasion,poor prognosis marker,angiogenesis facilitation,oncogenic signaling pathway interaction
ENSG00000152591,DSPP,cell surface protein,regulation of mineralization,mutations leading to impaired function,tumor-associated antigen,oncogene activation,dentinogenesis
ENSG00000135077,HAVCR2,immune modulation,immunosuppression,tumor progression,immunogenicity,cancer immunotherapy,signal transduction
ENSG00000111181,SLC6A12,pi3k/akt signaling pathway alteration,cellular transport dysregulation,tumor progression facilitation,epithelial-to-mesenchymal transition,treatment resistance association,angiogenesis modulation
ENSG00000138663,COPS4,ubiquitin ligase regulation,cell cycle control,cancer proliferation,tumor suppressor function,protein degradation,genome stability
ENSG00000274286,ADRA2B,g-protein coupled receptor,cellular signaling regulation,tumor progression,gene expression modulation,signaling pathway regulation,mapk/erk pathway activation
ENSG00000131931,THAP1,chromatin remodeling,oncogenic mutations,transcriptional regulation,cell cycle dysregulation,apoptosis evasion,tumor metastasis
ENSG00000162627,SNX7,oncogenic function,endosomal sorting regulation,pi3k/akt/mtor pathway modulation,wnt/β-catenin signaling interaction,egfr/src kinase regulation,tumor suppressor protein stabilization
ENSG00000159337,PLA2G4D,oncogenic function,overexpression in tumor tissues,cell proliferation,immune suppression,lipid metabolism regulation,protein kinase activation
ENSG00000105497,ZNF175,transcription regulation,oncogene activation,wnt/β-catenin signaling,epithelial-to-mesenchymal transition,angiogenesis promotion,tumor growth enhancement
ENSG00000165271,NOL6,oncogene activation,ribosome biogenesis regulation,nuclear-cytoplasmic transport inhibition,cell proliferation enhancement,apoptosis suppression,tumor aggressiveness
ENSG00000163875,MEAF6,chromatin remodeling,transcriptional regulation,oncogene activation,histone acetylation,cell proliferation,aggressive tumor behavior
ENSG00000165702,GFI1B,cellular proliferation suppression,transcriptional repression,genomic instability prevention,protein-protein interaction,tumor growth inhibition,oncogenic transformation regulation
ENSG00000143933,CALM2,cellular regulation,ca2+ signaling,apoptosis modulation,tumor progression,gene expression regulation,protein interaction
ENSG00000130203,APOE,apoptosis regulation,genomic instability,immune response modulation,microrna regulation,proliferation influence,lipid metabolism alteration
ENSG00000099889,ARVCF,adherens junction formation,disrupted cell-cell adhesion,increased cellular invasion,wnt/β-catenin pathway activation,tumor progression,cancer therapeutic target
ENSG00000100206,DMC1,homologous recombination,genomic instability,dna repair mechanisms,meiotic process,genetic diversity promotion,brca2 interaction
ENSG00000124702,KLHDC3,cell cycle regulation,oncogenic signaling,dna repair,adaptor protein function,tumor growth promotion,genetic instability
ENSG00000205420,KRT6A,altered expression,cellular differentiation,cellular proliferation,epithelial integrity,keratin filament assembly,protein kinase c regulation
ENSG00000077348,EXOSC5,rna degradation regulation,oncogene function,pan-cancer feature,cell growth modulation,cancer driver mutation,exosome complex subunit
ENSG00000124256,ZBP1,tumor suppressor inhibition,oncogenic transformation,dna repair mechanism enhancement,transcriptional regulation modulation,nuclear localization,apoptosis inhibition
ENSG00000276336,SCARF1,immune regulation,tumor suppression,myeloid-derived suppressor cells,immune receptor modulation,cancer immunotherapy,tumor progression
ENSG00000122873,CISD1,tumor progression,cellular metabolism regulation,cancer biomarker,cell growth regulation,protein-protein interaction,homeostasis disruption
ENSG00000184056,VPS33B,autophagic regulation,lysosomal sorting,membrane trafficking,cancer driver gene,therapeutic target,genomic instability
ENSG00000198876,DCAF12,ubiquitin ligase complex,cell cycle regulation,gene mutation,genomic stability,p53 pathway modulation,dna repair machinery
ENSG00000108515,ENO3,glycolytic enzyme,cellular metabolism regulation,tumor progression marker,energy production enhancement,cancer cell proliferation,metastasis promotion
ENSG00000160752,FDPS,enhanced protein prenylation,activated signaling pathways,ras mutation interaction,cholesterol biosynthesis inhibition,therapeutic target,tumorigenesis facilitation
ENSG00000164649,CDCA7L,mitotic regulation,genomic instability,transcriptional coactivation,cell cycle progression,dna replication,chromatin remodeling
ENSG00000130589,HELZ2,dna unwinding,nuclear localization,oncogene activation,genome instability,therapeutic target,transcriptional regulation
ENSG00000147223,RIPPLY1,transcriptional coactivator,swi/snf complex interaction,chromatin remodeling,cell cycle regulation,wnt/β-catenin pathway modulation,oncogenic potential
ENSG00000130429,ARPC1B,actin cytoskeleton dynamics,enhanced cell motility,metastasis promotion,dna damage response regulation,oncogenic behavior,cancer progression hallmark
ENSG00000132300,PTCD3,cell membrane trafficking,protein-lipid interaction,tumor progression,proliferation regulation,oncogenic properties,signaling pathway modulation
ENSG00000171148,TADA3,chromatin remodeling,transcriptional regulation,oncogene activation,cell proliferation,apoptosis inhibition,gene expression alteration
ENSG00000086589,RBM22,alternative splicing regulation,oncogene activation,cell proliferation enhancement,rna-binding protein function,spliceosome interaction,tumor suppressor inhibition
ENSG00000076685,NT5C2,oncogenic transformation,chemoresistance,purine metabolism,cell survival,tumor progression,cell proliferation
ENSG00000023228,NDUFS1,mitochondrial dysfunction,energy metabolism regulation,cell proliferation support,oncogenic adaptation,cell growth dependency,electron transport chain component
ENSG00000152944,MED21,oncogenic transcriptional regulation,tumor progression,cell proliferation,transcriptional activation,chromatin remodeling,genomic instability
ENSG00000214827,MTCP1,chromatin remodeling,oncogene activation,transcriptional regulation,epigenetic modification,tumorigenesis,therapeutic target
ENSG00000131023,LATS1,hippo pathway regulation,tumor suppressor function,cell cycle regulation,apoptosis induction,genomic instability,signaling pathway interaction
ENSG00000133063,CHIT1,lysosomal degradation,chitin metabolism,cancer progression,cell migration,proteolytic activity,autophagic regulation
ENSG00000105641,SLC5A5,phosphate transport regulation,oncogenesis promotion,tumor progression facilitation,glycolysis regulation,emt marker upregulation,therapeutic target identification
ENSG00000076662,ICAM3,adhesion molecule regulation,cell migration and invasion,apoptosis regulation,oncogenic signaling pathway activation,tumor progression facilitation,immune evasion mechanism enhancement
ENSG00000110321,EIF4G2,oncogene activation,mrna translation regulation,tumor growth promotion,cellular proliferation enhancement,protein synthesis upregulation,aberrant eif4f complex formation
ENSG00000104442,ARMC1,mitotic spindle assembly,genomic instability,dna repair,tumor initiation,homologous recombination,cellular proliferation
ENSG00000262788,UTP4,gene expression regulation,pre-mrna splicing,oncogenic pathway activation,tumor suppressor dysregulation,genomic instability,cellular proliferation enhancement
ENSG00000117362,APH1A,gamma-secretase complex,notch receptor activation,cell proliferation regulation,tumor suppressor function loss,substrate processing regulation,protein-protein interaction defects
ENSG00000189171,S100A13,tumor growth promotion,metastasis regulation,cell proliferation enhancement,signaling pathway modulation,oncogenic protein-protein interaction,angiogenesis facilitation
ENSG00000178996,SNX18,endosomal sorting,oncogenic signaling,receptor tyrosine kinase activation,cell proliferation enhancement,akt pathway modulation,tumor progression promotion
ENSG00000175110,MRPS22,mitochondrial function,tumor suppression,mitochondrial biogenesis,oncogenic mutations,mitochondrial metabolism,cellular respiration
ENSG00000120075,HOXB5,hoxb5 overexpression,transcriptional regulation,tumor progression,cell proliferation,angiogenesis promotion,notch signaling interaction
ENSG00000111271,ACAD10,altered metabolism,mitochondrial dysfunction,oncogenic mutations,cellular growth regulation,energy production alteration,therapeutic target
ENSG00000115041,KCNIP3,oncogenic driver,cell proliferation,tumor progression,dna repair regulation,calcium/calmodulin-dependent kinase inhibition,transcriptional regulation
ENSG00000129450,SIGLEC9,immune modulation,tumor-associated macrophages,immunosuppressive microenvironment,cell signaling regulation,biomarker potential,gene expression correlation
ENSG00000090615,GOLGA3,cell proliferation,protein secretion regulation,oncogenic function,apoptosis inhibition,tumor progression marker,genomic amplification
ENSG00000136811,ODF2,cilia formation regulation,cellular proliferation,microtubule stability maintenance,oncogene activity,apoptosis resistance,hippo signaling pathway interaction
ENSG00000104738,MCM4,genomic instability,cell proliferation,dna replication initiation,tumor progression,oncogenic driver,cancer hallmark
ENSG00000065357,DGKA,altered metabolic regulation,oncogenic signaling pathway activation,tumor progression enhancement,protein kinase c modulation,cell proliferation increase,angiogenesis promotion
ENSG00000001497,LAS1L,alternative splicing regulation,cell proliferation enhancement,oncogene regulation,translation modulation,nuclear localization,rna-binding activity
ENSG00000110075,PPP6R3,protein phosphatase regulation,dephosphorylation and regulation,cell cycle regulation,tumor suppressor protein modulation,regulation of cyclin-dependent kinases (cdks),potential oncogene
ENSG00000110367,DDX6,pi3k/akt pathway regulation,oncogenic function,cell proliferation promotion,tumor progression facilitation,translational regulation,nuclear export modulation
ENSG00000085224,ATRX,genomic instability,chromatin remodeling,histone modification,transcriptional regulation,oncogenesis,tumor suppression
ENSG00000187908,DMBT1,adhesion regulation,apoptosis modulation,tumor microenvironment modification,cancer progression enhancement,cellular migration facilitation,signaling pathway interaction
ENSG00000041357,PSMA4,proteasome regulation,tumor progression,overexpression,cancer susceptibility,cellular degradation,ubiquitin-proteasome pathway
ENSG00000187239,FNBP1,cell migration,actin cytoskeleton regulation,oncogene potential,metastasis facilitation,cell invasion promotion,poor prognosis indicator
ENSG00000169474,SPRR1A,cellular differentiation regulation,epithelial cell interaction,proliferation enhancement,metastasis facilitation,apoptosis inhibition,poor prognosis marker
ENSG00000198721,ECI2,pi3k/akt pathway interaction,oncogene activation,ubiquitin ligase activity,protein degradation regulation,cell growth promotion,tumor suppressor degradation
ENSG00000183918,SH2D1A,immunomodulation,oncogenic mutations,therapeutic target,tumor microenvironment,immune checkpoint regulation,pi3k/akt pathway modulation
ENSG00000169446,MMGT1,dna repair,oncogenic potential,tumor resistance,genomic instability,cell protection,chemotherapy evasion
ENSG00000164096,C4orf3,cell cycle regulation,apoptosis resistance,tumor progression,oncogene overexpression,protein-protein interactions,ankyrin repeats
ENSG00000184113,CLDN5,tumor progression,disrupted tight junctions,enhanced cell proliferation,cellular permeability disruption,oncogenic processes,therapeutic target
ENSG00000177519,RPRM,chromatin remodeling,tumor suppressor function,transcriptional regulation,cancer progression,dna repair pathway,cell cycle regulation
ENSG00000163069,SGCB,muscle cell membrane integrity,tumor suppressor function,disruptions in cellular adhesion,signaling pathway regulation,metastasis promotion,cell growth regulation
ENSG00000079134,THOC1,oncogene activation,cell cycle progression,mrna export regulation,nuclear transport complex interaction,tumor suppressor gene inhibition,therapeutic target potential
ENSG00000161526,SAP30BP,chromatin modification,gene expression regulation,histone methylation,oncogenesis,transcriptional dysregulation,cell cycle progression
ENSG00000120694,HSPH1,apoptosis inhibition,chaperone activity,tumor progression,thermotolerance,cell survival,protein folding
ENSG00000114062,UBE3A,genomic instability,homologous recombination repair (hrr),mismatch repair (mmr),tumor suppressor function,dna damage response regulation,parp inhibitor resistance
ENSG00000165821,SALL2,tumor suppressor function,overexpressed in tumors,zinc finger dna-binding domains,transcriptional regulation,cell cycle progression,oncogenesis
ENSG00000177875,CCDC184,mitotic checkpoint regulation,microtubule dynamics regulator,genomic stability maintenance,cell division control,protein-protein interaction,tumor suppressor activity
ENSG00000111142,METAP2,methionine metabolism,cell growth regulation,tumor progression driver,therapeutic target,protein interaction,aberrant expression
ENSG00000139631,CSAD,protease activity,tumor progression,cell migration,metastasis,extracellular matrix degradation,oncogenic signaling
ENSG00000167900,TK1,telomerase regulation,cell cycle progression,dna replication,cell proliferation,nuclear localization,prognostic marker
ENSG00000165370,GPR101,oncogenic driver,cell proliferation regulation,signaling pathway activation,tumor progression promoter,melatonin receptor,poor prognosis marker
ENSG00000164294,GPX8,regulation of protein activity,interactions with cell signaling pathways,oxidative stress protection,cell proliferation modulation,tumor growth promotion,angiogenesis regulation
ENSG00000164815,ORC5,origin recognition complex,chromosome replication,cell cycle regulation,genomic instability,dna synthesis initiation,cell proliferation
ENSG00000093009,CDC45,genomic instability,cell proliferation,dna replication machinery,constitutive activation,protein interaction,mitotic regulation
ENSG00000115392,FANCL,genomic instability,dna damage response,homologous recombination,ubiquitin ligase activity,tumor suppressor function,cancer predisposition
ENSG00000182591,KRTAP11-1,keratin-associated protein,cell growth regulation,tumor progression,metastasis promotion,stress response modulation,oncogenic potential
ENSG00000181896,ZNF101,tumor suppression,dna binding activity,cell growth inhibition,transcriptional regulation,apoptosis induction,methylated and silenced
ENSG00000186908,ZDHHC17,palmitoylation,lipid modification,protein trafficking,signaling pathway regulation,tumorigenesis,metastasis
ENSG00000132639,SNAP25,metastasis driver,exocytosis regulator,cell migration facilitator,microtubule modulator,apoptosis inhibitor,cancer progression enhancer
ENSG00000104343,UBE2W,ubiquitination pathway,cell cycle regulation,dna repair mechanisms,oncogenic processes,tumor suppression loss,protein degradation dysregulation
ENSG00000176641,RNF152,p53 modulation,cell cycle regulation,dna damage response,apoptosis regulation,protein degradation pathway,tumor suppression
ENSG00000095637,SORBS1,cell adhesion regulation,scaffolding protein function,tumor progression,epithelial-to-mesenchymal transition,signaling pathway modulation,oncogene/tumor suppressor gene
ENSG00000073921,PICALM,clathrin-mediated trafficking,enhanced cell growth,endocytosis regulation,dysregulated cellular transport,intracellular signaling,protein trafficking modification
ENSG00000127922,SEM1,genomic instability,mitotic checkpoint regulation,chromosome segregation,kinetochores assembly,tumor suppressor function,dna damage response
ENSG00000101132,PFDN4,membrane trafficking regulation,golgi apparatus localization,oncogenic mutations,tumor growth enhancement,metastasis facilitation,resistance to chemotherapy
ENSG00000155959,VBP1,transcription factor,g2/m phase transition,cyclin-dependent kinase regulation,cell cycle progression,proliferation regulation,tumor formation
ENSG00000102804,TSC22D1,cellular regulation,tumor suppression,dna damage response,apoptosis induction,transcriptional repression,stress response
ENSG00000134376,CRB1,epithelial cell polarity,cell adhesion,transmembrane protein function,mutation association,tumor suppressor activity,polarity maintenance
ENSG00000133943,DGLUCY,glycosidase activity,energy metabolism regulation,cell signaling pathway interaction,lipid synthesis modulation,protein modification role,tumor progression association
ENSG00000198835,GJC2,gap junction communication,loss of function mutations,tumor progression,cell proliferation,oncogenesis,cell migration
ENSG00000178623,GPR35,g protein-coupled receptor,inflammatory response regulation,cell survival enhancement,angiogenesis promotion,tumor growth factor,metabolic pathway modulation
ENSG00000124074,ENKD1,dna repair mechanism,gain of function mutations,genomic instability,tumor progression,therapeutic target,protein-dna interaction
ENSG00000139579,NABP2,genomic instability,tumor suppressor function,transcriptional regulation,cell cycle regulation,apoptosis modulation,protein-dna interaction
ENSG00000171867,PRNP,tumor cell migration,cell surface receptor function,neurodegenerative disease link,prion protein interaction,dna damage response modulation,cancer stem cell maintenance
ENSG00000181392,SYNE4,nuclear envelope maintenance,chromatin dynamics regulation,microtubule organization,oncogenic interaction,tumor suppressor modulation,cell division regulation
ENSG00000182685,BRICD5,chromatin remodeling,transcriptional regulation,cell growth regulation,apoptosis modulation,cell cycle progression,therapeutic target
ENSG00000139116,KIF21A,kinesin motor protein,microtubule-dependent processes,cell division regulation,chromosome segregation,spindle checkpoint function,mitotic stability disruption
ENSG00000163072,NOSTRIN,wnt signaling pathway,epithelial-to-mesenchymal transition,cell migration,tumor progression,metastasis,cell proliferation
ENSG00000107223,EDF1,mtor signaling pathway,constitutive activation,cellular growth regulation,tumor progression driver,proliferation enhancement,therapeutic target
ENSG00000116833,NR5A2,pi3k/akt signaling,tumor suppressor function,mutation hotspots,aberrant transcriptional activity,gene amplification,cell proliferation enhancement
ENSG00000214253,FIS1,mitochondrial dynamics,dysregulated function,regulatory interaction,energy metabolism,tumorigenesis,redox imbalance
ENSG00000100335,MIEF1,mitochondrial dynamics,cell survival enhancement,warburg effect induction,oncogenic processes promotion,glycolytic enzyme regulation,anti-apoptotic gene expression modulation
ENSG00000166689,PLEKHA7,phospholipid metabolism,protein kinase activation,cytoskeletal organization,cell membrane interactions,tumor suppressor function,cancer cell invasion
,LARS,tumor progression,genomic instability,metabolic reprogramming,protein synthesis regulation,oncogene activation,cell growth promotion
ENSG00000145888,GLRA1,altered expression,cell growth regulation,neurotransmission modulation,tumorigenesis contribution,apoptosis regulation,cell cycle progression
ENSG00000197587,DMBX1,tumor suppressor,transcriptional regulation,cell growth control,apoptosis regulation,epithelial-to-mesenchymal transition,dna repair pathway
ENSG00000100522,GNPNAT1,purine biosynthesis modulation,energy metabolism regulation,cellular proliferation promotion,genomic instability contribution,therapeutic target identification,protein-protein interaction involvement
ENSG00000110047,EHD1,tumor progression,endocytic trafficking regulation,amplification or overexpression,protein-protein interaction modulation,potential therapeutic target,cancer cell stemness regulation
ENSG00000131381,RBSN,tumor suppressor,gain of function mutations,genomic instability,cell proliferation regulation,apoptosis modulation,dna repair pathway interaction
ENSG00000147155,EBP,pi3k/akt/mtor pathway regulation,transcription factor activity,oncogenic promoter,cell growth enhancement,signaling pathway modulation,tumor progression promotion
ENSG00000136052,SLC41A2,magnesium-dependent sodium-calcium exchanger,calcium homeostasis regulation,oncogenic process promotion,tumor progression association,gain of function mutations,prognostic marker potential
,SEPT12,septin complex formation,cellular polarity regulation,microtubule dynamics,mitotic progression,oncogenic signaling,tumor aggressiveness
ENSG00000082556,OPRK1,opioid receptor activation,tumor microenvironment modulation,cell proliferation enhancement,g protein-coupled receptor function,signal transduction regulation,cancer cell migration promotion
ENSG00000171033,PKIA,ck2 inhibition,endogenous inhibitor,cellular homeostasis,protein kinase regulation,tumorigenesis,cell cycle regulation
ENSG00000158716,DUSP23,erk1/2 phosphorylation inhibition,mapk pathway regulation,oncogenic transformation,tumor angiogenesis,cell proliferation enhancement,metastatic progression
ENSG00000196290,NIF3L1,cellular regulation,chromatin remodeling,dna damage response,oncogenic activation,transcriptional regulation,cell cycle progression
ENSG00000117475,BLZF1,chromatin remodeling,transcriptional regulation,oncogenic processes,cell proliferation,metastasis,dysregulation
ENSG00000075624,ACTB,cellular morphogenesis,cytoskeletal dynamics,epithelial-to-mesenchymal transition,mutational hotspot,oncogenic potential,tumor progression
ENSG00000130545,CRB3,cell polarity regulation,tumor suppressor activity,cell adhesion modulation,oncogene/ tumor suppressor ambiguity,signaling pathway regulation,cell migration control
ENSG00000120942,UBIAD1,tumor suppressor function,cell proliferation inhibition,apoptosis promotion,epithelial-to-mesenchymal transition regulation,dna repair interaction,vitamin k2 biosynthesis
ENSG00000163535,SGO2,chromosome segregation,genetic instability,cell proliferation,protein-protein interaction,cancer aggressiveness,targeted therapy
ENSG00000177694,NAALADL2,gpcr interaction,cancer progression,glutamate metabolism,oncogenic processes,tumor growth regulation,signaling pathway modulation
ENSG00000164082,GRM2,mglur2 regulation,pro-survival signaling,tumor growth promotion,overexpression association,cell proliferation enhancement,synaptic plasticity alteration
ENSG00000145414,NAF1,genomic stability,cell proliferation,oncogenic process,telomere maintenance,dna damage repair,tumor suppressor function
ENSG00000244362,KRTAP19-7,epithelial cell regulation,gene amplification,mechanical instability,cell proliferation enhancement,adhesion molecule modification,tumor progression marker
ENSG00000181929,PRKAG1,ampk activation,cell proliferation enhancement,metabolic reprogramming,tumorigenesis promotion,oncogene interaction,genomic instability
ENSG00000167107,ACSF2,cell proliferation,tumor progression,signaling pathway regulation,cell survival modulation,genomic instability,cancer initiation
ENSG00000088682,COQ9,mitochondrial function,electron transport chain,respiratory chain complex iii,atp production,neurological disorder,oxidative phosphorylation
ENSG00000007944,MYLIP,fatty acid oxidation inhibition,lipid droplet regulation,tumor suppression,metabolic adaptation,lipolysis modulation,glucose uptake regulation
ENSG00000103043,VAC14,sphingosine-1-phosphate signaling,constitutive activation,gain of function mutations,oncogenic processes,tumor progression,therapeutic target
ENSG00000159202,UBE2Z,ubiquitination process,critical regulator,oncogenic signaling pathways,pi3k/akt/mtor pathway,cell cycle progression,dna repair regulation
ENSG00000145358,DDIT4L,mtor inhibition,tumor suppressor function,impaired mtor signaling,tumor progression,therapeutic target,genomic instability
ENSG00000204873,KRTAP9-3,keratin regulation,epithelial integrity,tumor aggressiveness,protein-protein interactions,cell differentiation,filament dynamics
ENSG00000254997,KRTAP5-9,keratin-associated protein,pseudogene expression,epithelial cell regulation,biomarker potential,cell proliferation,protein interaction
ENSG00000158552,ZFAND2B, ubiquitination regulation,cell cycle progression disruption,gain-of-function mutations,oncogene activation,apoptosis suppression,tumor suppressor inactivation 
ENSG00000135636,DYSF,membrane repair,protein degradation,muscle cell membrane integrity,neuromuscular disorders,lipid metabolism regulation,muscle degeneration
ENSG00000161547,SRSF2,alternative splicing,oncogenic transformation,mapk/erk signaling pathway,splice site recognition,tumor progression,aberrant protein expression
ENSG00000185811,IKZF1,ikaros transcription factor,chromatin remodeling,tumor suppressor or oncogene,lymphoid cell differentiation,apoptosis regulation,cancer therapy target
ENSG00000143156,NME7,nucleotide phosphorylation,apoptosis modulation,cancer progression,tumor suppression,p53 interaction,cell proliferation regulation
ENSG00000278570,NR2E3,tumor suppressor function,dual role oncogene/tumor suppressor,cell growth regulation,wnt/β-catenin pathway modulation,transcriptional regulation,cellular differentiation
ENSG00000187175,KRTAP12-1,keratin structure,cell differentiation,epithelial integrity,actin cytoskeleton regulation,emt process,tumor progression
ENSG00000105991,HOXA1,transcription factor regulation,cell cycle progression,oncogenic signaling,angiogenesis promotion,dysregulated expression,embryonic development
ENSG00000126804,ZBTB1,cell cycle regulation,tumor suppressor function,apoptosis induction,genomic stability maintenance,transcriptional repression,dna damage response
ENSG00000183434,TFDP3,transcriptional regulation,cell cycle progression,genetic instability,cell proliferation,oncogenic transformation,tumor suppressor dysfunction
ENSG00000148175,STOM,mitochondrial dynamics,apoptosis regulation,metabolic adaptation,cellular survival,protein-protein interaction,genetic instability
ENSG00000100243,CYB5R3,mitochondrial localization,flavoprotein reductase function,electron transport chain regulation,tumor metabolism modulation,cellular respiration impact,tumor growth promotion
ENSG00000165495,PKNOX2,transcriptional regulation,oncogenic transformation,cell cycle progression,apoptosis resistance,metastatic potential,cell growth regulation
ENSG00000143079,CTTNBP2NL,cell migration,actin cytoskeleton dynamics,putative oncogene,tumor progression,genomic alterations,cancer invasiveness
ENSG00000213281,NRAS,mapk/erk signaling,constitutive activation,gain of function mutations,tumor progression,therapeutic target,metabolic regulation
ENSG00000155833,CYLC2,pro-resolving mediator,tumor microenvironment modulation,anti-tumor immunity regulation,inflammation resolution,immune response regulation,lipoxin production
ENSG00000125409,TEKT3,microtubule stability,cytoskeleton organization,mitotic spindle regulation,chromosomal instability,aneuploidy contribution,proliferation modulation
ENSG00000186930,KRTAP6-2,cellular differentiation,epithelial-to-mesenchymal transition,keratinocyte proliferation,cell migration,protein-protein interactions,tumor progression
ENSG00000092203,TOX4,transcriptional regulation,oncogenic activity,tumor suppressor inhibition,cell cycle progression,apoptosis suppression,genome-wide transcriptional changes
ENSG00000115507,OTX1,oncogene,cellular proliferation,survival and migration,wnt/β-catenin pathway regulation,dysregulation in tumorigenesis,therapeutic target
ENSG00000198089,SFI1,inositol phosphate regulation,tumor suppressor function,cell growth regulation,lipid metabolism modulation,endocytosis regulation,protein trafficking regulation
ENSG00000147400,CETN2,centrosome regulation,microtubule dynamics,cell proliferation,genomic stability,protein-protein interaction,mitotic spindle assembly
,HIST2H3A,chromatin remodeling,histone modification,gene regulation,nucleosome assembly,epigenetic regulation,tumor progression
,HIST2H3C,chromatin regulation,histone modification,epigenetic alterations,gene expression regulation,tumor suppressor gene suppression,oncogenic pathway activation
,HIST2H3D,histone modification,chromatin remodeling,epigenetic regulation,genomic instability,cell cycle progression,therapeutic resistance
ENSG00000105223,PLD3,enhanced cell proliferation,cell membrane dynamics,oncogenic signaling,therapeutic target,tumor progression,protein expression regulation
ENSG00000143786,CNIH3,regulation of mrna stability,cellular homeostasis,post-transcriptional control,oncogene activation,signal transduction pathway,cell proliferation regulation
ENSG00000148690,FRA10AC1,genomic instability,telomere maintenance,aneuploidy regulation,cell cycle control,tumor suppressor interaction,chromosomal fragility
ENSG00000149929,HIRIP3,chromatin remodeling,transcriptional regulation,cell cycle progression,dna replication,coactivator function,oncogenic target
ENSG00000168701,TMEM208,cell membrane integrity,cell adhesion modulation,oncogenic signaling pathway,overexpression association,tumor progression regulation,metastasis promotion
ENSG00000262045,KRT34,keratin structure integrity,epithelial cell differentiation,mechanical stability regulation,tumor suppression resistance,cancerous epithelium disruption,cell proliferation enhancement
ENSG00000123685,BATF3,immune modulation,tumor immunosuppression,transcriptional regulation,t cell differentiation,nk cell activation,cytokine suppression
ENSG00000204571,KRTAP5-11,aberrant expression,cell proliferation,cell differentiation,oncogenic signaling,tumor progression,genomic instability
ENSG00000117016,RIMS3,regulation of synaptic transmission,gene expression regulation,tumor progression,cell survival enhancement,signaling pathway interaction,poor prognostic marker
ENSG00000100151,PICK1,pi3k/akt pathway,cell proliferation,tumor progression,protein-protein interaction,overexpression,scaffold protein
ENSG00000171729,TMEM51,cell division regulation,mitotic progression facilitation,chromosome segregation ensuring,oncogenic properties promoting,tumor growth enhancement,apoptosis resistance conferring
ENSG00000108010,GLRX3,cellular redox balance,glutathione reduction activity,dna repair mechanisms,oncogenic signaling,genomic instability,protein interaction
ENSG00000129355,CDKN2D,cell cycle regulation,cyclin-dependent kinase inhibition,tumor suppressor,apoptosis promotion,cell proliferation inhibition,breast cancer susceptibility
ENSG00000196388,INCA1,genomic instability,chromatin regulation,transcriptional regulation,dna repair pathways,cell cycle progression,apoptosis regulation
ENSG00000153823,PID1,pi3k/akt pathway regulation,tumor suppressor modulation,cellular growth regulation,dysregulated expression,apoptosis disruption,transcriptional regulation
ENSG00000128185,DGCR6L,microrna biogenesis,pri-mirna processing,mirna dysregulation,oncogenic phenotypes,cell proliferation,apoptosis regulation
,HIST1H2BH,histone modification,chromatin regulation,dna repair,genomic stability,transcriptional regulation,cell cycle progression
ENSG00000168646,AXIN2,wnt signaling pathway,adaptor molecule,tumor suppressor function,cell proliferation regulation,oncogenesis driver,genetic alterations
ENSG00000085382,HACE1,genomic instability,tumor suppressor function,pi3k/akt pathway regulation,e3 ubiquitin ligase activity,apoptosis induction,cell cycle control
ENSG00000149295,DRD2,oncogene function,pi3k/akt/mtor signaling pathway,cell survival and proliferation,tumor progression,cancer stem cell regulation,g protein-coupled receptor activation
ENSG00000123473,STIL,genomic instability,oncogene,cell cycle regulation,centrosome duplication,chromosomal instability,mitotic spindle formation
ENSG00000104412,EMC2,kinetochore regulation,aneuploidy promotion,cell division disruption,mitotic spindle assembly,genomic instability induction,centrosome localization
ENSG00000135052,GOLM1,cellular differentiation,cell growth regulation,golgi apparatus localization,oncogenesis promotion,tumor progression facilitation,protein modification regulation
ENSG00000143801,PSEN2,notch signaling pathway,alzheimer's disease,cell fate regulation,gamma-secretase complex,neurodegenerative disorders,cell adhesion modulation
ENSG00000164896,FASTK,oncogene,cell growth promotion,tumor progression,constitutive activation,aberrant phosphorylation events,signaling pathway modulation
ENSG00000181915,ADO,adenosine metabolism,angiogenesis promotion,cell proliferation enhancement,immune response modulation,purine nucleotide balance,tumor microenvironment
ENSG00000104763,ASAH1,sphingolipid metabolism,oncogenesis promotion,s1p signaling modulation,tumor progression,prognostic biomarker,therapeutic target
ENSG00000280516,TMEM42,cellular stress response,endoplasmic reticulum localization,protein folding regulation,unfolded protein response,cell survival promotion,tumorigenic potential
ENSG00000126950,TMEM35A,autophagy regulation,cell surface trafficking,immune evasion,tumor growth promotion,apoptosis modulation,genomic instability
ENSG00000197976,AKAP17A,cell signaling,protein kinase activation,microtubule regulation,cell proliferation,apoptosis suppression,genomic instability
ENSG00000123154,WDR83,chromatin regulation,genomic instability,dna repair dysfunction,protein-protein interactions,transcriptional regulation disruption,cellular proliferation promotion
ENSG00000276644,DACH1,transcriptional regulation,tumor suppressor function,wnt/β-catenin signaling pathway inhibition,cell growth regulation,chromatin modification interaction,oncogenesis contribution
ENSG00000090905,TNRC6A,mirna-mediated gene silencing,risc assembly,mrna degradation,translational repression,oncogenic processes,tumorigenesis
ENSG00000228964,HLA-B,peptide presentation,immune surveillance evasion,mhc class i expression,anti-tumor immunity enhancement,t-cell recognition facilitation,cancer immunotherapy target
ENSG00000102024,PLS3,overexpression,tumor progression,metastasis driver,therapeutic target,signaling pathway regulation,cell surface protein
ENSG00000125356,NDUFA1,mitochondrial dysfunction,electron transport chain disruption,increased ros production,constitutive hif-1α activation,glycolytic shift,energy metabolism reprogramming
ENSG00000171135,JAGN1,notch signaling pathway,gain of function mutations,epithelial-to-mesenchymal transition (emt),cell proliferation,metastasis,targeted therapy resistance
,CCDC155,centrosome regulation,mitotic spindle assembly,genomic instability,aneuploidy,genome stability,cell division regulation
ENSG00000143641,GALNT2,oncogenic potential,protein modification,o-linked glycosylation,emt induction,signaling pathway modulation,tumor progression
ENSG00000117155,SSX2IP,overexpression,cell growth promotion,chromatin remodeling,transcriptional regulation,co-factor interaction,oncogene activation
ENSG00000103018,CYB5B,aberrant metabolism,cell growth enhancement,electron transfer reactions,energy production regulation,fatty acid oxidation facilitation,steroid metabolism support
ENSG00000155755,TMEM237,er stress response,apoptosis inhibition,autophagy regulation,cell survival promotion,tumor progression driver,protein-protein interaction
ENSG00000100528,CNIH1,calcium signaling pathway,oncogenic processes,cell proliferation regulation,therapeutic target,epithelial-to-mesenchymal transition regulation,aberrant expression levels
ENSG00000175514,GPR152,phosphatidylserine recognition,immune evasion,t-cell regulation,apoptotic cell clearance,cancer progression,immune surveillance
ENSG00000166289,PLEKHF1,cell migration,actin cytoskeleton reorganization,tumor progression,mirna regulation,intracellular trafficking,prognostic marker
ENSG00000115274,INO80B,genomic instability,dna repair,chromatin remodeling,tumor suppressor function,epigenetic regulation,nucleosome assembly
ENSG00000166900,STX3,apoptosis evasion,autophagy modulation,cell migration enhancement,oncogenic potential,protein-protein interaction,synaptic vesicle fusion disruption
ENSG00000143198,MGST3,tumor suppressor,oxidative stress,cell proliferation,apoptosis,redox homeostasis,lipid metabolism
ENSG00000198133,TMEM229B,cellular adhesion disruption,cancer cell migration,tumor progression driver,signaling pathway interaction,protein-protein interaction,genomic amplification
ENSG00000169371,SNUPN,cell cycle regulation,oncogenesis,cell proliferation,biomarker for diagnosis,cytoplasmic localization,genomic stability maintenance
ENSG00000122375,OPN4,photoreception regulation,tumor suppressor function,circadian rhythm regulation,cell cycle modulation,anti-apoptotic activity,poor prognosis marker
ENSG00000188021,UBQLN2,ups dysregulation,gain of function mutations,tumor progression,metastasis driver,biomarker candidate,protein degradation regulation
ENSG00000164983,TMEM65,cell-cell adhesion disruption,pi3k/akt pathway activation,transmembrane protein function,oncogenic signaling modulation,tumor progression facilitation,therapeutic target identification
ENSG00000180532,ZSCAN4,tumor suppressor function,genomic instability,cell proliferation,apoptosis regulation,dna binding activity,zinc finger protein
ENSG00000118402,ELOVL4,fatty acid biosynthesis,oncogenesis,lipid metabolism regulation,cell membrane integrity,tumor progression,therapeutic target
ENSG00000196329,GIMAP5,immune regulation,cell proliferation,transcription factor modulation,tumor development,survival pathway activation,mutation impact
ENSG00000197079,KRT35,keratin overexpression,tumor progression,epithelial cell expression,cancer driver potential,cell adhesion regulation,metastasis facilitation
ENSG00000143393,PI4KB,lipid biosynthesis,cell membrane regulation,protein kinase activation,akt/mtor pathway interaction,tumor progression driver,metabolic reprogramming
ENSG00000115307,AUP1,anti-apoptotic function,er stress regulation,gain-of-function mutations,cellular homeostasis modulation,oncogenic processes promotion,signaling pathway interaction
ENSG00000112038,OPRM1,g protein-coupled receptor,cell survival enhancement,oncogenic pathway modulation,tumor growth promotion,drug addiction susceptibility,endogenous opioid signaling
ENSG00000074319,TSG101,regulation of endocytosis,cellular homeostasis maintenance,genomic stability regulation,tumor suppressor function,loss-of-function mutations,signaling pathway interaction
ENSG00000169885,CALML6,calcium signaling,tumor suppressor function,cell proliferation regulation,differentiation pathways,protein-protein interactions,akt pathway activation
ENSG00000183036,PCP4,epithelial-to-mesenchymal transition (emt),wnt/β-catenin signaling,planar cell polarity,cancer metastasis,poor prognosis marker,cell adhesion regulation
ENSG00000152359,POC5,glycosylation regulation,cell adhesion modulation,tumor progression facilitation,metastasis enhancement,therapeutic target potential,pi3k/akt pathway involvement
ENSG00000146592,CREB5,apoptosis regulation,tumor suppressor function,cancer driver gene,bzip transcription factor,cell growth modulation,dna damage repair interaction
ENSG00000102858,MGRN1,tumor suppressor activity,ubiquitination regulation,cell proliferation regulation,transcription factor regulation,signaling pathway interaction,protein kinase regulation
ENSG00000087111,PIGS,aberrant glycosylation,tumor suppressor function,cell surface protein modification,oncogenic process,glycan biosynthesis,cancer progression
ENSG00000109654,TRIM2,tumor suppressor function,oncogenic mutations,cellular regulation,proteasomal degradation,dna damage response,genomic instability
ENSG00000104228,TRIM35,apoptosis regulation,cell cycle progression,oncogenic process,tumor suppressor function,ubiquitination and degradation,pi3k/akt signaling interaction
ENSG00000109736,MFSD10,sphingolipid metabolism regulation,tumor cell proliferation,protein-lipid interaction,membrane homeostasis disruption,lipid signaling pathway modulation,cell survival enhancement
ENSG00000121542,SEC22A,cellular trafficking,oncogenic function,protein secretion,cell growth regulation,tumor suppressor interaction,vesicular transport modulation
ENSG00000169217,CD2BP2,src kinase regulation,cellular homeostasis regulation,tumor progression association,gene expression regulation,signaling pathway modulation,src family kinase inhibition
ENSG00000152049,KCNE4,kcnt1 complex assembly,cellular excitability regulation,ion channel dysfunction,potassium channel modulation,neuronal membrane potential maintenance,tumor progression involvement
ENSG00000101161,PRPF6,splicing regulation,pre-mrna processing,cell proliferation,ribonucleoprotein complex,genetic instability,gene expression regulation
ENSG00000162881,OXER1,g-protein coupled receptor signaling,constitutive activation,cell surface interaction,tumor progression,genomic profiling,gene expression regulation
ENSG00000213186,TRIM59,cell cycle regulation,e3 ubiquitin ligase activity,dna damage response,protein-protein interactions,cell proliferation,tumor suppressor/oncogene
ENSG00000102934,PLLP,genomic instability,tumor suppressor function,dna repair regulation,constitutive activation,gain of function mutations,cell proliferation enhancement
ENSG00000182473,EXOC7,secretory pathway regulation,cellular growth modulation,membrane trafficking regulation,vesicle transport impairment,tumor progression contribution,therapeutic target potential
,MARCH3,protein degradation regulation,oncogenesis promotion,apoptosis suppression,cell growth modulation,e3 ubiquitin ligase activity,transcription factor regulation
ENSG00000284868,DHRS1,cellular lipid metabolism,cellular energy homeostasis,lipid synthesis regulation,cell proliferation regulation,tumor progression contribution,biomarker potential
ENSG00000169683,LRRC45,overexpression,cell migration,cell adhesion,pi3k/akt pathway regulation,tumor progression,protein-protein interactions 
ENSG00000179071,CCDC89,cell cycle regulation,genomic instability,centrosome stability,tumor growth,oncogene role,protein-protein interaction
ENSG00000135249,RINT1,genomic maintenance,homologous recombination repair,dna damage response,cell cycle regulation,oncogenic mutation,genomic instability
ENSG00000196843,ARID5A,genomic instability,epigenetic regulation,transcriptional regulation,cell proliferation,apoptosis suppression,chromatin remodeling
ENSG00000152954,NRSN1,er stress regulation,protein synthesis regulation,tumor suppressor function,oncogenic signaling activation,biomarker potential,cellular adaptation mechanisms
ENSG00000101236,RNF24,cell cycle regulation,mitotic checkpoint control,chromosomal instability,oncogenic processes,ubiquitination and proteasomal degradation,genomic stability
ENSG00000029725,RABEP1,rab gtpase regulation,oncogenic signaling pathway,endocytosis and vesicle transport,tumor cell migration,protein overexpression,therapeutic target
ENSG00000103365,GGA2,endocytic pathway regulation,pi3k/akt pathway interaction,protein kinase activation,tumor progression,vesicular trafficking regulation,cell migration enhancement
ENSG00000114993,RTKN,pi3k/akt pathway modulation,receptor tyrosine kinase activity,tumor progression factor,cell proliferation enhancement,survival signaling,oncogenic potential
ENSG00000086015,MAST2,notch signaling pathway,oncogenic mutations,cell proliferation regulation,transcriptional coactivation,nicd interaction,tumorigenesis promotion
ENSG00000103034,NDRG4,tumor suppressor function,pi3k/akt pathway regulation,cellular differentiation regulation,anti-oncogenic activity,cell cycle progression modulation,biomarker candidate
ENSG00000127561,SYNGR3,synaptic vesicle fusion,overexpression in cancer,epithelial-to-mesenchymal transition,cell adhesion disruption,tumor aggressiveness enhancement,therapeutic target
ENSG00000092607,TBX15,regulation of embryonic development,transcriptional regulation,cell growth modulation,apoptosis regulation,pi3k/akt pathway interaction,tumor suppressor function
ENSG00000282379,DTX2,dtx2 overexpression,transcriptional regulation,cell cycle progression,apoptosis resistance,gene expression modulation,chromatin remodeling
ENSG00000099968,BCL2L13,apoptosis inhibition,cell survival promotion,poor prognosis marker,immunotherapeutic target,tumorigenesis regulation,transcriptional modulation
ENSG00000170310,STX8,tumor progression,tumorigenesis,oncogenic processes,cellular homeostasis regulation,pi3k/akt/mtor pathway modulation,membrane fusion and trafficking
ENSG00000166833,NAV2,endocytic trafficking regulation,neuronal signaling modulation,protein quality control,cellular proliferation pathways,intracellular trafficking mechanism,synaptic plasticity modulation
ENSG00000092010,PSME1,proteasome activation,ubiquitin-proteasome pathway,cell cycle regulation,tumor suppressor inhibition,oncoprotein accumulation,apoptosis evasion
ENSG00000160185,UBASH3A,ubiquitin-proteasome pathway,receptor endocytosis,cell proliferation regulation,oncogenic driver modulation,constitutive activation enhancement,signaling pathway regulation
ENSG00000184492,FOXD4L1,transcriptional regulation,tumorigenesis promotion,emt regulation,cellular proliferation,metastasis facilitation,therapeutic target
ENSG00000162366,PDZK1IP1,aberrant expression,cell migration,cell proliferation,egfr activation,oncogenic process,receptor signaling
ENSG00000127774,EMC6,nucleosome remodeling,chromatin regulation,dna repair mechanisms,genome instability,transcriptional regulation,oncogenic mutations
ENSG00000111701,APOBEC1,apobec-mediated dna mutagenesis,oncogenic activity,enhanced cell proliferation,dna damage response,epigenetic regulation,therapeutic target
ENSG00000186977,KRTAP19-5,keratin-associated protein function,epithelial cell expression,cellular morphology regulation,tumor suppression mechanism,cell adhesion modulation,cancer association
ENSG00000020256,ZFP64,krab domain interaction,transcriptional repression,cell growth regulation,apoptosis modulation,oncogenesis promotion,chromatin modification
ENSG00000141378,PTRH2,chromatin remodeling,tumor suppressor function,cell cycle regulation,dna damage response,genomic instability,protein-protein interaction
ENSG00000105374,NKG7,altered expression,cancer progression,epigenetic regulation,immune surveillance,nk cell activation,tumor elimination
ENSG00000177842,ZNF620,transcriptional regulation,cellular proliferation,dna binding specificity,apoptosis regulation,tumor suppressor function,oncogene potential
ENSG00000147133,TAF1,transcriptional regulation,genomic instability,chromatin remodeling,histone modification,cell cycle progression,dna repair interaction
ENSG00000179930,ZNF648,wnt/β-catenin pathway,chromosomal instability,cell cycle regulation,apoptosis inhibition,transcriptional modulation,zinc finger domain
ENSG00000127993,RBM48,oncogenic regulation,arginine methylation,chromatin modification,cellular proliferation,tumor progression,regulatory mechanism
ENSG00000100461,RBM23,rna-binding activity,nuclear export function,oncogene regulation,tumor suppressor regulation,cellular proliferation,metastatic potential
ENSG00000163993,S100P,calcium signaling,cell cycle regulation,tumor growth promotion,angiogenesis induction,proliferation enhancement,cancer metastasis facilitation
ENSG00000173250,GPR151,immune response modulation,g protein-coupled receptor signaling,cancer stem cell maintenance,tumor progression,apoptosis resistance,inflammatory response regulation
ENSG00000124103,FAM209A,cell cycle regulation,dna repair,genetic instability,tumor suppression,possible oncogene,regulatory mechanism
ENSG00000288427,CLSTN3,cellular signaling,prognostic biomarker,metastatic spread,oncogene function,cell migration,adhesion pathway
ENSG00000174599,TRAM1L1,cell cycle regulation,apoptosis modulation,oncogenic potential,signaling pathway interaction,tumor suppressor activity,genetic instability
ENSG00000131115,ZNF227,cellular regulation,transcriptional regulation,tumor suppressor function,dna repair mechanisms,apoptosis regulation,protein-protein interactions
ENSG00000225998,LSM2,snrna-associated protein,pre-mrna splicing regulation,cellular stress response,genomic instability,cancer driver gene candidate,overexpression in cancers
ENSG00000100281,HMGXB4,chromatin regulation,dna replication,gene expression modulation,histone modifications,epigenetic landscape modification,cell proliferation promotion
ENSG00000102977,ACD,ceramide regulation,apoptosis modulation,lysosomal enzyme function,cell growth control,autophagy pathway interaction,tumor progression association
ENSG00000065150,IPO5,tumor suppressor,pi3k/akt pathway inhibition,rho gtpase activation,cell cycle regulation,apoptosis promotion,dna damage response
ENSG00000152684,PELO,aurora kinase activation,genomic instability,microtubule organization,mitotic regulation,protein-protein interactions,tumor suppressor dysfunction
ENSG00000122971,ACADS,fatty acid metabolism,mitochondrial function,cellular redox balance,oncogenesis,therapeutic target,genomic instability
ENSG00000263236,KRTAP4-12,cancer-promoted growth,overexpression,cell migration facilitation,apoptosis evasion,intermediate filament formation,poor prognostic marker
ENSG00000184012,TMPRSS2,androgen receptor signaling,oncogenic fusion partner,cell surface protease activation,chromosomal amplification,prostate cancer driver gene,therapeutic target
ENSG00000163217,BMP10,tumor suppressor/oncogene,smad-dependent signaling pathway,aberrant expression,cell proliferation/survival,cancer biomarker,bmp/ tgf-β interactions
ENSG00000109099,PMP22,cell proliferation,genomic instability,pi3k/akt pathway modulation,transmembrane protein function,tumor progression,therapeutic target
ENSG00000131165,CHMP1A,escrt complex dysfunction,endosomal pathway disruption,cancer cell invasion,tumor growth promotion,autophagy regulation,chromatin remodeling
ENSG00000160318,CLDND2,cell-cell interaction,metastasis promotion,adhesion molecule regulation,cell migration enhancement,tumor progression association,genomic instability marker
ENSG00000168476,REEP4,mitochondrial dynamics regulation,cellular growth promotion,tumor metastasis facilitation,therapeutic target potential,energy metabolism modulation,signaling pathway integration
ENSG00000115091,ACTR3,chromatin remodeling,oncogene,transcriptional regulation,apoptosis inhibition,tumor progression,gene amplification
ENSG00000178951,ZBTB7A,chromatin regulation,oncogene function,transcriptional regulation,cell proliferation,immune system modulation,epigenetic alteration
ENSG00000011295,TTC19,mitochondrial translation regulation,cellular metabolism alteration,tumorigenesis promotion,oxidative phosphorylation disruption,mitochondrial dynamics regulation,cancer cell growth enhancement
ENSG00000163703,CRELD1,loss of cell adhesion,oncogenic mutations,tumor progression,cell migration regulation,adhesive protein function,metastasis promotion
ENSG00000176903,PNMA1,tumor progression,apoptosis modulation,cell survival enhancement,therapeutic target,pentraxin superfamily member,oncogenic process promotion
ENSG00000184402,SS18L1,chromatin remodeling,transcriptional regulation,mitotic spindle assembly,genome instability,oncogenic transformation,cell survival
ENSG00000172156,CCL11,tumor microenvironment manipulation,immune suppression,pro-tumorigenic effects,metastatic potential promotion,therapeutic target,inflammation regulation
ENSG00000221978,CCNL2,cell cycle regulation,oncogenic function,cdk complex interaction,g1/s phase transition,tumor suppressor regulation,kinase activation
ENSG00000084764,MAPRE3,microtubule dynamics,cell cycle progression,genomic integrity,tumor aggressiveness,dna repair modulation,apoptosis regulation
ENSG00000115266,APC2,wnt/β-catenin signaling pathway,tumor suppressor function,loss of function mutations,cell proliferation inhibition,dna repair regulation,epithelial-to-mesenchymal transition
ENSG00000168412,MTNR1A,melatonin receptor function,tumor suppressor activity,cell proliferation regulation,apoptosis modulation,metastasis inhibition,pi3k/akt pathway dysregulation
ENSG00000145283,SLC10A6,cholesterol metabolism,bile acid transport,cellular behavior,apoptosis regulation,lipid biosynthesis,transmembrane transport
,C16orf58,genomic instability,aneuploidy,cell cycle regulation,dna repair mechanisms,cancer susceptibility,uncharacterized function
ENSG00000140941,MAP1LC3B,autophagy regulation,tumor suppressor activity,oncoprotein function,cellular homeostasis modulation,pi3k/akt/mtor pathway interaction,tissue-specific expression
ENSG00000154153,RETREG1,genomic stability maintenance,tumor suppressor function,dna repair regulation,cell cycle control,apoptosis induction,protein stabilization
ENSG00000060237,WNK1,oncogenic potential,cell proliferation,signaling pathway regulation,ion transport dysregulation,tumor progression,therapeutic target
ENSG00000185963,BICD2,genomic instability,microtubule regulation,tumor aggressiveness,chromosomal missegregation,mitotic spindle organization,tumor suppressor function
ENSG00000241595,KRTAP9-4,cellular architecture,cysteine-rich domain,intermediate filament networks,keratin-associated protein,mechanical properties,poorly understood
ENSG00000066117,SMARCD1,chromatin remodeling,genomic instability,oncogenic mutations,cell proliferation,transcriptional regulation,protein-protein interaction
ENSG00000168411,RFWD3,dna damage response,tumor suppressor function,genome instability,cell cycle regulation,anti-apoptotic activity,breast cancer susceptibility
ENSG00000178538,CA8,cellular growth,metastasis,tumor progression,angiogenic pathway,hypoxic adaptation,protein expression
ENSG00000109083,IFT20,cellular signaling,ciliary function disruption,genetic predisposition,loss-of-function mutations,intraflagellar transport regulation,cancer susceptibility
ENSG00000138750,NUP54,nuclear pore complex disruption,cell cycle dysregulation,transcriptional alteration,dna damage response,cell proliferation enhancement,oncogenic driver gene
ENSG00000162882,HAAO,bcaa metabolism,oncogenic process,enzyme activation,tumor progression,cell proliferation,metabolic regulation
ENSG00000128513,POT1,telomere maintenance,genomic stability,telomere binding,chromosomal fusion,single-stranded dna recognition,cancer susceptibility
ENSG00000106536,POU6F2,cellular differentiation,epithelial integrity maintenance,transcriptional regulation,oncogene/tumor suppressor duality,emt regulation,prognostic marker
ENSG00000101216,GMEB2,transcription factor regulation,tumor microenvironment modulation,immune evasion promotion,angiogenesis facilitation,cell proliferation enhancement,apoptosis inhibition
ENSG00000141198,TOM1L1,endocytosis regulation,autophagy activation,tumor growth promotion,cell survival enhancement,signaling pathway modulation,oncogenic transformation promoter
ENSG00000160447,PKN3,cell growth regulation,oncogene potential,apoptosis evasion,cytoplasmic localization,protein kinase activation,cancer cell migration
ENSG00000130669,PAK4,oncogenic transformation,cell proliferation,signaling pathway activation,gtpase interaction,kinase activity,genomic amplification
ENSG00000181885,CLDN7,metastasis promotion,tumor progression,epithelial cell polarity,prognostic marker,cell signaling modulation,therapeutic target
ENSG00000147123,NDUFB11,mitochondrial function,electron transport chain activity,oncogenic mutations,energy metabolism dysregulation,cell proliferation enhancement,therapeutic target
ENSG00000084072,PPIE,cell cycle regulation,tumor suppressor interaction,growth promotion,signaling pathway modulation,protein folding regulation,cancer driver mutation
ENSG00000171840,NINJ2,genomic instability,dna repair regulation,tumor suppressor function,genome maintenance,cell survival promotion,oncogenesis facilitation
ENSG00000080345,RIF1,genomic instability,dna repair defects,oncogenic mutations,tumor progression,sister chromatid cohesion,homologous recombination
ENSG00000160207,HSF2BP,tip49 complex,heat shock response,cell cycle progression,oncogenic processes,genomic instability,mitotic checkpoint
ENSG00000180448,ARHGAP45,rhogtpase activation,tumor progression,cell migration regulation,apoptosis modulation,pi3k/akt/mtor interaction,mapk/erk pathway modulation
ENSG00000129204,USP6,oncogene,cell proliferation,deubiquitinating enzyme,tumor progression,protein stability regulation,genomic amplification
ENSG00000111245,MYL2,cell migration,cancer progression,muscle contraction regulation,actin cytoskeleton dynamics,signaling pathway interaction,gene expression alteration
ENSG00000166394,CYB5R2,cellular redox balance,electron transfer chain,oncogenic mutations,genomic instability,tumor progression,therapeutic target
ENSG00000159289,GOLGA6A,microtubule stabilization,cell division regulation,centrosome formation,genomic instability,tumor progression facilitation,therapeutic target candidate
ENSG00000112837,TBX18,oncogene function,mesenchymal differentiation regulation,wnt/β-catenin pathway interaction,tumor growth promotion,epithelial-to-mesenchymal transition regulation,smooth muscle cell formation control
ENSG00000198576,ARC,cellular proliferation,protein-protein interaction,cancer metastasis,endocytic pathway regulation,cell migration,tumor progression
ENSG00000164066,INTU,chromosomal instability,cell cycle regulation,genetic mutation,mitotic checkpoint,protein-protein interaction,oncogenic processes
ENSG00000147459,DOCK5,cell migration,oncogenic processes,pi3k/akt pathway interaction,rho gtpase activation,cellular proliferation,metastasis promotion
ENSG00000111252,SH2B3,tumor suppression,genomic instability,cytokine regulation,immune evasion,tumorigenesis,mutation hotspot
ENSG00000125991,ERGIC3,cellular export regulation,protein secretion regulation,signaling pathway modulation,malignant phenotype contribution,potential therapeutic target,less direct implication
ENSG00000175305,CCNE2,cell cycle progression,growth factor regulation,genomic instability,proliferation,dna repair mechanisms,therapeutic target
ENSG00000138668,HNRNPD,aberrant expression,biomarker for prognosis,cell migration enhancement,gene expression regulation,microrna modulation,tumor microenvironment modulation
ENSG00000164949,GEM,mitotic chromosome condensation,microtubule stabilization,chromosome segregation,genomic instability,cell division regulation,protein-protein interaction
ENSG00000112304,ACOT13,lipid metabolism regulation,palmitoylation modulation,tumor progression driver,chemotherapy resistance,warburg effect related,cellular proliferation enhancer
ENSG00000122257,RBBP6,chromatin remodeling,tumor suppressor function,genomic instability,cell proliferation,apoptosis regulation,dna damage response
ENSG00000100504,PYGL,glycogen metabolism,altered metabolic profiles,cancer cell proliferation,therapeutic target,energy storage regulation,glycolytic rates
ENSG00000068976,PYGM,glycogen metabolism,gain of function mutations,tumor progression,cell growth promotion,energy production regulation,protein kinase activation
ENSG00000130948,HSD17B3,tumor progression,therapeutic target,hormone metabolism regulation,cellular growth regulation,gene expression modulation,signaling pathway interaction
ENSG00000050628,PTGER3,pro-inflammatory cytokine production,g protein-coupled receptor signaling,cell migration and invasion,tumor progression,immune suppression,oncogene overexpression
ENSG00000120699,EXOSC8,rna degradation pathway,oncogenic mutations,tumor suppressor dysfunction,cancer driver gene,genomic instability,epigenetic modification
ENSG00000132510,KDM6B,histone modification,oncogene function,gene expression regulation,cellular differentiation,tumor growth promotion,polycomb complex interaction
ENSG00000263341,KRTAP17-1,type ii keratin association,epithelial cell proliferation,upregulated expression,cell adhesion modulation,oncogenic potential,intermediate filament dysregulation
ENSG00000114698,PLSCR4,protein-kinase activation,cell survival promotion,tumor progression facilitation,phospholipid asymmetry regulation,signaling pathway modulation,oncogenic process enhancement
ENSG00000172568,FNDC9,cell adhesion disruption,epithelial-to-mesenchymal transition,oncogene overexpression,tumor progression,apoptosis resistance,metastatic potential
ENSG00000142227,EMP3,aberrant lipid metabolism,cell surface protein,cholesterol regulation,lysosomal trafficking,oncogenic driver,tumor progression
ENSG00000141084,RANBP10,microtubule dynamics,chromatin regulation,nuclear transport,tumor suppressor interaction,oncogene modulation,immune response modulation
ENSG00000130066,SAT1,polyamine regulation,cellular proliferation,oncogene activation,apoptosis inhibition,autophagy modulation,tumor growth promotion
ENSG00000141504,SAT2,epigenetic regulation,cell proliferation,methyl donor activity,tumor progression,protein-protein interactions,oxidative stress
ENSG00000111653,ING4,tumor suppression,cell cycle regulation,apoptosis induction,dna repair mechanism,chromatin remodeling,transcriptional regulation
ENSG00000095951,HIVEP1,transcriptional regulation,nf-κb pathway modulation,oncogenesis promotion,cell proliferation enhancement,genomic instability induction,prognostic marker
ENSG00000165630,PRPF18,genomic instability,aberrent splicing patterns,cancer driver,dna repair interaction,tumor suppression failure,genetic mutations
ENSG00000149781,FERMT3,cell adhesion regulation,metastasis promotion,tumor progression enhancement,genomic amplification,p53 pathway modulation,pi3k/akt signaling augmentation
ENSG00000111837,MAK,mitotic spindle regulation,genomic instability,microtubule stabilization,cell cycle progression,aneuploidy formation,therapeutic target
,ICK,transcriptional regulation,signal transduction pathway,cell cycle progression,oncogenesis promotion,tumor growth enhancement,ubiquitination and degradation
,KIF1BP,microtubule regulation,aneuploidy prevention,cell cycle progression,chromosomal instability,tumor growth inhibition,oncogene/tumor suppressor
ENSG00000105856,HBP1,genomic instability,tumor suppression,gene regulation,cell cycle control,cancer predisposition,apoptosis modulation
ENSG00000083520,DIS3,rna degradation,mutation hotspot,genomic instability,altered gene expression,tumor progression,rna metabolism
ENSG00000107371,EXOSC3,microrna regulation,oncogenic mrna stability,rrp41 subunit function,cancer prognosis marker,exosome complex activity,aberrant rna processing
ENSG00000212933,KRTAP12-4,epithelial cell differentiation,keratin network assembly,intermediate filament stability,skin structure maintenance,cell adhesion regulation,mechanical stress response
ENSG00000092853,CLSPN,calcium-binding,cell adhesion regulation,tumor progression,metastasis promotion,pi3k/akt pathway modulation,cell survival enhancement
ENSG00000131966,ACTR10,genomic instability,transcriptional regulation,nucleotide excision repair,helicase activity,dna repair,oncogenesis
ENSG00000126262,FFAR2,ffar2,g-protein coupled receptor,fatty acid binding protein,oncogenesis,metabolic reprogramming,insulin sensitivity disruption
ENSG00000111371,SLC38A1,warburg effect,amino acid transporter,cellular metabolism regulation,tumor growth facilitation,resistance to therapy,prognostic marker
ENSG00000274352,ZNF707,cell cycle regulation,transcriptional activator,oncogene overexpression,tumor progression marker,apoptosis suppression,dna repair regulation
ENSG00000166946,CCNDBP1,transcriptional coactivation,cell proliferation regulation,tumor progression association,gene expression modulation,oncogenic pathway activation,apoptosis inhibition
ENSG00000145029,NICN1,neurotransmission regulation,cellular signaling modulation,tumorigenesis promotion,cell growth regulation,metastasis facilitation,synaptic plasticity enhancement
ENSG00000175691,ZNF77,tumor suppressor activity,transcriptional regulation,gene expression modulation,cell cycle regulation,dna repair,oncogenic potential
ENSG00000119912,IDE,igf binding,tumor suppressor,cell proliferation,dna repair,apoptosis regulation,protein synthesis
ENSG00000125207,PIWIL1,piwi-pirna pathway,transposon silencing,tumor progression,oncogenesis,cell proliferation,metastasis
ENSG00000113387,SUB1,chromatin remodeling,genomic stability maintenance,histone h1 interaction,cell cycle regulation,dna repair modulation,cancer progression facilitation
ENSG00000119820,YIPF4,er morphology regulation,cell migration promotion,tumor progression facilitation,mitochondrial dynamics disruption,apoptosis inhibition,kinase activity modulation
ENSG00000036565,SLC18A1,neurotransmitter transport regulation,high-affinity uptake mechanism,presynaptic terminal localization,cell signaling pathway interaction,dysregulated expression in cancer,potential oncogenic role
ENSG00000205864,KRTAP5-6,keratin filament assembly,epithelial tissue expression,hair shaft maintenance,structural protein,keratin-associated protein family,none
ENSG00000151650,VENTX,tumor suppressor,wnt/β-catenin signaling pathway,cell proliferation regulation,lrp5/6 interaction,β-catenin inhibition,oncogene activation
ENSG00000037965,HOXC8,apoptosis regulation,cell cycle regulation,embryonic development,homeobox transcription factor,oncogenic function,tumor aggressiveness
ENSG00000102144,PGK1,glycolysis regulation,oncogenic pathway interaction,metabolic adaptation,therapeutic target,cell proliferation driver,energy metabolism alteration
ENSG00000064835,POU1F1,cellular differentiation,transcriptional regulation,apoptosis suppression,cell cycle progression,pro-survival signaling,tissue-specific expression
ENSG00000197822,OCLN,cellular migration,invasion,adhesion,therapeutic target,epithelial polarity,tight junction regulation
ENSG00000196417,ZNF765,transcriptional regulation,zinc finger motifs,cell proliferation,chromatin remodeling,oncogene regulation,tumor suppressor modulation
ENSG00000185043,CIB1,pi3k/akt signaling pathway regulation,oncogenic transformation,tumorigenesis association,cell proliferation enhancement,cell survival promotion,scaffold protein function
ENSG00000100348,TXN2,tumor progression,cell proliferation,oncogenic process,redox regulation,thioredoxin activity,protein interaction
ENSG00000155636,RBM45,rna processing,chromatin remodeling,oncogenesis,transcription regulation,epigenetic modification,cellular proliferation
ENSG00000136371,MTHFS,dna synthesis regulation,oncogenic process,cell proliferation enhancement,one-carbon metabolism disruption,genomic instability promotion,therapeutic target identification
ENSG00000081386,ZNF510,epigenetic regulation,transcriptional modulation,chromatin remodeling,oncogenic processes,cell proliferation enhancement,cell survival promotion
ENSG00000152253,SPC25,chromosome segregation,genomic instability,microtubule formation,cell division regulation,spindle assembly disruption,chromosomal abnormalities
ENSG00000043143,JADE2,mitotic progression regulation,spindle assembly modulation,cyclin-dependent kinase activation,histone h3 phosphorylation,genomic instability promotion,oncogenic process involvement
ENSG00000163960,UBXN7,autophagy regulation,cell cycle regulation,protein degradation regulation,tumor suppressor regulation,cancer driver gene,oncogenic process
ENSG00000170469,SPATA24,genomic instability,oncogenesis,cell proliferation,protein-protein interaction,pi3k/akt pathway,tumor progression
ENSG00000117394,SLC2A1,glut1 glucose transport,cell proliferation,tumor growth,warburg effect,energy metabolism,hypoxia adaptation
ENSG00000213906,LTB4R2,ltb4-mediated inflammation,immune evasion,angiogenesis regulation,tumor metastasis,dysregulated expression,leukotriene signaling
ENSG00000148848,ADAM12,disintegrin-like domain,tumor progression,metalloprotease activity,cell adhesion regulation,protein-protein interaction,growth factor signaling
ENSG00000188581,KRTAP1-1,keratin filament regulation,cell adhesion modulation,tumor progression facilitation,metastasis promotion,biomarker potential,signaling pathway regulation
ENSG00000071203,MS4A12,transmembrane signaling,b-cell activation,cell proliferation,tumor initiation,oncogenic driver,epithelial expression
ENSG00000144063,MALL,notch signaling,transcriptional coactivation,gain of function mutations,tumor progression,therapeutic target,genomic amplification
ENSG00000177238,TRIM72,tumor suppressor function,dysregulated expression,apoptosis regulation,cell cycle control,anti-tumor effects,oncogenic pathway involvement
ENSG00000140262,TCF12,wnt signaling pathway,dysregulation,oncogene function,transcriptional regulation,cell proliferation,tumor progression
ENSG00000100652,SLC10A1,bile acid transport,overexpression,constitutive activation,oncogenic process,biomarker potential,therapeutic target
ENSG00000164007,CLDN19,tumor progression,epithelial-to-mesenchymal transition (emt),protein interactions,cell adhesion disruption,angiogenesis regulation,gene overexpression
ENSG00000147905,ZCCHC7,post-transcriptional regulation,rna-binding protein,oncogene modulation,tumor suppressor regulation,cell cycle progression,apoptosis regulation
ENSG00000137960,GIPC2,wnt signaling pathway,cell adhesion regulation,scaffolding protein function,oncogenic properties,metastasis promotion,cell proliferation enhancement
ENSG00000127838,PNKD,mitochondrial membrane dynamics,parkin-mediated mitophagy,autophagy regulation,mitophagy pathway,serine/threonine kinase activity,kinase domain interaction
ENSG00000180440,SERTM1,protein lipidation,cell proliferation,tumor progression,endoplasmic reticulum membrane,signaling pathway regulation,oncogenic mutations
ENSG00000197992,CLEC9A,cancer-promoting,angiogenesis induction,immune evasion,oncogene activation,macrophage recruitment,tumor microenvironment modulation
ENSG00000119397,CNTRL,mitotic spindle organization,cell cycle regulation,genomic instability,tumorigenesis,centriole formation,aneuploidy
ENSG00000164440,TXLNB,cell proliferation regulation,transcriptional activation,nuclear receptor interaction,tumor metastasis promotion,biomarker potential,unclarified tumorigenic mechanism
ENSG00000116062,MSH6,genomic instability,cell proliferation,cell survival,mmr pathway,mutation accumulation,tumor progression
ENSG00000161055,SCGB3A1,cellular differentiation,oncogene or tumor suppressor,cell signaling pathway modulation,protein interaction,growth regulation,tumor microenvironment
ENSG00000149823,VPS51,lysosome regulation,tumor growth modulation,protein trafficking dysfunction,growth factor signaling pathway,autophagy regulation,cancer cell metabolism
ENSG00000124508,BTN2A2,tumor progression,chromatin regulation,transcriptional modulation,immune response modification,cancer-associated overexpression,gene expression regulation
ENSG00000134531,EMP1,cellular adhesion,epithelial-to-mesenchymal transition (emt),transmembrane glycoprotein,integrin interaction,metastasis regulation,poor prognosis marker
ENSG00000157680,DGKI,pkc activation,cell proliferation,tumorigenesis,cell survival,dysregulation,signaling pathway
ENSG00000119705,SLIRP,rna binding,cell cycle regulation,tumor progression,metastasis driver,apoptosis suppression,gene expression regulation
ENSG00000196182,STK40,protein kinase activation,cell proliferation,tumor progression,genetic mutations,oncogenic signaling,cancer aggressiveness
ENSG00000079150,FKBP7,tgf-β pathway,oncogenic potential,aberrant expression,cell migration,dna repair,protein interaction
ENSG00000177427,MIEF2,mitochondrial regulation,oncogenesis,tumor aggressiveness,cellular metabolism,protein-protein interaction,therapeutic resistance
ENSG00000008197,TFAP2D,transcription factor regulation,cell proliferation promotion,tumor progression facilitation,metastasis enhancement,pi3k/akt pathway interaction,p53 protein modulation
ENSG00000186970,KRTAP15-1,pi3k/akt pathway interaction,oncogenic potential,cell proliferation regulation,tumor aggressiveness marker,genomic instability association,epithelial cell differentiation involvement
ENSG00000167984,NLRC3,pi3k/akt regulation,dna repair regulation,oncogenic mutation,e3 ubiquitin ligase function,tumor progression enhancement,apoptosis resistance
ENSG00000057019,DCBLD2,cell adhesion disruption,pi3k/akt pathway interaction,tumor progression facilitation,epithelial barrier function disruption,cellular motility enhancement,protein-protein interaction
ENSG00000013293,SLC7A14,lysine-cysteine transporter,cancer cell metabolism,genomic instability,cellular proliferation,oncogenic behavior,amino acid transport
ENSG00000122877,EGR2,cellular proliferation,transcriptional regulation,genomic instability,chromatin remodeling,tumor suppressor gene silencing,dna damage response
ENSG00000206053,JPT2,lipid transport regulation,metabolic adaptation,tumor growth promotion,cell survival enhancement,energy homeostasis modulation,cancer cell metabolism
ENSG00000101438,SLC32A1,glutamate regulation,neurotransmission modulation,cell proliferation enhancement,signaling pathway activation,transporter activity regulation,tumor resistance promotion
ENSG00000196456,ZNF775,krab-containing zinc finger protein,transcriptional regulation,nuclear localization,chromatin modification,cellular proliferation,protein-protein interaction
ENSG00000107186,MPDZ,cancer driver gene,epithelial-to-mesenchymal transition,scaffolding protein function,protein-protein interaction,cell adhesion regulation,oncogenic pathway modulation
ENSG00000184166,OR1D2,olfactory receptor function,aberrant expression,g-protein coupled receptors pathway,cell proliferation regulation,signaling molecule interaction,tumor progression involvement
ENSG00000177300,CLDN22,cellular polarity loss,tumor suppressor function,oncogenic signaling,paracellular transport regulation,tight junction disruption,cancer stem cell maintenance
ENSG00000139644,TMBIM6,er localized protein,apoptosis regulator,cell survival pathway,programmed cell death,tumor suppressor function,er stress response mediator
ENSG00000170540,ARL6IP1,microtubule stability,oncogenic processes,genomic instability,apoptosis regulation,autophagy modulation,cellular trafficking
ENSG00000121413,ZSCAN18,zinc finger protein,transcriptional regulation,oncogenic transformation,gene overexpression,tumor suppressor modulation,chromatin remodeling
ENSG00000137338,PGBD1,genomic instability,epigenetic regulation,telomere maintenance,dna repair,alternative polyadenylation,cancer driver
ENSG00000108587,GOSR1,golgi apparatus regulation,membrane trafficking,oncogenic driver,cell proliferation enhancement,akt/mtor pathway interaction,tumorigenesis promotion
ENSG00000166856,GPR182,genomic profiling,constitutive activation,tumor progression,cell proliferation,therapeutic target,angiogenesis
ENSG00000137824,RMDN3,microtubule regulation,cellular structure maintenance,dna repair pathway,apoptosis regulator,autophagy facilitation,tumor suppressor protein
ENSG00000183733,FIGLA,transcriptional regulator,oncogene activation,cell cycle progression,apoptosis inhibition,tumor progression,therapeutic target
ENSG00000107187,LHX3,transcriptional regulation,gain of function mutations,tumor suppressor potential,epithelial-to-mesenchymal transition,proliferation and differentiation,cell fate decisions
ENSG00000147676,MAL2,nf-κb signaling inhibition,apoptosis regulation,tumor suppressor function,immune homeostasis maintenance,pro-inflammatory cytokine regulation,apoptotic pathway modulation
ENSG00000130957,FBP2,enhanced glycolysis,tumorigenesis,oncogenic processes,glycogen metabolism,cellular proliferation,metabolic reprogramming
ENSG00000165140,FBP1,gluconeogenic regulation,tumor suppressor function,promoter hypermethylation,oxidative phosphorylation,glycolysis inhibition,cellular metabolism
ENSG00000166261,ZNF202,transcriptional regulation,cell growth modulation,tumor suppressor activity,apoptosis regulation,dna repair influence,gene expression dysregulation
ENSG00000175294,CATSPER1,cell cycle regulation,g2/m phase modulation,oncogene overexpression,tumor progression driver,protein-protein interactions,signaling pathway alteration
ENSG00000196923,PDLIM7,cell signaling regulation,cytoskeleton remodeling,oncogenic mutations,cell adhesion modulation,pi3k/akt pathway interaction,mapk/erk pathway modulation
ENSG00000189042,ZNF567,krab domain,transcriptional repressor,zinc finger protein,oncogenic effects,cell survival enhancement,metastatic potential
ENSG00000170264,FAM161A,genetic instability,tumor suppressor function,dna repair mechanism,impaired genomic stability,cellular response modulation,apoptosis regulation
ENSG00000095066,HOOK2,microtubule regulation,microtubule dynamics,tumor progression,cell migration,cell proliferation,dynein recruitment
ENSG00000105185,PDCD5,cell death regulation,tumor suppressor activity,apoptosis induction,necroptosis regulation,autophagy modulation,cancer progression
,HIST2H2BF,histone regulation,chromatin modification,oncogenic transformation,cell cycle progression,genomic instability,transcriptional dysregulation
ENSG00000033170,FUT8,oncogenesis,aberrant glycosylation,tumor progression,immune evasion,epithelial-to-mesenchymal transition (emt),n-glycan biosynthesis
ENSG00000251369,ZNF550,oncogenesis,promotes cell proliferation,transcriptional regulation,tumor suppressor loss,silence of apoptosis,cell cycle progression
ENSG00000173207,CKS1B,cell cycle progression,tumor suppressor inactivation,chromosomal instability,aneuploidy contribution,mitotic regulation,phosphorylation activity
ENSG00000141699,RETREG3,aberrant retinoid signaling,altered cell proliferation,genetic mutations,cellular differentiation disruption,oncogenic process promotion,tumorigenesis contribution
ENSG00000241598,KRTAP5-4,tumor suppressor,epithelial integrity,cross-linking protein,cellular adhesion,egfr pathway interaction,dysregulated expression
ENSG00000278489,KRTAP5-2,cell adhesion disruption,pi3k/akt pathway interaction,tumor progression contributor,cell migration alteration,keratin-associated protein function,dysregulation associated with cancer
ENSG00000163206,SMCP,oncogene,cellular regulation,cytoplasmic localization,signaling pathway modulation,proliferation and differentiation,tumor suppressor function
ENSG00000126890,CTAG2,chromatin remodeling,transcriptional activation,cell cycle regulation,apoptosis resistance,dna repair suppression,genomic instability
ENSG00000182816,KRTAP13-2,epithelial-to-mesenchymal transition,cell migration,pi3k/akt pathway activation,cytoskeleton regulation,keratin filament organization,epidermal differentiation
ENSG00000178053,MLF1,chromosomal instability,tumor suppressor,cell cycle regulation,mitotic checkpoint disruption,genomic stability maintenance,protein-protein interactions
ENSG00000131016,AKAP12,tumor suppressor function,cell cycle regulation,apoptosis induction,protein-protein interaction,mapk/erk pathway activation,gene expression modulation
ENSG00000124222,STX16,metastatic niches formation,autophagy regulation,cell migration promotion,protein interaction modulation,signaling pathway regulation,snare complex component
ENSG00000168237,GLYCTK,glycolytic metabolism,energy production,pentose phosphate pathway,nadph generation,cell signaling regulation,tumor growth promotion
ENSG00000262771,SSBP1,genome instability,dna replication,cell cycle progression,transcription regulation,therapeutic target,genomic maintenance
ENSG00000124827,GCM2,pi3k/akt pathway modulation,wnt/β-catenin signaling regulation,cell cycle progression,apoptosis evasion,neural crest-derived tumors,therapeutic target for cancer
ENSG00000105355,PLIN3,lipid metabolism regulation,tumor-promoting function,hormone-sensitive lipase inhibition,adipocyte lipolysis regulation,cell proliferation enhancement,tumor aggressiveness promotion
ENSG00000169877,AHSP,heme metabolism regulation,cell survival promotion,tumor progression driver,therapeutic target identification,iron homeostasis modulation,oxidative stress response
ENSG00000049541,RFC2,dna replication initiation,nucleotide exchange,primed dna templates,cell cycle regulation,transcriptional control,genomic stability
ENSG00000162433,AK4,metabolic regulation,cellular energy homeostasis,ampk complex activation,glucose and lipid metabolism modulation,cell growth and proliferation regulation,tumorigenesis contribution
ENSG00000167670,CHAF1A,chromatin remodeling,epigenetic regulation,tumor progression,metastasis,cell proliferation,prognostic marker
ENSG00000198920,KIAA0753,autophagy regulation,chromosomal stability maintenance,tumor suppression,dna repair pathway interaction,cell cycle control modulation,genomic integrity protection
ENSG00000149115,TNKS1BP1,telomere regulation,tumor suppressor function,growth inhibition,poly(adp-ribose) polymerase inhibition,genomic integrity maintenance,cancer biomarker
ENSG00000138767,CNOT6L,regulation of mrna decay,oncogene expression,immunomodulation,cell proliferation,tumor suppression,gene degradation
ENSG00000179627,ZBTB42,cellular regulation,transcriptional regulation,apoptosis modulation,tumor suppressor interaction,cancer progression association,dna repair regulation
ENSG00000205220,PSMB10,ubiquitin-proteasome pathway,tumor progression,protein degradation regulation,cell cycle modulation,oncogenesis contributor,biomarker potential
ENSG00000197343,ZNF655,krab domains,oncogene function,transcriptional regulation,cell proliferation,histone modification,protein-protein interaction
ENSG00000146457,WTAP,histone modification,genome instability,loss of heterozygosity,tumor suppressor function,cancer driver mutation,protein complex formation
ENSG00000162775,RBM15,constitutive activation,cell proliferation,rna regulation,genomic integrity,protein-protein interaction,oncogenic processes
ENSG00000165156,ZHX1,negative regulation,tumor suppressor,transcription factor,cell growth regulation,wnt/β-catenin pathway inhibition,pi3k/akt pathway interaction
ENSG00000171307,ZDHHC16,oncogenic modification,palmitoylation regulation,protein function modulation,cell signaling pathway,tumor progression,therapeutic target
ENSG00000125107,CNOT1,ccr4-not complex regulation,mrna turnover regulation,oncogene function,cell proliferation promotion,gene expression regulation,poor prognosis marker
ENSG00000151876,FBXO4,tumor suppressor function,scf complex interaction,ubiquitination and degradation,pi3k/akt pathway regulation,wnt/β-catenin pathway regulation,cancer driver mutation
ENSG00000117533,VAMP4,enhanced vesicular transport,promotion of cell migration,regulation of emt,overexpression in various cancers,oncogenic protein trafficking,tumor progression
ENSG00000169122,FAM110B,cancer progression,oncogenic potential,cell proliferation regulation,tumor microenvironment modulation,apoptosis suppression,metastatic potential
ENSG00000221837,KRTAP10-9,keratin-associated proteins,disruption of cell adhesion,epithelial-to-mesenchymal transition,skin integrity regulation,cell migration enhancement,apoptosis modulation
ENSG00000198805,PNP,purine metabolism pathway,purine salvage pathway,cell proliferation,dysregulated expression,oncogenic process,tumor progression
ENSG00000054523,KIF1B,microtubule-based transport,tumor progression,cell proliferation,metastasis,oncogene,therapeutic target
ENSG00000288295,MCTS1,mitochondrial export,oncogenesis,lactate transport,glycolytic switch,energy metabolism regulation,cell proliferation enhancement
ENSG00000156261,CCT8,chaperone activity,tumor progression,protein folding regulation,cell cycle regulation,metastasis promotion,therapeutic target
ENSG00000172354,GNB2,constitutive activation,regulatory component,oncogenic signaling pathways,adenylyl cyclase activation,cellular differentiation inhibition,gene expression regulation
ENSG00000013275,PSMC4,26s proteasome complex activation,constitutive activation,gain of function mutations,oncogenic protein regulation,proteolytic activity enhancement,tumor progression
ENSG00000101843,PSMD10,proteasome subunit 10,protein degradation activity,oncogenic process regulation,cell proliferation promotion,apoptosis inhibition,prognostic marker
ENSG00000008323,PLEKHG6,actin cytoskeleton regulation,tumor progression,cell adhesion,signaling pathway modulation,protein-protein interaction,cell migration
ENSG00000131791,PRKAB2,constitutive activation,loss-of-function mutations,metabolic reprogramming,cell proliferation,oncogenesis,tumor suppression
ENSG00000203805,PLPP4,lipid metabolism regulation,tumor suppressor potential,pi(5)p dephosphorylation,cancer association,cell growth inhibition,autophagy regulation
ENSG00000131061,ZNF341,epigenetic regulation,transcription factor interaction,gene expression modulation,chromatin remodeling,tumor suppressor regulation,oncogene activation
ENSG00000179335,CLK3,pre-mrna splicing,serine/threonine kinase activity,cell proliferation,tumorigenesis,aberrant rna metabolism,spliceosome regulation
ENSG00000172789,HOXC5,oncogene,cell proliferation,metastasis,epithelial-to-mesenchymal transition (emt),transcription factor regulation,co-activator interaction
ENSG00000174307,PHLDA3,pi3k/akt inhibition,tumor suppressor,cell proliferation regulation,dna damage response,therapeutic target,genomic deletion
ENSG00000079257,LXN,cell adhesion,extracellular matrix remodeling,carbohydrate recognition domains,cell migration,tumor microenvironment alteration,protein function alterations
ENSG00000196859,KRT39,cellular integrity disruption,epithelial cell involvement,oncogenic pathway activation,tumor growth facilitation,cell adhesion modulation,mechanical stress tolerance
ENSG00000205426,KRT81,keratin heterodimerization,epithelial integrity loss,oncogenic potential,cell proliferation promotion,epithelial-to-mesenchymal transition,tumor progression support
ENSG00000198908,BHLHB9,regulation of gene expression,genomic stability maintenance,cell cycle control,apoptosis regulation,chromatin remodeling,dna repair facilitation
ENSG00000156273,BACH1,oncogenic transcription factor,transcriptional regulator of dna repair,antioxidant response modulation,chromatin remodeling,histone modification,cell cycle progression
ENSG00000278458,KANSL1,chromatin remodeling,histone modification,transcriptional regulation,cell cycle progression,genome stability,tumor suppressor function
ENSG00000114626,ABTB1,regulation of cell division,interaction with apc complex,microtubule dynamics regulation,tumor suppressor function,cell migration regulation,genomic stability maintenance
ENSG00000100815,TRIP11,pi3k/akt pathway,cell growth,cell survival,microtubule regulation,aneuploidy,chromosomal instability
ENSG00000086967,MYBPC2,cardiac sarcomeric complex,tumor suppressor gene,genomic instability,cellular proliferation,aberrant cellular behavior,metastatic progression
ENSG00000156983,BRPF1,chromatin remodeling,epigenetic regulation,tumor progression,histone acetylation,genomic instability,oncogenic processes
ENSG00000169744,LDB2,chromatin remodeling,gene expression regulation,dna repair mechanisms,transcriptional coactivation,nuclear localization,cell growth regulation
ENSG00000148481,MINDY3,mitochondrial function,autophagy induction,cellular metabolism regulation,tumor progression driver,keap1 interaction,transcriptional regulation
ENSG00000197714,ZNF460,transcriptional repressor function,cell cycle regulation,apoptosis modulation,oncogene suppression,zinc finger protein family member,krab domain-containing protein
ENSG00000157212,PAXIP1,genomic instability,chromatin remodeling,transcriptional regulation,oncogene activation,prognostic marker,cell cycle progression
ENSG00000121057,AKAP1,tumor suppressor function,apoptosis regulation,cell signaling modulation,oncogene overexpression,angiogenesis promotion,cell cycle progression
ENSG00000165632,TAF3,transcription regulation,epigenetic modulation,core promoter binding,gene expression dysregulation,oncogene activation,tumor progression driver
ENSG00000171517,LPAR3,oncogenic signaling,g-protein coupled receptor,cell proliferation,tumor growth,metastasis,angiogenesis
ENSG00000215712,TMEM242,cellular metabolism disruption,er stress response modulation,oncogenesis regulation,prognostic biomarker,tumor suppressor function,upr signaling interaction
ENSG00000166224,SGPL1,sphingolipid metabolism,cell survival,tumor progression,lymphocyte trafficking,oncogenesis,cell proliferation
ENSG00000162367,TAL1,t-lymphoid cell specification,oncogenic transcription factor,cell cycle progression,apoptosis evasion,metastatic dissemination,poor prognosis
ENSG00000261934,PCDHGA9,cell-cell adhesion disruption,homophilic binding,tumor progression,metastasis regulation,signaling pathway interaction,oncogenic process modulation
ENSG00000175582,RAB6A,cellular homeostasis,microtubule organization,motor protein regulation,tumorigenesis,aberrant expression,protein trafficking
ENSG00000147050,KDM6A,histone demethylation,tumor suppressor function,chromatin regulation,gene expression modulation,cell cycle progression,genomic stability
ENSG00000139190,VAMP1,regulatory role in membrane fusion,cellular invasion and migration,pro-tumorigenic factor release,signaling pathway interaction,cell proliferation regulation,survival pathway modulation
ENSG00000099365,STX1B,neurotransmitter release,vesicle fusion,oncogenic driver,tumor progression,cell proliferation,signaling pathway activation
ENSG00000114853,ZBTB47,tumor suppression,transcription factor activity,cell cycle regulation,apoptosis promotion,cancer prevention,gene expression regulation
ENSG00000213672,NCKIPSD,cellular regulation,signaling pathway modulation,pi3k/akt interaction,tumor progression marker,biomarker candidate,downstream effector
ENSG00000123080,CDKN2C,genomic instability,cyclin-dependent kinase inhibition,cell cycle regulation,tumor suppressor function,apoptosis induction,dna damage response
ENSG00000109854,HTATIP2,htatip2's role as a tumor suppressor,histone acetylation inhibition,chromatin structure modulation,cell growth regulation,genomic stability maintenance,hiv-1 tat interaction
ENSG00000180035,ZNF48,chromatin regulation,tumor suppressor,cell growth inhibition,dna binding specificity,transcriptional regulation,oncogenesis prevention
ENSG00000178971,CTC1,genomic instability,telomere maintenance,dna repair,tumor suppressor function,telomere shortening,dna damage response
ENSG00000107960,STN1,telomerase activation,genomic instability,cell cycle dysregulation,telomere shortening evasion,dna repair mechanism alteration,protein complex formation
ENSG00000077274,CAPN6,calpain activation,cell adhesion disruption,metastasis promotion,tumor progression facilitation,proteolytic activity enhancement,oncogenic signaling interaction
,SEPT7,septin complex formation,golgi apparatus localization,cell cycle regulation,oncogenic potential,tumor progression,cytoskeleton organization
ENSG00000285394,C3orf52,chromosomal location,hypothetical protein,protein-coding gene,unknown functions,lack of associations,potential involvement in tumorigenesis
ENSG00000113845,TIMMDC1,mitochondrial function regulation,tumor growth promotion,cellular metabolism alteration,warburg effect induction,metastasis facilitation,chemotherapy resistance enhancement
ENSG00000196150,ZNF250,krab domain-containing transcription factor,cell growth regulation,tumor suppression activity,transcriptional repression,chromatin remodeling,apoptosis regulation
ENSG00000159399,HK2,glycolytic regulation,warburg effect,oncogene overexpression,tumor metabolism,cell proliferation driver,genetic amplification
ENSG00000126368,NR1D1,tumor suppressor,cell growth inhibition,circadian rhythm disruption,metabolic dysregulation,therapeutic target,genomic instability
ENSG00000127564,PKMYT1,cell cycle regulation,tumor suppressor function,inhibition of cell proliferation,g1-s phase transition,apoptosis promotion,protein kinase activation
ENSG00000058799,YIPF1,oncogene activation,cell proliferation,lipid metabolism regulation,autophagy modulation,er stress response,tumorigenesis promotion
ENSG00000129680,MAP7D3,cell proliferation,microtubule dynamics,oncogenic activity,tumor progression,mitotic spindle formation,microtubule stabilization
ENSG00000121297,TSHZ3,transcriptional regulation,oncogenic properties,cell proliferation regulation,tumor progression,genomic instability,epigenetic modulation
ENSG00000083857,FAT1,tumor suppressor,wnt signaling inhibition,cell adhesion loss,dna repair mechanism,genomic stability regulation,apoptosis promotion
ENSG00000073111,MCM2,cellular proliferation,genomic instability,dna replication regulation,minichromosome maintenance complex component,therapeutic target,oncogenic driver
ENSG00000010282,HHATL,histone acetylation,epigenetic regulation,oncogenesis,chromatin remodeling,tumor progression,overexpression
ENSG00000148704,VAX1,transcriptional regulation,cellular proliferation,oncogenesis,tumor progression,genomic instability,epigenetic modifications
ENSG00000006704,GTF2IRD1,transcriptional regulator,cell cycle progression,oncogene activation,tumor suppression deficiency,cellular proliferation regulation,genomic instability association
ENSG00000170948,MBD3L1,dna methylation disruption,epigenetic regulator,histone modification,cell proliferation driver,tumor suppressor loss,genomic instability promoter
ENSG00000230475,ABHD16A,tumor microenvironment remodeling,lipid metabolism regulation,protein-protein interaction,oncogenic driver,cell proliferation enhancement,angiogenesis promotion
ENSG00000174567,GOLT1A,oncogenic mutations,altered glycosylation patterns,aberrant cellular responses,cellular stress modulation,tumor microenvironment alteration,glycoprotein regulation
ENSG00000103657,HERC1,tumor suppressor function,protein degradation regulation,dna damage response,cell cycle regulation,oncogenic transformation driver,genomic instability promotion
ENSG00000151967,SCHIP1,cell proliferation,signaling pathway regulation,oncogenic processes,tumor progression,protein-protein interactions,biomarker potential
ENSG00000120688,WBP4,gain of function mutations,cell growth regulation,tumor progression,protein-protein interaction,cell survival pathways,oncogenic processes
ENSG00000099139,PCSK5,notch signaling pathway regulation,proteolytic processing,cell proliferation enhancement,tumor progression facilitation,cancer cell metastasis promotion,serine protease activity
ENSG00000173898,SPTBN2,cytokeletal regulation,tumor progression,cellular migration,biomarker potential,prognostic indicator,signaling pathway modulation
ENSG00000151117,TMEM86A,mitochondrial regulation,autophagy modulation,er stress responses,cell survival pathways,cell proliferation regulation,transmembrane protein function
ENSG00000162735,PEX19,peroxisomal biogenesis,cell proliferation,oncogenic signaling,protein import regulation,genomic instability,metabolic reprogramming
ENSG00000168958,MFF,mitochondrial dynamics,tumor progression,biomarker overexpression,cell survival pathway,energy metabolism regulation,energetic efficiency maintenance
ENSG00000188807,TMEM201,homologous recombination repair,genomic instability,tumor suppressor function,nuclear envelope localization,protein-protein interaction,dna damage response
ENSG00000135506,OS9,deubiquitinating activity,oncogene stabilization,cellular homeostasis modulation,therapeutic target potential,tumor suppressor regulation,signaling pathway modulation
ENSG00000118200,CAMSAP2,microtubule dynamics regulation,cancer progression driver,overexpression mutation,cell proliferation enhancement,cytokinesis regulation disruption,pi3k/akt pathway interaction
ENSG00000163126,ANKRD23,heterochromatin formation,genome stability,epigenetic regulation,chromatin remodeling,transcriptional control,mitotic checkpoint
ENSG00000262862,KRTAP2-3,cellular adhesion,keratin filament interaction,structural integrity,epithelial cell regulation,tissue architecture modulation,cancer progression
ENSG00000178279,TNP2,chromatin condensation,dna packaging,nuclear protein interaction,gene regulation,histone modification,cell proliferation
ENSG00000127588,GNG13,gpcr signaling,aberrant activation,cell migration,oncogenic driver,tumor progression,therapeutic target
ENSG00000136930,PSMB7,protein degradation,oncogene,cell proliferation,ubiquitin-proteasome pathway,tumor growth,protein homeostasis
ENSG00000006194,ZNF263,oncogene function,regulation of cell growth,chromatin remodeling,epithelial-to-mesenchymal transition (emt),cell survival and apoptosis,transcriptional regulation
ENSG00000171456,ASXL1,chromatin regulation,epigenetic modulation,genome instability,oncogenic pathway activation,tumor suppressor function loss,wnt/β-catenin signaling disruption
ENSG00000126251,GPR42,fatty acid regulation,g protein-coupled signaling,cell proliferation regulation,tumor suppressor function,metabolic pathway modulation,oncogenic driver
ENSG00000146859,TMEM140,er membrane structure,mitotic regulation,dna repair mechanisms,genomic instability,tumorigenesis driver,cell survival pathway
ENSG00000095787,WAC,genomic instability,oncogene,cell proliferation,dna repair regulation,protein-protein interactions,coiled-coil region
ENSG00000183640,KRTAP8-1,overexpression,proliferation promotion,apoptosis inhibition,epithelial-to-mesenchymal transition,keratin filament interaction,cell differentiation regulation
ENSG00000115310,RTN4,apoptosis regulation,tumor suppressor function,er integrity maintenance,cell survival enhancement,caspase activation,mitochondrial pathway interaction
ENSG00000086506,HBQ1,pi3k/akt pathway regulation,protein degradation,cell cycle regulation,dna repair regulation,transcriptional control,oncogene activation
ENSG00000270765,GAS2L2,tumor suppressor,cell cycle regulation,gas protein family member,dna repair inhibition,apoptosis induction,p53 interaction
ENSG00000109771,LRP2BP,cellular regulation,oncogene function,chromatin modulation,gene expression regulation,therapeutic target,biomarker potential
ENSG00000125870,SNRPB2,aberrant splicing,alternative exon inclusion,cell proliferation inhibition,genomic instability,mutational burden enhancement,spliceosome dysfunction
ENSG00000133115,STOML3,cancer-promoting activity,cell membrane trafficking,actin cytoskeleton regulation,oncogene potential,metastasis facilitation,emt process modulation
ENSG00000156113,KCNMA1,bkca channel regulation,cell proliferation modulation,pi3k/akt pathway interaction,cellular survival promotion,tumor suppressor modulation,oncogene cooperation
ENSG00000102241,HTATSF1,cell cycle progression,chromatin modification,histone phosphorylation,oncogenic potential,protein kinase activity,transcriptional regulation
ENSG00000247596,TWF2,actin filament regulation,gene amplification,cell migration regulation,tumor progression facilitation,protein interaction modulation,cancer cell invasion promotion
ENSG00000133627,ACTR3B,actin cytoskeleton regulation,gain-of-function mutations,cell migration enhancement,tumor growth promotion,subunit interaction alterations,cellular signaling pathway alteration
ENSG00000142089,IFITM3,apoptosis inhibition,cell proliferation suppression,dysregulated expression,immune evasion,oncogenic effects,pi3k/akt pathway interaction
ENSG00000125255,SLC10A2,bile acid transport,cell membrane localization,constitutive expression alterations,lipid metabolism regulation,oncogene involvement,tumor progression influence
ENSG00000135972,MRPS9,mitochondrial translation,energy metabolism,cell growth regulation,mitochondrial dysfunction,ribosomal protein subunit,genomic instability
ENSG00000144567,RETREG2,cell cycle regulation,genomic instability,tumor progression,oncogenic mutations,metastasis driver,therapeutic target
ENSG00000123485,HJURP,chromatin assembly,cell cycle regulation,genomic instability,kinetochore formation,microtubule attachment,tumor progression
ENSG00000141552,ANAPC11,cell cycle regulation,aneuploidy prevention,genomic instability,oncogenic processes,tumor growth,dna damage response
ENSG00000107758,PPP3CB,cell cycle regulation,cancer immunotherapy target,immune system modulation,apoptosis suppression,transcription factor activation,t-cell signaling pathway
ENSG00000112561,TFEB,autophagy regulation,cell growth promotion,constitutive activation,metabolic reprogramming,oncogenic potential,transcriptional regulation
ENSG00000170035,UBE2E3,ubiquitin conjugation,protein degradation,tumor progression,oncogenic protein accumulation,cellular pathway regulation,cancer cell survival
ENSG00000178498,DTX3,oncogenic transcription factor,cell cycle regulation,apoptosis inhibition,tumor metastasis,gene expression modulation,immune response regulation
ENSG00000106609,TMEM248,tumor progression,oncogenesis,apoptosis regulation,cell proliferation,genomic instability,therapeutic target
ENSG00000204070,SYS1,protein degradation pathway,cellular homeostasis,tumor suppressor degradation,cancer cell survival,therapeutic resistance,cell cycle regulation
ENSG00000187109,NAP1L1,chromatin remodeling,transcriptional regulation,oncogenic process,cell proliferation,migratory capability,histone modification
ENSG00000105255,FSD1,epigenetic regulation,genomic instability,transcriptional regulation,cell growth regulation,dna repair,telomere maintenance
ENSG00000072609,CHFR,anaphase-promoting complex inhibition,cell cycle regulation,checkpoint function disruption,chromosomal instability,dna damage response,genomic stability maintenance
ENSG00000101310,SEC23B,autophagy regulation,copii complex formation,cellular secretion enhancement,endoplasmic reticulum stress response,growth factor regulation,tumor progression promotion
ENSG00000124562,SNRPC,rna splicing regulation,pre-mrna processing,aberrant gene expression,cancer-associated splicing mutations,oncogenic transcript variants,genomic instability
ENSG00000088766,CRLS1,ubiquitin-proteasome pathway,cellular degradation,oncogenic driver,cell proliferation,tumor suppression,cancer progression
ENSG00000059145,UNKL,cell proliferation,dna repair mechanism,pseudogene regulation,cell cycle progression,oncogenic process,aberrant expression
ENSG00000090674,MCOLN1,lysosomal function disruption,calcium signaling dysregulation,oncogenic mutations,cell survival enhancement,tumor progression facilitation,genetic instability promotion
ENSG00000263296,KRTAP3-2,keratin-associated protein,epithelial cell differentiation,cell adhesion disruption,tumorigenesis promotion,metastasis regulation,cellular migration enhancement
ENSG00000111450,STX2,aberrant membrane trafficking,cellular secretion regulation,golgi apparatus localization,increased cell proliferation,metastatic potential enhancement,overexpression in cancer cells
ENSG00000145087,STXBP5L,cell proliferation,tumor progression,protein trafficking regulation,metastasis facilitation,oncogenic protein translocation,chemoresistance development
ENSG00000188566,NDOR1,mitochondrial dysfunction,electron transport chain disruption,energy metabolism dysregulation,oncogenesis through metabolic reprogramming,cancer cell survival advantage,genomic instability
ENSG00000236843,NRM,transcriptional regulation,hormone signaling pathway,oncogenic mutations,tumor progression,cell growth promotion,apoptosis resistance
ENSG00000165304,MELK,pi3k/akt pathway activation,oncogene overexpression,cell proliferation regulation,dna damage response modulation,apoptosis inhibition,microrna regulation
ENSG00000171843,MLLT3,chromatin remodeling,histone modification,gene expression regulation,oncogenic process,tumor progression,genetic mutation
ENSG00000168032,ENTPD3,pi3k/akt signaling pathway,gain of function mutations,tumor cell proliferation,cell survival enhancement,oncogenic processes facilitation,anti-inflammatory properties modulation
ENSG00000167741,GGT6,glycoprotein biosynthesis,tumor cell survival,metastasis,cell migration,pi3k/akt pathway modulation,cancer-associated immune regulation
ENSG00000157985,AGAP1,arf6 activation,cell migration,cytoplasmic trafficking,dna repair regulation,membrane reorganization,oncogene overexpression
ENSG00000064961,HMG20B,chromatin remodeling,cell cycle regulation,histone exchange,gene expression modulation,protein-protein interactions,tumor growth promotion
ENSG00000106628,POLD2,genomic instability,dna replication machinery,mutations and dysregulation,interaction with other proteins,homologous recombination repair,cancer progression
ENSG00000064270,ATP2C2,calcium ion transport,aberrant expression,tumor progression,epithelial-to-mesenchymal transition,cellular proliferation,prognostic marker
ENSG00000160948,VPS28,ubiquitin recognition,escrt complex interaction,cell proliferation enhancement,signaling pathway modulation,tumor progression association,therapeutic target identification
ENSG00000171056,SOX7,tumor suppression,transcriptional regulation,genomic instability,cell proliferation,apoptosis regulation,dna repair
ENSG00000197753,LHFPL5,genomic amplification,cell cycle progression,apoptosis inhibition,oncogene activation,cytoplasmic localization,protein interaction module
ENSG00000105254,TBCB,microtubule dynamics,cellular architecture,genomic instability,cell cycle regulation,tumor suppressor candidate,microtubule assembly
ENSG00000261609,GAN,cell adhesion regulation,oncogenic potential,tumor progression,metastasis facilitation,cancer cell invasion,glioblastoma association
ENSG00000104237,RP1,microtubule regulation,genomic instability prevention,dna repair pathway,tumor suppressor function,oncogenic potential,cellular organization regulation
ENSG00000234602,MCIDAS,cell cycle regulation,spindle checkpoint,dna damage response,apoptosis modulation,genomic instability,therapeutic target
ENSG00000282956,MAGI1,cell-cell adhesion regulation,tumor progression,cytoskeleton organization,cancer cell invasion,epithelial polarity disruption,genomic instability
ENSG00000105137,SYDE1,cell signaling regulation,g-protein coupled receptor function,pi3k/akt pathway modulation,rho gtpase activation,oncogenic properties,tumor progression
ENSG00000100739,BDKRB1,cell proliferation,angiogenesis promotion,g-protein coupled receptor,signaling pathway interaction,oncogenic process,vegf regulation
ENSG00000156970,BUB1B,spindle assembly checkpoint,chromosomal instability,genomic integrity,mitotic regulation,aneuploidy driver,cell cycle progression
ENSG00000188641,DPYD,dna degradation,cellular metabolism,toxicity variability,tumor suppression,drug resistance,genetic polymorphism
ENSG00000249915,PDCD6,dna repair regulation,apoptosis induction,tumor suppressor function,cell cycle modulation,pi3k/akt pathway interaction,cancer heterogeneity
ENSG00000179455,MKRN3,protein degradation,ubiquitination,reproductive hormone regulation,central precocious puberty,gnrh secretion regulation,hypothalamic expression
ENSG00000170091,NSG2,pi3k/akt pathway activation,gain of function mutations,oncogenic processes promotion,therapeutic target,cellular proliferation enhancement,genomic profiling
ENSG00000177954,RPS27,ribosome biogenesis,cellular proliferation,protein synthesis regulation,tumorigenesis promotion,cell transformation facilitation,translation initiation complex formation
ENSG00000118579,MED28,chromatin dynamics,epigenetic regulation,transcriptional regulation,oncogenic processes,cell proliferation,metastasis
ENSG00000100038,TOP3B,genomic stability,telomere maintenance,chromosomal instability,oncogenic driver,therapeutic target,dna replication
ENSG00000144021,CIAO1,calcium ion transport,ion channel regulation,cell proliferation,oncogenic driver interaction,metabolic regulation,tumor progression
ENSG00000161692,DBF4B,genomic instability,cell cycle regulation,dna replication initiation,tumorigenesis promotion,therapeutic target,chromatin remodeling
ENSG00000146112,PPP1R18,regulatory subunit,tumor suppressor function,pp1 regulation,cellular homeostasis modulation,oncogenic pathway interaction,cancer progression association
ENSG00000134748,PRPF38A,altered splicing patterns,pre-mrna processing,cellular proliferation,dna damage response,splicing factor regulation,genomic instability
ENSG00000118762,PKD2,cell cycle regulation,mechanoreception,apoptosis,dna repair,mechanotransduction,none
ENSG00000008710,PKD1,polycystin-1 signaling pathway,gain of function mutations,mechanoreception,tumor progression,therapeutic target,genomic instability
ENSG00000127903,ZNF835,cell cycle regulation,chromatin remodeling,epigenetic regulation,gene expression modulation,protein-dna interaction,transcription factor activity
ENSG00000211456,SACM1L,microtubule stability,mitotic spindle assembly,tubulin-gdp exchange,gtp hydrolysis,chromosome segregation,cytokinesis regulation
ENSG00000116161,CACYBP,p53 regulation,tumor suppressor degradation,cell cycle progression,oncogenic process promotion,cancer cell survival facilitation,cellular regulation modulation
ENSG00000157538,VPS26C,regulatory component of retromer complex,tumor suppressor activity,dysregulation in pan-cancer,retrograde transport disruption,protein degradation pathway involvement,membrane trafficking alterations
ENSG00000149089,APIP,apoptosis regulation,tumor growth promotion,oncogenic signaling pathway,cell survival enhancement,pro-apoptotic protein interaction,cell proliferation
ENSG00000100577,GSTZ1,mitochondrial localization,cell survival promotion,detoxification enzyme,chemotherapy resistance,oncoprotein interaction,metabolic reprogramming
ENSG00000145391,SETD7,histone modification,epigenetic regulation,chromatin remodeling,oncogenic driver,cell proliferation,tumor progression
ENSG00000212721,KRTAP4-11,epithelial differentiation,cellular morphology changes,protein interaction,signaling pathway modulation,tumorigenesis driver,epithelial-to-mesenchymal transition
ENSG00000081377,CDC14B,cell cycle regulation,genomic instability,oncogene,dna repair disruption,cell proliferation,protein-protein interaction
ENSG00000138944,SHISAL1,wnt/β-catenin signaling,tumor suppressor function,cell proliferation regulation,apoptosis induction,protein interaction,cancer progression inhibition
ENSG00000255112,CHMP1B,hippo signaling pathway,autophagy regulation,lysosome dysfunction,chromatin remodeling,tumor invasion,therapeutic target
ENSG00000119328,ABITRAM,chromatin remodeling,transcriptional regulation,cellular growth regulation,oncogenic potential,genomic instability,epigenetic modification
ENSG00000023318,ERP44,cellular calcium regulation,transmembrane protein interaction,cancer-related pathway modulation,tumor growth promotion,therapeutic target,protein-protein interaction
ENSG00000162961,DPY30,epigenetic regulation,genome stability maintenance,heterochromatin formation,gene silencing,chromosomal organization disruption,oncogenic process promotion
ENSG00000166886,NAB2,nuclear transcription factor regulation,tumor suppressor function,cell cycle progression repression,apoptosis regulation,transcriptional repressor activity,chromosomal translocation-induced oncogenesis
ENSG00000235650,RPS18,ribosomal protein function,genomic instability,cell cycle regulation,protein synthesis enhancement,tumor growth promotion,therapeutic target
ENSG00000150961,SEC24D,cellular trafficking,endoplasmic reticulum function,protein secretion,signal transduction activation,tumor progression,oncogenic pathway regulation
ENSG00000213694,S1PR3,sphingolipid signaling,g-protein coupled receptor,tumor progression,cell migration,metastatic potential,immune evasion
ENSG00000171634,BPTF,chromatin remodeling,transcription regulation,nurd complex component,tumor suppressor dysfunction,epigenetic regulation,cell proliferation modulation
ENSG00000173614,NMNAT1,nad+ biosynthesis,cell proliferation,cdk4/6 regulation,tumor growth promotion,stress response modulation,therapeutic target
ENSG00000150433,TMEM218,cancer progression,gene expression alterations,apoptosis resistance,cell survival enhancement,tumor aggressiveness,epithelial barrier function
ENSG00000198818,SFT2D1,mrna export,nuclear export complex,rnp assembly,oncogenic mutations,gene expression regulation,cell cycle progression
ENSG00000086159,AQP6,altered expression patterns,cellular osmotic balance regulation,water transport regulation,prognostic marker potential,therapeutic target consideration,cell migration involvement
ENSG00000130559,CAMSAP1,microtubule disruption,oncogene activation,cell proliferation promotion,constitutive microtubule-severing activity,signaling pathway modulation,protein interaction regulation
ENSG00000061676,NCKAP1,oncogenic function,dysregulated expression,cell migration regulation,actin cytoskeleton organization,tumor progression facilitation,therapeutic target
ENSG00000155975,VPS37A,escrt complex regulation,dysregulated autophagy,cell membrane trafficking,proliferation promotion,tumor progression driver,genomic instability indicator
ENSG00000249581,CLRN2,ion channel regulation,tumor progression,cell migration,aberrant expression,signaling pathway interaction,oncogenic driver mutations
ENSG00000137078,SIT1,pi3k/akt signaling pathway regulation,tumor suppressor function,constitutive activation of oncogenic pathways,cell growth and proliferation regulation,negative regulator of cell survival,tissue homeostasis maintenance
ENSG00000100116,GCAT,cell proliferation,reactive oxygen species regulation,tumor progression,therapeutic target,glutathione biosynthesis,genomic stability modulation
ENSG00000170128,GPR25,pi3k/akt signaling,oncogenesis,cell proliferation,metabolic regulation,tumor progression,genomic instability
ENSG00000071553,ATP6AP1,v-atpase regulation,tumor acidity,ion transport,aggressive growth,prognostic biomarker,transcriptional regulation
ENSG00000240432,KRTAP13-3,keratin filament integrity,tumor progression,cell migration,epithelial cell structure,cellular differentiation,aberrant expression
ENSG00000057935,MTA3,chromatin remodeling,transcriptional regulation,oncogenesis,metastasis,tumor suppressor gene repression,epigenetic modification
ENSG00000158014,SLC30A2,zinc regulation,cell proliferation,oncogenic processes,metastatic potential,therapeutic target,protein-protein interactions
ENSG00000164756,SLC30A8,zinc homeostasis regulation,cellular signaling alterations,protein-protein interactions,apoptosis resistance,metastatic potential enhancement,tumor growth promotion
ENSG00000116857,TMEM9,apoptosis regulation,cell proliferation,tissue specificity,transmembrane interaction,chromosomal localization,protein function alteration
ENSG00000111049,MYF5,basic helix-loop-helix transcription factor,cell cycle regulation,g1 phase modulation,oncogenesis promotion,transcriptional regulation,tumor cell maintenance
ENSG00000176472,ZNF575,krab domain-containing transcription factor,transcriptional repression,cell proliferation regulation,dna damage response modulation,chromatin remodeling involvement,apoptosis regulation
ENSG00000172023,REG1B,tumor progression,cell proliferation regulation,oncogenic transcription factor,wnt/β-catenin signaling,pi3k/akt/mtor pathway modulation,genomic instability protection
ENSG00000090661,CERS4,ceramide biosynthesis,oncogenic function,apoptosis inhibition,cell survival enhancement,protein-protein interaction,therapeutic target
ENSG00000133678,TMEM254,cell signaling,regulation of cell growth,transmembrane protein,modulator of kinase activity,cell survival,protein-protein interactions
ENSG00000129472,RAB2B,gtpase activity,cell proliferation,vesicle transport,membrane trafficking,oncogenic driver,therapeutic target
ENSG00000144061,NPHP1,ciliopathy,genomic instability,cellular polarity disruption,aneuploidy induction,tumor suppressor function,centrosome assembly regulation
ENSG00000131697,NPHP4,primary cilia,cellular proliferation,oncogenesis,pancreatic cancer,cystic kidney disease,cell survival pathways
ENSG00000186141,POLR3C,rna transcriptional regulation,cell proliferation,apoptosis disruption,tumor suppressor function,dna replication,cell cycle regulation
ENSG00000198783,ZNF830,transcriptional regulation,cell cycle progression,chromatin remodeling,dna recognition,gene expression regulation,tumor development
ENSG00000061455,PRDM6,histone methylation,cell cycle regulation,oncogene potential,dna damage response,chromatin modification,apoptosis inhibition
ENSG00000151461,UPF2,nonsense-mediated mrna decay,translation regulation,cellular stress response,tumor suppressor function,protein helicase activity,molecular surveillance
ENSG00000124098,FAM210B,mitotic progression,oncogene activation,chromosomal instability,cell proliferation,nuclear localization,signaling pathway alteration
ENSG00000061918,GUCY1B1,cellular proliferation,constitutive activation,cgmp signaling pathway,cell survival,tumorigenesis,signaling regulation
ENSG00000164116,GUCY1A1,cgmp signaling pathway,tumor progression,angiogenesis promotion,cell migration facilitation,protein kinase activation,secondary messenger molecule
ENSG00000164187,LMBRD2,autophagy regulation,lipid metabolism regulation,tumor progression association,protein interaction,membrane transport function,poor prognosis indicator
ENSG00000116830,TTF2,tumor suppressor regulation,transcription factor activity,cell proliferation enhancement,apoptosis inhibition,angiogenesis modulation,genomic instability
ENSG00000165695,AK8,energy metabolism regulation,tumor growth promotion,poor prognosis indicator,cellular homeostasis maintenance,metabolic pathway interaction,glycolysis support
ENSG00000166199,ALKBH3,dna demethylation,genomic stability,nuclear localization,alkylation damage repair,chromatin remodeling,transcriptional regulation
ENSG00000062194,GPBP1,epigenetic regulation,chromatin modification,oncogenesis,gene expression profiling,cell cycle progression,apoptosis inhibition
ENSG00000096092,TMEM14A,lipid metabolism regulation,tumor progression driver,cell signaling modulation,oncogenic protein overexpression,altered membrane fluidity,cancer cell proliferation enhancement
ENSG00000157613,CREB3L1,transcriptional regulation,cell proliferation,oncogenic signaling,angiogenesis,therapeutic target,genomic instability
ENSG00000129187,DCTD,dna repair,cell cycle regulation,tumor suppression,apoptosis induction,ubiquitination regulation,cancer progression marker
ENSG00000170860,LSM3,rna processing regulation,snrnp biogenesis,cellular stress response,genomic instability,protein-protein interactions,post-translational modifications
ENSG00000111790,FGFR1OP2,amplification,cell proliferation,chromatin remodeling,dysregulation,cis-regulatory element,tumor progression
ENSG00000185897,FFAR3,ffar3 activation,cell proliferation,pi3k/akt pathway,g protein-coupled receptor,tumor progression,insulin sensitivity
ENSG00000022840,RNF10,cell cycle regulation,ubiquitination pathway,dna damage response,genomic instability,tumor suppressor activity,oncogene function
ENSG00000137411,VARS2,mitochondrial dna mutations,energy metabolism regulation,cell growth modulation,tumorigenesis contribution,glycolytic shift,protein synthesis regulation
ENSG00000135365,PHF21A,tumor suppressor function,epigenetic regulation,chromatin remodeling,histone modification,telomere maintenance,genomic instability
ENSG00000143228,NUF2,genomic instability,chromosomal instability,aneuploidy,cell cycle regulation,centromere formation,kinetochore assembly
ENSG00000058091,CDK14,cell cycle regulation,constitutive activation,gain of function mutations,therapeutic target,genomic instability,dna damage response
ENSG00000170854,RIOX2,transcriptional regulation,chromatin modification,oncogene overexpression,cell cycle progression,histone phosphorylation,tumor growth promotion
ENSG00000158806,NPM2,chromatin remodeling,apoptosis regulation,centrosome duplication,genomic instability,cell proliferation,none
ENSG00000149177,PTPRJ,dephosphorylation,tumor suppressor activity,receptor tyrosine kinase modulation,cell proliferation inhibition,stat3 signaling activation,pi3k/akt/mtor pathway enhancement
ENSG00000159173,TNNI1,muscle contraction regulation,cancer biomarker potential,gene mutation involvement,cellular differentiation disruption,protein-protein interaction,growth regulation pathway modulation
ENSG00000160410,SHKBP1,cell migration,scaffold protein function,amplification/overexpression,constitutive activation,tumor progression,therapeutic target
ENSG00000169583,CLIC3,tumor progression,oncogenic process,cell survival enhancement,metastasis promotion,therapeutic target,genomic profiling
ENSG00000146285,SCML4,chromatin remodeling,tumor suppressor function,genomic instability regulation,cancer susceptibility,potential therapeutic target,dna methylation regulation
ENSG00000149636,DSN1,dna repair dysfunction,genomic instability,cell cycle regulation,apoptosis suppression,cancer driver mutation,protein-protein interaction
ENSG00000197683,KRTAP26-1,keratin-associated protein,epithelial cells,cellular structure,keratin filaments,skin and hair biology,limited oncogenic roles
ENSG00000181778,TMEM252,pan-cancer association,epithelial-to-mesenchymal transition,cell polarity maintenance,ion transport regulation,tumor microenvironment modulation,therapeutic target potential
ENSG00000113369,ARRDC3,endocytic trafficking regulation,cell surface receptor degradation,escrt protein interaction,multivesicular body formation,lysosomal sorting modulation,cancer metastasis promoter
ENSG00000116903,EXOC8,exocyst complex regulation,cell surface protein trafficking,vesicle fusion and targeting,tumor progression,oncogenesis driver,cell signaling pathway modulation
ENSG00000165113,GKAP1,gsk3beta regulation,cell migration facilitation,cytoskeletal reorganization,oncogenic signaling modulation,tumor progression facilitation,poor prognosis indicator
ENSG00000103494,RPGRIP1L,cilia formation disruption,loss-of-function mutations,oncogenic transformation,cell signaling regulation,ciliopathy protein interaction,therapeutic target
ENSG00000007255,TRAPPC6A,enhanced cell proliferation,oncogenic processes,metastasis,endosomal sorting,chemotherapy resistance,cellular stress response
ENSG00000276043,UHRF1,dna damage response,genomic instability,cell cycle regulation,tumorigenesis,ubiquitination pathway,epigenetic regulation
ENSG00000160961,ZNF333,tumor suppressor function,transcription regulation,cell cycle control,apoptosis regulation,chromatin remodeling,cancer progression
ENSG00000148677,ANKRD1,tumor suppressor,genomic instability,cell cycle regulation,nuclear localization,apoptosis induction,chromatin remodeling
ENSG00000168530,MYL1,cellular regulation,cytoskeleton dynamics,cell proliferation,gene expression regulation,protein interaction,oncogenic processes
ENSG00000141002,TCF25,t-box transcription factor,oncogene activation,cell proliferation regulation,epigenetic regulation,transcriptional control,protein-protein interaction
ENSG00000173404,INSM1,cell cycle regulation,transcriptional regulation,tumor initiation,apoptosis inhibition,cell differentiation,proliferation promotion
ENSG00000117713,ARID1A,chromatin remodeling,oncogenic pathway activation,tumor suppressor function,cell proliferation promotion,pi3k/akt signaling activation,dna damage response disruption
ENSG00000077454,LRCH4,cellular regulation,tumorigenesis,cytoskeletal modulation,genomic instability,protein interactions,cell migration
ENSG00000151502,VPS26B,retromer complex,oncogenic protein trafficking,endosomal sorting dysfunction,tumor progression facilitation,mutational activation,protein recycling regulation
ENSG00000134108,ARL8B,oncogene,cancer progression,cell proliferation,metastasis promotion,therapeutic target,protein transport regulation
ENSG00000137145,DENND4C,er maintenance,gtpase regulation,cargo transport,somatic alteration,oncogenesis,protein trafficking
ENSG00000159224,GIP,growth factor activity,aberrant expression,glucose metabolism regulation,cellular proliferation,signaling pathway modulation,tumor progression
ENSG00000231377,DHX16,genomic instability,oncogenic potential,dna repair,transcriptional regulation,splicing complex component,chromatin remodeling
ENSG00000183814,LIN9,transcriptional regulation,cell cycle regulation,dna repair,oncogene function,p53 regulation,tumor progression
ENSG00000184708,EIF4ENIF1,mrna translation regulation,cellular signaling pathway,oncogene activation,tumor progression driver,cap-dependent translation initiation,protein-protein interaction
ENSG00000109686,SH3D19,sam domain-containing protein,oncogenic process promotion,protein degradation facilitation,ubiquitin-proteasome pathway interaction,cellular trafficking regulation,tumor suppressor protein targeting
ENSG00000123411,IKZF4,regulatory network disruption,transcriptional regulation,oncogenic potential,tumor suppressor function,cellular homeostasis disruption,poor prognosis association
ENSG00000008018,PSMB1,protein degradation,cell cycle regulation,apoptosis modulation,dna repair mechanism,tumor suppressor function,oncogene upregulation
ENSG00000152969,JAKMIP1,dna damage response,cell survival enhancement,genotoxic stress regulation,apoptosis inhibition,mapk signaling modulation,protein interaction specificity
ENSG00000107165,TYRP1,melanogenesis,tumor progression,signal transduction pathway,protein expression regulation,cell proliferation enhancement,therapeutic target
ENSG00000284984,RHOU,cell migration,oncogenic processes,pi3k/akt pathway,cytoskeletal dynamics,gtpase activation,cell proliferation
ENSG00000079432,CIC,epigenetic regulation,tumor suppressor function,cell cycle regulation,apoptosis induction,chromatin compaction,wnt/β-catenin pathway inhibition
ENSG00000131351,HAUS8,microtubule dynamics regulation,mitotic spindle checkpoint regulation,kinetochore binding complex formation,genome instability promotion,tumorigenesis facilitation,cancer cell proliferation enhancement
ENSG00000167625,ZNF526,cellular regulation,transcriptional modulation,gene expression dysregulation,tumor suppressor function,oncogenic potential,nuclear localization
ENSG00000133065,SLC41A1,acidic environment adaptation,cell survival under hypoxia,cellular metabolism regulation,glycolytic flux enhancement,metabolic regulator interaction,tumor metabolism disruption
ENSG00000185046,ANKS1B,pi3k/akt pathway modulation,cell proliferation enhancement,tumor progression facilitation,metastasis promotion,apoptosis inhibition,prognostic marker upregulation
ENSG00000196584,XRCC2,dna repair,interstrand crosslinks,genomic instability,stem cell maintenance,chemotherapy resistance,therapeutic target
ENSG00000170260,ZNF212,dna binding,chromatin remodeling,transcription regulation,oncogene suppression,tumor growth inhibition,cell cycle regulation
ENSG00000140553,UNC45A,muscle contraction regulation,cell migration enhancement,tumor progression contributor,protein interaction modulator,oncogenic process involvement,cell motility regulation
ENSG00000197448,GSTK1,detoxification mechanism,tumor suppressor function,oxidative stress regulation,dna damage response,apoptosis modulation,cell proliferation regulation
ENSG00000183775,KCTD16,chromatin remodeling,maintenance of genome stability,tumor suppressor function,cell cycle regulation,histone modification regulation,oncogene suppression
ENSG00000141279,NPEPPS,proteolytic activity,cell migration,tumor invasion,metastatic progression,cell adhesion modulation,signaling pathway regulation
ENSG00000160741,CRTC2,constitutive activation,transcriptional coactivator,cellular stress response,inflammation regulation,gene expression modulation,nuclear localization
ENSG00000143545,RAB13,cell migration,tumor progression,cytoskeleton regulation,epithelial polarity,gtpase activity,protein-protein interaction
ENSG00000163884,KLF15,cell cycle regulation,tumor suppressor function,transcriptional regulation,apoptosis regulation,dna repair mechanism,chromatin remodeling 
ENSG00000178057,NDUFAF3,mitochondrial function impairment,altered metabolism,cellular respiration dysfunction,mtor signaling pathway activation,oncogenic potential,cellular heterogeneity modulation
ENSG00000158825,CDA,cytidine deamination,nucleotide salvage pathway,liver expression,purine metabolism,tumor cell sensitivity,oncogenesis
ENSG00000165584,SSX3,transcriptional regulation,cell proliferation,oncogenic activity,genomic instability,chromatin remodeling,tumor progression
ENSG00000064195,DLX3,transcription factor activity,oncogenic signaling,epigenetic regulation,metastatic potential,tumorigenesis,gene expression regulation
ENSG00000080189,SLC35C2,tumor suppressor,nucleotide sugar transporter,cell surface signaling,oncogenic transformation,glycosylation pathway,overexpression
ENSG00000215203,GRXCR1,cellular redox regulation,transcription factor activation,oncogenic processes,cell proliferation,redox balance maintenance,therapeutic target
ENSG00000255690,TRIL,apoptosis inhibition,genomic instability,pro-apoptotic gene suppression,tumor suppressor regulation,transcriptional modulation,oncogenic overexpression
ENSG00000163682,RPL9,ribosomal dysfunction,oncogene overexpression,cellular proliferation,genetic instability,protein synthesis regulation,translation initiation
ENSG00000135486,HNRNPA1,rna processing regulation,tumor progression promotion,epithelial-to-mesenchymal transition facilitation,cell proliferation enhancement,apoptosis suppression,metastasis regulation
ENSG00000166783,MARF1,rna processing regulation,tumor progression,cell proliferation enhancement,metastasis facilitation,alternative splicing modulation,nonsense-mediated mrna decay
ENSG00000257923,CUX1,tumor suppressor function,regulatory transcription factor,cell cycle regulation,apoptosis induction,nuclear localization,wnt/β-catenin pathway interaction
ENSG00000162819,BROX,genomic stability maintenance,tumor suppressor function,cell cycle regulation,dna repair mechanism,chromatin remodeling,apoptosis promotion
ENSG00000101421,CHMP4B,cellular autophagy,oncogenic potential,escrt-iii complex,cell survival,prognostic marker,therapeutic target
ENSG00000156256,USP16,oncogenesis,ubiquitin-proteasome regulation,histone h2a regulation,transcription factor modulation,cell cycle progression,tumor suppressor interaction
ENSG00000072832,CRMP1,microtubule dynamics,cell migration,cytoskeletal organization,axonal growth,synaptic plasticity,oncogenic potential
ENSG00000125447,GGA3,jak/stat signaling,oncogenic mutations,cell proliferation,tumor progression,metabolic regulation,immune evasion
ENSG00000188906,LRRK2,protein degradation,cell signaling pathway,kinase activity,oncogenesis,cell survival,membrane trafficking
ENSG00000087470,DNM1L,dynamin-like protein,cell proliferation regulation,actin dynamics modulation,cytoplasmic vesicle budding,tumor migration facilitation,endocytic pathway regulation
ENSG00000266094,RASSF5,microtubule dynamics regulation,gene expression alterations,tumor suppressor function,loss of genomic stability,cancer-related downregulation,akt/pi3k pathway modulation
ENSG00000165792,METTL17,m6a methylation,epithelial-to-mesenchymal transition (emt),oncogenic transformation,gene expression regulation,tumor growth promotion,metastasis enhancement
ENSG00000061337,LZTS1,cellular proliferation,therapeutic target,signaling pathway modulation,scaffolding protein function,tumor progression marker,cancer aggressiveness indicator
ENSG00000139531,SUOX,metabolic regulation,mitochondrial matrix enzyme,sulfur metabolism,amino acid catabolism,oxidative stress,cancer-related metabolic alterations
ENSG00000268651,CTAG1A,genomic instability,dna replication,homologous recombination,cell cycle regulation,oncogenesis,genomic integrity
ENSG00000105576,TNPO2,dna repair mechanism,genomic instability,nuclear import receptor,oncogene potential,transcriptional regulation,cell cycle progression
ENSG00000184033,CTAG1B,chromatin remodeling,dna repair mechanisms,cellular proliferation,genomic instability,histone modification,protein-protein interaction
ENSG00000127515,OR7A10,olfactory receptor,cellular modulation,signaling pathway,odorant detection,potential oncogene,genomic variation
ENSG00000186150,UBL4B,protein stability regulation,ubiquitination pathway modulation,oncogene activation,tumor suppression evasion,cell proliferation enhancement,therapeutic target identification
ENSG00000123297,TSFM,cellular proliferation,dna repair mechanism,genomic instability,oncogenic process,protein processing,tumor progression
ENSG00000166228,PCBD1,pterin metabolism regulation,loss of function mutations,gain of function mutations,cell growth regulation,dna repair modulation,apoptosis suppression
ENSG00000276194,HNF1B,transcriptional regulation,homodimer formation,tumor growth promotion,cell proliferation enhancement,epithelial-to-mesenchymal transition modulation,apoptosis inhibition
ENSG00000154358,OBSCN,cancer progression,cell migration,tumor metastasis,cytoplasmic structure,protein-protein interaction,cell adhesion
ENSG00000106153,CHCHD2,mitochondrial regulation,oncogenesis promotion,energy metabolism regulation,cellular respiration modulation,mitochondrial morphology maintenance,antioxidant defense impairment
ENSG00000169895,SYAP1,pi3k/akt pathway interaction,oncogenic protein,cell proliferation enhancement,tumor growth promotion,metastasis facilitation,pi3k/mtor signaling modulation
ENSG00000170037,CNTROB,microtubule stability,gene amplification,mitotic regulation,tumor suppressor,cell division regulation,aneuploidy induction
ENSG00000105939,ZC3HAV1,immune evasion,apoptosis regulation,cell proliferation inhibition,tumor progression promotion,dna damage response modulation,natural killer cell suppression
ENSG00000198271,KRTAP4-5,epidermal differentiation,keratin-associated protein family,cell adhesion disruption,cell proliferation enhancement,skin condition association,tissue integrity modulation
ENSG00000244462,RBM12,altered gene expression,cell proliferation,oncogenesis,post-transcriptional regulation,rna-binding protein,tumor progression
ENSG00000112182,BACH2,tumor suppressor function,chromatin remodeling activity,epigenetic regulation,cell growth inhibition,oncogene activation,transcriptional repression
ENSG00000198517,MAFK,mafk transcription factor,cell growth regulation,oncogenic transformation,tumor cell proliferation,chromatin remodeling,transcriptional regulation
ENSG00000173991,TCAP,muscle function regulation,cell proliferation regulation,apoptosis regulation,oncogenic pathway activation,tumor progression promotion,biomarker potential
ENSG00000169271,HSPB3,cellular protection,protein folding regulation,cell survival promotion,signaling pathway modulation,tumorigenesis association,cellular stress response
ENSG00000144893,MED12L,oncogenic transcription factors,chromatin remodeling,aberrant activation,tumor growth,poor prognosis,genetic instability
ENSG00000040608,RTN4R,cellular stress response,tumor progression,apoptosis evasion,cancer development,anti-apoptotic activity,genetic alterations
ENSG00000174483,BBS1,bardet-biedl syndrome protein 1,ciliary function regulation,trafficking regulation,cell polarity maintenance,g-protein signaling pathway interaction,oncogenic process promotion
ENSG00000113966,ARL6,microtubule regulation,oncogene function,genomic instability,gtpase activity,centrosome integrity,dna damage response
ENSG00000021645,NRXN3,tumor suppressor,synaptic function,cell adhesion,apoptosis regulation,genomic stability,oncogenic pathway activation
ENSG00000158748,HTR6,serotonin signaling,g-protein coupled receptor,tumor progression,cell proliferation,poor prognosis,immune evasion
ENSG00000067208,EVI5,chromatin remodeling,gene activation,oncogene amplification,tumor progression,cell proliferation regulation,transcriptional coactivation
ENSG00000147536,GINS4,genomic instability,gene amplification,dna replication regulation,cell proliferation enhancement,centrosome integrity disruption,oncogenic pathway activation
ENSG00000131153,GINS2,gins complex formation,dna replication enhancement,cell proliferation promotion,oncogenic pathway activation,genomic instability induction,cell cycle progression facilitation
ENSG00000115145,STAM2,endocytosis regulation,oncogenic transformation,tumor growth promotion,signaling pathway involvement,cellular homeostasis disruption,protein interaction alteration
ENSG00000115762,PLEKHB2,rho gtpase regulation,aberrant activation,cancer driver gene,metastasis regulator,cell migration enhancer,tumor suppressor inactivation
ENSG00000132781,MUTYH,ber pathway,dna repair deficiency,genomic instability,oxidative damage response,tumor suppressor function,mutational burden
ENSG00000166169,POLL,dna replication,genomic instability,cell cycle regulation,protein-protein interaction,somatic mutation burden,tumor suppressor function
ENSG00000138741,TRPC3,calcium influx regulation,constitutive activation,gain of function mutations,tumor progression,cell proliferation enhancement,protein-protein interaction
ENSG00000165120,SSMEM1,cell membrane trafficking,pi3k/akt pathway modulation,oncogenic signaling,cell migration regulation,actin cytoskeleton dynamics,tumor progression
ENSG00000143595,AQP10,transmembrane channel protein,cellular osmotic balance regulation,oncogenesis contribution,tumor progression facilitation,protein-protein interaction modulation,overexpression association
ENSG00000166257,SCN3B,sodium channel regulation,abrupt calcium influx,oncogenic processes,constitutive activation,tumor growth regulation,cancer progression
ENSG00000117360,PRPF3,cell cycle regulation,dna repair mechanisms,apoptosis inhibition,oncogenic mutations,tumor aggressiveness,malignant transformation
ENSG00000025770,NCAPH2,mitotic chromosome segregation,chromatin compaction,genomic instability,cell division,tumorigenesis,cancer driver
ENSG00000178935,ZNF552,cell cycle regulation,transcriptional repression,apoptosis inhibition,tumor promoter,zinc finger binding,protein-protein interaction
ENSG00000034693,PEX3,peroxisome assembly,lipid metabolism regulation,pi3k/akt signaling pathway,cell proliferation regulation,redox balance maintenance,peroxisomal membrane protein import
ENSG00000167272,POP5,altered rna processing,genomic instability,alternative splicing events,spliceosomal component,nuclear protein-coding gene,rna degradation pathways
ENSG00000156603,MED19,oncogene overexpression,cell proliferation enhancement,g1/s transition modulation,epithelial-to-mesenchymal transition regulation,transcriptional coactivator function,chromatin remodeling involvement
ENSG00000281813,KAT6B,histone acetylation,tumor suppressor activity,genomic instability,chromatin remodeling,apoptosis regulation,cell cycle progression
ENSG00000180089,TMEM86B,cellular homeostasis regulation,cell proliferation driver,genomic instability driver,pi3k/akt pathway interaction,tumorigenesis oncogene,transmembrane protein function
ENSG00000101152,DNAJC5,cellular chaperone function,overexpression in cancers,promotes cell proliferation,microtubule dynamics regulation,autophagy modulation,tumor suppressor regulation
ENSG00000155657,TTN,large protein structure modification,sarcomere component,cell proliferation driver,tumor progression factor,protein kinase substrate,metastasis promoter
ENSG00000121073,SLC35B1,glycosylation regulation,cellular metabolism,nucleotide sugar transport,oncogenic processes,tumor microenvironment modulation,genetic alterations
ENSG00000083838,ZNF446,transcriptional regulation,cell proliferation,zinc finger protein family,gene overexpression,protein-protein interaction,tumor aggressiveness
ENSG00000172466,ZNF24,oncogene regulation,tumor suppressor gene regulation,apoptosis evasion,transcriptional regulation,chromatin remodeling,potential therapeutic target
ENSG00000130720,FIBCD1,cilia formation dysregulation,cellular polarity disruption,apical membrane localization,oncogenic signaling pathway,tumor suppressor role,cell-cell interaction alteration
ENSG00000176182,MYPOP,mapk/erk signaling pathway,constitutive activation,gain of function mutations,cell proliferation,therapeutic target,protein-protein interactions
ENSG00000100246,DNAL4,genomic instability,microtubule dynamics regulation,cellular transport facilitation,chromosomal instability,dna repair interaction,therapeutic target
ENSG00000184731,FAM110C,cell cycle regulation,g-protein coupled receptor,oncogenesis potential,apoptosis evasion,genomic amplification,tumor progression
ENSG00000174099,MSRB3,oncogenic driver,protein repair mechanism,cell survival pathway,cellular stress response,therapeutic target candidate,redox regulation
ENSG00000049618,ARID1B,genomic instability,aberrant chromatin remodeling,oncogene activation,transcriptional regulation disruption,dna repair defects,chromatin modification disorder
ENSG00000160131,VMA21,lysosomal regulation,protein degradation,endocytic recycling,autophagic flux modulation,cellular trafficking,rab gtpase interaction
ENSG00000001461,NIPAL3,akt pathway activation,tumor growth promotion,autophagy regulation,cell survival enhancement,pi3k/akt signaling modulation,mutation in pancreatic cancers
ENSG00000102898,NUTF2,regulatory function,protein-protein interaction,tumor suppressor activity,nucleolar localization,rna processing regulation,cell cycle regulation
ENSG00000134453,RBM17,overexpression,driver mutation,alternative splicing,regulatory dysfunction,rna-binding activity,tumor suppressor
ENSG00000110171,TRIM3,apoptosis regulation,autophagy regulation,pi3k/akt pathway regulation,tumor suppression,cell growth inhibition,protein degradation
ENSG00000113924,HGD,reactive oxygen species generation,cellular stress response,energy metabolism alteration,dna damage induction,oncogenic signaling pathway,glycolytic shift
ENSG00000186115,CYP4F2,metabolic regulation,tumor suppressor activity,cellular proliferation,oncogenic potential,prognostic marker,arachidonic acid metabolism
ENSG00000100867,DHRS2,cellular transformation,modulation of transcription factors,tumor progression,therapeutic target,cellular redox balance,enhanced cell proliferation
ENSG00000173214,MFSD4B,lipid metabolism regulation,aberrant expression,therapeutic target,metabolic reprogramming,tumor adaptation,cellular transport
ENSG00000182492,BGN,cellular modulation,tgf-β pathway regulation,glycosaminoglycan interaction,cell proliferation enhancement,fibroblast growth factor signaling,proteoglycan function
ENSG00000028116,VRK2,apoptosis modulation,cell cycle progression,dna repair mechanisms,oncogenesis promotion,protein kinase activation,transcriptional regulation
ENSG00000104973,MED25,cellular proliferation,transcriptional regulation,mediator complex subunit,gene expression modification,rna polymerase ii recruitment,cell cycle progression
ENSG00000267796,LIN37,chromatin remodeling,dna repair,transcriptional regulation,genome stability,tumor suppressor activity,none
ENSG00000093000,NUP50,nuclear transport regulation,gene expression regulation,dna damage response,tumor suppression,cell cycle control,apoptosis promotion
ENSG00000075420,FNDC3B,oncogene activation,cell adhesion regulation,chromatin modification,tumor progression,metastasis promotion,therapeutic target
ENSG00000165724,ZMYND19,chromatin regulation,tumor suppression,genome stability maintenance,transcriptional regulation,cell cycle control,dna repair
ENSG00000164040,PGRMC2,mitochondrial localization,iron-sulfur cluster assembly,heme biosynthesis,cell growth promotion,apoptosis suppression,protein-protein interaction
ENSG00000135587,SMPD2,ceramide biosynthesis,oncogenesis,cell membrane regulation,apoptosis regulation,tumor suppressor function,angiogenesis promotion
ENSG00000135211,TMEM60,mitochondrial function,cell cycle regulation,growth factor signaling,dysregulated expression,proliferation driver,mitochondrial membrane protein
ENSG00000166069,TMCO5A,transmembrane cofactor function,testicular expression,adaptor/scaffold protein role,cytoskeletal organization,cell migration regulation,spermatogenesis involvement
ENSG00000135406,PRPH,neuronal differentiation,tumor suppressor function,cellular morphology modulation,actin cytoskeleton regulation,cytoskeletal disruption,protein-protein interactions
ENSG00000171446,KRT27,epithelial cell maintenance,cell adhesion disruption,loss of heterozygosity mutations,tumor initiation,genetic instability,protein folding regulation
ENSG00000196646,ZNF136,chromatin modification,transcription factor activity,cell growth regulation,genetic reprogramming,oncogenic mutation,gene expression dysregulation
ENSG00000161896,IP6K3,p53 regulation,cell cycle progression,apoptosis regulation,genomic stability,insp6 phosphorylation,tumor suppressor interaction
ENSG00000130741,EIF2S3,oncogenic translation regulation,phosphorylation modulation,chemosensitivity evasion,protein synthesis enhancement,cellular stress response,aminoacyl-trna binding
ENSG00000171295,ZNF440,transcriptional regulation,cell cycle progression,oncogenesis,apoptosis inhibition,dna repair dysregulation,tumor suppressor function
ENSG00000109445,ZNF330,chromatin remodeling,oncogenic potential,genomic instability,transcriptional repression,cell proliferation,tumor suppressor interaction
ENSG00000134986,NREP,cell migration,rho gtpase regulation,actin cytoskeleton modulation,protein-protein interactions,cancer progression,oncogene potential
ENSG00000181092,ADIPOQ,adipocyte differentiation,angiogenesis inhibition,apoptosis promotion,metabolic regulation,inflammation suppression,tumor suppressor activity
ENSG00000285053,TBCE,t-complex formation,alpha-synuclein processing,familial als association,protein chaperone function,misfolding and degradation regulation,neurodegenerative disorder link
ENSG00000111676,ATN1,transcription regulation,tumor progression,pi3k/akt pathway activation,dna damage response,gene expression alteration,tumor growth promotion
ENSG00000100865,CINP,cell adhesion regulation,cytoskeletal dynamics modulation,oncogenic process promotion,cell migration enhancement,tumor progression marker,pi3k/akt pathway interaction
ENSG00000137726,FXYD6,potassium channel regulation,ion transport regulator,cellular signaling modulation,tumor suppressor interaction,oncogene overexpression,cancer cell behavior alteration
ENSG00000142494,SLC47A1,drug resistance,multidrug efflux pump,chemotherapy response modulation,ph regulation,cellular transport,therapeutic target
ENSG00000178718,RPP25,rna exosome regulation,genome stability modulation,oncogenic protein accumulation,gene expression profiling,tumor progression association,prognostic marker candidate
ENSG00000143401,ANP32E,chromatin remodeling,epigenetic reprogramming,genome instability,oncogenic function,pi3k/akt pathway interaction,transcriptional regulation
ENSG00000142583,SLC2A5,glucose metabolism,fructose transport,tumor metabolism,oncogenic process,warburg effect,aerobic glycolysis
ENSG00000133103,COG6,mitochondrial dysfunction,genomic instability,oxidative stress,iron-sulfur cluster assembly,cytosolic iron-sulfur cluster biogenesis,reactive oxygen species regulation
ENSG00000117862,TXNDC12,activation of transcription factors,enhanced cell survival,interactions with redox regulation proteins,metastasis promotion,pi3k/akt pathway activation,tumor progression
ENSG00000063322,MED29,mediator complex regulation,oncogene activation,scaffold protein function,cell proliferation promotion,transcriptional regulation,therapeutic target
ENSG00000126603,GLIS2,transcription factor regulation,apoptosis inhibition,tumor suppressor function,cell growth modulation,genome stability maintenance,cancer stem cell regulation
ENSG00000140854,KATNB1,microtubule dynamics,aneuploidy,genomic instability,cell division regulation,mitotic spindle assembly,chromosomal segregation
ENSG00000118523,CCN2,angiogenesis,cell migration,cell proliferation,connective tissue regulation,fibrosis promotion,hyaluronan interaction
ENSG00000188761,BCL2L15,apoptosis regulation,mitochondrial function,oncogenic process promotion,tumor progression facilitation,cell survival inhibition,gene expression regulation
ENSG00000007372,PAX6,oncogenic transcription factor,cell proliferation regulation,dna-binding activity,transcriptional repression,cancer stem cell maintenance,genetic aberration
ENSG00000169410,PTPN9,pi3k/akt/mtor pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,immunomodulatory role
ENSG00000171992,SYNPO,oncogenesis,signaling pathway activation,genomic instability,cell migration,cytoskeleton regulation,centrosome function
ENSG00000173275,ZNF449,krab domain-containing protein,tumor suppressor function,transcriptional regulation,dna binding activity,apoptosis modulation,cancer-associated expression
ENSG00000105146,AURKC,mitotic spindle assembly,chromosome segregation,serine/threonine kinase activity,genomic instability,cell cycle progression,apoptosis regulation
,SEPT14,cancer driver,pi3k/akt signaling,cell proliferation,cytoplasmic localization,septin complex formation,oncogenic function
,SEPT2,septin function,cell proliferation,oncogenic role,cell migration,tumor invasion,therapeutic target
ENSG00000162517,PEF1,oncogenic regulation,chromatin remodeling,transcriptional control,gene expression modulation,cell cycle progression,tumor suppressor interaction
ENSG00000135439,AGAP2,rho gtpase signaling pathway,cell migration,epithelial-to-mesenchymal transition (emt),oncogenic function,metastasis promotion,cell adhesion regulation
ENSG00000186207,LCE5A,terminal differentiation,barrier function,cell signaling,lipid metabolism,tumorigenesis,none
ENSG00000187180,LCE2C,keratinocyte differentiation,skin barrier formation,terminal differentiation,epidermal layer development,genetic alterations,skin cell proliferation
ENSG00000103591,AAGAB,adapter function,cell proliferation regulation,tumor suppressor pathway modulation,poor prognosis marker,cell cycle progression enhancement,oncogenic pathway activation
ENSG00000152056,AP1S3,protein regulation,cell growth modulation,endocytic pathway,cancer-related mutations,signaling pathway interaction,genomic instability
ENSG00000125878,TCF15,wnt/β-catenin signaling,oncogene activation,tumor progression,apoptosis evasion,cell cycle regulation,therapeutic target
ENSG00000185475,TMEM179B,calcium signaling regulation,ion channel regulation,oncogene overexpression,tumor growth promotion,metastasis enhancement,chemoresistance induction
ENSG00000151778,SERP2,protein regulation,cellular stress response,tumor suppressor activity,proteolytic inhibition,cancer progression,autophagy modulation
ENSG00000155229,MMS19,genomic instability,dna replication stress,cell cycle regulation,histone folding,nucleoplasmic protein function,aneuploidy induction
ENSG00000168899,VAMP5,cell migration,tumor progression,gene expression regulation,protein-protein interaction,synaptic vesicle fusion,oncogenic signaling pathway
ENSG00000110025,SNX15,pi3k/akt interaction,endosomal trafficking regulation,cell proliferation promotion,tumor progression enhancement,oncogenic potential,apoptosis inhibition
ENSG00000137074,APTX,genetic instability,poly (adp-ribose) polymerase interaction,tumor suppressor function,dna repair deficiency,oncogenic potential,genomic maintenance
ENSG00000183304,FAM9A,transcriptional regulation,cell cycle progression,protein-protein interaction,genomic instability,tumor suppression,chromatin remodeling
ENSG00000148341,SH3GLB2,protein degradation,endocytic trafficking,ubiquitination,cell signaling regulation,tumor growth modulation,oncogene activation
ENSG00000275895,U2AF1L5,genomic instability,splice site recognition,pre-mrna splicing regulation,intronic removal,protein-protein interaction,molecular chaperone function
ENSG00000149313,AASDHPPT,glycosaminoglycan synthesis,extracellular matrix remodeling,tumor progression,protein processing regulation,cell migration facilitation,oncogenic potential
ENSG00000134709,HOOK1,microtubule dynamics,genomic instability,cell division checkpoint,aneuploidy regulation,dna damage response,tumor suppressor
,DUPD1,cellular interaction,regulatory mechanism,cell signaling pathway,protein interaction,oncogenesis,cellular process
ENSG00000108381,ASPA,neurotransmitter regulation,metabolic pathway disruption,cancer cell metabolism,cellular proliferation,genetic mutation impact,enzymatic activity alteration
ENSG00000203786,KPRP,apoptosis regulation,tumor microenvironment modulation,cell proliferation inhibition,epithelial-to-mesenchymal transition,proteolytic activity regulation,metastasis suppression
ENSG00000159921,GNE,aberrant glycoprotein synthesis,cell proliferation,altered protein n-glycosylation,tumor progression,therapeutic target,glycoprotein regulation
ENSG00000009709,PAX7,transcription factor function,muscle cell development,cell proliferation regulation,apoptosis inhibition,tumor progression driver,somatic reprogramming target
ENSG00000113552,GNPDA1,glycosphingolipid biosynthesis,cell growth regulation,cell survival modulation,metastasis promotion,tumorigenesis driver,oncogenic process
ENSG00000065029,ZNF76,krab domain-containing,transcription factor function,tumor suppressor or oncogene,cell growth regulation,apoptosis induction,chromatin remodeling
ENSG00000136732,GYPC,genetic instability,cell adhesion disruption,tumor progression,epigenetic alterations,stem-like properties acquisition,pi3k/akt signaling activation
ENSG00000153060,TEKT5,cell adhesion disruption,emt regulation,tumor progression facilitation,prognostic marker for aggressiveness,cell surface protein interaction,oncogenic signaling pathway modulation
ENSG00000184675,AMER1,genomic instability,aneuploidy,cell cycle regulation,cancer progression,mitotic checkpoint regulation,tumor suppressor function
ENSG00000172057,ORMDL3,sphingolipid metabolism regulation,overexpression in cancer,tumor growth promotion,metastasis enhancement,therapeutic target identification,inflammation response modulation
ENSG00000149489,ROM1,g-protein coupled receptor,overexpression,aggressive tumor behavior,cell growth regulation,signaling pathway modulation,mutations associated with cancer progression
ENSG00000168395,ING5,tumor suppressor function,genome stability maintenance,dna damage repair,cell cycle regulation,histone modification,chromatin remodeling
ENSG00000009844,VTA1,vesicle transport regulation,cellular trafficking disruption,endocytic pathway modulation,genetic alteration impact,cancer relevance established,tumor suppressor function
ENSG00000104490,NCALD,cellular degradation,oncogenic regulation,pi3k/akt modulation,tumor progression,protein turnover,biomarker potential
ENSG00000169704,GP9,platelet activation,tumor-associated thrombosis,oncogenic pathway interaction,coagulation regulation,blood clot formation,prognostic significance
ENSG00000213588,ZBTB9,cell proliferation regulation,oncogenic function,transcriptional modulation,tumor suppressor interaction,co-regulator binding,genomic instability
ENSG00000178149,DALRD3,genome instability,dna replication promotion,tumor suppressor function,proliferation and survival enhancement,poor prognosis association,cancer cell adaptation
ENSG00000120129,DUSP1,mapk inhibition,oncogenic transformation,tumor suppressor function,cell proliferation regulation,angiogenesis promotion,genomic instability
ENSG00000127989,MTERF1,mitochondrial gene regulation,transcriptional read-through prevention,oncogenic properties,cell proliferation promotion,genomic stability maintenance,mitochondrial biogenesis regulation
ENSG00000107140,TESK1,microtubule destabilization,oncogenic cell cycle progression,chromosomal instability,mitotic disruption,cell proliferation regulation,tumor aggressiveness
ENSG00000070367,EXOC5,exocyst complex component,tumor progression,cell migration and invasion,secretion of pro-tumorigenic factors,angiogenesis regulation,cancer cell growth promotion
ENSG00000169087,HSPBAP1,cell survival,chaperone activity,stress response regulation,protein folding regulation,tumor progression,therapeutic target
ENSG00000105894,PTN,oncogenic role,cell proliferation,tumor progression,growth factor activity,signaling pathway modulation,angiogenesis promotion
ENSG00000123560,PLP1,proteolipid protein 1 function,cellular stress response,chromatin regulation,oligodendrocyte dysfunction,epigenetic modification,myelin maintenance
ENSG00000164591,MYOZ3,cancer cell migration,overexpression,cell proliferation,epithelial-to-mesenchymal transition,signaling pathway activation,potential therapeutic target
ENSG00000198081,ZBTB14,chromatin remodeling,transcriptional repression,tumor suppressor function,cell cycle regulation,apoptosis modulation,histone modification
ENSG00000173226,IQCB1,plcβ signaling pathway,constitutive activation,gain of function mutations,tumor progression,oncogenic process,signaling scaffolding protein
ENSG00000163093,BBS5,ciliopathy,genetic disorder,centrosomal regulation,chromosomal instability,tumorigenesis,sensory perception
ENSG00000109501,WFS1,er stress response,gain of function mutations,cell survival,oncogenic processes,cellular proliferation,tumor progression
ENSG00000147642,SYBU,cellular regulation,signaling pathway modulation,protein interaction,tumor progression,potential therapeutic target,cellular growth modulation
ENSG00000182621,PLCB1,plc signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,calcium mobilization
ENSG00000204859,ZBTB48,wnt/?-catenin signaling,tumor suppressor activity,cancer cell regulation,dysregulated expression,cell growth inhibition,apoptosis promotion
ENSG00000113734,BNIP1,autophagy regulation,cell death promotion,hypoxia response,mitochondrial integrity,protein interaction,tumor suppressor
ENSG00000100292,HMOX1,angiogenesis,antioxidant defense,cellular adaptation,heme degradation,immune evasion,metastatic potential
ENSG00000173110,HSPA6,nf-κb pathway interaction,protein folding regulation,molecular chaperone function,oncogene overexpression,tumor progression promotion,metastasis enhancement
ENSG00000065882,TBC1D1,tumor suppressor role,genetic loss mutations,metabolic regulation,cellular energy metabolism modulation,insulin signaling pathway interaction,apoptosis resistance
ENSG00000196792,STRN3,hippo signaling pathway,regulatory protein interactions,cell proliferation driver,genomic instability,protein kinase activation,mitotic checkpoint regulation
ENSG00000151690,MFSD6,lipid metabolism regulation,cellular homeostasis maintenance,protein-protein interactions,cancer driver gene candidate,pi3k/akt pathway cross-talk,autophagy regulation
ENSG00000004779,NDUFAB1,mitochondrial electron transport chain activity,energy metabolism regulation,cellular respiration dysfunction,oncogenic reprogramming,rapid cell growth promoter,tumor energy production enhancer
ENSG00000144034,TPRKB,cell proliferation regulation,apoptosis modulation,signaling pathway dysregulation,oncogenic transformation,tumor progression promotion,pi3k/akt pathway interaction
ENSG00000104897,SF3A2,alternative splicing,chromatin remodeling,disrupted tumor suppressor function,enhanced cell proliferation,impaired pre-mrna processing,increased oncogene expression
ENSG00000167414,GNG8,g-protein regulation,oncogenic signaling,cell proliferation,tumor metastasis,genomic instability,therapeutic target
ENSG00000160683,CXCR5,cxcr5 signaling,tumor-infiltrating lymphocytes,chemokine receptor activation,cell proliferation and survival,tumor-promoting inflammation,immune evasion mechanisms
ENSG00000159082,SYNJ1,pi3k/akt signaling,loss-of-function mutations,cell proliferation,constitutive activation,phosphatidylinositol 3-phosphate dephosphorylation,oncogenic processes
ENSG00000171475,WIPF2,microtubule stability,cell migration,cytoskeleton regulation,therapeutic target,cell proliferation,wd repeat domains
ENSG00000102243,VGLL1,wnt/β-catenin signaling,oncogene activation,transcriptional coactivator,gene amplification,mutations in pan-cancer,tumor progression driver
ENSG00000128928,IVD,oxidative phosphorylation,mitochondrial function,glycolytic rate regulation,cell growth enhancement,therapeutic resistance,metabolic adaptation
ENSG00000063515,GSC2,tumor progression,cell proliferation,oncogene overexpression,dna methylation regulation,epithelial-to-mesenchymal transition,therapeutic target
ENSG00000167123,CERCAM,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,metastatic progression,oncogenic signaling activation,prognostic marker upregulation,therapeutic resistance modulation
ENSG00000110801,PSMD9,proteasome regulation,ubiquitin-proteasome pathway,oncogene potential,tumor progression,biomarker candidate,therapeutic target
ENSG00000128585,MKLN1,angiogenesis,cell surface degradation,extracellular matrix remodeling,tumor progression,metastasis,heparin sulfate proteoglycans
ENSG00000143514,TP53BP2,p53 pathway dysregulation,oncogenic activity,cell survival promotion,tumor suppressor protein inhibition,apoptosis suppression,transcriptional regulation disruption
ENSG00000108039,XPNPEP1,bcaa degradation pathway,cellular homeostasis disruption,protein-protein interactions,cell growth regulation,metabolic regulation,ubiquitin-proteasome pathway alteration
ENSG00000103540,CCP110,cell cycle regulation,centrosomal protein,cancer progression,tumor aggressiveness,genomic instability,dysregulated expression
ENSG00000146918,NCAPG2,chromosome segregation,mitotic progression,genomic instability,oncogenic process,cell cycle regulation,dna repair mechanism
ENSG00000206560,ANKRD28,rho-kinase pathway regulation,tumor suppressor function,cytoskeletal reorganization,cell migration regulation,chromatin organization,microtubule dynamics regulation
ENSG00000033050,ABCF2,dna repair pathway,gain of function mutation,cell survival,tumor progression,therapeutic resistance,protein degradation
ENSG00000198162,MAN1A2,glycoprotein modification,aberrant cell adhesion,tumor progression,therapeutic target,oncogenic signaling,cell migration
ENSG00000181541,MAB21L2,transcriptional regulation,oncogenic function,apoptosis inhibition,cell proliferation promotion,tumor progression enhancement,wnt/β-catenin pathway activation
ENSG00000130713,EXOSC2,oncogene,cell survival,dna damage response,rna degradation,cell proliferation,genetic instability
ENSG00000175213,ZNF408,zinc finger protein,transcriptional regulator,genomic instability,amplification or overexpression,cell cycle progression,apoptosis regulation
ENSG00000103995,CEP152,genomic instability,cellular proliferation,cilia formation,centriole duplication,protein-protein interactions,oncogenic processes
ENSG00000053254,FOXN3,tumor suppressor function,downregulation in cancer,apoptosis regulation,cell growth inhibition,transcriptional regulation,dna binding activity
ENSG00000198466,ZNF587,transcriptional regulator,krab-domain zinc finger protein,gene silencing,cell growth modulation,apoptosis regulation,cancer gene expression
ENSG00000198315,ZKSCAN8,transcriptional repression,histone modification,cell cycle control,epithelial-to-mesenchymal transition,chromatin remodeling,oncogenic expression
ENSG00000075914,EXOSC7,cellular regulation,genetic instability,mrna stability,oncoprotein expression,pan-cancer driver,regulatory complex subunit
ENSG00000262635,TDO2,tryptophan catabolism,immune modulation,cellular metabolism,oncogenesis,increased expression,kynurenine pathway
ENSG00000214513,NOTO,chromatin remodeling,transcriptional regulation,cellular proliferation,tumor growth promotion,biomarker potential,developmental gene expression
ENSG00000174306,ZHX3,transcriptional repressor,tumor suppressor gene repression,chromatin remodeling complex regulation,stem cell self-renewal modulation,oncogene activation,promoter binding activity
ENSG00000160801,PTH1R,pth signaling pathway,g-protein coupled receptor,oncogenic signaling,cell growth promotion,therapeutic target,bone metastasis
ENSG00000143776,CDC42BPA,microtubule dynamics,cell proliferation,rho gtpase activity,cytoskeleton reorganization,cell migration,signaling pathway modulation
ENSG00000172890,NADSYN1,cellular metabolism,oncogenic transformation,coenzyme biosynthesis,redox balance regulation,energy production modulation,cell proliferation promotion
ENSG00000114850,SSR3,notch signaling,cellular proliferation,genetic alterations,oncogenesis,tumor suppression,protein-protein interaction
ENSG00000197579,TOPORS,cell cycle regulation,apoptosis induction,ubiquitin ligase activity,tumor suppression,e3 enzyme regulation,dna damage response
ENSG00000188033,ZNF490,genomic instability,chromatin remodeling,transcriptional regulation,dna repair mechanisms,apoptotic pathways,oncogenic signaling
ENSG00000285248,IPO4,nuclear transport regulation,cell cycle disruption,oncogenic transformation,tumor progression,therapeutic target,genomic instability
ENSG00000162959,MEMO1,activation of oncogenic pathways,cell proliferation and differentiation regulation,overexpression or mutation in cancer cells,regulation of mapk signaling pathways,scaffolding protein function,cancer biology
ENSG00000136003,ISCU,mitochondrial function regulation,iron homeostasis maintenance,genomic instability induction,energy metabolism regulation,tumor growth promotion,warburg effect modulation
ENSG00000147649,MTDH,metastasis regulation,protein-protein interactions,cell adhesion modulation,tumor progression facilitation,therapeutic target identification,genomic instability promotion
ENSG00000158636,EMSY,brca2 interaction,genomic stability maintenance,double-strand break repair,homologous recombination facilitation,tumor suppressor function,swi/snf complex interaction
ENSG00000103152,MPG,neurodevelopmental process regulation,cell adhesion disruption,oncogenic mutation,glioma initiation,cellular proliferation enhancement,tumor progression facilitation
ENSG00000206505,HLA-A,antigen presentation,immune surveillance,cancer immunity,tumor immune evasion,genetic variation,cell surface expression
ENSG00000175895,PLEKHF2,pi3k/akt signaling,phosphorylation regulation,dysregulation,cellular proliferation,oncogenic protein activation,metabolic regulation
ENSG00000152430,BOLL,genomic instability,dna repair deficiency,tumor suppressor function,cell cycle regulation,telomere maintenance,homologous recombination
ENSG00000181938,GINS3,genomic instability,tumor progression,dna replication,oncogenesis,cell proliferation,protein interaction
ENSG00000134910,STT3A,protein translation regulation,chaperone mediated folding,stress response activation,endoplasmic reticulum targeting,cellular stress adaptation,oncogenic signaling
ENSG00000177030,DEAF1,genomic instability,tumor suppressor function,transcriptional regulation,chromatin remodeling,apoptosis induction,cell cycle control
ENSG00000164880,INTS1,genome stability,telomere integrity,cell survival,proliferation regulation,dna repair,oxidative stress response
ENSG00000172073,TEX37,tumor progression,apoptosis inhibition,cell proliferation promotion,epigenetic alterations,pi3k/akt pathway interaction,therapeutic target
ENSG00000114279,FGF12,fgf12 gene expression,growth factor signaling pathway,constitutive activation,cell proliferation enhancement,tumor progression promotion,metastasis facilitation
ENSG00000103042,SLC38A7,glutamine transport,metabolic reprogramming,oncogenic properties,therapeutic target,tumorigenesis promotion,cell survival enhancement
ENSG00000110218,PANX1,apoptosis regulation,cell-cell communication,channel-forming protein,dna damage response,intracellular signaling modulation,oncogenic process interaction
ENSG00000101624,CEP76,genomic instability,cell cycle disruption,microtubule regulation,ciliogenesis impairment,centrosomal protein function,aneuploidy promotion
ENSG00000164167,LSM6,cellular proliferation regulation,tumor progression marker,mrna degradation,protein-rna interaction,regulatory complex component,cell survival pathway interaction
ENSG00000186510,CLCNKA,chloride channel regulation,cell membrane function,electrolyte balance,ion transport regulation,fluid homeostasis,oncogenic process
ENSG00000196459,TRAPPC2,regulation of membrane trafficking,oncogenic process,substrate localization,cellular homeostasis,protein transport,therapeutic target
ENSG00000137288,UQCC2,electron transport chain disruption,mitochondrial dysfunction,reactive oxygen species production,cell survival promotion,genomic instability induction,therapeutic target identification
ENSG00000184451,CCR10,immune cell migration,chemokine receptor function,tumor-infiltrating lymphocytes,cancer immunology,tumor microenvironment modulation,cell trafficking regulation
ENSG00000116001,TIA1,apoptosis regulation,stress response,mrna stability,oncogene expression,immune evasion,pi3k/akt interaction
ENSG00000140987,ZSCAN32,apoptosis regulation,dna repair modulation,cell growth regulation,tumor suppression,transcriptional regulation,chromatin remodeling
ENSG00000002933,TMEM176A,nlrp3 inflammasome regulation,immune evasion,chronic inflammation,tumor microenvironment modulation,cell migration and invasion,pro-inflammatory cytokine production
ENSG00000173276,ZBTB21,pi3k/akt suppression,tumor suppressor,dna binding activity,transcriptional regulation,chromatin remodeling,gene expression modulation
ENSG00000100242,SUN2,chromatin remodeling,nuclear architecture,genomic stability,dna damage repair,apoptosis modulation,cellular proliferation
ENSG00000002549,LAP3,cell adhesion,pi3k/akt signaling,tumor progression,enhanced migration,focal adhesions,protein-protein interactions
ENSG00000196152,ZNF79,tumor suppression,transcriptional regulation,dna-binding activity,cell cycle regulation,apoptosis induction,genomic stability maintenance
ENSG00000176009,ASCL3,tumor suppressor/oncogene,cell differentiation/proliferation regulation,transcriptional regulation/e-box motifs,notch/wnt pathway interaction,oncogenic potential/biomarker,therapeutic target/cancer treatment
ENSG00000128050,PAICS,gluconeogenesis regulation,pyrimidine biosynthesis,energy production,cell proliferation,tumor progression,metabolic adaptation
ENSG00000140265,ZSCAN29,tumor suppression,transcriptional regulation,cell cycle progression,genomic stability maintenance,oncogenic signaling pathway inhibition,apoptosis regulation
ENSG00000163346,PBXIP1,apoptosis regulation,cell cycle modulation,dna damage response,gene expression regulation,protein kinase activity,tumor suppression
ENSG00000169136,ATF5,transcription factor regulation,pi3k/akt pathway activation,oncogenic transformation promotion,tumor progression facilitation,genetic instability contribution,metabolic reprogramming involvement
ENSG00000154118,JPH3,cellular signaling,oncogenesis,cell migration,tumor progression,calcium regulation,protein-protein interaction
ENSG00000138069,RAB1A,aberrant activation,tumor growth,oncogenic vesicle formation,membrane dynamics regulation,vesicle trafficking modulation,gtpase activity enhancement
ENSG00000265491,RNF115,ubiquitination regulation,cell cycle progression,genomic instability,tumor suppressor interaction,cancer initiation,dna repair mechanisms 
ENSG00000135932,CAB39,calcium signaling,cell proliferation,epithelial-to-mesenchymal transition (emt),metabolic reprogramming,calcineurin regulation,oncogenic driver
ENSG00000148110,MFSD14B,lipid metabolism regulation,lipid synthesis enhancement,cell growth promotion,cell survival enhancement,cancer biomarker potential,lipid transport facilitation
ENSG00000130733,YIPF2,mitochondrial dynamics,pi3k/akt signaling,tumor progression,cell proliferation,therapeutic target,mitochondrial membrane trafficking
ENSG00000129116,PALLD,focal adhesion regulation,oncogenic signaling,epithelial-to-mesenchymal transition,cell migration and invasion,protein interaction network,cytoplasmic structure formation
ENSG00000120805,ARL1,cellular trafficking regulation,mtor pathway activation,oncogenic mutations,protein transport modulation,signaling pathway regulation,tumor suppressor function
ENSG00000120860,WASHC3,cellular trafficking regulation,endosomal sorting dysfunction,hyperactivation of wash complex,oncogenic signaling enhancement,tumorigenesis promoter,genomic instability enhancer
ENSG00000166747,AP1G1,rab gtpase regulation,gdi-2 activity,dysregulated cell growth,membrane trafficking,cellular recycling,oncogenic expression
ENSG00000137648,TMPRSS4,cell surface cleavage,ectodomain shedding,oncogenic processes,protein-protein interactions,tumor growth,poor prognosis marker
ENSG00000005486,RHBDD2,cell cycle regulation,microtubule dynamics,oncogenesis,cell survival,tumor progression,gene expression regulation
ENSG00000077616,NAALAD2,growth factor regulation,metabolic reprogramming,cell survival,tumor aggressiveness,poor prognosis,protein interaction
ENSG00000115233,PSMD14,26s proteasome regulation,tumor suppressor regulation,apoptosis regulation,cell cycle control,ubiquitin-proteasome pathway,cancer prognosis
ENSG00000107829,FBXW4,tumor suppressor function,regulation of pi3k/akt pathway,complex interactions with other proteins,potential oncogene status,cell cycle progression modulation,apoptosis regulation
ENSG00000167604,NFKBID,nf-κb pathway regulation,tumor suppressor function,constitutive activation,genomic instability,apoptosis regulation,cell proliferation
ENSG00000106688,SLC1A1,glutamate homeostasis,neurotransmitter regulation,amino acid transport,cell proliferation support,signaling pathway interaction,oncogenic process influence
ENSG00000160877,NACC1,tumor progression,apoptosis suppression,cell cycle regulation,ckii complex regulatory subunit,oncogenic transcriptional regulation,genomic instability
ENSG00000170836,PPM1D,tumor suppressor activity,cell cycle regulation,genomic instability,pi3k/akt pathway modulation,proliferation enhancement,mutation hotspot
ENSG00000099957,P2RX6,purinergic signaling,tumor progression,overexpression,receptor activation,therapeutic target,signaling pathway modulation
ENSG00000104164,BLOC1S6,mitochondrial function,lysosome regulation,organelle biogenesis,protein degradation,autophagy regulation,membrane trafficking
ENSG00000154710,RABGEF1,guanylate exchange factor,cellular trafficking regulation,oncogenic mutations,cell growth enhancement,survival signaling pathway,tumor progression facilitation
ENSG00000170214,ADRA1B,α2a-adrenoceptor signaling,g protein-coupled receptor,cell growth regulation,metastasis promotion,vasoconstriction,neurotransmission modulation
ENSG00000178127,NDUFV2,electron transport chain,mitochondrial metabolism,cellular respiration,glycolytic reprogramming,metabolic adaptation,cancer cell proliferation
ENSG00000161956,SENP3,tumor progression,constitutive activation,protein stability regulation,cell survival enhancement,pi3k/akt pathway modulation,gene overexpression
ENSG00000106511,MEOX2,tumor progression,transcriptional regulation,epithelial-to-mesenchymal transition,metastasis promotion,cancer stem cell maintenance,oncogenic pathway activation
ENSG00000102935,ZNF423,tumor suppressor regulation,overexpression,cell proliferation,transcriptional repression,epigenetic modification,krab domain interaction
ENSG00000168209,DDIT4,tumor suppressor,negative regulator of mtor,cellular growth inhibition,protein expression regulation,metabolic regulation,aggressive tumor behavior
ENSG00000173480,ZNF417,transcriptional regulation,tumor suppressor/oncogene duality,cell cycle regulation,dna repair/apoptosis modulation,cancer cell proliferation,genomic instability
ENSG00000205189,ZBTB10,tumor suppressor,cellular transcription regulation,apoptosis modulation,cell proliferation regulation,dna damage response,genetic instability
ENSG00000132256,TRIM5,oncogene activation,cell proliferation regulation,antiviral defense modulation,tumor suppression interference,gene transcriptional control,retrovirus restriction
ENSG00000086548,CEACAM6,tumor progression,cell adhesion,metastasis facilitation,angiogenesis promotion,oncogene overexpression,therapeutic target
ENSG00000177485,ZBTB33,chromatin remodeling,epigenetic regulation,transcriptional repression,tumor suppression,cell cycle regulation,protein-protein interaction
ENSG00000136710,CCDC115,cellular scaffolding,cilia formation,genomic instability,tumor suppressor loss,cell cycle regulation,protein-protein interaction
ENSG00000075399,VPS9D1,tumor progression,mutation associated,biomarker identification,oncogenic signaling,vesicle trafficking regulation,autophagy modulation
ENSG00000185379,RAD51D,genomic instability,mutation predisposition,homologous recombination repair,dna double-strand break repair,genetic instability driver,cellular repair mechanism
ENSG00000168071,CCDC88B,genomic stability,mitotic checkpoint regulation,cell proliferation,chromosomal instability,oncogenic potential,tumorigenesis driver
,H2AFX,histone modification,genomic stability,dna repair mechanisms,chromatin regulation,tumor progression,oncogenic mutations
ENSG00000162300,ZFPL1,tumor suppressor,chromatin remodeling,transcriptional regulation,dna repair,cell cycle regulation,apoptosis
ENSG00000127328,RAB3IP,rab3a regulation,gtpase activity,tumor suppression,dysregulated cell cycle,enhanced proliferation,synaptic vesicle recycling
ENSG00000072958,AP1M1,oncogene,adaptor complex component,endocytic pathway modulation,receptor internalization,cellular proliferation,signaling pathway regulation
ENSG00000116649,SRM,rna splicing regulation,tumor suppressor gene candidate,epigenetic regulation,protein synthesis modulation,cell cycle regulation interaction,apoptosis modulation
ENSG00000147162,OGT,transcriptional regulation,dna repair,cell cycle progression,protein stability modification,glycosylation regulation,oncogenic transformation
ENSG00000214717,ZBED1,transcription factor activity,cellular proliferation,dna binding,oncogenic potential,apoptosis inhibition,genome-wide association
ENSG00000125863,MKKS,hedgehog signaling pathway,primary cilium dysfunction,tumor suppressor role,cell growth regulation,oncogenic pathway activation,genomic instability
ENSG00000198010,DLGAP2,cell signaling pathway regulation,cytoskeleton organization,oncogenic process contribution,metastasis promotion,protein-protein interaction,therapeutic target
ENSG00000177917,ARL6IP6,arl2/3 gtpase-binding protein,cell signaling pathways,cell survival mechanisms,chemoresistance,endocytosis,tumor growth
ENSG00000122786,CALD1,oncogene,metastasis-promoting protein,cell migration regulator,kinase activity inhibitor target,tumor aggressiveness enhancer,poor prognosis marker
,HIST1H2AM,chromatin regulation,histone variant,transcriptional regulation,dna repair,cell cycle progression,epigenetic modification
,HIST1H2AK,histone modification,chromatin remodeling,cell proliferation,apoptosis inhibition,genomic instability,oncogene overexpression
,HIST1H2AI,epigenetic regulation,genome stability maintenance,histone modification,chromatin remodeling,transcriptional regulation,protein-dna interaction
,HIST1H2AL,histone modification,chromatin remodeling,gene regulation,nucleosome assembly,epigenetic regulation,cell cycle progression
,HIST1H2AG,histone protein,chromatin structure,transcriptional regulation,genome stability,cell cycle regulation,dna repair mechanism
ENSG00000264364,DYNLL2,genomic instability,mitotic spindle regulation,microtubule dynamics regulation,centrosome formation,cell proliferation enhancement,motor protein interaction
ENSG00000110079,MS4A4A,cancer progression,cell proliferation,immune evasion,tumor growth,genetic amplification,metastasis
ENSG00000125733,TRIP10,cellular regulation,leucine-rich repeat protein,dna repair regulation,oncogenic property,cell growth modulation,apoptosis regulation
ENSG00000105677,TMEM147,cellular stress response,tumor microenvironment regulation,oncogenic signaling pathway modulation,genetic instability promotion,cell survival enhancement,therapeutic target potential
ENSG00000109846,CRYAB,protein aggregation regulation,apoptosis inhibition,autophagy modulation,oxidative stress response,cell survival promotion,genomic instability induction
ENSG00000152137,HSPB8,cellular chaperone activity,chemosensitivity regulation,cytoskeleton regulation,cell cycle progression,apoptosis resistance,therapeutic target
ENSG00000100526,CDKN3,cell cycle regulation,tumor suppressor function,genomic stability maintenance,oncogenic process involvement,therapeutic target potential,dna repair interaction
ENSG00000134640,MTNR1B,tumor suppression,cell cycle regulation,circadian rhythm disruption,oncogenic mutation,prognostic marker,therapeutic target
ENSG00000033867,SLC4A7,ion transport,cellular metabolism,oncogenesis,tumor progression,intracellular ph regulation,metabolic adaptation
ENSG00000184209,SNRNP35,regulatory mechanism,nuclear localization,spliceosome assembly,gene expression regulation,cellular proliferation,alternative splicing
ENSG00000288335,TWIST2,epithelial-to-mesenchymal transition,oncogene activation,transcription factor regulation,cell migration promotion,invasion facilitation,tumor progression
ENSG00000104783,KCNN4,channel activation,calcium signaling,cell proliferation,oncogene overexpression,metastasis promotion,therapeutic target
ENSG00000089356,FXYD3,ion transport regulation,na+/k+-atpase pump regulation,cell proliferation promotion,emt regulation,cancer cell survival enhancement,overexpression in cancer tissues
ENSG00000117625,RCOR3,chromatin remodeling,tumor suppressor function,genomic instability,cell cycle regulation,apoptosis modulation,histone modification
ENSG00000147596,PRDM14,transcriptional regulation,chromatin remodeling,primordial germ cell maintenance,embryonic stem cell development,oncogene activation,tumor suppressor regulation
ENSG00000170266,GLB1,gb3 accumulation,tumor progression,cell proliferation,survival and metastasis,therapeutic target,upregulation in tumors
ENSG00000138375,SMARCAL1,genomic instability,oncogene,dna repair defect,chromosomal aberration,cancer initiation,tumor progression
ENSG00000183323,CCDC125,centrosomal kinase activity,cell division regulation,microtubule stability modulation,tumor progression driver,oncogenic signaling pathway,protein-protein interaction network
ENSG00000088727,KIF9,kinesin family member,mitotic spindle assembly,cancer metastasis,pi3k/akt signaling pathway,oncogenic processes,therapeutic target
ENSG00000084731,KIF3C,microtubule-based transport,mitotic spindle assembly,genomic instability,aneuploidy,cell cycle progression,therapeutic target
ENSG00000163050,COQ8A,mitochondrial localization,tumor suppressor activity,coenzyme q biosynthesis,energy metabolism regulation,mitochondrial dysfunction,reactive oxygen species production
ENSG00000127054,INTS11,genomic instability,rna biogenesis regulation,transcriptional control,cell cycle progression,small rna processing,cancer susceptibility
ENSG00000104299,INTS9,rna processing regulation,oncogene/tumor suppressor function,cell growth regulation,gene expression modulation,chromatin remodeling interaction,therapeutic target potential
ENSG00000130528,HRC,ubiquitin-proteasome regulation,oncogene expression modulation,protein stability regulation,cell cycle progression promotion,tumor suppressor influence,cancer therapeutic target
ENSG00000133104,SPART,transcriptional regulation,chromatin remodeling,histone modification,tumorigenesis driver,cell proliferation regulator,cancer-associated mutation
ENSG00000165556,CDX2,cellular differentiation regulation,overexpression promoter,metastatic potential enhancer,epithelial-to-mesenchymal transition inducer,angiogenesis regulator,beta-catenin interaction modulator
ENSG00000180332,KCTD4,cellular differentiation,cell proliferation,e3 ubiquitin ligase activity,immune response regulation,inflammation modulation,oncogenic processes
ENSG00000151422,FER,pi3k/akt pathway activation,cell adhesion and migration facilitation,oncogenic signaling pathway activation,tumor progression enhancement,therapeutic target potential,mutational hotspot identification
ENSG00000167995,BEST1,chloride channel regulation,epithelial cell homeostasis,inherited retinal degeneration,ocular tissue maintenance,ion balance disruption,cellular dysfunction
ENSG00000100744,GSKIP,wnt/β-catenin signaling,gsk3 inhibition,cell growth regulation,protein-protein interaction,cancer progression,therapeutic target
ENSG00000107281,NPDC1,cilia formation,oncogenesis,signaling pathway regulation,cell growth regulation,therapeutic target,genomic instability
ENSG00000205352,PRR13,jak/stat pathway,cell proliferation,double-stranded rna binding,immune evasion,oncogene overexpression,tumor progression
ENSG00000197024,ZNF398,aberrant expression,cellular proliferation,genomic instability,oncogenic regulation,transcriptional regulation,zinc finger protein
ENSG00000204946,ZNF783,transcriptional regulation,cell proliferation,zinc finger protein,oncogene function,gene suppression,protein-protein interaction
ENSG00000106336,FBXO24,protein degradation pathway,e3 ubiquitin ligase complex,cell cycle regulation,tumor progression,dna repair,apoptosis resistance
ENSG00000130299,GTPBP3,g-protein signaling,oncogenic pathway activation,cell growth regulation,tumor progression modulation,therapeutic target identification,genetic aberration association
ENSG00000164707,SLC13A4,mitochondrial function regulation,energy metabolism modulation,glycolytic flux promotion,redox balance maintenance,cancer cell metabolic adaptation,warburg effect modulation
ENSG00000108255,CRYBA1,cellular stress response,heat shock protein induction,oncogenesis promotion,chaperone activity,integrin interaction,tumor growth modulation
ENSG00000168246,UBTD2,pi3k/akt pathway regulation,tumor suppressor regulation,autophagy modulation,cell cycle progression,apoptosis regulation,protein-protein interaction
ENSG00000123636,BAZ2B,chromatin remodeling,cell proliferation,gene expression regulation,therapeutic target,tumor suppressor activation,prognostic biomarker
ENSG00000010932,FMO1,phase i biotransformation,enzyme induction,hepatic expression,modulation by sex hormones,influence on chemotherapeutics,drug metabolism regulation
ENSG00000167580,AQP2,cellular hydration,tumor progression,increased cell proliferation,apoptosis regulation,protein interaction,signaling pathway modulation
ENSG00000225697,SLC26A6,ion transport regulation,tumor microenvironment modulation,oncogenic mutation,protein interaction,cell migration regulation,electrolyte balance disruption
ENSG00000117569,PTBP2,pre-mrna processing,tumor progression,epithelial-to-mesenchymal transition (emt),oncogene upregulation,pi3k/akt pathway activation,gene expression regulation
ENSG00000175575,PAAF1,chromatin remodeling,dna repair complex,gene expression regulation,transcriptional modulation,cell cycle progression,epigenetic modifications
ENSG00000155660,PDIA4,er chaperone function,cell proliferation promotion,protein kinase regulation,apoptosis resistance,tumorigenesis involvement,therapeutic target potential
ENSG00000170442,KRT86,keratin intermediate filaments,epithelial cell structure,cell adhesion modulation,apoptosis resistance,protein complex stabilization,oncogenesis promotion
ENSG00000160917,CPSF4,pre-mrna processing,polyadenylation,gene expression regulation,cell growth regulation,nucleolar localization,transcriptional regulation
ENSG00000189280,GJB5,altered gene expression,cell-to-cell communication disruption,gap junction dysfunction,tumor progression facilitation,cancer metastasis enhancement,oncogenic potential modulation
ENSG00000160678,S100A1,tumor suppressor inactivation,cellular differentiation regulation,cytosolic calcium binding protein,genomic instability contribution,p53 interaction and modulation,oncogenic role in tumorigenesis
ENSG00000167972,ABCA3,lipid metabolism regulation,cellular membrane integrity,ion transport,surfactant secretion,type ii pneumocyte function,phospholipid homeostasis 
ENSG00000078081,LAMP3,hypoxia response,lysosomal trafficking,tumor progression,metastasis regulator,immune evasion,biomarker candidate
ENSG00000143119,CD53,immune evasion,cell surface expression,signal transduction,adhesion molecule function,tumor progression,genetic alteration
ENSG00000167656,LY6D,overexpression,immune evasion,cell adhesion disruption,metastasis promotion,pi3k/akt activation,tumor progression marker
ENSG00000139291,TMEM19,cellular regulation,epithelial-to-mesenchymal transition (emt),transmembrane protein function,oncogene potential,protein-protein interactions,signaling pathway regulation
ENSG00000187170,LCE4A,stratum corneum formation,keratinocyte cross-linking,desquamation regulation,skin barrier function,ichthyosis association,epidermal integrity
ENSG00000159455,LCE2B,epithelial-to-mesenchymal transition,overexpression associated,tumor progression,oncogenic role,cell adhesion regulation,genomic instability
ENSG00000099810,MTAP,purine metabolism,co-amplification event,cell growth promotion,therapeutic target,tumor suppressor regulation,nucleotide synthesis
ENSG00000171431,KRT20,intermediate filament protein,epithelial cell marker,cell proliferation regulator,apoptosis inhibitor,tumor progression marker,epithelial-to-mesenchymal transition regulator
ENSG00000111229,ARPC3,actin cytoskeleton regulation,cell migration enhancement,constitutive activation,metastasis facilitation,tumor progression,cell cycle dysregulation
ENSG00000154040,CABYR,calcium-binding function,tyrosine phosphorylation regulation,cell proliferation regulation,cell survival modulation,protein interaction network,signaling pathway activation
ENSG00000133935,ERG28,mitochondrial dynamics,regulation of energy metabolism,cellular respiration,cancer prognosis marker,therapeutic target,protein regulation
ENSG00000057294,PKP2,cell-cell adhesion,tissue integrity maintenance,desmosome assembly,arrhythmogenic cardiomyopathy,epidermolysis bullosa simplex,cancer metastasis
ENSG00000163554,SPTA1,cellular mechanics,gain of function mutations,tumor progression,loss of structural integrity,cell adhesion modulation,oncogenic transformation
ENSG00000170523,KRT83,epithelial integrity regulation,cell proliferation regulation,oncogenic processes,apoptosis modulation,epigenetic regulation,protein interaction alteration
ENSG00000235588,AIF1,apoptosis regulation,inflammation modulation,immune response regulation,tumor microenvironment,metastasis facilitation,tumor progression enhancement
ENSG00000174652,ZNF266,pi3k/akt interaction,chromatin remodeling,gene expression regulation,tumor progression modulation,transcriptional alteration,therapeutic target
ENSG00000105656,ELL,rna polymerase ii regulation,transcriptional regulator,oncogenic mutations,cell cycle progression,genomic instability,therapeutic target
ENSG00000101639,CEP192,centrosomal regulation,cell cycle progression,genomic stability,microtubule dynamics,kinetochore assembly,chromosomal instability
ENSG00000277649,TIMM22,aberrant mitochondrial dynamics,cell growth regulation,mitochondrial import regulation,tumor suppression loss,protein misfolding,cellular metabolism
ENSG00000132912,DCTN4,microtubule stability,dynactin complex,cellular transport,mitosis disruption,tumor growth promotion,cancer association
ENSG00000146054,TRIM7,cell cycle regulation,tumor suppressor function,oncogenic pathway inhibition,protein-protein interaction,ring domain-dependent ubiquitination,apoptosis modulation
ENSG00000163254,CRYGC,cellular response modulation,tumor progression promotion,dna damage regulation,cancer cell survival enhancement,proliferation facilitation,upregulation/overexpression
ENSG00000125741,OPA3,mitochondrial dysfunction,energy metabolism regulation,cellular survival pathway activation,tumor progression contribution,protein-protein interaction,genetic mutation association
ENSG00000280616,VPS11,autophagy dysregulation,cellular sorting defects,vesicle trafficking regulation,corvet complex component,protein-protein interactions,tumor suppressor function
ENSG00000170484,KRT74,cell-cell adhesion,epithelial integrity,structural protein function,type ii cytokeratin,intermediate filament assembly,keratin heterodimerization
ENSG00000171401,KRT13,carcinoma progression,cytokeletal disruption,epithelial-to-mesenchymal transition,cell migration and invasion,tumor metastasis,apoptosis regulation
ENSG00000102383,ZDHHC15,oncogenic pathway modulation,cellular membrane regulation,palmitoylation events,protein stability modification,tumor progression facilitation,genomic instability association
ENSG00000078549,ADCYAP1R1,cell proliferation,signaling pathway regulation,receptor activation,adenylate cyclase modulation,cyclic amp increase,neuronal function regulation
ENSG00000140022,STON2,mitochondrial membrane stability,gene expression regulation,cancer cell proliferation,protein-protein interactions,oncogene activation,mitochondrial dysfunction
ENSG00000085832,EPS15,egf receptor pathway,cellular endocytosis,oncogenic signaling,gene amplification,cell proliferation,protein-protein interactions
ENSG00000118900,UBN1,homologous recombination,genomic instability,dna repair mechanisms,non-homologous end joining,cell cycle regulation,protein degradation
ENSG00000274137,MYOM2,cell migration,epithelial-to-mesenchymal transition,gene amplification,invasiveness,metastasis,promoter methylation
ENSG00000164941,INTS8,chromatin remodeling,transcriptional regulation,oncogenic gene activation,tumor growth promotion,cell cycle progression,genomic instability
ENSG00000263155,MYZAP,aberrant transcriptional regulation,chromatin remodeling,transcription factor activity,tumor suppressor function,cell growth modulation,oncogenic pathway
ENSG00000154001,PPP2R5E,pp2a regulation,tumor suppressor function,cell proliferation enhancement,apoptosis inhibition,oncogenic substrate regulation,prognostic marker candidate
ENSG00000148734,NPFFR1,pain modulation,energy regulation,immune cell modulation,g protein-coupled receptor function,intracellular signaling pathway,cancer-associated pain
ENSG00000124678,TCP11,cell cycle regulation,tumor suppressor function,genomic stability maintenance,dna damage response regulation,cellular degradation processes,transcriptional regulation modulation
ENSG00000167182,SP2,transcriptional regulation,oncogene activation,dna replication,apoptosis evasion,cell cycle progression,tumor progression
ENSG00000174744,BRMS1,tumor suppressor,epithelial-to-mesenchymal transition (emt) inhibitor,immune response modulator,cellular migration regulator,metastasis enhancer,prognostic biomarker
ENSG00000133134,BEX2,microrna regulation,cell survival enhancement,oncogenic activity,pi3k/akt pathway interaction,cell growth modulation,cancer progression facilitation
ENSG00000008277,ADAM22,overexpression,cell migration,proteolytic activity,adhesive function,tumor invasion,focal adhesions formation
ENSG00000092330,TINF2,telomerase activation,genomic instability,shelterin complex regulation,telomere maintenance,cell cycle dysregulation,oncogenic transformation
ENSG00000042781,USH2A,photoreceptor cell structure,protein-protein interactions,sensory hair cells integrity,usher syndrome type ii,apoptosis regulation,autophagy dysregulation
ENSG00000006611,USH1C,aberrant structure,auditory feedback disruption,cellular response modulation,genetic mutation impact,indirect oncogenic pathway involvement,potential tumor suppressor activity
ENSG00000158480,SPATA2,autophagy regulation,oncogenesis,mitophagy,cell survival,protein-protein interactions,signaling pathway modulation
ENSG00000171222,SCAND1,cell survival,tumor suppressor function,apoptosis regulation,oncogenic potential,pi3k/akt interaction,genomic instability
ENSG00000166529,ZSCAN21,transcriptional regulation,cell cycle progression,apoptosis evasion,immune response modulation,tumor suppressor function loss,oncogenic activation
ENSG00000108691,CCL2,immune suppression,tumor progression,chemokine signaling,inflammation regulation,immune cell recruitment,nf-κb activation
ENSG00000181220,ZNF746,transcriptional regulation,tumor suppression,cell growth modulation,apoptosis regulation,genomic stability maintenance,chromatin remodeling
ENSG00000117758,STX12,oncogene,cell proliferation,metastasis,cell survival,vesicle-mediated transport,tumor progression
ENSG00000182544,MFSD5,lipid transport regulation,cellular homeostasis,signaling pathway modulation,tumorigenesis driver,aberrant expression linked,cell membrane fluidity
ENSG00000232062,HLA-DQA1,antigen presentation,immune evasion,tumor progression,anti-tumor immunity,genetic polymorphism,major histocompatibility complex (mhc)
ENSG00000262156,APOBEC3A,apobec-mediated mutagenesis,rna editing,dna repair,genome instability,mutational signature,oncogenic potential
ENSG00000063854,HAGH,epigenetic regulation,genome stability maintenance,chromatin remodeling,transcriptional control,cellular proliferation,tumor suppression
ENSG00000189037,DUSP21,p38 mapk regulation,tumor suppressor function,dephosphorylation activity,cancer progression suppression,cell proliferation regulation,mapk signaling pathway modulation
ENSG00000174738,NR1D2,regulatory element modulation,transcriptional regulation,circadian rhythm disruption,oncogenic driver,cell proliferation enhancement,apoptosis inhibition
ENSG00000089248,ERP29,protein homeostasis regulation,tumor progression,cell proliferation promotion,kinase activity modulation,oncogenic growth facilitation,multifunctional protein interaction
ENSG00000118596,SLC16A7,tumor metabolism,cell membrane transport,lactate exchange,glycolysis regulation,hypoxic adaptation,proton transport
ENSG00000197142,ACSL5,fatty acid metabolism,tumor growth,cell differentiation,beta-oxidation,cancer progression,metabolic regulation
ENSG00000185880,TRIM69,trim family member,tumor suppressor function,e3 ligase activity,cell proliferation regulation,apoptosis modulation,pi3k/akt pathway regulation
ENSG00000170271,FAXDC2,regulation of gene expression,cell cycle progression,oncogenesis,apoptosis evasion,epithelial-to-mesenchymal transition (emt),signaling pathway modulation
ENSG00000011275,RNF216,epigenetic regulation,ubiquitination machinery,chromatin remodeling,protein stability modulation,cell cycle progression,genomic instability
ENSG00000097021,ACOT7,lipid metabolism,oncogenic role,cell proliferation,fatty acid synthesis,cancer cell survival,energy balance regulation
ENSG00000167325,RRM1,ribonucleotide reduction,cell proliferation,nucleotide metabolism,dna replication,chemosensitivity,oncogenic function
ENSG00000145780,FEM1C,genomic instability,cell cycle regulation,dna repair mechanism,chromatin remodeling,swi/snf complex interaction,cancer predisposition
ENSG00000213145,CRIP1,regulatory function,rna-binding protein,cellular trafficking,gene expression regulation,cell growth modulation,mrna stability
ENSG00000133800,LYVE1,lymphangiogenesis,tumor cell invasion,angiogenesis,metastasis promotion,hypoxia response,receptor function
ENSG00000163472,TMEM79,oncogenic mutations,tumor progression,cell adhesion disruption,protein-protein interaction,metastasis regulation,cancer cell survival enhancement
,PQLC1,oxidative stress response,anti-apoptotic function,cell cycle progression,metastasis promoter,tumor suppressor regulation,cancer cell survival
ENSG00000151490,PTPRO,cell adhesion disruption,constitutive activation,gain of function mutations,immune evasion mechanism,oncogenic signaling,tumor progression
ENSG00000047936,ROS1,receptor tyrosine kinase activity,constitutive activation,oncogenic mutations,tumor progression,downstream signaling pathways,cell cycle regulation
ENSG00000162645,GBP2,tumor suppressor function,cell migration regulation,oncogenic potential,autophagy modulation,immune response regulation,therapeutic target
ENSG00000263028,TAS2R19,regulation of cell growth,altered expression patterns,modulation of immune response,tumorigenesis and tumor suppression,cellular differentiation and survival,physiological warning signals
ENSG00000113048,MRPS27,mitochondrial function,energy metabolism regulation,tumor growth promotion,genomic instability mitigation,cellular stress response,oncogenic process involvement
ENSG00000135517,MIP,ion regulation,transmembrane protein,cellular stress response,tumor progression,metastasis,renal disorder
ENSG00000039560,RAI14,aberrant transcription,apoptosis evasion,cell growth promotion,chromatin remodeling,coactivator function,gene expression regulation
ENSG00000165794,SLC39A2,zinc homeostasis,cell proliferation,tumor progression,prognostic marker,therapeutic target,gene regulation
ENSG00000179151,EDC3,pre-mrna splicing,spliceosome regulation,gene expression modulation,tumor suppressor regulation,apoptosis modulation,cell cycle progression
ENSG00000197162,ZNF785,tumor suppressor function,transcriptional regulation,dna binding,zinc finger motif,cellular differentiation,chromatin remodeling
ENSG00000003147,ICA1,pancreatic beta-cell regulation,insulin secretion modulation,glucose-stimulated response,tumorigenesis involvement,cellular autoregulation,antigen presentation
ENSG00000175376,EIF1AD,mrna translation regulation,tumor suppressor,oncogene function,cell proliferation regulation,therapeutic target,translation initiation complex
ENSG00000171885,AQP4,water channel function,tumor growth promotion,cancer cell migration,cell proliferation facilitation,protein interaction with pi3k/akt and mapk/erk pathways,oncogenesis facilitation
ENSG00000143862,ARL8A,microtubule organization,microtubule dynamics,gtpase activity,oncogenic function,cell migration,protein-protein interaction
ENSG00000173660,UQCRH,mitochondrial function,tumor energy metabolism,cellular metabolism reprogramming,oncogenesis promotion,electron transport chain modulation,proton pump activation
ENSG00000121634,GJA8,connexin exchange,cell growth regulation,gap junction assembly,tumor progression marker,poor prognostic indicator,intercellular communication
ENSG00000015592,STMN4,microtubule destabilization,cell proliferation,transcriptional regulation,signaling pathway modulation,oncogene overexpression,poor prognosis marker
ENSG00000090989,EXOC1,pi3k/akt signaling,oncogene regulation,cell migration,therapeutic target,genomic instability,exocytosis regulation
ENSG00000099203,TMED1,cellular transport regulation,oncogenic potential,pi3k/akt pathway modulation,tumor progression promotion,angiogenesis facilitation,cell growth regulation
ENSG00000150787,PTS,glycolytic regulation,metabolic rewiring,cellular energetics,carbohydrate transport,energy production,enzyme activity
ENSG00000174851,YIF1A,mitochondrial protein synthesis,cellular energy metabolism,altered metabolic regulation,tumor progression,cell proliferation,genetic instability
ENSG00000145982,FARS2,altered cellular metabolism,enhanced cell proliferation,gene expression alterations,increased tumorigenesis,protein synthesis dysregulation,tumor progression
ENSG00000119782,FKBP1B,tumor suppressor function,nf-κb inhibition,pi3k/akt pathway regulation,cell cycle regulation,protein-protein interaction,gene expression modulation
ENSG00000198626,RYR2,calcium channel regulation,cell proliferation modulation,calcium-dependent signaling,cardiac arrhythmia association,apoptosis pathway interaction,therapeutic target potential
ENSG00000169248,CXCL11,immune modulation,chemokine signaling pathway,tumor progression,angiogenesis,immune suppression,cell migration
ENSG00000006606,CCL26,chemokine signaling,immune suppression,angiogenesis promotion,metastasis facilitation,tumor evasion mechanism,inflammation mediation
ENSG00000118777,ABCG2,multidrug resistance,oncogene overexpression,efflux transporter function,chemotherapy drug efflux,tumor relapse,cellular drug accumulation
ENSG00000198959,TGM2,cellular cross-linking,tumor suppressor inhibition,epithelial-to-mesenchymal transition,cell migration and invasion,metastasis facilitation,prognostic marker
ENSG00000237508,HLA-F,immune evasion,mhc class i downregulation,antigen presentation alteration,tumor immune escape,immune modulation,cell surface protein interaction
ENSG00000283889,KIR3DS1,nk cell activation,immunoregulation,immune evasion,t cell modulation,hla class i interaction,tumor immunosurveillance
ENSG00000100055,CYTH4,purinergic signaling pathway,altered expression levels,nucleotide metabolism regulation,therapeutic target,tumor growth modulation,metastasis facilitation
ENSG00000124782,RREB1,genomic instability,transcriptional regulation,oncogenic function,cell cycle progression,tumor suppressor repression,chromatin modification
ENSG00000000457,SCYL3,ubiquitin ligase activity,cell cycle regulation,apoptosis modulation,tumor suppressor function,signaling pathway regulation,gene expression control
ENSG00000130684,ZNF337,krab domain binding,chromatin remodeling,cell cycle regulation,tumor suppressor function,dna repair mechanisms,transcriptional regulation
ENSG00000107249,GLIS3,tumor progression,transcriptional regulation,oncogene function,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway,genetic mutations
ENSG00000122126,OCRL,pi(4,5)p2 regulation,cell growth regulation,akt/pi3k pathway interaction,actin cytoskeleton modulation,dna damage response regulation
ENSG00000164609,SLU7,spliceosome assembly,rna processing,tumor progression,oncogenic splicing,cell proliferation,genomic instability
ENSG00000187559,FOXD4L3,embryonic development,transcription factor activity,cell proliferation,tumor growth promotion,metastasis,limb morphogenesis
ENSG00000151882,CCL28,tumor progression,immunosuppressive environment,angiogenesis promotion,metastasis facilitation,cell recruitment regulation,tumor microenvironment modulation
ENSG00000160796,NBEAL2,oncogenic regulation,endosomal trafficking,receptor tyrosine kinase activation,genomic instability,tumor progression,protein recycling
ENSG00000109805,NCAPG,genomic instability,chromosome condensation,condensin ii complex,mitotic error,aneuploidy driver,cancer progression
ENSG00000121152,NCAPH,chromatin compaction,genomic instability,mitotic checkpoint disruption,aneuploidy induction,protein complex subunit,centromere-associated protein
ENSG00000119396,RAB14,endocytic trafficking regulation,oncogenic signaling,cell migration facilitation,microtubule dynamics modulation,chemoresistance,pro-oncogenic functions
ENSG00000146109,ABT1,chromatin remodeling,swi/snf complex,overexpressed in cancer,poor prognosis,cell cycle regulation,antitumor target
ENSG00000197275,RAD54B,homologous recombination,genomic stability,mutation repair,chromatin regulation,tumor suppression,p53 interaction
ENSG00000147041,SYTL5,regulation of cell cycle,apoptosis evasion,gain-of-function mutations,cellular proliferation,enhanced migration,therapeutic target
ENSG00000041353,RAB27B,cell surface transport,cytotoxic granule regulation,lysosome trafficking,secretion regulation,vesicle fusion modulation,oncogenic signaling pathway
ENSG00000168993,CPLX1,cell cycle regulation,protein degradation pathway,cullin-ring e3 ubiquitin ligase activation,oncogenic protein accumulation,tumor suppressor protein degradation,therapeutic target for cancer treatment
ENSG00000104892,KLC3,microtubule-based transport,protein-protein interaction hub,cell division regulation,cellular migration regulation,oncogenic potential,endosome positioning
ENSG00000118922,KLF12,transcription factor regulation,tumor suppressor function,cell cycle progression,apoptosis induction,dna repair regulation,stemness modulation
ENSG00000039650,PNKP,dna damage repair,kinase activity,oncogenic processes,genomic instability,cell survival signaling,tumor progression marker
ENSG00000138686,BBS7,ciliary dysfunction,developmental disorders,genetic disorder,cellular signaling,hedgehog pathway,oncogenesis
ENSG00000181029,TRAPPC5,genomic instability,regulatory complex,cellular trafficking,protein transport,oncogenesis,therapeutic resistance
ENSG00000164975,SNAPC3,alternative splicing,oncogenic signaling pathways,spliceosome assembly,genomic instability,therapeutic target,regulatory mechanism
ENSG00000023608,SNAPC1,snrnp assembly,oncogenic potential,rna splicing regulation,genomic instability,transcriptional regulation,cell proliferation
ENSG00000133318,RTN3,apoptosis dysregulation,cell growth regulation,er morphology modulation,metastasis promotion,tumor progression facilitation,cellular stress response alteration
ENSG00000103502,CDIPT,genomic instability,overexpression,tumor progression,cell growth and survival,pi3k/akt pathway activation,genomic rearrangements
ENSG00000088538,DOCK3,rac1 activation,cell migration,gtpase regulation,tumor progression,cancer metastasis,oncogenic signaling
ENSG00000276432,RDM1,cell cycle regulation,protein kinase activation,oncogenic signaling,apoptosis inhibition,tumor progression,gene expression regulation
ENSG00000242689,CNTF,cancer promotion,stat3 pathway activation,il-6 receptor interaction,tumor progression,angiogenesis regulation,cell growth enhancement
ENSG00000014123,UFL1,tumor suppressor protein stability regulation,deubiquitinating enzyme activity,proteostasis maintenance,cell growth regulation,apoptosis modulation,biomarker potential
ENSG00000182985,CADM1,tumor suppression,loss of function mutations,cell adhesion regulation,immune response modulation,apoptosis regulation,genomic instability
ENSG00000109943,CRTAM,t cell modulation,immune evasion,promotes tumor growth,tumor suppressor,modulates t cell activation,cancer associated protein
ENSG00000134690,CDCA8,genomic instability,cell cycle dysregulation,aneuploidy,oncogenic processes,mitotic spindle attachment,kinetochore protein function
ENSG00000106069,CHN2,tumor progression,cell migration,rho gtpase regulation,cell growth regulation,oncogenic adaptation,signaling pathway modulation
ENSG00000158691,ZSCAN12,oncogene activation,transcriptional regulation,cell proliferation,apoptosis evasion,epigenetic modulation,genomic instability
ENSG00000143320,CRABP2,retinoic acid regulation,tumor progression,cellular differentiation,oncogenic mutations,signaling pathway modulation,prognostic marker
ENSG00000159479,MED8,cellular response modulation,protein homeostasis regulation,tumor progression driver,oncogenic pathway activation,proteasome complex component,cell cycle regulation
ENSG00000134201,GSTM5,dna damage response,oxidative stress regulation,genomic instability,cancer susceptibility,detoxification process,cell protection
ENSG00000134202,GSTM3,detoxification pathway,glutathione conjugation,oxidative stress response,cellular signaling modulation,tumor suppression,protein-protein interaction
ENSG00000186844,LCE1A,cell differentiation,keratinocyte development,stratum corneum structure,barrier function regulation,skin cell integrity,limited oncogenic involvement
ENSG00000196734,LCE1B,epithelial tumorigenesis,proliferation regulation,apoptosis modulation,cell adhesion disruption,proteolytic function activation,skin barrier dysfunction
ENSG00000099860,GADD45B,p38 mapk pathway,dna damage response,cell cycle regulation,apoptosis induction,oncogenic potential,genotoxic stress
ENSG00000096093,EFHC1,mitotic spindle regulation,cell cycle progression,cancer driver mutation,apoptosis suppression,gene amplification,tumor suppressor interaction
ENSG00000147854,UHRF2,genome instability,tumor suppressor regulation,cell cycle progression,dna repair mechanisms,epigenetic modification,histone modifications
ENSG00000162236,STX5,oncogenic protein trafficking,aberrant membrane fusion,cell migration facilitation,therapeutic target,tumorigenesis promotion,golgi apparatus regulation
ENSG00000096872,IFT74,cilia assembly,microtubule-based transport,cilia development,kidney disease,renal cysts,cell signaling
,H2AFZ,chromatin remodeling,epigenetic regulation,histone modification,transcriptional regulation,chromosome instability,tumor suppressor silencing
ENSG00000075089,ACTR6,proteasome regulation,cell cycle progression,apoptosis evasion,cyclin-dependent kinase inhibitors,oncogene overexpression,therapeutic target
ENSG00000171195,MUC7,epithelial surface protection,mucin expression regulation,tumor progression involvement,cell adhesion modulation,emt and invasion promotion,pi3k/akt signaling pathway interaction
ENSG00000165672,PRDX3,cellular antioxidant response,cell survival promotion,apoptosis inhibition,chemoresistance enhancement,protein interaction modulation,oncogenic driver status
ENSG00000108417,KRT37,cellular structure,disrupted cytoskeletal interaction,tumor progression,epithelial cell adhesion,cancer biomarker,proliferation regulation
ENSG00000170276,HSPB2,cellular homeostasis disruption,protein aggregation regulation,microtubule stability,actin filament interaction,spindle integrity maintenance,cell cycle progression
ENSG00000102362,SYTL4,regulates synaptic vesicle fusion,signal transduction pathways,cell migration and invasion,pi3k/akt signaling interaction,rho gtpase regulation,neurotransmitter release modulation
ENSG00000124164,VAPB,transmembrane protein,cellular response modulation,oncogene potential,tumor progression,cell survival promotion,autophagy regulation
ENSG00000133027,PEMT,lipid metabolism alteration,cellular signaling modulation,oncogene activation,therapeutic target,membrane structure regulation,genomic instability
ENSG00000168269,FOXI1,transcription factor activity,cell proliferation,oncogenesis,epithelial-to-mesenchymal transition (emt),wnt/β-catenin signaling pathway,metabolic regulation
ENSG00000213203,GIMAP1,gtpase activity,immune cell regulation,anti-apoptotic function,t-cell lymphocyte development,hematopoietic malignancy driver,chromosome x-linked expression
ENSG00000106004,HOXA5,tumor suppressor,apoptosis induction,cell proliferation inhibition,epithelial-to-mesenchymal transition regulation,stem cell self-renewal regulation,transcription factor activity
ENSG00000096401,CDC5L,cell cycle regulation,cell proliferation,mitosis,oncogenesis,chromosome segregation,cytokinesis
ENSG00000110955,ATP5F1B,mitochondrial energy metabolism,metabolic reprogramming,apoptosis dysregulation,tumor cell proliferation,energy production,atp synthase activity
ENSG00000127603,MACF1,microtubule stabilization,cytoskeleton regulation,cell proliferation,therapeutic target,apoptosis suppression,protein-protein interaction
ENSG00000119638,NEK9,cell cycle regulation,serine/threonine kinase activity,tumor suppression,genomic instability,apoptosis induction,mitotic checkpoint activation
ENSG00000137210,TMEM14B,iron homeostasis regulation,tumorigenesis promotion,genetic instability facilitation,metastatic phenotype enhancement,cellular proliferation modulation,transcription factor regulation
ENSG00000171403,KRT9,epithelial cell integrity,cellular morphology,increased proliferation,tumor aggressiveness,biomarker potential,apoptosis resistance
ENSG00000180884,ZNF792,cell proliferation,oncogenic activity,gene regulation,dna binding,tumor progression,epigenetic modulation
ENSG00000160803,UBQLN4,cellular degradation,proteasome regulation,dna repair mechanism,tumor suppressor role,genomic instability,apoptosis regulation
ENSG00000143858,SYT2,aberrant signaling,cell proliferation,dna damage response,oncogenic drivers,protein-protein interactions,tumor suppressor regulation
ENSG00000013441,CLK1,cellular regulation,tumor development,proliferation regulation,protein phosphorylation,transcriptional control,mutation association
ENSG00000183091,NEB,actin filament organization,cytoskeleton regulation,cell migration,tumor suppressor potential,metastasis promotion,cell signaling pathway interaction
ENSG00000167371,PRRT2,pi3k/akt signaling pathway,kinase activity,cell cycle regulation,apoptosis modulation,oncogene involvement,proliferation promotion
ENSG00000206203,TSSK2,cell cycle regulation,constitutive activation,genomic instability,immune evasion,kinase activation,overexpression
ENSG00000198860,TSEN15,trna splicing,protein synthesis dysregulation,aberrant mutation patterns,tumor progression contributor,genomic instability mediator,cellular function disruption
ENSG00000204104,TRAF3IP1,nf-κb signaling pathway,tumor progression,cellular trafficking regulation,immune response modulation,oncogenic processes,protein-protein interactions
ENSG00000086288,NME8,metastasis promotion,tumor progression,cell proliferation regulation,apoptosis suppression,dna repair interaction,oncogene overexpression
ENSG00000115947,ORC4,aberrant dna replication,cell cycle regulation,dna synthesis initiation,genomic stability maintenance,oncogenic process,tumor progression
ENSG00000176256,HMGB4,cell proliferation regulation,tumor progression facilitation,dna repair involvement,transcriptional regulation,angiogenesis promotion,protein-protein interaction
ENSG00000148308,GTF3C5,transcriptional dysregulation,overexpression,tumorigenesis,oncogenic transformation,poor prognosis,aggressive tumor behavior
ENSG00000159231,CBR3,cellular metabolism,tumor growth,protein interaction,drug resistance,dysregulation,ancillary function
ENSG00000111737,RAB35,actin cytoskeleton regulation,cell migration promotion,gtpase activity modulation,microtubule dynamics control,oncogenic transformation facilitation,therapeutic target candidate
ENSG00000171792,RHNO1,rhno1 overexpression,cell migration regulation,rhogap activity,cytoskeleton organization,tumor progression,cell proliferation enhancement
ENSG00000108179,PPIF,mitochondrial regulation,pyruvate dehydrogenase complex,cellular respiration,energy homeostasis,metabolic reprogramming,tumor progression
ENSG00000155087,ODF1,microtubule dynamics regulation,cell division regulation,cytokinesis disruption,genomic instability promotion,cancer cell survival enhancement,tumor progression facilitation
ENSG00000187742,SECISBP2,secis binding protein regulation,selenoprotein biosynthesis impairment,oxidative stress induction,genomic instability promotion,transcriptional regulator function,antioxidant defense disruption
ENSG00000087152,ATXN7L3,genomic instability,cell survival regulation,transcriptional regulation,oncogenesis driver,tumor microenvironment modulation,dna damage response pathway
ENSG00000162714,ZNF496,transcriptional regulation,c2h2-type zinc finger motif,gene expression repression,cellular proliferation,dna binding,transcriptional repressor function
ENSG00000113739,STC2,angiogenesis promotion,cell migration enhancement,epithelial-to-mesenchymal transition,oncogenic signaling pathway modulation,tumor aggressiveness factor,upregulation in various cancers
ENSG00000198879,SFMBT2,epigenetic regulation,chromatin remodeling,tumor suppressor function,pi3k/akt pathway modulation,cell proliferation inhibition,histone modification complex interaction
ENSG00000174429,ABRA,cellular proliferation,genomic instability,drug resistance,therapeutic target,apoptosis regulation,tumor progression
ENSG00000112514,CUTA,calcium ion transport,cellular proliferation,tumor progression,therapeutic target,calcium homeostasis regulation,gene amplification
ENSG00000176476,SGF29,chromatin remodeling,genomic instability,oncogenic function,dna damage response,cell cycle regulation,transcriptional regulation
ENSG00000146618,FERD3L,heme biosynthesis,tumor growth promotion,cell proliferation modulation,protein-protein interaction,cancer overexpression,cellular respiration support
ENSG00000078295,ADCY2,pi3k/akt pathway,oncogenic transformation,gain of function mutations,cell proliferation regulation,adenylyl cyclase activity,tumor progression
ENSG00000091317,CMTM6,tumor suppression,cellular regulation,pi3k/akt pathway modulation,apoptosis regulation,immune response modulation,cancer progression
ENSG00000184489,PTP4A3,regulation of cell proliferation,modulation of oncogenic signaling,dephosphorylation of rtks and nrtks,interaction with adaptor proteins,impact on pi3k/akt/mtor pathway,contribution to tumorigenesis
ENSG00000135324,MRAP2,tumor growth,cortisol regulation,loss of function mutations,uncontrolled signaling,therapeutic target,genomic instability
ENSG00000167178,ISLR2,cell adhesion modulation,oncogenic transformation,tumor suppressor function,extracellular matrix interactions,signaling pathway regulation,cell proliferation enhancement
ENSG00000148229,POLE3,dna replication error,genetic instability induction,tumor progression promotion,therapeutic target,genomic stability maintenance,cellular proliferation enhancement
ENSG00000115350,POLE4,genetic instability,dna replication,translesion synthesis,genomic stability,oncogenesis,tumor progression
ENSG00000186442,KRT3,intermediate filament structure,epithelial cell adhesion,cellular differentiation,mechanical stability,cytoskeleton organization,protein folding regulation
ENSG00000196236,XPNPEP3,cellular degradation pathway,carboxypeptidase activity,lysosomal function alteration,metabolic regulation,autophagy interaction,protein degradation enhancement
ENSG00000137965,IFI44,cell cycle regulation,apoptosis evasion,immune response modulation,oncogenic potential,tumor suppressor interaction,cell proliferation enhancement
ENSG00000176049,JAKMIP2,cytokine receptor regulation,cell cycle progression,oncogenic transformation,tumorigenesis,signal transduction,dna repair
ENSG00000116035,VAX2,vax2 mutations,transcriptional regulation,epithelial-to-mesenchymal transition (emt),cell migration,cancer cell invasion,genetic dysregulation
ENSG00000182107,TMEM30B,genomic instability,cell cycle regulation,topoisomerase iiα interaction,tumor suppression,oncogenic mutation,cell growth modulation
ENSG00000099194,SCD,fatty acid desaturation,cell membrane integrity,lipid signaling pathway,cancer cell metabolism,tumor growth support,oncogene activation
ENSG00000159363,ATP13A2,cellular homeostasis regulation,mitochondrial function regulation,copper ion balance,oxidative stress modulation,zinc ion regulation,parkinson's disease association
ENSG00000173706,HEG1,cell proliferation,genomic instability,oncogene overexpression,therapeutic target,pi3k/akt pathway interaction,metastasis promotion
ENSG00000001631,KRIT1,microtubule regulation,dysregulation of cell cycle,cytoskeletal instability,chromosomal instability,tumor suppressor function,haploinsufficiency
ENSG00000237110,TAAR9,tumor suppressor function,pheromone detection,genomic instability,cell proliferation regulation,chemosensitivity loss,receptor activation
ENSG00000136021,SCYL2,ubiquitination regulation,tumor suppressor role,mitotic spindle organization,cell proliferation enhancement,apoptosis inhibition,pi3k/akt pathway activation
ENSG00000153574,RPIA,pentose phosphate pathway,warburg effect modification,anabolic process dysregulation,cancer metabolism reprogramming,cell growth promotion,genetic mutation impact
ENSG00000165389,SPTSSA,tumor progression,mutations,cell proliferation,apoptosis regulation,signaling pathway modulation,serine protease activity
ENSG00000122557,HERPUD2,er stress response,protein quality control,cell survival,genomic instability,apoptosis regulation,proliferation promotion
ENSG00000184787,UBE2G2,ubiquitin-conjugating enzyme function,protein stability regulation,cell cycle progression modulation,apoptosis evasion,tumor suppressor interaction,therapeutic target
ENSG00000080819,CPOX,heme biosynthesis,mitochondrial enzyme,oncogene potential,reactive oxygen species regulation,energy metabolism disruption,iron homeostasis alteration
ENSG00000176390,CRLF3,oncogene activation,cancer stem cell maintenance,dysregulated signaling pathway,cell proliferation enhancement,tumor growth promotion,leukemia-related mutations
ENSG00000122507,BBS9,genomic stability maintenance,tumor suppressor function,mitotic checkpoint regulation,cilia formation and function,dna integrity maintenance,cell growth regulation
ENSG00000133169,BEX1,cellular regulation,transcriptional regulation,oncogenic properties,tumor progression,cell growth regulation,protein-protein interactions
ENSG00000168453,HR,dna repair mechanism,genomic instability,homologous recombination,tumor progression,therapeutic target,genomic profiling
ENSG00000114638,UPK1B,cellular signaling,cell adhesion,apoptosis regulation,tumor aggressiveness,metastatic potential,protein-protein interaction
ENSG00000221829,FANCG,genomic instability,dna repair deficiency,tumor initiation,oncogene inactivation,cell cycle regulation,protein complex formation
ENSG00000101608,MYL12A,cell motility,epithelial-to-mesenchymal transition,actomyosin contractility,non-muscle myosin ii complex,signaling pathway modulation,cancer progression
ENSG00000183726,TMEM50A,mitochondrial membrane regulation,tumor suppressor activity,prognostic biomarker,cellular homeostasis disruption,apoptosis regulation,bcl-2 family interaction
ENSG00000172155,LCE1D,cell envelope maintenance,disrupted expression,tissue homeostasis,regulatory mechanism alterations,cellular stress response,oncogenesis potential
ENSG00000100749,VRK1,p53 regulation,oncogene activation,cell proliferation enhancement,apoptosis inhibition,serine/threonine kinase activity,cell cycle regulation
ENSG00000181449,SOX2,aberrant transcriptional regulation,constitutive activation,epithelial-to-mesenchymal transition,oncogenic function,transcriptional reprogramming,wnt/β-catenin pathway activation
ENSG00000078246,TULP3,tumor aggressiveness,oncogenic properties,microtubule stabilization,cell proliferation,cytoskeleton regulation,genomic instability
ENSG00000174780,SRP72,cellular transformation,constitutive activation,signaling pathway modulation,protein targeting disruption,rna processing regulation,tumor progression
ENSG00000156469,MTERF3,mitochondrial function regulation,tumor metabolism modulation,cellular energy production,translation regulation,oxidative phosphorylation disruption,tumorigenesis promotion
ENSG00000013503,POLR3B,ribosomal rna transcription,transcriptional regulation,oncogenic transformation,cell proliferation,protein synthesis increase,tumor progression
ENSG00000089041,P2RX7,ion channel function,purinergic signaling pathway,immune cell modulation,tumor microenvironment remodeling,cancer progression facilitation,potential therapeutic target
ENSG00000068001,HYAL2,metastasis promotion,cd44 interaction,tumor progression,extracellular matrix remodeling,cell migration enhancement,angiogenesis modulation
ENSG00000135185,TMEM243,cell migration,constitutive activation,genomic profiling,oncogene,phosphorylation regulation,therapeutic target
ENSG00000166889,PATL1,genomic instability,translational regulation,ribosome biogenesis,cell proliferation,tumor progression,therapeutic target
ENSG00000083937,CHMP2B,altered cellular morphology,gain of function mutations,enhanced cell growth,resistance to apoptosis,pi3k/akt pathway interaction,microtubule stabilization
ENSG00000214063,TSPAN4,epigenetic regulation,cell adhesion modulation,metastasis promotion,cell proliferation enhancement,signaling pathway interaction,tumor progression facilitation
ENSG00000178966,RMI1,hrr maintenance,genomic instability,gain of function mutations,chromosome segregation,tumor progression,therapeutic target
ENSG00000175643,RMI2,genomic instability,dna damage repair,cell cycle regulation,helicase activity,genetic instability,tumor suppressor function
ENSG00000152104,PTPN14,tumor suppressor,phosphatase inactivation,src/fyn activation,cell proliferation,metastasis promotion,cancer transformation
ENSG00000085563,ABCB1,multidrug resistance,chemoresistance predictor,overexpression,altered substrate transport,epigenetic regulation,cellular homeostasis
ENSG00000104341,LAPTM4B,lysosome function,mitochondrial regulation,cell adhesion,immune response modulation,pi3k/akt pathway activation,metastasis promotion
ENSG00000029364,SLC39A9,iron transporter function,hypoxia-inducible factor 1-alpha regulation,iron-dependent metabolic reprogramming,oxidative stress induction,cellular redox balance regulation,prognostic marker for poor prognosis
ENSG00000213996,TM6SF2,lipid metabolism regulation,tumor suppressor function loss,oncogenic potential,cellular homeostasis maintenance,lipid transport pathway modulation,cancer progression contribution
ENSG00000121570,DPPA4,embryonic development,translational regulation,tumor suppression,cancer initiation,stem cell maintenance,dna repair mechanism
ENSG00000176302,FOXR1,transcriptional regulation,oncogene overexpression,cell proliferation enhancement,epithelial-to-mesenchymal transition (emt),signaling pathway interaction,dna repair dysregulation
ENSG00000137185,ZSCAN9,tumor suppression,genomic instability,chromosomal alterations,transcriptional regulation,gene expression regulation,cell cycle control
ENSG00000134198,TSPAN2,tumor progression,tetraspanin function,cell adhesion regulation,oncogenic signaling,cell migration enhancement,overexpression in cancer
ENSG00000166448,TMEM130,er-stress response,lipid metabolism regulation,tumor growth promotion,oncogene activation,autophagy modulation,cellular stress response
ENSG00000119522,DENND1A,regulation of rab gtpase cycle,endocytosis and exocytosis regulation,tumor suppressor function,cellular membrane dynamics,protein-protein interaction,apoptosis regulation
ENSG00000162399,BSND,cell signaling regulation,potassium channel subunit,cell growth modulation,hearing loss association,therapeutic target,genomic instability
ENSG00000157978,LDLRAP1,ldlr regulation,cholesterol uptake,cell proliferation,cell signaling,lipid metabolism,genetic disorder
ENSG00000101367,MAPRE1,microtubule regulation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000128944,KNSTRN,cell cycle regulation,genomic instability,dna repair mechanisms,protein kinase activation,tumor aggressiveness,chromosomal alterations
ENSG00000221864,KRTAP12-2,keratin-associated protein,tumorigenesis,overexpression,oncogenesis,poor prognosis,aggressive tumor behavior
ENSG00000139192,TAPBPL,mhc class i antigen presentation pathway,gene regulation,oncogenesis,cell proliferation,immune suppression,antigen presentation machinery
ENSG00000110422,HIPK3,p53 regulation,apoptosis regulator,cell cycle progression,dna damage response,transcriptional modulation,genomic stability maintenance
ENSG00000198331,HYLS1,g2/m checkpoint regulation,tumor suppressor function,microtubule stabilization,cell cycle regulation,apc interaction,oncogene activation
ENSG00000187713,TMEM203,regulation of endosomal trafficking,cell proliferation and survival,oncogene activation,interaction with pi3k/mtor pathway,tumorigenesis promotion,elevated expression in cancer cells
ENSG00000171124,FUT3,cell adhesion disruption,glycosylation modulation,oncogenic signaling,pi3k/akt pathway interaction,tumor progression facilitation,immune evasion mechanisms
ENSG00000103528,SYT17,calcium-dependent exocytosis,vesicular trafficking regulation,endocytosis modulation,oncogenesis involvement,therapeutic target potential,synaptotagmin family member
ENSG00000100365,NCF4,oxidative stress regulation,redox signaling pathway disruption,cell growth promotion,tumor progression facilitation,metastasis enhancement,angiogenesis modulation
ENSG00000177301,KCNA2,oncogene,cellular excitability,potassium channel dysfunction,tumor growth,cell migration,pi3k/akt pathway interaction
ENSG00000050327,ARHGEF5,cell migration,rho gtpase activation,oncogenic signaling,tumor progression,therapeutic target,immune evasion
ENSG00000125818,PSMF1,proteasome activation,chemosensitization,tumor suppressor degradation,cell cycle progression,apoptosis regulation,ubiquitin ligase activity
ENSG00000137098,SPAG8,cell cycle regulation,chromosome instability,aneuploidy promotion,cancer stem cell maintenance,prognostic marker,therapeutic target
ENSG00000163848,ZNF148,krab domain-containing protein,transcriptional repression,cell growth regulation,apoptosis modulation,tumor suppression,dna sequence recognition
ENSG00000146469,VIP,vip signaling pathway,cell proliferation regulation,vasodilation and smooth muscle relaxation,modulation of immune response,tumor microenvironment regulation,therapeutic target
ENSG00000136636,KCTD3,apoptosis regulation,cell cycle control,tumor suppressor function,dna damage response,genomic instability,biomarker candidate
ENSG00000160471,COX6B2,mitochondrial dysfunction,energy metabolism regulation,glycolysis enhancement,tumor microenvironment adaptation,cellular respiration alteration,oxidative phosphorylation inhibition
ENSG00000280635,PROP1,transcriptional regulation,cell growth regulation,developmental processes,pituitary gland development,hormone production regulation,genomic stability maintenance
ENSG00000115255,REEP6,mitochondrial regulation,tumorigenesis association,pi3k/akt pathway interaction,cell survival enhancement,er stress response modulation,protein-protein interaction
ENSG00000125848,FLRT3,oncogenic driver,tumor growth promotion,cell adhesion modulation,angiogenesis regulation,metastasis facilitation,therapeutic target
ENSG00000109756,RAPGEF2,ras-raf-mek-erk signaling,oncogenic activation,gain of function mutations,tumor progression,epithelial-to-mesenchymal transition (emt),angiogenesis
ENSG00000148153,INIP,cellular regulation,insulin secretion,constitutive activation,cell proliferation,genomic instability,protein-protein interaction
ENSG00000183628,DGCR6,mirna biogenesis,drosha complex interaction,genomic instability,oncogene regulation,tumor progression,epigenetic modulation
ENSG00000077585,GPR137B,cellular regulation,signal transduction pathway,tumor progression,cell proliferation,oncogene/tumor suppressor gene,signal modulation
ENSG00000070019,GUCY2C,cgmp signaling,cell proliferation,tumor progression,smooth muscle relaxation,protein kinase activation,cell cycle regulation
ENSG00000172367,PDZD3,cellular adhesion disruption,cytoplasmic localization,tumor progression association,altered protein function,cell-to-cell interaction regulation,adhesion molecule function
ENSG00000105717,PBX4,transcriptional regulation,cell differentiation regulation,developmental process disruption,tumorigenesis involvement,oncogene activity,genomic instability
ENSG00000187210,GCNT1,glycosylation regulation,tumor progression,cell surface receptor modification,pi3k/akt pathway activation,epithelial-to-mesenchymal transition (emt),biomarker potential
ENSG00000177469,CAVIN1,metabolic reprogramming,tumor cell survival,loss of function mutations,glucose uptake enhancement,cell membrane organization,signal transduction modulation
ENSG00000149516,MS4A3,tumor progression,immune evasion,cell proliferation regulation,apoptosis inhibition,signaling pathway modulation,molecular interaction
ENSG00000163684,RPP14,regulatory function,cell proliferation,rna processing,proteostasis regulation,tumor progression,oncogenic pathway activation
ENSG00000173141,MRPL57,mitochondrial protein synthesis,impaired respiration,tumor growth,cell cycle regulation,oncogenic signaling,protein synthesis inhibition
ENSG00000213921,LEUTX,chromatin regulation,histone methylation,oncogenic function,cell cycle progression,dna repair mechanism,genomic instability
ENSG00000149179,C11orf49,rna-binding protein,oncogenic potential,gene expression regulation,mrna stability modulation,cellular proliferation enhancement,microrna regulation
ENSG00000143319,ISG20L2,ifn-α/β production regulation,tumor suppressor function,cell cycle regulation,apoptosis modulation,autophagy involvement,innate immune response modification
ENSG00000278062,ZNF251,cell proliferation,oncogene function,epithelial-to-mesenchymal transition,chromatin remodeling,gene transcription regulation,prognostic marker
ENSG00000196418,ZNF124,tumor suppressor function,transcriptional regulation,chromatin remodeling,cell cycle progression,apoptosis regulation,genomic instability
ENSG00000184507,NUTM1,oncogene,transcriptional regulation,cell proliferation,angiogenesis,epithelial-to-mesenchymal transition,protein-protein interactions
ENSG00000110680,CALCA,cellular growth,constitutive expression,growth factor signaling,metastatic potential,oncogenic function,tumor progression
ENSG00000138190,EXOC6,exocyst complex formation,rho gtpase pathway interaction,cell proliferation regulation,tumor progression enhancement,metastasis facilitation,therapeutic target
ENSG00000158882,TOMM40L,mitochondrial dynamics,tumor suppressor function,mitophagy regulation,cellular metabolism disruption,oncogenic signaling pathway activation,cancer predisposition gene
ENSG00000168758,SEMA4C,tumor progression,angiogenesis regulation,gain of function mutations,constitutive activation,oncogene activation,tumor metastasis
ENSG00000109084,TMEM97,cellular membrane integrity,apoptosis modulation,genomic instability,epigenetic regulation,cellular growth regulation,protein-protein interactions
,C6orf203,cellular regulation,nuclear localization,chromatin remodeling,transcriptional regulation,oncogenic potential,genomic instability
ENSG00000130675,MNX1,hoxa gene regulation,transcriptional activation,epithelial cell maintenance,promoter binding,cell proliferation,oncogenic function
ENSG00000196639,HRH1,apoptosis regulation,cell proliferation inhibition,histamine signaling,immune response modulation,tumor suppressor function,cell growth control
ENSG00000122033,MTIF3,mitochondrial function,energy metabolism regulation,protein synthesis initiation,aberrant glycolysis,warburg effect activation,tumor suppressor role
ENSG00000164741,DLC1,genomic instability,gtpase activation inhibition,tumor suppressor function,loss of expression mutations,cell migration regulation,cancer cell invasion
ENSG00000131142,CCL25,metastasis,immune suppression,angiogenesis,tumor cell migration,chemokine signaling,cancer progression
ENSG00000205323,SARNP,rna splicing regulation,tumor aggressiveness,poor prognosis marker,oncogene activation,cancer progression regulator,genomic instability mediator
ENSG00000134049,IER3IP1,regulatory function,interferon regulation,tumor progression,immunomodulation,viral response modulation,cellular interaction
ENSG00000183474,GTF2H2C,transcriptional regulation,tumor progression,cell growth regulation,protein-dna interaction,oncogenic processes,epigenetic modifications
ENSG00000101945,SUV39H1,epigenetic regulation,chromatin remodeling,histone methylation,tumor suppressor silencing,oncogene activation,transcriptional dysregulation
ENSG00000274675,GTF2H2C_2,transcriptional regulation,nucleotide excision repair,dna damage response,cell proliferation,tumor suppression,genomic instability
ENSG00000278369,KIR2DL3,potassium channel regulation,mutations affecting function,cellular homeostasis disruption,dysregulation implicated,cancer biology association,physiological process control
ENSG00000100372,SLC25A17,metabolic regulation,mitochondrial transport,cellular proliferation,energy metabolism,oxidative phosphorylation,dna repair mechanism
ENSG00000145945,FAM50B,ribosome biogenesis,cell cycle progression,tumorigenesis,pre-rrna processing,maturation regulation,genomic instability
ENSG00000206538,VGLL3,wnt/β-catenin signaling,constitutive activation,overexpression or mutation,chromatin remodeling,transcriptional coactivation,oncogene activation
ENSG00000181704,YIPF6,er homeostasis regulation,endoplasmic reticulum stress response,cell cycle regulation alteration,protein trafficking involvement,tumor growth promotion,oncogene overexpression
ENSG00000108960,MMD,genomic instability,gene amplification,mismatch repair deficiency,dna damage response,tumor progression,epigenetic regulation
ENSG00000132376,INPP5K,pi3k/akt signaling,tumor growth,cell survival,insulin signaling,oncogene function,metastasis progression
ENSG00000143365,RORC,rorγ mediated suppression,immune evasion mechanisms,tumor progression promotion,stat3/nf-κb interaction,inflammation regulation,transcriptional dysregulation
ENSG00000189143,CLDN4,tumor progression,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,oncogenic signaling pathway modulation,cancer cell invasion enhancement,metastasis promotion
ENSG00000176435,CLEC14A,tumor-promoting factor,cell migration and invasion,immune evasion mechanism,pi3k/akt signaling pathway,oncogenic processes,cell proliferation
ENSG00000147465,STAR,genomic instability,oncogene function,dna repair interactions,cell cycle regulation,therapeutic target,genomic profiling
ENSG00000077721,UBE2A,nf-κb pathway regulation,ubiquitination pathway,cell cycle regulation,transcriptional control,dna repair dysfunction,proteasome activation
ENSG00000179168,GGN,genomic stability,dna repair regulation,cell cycle regulation,anti-apoptotic function,chromosomal instability prevention,biological process regulation
ENSG00000273899,NOL12,nucleolar function,ribosome biogenesis,cell proliferation,oncogenic process,poor prognosis,apoptosis regulation
ENSG00000126070,AGO3,microrna-mediated regulation,argonaute protein function,tumor suppressor role,gene silencing,endonucleolytic cleavage,poor prognosis
ENSG00000169957,ZNF768,chromatin remodeling,tumor progression,oncogenesis,epigenetic regulation,gene expression modulation,zinc finger protein interaction
ENSG00000164438,TLX3,epithelial-to-mesenchymal transition,oncogenic transcription factor,aberrant cell cycle regulation,stem cell self-renewal,tumor suppressor gene repression,metastatic potential enhancement
ENSG00000150337,FCGR1A,antibody-dependent cellular cytotoxicity,immune evasion,fc-gamma receptor,phagocytosis,complement activation,myeloid cell function
ENSG00000000005,TNMD,tumor progression,immune evasion,cell survival,transmembrane receptor,oncogenic process,apoptosis regulation
ENSG00000177025,C19orf18,p53 inhibition,tumor progression,cell survival enhancement,apoptosis suppression,ubiquitin-proteasome pathway modulation,chaperone function
ENSG00000169249,ZRSR2,splice site recognition,alternative splicing regulation,tumor aggressiveness,oncogenic pathway activation,cellular homeostasis disruption,protein function alteration
ENSG00000106541,AGR2,protein secretion and degradation,epithelial-to-mesenchymal transition,cell proliferation enhancement,tumor progression facilitation,apoptosis suppression,emt regulator
ENSG00000131748,STARD3,lipid metabolism regulation,oncogenic signaling,protein-protein interaction,tumor progression,apoptosis modulation,cell growth promotion
ENSG00000198887,SMC5,genomic stability regulation,hrr facilitation,dna repair modulation,cancer cell survival,chromosomal segregation,genomic instability
,HIST1H1A,histone regulation,chromatin organization,cell cycle progression,apoptosis modulation,pi3k/akt signaling interaction,epigenetic reprogramming
ENSG00000187912,CLEC17A,immune modulation,tumor cell behavior modification,cell adhesion regulation,molecular recognition,cancer association,carbohydrate binding
ENSG00000162063,CCNF,cyclin-dependent kinase regulation,cell cycle progression,dna replication,genomic instability,oncogene activation,therapeutic target
ENSG00000136938,ANP32B,histone modification,tumor suppressor gene repression,chromatin structure regulation,transcriptional activation,cell signaling pathway interaction,oncogene regulation
ENSG00000106829,TLE4,wnt/β-catenin pathway regulation,corepressor function,tumor initiation and progression,epithelial-to-mesenchymal transition (emt),transcriptional regulation,stem cell maintenance
ENSG00000111670,GNPTAB,glycosphingolipid biosynthesis,cell surface molecule regulation,lysosomal dysfunction,cell growth promotion,metabolic regulation,tumor metastasis facilitation
ENSG00000173218,VANGL1,cell polarity disruption,pcd pathway dysregulation,tumor initiation,metastasis promotion,biomarker potential,signaling pathway interaction
ENSG00000085117,CD82,metastasis suppression,cell adhesion disruption,tumor aggressiveness promotion,pi3k/akt pathway modulation,loss-of-function mutations,adhesion molecule regulation
ENSG00000198919,DZIP3,oncogene,biomarker potential,emt regulation,cell adhesion modulation,protein-protein interactions,gene expression regulation
ENSG00000120992,LYPLA1,cancer driver,proliferation promotion,metastasis enhancement,lipid metabolism dysregulation,protein interaction modulation,tumor growth support
ENSG00000104131,EIF3J,initiation of protein synthesis,aberrant translation,oncogenesis,dysregulated protein synthesis,genomic instability,therapeutic target
ENSG00000182183,SHISAL2A,cellular differentiation,transcriptional regulation,tissue homeostasis,gene expression modulation,tumor suppression,cancer subtyping
ENSG00000164627,KIF6,microtubule regulation,mitotic spindle formation,cell proliferation,apoptosis regulation,dna replication,genomic instability
ENSG00000152977,ZIC1,oncogenic role,transcriptional regulation,epithelial-to-mesenchymal transition (emt),cell migration and invasion,apoptosis inhibition,metastasis enhancement
ENSG00000198429,ZNF69,transcriptional regulation,krab-zfp family member,gene repression,cellular growth modulation,apoptosis regulation,tumor suppressor gene regulation
ENSG00000066629,EML1,microtubule stabilization,drug resistance,oncogenic phenotypes,cell cycle regulation,apoptosis inhibition,cytoskeletal remodeling
ENSG00000182040,USH1G,cellular homeostasis maintenance,tumor suppressor functions,genomic stability regulation,intracellular trafficking modulation,actin cytoskeleton stabilization,apoptosis induction
ENSG00000130803,ZNF317,altered gene expression,chromatin remodeling,cell cycle regulation,tumor suppression,genetic instability,dysregulated transcription
ENSG00000087086,FTL,iron regulation,oncogenic pathway modulation,ferroptosis resistance,cell growth promotion,tumor progression association,therapeutic target potential
ENSG00000120913,PDLIM2,cellular adhesion regulation,cytokeletal remodeling,tumor progression,protein-protein interactions,metastasis promotion,cancer association
ENSG00000178175,ZNF366,apoptosis modulation,cell cycle regulation,chromatin remodeling,dna binding activity,genomic stability maintenance,transcriptional regulation
ENSG00000080493,SLC4A4,tumor microenvironment,acidic environment,metastasis promotion,cell survival enhancement,signaling pathway interaction,therapeutic target
ENSG00000167434,CA4,tumor microenvironment,hypoxic adaptation,cell proliferation,metabolic rewiring,angiogenesis promotion,therapeutic target
ENSG00000169188,APEX2,dna repair,genomic stability,base excision repair,apoptosis regulation,cell cycle progression,tumor suppressor
ENSG00000094916,CBX5,tumor suppression,oncogenic mutations,chromatin remodeling,epigenetic modifications,cellular proliferation,genomic instability
ENSG00000196549,MME,cd44 shedding,tumor progression,proteolytic activity,metastasis promotion,cancer cell invasion,cell signaling regulation
ENSG00000275724,NDUFA3,mitochondrial dysfunction,electron transport chain disruption,altered metabolic regulation,increased ros production,tumor microenvironment adaptation,hypoxia response modification
ENSG00000169592,INO80E,chromatin remodeling,dna repair mechanisms,cell cycle regulation,oncogenesis,protein-protein interactions,transcriptional activation
ENSG00000151365,THRSP,lipid metabolism regulation,thyroid hormone response,fatty acid oxidation,insulin signaling pathway interaction,tumor growth promotion,cancer progression association
ENSG00000139767,SRRM4,alternative splicing regulation,gene expression modulation,tumor progression promotion,pi3k/akt pathway interaction,oncogenic splice variant production,cancer prognosis indicator
ENSG00000147573,TRIM55,p63 binding,tumor suppressor function,cell cycle regulation,apoptosis induction,immune response modulation,dna repair pathway
ENSG00000126858,RHOT1,mitochondrial regulation,tumor suppressor functions,cell growth promotion,oncogene activation,protein interaction modulation,genomic instability
ENSG00000125814,NAPB,cell cycle regulation,genomic instability,chromatin remodeling,dna replication,nuclear protein function,transcriptional control
ENSG00000105755,ETHE1,endoplasmic reticulum stress response,proteostasis regulation,zinc-binding domain,redox regulation,tumor suppressor or oncogene,apoptosis regulation
ENSG00000164181,ELOVL7,enhanced fatty acid synthesis,fatty acid metabolism regulation,lipogenesis promotion,cell growth regulation,protein-protein interactions,therapeutic target
ENSG00000127507,ADGRE2,tumor progression,oncogenic driver,cell adhesion regulation,epithelial-to-mesenchymal transition,prognostic marker,migratory and invasive properties
ENSG00000100479,POLE2,genomic instability,error-prone repair,translesion synthesis,dna damage response,polymerase activity,tumor progression
ENSG00000132773,TOE1,apoptosis regulation,gain of function mutations,cell proliferation,genomic instability,oncogenic pathway activation,protein ubiquitination
ENSG00000102683,SGCG,cell-cell adhesion disruption,genetic alterations,multifunctional protein,oncogenic driver,tumor progression,impaired cellular interactions
ENSG00000166603,MC4R,dysregulation,tumor growth promotion,therapeutic target,cellular energy metabolism regulation,angiogenesis enhancement,immune response suppression
ENSG00000137207,YIPF3,er morphology regulation,gain-of-function mutations,therapeutic target,pi3k/akt pathway activation,autophagy regulation,cell proliferation enhancement
ENSG00000091844,RGS17,g-protein regulation,cell proliferation modulation,tumor suppression,signaling pathway regulation,protein interaction,cancer progression inhibition
ENSG00000206181,ELOA2,dead-box helicase function,rna splicing regulation,pre-mrna processing modulation,cell growth promotion,stress response activation,oncogenic potential
ENSG00000276463,TAF9,transcriptional regulation,genome-wide instability,cancer cell proliferation,chromatin remodeling,oncogenic transformation,epigenetic modulation
ENSG00000271605,MILR1,mitotic spindle assembly,cell cycle progression,proliferation promotion,oncogenic process,biomarker candidate,genomic instability 
ENSG00000113303,BTNL8,cellular regulation,immune modulation,tumor microenvironment,t-cell activation,oncogenic potential,biomarker candidate
ENSG00000110851,PRDM4,genomic instability,dna binding activity,epithelial-to-mesenchymal transition,transcription factor regulation,tumor suppressor function,oncogenic properties
ENSG00000155957,TMBIM4,apoptosis regulation,bax inhibition,cell survival enhancement,chemotherapy resistance,mitochondrial regulation,oncogenic transformation
ENSG00000134697,GNL2,cell proliferation,genetic instability,transcriptional regulation,rna splicing,signaling pathway modulation,oncogenic transformation
ENSG00000115750,TAF1B,transcriptional regulation,dna binding activity,cancer-related mutations,cell proliferation,rna polymerase recruitment,gene expression modulation
ENSG00000163687,DNASE1L3,apoptosis inhibition,dna degradation regulation,genome instability,tumor progression promotion,oncogenic potential,therapeutic target
ENSG00000125656,CLPP,mitochondrial proteolysis,cellular stress response,apoptosis regulation,protein quality control,tumor suppressor function loss,pleiotropic effects
ENSG00000151552,QDPR,cellular redox balance,resistance to oxidative stress,tumor progression,metabolic regulation,genomic stability maintenance,cell survival
ENSG00000103269,RHBDL1,pi3k/akt signaling pathway,cell proliferation,protein kinase activity,tumorigenesis,genomic amplification,chromosomal location
ENSG00000003393,ALS2,gef activity,gtpase regulation,endosomal transport,cell cycle regulation,apoptosis modulation,protein degradation pathway
ENSG00000145362,ANK2,reduced cell adhesion,cell migration,pi3k/akt interaction,epithelial-to-mesenchymal transition,tumor progression,protein-protein interaction
ENSG00000163697,APBB2,pi3k/akt pathway,oncogenic driver,tumor suppressor dysfunction,cell growth regulation,apoptosis inhibition,cell migration promotion
ENSG00000111262,KCNA1,oncogenic properties,regulation of cellular processes,potassium channel regulation,electrical excitability modulation,signaling pathway interaction,therapeutic target
ENSG00000115677,HDLBP,cholesterol regulation,lipid metabolism,lipoprotein assembly,tumor progression,cancer cell growth,potential therapeutic target
ENSG00000144224,UBXN4,ubiquitination pathway,tumor progression,cellular homeostasis regulation,ring-type ubiquitin ligase activity,apoptosis modulation,cancer overexpression
ENSG00000147164,SNX12,cancer-related regulation,endosomal trafficking,cellular growth regulation,cellular survival promotion,signaling pathway modulation,prognostic marker
ENSG00000284017,PLCL2,cellular signaling pathway modification,growth promotion,metabolic regulation enhancement,tumor progression facilitation,therapeutic target identification,ca2+ channel activation
ENSG00000204969,PCDHA2,cell-cell adhesion,tumor suppression,loss-of-function mutations,epigenetic silencing,signaling pathway regulation,metastatic potential
ENSG00000013297,CLDN11,epithelial-to-mesenchymal transition,cell migration promotion,tumor progression facilitation,cancer stemness maintenance,paracellular transport regulation,tight junction disruption
ENSG00000066405,CLDN18,wnt signaling disruption,tumor progression,epithelial-to-mesenchymal transition,cell proliferation regulation,chemoresistance,overexpression
ENSG00000090447,TFAP4,transcription regulation,oncogene activation,cell proliferation enhancement,dna replication modulation,aberrant gene expression,tumor progression promotion
ENSG00000158457,TSPAN33,cell adhesion molecule,cell migration regulator,integrin interaction partner,metastasis promoter,signal transducer,oncoprotein expression
ENSG00000129691,ASH2L,chromatin regulation,oncogene,pan-cancer driver,transcriptional regulation,cell proliferation,histone modification
ENSG00000122884,P4HA1,hypoxia adaptation,metabolic reprogramming,collagen stabilization,tumor growth promotion,oncogenic role,cellular metabolism regulation
ENSG00000149380,P4HA3,collagen biosynthesis,overexpression,increased metabolic activity,tumor progression,metastatic potential,proline metabolism
ENSG00000092529,CAPN3,pi3k/akt pathway activation,protease activity,cell proliferation regulation,apoptosis modulation,tumor progression promotion,genomic instability maintenance
ENSG00000135318,NT5E,regulatory mechanism,tumor microenvironment modulation,cancer-related cellular processes,cell signaling,immune responses regulation,diagnostic marker
ENSG00000061936,SFSWAP,cellular proliferation,tumor progression,transcriptional regulation,apoptosis inhibition,chromatin modification,oncogenesis promotion
ENSG00000170322,NFRKB,wnt/β-catenin pathway,pi3k/akt/mtor signaling,cell proliferation,tumor suppressor function,gene expression regulation,transcriptional modulation
ENSG00000132485,ZRANB2,transcriptional regulation,cell cycle progression,apoptosis inhibition,tumor suppressor gene inhibition,onco-protein interaction,therapeutic target
ENSG00000163630,SYNPR,oncogenic interaction,signaling pathway modulation,cell proliferation influence,tumor aggressiveness enhancement,microenvironment interaction,genomic alteration association
ENSG00000175283,DOLK,genomic instability,haploinsufficiency,tumor suppressor function,cellular homeostasis disruption,protein expression regulation failure,apoptosis inhibition
ENSG00000204197,KIFC1,microtubule dynamics,cell division regulation,tumor suppressor function,loss of function mutations,genomic instability,cell cycle progression
ENSG00000152818,UTRN,tumor metastasis,cell migration,poor prognosis,apoptosis resistance,p53 interaction,β-catenin interaction
ENSG00000187626,ZKSCAN4,tumor suppression,chromatin remodeling,transcriptional regulation,cell cycle control,apoptosis induction,histone modification
ENSG00000196345,ZKSCAN7,loss of function mutations,chromatin regulation,tumor progression,cell cycle regulation,apoptosis inhibition,genomic instability
ENSG00000184351,KRTAP19-1,epithelial-to-mesenchymal transition,apoptosis regulation,cytoskeleton modulation,cell adhesion disruption,tumor progression facilitation,oncogenic process modulation
ENSG00000143368,SF3B4,rna splicing,rna processing,regulatory mechanisms,cellular proliferation,oncogenic processes,aberrent gene expression
ENSG00000136819,C9orf78,cancer-related,potential tumor suppressor,cellular signaling pathway,nf-κb target,transmembrane protein,coiled-coil domain
ENSG00000078699,CBFA2T2,co-repressor function,transcriptional regulation,chromatin modulation,oncogenesis contribution,hematopoietic cell differentiation,genomic instability
ENSG00000030582,GRN,protein regulation,cellular proliferation,inflammation modulation,tumor progression,apoptosis resistance,nf-κb regulation
ENSG00000118434,SPACA1,pi3k/akt pathway,cell cycle regulation,apoptosis regulation,tumor progression,metastasis promotion,protein-protein interaction
ENSG00000147027,TMEM47,cellular adhesion,autophagy regulation,cancer progression,therapeutic target,epithelial integrity maintenance,cell migration
ENSG00000170417,TMEM182,cell membrane trafficking,endoplasmic reticulum function,oncogenic signaling,tumor growth promotion,therapeutic target,genomic regulation
ENSG00000136026,CKAP4,cytoskeletal regulation,proliferation enhancement,apoptosis suppression,cell survival pathway modulation,pi3k/akt pathway interaction,oncogenic protein expression
ENSG00000128271,ADORA2A,tumor growth,immune suppression,angiogenesis promotion,inflammation modulation,g-protein coupled signaling,neuroprotection disruption
ENSG00000132965,ALOX5AP,leukotriene biosynthesis,tumor progression,inflammatory response,angiogenesis,metastasis,stat3 interaction
ENSG00000091483,FH,angiogenesis promotion,cell proliferation enhancement,connective tissue maintenance,glycoprotein function,mechanical stress regulation,therapeutic target
ENSG00000167461,RAB8A,constitutive activation,gtpase activity,ras superfamily member,cancer cell migration,cellular trafficking regulation,epithelial-to-mesenchymal transition
ENSG00000178467,P4HTM,microtubule maintenance,cell division regulation,genomic instability prevention,tyrosinated alpha-tubulin incorporation,tumor suppressor function,cell cycle control
ENSG00000147677,EIF3H,translation regulation,gain of function mutations,cell proliferation,protein synthesis,oncogene/tumor suppressor,tumor microenvironment
ENSG00000177963,RIC8A,tumor suppressor loss,gtpase activation,cell migration promotion,oncogenic transformation,cell signaling regulation,gef activity alteration
ENSG00000186638,KIF24,genomic instability,aneuploidy,cell cycle regulation,tumor suppressor function,dna repair regulation,protein-protein interactions
ENSG00000006659,LGALS14,tumor progression,cell adhesion regulation,apoptosis modulation,signaling pathway interaction,extracellular matrix interaction,biomarker potential
ENSG00000123119,NECAB1,lipid metabolism regulation,cellular signaling modulation,pi3k/akt pathway interaction,tumor suppressor function,genomic instability contributor,chromatin remodeling involvement
ENSG00000067840,PDZD4,tumor growth,oncogenic potential,cell adhesion disruption,signaling pathway modulation,genomic alterations,protein-protein interactions
ENSG00000141252,VPS53,autophagy modulation,escrt machinery,mitotic spindle regulation,tumor suppressor degradation,cellular stress response,genomic instability
ENSG00000066455,GOLGA5,golgi apparatus dysfunction,cellular trafficking disruption,protein sorting alterations,tumor progression contribution,cellular process regulation,none
ENSG00000152518,ZFP36L2,apoptosis regulation,mrna stability regulation,tumor growth promotion,oncogenic mrna accumulation,auf1 protein interaction,au-rich element binding
ENSG00000091138,SLC26A3,ion transport regulation,tumor growth promotion,epithelial cell function disruption,cellular ph imbalance,oncogenesis association,genomic instability link
ENSG00000107738,VSIR,nf-κb signaling,loss-of-function mutations,immunodeficiency syndrome,cell survival regulation,proliferation modulation,genomic instability 
ENSG00000095906,NUBP2,cellular homeostasis regulation,genomic stability modulation,nucleotide metabolism influence,cell cycle progression regulation,oncogenic pathway involvement,chromatin remodeling effect
ENSG00000160179,ABCG1,cholesterol efflux,tumor progression,lipid metabolism regulation,poor prognosis marker,membrane localization,biological function alteration
ENSG00000172164,SNTB1,scaffolding protein,signaling pathway regulation,pi3k/akt/mtor interaction,gef/gap complex formation,cell growth modulation,tumor suppressor dysfunction
ENSG00000166974,MAPRE2,microtubule dynamics regulation,tumor progression,cell proliferation,apoptosis resistance,mitotic checkpoint disruption,therapeutic target
ENSG00000171970,ZNF57,cell proliferation,transcriptional regulation,tumor progression,oncogene overexpression,genomic instability,protein-protein interaction
ENSG00000050426,LETMD1,genomic instability,cell cycle regulation,dna damage response,brca pathway interaction,oncogenic potential,genomic integrity maintenance
ENSG00000176542,USF3,cell proliferation enhancement,oncogenic transcription factor,cell migration promotion,tumor suppressor inhibition,apoptosis evasion,overexpression association
ENSG00000130227,XPO7,nuclear transport,exportin-7,gene expression regulation,protein stability modulation,nes interaction,crm1-mediated export pathway
ENSG00000228250,LY6G6C,oncogene activation,apoptosis inhibition,tumor growth promotion,metastasis facilitation,immune evasion,signaling pathway modulation
ENSG00000167394,ZNF668,oncogenic transcriptional programs,gene overexpression,tumor suppressor dysregulation,chromatin remodeling,transcriptional regulation,anti-apoptotic function
ENSG00000285206,PTPMT1,pi3k/akt pathway modulation,aberrant activation,pathway regulation,tumor growth and survival,therapeutic resistance,cell signaling modification
ENSG00000173726,TOMM20,mitochondrial regulation,tumor metabolism,cellular growth,survival,calcium homeostasis,transmembrane protein
ENSG00000113282,CLINT1,genomic instability,enhanced dna damage response,tumor suppressor function,cell cycle regulation,protein-protein interaction,genetic stability maintenance
ENSG00000171360,KRT38,cellular architecture,epithelial-to-mesenchymal transition,overexpression,increased cell proliferation,protein expression regulation,intermediate filament function
ENSG00000170545,SMAGP,tumor progression,mitotic regulation,cell cycle control,protein-protein interactions,oncogenic potential,gene amplification
ENSG00000100296,THOC5,transcriptional regulation,oncogenic mrnas export,enhanced translation,tumor progression,cell proliferation,poor prognosis
ENSG00000090316,MAEA,chromosomal instability,mitotic regulation,centrosome function,microtubule dynamics,tumor progression,therapeutic target
ENSG00000144579,CTDSP1,transcriptional regulation,cellular interaction,genome stability,tumor suppressor,protein interaction network,chromatin remodeling
ENSG00000171604,CXXC5,chromatin remodeling,histone binding,genomic instability,tumorigenesis,gene regulation,dna repair pathways
ENSG00000146670,CDCA5,oncogenic potential,cell cycle regulation,amplification or overexpression,genomic instability,mitotic regulation,spindle checkpoint activation
ENSG00000111843,TMEM14C,chromosomal instability,constitutive expression,ion homeostasis disruption,oncogenic transformation,post-translational modification,regulatory mechanism disruption
ENSG00000159251,ACTC1,actin cytoskeleton disruption,cellular migration,oncogenic transformation,cytoskeletal dynamics alterations,protein-protein interactions,cell invasion enhancement
ENSG00000124721,DNAH8,microtubule structure,cilia function,developmental disorder,motility regulation,sensory perception,mutation hotspot
ENSG00000130560,UBAC1,tumor-suppression,ubiquitination pathway,protein quality control,cell proliferation regulation,genetic instability association,oncogenic transformation risk
ENSG00000180817,PPA1,metabolic reprogramming,mitochondrial function,cellular energy metabolism,glycolytic reconfiguration,atp production,oncogenesis
ENSG00000140931,CMTM3,emt modulation,tumor suppressor/oncogene,pi3k/akt pathway regulation,nf-κb activation,cancer metastasis,poor prognosis marker
ENSG00000288141,MRPL23,mitochondrial ribosome,ribosomal protein,protein synthesis,mitochondrial dynamics,cell division,energy metabolism
ENSG00000144040,SFXN5,oxidative stress modulation,iron homeostasis disruption,cell proliferation enhancement,protein-protein interactions,tumor microenvironment creation,apoptosis inhibition
ENSG00000128335,APOL2,angiogenesis promotion,tumor progression driver,immune evasion mechanism,cell migration enhancer,protein-protein interaction partner,lipid metabolism regulator
ENSG00000160191,PDE9A,camp regulation,oncogenic function,tumor progression,cell migration,angiogenesis,phosphodiesterase activity
ENSG00000109193,SULT1E1,estrogen metabolism,tumor growth regulation,hormone receptor interaction,cell proliferation modulation,oncogenesis link,therapeutic target status
ENSG00000139428,MMAB,aberrant metabolism,genomic instability,b12 metabolic pathway,cancer predisposition,folate-dependent metabolism,homocysteine levels
ENSG00000141503,MINK1,mapk signaling pathway,oncogene activation,kinase activity,protein-protein interactions,cell survival promotion,tumorigenesis induction
ENSG00000204361,NXPE2,genomic instability,protein degradation pathway,regulatory protein interaction,tumor suppression,e3 ubiquitin ligase interaction,cellular growth regulation
ENSG00000284009,PLSCR3,apoptosis modulation,phospholipid scrambling,cell migration regulation,calcium-dependent signaling,oncogenic potential,tumor progression facilitation
ENSG00000177854,TMEM187,calcium regulation,endoplasmic reticulum localization,store-operated channels,tumor suppression,loss-of-function mutations,proliferation and survival enhancement
ENSG00000164713,BRI3,angiogenesis regulation,notch signaling pathway disruption,cell proliferation enhancement,tumor progression promotion,vascularization increase,pro-tumorigenic environment creation
ENSG00000213064,SFT2D2,dna repair mechanisms,tumor suppression function,chromatin remodeling,gene regulatory networks,dna damage response pathways,epigenetic regulation
ENSG00000132563,REEP2,er morphology disruption,protein misfolding,chaperone dysfunction,tumor suppressor candidate,oncogenic expression,cellular homeostasis disruption
ENSG00000224470,ATXN1L,potential oncogene,transcriptional regulation,chromatin remodeling,protein-protein interaction,cellular dysregulation,tumorigenesis
ENSG00000198326,TMEM239,tumor progression,cell adhesion disruption,potential therapeutic target,cell proliferation enhancement,metastasis facilitation,cell migration promotion
ENSG00000196338,NLGN3,cell adhesion molecule,synaptic plasticity,neurodevelopmental disorders,x-linked mental retardation,autism spectrum disorder,cell-cell communication
ENSG00000052749,RRP12,ribosome biogenesis,cell growth modulation,protein synthesis regulation,tumor aggressiveness,poor prognosis,overexpression
ENSG00000198707,CEP290,cellular process regulation,cilia dysfunction,oncogene function,apoptosis inhibition,cell proliferation promotion,protein localization disruption
ENSG00000100711,ZFYVE21,cell growth regulation,tumor suppressor function,endosomal sorting complex interaction,cell proliferation modulation,pi3k/akt pathway interaction,tumor progression association
ENSG00000196116,TDRD7,mirna regulation,tumor suppressor function,precursor rna stabilization,autophagy induction,cellular proliferation,post-transcriptional control
ENSG00000143322,ABL2,constitutive activation,autophosphorylation,cell growth regulation,therapeutic target,oncogenic signaling,prognostic marker
ENSG00000185009,AP3M1,regulatory mechanism,constitutive activation,oncogenic driver,protein trafficking regulation,immune evasion mediator,cell cycle progression regulator
ENSG00000161202,DVL3,wnt signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000105176,URI1,cell polarity disruption,oncogenic transformation,cell adhesion regulation,tumor progression,therapeutic target,epithelial integrity maintenance
ENSG00000151092,NGLY1,er stress regulation,autophagy dysregulation,oncogenic glycoprotein accumulation,apoptosis evasion,protein homeostasis disruption,glycosylation pathway modulation
ENSG00000167565,SERTAD3,transcriptional regulation,chromatin remodeling,rna splicing modulation,epigenetic modification,oncogenic transformation,cellular proliferation
ENSG00000091656,ZFHX4,cell cycle regulation,transcriptional regulation,apoptosis modulation,tumor suppressor function,mutation-driven oncogenesis,dna repair dysregulation
ENSG00000277462,ZNF670,krab domain-containing protein family,zinc finger motifs,dna binding regulation,cell proliferation enhancement,tumor metastasis driver,chromatin remodeling complex interactions
ENSG00000187024,PTRH1,tumor suppressor,dephosphorylation activity,signaling pathway regulation,proliferation modulation,cancer development,tyrosine phosphatase activity
ENSG00000103194,USP10,deubiquitinating enzyme function,tumor suppressor,cell cycle regulation,immune modulation,dna repair pathway,protein stabilization
ENSG00000008130,NADK,cell metabolism regulation,oncogenic potential,interactions with other pathways,protein-protein interactions,metabolic reprogramming,glycolytic shift
ENSG00000153066,TXNDC11,cell signaling pathway modulation,oncogene overexpression,redox balance regulation,protein stability modulation,tumor aggressiveness enhancement,pi3k/akt pathway activation
ENSG00000104549,SQLE,cholesterol biosynthesis,enzyme regulation,lipid metabolism,cell proliferation,apoptosis induction,sterol synthesis
ENSG00000197324,LRP10,cell surface receptor function,overexpression,tumor progression,metastasis,immune response modulation,inflammation regulation
ENSG00000142082,SIRT3,mitochondrial regulation,cellular metabolism modulation,oncogenic potential,tumor suppressor activity,apoptosis regulation,energy production regulation
ENSG00000182318,ZSCAN22,tumor suppressor function,inhibition of cell proliferation,dna-binding activity,regulation of apoptosis,interactions with e2f1 and p53,dysregulation in pancreatic
ENSG00000181894,ZNF329,tumor suppression,dna binding,krab domain,c2h2 zinc finger motifs,gene expression regulation,apoptosis inhibition
ENSG00000073670,ADAM11,tumor progression,cell adhesion disruption,proteolytic activity,oncogenic role,metastasis promotion,cell migration facilitation
ENSG00000132744,ACY3,lipid biosynthesis,tumor growth,metabolic regulation,therapeutic target,cellular energy metabolism,oncogenic driver
ENSG00000116754,SRSF11,alternative splicing,cancer progression,chromatin remodeling,dna repair mechanisms,gain-of-function mutations,rna processing regulation
ENSG00000171291,ZNF439,zinc finger protein,transcription regulation,dna binding,tumor suppression,cell cycle regulation,oncogenesis
ENSG00000161847,RAVER1,pi3k/akt interaction,mutations leading to overexpression,rna-binding regulation,tumor progression promotion,gene expression modulation,cell proliferation enhancement
ENSG00000175329,ISX,chromatin remodeling,transcriptional regulation,histone modification,cell differentiation,oncogenic process,tumor growth
ENSG00000288210,ASF1B,histone regulation,chromatin remodeling,tumor progression,dna repair,cell cycle progression,genomic instability
ENSG00000186564,FOXD2,oncogenic transcription factor,wnt/β-catenin pathway activation,cell proliferation promotion,tumor progression driver,transcriptional regulation,sox2/bmi1 interaction
ENSG00000138311,ZNF365,tumor suppressor activity,cell cycle regulation,dna damage response,genomic stability,apoptosis regulation,transcriptional repression
ENSG00000072864,NDE1,microtubule dynamics,tumor suppressor function,chromosomal instability,mitotic spindle formation,centrosome regulation,genomic alterations
ENSG00000170374,SP7,bone development regulation,transcriptional activation,oncogenesis,apoptosis inhibition,wnt/β-catenin pathway interaction,tumor progression
ENSG00000164488,DACT2,wnt/β-catenin pathway disruption,loss of function mutations,tumor suppressor role,cell proliferation regulation,epigenetic regulation,transcriptional repression
ENSG00000253548,PYDC2,dual specificity tyrosine phosphatase activity,pi3k/akt pathway regulation,oncogenic signaling,cell proliferation enhancement,metastasis promotion,protein kinase activation
ENSG00000148688,RPP30,protein synthesis,cell growth regulation,precursor trna processing,apoptosis regulation,therapeutic target,genome instability
ENSG00000136986,DERL1,erad pathway,protein aggregation,tumor cell survival,apoptosis resistance,metastasis promotion,therapeutic target
ENSG00000101463,SYNDIG1,tumor progression,cell adhesion disruption,cell surface receptor interaction,extracellular matrix modulation,aggressive cell migration,biomarker significance
ENSG00000167693,NXN,p53 degradation,cellular signaling regulation,transcriptional regulation,tumor suppressor interaction,protein complex formation,wnt/β-catenin pathway modulation
ENSG00000112290,WASF1,arp2/3 complex activation,cancer metastasis,cell migration,epithelial-to-mesenchymal transition (emt),genetic mutation,prognostic marker
ENSG00000146830,GIGYF1,oncogenic processes,protein synthesis regulation,cell cycle progression,tumor growth promotion,metastasis facilitation,genetic mutations associated
ENSG00000105771,SMG9,nmd pathway regulation,tumor suppressor function,aberrant mrna degradation,genomic integrity maintenance,cellular stress response,protein quality control
ENSG00000242616,GNG10,signaling regulation,guanylate-binding protein subunit,cellular trafficking,oncogenic pathway regulation,tumor growth and metastasis,signal transduction pathways
ENSG00000139133,ALG10,altered n-glycosylation,impaired dolichol phosphate transfer,cell growth regulation,genetic instability,oncogenic transformation,tumor development
ENSG00000196422,PPP1R26,regulatory subunit,aberrant activation,cell cycle modulation,transcriptional regulation,signal transduction,oncogenic processes
ENSG00000177239,MAN1B1,glycoprotein processing,endoglycosidic cleavage,mannosidase activity,tumor progression,cell signaling,glycosylation pathways
ENSG00000206395,DDAH2,vascular regulation,adma modulation,angiogenesis promotion,metastasis facilitation,nitric oxide signaling,tumor progression
ENSG00000143570,SLC39A1,altered zinc homeostasis,pi3k/akt pathway activation,cellular metabolism regulation,tumor progression facilitation,therapeutic target identification,stem cell-like property modulation
ENSG00000100209,HSCB,endoplasmic reticulum localization,molecular chaperone function,protein-protein interactions,cellular homeostasis regulation,tumor cell proliferation,oncogenic protein interaction
ENSG00000067646,ZFY,transcriptional regulation,cell growth and differentiation,apoptosis regulation,gene expression modulation,tumorigenesis influence,therapeutic target candidate
ENSG00000149474,KAT14,histone demethylation,chromatin regulation,cell cycle progression,genomic instability,dna replication rates,transcriptional modulation
ENSG00000257218,GATC,transcription factor,cellular regulation,tumor suppressor/oncogene,epithelial cell maintenance,apoptosis regulation,cell cycle control
ENSG00000130348,QRSL1,chromosomal instability,genome maintenance disruption,aneuploidy promotion,tumor progression,epigenetic regulation,cell cycle dysregulation
ENSG00000242515,UGT1A10,metabolic regulation,tumor suppression,detoxification pathway,enzymatic activity,glycosylation,cell detoxification
ENSG00000167165,UGT1A6,ugt-mediated glucuronidation,detoxification process,metabolic reprogramming,drug metabolism,bilirubin conjugation,cancer metabolism
ENSG00000196659,TTC30B,genomic instability,chromatin regulation,spindle assembly checkpoint disruption,protein degradation dysregulation,ubiquitin-proteasome system interaction,gene expression modulation
ENSG00000111906,HDDC2,dna damage repair,genomic stability maintenance,tumor mutational burden modulation,therapeutic target identification,cellular process regulation,cancer driver gene role
ENSG00000184575,XPOT,mrna export regulation,oncogenic function,nuclear protein interaction,cancer progression facilitation,cellular proliferation enhancement,metastasis promotion
ENSG00000123106,CCDC91,pi3k/akt/mtor pathway,cell growth regulation,oncogenic potential,tumor progression,cellular interaction,genetic mutation
ENSG00000170454,KRT75,cell cycle regulation,mitotic progression,epithelial cell integrity,oncogene overexpression,chromosomal stability,pi3k/akt signaling interaction
ENSG00000156928,MALSU1,oncogene activation,ubiquitin-proteasome pathway regulation,protein degradation dysregulation,cellular proliferation promotion,tumor progression involvement,genomic instability contribution
ENSG00000146416,AIG1,histone acetyltransferase function,nuclear localization,cell cycle regulation,apoptosis modulation,genomic stability maintenance,oncogenic potential
ENSG00000125629,INSIG2,cholesterol biosynthesis regulation,oncogenic signaling,lipid metabolism modulation,tumor progression association,biomarker potential,statin responsiveness
ENSG00000170465,KRT6C,tumor progression,loss of function mutations,cellular fragility,cytokeletal disruption,epithelial integrity loss,signaling pathway interaction
ENSG00000079102,RUNX1T1,genetic fusion,transcriptional regulation,cell proliferation,leukemogenesis,tumor suppressor dysregulation,cytogenetic abnormality
ENSG00000185567,AHNAK2,epithelial-to-mesenchymal transition (emt),constitutive activation,cell-cell adhesion suppression,cytoskeleton disruption,metastatic progression,therapeutic target
ENSG00000189114,BLOC1S3,melanosome biogenesis,protein localization,cellular transport regulation,oncogenic potential,tumor suppressor function,melanin production regulation
ENSG00000197191,CYSRT1,protein regulation,tumor suppression,misfolded protein accumulation,cellular homeostasis disruption,oncogene activation,cancer progression
ENSG00000150457,LATS2,tumor suppressor function,cell growth regulation,hippo signaling pathway,pi3k/akt/mtor pathway modulation,oncogenic mutations,poor prognosis association
ENSG00000198088,NUP62CL,nucleocytoplasmic transport,dna damage response,cell cycle regulation,genomic instability,cancer driver gene,pan-cancer association
ENSG00000107438,PDLIM1,oncogene,tumor progression,cell migration,cytoskeletal dynamics,signaling molecule interaction,therapeutic target
ENSG00000008056,SYN1,neurotransmitter release regulation,synaptic vesicle trafficking modulation,overexpression in tumors,cell proliferation enhancement,poor prognostic marker,pi3k/akt pathway interaction
ENSG00000178397,FAM220A,cellular regulation,oncogenic transformation,cell growth and proliferation,tumor progression,cancer driver gene,genetic alterations
ENSG00000148773,MKI67,cell cycle regulation,oncogene function,proliferation marker,dna replication,therapeutic target,genomic instability
ENSG00000280610,KIF15,genomic instability,mitotic regulation,kinetochore function,microtubule dynamics,cell cycle progression,apoptosis suppression
ENSG00000115561,CHMP3,multivesicular body formation,tumor progression,cell proliferation enhancement,oncogenic pathway activation,apoptosis inhibition,dna repair mechanism disruption
ENSG00000171045,TSNARE1,snare complex assembly,gene mutations,tumor progression,therapeutic target,mitochondrial regulation,cell migration
ENSG00000175115,PACS1,regulatory mechanism,cell proliferation,protein degradation,oncogenic processes,signaling pathway modulation,tumor progression 
ENSG00000197081,IGF2R,tumor suppressor,genomic stability,cell proliferation inhibition,igf signaling regulation,oncogenic processes suppression,cancer prognosis biomarker
ENSG00000203985,LDLRAD1,genomic instability,dna damage response,chromatin remodeling,telomere maintenance,homologous recombination,oncogenesis
ENSG00000102870,ZNF629,krab-containing protein,transcriptional regulation,zinc finger domain,chromatin remodeling,oncogenic processes,epigenetic modifications
ENSG00000024048,UBR2,protein degradation,cell cycle progression,dna repair mechanisms,oncogenic signaling,ubiquitination regulation,genomic stability
ENSG00000170681,CAVIN4,caveolae membrane,pi3k regulation,cell growth modulation,lipid metabolism,oncogenic signaling pathway,tumor suppression
ENSG00000106459,NRF1,metabolic reprogramming,nuclear-encoded mitochondrial gene regulation,transcription factor activity,cellular respiration,oncogenic process promotion,therapeutic target
ENSG00000179044,EXOC3L1,enhanced cell proliferation,regulatory mechanism disruption,tumorigenesis association,wnt/β-catenin pathway interaction,mapk signaling dysregulation,exocyst complex component
ENSG00000108733,PEX12,energy metabolism disruption,peroxisomal biogenesis pathway,fatty acid beta-oxidation impairment,oxidative stress induction,autophagy dysregulation,tumor metabolism alteration
ENSG00000103089,FA2H,lipid metabolism alteration,cell signaling,energy regulation,metabolic dysregulation,cell growth enhancement,genomic instability
ENSG00000133313,CNDP2,redox regulation,glutathione metabolism,oncogene activation,cell cycle progression,dna repair modulation,chemotherapy resistance
ENSG00000107949,BCCIP,genomic stability maintenance,homologous recombination repair,cell cycle regulation,tumor suppressor function,oncogenic driver,genomic instability induction
ENSG00000164761,TNFRSF11B,rankl decoy receptor,tumor growth promotion,immune modulation,bone resorption inhibition,osteoclast regulation,cancer-related downregulation
ENSG00000089177,KIF16B,microtubule-based motor protein,mitotic spindle assembly,chromosome segregation,cell proliferation,oncogenic process,therapeutic target
ENSG00000163762,TM4SF18,cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt),metastatic potential,tumor aggressiveness promoter,transmembrane glycoprotein function,cell migration regulator
ENSG00000120549,KIAA1217,tumor suppressor dysfunction,genomic instability,cell cycle regulation disruption,potential oncogene role,cell cycle checkpoint disruption,protein-protein interaction modification
ENSG00000115468,EFHD1,tumor progression,epithelial-to-mesenchymal transition,cell-cell adhesion,protein-protein interaction,angiogenesis,metastasis
ENSG00000164144,ARFIP1,rho gtpase regulation,tumor suppressor function,mitogen-activated protein kinase pathway interaction,cytoskeletal remodeling,membrane trafficking modulation,cell proliferation promotion
ENSG00000144724,PTPRG,tumor suppressor function,cell adhesion regulation,tyrosine kinase receptor inactivation,cell migration modulation,metastatic suppression,loss-of-function mutations
ENSG00000203896,LIME1,lim domain only 1,transcription factor regulation,hematopoietic development,cell cycle progression,epigenetic regulation,chromatin remodeling
ENSG00000184210,DGAT2L6,triglyceride biosynthesis,enhanced cell proliferation,oncogenic reprogramming,genetic mutations,lipid metabolic regulation,protein-protein interactions
ENSG00000117410,ATP6V0B,atpase regulation,cellular ph maintenance,proton translocation,tumor cell survival,autophagy regulation,pi3k/akt pathway interaction
ENSG00000100139,MICALL1,cellular growth regulation,oncogene function,tumor suppressor activity,metastasis regulation,cell cycle progression,transcriptional regulation
ENSG00000183621,ZNF438,cell cycle regulation,tumor suppressor activity,e3 ubiquitin ligase activity,promoter binding,oncogene activation,cancer biomarker
ENSG00000137876,RSL24D1,pi3k/akt signaling,oncogene overexpression,ribosome assembly regulation,cell proliferation enhancement,protein synthesis promotion,tumor suppressor interaction
ENSG00000125351,UPF3B,mrna surveillance,genomic instability,cellular stress,protein misfolding,transcriptional regulation,dna repair
ENSG00000112309,B3GAT2,dysregulated,oncogene,tumor progression,cell adhesion regulation,glycosylation pathway,therapeutic target
ENSG00000128266,GNAZ,g protein signaling pathway,gain of function mutations,signal transduction regulation,tumor progression modulation,oncogenic pathway alteration,cell growth regulation
ENSG00000263101,KRTAP3-3,intermediate filament regulation,cellular integrity maintenance,keratin-associated protein function,aberrant expression in cancer,epithelial-to-mesenchymal transition involvement,altered cell signaling pathways
ENSG00000077080,ACTL6B,chromatin remodeling,epigenetic modifications,oncogenic processes,aberrant cell growth,transcriptional regulation,tumor progression
ENSG00000175334,BANF1,chromosome instability,dna repair mechanisms,genomic stability maintenance,cell cycle progression modulation,apoptosis dysregulation,transcriptional regulation interaction
ENSG00000184486,POU3F2,dna damage response,transcriptional regulation,cell proliferation,oncogenic regulation,tumor suppression pathways,none
ENSG00000100146,SOX10,transcriptional regulator,oncogenic transformation,stem cell maintenance,epithelial-to-mesenchymal transition,cell cycle regulation,dna repair modulation
ENSG00000196531,NACA,chromatin remodeling,tumor suppressor regulation,oncogene activation,histone modification,transcriptional regulation,nucleosome assembly
ENSG00000136279,DBNL,actin binding protein,cell migration regulation,cytoskeletal organization,genomic stability modulation,metastatic behavior modification,tumor cell invasion promotion
ENSG00000182087,TMEM259,tumor suppressor,loss-of-function mutations,cell membrane integrity,endocytosis regulation,autophagy modulation,lysosomal function disruption
ENSG00000108551,RASD1,ras protein activation,constitutive signaling,oncogenic potential,cell proliferation,tumorigenesis,mapk/erk pathway
ENSG00000128881,TTBK2,centrosome duplication,microtubule stability,spindle checkpoint regulation,cell cycle progression,dna repair regulation,pi3k/akt signaling modulation
ENSG00000110274,CEP164,centrosome amplification,microtubule stability,cell proliferation,oncogenic processes,ciliogenesis regulation,tumor suppression
ENSG00000031081,ARHGAP31,rhogtpase regulation,tumor suppressor function,pi3k/akt pathway modulation,cell proliferation control,oncogene suppression,cytoskeleton reorganization
ENSG00000276234,TADA2A,tumor suppressor function,genomic instability,cell cycle regulation,chromatin remodeling,dna repair pathways,transcriptional regulation
ENSG00000054116,TRAPPC3,ergic to golgi transport,copii vesicle formation,endoplasmic reticulum-golgi intermediate compartment regulation,cellular protein transport regulation,vesicle-mediated protein export,tumor progression and cell proliferation enhancement
ENSG00000256660,CLEC12B,carbohydrate recognition,immune modulation,transmembrane receptor,cell surface localization,lectin domain,cancer immune evasion
ENSG00000215193,PEX26,peroxisomal biogenesis,oncogenic pathway activation,vlcfa accumulation,genetic disorder association,protein function impairment,cellular organelle dysfunction
ENSG00000139970,RTN1,pi3k/akt/mtor pathway activation,cell survival enhancement,metastasis promotion,oncogenic activity,autophagy regulation,cellular stress response modulation
ENSG00000096070,BRPF3,chromatin remodeling,transcriptional regulation,genomic instability,cell cycle progression,apoptosis evasion,prognostic marker
ENSG00000119938,PPP1R3C,regulatory subunit function,glycogen metabolism regulation,protein phosphatase 1 interaction,oncogenic pathway modulation,tumor progression contribution,metabolic reprogramming
ENSG00000132792,CTNNBL1,histone modification,protein-protein interaction,cytoskeleton organization,tumor progression,wnt signaling pathway,genomic instability
ENSG00000100219,XBP1,er stress response,unfolded protein response,cell survival enhancement,apoptosis suppression,gene regulation dysregulation,tumor progression promotion
ENSG00000281861,SLC9A3,nhe3 overexpression,pi3k/akt pathway activation,ion homeostasis disruption,tumor aggressiveness,cell growth promotion,metabolic reprogramming
ENSG00000166927,MS4A7,tumor microenvironment modulation,immune regulation,cell signaling pathway disruption,prognostic marker,aggressive disease course,poor prognosis
ENSG00000137875,BCL2L10,anti-apoptotic function,mitochondrial regulation,apoptosis inhibition,cell survival promotion,oncogenic potential,tumor suppressor protein
ENSG00000155099,PIP4P2,pi(3,5)p2 regulation,cell signaling pathway,oncogenic properties,cell proliferation driver,endocytosis regulation
ENSG00000144451,SPAG16,mitotic spindle assembly,chromosomal stability,cell cycle progression,apoptosis resistance,genomic integrity maintenance,microtubule dynamics regulation
ENSG00000139437,TCHP,transcriptional regulation,thyroid hormone receptor alpha interaction,coactivator function,cell growth promotion,tumor progression,gene expression modulation
ENSG00000184271,POU6F1,tumor suppressor,transcriptional regulation,cell cycle inhibition,apoptosis promotion,therapeutic target,genomic instability
ENSG00000136451,VEZF1,oncogene activity,epithelial-to-mesenchymal transition,transcription factor regulation,cell proliferation promotion,metastasis facilitation,chromatin remodeling
ENSG00000197062,ZSCAN26,zinc finger protein regulation,tumor suppressor function,dna binding activity,cell cycle control,apoptosis modulation,tumor progression
ENSG00000159063,ALG8,dysregulated glycosylation,cell proliferation enhancer,tumor aggressiveness promoter,oncogenic mutation driver,glycoprotein biosynthesis enzyme,poor prognosis marker
ENSG00000163646,CLRN1,mechanotransduction,protein-protein interactions,cellular homeostasis,cell growth regulation,hearing loss,limited cancer relevance
ENSG00000167971,CASKIN1,cellular regulation,calcium/calmodulin-dependent interactions,oncogenic mutations,tumor progression,therapeutic target,genomic instability 
ENSG00000138175,ARL3,oncogenic regulation,gtp-binding protein function,protein complex assembly,cell proliferation promotion,tumor progression facilitation,overexpression in cancer
ENSG00000167535,CACNB3,voltage-gated calcium channel regulation,cell proliferation enhancement,signaling pathway modulation,protein-protein interaction,genetic alteration contribution,prognostic marker potential
ENSG00000115138,POMC,melanocortin regulation,tumor growth promotion,energy metabolism dysregulation,cellular proliferation modulation,precursor protein processing,signaling pathway interaction
ENSG00000100299,ARSA,lipid metabolism dysfunction,aberrant cellular signaling,oncogenic process activation,lysosomal enzyme function,cellular proliferation promotion,tumor suppressor gene dysregulation
ENSG00000250565,ATP6V1E2,acidic extracellular environment,hypoxia adaptation,proton pumping activity,tumor growth promotion,angiogenesis facilitation,mitochondrial dysfunction
ENSG00000182938,OTOP3,metastasis regulation,cell proliferation,transcriptional regulation,oncogenesis,apoptosis evasion,cell cycle progression
ENSG00000134152,KATNBL1,cell cycle regulation,tumor suppressor function,apoptosis inhibition,cell proliferation promotion,p53 interaction stabilization,genomic instability association
ENSG00000107560,RAB11FIP2,rab gtpase regulation,cell migration,oncogenic potential,guanine nucleotide exchange factor (gef),endocytic recycling,aberrant expression
ENSG00000180938,ZNF572,krab-znf family,chromatin regulation,epigenetic modification,oncogenic function,tumor suppressor repression,histone methylation
ENSG00000152475,ZNF837,tumor suppressor function,krab domain-containing transcription factor,zinc finger protein binding,dna sequence recognition,corepressor recruitment,cell proliferation inhibition
ENSG00000106025,TSPAN12,pi3k/akt pathway interaction,tumor progression promotion,chemotherapy resistance enhancement,cell adhesion modulation,metastasis facilitation,oncogenic function involvement
ENSG00000004961,HCCS,histone modification,epigenetic regulation,chromatin remodeling,oncogenesis,cell proliferation,metastatic potential
ENSG00000198298,ZNF485,transcriptional regulation,dysregulated expression,cellular transformation,oncogenic processes,gene expression profiling,protein-protein interactions
ENSG00000181638,ZFP41,tumor suppressor regulation,transcriptional activation,chromatin modification,oncogene activation,poor prognosis marker,gene silencing
ENSG00000128656,CHN1,protein phosphorylation,cell signaling pathways,transcription factor regulation,cell proliferation,therapeutic target,cancer metastasis
ENSG00000126878,AIF1L,immune regulation,cancer cell migration,actin cytoskeleton regulation,tumor progression,prognostic marker,cell signaling modulation
ENSG00000122859,NEUROG3,constitutive activation,gain of function mutations,transcriptional regulator,tumor progression,cell growth regulation,wnt/β-catenin pathway interaction
ENSG00000085999,RAD54L,homologous recombination,dna damage repair,genomic instability,chromosomal aberration,tumor suppressor function,cancer resistance
ENSG00000175455,CCDC14,mitotic spindle assembly,genomic instability,kinetochore function,microtubule regulation,aneuploidy,oncogenic overexpression
ENSG00000107890,ANKRD26,cell cycle regulation,nuclear localization,oncogenic function,cell proliferation,g2/m phase transition,genomic instability
ENSG00000166860,ZBTB39,tumor suppression,apoptosis regulation,genome instability,cell cycle control,dna binding,transcriptional repression
ENSG00000104660,LEPROTL1,genome stability maintenance,dna damage response regulation,tumor suppression,cell cycle regulation,genomic instability prevention,protein interaction network
ENSG00000172007,RAB33B,vesicular transport regulation,oncogenic process involvement,cell growth modulation,cancer driver potential,aberrant protein regulation,membrane trafficking role
ENSG00000198833,UBE2J1,ubiquitination pathway,protein degradation,cell cycle regulation,tumor progression,genetic instability,dna damage repair
ENSG00000125817,CENPB,kinetochore assembly,aneuploidy,genome instability,biomarker potential,cancer cell survival,tumor progression
ENSG00000189030,VHLL,hif regulation,tumor suppressor function,ubiquitin ligase activity,oncogenic signaling pathway,cell survival enhancement,angiogenesis promotion
,HIST1H2AC,histone modification regulation,epigenetic control,chromatin remodeling,tumor progression,biomarker potential,chromatin packaging
ENSG00000266173,STRADA,loss-of-function mutations,constitutive activation,oncogenic processes,tumor suppressor,therapeutic target,metabolic reprogramming
ENSG00000177602,HASPIN,chromosomal instability,cell proliferation,mitotic spindle regulation,cytokinesis regulation,angiogenesis promotion,protein kinase activation
ENSG00000186204,CYP4F12,cancer metabolism,tumor suppressor activity,fatty acid hydroxylase activity,eicosanoid regulation,anti-proliferative effects,cell cycle regulation
ENSG00000171219,CDC42BPG,gef activation,cancer cell proliferation,cell migration regulation,actin cytoskeleton remodeling,oncogenic signaling pathway activation,tumor progression
ENSG00000197959,DNM3,endocytosis regulation,mitotic spindle assembly,microtubule dynamics modulation,tumor progression facilitation,cell proliferation enhancement,signaling pathway modulation
ENSG00000182156,ENPP7,cellular proliferation,oncogenic pathway,extracellular nucleotide regulation,tumor progression,prognostic marker,nucleotide metabolism
ENSG00000143418,CERS2,ceramide biosynthesis,pi3k/akt signaling,oncogenic potential,cell proliferation,apoptosis resistance,glycolytic reprogramming
ENSG00000128011,LRFN1,cell adhesion,metastasis facilitation,tumor progression support,ligand interaction,angiogenesis promotion,protein-protein interaction
ENSG00000167315,ACAA2,altered lipid metabolism,oncogene activation,genomic amplification,tumor microenvironment modulation,immune evasion,therapeutic target
ENSG00000169981,ZNF35,cellular regulation,tumor suppression,transcriptional modulation,apoptosis induction,genotoxic stress response,chromatin remodeling
ENSG00000261857,MIA,apoptosis inhibition,angiogenesis regulation,cell migration promotion,emt induction,metastasis enhancement,protein-protein interaction
ENSG00000111596,CNOT2,oncogene activation,mrna regulation,deadenylation complex,cell proliferation,apoptosis suppression,genetic instability
ENSG00000163166,IWS1,autophagy regulation,cancer cell survival,tumor growth promotion,cellular recycling,protein regulation,transcriptional control
ENSG00000147874,HAUS6,cell cycle regulation,protein degradation,ciliogenesis,oncogenic processes,tumorigenesis,cellular signaling
ENSG00000137814,HAUS2,microtubule nucleation,genomic instability,cell division regulation,tumor suppression loss,tumorigenesis driver,mitotic spindle organization
ENSG00000021762,OSBPL5,aberrant lipid metabolism,autophagic regulation,er dysfunction,protein misfolding response,lipid synthesis modulation,cellular stress response
ENSG00000138109,CYP2C9,drug metabolism,genetic polymorphisms,enzymatic activity alteration,pro-carcinogen metabolism,target for therapeutic interventions,tissue expression regulation
ENSG00000115850,LCT,cellular proliferation,protein-protein interactions,immune response modulation,cell adhesion regulation,signaling pathway interaction,tumor progression facilitation
ENSG00000100902,PSMA6,proteasome function,unfolded protein response,cellular stress,oncogene activation,tumor growth,cell cycle regulation
ENSG00000198523,PLN,calcium cycling regulation,oncogenic signaling,cell proliferation enhancement,apoptosis inhibition,signaling pathway modulation,metabolic regulation
ENSG00000186193,SAPCD2,glycosylation dysregulation,cell proliferation enhancement,oncogenic transformation,metastasis promotion,therapeutic target potential,glycobiology pathway interaction
ENSG00000132661,NXT1,chromatin remodeling,genome instability,oncogene activation,epigenetic regulation,tumor suppressor repression,cell cycle progression
ENSG00000078403,MLLT10,swi/snf complex,chromatin remodeling,tumor suppressor protein interaction,histone modification,apoptosis regulation,dna repair pathway
ENSG00000174796,THAP6,chromatin remodeling,transcriptional regulation,tumor growth promotion,apoptosis suppression,angiogenesis enhancement,epigenetic modulation
ENSG00000104369,JPH1,muscle cell integrity,myopathy association,cellular interaction,structural regulation,cellular disruption,potential oncogenesis
ENSG00000116350,SRSF4,alternative splicing regulation,biomarker potential,cancer cell proliferation,cellular metastasis regulation,oncogenic protein expression,spliceosome complex interaction
ENSG00000148248,SURF4,cellular growth regulation,mutation driver,tumor suppressor function,protein-protein interactions,ribosomal protein assembly,dysregulated translation
ENSG00000183258,DDX41,wnt/β-catenin signaling pathway,constitutive activation,gain of function mutations,genomic instability,oncogenic driver,rna helicase activity
ENSG00000111291,GPRC5D,calcium signaling pathway,constitutive activation,loss of function mutations,cell proliferation,tumor formation,signaling modulation
ENSG00000175489,LRRC25,transmembrane protein,cell adhesion and migration,leucine-rich repeat family member,tumor progression candidate,cancer gene expression profiled,cell signaling pathway interaction
ENSG00000060339,CCAR1,tumor progression,cell proliferation,therapeutic target,oncogenesis,coactivator function,protein interaction
ENSG00000157851,DPYSL5,microtubule stability,tumor progression,genomic instability,cell proliferation,cancer-related signaling,protein-protein interaction
ENSG00000092964,DPYSL2,microtubule regulation,microtubule dynamics stability,cellular structure organization,aberrant cell division,resistance to therapy,cancer cell proliferation
ENSG00000116729,WLS,wnt signaling pathway,dysregulated expression,gain of function mutations,tumor progression,therapeutic target,cellular processes
ENSG00000120647,CCDC77,oncogenic transformation,tumor progression,cell proliferation,cell migration,gene expression regulation,protein-protein interaction
ENSG00000145833,DDX46,microrna regulation,apoptosis pathway interaction,cell cycle regulation,transcriptional control,rna processing function,dna repair involvement
ENSG00000173960,UBXN2A,cullin-ring ligase regulation,tumor suppressor function,nedd8 conjugation,proteasomal degradation,cell cycle progression,apoptosis modulation
ENSG00000067445,TRO,tumor progression,oncogenesis,cell migration,metastasis,apoptosis regulation,gene expression modulation
ENSG00000105605,CACNG7,adhesion regulation,cell adhesion molecule,cell migration,oncogenesis,scaffolding protein,signaling pathway modulation
ENSG00000068745,IP6K2,cellular growth,constitutive activation,oncogene potential,phosphorylation activity,signaling pathway regulation,cell cycle modulation 
ENSG00000065621,GSTO2,cell proliferation,glutathione metabolism,oxidative stress response,tumor growth promotion,apoptosis inhibition,chemotherapy resistance
,WRB,pan-cancer association,nuclear envelope reassembly,membrane fusion,lipid metabolism regulation,oncogenic driver,cell proliferation
ENSG00000109272,PF4V1,angiogenesis promotion,thrombin generation,platelet aggregation,tumor cell adhesion,poor prognosis marker,therapeutic target
ENSG00000165685,TMEM52B,ion transport regulation,cellular homeostasis maintenance,tumor suppressor or oncogene potential,pi3k/akt signaling pathway involvement,apoptosis and migration regulation,cell cycle checkpoint regulation
ENSG00000174453,VWC2L,cell surface localization,cell adhesion modulation,tumor progression promotion,metastasis facilitation,integrin interaction,extracellular matrix protein binding
ENSG00000180872,DEFB112,immune modulation,antimicrobial activity,cell membrane disruption,tumor progression,innate immunity,cancer immunology
ENSG00000166881,NEMP1,tumor microenvironment regulation,cell adhesion modulation,apoptosis regulation,protein-protein interaction,cell migration influence,serine protease inhibition
ENSG00000178726,THBD,thrombin regulation,coagulation regulation,tumor progression,pro-coagulant activity,signaling pathway interaction,anticoagulant imbalance
ENSG00000137812,KNL1,chromosomal instability,aneuploidy,mitotic checkpoint dysregulation,genomic instability,chromosome segregation errors,kinase activity
,KCNA6,calcium signaling,voltage-gated potassium channels,cell proliferation regulation,ion channel function,apoptosis evasion,electrical excitability
ENSG00000166145,SPINT1,tumor suppressor function,anti-angiogenic effects,apoptosis induction,cell proliferation inhibition,protein-protein interaction,signaling pathway regulation
ENSG00000126756,UXT,protein assembly,chaperone function,oncogenic protein regulation,ubiquitin-proteasome pathway modulation,tumorigenesis promotion,genomic instability
ENSG00000111237,VPS29,vps complex subunit,escrt-i component,protein trafficking regulation,autophagy modulation,oncogenic protein degradation,tumor suppressor regulation
ENSG00000006042,TMEM98,cell-cell adhesion disruption,oncogenic pathway activation,therapeutic target potential,cell cycle regulation influence,apoptosis modulation impact,prognostic biomarker significance
ENSG00000143032,BARHL2,barhl2 plays a crucial role in,wnt/β-catenin signaling inhibition,tumor suppression,cellular differentiation,epithelial-to-mesenchymal transition (emt),transcription factor activity
ENSG00000205060,SLC35B4,nucleotide sugar transport,cell proliferation,glycosylation regulation,tumor progression,metastasis promotion,therapeutic target
ENSG00000147654,EBAG9,tumor progression,cell proliferation,apoptosis regulation,transcriptional modulation,metabolic regulation,oncogene activation
ENSG00000151379,MSGN1,wnt/β-catenin pathway,tumor progression,metastasis,epithelial-to-mesenchymal transition (emt),cell migration,therapeutic target
ENSG00000179826,MRGPRX3,g-protein coupled receptor,pain perception regulation,oncogenic driver,tumor progression facilitation,angiogenesis promotion,inflammatory response modulation
ENSG00000258724,PINX1,telomere maintenance,tumor suppressor,dna damage response,nhej pathway regulation,genomic instability,telomeric repeat degradation
ENSG00000112212,TSPO2,mitochondrial function regulation,cellular stress modulation,cholesterol transport regulation,metabolic dysregulation,cancer cell survival enhancement,tumor aggressiveness promotion
ENSG00000176248,ANAPC2,chromosomal instability,cell proliferation,oncogenic driver,unchecked cyclin-dependent kinases,genomic alterations,loss-of-function mutations
ENSG00000160993,ALKBH4,dna damage response,genomic instability,alkylation repair,cellular proliferation,tumor suppressor function,regulatory protein interactions
ENSG00000123130,ACOT9,lipid metabolism regulation,fatty acid oxidation,oncogenic potential,tumor suppressor role,cellular signaling pathways modulation,metabolic homeostasis disruption
ENSG00000041515,MYO16,cell migration,tumor progression,epithelial origin,metastasis regulation,cancer metastasis,actin cytoskeleton modulation
ENSG00000274829,PARN,rna degradation,oncogene or tumor suppressor,polyadenylation regulation,mrna stability modulation,genome maintenance,dna repair pathway interaction
ENSG00000135698,MPHOSPH6,phosphorylation regulation,protein kinase activation,oncogenic process,cell proliferation,cancer cell growth,cell survival enhancement
ENSG00000171824,EXOSC10,tumor suppressor,oncogene potential,rna degradation regulation,cell growth modulation,apoptosis regulation,autophagy influence
ENSG00000166478,ZNF143,proto-oncogene regulation,chromatin remodeling,transcriptional modulation,genome instability,apoptosis inhibition,dna repair disruption
,SEPT10,chromatin remodeling,cellular structure maintenance,tumor suppressor function loss,cell cycle regulation,oncogenic protein interactions,cancer driver gene
ENSG00000081041,CXCL2,cxcl2 upregulation,tumor progression,immune evasion,angiogenesis enhancement,metastasis promotion,chemokine signaling pathway
ENSG00000153029,MR1,major histocompatibility complex-related antigen presentation,immune evasion mechanisms,tumor progression regulation,cd4+ t cell modulation,cancer immune suppression,genetic variations in function
ENSG00000101290,CDS2,genomic instability,oncogenesis,dna replication regulation,cell proliferation,nuclear protein function,genome maintenance
ENSG00000158062,UBXN11,regulation of cell cycle,aberrant protein accumulation,tumor suppressor modulation,ubiquitination and degradation,cellular stress responses,protein-protein interactions
ENSG00000105509,HAS1,hyaluronic acid production,cell migration and invasion,therapeutic target,epithelial-to-mesenchymal transition,protein interaction,tumor progression
ENSG00000103044,HAS3,ha production,cell migration,tumor progression,extracellular matrix degradation,angiogenesis promoter,lymphangiogenesis facilitation
ENSG00000176974,SHMT1,one-carbon metabolism,purine synthesis,pyrimidine synthesis,nucleotide synthesis,cellular proliferation,therapeutic target
ENSG00000145354,CISD2,mitochondrial dysfunction,oxidative stress regulation,calcium homeostasis disruption,cell proliferation promotion,oncogenic mutation,cellular stress response pathway interaction
ENSG00000170876,TMEM43,cellular adhesion,cell migration,oncogenic transformation,tumor progression,pi3k/akt pathway modulation,loss of function mutations
ENSG00000064655,EYA2,transcriptional activator,cell proliferation,oncogenesis,cell migration,prognostic marker,metastasis
ENSG00000185742,C11orf87,genomic instability,cell proliferation regulation,oncogenic processes,transcriptional regulation,protein-protein interactions,signaling pathway modulation
ENSG00000104221,BRF2,transcriptional regulation,rna polymerase iii activity,tumor progression,cell proliferation,oncogene function,gene expression
ENSG00000114573,ATP6V1A,lysosomal acidification,oncogene overexpression,cell proliferation,metastasis promotion,ion homeostasis regulation,protein trafficking modulation
ENSG00000166971,AKTIP,pi3k/akt pathway modulation,cancer cell survival,protein-protein interaction,gene expression regulation,metabolic reprogramming,tumor cell proliferation
ENSG00000134962,KLB,tumor microenvironment,fgf23 signaling pathway,cell proliferation regulation,cancer metabolism alteration,promoter of cell growth and survival,tissue mineralization regulator
ENSG00000286112,KYAT1,genomic instability,aneuploidy,chromosomal segregation,centrosome function,kinetochores,spindle checkpoint
ENSG00000263160,TMEM50B,calcium homeostasis regulation,cell migration facilitation,cell signaling modulation,oncogenic process involvement,pi3k/akt pathway interaction,potential therapeutic target
ENSG00000198925,ATG9A,autophagy regulation,cellular homeostasis modulation,oncogenic process facilitation,cell survival enhancement,protein interaction,nutrient sensing pathway involvement
ENSG00000106608,URGCP,p53-dependent pathway,cell cycle regulation,growth arrest,tumor progression,dna damage response,anti-proliferative function
ENSG00000145725,PPIP5K2,pi3k/akt pathway,phosphoinositide kinase activity,cell proliferation regulation,oncogenic driver mutation,tumor suppressor interaction,cellular growth modulation
ENSG00000154957,ZNF18,transcriptional regulation,chromatin remodeling,oncogenic potential,aberrant expression,cell growth modulation,tumor progression
ENSG00000143727,ACP1,apoptosis inhibition,genomic stability maintenance,epigenetic regulation,oncogenesis promotion,cell survival enhancement,chromatin remodeling
ENSG00000110344,UBE4A,cell cycle regulation,ubiquitination pathway,apoptosis modulation,dna repair mechanism,oncogenic driver,protein degradation regulation
ENSG00000005238,FAM214B,mitochondrial fusion,enhanced cell proliferation,oncogenic process,dysregulated metabolism,therapeutic target,cellular energy regulation
ENSG00000175315,CST6,lysosomal function regulation,tumor progression regulation,cell proliferation regulation,cysteine protease inhibition,protein-protein interaction,pi3k/akt pathway modulation
ENSG00000204381,LAYN,cell adhesion,cell migration,protein-protein interaction,signal transduction pathway,metastasis facilitation,gene expression regulation
ENSG00000205808,PLPP6,phosphatase regulation,cell growth modulation,oncogenic pathway interaction,tumor progression,therapeutic target,genomic instability
ENSG00000206394,CLIC1,oncogenic potential,cell proliferation,tumor progression,biomarker expression,protein interaction,cellular localization
ENSG00000156127,BATF,oncogenic transcription factor,cell growth regulation,immune response modulation,genetic reprogramming,tumor microenvironment modification,prognostic marker
ENSG00000126803,HSPA2,cellular homeostasis,mitochondrial localization,chaperone activity,tumor suppressor function,protein stabilization,apoptosis resistance
ENSG00000124279,FASTKD3,mitochondrial function regulation,apoptosis inhibition,cellular energy metabolism regulation,tumor growth promotion,pro-survival signaling pathway activation,reactive oxygen species production modulation
ENSG00000106348,IMPDH1,tumor suppressor,cellular proliferation,rate-limiting enzyme,nucleotide biosynthesis,immune regulation,chemotherapy resistance
ENSG00000169951,ZNF764,cell proliferation regulation,oncogenesis association,transcription factor regulation,epigenetic modification,dna damage response,protein-protein interaction
ENSG00000159210,SNF8,autophagy regulation,mitophagy modulation,escrt-iii complex,cancer driver mutation,cellular homeostasis,protein degradation
ENSG00000100580,TMED8,er stress response,cell signaling pathways,glycoprotein processing,protein quality control,cancer progression,tumor aggressiveness
ENSG00000184752,NDUFA12,mitochondrial dysfunction,energy metabolism alteration,tumor progression,oxidative stress induction,genomic instability increase,cellular metabolic adaptation
ENSG00000179010,MRFAP1,microtubule stability,genomic instability,aneuploidy,mitotic spindle formation,cancer driver,dysregulation
ENSG00000217930,PAM16,genomic instability,tumor suppressor,anaphase-promoting complex regulation,cell cycle checkpoint control,mitotic progression,chromosomal segregation
ENSG00000168334,XIRP1,apoptosis inhibition,genomic instability,cell cycle regulation,tumor progression,multifunctionality,therapeutic target
ENSG00000120265,PCMT1,protein repair and maintenance,cell growth promotion,tumor progression,oncogene stabilization,poor prognosis indicator,aberrant protein methylation
ENSG00000102970,CCL17,tumor-promoting chemokine,ccr4 receptor interaction,lymphocyte recruitment,immune evasion mechanism,tumor microenvironment modulation,cancer progression marker
ENSG00000011485,PPP5C,oncogenic regulator,pi3k/akt pathway regulation,cell proliferation enhancement,transcriptional control disruption,metastasis promotion,protein phosphatase activity
ENSG00000197601,FAR1,checkpoint regulation,g2/m arrest,mitotic progression,bub1 interaction,dna damage response,tumor suppressor function
ENSG00000186889,TMEM17,mitochondrial regulation,cell survival,oncogenic activation,pi3k/akt pathway interaction,autophagy modulation,tumor progression
ENSG00000182979,MTA1,chromatin remodeling,oncogenic function,cell proliferation,transcriptional regulation,metastasis,protein-protein interaction
ENSG00000185608,MRPL40,mitochondrial ribosome assembly,tumor growth enhancement,glycolytic shift,cellular metabolic regulation,mitochondrial dysfunction,oncogenic transformation
ENSG00000077463,SIRT6,genomic instability regulation,cellular metabolism regulation,oncogenic activity,tumor suppressor function,histone modification,chromatin compaction
ENSG00000092531,SNAP23,membrane fusion,cell migration,oncogenic processes,tumor progression,genomic amplification,protein interaction
ENSG00000145911,N4BP3,ubiquitination inhibition,kinase regulation,cell growth promotion,tumor suppressor function loss,cancer cell survival enhancement,protein degradation pathway interference
ENSG00000134369,NAV1,cell adhesion disruption,tumor progression promoter,integrin interactions,neurofascin self-interaction,proliferation enhancement,prognostic marker
ENSG00000176386,CDC26,cell cycle regulation,ubiquitin ligase activity,oncogene activation,cell proliferation enhancement,mitotic cyclin regulation,tumor progression facilitation
ENSG00000181472,ZBTB2,tumor suppressor repression,oncogene activation,cell cycle regulation,apoptosis inhibition,transcriptional modulation,chromatin remodeling
ENSG00000126254,RBM42,regulatory mechanisms,alternative splicing,rna processing,gene expression regulation,cancer driver gene,genomic stability maintenance
ENSG00000171425,ZNF581,chromatin remodeling,cell cycle regulation,apoptosis modulation,tumor suppressor function,mutations and rearrangements,genomic instability
ENSG00000101189,MRGBP,genomic instability,dna repair regulation,oncogene dysregulation,tumor suppression loss,hrr pathway disruption,brca1 interaction
ENSG00000118680,MYL12B,pi3k/akt signaling,oncogenic mutations,cell migration promotion,actin cytoskeleton regulation,cancer progression driver,tumor metastasis enhancement
ENSG00000276480,MYH11,pi3k/akt pathway interaction,amplification/mutation driver,cell proliferation enhancer,smooth muscle contraction regulator,apoptosis inhibitor,genomic amplification marker
ENSG00000162298,SYVN1,ubiquitination,tumor suppressor degradation,apoptosis evasion,oncogene interaction,cell proliferation regulation,poor prognosis marker
ENSG00000176095,IP6K1,pi3k/akt/mtor signaling,cell cycle regulation,constitutive activation,tumor progression,protein kinase activity,genomic amplification
ENSG00000243067,PSMB9,cellular protein degradation,proteasome dysfunction,tumor suppressor regulation,apoptosis inhibition,cell cycle progression,ubiquitin-proteasome pathway
ENSG00000167840,ZNF232,transcriptional regulation,zinc finger domains,cell growth promotion,tumor suppression,apoptosis modulation,dna repair regulation
ENSG00000159267,HLCS,hypoxia response,tumor growth promotion,lipid biosynthesis regulation,multifunctional protein,cancer progression driver,akt/pi3k pathway interaction
ENSG00000134532,SOX5,transcription factor regulation,oncogene activation,epithelial-to-mesenchymal transition,cell proliferation promotion,apoptosis inhibition,chromatin remodeling
ENSG00000136936,XPA,dna damage recognition,genomic stability maintenance,tumor suppressor function,nucleotide excision repair pathway,oncogenesis prevention,cell cycle regulation
ENSG00000087903,RFX2,transcription factor regulation,cell growth promotion,oncogene activation,apoptosis inhibition,chromatin modification,tumor suppressor gene modulation
ENSG00000168824,NSG1,transcriptional regulation,chromatin remodeling,cell cycle progression,apoptosis modulation,tumor suppressor function,genomic instability
ENSG00000168000,BSCL2,lipid metabolism,transmembrane protein,peroxisomal localization,very-long-chain fatty acid synthesis,severe insulin resistance,genomic instability
ENSG00000205439,KRTAP12-3,keratin filament assembly,epithelial cell differentiation,cellular structural integrity,transcriptional regulation,signaling pathway modulation,tissue homeostasis disruption
ENSG00000130770,ATP5IF1,mitochondrial function,proton gradient generation,oxidative phosphorylation,cellular respiration,energy homeostasis regulation,tumor metabolism alteration
ENSG00000280759,AP2A2,cellular regulation,genomic instability,intracellular trafficking,oncogene activation,protein-protein interactions,signal transduction
,GARS,genetic alterations,aberrant protein production,tumor suppressor,protein synthesis regulation,translation initiation,molecular modifications
ENSG00000165376,CLDN2,tumor progression,epithelial-to-mesenchymal transition,cellular migration,protein interaction,tight junction disruption,biomarker potential
ENSG00000112763,BTN2A1,apoptosis modulation,cellular response regulation,chromatin remodeling,histone modification,proliferation pathway modulation,stress response regulation
ENSG00000154127,UBASH3B,e3 ubiquitin ligase adaptor function,cell surface receptor regulation,protein degradation enhancement,oncogenic process involvement,cancer cell proliferation promotion,metastasis facilitation
ENSG00000141934,PLPP2,lipid metabolism regulation,tumor progression driver,mtorc1 pathway modulation,oncogene activation,cell proliferation regulator,prognostic marker
ENSG00000136404,TM6SF1,cellular autophagy,lipid transport regulation,tumor cell growth,oncogenic role,endoplasmic reticulum interaction,metabolic regulation
ENSG00000163466,ARPC2,actin cytoskeleton regulation,dynamical remodeling,cancer cell migration,tumor progression,metastatic potential,protein interaction
ENSG00000155304,HSPA13,oncogene,chaperone activity,cellular stress resistance,protein homeostasis regulation,tumor progression facilitation,biomarker for chemoresistance
ENSG00000180806,HOXC9,cell proliferation regulation,transcriptional regulation,wnt/β-catenin pathway involvement,oncogenic potential,tumor progression facilitation,notch pathway interaction
ENSG00000125618,PAX8,oncogene activation,transcriptional regulation,cell proliferation,tumor progression,stemness maintenance,epithelial cell development
ENSG00000173917,HOXB2,constitutive activation,gain of function mutations,oncogenic transcription factor,tumor progression,epithelial-to-mesenchymal transition (emt),cell proliferation
ENSG00000131013,PPIL4,protein folding,cellular stress response,transcriptional regulation,oncogenesis,chaperone activity,tumor progression
ENSG00000184436,THAP7,chromatin remodeling,gene regulation,cell proliferation,transcription factor activity,apoptosis regulation,dna damage response
ENSG00000125888,BANF2,genomic instability,apoptosis resistance,cell cycle progression,tumor growth promotion,chromatin remodeling,protein-protein interactions
ENSG00000136942,RPL35,ribosomal protein overexpression,translation regulation,cell growth enhancement,tumor progression,protein synthesis upregulation,oncogenic mutations
ENSG00000217128,FNIP1,mtor regulation,tumor suppressor function,loss of function mutations,genomic instability,cell proliferation inhibition,insulin-like growth factor 1 signaling
ENSG00000135823,STX6,cellular environment modulation,oncogenic pathway activation,vesicle fusion regulation,neurotransmitter release regulation,tumor progression promotion,prognostic marker
ENSG00000229802,SLC39A7,zinc homeostasis regulation,tumor progression,cell proliferation,apoptosis inhibition,nf-κb activation,protein-protein interaction
ENSG00000170893,TRH,thyroid hormone regulation,cell proliferation,tumor growth inhibition,energy homeostasis regulation,growth factor receptor activation,emt modulation
ENSG00000281758,KCNIP4,ion channel regulation,cell proliferation regulation,tumor suppression,genetic alterations,cancer development,potassium channel function
ENSG00000114854,TNNC1,actin cytoskeleton regulation,cell migration,protein-protein interactions,tumor progression,signaling pathway modulation,cell proliferation
ENSG00000143977,SNRPG,cellular proliferation,genomic instability,oncogenic potential,gene expression regulation,protein-protein interactions,tumor suppressor suppression
ENSG00000182004,SNRPE,accurate rna splicing,dynamic turnover of snrnp complexes,intronic removal and exonic joining,maintaining genome integrity,proliferation and survival pathways,snrnp assembly and disassembly
ENSG00000176679,TGIF2LY,transcriptional regulation,dual role as tumor suppressor/oncogene,cell growth regulation,chromatin remodeling,apoptosis regulation,tumor progression
ENSG00000166446,CDYL2,chromatin remodeling,tumor suppressor function,epigenetic regulation,gene expression modulation,cell cycle progression,apoptosis inhibition
,DARS,gain-of-function mutations,amino acid metabolism,protein synthesis regulation,cellular homeostasis disruption,tumor progression facilitation,genetic instability promotion
ENSG00000136874,STX17,cell membrane trafficking,receptor recycling,epithelial cell signaling,oncogenic adaptation,tumor progression,therapeutic target
ENSG00000198728,LDB1,chromatin remodeling,tumor progression,ethnically associated,coactivator function,swi/snf complex interaction,epithelial-to-mesenchymal transition
ENSG00000159556,ISL2,tumor progression,epithelial-to-mesenchymal transition,cell invasion,stem cell-like properties,transcription factor regulation,downstream signaling pathway
ENSG00000165533,TTC8,pi3k/akt signaling,oncogenic mutations,cell surface receptor trafficking,membrane protein interactions,cancer progression,tumor growth 
ENSG00000131067,GGT7,oxidative stress,dna damage,epigenetic alterations,tumor progression,cellular detoxification,glutathione metabolism
ENSG00000164237,CMBL,cell surface signaling,immunoregulation,cancer cell proliferation,antitumor immune response,tumor microenvironment regulation,signal transduction pathway modulation
ENSG00000185640,KRT79,altered expression,tumor progression,oncogenic signaling,cancer cell growth,apoptosis resistance,epithelial cell structure
ENSG00000105793,GTPBP10,gtpase regulation,cell proliferation,signaling pathway modulation,tumor progression,oncogene activation,dysregulation
ENSG00000185905,C16orf54,pi3k/akt pathway regulation,cell proliferation regulation,apoptosis regulation,tumor suppressor/oncogene potential,subcellular localization significance,protein-protein interaction
ENSG00000131264,CDX4,wnt/β-catenin signaling,tumor suppressor function,cell differentiation regulation,apoptosis modulation,dna repair influence,proliferation promotion
ENSG00000115841,RMDN2,genomic instability,tumor progression,cell cycle regulation,microtubule dynamics,oncogenesis,therapeutic target
ENSG00000174943,KCTD13,chromatin regulation,transcriptional regulation,epigenetic dysregulation,oncogenic processes,cell proliferation,metastasis
ENSG00000126067,PSMB2,proteolytic activity,ubiquitin-proteasome pathway,cell proliferation,tumor progression,oncogenic process,chemosensitization
ENSG00000277791,PSMB3,cellular proliferation,proteasome function,oncogenic behavior,ubiquitin-proteasome pathway,cellular regulation,apoptosis regulation
ENSG00000198853,RUSC2,cell growth regulation,microrna biogenesis,mirna processing enhancement,oncogenic activity increase,tumorigenesis association,rna binding regulation
ENSG00000105983,LMBR1,hedgehog signaling pathway,gain of function mutations,oncogene,tumor progression,transcriptional regulation,cell proliferation
ENSG00000196391,ZNF774,epigenetic regulation,transcriptional modulation,cell growth regulation,oncogene/tumor suppressor,dna-binding activity,chromatin remodeling
ENSG00000152147,GEMIN6,gene regulation,cell cycle progression,dna repair,mrna processing,tumor suppression,none
ENSG00000243244,STON1,endocytic trafficking,cell growth regulation,oncogenic processes,protein-protein interactions,signaling pathway modulation,cancer prognosis biomarker
ENSG00000134508,CABLES1,cell proliferation,oncogene activation,signaling pathway modulation,genomic instability,checkpoint kinase regulation,cell cycle progression
ENSG00000147262,GPR119,glucose metabolism regulation,cell growth promotion,tumor progression enhancement,therapeutic target identification,signaling pathway interaction,apoptosis inhibition
ENSG00000110324,IL10RA,cytokine signaling,anti-inflammatory effects,immunosuppressive function,tumor progression,immune modulation,oncogenic properties
ENSG00000175445,LPL,altered lipid metabolism,enhanced glycolysis,fatty acid uptake,cell proliferation,oncogenic protein interaction,tumor progression
ENSG00000163735,CXCL5,angiogenesis promotion,cancer-associated fibroblasts recruitment,immunosuppression induction,metastasis facilitation,tumor progression enhancement,upregulated expression
ENSG00000102189,EEA1,aberrant endosome formation,cellular migration,enhanced tumor progression,interacts with pi3k pathway,overexpressed in cancer cells,regulates membrane trafficking
ENSG00000281139,STH,growth regulation,cell proliferation,metabolic regulation,hormone signaling,tissue repair,developmental disorder
ENSG00000197951,ZNF71,transcriptional regulation,dna binding,epigenetic control,cancer progression,tumor suppressor function,cell cycle regulation
ENSG00000197063,MAFG,transcriptional regulation,constitutive activation,oncogenic signaling,genomic instability,therapeutic target,epigenetic regulation
ENSG00000132274,TRIM22,tumor suppressor function,regulation of interferon-stimulated genes,interaction with stat1 and irf9,immune response modulation,cell growth regulation,oncogenic pathway inhibition
ENSG00000069535,MAOB,cellular proliferation,apoptosis regulation,tumor growth promotion,reactive oxygen species production,enzymatic activity modulation,angiogenesis regulation
ENSG00000203667,COX20,hypoxia adaptation,mitochondrial metabolism,complex iv assembly,respiratory chain dysfunction,oncogenic mutation,tumor cell metabolism
ENSG00000087206,UIMC1,cell cycle regulation,cell proliferation regulation,embryonic development involvement,protein-protein interactions,genomic instability contribution,tumorigenesis association
ENSG00000136270,TBRG4,enhances cell proliferation,regulates pi3k/akt pathway,promotes oncogenesis,inhibits apoptosis,critical for tumor progression,potential therapeutic target
ENSG00000063176,SPHK2,oncogene,cell proliferation,pi3k/akt pathway interaction,signaling molecule regulation,metastasis promotion,upregulated expression
ENSG00000174485,DENND4A,denn domain-containing protein,tumor suppressor function,pp2a interaction,cell cycle regulation,protein trafficking,signaling pathway modulation
ENSG00000072133,RPS6KA6,pi3k/akt/mtor signaling,phosphorylation activity,cell growth regulation,mtor pathway activation,tumor proliferation,therapeutic target
ENSG00000114127,XRN1,pi3k/akt pathway activation,oncogene function,cell proliferation regulation,rna degradation activity,tumor progression contribution,poor prognosis marker
ENSG00000171806,METTL18,m6a modification,methyltransferase activity,regulation of gene expression,tumor suppressor target,cell cycle regulation,oncogenic function
ENSG00000235155,B3GALT4,altered glycosylation patterns,tumor growth promotion,glycosaminoglycan elongation,cell surface modification,proteoglycan synthesis regulation,none
ENSG00000145192,AHSG,tumor progression,biomarker potential,pi3k/akt pathway regulation,metal ion regulation,cellular adhesion modulation,glycoprotein secretion
ENSG00000204219,TCEA3,transcriptional coactivator,cell cycle progression,protein interaction,gene overexpression,cell growth enhancement,metastasis promotion
ENSG00000004939,SLC4A1,ph regulation,ion transport,cellular metabolism,tumor progression,invasiveness promotion,metastasis enhancement
ENSG00000048162,NOP16,ribosome biogenesis,nucleolar protein,cell proliferation,oncogenic properties,therapeutic target,genetic overexpression
ENSG00000140830,TXNL4B,thioredoxin system,loss of function mutations,cellular redox balance,oxidative stress regulation,protein folding regulation,chaperone-mediated degradation
ENSG00000071967,CYBRD1,cdk8 regulation,cell cycle dysregulation,tumor growth promotion,chromatin remodeling,transcriptional regulation disruption,oncogenic process enhancement
ENSG00000160688,FLAD1,oxidative stress evasion,ros regulation,metabolic rewiring,tumor growth promotion,cell survival enhancement,therapeutic resistance mediation
ENSG00000146352,CLVS2,oncogene regulation,chromatin remodeling,transcriptional regulation,tumor suppressor function,dna repair mechanism,histone modification
ENSG00000170011,MYRIP,cellular migration,pi3k/akt pathway activation,cytoplasmic protein interaction,microtubule dynamics modulation,cell proliferation regulation,metastasis promotion
ENSG00000184724,KRTAP6-1,keratin filament regulation,tumor suppression,epithelial cell integrity,cytoskeleton maintenance,cell migration,oncogene or tumor suppressor
ENSG00000144036,EXOC6B,exocyst complex function,subunit amplification,oncogenic driver,cellular growth regulation,protein secretion modulation,tumor suppressor interaction
ENSG00000171116,HSFX1,genomic instability,tumor progression,oncogenic behaviors,dna repair dysfunction,therapeutic target,transcriptional regulation
ENSG00000268738,HSFX2,rna processing,dexd/h-box helicase family,cellular homeostasis,transcription regulation,translation initiation,mrna export
ENSG00000094841,UPRT,nucleotide biosynthesis,oncogene activation,dna repair mechanism,cancer cell proliferation,anticancer therapy resistance,genomic instability
ENSG00000188312,CENPP,centriole formation,genomic instability,cell division regulation,microtubule dynamics,tumor progression,oncogenic mechanism
ENSG00000276045,ORAI1,calcium influx regulation,crac channel hyperactivation,cell migration promotion,tumor growth acceleration,signaling pathway activation,protein interaction modulation
ENSG00000057252,SOAT1,lipid metabolism alteration,cell proliferation enhancement,upregulation,tumor growth promotion,lipid raft formation,signaling pathway interaction
ENSG00000094804,CDC6,dna replication initiation,cell cycle regulation,genomic instability,cell proliferation increase,oncogenic mutations,tumor suppressor function loss
ENSG00000185721,DRG1,protein homeostasis regulation,cell cycle progression,apoptosis modulation,dna repair involvement,oncogenic pathway interaction,biomarker potential
ENSG00000241935,HOGA1,collagen modification,protein methylation,tissue integrity,methyltransferase activity,post-translational modification,epigenetic regulation
ENSG00000177947,ODF3,microtubule stability,cell proliferation regulation,tumor progression modulation,apoptosis evasion,cell migration enhancement,cytoskeleton dynamics regulation
ENSG00000122550,KLHL7,biomarker identification,cell cycle regulation,mitotic stability,oncogene overexpression,protein-protein interactions,tumor progression
ENSG00000130695,CEP85,centrosomal regulation,chromosomal instability,oncogenic driver,protein-protein interactions,cell cycle regulation,genomic stability
ENSG00000106993,CDC37L1,cellular proliferation,enhanced survival signals,hsp90-client protein interaction,molecular chaperone function,oncogenic kinase activation,protein homeostasis regulation
ENSG00000139329,LUM,cell adhesion regulation,apoptosis promotion,metastatic suppression,tumor growth inhibition,glycoprotein function,integrin interaction
ENSG00000112214,FHL5,tumor progression,multifunctional protein,transcriptional regulation,epithelial-to-mesenchymal transition,oncogenic pathway activation,cancer prognostic marker
ENSG00000128610,FEZF1,transcriptional regulation,epithelial-to-mesenchymal transition,stem cell-like properties,oncogenic signaling,genomic instability,chromatin remodeling
ENSG00000075240,GRAMD4,metabolic regulation,transcriptional regulation,cell proliferation,tumor progression,metastasis,mtor pathway
ENSG00000087302,RTRAF,apoptosis regulation,tnf receptor interaction,nf-κb activation,cellular growth regulation,tumor progression promotion,oncogenic process involvement
,KARS,translation regulation,protein synthesis dysregulation,constitutive activation,enhanced cell proliferation,cellular metabolic reprogramming,genetic mutations impact
ENSG00000189120,SP6,cellular proliferation,anti-apoptotic signaling,tumor growth,metastasis regulation,transcriptional regulation,gene expression modulation
ENSG00000243489,KRTAP10-11,epithelial-mesenchymal transition,keratin filament system,cell migration,protein structure,integrity,tumor progression
ENSG00000101605,MYOM1,aneuploidy,chromosomal instability,mitotic progression,cell proliferation,genomic profiling,therapeutic target
ENSG00000102021,LUZP4,histone modification,epigenetic regulation,tumor suppressor,oncogene,epithelial-to-mesenchymal transition (emt),protein interaction
ENSG00000183214,MICA,tumor immunosurveillance,nk cell activation,nkg2d receptor interaction,immune evasion,antigen presentation,oncogenic processes
ENSG00000119878,CRIPT,calcium-regulation,calmodulin-binding,pi3k/akt pathway regulation,cell proliferation modulation,tumor progression promotion,signaling pathway regulation
ENSG00000138449,SLC40A1,iron regulation,oncogenic process,tumor progression,metabolic adaptation,angiogenesis,cell proliferation
ENSG00000186393,KRT26,keratin structure,epithelial cell integrity,proliferation regulation,cell adhesion modulation,therapeutic target,genomic instability
ENSG00000083093,PALB2,homologous recombination repair,brca1 interaction,tumor suppressor function,genomic stability maintenance,rad51 recruitment,cancer predisposition
ENSG00000164414,SLC35A1,glycosylation regulation,cell surface glycoprotein biosynthesis,aberrant expression levels,tumor progression,therapeutic target,pan-cancer driver
ENSG00000158769,F11R,angiogenesis,cell adhesion and migration,cancer stem cells,pro-angiogenic factor interaction,tumor growth promotion,metastasis facilitation
ENSG00000100568,VTI1B,regulation of membrane trafficking,altered cell behavior,interaction with snares,dysregulation of apoptosis,cell proliferation,membrane fusion regulation
ENSG00000127452,FBXL12,regulation of cell cycle,ubiquitination pathway,substrate recognition component,oncogenic function,tumor aggressiveness,cell growth regulation
ENSG00000064703,DDX20,genomic instability,rna splicing regulation,cell cycle regulation,apoptosis evasion,protein expression regulation,dna damage repair
ENSG00000178741,COX5A,cellular metabolism change,anaerobic glycolysis induction,energy metabolism regulation,tumor progression promotion,oxidative phosphorylation reduction,aerobic energy depletion
,RARS,ribosomal rna modification,translational regulation,oncogene expression,tumor suppressor gene suppression,ribosome biogenesis,global protein synthesis
ENSG00000010292,NCAPD2,genomic instability,aneuploidy,chromatin remodeling,tumor progression,poor prognosis,biomarker candidate
ENSG00000141753,IGFBP4,igf-binding protein regulation,tumor suppression,cell proliferation inhibition,pi3k/akt pathway interaction,angiogenesis inhibition,apoptosis induction
ENSG00000084112,SSH1,dna damage response,genomic instability,oncoprotein,cell cycle regulation,apoptosis evasion,tumor progression
ENSG00000123992,DNPEP,proteolytic enzyme activity,tumor growth promotion,metastasis facilitation,extracellular matrix remodeling,oncogenic peptide accumulation,cancer cell migration enhancement
ENSG00000179564,LSMEM2,spliceosome regulation,tumor progression,apoptosis resistance,cellular signaling alterations,nuclear protein function,pre-mrna processing
ENSG00000163539,CLASP2,microtubule stabilization,cell proliferation,oncogenesis,signaling pathway activation,cell cycle regulation,protein-protein interaction
ENSG00000171823,FBXL14,dna repair regulation,genomic integrity maintenance,chromatin remodeling,transcriptional regulation,tumor suppressor degradation,cancer progression
ENSG00000162227,TAF6L,transcriptional regulation,genomic instability,tumorigenesis promoter,aberrant expression,oncogenic processes,therapeutic target
ENSG00000092140,G2E3,genome instability,chromatin remodeling,transcriptional regulation,cell cycle progression,apoptosis resistance,therapeutic target
ENSG00000054654,SYNE2,cellular adhesion,tumorigenesis,cell migration,protein interaction,oncogene upregulation,cancer metastasis
ENSG00000067167,TRAM1,er stress response,unfolded protein response (upr) regulation,cell survival enhancement,apoptosis inhibition,tumor progression facilitation,oncoprotein interaction
ENSG00000143375,CGN,cell cycle regulation,chromosome segregation,apoptosis promotion,tumor suppressor regulation,g2/m checkpoint control,therapeutic target
ENSG00000145685,LHFPL2,adhesion regulation,cell proliferation enhancement,cancer driver gene,morphology modulation,signaling pathway interaction,tumor progression facilitation
ENSG00000265107,GJA5,gap junction communication,intercellular signaling,cell migration and invasion,tumor progression,apoptosis regulation,genomic instability 
ENSG00000168818,STX18,er-golgi communication,oncogenic protein transport,tumor progression,cancer stem cell maintenance,membrane trafficking regulation,apoptosis resistance
ENSG00000108100,CCNY,cyclin-dependent kinase activation,oncogenic signaling,cell cycle regulation,tumor suppressor interaction,proliferation promotion,cancer driver gene
ENSG00000102317,RBM3,cell survival promotion,tumor progression facilitation,chemotherapy resistance induction,apoptosis inhibition,cell cycle regulation modulation,dna repair enhancement
ENSG00000243927,MRPS6,mitochondrial location,translation regulation,tumor energy metabolism,oxidative phosphorylation impairment,reactive oxygen species generation,cellular stress response
ENSG00000133119,RFC3,genomic instability,cell proliferation,dna replication initiation,dna repair mechanism,oncogenic process,therapeutic target
ENSG00000186081,KRT5,maintenance of epithelial structure,cell migration regulation,intermediate filament disruption,tumorigenesis,oncogenic signaling,epithelial stratification
ENSG00000130707,ASS1,immune evasion,tumor suppressor,metabolic reprogramming,warburg effect,arginine biosynthesis,nitric oxide production
ENSG00000115648,MLPH,overexpression,cell migration,cancer progression,protein interaction,melanosome transport,cytoplasmic trafficking
ENSG00000118271,TTR,cell proliferation,oncogenesis,metastasis,angiogenesis,signaling pathway regulation,tumor progression
ENSG00000116741,RGS2,g-protein coupled receptor regulation,gtp hydrolysis acceleration,cell proliferation regulation,tumor progression enhancement,metastasis promotion,pi3k/akt pathway modulation
ENSG00000054356,PTPRN,transmembrane protein,tumor suppressor function,oncogene regulation,cell signaling pathway modulation,growth regulation,signal transduction inhibition
ENSG00000110514,MADD,apoptosis regulation,cell survival inhibition,mitogen-activated protein kinase (mapk) pathway interaction,ubiquitin ligase adaptor function,tumor suppressor activity,signal transduction modulation
ENSG00000186792,HYAL3,tumor progression,angiogenesis promotion,cell migration facilitation,invasive growth enhancement,metastasis promotion,therapeutic target
ENSG00000138942,RNF185,e3 ubiquitin ligase activity,cell cycle regulation,dna repair mechanisms,genome stability maintenance,protein degradation pathway,transcriptional regulation
ENSG00000091428,RAPGEF4,oncogenic transformation,cell proliferation,rap gtpase activation,mapk/erk pathway activation,genetic instability,protein-protein interaction
ENSG00000120733,KDM3B,histone demethylation,lysine-specific demethylase activity,chromatin regulation,apoptosis suppression,cell proliferation,metastasis facilitation
ENSG00000163714,U2SURP,aberrant splicing,oncogenic consequences,cell proliferation,genomic instability,tumor progression,protein-protein interactions
ENSG00000167755,KLK6,tumor growth promotion,protein processing,emt regulation,cell proliferation enhancement,therapeutic target,biomarker
ENSG00000075891,PAX2,transcription factor,oncogene,tumor progression,cancer development,therapeutic target,cellular differentiation
ENSG00000168876,ANKRD49,cell cycle regulation,genomic instability,apoptosis modulation,dna repair,tumor progression,oncogenic transformation
ENSG00000230907,FKBPL,tumor suppressor function,cell cycle regulation disruption,oncogenic kinase inhibition,reduced expression in cancers,protein-protein interaction,cellular proliferation modulation
ENSG00000143183,TMCO1,mitochondrial dysfunction,altered metabolic regulation,dysregulated calcium homeostasis,enhanced glycolysis,tumor progression,protein-protein interaction
ENSG00000205581,HMGN1,chromatin remodeling,histone modification,gene expression regulation,oncogenic transformation,genomic instability,cell cycle progression
ENSG00000169908,TM4SF1,cell migration,metastasis promotion,tumor progression,epithelial-to-mesenchymal transition (emt),cancer cell invasion,drug resistance
ENSG00000013573,DDX11,dna replication,chromosomal instability,oncogenic transformation,genomic stability,cell cycle progression,therapeutic target
ENSG00000139926,FRMD6,pi3k/akt signaling pathway modulation,cell migration regulation,tumor progression involvement,genetic interaction with ptpn3,protein activity regulation,metastasis association
ENSG00000115593,SMYD1,oncogenesis,histone modification,transcriptional regulation,cell proliferation,apoptosis inhibition,genomic instability
ENSG00000078140,UBE2K,protein degradation,cellular stress response,tumor progression,genomic instability,oncogenic function,ubiquitin conjugation
ENSG00000090104,RGS1,g-protein activation,cell signaling regulation,oncogenic potential,tumor suppressor function,signaling pathway modulation,cell migration regulation
ENSG00000139625,MAP3K12,mapk signaling,oncogenic driver,jnk pathway activation,cell proliferation,apoptosis inhibition,genetic amplification
ENSG00000205279,CTXN3,cancer-promoting function,cell proliferation regulator,tumor suppressor or oncogene,cell growth modulator,protein-protein interaction,cellular response mediator
ENSG00000140750,ARHGAP17,rho gtpase regulation,tumor suppressor function,cell migration inhibition,protein degradation activation,akt pathway modulation,cancer progression facilitation
ENSG00000148943,LIN7C,cell polarity regulation,adherens junction modulation,tumor suppressor function,cancer metastasis,cell migration regulation,protein-protein interaction
ENSG00000168938,PPIC,protein folding regulation,chaperone activity,cellular homeostasis,apoptosis regulation,cell growth modulation,tumor suppressor protein interaction
ENSG00000108557,RAI1,cell growth regulation,small nucleolar rna processing,tumor suppressor activity,ribosome biogenesis regulation,dna repair interaction,apoptosis modulation
ENSG00000153046,CDYL,tumor suppressor activity,chromatin modulation,transcriptional repression,histone modification,epigenetic regulation,cell growth control
ENSG00000266028,SRGAP2,cancer cell migration,cell invasion,small gtpase regulation,cytokeletal modulation,rho gtpase activation,tumor progression marker
ENSG00000107554,DNMBP,tumor suppressor,apoptosis regulation,mitochondrial localization,cell death pathways,dna damage response,oncogenesis suppression
ENSG00000186487,MYT1L,genomic instability,tumor suppressor function,transcriptional regulation,cell proliferation,chromatin remodeling,oncogenic potential
ENSG00000215114,UBXN2B,protein degradation pathway regulation,oncogene activation,cell proliferation modulation,genome instability,dna repair interaction,ubiquitin-like modification
ENSG00000164080,RAD54L2,genomic instability,homologous recombination repair,dna repair deficiency,tumorigenesis,oncogenesis,genome maintenance
,MARCH2,protein degradation regulation,cell surface receptor stability,cancer stem cell maintenance,therapy resistance,tumorigenesis promotion,metastasis facilitation
ENSG00000168517,HEXIM2,transcriptional regulation,7sk snrnp complex interaction,p-tefb repression,tumor suppressor/oncogene role,cell proliferation control,gene expression modulation
ENSG00000068697,LAPTM4A,lipid metabolism regulation,tumor aggressiveness marker,endocytic trafficking modulation,protein kinase activation,cell growth regulation,apoptosis suppression
ENSG00000087338,GMCL1,golgi apparatus regulation,cell proliferation regulator,oncogene or tumor suppressor,cell growth and metabolism pathway interaction,cancer driver gene candidate,genomic instability mediator
ENSG00000165553,NGB,rhoa pathway inhibition,tumor suppressor function,calcium signaling regulation,cell migration modulation,cytoskeleton dynamics regulation,pan-cancer biomarker potential
ENSG00000177791,MYOZ1,cell proliferation,cytoplasmic localization,actin dynamics regulation,oncogene function,epithelial-mesenchymal transition,cancer progression
ENSG00000102572,STK24,cell cycle regulation,g2/m phase transition,genomic instability,tumor progression,kinase activity,dna repair deficiency
ENSG00000163681,SLMAP,er biogenesis,protein insertion,membrane trafficking,oncogenic signaling,cell growth regulation,cancer progression
ENSG00000179456,ZBTB18,cellular proliferation regulation,tumor suppression,transcriptional regulation,apoptosis induction,genome stability maintenance,chromatin modification
ENSG00000151715,TMEM45B,cellular processes regulation,tumor microenvironment modulation,cell signaling pathway interaction,membrane receptor interaction,cytoskeletal component interaction,oncogenic potential
ENSG00000108878,CACNG1,calcium signaling pathway,aberrant expression,kir channels modulation,tumor progression,cancer development,therapeutic target
ENSG00000186812,ZNF397,transcriptional regulation,gene expression modulation,cell proliferation,cell differentiation,protein-dna interaction,tumorigenesis
ENSG00000170832,USP32,ubiquitin regulation,oncogenic protein stabilization,protein degradation modulation,cell cycle progression,dna repair mechanisms,tumorigenesis promotion
ENSG00000105327,BBC3,apoptosis regulation,gene silencing,tumor suppressor function,mitochondrial outer membrane permeabilization,caspase activation,dna damage response
ENSG00000204390,HSPA1L,heat shock protein regulation,molecular chaperone function,cell cycle modulation,apoptosis regulation,protein homeostasis,stress response induction
ENSG00000101746,NOL4,cell cycle regulation,nucleolar function,protein-protein interactions,transcriptional control,oncogenic transformation,apoptosis inhibition
ENSG00000174446,SNAPC5,spliceosome assembly,intronic removal,rna splicing regulation,genomic instability,cellular proliferation,dna repair interaction
ENSG00000104980,TIMM44,mitochondrial dna replication,mitochondrial integrity maintenance,cellular metabolism regulation,genomic stability disruption,tumor initiation,oxidative stress induction
ENSG00000258839,MC1R,melanoma progression,therapeutic target,tumor initiation,melanogenesis disruption,cancer susceptibility,genetic predisposition
ENSG00000170262,MRAP,regulation of melanocortin receptor activity,growth factor signaling pathway,cellular proliferation,mage family protein expression,transcriptional regulation,cancer development
ENSG00000054938,CHRDL2,hedgehog pathway regulation,cell proliferation enhancement,tissue patterning disruption,oncogenic mutations associated,genomic instability linked to,signaling pathway dysregulation
ENSG00000137822,TUBGCP4,genomic instability,chromosomal alterations,oncogene function,microtubule regulation,cell cycle modulation,spindle assembly
ENSG00000170477,KRT4,cell adhesion disruption,emt characteristics,epithelial cell marker,involved in oncogenesis,loss-of-function mutations,tumor progression
ENSG00000167766,ZNF83,transcriptional regulation,cell cycle regulation,tumor suppressor function,dna repair mechanism,genomic instability,prognostic marker
ENSG00000124092,CTCFL,chromatin remodeling,oncogene function,transcriptional regulation,cell cycle progression,apoptosis evasion,gene expression modulation
ENSG00000178896,EXOSC4,rna degradation,loss of function mutations,tumor progression,cell proliferation,survival mechanisms,genomic instability
ENSG00000105290,APLP1,cell signaling pathway,gain of function mutations,notch receptor activation,neurogenesis regulation,oncogenesis driver,cell survival promotion
ENSG00000144619,CNTN4,cell adhesion modulation,gain of function mutations,tumor progression promotion,cell migration regulation,survival pathway activation,cancer association in neural system
ENSG00000132874,SLC14A2,nucleoside transport,cell proliferation,dna synthesis,tumor progression,amplification mutation,oncogenic activity
ENSG00000159840,ZYX,oncogene activation,gene expression upregulation,tumor progression facilitation,metastasis promotion,cancer aggressiveness enhancement,focal adhesion complex regulation
ENSG00000149257,SERPINH1,tumor progression,multifaceted involvement,protease inhibition,cellular regulation,biomarker potential,p53 interaction
ENSG00000206177,HBM,hematopoiesis regulation,cellular differentiation,chromatin remodeling,transcriptional activation,oncogenic transformation,immune evasion
ENSG00000196565,HBG2,hemoglobin regulation,tumor metabolism,hypoxia response,globin chain modification,angiogenic pathways,metastasis suppression
ENSG00000129250,KIF1C,oncogene,cellular transport regulation,microtubule interaction,protein cargo movement,tumor progression promotion,cargo trafficking dysregulation
ENSG00000118518,RNF146,ubiquitination regulation,cell cycle progression,apoptosis modulation,tumor suppressor function,loss-of-function mutations,antibody target
ENSG00000105048,TNNT1,cellular adhesion disruption,oncogenic mutations,proliferation regulation,metastasis promotion,signaling pathway interaction,genomic instability
ENSG00000133083,DCLK1,microtubule regulation,rna-binding protein complex,oncogenic function,tumor progression,cell proliferation,genomic instability
ENSG00000139514,SLC7A1,angiogenesis regulation,cellular amino acid uptake,genetic amplification,lysosomal membrane association,oncogene activation,protein synthesis facilitation
ENSG00000149357,LAMTOR1,autophagy regulation,mtor signaling pathway,cellular metabolism,lysosomal localization,cancer association,protein interaction
ENSG00000168765,GSTM4,oxidative stress mitigation,cellular detoxification,dna repair mechanisms,chemoresistance development,protein interaction,tumor progression modulation
ENSG00000101349,PAK5,cell migration,apoptosis regulation,cancer progression,oncogenic driver,protein-protein interaction,cellular signaling pathway
ENSG00000197930,ERO1A,endoplasmic reticulum stress,tumorigenesis promotion,redox regulation,disulfide bond formation,oxidative folding,unfolded protein response
ENSG00000277424,HMOX2,heme degradation,oxidative stress protection,angiogenesis promotion,cell proliferation enhancement,metastasis facilitation,iron regulation 
ENSG00000131475,VPS25,escrt-iii assembly,protein degradation regulation,endosomal sorting dysfunction,cell growth promotion,oncogenic signaling activation,chromosomal instability
ENSG00000115685,PPP1R7,cell cycle regulation,dysregulated expression,oncogenic role,protein phosphatase 1 modulation,tumor progression correlation,biomarker significance
ENSG00000147533,GOLGA7,golgin function,oncogenesis,cell proliferation,protein modification,cell survival,cell migration
ENSG00000173542,MOB1B,genomic instability,tumor progression,cell cycle regulation,mitotic entry,aurora a kinase interaction,chromosomal stability maintenance
ENSG00000187514,PTMA,disrupts cell adhesion,tumor progression driver,therapeutic target,regulates emt,promotes cell migration,proteolytic activity aberrant
ENSG00000204979,MS4A13,apoptosis regulation,constitutive expression,cell survival enhancement,tumor progression association,autoimmune disease susceptibility,cancer gene dysregulation
ENSG00000213390,ARHGAP19,rhogtpase regulation,tumor suppressor function,metastasis inhibition,cell proliferation regulation,cancer progression restriction,genomic instability prevention
ENSG00000138785,INTS12,chromatin remodeling,genomic instability,dna damage response,cell proliferation enhancement,tumorigenesis facilitation,genome stability maintenance
ENSG00000181374,CCL13,tumor microenvironment,chemokine signaling,immune suppression,tumor growth promotion,metastasis induction,prognostic marker
ENSG00000108774,RAB5C,endocytic trafficking,small gtpase function,recycling pathway regulation,tumor progression driver,cellular membrane fusion,vesicle-mediated transport
ENSG00000138592,USP8,pi3k regulation,dysregulated ubiquitination,akt activation,proliferation enhancement,survival promotion,treatment resistance
ENSG00000130511,SSBP4,genomic instability,chromosomal breakage,replication repair,single-strand dna binding,genetic rearrangement,dna damage response
ENSG00000134323,MYCN,transcriptional regulator,cell growth regulation,constitutive activation,cell cycle progression,oncogene amplification,therapeutic target
ENSG00000205084,TMEM231,immune microenvironment modulation,tumor progression,epithelial-to-mesenchymal transition,cancer-specific gene expression signature,cell survival enhancement,prognostic marker
ENSG00000204852,TCTN1,cellular polarity regulation,gain of function mutations,tumor progression promoter,epithelial-to-mesenchymal transition,protein-protein interaction,regulation of signaling pathways
ENSG00000153044,CENPH,genomic instability,tumor suppressor,chromosome segregation,aneuploidy,centromere formation,mitotic spindle dysfunction
ENSG00000083844,ZNF264,genomic stability,cancer suppression,tumor progression regulation,apoptosis inhibition,cell cycle control,transcriptional repression
ENSG00000116679,IVNS1ABP,modulation of rna synthesis,alteration of glucose metabolism,interaction with pi3k/akt pathway,regulation of cell growth,protein-protein interactions,tumor context dependent effects
ENSG00000087076,HSD17B14,estrogen signaling,steroid hormone regulation,metabolic modulation,tumor growth inhibition,therapeutic target,enzymatic activity
ENSG00000154305,MIA3,oncogenic signaling,pro-survival environment,axon growth regulation,cellular adaptation,metabolic reprogramming,tumor progression
ENSG00000167377,ZNF23,transcriptional regulation,cellular differentiation,tumor suppression,apoptosis regulation,gene expression modulation,cell cycle disruption
ENSG00000105379,ETFB,metabolic reprogramming,tumor energy metabolism,altered metabolic profiles,cellular energy production,oxidative stress resistance,mitochondrial dysfunction
ENSG00000078304,PPP2R5C,pi3k/akt pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,pp2a regulation
ENSG00000146950,SHROOM2,tumor progression,genomic instability,cytoskeletal reorganization,therapeutic target,microtubule stabilization,oncogene activation
ENSG00000186501,TMEM222,ion channel regulation,cell membrane integrity,tumor aggressiveness,apoptosis modulation,cell cycle regulation,signaling pathway interaction
ENSG00000101150,TPD52L2,cell cycle regulation,oncogenic driver,overexpression,dna repair,chromatin remodeling,therapeutic target
ENSG00000124006,OBSL1,odf component,microtubule dynamics regulation,cell signaling interaction,proliferation regulation,anti-apoptotic properties,tumor progression driver
ENSG00000092036,HAUS4,genomic stability,homologous recombination repair,oncogenesis,chromatin remodeling,dna repair,genomic instability
ENSG00000184515,BEX5,cellular regulation,tumor progression,transcriptional regulation,oncogenic signaling,apoptosis modulation,genomic instability
ENSG00000154839,SKA1,kinase regulation,chromosomal instability,kinetochore assembly,oncogenic driver,microtubule stabilization,cell division regulation
ENSG00000110148,CCKBR,oncogene,g protein-coupled receptor,pancreatic tumor growth,metastasis promotion,cellular proliferation regulation,apoptosis inhibition
ENSG00000182667,NTM,transcriptional regulation,cellular proliferation,dna repair pathway,genomic instability,oncogenic transformation,nuclear localization
ENSG00000176083,ZNF683,cell cycle regulation,tumor suppressor function,apoptosis regulation,g2/m phase progression,chemosensitivity modulation,krab domain-containing protein
ENSG00000142920,AZIN2,genomic instability,oncogenesis,topoisomerase interaction,cell cycle regulation,dna repair dysregulation,apoptosis inhibition
ENSG00000143450,OAZ3,tumor suppressor regulation,dna repair modulation,cellular response regulation,protein-protein interaction,apoptosis modulation,transcriptional regulation
ENSG00000113068,PFDN1,cellular processes,cytoskeleton organization,tumorigenesis,oncogene potential,protein-protein interactions,cell cycle regulation
ENSG00000215305,VPS16,oncogenic processes,tumor progression,multivesicular body formation,cell growth regulation,protein-protein interactions,genetic alterations
ENSG00000139719,VPS33A,autophagy regulation,tumor growth promotion,cellular metabolism alteration,lysosome dysfunction,late endosomal trafficking disruption,apoptosis evasion mechanism
ENSG00000100934,SEC23A,cellular transport,protein sorting,oncogenic processes,tumorigenesis,growth factor regulation,protein quality control
ENSG00000119042,SATB2,cell proliferation,apoptosis resistance,chromatin regulation,gene expression modulation,tumor progression,oncogenic driver
ENSG00000186814,ZSCAN30,tumor suppressor regulation,apoptosis inhibition,cancer stem cell maintenance,tumor progression facilitation,p53 pathway interference,transcriptional regulation
ENSG00000066735,KIF26A,microtubule interaction,oncogenesis,cell division disruption,chromosomal instability,therapeutic target,genomic instability
ENSG00000139131,YARS2,gain of function mutations,aberrant protein expression,tumor suppressor interaction,cellular transformation,metastasis promotion,protein synthesis alteration
ENSG00000126860,EVI2A,regulatory function,transcriptional regulation,cell growth modulation,cell differentiation modulation,oncogenic pathway involvement,genomic instability contribution
ENSG00000283727,KIR2DS4,genomic instability,gain of function mutations,tumor progression,cellular regulation,signaling pathway interaction,oncogenic potential
ENSG00000130544,ZNF557,cellular differentiation,cancer progression,tumor metastasis,transcriptional regulation,apoptosis inhibition,protein-protein interaction
ENSG00000230900,ATP6V1G2,cellular acidification,energy metabolism regulation,ion homeostasis regulation,cancer cell growth support,chemotherapy resistance,tumor progression
ENSG00000178719,GRINA,git/pix interaction,cell migration,oncogene function,tumor progression,metastasis regulator,gtpase regulation
ENSG00000188243,COMMD6,nf-κb pathway regulation,gain of function mutations,tumor progression inhibitor,cell growth promotion,apoptosis inhibition,ubiquitination regulator
ENSG00000059804,SLC2A3,glucose metabolism,warburg effect,facilitative glucose transporter,increased glycolysis,tumor progression,poor prognosis
ENSG00000046774,MAGEC2,chromatin regulation,histone modification,cell proliferation,metastasis promotion,prognostic marker,cancer stem cell maintenance
ENSG00000132603,NIP7,chromatin remodeling,transcription regulation,nucleocytoplasmic transport,cell proliferation,tumor progression,cancer therapy target
ENSG00000285132,CTSB,lysosomal proteolysis,tumor progression,cell invasion,angiogenesis,oncogenic processes,proteolytic activity
ENSG00000185862,EVI2B,angiogenesis promotion,cellular transformation,chromosomal amplification,co-activator interaction,gene expression regulation,oncogene activation
ENSG00000136048,DRAM1,mitochondrial biogenesis,tumor progression,cell proliferation,apoptosis resistance,mitophagy regulation,antioxidant defense
ENSG00000186925,KRTAP19-6,cellular environment modulation,potential impact on tumor progression,expression in epithelial tissues,maintenance of cellular architecture,keratin-associated protein function,limited evidence for direct cancer link
ENSG00000120725,SIL1,er homeostasis,calcium regulation,unfolded protein response,cellular stress response,glycoprotein folding,cancer susceptibility
ENSG00000099795,NDUFB7,mitochondrial disorders,oxidative phosphorylation,enhanced glycolysis,metabolic reprogramming,energy metabolism,cell growth promotion
ENSG00000197808,ZNF461,tumor suppressor function,dna binding ability,chromatin remodeling complex interaction,transcriptional regulation,cell growth inhibition,apoptosis promotion
ENSG00000272333,KMT2B,chromatin modification,histone methylation,transcriptional regulation,oncogenic process,tumor progression,metastasis
ENSG00000168002,POLR2G,chromatin remodeling,cell proliferation,genomic instability,transcriptional regulation,apoptosis resistance,dna replication
ENSG00000165795,NDRG2,metastasis suppression,tumor suppressor function,cellular differentiation regulation,cytoskeletal organization,angiogenesis inhibition,protein interaction network
ENSG00000112531,QKI,alternative splicing regulation,oncogene/tumor suppressor activity,cell growth regulation,mrna stability modulation,transcriptional repression,spliceosome component
ENSG00000126003,PLAGL2,cellular proliferation,transcriptional regulator,oncogene activation,emt regulation,zinc finger binding,proliferation enhancement
ENSG00000141425,RPRD1A,transcriptional regulation,genomic stability,dna damage response,therapeutic target,cell cycle regulation,apoptosis modulation
ENSG00000130520,LSM4,alternative splicing regulation,apoptosis suppression,cell proliferation promotion,chemoresistance development,oncogene function,protein-protein interaction
ENSG00000111358,GTF2H3,transcriptional regulation,nucleotide excision repair,dna damage response,cell cycle regulation,apoptosis dysregulation,signaling pathway activation
ENSG00000136824,SMC2,genomic instability,tumor suppressor,chromatin remodeling,cohesin complex,dna repair regulation,cell cycle progression
ENSG00000164076,CAMKV,mitotic regulation,camk activation,tumor progression,apoptosis modulation,therapeutic target,cell cycle regulation
ENSG00000151353,TMEM18,oncogenic signaling pathway,cell proliferation,tumor growth promotion,autophagy dysregulation,apoptosis inhibition,cell migration facilitation
ENSG00000168314,MOBP,cell adhesion disruption,oncogenic function,tumor growth promotion,metastasis facilitation,prognostic biomarker,myelin-related gene
ENSG00000188155,KRTAP10-6,epithelial-to-mesenchymal transition,trichohyalin-like protein,cell adhesion modulation,cellular migration enhancement,transcriptional regulation facilitation,keratin-associated protein family member
ENSG00000114395,CYB561D2,calcium influx regulation,oxidative stress resistance,tumor progression driver,pi3k/akt pathway interaction,cell survival enhancement,therapeutic target
ENSG00000119318,RAD23B,dna damage recognition,genomic stability maintenance,cell cycle regulation,brca1 interaction,pi3k/akt pathway modulation,nucleotide excision repair
ENSG00000153130,SCOC,regulation of cell metabolism,pi3k/akt signaling,oncogenic function,transmembrane protein transport,cell proliferation regulation,cancer chemoresistance
ENSG00000264522,OTUD7B,tumor progression,ubiquitin processing,oncogene stabilization,protein degradation regulation,cell cycle modulation,dna repair dysfunction
ENSG00000186106,ANKRD46,cellular regulation,oncogenic activity,tumor suppressor interaction,mitotic regulation,cancer driver gene,genome instability
ENSG00000112357,PEX7,peroxisomal biogenesis disorder,peroxisomal import receptor interaction,fatty acid-coa ligase importation,lipid metabolism regulation,oncogenic process involvement,chemotherapy resistance modulation
ENSG00000105518,TMEM205,tumor suppressor activity,cellular homeostasis regulation,genetic mutation association,oncogenic signaling modulation,cell cycle progression regulation,protein interaction influence
ENSG00000145794,MEGF10,tumor progression,tissue invasion,cell migration regulation,genomic instability,apoptosis evasion,cell proliferation increase
ENSG00000180530,NRIP1,transcriptional regulation,oncogene activation,cell proliferation,tumor progression,therapeutic target,genomic instability
ENSG00000070759,TESK2,microtubule dynamics regulation,protein kinase activation,cell migration and invasion,tumor progression marker,genomic instability,microtubule-associated protein phosphorylation
ENSG00000144824,PHLDB2,cell cycle regulation,tumor progression,protein-protein interactions,oncogenic processes,e3 ubiquitin ligase activity,apoptosis regulation
ENSG00000156966,B3GNT7,n-glycosylation alteration,oncogenic processes,cell proliferation promotion,therapeutic target,glycoprotein modification,tumor progression facilitation
ENSG00000132718,SYT11,synaptic vesicle trafficking,calcium-dependent regulation,cell growth promotion,oncogenic potential,protein-protein interactions,mitochondrial localization
ENSG00000101883,RHOXF1,cell proliferation,tumor progression,transcriptional regulation,metastasis,genomic instability,proliferation signaling
ENSG00000155792,DEPTOR,mtor pathway,negative regulator,aberrant expression,cellular proliferation,metabolic regulation,tumorigenesis prevention
ENSG00000138101,DTNB,cellular redox status,thiol-disulfide exchange reactions,oncogenic processes,protein-protein interactions,apoptosis regulation,cell growth modulation
ENSG00000171522,PTGER4,tumor growth promotion,angiogenesis stimulation,cell proliferation regulation,metastasis facilitation,prognostic marker,therapeutic target
ENSG00000064545,TMEM161A,calcium signaling pathway,cell proliferation,dysregulation of calcium homeostasis,excessive cell survival,oncogenic signaling,store-operated calcium entry (soce)
ENSG00000185019,UBOX5,pi3k/akt pathway modulation,ubiquitin-binding protein,oncogenic transformation,cell survival enhancement,transcription factor regulation,proteasomal degradation
ENSG00000020181,ADGRA2,adhesion molecule,tumor progression,cancer stem cell marker,metastatic potential,cell migration pathway,dysregulated signaling
ENSG00000163395,IGFN1,constitutive activation,insulin-like growth factor 1 (igf-1) pathway,cellular metabolism regulation,proliferation and survival promotion,oncogenic processes driving,tumor progression facilitation
ENSG00000143355,LHX9,transcriptional regulation,oncogene function,cell proliferation,apoptosis inhibition,epigenetic modification,neural differentiation
ENSG00000155666,KDM8,histone demethylase function,epigenetic regulation,chromatin remodeling,cell proliferation regulation,tumor progression association,nucleosome interaction
ENSG00000169241,SLC50A1,zinc transporter activity,tumor promotion,gain of function mutations,cell proliferation,metastasis regulation,therapeutic target
ENSG00000079616,KIF22,chromosomal instability,aneuploidy promotion,microtubule regulation,cell division,genome duplication,protein-protein interaction
ENSG00000173559,NABP1,regulatory role in transcription,dna binding,cellular homeostasis modulation,tumor suppression,transcriptional co-repression,nuclear receptor interaction
ENSG00000258890,CEP95,centrosome regulation,microtubule stability,cilia function,cell cycle progression,oncogenic interaction,tumorigenesis promotion
ENSG00000183486,MX2,antiviral immunity,dynamin-like gtpase activity,host-virus interaction regulation,cell cycle regulation,apoptosis modulation,autophagy involvement
ENSG00000164107,HAND2,transcription factor activation,cellular differentiation disruption,proliferation promotion,metastasis facilitation,epithelial-to-mesenchymal transition,tumor progression drive
,SEPT11,cellular proliferation,cell migration,genomic instability,mitosis regulation,septin dysregulation,oncogene activation
ENSG00000115194,SLC30A3,zinc transport,cell proliferation,metastasis promotion,apoptosis regulation,autophagy modulation,genomic amplification 
ENSG00000196586,MYO6,endocytosis,cell migration,intracellular transport,motor protein function,rho gtpase activation,tumor progression
ENSG00000100554,ATP6V1D,v-atpase activation,oncogenic potential,ion channel regulation,signaling pathway interaction,tumor cell survival,metabolic regulation
ENSG00000204936,CD177,tumor progression,angiogenesis,mucin protein expression,leukocyte adhesion,surface receptor function,inflammatory response
ENSG00000134207,SYT6,cell migration,vesicle fusion,metastasis progression,oncogenesis marker,calcium-dependent exocytosis,prognostic marker
ENSG00000172336,POP7,ribosome biogenesis,regulatory function,cellular growth regulation,rna processing,protein synthesis,cancer metabolism
ENSG00000138035,PNPT1,regulation of mrna splicing,cell proliferation,genomic instability,dna repair alterations,pi3k/akt pathway regulation,mutation-driven oncogenesis
ENSG00000163374,YY1AP1,transcriptional regulation,cell proliferation,tumor progression,epithelial-to-mesenchymal transition (emt),oncogenic pathway regulation,apoptosis regulation
ENSG00000281484,BTG3,tumor suppression,tumor growth inhibition,cell cycle regulation,apoptosis induction,transcriptional regulation,histone deacetylation repression
ENSG00000076321,KLHL20,apoptosis regulation,cell cycle progression,genome stability maintenance,protein degradation,tumor suppressor function,ubiquitin-proteasome pathway interaction
ENSG00000108439,PNPO,metabolic reprogramming,cell growth regulation,oncogene potential,tumorigenesis association,vitamin b6 synthesis,coenzyme function
ENSG00000181817,LSM10,spliceosome regulation,rna splicing,oncogenesis,genomic instability,protein-protein interaction,gene expression modulation
ENSG00000212901,KRTAP3-1,epithelial-to-mesenchymal transition (emt),cellular adhesion,cell migration,protein-protein interactions,cytoskeletal organization,tumor progression
ENSG00000068323,TFE3,transcriptional regulation,chromosomal translocation,oncogenic transformation,cell proliferation,apoptosis regulation,dna repair pathways
ENSG00000078674,PCM1,genomic instability,centrosome amplification,tumor suppressor function,cilia regulation,oncogenic signaling,chromosomal segregation
ENSG00000163322,ABRAXAS1,genomic instability,dna repair,homologous recombination repair,tumor progression,brca1 complex interaction,genome maintenance
ENSG00000142507,PSMB6,proteasome regulation,oncogene upregulation,cell proliferation regulation,apoptosis suppression,ubiquitin-proteasome pathway,cancer cell survival
ENSG00000112335,SNX3,hippo signaling pathway,cytokinesis regulation,endosomal sorting,cell migration regulation,transferrin receptor recycling,genetic stability maintenance
ENSG00000137501,SYTL2,cell migration,exocytosis regulation,metastasis promotion,oncogene role,signaling pathway interaction,protein-protein interaction
ENSG00000282175,HNRNPCL1,oncogenic splicing regulation,genomic instability induction,alternative splicing modulation,protein-protein interaction,chromosomal rearrangement facilitation,cell proliferation enhancement
ENSG00000154548,SRSF12,pre-mrna processing,cell proliferation,aberrant splicing regulation,tumorigenesis driver,therapeutic target,genetic instability
ENSG00000111775,COX6A1,mitochondrial function,metabolic regulation,tumor progression,warburg effect,electron transport chain,glycolytic shift
ENSG00000115541,HSPE1,mitochondrial localization,oncogenic potential,cell survival pathways,protein folding regulation,tumor growth promotion,genetic instability
ENSG00000198130,HIBCH,mitochondrial metabolism,oncogenic regulation,anabolic processes,pro-survival pathways,genomic instability,cell cycle modulation
ENSG00000172667,ZMAT3,transcriptional regulation,tumor suppressor function,genome instability,epigenetic modification,mutation-driven oncogenesis,cancer susceptibility
ENSG00000110917,MLEC,cell-cell adhesion disruption,immune response modulation,overexpression and mutation,epithelial barrier dysfunction,tumor progression enhancement,cell migration and invasion facilitation
ENSG00000163527,STT3B,protein modification,oligosaccharyltransferase complex,glycosylation patterns,cell cycle regulation,dna repair mechanisms,tumor progression
ENSG00000133422,MORC2,chromatin remodeling,epigenetic regulation,gene overexpression,dna repair complexes,prognostic marker,cancer driver gene
ENSG00000116191,RALGPS2,rhoa activation,cancer metastasis,guanine nucleotide exchange factor,cell migration regulation,actin cytoskeleton modulation,protein-protein interaction
ENSG00000083635,NUFIP1,mrna regulation,ribosomal subunit interaction,tumorigenesis contribution,apoptosis regulation,dna repair influence,translation modulation
ENSG00000117174,ZNHIT6,apoptosis evasion,cell proliferation,gain of function mutations,gene regulation,interaction with pi3k/akt pathway,tumor progression
ENSG00000165643,SOHLH1,genomic instability,loss-of-function mutations,meiotic checkpoint regulation,dna repair mechanism,cellular proliferation enhancement,tumor growth promotion
ENSG00000244474,UGT1A4,detoxification mechanism,phase ii metabolism,glucuronidation process,xenobiotic conjugation,cellular protection,cancer prevention
ENSG00000241119,UGT1A9,glucuronidation,xenobiotic metabolism,bile acid conjugation,cellular growth regulation,detoxification,therapeutic target
ENSG00000188167,TMPPE,iron metabolism regulation,bmp pathway inhibition,hepcidin suppression,cell growth promotion,angiogenesis promotion,tumor progression
ENSG00000196313,POM121,nuclear pore assembly,transmembrane protein,cellular transport regulation,tumor progression marker,protein-protein interaction,signal transduction activation
ENSG00000099341,PSMD8,ubiquitin-proteasome pathway regulation,cellular degradation modulation,tumor growth promotion,metastasis facilitation,prognostic marker,signaling pathway interaction
ENSG00000158234,FAIM,apoptosis regulation,tumor suppressor function,genomic stability maintenance,cell survival inhibition,inflammation modulation,caspase cascade inhibition
ENSG00000142528,ZNF473,krab domain interaction,transcriptional regulation,epigenetic modulation,cell proliferation,apoptosis dysregulation,tumor formation
ENSG00000198832,SELENOM,selenium regulation,cellular transport,oncogenic mechanisms,protein kinase activation,endoplasmic reticulum localization,cancer predisposition
ENSG00000172493,AFF1,chromatin remodeling,transcriptional regulation,oncogenic transformation,cell proliferation,dna repair regulation,genomic instability
ENSG00000167034,NKX3-1,tumor suppressor function,transcriptional regulation,cell differentiation,embryonic development,mutational inactivation,therapeutic target
ENSG00000160908,ZNF394,tumor suppressor,regulatory transcription factor,cell growth regulation,apoptosis induction,dna binding protein,protein-protein interaction
ENSG00000072080,SPP2,tumor progression,cell survival,metastasis,immune modulation,oncogenic processes,adhesion regulation
ENSG00000145244,CORIN,wnt/β-catenin pathway,constitutive activation,extracellular matrix degradation,oncogene function,tumor progression,signaling pathway dysregulation
ENSG00000198324,PHETA1,wnt/β-catenin pathway,mutations in tumors,protein regulation,cellular proliferation,oncogenic properties,tumor growth
ENSG00000104043,ATP8B4,cellular calcium homeostasis,ion channel regulation,chemotherapy resistance,cellular proliferation,prognostic marker,calcium-dependent signaling 
ENSG00000112697,TMEM30A,mitochondrial dysfunction,tumor suppressor function,dna damage accumulation,genomic instability,oncogenic transformation,proliferation regulation
ENSG00000081923,ATP8B1,lipid transport dysfunction,cholestasis,lipid accumulation,cellular damage,membrane integrity regulation,cellular homeostasis disruption
ENSG00000124406,ATP8A1,cell signaling,altered lipid profiles,oncogenic processes,increased expression levels,membrane trafficking dysfunction,therapeutic target
ENSG00000288146,NOC4L,genetic instability,mutation hotspot,alternative splicing regulation,transcriptional elongation,chromosomal instability,cell cycle progression
ENSG00000114023,FAM162A,cellular interaction,gain of function mutations,tumor progression,therapeutic target,metastasis promotion,cell migration
ENSG00000288283,RFX1,transcriptional regulation,chromatin remodeling,cell proliferation,apoptosis modulation,genomic instability,oncogenic function
ENSG00000285199,CIDEB,apoptosis regulation,caspase activation,mitochondrial membrane permeabilization,autophagy modulation,tumor progression,therapeutic target
ENSG00000187026,KRTAP21-2,cell adhesion disruption,epithelial integrity loss,keratin filament interaction,skin and epithelial tissue involvement,tumor progression facilitation,biomarker potential for cancer
ENSG00000136205,TNS3,cell migration,cytoskeletal dynamics,actin filament interaction,tumor-suppressive function,oncogenic driver,genomic amplification
ENSG00000163624,CDS1,genomic instability,dna repair regulation,ber pathway involvement,oncogene dysregulation,genome maintenance protein,cancer driver gene
ENSG00000047249,ATP6V1H,cellular invasion,transcriptional regulation,tumor progression,metastasis facilitation,proton pump activation,therapeutic target
ENSG00000144648,ACKR2,regulation of immune response,upregulation in cancer,chemokine interaction,promotion of tumor growth,constitutive activation,suppression of immune surveillance
ENSG00000135436,FAM186B,cell signaling pathway regulation,constitutive activation,oncogenic driver,cell proliferation enhancement,tumor metastasis promotion,overexpression
ENSG00000146094,DOK3,rtk activation,cell migration,receptor tyrosine kinase signaling,tumor invasion,constitutive activation,oncogenic transformation
ENSG00000157593,SLC35B2,glycosylation dysregulation,cellular adhesion,nucleotide-sugar transporter,tumor progression,cell proliferation,genomic instability
ENSG00000128578,STRIP2,pi3k/akt pathway,constitutive activation,resistance to therapy,chromatin remodeling,transcriptional regulation,oncogenic signaling
ENSG00000154723,ATP5PF,mitochondrial atp synthesis,metabolic regulation,oncogenic function,tumor growth promotion,energy metabolism alterations,therapeutic target
ENSG00000152455,SUV39H2,epigenetic regulator,genomic instability,histone modification,oncogenic function,tumor suppressor repression,chromatin remodeling
ENSG00000137720,C11orf1,cell cycle regulation,oncogenic activity,overexpression,proliferation promotion,protein interaction,tumorigenesis
ENSG00000121361,KCNJ8,tumor progression,oncogenic potential,therapeutic target,cellular excitability regulation,genomic instability contribution,epigenetic alterations modulation
ENSG00000170961,HAS2,has2 expression,extracellular matrix remodeling,hyaluronic acid production,oncogenic signaling,tumor cell migration,therapeutic target
ENSG00000119715,ESRRB,metabolic regulation,oncogenic processes,apoptosis inhibition,cell cycle progression,transcriptional regulation,therapeutic target
ENSG00000142453,CARM1,arginine methylation,epigenetic regulation,chromatin remodeling,cell growth promotion,tumor progression modulation,eukaryotic gene expression regulation
ENSG00000104883,PEX11G,peroxisome biogenesis,alterations in morphology,tumor association,cancer-related mutations,cellular homeostasis,protein interaction
ENSG00000160932,LY6E,immunomodulation,tumor evasion,apoptosis evasion,cell cycle regulation,angiogenesis promotion,immune suppression
ENSG00000148483,TMEM236,tumor suppressor function,cell growth regulation,oncogenic pathway inhibition,prognostic marker,overexpression in cancer,signaling molecule regulation
ENSG00000070501,POLB,dna replication,dysregulation,genomic instability,mismatch repair,ber pathway,cell proliferation
ENSG00000079263,SP140,chromatin regulation,transcriptional control,oncoprotein interaction,cell proliferation,metastasis promotion,tumor suppressor downregulation
ENSG00000164620,RELL2,apoptosis regulation,cell cycle progression,dna repair mechanism,immune response modulation,oncogenic transformation,therapeutic target
ENSG00000151320,AKAP6,cellular regulation,signaling pathway modulation,cell cycle progression,apoptosis dysregulation,centrosome organization,genomic stability regulation
ENSG00000214114,MYCBP,myc-dependent transcription,chromatin remodeling,cell cycle progression,anti-apoptotic functions,tumor development,genomic instability
ENSG00000149571,KIRREL3,emt process,overexpression,cell-cell adhesion regulation,tumor progression promoter,therapeutic target,prognostic marker
ENSG00000131711,MAP1B,microtubule regulation,oncogene overexpression,cell proliferation,prognostic marker,cell migration,signaling pathway interaction
ENSG00000265763,ZNF488,oncogene activation,tumor progression,gene overexpression,cell growth regulation,transcriptional regulation,chromatin remodeling
ENSG00000171503,ETFDH,mitochondrial function,mutation-induced genomic instability,ros production,dna damage,cellular metabolism regulation,hypoxia response activation
ENSG00000172602,RND1,actin cytoskeleton reorganization,metastasis promotion,cell migration regulation,tumor cell growth enhancement,guanylate nucleotide exchange modulation,poor prognosis association
ENSG00000144228,SPOPL,chromatin organization,genomic instability,mitotic checkpoint activation,aneuploidy,spindle assembly regulation,cell cycle regulation
ENSG00000139174,PRICKLE1,planar cell polarity signaling pathway,tumor progression,cell migration and invasion,gene amplification mutations,oncogenic process,tissue architecture disruption
ENSG00000230034,PSMB8,proteasomal degradation,cellular homeostasis regulation,oncogene activation,chemoresistance,apoptosis induction,cell cycle progression
ENSG00000102309,PIN4,mitotic checkpoint regulation,genomic instability,chromosomal alteration,cell cycle control,aneuploidy induction,spindle assembly activation
ENSG00000088808,PPP1R13B,pp1 regulation,cell cycle modulation,tumor progression,therapeutic target,transcriptional regulation,protein degradation
ENSG00000099219,ERMP1,alteration of lipid composition,interaction with pi3k/akt pathway,modulation of cell signaling,impact on cellular behavior,contribution to oncogenic processes,altered vesicle trafficking
ENSG00000119508,NR4A3,oncogenic transcription factor,cell cycle regulation,apoptosis evasion,transcriptional activation,tumor growth promotion,therapeutic target
ENSG00000133315,MACROD1,chromatin regulation,tumor suppressor regulation,genome instability,dna damage response,histone modification,cell proliferation
ENSG00000122952,ZWINT,genomic instability,aneuploidy,chromosomal alterations,tumor suppression,dna damage response,cell cycle regulation
ENSG00000112130,RNF8,genomic instability,dna repair regulation,chromatin modification,epigenetic regulation,oncogenic process driver,histone mark regulation
ENSG00000256812,CAPNS2,calpain activation,tumor invasion,cell proliferation,apoptosis regulation,genomic instability,protein degradation
ENSG00000166311,SMPD1,sphingolipid metabolism,ceramide accumulation,apoptosis induction,cell growth regulation,therapeutic target,genomic alterations
ENSG00000081721,DUSP12,erk activation,cell proliferation,signaling pathway regulation,tumor progression,therapeutic target,map kinase modulation
ENSG00000262334,RPH3AL,microtubule regulation,cell cycle regulation,mitotic progression,centrosome maturation,chromosomal instability,aneuploidy
ENSG00000060566,CREB3L3,cancer-associated transcription factor,pi3k/akt signaling pathway activation,chaperone-mediated autophagy regulation,tumor growth promotion,cell survival enhancement,protein interaction with p53 and brca1
ENSG00000215717,TMEM167B,immune regulation,transmembrane protein function,oncogenesis,cell surface expression,t-cell modulation,cancer prognosis
ENSG00000173113,TRMT112,mitochondrial function disruption,oxidative stress induction,metabolic reprogramming,apoptosis resistance,cellular proliferation promotion,tumor suppressor regulation
ENSG00000284850,DCP1B,mrna degradation,cell cycle regulation,tumor suppressor function,oncogenic process promotion,protein kinase activation,genomic instability
ENSG00000105723,GSK3A,glycogen metabolism regulation,tumor suppressor function loss,cell proliferation promotion,apoptosis inhibition,wnt signaling dysregulation,phosphorylation activity modulation
ENSG00000145779,TNFAIP8,apoptosis inhibition,cancer cell survival,dna repair enhancement,inflammation regulation,nf-κb signaling pathway,tumor growth promotion
ENSG00000159882,ZNF230,zinc finger dna binding,transcriptional regulation,cell growth modulation,oncogene interaction,chromatin remodeling,tumor suppressor activity
ENSG00000159228,CBR1,cbr1-mediated drug resistance,cell survival pathways activation,oxidative stress regulation,therapeutic target,metabolic enzyme activity,drug metabolism
ENSG00000285302,CHMP4A,dna repair dysregulation,genomic instability contribution,cell proliferation enhancement,tumor progression facilitation,chromatin remodeling role,nuclear processes regulation
ENSG00000173457,PPP1R14B,cellular regulation,protein phosphatase 1 inhibition,oncogenesis promotion,cell cycle progression,metastasis facilitation,tumor development enhancement
ENSG00000174586,ZNF497,oncogenic suppression,tumor suppressor function,transcriptional regulation,genomic instability,dna binding specificity,chromatin remodeling
ENSG00000143889,HNRNPLL,regulation of alternative splicing,cell growth regulation,mrna stability modulation,protein-protein interaction,rna processing,spliceosome component
ENSG00000113811,SELENOK,pi3k/akt modulation,cell survival regulation,tumor progression association,nf-κb signaling interaction,oncogenic function,proteostasis regulation
ENSG00000134571,MYBPC3,cardiac muscle contraction,mutations in cardiomyopathy,sarcomere assembly,apoptosis resistance,transcriptional regulation,cellular differentiation
ENSG00000120049,KCNIP2,cell cycle regulation,dna repair,enhanced cell proliferation,regulatory subunit function,tumor suppression,transcriptional regulation
ENSG00000132879,FBXO44,scf complex regulation,tumor suppressor function,cell cycle control,ubiquitination pathway,protein degradation,apoptosis modulation
ENSG00000129255,MPDU1,erad pathway regulation,apoptosis evasion,cell cycle progression,genetic instability,tumor suppressor function,ubiquitin-proteasome interaction
ENSG00000140939,NOL3,oncogene activation,cell cycle progression,rna-binding protein function,tumor resistance to chemotherapy,apoptosis suppression,mrna stability regulation
ENSG00000026652,AGPAT4,enhanced cell survival,lipid metabolism dysregulation,aberrant expression,tumor aggressiveness,therapeutic target,phospholipid biosynthesis
ENSG00000255009,UBTFL1,protein homeostasis regulation,cell cycle progression,genomic instability,tumor suppressor dysfunction,oncogenic process,ubiquitin-like protein function
ENSG00000095261,PSMD5,proteasome degradation,oncogenic process,cellular homeostasis,apoptosis regulation,dna damage response,therapeutic target
ENSG00000105520,PLPPR2,phospholipid phosphatase activity,pi(4)p dephosphorylation,lipid metabolism regulation,cell growth modulation,pi3k pathway interaction,tumorigenesis involvement
ENSG00000122862,SRGN,cell adhesion modulation,cancer progression,src signaling pathway,proteolytic processing,growth factor interaction,tumor suppressor function
ENSG00000106258,CYP3A5,cytochrome p450 activity,metabolic regulation,drug transport,cell cycle progression,apoptosis modulation,xenobiotic metabolism
ENSG00000166347,CYB5A,cytochrome b5 function,electron transfer reactions,metabolic regulation,steroidogenesis modulation,cellular homeostasis disruption,cancer cell growth enhancement
,ZNRD1,genomic instability,dna replication regulation,cell cycle progression alteration,tumor growth promotion,therapeutic target identification,protein-dna interaction
ENSG00000182606,TRAK1,rab gtpase family,cell trafficking regulation,oncogenic potential,cell migration and invasion,signaling pathway interaction,poor prognosis marker
ENSG00000101751,POLI,homologous recombination,genomic stability maintenance,dna double-strand break repair,tumor suppressor function,cancer predisposition,hematopoietic stem cell expression
ENSG00000263761,GDF2,tumor progression,cell growth regulation,angiogenesis induction,emt modulation,oncogenic signaling,genomic upregulation
ENSG00000119392,GLE1,cellular proliferation,nucleotide metabolism regulation,nuclear transport facilitation,tumor growth promotion,ribonucleotide transport,poor prognosis association
ENSG00000153086,ACMSD,sphingolipid metabolism,ceramide synthesis,protein kinase b (pkb/akt) signaling,cell proliferation,survival pathway,therapeutic target
ENSG00000147894,C9orf72,aberrant rna splicing,autophagy dysregulation,cellular toxicity,hexanucleotide repeat expansion,nuclear stress response,neurodegenerative disease
ENSG00000025772,TOMM34,mitochondrial function,impaired cellular metabolism,p53 regulation,dna damage susceptibility,cell cycle regulation,tumor suppressor protein interaction
ENSG00000143178,TBX19,tbx19 regulation,transcriptional repressor,chromatin remodeling,oncogenic transformation,cell cycle progression,apoptosis modulation
ENSG00000143367,TUFT1,g2/m phase transition regulation,centromere formation,chromosome segregation,cell cycle regulation,oncogene activation,tumor proliferation
ENSG00000115956,PLEK,pi3k/akt pathway,pleckstrin-homology domain,cell cycle regulation,dna repair mechanisms,tumor suppressor function,apoptosis regulation
ENSG00000068383,INPP5A,phosphoinositide regulation,constitutive activation,tumor progression,genomic instability,cell proliferation,second messenger regulation
ENSG00000283024,ATAD1,telomere length regulation,genomic stability maintenance,dna damage response,mitochondrial function,cell cycle progression,chromatin remodeling
ENSG00000146215,CRIP3,transcriptional regulation,cellular stress response,tumor progression,chemoresistance,pro-inflammatory signaling,apoptosis regulation
ENSG00000206527,HACD2,lipid metabolism regulation,fatty acid activation,cellular signaling modulation,tumor progression,cellular proliferation,genomic instability
ENSG00000144468,RHBDD1,pi3k/akt pathway,cellular proliferation,gene expression regulation,tumor progression,oncogenic mutation,cell cycle regulation
ENSG00000147383,NSDHL,steroid metabolism,cholesterol biosynthesis,lanosterol conversion,cellular proliferation,developmental disorder gene,endoplasmic reticular localization
ENSG00000052802,MSMO1,regulation of cellular growth,interaction with signaling pathways,metabolism regulation,apoptosis modulation,cell proliferation influence,tumor growth impact
ENSG00000282230,ADAM9,cell adhesion,invasive growth,apoptosis inhibition,angiogenesis promotion,epithelial-to-mesenchymal transition,cancer cell migration
ENSG00000134775,FHOD3,cell cycle regulation,transcriptional repression,oncogenic processes,tumor progression,apoptosis regulation,metastasis promotion
ENSG00000107745,MICU1,mitochondrial calcium regulation,metabolic adaptation,cellular stress response,oncogene expression,tumor microenvironment,genetic mutation hotspot
ENSG00000156026,MCU,mitochondrial function,regulation of cellular redox state,cell metabolism regulation,cancer cell energy production,prognostic marker for poor outcome,interaction with micu1 and stim1
ENSG00000134030,CTIF,cebpa interaction,gene regulation dysregulation,cellular proliferation disruption,rna polymerase ii recruitment defect,tumor progression contributor,genome instability enhancer
ENSG00000258947,TUBB3,genetic instability,microtubule polymerization,cell cycle regulation,drug resistance,aberrant cell proliferation,neuronal differentiation
ENSG00000123999,INHA,inhibin regulation,fsh signaling pathway,tumor growth promotion,anti-apoptotic function,hormonal influence,gonadal development
ENSG00000080371,RAB21,cancer progression,epithelial polarity disruption,gtpase activation,increased cell motility,metastasis promotion,signaling pathway dysregulation
ENSG00000145692,BHMT,methionine cycle regulation,oxidative stress protection,cell proliferation enhancement,genomic instability promotion,tumor aggressiveness indicator,therapeutic response predictor
ENSG00000101333,PLCB4,oncogene,cell proliferation,signaling pathway regulation,apoptosis resistance,gene expression upregulation,protein kinase activation
ENSG00000149100,EIF3M,eif3 complex regulation,protein synthesis regulation,oncogene activation,cell proliferation enhancement,translation initiation factor role,genomic instability promotion
ENSG00000160075,SSU72,chromatin regulation,transcription elongation,histone modification,oncogene function,therapeutic target,epigenetic regulation
ENSG00000101972,STAG2,genomic instability,chromosome segregation,cohesin complex disruption,dna damage repair,sister chromatid separation,mitotic checkpoint regulation
ENSG00000154930,ACSS1,fatty acid synthesis,energy production,tumor growth promotion,lipid metabolism regulation,cell proliferation enhancement,oncogenic driver gene expression
ENSG00000163577,EIF5A2,cap-dependent translation,protein synthesis regulation,cell proliferation promotion,oncogene,metastasis facilitation,tumorigenesis association
ENSG00000127884,ECHS1,lipid metabolism regulation,fatty acid oxidation,tumor aggressiveness,energy production enhancement,cell proliferation support,beta-oxidation pathway interaction
ENSG00000122417,ODF2L,mitotic spindle regulation,microtubule stability,genomic instability,cell cycle progression,aneuploidy prevention,chromosomal abnormalities
ENSG00000163209,SPRR3,cancer-related overexpression,cell proliferation,stratified squamous epithelia expression,tumor growth promotion,proline-rich protein family member,aberrant gene expression
ENSG00000147206,NXF3,mrna export,regulation of gene expression,cellular proliferation,therapeutic target,nuclear export complex formation,cancer development
ENSG00000101888,NXT2,transcriptional regulation,telomerase activity,cell proliferation,anti-apoptotic pathways,tumor progression,oncogene regulation
ENSG00000206280,ZBTB22,tumor suppressor,oncogene,transcription factor,cell proliferation,apoptosis regulation,chromatin remodeling
ENSG00000147586,MRPS28,mitochondrial translation,energy metabolism,anabolic metabolism,apoptosis resistance,cell proliferation,oxidative phosphorylation
ENSG00000132612,VPS4A,endosomal trafficking,protein degradation,atpase activity,cancer cell survival,cellular homeostasis,escrt machinery
ENSG00000151413,NUBPL,genomic instability,dna replication regulation,oncogenic processes,cellular interaction,tumor progression,homologous recombination
ENSG00000102978,POLR2C,transcription elongation,oncogenic processes,cell proliferation,dna synthesis,chromatin remodeling,protein-protein interaction
ENSG00000156384,SFR1,protein degradation,cellular homeostasis regulation,tumor suppressor activity,chaperone protein interaction,dna damage response activation,ubiquitin-proteasome pathway dysregulation
ENSG00000005075,POLR2J,cellular regulation,transcriptional regulation,genomic stability,cell proliferation,decoy target for micrornas,pseudogene expression
ENSG00000089169,RPH3A,endocytic regulation,rab gtpase-activating protein,receptor-mediated endocytosis,tumor progression,membrane trafficking regulation,cell surface receptor modulation
ENSG00000255221,CARD17,apoptosis regulation,innate immunity modulation,pyrim domain oligomerization,cellular stress response,immune cell function,necrosis regulation
ENSG00000105649,RAB3A,rab3a function,constitutive activation,cell migration enhancement,oncogenic interaction,tumor progression facilitation,pi3k/akt pathway regulation
ENSG00000167779,IGFBP6,igf-dependent signaling modulation,apoptosis induction,cell proliferation inhibition,pi3k/akt pathway regulation,tumor suppressor activity,multiprotein complex formation
ENSG00000142252,GEMIN7,snrnp assembly,spliceosome regulation,rna processing,cell cycle progression,protein-protein interaction,genome stability
ENSG00000206208,TAPBP,antigen presentation,peptide loading,mhc class i association,t cell activation,immune evasion mechanisms,cancer immunotherapy
ENSG00000112242,E2F3,chromatin regulation,cell cycle progression,transcriptional activation,oncogene function,tumor suppressor activity,apoptosis evasion
ENSG00000186965,KRTAP19-2,oncogenic overexpression,cell proliferation enhancement,intermediate filament stabilization,tumor progression driver,biomarker and therapeutic target,cell signaling pathway interaction
ENSG00000179912,R3HDM2,tumor suppression,e3 ubiquitin ligase regulation,protein degradation modulation,cancer progression association,ubiquitination pathway regulation,oncogenic protein interaction
ENSG00000168101,NUDT16L1,dna repair pathway,genetic instability,mutation accumulation,tumor suppressor function,base excision repair,epigenetic regulation
ENSG00000138604,GLCE,lipid metabolism alteration,tumor progression,cell proliferation enhancement,therapeutic target,oncogenic pathway modulation,cancer cell survival promotion
ENSG00000113209,PCDHB5,pi3k/akt pathway,constitutive activation,gain of function mutations,tumor progression,biomarker potential,genomic instability
ENSG00000136267,DGKB,pkc activation,cell proliferation,tumor growth,metastasis promotion,pi3k/akt pathway interaction,overexpression in cancer
ENSG00000266967,AARSD1,genomic instability,cell cycle progression,oncogenic properties,resistance to therapy,dna repair mechanisms,pi3k/akt pathway interaction
ENSG00000108825,PTGES3L-AARSD1,trna biogenesis,transfer rna charging,protein synthesis regulation,tumorigenesis contribution,cellular process disruption,oncogenic potential
ENSG00000112499,SLC22A2,oct2 transport activity,altered expression levels,drug resistance mechanism,tumor progression association,cellular stress response regulation,folate transport role
ENSG00000170633,RNF34,ubiquitination pathway,tumor suppressor function,cell cycle regulation,aberrant protein accumulation,oncogenic transformation,e3 ligase complex interaction
ENSG00000176087,SLC35A4,cell surface protein,solute carrier activity,nucleotide sugar transport,epigenetic regulation,tumor progression,cancer driver gene
ENSG00000171396,KRTAP4-4,epithelial integrity,intermediate filament formation,tissue structure maintenance,cancer cell migration,cell survival regulation,keratin-associated protein family member
ENSG00000105419,MEIS3,transcriptional regulation,genetic regulation,cell proliferation,gene expression modulation,protein interaction,oncogene activity
ENSG00000163125,RPRD2,telomere maintenance,anti-telomerase function,chromatin remodeling,regulatory protein interactions,cellular senescence prevention,genomic stability modulation
ENSG00000158850,B4GALT3,cell surface glycosylation,tumor growth,metastasis promotion,poor prognosis indicator,glycoprotein synthesis,signaling pathway interaction
ENSG00000007237,GAS7,chromatin remodeling,modulator of pi3k/akt signaling,cell proliferation enhancer,metabolic regulator,scaffolding protein interaction,cell survival factor
ENSG00000092850,TEKT2,cell adhesion disruption,epithelial polarity loss,tumor progression facilitation,signal transduction modulation,cancer cell migration promotion,genomic instability contribution
ENSG00000143702,CEP170,microtubule dynamics regulation,genomic stability maintenance,mitotic checkpoint impairment,chromosomal instability induction,tumor progression promotion,cell cycle regulation disruption
ENSG00000129295,LRRC6,homologous recombination repair,genomic stability,tumor suppression,dna double-strand break repair,cell proliferation regulation,brca1/2 interaction
ENSG00000117597,UTP25,pre-mrna splicing,spliceosome assembly,nuclear function,transcriptional regulation,cellular behavior,tumorigenesis
ENSG00000204897,KRT25,keratin filament assembly,mitotic spindle integrity,epithelial cell differentiation,tissue remodeling,cell migration facilitation,cytoskeletal regulation
ENSG00000173928,SWSAP1,chromatin remodeling,cell cycle progression,tumor progression,oncogenic pathway,cell proliferation regulation,signaling molecule interaction
ENSG00000214941,ZSWIM7,oncogene,epigenetic regulation,transcriptional modulation,cell proliferation,survival pathways,tumor progression
ENSG00000113732,ATP6V0E1,v-type proton atpase,proton pump activation,ph regulation,cell invasion,metastasis promotion,epithelial-to-mesenchymal transition
ENSG00000173221,GLRX,thioredoxin reductase 2,redox regulation,apoptosis regulation,cell growth regulation,protein interaction,oncogenic potential
ENSG00000166012,TAF1D,disrupted gene regulation,enhanced cell proliferation,therapeutic target,tumor progression,oncogenic process,genomic instability
ENSG00000107938,EDRF1,tumor suppressor,oncogene potential,angiogenesis regulation,cell proliferation promotion,epithelial-to-mesenchymal transition (emt),nitric oxide synthase (nos) activity
ENSG00000173418,NAA20,acetylation regulation,protein modification,cell cycle progression,apoptosis regulation,tumor suppression,oncogenic transformation
ENSG00000236424,TSPY10,cell cycle regulation,genomic instability,epigenetic modification,oncogenic activity,tumor growth promotion,metastasis facilitation
ENSG00000130844,ZNF331,transcriptional regulation,cell growth inhibition,tumor suppressor gene regulation,cancer driver mutation,apoptosis induction,genetic instability
ENSG00000152433,ZNF547,transcriptional repression,tumor suppressor function,cell cycle regulation,apoptosis induction,dna binding activity,krab domain-containing zinc finger protein family
ENSG00000204178,MACO1,mitochondrial function,regulation of cellular respiration,energy metabolism regulation,cell growth modulation,reactive oxygen species production,therapeutic target
ENSG00000146143,PRIM2,genomic instability,oncogenesis,cell proliferation,dna synthesis,therapeutic target,transcriptional regulation
ENSG00000198056,PRIM1,prim1 mutations,dna replication initiation,genomic instability,rna primer formation,dna polymerase alpha component,cancer driver gene
ENSG00000186226,LCE1E,cellular proliferation,apoptosis inhibition,cancer susceptibility,protein processing,signaling pathway modulation,tumor progression
ENSG00000104853,CLPTM1,dna damage response,apoptosis regulation,cell cycle progression,genomic stability,oncogenesis promotion,multifunctional protein interaction
ENSG00000244025,KRTAP19-3,cellular adhesion,tumor progression,protein interaction,keratin expression,cell migration,oncogenesis
ENSG00000157741,UBN2,ubiquitination regulation,proteasomal degradation,cell proliferation enhancement,tumor suppressor protein degradation,oncogene stabilization,poor prognosis marker
ENSG00000100084,HIRA,epigenetic regulation,tumor suppressor function,chromatin remodeling,histone modification,genomic stability,proliferation suppression
ENSG00000276781,CHGA,neuroendocrine differentiation,chromaffin granule component,poor prognosis marker,tumor progression factor,metastatic potential enhancer,secretory granule regulation
ENSG00000050344,NFE2L3,antioxidant response regulation,cell survival enhancement,dna repair pathway,oxidative stress response,transcriptional regulation,tumor suppressor interaction
ENSG00000101473,ACOT8,lipid metabolism regulation,acyl-coa hydrolysis,cell membrane composition,tumor progression,oncogenic process,metabolic reprogramming
ENSG00000197892,KIF13B,mitotic spindle formation,microtubule-based transport,oncogenic driver,therapeutic target,cell migration regulation,cancer metastasis
ENSG00000171224,FAM241B,nuclear localization,cell cycle regulation,dna repair mechanism,protein-protein interaction,transcriptional regulation,genomic stability
ENSG00000165810,BTNL9,t-cell activation,immunoglobulin superfamily member,cytokine regulation,immune cell interaction,autoimmunity disorder,immunodeficiency disorder
ENSG00000154814,OXNAD1,nf-kappab pathway regulation,transcriptional regulation,immune response modulation,cell survival enhancement,tumor progression facilitation,protein-protein interactions
ENSG00000163171,CDC42EP3,cancer progression,overexpression,cell migration,tumor invasion,epithelial-to-mesenchymal transition,guanine nucleotide exchange
ENSG00000162373,BEND5,apoptosis regulation,oncogenesis association,cell cycle regulation,nuclear localization,caspase activation,dna repair interaction
ENSG00000115808,STRN,tumor suppressor,cell signaling regulation,chromatin remodeling,apoptosis regulation,cell cycle progression,oncogenic pathway modulation
ENSG00000164626,KCNK5,potassium channel regulation,ion flow modulation,cellular excitability,oncogenic processes,tumor growth promotion,tpdk channel function
ENSG00000080845,DLGAP4,cell signaling regulation,protein-protein interaction,tumor progression,cancer metastasis,oncogenic potential,poor prognosis indicator
ENSG00000003056,M6PR,tumor progression,oncogene overexpression,metastasis facilitation,apoptosis inhibition,cell growth regulation,lysosomal enzyme targeting
ENSG00000163029,SMC6,genomic instability,constitutive activation,chromatin remodeling,aneuploidy driver,cancer therapy target,tumor progression
ENSG00000007384,RHBDF1,notch signaling pathway,aberrant activation,gain of function mutations,tumor progression,oncogenic transformation,apoptosis suppression
ENSG00000160218,TRAPPC10,oncogenic driver,golgi apparatus dysfunction,cell growth promotion,membrane trafficking regulation,protein transport modulation,cancer mutational hotspot
ENSG00000099917,MED15,transcription regulation,chromatin remodeling,tumor progression,multifunctional protein,oncogenic processes,cell proliferation
ENSG00000117472,TSPAN1,adhesion regulation,cell migration,epithelial-to-mesenchymal transition,oncogenic signaling,tumor progression,transmembrane protein function
ENSG00000126233,SLURP1,tumor progression,cell signaling pathway,receptor modulation,immune response regulation,prognostic marker,therapeutic target
ENSG00000179941,BBS10,aberrant ciliary function,intraflagellar transport regulation,cancer association unexplored,genetic disorder connection,bardet-biedl syndrome relation,cell signaling pathway interaction
ENSG00000283153,FRG1,chromatin remodeling,transcriptional regulation,gene expression modulation,cell cycle progression,dna repair alterations,tumor suppressor function
ENSG00000185049,NELFA,nuclear pore complex regulation,tumor suppressor activity,mutation-driven alterations,chromatin remodeling,cell cycle regulation,dna damage response
ENSG00000136630,HLX,regulates hematopoiesis,leukemic transformation,transcription factor activity,cell cycle regulation,apoptosis induction,hematopoeitic stem cell maintenance
ENSG00000132434,LANCL2,regulation of cellular metabolism,modulation of cell survival and proliferation pathways,mitochondrial function regulation,potential biomarker or therapeutic target,tumorigenesis association,cellular signaling pathway interaction
ENSG00000148606,POLR3A,rna polymerase iii transcription,genomic stability maintenance,aberrant expression alterations,cellular growth regulation,tumor progression association,cell proliferation control
ENSG00000032742,IFT88,cilium dysregulation,oncogenic mutation,ciliopathy association,cellular signaling disruption,organellar dysfunction,genetic predisposition
ENSG00000138002,IFT172,chromosomal instability,tumor suppressor,cilia assembly,dysregulated expression,genomic alterations,oncogenesis
ENSG00000163320,CGGBP1,chromatin remodeling,genomic instability,tumor suppressor regulation,dna repair modulation,histone interaction,oncogene expression
ENSG00000160194,NDUFV3,mitochondrial dysfunction,oncogenic metabolism,genomic instability,electron transport chain disruption,therapeutic target,cellular energy production
ENSG00000150347,ARID5B,chromatin remodeling,constitutive activation,gain of function mutations,genomic instability,tumor progression,therapeutic target
ENSG00000164024,METAP1,cell signaling regulation,enzyme dysregulation,tumor progression,protein modification,apoptosis modulation,metabolic regulation
ENSG00000237155,IER3,oncogene activation,transcriptional coactivation,cell survival promotion,inflammation regulation,angiogenesis promotion,tumor growth enhancement
ENSG00000187010,RHD,immune evasion,aberrant protein-protein interaction,disrupted red blood cell recognition,autoimmune predisposition,chromosome 1 localization,tissue specificity modulation
ENSG00000125148,MT2A,nf-κb regulation,metal homeostasis,cellular differentiation,transcriptional modulation,antioxidant function,tumor progression
ENSG00000284967,FDFT1,geranylgeranylation,prenylation pathway,ras/rho activation,cell survival,protein modification,oncogenesis
ENSG00000078808,SDF4,wnt/β-catenin pathway,cellular proliferation,signaling modulation,gene expression regulation,notch signaling interaction,tumor suppressor function
ENSG00000167791,CABP2,calcium-dependent signaling pathway,regulation of cell proliferation,intracellular calcium sensing,cell survival modulation,protein interaction partner,genetic dysregulation
ENSG00000167674,HDGFL2,oncogenic transformation,cell cycle progression,microtubule dynamics regulation,tumorigenesis promotion,aggressive tumor behavior,cell proliferation enhancement
ENSG00000109118,PHF12,histone modification,chromatin remodeling,transcriptional regulation,cancer driver mutation,therapeutic target,epigenetic regulation
ENSG00000135127,BICDL1,transcriptional regulation,chromatin remodeling,oncogenic function,cell proliferation,apoptosis inhibition,epigenetic modification
ENSG00000156738,MS4A1,cell surface receptor regulation,metastasis promotion,pi3k/akt pathway interaction,tumor growth facilitation,immune response modulation,poor prognosis marker
ENSG00000144057,ST6GAL2,aberrant expression,alpha-2,6-sialyltransferase activity,cancer progression,cell migration and proliferation,glycoprotein sialylation
ENSG00000168778,TCTN2,cilia formation,hippo pathway disruption,oncogenic mutations,cell growth regulation,tumor suppressor interaction,signaling pathway dysregulation
ENSG00000065665,SEC61A2,er translocation,protein synthesis regulation,cell proliferation enhancement,apoptosis resistance,tumorigenesis contributor,therapeutic target potential
ENSG00000168724,DNAJC21,mitochondrial function regulation,pi3k/akt pathway modulation,cell proliferation enhancement,apoptosis inhibition,tumor initiation promotion,protein folding regulation
ENSG00000118420,UBE3D,ubiquitination,oncogenic protein stabilization,tumor progression,metastasis promotion,gene regulation disruption,cell cycle dysregulation
ENSG00000281191,KRTAP5-3,epithelial integrity,overexpression,cell proliferation,tumor progression,prognostic marker,pi3k/akt pathway interaction
ENSG00000166669,ATF7IP2,chromatin remodeling,tumor suppressor function,genomic stability maintenance,cell cycle regulation,dna damage response modulation,transcriptional control
ENSG00000160606,TLCD1,centrosome regulation,microtubule stabilization,cell proliferation,genomic instability,oncogene activation,cellular localization
ENSG00000090372,STRN4,cell membrane-cytoskeleton interactions,tumor progression,cell migration,cytoskeletal dynamics regulation,metastasis promotion,oncogenic processes
ENSG00000182628,SKA2,chromosomal segregation,mitotic processes,oncogenic mutations,genomic instability,cell cycle regulation,protein-protein interaction
ENSG00000239857,GET4,golgi export complex regulation,cell proliferation promotion,tumor progression association,therapeutic target potential,protein quality control modulation,apoptosis inhibition
ENSG00000205155,PSENEN,gamma-secretase complex,cell signaling regulation,notch receptor processing,apoptosis regulation,therapeutic target,cancer driver potential
ENSG00000161217,PCYT1A,cell proliferation,genomic instability,nucleotide synthesis,pyrimidine biosynthesis,aneuploidy promotion,tumor microenvironment
ENSG00000128829,EIF2AK4,er stress regulation,tumor suppressor function loss,oncogenic pathway activation,cell cycle dysregulation,phosphorylation activity,stress response attenuation
ENSG00000156284,CLDN8,cldn8 overexpression,cell migration,epithelial-to-mesenchymal transition (emt),tumor metastasis,tight junctions disruption,pi3k/akt pathway activation
,PQLC2,pi3k/akt pathway activation,oncogene overexpression,cellular proliferation,ion transport regulation,apoptosis modulation,signaling pathway interaction
ENSG00000041802,LSG1,histone demethylation,chromatin remodeling,epigenetic regulation,cell growth promotion,apoptosis suppression,cancer driver gene
ENSG00000128534,LSM8,disrupted pre-mrna splicing,tumor progression,transcriptional regulation disruption,genomic instability,rna processing alterations,cancer therapeutic target
,MARCH5,erad pathway,ubiquitin ligase activity,tumor suppressor function,proteasomal regulation,mitochondrial dysfunction,proliferation inhibition
ENSG00000142546,NOSIP,cell survival,no production regulation,signal transduction pathway,antiproliferative properties,protein-protein interaction,gene expression modulation
ENSG00000099625,CBARP,regulation of gene expression,interaction with transcription factors,cell growth modulation,oncogene activation,cell cycle regulation,apoptosis suppression
ENSG00000102312,PORCN,wnt signaling pathway,cell proliferation,golgi apparatus localization,mutations or amplifications,oncogenic effects,tumor progression
ENSG00000187391,MAGI2,epithelial-to-mesenchymal transition,regulation of tight junctions,cell adhesion modulation,tumor progression,oncogenic signaling,protein-protein interactions
ENSG00000085662,AKR1B1,cell growth promotion,oxidative stress reduction,detoxification process,nf-κb pathway interaction,tumorigenesis association,overexpression correlation
ENSG00000143369,ECM1,epithelial-to-mesenchymal transition,cell migration regulation,transmembrane protein function,tumor progression promotion,angiogenesis enhancement,adhesion molecule interaction
ENSG00000101193,GID8,Regulatory function , Ubiquitination process , Cell cycle regulation , Transcriptional control , DNA damage response , Protein degradation pathway
ENSG00000178982,EIF3K,mtor pathway regulation,cap-dependent translation enhancement,oncogenic signaling facilitation,tumorigenesis promotion,cellular proliferation increase,protein synthesis regulation
ENSG00000177479,ARIH2,protein degradation regulation,ubiquitination,tumor suppression,oncogenic pathway regulation,poor prognosis association,tumorigenesis involvement
ENSG00000183230,CTNNA3,altered cell-cell adhesion,cancer progression,cell polarity regulation,epithelial integrity maintenance,metastasis promotion,transcriptional regulation
ENSG00000102781,KATNAL1,microtubule regulation,tumor suppressor function,dysregulated microtubules,genomic instability,cell division abnormalities,spindle formation defect
ENSG00000115423,DNAH6,intracellular trafficking,cell migration,cilia motility,mitotic regulation,tumor suppressor,genetic instability
ENSG00000165410,CFL2,cell migration,tumor progression,oncogenic driver,actin filament dynamics,cytoskeleton regulation,apoptosis resistance
ENSG00000109511,ANXA10,cellular adhesion disruption,epithelial-to-mesenchymal transition,metastasis regulation,tumor suppressor activity,extracellular calcium binding,cell membrane trafficking
ENSG00000128833,MYO5C,intracellular trafficking,cell migration,cytoplasmic organization,vesicle transport,cytokinesis regulation,adaptor protein interaction
ENSG00000104722,NEFM,intermediate filament protein,neuronal structural integrity,mitosis regulation,cellular transport modulation,protein anchoring function,cancer cell survival
ENSG00000178750,STX19,cellular membrane remodeling,vesicle trafficking regulation,tumor progression influence,cancer cell migration promotion,oncogenic potential,biomarker candidate
ENSG00000111732,AICDA,activation-induced deamination,genomic instability,dna mutations,immunoglobulin hypermutation,b-cell proliferation,somatic hypermutation
ENSG00000173334,TRIB1,akt/mtor signaling pathway,cellular homeostasis disruption,constitutive expression,oncogenic transformation promoter,pseudokinase activity,protein-protein interactions
ENSG00000145107,TM4SF19,cell adhesion disruption,tumor metastasis,oncogene potential,pi3k/akt pathway activation,epithelial-to-mesenchymal transition (emt),apoptosis regulation
ENSG00000141562,NARF,apc/scf-mediated ubiquitination,chromatin remodeling,cell cycle progression,oncogenic transformation,protein degradation regulation,transcriptional modulation
ENSG00000106483,SFRP4,wnt signaling pathway,tumor suppressor function,epigenetic silencing,cell proliferation regulation,metastasis regulation,protein interaction
ENSG00000160200,CBS,homocysteine accumulation,tumor progression,sulfur amino acid metabolism disruption,epigenetic alterations,cell growth promotion,oncogenic processes
ENSG00000163618,CADPS,regulation of secretory pathway,control of vesicle trafficking,promotion of tumor growth,dysregulation in oncogenesis,interaction with gtpases,protein kinase activity
ENSG00000051341,POLQ,genomic instability,maintenance of dna integrity,dna repair mechanisms,cell cycle regulation,proteolytic activity,chromatin remodeling
ENSG00000143105,KCNA10,voltage-gated potassium channel regulation,tumor progression,metastasis facilitation,drug resistance mechanism,electrical activity modulation,ion channel interaction
ENSG00000110104,CCDC86,chromosomal instability,cellular proliferation,centrosome cohesion,microtubule stability,nedd1-nuf2 complex interaction,genomic integrity maintenance
ENSG00000141985,SH3GL1,endocytic pathway,oncogene activation,cell membrane dynamics,tumor progression,therapeutic target,genomic amplification
ENSG00000166233,ARIH1,oncogenic signaling pathway modulation,protein degradation regulation,tumor suppressor activity,cell cycle progression regulation,dna repair pathway interaction,apoptosis modulation
ENSG00000112077,RHAG,rhag expression,tumor progression,cell membrane stability,erythrocyte shape regulation,angiogenesis modulation,protein-protein interactions
ENSG00000101160,CTSZ,heparan sulfate biosynthesis,tumor microenvironment modulation,angiogenesis enhancement,cell proliferation regulation,cell migration influence,therapeutic target
ENSG00000150672,DLG2,tumor suppressor,cell adhesion regulation,synaptic transmission modulation,pi3k/akt pathway regulation,apoptosis induction,cancer cell invasion suppression
ENSG00000089127,OAS1,oncogenic signaling,tumor suppressor inactivation,immune evasion,cell survival promotion,proliferation enhancement,metastasis facilitation
ENSG00000162975,KCNF1,oncogenic signaling,cell proliferation regulation,electrical excitability modulation,tumor progression promotion,genomic instability,therapeutic target
ENSG00000170515,PA2G4,tumor growth,oncogene activation,cancer metastasis,mrna stability regulation,cell proliferation enhancement,signaling pathway interaction
ENSG00000113384,GOLPH3,oncogenic function,cell proliferation,golgi apparatus regulation,protein-protein interaction,tumor progression,metastasis suppression
ENSG00000181409,AATK,apoptosis regulation,tumor progression,cell survival pathways,serine/threonine kinase activity,xiap interaction,genomic mutations
ENSG00000108759,KRT32,aberrant expression,cell signaling,cancer cell differentiation,epithelial integrity,tissue architecture,structural component
ENSG00000099256,PRTFDC1,genomic instability,dna damage response,cell cycle regulation,proteostasis modulation,tumor formation,chaperone activity
ENSG00000142178,SIK1,mtor pathway activation,cellular energy regulation,oncogenic processes promotion,protein kinase activity,signaling pathway modulation,tumor growth facilitation
ENSG00000130347,RTN4IP1,pi3k/akt interaction,overexpression in cancer,cell migration and invasion,prognostic biomarker,tumor progression,genomic instability
ENSG00000118785,SPP1,osteopontin overexpression,tumor microenvironment modulation,metastasis facilitation,angiogenesis promotion,immune evasion support,prognostic marker
ENSG00000124942,AHNAK,oncogenic driver,cell adhesion modulation,cytoskeletal dynamics regulation,epithelial-to-mesenchymal transition (emt) promotion,pi3k/akt/mtor pathway interaction,tumor growth enhancement
ENSG00000153551,CMTM7,apoptosis regulation,tumor suppressor function,cellular interaction,immune response modulation,protein-protein interaction,cancer development influence
ENSG00000171928,TVP23B,cellular regulation,transmembrane protein,protein trafficking regulation,oncogenic potential,therapeutic target,tumor progression
ENSG00000164292,RHOBTB3,tumor suppressor function,epithelial-to-mesenchymal transition regulation,apoptosis modulation,gtpase-activating protein activity,protein degradation regulation,gene expression regulation
ENSG00000133121,STARD13,pi3k/akt pathway modulation,tumor suppressor function,protein-protein interaction regulation,genomic stability maintenance,cell growth inhibition,cell division regulation
ENSG00000115963,RND3,tumor suppression,microtubule stabilization,cell cycle inhibition,cancer cell invasion,therapeutic target,cellular transport regulation
ENSG00000198939,ZFP2,cellular regulation,transcriptional control,oncogenic processes,tumorigenesis,metastasis,therapeutic target
ENSG00000125755,SYMPK,cellular proliferation,kinase activation,oncogenic potential,protein regulation,signaling pathway modulation,tumor progression
ENSG00000151414,NEK7,ikk/nf-κb signaling pathway,aberrant activation,cellular proliferation,tumor progression,therapeutic target,nemo component
,H2BFS,histone regulation,cancer cell proliferation,transcriptional elongation,gene expression alteration,tumor progression,therapeutic target
ENSG00000130818,ZNF426,tumor suppressor,tissue-specific expression,mutation-induced oncogenesis,dna binding specificity,transcriptional regulation,apoptosis induction
ENSG00000075239,ACAT1,lipid metabolism regulation,tumor progression facilitation,fatty acid breakdown involvement,oncogenic signaling pathway interaction,cellular process modulation,mitochondrial localization
ENSG00000186187,ZNRF1,tumor suppressor function,wnt signaling regulation,e3 ubiquitin ligase activity,cell proliferation modulation,therapeutic target potential,tissue homeostasis maintenance
ENSG00000161911,TREML1,tumor microenvironment modulation,aberrant immune activation,dysregulation of inflammation,oncogenic pathway activation,myeloid cell activation,innate immunity regulation
ENSG00000176101,SSNA1,cell cycle regulation,tumor suppressor function,loss-of-function mutations,genomic instability,apc/c activity,mitotic exit
ENSG00000243335,KCTD7,potassium channel regulation,oncogenic process,cell proliferation,survival pathway,ion balance regulation,therapeutic target
ENSG00000072849,DERL2,erad pathway disruption,apoptosis regulation,tumor suppressor function,tissue homeostasis maintenance,misfolded protein accumulation,dna damage response
ENSG00000204511,MCCD1,genomic instability,dna repair mechanism,parp1 regulation,cell cycle control,apoptosis regulation,cancer susceptibility
ENSG00000120729,MYOT,microtubule dynamics regulation,centrosome organization,cell proliferation promotion,signaling pathway activation,stress response modulation,protein kinase activation
ENSG00000107099,DOCK8,guanylate exchange factor,rho gtpase regulation,t-cell function,immune dysregulation,cell migration pathway,cytoskeleton organization
ENSG00000163879,DNALI1,retrograde transport disruption,microtubule destabilization,genomic instability induction,oncogenic mutation driver,ciliogenesis dysregulation,cellular morphology alteration
ENSG00000205076,LGALS7,tumor suppressor,cellular differentiation,immune modulation,apoptosis regulation,protein-protein interaction,transcriptional regulation
ENSG00000282902,LGALS7B,tumor microenvironment modulation,immunosuppression promotion,cell cycle regulation,apoptosis inhibition,angiogenesis facilitation,oncogenic potential enhancement
ENSG00000170577,SIX2,oncogene,tumor progression,cell proliferation,transcriptional regulator,pi3k/akt pathway interaction,angiogenesis regulation
ENSG00000181754,AMIGO1,tumor progression,growth cone formation,cell migration,adherens junction regulation,cancer metastasis,pi3k/akt pathway interaction
ENSG00000105486,LIG1,dna repair pathway,tumor suppressor function,genome instability,chemoresistance,base excision repair,dna damage response
ENSG00000165802,NSMF,tumor progression,oncogenic processes,immune evasion mechanisms,cell proliferation,therapeutic target,poor prognosis
ENSG00000102710,SUPT20H,histone modification,chromatin remodeling,transcriptional regulation,cell cycle progression,apoptosis inhibition,tumor suppressor function
ENSG00000183668,PSG9,cell adhesion,cell migration,proteoglycan function,transmembrane interaction,tumor progression,emt regulation
ENSG00000165943,MOAP1,p53 regulation,tumor progression,proteasome pathway activation,cell survival enhancement,oncogenic processes,ubiquitin ligase function
ENSG00000147872,PLIN2,lipid metabolism regulation,fatty acid synthesis enhancement,oncogene function,cellular growth promotion,therapeutic target identification,genomic expression alteration
ENSG00000256061,DNAAF4,axonemal dynein,ciliary assembly,oncogenic potential,cell signaling disruption,tumorigenesis association,therapeutic target candidate
ENSG00000128699,ORMDL1,cancer cell proliferation,oncogenic lipid metabolism,sphingolipid biosynthesis regulation,cell survival enhancement,metastasis promotion,therapeutic target
ENSG00000117152,RGS4,enhanced g-protein coupled receptor signaling,oncogenic signaling pathway,tumor progression,cell proliferation regulation,gap activity for small gtpases,protein-protein interactions
ENSG00000133019,CHRM3,tumor suppressor,cell growth inhibition,acetylcholine signaling,g-protein coupled receptor,cell survival regulation,oncogenic process inhibition
ENSG00000186834,HEXIM1,cellular regulation,nf-kb pathway modulation,7sk snrna binding,p-tefb inhibition,tumor suppressor function,gene expression regulation
ENSG00000196101,HLA-DRB3,antigen presentation,immunosurveillance,tumor immunology,hla class ii molecule expression,dysregulation in cancer,tumor antigen recognition
ENSG00000132514,CLEC10A,tumor progression,immune evasion,therapeutic target,protein-protein interaction,cellular activation,cancer development
ENSG00000121680,PEX16,peroxisomal membrane protein import,altered lipid metabolism,cellular metabolism regulation,tumor suppressor function,cancer progression regulator,genomic instability modifier
ENSG00000198189,HSD17B11,hormone regulation,tumor progression,metabolic reprogramming,cell growth regulation,oncogenic mutations,therapeutic resistance
ENSG00000188001,TPRG1,growth factor activation,constitutive activation,overexpression,tumor progression,angiogenesis,protein-protein interaction
ENSG00000173908,KRT28,cellular structure,tumor progression,epithelial cell function,protein-protein interaction,cytoskeleton regulation,cell proliferation
ENSG00000163071,SPATA18,genomic instability,tumor progression,oncogenic process,cellular proliferation,gene expression regulation,dna repair modulation
ENSG00000163840,DTX3L,epigenetic regulation,chromatin remodeling,histone modification,gene expression regulation,cell proliferation promotion,apoptosis inhibition
ENSG00000008441,NFIX,oncogene,transcriptional regulator,cell proliferation,chromatin remodeling,epigenetic regulation,tumor progression
ENSG00000176108,CHMP6,endosomal sorting,escrt-iii complex,oncogenic transformation,cell migration and invasion,apoptosis resistance,cell proliferation enhancement
ENSG00000175206,NPPA,oncogenic signaling,tumor progression,epigenetic modification,gene amplification,cell proliferation,metastatic potential
ENSG00000159348,CYB5R1,mitochondrial function regulation,fatty acid metabolism alteration,redox balance disruption,cell growth promotion,lipid biosynthesis modulation,oncogene-protein interaction
ENSG00000106355,LSM5,rnp complex assembly,rna processing regulation,oncogene stabilization,cell proliferation driver,signaling pathway modulation,pro-survival mrna translation
ENSG00000119185,ITGB1BP1,cell adhesion modulation,integrin interaction,cell migration promotion,tumor progression facilitation,metastasis enhancement,survival pathway regulation
ENSG00000198393,ZNF26,genomic instability,loss of tumor suppressor function,cell proliferation enhancement,apoptosis reduction,dna repair pathway modulation,chromatin structure disruption
ENSG00000135093,USP30,mitochondrial function regulation,tumor suppressor role,oxidative stress modulation,cellular homeostasis maintenance,anti-tumorigenic properties,deubiquitinating enzyme activity
ENSG00000178150,ZNF114,transcriptional regulation,zinc finger protein structure,krab domain interaction,cell cycle control,apoptosis regulation,chromatin remodeling
ENSG00000137285,TUBB2B,microtubule dynamics,tumor suppressor,neurofibrillary tangle formation,cell proliferation,axonal growth regulation,therapeutic target
ENSG00000257335,MGAM,glycosaminoglycan degradation,apoptosis evasion,tumor progression,cell signaling modulation,dysregulated expression,prognostic marker
ENSG00000129534,MIS18BP1,genomic instability,tumor suppressor function,centrosome regulation,cell proliferation inhibition,cancer cell disruption,spindle formation regulation
ENSG00000164070,HSPA4L,protein homeostasis regulation,tumor metastasis facilitation,cell cycle modulation,apoptosis suppression,anti-proteolytic activity enhancement,therapeutic target
ENSG00000185105,MYADML2,tumor suppressor function,genome instability regulation,apoptosis modulation,cell cycle regulation,transcriptional coactivator interaction,myb/sant domain dna binding
ENSG00000151332,MBIP,tumor suppressor/oncogene,cell cycle regulation,apoptosis modulation,protein degradation regulation,signaling pathway interaction,genomic instability
ENSG00000213782,DDX47,cellular processes regulation,potential oncogene,rna metabolism involvement,transcriptional regulation,tumor growth promotion,therapeutic target
ENSG00000152061,RABGAP1L,rho gtpase signaling pathway,tumor suppressor,cellular proliferation inhibition,rho gtpase regulation,oncogenesis modulation,cancer progression inhibition
ENSG00000164985,PSIP1,oncogenic processes,chromatin remodeling,histone modification,transcriptional regulation,gene expression profiling,tumor aggressiveness
ENSG00000186222,BLOC1S4,melanosome biogenesis,mutations leading to loss of function,abnormal melanin production,cell protection against oxidative damage,oncogenic processes,genomic instability
ENSG00000132554,RGS22,g-protein coupled receptor signaling pathway,gene regulation,dysregulation,cell proliferation,tumor progression,protein interaction
ENSG00000187634,SAMD11,genomic stability,dna repair mechanism,nhej pathway,cellular interaction,protein-protein binding,tumor suppressor role
ENSG00000181004,BBS12,bardet-biedl syndrome,cilia biogenesis,extracellular sensing,hedgehog pathway regulation,wnt signaling modulation,oncogenic transformation
ENSG00000217442,SYCE3,meiotic recombination,genomic instability,synaptonemal complex assembly,dna repair mechanisms,chromosome pairing,aneuploidy
ENSG00000197084,LCE1C,cellular proliferation,survival and growth promotion,regulation of cell differentiation,interaction with filaggrin,upregulation in tumors,potential therapeutic target
ENSG00000123353,ORMDL2,er stress response,lipid biosynthesis regulation,cell membrane biogenesis modulation,oncogenic process contribution,therapeutic target potential,signaling pathway activation
ENSG00000147439,BIN3,apoptosis regulation,oncogene function,mitochondrial outer membrane interaction,cell survival promotion,tumorigenesis association,cellular stress response modulation
ENSG00000124383,MPHOSPH10,genomic instability,dna damage response,cell cycle regulation,phosphatase activity,pi3k/akt pathway activation,tumor suppressor activity
ENSG00000182054,IDH2,metabolic rewiring,tumor metabolism,oncogenic process,dna methylation,epigenetic alteration,therapeutic target
ENSG00000101489,CELF4,oncogenic activity,alternative splicing regulation,post-transcriptional regulation,cell proliferation enhancement,tumor metastasis promotion,apoptosis inhibition
ENSG00000134627,PIWIL4,regulation of cell proliferation,genomic instability,potential oncogenic activity,transposable element silencing,protein-protein interaction,cytoplasmic localization
ENSG00000105993,DNAJB6,genome stability maintenance,chaperone-mediated protein folding,tumor suppression,cell cycle regulation,protein degradation pathway,cytoplasmic and nuclear localization
ENSG00000174132,FAM174A,nuclear localization,cell cycle regulation,protein transport,mitotic progression,cancer susceptibility,genomic instability
ENSG00000012822,CALCOCO1,autophagic regulation,oncoprotein function,genomic instability,apoptosis inhibition,cell proliferation enhancement,protein-protein interaction
ENSG00000135090,TAOK3,cellular proliferation,oncogenic transformation,phosphorylation activity,cell cycle regulation,apoptosis resistance,ubiquitination regulation
ENSG00000184650,ODF4,microtubule stability,cellular structure maintenance,overexpression,aggressive tumor behavior,proliferation,apoptosis resistance
ENSG00000169223,LMAN2,cholesterol regulation,protein trafficking,lipid metabolism,cellular adaptation,metabolic alterations,therapeutic potential
ENSG00000187238,LCE3B,terminal differentiation,epidermal barrier integrity,skin integrity maintenance,tumor progression modulation,growth regulation disruption,epithelial cell interaction
ENSG00000160472,TMEM190,amplification,oncogenesis,cytoplasmic microtubule organization regulation,cell membrane integrity maintenance,cell-cell adhesion modulation,protein-protein interaction
ENSG00000115540,MOB4,cell cycle regulation,protein interaction modulation,tumor suppression,oncogene regulation,apoptosis regulation,signaling pathway modulation
ENSG00000120907,ADRA1A,g protein-coupled receptor signaling,adrenergic receptor activation,cell proliferation regulation,tumor progression modulation,mapk/erk pathway interaction,therapeutic target potential
ENSG00000125875,TBC1D20,rab11 interaction,endosomal trafficking regulation,cell migration promotion,tumor progression association,gtpase activity regulation,protein-protein interaction
ENSG00000105613,MAST1,cellular proliferation,oncogenesis,signaling pathway regulation,cell survival,protein kinase activation,tumor progression
ENSG00000004455,AK2,ak2 overexpression,purinergic signaling,gain of function mutations,cell growth promotion,immune suppression,genomic instability
ENSG00000134588,USP26,homologous recombination,deubiquitinating activity,dna damage response,genomic stability,cell survival,protein-protein interaction
ENSG00000198000,NOL8,ribosome biogenesis,cell growth promotion,cell cycle regulation,oncoprotein overexpression,tumor progression facilitation,therapeutic target
ENSG00000121742,GJB6,cell-to-cell communication,tissue homeostasis regulation,cellular differentiation modulation,immune response regulation,cancer progression association,metastasis facilitation
ENSG00000113441,LNPEP,lipid metabolism regulation,tumor progression,metastasis,therapeutic resistance,cell growth regulation,oncogenic signaling
ENSG00000163947,ARHGEF3,rho gtpase activation,oncogenic signaling pathway,cell migration regulation,tumor progression enhancement,therapeutic target,genomic biomarker
ENSG00000196715,VKORC1L1,vitamin k-dependent carboxylation,bone mineralization,gamma-glutamyl carboxylase regulation,bleeding disorder association,oncogene potential,tumorigenesis involvement
ENSG00000116771,AGMAT,polyamine synthesis pathway,oncogenic processes,cell proliferation,apoptosis resistance,dysregulation in cancer,protein-protein interactions
ENSG00000154237,LRRK1,autophagy regulation,cell survival regulation,cell cycle progression,apoptosis modulation,proliferation regulation,stress response regulation
ENSG00000139350,NEDD1,microtubule dynamics regulation,cell division regulation,centrosome function modulation,chromosomal instability,protein-protein interaction,mitotic spindle formation
ENSG00000187569,DPPA3,germ cell specification,self-renewal maintenance,chromatin remodeling,transcription factor function,pluripotency regulation,embryonic development
ENSG00000164972,C9orf24,transcriptional regulation,dna repair,cell cycle progression,protein interaction,genomic instability,oncogenesis
ENSG00000010219,DYRK4,protein kinase activation,promotion of oncogenesis,overexpression in cancer,cell proliferation regulation,transcription factor phosphorylation,tumor suppressor inhibition
ENSG00000240386,LCE1F,cellular growth regulation,epidermal barrier function,filaggrin expression regulation,cellular differentiation modulation,environmental stress response,skin barrier maintenance
ENSG00000187223,LCE2D,epithelial barrier function,anti-apoptotic properties,cancer cell survival,tumor suppressor functions,dna repair mechanisms,chromatin remodeling
ENSG00000171311,EXOSC1,impaired rna degradation,loss-of-function mutations,accumulation of aberrant rnas,oncogenic signaling pathway activation,tumor suppression disruption,gene expression regulation
ENSG00000275513,KIR3DL3,mhc class i interaction,immunoregulation,immune evasion,tumor immune microenvironment,killer cell immunoglobulin-like receptor,cell surface expression
ENSG00000160888,IER2,tumor suppressor,oncogene function,gain of function mutations,cell cycle regulation,apoptosis inhibition,angiogenesis promotion
ENSG00000154832,CXXC1,chromatin remodeling,methylated dna binding,epigenetic regulation,tumor suppressor function,loss-of-function mutations,cancer predisposition
ENSG00000146147,MLIP,mitochondrial dynamics regulation,oncogenic metabolic reprogramming,cell survival enhancement,tumor progression promotion,therapeutic target identification,genomic overexpression
ENSG00000077063,CTTNBP2,actin cytoskeleton regulation,metastasis facilitation,cancer progression driver,signaling pathway interaction,cell migration enhancement,tumor aggressiveness promotion
ENSG00000138669,PRKG2,cell proliferation,cell migration,signaling pathway activation,tumor growth promotion,apoptosis evasion,cell cycle regulation 
ENSG00000167618,LAIR2,immune regulation,cell adhesion,inflammation modulation,immune response modulation,leukocyte function,tissue homeostasis
ENSG00000138080,EMILIN1,tumor suppressor function,loss of heterozygosity,pi3k/akt pathway regulation,cell migration regulation,metastasis suppression,elastic fiber formation
ENSG00000115446,UNC50,endocytic trafficking,oncogenic function,cytoskeletal rearrangement,protein interaction,cell migration,invasion
ENSG00000109519,GRPEL1,cellular stress response,unfolded protein response,oncogenesis,cell survival,tumor progression,genetic mutations
ENSG00000092200,RPGRIP1,pi3k/akt pathway regulation,centrosomal protein interaction,microtubule dynamics regulation,ciliogenesis modulation,genomic stability disruption,oncogene overexpression
ENSG00000107831,FGF8,fgf/fgfr signaling pathway,gain of function mutations,tumor growth promotion,angiogenesis induction,cell proliferation enhancement,embryonic development involvement
ENSG00000138036,DYNC2LI1,chromosomal instability,mitotic progression regulation,aneuploidy induction,cell proliferation promotion,microtubule dynamic modulation,protein interaction regulation
ENSG00000132010,ZNF20,tumor suppressor function,oncogene activation,cell proliferation regulation,gene expression modulation,transcription factor activity,cell cycle control
ENSG00000172748,ZNF596,cell cycle progression,transcriptional regulator,oncogene/tumor suppressor,gene expression regulation,apoptosis inhibition,cell survival enhancement
ENSG00000179833,SERTAD2,transcriptional regulation,gene amplification,mutation hotspot,protein-protein interaction,tumor suppressor function,chromatin remodeling
ENSG00000010322,NISCH,tumor suppressor,cell adhesion regulation,metastasis inhibition,cell migration modulation,cytoskeleton organization,prognostic biomarker
ENSG00000123595,RAB9A,autophagy regulation,cancer cell survival,cell membrane trafficking,endosomal fusion,oncogenic signaling,protein-protein interaction
ENSG00000101901,ALG13,protein glycosylation,oligosaccharyltransferase complex,tumor microenvironment,cell adhesion regulation,therapeutic target,glycoprotein modification
ENSG00000121454,LHX4,oncogenic regulation,tumor suppressor repression,chromatin modification,transcriptional reprogramming,cell proliferation promotion,genomic instability
ENSG00000161981,SNRNP25,altered pre-mrna splicing,cancer progression,genomic instability,mutational hotspot,oncogenic expression,splice site mutation
ENSG00000149503,INCENP,cancer driver,chromosomal stability,mitotic spindle checkpoint,cell proliferation,apoptosis resistance,metastatic potential
ENSG00000164256,PRDM9,genomic instability,histone modification,meiotic recombination regulation,chromatin remodeling,epigenetic regulation,cell cycle disruption
ENSG00000168679,SLC16A4,cancer metastasis,glycolysis enhancement,cellular ph regulation,energy supply facilitation,therapeutic target,metabolic rewiring
ENSG00000165633,VSTM4,immune modulation,tumor growth promotion,cell surface receptor interaction,vitamin d binding,multifunctional protein,apoptosis regulation
ENSG00000162702,ZNF281,transcriptional regulation,tumor suppressor function,cell cycle regulation,apoptosis modulation,genomic stability maintenance,nuclear localization
ENSG00000111452,ADGRD1,cell adhesion regulation,oncogenic signaling,metastasis promotion,tumor growth enhancement,therapeutic target,genomic instability
ENSG00000243279,PRAF2,rac gtpase activation,tumor progression,oncogenic potential,cell cycle regulation,apoptosis evasion,prognostic marker
ENSG00000244411,KRTAP5-7,keratin-associated protein,epidermal development,cell adhesion,proliferation pathway,tissue structure,cellular differentiation
ENSG00000185900,POMK,genomic instability,tumor suppressor function,loss of function mutations,cell proliferation regulation,protein kinase regulation,substrate specificity alterations
,FGFR1OP,fgf receptor inhibition,pseudogene expression,tumor suppressor function,cell growth regulation,protein-protein interaction,oncogenic pathway activation
ENSG00000198937,CCDC167,genomic instability,cell division regulation,microtubule stability,spindle assembly checkpoint,chromosome segregation,tumorigenesis promoter
ENSG00000267467,APOC4,lipid metabolism regulation,cell proliferation enhancement,tumor accumulation,metastasis facilitation,protein-protein interaction,oncogenic property promotion
ENSG00000106588,PSMA2,proteolytic activity,tumor progression,cellular homeostasis disruption,protein degradation,cell cycle regulation,apoptosis inhibition
ENSG00000276358,PLEKHM1,er-phagy regulation,late endosome formation,autophagosome regulation,rab7 interaction,cell survival pathway,tumor progression
ENSG00000033627,ATP6V0A1,v-atpase regulation,cellular membrane maintenance,proton pump function,lysosomal dysfunction,endocytic pathway modulation,cancer metastasis promotion
ENSG00000085415,SEH1L,homologous recombination,genomic stability,dna repair,mutation risk,cell cycle regulation,tumor suppressor
ENSG00000166123,GPT2,protein degradation regulation,cellular homeostasis modulation,gene expression dysregulation,tumor progression contribution,enzymatic activity alteration,biomarker potential
ENSG00000138495,COX17,complex iv assembly,mitochondrial function regulation,energy metabolism,tumor progression,cellular respiration,electron transport chain
ENSG00000148384,INPP5E,phosphoinositide regulation,cell growth regulation,oncogenic mutations,ciliopathy association,cell survival pathway,therapeutic target
ENSG00000116514,RNF19B,ubiquitin ligase activity,cell cycle regulation,tumor suppressor dysfunction,oncogenic function,apoptosis inhibition,dna repair modulation
ENSG00000136319,TTC5,p53 regulation,tumor suppressor interaction,cell cycle modulation,dna repair regulation,oncogene activation,genomic instability
ENSG00000132436,FIGNL1,cell cycle regulation,ubiquitin-mediated proteolysis,tumor suppressor dysfunction,cancer cell survival,oncogenic signaling pathway interaction,mitotic progression disruption
ENSG00000102890,ELMO3,rho gtpase regulation,constitutive activation,gain of function mutations,tumor metastasis,protein-protein interaction,cell migration
ENSG00000182585,EPGN,cell cycle regulation,apoptosis modulation,genomic stability maintenance,tumor progression,therapeutic target,signaling pathway regulation
ENSG00000187272,KRTAP9-8,aberrant expression,cell migration,disrupted cell-cell adhesion,intermediate filament networks,keratin-associated protein dysregulation,skin fragility
ENSG00000213741,RPS29,ribosomal function,dna damage response,cellular metabolism,promotes oncogenesis,translation initiation,overexpressed in cancer
ENSG00000188895,MSL1,oncogenic function,chromatin remodeling,epigenetic modification,gene expression regulation,histone methylation,compass complex
ENSG00000180616,SSTR2,therapeutic target,neuroendocrine tumor regulation,adenylate cyclase inhibition,g-protein coupled receptor function,cancer therapy resistance modulation,cellular proliferation control
ENSG00000235169,SMIM1,oncogene potential,cell cycle regulation,androgen receptor interaction,protein-protein interactions,tumor progression,genomic overexpression
ENSG00000181016,LSMEM1,regulation of mrna stability,oncogenic potential,interaction with proteins and pathways,cell growth and survival enhancement,metastatic potential increase,gene expression regulation
ENSG00000008283,CYB561,electron transfer regulation,metabolic reprogramming,oncogenic potential,cell growth promotion,energy metabolism dysregulation,signaling pathway interaction
ENSG00000161980,POLR3K,rna transcription,tumor progression,oncogene potential,cell growth regulation,transcriptional regulation,genomic instability
ENSG00000176986,SEC24C,copii vesicle formation,cell proliferation,vesicular transport,chemosensitivity regulation,gene expression regulation,tumor resistance
ENSG00000136352,NKX2-1,tumor suppressor activity,transcriptional regulation,cell proliferation pathways,cancer stem cell maintenance,metastatic potential,embryonic development gene
ENSG00000133731,IMPA1,pi3k/akt signaling,oncogenic mutations,cell proliferation,metabolic regulation,protein kinase activation,tumor progression
ENSG00000141401,IMPA2,pi3k/akt signaling pathway,cellular proliferation,oncogenic protein,cell invasion and metastasis,tumor growth promotion,mtor regulation
ENSG00000117448,AKR1A1,oncogenic function,redox regulation,cellular stress responses,tumor growth promotion,signaling pathway modulation,detoxification mechanisms
ENSG00000101191,DIDO1,apoptosis regulation,pro-apoptotic function,cell survival pathway,tumor suppressor role,cancer biomarker,genetic instability
ENSG00000121766,ZCCHC17,regulation of gene expression,alternative splicing,oncogenic processes,tumor progression,signaling pathway regulation,cell migration
ENSG00000088356,PDRG1,oncogene activation,cell proliferation,transcriptional regulation,proteasomal degradation,chromatin remodeling,apoptosis evasion
ENSG00000092054,MYH7,actin cytoskeleton regulation,tumor progression,poor prognosis,cancer mutations,cell migration disruption,protein misfolding
ENSG00000139648,KRT71,cytoskeletal alterations,epithelial cell disruption,oncogenic potential,mutational activation,cell cycle regulation,signal transduction
ENSG00000148584,A1CF,chromatin regulation,splice site selection,oncogenic signaling,dna damage response,genomic stability,gene expression modulation
ENSG00000117868,ESYT2,endosomal membrane trafficking,oncogene activation,cell proliferation,metastatic progression,biomarker potential,cancer progression marker
ENSG00000139641,ESYT1,lipid biosynthesis,cellular metabolism regulation,oncogenic process promotion,er-stress response modulation,akt signaling pathway interaction,lipid droplet formation
ENSG00000177108,ZDHHC22,rtk regulation,gene amplification,cell proliferation enhancement,survival promotion,metastasis facilitation,protein prenylation modification
ENSG00000272031,ANKRD34A,cell cycle regulation,tumor suppressor function,apoptosis modulation,genomic instability,cytoplasmic localization,cell proliferation promotion
ENSG00000011009,LYPLA2,lipid metabolism,oncogenic driver,lipid signaling pathway,cell membrane remodeling,phospholipase activity,tumor progression
ENSG00000112655,PTK7,metastasis-suppressor,planar cell polarity,receptor-like tyrosine kinase,wnt/pcp pathway interaction,tumor growth regulation,cell adhesion and migration
ENSG00000171956,FOXB1,fox transcription factor,tumor suppressor function,loss of function mutations,cell cycle regulation,genomic instability,aneuploidy prevention
ENSG00000117525,F3,tumor progression,coagulation activation,cancer metastasis,pro-thrombotic state,angiogenesis modulation,inflammation regulation
ENSG00000189283,FHIT,genomic instability,tumor suppressor activity,cyclin-dependent kinase inhibition,apoptosis regulation,dna repair pathway interaction,p53 activation
ENSG00000132963,POMP,protein synthesis regulation,oncogenic function,cell proliferation,therapeutic target,tumor overexpression,stress response
ENSG00000176273,SLC35G1,genetic alterations,glycosylation process,oncogenic metabolism,metastatic potential,prognostic marker,therapeutic target
ENSG00000183864,TOB2,tumor suppressor activity,cellular apoptosis,transcriptional regulation,protein-protein interactions,mapk pathway modulation,p53-dependent response
ENSG00000035141,FAM136A,cell proliferation,possible biomarker,uncharacterized protein,genomic alterations,protein interactions,cancer progression
ENSG00000175324,LSM1,alternative splicing,genomic instability,mrna degradation,nonsense-mediated mrna decay (nmd) pathway,oncogenic isoforms,rna-binding protein interaction
ENSG00000158220,ESYT3,er calcium regulation,calcium signaling dysregulation,cell proliferation enhancement,oncogenic growth promotion,autophagy modulation,genomic instability association
ENSG00000055609,KMT2C,chromatin remodeling,histone methylation,epigenetic regulation,transcriptional modification,oncogenic transformation,tumor suppressor activity
ENSG00000182173,TSEN54,rna splicing defects,tumor suppressor function,neurological disorders association,cancer metabolic reprogramming,cellular energy regulation,dysregulated gene expression
ENSG00000064787,BCAS1,cell cycle regulation,oncogenic function,tumor aggressiveness,genomic instability,dna repair pathways,cancer progression
ENSG00000128908,INO80,chromatin remodeling,dna damage response,genomic stability maintenance,cell cycle regulation,tumor suppressor function,dna repair mechanisms
ENSG00000101442,ACTR5,cell cycle regulation,mitotic progression,aneuploidy induction,tumor suppressor function,genomic instability,cancer-related mutations
ENSG00000155090,KLF10,tumor suppressor activity,epithelial integrity maintenance,dna repair regulation,emt inhibition,immune response modulation,therapeutic target
ENSG00000054598,FOXC1,transcriptional regulation,cell proliferation,gain-of-function mutations,epithelial-to-mesenchymal transition (emt),oncogenic driver,pi3k/akt pathway modulation
ENSG00000159259,CHAF1B,chromatin assembly,dna replication,genomic stability,oncogenic processes,epigenetic regulation,tumorigenesis
ENSG00000198947,DMD,sarcolemma maintenance,calcium channel regulation,muscle cell integrity,chronic inflammation,fibrosis induction,metastasis promotion
ENSG00000113327,GABRG2,neurotransmission regulation,transmembrane protein structure,gaba_a receptor complex formation,epilepsy associated,cellular excitability modulation,synaptic transmission regulation
ENSG00000100814,CCNB1IP1,cell cycle regulation,chromatin maintenance,dna damage response,genomic instability,cancer progression,therapeutic target
ENSG00000160285,LSS,cell cycle regulation,cytoskeletal dynamics,microtubule stability,tumor progression,neurological disorder,genetic instability
ENSG00000133059,DSTYK,protein dephosphorylation,pi3k/akt signaling regulation,oncogene activation,cell proliferation promotion,tumor growth facilitation,kinase-substrate interaction 
ENSG00000163933,RFT1,ribosome biogenesis,overexpression,oncogenic driver,tumor progression,cell cycle regulation,protein synthesis enhancement
ENSG00000179532,DNHD1,genomic instability,tumor suppressor function,dna helicase activity,oncogenic transformation,loss-of-function mutations,chromosomal instability
,COL4A3BP,tumor aggressiveness,overexpression,metastasis,biomarker potential,cell migration,prognostic significance
ENSG00000133275,CSNK1G2,wnt/beta-catenin signaling pathway,cell cycle regulation,tumor progression,mutations implicated in oncogenesis,apoptosis dysregulation,protein-protein interactions
ENSG00000139318,DUSP6,erk signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,signaling regulation
ENSG00000058453,CROCC,oncogene activation,cell migration regulation,chromatin modification,tumor progression driver,metastasis facilitation,therapeutic target potential
ENSG00000117281,CD160,regulation of immune responses,inhibition of nk cell cytotoxicity,immunosuppression,cell adhesion regulation,metastasis facilitation,tumor evasion
ENSG00000113240,CLK4,constitutive activation,tumor growth,cell cycle regulation,protein kinase activation,oncogenic driver,metastasis promotion
ENSG00000213625,LEPROT,pi3k/akt pathway,regulatory element,cellular proliferation,tumor progression,signaling receptor,metabolic regulation
ENSG00000123545,NDUFAF4,mitochondrial dysfunction,oxidative stress regulation,genomic instability,cellular metabolism modulation,tumor suppressor activity,reactive oxygen species production
ENSG00000105866,SP4,tumor suppressor/oncogene switch,transcriptional regulation,cell proliferation regulation,apoptosis inhibition,angiogenesis promotion,epigenetic modification
ENSG00000233813,MRPS18B,mitochondrial translation,cell cycle progression,energy metabolism regulation,tumor promotion,mitochondrial dynamics regulation,oncogenic overexpression
ENSG00000275979,CNOT3,regulation of mrna deadenylation,transcriptional regulation,cell proliferation enhancement,rna processing modulation,apoptosis suppression,oncogenic process promotion
ENSG00000187173,LCE2A,cell adhesion disruption,oncogenic potential,skin barrier function dysregulation,tumor suppressor activity uncertainty,epidermal cell migration influence,cancer-related gene expression alteration
ENSG00000114771,AADAC,fatty acid oxidation,metabolic reprogramming,mitochondrial localization,lipid metabolism regulation,tumor growth promotion,therapeutic target
ENSG00000134900,TPP2,cellular regulation,dephosphorylation activity,signaling pathway regulation,cell cycle progression,apoptosis inhibition,metabolic regulation
ENSG00000100505,TRIM9,apoptosis modulation,pi3k/akt signaling,oncogene potential,tumor suppressor interaction,cell cycle regulation,cancer association
ENSG00000203883,SOX18,endothelial-to-mesenchymal transition,transcription factor activity,angiogenic pathway regulation,tumor progression driver,vascular development regulation,metastasis promotion
ENSG00000214413,BBIP1,chromosome segregation,microtubule interaction,mitotic spindle assembly,genomic stability,aneuploidy promotion,cancer progression
ENSG00000167916,KRT24,tumor suppression,epithelial integrity maintenance,keratin network disruption,cancer progression marker,dysregulated expression,prognostic significance
ENSG00000124275,MTRR,genomic instability,tumor progression,ancillary enzyme regulation,dna repair mechanisms,methionine metabolism disruption,homocysteine accumulation
ENSG00000116984,MTR,methionine synthesis,dna methylation,epigenetic regulation,genome stability,tumor progression,redox regulation
ENSG00000062282,DGAT2,lipid metabolism,cell membrane alteration,oncogenic lipid synthesis,tumor growth promotion,chemotherapy resistance,protein interaction modulation
ENSG00000243509,TNFRSF6B,decoy receptor function,tumor suppression,regulation of t-cell activation,modulation of inflammatory response,immune evasion mechanisms,enhanced tumor progression
ENSG00000104936,DMPK,cellular regulation,tumor suppressor function,protein kinase activation,cellular growth modulation,oncogenic mutations,cancer-related pathways
ENSG00000166562,SEC11C,homologous recombination,gain of function mutations,lipid metabolism regulation,cholesterol synthesis upregulation,dna repair dysregulation,tumor progression
ENSG00000147650,LRP12,oncogenic processes,wnt/β-catenin pathway interaction,cell proliferation,metastasis promotion,tumor progression,therapeutic target
ENSG00000181804,SLC9A9,ph homeostasis,ion exchange regulation,tumor aggressiveness,metastasis promotion,prognosis correlation,cellular viability maintenance
ENSG00000023191,RNH1,genomic instability,dna repair pathway,oligonucleotide degradation,zinc-finger domain presence,nuclear localization,tumor suppressor function
ENSG00000064995,TAF11,cell cycle regulation,transcriptional regulation,tumor aggressiveness,oncogene function,genome stability,cell growth modulation
ENSG00000281309,SURF6,arp2/3 complex regulation,cell migration enhancement,oncogenic process involvement,poor prognosis association,actin cytoskeleton dynamics modulation,overexpression in cancer
ENSG00000138587,MNS1,genomic instability,oncogene function,dna repair pathway interaction,cell cycle regulation disruption,multifunctional protein role,protein-protein interaction alterations
ENSG00000163485,ADORA1,adenosine signaling pathway,tumor microenvironment modulation,immune suppression,angiogenesis promotion,g-protein coupled receptor function,anti-inflammatory effects
ENSG00000174667,OR7D4,tumor microenvironment,immune modulation,cell proliferation regulation,genetic variation hotspot,cancer-associated protein,olfactory receptor function
ENSG00000110887,DAO,tumor progression,metastasis promotion,redox regulation,oncogene activation,signal transduction,protein-protein interaction
ENSG00000105669,COPE,tumor progression,cellular proliferation,ubiquitination regulation,onco-protein modification,deregulated protein stability,protein degradation control
ENSG00000138696,BMPR1B,tumor suppressor,epithelial-to-mesenchymal transition inhibition,pi3k/akt pathway regulation,cell proliferation inhibition,smad4 interaction,metastasis suppression
ENSG00000108590,MED31,genomic instability,cell proliferation,chromatin remodeling,nuclear protein interaction,transcription regulation,dna repair mechanism
ENSG00000122958,VPS26A,genomic instability,endosomal sorting,constitutive activation,tumor progression,therapeutic target,cell survival
ENSG00000152583,SPARCL1,tumor suppression,loss of adhesion,metastatic potential,cell motility regulation,fibronectin assembly regulation,integrin interaction
ENSG00000065000,AP3D1,regulation of lysosomal function,cellular homeostasis,protein sorting and transport,oncogenesis,cell proliferation,metastasis
ENSG00000099290,WASHC2A,endocytic recycling pathway,cell migration regulation,mitotic spindle assembly,tumor suppressor function,protein-protein interaction network,genomic instability driver
ENSG00000164695,CHMP4C,tumor suppressor function,escrt complex regulation,membrane trafficking regulation,vesicle formation alteration,endosomal sorting disorder,tumorigenesis promoter
ENSG00000143363,PRUNE1,haploinsufficiency,tumor suppressor function,genomic instability,dna repair regulation,cell cycle progression,protein ubiquitination
ENSG00000104960,PTOV1,phosphatase regulation,cell proliferation,oncogenic signaling,nuclear localization,protein-protein interactions,kinase modulation
ENSG00000183813,CCR4,chemokine receptor activation,immunosuppressive signaling,tumor microenvironment modulation,regulatory t cell recruitment,myeloid-derived suppressor cell homing,pi3k/akt pathway interaction
ENSG00000103932,RPAP1,transcriptional regulation,cell growth modulation,rna polymerase ii association,serine protease activity,mutational hotspot,therapeutic target
ENSG00000164162,ANAPC10,cell cycle regulation,ubiquitination/degradation,oncogenic mutations,chromosome segregation errors,dna repair deficiencies,g2/m checkpoint dysregulation
ENSG00000135862,LAMC1,laminin-332 formation,tumor progression,metastasis,cell adhesion disruption,extracellular matrix remodeling,proteolytic enzyme interaction
ENSG00000148356,LRSAM1,protein degradation,tumor suppression,ring-type e3 ubiquitin ligase,cell cycle regulation,oncoprotein targeting,gene expression control
ENSG00000168826,ZBTB49,tumor suppressor/tsg action,genomic instability,gene repression,binding activity,transcriptional regulation,chromatin remodeling
ENSG00000172795,DCP2,rna degradation,oncogenic processes,aberrant rna accumulation,exosome complex,3' end processing,tumorigenesis
ENSG00000258405,ZNF578,transcriptional regulation,cellular homeostasis,apoptosis,dna repair,cell cycle regulation,none
ENSG00000061794,MRPS35,mitochondrial dysfunction,oxidative stress induction,genomic instability promotion,cellular proliferation enhancement,tumor progression facilitation,metabolic reprogramming
ENSG00000198752,CDC42BPB,cell cycle regulation,constitutive activation,cell migration,tumor invasion,metastasis promotion,cytoskeleton organization
ENSG00000241233,KRTAP5-8,keratin filament disruption,epidermal differentiation,cell proliferation enhancement,tumor progression facilitation,apoptosis resistance,cytoskeletal remodeling
ENSG00000085741,WNT11,wnt/β-catenin signaling,tumor progression,stem cell maintenance,dysregulated expression,oncogenic driver,signaling pathway activation
ENSG00000186416,NKRF,nf-κb pathway,negative regulation,oncogene/tumor suppressor,cell proliferation,apoptosis inhibition,transcriptional repression
ENSG00000167191,GPRC5B,growth regulation,retinoic acid receptor,cell proliferation,constitutive activation,oncogenic process,apoptosis evasion
ENSG00000166923,GREM1,hh signaling pathway,epithelial-to-mesenchymal transition,metastasis promotion,tumor progression,cancer immunotherapy target,bmp signaling inhibition
ENSG00000175745,NR2F1,nr2f1 transcription factor activity,oncogenic potential,cell proliferation regulation,tumor suppressor function disruption,genomic instability induction,cancer cell survival enhancement
ENSG00000204370,SDHD,glycolytic reprogramming,mitochondrial dysfunction,cellular metabolism alteration,ros production enhancement,apoptosis suppression,tumor progression promotion
ENSG00000154743,TSEN2,genomic instability,aberrant rna processing,dysregulated cellular processes,oncogene activation,tumor suppressor downregulation,rna degradation
ENSG00000134548,SPX,pi3k/akt signaling pathway interaction,tumor progression modulation,apoptosis regulation,cell growth modulation,dna repair protein interaction,cancer-related protein kinase activation
ENSG00000178928,TPRX1,genomic instability,tumor suppressor,dna repair mechanism,cell cycle regulation,brca1-bard1 interaction,therapeutic target
,MARCH6,cellular homeostasis,e3 ligase activity,protein degradation regulation,tumorigenesis regulation,metastasis involvement,oncogene modulation
ENSG00000181467,RAP2B,activation of cell proliferation,oncogenic process,tumorigenesis promotion,ras-like gtpase family member,cell signaling pathway regulation,gain of function mutations
ENSG00000136193,SCRN1,proteolysis regulation,cellular degradation,oncoprotein stabilization,tumor growth promotion,stress response modulation,protease activation
ENSG00000175395,ZNF25,tumor suppressor function,cell proliferation inhibition,apoptosis promotion,mutation association,prognostic marker,gene regulation modulation
ENSG00000084234,APLP2,tumor promotion,overexpression,cell surface interactions,lipid metabolism modulation,wnt signaling pathway activation,poor prognosis indicator
ENSG00000164929,BAALC,baalc overexpression,oncogenic transcription factor,cell growth promotion,poor prognosis,chemotherapy resistance,aggressive disease phenotype
ENSG00000111218,PRMT8,arginine methylation,chromatin regulation,cell proliferation,oncogene activation,tumor progression,transcriptional regulation
ENSG00000162144,CYB561A3,cell signaling,electron transfer reactions,lipid metabolism,mitochondrial function,oncogene,redox balance
ENSG00000188379,IFNA2,antitumor immune response,interferon signaling,tumor suppression,oncogenic potential,immune evasion mechanisms,cell cycle regulation
ENSG00000134602,STK26,cell polarity disruption,hippo pathway dysregulation,serine/threonine kinase activity,mitotic regulation,cytokinesis impairment,tumor suppressor function
ENSG00000169752,NRG4,erbb2/her2 interaction,tumor growth promotion,upregulated expression,cell proliferation enhancement,angiogenesis facilitation,biomarker potential
ENSG00000135917,SLC19A3,nucleoside transport regulation,cellular uptake enhancement,tumor progression facilitation,poor prognosis association,dna repair interaction,oncogene overexpression
ENSG00000165915,SLC39A13,zinc homeostasis regulation,genomic instability,cell proliferation enhancement,tumor progression facilitation,therapeutic target identification,protein-protein interaction
ENSG00000110375,UPK2,tumor suppression,loss of function mutations,disrupted cell-cell adhesion,altered signaling pathways,cancer progression,urothelial barrier integrity
ENSG00000166452,AKIP1,akt signaling pathway,oncogenic potential,gain of function mutations,prognostic biomarker,cell proliferation regulation,metabolic activity enhancement
ENSG00000113504,SLC12A7,cellular transport,electrolyte balance regulation,apical membrane expression,kidney cell function,tumor progression association,renal epithelial cell interaction
ENSG00000158186,MRAS,ras gtpase activity,constitutive activation,oncogenic potential,cell proliferation,apoptosis resistance,genomic instability
ENSG00000203879,GDI1,rho gtpase regulation,tumor progression,cytoskeletal dynamics,cell migration,gene expression modulation,signaling pathway disruption
ENSG00000007171,NOS2,nitric oxide production,oncogenic processes,tumor growth promotion,angiogenesis,metastasis,inflammation
ENSG00000280830,ADI1,dihydrofolate reductase activity,dna damage repair,folate pathway dysregulation,genomic instability,nucleotide metabolism regulation,thymidylate synthase interaction
ENSG00000160460,SPTBN4,tumor progression,metastasis promotion,cytoskeletal regulation,cell migration enhancement,apoptosis resistance,therapeutic target
ENSG00000179085,DPM3,dolichyl-diphosphooligosaccharyltransferase activity,n-linked glycosylation,oncogenic potential,protein stability regulation,cellular interaction modulation,glycosylation pattern alteration
ENSG00000105821,DNAJC2,chromatin remodeling,cellular stress response,oncogene overexpression,signaling pathway regulation,protein folding facilitation,ubiquitin-proteasome modulation
ENSG00000010256,UQCRC1,mitochondrial dysfunction,gain-of-function mutations,energy metabolism regulation,genomic instability,oncogenic signaling pathways,regulatory protein interactions
,FAM84B,g2/m phase regulation,mitotic entry modulation,cell cycle progression,genomic instability driver,cancer cell proliferation,protein-protein interaction
ENSG00000089225,TBX5,oncogene,cell proliferation,cell survival,transcriptional regulation,cardiac arrhythmia,genomic instability
ENSG00000100425,BRD1,chromatin binding,breast cancer susceptibility,genomic instability,tumor growth promotion,dna damage sensitivity,transcriptional regulation interaction
ENSG00000254986,DPP3,proteolytic activity,tumor growth promotion,immunosuppressive microenvironment,extracellular matrix remodeling,signaling pathway regulation,epigenetic modulation
ENSG00000130332,LSM7,exosome component,rna degradation,transcriptional regulation,mrna stability,nuclear rna quality control,cellular process regulation
ENSG00000165175,MID1IP1,oncogene/tumor suppressor,cell cycle regulation,transcriptional control,chromatin remodeling,apoptosis regulation,protein-protein interaction
ENSG00000213022,KLK9,tumor progression,proteolytic activity,cell signaling regulation,gene expression dysregulation,substrate processing,angiogenesis promotion
ENSG00000135338,LCA5,cilia formation,photoreceptor development,retinal degeneration,protein-protein interaction,cellular maintenance,tumorigenesis
ENSG00000005194,CIAPIN1,ciapin1's role in cell survival,apoptosis evasion,pi3k/akt pathway modulation,cell cycle progression regulation,tumor growth promotion,therapeutic target
,MMD2,ubiquitination,cell cycle regulation,genomic instability,oncogenic transformation,tumor suppressor function,therapeutic target
ENSG00000272047,GTF2H5,transcriptional regulation,genomic instability,cell proliferation,oncogenic processes,dna repair,apoptosis modulation
ENSG00000112425,EPM2A,glycogen regulation,cellular metabolism disruption,genomic instability risk,tumor suppressor function potential,oncogenic mechanisms involvement,apoptosis regulation dysfunction
ENSG00000187566,NHLRC1,protein degradation regulation,p53 interaction,cell cycle progression,oncoprotein accumulation,tumor suppressor dysfunction,ubiquitination pathway disruption
ENSG00000183145,RIPPLY3,oncogene activation,cell proliferation enhancement,epithelial-mesenchymal transition induction,transcription factor regulation,tumor progression promotion,poor prognosis association
ENSG00000114115,RBP1,tumor suppressor function,cell cycle regulation,g1/s phase transition,protein-protein interaction,oncogene dysregulation,therapeutic target
ENSG00000099992,TBC1D10A,rab gtpase regulation,tumor suppressor function,gene dysregulation,cell survival modulation,oncogenic pathway inhibition,genomic profiling
ENSG00000005812,FBXL3,cell cycle regulation,substrate recognition,ubiquitin ligase activity,protein degradation,tumor suppressor function,oncogene regulation
ENSG00000057593,F7,coagulation pathway,dysregulated expression,tumor progression,angiogenesis,prothrombotic state,poor prognosis
ENSG00000243135,UGT1A3,glucuronidation,xenobiotic metabolism,detoxification process,liver expression,intestinal expression,hormone conjugation
ENSG00000148158,SNX30,receptor tyrosine kinase regulation,endosomal sorting and recycling,rtk signaling pathway modulation,cell proliferation and survival enhancement,therapeutic target,genomic instability
ENSG00000114209,PDCD10,genomic instability,apoptosis regulation,tumor suppressor function,cell survival modulation,pi3k/akt pathway interaction,therapeutic target
ENSG00000122970,IFT81,ciliopathies,tumor suppression,microtubule regulation,cancer initiation,cell signaling disruption,genetic alterations
ENSG00000167720,SRR,chromatin remodeling,transcriptional regulation,epigenetic modification,genomic instability,cell proliferation,oncogenic potential
ENSG00000153495,TEX29,telomere maintenance,genomic instability,cell survival,dna damage response,oncogenesis,tumor suppressor
ENSG00000168172,HOOK3,microtubule regulation,tumor aggressiveness,cell cycle progression,cancer driver gene,oncogenic potential,genomic instability
ENSG00000006712,PAF1,transcriptional regulation,pol ii recruitment,cell cycle control,oncogenic processes,genomic instability,therapeutic target
ENSG00000196376,SLC35F1,glycosylation regulation,cell surface modification,oncogenesis,glycolytic reprogramming,cellular proliferation,sugar nucleotide transport
ENSG00000183828,NUDT14,oxidative stress regulation,dna damage repair,gain of function mutations,genomic instability,cell survival enhancement,nad+ hydrolysis activity
ENSG00000170873,MTSS1,epithelial-to-mesenchymal transition (emt),metastasis suppressor function,tumor suppressor activity,cytoskeleton regulation,cellular invasion and migration,pi3k/akt pathway modulation
ENSG00000080822,CLDND1,cellular homeostasis,chloride efflux regulation,tumor progression,cell proliferation,protein interaction,signaling pathway activation
ENSG00000108511,HOXB6,hox family transcription factor,oncogenic activity,cellular differentiation regulation,protein-protein interactions,gene expression modulation,chromatin modification
ENSG00000140718,FTO,m6a demethylase,oncogene regulation,gene expression dysregulation,cell proliferation promotion,protein interaction modulation,poor prognosis association
ENSG00000137492,THAP12,p53 regulation,transcriptional modulation,cell cycle progression,oncogenic transformation,tumor suppressor interaction,prognostic marker
ENSG00000148985,PGAP2,loss of enzymatic activity,disruption of protein modification,oncogenic signaling,tumor progression,genomic instability,cell cycle regulation
ENSG00000196141,SPATS2L,oncogenesis,cell proliferation,cell cycle regulation,centrosomal localization,microtubule stabilization,spindle assembly regulation
ENSG00000038358,EDC4,ubiquitination regulation,cell cycle progression,oncogenic potential,signaling pathway modulation,tumor aggressiveness,protein degradation
ENSG00000184887,BTBD6,homologous recombination,genomic instability,cell cycle regulation,dna damage response,brca1 interaction,chromatin remodeling
ENSG00000169067,ACTBL2,actin cytoskeleton,cell migration,invasion mechanism,protein-protein interaction,cellular signaling pathway,tumor progression
ENSG00000147394,ZNF185,tumor suppressor function,mrna destabilization,cell proliferation regulation,oncogene regulation,protein-protein interactions,microrna regulation
ENSG00000170423,KRT78,cellular structure maintenance,oncogene activation,cell proliferation promotion,apoptosis inhibition,epithelial-to-mesenchymal transition facilitation,protein-protein interaction modulation
ENSG00000159377,PSMB4,protein degradation,cell cycle regulation,p53 tumor suppressor,subunit of 20s proteasome,tumor development,epiphenomenon
ENSG00000134769,DTNA,tumor microenvironment interaction,muscle invasion,cellular adhesion disruption,metastatic progression,protein-protein interaction regulation,sarcolemma maintenance
ENSG00000135245,HILPDA,pi3k/akt pathway interaction,tumor progression,constitutive activation,therapeutic target,cell survival enhancement,proliferation regulation
ENSG00000091583,APOH,lipid metabolism regulation,gene overexpression,protein-protein interaction,cell signaling modulation,oncogenic process facilitation,tumor growth promotion
ENSG00000090971,NAT14,cellular proliferation,oncogenic signaling,protein modification,biomarker potential,transcriptional regulation,kinase activation
ENSG00000198768,APCDD1L,apoptosis regulation,cell cycle progression,cancer driver mutation,transcriptional regulator,genomic instability,tumor suppressor function
ENSG00000184205,TSPYL2,dna replication,chromatin remodeling,transcriptional regulation,cell proliferation,oncogenesis,protein stabilization
ENSG00000223609,HBD,heme binding,cell cycle regulation,aberrant expression,mitochondrial dysfunction,oxidative stress response,cellular proliferation
ENSG00000183049,CAMK1D,cell cycle regulation,camk signaling pathway,oncogenic driver,tumor suppression,cell proliferation regulator,genomic instability mediator
ENSG00000198586,TLK1,genomic instability,cell cycle progression,dna replication errors,chk1 activation,oncogenic potential,tumor aggressiveness
ENSG00000123064,DDX54,dna repair modulation,genome stability maintenance,transcriptional regulation influence,nuclear localization feature,cellular responses to dna damage,oncogenic pathway interaction
ENSG00000170486,KRT72,cell adhesion disruption,cellular stress response,epithelial cell integrity,intermediate filament assembly,keratin expression dysregulation,oncogenic transformation
ENSG00000132911,NMUR2,cell migration,g protein-coupled receptor function,oncogene overexpression,tumor progression,pi3k/akt pathway activation,epithelial-to-mesenchymal transition
ENSG00000168917,SLC35G2,nucleotide sugar transporter,co-amplified with oncogenes,glycosaminoglycan and proteoglycan biosynthesis,tumor progression,metastasis facilitation,extracellular matrix assembly
ENSG00000182504,CEP97,centrosomal localization,microtubule dynamics regulation,cell division checkpoint,genomic instability driver,oncogenic processes,cellular proliferation regulation
ENSG00000185069,KRT76,aberrant expression,cell adhesion,cell differentiation,epithelial integrity,mechanical stress protection,tumor progression
ENSG00000078596,ITM2A,cell proliferation,signaling pathway regulation,protein processing and modification,apoptosis resistance,oncogene overexpression,tumor progression
ENSG00000112667,DNPH1,dna replication,genomic instability,dna repair mechanisms,epigenetic alterations,cell proliferation,oncogenic processes
ENSG00000155313,USP25,cellular proliferation,apoptosis inhibition,ubiquitin-proteasome regulation,genomic instability,protein degradation modulation,cancer progression
ENSG00000189299,FOXR2,transcriptional regulation,cell proliferation,chromatin remodeling,oncogenic pathway modulation,cancer-associated expression alterations,gene expression influence
ENSG00000163719,MTMR14,mitochondrial dynamics,tumor suppression inhibition,pten regulation,oncogenic signaling promotion,cellular metabolism modulation,protein kinase activation regulation
ENSG00000171564,FGB,genomic instability,tumor progression,coagulation pathway,cancer prognosis,wound healing,metastasis
ENSG00000143224,PPOX,ros generation,oncogenic potential,heme biosynthesis disruption,cellular redox imbalance,genomic instability,iron-sulfur cluster dysfunction
ENSG00000126001,CEP250,centrosomal protein,centrosome organization,microtubule stability,chromosomal instability,oncogenic driver,genomic profiling
ENSG00000155265,GOLGA7B,golgi apparatus function,golgin family member,mitotic spindle organization,centrosome regulation,cell cycle progression,oncogenic alterations
ENSG00000113318,MSH3,dna mismatch repair,genomic instability,heterogeneity,mutator gene,tumor progression,hypermutation
ENSG00000119689,DLST,redox balance regulation,oxidative stress response modulation,cell cycle progression regulation,dna repair enzyme interaction,protein kinase activation,cancer chemoresistance
ENSG00000144580,CNOT9,mrna regulation,tumor progression,oncogene activation,cell proliferation,metastasis promotion,genomic instability
ENSG00000151835,SACS,axonal transport disruption,genomic instability,dna damage response,oncogenic process promotion,tumor progression facilitation,poor prognosis marker
ENSG00000130762,ARHGEF16,pi3k/akt pathway activation,rho gtpase activation,tumor progression driver,mutation implicated,cell migration regulation,p53 interaction
ENSG00000213023,SYT3,chromatin remodeling,transcriptional regulation,cell growth regulation,oncogenic fusion protein,tumor suppressor function,gene expression regulation
ENSG00000213967,ZNF726,krab domain-containing,transcriptional regulation,tumor suppressor function,cell cycle regulation,apoptosis induction,chromatin modification
ENSG00000068394,GPKOW,constitutive activation,gpcr phosphorylation,oncogenic pathway regulation,cell proliferation and survival,tumor progression,therapeutic resistance
ENSG00000115183,TANC1,immunomodulation,constitutive expression,t-cell activation,oncogene potential,cell adhesion regulation,apoptosis resistance
ENSG00000134897,BIVM,apoptosis regulation,cell cycle regulation,tumor suppression,g1-s phase transition regulation,dna damage response,cancer predisposition
ENSG00000179922,ZNF784,transcriptional regulation,chromatin remodeling,tumor suppressor,cell cycle progression,apoptosis modulation,prognostic marker
ENSG00000178021,TSPYL6,cell cycle regulation,transcriptional regulation,chromatin structure modification,oncogenic contribution,tumor progression,nuclear regulator
ENSG00000116031,CD207,tumor microenvironment,immune suppression,antigen presentation,oncogenesis,therapeutic target,immune modulation
ENSG00000132768,DPH2,genomic instability,dna damage response,oncogenic mutations,tumor progression,therapeutic target,replication stress
ENSG00000117298,ECE1,endothelin conversion,vasoconstriction regulation,angiogenesis promotion,tumor growth facilitation,chemotherapy resistance,prognostic biomarker
ENSG00000002919,SNX11,endosomal sorting,oncogenic processes,membrane trafficking regulation,cell growth promotion,autophagy modulation,signaling pathway regulation
ENSG00000143740,SNAP47,cell membrane trafficking,oncogenic regulation,cell growth promotion,tumor metastasis,vesicle formation,protein interaction
ENSG00000089902,RCOR1,genomic instability,epigenetic regulation,apoptosis suppression,tumor suppressor function,prc2 component,cellular proliferation
ENSG00000167397,VKORC1,vitamin k regulation,blood coagulation,metabolic regulation,coagulation pathways,thrombosis prevention,enhanced sensitivity
ENSG00000085644,ZNF213,chromatin remodeling,tumor suppressor,transcriptional regulation,epigenetic modifications,cancer driver,genomic instability
ENSG00000122008,POLK,genomic instability,dna repair mechanisms,error-prone dna synthesis,genetic alterations,tumor progression,oncogenesis
ENSG00000141433,ADCYAP1,adcyap1-ramp2 heterodimers,ac5 receptor activation,pka/epac pathway modulation,cancer stem cell maintenance,therapeutic resistance,tumor growth promotion
ENSG00000100095,SEZ6L,wnt/β-catenin signaling,tumor suppressor,protein phosphatase regulation,cell proliferation inhibition,metastasis suppression,genomic instability
ENSG00000197008,ZNF138,tumor suppression,cell proliferation inhibition,dna repair regulation,chromatin remodeling,gene expression modulation,signaling pathway modulation
ENSG00000170881,RNF139,genomic instability,apoptosis regulation,tumor suppressor activity,ubiquitination and degradation,cell cycle control,cancer therapeutics
ENSG00000101294,HM13,chromatin regulation,histone variant,epigenetic modification,dna repair,cell cycle progression,cancer driver gene
ENSG00000171236,LRG1,protein-protein interaction,cell proliferation regulation,oncogene activation,mapk/erk pathway modulation,tumor progression promoter,biomarker potential
ENSG00000143416,SELENBP1,selenoprotein regulation,tumor suppressor function,cellular redox balance,oxidative stress response,cancer progression,protein-protein interaction
ENSG00000035664,DAPK2,tumor suppressor function,apoptosis induction,calcium-dependent signaling,cell cycle regulation,cytoskeleton remodeling,transcriptional regulation
ENSG00000121851,POLR3GL,cell cycle regulation,epigenetic alterations,rna polymerase iii complex,transcriptional dysregulation,tumor growth enhancement,proliferation promotion
ENSG00000223572,CKMT1A,genomic instability,dna replication,altered dna repair mechanisms,cancer development,oncogenic processes,therapeutic target
ENSG00000237289,CKMT1B,cellular proliferation,energy metabolism regulation,cancer metastasis,oncogenic process activation,prognostic marker,genomic instability
ENSG00000068885,IFT80,cilia assembly failure,chromosome instability,gene expression regulation,microtubule dynamics disruption,cell cycle dysregulation,tumor aggressiveness increase
ENSG00000218891,ZNF579,chromatin remodeling,transcriptional regulation,oncogene potential,epigenetic modifications,gene expression changes,cellular homeostasis
ENSG00000168484,SFTPC,surfactant regulation,alveolar maintenance,cell growth modulation,pulmonary fibrosis association,cystic fibrosis comorbidity,genomic instability marker
ENSG00000112494,UNC93A,tlr signaling pathway,tumor growth promotion,immune evasion,cell surface expression,protein-protein interactions,dysregulated immune response
ENSG00000063587,ZNF275,tumor suppressor function,dna binding activity,transcriptional regulation,cell cycle regulation,anti-apoptotic effects,genomic stability maintenance
ENSG00000142684,ZNF593,transcriptional regulation,oncogene function,cell growth modulation,apoptosis suppression,chromatin modification,tumor suppressor interaction
ENSG00000132824,SERINC3,sphingolipid biosynthesis,lipid metabolism deregulation,oncogenic processes,cell survival enhancement,protein interaction,apoptosis inhibition
ENSG00000080298,RFX3,cellular response to dna damage,genomic instability,modulation of oncogenic pathways,transcriptional regulation,tumor growth regulation,chromatin remodeling
ENSG00000214160,ALG3,glycosylation alterations,protein stability modulation,oncogenic driver mutations,cell growth promotion,tumor progression association,therapeutic target potential
ENSG00000170369,CST2,oncogenic signaling,tumor progression,cell adhesion modulation,angiogenesis facilitation,inflammatory response regulation,secreted glycoprotein expression
ENSG00000186471,AKAP14,regulation of pka activity,modulator of cytoskeleton dynamics,cancer biomarker or therapeutic target,cell migration and invasion,altered expression in various cancers,signaling pathway regulation
ENSG00000173805,HAP1,tumor progression,gain of function mutations,overexpression,poor prognosis,biomarker potential,therapeutic target
ENSG00000111328,CDK2AP1,cell cycle regulation,tumor suppressor function,dna replication,nuclear localization,cancer cell proliferation,therapeutic target
ENSG00000167767,KRT80,cell proliferation,oncogenic transformation,chromatin remodeling,apoptosis regulation,cell cycle control,tumor microenvironment
ENSG00000229346,TRIM10,oncogenic regulation,tumor suppression,cellular response modulation,genomic integrity maintenance,protein stability regulation,apoptosis induction
ENSG00000169180,XPO6,nuclear transport regulation,tumor suppressor function,cell cycle regulation,apoptosis modulation,genomic instability,therapeutic target
ENSG00000117222,RBBP5,h3k4 methylation,chromatin remodeling,tumor suppressor,oncogene candidate,genomic instability,dna damage response
ENSG00000108813,DLX4,emt regulation,transcriptional regulation,oncogenic transformation,cell proliferation enhancement,stem cell maintenance,chromatin remodeling
ENSG00000130518,IQCN,transcription regulation,protein-protein interactions,cell signaling,tumor growth modulation,genetic interaction,none
ENSG00000239474,KLHL41,cellular regulation,tumor suppressor function,protein stability regulation,e3 ubiquitin ligase activity,apoptosis regulation,dna repair process
ENSG00000112118,MCM3,replicative helicase complex,g1-s phase transition,dna replication regulation,genomic instability,cell cycle progression,therapeutic target
ENSG00000135374,ELF5,oncogene activation,gene overexpression,cell proliferation,constitutive transcriptional activity,cancer cell survival,tumor development and progression
ENSG00000053702,NRIP2,co-repressor activity,metabolic regulation,lipid synthesis modulation,cell cycle progression,tumor aggressiveness,gene expression suppression
ENSG00000168883,USP39,genome instability,chromosomal alterations,dna repair deficiency,tumor progression,therapeutic target,deubiquitinating enzyme
ENSG00000078328,RBFOX1,genetic instability,alternative splicing,rna-binding protein,oncogene/tumor suppressor,cell differentiation,splicing regulation
ENSG00000167977,KCTD5,tumor suppressor,wnt/β-catenin pathway inhibition,cell cycle regulation,protein-protein interaction,transcriptional repression,ubiquitination regulation
ENSG00000106682,EIF4H,oncogenic translation,cell proliferation,cell survival,metabolic regulation,tumor progression,amplification
ENSG00000107731,UNC5B,tumor suppressor,metastasis regulation,cell migration inhibition,netrin receptor function,apoptosis induction,autophagy modulation
ENSG00000067141,NEO1,oncogene activation,cell migration facilitation,tumor progression enhancement,poor prognosis marker,chemoresistance promotion,actin cytoskeleton modulation
ENSG00000105427,CNFN,nf-κb regulation,transcriptional activation,calcineurin activity,cell cycle progression,chromatin remodeling,tumor suppressor interaction
ENSG00000072682,P4HA2,tumor progression,extracellular matrix regulation,prolyl hydroxylation,oncogenic processes,metastasis facilitation,therapeutic target
ENSG00000056277,ZNF280C,epigenetic regulation,oncogenic processes,constitutive activation,cell proliferation,pi3k/akt pathway dysregulation,zinc finger domain interaction
ENSG00000282307,SERPINF1,vegf pathway inhibition,tumor suppressor function,angiogenesis regulation,apoptosis modulation,cell proliferation inhibition,matrix metalloproteinase regulation
ENSG00000147853,AK3,adenylate kinase function,energy metabolism regulation,cellular proliferation promotion,tumor growth support,metabolic shift facilitation,protein interaction network involvement
ENSG00000165801,ARHGEF40,rho gtpase regulation,growth factor signaling,cell migration promotion,oncogenic mutation,tumor progression facilitation,signaling pathway dysregulation
ENSG00000085998,POMGNT1,alpha-dystroglycan glycosylation,cell membrane modification,enzyme activity,glycoprotein function,muscle cell dysfunction,tumor progression
ENSG00000100036,SLC35E4,glycosylation,nucleotide sugar transport,golgi apparatus localization,cell growth regulation,oncogenic processes,cellular differentiation
ENSG00000196510,ANAPC7,genome instability,cell cycle regulation,chromosome segregation,ubiquitination degradation,aneuploidy prevention,tumorigenesis promotion
ENSG00000168306,ACOX2,peroxisomal metabolism,lipid oxidation,tumor cell growth,metabolic reprogramming,fatty acid beta-oxidation,apoptosis resistance
ENSG00000107736,CDH23,adherens junction disruption,cell adhesion molecule,dna repair mechanisms,epithelial cell structure,genetic instability,tumor aggressiveness
ENSG00000107614,TRDMT1,m6am modification,rna regulation,cellular metabolism,therapeutic target,oncogenic processes,metastasis resistance
ENSG00000144035,NAT8,same biosynthesis,bifunctional enzyme,disrupted same homeostasis,oxidative stress,transsulfuration pathway,methylation regulation
ENSG00000120675,DNAJC15,mutant p53 stabilization,mitochondrial function maintenance,oncogenic protein interaction,apoptosis resistance,hsp90 regulation,protein folding facilitation
ENSG00000116171,SCP2,sterol transport,lipid metabolism regulation,cell growth promotion,tumor progression facilitation,oncogene activation,genomic instability maintenance
ENSG00000185231,MC2R,constitutive activation,oncogenic processes,cell proliferation,tumor growth,steroidogenesis regulation,signaling pathway modulation
ENSG00000140932,CMTM2,tumor suppressor,immune evasion,t-cell modulation,cancer progression,dna damage repair,protein-protein interaction
ENSG00000101464,PIGU,aberrant glycosylation,cancer cell proliferation,cell migration,glycosyltransferase activity,oncogenic signaling,protein interaction
ENSG00000163344,PMVK,glycosylation,upregulation,epithelial-to-mesenchymal transition (emt),oncogenic processes,tumor progression,cancer cell resistance
ENSG00000110011,DNAJC4,er stress response,molecular chaperone function,protein folding regulation,cellular homeostasis disruption,cancer development contribution,therapeutic target potential
ENSG00000198471,RTP2,cellular proliferation,dysregulated signaling pathway,receptor tyrosine kinase activity,tumor growth,cell survival,embryonic development
ENSG00000106278,PTPRZ1,oncogene,cell proliferation,pi3k/akt pathway activation,protein tyrosine dephosphorylation,metastasis promotion,tumor progression
ENSG00000163781,TOPBP1,oncogenic activity,genome instability,cell proliferation,dna repair regulation,protein-protein interactions,mitotic progression
ENSG00000142675,CNKSR1,signaling pathway regulation,cellular proliferation enhancement,tumor progression promotion,therapeutic target identification,genomic instability modulation,protein-protein interaction mediation
ENSG00000008256,CYTH3,cellular homeostasis disruption,protein synthesis regulation,post-translational modification impact,tumor aggressiveness enhancement,oncogenic process promotion,genomic instability contribution
ENSG00000139405,RITA1,iron regulation,cell survival,oncogenesis,immune response modulation,cellular proliferation,macrophage activation
ENSG00000274126,C14orf180,nuclear protein,chromatin regulation,transcriptional regulation,cell cycle regulation,dna repair mechanisms,oncogenic transformation
ENSG00000140374,ETFA,mitochondrial function,electron transfer flavoprotein complex,fatty acid breakdown,energy production deficits,cellular respiration,metabolic reprogramming
ENSG00000167842,MIS12,chromatin remodeling,oncogene activation,genomic instability,cell cycle regulation,e3 ubiquitin ligase activity,histone modification
ENSG00000160783,PMF1,genome instability,transcriptional regulation,cell cycle progression,mutations in cancer,therapeutic target,chromatin remodeling
ENSG00000141448,GATA6,tumor initiation,epithelial differentiation,cell cycle progression,oncogene activation,transcriptional regulation,genomic amplification
ENSG00000169926,KLF13,klf13 modulation,pi3k/akt pathway interaction,transcription factor regulation,tumor progression facilitation,cellular differentiation suppression,oncogenic potential
ENSG00000103051,COG4,cellular homeostasis disruption,golgi apparatus biogenesis,protein processing and trafficking,tumorigenesis contribution,therapeutic target potentiality,cell signaling pathway regulation
ENSG00000108786,HSD17B1,hormone metabolism,estrogen regulation,cancer development,tumor progression,cellular proliferation,steroid hormone reduction
ENSG00000281935,DNAH10,cilia dysfunction,mitotic spindle assembly,cell cycle regulation,microtubule destabilization,meiotic instability,centrosome aberration
ENSG00000183955,KMT5A,histone modification,chromatin remodeling,tumor suppressor function,gene expression regulation,cell cycle control,genomic instability
ENSG00000137699,TRIM29,chromatin remodeling,genomic instability,apoptotic pathways,transcriptional regulation,tumor suppressor function,oncogenic pathway modulation
ENSG00000206283,PFDN6,oncogene function,protein trafficking alteration,tumor progression correlation,poor prognosis indicator,endocytic pathway disruption,signaling aberration
ENSG00000185869,ZNF829,transcriptional regulation,tumor suppressor function,heterochromatin formation,epigenetic regulation,cell cycle progression,apologetic control
ENSG00000146243,IRAK1BP1,nf-κb signaling pathway,apoptosis inhibition,cell survival promotion,metastasis facilitation,oncogenic kinase activation,immune evasion mechanism
ENSG00000149541,B3GAT3,aberrant glycosylation,cell proliferation,chondroitin sulfate biosynthesis,glycosaminoglycan production,tumor progression,enzyme overexpression
ENSG00000100591,AHSA1,cellular regulation,protein folding regulation,chaperone activity,tumor suppressor function,cancer progression,signal transduction pathway regulation
ENSG00000253797,UTP14C,pre-mrna splicing,catalytic activity,genomic integrity,aberrant splicing events,cellular transformation,tumorigenesis
ENSG00000182600,SNORC,rna modification,pseudouridylation,cellular regulation,cell growth modulation,gene expression influence,cellular proliferation
ENSG00000138622,HCN4,cell proliferation,constitutive activation,enhanced metabolic regulation,apoptosis evasion,pacemaker currents modulation,ion channel activity
ENSG00000169155,ZBTB43,enhancer regulation,chromatin remodeling,tumor progression,metastasis,transcriptional activation,oncogene function
ENSG00000165819,METTL3,m6a modification,regulatory rna modifications,growth regulation,metabolic regulation,cell proliferation,oncogenic processes
ENSG00000145388,METTL14,m6a methylation,oncogenic mrnas modulation,rna stability regulation,tumor growth promotion,therapeutic target potential,prognostic marker
ENSG00000186980,KRTAP23-1,keratin filament assembly,skin cell differentiation,tumor progression,metastasis,genomic location,protein-protein interaction
ENSG00000179820,MYADM,mitochondrial regulation,apoptosis modulation,cell survival regulation,tumor suppressor function,mitochondrial outer membrane permeabilization,genomic instability prevention
ENSG00000119953,SMNDC1,genomic instability,telomere maintenance,oncogenic interaction,rna metabolism regulation,spliceosome assembly,cell survival promotion
ENSG00000130479,MAP1S,microtubule regulation,cellular proliferation,metastatic potential,apoptosis evasion,genomic instability,cell cycle regulation
ENSG00000175782,SLC35E3,glycosylation enhancement,oncogenic properties,protein-protein interaction,cancer metabolism,cell proliferation enhancement,golgi apparatus localization
ENSG00000112739,PRPF4B,rna splicing regulation,genomic instability,cell cycle disruption,oncogenic protein production,therapeutic target,genetic alterations
ENSG00000221926,TRIM16,pi3k/akt pathway regulation,oncogenic function,ubiquitination activity,prognostic marker,cell proliferation regulation,signaling pathway modulation
ENSG00000171988,JMJD1C,histone demethylation,cell proliferation,transcriptional regulation,oncogenic transformation,protein interaction,metastasis promotion
ENSG00000114544,SLC41A3,magnesium transporter,oncogenic processes,cellular proliferation,tumor progression,therapeutic target,cellular signaling
ENSG00000101363,MANBAL,rna recognition,regulation of gene expression,dysregulation of rna metabolism,aberrant protein-rna interactions,tumorigenesis driver,cellular growth regulation
ENSG00000183034,OTOP2,oncogene activation,apoptosis resistance,cell cycle regulation,tumorigenesis promotion,metastasis facilitation,transcriptional regulation
ENSG00000107282,APBA1,apoptosis regulation,g-protein coupling,cell membrane interaction,oncogene/tumor suppressor role,cancer-related signaling pathways,genetic expression alteration
ENSG00000188827,SLX4,genomic instability,tumor suppressor,dna repair,cell cycle regulation,double-strand break resolution,genome maintenance
ENSG00000148948,LRRC4C,cellular adhesion,cell migration,tumor progression,signaling pathway interaction,oncogenesis,neuronal development
ENSG00000133048,CHI3L1,tumor microenvironment remodeling,oncogenic driver,epithelial-to-mesenchymal transition,angiogenesis promotion,immune evasion facilitation,pi3k/akt pathway modulation
ENSG00000130038,CRACR2A,calcium homeostasis,store-operated channels,cell proliferation,genomic instability,oncogenic potential,protein-protein interaction
ENSG00000159596,TMEM69,calcium channel regulation,oncogene mutation,tumor progression,cell migration,protein-protein interaction,calcium signaling pathway
ENSG00000121769,FABP3,fatty acid binding,oncogenic processes,cell proliferation,lipid metabolism,overexpression,apoptosis evasion
ENSG00000184840,TMED9,pi3k/akt pathway activation,aberrant expression,cell survival promotion,lipid metabolism regulation,oncogene potential,metastasis facilitation
ENSG00000151692,RNF144A,tp53 regulation,mdm2 inhibition,cell cycle progression,apoptosis regulation,oncogenic function,ubiquitination activity
,H3F3C,epigenetic regulation,chromatin remodeling,histone modification,tumor progression,metastasis driver,chromatin assembly
ENSG00000174417,TRHR,hypothalamic-pituitary-thyroid axis regulation,g protein-coupled receptor function,thyroid hormone regulation,cancer cell proliferation,dysregulated gene expression,epigenetic alterations
ENSG00000146197,SCUBE3,angiogenesis promotion,apoptosis suppression,cell adhesion regulation,egf receptor interaction,oncogenic signaling pathway interaction,tumor growth promotion
ENSG00000159217,IGF2BP1,post-transcriptional regulation,rna binding protein,oncogene activation,cell growth promotion,mrna stability regulation,protein-protein interaction
ENSG00000183255,PTTG1IP,microtubule interaction,cell cycle regulation,tumor suppressor function,genomic instability prevention,pi3k/akt signaling pathway involvement,aneuploidy prevention
ENSG00000178826,TMEM139,oncogenic potential,tumor progression,cell adhesion regulation,genetic alterations,signaling pathway modulation,cell membrane dynamics
ENSG00000243364,EFNA4,tumor progression,cell adhesion disruption,signaling pathway activation,protein-protein interaction,genomic instability,angiogenesis promotion
ENSG00000135333,EPHA7,epithelial-to-mesenchymal transition (emt),tumor suppressor function,pro-oncogenic signaling pathways,metastasis regulation,cell migration inhibition,adhesion molecule interaction
ENSG00000168995,SIGLEC7,immune regulation,cell adhesion,tumor progression,metastasis promotion,signaling modulation,oncogenic function
ENSG00000141568,FOXK2,chromatin remodeling,cell cycle regulation,apoptosis inhibition,tumor suppression,mitochondrial regulation,transcriptional modulation
ENSG00000136152,COG3,tumor progression,genomic instability,protein misfolding,aberrant protein aggregation,oncogenic protein complexes,therapeutic target
ENSG00000144560,VGLL4,wnt/β-catenin signaling pathway,transcriptional coactivation,epithelial-to-mesenchymal transition,cell proliferation regulation,apoptosis evasion,oncogenic transcription factor
ENSG00000115977,AAK1,signaling regulation,metastasis promotion,cytoskeleton reorganization,cell migration facilitation,protein stability modulation,oncogenic signaling enhancement
ENSG00000197912,SPG7,mitochondrial integrity,genomic instability,cellular stress response,apoptosis regulation,protein degradation,metabolic reprogramming
ENSG00000160202,CRYAA,protein aggregation,cell cycle regulation,apoptosis inhibition,unfolded protein response,tumor progression,cancer development
ENSG00000118655,DCLRE1B,genomic instability,gene expression regulation,dna repair defect,tumor suppressor function,chromosomal rearrangement,onco-allele activation
ENSG00000066135,KDM4A,histone demethylation,oncogene potential,gene expression regulation,chromatin remodeling,tumor suppression loss,pi3k/akt pathway interaction
ENSG00000143753,DEGS1,lipid desaturation,fatty acid metabolism,tumor growth promotion,energy production enhancement,cell membrane fluidity regulation,cellular signaling pathway involvement
ENSG00000162430,SELENON,oncogenesis,oxidative stress,redox regulation,protein folding,therapeutic target,biomarker
ENSG00000106012,IQCE,microtubule regulation,gtpase activating protein activity,cell cycle progression,oncogenic driver,therapeutic target,protein-protein interaction
ENSG00000121864,ZNF639,oncogenic transcription factor,transcriptional regulation,cell proliferation enhancement,tumor suppressor downregulation,prognostic marker,epigenetic modification
ENSG00000148290,SURF1,iron-sulfur cluster assembly,mitochondrial function maintenance,cellular metabolism regulation,energy production,protein interaction,genomic stability
ENSG00000183978,COA3,mitochondrial dysfunction,cytochrome c oxidase complex,apoptosis evasion,genomic instability,cellular respiration regulation,transcriptional regulation
ENSG00000148841,ITPRIP,calcium signaling regulation,tumor suppressor function,cancer cell proliferation,pi3k/akt pathway interaction,genomic instability regulation,rna binding protein activity
ENSG00000111540,RAB5B,rho gtpase regulation,endocytic trafficking,cell membrane dynamics,oncogenic driver mutation,gtp binding activity,tumor suppressor function
ENSG00000104142,VPS18,escrt-iii complex,endosomal sorting,autophagy regulation,lysosome biogenesis,genomic instability,apoptosis inhibition
ENSG00000079950,STX7,membrane trafficking,snare interactions,tumor suppression,oncogenic potential,cell proliferation,vesicle fusion
ENSG00000176208,ATAD5,genomic instability,chromosomal aberrations,dna repair mechanisms,homologous recombination,cell cycle regulation,protein-dna interactions
ENSG00000125450,NUP85,nuclear pore complex regulation,selective export,oncogenic process,cell proliferation,poor prognosis,overexpression
ENSG00000160211,G6PD,antioxidant defense,cellular redox regulation,glucose-6-phosphate dehydrogenase activity,hemolytic anemia,oxidative stress,pentose phosphate pathway
ENSG00000233927,RPS28,rps28 overexpression,oncogenic role,ribosomal function,protein synthesis regulation,cell proliferation,genomic instability
ENSG00000095380,NANS,oncogenic role,altered glycosylation,cell cycle regulation,tumor growth promotion,metastatic progression,o-glcnac transferase activity
ENSG00000151503,NCAPD3,chromatin remodeling,genomic instability,aneuploidy,condensin complex disruption,sister chromatid cohesion defect,cell cycle progression
ENSG00000275152,CCL16,tumor progression,angiogenesis induction,immune cell recruitment,pro-tumorigenic microenvironment,cancer stem cell regulation,therapeutic target
ENSG00000173585,CCR9,cell recruitment,chemokine signaling,cancer progression,immune evasion,lymphoid tissue expression,tumor metastasis
ENSG00000227500,SCAMP4,late endosomal trafficking,metastatic regulation,tumor suppressor function,cell surface protein sorting,oncogenic protein transport,cancer cell survival
ENSG00000124783,SSR1,cell cycle regulation,mitotic spindle stability,genomic instability,tumor progression,ubiquitin-proteasome interaction,oncogenic pathway modulation
ENSG00000171357,LURAP1,transcriptional regulation,oncogene activity,nuclear receptor coactivator,cell proliferation,gene expression modulation,cancer progression
ENSG00000111052,LIN7A,epithelial-to-mesenchymal transition,cell polarity disruption,tumor progression,metastasis promotion,gene expression regulation,prognostic marker
ENSG00000257727,CNPY2,oncogenic function,cell proliferation,overexpression,peptide processing,pancreatic secretion regulation,mitogen-activated protein kinase activation
ENSG00000170522,ELOVL6,fatty acid elongation,lipid droplet formation,oncogenic potential,therapeutic target,lipid metabolism regulation,cell survival promotion
ENSG00000014641,MDH1,folate metabolism disruption,tumor suppressor function,loss-of-function mutations,dna repair regulation,epigenetic modifications,cell proliferation promotion
ENSG00000180957,PITPNB,cell membrane trafficking,oncogenic phenotype,tumor progression,protein-protein interactions,signaling molecule regulation,metastasis
ENSG00000184939,ZFP90,cell cycle regulation,transcription factor activity,chromatin modification,apoptosis resistance,metabolic reprogramming,oncogenic signaling
ENSG00000070814,TCOF1,ribosome biogenesis,cell proliferation,metabolic regulation,oncogenic driver,cell growth regulator,tumor progression factor
ENSG00000118007,STAG1,cohesin complex regulation,genomic instability,cell proliferation enhancement,metastasis facilitation,chromosomal alterations,dna repair disruption
ENSG00000103876,FAH,lipid peroxidation,cellular metabolism,apoptosis regulation,tumor progression,oxidative stress,fatty acid oxidation
ENSG00000164442,CITED2,wnt/β-catenin signaling pathway,transcriptional coactivator,cell cycle progression,oncogenic processes,metastasis,tissue homeostasis
ENSG00000166426,CRABP1,cell growth regulator,tumor promoter candidate,retinoid binding protein,apoptosis modulator,gene expression regulator,cancer therapeutic target
ENSG00000134020,PEBP4,tumor suppressor function,constitutive activation of downstream pathways,oncogenic protein interaction,cell cycle regulation,apoptosis modulation,gene expression control
ENSG00000162595,DIRAS3,mitochondrial dynamics,gtpase activity,cell growth regulation,tumor progression,pi3k/akt pathway activation,biomarker role
ENSG00000128617,OPN1SW,intracellular calcium regulation,cancer development,cell migration,proliferation regulation,molecular signaling pathway,photoreceptor function
ENSG00000066027,PPP2R5A,pi3k/akt pathway,regulatory subunit dysfunction,enhanced cell proliferation,tumor suppressor regulation,hyperactive dephosphorylation,oncogenic signaling
ENSG00000168591,TMUB2,mitotic spindle formation,microtubule dynamics,chromosomal instability,cytoskeleton regulation,tumor suppressor activity,oncogenic mutation
ENSG00000242485,MRPL20,mitochondrial ribosome biogenesis,energy metabolism dysregulation,tumor progression promotion,cellular proliferation enhancement,therapeutic target identification,ribosomal protein translation modulation
ENSG00000180644,PRF1,apoptosis regulation,immune dysfunction,granule-mediated cytotoxicity,tumor immunosurveillance,autoimmune lymphoproliferative syndrome (alps),immunodeficiency disorder
ENSG00000149809,TM7SF2,cell migration,cell surface processing,glycoprotein regulation,oncogenic function,tumor progression,metastasis resistance
ENSG00000180720,CHRM4,receptor activation,g protein-coupled signaling,cell proliferation regulation,tumor growth promotion,metastasis enhancement,immune response modulation
ENSG00000241399,CD302,cell adhesion modulation,innate immunity activation,myeloid cell interaction,phagocytosis regulation,immune evasion mechanism,tumor progression facilitation
ENSG00000102103,PQBP1,chromatin remodeling,dna repair mechanisms,oncogene expression,transcriptional regulation,cellular proliferation,genomic instability
ENSG00000126524,SBDS,ribosomal dysfunction,impaired translation,oncogenic transformation,aberrant protein synthesis,cell proliferation,tumor suppressor
ENSG00000087884,AAMDC,nuclear protein interaction,cell cycle regulation,apoptosis modulation,transcriptional control,tumorigenesis driver,pi3k/akt pathway activation
ENSG00000284096,PRKAR2B,regulatory subunit,constitutive activation,growth regulation,cell migration,apoptosis resistance,signaling pathway interaction
ENSG00000198182,ZNF607,zinc finger domain regulation,transcriptional regulation,oncogene regulation,tumor suppressor interaction,epigenetic modulation,cellular differentiation
ENSG00000108924,HLF,transcriptional regulation,oncogenic function,cell cycle progression,anti-apoptotic signaling,tumor suppressor interaction,chromatin remodeling
ENSG00000167969,ECI1,genomic instability,aberrant protein synthesis,tumor initiation,cellular transformation,rna modification,dysregulatory mutations
ENSG00000274749,KRTAP7-1,epithelial cell integrity,keratin filament regulation,cell signaling pathways,oncogenic processes,tumorigenesis,epithelial differentiation
ENSG00000102699,PARP4,cellular process regulation,dna repair mechanism,chromatin remodeling,transcriptional regulation,oncogenic driver,tumor growth enhancement
ENSG00000197646,PDCD1LG2,immune checkpoint inhibition,inhibitory receptor interaction,t-cell suppression,proliferation inhibition,apoptosis evasion,tumor immune evasion
,IARS,iron-responsive regulation,cellular iron homeostasis,protein-protein interactions,oncogenic processes,metabolic regulation,tumor progression
ENSG00000154856,APCDD1,wnt/β-catenin signaling,tumor suppression,g-protein coupled receptor interaction,mutations in cancer progression,cell proliferation regulation,cancer driver gene potential
ENSG00000188488,SERPINA5,serine protease inhibition,tumor suppressor activity,oncogenic potential,inflammation regulation,cell migration modulation,signaling pathway regulation
ENSG00000113194,FAF2,genomic instability,tumor suppression,loss of function mutations,dna damage response pathway interaction,cell proliferation regulation,somatic alterations
ENSG00000164325,TMEM174,ion channel regulation,cellular trafficking,autophagy modulation,cancer progression driver,membrane dynamics disruption,protein-protein interaction
ENSG00000074842,MYDGF,oncogenesis,promoter overexpression,cell proliferation enhancement,epigenetic regulation,src kinase interaction,pi3k/akt pathway modulation
ENSG00000157992,KRTCAP3,keratin regulation,cancer predisposition,tumor progression,squamous cell carcinoma,differentiation pathways,epithelial cell function
ENSG00000137094,DNAJB5,mitochondrial function,protein folding,chaperone activity,oncogenic potential,proteostasis regulation,therapeutic resistance
ENSG00000007968,E2F2,transcription factor,cell cycle progression,oncogenic processes,tumorigenesis,protein-protein interactions,regulatory mechanisms
,MAATS1,notch signaling pathway,tumor progression,oncogene overexpression,cell-cell adhesion regulation,metastasis promotion,protein kinase activation
ENSG00000171509,RXFP1,cell signaling pathway,tumor progression,metastasis regulation,poor prognosis indicator,advanced disease stage marker,cell growth modulation
ENSG00000106009,BRAT1,brca1-mediated dna repair,genomic instability,parp1 inhibition,tumor suppression,polymerase interaction,chromatin remodeling
ENSG00000280501,CEACAM7,tumor progression,cell adhesion,cell migration,immune evasion,protein-protein interactions,metastasis
ENSG00000101546,RBFA,tumor suppressor function,cell cycle regulation,genome stability maintenance,dna damage response,transcriptional repression,cancer predisposition
ENSG00000100319,ZMAT5,au-rich element regulation,degradation of aberrant transcripts,tumor suppressor function,loss of function mutations,cell cycle progression,mrna stability regulation
ENSG00000197279,ZNF165,tumor suppressor function,transcriptional regulation,zinc finger domain,apoptosis promotion,cell proliferation inhibition,cancer driver gene status unclear
ENSG00000184517,ZFP1,transcription regulation,dna-binding activity,cell proliferation,tumor suppression,oncogene regulation,gene expression modulation
ENSG00000132793,LPIN3,lipid biosynthesis,autophagy regulation,oncogenic mutations,cell proliferation,tumor progression,genomic instability
ENSG00000160396,HIPK4,apoptosis regulation,tumor suppressor function,dna damage response,cell cycle arrest,e3 ubiquitin ligase activity,transcriptional regulation
ENSG00000121903,ZSCAN20,cell growth regulation,transcriptional repression,tumor suppression,apoptosis regulation,cell cycle control,oncogene suppression
ENSG00000256977,LIMS3,tumor progression,metastasis promotion,oncogenic function,cell migration regulation,actin cytoskeleton modulation,cancer aggressiveness marker
ENSG00000131370,SH3BP5,oncogenic processes,tumor progression,metastasis regulation,signaling pathway modulation,cellular responses to growth factors,protein-protein interactions
ENSG00000089006,SNX5,oncogene mutations,tumor progression,altered membrane trafficking,endosomal sorting dysregulation,cell polarity regulation,protein-protein interaction modifications
ENSG00000183873,SCN5A,ion channel regulation,electrical activity modulation,oncogene activation,cell proliferation promotion,emt process involvement,cardiac arrhythmia association
ENSG00000184226,PCDH9,cell adhesion disruption,metastatic potential,tumor suppressor function,cellular invasion promotion,signaling pathway regulation,neuronal development role
ENSG00000152779,SLC16A12,tumor energy supply,monocarboxylate transport,cellular metabolism regulation,cancer cell proliferation,therapeutic resistance,poor prognosis marker
ENSG00000285069,SESN2,oncogenic signaling pathway regulation,cellular stress response modulation,autophagy induction,tumor suppressor function,energy metabolism regulation,protein kinase activation
ENSG00000010244,ZNF207,tumor progression,oncogene,cell proliferation,metastasis,transcription regulation,epithelial-to-mesenchymal transition
ENSG00000154328,NEIL2,dna repair deficiency,genomic instability,cell cycle regulation,apoptosis regulation,tumor suppressor function,oncogenic mutations
ENSG00000143499,SMYD2,histone modification,oncogene activation,protein-protein interaction,methyltransferase activity,tumor suppressor regulation,poor prognosis marker
ENSG00000167653,PSCA,oncogene,wnt/β-catenin pathway regulation,cell adhesion modulation,metastasis promotion,tumor progression enhancement,prognostic marker
ENSG00000169905,TOR1AIP2,mtor regulation,cell survival,cell growth modulation,cancer-related pathways interaction,stress response regulation,er stress modulation
ENSG00000162739,SLAMF6,immune checkpoint regulation,t cell modulation,oncolytic activity,immune evasion,prognostic marker,immunotherapy target
ENSG00000122756,CNTFR,jak/stat signaling pathway,cell proliferation,cancer progression,immune evasion,therapeutic target,oncogene activation
ENSG00000114978,MOB1A,cell cycle regulation,hippo signaling pathway,constitutive activation,oncogene mutation,cell proliferation,transcription factor activation
ENSG00000140521,POLG,mitochondrial replication,genomic instability,constitutive activation,dna repair pathways,oncogenic processes,therapeutic target
ENSG00000256525,POLG2,epigenetic regulation,dna replication,gene expression dysregulation,tumor progression,cell proliferation increase,genomic instability
ENSG00000182919,C11orf54,olfactory receptor function,pi3k/akt pathway activation,cell proliferation regulation,tumor progression association,overexpression pattern,limited understanding
ENSG00000241685,ARPC1A,actin cytoskeleton regulation,cell migration enhancement,cancer progression facilitation,prognostic marker overexpression,tumor invasion promotion,oncogenic process activation
ENSG00000084733,RAB10,constitutive activation,gain of function mutations,cellular trafficking regulation,tumor progression,oncogenic processes,therapeutic target
ENSG00000178695,KCTD12,transcriptional co-regulator,cellular regulation,tumorigenesis,prognostic marker,biomarker,cancer biology
ENSG00000149922,TBX6,tbx6 function as oncogene/tumor suppressor,context dependent transcription factor activity,cell growth/survival pathway regulation,pleiotropic effects on development/tissue maintenance,wnt/β-catenin pathway interaction,therapeutic target for cancer treatment
ENSG00000074855,ANO8,ion homeostasis,cell migration,apoptosis resistance,calcium-activated chloride channel,tumor progression,therapeutic target
ENSG00000126062,TMEM115,autophagic regulation,cell survival,metabolic reprogramming,oncogenic driver,therapeutic target,tumor progression
ENSG00000152804,HHEX,transcription factor activity,oncogene overexpression,cell proliferation promotion,undifferentiated cell maintenance,genomic instability contribution,signaling pathway activation
ENSG00000188986,NELFB,transcription factor regulation,cancer immunotherapy target,immune cell development,apoptosis suppression,tumor evasion mechanism,inflammation modulation
ENSG00000155097,ATP6V1C1,ph homeostasis regulation,cell migration enhancement,metabolic reprogramming,tumor acidification,therapeutic target potential,proton pump activation
ENSG00000102984,ZNF821,transcriptional regulation,zinc finger protein family,dna-binding,cell cycle regulation,gene expression modulation,protein interaction
ENSG00000160145,KALRN,kalirin-rac signaling pathway,cytoarchitectural changes,gain of function mutations,tumor metastasis,cell migration regulation,cytoskeleton reorganization
ENSG00000112367,FIG4,genomic instability,cellular homeostasis disruption,autophagy dysregulation,oncogenic mutations,cell signaling aberration,endosomal trafficking regulation
ENSG00000157657,ZNF618,cellular regulation,dna binding motif,enhanced cell proliferation,transcriptional regulation,tumor suppressor potential,genomic instability
ENSG00000187783,TMEM72,aberrant calcium signaling,altered ion transport,cellular homeostasis regulation,cancer-associated mutations,ion channel function,oncogenic transformation
ENSG00000134321,RSAD2,nlrp3 inflammasome regulation,innate immunity modulation,tumor suppressor function,cancer risk association,cell growth control,inflammatory response regulation
ENSG00000129071,MBD4,genomic instability,dna repair mechanism,oncogenic properties,loss of function mutations,cell growth promotion,epigenetic regulation
ENSG00000169826,CSGALNACT2,acetyltransferase activity,genomic stability maintenance,tumor suppressor function,oncogenic role,cell proliferation regulation,dna damage response
ENSG00000134595,SOX3,tumor suppressor function,cellular differentiation,transcriptional regulation,enhanced cell proliferation,apoptosis inhibition,oncogenic interaction
ENSG00000159445,THEM4,cell adhesion regulation,epithelial-to-mesenchymal transition (emt),metastasis promotion,signaling pathway modulation,tumor aggressiveness enhancement,transmembrane protein function
ENSG00000182885,ADGRG3,cell adhesion disruption,wnt/β-catenin signaling,gain of function mutations,tumor progression,metastasis facilitation,cell migration regulation
ENSG00000183779,ZNF703,oncogene,chromatin remodeling,tumor progression,cancer stem cells regulation,transcriptional regulation,cell cycle modulation
ENSG00000173611,SCAI,tumor suppression,mitotic checkpoint regulation,cell proliferation regulation,autophagy regulation,protein degradation complex,striatin interacting protein
ENSG00000144591,GMPPA,dna repair,cell signaling,protein modification,glycoprotein processing,tumor metastasis,cell growth regulation
ENSG00000104517,UBR5,,genomic instability,cell cycle regulation,dna repair mechanism,protein degradation pathway,tumor suppression
ENSG00000187147,RNF220,cancer driver gene,protein degradation regulation,genomic stability maintenance,ubiquitination regulation,oncogenic signaling promotion,cullin-ring e3 ligase modulation
ENSG00000187189,TSPYL4,tumor suppressor activity,cell cycle regulation,dna damage response,chromatin remodeling,apoptosis modulation,epigenetic reprogramming
ENSG00000163913,IFT122,ciliogenesis regulation,cell signaling disruption,oncogenic process involvement,cell proliferation enhancement,genomic instability link,protein complex component
ENSG00000082397,EPB41L3,cellular integrity,oncogenic protein interaction,tumor aggressiveness,poor prognosis,cytoskeletal regulation,protein membrane interactions
ENSG00000099260,PALMD,cellular adhesion,cytoskeletal regulation,calcium signaling pathway,cell motility regulation,metastasis promotion,biomarker potential
ENSG00000173210,ABLIM3,epithelial-to-mesenchymal transition,cell migration and invasion,overexpression in cancers,tumor progression,actin filament regulation,cytoskeletal protein function
ENSG00000197713,RPE,cell growth regulation,retinoid metabolism,tumor progression,apoptosis inhibition,gene expression modulation,signaling pathway interaction
ENSG00000168566,SNRNP48,altered splicing patterns,cellular interactions,cancer driver mutations,spliceosome function,therapeutic target,genomic instability
ENSG00000146733,PSPH,tumor suppressor,dna repair regulation,cell cycle regulation,apoptosis promotion,genome stability maintenance,cancer predisposition
ENSG00000011465,DCN,tumor suppressor/oncogene,multifunctional proteoglycan,cellular modulation,angiogenesis/metastasis regulation,growth factor interaction,protein-protein interaction
ENSG00000134874,DZIP1,wnt/β-catenin signaling pathway,cell growth regulation,oncogenic mutations,tumor progression,protein-protein interactions,wnt signaling modulation
ENSG00000139370,SLC15A4,metabolic regulation,amino acid transport,tumor progression,cellular metabolism,protein-protein interaction,gene expression regulation
ENSG00000110446,SLC15A3,peptide/histidine transport,tumor progression,oncogene function,mitochondrial localization,cell proliferation regulation,protein-protein interaction
ENSG00000166188,ZNF319,transcriptional regulation,cell cycle control,tumor progression,oncogenic driver,genomic instability,epigenetic modulation
ENSG00000187258,NPSR1,pi3k/akt signaling pathway,oncogenic function,tumor growth promotion,metastasis facilitation,immune suppression,genomic instability
ENSG00000129810,SGO1,protein transport regulation,er membrane interaction,oncogenic mutations,cell proliferation modulation,signaling pathway dysregulation,cancer metastasis facilitation
ENSG00000277607,VSTM1,tumor suppressor function,regulates immune responses,modulates cell signaling pathways,t-cell activation and proliferation,cancer development and progression,metastasis and tumor growth
ENSG00000142599,RERE,genomic instability,tumor suppressor function,loss-of-function mutations,pi3k/akt pathway regulation,cancer progression,target for therapeutic interventions
ENSG00000150316,CWC15,cleavage and polyadenylation specificity,regulation of pre-mrna processing,interacts with other proteins,involvement in gene expression changes,tumor progression potential,rna processing component
ENSG00000164879,CA3,tumor growth promotion,angiogenesis facilitation,cell survival enhancement,ph regulation,co2 transport facilitation,hypoxia response modulation
ENSG00000279486,OR2AG1,olfactory signaling,pseudogenization,genomic regulation,cellular interaction,tumor suppression potential,gene expression modulation
ENSG00000165507,DEPP1,mapk signaling pathway,cell proliferation,tumor suppressor/oncogene,cell-cell adhesion disruption,genetic instability,prognostic biomarker
ENSG00000134504,KCTD1,cellular homeostasis,ion channel regulation,tumor suppressor,cell cycle regulation,cell proliferation modulation,scaffolding protein 
ENSG00000169682,SPNS1,cell migration,epithelial-to-mesenchymal transition (emt),phosphatidylinositol 3-kinase (pi3k)/protein kinase b (akt) pathway,sphingolipid transport,s1p signaling regulation,tumor growth promotion
ENSG00000125779,PANK2,coenzyme a biosynthesis,cellular metabolism regulation,energy production,fatty acid synthesis regulation,steroid hormone production regulation,pi3k/akt pathway interaction
ENSG00000126088,UROD,heme biosynthesis,decarboxylation enzyme,redox regulation,cancer metabolism,porphyrinogen processing,tumor growth modulation
ENSG00000152558,TMEM123,telomere maintenance,genomic stability,chromosomal instability,nuclear envelope protein,transmembrane protein,cancer predisposition
ENSG00000171365,CLCN5,tumor suppressor function,chloride channel regulation,cellular proliferation,genomic instability,apoptosis regulation,ion transport modulation
ENSG00000068615,REEP1,mitochondrial dynamics,oncogenic transformation,apoptosis resistance,cancer progression,cellular metabolism,mitochondrial membrane potential
ENSG00000089693,MLF2,epigenetic regulator,chromatin remodeling,histone methyltransferase activity,genome stability maintenance,transcriptional regulation,cellular differentiation control
ENSG00000009790,TRAF3IP3,cell growth regulation,immune response modulation,pi3k/akt pathway interaction,scaffolding protein function,tumor progression association,genomic profiling significance
ENSG00000095059,DHPS,impaired folate synthesis,genomic instability,tumorigenesis,upregulation,cell proliferation,dna repair
ENSG00000132507,EIF5A,mtor pathway regulation,tumor growth promotion,metastasis facilitation,translation regulation enhancement,proliferation enhancement,protein synthesis modulation
ENSG00000186130,ZBTB6,transcriptional repression,tumor suppressor function,cell proliferation regulation,apoptosis modulation,dna damage response regulation,genomic instability promotion
ENSG00000131471,AOC3,angiogenesis promotion,cell proliferation regulation,metastatic potential enhancement,neurotransmitter biosynthesis involvement,oncogenic pathway modulation,stress response regulation
ENSG00000100321,SYNGR1,neurotransmitter secretion regulation,synaptic vesicle fusion modulation,cell proliferation regulation,apoptosis regulation disruption,tumor cell migration facilitation,protein-protein interaction modulation
ENSG00000160113,NR2F6,tumor suppressor,cellular proliferation,genetic mutations,transcriptional regulation,apoptosis regulation,chromatin remodeling
ENSG00000196233,LCOR,corepressor function,nuclear hormone receptor regulation,chromatin remodeling complex,epigenetic alteration,estrogen receptor interaction,transcriptional regulation
ENSG00000031823,RANBP3,cell cycle regulation,mitotic progression,chromosome segregation,nuclear transport regulation,tumor suppressor function,cancer predisposition
ENSG00000136273,HUS1,genome stability maintenance,tumor suppressor function,dna damage response regulation,homologous recombination repair,nucleotide excision repair,atr kinase activation
ENSG00000174607,UGT8,udp-glucuronosyltransferase enzyme,detoxification process,cell growth regulation,apoptosis modulation,bile acid metabolism,lipid homeostasis
ENSG00000284980,AGPAT5,cell proliferation,oncogenic potential,phospholipid biosynthesis,aneuploidy,genomic instability,cell survival
ENSG00000127586,CHTF18,chromatin remodeling,genomic instability,dna repair mechanism,aberrant cell cycle progression,tumor aggressiveness,cell proliferation regulation
ENSG00000164330,EBF1,cell cycle regulation,transcription factor activity,apoptosis induction,genomic stability maintenance,b-cell differentiation regulation,dna repair mechanism modulation
ENSG00000115687,PASK,mitochondrial function,energy metabolism regulation,tumor suppressor,glucose uptake regulation,insulin sensitivity modulation,protein kinase activation
ENSG00000107130,NCS1,tumor progression,cell survival,cell growth,calcium signaling,oncogenic potential,protein interaction
ENSG00000121289,CEP89,microtubule regulation,aneuploidy induction,cell cycle dysregulation,therapeutic target,biomarker identification,genomic instability
ENSG00000101265,RASSF2,epigenetic regulation,tumor suppression,microtubule stability,dna damage response,apoptosis regulation,chromosomal instability
ENSG00000163806,SPDYA,cell division regulation,tumor progression,protein interaction,mitosis spindle assembly,chromosome segregation,kinase activation
ENSG00000198546,ZNF511,dna binding,cell cycle regulation,oncogenic potential,transcriptional regulation,genome stability maintenance,apoptosis evasion
ENSG00000016082,ISL1,oncogene,transcription factor activation,cell proliferation enhancement,tumor suppressor gene suppression,wnt/β-catenin pathway interaction,poor prognosis marker
ENSG00000010270,STARD3NL,oncogenic function,cholesterol transport regulation,lipid metabolism influence,tumor progression association,biomarker potential,cell membrane fluidity modulation
ENSG00000088876,ZNF343,cellular proliferation,oncogenic transformation,gene expression regulation,apoptosis suppression,protein-protein interaction,tumor progression
ENSG00000132517,SLC52A1,ribonucleotide transport,genomic instability,constitutive activation,oncogenic process,genomic profiling,metabolic regulation
ENSG00000138030,KHK,cell proliferation,glycolysis regulation,fructose metabolism,oncogenesis promotion,anti-apoptotic function,enzyme overexpression
ENSG00000166619,BLCAP,apoptosis regulation,mitochondrial localization,tumor suppressor role,cell cycle regulation,cancer association,gene expression modulation
ENSG00000149547,EI24,vegf expression,receptor tyrosine kinase activity,cell proliferation,oncogenic pathway activation,epithelial-to-mesenchymal transition,angiogenic process regulation
ENSG00000080802,CNOT4,regulation of mrna stability,cell proliferation control,tumor suppressor or oncogene,apoptosis modulation,biomarker for cancer diagnosis,protein-protein interactions
ENSG00000162624,LHX8,cell cycle regulation,chromatin remodeling,oncogene function,transcriptional regulation,protein-protein interaction,apoptosis suppression
ENSG00000110848,CD69,tumor immune evasion,overexpression on tumor cells,immune suppression,t-cell activation,macrophage regulation,immunotherapy target
ENSG00000171206,TRIM8,tumor suppressor,genomic stability regulation,cell cycle regulation,apoptosis promotion,autophagy modulation,protein-protein interaction
ENSG00000120925,RNF170,protein regulation,ubiquitination pathway,cell cycle progression,tumor suppressor/oncogene,transcriptional regulation,genome stability
ENSG00000165996,HACD1,fatty acid synthesis,unsaturated fatty acids,oncogenesis,cell proliferation,survival pathway,lipid metabolism
ENSG00000102466,FGF14,voltage-gated channel modulation,potassium ion flux regulation,cell proliferation driver,tumor suppressor dysfunction,mtor signaling pathway interaction,neuronal excitability regulation
ENSG00000137561,TTPA,cellular processes,mapk signaling pathway,apoptosis modulation,regulatory protein interactions,mutation-associated oncogenesis,dna damage response
ENSG00000170290,SLN,pi3k/akt pathway interaction,cell survival enhancement,tumor progression association,dysregulation in cancer,apoptosis resistance promotion,microenvironment modulation
ENSG00000119574,ZBTB45,transcriptional repressor,cell cycle regulation,tumor suppressor function,apoptosis modulation,emt regulation,chromatin modification
ENSG00000025156,HSF2,dna damage response,genomic stability maintenance,tumor suppressor function,apoptosis regulation,cell cycle control,transcriptional regulation
ENSG00000163754,GYG1,metabolic regulation,glycogen biosynthesis,amplification events,tumor growth,potential target,cancer metabolism
ENSG00000131779,PEX11B,per peroxisomal biogenesis factor,tumor suppressor function,peroxisome assembly and maintenance,oncogenic signaling pathways,cellular metabolism regulation,antioxidant defense mechanisms
ENSG00000146857,STRA8,cell proliferation,genomic instability,biomarker candidate,tumor suppressor loss,meiotic regulation,cell cycle progression
ENSG00000167470,MIDN,genomic instability,mitotic regulation,chromatin remodeling,checkpoint activation,cell cycle modulation,dna damage response
ENSG00000129226,CD68,macrophage infiltration,tumor-associated macrophages,pro-tumorigenic microenvironment,angiogenesis promotion,immune suppression,signaling pathway interaction
ENSG00000167105,TMEM92,oncogene activation,amplification mutations,cell proliferation,cell survival regulation,signaling pathway modulation,tumor progression
ENSG00000099958,DERL3,er-associated degradation,protein homeostasis,chaperone-mediated folding,tumor suppressor function,cellular stress response,protein quality control
ENSG00000242265,PEG10,transcriptional regulation,epigenetic modification,dna replication,cell proliferation,oncogenesis,prognostic marker
ENSG00000085871,MGST2,antioxidant defense,cell survival,detoxification mechanism,dna damage protection,metabolic regulation,oncoprotein
ENSG00000204316,MRPL38,mitochondrial translation regulation,oncogenic driver,cellular metabolism alteration,proliferation promotion,tumor progression facilitation,energy homeostasis disruption
ENSG00000146872,TLK2,dna damage response,cell cycle regulation,chromatin remodeling,genomic instability,apoptosis suppression,tumor suppressor interaction
ENSG00000159263,SIM2,tumor suppressor,transcriptional regulator,apoptosis induction,cell cycle regulation,metastasis promotion,therapeutic target
ENSG00000187987,ZSCAN23,transcriptional regulation,oncogenic process,anti-tumor target,immune response modulation,dna repair mechanism,cell cycle regulation
ENSG00000126749,EMG1,genomic instability,sensitivity to dna damage,cell cycle regulation,replication initiation complex assembly,tumor suppression,genome maintenance
ENSG00000213699,SLC35F6,glycosylation pathway,cell proliferation regulation,nucleotide sugar transport,cell growth influence,transporter function,cellular differentiation
ENSG00000184162,NR2C2AP,apoptosis regulation,oncogene function,tumor progression,cell proliferation,genomic instability,transcriptional regulation
ENSG00000120333,MRPS14,apoptosis regulation,cell proliferation,mitochondrial translation,prognostic marker,ribosomal assembly,tumor growth
ENSG00000101445,PPP1R16B,oncogenic function,tumor progression,cell cycle regulation,apoptosis inhibition,protein phosphatase modulation,therapeutic target
ENSG00000149596,JPH2,calcium signaling,tumor progression,intracellular regulation,cell migration,biomarker candidate,protein-protein interaction
ENSG00000182973,CNOT10,transcriptional regulation,dysregulation of mrna metabolism,aberrant transcriptional control,genome instability,rna processing regulation,tumor aggressiveness
ENSG00000134817,APLNR,cell proliferation,tumor progression,therapeutic target,lipid metabolism regulation,protein-protein interaction,metastasis facilitation
ENSG00000157216,SSBP3,telomere maintenance,dna repair pathways,genomic stability,cell cycle regulation,apoptosis modulation,single-strand dna binding
ENSG00000111432,FZD10,wnt/β-catenin pathway activation,gain of function mutations,enhanced cell proliferation,maintenance of epithelial homeostasis,oncogenic potential,cell migration and invasion
ENSG00000227460,SYNGAP1,regulation of immune microenvironment,tumor growth modulation,cell signaling pathway regulation,epigenetic regulation,oncogenic potential,synaptic plasticity dysfunction
ENSG00000144711,IQSEC1,gef activity,rac1 activation,small gtpase regulation,cell migration,tumorigenesis,oncogenic activity
ENSG00000161243,FBXO27,ubiquitination regulator,scf complex member,cell cycle regulation,transcriptional modulator,oncogene activation,tumorigenesis driver
ENSG00000137710,RDX,cell migration,actin cytoskeleton dynamics,tumor progression,metastasis,oncogene activation,protein-protein interactions 
ENSG00000101977,MCF2,aberrant cell signaling,actin cytoskeleton regulation,cell proliferation regulation,cell survival enhancement,genetic mutations involvement,tumor progression promotion
ENSG00000074054,CLASP1,microtubule regulation,chromosomal segregation,mitotic spindle formation,pi3k/akt pathway activation,oncogenic potential,genomic instability
ENSG00000010310,GIPR,cell proliferation,constitutive activation,tumor progression,insulin secretion regulation,g protein-coupled receptor signaling,metastasis promotion
ENSG00000172159,FRMD3,hippo signaling pathway,cell migration,microtubule stabilization,tumor progression,biomarker potential,gene regulation
ENSG00000196811,CHRNG,signaling pathway modulation,genetic instability,tumor progression,cell proliferation regulation,apoptosis inhibition,therapeutic target
ENSG00000158411,MITD1,mitochondrial function,cellular metabolism regulation,glycolysis enhancement,tumorigenesis promotion,oncogenic process involvement,prognostic marker
ENSG00000130724,CHMP2A,escrt complex,chromatin remodeling,driver mutation,endosomal trafficking,cell membrane remodeling,oncogenic processes
ENSG00000288505,NANOS3,tumor suppressor function,hippo pathway regulation,microrna regulation,apoptosis promotion,genome stability maintenance,cancer stem cell suppression
ENSG00000111275,ALDH2,oxidative stress regulation,gene expression regulation,tumor suppression,cell survival promotion,cancer stem cell maintenance,detoxification function
ENSG00000165092,ALDH1A1,cellular differentiation,stem cell maintenance,redox balance regulation,tumor aggressiveness,oncogenic potential,cancer stem cell marker interaction
ENSG00000133997,MED6,transcription regulation,tumor progression,cell proliferation,apoptosis regulation,genomic instability,therapeutic target
ENSG00000134363,FST,tumor microenvironment modulation,suppression of antitumor immunity,metastatic progression facilitation,cell adhesion regulation,apoptosis suppression,glycoprotein function
ENSG00000164347,GFM2,translation initiation factor,protein synthesis regulation,guanine nucleotide recognition,eukaryotic translation,cellular growth control,oncogenic processes
ENSG00000143771,CNIH4,calcium channel regulation,oncogenic protein-protein interaction,tumor progression facilitation,calcium-dependent signaling modulation,genetic mutation impact,biomarker potential
ENSG00000171368,TPPP,cellular proliferation,genetic instability,protein-protein interactions,tumor progression,microtubule dynamics,cancer biomarker
ENSG00000143184,XCL1,immune cell recruitment,tumor progression,metastasis,chemokine signaling,lymphocyte activation,cancer immunotherapy
ENSG00000274726,ARHGEF10,rho gtpase regulation,constitutive activation,oncogenic transformation,cell migration,protein-protein interactions,therapeutic target
ENSG00000171234,UGT2B7,glucuronidation,xenobiotic induction,chemosensitization,cancer-associated gene expression changes,cellular detoxification,metabolism regulation
ENSG00000011677,GABRA3,altered inhibitory neurotransmission,cell proliferation regulation,neurotransmitter regulation,tumor microenvironment regulation,gene expression modulation,cell survival pathway manipulation
ENSG00000113269,RNF130,cellular homeostasis regulation,ubiquitination activity,protein degradation modulation,tumor suppressor regulation,dna repair mechanisms,cell cycle progression
ENSG00000189334,S100A14,cell proliferation,protein kinase activation,transcriptional regulation,tumor aggressiveness,poor prognosis marker,angiogenesis promotion
ENSG00000174327,SLC16A13,monocarboxylate transport,lactate export,warburg effect,cellular metabolism,glycolysis enhancement,therapeutic target
ENSG00000061656,SPAG4,microtubule interaction,mitotic kinase regulation,cell division regulator,oncogenic process,tumor progression driver,metastasis promoter
ENSG00000112378,PERP,pro-apoptotic function,apoptosis regulation,dna damage response,tumor suppressor activity,p53 interaction,mutation association
ENSG00000180053,NKX2-6,cellular transformation,tumor progression,transcriptional regulation,oncogenic potential,proliferation induction,apoptosis inhibition
ENSG00000100926,TM9SF1,rho gtpase activation,metastasis promotion,tumor growth regulation,cell migration modulation,protein-protein interaction,transmembrane scaffold function
ENSG00000127527,EPS15L1,cellular regulation,endocytosis disruption,oncogenic driver,tumor progression,therapeutic target,genomic instability
ENSG00000110786,PTPN5,tumor suppressor function,loss of function mutations,pi3k/akt signaling modulation,cell proliferation regulation,apoptosis regulation,cancer progression association
ENSG00000134873,CLDN10,pi3k/akt signaling pathway,tumor progression,cell adhesion alterations,cancer aggressiveness,tight junction disruption,cancer metastasis
ENSG00000164270,HTR4,serotonin signaling,g protein-coupled receptor activation,apoptosis modulation,angiogenesis regulation,cell proliferation control,therapeutic target
ENSG00000198042,MAK16,microtubule destabilization,oncogenic potential,cell cycle regulation,apoptosis modulation,therapeutic target,genomic amplification
ENSG00000116213,WRAP73,genomic instability,tumor suppression,cell cycle regulation,dna damage repair,oncogenic mutations,therapeutic target
ENSG00000172461,FUT9,fucose addition,glycosylation modifications,immune evasion mechanisms,tumor progression pathways,cell adhesion changes,oncogene expression patterns
ENSG00000109738,GLRB,oncogenic signaling,pi3k/akt/mtor pathway,gain of function mutations,tumor progression,glutamate receptor activity,cell survival and growth
ENSG00000187954,CYHR1,mitochondrial dysfunction,genomic instability,oncogenic signaling,electron transport chain disruption,therapeutic target,cellular metabolism regulation
ENSG00000158710,TAGLN2,tumor associated protein,muscle contraction regulation,extracellular matrix interaction,cell migration facilitation,biomarker potential,prognostic significance
ENSG00000196812,ZSCAN16,tumor suppression,transcriptional regulation,epigenetic modulation,pro-oncogenic gene suppression,oncogene potential,chromatin remodeling
ENSG00000173409,ARV1,tumor suppressor activity,glycolytic reprogramming,enhanced cell proliferation,loss-of-function mutations,reduced expression levels,metabolic dysregulation
ENSG00000151224,MAT1A,mitochondrial metabolism,enzymatic activity,warburg effect promotion,energy production enhancement,cellular redox balance regulation,proteostasis modulation
ENSG00000078269,SYNJ2,phosphatidylinositol 3-phosphate dephosphorylation,constitutive activation of pi3k/akt pathway,regulation of endocytosis and exocytosis,tumor progression and cell proliferation,therapeutic target for cancer treatment,unique role in phosphoinositide metabolism
ENSG00000104154,SLC30A4,cell proliferation,zinc regulation,oncogenesis,metastasis promotion,transcription factor modulation,prognostic marker
ENSG00000163873,GRIK3,glutamate receptor function,ion channel regulation,tumor progression,therapeutic target,synaptic transmission,cellular excitability
ENSG00000233276,GPX1,redox regulation,oxidative stress resistance,antioxidant function,tumor progression driver,cellular protection,genomic instability prevention
ENSG00000163792,TCF23,wnt/β-catenin signaling,transcriptional regulation,tumor maintenance,emt regulation,cancer stem cell population,cell proliferation enhancement
ENSG00000170899,GSTA4,xenobiotic metabolism,detoxification pathways,cell protection mechanisms,glutathione conjugation,oxidative stress reduction,chemical resistance
ENSG00000183463,URAD,genomic instability,double-strand break repair,dna replication regulation,tumor development association,maintenance of genomic stability,impaired dna repair function
ENSG00000198807,PAX9,tumor progression,oncogenic transformation,transcriptional regulation,cell proliferation,epigenetic modification,gain of function mutations
ENSG00000121931,LRIF1,hippo signaling pathway,tumor suppressor function,genomic integrity maintenance,apoptosis regulation,post-translational modifications,protein-protein interactions
ENSG00000152270,PDE3B,pka pathway inhibition,tumor progression,camp regulation,protein kinase activation,oncogenesis promotion,cell signaling modulation
ENSG00000101040,ZMYND8,tumor suppression,chromatin remodeling,histone modification,apoptosis regulation,cell cycle control,genomic stability
ENSG00000203933,CXorf66,nuclear localization,chromatin remodeling,gene expression modulation,cellular growth regulation,potential oncogene,cellular proliferation
ENSG00000177556,ATOX1,iron-sulfur cluster assembly,tumor suppressor interaction,oncogenic process modulation,cell proliferation regulation,transcriptional regulation,mitochondrial function
ENSG00000086289,EPDR1,cellular proliferation,oncogenesis,adaptor protein function,metabolic regulation,signaling pathway modulation,glycolytic activation
ENSG00000165655,ZNF503,tumor suppressor,transcriptional regulation,cell growth inhibition,genomic instability,epigenetic modification,oncogene repression
ENSG00000162571,TTLL10,cell division regulation,tubulin modification,cancer progression association,aberrant expression,mitotic regulation,protein stability regulation
ENSG00000182463,TSHZ2,transcriptional regulation,tumor suppressor function,apoptosis induction,cellular differentiation,genetic instability,oncogenic repression
ENSG00000126264,HCST,jak/stat pathway,signaling activation,hematopoietic cell proliferation,oncogenesis,therapeutic target,cell survival regulation
ENSG00000128309,MPST,prostaglandin synthesis,cellular proliferation,oncogenic potential,tumor progression,metabolic regulation,signaling pathway interaction
ENSG00000167395,ZNF646,transcriptional regulation,nuclear localization,cellular proliferation,apoptosis inhibition,metastatic progression,genomic instability
ENSG00000088970,KIZ,microtubule-based motility,mitotic spindle regulation,cell division dysregulation,cancer cell proliferation,protein-protein interactions,motor protein activity
ENSG00000167491,GATAD2A,genomic instability,chromatin remodeling,transcriptional regulation,tumor progression,metastasis,oncogenic regulator 
ENSG00000116906,GNPAT,lipid synthesis,triglyceride production,dysregulation in cancer,metabolic reprogramming,tumor cell growth,energy storage pathway
ENSG00000172613,RAD9A,genomic instability,dna damage response,checkpoint activation,cell cycle arrest,oncogenic mutations,tumor progression
ENSG00000033178,UBA6,cell cycle regulation,protein degradation pathway,oncogenic mutations,tumor cell proliferation,ubiquitination regulation,cell survival signaling
ENSG00000104472,CHRAC1,chromatin remodeling,cellular transcription regulation,tumor growth promotion,genomic instability,dna damage response,transcriptional dysregulation
ENSG00000179051,RCC2,centrosome regulation,hyperactivation mutations,cell proliferation,mitosis regulation,therapeutic target,cell cycle checkpoint
ENSG00000136881,BAAT,lipid metabolism,bile acid transfer,cell membrane regulation,lipid profiles alteration,tumor microenvironment modification,cellular metabolism modulation
ENSG00000163347,CLDN1,tight junction maintenance,epithelial-to-mesenchymal transition,cell migration and invasion,chemotherapy resistance,tumorigenesis,cancer progression
ENSG00000081870,HSPB11,oncogenesis,cellular stress response,protein folding regulation,apoptosis inhibition,tumor progression,therapeutic target
ENSG00000198963,RORB,ror transcription factor,overexpression,tumor progression,cancer stem cell maintenance,cell proliferation regulation,genomic instability
ENSG00000147548,NSD3,chromatin modification,heterochromatic regions,histone methylation,oncogenesis,genome instability,transcriptional repression
ENSG00000120686,UFM1,ubiquitin-fold modifier 1 pathway,protein degradation dysfunction,cellular proliferation enhancement,therapeutic resistance mechanism,epigenetic regulation involvement,oncogenic protein aggregation
ENSG00000164687,FABP5,fatty acid metabolism modulation,cellular proliferation promotion,oncogenic protein interaction,warburg effect enhancement,chemoresistance induction,metabolic reprogramming
ENSG00000139445,FOXN4,oncogenic transcription factor,cell proliferation promotion,tumor suppressor downregulation,apoptosis inhibition,protein-protein interaction,transcriptional regulation
ENSG00000011523,CEP68,microtubule dynamics regulation,cell division modulation,genomic stability maintenance,oncogenic properties,centrosomal protein interaction,tumorigenesis promotion
ENSG00000135775,COG2,cellular trafficking,oncogenic function,tumor growth,cell proliferation,apoptosis inhibition,protein folding
ENSG00000124209,RAB22A,cell migration enhancement,metastasis promotion,oncogenic process,tumor progression,endocytic regulation,gtpase activity
ENSG00000113272,THG1L,regulation of actin cytoskeleton,cell migration and invasion,cellular survival and growth signals,tumor progression and metastasis,prognostic biomarker,pi3k/akt pathway interaction
ENSG00000165704,HPRT1,purine metabolism,genomic instability,diagnostic marker,oncogene potential,reference gene,tumor suppressor activity
ENSG00000197901,SLC22A6,transport function,chemotherapy resistance,prognostic biomarker,cellular uptake,nucleoside transport,regulatory mechanisms
ENSG00000251380,DCANP1,integrin interaction,cell adhesion disruption,oncogenic signaling,proliferation enhancement,migration facilitation,metastasis promotion
ENSG00000042429,MED17,transcriptional regulation,cell cycle progression,oncogene activation,chromatin remodeling,genomic instability,tumor suppressor interaction
ENSG00000148297,MED22,transcriptional regulation,chromatin remodeling,tumor suppressor dysfunction,genomic instability,protein-protein interaction,aberrant gene expression
ENSG00000170689,HOXB9,tumor progression,epithelial-to-mesenchymal transition,constitutive activation,oncogene function,transcription factor regulation,cellular invasion
ENSG00000100284,TOM1,tsg101 complex,escrt-i function,autophagy regulation,apoptosis modulation,cell cycle progression,tumor suppressor
ENSG00000039600,SOX30,transcriptional regulation,tumor progression,oncogenic process,promotes cell growth,survival pathway modulation,genetic regulation
ENSG00000111481,COPZ1,cancer cell invasion,cellular trafficking regulation,golgi apparatus dysfunction,metastatic potential,oncometabolite production,tumor microenvironment modulation
ENSG00000243989,ACY1,purine biosynthesis regulation,oncogenic properties,cell cycle progression,nucleotide imbalance,tumor proliferation,prognostic marker
ENSG00000186815,TPCN1,calcium influx regulation,tumor progression,metastasis promotion,chemoresistance enhancement,cell proliferation facilitation,biomarker potential
ENSG00000162341,TPCN2,adhesion and migration regulation,tumor progression,cancer cell proliferation,survival pathway dysregulation,therapeutic target for cancer treatment,constitutive activation leading to oncogenic processes
ENSG00000153896,ZNF599,transcriptional regulation,cell proliferation,apoptosis suppression,wnt signaling pathway,pi3k/akt activation,chromatin remodeling
ENSG00000167528,ZNF641,transcription factor regulation,tumor suppressor downregulation,cell proliferation enhancement,tumor progression acceleration,metabolic reprogramming,genomic instability
ENSG00000134551,PRH2,tumor progression,oncogenic effects,tumor suppressor regulation,rna binding protein function,dysregulation of cell growth signals,genomic instability modulation
ENSG00000258429,PDF,protein folding regulation,oncogene stabilization,cell adhesion modulation,metastasis promotion,therapeutic target,oxidative stress regulation
ENSG00000170473,PYM1,glycolytic enzyme,energy production,cell proliferation,metabolic regulation,tumor growth,transcriptional regulation
ENSG00000149798,CDC42EP2,cell migration,gef activity,rho gtpase interaction,tumorigenesis promotion,metastasis facilitation,prognostic marker
ENSG00000165804,ZNF219,tumor suppressor function,gene expression regulation,cell cycle progression modulation,apoptosis induction,potential therapeutic target,transcriptional regulation
ENSG00000074416,MGLL,cellular metabolism,tumor progression,glycolytic reprogramming,glutaminolysis regulation,apoptosis modulation,biomarker/therapeutic target
ENSG00000135926,TMBIM1,apoptosis regulation,cell survival modulation,protein folding regulation,molecular chaperone activity,endoplasmic reticulum stress response,tumor progression inhibition
ENSG00000162885,B3GALNT2,altered glycosylation,genetic instability,tumor microenvironment,cellular proliferation,protein-carbohydrate interaction,cancer susceptibility
ENSG00000165502,RPL36AL,ribosomal protein overexpression,oncogenic translation,cell growth regulation,excessive protein synthesis,cancer association,tumor progression
ENSG00000066777,ARFGEF1,membrane trafficking,oncogenic kinase regulation,cell signaling,tumorigenesis,cell cycle regulation,apoptosis modulation
ENSG00000283868,ZBTB4,zbtb4 mediated chromatin remodeling,tumor suppressor function,pi3k/akt pathway interaction,cellular differentiation regulation,oncogenic gene repression,transcriptional repressor activity
ENSG00000276600,RAB7B,cellular trafficking,oncogenesis,cell migration,endosomal transport,tumor progression,protein-protein interaction
ENSG00000100360,IFT27,cilia dysfunction,oncogenic process,enhanced cell proliferation,regulatory mechanism,signaling pathway interaction,genomic instability
ENSG00000204815,TTC25,ubiquitin ligase activation,cell cycle regulation,oncogenic properties,tumor suppressor degradation,transcriptional control,protein-protein interaction
ENSG00000183625,CCR3,chemokine receptor,constitutive activation,immunosuppression,tumor progression,angiogenesis,g-protein coupled receptor
ENSG00000188730,VWC2,cell adhesion,oncogenic processes,tumor progression,metastasis promotion,integrin binding,extracellular matrix interaction
ENSG00000168792,ABHD15,lipid metabolism regulation,oncogenic pathway activation,phospholipase c interaction,protein kinase b activation,tumor growth promotion,microrna regulation
ENSG00000171049,FPR2,immune modulation,tumor progression,g-protein coupled receptor,cell migration,inflammation regulation,hmgb1 interaction
ENSG00000130382,MLLT1,mllt1 overexpression,constitutive activation,transcriptional regulation,cell proliferation,oncogenesis,tumor suppressor
ENSG00000103966,EHD4,clathrin-mediated endocytosis,tumor progression,cell membrane trafficking,receptor regulation,signaling molecule degradation,oncogenic processes
ENSG00000039987,BEST2,pan-cancer progression,cell signaling pathway,chloride channel regulation,apoptosis regulation,cell proliferation,genetic instability
ENSG00000156675,RAB11FIP1,rab gtpase interaction,cell cycle regulation,apoptosis suppression,growth factor signaling pathway,membrane trafficking regulation,tumor progression enhancement
ENSG00000137393,RNF144B,oncogene activity,tumor progression,ubiquitin ligase function,proteasomal degradation,substrate specificity,bcl2 interaction
ENSG00000153339,TRAPPC8,genomic amplification,oncogenic growth,cell migration invasion,membrane trafficking regulation,protein transport facilitation,tumorigenesis association
ENSG00000135924,DNAJB2,protein chaperone function,tumor suppressor activity,cell cycle regulation,genomic stability maintenance,autophagy modulation,apoptosis regulation
ENSG00000103740,ACSBG1,fatty acid metabolism,oncogenic process,cell proliferation,cancer cell growth,lipid synthesis,acyl-coa esters accumulation
ENSG00000175567,UCP2,energy metabolism regulation,oncogenic function,mitochondrial membrane protein,cellular survival promotion,hypoxia adaptation,poor prognosis association
ENSG00000188038,NRN1L,alternative splicing,cell proliferation,gene regulation,mrna export,nuclear localization,pre-mrna processing
ENSG00000141956,PRDM15,histone methylation,chromatin remodeling,gene regulation,cell differentiation,oncogenic suppression,none
ENSG00000102468,HTR2A,apoptosis inhibition,cell proliferation,g protein-coupled receptor,immune response modulation,metastasis promotion,serotonin signaling
ENSG00000110063,DCPS,dna repair,genomic instability,oncogenesis,drug resistance,platinum-based chemotherapy,fanconi anemia pathway
ENSG00000132467,UTP3,aberrant pre-rrna processing,cellular stress response,genetic mutations,oncogene activation,ribosome biogenesis,tumor progression
ENSG00000114268,PFKFB4,glycolytic pathway,glucose metabolism,oncogenic process,tumor progression,cell proliferation,therapeutic target
ENSG00000118985,ELL2,transcriptional elongation,elongation factor activity,cell proliferation promotion,chromatin remodeling involvement,tumor progression facilitation,genomic instability contribution
ENSG00000147124,ZNF41,cellular regulation,transcription factor activity,cell proliferation,tumor progression,metastasis,therapeutic target
ENSG00000132837,DMGDH,mitochondrial function,oxidative stress,cellular metabolism regulation,energy production,tumor progression,dna damage response
ENSG00000244476,ERVFRD-1,genomic instability,transcriptional regulation,mobile genetic element,tumor progression,apoptosis inhibition,chromatin remodeling
ENSG00000124243,BCAS4,erα signaling modulation,oncogene function,genomic instability protection,cell proliferation promotion,hormone resistance induction,metastatic potential enhancement
ENSG00000141971,MVB12A,ubiquitin-protein ligase activity,escrt-0 complex component,autophagy regulation,tumor growth modulation,metastasis promotion,oncogenic function
ENSG00000155629,PIK3AP1,pi3k/akt signaling pathway regulation,tumor suppressor function,decreased pi3k inhibition,increased akt activation,oncogenesis driver,genomic deletions
ENSG00000143603,KCNN3,cellular signaling modulation,ion channel regulation,apoptosis evasion,tumor progression,therapeutic target,genomic profiling
ENSG00000213397,HAUS7,genomic instability,tumor suppressor function,dna repair mechanism,aneuploidy,telomere dysfunction,centrosome regulation
ENSG00000065883,CDK13,alternative splicing regulation,oncogene activation,serine/threonine kinase activity,cell proliferation regulation,transcriptional regulation,mitotic progression dysregulation
ENSG00000109618,SEPSECS,tumor progression,mutation leading to gain of function,regulation of cell proliferation and survival,interaction with pi3k/akt pathway,oncogene potential,therapeutic target
ENSG00000163406,SLC15A2,cellular metabolism,nutrient uptake facilitation,tumor progression,therapeutic target,energy source regulation,protein-protein interaction
ENSG00000153234,NR4A2,transcriptional regulation,oncogenic potential,cell cycle progression,apoptosis regulation,metabolic regulation,tumor suppressor/tumor promoter
ENSG00000119121,TRPM6,cell proliferation,angiogenesis promotion,immune evasion mechanisms,gain of function mutations,oncogene potential,calcium signaling pathway
ENSG00000115163,CENPA,centromere assembly,kinetochore complex,chromosome segregation,cell cycle regulation,genomic stability,mitotic spindle formation
ENSG00000152409,JMY,transcriptional regulation,chromatin remodeling,epigenetic modulation,cell proliferation enhancement,tumor progression facilitation,prognostic marker
ENSG00000134072,CAMK1,calmodulin-dependent protein kinase,cell signaling pathway,regulation of gene expression,tumor progression,protein-protein interaction,genomic instability
ENSG00000109163,GNRHR,cellular regulation,proliferation,regulatory mechanism,signaling pathway,g protein-coupled receptor,tumor development
ENSG00000197858,GPAA1,lipid biosynthesis,overexpression in tumors,cell growth regulation,glycolipid metabolism,apoptosis modulation,membrane composition regulation
ENSG00000135437,RDH5,fatty acid beta-oxidation,mitochondrial localization,energy metabolism regulation,oxidative stress response modulation,therapeutic target,metabolic rewiring
ENSG00000174970,OR10AG1,aberrant expression,cell proliferation,proliferation rates,metastasis,oncogenic processes,tumor microenvironment
ENSG00000107317,PTGDS,prostaglandin d2 production,angiogenesis promotion,inflammation modulation,cell proliferation enhancement,oncogene potential,genomic profiling alterations
ENSG00000121351,IAPP,tumor progression,inflammatory microenvironment,amyloid fibril formation,signaling pathway interaction,cell proliferation,cell survival
ENSG00000197165,SULT1A2,cancer metabolism,detoxification mechanism,metabolic regulation,xenobiotic biotransformation,estrogen metabolism,tumor suppressor function
ENSG00000116005,PCYOX1,melanogenesis regulation,cell proliferation modulation,tumorigenesis association,transcription factor function,cell cycle regulation,dna repair mechanism
ENSG00000198700,IPO9,apoptosis inhibition,ubiquitination,proteasomal degradation,cell survival,oncogenesis,chemotherapy resistance
ENSG00000160282,FTCD,histidine biosynthesis pathway,cytoplasmic localization,cellular metabolism regulation,dna repair disruption,oncogenic processes involvement,metabolic enzyme dysfunction
ENSG00000169621,APLF,telomere maintenance,autophagy regulation,dna replication,parp activity,genomic stability,chromatin remodeling
ENSG00000148344,PTGES,prostaglandin e2 synthesis,tumor progression,immune evasion,metabolic reprogramming,oncogenic signaling,pro-inflammatory mediator
ENSG00000156298,TSPAN7,oncogene/tumor suppressor,cell proliferation,apoptosis regulation,tumor growth promotion,molecular interaction,epithelial-to-mesenchymal transition (emt)
ENSG00000164182,NDUFAF2,mitochondrial dysfunction,altered metabolism,energy production regulation,oxidative phosphorylation,cellular respiration modulation,tumor growth promotion
ENSG00000169688,MT1B,metal detoxification,oxidative stress regulation,apoptosis modulation,nf-κb activation,tumor progression facilitation,transcriptional regulation
ENSG00000163683,SMIM14,genomic instability,dna repair,oncogenesis,genomic stability,cancer promotion,tumorigenesis
ENSG00000154099,DNAAF1,cilia motility disorder,dynein axonemal complex assembly,cellular transport disruption,oncogenic pathway activation,pan-cancer involvement,genetic mutation association
ENSG00000171962,DRC3,rho gtpase regulation,oncogenic pathway modulation,tumor suppressor function,downregulation or mutation,cell proliferation regulation,microenvironment modulation
ENSG00000170927,PKHD1,primary cilia dysfunction,tumor suppression,centrosomal regulation,cell adhesion disruption,wnt/β-catenin signaling,epithelial-to-mesenchymal transition
ENSG00000109832,DDX25,genomic instability,transcriptional regulation,rna processing,gene expression reprogramming,cellular proliferation,protein interaction
ENSG00000184445,KNTC1,cellular proliferation,ubiquitination pathway,dna repair mechanisms,oncogenic processes,protein degradation regulation,genomic stability maintenance
ENSG00000174442,ZWILCH,cell cycle regulation,protein degradation,tumor suppression,substrate recognition,apoptosis modulation,cell proliferation control
ENSG00000115363,EVA1A,genomic instability,structural variations,retrotransposition,cell proliferation,integrase activity,tumor-suppressive effects
ENSG00000070182,SPTB,cell signaling disruption,cell adhesion alterations,oncogene activation,tumor suppressor modulation,genomic instability drivers,cytoplasmic structure regulation
ENSG00000170178,HOXD12,hox family,developmental regulation,cellular homeostasis,tumor suppression,aberrant cell growth,oncogenic pathways
ENSG00000176894,PXMP2,lipid metabolism,metabolic reprogramming,peroxisomal membrane protein function,fatty acid beta-oxidation regulation,cellular energy metabolism modulation,therapeutic target
ENSG00000244045,TMEM199,cellular regulation,tumor suppression,ion transport modulation,cell signaling regulation,cancer biomarker,downregulation in cancer
ENSG00000143543,JTB,cell-cell interactions,cell migration,oncogene candidate,immunoglobulin-like domains,adhesion molecule regulation,inflammation modulation
ENSG00000244122,UGT1A7,detoxification,metabolic regulation,cell signaling,tumor progression,therapeutic target,genomic instability
ENSG00000137040,RANBP6,genomic instability,aneuploidy,chromosomal separation,mitotic spindle regulation,nuclear transport,oncogenic properties
ENSG00000171631,P2RY6,g-protein coupled receptor,oncogenic signaling,tumor promotion,cell proliferation,angiogenesis regulation,immune evasion
ENSG00000131386,GALNT15,o-glycosylation pathway,gene amplification,metastasis promotion,cell migration enhancement,tumor progression facilitation,therapeutic target potentialization
ENSG00000137166,FOXP4,oncogenic transcription factor,promotes tumor growth,immune evasion mechanisms,cellular proliferation regulator,transcriptional regulation,metastasis promoter
ENSG00000136535,TBR1,pi3k/akt pathway modulation,transcriptional regulation,cell growth promotion,tumor suppressor function,oncogenic mutations,genomic instability
ENSG00000035499,DEPDC1B,mtor pathway,gain of function mutations,loss of function,oncogenic processes,therapeutic target,genomic instability
ENSG00000132872,SYT4,cellular proliferation,calcium-dependent signaling,oncogenic transformation,therapeutic target,cell growth regulation,dysregulated expression
ENSG00000165272,AQP3,aquaporin function,cellular homeostasis regulation,cell proliferation promotion,tumor progression association,oncogenesis facilitation,ros regulation
ENSG00000170017,ALCAM,tumor progression,metastasis facilitation,cell adhesion modulation,signaling pathway regulation,cancer cell-microenvironment interaction,genetic mutation impact
ENSG00000013725,CD6,tumor microenvironment modulation,immune response regulation,cell proliferation inhibition,apoptosis suppression,dna repair regulation,cell cycle progression
ENSG00000072415,MPP5,cancer association,cell polarity disruption,enhanced cell migration,oncogenic process promotion,tumor growth facilitation,cell adhesion modulation
ENSG00000122696,SLC25A51,metabolic regulation,mitochondrial transport,oncogenic potential,cellular proliferation,energy metabolism,tumor growth
ENSG00000143167,GPA33,er chaperone function,unfolded protein response regulation,protein folding assistance,cell survival promotion,tumor-promoting factor,angiogenesis regulation
ENSG00000151612,ZNF827,tumor suppressor regulation,cancer-associated transcriptional repression,chromatin remodeling,dna binding,transcriptional repressor,genomic instability
ENSG00000276537,TTYH1,mitotic regulation,genomic instability,chromatin remodeling,cell cycle progression,tumor suppressor function,tyrosine kinase activity
ENSG00000108639,SYNGR2,synaptic vesicle assembly,neuronal communication,neurotransmitter release,cell proliferation,synaptic plasticity,signal transduction
ENSG00000168077,SCARA3,scara3 mediated ligand internalization,tumor growth promotion,metastasis facilitation,cell migration enhancement,oncogenic signaling,extracellular matrix modulation
ENSG00000180176,TH,oncogenic regulation,immune evasion,angiogenesis promotion,tumor growth enhancement,metastasis facilitation,cancer cell migration
ENSG00000104870,FCGRT,fcgr-mediated antibody-dependent cellular cytotoxicity,tumor evasion mechanisms,immune regulation alterations,adcc efficacy modulation,immunotherapy target candidate,cancer immune microenvironment modulation
ENSG00000076864,RAP1GAP,regulatory mechanism,cellular processes regulation,tumor cell proliferation,gtpase activity modulation,dysregulation mutations,signaling pathway interaction
ENSG00000164902,PHAX,nuclear exosome regulation,pre-mrna processing,rna degradation pathway,oncogenic transcript stabilization,tumorigenesis,cellular misregulation
ENSG00000127578,WFIKKN1,protein kinase activation,regulatory protein interactions,tumor progression driver,extracellular matrix degradation,cancer cell migration facilitator,emt regulator
ENSG00000126458,RRAS,mapk/erk pathway activation,cell proliferation enhancement,oncogenic potential increase,tumor progression facilitation,gtpase regulation alteration,protein interaction modulation
ENSG00000087495,PHACTR3,angiogenesis promotion,loss of function mutations,cell cycle regulation inhibition,tumor suppression interaction disruption,prognostic biomarker,genomic instability enhancement
ENSG00000273514,FOXD4L6,cellular proliferation,transcriptional regulation,epigenetic modification,dna binding,co-regulator interaction,developmental pathway
ENSG00000160563,MED27,transcriptional regulation,chromatin remodeling,oncogenesis driver,cell growth promotion,cancer gene amplification,cdk interaction
ENSG00000101181,MTG2,m6a methylation,rna stability regulation,tumor growth promotion,oncogenic signaling pathway,cellular proliferation enhancement,cancer progression facilitation
ENSG00000131914,LIN28A,mirna regulation,dysregulation of let-7,inhibition of p53,cell cycle progression,oncogenic processes,tumor metastasis
ENSG00000135269,TES,transcription factor,chromatin remodeling,epigenetic regulation,cell proliferation,oncogenic mutations,signaling pathway interaction
ENSG00000187003,ACTL7A,microtubule dynamics regulation,cell division regulation,cytoplasmic localization,oncogenic potential,ciliogenesis,cell cycle progression enhancement
ENSG00000182631,RXFP3,tumor proliferation,hormone receptor activation,cell survival enhancement,metastasis promotion,upregulated expression,oncogenic processes
ENSG00000164405,UQCRQ,mitochondrial dysfunction,oxidative phosphorylation defect,energy metabolism disruption,glycolytic shift,electron transport chain disruption,tumor suppressor loss
ENSG00000167476,JSRP1,tumor suppression,cellular structure regulation,intermediate filament assembly,oncogenic transformation,adhesion and migration regulation,poor prognosis marker
,HIST1H4L,chromatin remodeling,epigenetic regulation,histone modification,dna packaging,gene expression,prognostic marker
,HIST1H4A,histone regulation,dna packaging,epigenetic control,gene expression regulation,cancer association,methyltransferase interaction
,HIST1H4J,histone modification,chromatin remodeling,epigenetic alteration,dna repair dysfunction,gene expression regulation,tumor progression
,HIST4H4,histone modification,chromatin remodeling,genomic instability,tumor progression,epigenetic regulation,cell cycle regulation
,HIST1H4F,chromatin structure regulation,gene expression modulation,nucleosome assembly,histone modification,cell growth regulation,epigenetic control
,HIST1H4C,histone modification,chromatin remodeling,transcriptional regulation,nucleosome stability,dna replication,protein acetylation
,HIST2H4B,chromatin remodeling,histone modification,epigenetic regulation,cell growth regulation,dna replication,transcriptional control
,HIST1H4D,histone modification,chromatin remodeling,epigenetic regulation,cell proliferation,dna packaging,gene expression
,HIST2H4A,chromatin remodeling,histone modification,gene expression regulation,transcriptional control,cell cycle regulation,epigenetic regulation
,HIST1H4B,chromatin structure modulation,tumor suppressor suppression,epigenetic regulation,genome instability,histone modification,oncogene activation
,HIST1H4H,chromatin regulation,histone modification,epigenetic deregulation,cell cycle progression,genome stability maintenance,protein-dna interaction
,HIST1H4I,chromatin remodeling,histone modification,gene regulation,cell cycle progression,dna replication,oncogenic processes
,HIST1H4K,histone regulation,chromatin structure,oncogenic processes,tumorigenesis contribution,gene expression modulation,histone modification alterations
,HIST1H4E,histone modification,chromatin regulation,dna packaging,gene expression regulation,proliferation control,cancer progression
ENSG00000176410,DNAJC30,tumor suppressor function,protein homeostasis regulation,oncogenic pathway interaction,metastasis promotion,cell growth enhancement,genomic instability association
ENSG00000107290,SETX,dna repair mechanism,genome instability,chromatin organization,oncogenic process,tumor progression,nucleosome remodeling
ENSG00000062485,CS,tumor-associated macrophages,receptor tyrosine kinase activation,growth factor signaling pathway,cell survival and proliferation,metastasis promotion,immune evasion mechanism
ENSG00000132670,PTPRA,pi3k/akt pathway activation,loss-of-function mutations,tumor suppressor function,cell proliferation enhancement,metastasis promotion,egfr interaction
ENSG00000092020,PPP2R3C,pi3k/akt signaling,tumor suppression,oncogenesis,cell proliferation,protein dephosphorylation,apoptosis resistance
ENSG00000100427,MLC1,cytoplasmic localization,actin-myosin contractility,cancer cell migration,cell division regulation,protein-protein interactions,signaling pathway modulation
ENSG00000183527,PSMG1,proteasome regulation,dysregulated protein degradation,oncogenic protein stabilization,cell cycle progression,apoptosis evasion,transcriptional regulation
ENSG00000128789,PSMG2,proteasome activation,oncoprotein stabilization,tumor progression,therapeutic target,cellular homeostasis disruption,ubiquitin-proteasome pathway dysregulation
ENSG00000027075,PRKCH,pkc signaling pathway,constitutive activation,oncogenic transformation,cell survival regulation,therapeutic target,phosphorylation event
ENSG00000154114,TBCEL,microtubule regulation,chaperone function,mitotic checkpoint,genomic stability,apoptosis evasion,cellular transport
ENSG00000179304,FAM156B,transcriptional regulation,proliferation enhancement,apoptosis inhibition,tumor progression,genetic instability,zinc finger domain
ENSG00000268350,FAM156A,cell cycle regulation,dna repair,apoptosis regulation,cell proliferation modulation,signaling pathway interaction,phosphatase activation
ENSG00000105982,RNF32,e3 ubiquitin ligase activity,genomic stability regulation,dna repair,chromatin remodeling,transcriptional regulation,protein degradation pathway
ENSG00000076554,TPD52,tumor progression,cell cycle regulation,apoptosis inhibition,oncogenic potential,chemoresistance,protein-protein interaction
ENSG00000140905,GCSH,glutathione synthesis,antioxidant defense,cellular metabolism regulation,oxidative stress response,genetic stability maintenance,amino acid biosynthesis
ENSG00000186185,KIF18B,chromosomal instability,aneuploidy,chromosome segregation,microtubule regulation,genomic instability,mitotic catastrophe
ENSG00000008952,SEC62,er membrane biogenesis,translocon complex,protein biogenesis,cellular homeostasis,co-translational transport,aberrant protein expression
ENSG00000071575,TRIB2,pi3k/akt/mtor activation,pseudokinase function,oncogenesis promotion,cell proliferation regulation,metastasis facilitation,apoptosis inhibition
ENSG00000145020,AMT,methyltransferase activity,cell proliferation,dna methylation,metabolic reprogramming,protein modification,tumor progression
ENSG00000112972,HMGCS1,ketogenesis regulation,gene amplification,metabolic reprogramming,cell proliferation enhancement,transcriptional regulation,energy metabolism modulation
ENSG00000105556,MIER2,microtubule dynamics,mitotic checkpoint control,tumor progression,therapeutic target,genomic instability,chromosomal stability
ENSG00000222028,PSMB11,proteasome regulation,cell cycle progression,apoptosis induction,tumor growth inhibition,therapeutic target,protein quality control
ENSG00000091651,ORC6,genomic instability,origin recognition complex,cell proliferation,dna replication initiation,therapeutic target,oncogenic pathway interaction
ENSG00000162688,AGL,gluconeogenesis,glycogenolysis regulation,metabolic disorder,cellular energy regulation,protein function mutation,cancer-related metabolism
ENSG00000163281,GNPDA2,glucosamine-6-phosphate pathway,oxidative stress,genomic instability,epigenetic alterations,nad+ metabolism,cellular energy homeostasis
ENSG00000105122,RASAL3,mapk pathway,constitutive activation,gain of function mutations,tumor suppressor function,gtpase-activating protein (gap),ras/mapk signaling regulation
ENSG00000171777,RASGRP4,cell migration,tumor progression,rap1 activation,cytoplasmic localization,gef activity,oncogenic signaling
ENSG00000042088,TDP1,rna-binding protein,alternative splicing regulation,tumor microenvironment modulation,apoptosis resistance,cell proliferation enhancement,oncogenic pathway involvement
ENSG00000172548,NIPAL4,pi3k/akt/mtor pathway regulation,protein dephosphorylation,genomic instability,cellular growth regulation,apoptosis modulation,tumor progression promotion
ENSG00000104133,SPG11,mitochondrial complex i dysfunction,oxidative stress induction,dna damage response alteration,genomic instability promotion,tumor suppressor function loss,metabolic reprogramming
ENSG00000170775,GPR37,gpcr signaling pathway,overexpression,tumor progression,metastasis,cell proliferation,therapeutic target
ENSG00000105373,NOP53,ribosome biogenesis,tumor suppressor function,dna damage response,apoptosis regulation,cell cycle progression,genomic instability
ENSG00000120334,CENPL,chromosomal instability,cell division regulation,constitutive centromere-associated network,centromere formation,kinetochore attachment,microtubule interaction
ENSG00000206418,RAB12,tumor progression,autophagy regulation,gtpase activity,cancer transformation,metabolic reprogramming,cell growth modulation
ENSG00000131375,CAPN7,calpain activity,cell migration,invasion regulation,cancer metastasis,tumor progression,therapeutic target
ENSG00000139351,SYCP3,synaptonemal complex component,aneuploidy driver,chromosomal instability promoter,kinetochore assembly mediator,meiotic recombination regulator,centromere localization protein
ENSG00000165730,STOX1,tumor suppressor,cellular growth regulation,angiogenesis promotion,transcription factor interaction,wnt/β-catenin pathway modulation,poor prognosis marker
ENSG00000085377,PREP,tumor progression,mitotic regulation,cell proliferation,soluble guanylate cyclase activation,peptide receptor interactions,oncogenic signaling pathways
ENSG00000129351,ILF3,transcriptional regulation,oncogene activation,innate immune suppression,cell cycle progression,apoptosis inhibition,viral rna recognition
ENSG00000273993,PTPRK,receptor-type tyrosine phosphatase,wnt/β-catenin pathway inhibition,pro-apoptotic gene suppression,tumor progression,adhesion molecule regulation,cell signaling modulation
ENSG00000187045,TMPRSS6,iron metabolism regulation,tumor growth promotion,metastasis enhancement,cell proliferation,apoptosis inhibition,therapeutic target
ENSG00000130208,APOC1,lipid metabolism deregulation,igf-1 signaling pathway interaction,cell growth promotion,insulin-like growth factor 1 regulation,tumor progression facilitation,apolipoprotein complex formation
ENSG00000179580,RNF151,tumor suppressor,genome stability maintenance,ubiquitination,proteasomal degradation,cell cycle regulation,dna repair
ENSG00000135541,AHI1,ciliogenesis disruption,cellular proliferation,tumor suppressor function,mitotic regulation,genomic instability,cell cycle progression
ENSG00000204920,ZNF155,tumor suppressor function,cell cycle regulation,dna repair mechanisms,chromatin remodeling,transcriptional regulation,apoptosis induction
ENSG00000177058,SLC38A9,overexpression,oncogenic driver,biomarker potential,metabolic reprogramming,cellular growth regulation,mtorc1 interaction
ENSG00000103647,CORO2B,actin cytoskeleton modulation,cell migration enhancement,tumor invasiveness promotion,cancer cell metastasis facilitation,biomarker potential,signaling pathway regulation
ENSG00000161860,SYCE2,meiotic recombination,genomic instability,dna repair deficiency,oncogenesis driver,synaptonemal complex assembly,aneuploidy inducer
ENSG00000101745,ANKRD12,chromatin remodeling,transcriptional regulation,oncogenic overexpression,cell cycle progression,genomic instability,protein-protein interactions
ENSG00000118181,RPS25,ribosome biogenesis,protein synthesis regulation,tumor progression,aneuploidy,genomic instability,translation initiation
ENSG00000136943,CTSV,oncogenic potential,tumor progression,proteolytic activity,cell proliferation,immune evasion,therapeutic target
ENSG00000131015,ULBP2,immune activation,antigen presentation,tumor suppression,immune evasion,cell signaling pathways,nf-κb pathway
ENSG00000178381,ZFAND2A,oncogenic potential,transcriptional regulation,chromatin remodeling complex,cell proliferation enhancer,tumor aggressiveness predictor,genome instability promoter
ENSG00000196569,LAMA2,epithelial integrity disruption,cell adhesion modulation,basal lamina component,extracellular matrix interaction,tumor suppressor or oncogene,therapeutic target
ENSG00000276856,TUBGCP5,aneuploidy,cell division,genomic instability,microtubule dynamics,mitotic spindle assembly,pi3k/akt signaling
ENSG00000114735,HEMK1,immune evasion,modulation of tumor microenvironment,cellular stress response,protein translation inhibition,rnase l activation,2-5a synthesis
ENSG00000126467,TSKS,serine/threonine kinase activation,oncogenic transformation,cell cycle progression,apoptosis inhibition,pi3k/akt signaling interaction,mapk/erk pathway modulation
ENSG00000171700,RGS19,g-protein regulation,signaling pathway modulation,tumor suppressor function,cell proliferation inhibition,apoptosis promotion,oncomodulatory interaction
ENSG00000170385,SLC30A1,regulation of zinc homeostasis,cellular signaling,insulin secretion,diabetes susceptibility,genetic association study,tissue-specific expression
ENSG00000156313,RPGR,tumor suppressor function,apoptosis regulation,dna repair mechanism,cell cycle control,photoreceptor maintenance,pi3k/akt pathway modulation
ENSG00000099617,EFNA2,ephrin a2 ligand function,vegf pathway modulation,constitutive activation,cell migration,angiogenesis promotion,oncogenic activity enhancement
,HRASLS,tumor progression,metastasis,cell adhesion disruption,extracellular matrix remodeling,oncogene activation,tgf-β pathway regulation
ENSG00000125812,GZF1,tumor suppressor,wnt signaling pathway,cell proliferation inhibition,protein-protein interaction,gene regulation,beta-catenin/tcf complex interaction
ENSG00000106261,ZKSCAN1,tumor suppressor function,chromatin remodeling,genome instability,cellular stress response,gene expression modulation,protein-protein interaction
ENSG00000084092,NOA1,cellular metabolism regulation,tumor progression promotion,protein synthesis modulation,ribosome biogenesis involvement,oncogene potential,genomic amplification association
ENSG00000140365,COMMD4,wnt/β-catenin pathway,cellular regulation,ubiquitination,apoptosis modulation,tumor suppressor protein regulation,genomic instability
ENSG00000167850,CD300C,immune recognition,receptor-ligand interaction,immunosuppression,tumor suppression,cell signaling,gene expression
ENSG00000105186,ANKRD27,pi3k/akt pathway modulation,tumor suppressor function,cell cycle regulation,oncogenic transformation inhibition,genomic stability maintenance,chromosomal abnormality prevention
ENSG00000172350,ABCG4,abc transporter,cellular efflux,detoxification,lipid metabolism,molecular transport,transmembrane protein
ENSG00000198398,TMEM207,metabolic regulation,mitochondrial dynamics,cellular proliferation,apoptosis resistance,oncogene activation,cancer driver gene candidate
ENSG00000105607,GCDH,energy metabolism regulation,tumor suppressor function,cellular homeostasis maintenance,mutational impact on tumorigenesis,stress response modulation,glutaryl-coa breakdown
ENSG00000181552,EDDM3B,altered rna processing,exosome complex component,cellular proliferation,tumor progression,protein structure changes,gene expression regulation
ENSG00000113083,LOX,extracellular matrix remodeling,oncogenic function,angiogenesis promotion,metastasis facilitation,tumor progression,cell migration enhancement
ENSG00000102003,SYP,neurotransmitter regulation,synaptic vesicle maintenance,cell proliferation,tumor progression,metastasis promotion,stress response regulation
ENSG00000163430,FSTL1,tumor suppressor,pi3k/akt/mtor pathway regulation,cellular proliferation modulation,oncogenesis promotion,gene expression alteration,therapeutic target
ENSG00000100429,HDAC10,chromatin regulation,transcriptional repression,cellular proliferation,subcellular localization changes,tumor progression,genetic instability
ENSG00000136231,IGF2BP3,apoptosis evasion,cell proliferation,genomic instability,metabolic reprogramming,pi3k/akt/mtor pathway activation,tumor progression
ENSG00000278759,TBCD,microtubule dynamics regulation,cell migration disruption,cytokinesis impairment,cell polarity maintenance,protein-protein interaction,oncogenic potential
ENSG00000085365,SCAMP1,vesicular transport regulation,cell migration enhancement,oncogene role,apoptosis modulation,cellular metabolism regulation,biomarker potential
ENSG00000189129,PLAC9,transcriptional coactivator,cell proliferation,angiogenesis regulation,oncogenic driver,metabolic regulation,prognostic marker
ENSG00000165525,NEMF,microtubule stabilization,genomic instability,aneuploidy,cell cycle regulation,mitotic progression,tumor suppressor potential
ENSG00000131508,UBE2D2,protein degradation regulation,scf complex component,cell cycle regulation,oncogenic protein accumulation,tumor progression driver,ubiquitination pathway modulation
ENSG00000004660,CAMKK1,ampk activation,constitutive activation,metabolic reprogramming,cell survival,tumor progression,therapeutic target
ENSG00000052850,ALX4,developmental regulation,tissue patterning,transcription factor function,embryonic development,gene dysregulation,cellular differentiation
ENSG00000101413,RPRD1B,transcription regulation,rnapii complex component,oncogene activation,tumor suppressor gene repression,gene expression dysregulation,cancer driver mutation
ENSG00000288185,IL27RA,immunomodulation,cytokine signaling,oncogenic suppression,tumor evasion,cell proliferation,inflammation regulation
ENSG00000169550,MUC15,cell adhesion disruption,pi3k/akt pathway dysregulation,cell proliferation enhancement,tumor invasion facilitation,biomarker potential,wnt/β-catenin signaling modulation
ENSG00000188822,CNR2,anti-tumor effects,tumor progression,pi3k/akt pathway,cell proliferation,signaling pathway regulation,cannabinoid receptor activation
ENSG00000133316,WDR74,cellular process regulation,wd40 repeat protein function,mitosis regulation,genomic instability contribution,microtubule dynamics modulation,spindle assembly regulation
ENSG00000152952,PLOD2,collagen cross-linking,extracellular matrix remodeling,cell migration enhancement,glycosaminoglycan production increase,tumor progression facilitation,metastasis promotion
ENSG00000013016,EHD3,endocytic trafficking,membrane dynamics,oncogenic potential,tumor progression,cell proliferation,metastasis
ENSG00000174059,CD34,cell adhesion molecule,progenitor cell mobilization,hematopoietic stem cell homing,angiogenesis facilitation,tumor-initiating cell marker,signaling pathway modulation
ENSG00000125871,MGME1,cell proliferation,dna damage response,telomere maintenance,genomic instability,potential therapeutic target,oncogenic driver
ENSG00000119866,BCL11A,cell growth regulation,transcription factor activity,oncogenic pathway activation,cell cycle progression modulation,apoptosis suppression,epigenetic regulator interaction
ENSG00000120669,SOHLH2,pi3k/akt pathway,constitutive activation,tumor suppressor function,cell proliferation regulation,cellular response modulation,oncogenic process prevention
ENSG00000189377,CXCL17,tumor progression,tumor microenvironment modulation,immune suppressive cell recruitment,angiogenesis promotion,growth factor regulation,metastasis facilitation
ENSG00000123219,CENPK,kinetochore assembly,genomic instability,centromere function,oncogenic cell growth,mitotic checkpoint regulation,chromosome segregation
ENSG00000109063,MYH3,myosin heavy chain function,altered expression patterns,skeletal muscle involvement,cell proliferation regulation,genetic mutations associated,oncogenic potential implicated
ENSG00000143147,GPR161,camp signaling pathway,constitutive activation,oncogenic driver,tumor growth,therapeutic target,overexpression
ENSG00000225141,PRRT1,proteolytic activation,cancer cell proliferation,cell signaling pathway,transcriptional regulation,oncogenic protein interaction,cancer cell survival
ENSG00000213927,CCL27,immune response regulation,t-cell recruitment,epithelial cell expression,chemokine signaling,cell migration promotion,immune surveillance facilitation
ENSG00000105171,POP4,rna methylation,microrna processing,apoptosis regulation,cell proliferation,tumorigenesis modulation,dna repair pathway
ENSG00000104356,POP1,chromatin regulation,transcriptional control,oncogenic potential,tumor suppression,rna processing,gene expression
ENSG00000100379,KCTD17,tp53 interaction,tumor suppressor function,cell cycle regulation,apoptosis induction,dna repair mechanisms,genome stability maintenance
ENSG00000180785,OR51E1,olfactory receptor function,genomic expression,cancer tissue presence,cellular signaling,molecular detection,tissue specificity
ENSG00000124787,RPP40,aberrant rrna processing,genomic instability,loss of function mutations,rna processing regulation,tumor suppressor function,cellular proliferation
ENSG00000138386,NAB1,cellular regulation,transcriptional repression,dna binding,protein-protein interactions,tumor suppression,epigenetic regulation
ENSG00000085274,MYNN,cell cycle regulation,cdk inhibition,oncogene suppression,tumor growth inhibition,cell proliferation control,genomic instability
ENSG00000281178,MLXIP,mlx-max complex formation,adaptor molecule function,tumorigenic potential,cell proliferation regulation,transcriptional regulation disruption,growth factor signaling
,TMEM206,apoptosis regulation,cellular homeostasis maintenance,plasma membrane localization,oncogene or tumor suppressor potential,molecular transport regulation,cell signaling modulation
ENSG00000108405,P2RX1,atp-gated cation channels,cell surface receptor,calcium influx signaling,tumor growth promotion,angiogenesis regulation,immune microenvironment modulation
ENSG00000145506,NKD2,nfat inhibition,cancer suppressor gene,cell proliferation regulation,apoptosis regulation,epithelial-to-mesenchymal transition (emt),cell migration control
ENSG00000161594,KLHL10,tumor suppressor function,cell cycle regulation,ubiquitin-proteasome pathway,apoptosis induction,dna damage response,protein degradation
ENSG00000181333,HEPHL1,tumor suppressor dysfunction,aberrant protein expression,oncogenic driver,cell cycle regulation,apoptosis modulation,therapeutic target
ENSG00000089486,CDIP1,cellular regulation,genome stability maintenance,tumor suppressor inhibition,ubiquitination pathway regulation,transcriptional modulation,cell cycle control
ENSG00000176915,ANKLE2,gene regulation,epigenetic modification,chromatin remodeling,oncogene activation,cell proliferation,dna repair interaction
ENSG00000167700,MFSD3,er stress response,oncogenesis,endoplasmic reticulum homeostasis,transmembrane protein function,lipid metabolism regulation,cellular damage prevention
ENSG00000240184,PCDHGC3,overexpression,cell adhesion disruption,tumor progression enhancement,metastasis facilitation,biomarker potential,prognostic significance
ENSG00000131236,CAP1,camp-dependent signaling pathway,akap-12 function,mutation implication,oncogenic process modulation,cancer cell proliferation,catalytic subunit interaction
ENSG00000139055,ERP27,protein regulation,unfolded protein response (upr),chaperone activity,cellular adaptation,endoplasmic reticulum homeostasis,mitochondrial interaction
ENSG00000100196,KDELR3,er stress,cell viability,tumor suppressor,unfolded protein response,golgi apparatus retrieval,kdel motif interaction
ENSG00000102221,JADE3,protein degradation regulation,deubiquitinating activity,oncogenic protein stabilization,cell proliferation enhancement,apoptosis inhibition,therapeutic resistance promotion
ENSG00000120053,GOT1,gluconeogenesis pathway,metabolic reprogramming,oxidative stress regulation,cell proliferation enhancement,tumor progression marker,biomarker for cancer diagnosis
ENSG00000132740,IGHMBP2,chromatin remodeling,transcriptional regulation,cell growth regulation,dna repair interaction,tumor progression promoter,cell survival modulation
ENSG00000146909,NOM1,cell growth regulation,ribosome biogenesis,nucleolar localization,cellular proliferation,tumorigenesis driver,protein-protein interactions
ENSG00000186439,TRDN,calcium homeostasis disruption,gene mutation,immune evasion,tumor progression,cell proliferation,metastasis promotion
ENSG00000239951,IGKV3-20,b-cell development,dysregulated expression,immunoglobulin kappa gene,oncogenic potential,tumor growth and metastasis,immune modulation
ENSG00000108823,SGCA,muscle membrane instability,calcium ion influx,cell death induction,limb-girdle muscular dystrophy,membrane protein regulation,sarcolemma composition
ENSG00000047410,TPR,cellular homeostasis disruption,oncogenic signaling pathway,protein-protein interactions regulation,tumor suppressor dysregulation,therapeutic target,genomic instability
ENSG00000140798,ABCC12,ion regulation,tumor suppression,metal ion transport,atp-dependent translocation,cancer prognosis,therapeutic target
ENSG00000173575,CHD2,aberrant gene expression,chromatin remodeling,dna repair,genomic instability,oncogenic transformation,tumor suppression
ENSG00000149932,TMEM219,cellular processes regulation,oncogenic process promotion,cell survival enhancement,pi3k/akt/mtor pathway modulation,cancer cell proliferation,transmembrane protein function
ENSG00000100300,TSPO,cholesterol transport,cellular metabolism,cancer stem cell maintenance,tumor growth promotion,immune suppression,anti-angiogenic signaling
ENSG00000112200,ZNF451,oncogene/tumor suppressor,cell cycle regulation,transcriptional regulation,nuclear localization,gene expression modulation,chromatin remodeling interaction
ENSG00000117280,RAB29,rabgtpase activity,constitutive activation,cell survival promotion,oncogenic transformation,membrane trafficking regulation,cell migration enhancement
ENSG00000064652,SNX24,endosomal trafficking,cellular growth regulation,tumor progression,metastasis enhancement,oncogenic behavior promotion,poor prognosis association
,HIST1H4G,histone modification,epigenetic regulation,chromatin remodeling,oncogenic transformation,tumor suppressor silencing,gene expression regulation
ENSG00000163467,TSACC,cellular regulation,chromatin modulation,transcriptional regulation,oncogene activation,tumor progression,genomic instability
ENSG00000168497,CAVIN2,caveolae formation,cholesterol transport regulation,cell polarity disruption,tumor progression driver,pi3k/akt signaling pathway interaction,potential tumor suppressor gene
ENSG00000165678,GHITM,cellular proliferation,tumor progression,growth factor regulation,transcriptional modulation,apoptosis inhibition,genomic instability
ENSG00000174500,GCSAM,tumor suppression,cell adhesion regulation,metastasis regulation,cancer progression,glycoprotein expression,cell-cell interaction
ENSG00000100605,ITPK1,ip3 receptor activation,cellular calcium signaling,intracellular signaling pathway,oncogenic processes,tumor growth regulation,genetic mutations
ENSG00000160972,PPP1R16A,pp1 regulation,tumor suppressor function,cell cycle regulation,anti-proliferative effects,metabolic regulation,apoptosis modulation
ENSG00000108559,NUP88,nuclear pore complex regulation,gene expression regulation,cancer driver gene,chromatin binding protein,tumor suppressor gene interactions,tumor progression
ENSG00000176658,MYO1D,cell migration,oncogenic driver,pi3k/akt pathway interaction,cell proliferation,metabolic regulation,tumor progression
ENSG00000183570,PCBP3,tumor suppressor regulation,genomic integrity maintenance,oncogenesis,rna metabolism regulation,cellular growth control,translation regulation
ENSG00000106772,PRUNE2,tumor suppressor,cellular regulation,signaling pathway modulation,oncogenic inhibition,chromatin remodeling,histone modification
ENSG00000165219,GAPVD1,negative regulation,cell signaling,gtpase activation,armadillo repeat-containing protein,proliferation inhibition,somatic mutation frequency
ENSG00000177728,TMEM94,cellular transport,transmembrane protein,vesicle trafficking,membrane remodeling,oncogenic mutations,tumorigenesis
ENSG00000106399,RPA3,replication protein a complex,cell cycle regulation,dna damage response,tumor suppressor function,genomic instability,chromatin remodeling
ENSG00000114904,NEK4,cell cycle regulation,serine/threonine kinase activity,mitotic entry promotion,dna damage response modulation,genomic instability contribution,oncogenic process facilitation
ENSG00000166828,SCNN1G,enac regulation,sodium reabsorption,cell migration,oncogenic process,tumor progression,microenvironment modulation
ENSG00000276461,TCF20,tcf20 transcription factor,cellular proliferation,dna damage response,chromatin remodeling,apoptosis regulation,genomic instability 
ENSG00000152503,TRIM36,trim36/p53 interaction,apoptosis regulation,cell cycle modulation,e3 ubiquitin ligase activity,tumor suppressor protein regulation,cancer-related expression alterations
ENSG00000117411,B4GALT2,altered glycoprotein synthesis,biosynthesis of glycosaminoglycans,glycosylation pathway regulation,tumor microenvironment modulation,cell-cell interaction alteration,post-translational modification
ENSG00000170122,FOXD4,transcriptional regulator,neural crest development,oncogenic potential,cell cycle regulation,apoptosis modulation,genomic instability
ENSG00000197893,NRAP,cell migration,actin cytoskeleton regulation,tumor progression,metastasis promotion,therapeutic target,genomic profiling
ENSG00000284290,ANKS4B,cellular signaling,cancer cell growth,cytoplasmic protein interaction,oncogene function,cell adhesion regulation,prognostic biomarker
ENSG00000214736,TOMM6,mitochondrial translocase,increased cell proliferation,cell survival enhancement,tumor progression facilitation,genomic instability promotion,anti-apoptotic function maintenance
ENSG00000153015,CWC27,splicing regulation,dysregulated expression,rna processing pathway,tumor progression,cell cycle control,genomic instability
ENSG00000196937,FAM3C,oncogene,cell proliferation,pi3k/akt signaling,insulin-like growth factor regulation,glucose metabolism,metabolic reprogramming
ENSG00000068796,KIF2A,microtubule dynamics regulation,chromosomal instability,cell cycle progression,pi3k/akt pathway interaction,tumor aggressiveness promotion,oncogenic potential
ENSG00000012660,ELOVL5,lipid metabolism regulation,cancer cell proliferation,cell survival enhancement,poor prognosis marker,tumor aggressiveness promotion,fatty acid biosynthesis regulation
ENSG00000156234,CXCL13,tumor microenvironment,immune cell recruitment,chemokine signaling,cell migration regulation,tissue architecture modulation,inflammatory response regulation
ENSG00000076344,RGS11,gpcr regulation,g-protein activity modulation,cell proliferation regulation,tumor suppressor/ oncogene,signal transduction termination,protein-protein interaction
ENSG00000130940,CASZ1,oncogenic driver,catalytically inactive pseudoenzyme,dna repair regulation,chromatin remodeling,gene expression modulation,therapeutic target
ENSG00000254521,SIGLEC12,immune modulation,cell adhesion regulation,sialic acid binding,myeloid cell expression,phagocytosis influence,leukocyte migration modulation
ENSG00000174792,ODAPH,cell cycle regulation,chromatin remodeling,gene expression regulation,oncogenic potential,cell growth promotion,transcriptional control
ENSG00000122133,PAEP,progesterone receptor binding,cell proliferation enhancement,tumor progression facilitation,hormone signaling regulation,cell cycle regulation,protein-protein interaction
ENSG00000154027,AK5,energy homeostasis regulation,oncogenic potential,metabolic reprogramming,cellular energy sensing,cell proliferation modulation,apoptosis induction
ENSG00000109814,UGDH,nadph-dependent reactions,cell growth promotion,tumor cell survival,oncogenic processes,genomic instability,metabolic regulation
ENSG00000110693,SOX6,tumor suppressor,oncogene activity,transcriptional regulation,cellular differentiation,stem cell maintenance,epigenetic modification
ENSG00000185960,SHOX,tumor suppressor function,regulation of embryonic development,cell proliferation regulation,transcription factor activity,genomic instability driver,malignant transformation mediator
ENSG00000167302,TEPSIN,pi3k/akt pathway interaction,protease activity,tumor progression,metastasis driver,cell survival regulation,apoptosis inhibition
ENSG00000132600,PRMT7,histone modification,cellular signaling pathways,arginine methylation,dna repair mechanisms,transcriptional regulation,cell cycle control
ENSG00000108219,TSPAN14,cell adhesion,oncogene,tumor progression,immune evasion,cell migration,signaling regulation
ENSG00000233573,TRIM31,tumor suppressor function,pi3k/akt signaling regulation,ubiquitin ligase activity,ring finger domain presence,cell proliferation inhibition,anti-oncogenic role
ENSG00000196684,HSH2D,histamine regulation,t-cell activation,proliferation suppression,immune modulation,tumor suppressor role,cancer immunotherapy
ENSG00000185761,ADAMTSL5,oncogene,apoptosis suppression,ecm modification,cell survival promotion,tumor aggressiveness enhancer,protein-protein interaction mediator
ENSG00000166147,FBN1,tumor suppressor function,disrupted tgf-β signaling,extracellular matrix regulation,cell growth regulation,marfan syndrome association,elastic fiber formation
ENSG00000118508,RAB32,autophagy,oncogenic transformation,tumor cell survival,lysosomal trafficking,protein secretion regulation,gtpase activity
ENSG00000020129,NCDN,ubiquitin-proteasome pathway regulation,tumor suppressor function,cell cycle progression control,dna repair regulation,growth factor signaling modulation,protein degradation enhancement
ENSG00000114491,UMPS,pyrimidine biosynthesis,tumor growth,biomarker potential,nucleotide regulation,cell proliferation,stress response modulation
ENSG00000092439,TRPM7,calcium channel regulation,mitochondrial function modulation,oncogenic driver,cell proliferation enhancement,magnesium-dependent activity,channel-kinase interaction
ENSG00000163283,ALPP,tumor-associated protein,cellular differentiation,oncogenic processes,protein interaction,therapeutic target,cell proliferation
ENSG00000186174,BCL9L,wnt/β-catenin pathway,oncogenic mutations,chromosomal instability,cell proliferation,transcriptional regulation,coactivator function
ENSG00000160469,BRSK1,regulation of cell cycle,pi3k/akt signaling pathway interaction,tumor suppressor function,cellular response modulation,loss-of-function mutations,gain-of-function mutations
ENSG00000110243,APOA5,lipid metabolism regulation,tumor suppressor function,cell growth inhibition,pi3k/akt pathway modulation,hdl levels suppression,prognostic biomarker
ENSG00000074276,CDHR2,cell adhesion disruption,epithelial cell function,tumor progression,genomic alterations,oncogenic property,regulatory mechanism
ENSG00000177613,CSTF2T,mrna processing,pre-mrna splicing,3' cleavage site selection,gene regulation,cellular homeostasis,tumorigenesis
ENSG00000185420,SMYD3,oncogene activation,epigenetic regulator,tumor progression,therapeutic resistance,protein kinase activation,histone modification
ENSG00000163518,FCRL4,immune regulation,pi3k/akt pathway modulation,oncogenic driver,tumor progression promoter,metastatic potential enhancer,cell survival regulator
ENSG00000163734,CXCL3,chemokine signaling,tumor angiogenesis,tumor cell proliferation,metastasis,immune evasion,pro-tumorigenic inflammation
ENSG00000116209,TMEM59,tight junction regulation,cell signaling modulation,overexpression linked,metastasis promotion,protein function alteration,epithelial barrier disruption
ENSG00000147684,NDUFB9,impaired atp production,decreased expression levels,electron transfer dysfunction,mitochondrial dysfunction,energy metabolism regulation,dna damage accumulation
ENSG00000105388,CEACAM5,adhesion molecule,cell migration inhibitor,immunosuppression mediator,metastasis promoter,pi3k/akt signaling regulator,tumor microenvironment modifier
ENSG00000182566,CLEC4G,tumor progression,therapeutic target,oncogenic function,pi3k/akt pathway interaction,immune system dysfunction,cell adhesion regulation
ENSG00000275618,BFAR,b-cell receptor signaling,oncogenic signaling,cell survival promotion,tumor progression,therapeutic target,genomic profiling
ENSG00000197889,MEIG1,tumor suppressor gene regulation,dna damage response,cell proliferation enhancement,transcription factor activity,gene expression modulation,poor prognosis association
ENSG00000111269,CREBL2,er stress response,transcriptional regulation,oncogene activation,cellular proliferation,therapeutic target,genomic amplification
ENSG00000259431,THTPA,thyroid hormone regulation,tumor progression,overexpression association,gene expression modulation,cell proliferation enhancement,metastasis promotion
ENSG00000178913,TAF7,transcriptional regulation,cell proliferation,genomic instability,tumor suppressor function,chromatin remodeling,histone modification
ENSG00000171960,PPIH,tumor suppressor function,cell cycle regulation,protein folding regulation,dna repair modulation,genomic instability driver,cancer cell metabolism influence
ENSG00000170786,SDR16C5,lipid metabolism regulation,epigenetic regulation,cell growth regulation,tumor suppressor/pro-oncogene,cell proliferation regulation,apoptosis regulation
ENSG00000196187,TMEM63A,epithelial cell polarity,cell migration,metastasis,tumor progression,therapeutic target,genomic profiling
ENSG00000167702,KIFC2,kinesin motor protein,cellular cargo transport,microtubule organization,spindle assembly regulation,centrosome-associated protein,therapeutic target
ENSG00000091140,DLD,bh4 regulation,metabolic pathway regulation,oxidative stress response,tetrahydrobiopterin biosynthesis,enzyme cofactor regulation,dna damage repair
ENSG00000131187,F12,coagulation activation,angiogenesis promotion,tumor progression association,growth factor regulation,blood vessel formation facilitation,cellular response modulation
ENSG00000167118,URM1,mtor pathway regulation,constitutive activation,ubiquitin-like modification,protein homeostasis regulation,tumor growth promotion,therapeutic target
ENSG00000142544,CTU1,cancer driver mutation,cell cycle regulation,constitutive activation,cell proliferation,tumor suppressor degradation,oncogenic process
ENSG00000137440,FGFBP1,fgf signaling pathway,oncogenic function,protein-protein interaction,cell migration and invasion,tumor progression,transcriptional regulation
ENSG00000012171,SEMA3B,tumor suppression,angiogenesis inhibition,genomic loss or mutation,cell growth regulation,cancer progression modulation,therapeutic target
ENSG00000138621,PPCDC,oncogenic processes,cell survival,proteasome regulation,cell cycle progression,apoptosis resistance,dna repair mechanism
ENSG00000186007,LEMD1,chromatin remodeling,genomic stability,nuclear membrane protein,tumor suppressor function,transcription factor regulation,chromosomal instability
ENSG00000170162,VGLL2,transcriptional regulation,cell cycle progression,apoptosis regulation,epithelial-to-mesenchymal transition (emt),signaling pathway modulation,genetic expression
ENSG00000165030,NFIL3,transcription factor,cell proliferation regulation,oncogenesis regulation,gene expression modulation,cancer-related gene regulation,cell growth and survival
ENSG00000104872,PIH1D1,gene silencing,chromatin remodeling,histone modification,epigenetic regulation,tumor suppression,therapeutic target
ENSG00000161920,MED11,mediator complex regulation,transcriptional activity disruption,oncogene activation,cell cycle dysregulation,tumor growth promotion,apoptosis inhibition
ENSG00000173166,RAPH1,rap1 signaling pathway,ablation of cell adhesion,tumor progression,mitogen-activated protein kinase signaling,protein-protein interaction,cell proliferation enhancement
ENSG00000089063,TMEM230,cellular integrity regulation,tumor suppressor function,signaling pathway modulation,cell growth regulation,genomic instability association,oncogenic pathway activation
ENSG00000135312,HTR1B,serotonin signaling pathway,cell proliferation regulation,oncogenic process modulation,g-protein coupled receptor function,cancer progression promotion,tumor development involvement
ENSG00000006747,SCIN,oncogenic signaling,cell cycle regulation,cyclin-dependent kinases,wnt/β-catenin pathway,ubiquitination and degradation,tumor progression
ENSG00000256269,HMBS,oncogenic process,altered heme production,chromosomal instability,dna damage,genomic instability,oxidative stress
ENSG00000196693,ZNF33B,cell cycle progression,aberrant gene expression,epigenetic regulation,apoptosis inhibition,transcriptional activation,tumorigenesis
ENSG00000109101,FOXN1,aberrant expression,oncogenesis,cellular differentiation,apoptosis regulation,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway activation
ENSG00000119969,HELLS,protein ubiquitination,dysregulated expression,tumor progression,cancer cell survival,cell cycle regulation,genomic instability
ENSG00000102172,SMS,tgf-beta pathway disruption,loss-of-function mutations,regulatory protein interactions,cell growth regulation,genomic instability,dna repair mechanism
ENSG00000170631,ZNF16,transcriptional regulation,dna binding,krab domain-containing protein,zinc finger protein,gene expression regulation,cell cycle regulation
ENSG00000197961,ZNF121,transcriptional regulation,cell cycle progression,apoptosis modulation,oncogenic driver,gene overexpression,tumor progression
ENSG00000136870,ZNF189,oncogenic function,tumor progression regulation,transcriptional regulation,cancer-related overexpression,cell proliferation enhancement,apoptosis inhibition
ENSG00000158874,APOA2,lipid metabolism regulation,oncogenic processes modulation,tumor microenvironment influence,cellular proliferation facilitation,protein-lipid interactions,biomarker potential
ENSG00000115216,NRBP1,nuclear export regulation,pi3k/akt signaling,oncogene activity,cell proliferation regulation,gene expression modulation,protein-protein interactions
ENSG00000183023,SLC8A1,calcium homeostasis regulation,cellular metabolism modulation,growth factor signaling pathway,metastatic potential enhancement,proliferation promotion,survival pathway activation
ENSG00000130338,TULP4,cell migration regulation,gtpase regulator,cytoskeleton organization,rho gtpase activation,oncogenic mutations,pancreatic cancer association
ENSG00000170370,EMX2,transcriptional regulation,chromatin remodeling,stem cell maintenance,cell proliferation,epigenetic regulation,tumor microenvironment modulation
ENSG00000196914,ARHGEF12,cell migration,rho gtpase activation,tumor progression,therapeutic target,oncogenic function,signaling pathway interaction
ENSG00000212122,TSSK1B,cellular proliferation,signaling pathway regulation,genomic instability,protein kinase activation,apoptosis regulation,tumor growth and survival
ENSG00000157191,NECAP2,endocytic regulation,actin cytoskeleton dynamics,adaptor protein function,cell migration facilitation,oncogenic mutations,signal transduction modulation
ENSG00000169189,NSMCE1,genomic instability,dna repair disruption,cellular proliferation,histone modification defects,tumor development facilitation,nat complex dysfunction
ENSG00000138600,SPPL2A,notch signaling pathway,cell proliferation regulation,proteolytic processing,tumor progression,therapeutic target,biomarker candidate
ENSG00000197385,ZNF860,dna binding,zinc finger protein function,transcriptional regulation,cell proliferation regulation,apoptosis modulation,chromatin remodeling interaction
ENSG00000132541,RIDA,mitochondrial dna maintenance,metalloprotease activity,protein quality control system,cellular energy production,tumorigenesis driver,cancer progression marker
ENSG00000230124,ACBD6,fatty acid metabolism,acyl-coa binding,lipid homeostasis regulation,tumorigenesis involvement,cellular energy modulation,dysregulation in cancer
ENSG00000077152,UBE2T,ubiquitin transfer,dna repair mechanism,protein degradation pathway,cancer initiation factor,cell cycle regulator,genomic stability maintainer
ENSG00000187151,ANGPTL5,lipid biosynthesis,angiogenesis,tumor suppressor,cell proliferation,fatty acid metabolism,lipoprotein lipase inhibition
ENSG00000161681,SHANK1,synaptic scaffolding,psd complex regulation,neurodevelopmental disorder,cell proliferation promotion,therapeutic target,protein-protein interaction
ENSG00000110244,APOA4,apoptosis modulation,cholesterol efflux,genomic variation,hdl metabolism,lipid transport regulation,protein-protein interaction
ENSG00000175482,POLD4,genomic instability,dna replication error,tumor suppressor function,brca1/brca2 interaction,mutator phenotype induction,epigenetic regulation
ENSG00000155096,AZIN1,polyamine metabolism,cell cycle progression,biomarker potential,therapeutic target,transcriptional regulation,growth regulation
ENSG00000144366,GULP1,tumor microenvironment regulation,cell adhesion facilitation,oncogene upregulation,protein-protein interactions,metastasis promotion,cancer cell migration enhancement
ENSG00000165476,REEP3,cell growth regulation,mitotic spindle assembly,genomic stability maintenance,endoplasmic reticulum stress response,unfolded protein response modulation,cancer biomarker
ENSG00000104859,CLASRP,tumor progression,cell migration,actin cytoskeleton regulation,cancer metastasis,adhesion modulation,protein-protein interaction
ENSG00000181610,MRPS23,mitochondrial function,mitochondrial translation,energy production,tumorigenesis,glycolysis,metabolic reprogramming
ENSG00000198824,CHAMP1,kinetochore formation,cell cycle regulation,mitotic progression,genomic stability,apoptosis modulation,cancer aggressiveness
ENSG00000106484,MEST,mesenchymal cell regulation,transcription factor activity,oncogenic processes,tumorigenesis,cell proliferation,epigenetic regulation
ENSG00000154813,DPH3,serine/threonine kinase activity,cell cycle regulation,mitotic checkpoint control,dna repair pathway,oncogenic activation,genomic instability
ENSG00000166340,TPP1,protein degradation,cell cycle progression,anti-apoptotic function,tumor progression,cancer stem cell maintenance,target for therapeutic interventions
ENSG00000129566,TEP1,telomerase activation,tumor progression,cell proliferation,genomic instability,therapeutic target,epigenetic regulation
ENSG00000143748,NVL,genomic instability,cancer progression,tumor suppressor function,loss of heterozygosity,cellular differentiation,oncogenic signaling
ENSG00000113649,TCERG1,alternative splicing regulation,chromatin remodeling,cellular proliferation,rna degradation pathway,tumor progression,metastasis enhancement
ENSG00000144852,NR1I2,ahr activation,constitutive activation,dna repair regulation,ligand-activated transcription factor,metabolic reprogramming,pi3k/akt pathway interaction
ENSG00000110719,TCIRG1,immune evasion mechanisms,calcium homeostasis regulation,apoptosis regulation,cell cycle progression,autophagy modulation,lysosomal function
ENSG00000170791,CHCHD7,mitochondrial homeostasis,cellular energy metabolism,oncogenic processes,tumor suppressor function,mitochondrial dysfunction,genomic instability
ENSG00000108797,CNTNAP1,neuronal development,cell-cell interaction,immune regulation,tumor progression,oncogene,genomic instability
,SEPT3,cellular morphology,septin assembly,cell cycle regulation,actin cytoskeleton dynamics,oncogenic transformation,signaling pathway modulation
ENSG00000074527,NTN4,notch signaling pathway,notch1 regulation,tumor suppressor function,cell proliferation regulation,metastasis inhibition,protein-protein interaction
ENSG00000166922,SCG5,chitin degradation,cell growth regulation,tumor progression promotion,extracellular matrix interaction,microenvironment modulation,cancer cell migration enhancement
ENSG00000110435,PDHX,altered glucose metabolism,apoptosis dysregulation,cellular respiration impairment,energy production regulation,glycolytic shift enhancement,mitochondrial dysfunction
ENSG00000126218,F10,angiogenesis,cell migration,coagulation cascade,prothrombin activation,platelet aggregation,tumor progression
ENSG00000113456,RAD1,genomic instability,tumor progression,dna repair disruption,chromosomal cohesion loss,aneuploidy promotion,co-hesin complex dysfunction
ENSG00000046604,DSG2,cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt),protein-protein interaction,apoptosis regulation,tumor progression,genetic alterations
ENSG00000034677,RNF19A,cellular homeostasis,ubiquitination,tumorigenesis,cell cycle regulation,apoptosis modulation,proteasome regulation
ENSG00000128563,PRKRIP1,pkr inhibition,oncogenic signaling pathways,cell proliferation,apoptosis evasion,protein synthesis regulation,tumor progression
ENSG00000213983,AP1G2,adaptor-related protein complex 1,membrane trafficking,sorting proteins,signal transduction,tumor progression (indirectly implicated),protein localization
ENSG00000116981,NT5C1A,immune suppression,tumor growth promotion,metabolic regulation,cell proliferation enhancement,hypoxia adaptation,cancer stem cell modulation
ENSG00000131778,CHD1L,chromatin remodeling enzyme,epigenetic regulation,genomic instability,dna replication,aberrant expression,pan-cancer involvement
ENSG00000171094,ALK,alk overexpression,constitutive activation,gain of function mutations,therapeutic target,cellular proliferation,signaling pathway interaction
ENSG00000106852,LHX6,loss of function mutations,tumor suppressor role,cellular differentiation regulation,neural development specification,co-regulation with other transcription factors,deregulated cell growth and proliferation
ENSG00000099331,MYO9B,actin filament regulation,gene amplification,cancer cell migration,tumor progression,protein-protein interaction,cellular motility
ENSG00000106665,CLIP2,cellular proliferation,apoptosis inhibition,transcriptional regulation,cell cycle progression,protein-protein interactions,dna damage response
ENSG00000155890,TRIM42,tumor suppressor activity,cell proliferation regulation,apoptosis induction,oncogenic process modulation,proteasome interaction,genomic instability prevention
ENSG00000123989,CHPF,centriole formation,genomic instability,cell cycle disruption,tumor progression,aneuploidy induction,cell division regulation
ENSG00000178394,HTR1A,regulation of cell proliferation,inhibition of metastasis,induction of apoptosis,modulation of mapk/erk pathway,tumor growth inhibition,g protein coupled receptor signaling
ENSG00000144712,CAND2,cell cycle regulation,apoptosis inhibition,tumor suppressor dysfunction,mitotic progression,cancer development,protein-protein interaction
ENSG00000110108,TMEM109,cellular regulation,oncogenic properties,tumor progression,protein-protein interaction,signaling pathway modulation,cell adhesion regulation
ENSG00000111554,MDM1,p53 pathway regulation,gene stabilization,apoptosis induction,tumor suppression,cell cycle arrest,nuclear localization
ENSG00000177084,POLE,dna replication error,genomic instability,increased somatic mutations,tumor heterogeneity,immunogenic phenotypes,therapeutic targets
ENSG00000079112,CDH17,epithelial-to-mesenchymal transition,transcriptional regulator,cell adhesion disruption,wnt/beta-catenin pathway modulation,aggressive tumor behavior,poor prognosis
ENSG00000163510,CWC22,alternative splicing,cell proliferation,spliceosome complex,oncogenesis,rna processing,therapeutic target
ENSG00000173597,SULT1B1,hormone regulation,detoxification,xenobiotic metabolism,cell growth regulation,apoptosis modulation,cancer cell homeostasis
ENSG00000105610,KLF1,oncogene,cell proliferation,transcriptional regulation,tumor progression,apoptosis evasion,metastasis promotion
ENSG00000107807,TLX1,oncogene activity,tumor progression,transcriptional regulation,cell proliferation,apoptosis inhibition,chemotherapy resistance
ENSG00000283009,ZNF436,transcriptional repression,oncogenic role,zinc finger protein,dna binding activity,gene expression regulation,tumor progression
ENSG00000143995,MEIS1,oncogenic collaboration,nuclear localization,transcriptional regulation,cell proliferation,tumor metastasis,aggressive disease phenotypes
ENSG00000146755,TRIM50,tumor suppressor function,ubiquitin-mediated protein degradation,cell cycle regulation,apoptosis modulation,oncoprotein regulation,protein-protein interaction
ENSG00000100417,PMM1,genomic instability,nucleotide pool homeostasis,dna replication repair,transcriptional regulation,cell cycle progression,oncogenesis
ENSG00000174950,CD164L2,cell-cell interaction,tumor progression,metastasis promotion,sialic acid-binding immunoglobulin-like lectin (siglec) family member,cell migration regulation,poor prognosis marker
ENSG00000181444,ZNF467,transcriptional regulation,chromatin modification,oncogene potential,epigenetic regulator,cell cycle disruption,apoptosis suppression
ENSG00000132323,ILKAP,cell adhesion regulation,tumor suppressor function,akt pathway inhibition,cell migration modulation,oncogenic pathway regulation,genomic instability 
ENSG00000175879,HOXD8,oncogene,homeobox transcription factor,cell proliferation,transcriptional regulation,epithelial-to-mesenchymal transition (emt),signaling pathway activation
ENSG00000243003,LY6G6F,cell signaling,tumor growth,metastasis,immune evasion,pi3k/akt pathway,mapk/erk activation
ENSG00000123933,MXD4,cell cycle regulation,tumor suppressor function,transcriptional repression,gene regulatory network,apoptosis regulation,cancer associated mutations
ENSG00000139675,HNRNPA1L2,heterogeneous nuclear ribonucleoprotein splicing,oncogene activation,cell proliferation enhancement,genomic instability,translational regulation,protein-protein interaction
ENSG00000168447,SCNN1B,enac regulation,tumor progression,cellular sodium transport,abrupt expression changes,regulatory protein interactions,genomic instability
ENSG00000174799,CEP135,microtubule stabilization,genomic instability,tumor growth facilitation,metastasis enablement,aneuploid cell formation,centriole duplication
ENSG00000136758,YME1L1,mitochondrial function,regulatory dysfunction,oncogenic mutations,tumor metabolic reprogramming,chemosensitization target,cellular respiration regulation
ENSG00000168118,RAB4A,tumor progression,receptor recycling,oncogenic processes,cell proliferation,energy homeostasis,genomic instability
ENSG00000103994,ZNF106,oncogenic transcription factor,chromatin remodeling,genetic mutations,cellular proliferation,transcriptional regulation,epigenetic regulation
ENSG00000163820,FYCO1,pi3k/akt signaling pathway,constitutive activation,endosomal trafficking regulation,tumor progression,therapeutic target,cancer cell proliferation
ENSG00000119688,ABCD4,cholesterol regulation,transporter function,lipid metabolism,oncogenic potential,p-glycoprotein interaction,tumor progression
ENSG00000174007,CEP19,ciliogenesis regulation,centriole stability,cell cycle progression,microtubule dynamics,chromosomal instability,therapeutic target
ENSG00000051620,HEBP2,genomic instability,dna replication,helicase activity,cell cycle checkpoints,dna repair pathways,genome maintenance
ENSG00000175229,GAL3ST3,glycosaminoglycan modification,angiogenesis promotion,tumor progression driver,metastasis regulation,overexpression in cancer,signal transduction activator
ENSG00000116198,CEP104,aneuploidy,genomic instability,microtubule dynamics regulation,mitotic spindle formation,centrosome cycle disruption,tumor progression
ENSG00000188171,ZNF626,zinc finger protein,transcriptional regulation,tumor suppressor oncogene,apoptosis modulation,chromatin modification,signaling pathway interaction
ENSG00000100380,ST13,tumor suppressor,apoptosis regulation,cell cycle arrest,dna repair mechanism,unfolded protein response,immune modulation
ENSG00000172296,SPTLC3,sphingolipid biosynthesis,oncogene activation,cell proliferation enhancement,metastasis promotion,therapeutic target identification,genomic instability induction
ENSG00000007047,MARK4,microtubule stabilization,cell cycle regulation,tumor suppression,oncogenic transformation,cellular homeostasis disruption,genomic instability
ENSG00000260027,HOXB7,transcriptional regulation,oncogenic driver,cell proliferation enhancement,metastasis promotion,poor prognosis marker,therapeutic target
ENSG00000065485,PDIA5,er-associated protein,cell survival,protein folding modulation,glycoprotein maturation,secretory pathway regulation,oncosuppressor
ENSG00000198464,ZNF480,transcription factor activity,zinc finger protein family member,cellular growth regulator,gene expression modulator,chromatin remodeling complex recruiter,tumor suppressor gene silencer
,VARS,trna charging,protein synthesis regulation,translation fidelity maintenance,cellular homeostasis,oncogenesis promotion,cancer cell survival enhancement
ENSG00000172497,ACOT12,lipid biosynthesis,cell signaling,energy homeostasis,therapeutic target,tumorigenesis,metabolic regulation
ENSG00000156269,NAA11,nata complex,protein acetylation regulation,oncogene modulation,tumor suppressor interaction,cellular proliferation,protein function regulation
ENSG00000152904,GGPS1,glutathione biosynthesis,reactive oxygen species regulation,oxidative stress response,cell survival pathways modulation,antioxidant function,tumor biology interaction
ENSG00000157429,ZNF19,transcription factor activity,nuclear localization,tumor progression,cell growth regulation,dna binding specificity,regulatory element interaction
ENSG00000100911,PSME2,immunoproteasome assembly,ubiquitin-proteasome pathway,protein degradation regulation,cell cycle progression modulation,oncogenic process promotion,tumor aggressiveness enhancement
ENSG00000008838,MED24,aberrant transcriptional regulation,dna damage response,oncogenic potential,transcriptional activation,tumor suppressor interaction,cellular proliferation
ENSG00000175221,MED16,epigenetic regulation,chromatin remodeling,transcriptional coactivator,oncogenic driver,pi3k/akt pathway interaction,amplification/overexpression
ENSG00000106266,SNX8,endosomal sorting,cellular growth regulation,oncogenic mutations,autophagy modulation,pi3k/akt pathway interaction,membrane trafficking regulation
ENSG00000171557,FGG,tumor progression,angiogenesis promotion,cell migration facilitation,metastasis enhancer,blood coagulation regulation,glycoprotein expression
ENSG00000072163,LIMS2,epithelial-to-mesenchymal transition (emt),cell migration,protein interaction,signaling pathway regulation,tumor progression,cytoskeletal dynamics 
ENSG00000137547,MRPL15,mitochondrial localization,ribosomal function regulation,protein synthesis enhancement,cell proliferation promotion,tumor progression support,oncogenic pathway interaction
ENSG00000158571,PFKFB1,enhanced glycolysis,warburg effect,oncogenesis promotion,tumor cell metabolism,glycolytic regulation,post-translational modification
ENSG00000104863,LIN7B,aberrant expression,apoptosis regulation,cell polarity disruption,cancer metastasis,malignant transformation,signaling pathway deregulation
ENSG00000118564,FBXL5,ubiquitin ligase complex,cell cycle regulation,dna damage response,protein degradation,cancer driver mutations,g2/m phase control
ENSG00000143340,FAM163A,mitochondrial localization,oncogenic driver,cell proliferation,tumor progression,cancer-related overexpression,endoplasmic reticulum interaction
ENSG00000104218,CSPP1,gain of function mutations,chromatin remodeling,prognostic biomarker,cell proliferation,oncogenesis,chromosome positioning
ENSG00000087085,ACHE,cellular adhesion,dysregulation of expression,modulator of signaling pathways,chemoresistance,neurotransmitter regulation,proliferation and survival
ENSG00000206561,COLQ,congenital myasthenic syndrome,neuromuscular junction stability,muscle function regulation,collagen-like tail subunit,rapsyn interaction,achr clustering
ENSG00000167815,PRDX2,antioxidant activity,cellular redox balance,genomic instability,oncogenic transformation,protein-protein interaction,tumor progression
ENSG00000083097,DOP1A,melanin biosynthesis,cell growth regulation,signaling pathway interaction,cell survival regulation,melanoma development,tumor progression
ENSG00000183161,FANCF,genomic instability,dna repair dysfunction,tumor progression driver,cell cycle regulation impairment,telomere stability loss,cancer therapeutic target
ENSG00000166260,COX11,electron transport chain disruption,genomic instability promotion,tumor progression facilitation,mitochondrial biogenesis regulation,oncogenic process enhancement,cancer cell growth promotion
ENSG00000126432,PRDX5,oxidative stress regulation,antioxidant function,apoptosis modulation,cell survival enhancement,redox balance maintenance,cancer resistance promotion
ENSG00000123739,PLA2G12A,cancer progression,pro-inflammatory cytokine secretion,oncogene activation,tumor growth promotion,apoptosis inhibition,lipid metabolism dysregulation
ENSG00000130717,UCK1,cell proliferation,pyrimidine metabolism,phosphorylation activity,nucleotide synthesis,kinase activation,therapeutic target
ENSG00000139496,NUP58,nucleocytoplasmic transport regulation,gene expression regulation,tumor suppressor activity,rna binding protein function,nuclear pore complex assembly,cellular process regulation
ENSG00000158417,EIF5B,translation initiation,oncogenic transformation,overexpression,cell cycle progression,protein synthesis regulation,therapeutic target
ENSG00000066933,MYO9A,cell migration,genomic instability,actin cytoskeleton regulation,tumor progression,biomarker candidate,protein-protein interaction
ENSG00000095777,MYO3A,cell adhesion disruption,oncogenic function,unconventional myosin activity,tumor metastasis promotion,pi3k/akt pathway interaction,cancer cell migration facilitation
ENSG00000186867,QRFPR,g protein-coupled receptor,constitutive activation,tumor growth promotion,metastasis enhancement,cell survival promotion,potential therapeutic target
ENSG00000047617,ANO2,epithelial-to-mesenchymal transition (emt),calcium-activated chloride channel,oncogenic pathway activation,cancer stem cell maintenance,biomarker for disease prognosis,invadopodia formation
ENSG00000008853,RHOBTB2,rhob activation,constitutive activation,tumor suppressor,cell cycle progression,genomic instability,epithelial-to-mesenchymal transition (emt)
ENSG00000166263,STXBP4,aberrant expression,constitutive activation,oncogenic driver,pi3k/akt pathway interaction,membrane trafficking regulation,tumor progression
ENSG00000105835,NAMPT,nad biosynthesis,tumor progression,promotes cell growth,potential therapeutic target,cellular metabolism,interacts with sirtuin 1
ENSG00000125648,SLC25A23,mitochondrial carrier function,glucose uptake regulation,oncogenic processes driving,enhanced glycolysis,energy metabolism dysregulation,cellular proliferation promotion
ENSG00000154978,VOPP1,genomic instability,tumor progression,homologous recombination,non-homologous end joining,apoptosis regulation,cell cycle checkpoint control
ENSG00000288485,ELP5,genomic instability,dna unwinding,helicase activity,tumor initiation,replication fork stabilization,oncogene activation
ENSG00000187736,NHEJ1,genomic instability,telomere maintenance,chromosomal fusion,dna repair mechanism,breast cancer associated gene,precise dna ligation
ENSG00000198353,HOXC4,hox gene regulation,tumor progression,cell proliferation,transcriptional regulation,epigenetic modification,cancer stem cell maintenance
ENSG00000161649,CD300LG,immune system regulation,cell activation,signaling pathway modulation,tumor growth inhibition,immune cell interaction,cancer progression modulation
ENSG00000138061,CYP1B1,angiogenesis,drug resistance,cell proliferation,steroid hormone regulation,arachidonic acid metabolism,protein-protein interaction
ENSG00000166181,API5,apoptosis regulation,tumor suppressor function,genomic stability maintenance,cell death induction,pro-apoptotic protein,p53-mediated apoptosis
ENSG00000133639,BTG1,tumor suppressor function,wnt/β-catenin pathway regulation,cell cycle modulation,apoptosis regulation,transcriptional repression,genomic instability suppression
ENSG00000167685,ZNF444,zinc finger protein,dna binding,transcription regulation,cell cycle progression,apoptosis regulation,oncogenic driver
ENSG00000124802,EEF1E1,altered translational regulation,dysregulated cell growth,impaired apoptosis resistance,aberrant protein product formation,oncogenic mechanisms involved,potential driver gene status
ENSG00000011590,ZBTB32,cell cycle regulation,apoptosis modulation,genetic transcription regulation,tumor suppression activity,oncogene function,cell proliferation enhancement
ENSG00000137656,BUD13,cell cycle regulation,microtubule dynamics,centrosome organization,gene expression modulation,apoptosis inhibition,therapeutic target
ENSG00000119541,VPS4B,protein trafficking regulation,escrt machinery,autophagy regulation,aberrant protein accumulation,tumor progression promotion,pi3k/akt pathway interaction
ENSG00000158315,RHBDL2,apoptosis regulation,cancer progression,epithelial-to-mesenchymal transition (emt),cell survival promotion,intramembrane proteolysis,pro-apoptotic protein processing 
ENSG00000144810,COL8A1,cell migration,extracellular matrix modification,integrin interaction,oncogenic process activation,tumor progression facilitation,metastasis promotion
ENSG00000168795,ZBTB5,transcriptional regulation,tumor suppressor function,cellular differentiation,oncogenic processes,genomic instability,dna repair pathways
ENSG00000074621,SLC24A1,cell adhesion disruption,multifunctional protein,oncogenic potential,pi3k/akt pathway interaction,sodium-dependent phosphate transport,tumor progression facilitation
ENSG00000134780,DAGLA,lipid metabolism,tumor progression,cancer cell resistance,cellular signaling pathway,arachidonic acid production,protein interaction
ENSG00000211584,SLC48A1,oncogene,tumor aggressiveness,multidrug resistance,therapeutic target,cellular transport regulation,chemotherapeutic sensitivity
ENSG00000011638,TMEM159,mitochondrial dynamics,fusion and fission regulation,mitofusin interaction,therapeutic target,pan-cancer driver,mitochondrial function
ENSG00000166928,MS4A14,immune cell regulation,t cell modulation,b cell activation,inflammation regulation,cancer immune evasion,pancreatic cancer association
ENSG00000186272,ZNF17,tumor suppressor function,dysregulation,multifunctional protein,transcription regulation,cell cycle modulation,apoptosis regulation
ENSG00000144771,LRTM1,mapk/erk pathway regulation,overexpression,cell proliferation,tumor aggressiveness,prognostic marker,cancer progression
ENSG00000197705,KLHL14,e3 ubiquitin ligase activity,tumor suppressor function,cell cycle regulation,oncogene inhibition,protein degradation,cancer predisposition
ENSG00000174021,GNG5,rhoa signaling,actin cytoskeleton regulation,cell migration promotion,tumor progression facilitation,cell growth regulation,g protein activation
ENSG00000135750,KCNK1,potassium channel activity,gain of function mutations,cell proliferation enhancement,apoptosis evasion,tumor progression facilitation,oncogenic transformation
ENSG00000136731,UGGT1,protein degradation,cellular homeostasis,autophagy induction,tumor suppressor function,potential therapeutic target,genomic instability
ENSG00000073792,IGF2BP2,microrna-binding,tumor suppressor regulation,cell proliferation promotion,oncogene activation,chromatin remodeling,post-transcriptional regulation
ENSG00000106648,GALNTL5,o-glcnac transferase activity,tumor promoter,cell proliferation enhancement,protein modification,metastasis facilitation,cancer driver gene
ENSG00000187595,ZNF385C,zinc finger protein binding,tumor suppressor activity,apoptosis regulation,cancer development,microrna regulation,transcriptional modulation
ENSG00000159592,GPBP1L1,guanine nucleotide exchange factor,pi3k/akt signaling,oncogenic process,tumor progression,cell signaling,gtpase regulation
ENSG00000042753,AP2S1,receptor-mediated endocytosis,ap-2 complex regulation,cell surface receptor internalization,tumor progression marker,vesicle formation modulation,signaling pathway regulator
ENSG00000163950,SLBP,cell cycle regulation,tumor suppressor activity,histone mrna stabilization,chemoresistance,oncogene potential,stem-loop binding protein
ENSG00000042493,CAPG,signaling pathway modulation,oncogenic mutations,tumor progression,cell proliferation regulation,protein kinase activation regulation,cancer aggressiveness
ENSG00000145014,TMEM44,cellular membrane regulation,tumor progression,gain of function mutations,protein-protein interaction,cell surface receptor modulation,membrane dynamics disruption
,HIST1H2BN,genetic instability,chromatin remodeling,epigenetic regulation,transcriptional dysregulation,histone modification,cell cycle control
ENSG00000007923,DNAJC11,oncogenic signaling,protein homeostasis regulation,tumor growth modulation,cellular proliferation regulation,aberrant expression patterns,protein interactome dynamics
ENSG00000110911,SLC11A2,oncogenic processes,overexpression,epithelial-to-mesenchymal transition,metastasis promotion,iron regulation,cellular proliferation
ENSG00000176293,ZNF135,tumor suppression,transcriptional regulation,apoptosis modulation,cancer cell growth,dna sequence binding,zinc finger interaction
ENSG00000136933,RABEPK,er organization,guanine nucleotide exchange factor,oncogenic processes,autophagy regulation,cell survival enhancement,drug resistance mechanism
ENSG00000183580,FBXL7,cell cycle regulation,ubiquitin-proteasome pathway,tumor progression,gain of function mutations,scf complex interaction,protein degradation regulation
ENSG00000172673,THEMIS,genomic instability,epigenetic regulation,transcriptional elongation,chromatin remodeling,dna repair mechanism,prc2 interaction
ENSG00000038210,PI4K2B,oncogenic driver,phosphoinositide metabolism,lipid regulation,cell proliferation,signaling pathway interaction,cancer cell survival
ENSG00000198408,OGA,o-glcnac modification,cancer cell metabolism,dysregulated enzyme activity,apoptosis regulation,tumor suppressor interaction,oncogene modulation
ENSG00000162639,HENMT1,genomic instability,telomere shortening,cancer development,oncogenic transformation,dna repair regulation,nuclear protein interaction
ENSG00000113838,TBCCD1,tumor suppressor function,microtubule dynamics regulation,chromosome segregation defect,mitotic spindle assembly checkpoint,tumor progression facilitation,cancer driver mutation
ENSG00000137261,KIAA0319,cell cycle regulation,tumor progression,cell proliferation,metastasis,prognostic marker,oncogenesis
ENSG00000196968,FUT11,lewis x antigen biosynthesis,cell adhesion molecule,glycosylation pathway,tumor progression,metastasis enhancer,prognostic biomarker
ENSG00000137204,SLC22A7,oncogene activation,drug resistance,cellular efflux modulation,tumor progression,chemotherapy interaction,genomic instability
ENSG00000215251,FASTKD5,mitochondrial regulation,apoptosis regulation,cellular metabolism alteration,oncogenic signaling promotion,genomic instability contribution,tumor progression facilitation
ENSG00000196935,SRGAP1,regulatory role in rho gtpase activity,tumor suppressor function,cell migration and invasion,cytoskeleton dynamics regulation,dna damage response,apoptosis modulation
ENSG00000143149,ALDH9A1,chromatin remodeling,cell growth regulation,dna repair modulation,cellular oxidation reactions,protein-protein interactions,altered expression levels
ENSG00000140459,CYP11A1,steroid hormone synthesis,xenobiotic metabolism,metabolic reprogramming,endocrine disorder,congenital adrenal hyperplasia,enzymatic catalysis
ENSG00000083307,GRHL2,epithelial-to-mesenchymal transition (emt),transcription factor regulation,gene expression modulation,tumor suppression,wnt/β-catenin pathway modulation,metastasis promotion
ENSG00000126787,DLGAP5,cell-cell adhesion disruption,oncogenic signaling,pi3k/akt pathway activation,enhanced cell survival,overexpression associated with poor prognosis,potential biomarker for diagnosis and treatment
ENSG00000115271,GCA,altered metabolism,glycolysis upregulation,glutaminolysis activation,hypoxia adaptation,tumor growth promotion,therapeutic target
ENSG00000197956,S100A6,calcium-binding protein,cell migration and invasion,tumor progression and metastasis,angiogenesis promotion,proteostasis regulation,p53 interaction
ENSG00000105298,CACTIN,cellular stress response,mrna translation regulation,cancer driver gene,tumor suppressor function,cell growth regulation,oncogene properties
ENSG00000278210,KRTAP5-1,oncogenic potential,tumor progression,epithelial-to-mesenchymal transition,cell adhesion modulation,cytoskeleton stabilization,protein-protein interaction
ENSG00000136813,ECPAS,cell cycle regulation,proliferation,chromatin remodeling,tumorigenesis,overexpression,cell growth
ENSG00000104044,OCA2,melanization regulation,eumelanin production,pigmentation disorders,skin conditions association,albinism forms,recessive inheritance patterns
,ADPRHL2,genomic instability,dna damage response,oncogenic pathway activation,cell cycle regulation,apoptosis suppression,tumor growth promotion
ENSG00000196576,PLXNB2,cell adhesion regulation,growth factor receptor interaction,tumor growth promotion,metastasis facilitation,cytoskeletal remodeling,rho gtpase activation
ENSG00000151465,CDC123,cell cycle regulation,oncogenic role,genomic instability,protein-protein interactions,apoptosis inhibition,mitotic progression
ENSG00000170915,PAQR8,steroid hormone regulation,dysregulated expression,cell growth modulation,onco-protein interaction,lipid metabolism involvement,oncogenesis association
ENSG00000000419,DPM1,n-glycosylation pathway,protein modification,glycomic alterations,tumor cell proliferation,cellular interactions,therapeutic target
ENSG00000228987,HLA-DRA,immune surveillance,antigen presentation,tumor evasion,immune suppression,mhc class i region,peptide loading
ENSG00000168621,GDNF,cell proliferation,ret signaling pathway,neurotrophic factor activity,tumor progression,angiogenesis regulation,therapeutic target
ENSG00000115504,EHBP1,rho gtpase regulation,cell adhesion disruption,metastatic progression,protein degradation regulation,cancer cell migration,ubiquitin ligase interaction
ENSG00000113621,TXNDC15,oncogenic overexpression,disulfide bond regulation,cell signaling modulation,protein folding facilitation,epithelial-to-mesenchymal transition,cell growth promotion
ENSG00000108592,FTSJ3,ubiquitin-proteasome regulation,cell cycle control,protein homeostasis,tumorigenesis promotion,cell proliferation,oncogenic activity
ENSG00000221859,KRTAP10-10,keratin filament interaction,epithelial cell maintenance,tumor progression disruption,cellular adhesion alteration,cancer-associated protein expression,dysregulated gene expression
ENSG00000151475,SLC25A31,mitochondrial transport,acylcarnitine metabolism,glycolysis enhancement,fatty acid oxidation increase,rapid cell growth,proliferation regulation
ENSG00000149262,INTS4,recruitment of rna polymerase ii complex,transcriptional regulation,cell proliferation,apoptosis evasion,tumor aggressiveness,cancer stem cell maintenance
ENSG00000081019,RSBN1,genomic instability,cell proliferation,tumor suppressor function,dna repair,cell cycle regulation,mutation hotspot
ENSG00000203859,HSD3B2,oncogenic regulation,steroid hormone biosynthesis,cell proliferation,cancer stem cell maintenance,tumor growth promotion,genomic instability
ENSG00000006059,KRT33A,keratinization pathway,antibody target,cancer progression marker,epithelial integrity maintenance,tumor aggressiveness,tissue specificity
,HRASLS2,regulation of ras-related gtpases,activation of rala/b gtpases,gdp/gtp exchange stimulation,cell growth regulation,signaling pathway modulation,oncogenic process involvement
ENSG00000177853,ZNF518A,transcriptional regulation,krab domain-containing protein,histone modification,tumor suppressor function,oncogene expression,cell proliferation regulation
ENSG00000186300,ZNF555,cellular proliferation inhibition,genomic stability maintenance,apoptosis promotion,cell cycle regulation,tumor suppression,transcriptional regulation
ENSG00000163098,BIRC8,inhibitor of apoptosis,protein-protein interactions,e3 ubiquitin ligase activity,cellular survival pathways,tumor progression,immune regulation
ENSG00000139209,SLC38A4,nutrient transport regulation,cell proliferation enhancement,oncogenic potential,protein synthesis facilitation,metabolic pathway interaction,tumor growth promotion
ENSG00000106330,MOSPD3,cell surface recognition,cell adhesion regulation,integrin interaction,pi3k/akt pathway modulation,tumor progression,metastasis regulation
ENSG00000107959,PITRM1,mitochondrial function,redox balance disruption,gene mutations,metabolic reprogramming,oncogenic alterations,iron-sulfur cluster biogenesis
ENSG00000139163,ETNK1,bifunctional enzyme,cellular membrane synthesis,phospholipid metabolism regulation,oncogenic signaling activation,tumor growth promotion,metabolic reprogramming
ENSG00000175893,ZDHHC21,aberrant protein glycosylation,cancer progression,cell growth regulation,glycoprotein modification,n-glycosylation pathway,oncogenic transformation
ENSG00000124370,MCEE,metabolic reprogramming,oncogenic function,cellular energy metabolism,glycolytic shift,tumor growth promotion,cancer metabolic vulnerabilities
ENSG00000123338,NCKAP1L,cell migration regulation,actin cytoskeleton remodeling,epithelial-to-mesenchymal transition (emt),metastasis promotion,oncogenic signaling pathway modulation,cancer cell invasion enhancement
ENSG00000162676,GFI1,transcriptional repressor,tumor suppressor,cell proliferation regulation,apoptosis evasion,chromatin modification,histone methylation
ENSG00000153179,RASSF3,microtubule stability,epigenetic silencing,tumor suppressor function,cell cycle regulation,apoptosis regulation,gene silencing
ENSG00000121749,TBC1D15,rab5 gtpase activation,cellular trafficking regulation,gap activity,mitochondrial targeting,cell signaling disruption,tumor growth promotion
ENSG00000116141,MARK1,microtubule regulation,tumor suppressor function,mitotic progression,cell division regulation,protein kinase activity,signaling pathway interaction
ENSG00000265817,FSBP,fbp-expression,tumor progression,cell adhesion,metastasis,angiogenesis,hypoxia-induced
ENSG00000143774,GUK1,guanine nucleotide binding,dna replication,guanylate kinase activity,tumor growth promotion,oncogenic protein interaction,metabolic regulation alteration
ENSG00000174992,ZG16,oncogenic interactions,transcriptional regulation,tumor progression,cell differentiation,epithelial-to-mesenchymal transition (emt),apoptosis
ENSG00000104833,TUBB4A,microtubule dynamics,aberrant protein expression,cell cycle disruption,chromosomal instability,metastatic potential,therapeutic target
ENSG00000165782,PIP4P1,phosphoinositide regulation,cell proliferation,membrane trafficking,oncogenic pathway,cell survival,signaling activation
ENSG00000188026,RILPL1,genomic instability,cell cycle progression,dna repair mechanisms,oncogenic mutations,tumor growth promotion,protein ubiquitination
ENSG00000185246,PRPF39,spliceosome regulation,genomic instability,premature termination codon (ptc) formation,cell proliferation enhancement,oncogenic pathway activation,pre-mrna splicing defect
ENSG00000127481,UBR4,ubiquitination pathway,tumor suppressor function,proteasomal degradation regulation,cell growth regulation,substrate recognition mechanism,gene expression modulation 
ENSG00000102967,DHODH,mitochondrial enzyme,pyrimidine biosynthesis,nucleotide synthesis,cellular metabolism,tumor metabolism,oncogenic activation
ENSG00000123179,EBPL,cellular response,genome maintenance,dna damage repair,tumor suppression,oncogenic mutation prevention,rna processing regulation
ENSG00000166317,SYNPO2L,cell cycle regulation,tumor progression,chromatin modification,nuclear enrichment,cell proliferation,oncogenesis
ENSG00000189433,GJB4,gap junction regulation,cell-cell communication disruption,ion and metabolite exchange,tissue homeostasis regulation,skin disorder association,connexin dysfunction link
ENSG00000116783,TNNI3K,cell growth promotion,genome instability contributor,telomere maintenance regulator,oncogenic signaling mediator,therapeutic target potential,biomarker significance
ENSG00000129991,TNNI3,tumor progression,cancer driver,cell proliferation,cell migration,cell cycle regulation,protein interaction
ENSG00000143882,ATP6V1C2,v-atpase activation,metabolic reprogramming,autophagy promotion,lysosomal function enhancement,tumor growth facilitation,cellular adaptation modulation
ENSG00000117133,RPF1,rna regulation,dysregulated expression,oncogenic process,tumor progression,metastasis,nuclear export
ENSG00000275416,KIR3DL2,immune regulation,nk cell activation,hla class i interaction,tumor immune evasion,cancer immunology,kir family receptor
ENSG00000186862,PDZD7,cellular adhesion,signaling pathway interaction,receptor tyrosine kinase regulation,tumor progression,gene expression modulation,dysregulation in cancer
ENSG00000123329,ARHGAP9,rho gtpase regulation,cell proliferation,tumor metastasis,pi3k/akt signaling,cell migration,oncogenic processes
ENSG00000122644,ARL4A,cellular signaling pathway,gtpase activity,protein trafficking regulation,intracellular interaction partner,oncogenic mutation driver,tumor growth promotion
ENSG00000177683,THAP5,therapeutic target,transcriptional regulation,chromatin remodeling,oncogenesis promoter,cell cycle progression,apoptosis suppression
ENSG00000114346,ECT2,cell cycle regulation,oncogenic mutations,mitotic spindle stability,genomic instability,oncoprotein overexpression,tumor metastasis
ENSG00000159459,UBR1,aberrant expression,chromosomal instability,dna damage response,oncogenesis,protein degradation pathways,therapeutic target
ENSG00000180304,OAZ2,oncogenesis,transcriptional regulation,cell growth promotion,protein interaction modulation,dna damage response dysregulation,biomarker significance
ENSG00000274145,RILP,lysosomal regulation,autophagy modulation,apoptosis regulation,tumor progression,lysosome dynamics,rab7 interaction
ENSG00000168014,C2CD3,tumor suppressor,cell cycle regulation,protein stability alterations,apoptosis dysregulation,oncogenic processes alteration,signaling pathway modulation
ENSG00000105655,ISYNA1,aberrant splicing,cellular stress response,genomic instability,heterogeneous nuclear ribonucleoproteins (hnrnps) interaction,oncogenesis promotion,rna metabolism regulation
ENSG00000213347,MXD3,tumor suppressor function,downregulation or mutation,cell growth regulation,differentiation inhibition,oncogenic gene expression,apoptosis induction
ENSG00000163219,ARHGAP25,tumor suppressor function,rho gtpase regulation,cell migration inhibition,oncogenic activity suppression,pi3k/akt pathway modulation,cytoskeletal dynamics regulation
ENSG00000152601,MBNL1,rna-binding protein,post-transcriptional regulation,splicing patterns,alternative splicing,gene expression modulation,muscle function and development
ENSG00000116237,ICMT,methyltransferase activity,oncogenic process,protein modification,cellular growth regulation,ras superfamily interaction,chemoresistance
ENSG00000267855,NDUFA7,mitochondrial function,energy metabolism,tumor suppressor,cell signaling pathways,epigenetic regulation,glycolytic shift
ENSG00000184661,CDCA2,cell cycle regulation,genomic instability,oncogenic function,chromosomal stability,replication licensing,mitotic progression
ENSG00000135241,PNPLA8,lipid metabolism regulation,protein kinase interaction,cellular stress response,oncogene/tumor suppressor potential,autophagy modulation,endoplasmic reticulum stress
ENSG00000144230,GPR17,angiogenesis,dual functionality,oncogene/tumor suppressor,g-protein coupled signaling,vegf pathway modulation,cell proliferation regulation
ENSG00000065911,MTHFD2,oncogenic activation,gain of function mutations,one-carbon metabolism pathway,methyltransferase activity,tumor suppressor loss,genomic instability
ENSG00000170779,CDCA4,cell cycle progression,g2/m phase transition,chromatin regulation,dna replication,genomic stability,oncogenic function
ENSG00000167037,SGSM1,oncogene function,pi3k/akt pathway regulation,cell proliferation modulation,tumor progression driver,gene expression regulation,metastasis promoter
ENSG00000162413,KLHL21,tumor suppression,cell proliferation regulation,epithelial-to-mesenchymal transition,cell migration and invasion,ubiquitin ligase activity,kinase regulatory function
ENSG00000186462,NAP1L2,chromatin regulation,gene expression disruption,cell cycle progression,aberrant transcriptional programs,oncogenic drivers,protein-protein interactions
ENSG00000101752,MIB1,cell cycle regulation,gene amplification,oncoprotein overexpression,protein-protein interactions,tumor progression,proliferation regulation
ENSG00000103343,ZNF174,epigenetic regulation,transcriptional repression,tumor suppressor function,cell cycle progression,apoptosis regulation,chromatin remodeling
ENSG00000167244,IGF2,igf2 overexpression,promoter hypermethylation,cell proliferation,tumor progression,imprinting mechanism disruption,angiogenesis promotion
ENSG00000176788,BASP1,cellular adhesion,mitochondrial function regulation,tumor progression,protein-protein interactions,cell signaling modulation,gene expression regulation
ENSG00000171163,ZNF692,transcriptional regulation,cell proliferation inhibition,tumor suppressor function,krab-containing zinc finger protein family,apoptosis induction,chromatin remodeling
ENSG00000163312,HELQ,chromosomal instability,genomic maintenance,dna repair dysfunction,tumor suppressor function,nuclear localization,protein-dna interaction
ENSG00000255302,EID1,cell cycle regulation,genomic instability,tumor suppressor inhibition,oncogene activation,p53 pathway modulation,protein-protein interaction
ENSG00000128654,MTX2,mtx2 is involved in,extracellular matrix degradation,cell migration and invasion,angiogenesis promotion,immune microenvironment modulation,tumor microenvironment disruption
ENSG00000105707,HPN,tumor progression,angiogenesis and metastasis,oncogene activity,inflammation modulation,cell signaling regulation,prognostic marker
ENSG00000151632,AKR1C2,metabolic reprogramming,tumor progression,cell proliferation,steroid hormone regulation,xenobiotic metabolism,signaling pathway modulation
ENSG00000163686,ABHD6,pa regulation,oncogenic pathway activation,lipid metabolism dysregulation,tumor progression promotion,therapeutic target potential,genomic instability maintenance
ENSG00000168259,DNAJC7,chaperone function,cell growth regulation,oncogenic interaction,protein stability modulation,tumor progression promotion,autophagy regulation
ENSG00000164309,CMYA5,cell adhesion disruption,tumor progression,metastasis facilitation,prognostic biomarker,therapeutic target,signaling pathway activation
ENSG00000251247,ZNF345,oncogenic transcription factor,krab domain-containing protein,cell proliferation regulator,apoptosis inhibitor,signaling pathway modulator,transcriptional repressor
ENSG00000078098,FAP,mitochondrial dysfunction,cellular respiration regulation,tumor suppressor function,dna damage induction,oncogenesis promotion,energy metabolism alteration
ENSG00000120937,NPPB,oncogene potential,epithelial-to-mesenchymal transition induction,cell growth regulation,poor prognosis association,metastasis promotion,vasodilation and natriuresis regulation
ENSG00000116898,MRPS15,mitochondrial function,tumor suppressor activity,cancer progression,autophagy regulation,cellular metabolism alteration,ribosome assembly
ENSG00000171914,TLN2,cell migration,metastasis promotion,cytoskeletal regulation,microtubule interaction,prognostic marker,tumor progression
ENSG00000102575,ACP5,tumor progression,genetic mutation,cell proliferation,apoptosis regulation,metastasis enhancement,cancer stem cell maintenance
ENSG00000131069,ACSS2,lipid biosynthesis,cellular energy production,short-chain fatty acid metabolism,oncogenic properties,glycolysis enhancement,tumor growth facilitation
ENSG00000120329,SLC25A2,mitochondrial metabolism,cellular energy homeostasis,fatty acid transport,tumorigenesis promotion,metabolic adaptation,redox regulation
ENSG00000079308,TNS1,nf-κb activation,chronic inflammation,pro-inflammatory cytokine regulation,cell survival modulation,immune response regulation,tumor necrosis factor-alpha interaction
ENSG00000185504,FAAP100,genomic instability,homologous recombination repair,brca1 interaction,tumor suppressor function,double-strand break repair,oncogenic transformation
ENSG00000272835,SMDT1,genomic instability,chromosomal abnormalities,tumor growth,cell proliferation,dna repair modulation,ploidy increase
ENSG00000096654,ZNF184,tumor progression,transcriptional regulation,cell proliferation,signaling pathway modulation,therapeutic target,biomarker
ENSG00000153560,UBP1,ubiquitin removal,cell cycle regulation,tumor suppression,oncogenic protein interaction,cancer cell proliferation,dna repair mechanism
ENSG00000185088,RPS27L,genomic instability,dna damage response,cell proliferation,ribosomal biogenesis,translation initiation,mrna regulation
ENSG00000121039,RDH10,oncogene,tumor progression,cell proliferation,therapeutic target,cellular metabolism regulation,glucocorticoid modulation
ENSG00000138182,KIF20B,chromatin modification,cell cycle regulation,aneuploidy driver,cytokinesis inhibition,protein kinase activation,kinase activity disruption
ENSG00000021300,PLEKHB1,pi3k/akt signaling pathway,constitutive activation,cell proliferation,scaffolding protein,tumor progression,therapeutic target
,NUPL2,nuclear transport regulation,genomic instability,aneuploidy induction,cell division dysregulation,chromatin remodeling,epigenetic regulation
ENSG00000241973,PI4KA,phosphoinositide biosynthesis,oncogenic signaling,cell proliferation,apoptosis regulation,therapeutic target,lipid metabolism
ENSG00000046647,GEMIN8,genome stability maintenance,cellular rna processing,histone modification regulation,mitotic progression regulation,snrnp assembly,cancer suppressor
ENSG00000100191,SLC5A4,na+/glucose cotransporter,cellular metabolism regulation,cancer cell proliferation,glucose uptake enhancement,therapeutic target identification,interaction with pi3k/akt signaling pathway
ENSG00000198961,PJA2,immune regulation,tumor-infiltrating immune cells,antitumor immunity,cellular metabolism,peptidoglycan recognition,protein-protein interactions
ENSG00000138135,CH25H,cellular metabolism,oncogene activation,tumor progression,protein-protein interaction,cancer cell proliferation,metabolic regulation
ENSG00000205899,BHLHA9,cell cycle progression,transcriptional regulation,apoptosis suppression,overexpression in cancer,heterodimer formation,histone modification
ENSG00000171016,PYGO1,wnt/β-catenin signaling pathway,oncogene overexpression,transcriptional regulation,cell proliferation,prognostic marker,chromatin remodeling
,CASC4,long non-coding rna,tumor suppressor function,chromatin regulation,microrna regulation,cellular proliferation regulation,polycomb repressive complex 2 interaction
ENSG00000124571,XPO5,exportin-5 function,constitutive activation,gain of function mutations,mutant p53 accumulation,cellular export regulation,therapeutic target
ENSG00000197497,ZNF665,dna damage response,tumor progression,transcriptional regulation,epithelial-to-mesenchymal transition,oncogenic properties,biomarker for cancer diagnosis
ENSG00000129221,AIPL1,genomic instability,protein quality control,cell growth regulation,survival pathway regulation,cytoplasmic protein,ubiquitin-proteasome system
ENSG00000064999,ANKS1A,chromatin regulation,oncogenic function,heterochromatin formation,cell cycle progression,gene expression modulation,dna damage response
ENSG00000197756,RPL37A,ribosomal protein function,aberrant cell growth,altered metabolism,cellular proliferation,dysregulated protein synthesis,tumor progression
ENSG00000145592,RPL37,ribosome biogenesis,protein synthesis dysregulation,cellular proliferation,protein quality control disruption,oncogenic mutations,tumor progression
ENSG00000160883,HK3,glycolytic regulation,glucose phosphorylation,cell growth enhancement,energy production facilitation,tumor suppressor potential,warburg effect association
ENSG00000112210,RAB23,cellular trafficking,pi3k/akt/mtor pathway regulation,oncogenic processes,cell proliferation,epithelial-to-mesenchymal transition,protein-protein interaction
ENSG00000107672,NSMCE4A,p53 regulation,protein homeostasis disruption,cell cycle progression dysregulation,tumor suppressor dysfunction,ubiquitin-proteasome pathway modulation,mitotic checkpoint control
ENSG00000165061,ZMAT4,tumor suppressor activity,transcriptional regulation,cell cycle progression,apoptosis modulation,dna repair regulation,genomic instability
ENSG00000100426,ZBED4,tumor suppressor function,transcriptional regulation,chromatin remodeling,cell proliferation,dna damage response,epigenetic modifications
ENSG00000167194,C16orf92,tmem14a overexpression,cell migration,cell proliferation,src kinase activation,pi3k/akt pathway interaction,mapk/erk signaling modulation
ENSG00000137996,RTCA,retinoic acid transport,retinoic acid receptors activation,cellular differentiation,tumor growth regulation,transcriptional regulation,protein interaction
ENSG00000167258,CDK12,genomic instability,tumor suppressor function,transcriptional regulation,cell proliferation,resistance to chemotherapy,impaired dna repair pathway
ENSG00000166569,CPLX4,cell proliferation,oncogenesis,dna damage response,cell signaling pathway,therapeutic target,overexpression
ENSG00000101577,LPIN2,lipid biosynthesis,aberrant signaling pathways,oncogenic processes,cancer cell metabolism,phosphatidic acid phosphatase activity,genomic instability
ENSG00000102471,NDFIP2,altered protein stability,cancer driver mutation,cell cycle regulation,protein degradation pathway,ubiquitination complex modulation,tumor suppressor regulation
ENSG00000167548,KMT2D,histone methylation,gain-of-function mutations,chromatin regulation,genomic instability,tumor suppressor activity,cancer epigenetics
ENSG00000104885,DOT1L,epigenetic regulation,histone modification,methyltransferase activity,chromatin structure,transcriptional activation,cellular proliferation 
ENSG00000005108,THSD7A,wnt/β-catenin pathway,epithelial-to-mesenchymal transition,tumor progression,cell migration and invasion,oncogenesis,prognostic marker
ENSG00000113657,DPYSL3,aberrant expression,axonal transport disruption,cell division dysregulation,cytoskeletal component,dna repair impairment,microtubule stability modulation
ENSG00000198844,ARHGEF15,rho gtpase activation,tumor progression,cell migration,oncogenic driver,signaling pathway dysregulation,cancer metastasis
ENSG00000007545,CRAMP1,cell growth regulation,dysregulated expression,antimicrobial properties,tumor microenvironment modulation,stress response regulation,oncogenesis association
ENSG00000154917,RAB6B,microtubule regulation,cell proliferation,metastasis promotion,oncogenic interaction,gtpase function,cancer driver potential
ENSG00000099940,SNAP29,vesicle trafficking regulation,cell growth promotion,oncogenic pathway support,kinase/phosphatase modulation,tumor progression facilitation,therapeutic target potential
ENSG00000173011,TADA2B,genomic instability,chromatin regulation,dna repair mechanisms,transcriptional control,oncogenic transformation,potential therapeutic target
ENSG00000102901,CENPT,chromosomal instability,aneuploidy,mitosis regulation,centrosome amplification,kinetochore assembly,spindle attachment
ENSG00000203760,CENPW,genomic instability,chromosomal abnormalities,oncogenic function,tumor progression,therapeutic target,cell cycle regulation
ENSG00000166866,MYO1A,actin cytoskeleton modulation,cell migration and invasion,tumor progression and metastasis,apoptosis evasion,cell cycle regulation,therapeutic target
ENSG00000134262,AP4B1,ap-4 complex,cell proliferation,cargo protein sorting,tumor progression,protein trafficking,adaptor-complex interaction
ENSG00000181045,SLC26A11,chloride secretion,ion transport regulation,pancreatic expression,cell growth regulation,bicarbonate absorption,tumorigenesis initiation
ENSG00000170561,IRX2,emt regulation,transcriptional repression,wnt/β-catenin pathway interaction,cancer stem cell maintenance,epithelial plasticity,prognostic biomarker 
ENSG00000222011,FAM185A,centrosome regulation,cell cycle progression,oncogenic potential,biomarker candidate,protein-protein interactions,genomic stability
ENSG00000256771,ZNF253,apoptosis regulation,transcriptional repression,dna damage response,zinc finger binding,cell growth modulation,chromatin remodeling
ENSG00000164087,POC1A,dna damage response,genomic instability,tumor suppression,oncogenic activation,cell proliferation enhancement,mutational burden increase
ENSG00000137962,ARHGAP29,arf1 activation,cell migration,cytoskeletal remodeling,endocytic pathway modulation,oncogene interaction,pi3k/akt signaling
ENSG00000107447,DNTT,dna replication,genomic instability,chromatin remodeling,dna repair,cell cycle progression,oncogene function
ENSG00000205339,IPO7,protein synthesis regulation,tumor development contribution,cell cycle progression regulation,apoptosis modulation,prognostic biomarker potential,mtor pathway interaction
ENSG00000158104,HPD,lipid metabolism regulation,tumor progression,cell growth and proliferation regulation,therapeutic target,protein prenylation modulation,mevalonate-derived products influence
ENSG00000113460,BRIX1,chromatin remodeling,gene regulation,transcriptional regulation,cancer susceptibility,gene expression modulation,cell cycle progression
ENSG00000079215,SLC1A3,glutamate regulation,transmembrane transport,cell survival signaling,tumor growth promotion,biomarker potential,therapeutic target interaction
ENSG00000166025,AMOTL1,angiopoietin-like 7 regulation,hippo/yap signaling pathway inhibition,tumor suppressor function loss,cell migration regulation,metastasis suppression,genomic instability
ENSG00000100523,DDHD1,lysosomal function regulation,lipid metabolism modulation,endocytic pathway involvement,autophagic process regulation,oncogenic potential,cellular homeostasis disruption
ENSG00000090581,GNPTG,oncogenic function,altered glycosylation,protein trafficking regulation,signaling pathway modulation,biomarker potential,glycoprotein accumulation
ENSG00000133302,SLF1,genomic instability,aneuploidy,chromatin remodeling,transcriptional regulation,tumor suppressor function,loss of heterozygosity
ENSG00000161082,CELF5,rna binding protein,alternative splicing regulation,oncogenic processes modulation,cell cycle progression regulation,metastasis facilitation,tumor suppression evasion
ENSG00000155961,RAB39B,oncogenic activity,constitutive activation,cell migration regulation,trafficking modulation,downstream pathway activation,pro-oncogenic signaling
ENSG00000184984,CHRM5,muscarinic acetylcholine receptor activation,g-protein coupled receptor function,mapk/erk signaling pathway involvement,cell proliferation enhancement,tumor growth promotion,cancer cell migration facilitation
ENSG00000122882,ECD,altered expression,cellular homeostasis disruption,ion transport regulation,oncogenic potential,therapeutic target,tumor progression
ENSG00000162614,NEXN,epithelial-to-mesenchymal transition,cell adhesion disruption,tumor progression,metastasis,poor prognosis,cytoskeletal regulation
ENSG00000172403,SYNPO2,microtubule regulation,tumor progression,prognostic biomarker,cancer cell survival,cell proliferation,stress response pathway
ENSG00000198301,SDAD1,genomic instability,replication stress regulation,mitotic catastrophe prevention,dna damage response pathway,atm/atr kinase activation,genome stability maintenance
ENSG00000189308,LIN54,histone modification,epigenetic regulation,oncogenic function,aberrant gene expression,tumor suppressor loss,chromatin remodeling
ENSG00000110925,CSRNP2,oncogenic transcript regulation,rna processing,tumor progression,therapeutic target,aberrant expression,cell proliferation enhancement
ENSG00000044446,PHKA2,altered energy metabolism,constitutive activation,gain of function mutations,tumor progression,cellular reprogramming,glycolytic enzyme regulation
ENSG00000154803,FLCN,oncogenic signaling,tumor suppressor function,disrupted cellular metabolism,energy homeostasis regulation,protein-protein interactions disruption,genetic predisposition
ENSG00000104055,TGM5,tumor progression,cell proliferation,epithelial-to-mesenchymal transition,transglutaminase activity,substrate specificity,apoptosis regulation
ENSG00000130150,MOSPD2,tumor microenvironment modulation,immune evasion promotion,cell migration facilitation,oncogenic signaling pathway interaction,apoptosis inhibition,inflammation regulation 
ENSG00000138738,PRDM5,tumor suppressor function,dna damage response,cell cycle regulation,transcriptional repression,oncogene regulation,chromatin modification
ENSG00000107897,ACBD5,lipid metabolism regulation,peroxisomal function maintenance,mitochondrial integrity modulation,oncogenic lipid synthesis,cell proliferation enhancement,signaling pathway interaction
ENSG00000198815,FOXJ3,aberrant transcriptional activity,cell cycle regulation,apoptosis inhibition,tumorigenesis contribution,oncogenic protein interaction,pi3k/akt signaling pathway modulation
ENSG00000168280,KIF5C,microtubule stabilization,chromosome segregation,oncogenesis,mitosis regulation,tumor progression,motor protein activity
ENSG00000168309,FAM107A,cell cycle regulation,g1/s phase transition,tumorigenesis,cell proliferation,oncogene activation,biomarker expression
ENSG00000197857,ZNF44,zinc finger protein,chromatin regulation,gene repression,tumorigenesis,apoptosis regulation,cell cycle progression
ENSG00000143185,XCL2,immune cell recruitment,tumor-infiltrating lymphocytes,anti-tumor immunity,cell signaling pathway activation,chemokine expression,cancer immunotherapy
ENSG00000156345,CDK20,cell cycle regulation,gain of function mutations,dna replication and repair,epigenetic regulation,cancer progression,oncogenic processes
ENSG00000179796,LRRC3B,pi3k/akt pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genome stability
ENSG00000058804,NDC1,nuclear pore complex assembly,tumor suppressor activity,cell cycle regulation,dna repair mechanism,genome stability maintenance,protein-protein interactions
ENSG00000173258,ZNF483,cellular regulation,transcriptional modulation,oncogenic function,tumor development,gene expression alterations,aberrant dna binding
ENSG00000177272,KCNA3,ion channel regulation,cell proliferation,tumor progression,potential therapeutic target,signaling pathway modulation,epigenetic regulation
ENSG00000169903,TM4SF4,emt induction,cell surface receptor regulation,metastasis promotion,poor prognosis indicator,therapeutic target,epithelial-to-mesenchymal transition
ENSG00000160055,TMEM234,cell migration,loss of adhesion,metastasis formation,epithelial polarity,cell proliferation,tumor progression
ENSG00000165675,ENOX2,cell cycle progression,tumor promotion,apoptosis regulation,angiogenesis modulation,therapeutic resistance,prognostic marker
ENSG00000120658,ENOX1,cell adhesion regulation,apoptosis modulation,pi3k/akt pathway interaction,tumor progression association,metastasis facilitation,cell cycle regulation alteration
ENSG00000164283,ESM1,cell adhesion regulation,tumor progression,metastasis facilitation,extracellular matrix interaction,protein-protein interaction,cancer metastasis 
ENSG00000119707,RBM25,rna binding,alternative splicing,genome instability,tumorigenesis,oncogene function,apoptosis regulation
ENSG00000181544,FANCB,genomic instability,tumor suppressor,cell cycle regulation,dna repair pathway,apoptosis regulation,fanconi anemia pathway
ENSG00000014138,POLA2,dna replication,genomic instability,chromosomal abnormalities,altered dna repair,oncogenic driver,therapeutic target
ENSG00000088756,ARHGAP28,rhogtpase regulation,tumor progression,apoptosis suppression,cell proliferation control,cytoskeletal remodeling,oncogenic signaling
ENSG00000119231,SENP5,oncogene,protein stabilization,cell cycle regulation,apoptosis inhibition,chemoresistance,tumor progression
ENSG00000122643,NT5C3A,tumor suppressor function loss,metabolic reprogramming,oncogenic driver mutation,cell proliferation enhancement,apoptosis inhibition,genomic instability induction
ENSG00000178386,ZNF223,zinc finger protein binding,cell cycle regulation,transcription factor activity,chromatin remodeling,gene expression modulation,oncogenic potential
ENSG00000143158,MPC2,cardiac muscle contraction,muscle relaxation,cardiomyopathy,hypertrophic heart disease,dilated heart disease,muscle dysfunction
ENSG00000156170,NDUFAF6,mitochondrial biogenesis,mitochondrial dysfunction,complex i assembly,tumor suppressor gene,glycolytic shift,glutaminolytic adaptation
ENSG00000188818,ZDHHC11,pi3k/akt signaling pathway regulation,oncogenic function,protein s-palmitoylation modification,cell proliferation enhancement,metabolic regulation involvement,therapeutic target potential
ENSG00000285262,MCPH1,genomic instability,dna replication regulation,cell cycle checkpoint,tumorigenesis,microcephaly,apoptosis inhibition
ENSG00000041880,PARP3,genomic instability,dna repair mechanism,chromatin regulation,epigenetic modulation,oncogenesis facilitation,therapeutic potential
ENSG00000127526,SLC35E1,nucleotide sugar transport,cellular metabolism,oncogenic transformation,glycoconjugate synthesis,apoptosis regulation,tumor growth promotion
ENSG00000136383,ALPK3,regulation of cell cycle progression,alkaline phosphatase activity,oncogenic signaling pathway modulation,cellular differentiation inhibition,apoptosis regulation,therapeutic target
ENSG00000176014,TUBB6,microtubule stability,mitotic spindle assembly,cell division regulation,tumor suppressor function,cancer driver mutation,chemo-resistance mechanism
ENSG00000113615,SEC24A,cellular transport regulation,tumor progression,oncogene activation,protein secretion regulation,growth factor regulation,apoptosis inhibition
ENSG00000064313,TAF2,tata-binding protein-associated factor 2,cell proliferation,chromatin remodeling,gene expression regulation,oncogene modulation,transcriptional dysregulation
ENSG00000120802,TMPO,chromatin regulation,genomic instability,epigenetic alterations,histone modification,dna replication,cell cycle progression
ENSG00000101850,GPR143,melanogenesis regulation,pigment cell development,cellular pigmentation,skin pigmentation disorders,alpha-melanocyte-stimulating hormone receptor,signaling pathway intersection
ENSG00000185818,NAT8L,protein acetylation,metabolic regulation,oncogenic process,cell survival,cellular metabolism,sirt1 interaction
ENSG00000091164,TXNL1,nf-κb pathway activation,oncogenic signaling,tumor progression,metastasis promotion,glycolytic enhancement,protein folding regulation
ENSG00000142449,FBN3,cell proliferation,survival pathway regulation,oncogene activation,co-activator/co-repressor function,tumor growth promotion,metastasis enhancement
ENSG00000171316,CHD7,chromatin remodeling,epigenetic regulation,oncogenic processes,genome stability,tumor microenvironment,pediatric cancers
ENSG00000227804,PPP1R10,pp1 regulation,substrate specificity modulation,cell cycle progression regulation,apoptosis regulation,tumorigenesis association,protein interaction
ENSG00000005513,SOX8,transcriptional regulation,tumor suppressor function,embryonic development,cell fate determination,cancer stem cell maintenance,tumor aggressiveness
ENSG00000136859,ANGPTL2,metabolic reprogramming,tumor progression,insulin sensitivity modulation,lipid metabolism regulation,cell proliferation enhancement,protein-protein interaction
ENSG00000085840,ORC1,genomic instability,cancer progression,cell proliferation,origin recognition complex (orc),dna replication initiation,tumor suppressor
ENSG00000127528,KLF2,transcriptional regulation,tumor suppressor,oncogenic properties,angiogenesis promotion,inflammatory response modulation,post-translational modification dependence
ENSG00000083535,PIBF1,tumor suppressor activity,oncogene function,cell cycle regulation,gene expression modulation,protein-protein interaction,overexpression in cancer
ENSG00000083168,KAT6A,histone acetyltransferase activity,gene amplification,cancer driver,transcriptional regulation,tumor growth,promoter hypermethylation
ENSG00000175155,YPEL2,microrna regulation,chromatin remodeling,oncogenic transformation,cell cycle regulation,gene expression modulation,protein-protein interactions
ENSG00000011028,MRC2,tumor progression,metastasis promotion,cell migration regulation,matrix remodeling,stress response regulation,protein-protein interaction
ENSG00000204176,SYT15,genomic instability,chromosomal amplification,cell proliferation enhancement,dna repair disruption,protein-protein interaction alteration,oncogenic driver status
ENSG00000188257,PLA2G2A,oncogene,cancer cell migration,cell membrane remodeling,lipid metabolism modulation,pro-inflammatory mediator production,therapeutic target
ENSG00000203877,RIPPLY2,wnt/β-catenin signaling,transcriptional coactivator,oncogene activation,cell proliferation,tumor progression,therapeutic target
ENSG00000172780,RAB43,gtp-binding protein,tumor progression,cell migration,protein transport,membrane trafficking,vesicular trafficking
ENSG00000154451,GBP5,pi3k/akt signaling,overexpression,cell proliferation,cell survival,regulation of autophagy,protein-protein interaction
ENSG00000064419,TNPO3,nuclear import receptor,phosphorylated transcription factor binding,dna repair regulation,cell cycle dysregulation,oncogenic protein transport,tumor suppressor function disruption
ENSG00000168079,SCARA5,cellular uptake,tumor progression,metastasis promotion,cancer cell migration,angiogenesis regulation,cell survival enhancement
ENSG00000198015,MRPL42,mitochondrial translation,tumor progression,energy metabolism regulation,cell growth promotion,metabolic reprogramming,ribosomal assembly
ENSG00000158195,WASF2,actin cytoskeleton regulation,cell migration and invasion,cytoskeletal remodeling,enhanced cell proliferation,genetic instability,pi3k/akt signaling modulation
ENSG00000100302,RASD2,tumor suppressor,small gtp-binding protein,ras superfamily interaction,cell growth regulation,differentiation modulation,oncogenic process suppression
ENSG00000153885,KCTD15,cell cycle regulation,gene expression modulation,transcriptional regulation,dna damage response,p53 pathway interaction,tumor suppressor function
ENSG00000196406,SPANXD,cell signaling regulation,dysregulation in tumorigenesis,interaction with pi3k/akt pathway,metastatic process modulation,oncogenic process enhancement,tumorigenesis facilitation
ENSG00000118096,IFT46,hedgehog signaling pathway,cell cycle progression,apoptosis regulation,cilia assembly,molecular transport complex,genomic instability
ENSG00000165646,SLC18A2,glutamate regulation,vesicular transport,neurotransmission modulation,cellular energy metabolism,ion homeostasis regulation,tumor microenvironment alteration
ENSG00000162992,NEUROD1,transcriptional regulation,oncogenic function,cell proliferation promotion,tumor suppressor activity,neuronal differentiation regulation,genetic cooperation with other oncogenes
ENSG00000121621,KIF18A,microtubule regulation,chromosome segregation,cytokinesis errors,cell cycle progression,genomic instability,therapeutic target
ENSG00000196091,MYBPC1,tumor suppressor,pi3k/akt pathway regulation,cell proliferation inhibition,apoptosis promotion,muscle contraction regulation,oncogenesis inhibition
ENSG00000109787,KLF3,transcriptional regulation,tumor suppression,epithelial-to-mesenchymal transition (emt),cell proliferation inhibition,histone modification,apoptosis induction
ENSG00000176058,TPRN,g-protein signaling pathway,cell growth regulation,apoptosis evasion,tumorigenic potential,metabolic reprogramming,cell cycle progression
ENSG00000129455,KLK8,tumor progression,proteolytic activity,angiogenesis regulation,cancer metastasis,mitotic activity enhancement,cell migration facilitation
ENSG00000196220,SRGAP3,cell migration inhibition,rho gtpase regulation,tumor suppressor function,oncogenic protein modulation,cell polarity establishment,biomarker significance
ENSG00000025796,SEC63,er stress response,protein misfolding,cellular proliferation,apoptosis evasion,autophagy regulation,chaperone function
ENSG00000183837,PNMA3,altered expression,cell proliferation,cell survival,cancer progression,therapeutic target,oncogenic process
ENSG00000169933,FRMPD4,loss-of-function mutations,tumor suppressor,rho/rock pathway regulation,cell migration regulation,epithelial-to-mesenchymal transition (emt),therapeutic target
ENSG00000140829,DHX38,genomic instability,onco-suppressor function,tumor promoter,genetic mutations,cellular proliferation,rna processing
ENSG00000140092,FBLN5,cell adhesion disruption,angiogenesis promotion,tumor progression facilitation,growth factor regulation,signaling pathway interaction,genetic instability contribution
,CD3EAP,t cell activation,signaling pathway regulation,immune surveillance dysregulation,cancer cell proliferation,therapeutic target,genomic instability
ENSG00000119431,HDHD3,pi3k/akt pathway,overexpressed,regulatory function,cellular localization,oncogenic potential,signaling pathway modulation
ENSG00000072310,SREBF1,lipid metabolism regulation,transcription factor activation,cell proliferation promotion,post-translational modification regulation,cancer cell survival enhancement,tumor progression association
,FAM173A,ubiquitination pathway,protein degradation,cell cycle regulation,dna repair mechanisms,transcriptional regulation,protein homeostasis
ENSG00000124217,MOCS3,methionine cycle regulation,genomic instability,s-adenosylmethionine synthesis,dna methylation disruption,reactive oxygen species accumulation,cell survival pathway alterations
ENSG00000149927,DOC2A,calcium-binding protein,apoptosis regulation,cell signaling modulation,pi3k/akt pathway interaction,cancer cell survival,subcellular localization alteration
ENSG00000101162,TUBB1,microtubule dynamics,chromosome separation,cell cycle progression,apoptosis evasion,therapeutic resistance,tumorigenesis
ENSG00000123307,NEUROD4,transcriptional regulation,cell proliferation,apoptosis inhibition,neuronal differentiation,cancer tumorigenesis,cell cycle progression
ENSG00000153786,ZDHHC7,aberrant protein palmitoylation,oncogenic transformation,protein function regulation,cell signaling modulation,tumorigenesis association,substrate specificity
ENSG00000008086,CDKL5,brain development,cell cycle regulation,neuronal proliferation,epilepsy susceptibility,intellectual disability risk,autism spectrum disorder link
ENSG00000172139,SLC9C1,monocarboxylate transport,cellular adaptation,oncogenic process,energy metabolism,cell proliferation,tumor microenvironment
ENSG00000226650,KIF4B,cell division regulation,mitotic progression,tumor growth promotion,oncogene activation,spindle assembly checkpoint disruption,microtubule dynamics modulation
ENSG00000177143,CETN1,cell cycle regulation,microtubule dynamics,dna damage response,apoptosis regulation,ciliogenesis disruption,tumor progression
ENSG00000108591,DRG2,glucose transporter,neurological disorders,altered expression,tumor metabolism,cellular regulation,transcriptional control
ENSG00000185962,LCE3A,epithelial tumor susceptibility,cell proliferation regulation,cell differentiation regulation,permeability barrier disruption,dna repair interaction,apoptosis modulation
ENSG00000007908,SELE,cell adhesion molecule,angiogenesis facilitation,metastasis promotion,poor prognosis marker,tumor cell recruitment,signaling pathway interaction
ENSG00000138162,TACC2,microtubule regulation,tumor suppressor,cell cycle progression,mitotic spindle formation,chromosomal instability,aneuploidy
ENSG00000120656,TAF12,transcriptional regulation,cell proliferation,oncogenic potential,therapeutic target,chromatin modulation,none
ENSG00000285007,REC8,meiosis specific cohesin,genomic instability,chromosome segregation error,oncogene overexpression,cell proliferation enhancer,therapeutic target
ENSG00000128641,MYO1B,actin-dependent processes,cell migration,invasiveness,rho gtpase regulation,tumor progression,unconventional myosin function
ENSG00000106689,LHX2,oncogenic potential,transcriptional regulation,cell proliferation,apoptosis modulation,angiogenesis promotion,metastasis association
ENSG00000152822,GRM1,tumor progression,cell proliferation,pi3k/akt signaling,metastasis promotion,mapk/erk activation,g-protein coupling
ENSG00000048828,FAM120A,genomic stability,dna damage response,apoptosis regulation,cell cycle progression,genetic instability,oncogenic mutation
ENSG00000087589,CASS4,genomic instability,tumor suppressor,cell cycle regulation,dna repair mechanisms,chromosomal abnormalities,oncogenic mutations
ENSG00000011260,UTP18,chromatin regulation,dna repair mechanism,transcriptional activation,oncogenesis driver,cell cycle progression,genomic instability
ENSG00000089876,DHX32,genomic instability,alternative polyadenylation,helicase activity,dna damage response,tumor suppressor function,rna processing
ENSG00000179111,HES7,wnt/β-catenin signaling,transcriptional repressor function,g2/m phase regulation,tumor progression,oncogene role,cell proliferation enhancement
ENSG00000177096,PHETA2,transcriptional regulation,tumor progression,genomic instability,oncogenic transformation,cell proliferation,metastasis
ENSG00000182372,CLN8,autophagy dysregulation,cellular degradation,lysosome membrane protein,mitochondrial dysfunction,neurodegenerative disease association,protein recycling
ENSG00000160294,MCM3AP,overexpression,cell proliferation,tumor suppressor regulation,dna synthesis initiation,cell cycle regulation,oncogenesis driver
ENSG00000138115,CYP2C8,metabolic regulation,drug metabolism,cell cycle progression,apoptosis modulation,dna repair interaction,xenobiotic detoxification
ENSG00000171169,NAIF1,genomic instability,apoptosis regulation,chromatin remodeling,cell cycle modulation,protein interaction,dna repair mechanisms
ENSG00000123104,ITPR2,calcium signaling pathway,gain of function mutations,store-operated calcium entry,cell proliferation,intracellular signaling,tumor progression
ENSG00000133107,TRPC4,calcium channel regulation,oncogenic signaling pathway activation,cell growth promotion,metastatic potential enhancement,cell adhesion modulation,protein-protein interaction
ENSG00000109775,UFSP2,proteasome regulation,tumor growth promotion,oncogenic protein accumulation,poor prognosis association,therapeutic target,genomic instability
ENSG00000082641,NFE2L1,transcriptional regulator,cellular adaptation,oxidative stress response,tumor growth promotion,metabolic regulation,antioxidant gene expression
ENSG00000165480,SKA3,spindle checkpoint regulation,aneuploidy,chromosomal instability,oncogenic process,poor prognosis,microtubule attachment
ENSG00000163701,IL17RE,nf-κb pathway activation,constitutive inflammation,angiogenesis promotion,metastasis facilitation,therapeutic target,immune evasion
ENSG00000149573,MPZL2,antigen presentation,cell proliferation regulation,disrupted cellular function,oncogenic process,cancer driver gene,tumor progression
ENSG00000160588,MPZL3,cell surface receptor regulation,gene expression alterations,oncogenic transformation,tumor aggressiveness indicator,signaling pathway disruption,protein-protein interaction
ENSG00000214511,HIGD1C,mitochondrial function regulation,redox balance modulation,antioxidant defense mechanism,cellular energy homeostasis disruption,tumor progression facilitation,metabolic reprogramming
ENSG00000092051,JPH4,cell membrane regulation,calcium signaling pathway,tumor progression,therapeutic target,genomic instability,cell growth modulation
ENSG00000197557,TTC30A,mitochondrial regulation,tetratricopeptide repeat-containing protein,cellular stress responses,oncogenic signaling modulation,energy metabolism reprogramming,therapeutic target
ENSG00000141524,TMC6,adherens junction regulation,cell polarity modulation,epithelial integrity loss,tumorigenicity enhancement,cell-cell adhesion disruption,metastasis promotion
ENSG00000064102,INTS13,genomic instability,chromatin remodeling,phosphorylation activation,homologous recombination,epigenetic regulation,tumor progression
ENSG00000197296,FITM2,dna repair mechanisms,genomic stability maintenance,cell cycle regulation,chromatin remodeling,tumor suppressor function,immune system modulation
ENSG00000049883,PTCD2,mitochondrial localization,antioxidant function,tumor suppressor,cell proliferation inhibition,apoptosis induction,oxidative stress regulation
ENSG00000090889,KIF4A,mitotic checkpoint regulation,genomic instability,cell cycle progression,dna damage response,chromosome segregation,oncogenic driver gene
ENSG00000272325,NUDT3,dna repair deficiency,atr/chk1 pathway activation,genome instability,cancer predisposition,cell cycle dysregulation,protein-protein interaction
ENSG00000092295,TGM1,cellular cross-linking,dna damage,epigenetic regulation,metastasis promotion,oncogenic transformation,protein modification
ENSG00000106367,AP1S1,oncogenic driver,tumor progression,genomic instability,cell proliferation enhancement,protein interaction regulation,metastasis promotion
ENSG00000168255,POLR2J3,transcription initiation,rna polymerase subunit,chromatin remodeling,gene expression regulation,cell proliferation modulation,genomic stability maintenance
ENSG00000175756,AURKAIP1,aurora kinase regulation,cell cycle checkpoint,genomic stability,mitotic inhibition,tumor suppression,protein-protein interaction
ENSG00000132972,RNF17,ubiquitin ligase activity,cell cycle regulation,tumor suppressor protein degradation,oncogenic process promotion,cancer-related pathway interaction,overexpression in cancer
ENSG00000100056,ESS2,genomic instability,oncogene activation,cell cycle regulation,transcriptional control,protein degradation,cellular signaling pathways
ENSG00000183019,MCEMP1,microtubule regulation,cell proliferation,mutational activation,cancer progression,oncogenic driver,protein complex formation
ENSG00000157131,C8A,complement activation,cell lysis,immune evasion,tumor progression,membrane attack complex,innate immune response
ENSG00000140650,PMM2,aberrant glycosylation,glycosylation pathway disruption,cell surface modification,tumor progression,cancer cell survival,genetic predisposition
ENSG00000146414,SHPRH,chromosomal instability,genomic alterations,dna repair regulation,cell cycle control,tumor suppressor function,protein kinase regulation
ENSG00000100796,PPP4R3A,pp4 pathway regulation,dna repair dysfunction,aneuploidy driver,genomic instability,tumor suppressor downregulation,cell cycle progression disruption
ENSG00000118160,SLC8A2,calcium signaling alteration,cell migration facilitation,driver gene mutation,metastasis promotion,oncogene overexpression,therapeutic target
ENSG00000163935,SFMBT1,oncogenic function,chromatin remodeling,gene expression regulation,tumor suppressor silencing,genomic instability,dna repair mechanism disruption
ENSG00000133874,RNF122,oncogene activation,ubiquitin ligase activity,cell cycle regulation,apoptosis inhibition,tumor progression,protein degradation
ENSG00000068971,PPP2R5B,cell cycle regulation,dna repair mechanism,apoptosis induction,tumor suppressor function,epigenetic regulation,dysregulation of pi3k/akt pathway
ENSG00000115919,KYNU,immune evasion,amino acid metabolism regulation,tumor microenvironment modulation,cell proliferation promotion,therapeutic target potential,cancer driver mutation
ENSG00000129235,TXNDC17,mitochondrial localization,anti-apoptotic activity,cell survival pathway,protein-protein interactions,cancer overexpression,therapeutic target
ENSG00000188738,FSIP2,cell cycle regulation,apoptosis inhibition,proliferation enhancement,tumor aggression promotion,oncogenic signaling,chromatin modification
ENSG00000131730,CKMT2,glycolytic reprogramming,metabolic dysregulation,cellular energy homeostasis,tumor growth promotion,constitutive activation mutations,therapeutic target
ENSG00000112164,GLP1R,pancreatic beta-cell regulation,g protein-coupled receptor signaling,proliferation enhancement,insulin sensitivity modulation,hypothalamic appetite regulation,tumor promotion overexpression
ENSG00000168959,GRM5,mglur5 overexpression,neurotransmission modulation,pi3k/akt pathway activation,tumor progression driver,synaptic plasticity regulation,cancer cell growth promotion
ENSG00000177599,ZNF491,tumor suppressor,chromatin regulation,gene expression modulation,cell growth regulation,oncogenic transformation,epigenetic regulation
ENSG00000185101,ANO9,cellular signaling,tumor progression,metastasis promotion,ion transport regulation,plasma membrane localization,protein interaction modulation
ENSG00000163412,EIF4E3,mtor pathway regulation,constitutive activation,cell cycle progression,protein synthesis regulation,oncogene overexpression,autophagy modulation
ENSG00000175220,ARHGAP1,rho gtpase regulation,tumor suppressor function,cell proliferation regulation,apoptosis modulation,protein-protein interactions,gtpase activity regulation
ENSG00000101842,VSIG1,immune evasion,tumor suppression,t-cell regulation,regulatory t-cell expansion,immunotherapeutic target,cancer progression
ENSG00000169021,UQCRFS1,mitochondrial dysfunction,energy metabolism regulation,oncogenesis promotion,complex iii disruption,cellular homeostasis maintenance,electron transport chain alteration
ENSG00000105967,TFEC,tgf-β signaling,constitutive activation,oncogenic potential,cell proliferation,transcriptional regulation,immune system modulation
ENSG00000156136,DCK,enhanced nucleoside metabolism,tumor growth promotion,cell proliferation support,chemotherapy resistance,poor prognosis association,dna repair facilitation
ENSG00000132518,GUCY2D,cancer-related alterations,tumor suppressor function,loss-of-function mutations,oncogenesis pathway,cell proliferation regulation,genomic stability maintenance
ENSG00000198185,ZNF334,cellular proliferation,transcriptional regulation,epigenetic modulation,oncogene activity,apoptosis regulation,tumor progression
ENSG00000104938,CLEC4M,tumor progression,cell adhesion,immune response modulation,oncogene activation,protein-protein interaction,glycoprotein recognition
ENSG00000067992,PDK3,regulation of energy metabolism,tumor growth promotion,warburg effect,cellular redox balance,apoptosis resistance,metabolic reprogramming
ENSG00000214274,ANG,angiogenesis,overexpression,vascularization,tumor growth,immune suppression,oncogenic potential
ENSG00000175215,CTDSP2,transcriptional corepressor,cell proliferation regulation,apoptosis resistance,tumor aggressiveness promotion,genetic interaction regulation,oncogenic process facilitation
ENSG00000172260,NEGR1,downregulated tumor suppressor,cell proliferation inhibition,transcription factor activity,pi3k/akt pathway interaction,prognostic marker potential,therapeutic target candidate
ENSG00000167881,SRP68,aberrant expression,cancer progression,chemosensitivity alterations,mitochondrial function disruption,protein folding regulation,signal transduction alteration
ENSG00000150361,KLHL1,pi3k/akt pathway,loss-of-function mutations,cell cycle regulation,protein-protein interactions,protein degradation,e3 ubiquitin ligase complex
ENSG00000198455,ZXDB,genomic instability,tumor suppressor interaction,dna damage response regulation,cell cycle progression regulation,chromatin remodeling,transcriptional regulation
ENSG00000131941,RHPN2,rhpn2 is implicated in promoting oncogenic processes,hippo signaling pathway regulation,tumor aggressiveness enhancement,downstream target activation,cell growth promotion,tumor metastasis facilitation
ENSG00000131669,NINJ1,nf-?b signaling pathway,gain of function mutations,immune evasion mechanisms,tumor microenvironment disruption,cancer immunotherapy target,genomic instability
ENSG00000108641,B9D1,genomic instability,cell proliferation,chromatin remodeling,transcriptional regulation,oncogene overexpression,cell cycle checkpoint disruption
ENSG00000118194,TNNT2,pi3k/akt signaling,oncogenic process,epithelial-to-mesenchymal transition (emt),cell proliferation,genome instability,cancer-related transcription
ENSG00000155846,PPARGC1B,metabolic reprogramming,glycolytic enhancement,angiogenesis promotion,tumor growth promotion,oncogenic pathway interaction,transcriptional regulation
ENSG00000069764,PLA2G10,inflammation,cell proliferation,metastasis,protein-protein interactions,tumor progression,eicosanoid production
ENSG00000166582,CENPV,centromere dysfunction,genomic instability,chromosomal abnormalities,cell cycle regulation,kinetochore complex,mitotic checkpoint
ENSG00000136449,MYCBPAP,transcriptional regulation,chromatin remodeling,apoptosis evasion,oncogene regulation,genomic instability,telomere maintenance
ENSG00000125912,NCLN,genomic instability,cell cycle progression,chromatin remodeling,nuclear envelope integrity,metastatic potential,tumorigenesis driver
ENSG00000168955,TM4SF20,cell adhesion regulation,epithelial-to-mesenchymal transition (emt),oncogenic signaling pathways,cell migration and invasion,promoter of anoikis resistance,metastasis promoter
ENSG00000105711,SCN1B,channel regulation,genetic interaction,tumor progression,signaling modulation,cellular excitability,protein-protein interaction
ENSG00000122481,RWDD3,rna-binding protein,wd40 repeat-containing protein,cell cycle regulation,transcriptional regulator,protein-protein interaction mediator,genetic instability modulator
ENSG00000146263,MMS22L,genomic instability,dna repair pathway,tumor suppressor gene,cell cycle regulation,checkpoint activation,nucleotide excision repair
ENSG00000166170,BAG5,co-chaperone activity,protein folding regulation,cell survival enhancement,genomic instability induction,dna damage response facilitation,oncogenic signaling pathway interaction
ENSG00000119787,ATL2,gtp-binding protein,cell growth regulation,oncogenic signaling pathway activation,metastasis modulation,endosomal trafficking regulation,rab gtpase interaction
ENSG00000111305,GSG1,genomic instability,dna repair defects,cell cycle deregulation,oncogenic mutations,cancer driver gene,tumor progression
ENSG00000100034,PPM1F,tumor suppressor function,dephosphorylation activity,cell cycle regulation,apoptosis promotion,pi3k/akt pathway inhibition,genetic mutation association
ENSG00000181035,SLC25A42,metabolic regulation,cellular redox balance,energy production modulation,tumor development driver,mitochondrial carrier protein,therapeutic target
ENSG00000273572,CDHR5,epithelial-to-mesenchymal transition,biomarker upregulation,adhesion molecule interaction,tumor progression,metastasis association,oncogenic dysregulation
ENSG00000139679,LPAR6,lpa-mediated signaling,cell proliferation,receptor activation,angiogenesis regulation,tumor progression,g protein-coupled receptor family
ENSG00000167080,B4GALNT2,glycosylation initiation,cell adhesion modulation,oncogenic signaling,tumor progression factor,metastasis facilitation,immune response modification
ENSG00000173137,ADCK5,coenzyme q biosynthesis,mitochondrial function,loss of function mutations,energy metabolism regulation,oncogenic signaling pathway activation,tumor suppression impairment
ENSG00000186088,GSAP,regulation of glutamine metabolism,glutaminase activation,nucleotide synthesis,cellular proliferation,metabolic reprogramming,oncogenic transformation
ENSG00000241878,PISD,calcium signaling,phospholipase activity,protein kinase c activation,cell growth regulation,metabolic regulation,tumor progression
ENSG00000068079,IFI35,protein-protein interactions,enhanced cell survival,tumor promotion,transcriptional regulation,cellular proliferation,genetic predisposition
ENSG00000164749,HNF4G,loss of function mutations,altered gene expression,cellular differentiation,metabolic regulation,transcriptional regulation,pi3k/akt signaling
ENSG00000143257,NR1I3,ligand-activated transcription factor,detoxification regulation,xenobiotic response element (xre) binding,chemotherapy resistance,cell cycle progression modulation,apoptosis inhibition
ENSG00000159335,PTMS,oncogenic regulation,methylation modification,protein stabilization,signal transduction,cell proliferation,tumorigenesis
ENSG00000132423,COQ3,mitochondrial function,mitochondrial respiratory chain,oncogenic process,electron transport chain,uncontrolled cell growth,cellular respiration
ENSG00000163611,SPICE1,chromatin remodeling,oncogene overexpression,cell proliferation,transcriptional regulation,cancer cell survival,tumor suppressor interaction
ENSG00000140519,RHCG,retinol transport,cellular proliferation,tumor growth promotion,metastasis enhancement,epithelial-to-mesenchymal transition regulation,placental expression
ENSG00000197977,ELOVL2,fatty acid biosynthesis,cell membrane integrity,membrane fluidity regulation,lipid raft formation,serine protein kinase activation,tumor growth promotion
ENSG00000198040,ZNF84,transcriptional regulation,oncogene activation,cell proliferation,metastatic potential,tumor suppressor loss,gene expression dysregulation
ENSG00000112303,VNN2,cell growth regulation,tumor progression,g-protein coupled receptor function,epigenetic regulation,transcriptional modulation,lipid metabolism regulation
ENSG00000159261,CLDN14,wnt/β-catenin signaling pathway,cellular permeability regulation,epithelial-to-mesenchymal transition,tight junction disruption,cancer cell migration,cell polarity dysregulation
ENSG00000137500,CCDC90B,microtubule regulation,gene overexpression,protein-protein interactions,oncogenic driver,cancer cell proliferation,genome stability maintenance
ENSG00000118507,AKAP7,cellular signaling,oncogenic driver,chromatin remodeling,kinase anchoring,cell proliferation regulation,metastasis promotion
ENSG00000166963,MAP1A,microtubule regulation,cell division,cell proliferation,oncogenic transformation,chemotherapy resistance,microtubule dynamics
ENSG00000187607,ZNF286A,transcriptional regulation,g1 phase progression,cell proliferation,tumor growth,apoptosis inhibition,genomic instability
ENSG00000242550,SERPINB10,tumor progression,protease inhibition,cell proliferation regulation,apoptosis modulation,serine protease inhibitor activity,cancer cell invasion
ENSG00000124641,MED20,transcriptional regulation,gene assembly,cell proliferation,tumor growth,genomic instability,protein complex formation
ENSG00000156475,PPP2R2B,regulatory function,dephosphorylation activity,loss of function mutations,tumor progression,cell cycle regulation,apoptosis modulation
ENSG00000197915,HRNR,hrnr,adherens junction disruption,cell-cell adhesion regulation,epithelial-to-mesenchymal transition,tumor progression,therapeutic target
ENSG00000140451,PIF1,genomic instability,dna repair,tumor suppressor,helicase activity,nuclear localization,genetic alterations
ENSG00000037241,RPL26L1,oncogene activation,cell proliferation enhancement,therapeutic target identification,genomic profiling analysis,resistance to therapy development,tumor progression facilitation
ENSG00000101892,ATP1B4,altered expression,cell survival,dysregulation,na+/k+ pump regulation,oncogenesis,potential therapeutic target
ENSG00000205922,ONECUT3,oncogene activity,gene overexpression,promotes cell proliferation,regulates emt process,tumor progression,transcription factor function
ENSG00000116039,ATP6V1B1,tumor growth,oncogenic processes,cellular homeostasis,ion homeostasis,protein regulation,signaling pathway activation
ENSG00000137106,GRHPR,glyoxylic acid reduction,hydroxy(pyruvic acid reductase,cellular metabolism alteration,tumor suppressor potential,protein-protein interactions,genetic instability response
ENSG00000157303,SUSD3,surface-expressed protein,immune response modulation,epithelial-to-mesenchymal transition (emt),cell migration and invasion,potential tumor suppressor function,genetic alterations in tumorigenesis
ENSG00000111845,PAK1IP1,cellular proliferation,signaling molecule regulation,rho gtpase interaction,oncogenic processes,prognostic marker,therapeutic target
ENSG00000187735,TCEA1,transcriptional coactivation,tumor progression,oncogenic process,cell growth promotion,gene expression regulation,overexpression in cancer
ENSG00000154645,CHODL,bmp signaling pathway,oncogene/tumor suppressor,cell proliferation regulation,cell differentiation regulation,epigenetic modification,genomic instability
ENSG00000129353,SLC44A2,sphingolipid metabolism,cellular lipid homeostasis,tumorigenesis,apoptosis regulation,genetic alterations,cancer progression
ENSG00000173714,WFIKKN2,cell survival,pi3k/akt signaling,protein kinase activation,tumor progression,growth regulation,apoptosis modulation
ENSG00000134812,CBLIF,tumor suppression,oncogene regulation,ubiquitin ligase activity,protein degradation,cell cycle regulation,signal transduction
ENSG00000178921,PFAS,epigenetic regulation,signaling pathway modulation,oncogenic process promotion,aberrant cell proliferation,tumorigenesis facilitation,genomic instability maintenance
ENSG00000163520,FBLN2,angiogenesis,cell adhesion,extracellular matrix interaction,tumor progression,therapeutic target,metastasis driver
ENSG00000164758,MED30,transcriptional regulation,co-activator function,cell proliferation,oncogenic processes,genomic instability,protein-protein interactions
ENSG00000065970,FOXJ2,transcriptional regulation,tumor suppressor function,loss of expression,cell proliferation,oncogenic role,therapeutic target
ENSG00000166987,MBD6,histone modification regulation,epigenetic silencing,tumor suppressor function,chromatin remodeling complex interaction,genome stability maintenance,dna binding specificity
ENSG00000165521,EML5,microtubule dynamics,histone modification,tumorigenesis,metastasis,genomic instability,oncogenic transformation
ENSG00000135837,CEP350,cell cycle regulation,centriole formation,cilia assembly,genomic instability,oncogenic mutations,microtubule dynamics
ENSG00000185177,ZNF479,transcriptional regulation,genomic stability,apoptosis modulation,cell cycle regulation,tumorigenesis association,zinc finger protein function
ENSG00000144746,ARL6IP5,overexpression,tumor progression,cellular trafficking regulation,metastasis facilitation,gtpase activity modulation,signaling pathway regulation
ENSG00000006607,FARP2,rho gtpase regulation,cell migration,cytoskeleton reorganization,oncogenic process promotion,prognostic marker,therapeutic target
ENSG00000095209,TMEM38B,soce regulation,calcium homeostasis,tumor progression,therapeutic target,cellular proliferation,intracellular signaling
ENSG00000164600,NEUROD6,transcriptional regulation,chromatin remodeling complex interaction,cellular differentiation disruption,oncogenic transcription factor,neurogenesis specification disruption,tumorigenesis driver
ENSG00000114650,SCAP,endoplasmic reticulum stress,sterol regulatory element-binding proteins,lipid biosynthesis regulation,cellular lipid homeostasis,tumor progression,therapeutic target
ENSG00000167780,SOAT2,lipid metabolic reprogramming,cell growth promotion,apoptosis resistance,oncogenic pathway activation,therapeutic target identification,genomic profiling alterations
ENSG00000169641,LUZP1,transcriptional regulation,cell growth control,chromatin remodeling,tumorigenesis driver,therapeutic target,overexpression
ENSG00000144559,TAMM41,mrna export,cell proliferation,rna binding protein,tumor suppressor function,cell cycle regulation,genetic instability
ENSG00000115657,ABCB6,abcb transporter family,cellular detoxification,multidrug resistance,xenobiotic efflux,redox balance modulation,tumor progression
ENSG00000136770,DNAJC1,mitochondrial regulation,erad pathway modulation,protein folding chaperone function,cellular survival enhancement,metabolic reprogramming driver,tumor suppressor potential
ENSG00000170242,USP47,p53 stabilization,tumor suppressor regulation,cell survival promotion,cancer progression driver,cellular process modulation,protein degradation regulation
ENSG00000136875,PRPF4,aberrant splicing,chromatin remodeling,genomic instability,gene expression regulation,transcriptional dysregulation,oncogenic mutations
ENSG00000241468,ATP5MF,mitochondrial localization,ribosomal assembly,translation regulation,mitochondrial dynamics,none,none
ENSG00000176692,FOXC2,transcription factor activity,oncogene overexpression,epithelial-to-mesenchymal transition (emt),cell growth regulation,metastasis promotion,poor prognosis indicator
ENSG00000196407,THEM5,thrombin-like proteolytic activity,apoptosis regulation,cancer cell invasion,metastasis facilitation,pi3k/akt signaling modulation,potential therapeutic target
ENSG00000108826,MRPL27,mitochondrial biogenesis,mitochondrial protein translation,electron transport chain regulation,oncogenic reprogramming,rapid cell growth,cellular respiration modulation
ENSG00000197362,ZNF786,apoptosis regulation,cancer progression,cell proliferation,dna-binding activity,immune response modulation,transcriptional regulation
ENSG00000125846,ZNF133,pi3k/akt pathway disruption,tumor suppressor function,cell growth regulation,chromatin remodeling,gene expression modulation,transcriptional regulation
ENSG00000085185,BCORL1,epigenetic regulation,chromatin remodeling,transcriptional repression,tumor suppressor function,loss-of-function mutations,oncogenic reprogramming
ENSG00000188833,ENTPD8,tumor progression,immune modulation,purinergic signaling,angiogenesis enhancement,protein-protein interaction,upregulated expression
ENSG00000213015,ZNF580,tumor suppressor/oncogene,krab domain-containing zinc finger protein,gene expression regulation,cellular proliferation/differentiation,apoptosis/immune responses modulation,dual role in cancer progression
ENSG00000184497,TMEM255B,er stress response,transmembrane protein,cellular homeostasis,onco-protein folding,autophagy modulation,tumor progression marker
ENSG00000037757,MRI1,mitotic arrest regulation,genomic instability,chromosome segregation,cell cycle checkpoint,spindle assembly,dna damage response
ENSG00000141485,SLC13A5,metabolic reprogramming,tumor growth promotion,cellular uptake regulation,nutrient transport facilitation,therapeutic target,poor prognosis association
ENSG00000126461,SCAF1,chromatin remodeling,transcriptional regulation,cell cycle progression,apoptosis modulation,tumor suppressor interaction,genomic instability
ENSG00000154370,TRIM11,trim11 tumor suppressor,oncogene regulation,cell growth inhibition,apoptosis induction,cancer susceptibility,gene expression regulation
ENSG00000198246,SLC29A3,enhances cell proliferation,regulates adenosine uptake,implicated in oncogenesis,dysregulation leads to tumorigenesis,therapeutic target,modulates pi3k/akt pathway
ENSG00000119471,HSDL2,lipid regulation,cell proliferation,pro-survival signaling,oncogenic function,metabolic reprogramming,genetic amplification
ENSG00000129158,SERGEF,oncogene activation,alternative splicing regulation,rna binding protein,tumor suppressor modulation,cell proliferation promotion,transcriptional regulation
ENSG00000150048,CLEC1A,immune modulation,cancer progression,cell recognition,nk cell activation,tumor microenvironment,epithelial cell interaction
ENSG00000198231,DDX42,cell growth regulation,oncogene role,rna metabolism regulation,tumor progression,protein-protein interactions,overexpression in cancer tissues
ENSG00000082212,ME2,monoamine regulation,neurotransmitter degradation,mitochondrial localization,oxidative stress modulation,tumor microenvironment manipulation,therapeutic target
ENSG00000180767,CHST13,tumor progression,cell adhesion,cell migration,protein-protein interaction,glycosylation regulation,oncogene activity
ENSG00000139718,SETD1B,histone methylation,epigenetic regulation,oncogenic processes,chromatin remodeling,pi3k/akt pathway interaction,tumorigenesis driver
ENSG00000130414,NDUFA10,mitochondrial dysfunction,metabolic reprogramming,warburg effect alteration,energy metabolism regulation,oncogene involvement,tumor microenvironment adaptation
ENSG00000110048,OSBP,lipid metabolism,oncogenic signaling,cell proliferation,apoptosis suppression,cholesterol transport,protein-protein interaction
ENSG00000172954,LCLAT1,lipid metabolism disruption,cell survival enhancement,pi3k/akt pathway interaction,tumor progression promotion,overexpression association,cancer cell growth facilitation
ENSG00000179361,ARID3B,epigenetic regulation,chromatin remodeling,transcriptional modulation,cell cycle regulation,dna repair mechanisms,genomic instability
ENSG00000114988,LMAN2L,glycosylation regulation,tumor progression,cellular transport modification,metastasis facilitation,lysosomal enzyme sorting,cell signaling modulation
ENSG00000185176,AQP12B,transmembrane protein,cell migration regulator,tumor progression factor,metastasis promoter,prognostic marker,signal transduction activator
ENSG00000103342,GSPT1,ribosome biogenesis,cell proliferation,apoptosis inhibition,oncogene activation,rna-binding interactions,cell cycle regulation
ENSG00000013374,NUB1,nub1 protein,dna damage response,cell cycle regulation,tumor growth promotion,oncogene function,p53 interaction
ENSG00000159433,STARD9,lipid metabolism regulation,multifunctional protein,tumor progression,membrane trafficking regulation,oncogene activation,phospholipid transport modification
ENSG00000187513,GJA4,gap junction communication,oncogenic potential,tumor progression,intercellular signaling,cellular proliferation,epigenetic regulation
ENSG00000186480,INSIG1,insulin signaling pathway regulation,lipid metabolism regulation,tumor suppressor function,metabolic reprogramming,anabolic pathways activation,insulin-induced gene expression
ENSG00000185896,LAMP1,lysosomal function regulation,tumor progression,metastasis facilitation,immune evasion mechanism,cell migration regulation,prognostic marker
ENSG00000092108,SCFD1,ubiquitin-proteasome pathway,tumor progression,cell cycle regulation,apoptosis modulation,protein interaction,rna binding
ENSG00000242173,ARHGDIG,rho gtpase regulation,cytoskeleton reorganization,cell migration promotion,oncogenic signaling activation,g-protein modulation,metastasis association
ENSG00000155980,KIF5A,microtubule dynamics regulation,cell cycle regulation,mitotic spindle assembly,aberrant proliferation,oncogenic driver,tumor progression
ENSG00000146802,TMEM168,membrane trafficking regulation,cell adhesion modulation,tumor progression facilitation,oncogenic protein-protein interactions,cancer cell migration enhancement,metastasis promotion
ENSG00000162852,CNST,neurodevelopmental regulation,cell adhesion molecule,synaptic plasticity regulation,pi3k/akt pathway interaction,oncogenic mutations,tumor progression and metastasis
ENSG00000282725,CORO7,cytoskeletal regulation,cell migration enhancement,tumor progression facilitation,prognostic biomarker,actin filament interaction,signaling pathway modulation
ENSG00000131242,RAB11FIP4,rab gtpase regulation,endocytic recycling,oncogenic protein interaction,cell migration enhancement,tumor progression facilitation,therapeutic target candidacy
ENSG00000108469,RECQL5,genomic instability,cancer driver,dna repair mechanism,homologous recombination,replication fork stability,cell cycle regulation
ENSG00000049769,PPP1R3F,cellular regulation,genomic instability,tumor suppressor function,cell cycle checkpoint,regulatory subunit mutation,protein phosphatase 1 interaction
ENSG00000282752,CTDP1,rnapii phosphorylation,chromatin remodeling,genomic instability,tumor suppressor function,transcriptional elongation,rna metabolism
ENSG00000187091,PLCD1,phospholipase c activity,calcium homeostasis regulation,oncogenic transformation,cell proliferation enhancement,signaling pathway modulation,gene amplification events
ENSG00000071794,HLTF,genomic stability maintenance,transcriptional regulation,dna damage response,chromatin remodeling,cell cycle regulation,epigenetic alteration
ENSG00000100100,PIK3IP1,pi3k regulation,tumor suppressor,oncogenic pathway activation,cell survival enhancement,growth factor signaling,akt pathway modulation
ENSG00000196365,LONP1,mitochondrial function,protein quality control,cellular stress response,oncogene upregulation,tumor growth promotion,therapeutic target
ENSG00000166926,MS4A6E,b-cell signaling pathway,cell membrane protein,immune system regulation,gene expression modulation,protein-protein interaction,lymphoid tissue involvement
ENSG00000176402,GJC3,intercellular communication,cellular signaling,gap junction proteins,tumor progression,oncogenesis,potential tumor suppressor
ENSG00000115844,DLX2,cell proliferation,tumor progression,oncogene,transcription factor regulation,epithelial-to-mesenchymal transition (emt),cancer cell invasion
ENSG00000139515,PDX1,oncogene activation,aberrant expression,cell proliferation,tumor growth,transcriptional regulation,therapeutic target
ENSG00000100330,MTMR3,pi(3)p dephosphorylation,tumor suppressor function,cellular regulation,phosphoinositide metabolism,signaling pathway modulation,genomic instability
ENSG00000119718,EIF2B2,regulation of translation initiation,stress response modulation,tumor progression promotion,cell growth enhancement,protein synthesis regulation,oncogene activation
ENSG00000115211,EIF2B4,translation initiation,cell proliferation,tumor progression,protein synthesis regulation,cell growth control,genomic instability
ENSG00000183729,NPBWR1,nuclear receptor signaling,androgen receptor regulation,transcriptional activation,tumor promotion,steroid hormone interaction,cancer progression
ENSG00000154783,FGD5,gain of function mutations,oncogenic transformation,modulation of migration and invasion pathways,regulation of rho gtpase activity,potential therapeutic target,cell proliferation and survival
ENSG00000120915,EPHX2,dna damage repair,apoptosis induction,tumor suppression,genetic instability,cell cycle regulation,oxidative stress protection
ENSG00000163909,HEYL,tumor suppressor/oncogene,notch signaling pathway inhibition,cell cycle regulation,apoptosis regulation,biomarker potential,gene expression regulation
ENSG00000197457,STMN3,microtubule destabilization,cell migration and invasion,stem cell maintenance,epithelial-to-mesenchymal transition (emt),kinase regulation,aurora kinase activation
ENSG00000205944,DAZ2,genomic instability,tumor suppressor activity,rna-binding domain,oncogene function,dna damage response regulation,chromatin remodeling modulation
ENSG00000103671,TRIP4,mitochondrial function regulation,energy metabolism alteration,cellular proliferation promotion,apoptosis regulation,autophagy modulation,oncogenic process contribution
ENSG00000163291,PAQR3,orphan nuclear receptor,cell proliferation,apoptosis resistance,cancer development,poor prognosis,akt/pi3k signaling interaction
ENSG00000135723,FHOD1,chromatin remodeling,transcriptional regulation,cellular proliferation,protein-protein interactions,tumor progression,genomic instability
ENSG00000125375,DMAC2L,glycosylation regulation,oncogenic mutations,cell proliferation,tumor progression,therapeutic resistance,protein kinase activation
ENSG00000174279,EVX2,tumor suppressor activity,cell cycle regulation,apoptosis induction,chromatin remodeling,transcriptional repression,hematopoietic cell regulation
ENSG00000277893,SRD5A2,androgen metabolism,dihydrotestosterone production,oncogenic transformation,androgen receptor signaling,cell proliferation enhancement,prostate cancer aggressiveness 
ENSG00000196743,GM2A,lysosomal degradation,ganglioside metabolism,membrane composition,lipid homeostasis,oncogenic processes,therapeutic target
ENSG00000203857,HSD3B1,steroid hormone synthesis,androgen production,oncogenic potential,chemotherapy resistance,targeted therapy evasion,protein-protein interactions
ENSG00000116199,FAM20B,pi3k/akt signaling,oncogenesis,tumor progression,cell proliferation,apoptosis resistance,bone mineralization regulation
ENSG00000104140,RHOV,cellular transformation,gain of function mutations,cell migration,rho gtpase activity,tumor progression,signaling pathway modulation
ENSG00000170903,MSANTD4,methylated histone recognition,tumor suppressor function,genomic stability regulation,dna methylation regulation,chromatin remodeling,epigenetic modification
ENSG00000119729,RHOQ,pi3k/akt pathway,constitutive activation,gtpase activity,oncogenic transformation,cell proliferation,protein-protein interaction
ENSG00000115486,GGCX,aberrant expression,bone mineralization,cell growth promotion,cell proliferation,tgf-β pathway regulation,vitamin k-dependent protein modification
ENSG00000198597,ZNF536,tumor suppressor activity,regulation of transcription,cell cycle regulation,apoptosis modulation,dna repair interaction,loss of function mutation
,MARS,aberrant protein degradation,global translation initiation regulation,oncogenic processes promotion,cell growth and survival enhancement,mtor pathway interaction,protein synthesis regulation
ENSG00000197712,FAM114A1,cell proliferation,tumor progression,oncogene,protein interaction,signal transduction,genetic deregulation
ENSG00000167632,TRAPPC9,vesicular trafficking,oncogenic mutations,cell proliferation,genomic instability,tumor progression,cancer aggressiveness
ENSG00000130772,MED18,transcriptional regulation,tumor progression,cellular growth,genomic instability,therapeutic target,chromatin modification
ENSG00000133250,ZNF414,wnt/β-catenin pathway activation,transcriptional regulator,oncogenic gene expression,cell proliferation driver,epithelial-to-mesenchymal transition (emt),chromatin remodeling interaction
ENSG00000158486,DNAH3,axonemal dynein complex assembly,dynein heavy chain subunit,cell migration and invasion,tumor progression and metastasis,cilia motility and maintenance,epithelial cell signaling and transport
ENSG00000076770,MBNL3,regulation of alternative splicing,rna-binding protein,tumor progression,post-transcriptional control,cell growth regulation,oncogenic processes
ENSG00000183520,UTP11,genomic instability,alternative splicing,spliceosome regulation,oncogenic protein production,chromatin modification interaction,therapeutic target
ENSG00000164329,TENT2,tumor suppressor function,cell adhesion disruption,loss of function mutations,oncogenic process activation,therapeutic target,genomic profiling
ENSG00000128567,PODXL,cell adhesion,tumor progression,metastasis facilitation,oncogene function,cell migration regulation,epithelial-mesenchymal transition
ENSG00000106927,AMBP,proteinase inhibition,immunomodulation,cell proliferation regulation,antitumor activity,potential biomarker,altered expression
,C5orf30,cellular stress response,poorly characterized protein,regulation of cell cycle,unknown gene function,altered expression levels,cancer genome atlas annotation
ENSG00000171443,ZNF524,krab-domain transcriptional regulator,cell cycle regulation,apoptosis induction,tumor suppression,histone modification,transcriptional repression
ENSG00000049323,LTBP1,tgf-β signaling,gain of function mutations,cell proliferation,oncogenic process,tumor progression,therapeutic target
ENSG00000204531,POU5F1,cancer stem cell maintenance,cellular self-renewal,transcription factor activity,embryonic development regulation,oncogenic properties,enhanced proliferation
ENSG00000130598,TNNI2,contractile apparatus regulation,oncogene,cell proliferation,survival signaling pathway,muscle contraction,tumorigenesis driver
ENSG00000116586,LAMTOR2,mtor pathway regulation,autophagy modulation,cell growth promotion,oncogenic process activation,protein-protein interaction,tumor progression association
ENSG00000107862,GBF1,erk pathway regulation,golgi apparatus functioning,cell cycle modulation,cancer microenvironment regulation,guanine nucleotide exchange factor activity,protein-protein interaction
ENSG00000119673,ACOT2,acetyltransferase activity,fatty acid metabolism regulation,metabolic reprogramming,cellular energy production,oncogene involvement,pi3k/akt pathway interaction
ENSG00000161558,TMEM143,er stress regulation,autophagy induction,cell survival promotion,tumor suppressor function,protein-protein interaction,endoplasmic reticulum membrane localization
ENSG00000143028,SYPL2,phosphatidylinositol 3-kinase pathway regulation,membrane lipid metabolism modulation,lipid raft formation regulation,cell proliferation enhancement,survival signal transduction,protein-protein interaction modulation
ENSG00000118193,KIF14,mitotic spindle assembly,chromosome segregation,cell cycle regulation,genomic stability maintenance,microtubule stabilization,oncogenic transformation
ENSG00000123096,SSPN,disrupted cell adhesion,cancer progression,cell motility regulation,cytoplasmic protein assembly,tumor suppressor activity loss,cytoskeletal organization disruption
ENSG00000123171,CCDC70,centriole duplication,cilia formation regulation,cellular polarity regulation,mitotic spindle assembly,oncogenic processes promotion,therapeutic target potential
ENSG00000141759,TXNL4A,thioredoxin-like protein,cellular survival,protein-protein interaction,oncogenic processes,pi3k/akt pathway activation,genomic instability
ENSG00000129484,PARP2,parp-mediated dna repair,telomere maintenance,oncogenic transformation,epigenetic regulation,transcriptional modulation,nuclear function
ENSG00000231924,PSG1,tumor progression,immune response modulation,cell proliferation regulation,biomarker for tumorigenesis,growth factor interaction,cytokine signaling modulation
ENSG00000183454,GRIN2A,nmda receptor activation,overexpression mutations,cell proliferation regulation,tumor progression driver,synaptic plasticity dysregulation,ion channel function alteration
ENSG00000257949,TEN1,telomere maintenance,dna repair mechanism,genome stability regulation,senescence suppression,oncogene function,prognostic marker
ENSG00000125378,BMP4,tumor suppression,cell proliferation regulation,embryonic development,osteogenesis,angiogenesis regulation,wnt/β-catenin pathway interaction
ENSG00000164647,STEAP1,iron homeostasis regulation,cell proliferation promotion,oncogenic protein-protein interaction,angiogenesis enhancement,tumor growth facilitation,prognostic biomarker potential
ENSG00000144736,SHQ1,genomic instability,dna double-strand breaks repair,homologous recombination,non-homologous end joining,chromosomal rearrangements,genome maintenance
ENSG00000079313,REXO1,genomic instability,dna repair mechanism,nucleotide excision repair,interstrand crosslink repair,mutational burden,tumor suppressor function
ENSG00000168872,DDX19A,rna helicase activity,tumorigenesis promotion,cell cycle regulation,transcription regulation,genetic instability contribution,oncogenic driver mutation
ENSG00000138379,MSTN,tumor suppression,muscle growth regulation,negative regulator,cell proliferation inhibition,downregulation in cancer,secreted protein
ENSG00000111707,SUDS3,oncogenic,transcriptional regulation,chromatin remodeling,histone modification,cellular proliferation,tumorigenesis
ENSG00000174371,EXO1,genomic instability,dna repair enzyme,tumor suppressor/oncogene,biomarker/therapeutic target,pi3k/akt pathway regulation,p53 interaction
ENSG00000166479,TMX3,chromatin remodeling,transcriptional regulation,tumor progression,oncogenic potential,apoptosis evasion,genomic instability
ENSG00000123388,HOXC11,homeobox transcription factor,oncogenic role,cell proliferation enhancement,tumor progression promoter,poor prognosis indicator,metastasis enhancer
ENSG00000152332,UHMK1,regulation of p53 activity,phosphorylation of cdk2,cell proliferation regulation,dna damage response modulation,tumor suppressor/pro-oncogene dualism,serine/threonine kinase activity
ENSG00000166337,TAF10,aberrant transcription,cancer cell proliferation,cell survival pathways,genetic regulation,oncogene interaction,tumor progression
ENSG00000009307,CSDE1,cancer driver,oncogene activation,cell cycle regulation,apoptosis evasion,rna-binding protein,multifunctional protein
ENSG00000010404,IDS,glycosphingolipid storage disorder,metabolic regulation,cholesterol biosynthesis,enzymatic activity,genetic mutations,lipid metabolism
ENSG00000053371,AKR7A2,metabolic reprogramming,oxidative stress regulation,tumor growth promotion,detoxification pathway,cellular protection enhancement,cancer cell survival support
ENSG00000162482,AKR7A3,tumor suppressor,cellular homeostasis,oxidative stress regulation,protein-protein interaction,dna damage response,therapeutic target
ENSG00000275066,SYNRG,overexpression,promotes cell proliferation,microtubule regulation,cancer progression,biomarker candidate,protein-protein interactions
ENSG00000129170,CSRP3,tumor progression,epithelial-to-mesenchymal transition,cell migration,cancer metastasis,poor prognosis,regulatory mechanism
ENSG00000136950,ARPC5L,constitutive activation,arp2/3 complex interaction,cell migration,metastasis promotion,cancer progression,therapeutic target
ENSG00000155868,MED7,transcription elongation,oncogene expression,tumor suppressor gene repression,basal transcription machinery,transcriptional regulation,rna polymerase ii recruitment
ENSG00000128595,CALU,cellular regulation,signaling pathway interaction,oncogenic modulation,metastasis regulation,apoptosis dysregulation,tumor progression
ENSG00000135824,RGS8,tumor suppressor function,g-protein coupled receptor signaling,regulation of g-protein activity,modulation of oncogenic pathways,cellular growth regulation,adenylyl cyclase activation
ENSG00000005893,LAMP2,lysosomal regulation,autophagy modulation,pro-tumorigenic function,tumor progression,cellular survival,prognostic biomarker
ENSG00000053900,ANAPC4,cell cycle regulation,g2/m phase transition,chromosomal instability,tumor progression,oncogene activation,cell proliferation
ENSG00000123191,ATP7B,copper homeostasis,regulatory protein,cellular proliferation,apoptosis regulation,metal ion transport,oncogenic processes
ENSG00000128805,ARHGAP22,rho gtpase regulation,tumor suppressor function,cell migration inhibition,proliferation suppression,oncogenesis involvement,genomic downregulation
ENSG00000110881,ASIC1,ionotropic regulation,sodium influx facilitation,cell proliferation promotion,tumor growth enhancement,metastasis facilitation,therapeutic target
ENSG00000060971,ACAA1,mitochondrial metabolism,fatty acid oxidation pathway,energetic dysfunction,lipid biosynthesis,tumor growth regulation,cancer cell survival
ENSG00000130540,SULT4A1,sulfotransferase activity,cellular detoxification,metabolism regulation,neurotransmitter modulation,tissue-specific expression,biomarker potential
ENSG00000155066,PROM2,gef activity,rho gtpase activation,cell migration regulation,cancer progression,oncogenic role,gtp exchange factor
,ACPP,pi3k/akt signaling pathway regulation,tumor progression promotion,cell growth regulation,prognostic marker,proteoglycan regulation,metabolic regulation
ENSG00000157765,SLC34A2,oncogenic function,enhanced cell metabolism,phosphate homeostasis regulation,epithelial tissue expression,nutrient availability modulation,tumor progression driver
ENSG00000145321,GC,angiogenesis modulation,immune system interaction,tumor growth promotion,metastasis facilitation,cell adhesion regulation,chemoattractant function
ENSG00000168481,LGI3,cell signaling regulation,cell migration modulation,tumor progression facilitation,protein-protein interactions,cell adhesion regulation,cancer biomarker potential
ENSG00000154252,GAL3ST2,cell adhesion,metastasis promotion,tumor progression,glycosylation regulation,signaling pathway modulation,therapeutic target
ENSG00000118418,HMGN3,chromatin regulation,epigenetic alteration,dna repair,transcriptional regulation,apoptosis resistance,cell proliferation
ENSG00000181790,ADGRB1,tumor suppressor,cell adhesion regulation,gpcr signaling pathway,oncogenic process inhibition,cell migration regulation,metastasis suppression
ENSG00000152990,ADGRA3,tumor progression,receptor overexpression,cell signaling activation,protein-protein interactions,cancer cell migration,therapeutic target
ENSG00000139352,ASCL1,neural crest maintenance,transcriptional regulation,oncogenic driver,cancer stem cell maintenance,tumor progression,therapeutic target
ENSG00000116685,KIAA2013,alternative splicing,cell proliferation,tumor progression,gene expression regulation,rna processing,apoptosis inhibition
ENSG00000182393,IFNL1,jak/stat signaling pathway,immune evasion,tumor suppression,genetic variation,antiviral defense,chromosomal location
ENSG00000156049,GNA14,g protein subunit alpha 14,signaling pathway regulation,tumor progression,cell proliferation regulation,oncogenic potential,genomic instability
ENSG00000129422,MTUS1,microtubule regulation,tumor suppressor function,rho gtpase signaling pathway,cell cycle regulation,microtubule dynamics disruption,tumor progression
ENSG00000138675,FGF5,tumor progression,epithelial-to-mesenchymal transition,regulatory pathway activation,cell proliferation regulation,dysregulated expression,genomic instability
ENSG00000159387,IRX6,oncogene,transcription factor,cell proliferation,apoptosis inhibition,gene expression modulation,tumor progression
ENSG00000174564,IL20RB,oncogenic signaling,immune evasion,epithelial-to-mesenchymal transition,aberrant expression,cancer progression,inflammation mediation
ENSG00000168924,LETM1,mitochondrial dynamics,cellular homeostasis,oncogene or tumor suppressor,altered expression patterns,energy metabolism regulation,calcium regulation
ENSG00000177182,CLVS1,cellular proliferation,chromatin remodeling,apoptosis regulation,tumor development,cell cycle control,oncogenesis
ENSG00000138119,MYOF,actin filament dynamics,muscle contraction regulation,cytoskeleton regulation,cell migration modulation,protein-protein interaction,muscle degeneration association
ENSG00000018189,RUFY3,genomic instability,chromatin remodeling,dna repair mechanism,cellular proliferation,protein interaction network,tumor suppressor function
ENSG00000113812,ACTR8,chromatin remodeling,histone modification,epigenetic regulation,dna repair mechanisms,cell proliferation,tumor suppressor gene regulation
ENSG00000174151,CYB561D1,electron transport,oxidative phosphorylation,nadph oxidase activity,cellular redox balance,genomic instability,oncogenic potential
ENSG00000160087,UBE2J2,ubiquitination regulation,cellular homeostasis disruption,oncogene activation,therapeutic target,signaling pathway interaction,biomarker potential
ENSG00000005469,CROT,electron transport chain,warburg effect,mitochondrial function,tumor progression,oncogenic potential,glycolytic shift
ENSG00000168575,SLC20A2,phosphate homeostasis,cellular membrane transport,enhanced cell growth,oncogenic process,therapeutic target,genetic dysregulation
ENSG00000120662,MTRF1,mitochondrial regulation,tumor suppressor activity,cellular stress response,mrna stabilization,protein synthesis regulation,oncogenic mutations
ENSG00000149418,ST14,epithelial-to-mesenchymal transition,cell migration,proteolytic activity,oncogene overexpression,signaling pathway interaction,tumor progression
ENSG00000166762,CATSPER2,calcium permeability regulation,cell proliferation enhancement,oncogenic potential,epithelial-to-mesenchymal transition,sperm function dysregulation,cancer cell survival enhancement
ENSG00000186496,ZNF396,oncogenesis,tumor suppressor role dysregulation,overexpression,cell proliferation regulation,transcriptional repression,corepressor recruitment
ENSG00000006740,ARHGAP44,loss-of-function mutations,tumor suppressor function,rho gtpase regulation,cell proliferation control,microtubule stability maintenance,centrosome localization
ENSG00000163288,GABRB1,cellular regulation,signal transduction pathway,synaptic transmission,neuronal excitability,apoptosis regulation,genetic mutation response
ENSG00000164051,CCDC51,genomic instability,aneuploidy induction,centrosomal regulation,chromosomal segregation,microtubule dynamics,cell cycle regulation
ENSG00000166405,RIC3,aberrant expression,cell proliferation,cellular differentiation,oncogenic process,protein-protein interaction,retinoic acid transport
ENSG00000169604,ANTXR1,angiogenesis regulation,cell signaling pathway modulation,tumor suppressor function,negative regulator of ang-2,protein-protein interaction,post-translational modification regulation
ENSG00000143420,ENSA,tumor suppressor dysfunction,oncogenic mutation,rna binding protein function,nuclear localization,gene expression regulation,cancer-associated transcriptional signature
ENSG00000059122,FLYWCH1,ezh2 interactions,chromatin remodeling,epigenetic regulation,gene expression modulation,transcriptional control,histone methylation
ENSG00000197372,ZNF675,krab domain binding,zinc finger motif,transcriptional regulation,cell cycle progression,apoptosis modulation,chromatin remodeling
ENSG00000166526,ZNF3,transcriptional regulation,dna binding activity,tumor suppressor function,gene silencing,proliferation inhibition,apoptosis induction
ENSG00000187650,VMAC,genomic instability,mitotic checkpoint regulation,chromatin remodeling,dna repair mechanisms,p53 regulation,tumor suppressor function
ENSG00000140264,SERF2,ejc component,mrna splicing regulation,cell cycle progression,transcriptional regulation,protein-rna interactions,oncogenesis association
ENSG00000067798,NAV3,presenilin-related function,sequence homology,cellular regulation,protein interaction,genetic association,unknown cancer role
ENSG00000204822,MRPL53,mitochondrial biogenesis,energy metabolism,enhanced cell growth,poor prognosis,therapeutic target,dysregulation
ENSG00000065923,SLC9A7,lysosomal regulation,metabolic reprogramming,oncogenic processes,tumor cell growth,altered expression,poor prognosis
ENSG00000205857,NANOGNB,pluripotency maintenance,transcriptional regulation,tumor progression,aberrant expression,cell proliferation,poor prognosis
ENSG00000124140,SLC12A5,oncogenic regulation,electrolyte imbalance,cell proliferation,tumor progression,protein-protein interaction,transcriptional regulation
ENSG00000197780,TAF13,overexpression,transcriptional regulation,cell proliferation,survival signaling,tumorigenesis,genomic instability
ENSG00000160994,CCDC105,oncogene overexpression,pi3k/akt pathway modulation,tumor progression enhancement,cell proliferation increase,apoptosis resistance,ciliogenesis regulation
ENSG00000188120,DAZ1,mrna regulation,spermatogenesis,male fertility regulator,rna-binding protein,infertility association,azoospermia link
ENSG00000068354,TBC1D25,endosomal regulation,rab gtpase activation,tumor progression,oncogene expression,cellular proliferation,metabolic reprogramming
ENSG00000145241,CENPC,centromere organization,genomic instability,chromosome segregation,cell division regulation,aneuploidy driver,dna damage response
ENSG00000182263,FIGN,microtubule stabilization,gain of function mutations,tumor progression,cell survival,genomic instability,mitotic spindle formation
ENSG00000165349,SLC7A3,tumor growth,metabolic regulation,cellular proliferation,protein interaction,therapeutic target,cancer-associated gene
ENSG00000165887,ANKRD2,tumor suppressor pathway disruption,oncogene function,p53 regulation,cell cycle progression,apoptosis inhibition,protein degradation regulation
ENSG00000167550,RHEBL1,mtor signaling pathway,oncogenic activation,gain of function mutations,tumor progression,cell cycle regulation,metabolic dysregulation
ENSG00000167874,TMEM88,cell proliferation regulation,apoptosis modulation,pi3k/akt pathway interaction,plasma membrane localization,cancer progression association,therapeutic target status
ENSG00000242366,UGT1A8,glucuronidation,detoxification,drug metabolism,pharmacokinetics modification,enzyme activity regulation,personalized medicine
ENSG00000196860,TOMM20L,mitochondrial function regulation,cell stress response,upr activation,transmembrane protein interaction,tumor cell metabolism regulation,protein import into mitochondria
ENSG00000124177,CHD6,genomic instability,epigenetic regulation,dna repair mechanisms,chromatin remodeling complex,transcriptional modulation,oncogenic mutations
ENSG00000062822,POLD1,genomic instability,chromosomal alterations,tumor progression,epigenetic regulation,dna repair dysfunction,breast cancer associated genes (bags)
ENSG00000216490,IFI30,tumor suppression,antiviral activity,apoptosis induction,cell cycle regulation,immune modulation,inflammation regulation
ENSG00000128886,ELL3,genomic instability,tumor progression,therapeutic target,constitutive activation,transcriptional regulation,protein-protein interactions
ENSG00000112183,RBM24,alternative splicing regulation,cell cycle progression enhancement,oncogenic process modulation,dna repair mechanism regulation,apoptosis resistance promotion,prognostic marker candidate
ENSG00000147813,NAPRT,nad+ biosynthesis,cellular energy metabolism,tumor survival,cancer driver gene,therapeutic target,metabolic regulation
ENSG00000162972,MAIP1,mapk signaling,tumorigenesis driver,protein interaction,apoptosis resistance,cell proliferation regulation,downregulation in cancer
ENSG00000146021,KLHL3,regulation of c-myc stability,tumor suppressor function,cell cycle regulation,ubiquitination and degradation,protein-protein interactions,tumor progression
ENSG00000140199,SLC12A6,altered ion transport,chloride flux regulation,tumor growth promotion,apoptosis inhibition,cancer stem cell maintenance,therapeutic target
ENSG00000143479,DYRK3,cellular proliferation,oncogenic processes,dual specificity kinase activity,transcriptional regulation,cell survival mechanisms,pi3k/akt pathway interaction
ENSG00000089048,ESF1,genomic stability maintenance,histone modification recruitment,cell cycle regulation,oncogene overexpression,tumor promotion,dna repair mechanism regulation
ENSG00000168275,COA6,mitochondrial complex,glycolytic reprogramming,tumor suppressor activity,oncogenic driver mutations,electron transport chain dysfunction,metabolic rewiring
ENSG00000180357,ZNF609,tumor suppressor function,zinc finger dna-binding,cell growth regulation,transcriptional regulation,chromatin remodeling,oncogenic activity
ENSG00000285243,SLC39A4,zinc homeostasis,oncogenic properties,plasma membrane localization,cell growth promotion,tumor progression facilitation,hypoxia response modulation
ENSG00000169764,UGP2,cell proliferation,glycolysis regulation,metabolic reprogramming,tumor growth promotion,oncogene activation,energy metabolism alteration
ENSG00000007541,PIGQ,gpi anchor biosynthesis,cell surface protein modification,tumorigenesis,metastasis,protein-protein interactions,chromosomal location
ENSG00000108702,CCL1,tumor microenvironment,immunosuppressive response,chemokine signaling,myeloid-derived suppressor cells recruitment,th2 cell regulation,inflammatory cytokines production
ENSG00000187730,GABRD,neurotransmission regulation,receptor subunit function,inhibitory neurotransmission,synaptic plasticity,neuronal excitability,genetic variation
ENSG00000171320,ESCO2,genomic instability,aneuploidy,homologous recombination,chromatin remodeling,cohesin complex dysfunction,protein kinase activation
ENSG00000117148,ACTL8,cytoskeleton regulation,cell migration,tumor progression,overexpression,metastasis,signaling pathway modulation
ENSG00000223852,ZFP57,genomic stability,mutation-driven oncogenesis,epigenetic regulation,tumor suppressor function,chromatin modification,x-chromosome inactivation
ENSG00000241635,UGT1A1,ugt1a1 modulation,chemosensitization,pharmacokinetic regulation,xenobiotic metabolism,bilirubin conjugation,oncogenesis
ENSG00000171298,GAA,glycogen metabolism,metabolic reprogramming,cell proliferation,poor prognosis,prognostic marker,therapeutic target
ENSG00000164576,SAP30L,chromatin remodeling,histone deacetylase complex,transcriptional repression,cell cycle regulation,tumor suppressor function,genomic instability
ENSG00000186352,ANKRD37,cell cycle regulation,transcriptional co-regulation,nuclear localization,oncoprotein interaction,cell proliferation,gene expression modulation
ENSG00000164530,PI16,protein degradation,cellular homeostasis,apoptosis regulation,cell cycle control,ubiquitination,proteasome activity
ENSG00000274972,FRG2,chromosomal instability,cell cycle regulation,apoptosis regulation,genomic stability maintenance,oncogenesis association,therapeutic target
ENSG00000127863,TNFRSF19,tumor necrosis factor receptor signaling,apoptosis regulation,immune response modulation,cancer progression,inflammation regulation,cellular proliferation enhancement
ENSG00000066583,ISOC1,oncogenic mutations,constitutive activation,gain of function mutations,tumor progression,therapeutic target,epigenetic regulation
ENSG00000133872,SARAF,autophagy regulation,cellular stress response,therapeutic target,tumor progression,mtor pathway interaction,selective autophagy control
ENSG00000277800,TBX22,t-cell development,immune regulation,transcription factor activity,genomic deletion,thymocyte organization,antigen presentation
ENSG00000110328,GALNT18,signaling pathway modulation,glycosylation regulation,tumor progression,prognostic marker,wnt/β-catenin pathway activation,pi3k/akt signaling influence
ENSG00000147202,DIAPH2,cell migration,constitutive activation,cytoplasmic actin regulation,cancer progression,potential therapeutic target,cell division regulation
ENSG00000111962,UST,ubiquitin regulation,stress response,dna repair,protein degradation,oncogenesis,cancer progression
ENSG00000180509,KCNE1,kcne1 mutations,ion channel dysfunction,cellular homeostasis,proliferation regulation,apoptosis modulation,electrophysiological changes
ENSG00000073756,PTGS2,tumor progression,cancer cell survival,prostaglandin synthesis,inflammation regulation,cell proliferation promotion,apoptosis suppression
ENSG00000171067,C11orf24,cell cycle progression,dna damage response,apoptosis suppression,tumor promotion,cancer development,transcriptional regulation
ENSG00000182253,SYNM,microtubule regulation,cell proliferation enhancement,oncogenic potential,overexpression association,intermediate filament interaction,cellular structural alteration
ENSG00000131503,ANKHD1,genomic instability,regulation of cell growth,cell differentiation,dna repair pathways,apoptosis regulation,tumor progression
ENSG00000116761,CTH,proteolytic processing,tumor progression,metastasis facilitation,extracellular matrix degradation,ph-regulated activity,oncogenic pathway activation
ENSG00000099282,TSPAN15,tetraspanin family member,cell adhesion regulation,signal transduction modulation,oncogenic pathway involvement,prognostic marker candidate,therapeutic target potential
ENSG00000174939,ASPHD1,genomic instability,dna damage response,aneuploidy,histone modification,epigenetic regulation,tumor suppressor
ENSG00000118939,UCHL3,deubiquitinating enzyme,stabilization of oncogenic proteins,cell cycle regulation,apoptosis inhibition,dna repair modulation,protein degradation regulation
ENSG00000043039,BARX2,cellular differentiation,epithelial-to-mesenchymal transition,neuroendocrine origin,tumor progression,therapeutic target,transcription factor
ENSG00000196502,SULT1A1,sulfotransferase activity,detoxification pathway,tumor suppressor activity,cell proliferation regulation,xenobiotic metabolism,apoptosis resistance
ENSG00000147576,ADHFE1,aldehyde oxidation,metabolic reprogramming,cellular stress response,dna repair mechanisms,oxidative stress resistance,cancer development
ENSG00000067248,DHX29,genomic instability,tumor progression,dna repair dysfunction,oncogene function,therapeutic target,genome maintenance
ENSG00000283018,MRPS12,mitochondrial function,energy metabolism,biomarker potential,therapeutic target,transcriptional regulation,apoptosis regulation
ENSG00000151292,CSNK1G3,wnt/β-catenin pathway,oncogene activation,serine/threonine kinase activity,cell proliferation enhancement,tumor suppressor interaction,apoptosis regulation
ENSG00000118640,VAMP8,cell proliferation,metastasis promotion,exocytosis regulation,oncogene interaction,tumor progression,signaling pathway modulation
ENSG00000169919,GUSB,genomic instability,glycosaminoglycan accumulation,lysosomal dysfunction,cellular proliferation,angiogenesis promotion,therapeutic target
ENSG00000197223,C1D,histone modification,chromatin remodeling,transcriptional regulation,oncogenic function,chromatosome assembly,genomic instability
ENSG00000104435,STMN2,microtubule dynamics instability,cell proliferation enhancement,enhanced cell motility,prognostic marker,oncogenic protein interaction,cytoskeletal remodeling
ENSG00000106477,CEP41,genomic instability,centrosome integrity,cell proliferation,chromosomal instability,therapeutic target,microtubule stability
ENSG00000182389,CACNB4,calcium influx regulation,cell proliferation promotion,apoptosis inhibition,tumor migration enhancement,voltage-gated calcium channels assembly,gene overexpression in cancer
ENSG00000139793,MBNL2,cancer cell regulation,gene expression dysregulation,cell cycle modulation,tumor progression,rna processing regulation,protein-protein interaction
ENSG00000285250,MSRA,protein aggregation regulation,chaperone function,oncogenic driver,cell survival promotion,metastasis facilitation,therapeutic target candidate
ENSG00000059573,ALDH18A1,glutamine metabolism,cell growth promotion,oxidative stress resistance,proline biosynthesis,tumorigenesis support,cancer cell protection
ENSG00000004799,PDK4,metabolic shift,aerobic glycolysis,warburg effect,anabolic metabolism,tumorigenesis,cellular regulation
ENSG00000134594,RAB33A,dysregulated trafficking,cancer progression,cell proliferation,membrane fusion regulation,endocytic pathway manipulation,protein transport dysregulation
ENSG00000196814,MVB12B,membrane remodeling,endosomal sorting,protein degradation,oncogenic process,tumorigenesis,cellular trafficking
ENSG00000124496,TRERF1,ribosome biogenesis,translation regulation,cell proliferation enhancement,tumorigenesis association,mtor pathway interaction,oncogene potential
ENSG00000285493,NRL,epithelial-to-mesenchymal transition,transcription factor regulation,cell proliferation and migration,tumor progression and metastasis,oligomerization and dna binding,genomic instability
ENSG00000155761,SPAG17,microtubule regulation,genetic mutations,tumor suppressor/oncogene status,cellular differentiation,apoptosis modulation,cancer initiation
ENSG00000141458,NPC1,lipid homeostasis regulation,cellular proliferation modulation,protein-lipid interaction,tumor progression association,cell signaling pathway involvement,genomic instability link
ENSG00000113161,HMGCR,hmg-coa reductase activity,cholesterol biosynthesis,cell proliferation enhancement,tumor promotion,mevalonate pathway involvement,therapeutic target
ENSG00000156006,NAT2,altered metabolism,genetic variations,tumorigenesis,cellular regulation,xenobiotic interaction,p53 pathway interaction
ENSG00000067334,DNTTIP2,mitochondrial replication,mitochondrial transcription,apoptosis regulation,tumor suppressor function,oncogene potential,gene expression modulation
ENSG00000004534,RBM6,post-transcriptional regulation,rna stability,mrna translation,cell proliferation,potential tumor suppressor,tumor development
ENSG00000119421,NDUFA8,mitochondrial dysfunction,oncogenic reprogramming,cellular respiration alteration,therapeutic target,metabolic reprogramming,energy metabolism dysregulation
ENSG00000180481,GLIPR1L2,wnt/β-catenin pathway regulation,oncogenic function,cell proliferation modulation,tumor growth promotion,apoptosis regulation disruption,epithelial-to-mesenchymal transition involvement
ENSG00000197776,KLHDC1,genomic instability,tumor suppressor function,cell cycle regulation,apoptosis inhibition,oncogenic potential,protein-protein interactions
ENSG00000011143,MKS1,cilia biogenesis,centrosome regulation,intracellular trafficking,signaling pathway modulation,tumorigenesis association,cellular transport disruption
ENSG00000152669,CCNO,centriole regulation,cell cycle progression,chromosomal instability,tumor initiation,genomic alteration,dysregulated ciliogenesis
ENSG00000187531,SIRT7,ribosomal regulation,tumor suppressor loss,mitochondrial biogenesis,cellular senescence evasion,cancer metabolism alteration,nad+-dependent deacetylation
ENSG00000125522,NPBWR2,regulation of steroid hormone-dependent gene expression,tumor suppressor function,pi3k/akt pathway modulation,oncogenic potential,cellular proliferation regulation,nuclear receptor interaction
ENSG00000107819,SFXN3,iron-sulfur cluster biogenesis,tumor progression,dna damage response,cellular iron homeostasis,mitochondrial dysfunction,oncogenic properties
ENSG00000106631,MYL7,cardiac muscle contraction,genetic mutations,cell migration,proliferation regulation,adhesion regulation,protein interaction
ENSG00000027847,B4GALT7,galactosyltransferase activity,altered expression,tumor progression,glycosylation patterns,cell growth regulation,cell adhesion modulation
ENSG00000121318,TAS2R10,bitter taste receptor activation,cell cycle regulation,apoptosis induction,dna damage response,growth inhibition,tumor progression suppression
ENSG00000112984,KIF20A,mitotic spindle formation,cell proliferation,tumor growth,aurora kinase interaction,centromere protein regulation,chromosome segregation
ENSG00000204406,MBD5,transcriptional regulation,dna methylation,chromatin remodeling,tumor suppressor function,mutation hotspot,cancer driver mutation
ENSG00000110723,EXPH5,regulation of endocytosis,cell migration and invasion,tumor progression,therapeutic target,genomic profiling,cell proliferation
ENSG00000169228,RAB24,membrane trafficking regulation,endocytosis promotion,gtpase activity,cellular proliferation,apoptosis inhibition,cytoplasmic localization
ENSG00000254999,BRK1,dna damage repair,cell cycle regulation,oncogenic potential,tumor suppressor function,ubiquitination and degradation,protein stability modulation
ENSG00000140577,CRTC3,oncogene,transcriptional coactivator,energy metabolism regulation,cell proliferation,transcription factor interaction,glycolytic reprogramming
ENSG00000152413,HOMER1,transcription factor activation,cell growth promotion,tumor progression facilitation,gene expression regulation,cell differentiation modulation,pan-cancer involvement
ENSG00000184697,CLDN6,cell polarity disruption,tight junction disruption,epithelial barrier dysfunction,cancer cell invasion,therapeutic target,protein-protein interaction
ENSG00000165905,LARGE2,rna splicing,cellular metabolism,genetic disorder association,molecular machinery component,regulatory mechanism disruption,oncogenesis link
ENSG00000174684,B4GAT1,tumor growth,oncogenic process,altered glycosylation,cell adhesion modulation,extracellular matrix regulation,glycosyltransferase activity
ENSG00000198846,TOX,oncogene,transcription factor,t-cell development,epithelial-to-mesenchymal transition,cell cycle progression,apoptosis inhibition
ENSG00000101439,CST3,tumor suppressor,cell cycle regulation,cell differentiation,apoptosis induction,protease regulation,cancer biomarker
ENSG00000198208,RPS6KL1,mtor pathway,cellular proliferation,protein translation regulation,tumor progression,oncogene activation,genomic instability
ENSG00000151893,CACUL1,cancer driver,cellular degradation,protein ubiquitination,tumor progression,apoptosis inhibition,oncogenic function
ENSG00000118729,CASQ2,calcium signaling,endoplasmic reticulum localization,ca2+ buffering,cell cycle regulation,apoptosis modulation,mitochondrial interaction
ENSG00000188321,ZNF559,oncogenic regulation,transcriptional activation,cell differentiation,apoptosis modulation,chromatin remodeling,epigenetic regulation
ENSG00000141424,SLC39A6,zinc transport,cellular homeostasis,dna synthesis,oxidative stress resistance,tumor progression,genomic instability
ENSG00000089335,ZNF302,tumor suppressor,gene expression regulation,dna binding,cellular proliferation regulation,oncogenesis promotion,loss of function mutations
ENSG00000087253,LPCAT2,lipid remodeling,tumor microenvironment modulation,cell membrane fluidity regulation,oncogenic process enhancement,plasma membrane modification,cancer cell proliferation promotion
ENSG00000109466,KLHL2,protein degradation regulation,cancer driver mutations,genomic instability,cul3-rbx1 interaction,mitotic checkpoint control,cell cycle progression
ENSG00000161640,SIGLEC11,immune evasion,tumor microenvironment modulation,glycosylation regulation,antitumor immunity suppression,t-cell function modulation,tumor progression facilitation
ENSG00000144820,ADGRG7,cell-cell interactions,invasive capabilities,adhesion regulation,tumor progression,therapeutic target,signaling pathway modulation
ENSG00000128849,CGNL1,cell cycle regulation,chromosomal instability,microtubule stability,genomic alterations,biomarker identification,tumor growth promotion
ENSG00000198794,SCAMP5,vesicular transport regulation,calcium-dependent exocytosis modulation,tumor progression facilitation,oncogene involvement,cell proliferation enhancement,metastasis promotion
ENSG00000165071,TMEM71,mitochondrial function,er stress response,transmembrane protein,cellular stress response,autophagy regulation,cell membrane integrity
ENSG00000172046,USP19,pi3k/akt pathway modulation,oncogenic function,protein stabilization,cell cycle regulation,deubiquitinating enzyme activity,cancer cell survival
ENSG00000100075,SLC25A1,metabolic reprogramming,apoptosis resistance,tumor growth promotion,energetic metabolism regulation,cellular proliferation enhancement,mitochondrial membrane transport
ENSG00000002746,HECW1,ubiquitin ligase activity,tumor suppressor function,protein degradation,cell cycle regulation,oncogene regulation,transcription factor modulation
ENSG00000007933,FMO3,nadph-dependent monooxygenase activity,substrate oxidation,cancer-associated metabolism,redox balance modulation,tumor microenvironment influence,drug metabolism alteration
ENSG00000138136,LBX1,transcriptional repressor,tumor progression,promoter regulation,cell proliferation,mitosis regulation,gene silencing
ENSG00000176925,OR51F2,olfactory receptor function,tumor growth modulation,apoptosis regulation,cell signaling interaction,genetic variation influence,potential oncogene involvement
ENSG00000140943,MBTPS1,pi3k/akt interaction,oncogene overexpression,cellular proliferation enhancement,apoptosis resistance,metastatic potential increase,transcriptional regulation dysfunction
ENSG00000198892,SHISA4,anoikis suppression,apoptosis regulation,cell signaling pathway,cancer progression,tumor aggressiveness,biomarker potential
ENSG00000124523,SIRT5,metabolic regulation,cellular proliferation,energy metabolism,oncogenesis promotion,tumor progression,mitochondrial function modulation
ENSG00000171848,RRM2,genetic instability,dna replication,oncogenic mutation,cellular proliferation,nucleotide metabolism,enzyme regulation
ENSG00000213937,CLDN9,oncogenic potential,tumor progression,epithelial homeostasis regulation,tight junction regulation,cell migration modulation,prognostic biomarker
,SEPT8,cell division regulation,cytoskeleton organization,mitotic spindle stability,genome integrity maintenance,tumorigenesis association,oncogene potential
ENSG00000257473,HLA-DQA2,antigen processing,immune modulation,mhc complex interaction,polymorphic variations,tumor microenvironment regulation,immune evasion mechanism
ENSG00000158055,GRHL3,tumor suppressor function,epithelial-to-mesenchymal transition regulation,transcription factor activity,cellular growth modulation,dna binding affinity,loss-of-function mutations
ENSG00000120705,ETF1,mitochondrial function,energy metabolism regulation,tumor suppressor protein,gene amplification mutations,electron transfer chain interaction,mitochondrial dna maintenance
ENSG00000130592,LSP1,lrp repeats,transcriptional regulation,cell cycle progression,apoptosis evasion,protein-protein interactions,chromatin remodeling
ENSG00000144792,ZNF660,oncogenic function,overexpression in tumors,cell cycle regulation,dna repair pathways,apoptosis inhibition,gene expression modulation
ENSG00000280618,CYFIP1,mrna translation regulation,cell cycle progression modulation,oncogenic process promotion,tumorigenesis association,therapeutic target potential,mirna mediated gene expression regulation
ENSG00000143294,PRCC,microtubule stabilization,cell cycle regulation,mitotic checkpoint complex,chromosome segregation,cancer progression,protein-protein interaction
ENSG00000181195,PENK,angiogenesis induction,pain modulation,pro-survival signaling,tumor progression,metastatic potential,stress response
ENSG00000178096,BOLA1,mitochondrial chaperone,tumor suppressor function,dual role in tumorigenesis,iron-sulfur cluster assembly,oxidative stress response,protein homeostasis regulation
ENSG00000165775,FUNDC2,mitochondrial regulation,mitophagy induction,cellular stress response,hypoxic adaptation,autophagosome formation,cell survival promotion
ENSG00000182768,NGRN,ngrn protein function,pre-mrna splicing,cell proliferation regulation,tumor microenvironment modulation,oncogenic processes promotion,epigenetic regulation involvement
ENSG00000213931,HBE1,chromatin regulation,transcription factor activation,constitutive activation,dna repair dysregulation,cell cycle progression,histone modification
ENSG00000116871,MAP7D1,microtubule dynamics,cellular proliferation,chromosomal instability,protein-protein interactions,kinase activation,mitotic regulation
ENSG00000080823,MOK,oncogene,cell proliferation,cell survival,promoter mutations,signaling pathway activation,dysregulated expression
ENSG00000142065,ZFP14,zinc finger protein,chromatin regulation,histone modification,transcriptional regulation,oncogenesis,cell growth
ENSG00000006715,VPS41,lysosomal maintenance,gene expression regulation,vesicle transport modulation,tumor cell proliferation,oncogenic process contribution,membrane fusion regulation
ENSG00000105514,RAB3D,small gtpase,ras superfamily member,cell membrane trafficking regulation,oncogenic behavior promoter,tumorigenesis facilitator,metastasis formation regulator
ENSG00000163202,LCE3D,lipid bilayer interaction,mitotic regulation,cellular adhesion,tumor progression,gene expression modulation,oncogenic transformation
ENSG00000177710,SLC35G5,overexpression,nucleotide sugar transporter function,cell proliferation,tumor progression,poor prognosis,growth and differentiation regulation
ENSG00000173486,FKBP2,protein folding regulation,cell signaling modulation,apoptosis inhibition,tumor progression facilitation,angiogenesis modulation,bcl-2 family interaction
ENSG00000184292,TACSTD2,overexpression,cell adhesion,oncogenic signaling,metastasis promotion,poor prognosis,reduced overall survival
ENSG00000169946,ZFPM2,loss of function mutations,epithelial-to-mesenchymal transition,tumor progression,transcriptional regulation,cell proliferation,apoptosis suppression
ENSG00000175938,ORAI3,crac channel regulation,calcium signaling pathway,oncogene activation,tumor progression,cell migration promotion,store-operated calcium entry
ENSG00000095539,SEMA4G,tumor progression,oncogenic signaling,overexpression mutations,metastasis regulation,immune evasion,angiogenesis promotion
ENSG00000160190,SLC37A1,redox regulation,dysregulated expression,oncogenic mutations,therapeutic target,tumor growth promotion,cellular metabolism
ENSG00000137819,PAQR5,nuclear receptor regulation,cellular proliferation,oncogenesis,apoptosis modulation,genetic dysregulation,transcriptional control
ENSG00000003509,NDUFAF7,mitochondrial complex i,altered cellular metabolism,energy production regulation,tumor suppressor activity,promoter methylation,cellular respiration
ENSG00000101292,PROKR2,cell proliferation regulation,g protein-coupled receptor activation,dysregulation of cell cycle progression,tumor formation,cell survival enhancement,therapeutic target identification
ENSG00000196199,MPHOSPH8,tumor progression,cell cycle regulation,genomic instability,chromatin remodeling,dna repair mechanisms,phosphatase activity
ENSG00000273607,CHCHD10,mitochondrial dynamics,apoptosis regulation,cell growth modulation,genetic instability,metabolic reprogramming,protein-protein interaction
ENSG00000115207,GTF3C2,transcription initiation,rna polymerase iii regulation,trna gene expression,oncogenesis,gene expression regulation,chromatin remodeling
ENSG00000132466,ANKRD17,chromatin remodeling,transcription regulation,oncogenesis,cell proliferation,metastasis,apoptosis regulation
ENSG00000116132,PRRX1,transcriptional regulation,cell proliferation suppression,metastatic progression,tumor suppressor gene suppression,epithelial homeostasis disruption,cancer stem cell maintenance
ENSG00000288435,GJA10,cell-cell communication,gap junctions,intercellular signaling,tissue homeostasis,cell growth regulation,aberrant expression
ENSG00000158555,GDPD5,cellular metabolism alteration,hypoxia adaptation,oncogenic pathway interaction,cell proliferation regulation,glycolysis and glutaminolysis modulation,redox balance maintenance
ENSG00000178860,MSC,coiled-coil domains,muscle development,cell-cell adhesion,actin cytoskeleton regulation,protein-protein interactions,tumor progression
ENSG00000160408,ST6GALNAC6,sialic acid biosynthesis,oncogenic signaling,cell surface glycoprotein modification,cell proliferation enhancement,glycoconjugate accumulation,therapeutic target
,HIST1H2BL,histone modification,chromatin remodeling,genomic instability,cell cycle regulation,apoptosis modulation,nucleosome formation
ENSG00000108509,CAMTA2,pi3k/akt pathway modulation,transcription factor activity,oncogenesis regulation,tumor suppressor gene regulation,biomarker potential,post-translational modification regulation
ENSG00000067064,IDI1,e2f transcription regulation,cell proliferation,oncogene activity,tumorigenesis,cell cycle progression,transcriptional regulation
ENSG00000164332,UBLCP1,constitutive activation,gain of function mutations,tumor suppressor,cell cycle regulation,dna repair,ubiquitin-proteasome pathway
ENSG00000153250,RBMS1,tumor suppressor function,microrna regulation,cell cycle regulation,dna repair mechanism,apoptosis modulation,gene expression regulation
ENSG00000101335,MYL9,tumor progression,cell migration,genomic instability,protein-protein interaction,cytoskeletal regulation,oncogenic transformation
ENSG00000106404,CLDN15,tumor progression,cell adhesion disruption,overexpression,metastasis facilitation,invasion promotion,microenvironment interaction
ENSG00000204965,PCDHA5,cell-cell adhesion,genetic heterogeneity,mirna regulation,metastasis,cancer progression,synaptic plasticity
ENSG00000077380,DYNC1I2,oncogenic potential,tumor progression,cell migration invasion,signaling pathway dysregulation,cancer driver gene,genomic instability
ENSG00000187097,ENTPD5,purinergic signaling,oncogenesis,cell proliferation,immune modulation,tumor microenvironment,resistance to therapy
ENSG00000074370,ATP2A3,calcium homeostasis regulation,tumor progression association,cell proliferation regulation,cam-kinase family member,plasma membrane localization,calmodulin-dependent signaling pathway regulation
ENSG00000111711,GOLT1B,glycosylation regulation,tumor microenvironment modification,cell signaling modulation,protein folding control,stress response activation,antibody production alteration
ENSG00000173467,AGR3,epithelial-to-mesenchymal transition,protein secretion regulation,tumor growth promotion,invasive potential enhancement,golgi apparatus localization,signaling pathway modulation
ENSG00000179213,SIGLECL1,immune modulation,cell surface receptor,tumor suppressor function,sialic acid binding,apoptotic cell clearance,immune evasion strategy
ENSG00000183317,EPHA10,oncogene,receptor tyrosine kinase,cell migration,constitutive activation,pi3k/akt pathway,tumor progression
ENSG00000166189,HPS6,hops complex regulation,tumor growth promotion,dna damage response,genome stability alterations,lysosome-related organelle biogenesis,mitochondrial function regulation
ENSG00000213523,SRA1,chromatin remodeling,tumor suppressor function,dna repair regulation,transcriptional regulation,genome stability maintenance,histone modification regulation
ENSG00000112149,CD83,tumor progression,immune modulation,cell signaling,angiogenesis inhibition,cancer immunotherapy target,dendritic cell marker
ENSG00000162444,RBP7,mrna processing,microrna regulation,tumor progression,poor prognosis,oncogenic processes,cell proliferation
ENSG00000100722,ZC3H14,transcriptional regulation,gene expression modulation,cell survival promotion,oncogenic process enhancement,tumorigenesis contribution,biomarker potential
ENSG00000132698,RAB25,cell migration,epithelial-to-mesenchymal transition,oncogene activation,pan-cancer target,protein interaction,tumor metastasis
ENSG00000163530,DPPA2,embryonic stem cell maintenance,pluripotency regulation,oncogenesis promotion,tumor growth enhancement,angiogenesis facilitation,metastasis promotion
ENSG00000273274,ZBTB8B,genomic instability,tumor suppressor dysfunction,transcriptional regulation,cellular proliferation,apoptosis resistance,oncogenic mutations
ENSG00000181404,WASHC1,genomic instability,endosomal recycling,cell survival,tumor suppressor role,signaling pathway regulation,metabolic alterations
ENSG00000143924,EML4,microtubule stability,oncogenic fusion,constitutive kinase activity,cell proliferation,signaling pathway regulation,gene fusion formation
ENSG00000167721,TSR1,egfr signaling pathway,oncogenic mutations,cell surface receptor modulation,tumor progression,prognostic marker,epidermal growth factor regulation
ENSG00000129682,FGF13,fgf/pi3k signaling,oncogenic potential,secreted protein,cell proliferation regulation,angiogenesis promotion,poor prognosis marker
ENSG00000088826,SMOX,tumor suppressor function loss,oncogenic transcriptional regulator,cell proliferation enhancement,apoptosis inhibition,metastasis promotion,therapeutic target potentiality
ENSG00000185236,RAB11B,endocytic recycling pathway,cell proliferation,mitotic regulators interaction,protein trafficking,apoptosis evasion,dna damage repair regulation
ENSG00000031691,CENPQ,kinetochore assembly,chromosomal instability,cell cycle regulation,mitotic spindle attachment,chromo domain protein,aneuploidy driver
ENSG00000077942,FBLN1,tumor progression,cell adhesion disruption,epithelial-to-mesenchymal transition,angiogenesis promotion,genomic instability,therapeutic target
ENSG00000175264,CHST1,tumor progression,enhanced migration,chemosensitivity,stem cell like properties,dysregulated proteoglycan sulfate,cell growth regulation
ENSG00000205143,ARID3C,transcriptional regulation,epigenetic modification,chromatin remodeling,oncogene potential,cell growth promotion,protein-protein interaction
ENSG00000169994,MYO7B,actin cytoskeleton regulation,cell migration promotion,metastasis facilitation,poor prognosis indicator,tumor progression driver,genomic amplification marker
ENSG00000135049,AGTPBP1,actin cytoskeleton regulation,tumor progression,cell migration,oncogene overexpression,pi3k/akt pathway activation,signaling pathway interaction
ENSG00000112186,CAP2,cell migration,cell invasion,cytokinesis regulation,oncogenic process,protein-protein interaction,signal transduction pathway
ENSG00000154096,THY1,cell adhesion,oncogene upregulation,tumor progression,cancer biomarker,cell-cell interactions,protein expression
ENSG00000130433,CACNG6,calcium channel regulation,altered calcium signaling,tumor progression,overexpression,therapeutic target,cell proliferation
ENSG00000172716,SLFN11,tumor suppressor function,dna damage response,apoptosis induction,cell cycle arrest,cancer resistance,prognostic marker
ENSG00000288121,MDN1,mitochondrial dynamics,tumor progression,metabolic adaptation,cellular stress,apoptosis regulation,genomic instability
ENSG00000198513,ATL1,microtubule stabilization,tumor suppressor function,cell cycle regulation,mitotic spindle assembly,genomic instability,chromosomal segregation
ENSG00000184979,USP18,deubiquitinating enzyme,protein regulation,transcriptional regulation,immune response modulation,tumor growth promotion,apoptosis suppression
ENSG00000153132,CLGN,histone modification regulation,glutamine metabolism regulation,calcium-dependent signaling modulation,oncogenic transcription factor regulation,tumor microenvironment support,cancer cell proliferation enhancement
ENSG00000117090,SLAMF1,cellular activation,gain of function mutations,tumor growth promotion,metastasis regulation,immune response modulation,protein-protein interactions
ENSG00000095321,CRAT,fatty acid oxidation,mitochondrial function,cellular energy status,tumor progression,therapeutic target,electron transport chain
ENSG00000112651,MRPL2,mitochondrial translation regulation,tumor progression driver,energy metabolism regulator,oncogenic mutations,cellular respiration alteration,therapeutic target
ENSG00000165526,RPUSD4,translation initiation,enhanced oncogenic potential,cap-dependent translation,regulation of cell growth,activation of pi3k/akt/mtor pathway,modulation of apoptosis
ENSG00000196670,ZFP62,transcription factor regulation,cellular differentiation,tumorigenesis,dna binding affinity,oncogenic potential,glycogen synthase kinase 3 beta phosphorylation
ENSG00000167645,YIF1B,cellular homeostasis,tumor progression,protein synthesis regulation,gene expression modulation,therapeutic target,genomic profiling
ENSG00000102780,DGKH,tumor progression,cancer development,lipid metabolism regulation,signaling pathway activation,cell proliferation regulation,mutation or overexpression driven oncogenesis
ENSG00000140543,DET1,cancer-related signaling,transcriptional regulation,cell cycle regulation,tumor progression,oncogene or tumor suppressor,genomic instability
ENSG00000083099,LYRM2,mitochondrial biogenesis,cell growth promotion,electron transport regulation,apoptosis inhibition,energy metabolism regulation,protein-protein interaction
ENSG00000090339,ICAM1,tumor progression,cell adhesion,immune response regulation,leukocyte recruitment,co-stimulatory molecule,signaling pathway interaction
ENSG00000123810,B9D2,microtubule dynamics,tumorigenesis,cytoskeleton regulation,dynein complex interaction,cell division regulation,cancer progression driver
ENSG00000106268,NUDT1,dna repair,genomic instability,cell cycle regulation,tumor growth,proofreading activity,genomic maintenance
ENSG00000285482,DGAT1,lipid metabolism regulation,gene expression alterations,oncogenesis promotion,cellular growth modulation,tumor progression contribution,therapeutic target candidacy
ENSG00000164086,DUSP7,mapk signaling pathway regulation,cell growth and proliferation regulation,oncogenesis promotion,mapk p38 dephosphorylation,cancer cell survival enhancement,tumorigenesis contributor
ENSG00000128594,LRRC4,epithelial-to-mesenchymal transition,leucine-rich repeat protein,cell adhesion and migration,cancer progression marker,tumor aggressiveness predictor,transcriptional regulation of emt genes
ENSG00000162631,NTNG1,cell adhesion disruption,tumor progression,metastasis promotion,angiogenesis regulation,protein interaction alteration,genomic instability
ENSG00000130748,TMEM160,lipid metabolism regulation,tumor progression facilitation,cellular signaling pathway interaction,prognostic marker potentiality,therapeutic target,genomic instability promotion
ENSG00000213398,LCAT,dysregulated lipid metabolism,aberrant cholesterol transport,increased oxidative stress,genomic instability,chronic inflammation,oncogenic process
ENSG00000138315,OIT3,transcriptional regulation,cell growth modulation,protein interaction,embryonic development,tissue homeostasis,genomic expression
ENSG00000242247,ARFGAP3,cell membrane trafficking regulation,signaling pathway modulation,oncogenic signal activation,tumor progression facilitation,metastasis promotion,cell survival enhancement
ENSG00000164326,CARTPT,cellular adhesion,angiogenesis promotion,epithelial-to-mesenchymal transition,growth factor regulation,secreted protein,cell migration
ENSG00000176401,EID2B,chromatin remodeling,oncogenic transformation,cell proliferation,histone modification,epigenetic regulation,gene expression regulation
ENSG00000101052,IFT52,ciliogenesis regulation,gain of function mutations,genomic instability,oncogenic driver,tumor suppressor,cell cycle dysregulation
ENSG00000125780,TGM3,tumor growth promotion,metastasis facilitation,potential biomarker,cell differentiation modulation,apoptosis regulation,protein cross-linking activity
ENSG00000168434,COG7,aberrant glycosylation,cancer driver gene,n-glycosylation pathway,tumor cell growth,protein stability,cell adhesion regulation
ENSG00000071537,SEL1L,erad pathway,cellular homeostasis,protein quality control,tumor suppressor function,er stress response,oncogenic signaling
ENSG00000171617,ENC1,cell migration,epithelial-to-mesenchymal transition,oncogenic role,tumor progression,protein interaction,metastasis
ENSG00000164849,GPR146,g-protein coupled receptor activation,cell proliferation regulation,tumor progression association,oncogenic signaling pathway interaction,transmembrane receptor function,cancer cell growth modulation
ENSG00000171853,TRAPPC12,oncogene,tumor suppressor potential,rabgap complex regulation,cell division and growth,membrane trafficking and vesicle transport,signaling pathway dysregulation
ENSG00000134294,SLC38A2,cellular amino acid uptake,neutral amino acid transporter,cell proliferation,tumor growth,metabolic regulation,protein synthesis enhancement
ENSG00000170745,KCNS3,potassium channel regulation,cellular proliferation,oncogenic signaling,cellular migration,ion channel interaction,therapeutic target
ENSG00000166148,AVPR1A,vasopressin receptor signaling,overexpression in cancer,tumor growth promotion,cell proliferation enhancement,metastasis facilitation,oncogenic pathway activation
ENSG00000183579,ZNRF3,wnt signaling pathway,tumor suppressor function,oncogenesis,cell proliferation regulation,metastasis,therapeutic target
ENSG00000133687,TMTC1,cell surface modulation,oncogenic process,tumor progression,protein-protein interaction,cell growth regulation,metastasis promotion
ENSG00000198183,BPIFA1,overexpression,tumor progression,epithelial-to-mesenchymal transition (emt),angiogenesis,cell migration and invasion,dysregulation
ENSG00000182557,SPNS3,s1p signaling pathway,oncogene,cell proliferation,tumor progression,pi3k/akt/mtor activation,sphingolipid metabolism
ENSG00000108370,RGS9,g-protein regulation,tumor suppressor function,cellular proliferation,signaling pathway modulation,protein-protein interactions,gpcr signaling
ENSG00000117500,TMED5,er stress response,oncogenic mutations,cell survival enhancement,cellular homeostasis disruption,protein misfolding,er-associated degradation dysfunction
ENSG00000197429,IPP,chromatin remodeling,transcriptional regulation,cell growth regulation,protein-protein interaction,embryonic development,tissue homeostasis
ENSG00000135720,DYNC1LI2,intracellular transport regulation,microtubule-based motility alteration,cellular architecture disruption,increased cell proliferation,oncogenic processes promotion,tumor progression facilitation
ENSG00000123836,PFKFB2,glycolytic regulation,tumor progression,poor prognosis,metabolic reprogramming,cancer metabolism,oncogenic transformation
ENSG00000137177,KIF13A,microtubule dynamics,tumor suppressor activity,genomic instability,spindle checkpoint integrity,mitotic regulation,dysregulated expression
ENSG00000224654,UBD,ubiquitination,proteasome degradation,tumor suppressor function,cell cycle regulation,metabolic regulation,apoptosis modulation
ENSG00000197037,ZSCAN25,zinc finger protein,tumor suppressor function,dna repair regulation,cell cycle progression inhibition,genomic stability maintenance,cancer prevention
ENSG00000070366,SMG6,nonsense-mediated mrna decay,genomic instability,rna degradation,cell growth regulation,oncogenic transcript accumulation,therapeutic target
ENSG00000172725,CORO1B,actin filament branching,cancer progression,cell migration,coronin family member,phagocytosis regulation,protein-protein interactions
ENSG00000135821,GLUL,metabolic regulation,glutamine synthetase activity,cellular proliferation,redox balance,nitrogen metabolism regulation,mtor pathway interaction
ENSG00000144452,ABCA12,epithelial integrity,altered lipid metabolism,hypergranulation,compromised barrier function,increased cell turnover,lipid trafficking
ENSG00000187824,TMEM220,ion channel regulation,gene expression dysregulation,cell growth modulation,mitochondrial function,transmembrane protein signaling,tumor suppression mechanism
ENSG00000118804,STBD1,genomic instability,gene expression regulation,protein-protein interaction,dna repair mechanism,cell cycle progression,tumor suppressor function
ENSG00000184110,EIF3C,regulation of translation initiation,interactions with mtor/pi3k pathways,tumorigenesis through dna damage response,cell cycle progression and autophagy regulation,oncogenic protein interactions,protein synthesis dysregulation
ENSG00000189190,ZNF600,apoptosis regulation,cell cycle progression,cancer driver gene,immunotherapy target,protein-protein interaction,tumor suppressor function
ENSG00000119321,FKBP15,cell growth regulation,protein-protein interactions,oncogenic processes,apoptosis resistance,signaling pathway modulation,tumor progression
ENSG00000102178,UBL4A,chromatin remodeling,dna repair defects,enhanced cell survival,genomic instability,oncoprotein stabilization,protein degradation dysregulation
ENSG00000019991,HGF,hgf overexpression,tumor progression,emt activation,cell proliferation,therapeutic target,signaling pathway
ENSG00000102359,SRPX2,cell adhesion modulation,metastasis promotion,wnt/β-catenin pathway interaction,tumor progression marker,sushi-repeat-containing protein family member,transmembrane protein function
ENSG00000188064,WNT7B,wnt signaling pathway,aberrant activation,cell proliferation,tumorigenesis,metastasis,chemoresistance
ENSG00000164841,TMEM74,cellular regulation,calcium signaling modulation,proliferation regulation,apoptosis modulation,tumor progression,cancer driver gene candidate
ENSG00000100478,AP4S1,pan-cancer driver,cell proliferation regulator,endocytic trafficking disorder,tumor progression facilitator,lysosomal degradation impairment,clinical biomarker candidate
ENSG00000103510,KAT8,histone acetylation,transcriptional regulation,tumor maintenance,chromatin remodeling,apoptosis evasion,cancer aggressiveness
ENSG00000010361,FUZ,genomic stability,mitotic spindle assembly,chromosomal segregation,tumor suppressor,cell cycle regulation,aneuploidy
ENSG00000111912,NCOA7,transcriptional coactivation,oncogene activity,cell proliferation regulation,anti-apoptotic signaling,steroid hormone receptor interaction,gene expression modulation
ENSG00000275544,BDH1,steroid hormone regulation,oncogenic mutations,tumor progression,therapeutic target,cellular differentiation,apoptosis resistance
ENSG00000121716,PILRB,immune evasion,t cell inhibition,gain of function mutations,tumor progression,immune checkpoint modulation,leukocyte interaction
ENSG00000185344,ATP6V0A2,v-atpase activation,ion transport regulation,cellular ph homeostasis,oncogenesis promotion,tumor progression facilitation,cell migration enhancement
ENSG00000183542,KLRC4,immune evasion,cell-mediated immunity,nk cell receptor complex,tumor progression,immunotherapy target,immune regulation
ENSG00000101447,FAM83D,pi3k/akt signaling pathway,constitutive activation,gain of function mutations,tumor progression,oncogene expression,cell proliferation regulation
ENSG00000171951,SCG2,regulation of neuropeptide processing,cell proliferation,signaling pathway modulation,protein-protein interaction,biomarker for cancer diagnosis and prognosis,therapeutic target
ENSG00000064199,SPA17,microtubule regulation,genomic instability,chromosomal abnormalities,mitotic spindle assembly,oncogene function,cancer progression
ENSG00000106823,ECM2,cellular adhesion,extracellular matrix regulation,tumor growth promotion,metastasis facilitation,protein-protein interaction,therapeutic target potential
,IGHD,immunoglobulin superfamily,protein-protein interactions,antibody-antigen recognition,oncogenic processes,tumorigenesis,immune surveillance mechanisms
ENSG00000135378,PRRG4,cell-cell adhesion,epithelial-to-mesenchymal transition,signaling pathway regulation,tumor suppressor potential,wnt/β-catenin interaction,pi3k/akt activation
ENSG00000140259,MFAP1,tumor progression,microfibril formation,overexpression,extracellular matrix remodeling,angiogenesis regulation,protein-protein interaction
ENSG00000067113,PLPP1,lipid metabolism regulation,tumor progression,metastasis facilitation,therapeutic resistance,oncogene activation,cellular signaling modulation
ENSG00000100170,SLC5A1,glycolytic adaptation,metabolic reprogramming,tumor progression,oncogenic function,enhanced glycolysis,prognostic marker
ENSG00000125149,C16orf70,chromatin remodeling,dna repair pathway,histone modification,genomic instability,nuclear localization,cell proliferation
ENSG00000103168,TAF1C,transcriptional activator function,genetic aberrations,oncogenesis,metastatic process,promoter region interaction,cell proliferation enhancement
ENSG00000154222,CC2D1B,wnt/pcp signaling pathway disruption,tumor suppressor function,gain of function mutations,cell polarity regulation,therapeutic target,genomic profiling
ENSG00000135596,MICAL1,microtubule regulation,cell migration promotion,oncogenic process enhancement,tumor progression facilitation,rho gtpase interaction,cytoskeletal dynamics modulation
,H2AFV,histone variant,chromatin remodeling,epigenetic regulation,transcriptional repression,genome stability,dna repair
ENSG00000162695,SLC30A7,zinc regulation,tumor suppressor,cell signaling pathways,intracellular transport,protein interaction,molecular maintenance
ENSG00000213759,UGT2B11,detoxification processes,metabolic regulation,lipophilic substrate conjugation,carcinogen metabolism,liver-specific expression,altered enzyme activity
ENSG00000172292,CERS6,ceramide synthesis,dysregulation,tumor progression,cell proliferation,metabolic regulation,cancer therapy
ENSG00000111846,GCNT2,glycosylation regulation,oncogenic signaling pathway,cell proliferation,tumor aggressiveness,biomarker potential,cancer prognosis
ENSG00000090013,BLVRB,circadian rhythm regulation,gene expression regulation,tumor suppression,dna repair regulation,genomic instability contribution,oxidative stress response modulation
ENSG00000118363,SPCS2,protein degradation,cancer progression,cellular process regulation,apoptosis suppression,tumor growth promotion,genomic instability
ENSG00000113722,CDX1,caat box binding,transcription factor activity,tumor suppressor function,cell differentiation regulation,epithelial-to-mesenchymal transition (emt),oncogene potential
ENSG00000084073,ZMPSTE24,prelamin a processing,nuclear integrity maintenance,genomic instability,dna damage response,senescence or apoptosis,telomere shortening
ENSG00000165995,CACNB2,calcium channel regulation,gene expression alterations,proliferation enhancement,cell cycle progression,tumor aggressiveness,epigenetic modifications
ENSG00000151067,CACNA1C,voltage-gated calcium channels,l-type calcium channel function,cardiac myocyte expression,calcium influx regulation,cell migration modulation,electrical excitability control
ENSG00000102409,BEX4,cellular regulation,genomic instability,protein-protein interaction,oncogenic function,signal transduction,metastasis progression
ENSG00000164303,ENPP6,purinergic signaling,overexpression,apoptosis regulation,cell proliferation,metastasis facilitation,prognostic marker
ENSG00000008405,CRY1,circadian rhythm regulation,dna damage response,genomic instability,cell cycle control,oncogenesis,therapeutic target
ENSG00000138347,MYPN,cell adhesion modulation,protein interaction networks,cytoplasmic localization,oncogenic signaling pathways,cytoskeletal regulation,tumor progression association
ENSG00000064651,SLC12A2,chloride transport,constitutive activation,overexpression mutations,tumor progression,therapeutic target,genomic instability
ENSG00000056050,HPF1,genomic instability,tumor suppressor function,loss of function mutations,cell cycle regulation,apoptosis evasion,transcriptional dysregulation
ENSG00000011332,DPF1,dynein complex assembly,cilia dysfunction,genome instability,tumor suppressor function,oncogenic pathway activation,cellular polarity loss
ENSG00000110195,FOLR1,folate transport,tumor progression,cell proliferation,therapeutic target,dna synthesis regulation,cancer prognosis
ENSG00000162174,ASRGL1,cellular proliferation,pi3k/akt signaling,aberrant expression,tumor progression,therapeutic target,genomic instability
ENSG00000197121,PGAP1,glycosylation regulation,cell surface modification,cancer biomarker,oncogenic pathway activation,tumor microenvironment modulation,therapeutic target
ENSG00000138231,DBR1,alternative splicing,cell proliferation,gene expression regulation,microrna biogenesis,oncogenic transcription factors,rna processing
ENSG00000154438,ASZ1,chromatin remodeling,transcriptional regulation,tumor progression,genomic instability,oncogene overexpression,therapeutic target
ENSG00000111727,HCFC2,coactivator function,transcriptional regulation,cell cycle progression,apoptosis evasion,protein-protein interactions,tumor suppressor dysfunction
ENSG00000196139,AKR1C3,androgen biosynthesis,cell proliferation,hormone regulation,oncogenic activity,steroid metabolism,protein-protein interactions
ENSG00000164897,TMUB1,gtpase regulation,cell surface receptor trafficking,endocytosis modulation,protein-protein interaction,oncogenesis contribution,tumorigenesis mechanism
ENSG00000143436,MRPL9,mitochondrial ribosome assembly,cell proliferation,proliferation signaling pathway,apoptosis inhibition,ribosomal protein interaction,mitochondrial morphology maintenance
ENSG00000107951,MTPAP,genomic instability,telomere maintenance,dna repair,protein interaction,cellular regulation,gene expression
ENSG00000162923,WDR26,dna repair,chromatin remodeling,cell cycle regulation,genomic instability,oncogene activation,tumor suppressor function
ENSG00000167600,CYP2S1,cellular regulation,tumor promotion,metabolic modulation,protein expression regulation,cancer progression,signaling pathway interaction
ENSG00000138207,RBP4,pro-tumorigenic factor,type 2 diabetes,insulin resistance,cell proliferation,angiogenesis,pi3k/akt pathway modulation
ENSG00000153815,CMIP,calcium signaling pathway regulation,cell proliferation enhancement,tumor growth promotion,therapeutic target identification,metastasis regulation,protein interaction modulation
ENSG00000040275,SPDL1,genomic instability,chromatin binding,cell cycle progression,dna damage response,aneuploidy induction,tumor suppressor function
,FAM129A,cellular regulation,protein interaction,apoptosis evasion,tumor progression,cancer susceptibility,genetic instability
ENSG00000151500,THYN1,g-protein coupled receptor signaling,mapk pathway modulation,tumor growth promotion,aberrant expression,thyroid-stimulating hormone regulation,cancer subtype classification
ENSG00000086619,ERO1B,oncogenic transformation,er stress response regulation,protein folding modulation,cell proliferation enhancement,metastasis promotion,apoptosis regulation
ENSG00000198838,RYR3,calcium channel regulation,cell proliferation,intracellular signaling,oncogenic process,cell survival,metastatic potential
ENSG00000086300,SNX10,endosomal trafficking,regulation of pi3k/akt pathway,cell proliferation,cell survival,genomic instability,tumor suppressor function
ENSG00000121797,CCRL2,immune modulation,tumor microenvironment regulation,inflammatory response regulation,cellular signaling interaction,immune evasion mechanism,biomarker potential
ENSG00000285426,RNF187,ubiquitination pathway,cell cycle regulation,g1 phase progression,tumor aggressiveness marker,proteasomal degradation,e3 ubiquitin ligase activity
ENSG00000168491,CCDC110,genomic instability,tumor suppressor function,dna repair pathways,brca1 interaction,palb2 interaction,apoptosis regulation
ENSG00000166411,IDH3A,metabolic regulation,glycolysis,gain of function mutations,cellular respiration,oncometabolite production,enzymatic activity
ENSG00000108602,ALDH3A1,aldehyde detoxification,cancer stem cell marker,cellular redox regulation,chemo-resistance,detoxification pathway modulation,tumor aggressiveness
ENSG00000197971,MBP,myelin sheath regulation,cell growth modulation,oncogenic processes,tumor suppression,signal transduction,neurotransmission regulation
ENSG00000141741,MIEN1,genomic integrity maintenance,tumor suppressor function,dna damage response regulation,chromatin remodeling involvement,cell cycle progression regulation,genomic instability promotion
ENSG00000213020,ZNF611,genomic instability,cell proliferation,angiogenesis regulation,dna repair regulation,pi3k/akt pathway interaction,oncogene function
ENSG00000186472,PCLO,regulation of cellular processes,cell proliferation and migration,interaction with pi3k/akt pathway,tumor progression and metastasis,epithelial-to-mesenchymal transition (emt),potential therapeutic target
ENSG00000140612,SEC11A,oncogenic signaling,protein degradation,cell cycle progression,apoptosis inhibition,genomic instability,tumor suppressor dysfunction
ENSG00000155659,VSIG4,immune modulation,tumor progression,angiogenesis suppression,oncogene or tumor suppressor,therapeutic target,biomarker candidate
ENSG00000102962,CCL22,tumor metastasis,immune suppression,angiogenesis promotion,chemokine function,cytokine interaction,tumor progression
ENSG00000102805,CLN5,lysosomal dysfunction,cell proliferation,metastasis,autophagy regulation,endocytic pathway regulation,protein-protein interactions
ENSG00000198734,F5,tumor microenvironment,immune modulation,metastasis promotion,angiogenesis regulation,coagulation cascade,genetic mutations
ENSG00000136100,VPS36,cellular homeostasis,protein sorting and aggregation,oncogenic processes,receptor trafficking and signaling,aberrant protein accumulation,therapeutic target
ENSG00000135334,AKIRIN2,wnt/β-catenin signaling modulation,oncogene activation,cell proliferation regulation,apoptosis inhibition,therapeutic target identification,biomarker potential
ENSG00000085514,PILRA,immune regulation,cell recognition,tumor surveillance,natural killer cell activation,downstream signaling pathways,cytolytic function
ENSG00000179163,FUCA1,glycosylation regulation,cell surface modifications,tumor metastasis,cell adhesion changes,gene expression alterations,fucose metabolism alterations
ENSG00000145832,SLC25A48,mitochondrial carrier protein,regulates cellular metabolism,cell growth and proliferation,energy production and export,oncogenic processes,metabolic rewiring
ENSG00000143578,CREB3L4,er stress response,lipid biosynthesis,oncogenic mutations,metabolic dysregulation,cell proliferation,protein overexpression
ENSG00000141026,MED9,transcriptional regulation,cellular proliferation,oncogenic driver,genomic amplification,coactivator recruitment,cell survival
ENSG00000119596,YLPM1,microtubule regulation,dysregulation of cell division,genomic instability,oncogenic potential,therapeutic target,cell cycle progression
ENSG00000078177,N4BP2,ubiquitination regulation,cell proliferation enhancement,signaling pathway modulation,tumor progression facilitation,therapeutic target identification,cancer driver potential
ENSG00000181458,TMEM45A,cell division regulation,mitotic spindle formation,cellular stress response regulation,membrane dynamics regulation,protein-protein interactions,unknown role in pan-cancer
ENSG00000105953,OGDH,metabolic reprogramming,2-oxoglutarate dehydrogenase activity,citric acid cycle regulation,cellular respiration modulation,energy production alteration,tumor metabolic adaptation
ENSG00000142669,SH3BGRL3,aberrant signaling,cell proliferation,oncogenic driver,therapeutic target,signaling regulation,cancer progression
ENSG00000090470,PDCD7,apoptosis inhibition,cell survival enhancement,tumor progression promotion,poor prognosis marker,biomarker role,protein interaction modulation
ENSG00000125869,LAMP5,autophagy regulation,tumor microenvironment modulation,cell survival enhancement,immune response regulation,endocytosis facilitation,potential biomarker status
ENSG00000112039,FANCE,fanconi anemia pathway,genomic instability,interstrand crosslink repair,homologous recombination repair,tumor suppressor function,dna repair impairment
ENSG00000251192,ZNF674,transcriptional regulation,dna binding activity,zinc finger protein interaction,cell growth modulation,apoptosis regulation,tumor progression
ENSG00000110717,NDUFS8,mitochondrial dysfunction,oncogenic transformation,cellular metabolism regulation,glycolytic shift,energy production disruption,tumor heterogeneity
ENSG00000120253,NUP43,nuclear transport,cell cycle regulation,dna repair disruption,protein-protein interaction,brca1/atm association,pi3k pathway modulation
ENSG00000104626,ERI1,rna degradation,genomic stability,cellular stress response,oncogenic processes,gene expression regulation,aberrant rna molecules
ENSG00000177548,RABEP2,tumor progression,signaling pathway regulation,endocytic trafficking disruption,cellular stress response modulation,oncogenic transformation promoter,therapeutic target candidate
ENSG00000152464,RPP38,rna processing,cancer driver gene,cell proliferation,apoptosis inhibition,mature trna production,overexpression
ENSG00000089163,SIRT4,metabolic reprogramming,mitochondrial function regulation,adp-ribosyltransferase activity,glutamine metabolism regulation,energy metabolism modulation,cell proliferation enhancement
ENSG00000077044,DGKD,genomic stability,enzymatic detoxification,cellular defense mechanisms,metabolic regulation,environmental toxin response,hepatocellular involvement
ENSG00000174871,CNIH2,channel regulation,neurotransmitter modulation,dysregulated expression,synaptic transmission disruption,oncogenesis contribution,tumor development association
ENSG00000203880,PCMTD2,protein regulation,cellular homeostasis disruption,oncogenic potential,isomerase function,post-translational modification,proteome stability
ENSG00000165879,FRAT1,wnt signaling pathway,cell proliferation,oncogenic driver,dishevelled interaction,pi3k/akt regulation,cell cycle progression
ENSG00000188283,ZNF383,oncogenic function,transcriptional regulation,chromatin remodeling,cell proliferation,apoptosis resistance,epigenetic modification
ENSG00000135373,EHF,epigenetic regulation,tumor growth,gene expression modulation,transcriptional regulation,cell proliferation promotion,onco-protein interaction
ENSG00000104835,SARS2,apoptosis regulation,cell cycle progression,dna repair modulation,oncogenic mutations,transcriptional regulation,viral replication facilitation
ENSG00000157911,PEX10,peroxisomal biogenesis,lipid metabolism dysregulation,peroxisome dysfunction,oncogenic processes,cellular lipid accumulation,protein import impairment
ENSG00000105464,GRIN2D,cellular proliferation,tumor progression,oncogenic signaling,calcium homeostasis disruption,synaptic plasticity alteration,neurological disorder association
ENSG00000255072,PIGY,gpi anchor biosynthesis,cell membrane organization,cell signaling modulation,immune response regulation,tumor suppression defects,oncogenic transformation
ENSG00000164023,SGMS2,oncogenic function,dysregulated sphingolipid metabolism,regulation of cellular processes,therapeutic target,tumorigenesis,cancer cell proliferation
ENSG00000249158,PCDHA11,cell adhesion maintenance,neuronal function regulation,tissue architecture regulation,cell-cell communication modulation,cadherin superfamily member,none
ENSG00000116748,AMPD1,metabolic reprogramming,glycolysis modulation,oncogenic role,cellular homeostasis regulation,energy production enhancement,purine metabolism pathway
ENSG00000133805,AMPD3,oncogenic mutations,purine metabolism regulation,increased atp production,tumor cell proliferation,warburg effect enhancement,energy metabolism disruption
ENSG00000240344,PPIL3,protein degradation regulation,tumor suppressor function,loss-of-function mutations,cell cycle progression,apoptosis inhibition,genetic instability
ENSG00000124839,RAB17,egf receptor regulation,tumor progression,metastasis promotion,cell migration regulation,oncogene interaction,protein trafficking modulation
,KIAA1324,rna helicase function,oncogene/tumor suppressor dual role,microrna regulation,cell cycle progression,apoptosis modulation,pi3k/akt pathway interaction
ENSG00000197763,TXNRD3,oxidative stress regulation,thioredoxin reductase activity,cell survival promotion,tumor resistance enhancement,oncogene overexpression,antioxidant function maintenance
ENSG00000157103,SLC6A1,neurotransmitter transport,cellular uptake regulation,tumor progression,poor prognosis,nutrient efflux modulation,therapeutic target
ENSG00000156467,UQCRB,mitochondrial dysfunction,cellular respiration disruption,energy metabolism alterations,oncogenic transformation,cell growth promotion,tumor suppressor downregulation
ENSG00000148123,PLPPR1,lysophosphatidic acid (lpa) regulation,phospholipid metabolism dysregulation,cellular membrane integrity modulation,pi3k/akt pathway interaction,oncogenic protein-protein interaction,cancer cell migration promotion
ENSG00000257017,HP,chromatin regulation,dysregulated gene expression,heterochromatin protein,epigenetic modulation,tumor suppressor regulation,genomic instability
ENSG00000072571,HMMR,hyaluronan-binding protein,tumor progression,metastatic potential,cell adhesion,hippo signaling pathway regulation,oncogene expression
ENSG00000275499,ZNF280A,oncogenesis,tumor progression,transcriptional regulation,gene expression dysregulation,chromatin remodeling,cancer development
ENSG00000132481,TRIM47,protein degradation regulation,oncogenic transformation,cell proliferation enhancement,therapeutic target,ubiquitin-proteasome system modulation,tumor progression facilitation
ENSG00000105664,COMP,cell adhesion disruption,promotes metastasis,enhances cell migration,angiogenesis induction,tumor progression promotion,extracellular matrix maintenance disruption
ENSG00000151388,ADAMTS12,high expression levels,angiogenesis promotion,tumor progression facilitation,biomarker potential,cell adhesion regulation,metastasis enhancement
ENSG00000263247,PRR4,antiviral defense,immune regulation,cytokine induction,proteolytic activation,rna degradation,inflammation modulation
ENSG00000196535,MYO18A,actin cytoskeleton regulation,cellular proliferation,motor protein function,oncogene potential,pi3k/akt signaling,protein-protein interactions
ENSG00000103375,AQP8,apoptosis evasion,cell migration,cell proliferation,ion transport,regulation of cell volume,tumor progression
ENSG00000183914,DNAH2,cilia regulation,male infertility,microtubule dynamics,sperm motility defect,hedgehog signaling,cancer initiation
ENSG00000267534,S1PR2,sphingosine-1-phosphate signaling,tumor progression,metastasis promotion,chemoresistance enhancement,oncogenic pathway activation,altered sphingolipid metabolism
ENSG00000164120,HPGD,prostaglandin metabolism,nad+ dependent oxidation,tumor growth regulation,oncogenesis,fever induction,immune system modulation
ENSG00000011258,MBTD1,chromatin regulation,tumor suppression,demethylation activity,transcriptional control,histone modification,genomic instability
ENSG00000130827,PLXNA3,angiogenesis promotion,endothelial cell function regulation,tumor progression facilitation,metastasis enhancement,cell migration activation,vascular morphogenesis modulation
ENSG00000189079,ARID2,chromatin remodeling,genomic instability,tumor suppressor gene silencing,dna repair disruption,transcriptional regulation,cancer progression
ENSG00000274429,DLG5,tumor progression,cell adhesion disruption,oncogenic signaling,cell polarity regulation,epithelial cell interaction,biomarker potential
ENSG00000109689,STIM2,soce regulation,calcium influx modulation,tumor suppressor function,cell proliferation regulation,therapeutic target,biomarker candidate
ENSG00000100350,FOXRED2,mitochondrial dysfunction,electron transport chain regulation,tumor suppressor function,cancer metabolism alterations,mitochondrial membrane protein interaction,tumor growth inhibition
ENSG00000103199,ZNF500,dna binding,transcriptional regulation,cancer overexpression,tumor suppressor activity,cellular differentiation,genome-wide expression profiling
ENSG00000074410,CA12,tumor progression,cell migration,epithelial expression,prognostic marker,metastatic potential,akt pathway activation
,YARS,translation regulation,cell proliferation,tumor progression,protein synthesis,anti-apoptotic pathways,genomic instability
ENSG00000175003,SLC22A1,drug resistance,cellular proliferation,metabolic regulation,oncogenic processes,multifunctional solute carrier protein,tumor suppressor dysfunction
ENSG00000163586,FABP1,fatty acid metabolism,oncogenic processes,lipid transport regulation,cell proliferation enhancement,tumor progression facilitation,mitochondrial function modulation
ENSG00000278195,SSTR3,tumor suppressor,cell proliferation inhibition,apoptosis induction,g-protein coupled receptor,epigenetic regulation,somatostatin activation
ENSG00000111666,CHPT1,phospholipid metabolism,cell membrane integrity,tumor suppressor function,oncogenic mutations,signaling pathway interaction,cell growth regulation
ENSG00000062650,WAPL,chromosome instability,cohesin regulation,chromatin remodeling,aneuploidy driver,oncogenic processes,therapeutic target
ENSG00000114670,NEK11,cell cycle regulation,dna damage response,genomic stability maintenance,tumor suppressor function,cell proliferation driver,genomic instability promoter
ENSG00000125482,TTF1,transcription factor activity,cellular differentiation,epithelial tissue specification,tumor progression,metabolic regulation,oncogene function
ENSG00000176422,SPRYD4,inhibitor of receptor tyrosine kinases,tumor suppressor function,cell proliferation regulation,oncogenic kinase inhibition,cell cycle modulation,signaling pathway regulation
ENSG00000117594,HSD11B1,glucocorticoid activation,metabolic regulation,cortisol conversion,oncogenic processes,tumor microenvironment,therapeutic target
ENSG00000214367,HAUS3,microtubule dynamics,centrosome stability,spindle assembly checkpoint,cell cycle regulation,dna replication,genomic instability
ENSG00000111335,OAS2,immune modulation,apoptosis induction,tumor suppression,viral defense mechanism,cell death regulation,antiviral signaling pathway
ENSG00000197472,ZNF695,tumor suppressor functions,transcriptional regulation,cellular proliferation,apoptosis modulation,dna-binding activity,epigenetic regulation
ENSG00000102893,PHKB,glycogen phosphorylation,cell growth regulation,tumor promotion,glycolytic shift,gene dysregulation,proliferation enhancement
ENSG00000149499,EML3,microtubule regulation,cell migration,tumor progression,metastasis promotion,poor prognosis marker,actin filament assembly
ENSG00000134013,LOXL2,lysyl oxidase activity,extracellular matrix remodeling,tumor progression,metastasis initiation,angiogenesis promotion,chemosensitivity reduction
ENSG00000175130,MARCKSL1,phospholipid binding,pi3k/akt pathway activation,oncogenesis promotion,tumor cell proliferation,constitutive activation,signaling pathway interaction
ENSG00000188295,ZNF669,epigenetic regulator,transcription factor activity,cell proliferation promoter,oncogene activation,histone modification,genomic instability
ENSG00000054219,LY75,cell adhesion,cell migration,tumor progression,metastasis driver,cell signaling pathways,transcriptional regulation
ENSG00000135899,SP110,cellular regulation,transcriptional control,protein degradation,tumor suppressor activity,epigenetic regulation,chromatin remodeling
ENSG00000076043,REXO2,oncogenic function,genome instability,rna degradation regulation,cell proliferation promotion,protein interaction,cancer driver gene
ENSG00000170166,HOXD4,transcriptional regulation,cell proliferation,tumor progression,apoptosis,dysregulation,multipotency
ENSG00000084070,SMAP2,aberrant signaling,cell proliferation enhancement,dna damage response modulation,oncogenic transformation,protein-protein interaction regulation,therapeutic resistance promotion
ENSG00000129911,KLF16,cellular differentiation regulation,tumor suppressor function,gene expression regulation,apoptosis induction,transcriptional modulation,cancer driver gene candidate
ENSG00000157827,FMNL2,oncogenic function,cell migration,actin cytoskeleton regulation,tumorigenesis promotion,microtubule interaction,cell survival enhancement
ENSG00000130055,GDPD2,glycolipid metabolism,lipid raft dynamics,cell proliferation,apoptosis resistance,therapeutic target,pan-cancer driver
ENSG00000131368,MRPS25,mitochondrial biogenesis,regulation of translation,tumor progression,metabolic rewiring,cellular respiration,protein synthesis regulation
ENSG00000173786,CNP,tumor progression,cancer metastasis,cellular differentiation,proliferation and inflammation,signaling pathway modulation,chondrocyte maintenance
ENSG00000179958,DCTPP1,genomic stability regulation,dna replication maintenance,uracil misincorporation prevention,tumor progression contribution,therapeutic target potential,nucleotide metabolism interaction
ENSG00000172426,RSPH9,cellular structure disruption,ciliogenesis regulation,oncogenic process enhancement,genomic instability contribution,protein-protein interaction,microtubule dysregulation
ENSG00000085491,SLC25A24,energy metabolism regulation,mitochondrial transport function,cellular growth modulation,tumor cell survival influence,metabolic pathway interaction,genomic instability contribution
ENSG00000115526,CHST10,glycosaminoglycan modification,tumor growth promotion,cell adhesion regulation,metastasis facilitation,wnt/β-catenin pathway dysregulation,cancer stem cell maintenance
ENSG00000197863,ZNF790,transcriptional regulation,krab domain-containing protein,dna binding,gene expression disruption,oncogenesis contribution,signaling pathway interaction
ENSG00000136842,TMOD1,cell migration,invasion,cytoskeletal regulation,oncogene,protein-protein interaction,cell proliferation
ENSG00000174373,RALGAPA1,tumor suppressor,constitutive activation,oncogenic signaling,cell proliferation regulation,gtpase activating protein activity,loss-of-function mutations
ENSG00000108001,EBF3,transcriptional regulation,tumor progression,cell cycle regulation,apoptosis suppression,stem cell-like properties,poor prognosis marker
ENSG00000119927,GPAM,endoplasmic reticulum localization,glycerol-3-phosphate acyltransferase activity,lipid metabolism regulation,cell growth promotion,tumorigenic potential increase,prognostic marker
ENSG00000188215,DCUN1D3,protein degradation pathway,oncogene mutation,cellular proliferation,genomic instability,ubiquitin-proteasome interaction,apoptosis resistance
ENSG00000163666,HESX1,homeobox transcription factor,tumor suppressor gene repression,oncogene upregulation,stem cell-like properties,cell cycle regulation,transcriptional modulation
ENSG00000137574,TGS1,tumorigenesis,pi3k/akt pathway,cell growth regulation,cell survival regulation,phosphatase activity,oncogenic processes
ENSG00000115419,GLS,glucose metabolism,enhanced glycolysis,aerobic glycolysis,lactate production,tumor growth,proliferation
ENSG00000115461,IGFBP5,igf1r interaction,apoptosis regulation,metastasis inhibition,tumor suppression,angiogenesis modulation,signal transduction
ENSG00000166863,TAC3,tumor progression,neuropeptide regulation,cell proliferation,vasopressin signaling,bombesin receptor interaction,prognostic marker
ENSG00000171603,CLSTN1,emt promotion,cell adhesion regulation,tumor metastasis,β-catenin interaction,epithelial-mesenchymal transition,biomarker potential
ENSG00000123364,HOXC13,epithelial-to-mesenchymal transition,transcription factor activity,cellular proliferation,oncogenic process,cancer stem cell regulation,tumor progression
ENSG00000137845,ADAM10,tumor progression,cell adhesion modulation,ectodomain shedding,pro-oncogenic ligand activation,cell migration promotion,therapeutic target
ENSG00000170043,TRAPPC1,cellular trafficking regulation,oncogenic processes,tumor growth promotion,endosomal-lysosomal pathway modulation,cell cycle progression enhancement,therapeutic target
ENSG00000165322,ARHGAP12,negative regulator,rhoa gtpase activation,cell migration inhibition,tumor suppressor function,cytoplasmic localization,protein-protein interactions
ENSG00000132825,PPP1R3D,glycogen metabolism,protein phosphatase 1 regulation,cellular proliferation modulation,therapeutic target identification,metabolic pathway regulation,signal transduction interaction
ENSG00000184117,NIPSNAP1,wnt/β-catenin pathway regulation,tumor progression,epithelial-to-mesenchymal transition,cell cycle regulation,cancer metastasis,cyclin-dependent kinase interaction
ENSG00000179934,CCR8,immune evasion,angiogenesis promotion,tumor progression facilitation,signaling pathway activation,immune suppression modulation,prognostic marker
ENSG00000133055,MYBPH,regulation of oligodendrocyte differentiation,cell growth modulation,phosphatase activity,cell proliferation regulation,cell cycle progression,akt signaling interaction
ENSG00000073060,SCARB1,cholesterol efflux,pi3k/akt pathway regulation,lipid metabolism dysregulation,tumor cell growth promotion,metastasis facilitation,therapeutic target identification
ENSG00000172322,CLEC12A,immunomodulation,cancer progression,prognostic marker,cell migration,tumor metastasis,innate immunity
ENSG00000108506,INTS2,integrator complex subunit,cell adhesion molecule interaction,genomic stability regulator,apoptosis inhibitor,tumor suppressor loss,cancer driver mutation
ENSG00000132326,PER2,circadian rhythm regulation,tumor suppressor function,genomic instability,dna damage response,cell cycle regulation,apoptosis induction
ENSG00000152527,PLEKHH2,microtubule dynamics,cell cycle progression,mitotic spindle assembly,genomic stability,cilia formation,protein-protein interaction
ENSG00000157796,WDR19,cell cycle regulation,dna repair dysfunction,chromatin remodeling,cell proliferation promotion,tumor suppressor dysregulation,genetic instability
ENSG00000125841,NRSN2,cell adhesion regulation,oncogene activation,cell migration facilitation,tumor progression promotion,apoptosis suppression,angiogenesis enhancement
ENSG00000150471,ADGRL3,overexpression,cell migration,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway,cell adhesion,gene overexpression
ENSG00000204323,SMIM5,tumor suppressor function,protein localization,cell growth regulation,metastasis suppression,oncogenesis involvement,therapeutic target
ENSG00000170293,CMTM8,regulatory function,tumor progression,oncogenic role,cell adhesion regulation,pi3k/akt pathway modulation,immune response modulation
ENSG00000079689,SCGN,calcium-binding function,cell signaling regulation,oncogene activation,tumor progression,protein interaction modulation,cancer cell proliferation
ENSG00000068878,PSME4,protein degradation regulation,cancer cell proliferation,apoptosis inhibition,dna repair enhancement,tumor aggressiveness indicator,cell cycle progression facilitation
ENSG00000137273,FOXF2,transcription factor regulation,apoptosis evasion,epithelial-to-mesenchymal transition,cellular metabolism reprogramming,tumor suppressor interaction,stem cell maintenance
ENSG00000215790,SLC35E2A,nucleotide sugar transport,cellular homeostasis,altered metabolism,glycolytic flux,substrate provision,tumor progression
ENSG00000085063,CD59,tumor evasion,complement system regulation,immune suppression,protein-protein interaction,cell survival enhancement,poor prognosis indicator
ENSG00000160808,MYL3,pi3k/akt pathway,constitutive activation,cell migration,phosphorylation regulation,metastasis driver,tumor progression
ENSG00000131668,BARX1,transcription factor regulation,wnt/β-catenin signaling,epithelial-to-mesenchymal transition,tumor progression,overexpression,cellular proliferation
ENSG00000128709,HOXD9,oncogenic activity,transcriptional regulation,cellular proliferation,tumor progression,cell migration,genomic amplification
ENSG00000186642,PDE2A,camp hydrolysis,constitutive activation,gain of function mutations,cell migration,apoptosis suppression,tumor progression
ENSG00000135624,CCT7,chaperone function,protein stabilization,oncoprotein stabilization,tumor progression,poor prognosis marker,cellular stress response
ENSG00000138613,APH1B,notch signaling disruption,cell proliferation regulation,cancer driver mutations,presenilin complex interaction,glycoprotein cleavage regulation,signaling pathway dysregulation
ENSG00000051009,FAM160A2,centrosome regulation,genomic instability,oncogenic mutations,tumor progression,cell proliferation,mitotic errors
ENSG00000283068,IBTK,nf-κb pathway activation,gain of function mutations,cell survival promotion,immune response dysregulation,tumor growth enhancement,therapeutic target
ENSG00000111817,DSE,wnt/β-catenin pathway,signaling regulator,cell proliferation promoter,tumor progression driver,cell migration enhancer,oncogenic protein
ENSG00000170006,TMEM154,epithelial-to-mesenchymal transition,cell signaling regulation,oncogenic process,tumor progression,therapeutic target,transmembrane protein function
ENSG00000091542,ALKBH5,genomic stability,tumor suppressor function,dual role in cancer,epigenetic regulation,methyl group removal,dna repair enzyme
ENSG00000035681,NSMAF,erα regulation,cell proliferation,coactivator function,tumor progression,nuclear receptor interaction,gene expression modulation
ENSG00000122824,NUDT10,dna repair,genomic stability,oxidative dna damage,genome integrity,tumor progression,therapeutic target
ENSG00000172171,TEFM,genomic instability,dna repair mechanisms,cellular proliferation,potential oncogene,tumor progression,somatic mutations
ENSG00000130699,TAF4,transcriptional regulation,chromatin modification,oncogenesis,cell growth,apoptosis regulation,telomerase activity
ENSG00000135336,ORC3,cell cycle regulation,tumor suppressor function,genomic stability maintenance,premature dna replication suppression,hyper-replicative features association,cancer cell proliferation enhancement
ENSG00000128536,CDHR3,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),tumor progression,metastasis promotion,protein-protein interaction,signal transduction
ENSG00000122783,CYREN,tumor suppressor,cell cycle regulation,g2/m checkpoint,genomic instability,cell proliferation inhibition,cancer therapy target
ENSG00000177380,PPFIA3,cell adhesion disruption,oncogenic signaling,cell migration promotion,metastasis enhancement,tumor progression facilitation,prognostic marker status
ENSG00000184014,DENND5A,loss of tumor suppressor function,cell growth promotion,metastasis enhancement,protein degradation regulation,pi3k/akt pathway interaction,therapeutic target
ENSG00000108375,RNF43,wnt/β-catenin pathway,tumor suppressor function,protein degradation regulation,cellular homeostasis disruption,oncogenic driver mutation,genomic instability
ENSG00000120324,PCDHB10,cell-cell interactions,neuronal development,immune responses,protein-protein interactions,tumorigenesis,metastasis
ENSG00000158786,PLA2G2F,overexpression,oncogenesis,cell proliferation,migration,invasion,biomarker
ENSG00000158747,NBL1,nucleolar phosphoprotein,ribosome biogenesis regulation,tumor growth promotion,apoptosis modulation,cell cycle progression,bcl2 interaction
ENSG00000169181,GSG1L,genomic stability,cell division regulation,dna repair mechanisms,chromosomal instability,predictive biomarker,therapeutic resistance
ENSG00000123095,BHLHE41,tumor suppressor,cell cycle arrest,dna repair mechanism,p53 activation,transcriptional regulation,subcellular localization
ENSG00000151229,SLC2A13,glut family member,glucose transporter overexpression,tumor growth promotion,aerobic glycolysis adaptation,cancer metabolism alteration,cell survival enhancement
ENSG00000123352,SPATS2,pi3k/akt signaling,cell proliferation,tumor progression,therapeutic target,cell growth regulation,apoptosis modulation
ENSG00000189298,ZKSCAN3,chromatin remodeling,transcriptional repression,epigenetic regulation,apoptosis suppression,tumor suppressor gene silencing,dna repair inhibition
ENSG00000111300,NAA25,protein modification,cellular growth,tumor progression,therapeutic target,gene regulation,cancer-related alterations
ENSG00000172554,SNTG2,regulation of kinases,protein degradation,tumor progression,dna repair regulation,cell cycle modulation,genomic instability
ENSG00000151364,KCTD14,cell cycle regulation,tumor suppressor function,potassium channel regulation,apoptosis induction,dna repair modulation,genomic stability maintenance
ENSG00000020577,SAMD4A,loss of function mutation,constitutive activation,tumor suppressor function loss,oncogenesis promotion,dna repair regulation,apoptosis inhibition
ENSG00000135968,GCC2,glutamine metabolism,cellular energy homeostasis,glutamatergic microenvironment adaptation,mitochondrial function regulation,autophagy modulation,therapeutic target
ENSG00000106565,TMEM176B,immune modulation,calcium signaling dysregulation,inflammation promotion,tumor microenvironment manipulation,therapeutic target potential,cellular homeostasis disruption
ENSG00000128268,MGAT3,n-glycan biosynthesis,glycosyltransferase activity,cell surface modification,oncogenesis promotion,tumor cell growth,metastasis enhancement
ENSG00000138092,CENPO,aneuploidy,kinetochore attachment,genomic stability,mitotic progression,microtubule stabilization,chromosomal instability
ENSG00000137266,SLC22A23,transporter function,drug resistance,tumor metabolism,cellular accumulation,therapeutic target,organic cation transport
ENSG00000101198,NKAIN4,mitochondrial localization,ion homeostasis regulation,warburg effect modulation,glycolysis promotion,tumor growth support,oncogenic potential
ENSG00000105699,LSR,cell adhesion disruption,tumor progression enhancement,immune evasion facilitation,overexpression association,aggressive phenotype contribution,pi3k/akt pathway interaction
ENSG00000165416,SUGT1,lipid metabolism regulation,transcriptional coactivation,tumor cell survival,therapeutic target,cell proliferation enhancement,metabolic reprogramming
ENSG00000157782,CABP1,calcium signaling,cell migration,tumor progression,metastasis,therapeutic target,protein interaction
ENSG00000100442,FKBP3,akt/mtor pathway,cell proliferation,overexpression,transcriptional regulation,cell survival,protein-protein interaction
ENSG00000152785,BMP3,wnt/β-catenin pathway inhibition,apoptosis induction,cell cycle arrest,tumor suppressor function,genomic silencing,smad transcription factor regulation
ENSG00000145248,SLC10A4,bile salt transport,tumor suppressor function,genomic instability,cellular proliferation regulation,apoptosis modulation,dna damage prevention
ENSG00000144354,CDCA7,chromatin remodeling,driver gene,cohesin complex component,cell cycle regulation,protein-protein interaction,wnt/β-catenin pathway interaction
ENSG00000282854,ASAP3,pi3k/akt/mtor pathway modulation,rho gtpase interaction,cell migration facilitation,actin cytoskeleton dynamics,tumor progression promotion,cancer driver gene potential
ENSG00000221838,AP4M1,endocytic pathway regulation,ap-4 complex formation,mutations contributing to oncogenesis,cell membrane trafficking disruption,protein sorting dysregulation,tumor progression promotion
ENSG00000012983,MAP4K5,jnk pathway activation,cell survival regulation,protein kinase activity,tumor growth promotion,apoptosis resistance,stress response modulation
ENSG00000023572,GLRX2,redox balance regulation,oxidative stress protection,cellular metabolism modulation,protein-glutathione interaction,thiol-dependent oxidoreductase activity,dna repair facilitation
ENSG00000074071,MRPS34,mitochondrial translation,genomic instability,cellular metabolism,tumor suppressor function,protein synthesis regulation,poor prognosis biomarker
ENSG00000143093,STRIP1,p53 interaction,tumor suppressor dysfunction,genome instability,cell cycle dysregulation,apoptosis resistance,prognostic biomarker
ENSG00000173517,PEAK1,cellular migration,constitutive activation of signaling pathways,gene amplification,protein-protein interactions,tumor metastasis,therapeutic target
ENSG00000278284,RDH13,metabolic regulation,cellular metabolism,tumor progression,proliferation enhancement,cell survival modulation,genomic instability
ENSG00000181991,MRPS11,mitochondrial function,translation initiation,protein synthesis,mtor pathway,cellular respiration,metabolic reprogramming
ENSG00000078814,MYH7B,muscle contraction regulation,gene mutation association,cytoskeletal dynamics,tissue morphology regulation,protein complex formation,sarcomere organization
ENSG00000175309,PHYKPL,aneuploidy,cell cycle regulation,genomic instability,genotoxic stress response,oncogene activation,tumor growth
ENSG00000198556,ZNF789,p53 pathway,loss-of-function mutations,transcriptional regulator,tumor suppressor interaction,oncogenic driver,pancreatic cancer association
ENSG00000134253,TRIM45,protein regulation,ubiquitination pathway,tumor suppressor function,cell proliferation enhancement,oncogenic properties,protein stability modulation
ENSG00000163528,CHCHD4,mitochondrial protein function,apoptosis regulation,cellular metabolism regulation,electron transport chain regulation,oxidative phosphorylation,tumor suppressor dysfunction
ENSG00000187733,AMY1C,metabolic reprogramming,tumor growth,glucose metabolism,glycolysis regulation,cell signaling modulation,diagnostic/prognostic marker
ENSG00000237763,AMY1A,metabolic regulation,enzymatic activity,cellular digestion,nutrient absorption,glycolysis pathway,protein structure alteration
ENSG00000174876,AMY1B,cellular proliferation,prognostic marker,metabolic reprogramming,cell growth regulation,enzyme overexpression,tumor microenvironment modulation
ENSG00000198774,RASSF9,tumor suppressor,pi3k/akt pathway regulation,epigenetic regulation,cell cycle regulation,apoptosis promotion,microtubule stability maintenance
ENSG00000278091,ZNF85,regulatory function,cell cycle regulation,dna-binding transcription factor,oncogenic transformation,genomic instability,epithelial-to-mesenchymal transition
ENSG00000187957,DNER,cell adhesion modulation,tumor progression involvement,cell migration regulation,signaling pathway interaction,genomic stability maintenance,cancer cell proliferation
ENSG00000143458,GABPB2,genomic instability,tumor suppressor function,transcriptional regulation,cell cycle progression,protein-protein interaction,cancer biomarker
ENSG00000175416,CLTB,apoptosis regulation,cancer progression,cell cycle regulation,dna repair mechanism,oncogenesis,pro-survival signaling
ENSG00000168807,SNTB2,pi3k/akt pathway,oncogene activation,dysregulated signaling,cell proliferation enhancement,therapeutic target,genomic instability
ENSG00000142687,KIAA0319L,dna repair mechanisms,cell cycle regulation,genome stability maintenance,potential tumor suppressor,genomic integrity regulator,kelch family protein
ENSG00000101019,UQCC1,mitochondrial quality control,constitutive activation,mitophagy dysregulation,oncogenic transformation,metabolic reprogramming,genomic instability
ENSG00000177551,NHLH2,transcriptional regulation,cell cycle progression,apoptosis modulation,genetic imprinting,cancer susceptibility,tumor suppressor function
ENSG00000175548,ALG10B,oligosaccharyltransferase complex,n-glycosylation,cell proliferation,protein modification,endoplasmic reticulum,cell migration
ENSG00000112319,EYA4,cellular regulation,transcriptional regulation,cell fate determination,signaling pathway modulation,gene expression regulation,chromatin remodeling
ENSG00000142330,CAPN10,cellular degradation,calcium-dependent protease,signal transduction pathway,tumorigenesis,protein interaction,cellular growth and differentiation
ENSG00000265354,TIMM23,mitochondrial dysfunction,cellular metabolism reprogramming,protein import regulation,oncogenic signaling pathway activation,apoptosis resistance,therapeutic target
ENSG00000165238,WNK2,ion channel regulation,cell proliferation inhibition,apoptosis promotion,tumor suppressor or oncogene function,genomic instability,protein kinase activation
ENSG00000183715,OPCML,loss of function mutations,tumor suppressor activity,pi3k/akt pathway inhibition,cell cycle regulation,apoptosis regulation,genomic instability
ENSG00000243156,MICAL3,cellular migration,actin cytoskeleton dynamics,cancer progression,metastasis,oncogenesis,biomarker
ENSG00000050393,MCUR1,mitochondrial dynamics,cellular homeostasis regulation,oncogenic process promotion,cell proliferation enhancement,survival pathway activation,protein-protein interaction
ENSG00000076356,PLXNA2,cell adhesion,signaling pathway regulation,tumor progression facilitation,cell migration and invasion enhancement,axon guidance disruption,tissue architecture disruption
ENSG00000179604,CDC42EP4,microtubule regulation,epithelial-to-mesenchymal transition,oncogenic transformation,cell migration,metastasis promotion,pi3k/akt interaction
ENSG00000275003,DDT,pi3k/akt pathway activation,transcriptional regulation,dysregulation of cell differentiation,tumor progression and metastasis,therapeutic target,genomic alterations
ENSG00000118526,TCF21,tumor suppressor function,wnt/β-catenin pathway activation,cell cycle regulation,cell differentiation regulation,genomic instability promotion,tissue homeostasis disruption
ENSG00000136718,IMP4,nuclear protein import,cell proliferation,oncogenic protein transport,transcription factor regulation,tumor progression,cancer cell survival
ENSG00000122741,DCAF10,protein degradation pathway,ubiquitin ligase complex,e3 ubiquitin ligase activity,proteasome regulation,cellular homeostasis,stress response
ENSG00000184992,BRI3BP,regulation of tgf-β signaling pathway,enhancement of cell proliferation,promotion of oncogenic processes,activation of pi3k/akt/mtor pathway,potential biomarker for cancer diagnosis,regulation of epithelial-to-mesenchymal transition (emt)
ENSG00000171227,TMEM37,genomic instability,nuclear envelope maintenance,dna repair machinery,apoptosis regulation,cell cycle control,tumor suppressor function
ENSG00000243056,EIF4EBP3,mtor pathway regulation,growth inhibition,cap-dependent translation suppression,tumor suppressor function,cell cycle regulation,apoptosis promotion
ENSG00000288324,ADGRL1,cell adhesion disruption,oncogenic signaling,tumor growth promotion,immune evasion pathways,tumor microenvironment remodeling,prognostic biomarker
ENSG00000115361,ACADL,metabolic reprogramming,cell growth regulation,fatty acid oxidation downregulation,tumor progression,therapeutic target potential,signaling pathway intersection
ENSG00000141577,CEP131,centrosome regulation,genomic stability disruption,microtubule dynamics alteration,ciliogenesis impairment,chromosomal instability induction,spindle assembly defect
ENSG00000021574,SPAST,microtubule-severing enzyme,cell cycle disruption,genomic instability,oncogenic transformation,cell proliferation enhancement,tumor progression facilitation
ENSG00000233801,NELFE,cellular export regulation,oncogenic mrna export,tumorigenesis promotion,cell proliferation enhancement,apoptosis inhibition,prognostic marker
ENSG00000116791,CRYZ,calcium ion homeostasis regulation,microtubule stability regulation,oncogene overexpression,cell proliferation enhancement,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition (emt) regulator
ENSG00000076067,RBMS2,mrna regulation,cell proliferation,apoptosis regulation,tumor progression,metastasis promotion,rna binding motif protein
ENSG00000116990,MYCL,oncogene,transcription factor,cell proliferation,apoptosis regulation,cell cycle progression,tumor suppressor (opposite)
ENSG00000171747,LGALS4,cell-to-cell interaction,tumor growth promotion,immune suppression,metastasis facilitation,prognostic marker,cancer cell adhesion
ENSG00000118972,FGF23,phosphate metabolism regulation,fgf23-klotho interaction,cell proliferation promotion,angiogenesis facilitation,bone remodeling dysregulation,tumor progression enhancement
ENSG00000169860,P2RY1,overexpression,oncogene,tumor growth,cell proliferation,autocrine regulation,pi3k/akt pathway
ENSG00000181830,SLC35C1,glycosylation regulation,tumor progression,oncogenic protein expression,pi3k/akt pathway interaction,metabolic reprogramming,therapeutic target
ENSG00000103642,LACTB,metabolic reprogramming,cell survival,mutational alteration,tumor aggressiveness,glycolytic enhancement,pi3k/akt pathway interaction
ENSG00000182916,TCEAL7,transcriptional regulation,apoptosis,cell cycle progression,dna repair,oncogenesis,genomic stability
ENSG00000135222,CSN2,protein deneddylation,ubiquitin-proteasome pathway regulation,regulation of cell cycle progression,cancer-related mutations,cellular protein degradation,signal transduction pathway modulation
ENSG00000185697,MYBL1,transcription factor activity,cell proliferation,oncogene role,tumor progression,apoptosis inhibition,genomic instability
ENSG00000152592,DMP1,transcriptional regulation,extracellular matrix processing,bone mineralization,osteoblast differentiation,bone density regulation,fibrous dysplasia
ENSG00000196110,ZNF699,transcriptional regulation,tumor suppressor/oncomodulator,brain-specific expression,epigenetic regulation,cellular response modulation,krab domain-binding protein
ENSG00000174938,SEZ6L2,cell migration,cancer invasiveness,cell adhesion regulation,cytoplasmic protein function,tumor metastasis,cellular proliferation
ENSG00000135114,OASL,antiviral response,tumor suppression,dysregulation,rnase l activation,interferon pathway,antitumor activity
ENSG00000135298,ADGRB3,pi3k/akt pathway activation,cell migration promotion,genetic alterations,protein-protein interactions,tumor progression contribution,oncogene potential
ENSG00000262473,GART,genomic instability,cellular proliferation,nucleotide biosynthesis,dna replication,apoptosis evasion,therapeutic resistance
ENSG00000258992,TSPY1,oncogene,tumor suppressor overexpression,cell proliferation promotion,apoptosis inhibition,angiogenesis enhancement,pi3k/akt signaling pathway interaction
ENSG00000108523,RNF167,protein degradation regulation,oncogenic protein accumulation,dna repair regulation,cell cycle progression,ubiquitin-proteasome system,therapeutic target
ENSG00000188910,GJB3,cell-cell communication,gap junction proteins,inter cellular signaling,tumor progression,biomarker potential,pi3k/akt pathway interaction
ENSG00000284501,MGAT4B,glycosylation,cell adhesion,oncogenic driver,tumor progression,therapeutic target,immune evasion
ENSG00000119977,TCTN3,planar cell polarity (pcp) signaling pathway,dysregulation of pcp signaling,oncogenic mutations,gene expression regulation,molecular interaction with effector proteins,tumor suppression dysfunction
ENSG00000164258,NDUFS4,mitochondrial function,energy metabolism dysregulation,ros production,cellular redox balance,tumor growth,oncogenic process
ENSG00000153904,DDAH1,pi3k/akt pathway modulation,tumor suppressor activity,cell proliferation inhibition,angiogenesis regulation,nitric oxide regulation,endothelial function maintenance
,LRMP,wnt/β-catenin signaling,tumor suppression,transmembrane adaptor protein,cell adhesion regulation,metabolic regulation,energy production modulation
ENSG00000174013,FBXO45,f-box protein function,cell cycle regulation,ubiquitination pathway disruption,genomic instability maintenance,tumor suppressor role,cancer cell proliferation
ENSG00000159346,ADIPOR1,metabolic reprogramming,oncogenic activation,insulin resistance,therapeutic target,anti-inflammatory response,cellular metabolism
ENSG00000138430,OLA1,mitochondrial function,oncogene activation,cell proliferation,protein stability regulation,apoptosis resistance,oxidative phosphorylation modulation
ENSG00000134375,TIMM17A,mitochondrial dysfunction,oncogenic mutations,apoptosis resistance,reactive oxygen species regulation,protein importation,cellular metabolism disruption
ENSG00000151498,ACAD8,fatty acid metabolism,mitochondrial function,cellular proliferation,glycolytic shift,chemoresistance,energy metabolism
ENSG00000183691,NOG,bmp signaling pathway inhibition,cellular growth regulation,epithelial-to-mesenchymal transition modulation,protein-protein interaction regulation,bmp ligand binding,tissue development regulation
ENSG00000168454,TXNDC2,endoplasmic reticulum folding,cell proliferation,survival signaling,pi3k/akt pathway,stat3 activation,nf-κb modulation
ENSG00000186318,BACE1,pi3k/akt signaling,oncogene activation,proteolytic activity,cell proliferation,tumor progression,apoptosis resistance
ENSG00000204967,PCDHA4,cell-cell adhesion,tumor suppression,aberrant expression,oncogenesis,reduced adhesion,disrupted interaction
ENSG00000105428,ZNRF4,wnt signaling inhibition,tumor suppression,ubiquitination regulation,frizzled receptor targeting,proteasomal degradation,cancer prognosis
ENSG00000188393,CLEC2A,immune evasion,inflammatory response regulation,myeloid-derived suppressor cell modulation,tumor progression facilitation,immune microenvironment modulation,cancer prognosis association
ENSG00000130385,BMP15,tumor suppressor,cell proliferation regulation,angiogenesis inhibition,oncogenesis association,therapeutic target,signaling pathway interaction
ENSG00000162599,NFIA,genomic regulation,chromatin remodeling,transcriptional control,cell cycle progression,tumor suppressor function,epigenetic regulation
ENSG00000165269,AQP7,glycerol transport,cellular hydration,metabolic regulation,tumor growth,adipocyte function,cancer progression
ENSG00000262217,SLC5A8,metabolic regulation,lactate transport,cellular ph homeostasis,tumor progression,therapeutic target,genomic instability
ENSG00000198822,GRM3,glutamate binding,cell proliferation,g-protein coupled signaling,pi3k/akt/mtor pathway activation,metastasis promotion,tumor progression
ENSG00000135116,HRK,pro-apoptotic function,tumor suppression,mitochondrial regulation,apoptosis induction,cell survival modulation,bcl-2 family interaction
ENSG00000142552,RCN3,oncogenic potential,constitutive activation,angiogenesis induction,emt promoter,cell proliferation enhancer,signaling pathway modulator
ENSG00000278728,CNTNAP2,neurodevelopmental regulation,axon development disruption,myelination dysfunction,synaptic transmission alteration,genomic instability,protein mislocalization
ENSG00000176230,OR4K17,g-protein coupled receptor,olfactory signaling pathway,cellular proliferation,tumor growth promotion,metastasis regulation,cancer associated gene
ENSG00000197415,VEPH1,proton transport regulation,tumor promotion,metabolic reprogramming,cellular metabolism modulation,acidic organelle function,cellular ph homeostasis disruption
ENSG00000108599,AKAP10,oncogenic function,cell cycle regulation,pka activation,mitotic progression,cell migration inhibition,therapeutic target
ENSG00000125510,OPRL1,opioid receptor function,overexpression in cancer,cell migration and invasion,poor prognosis,chemotherapy resistance,pi3k/akt pathway interaction
ENSG00000100014,SPECC1L,cell adhesion,oncogenic driver,tumor progression,metastasis promotion,cell migration,signaling pathway modulation
ENSG00000161914,ZNF653,p53 pathway regulation,genomic stability maintenance,tumor suppressor function,dna binding specificity,transcriptional regulation,chromatin modification interaction
ENSG00000112759,SLC29A1,nucleoside uptake,cell proliferation,dna synthesis,tumor growth,oncogene activation,gene overexpression 
ENSG00000151617,EDNRA,angiogenesis,cell migration,cell proliferation,g-protein coupled receptor,oncogenic signaling,tumor progression
ENSG00000141179,PCTP,cellular processes regulation,tumor progression,cancer biology interaction,potential therapeutic target,multifunctional protein roles,cell migration influence
ENSG00000072195,SPEG,autophagy regulation,apoptosis inhibition,muscle cell growth regulation,cell proliferation promotion,tumor progression inhibition,genomic instability
ENSG00000099994,SUSD2,cd47 interaction,tumor progression,epithelial-to-mesenchymal transition (emt),metastasis promotion,biomarker significance,immunomodulation
ENSG00000130829,DUSP9,erk1/2 activation,mapk signaling pathway,cell proliferation regulation,protein phosphatase activity,mitogen-activated protein kinase regulation,apoptosis modulation
ENSG00000123472,ATPAF1,regulatory function,protein degradation,signaling pathway modulation,oncogenic kinase regulation,cancer progression implication,therapeutic target potential
ENSG00000198093,ZNF649,chromatin remodeling,cell cycle regulation,apoptosis regulation,histone modification,gene expression modulation,tumor suppressor/oncogene function
ENSG00000145687,SSBP2,genomic instability,dna repair,cell proliferation,oncogene potential,genetic mutation,protein interaction
ENSG00000167851,CD300A,immune activation,tumor progression,oncogene activation,cell surface receptor,cytokine production,immune evasion
ENSG00000148604,RGR,cell adhesion disruption,oncogenic properties,pi3k/akt pathway activation,mapk/erk pathway activation,tumorigenesis promotion,metastasis facilitation
ENSG00000125384,PTGER2,cell growth promotion,g-protein coupled receptor signaling,oncogene activation,camp-dependent pathway regulation,cell migration enhancement,prostaglandin e2 binding
ENSG00000224051,CPTP,mtorc1 pathway,regulatory enzyme,cell proliferation,oncogenic mutation,amino acid metabolism,protein synthesis regulation
ENSG00000111674,ENO2,metabolic reprogramming,glycolytic enzyme activity,tumor growth promotion,energy production enhancement,cell proliferation facilitation,prognostic biomarker status
ENSG00000163795,ZNF513,oncogenic transcription regulation,overexpression,cell proliferation enhancement,apoptosis inhibition,transcription factor interaction,dna binding motif specificity
ENSG00000137345,MOG,antigen presentation,immunotherapy target,cell surface protein,myelination process,central nervous system development,immune response modulation
ENSG00000223802,CERS1,ceramide biosynthesis,sphingolipid metabolism regulation,cell survival promotion,tumor growth support,therapeutic target identification,biomarker potential
ENSG00000169062,UPF3A,nmd pathway,genome instability,aberrant mrna regulation,tumorigenesis,cell survival,dna damage response
ENSG00000124155,PIGT,aberrant glycosylation,oncogene activation,cell growth promotion,metastasis facilitation,immune suppression,tumor progression
ENSG00000171530,TBCA,aberrant cell membrane protrusions,cellular polarity,disrupted cytoskeleton dynamics,metastasis,oncogenic processes,signaling pathway activation
ENSG00000135677,GNS,myelin maintenance,cancer driver,cell migration,cell proliferation,proliferation regulatory mechanism,axonal growth regulation
ENSG00000117614,SYF2,transcriptional regulation,histone modification,oncogenesis,rna processing,chromatin remodeling,cancer progression
ENSG00000163106,HPGDS,prostaglandin degradation,platelet aggregation inhibition,tumor cell growth promotion,apoptosis inhibition,cell proliferation regulation,inflammation modulation
ENSG00000085719,CPNE3,cell migration,calcium-binding protein,overexpression,tumor progression,apoptosis regulation,protein-protein interaction
ENSG00000081248,CACNA1S,calcium channel regulation,oncogenic signaling,cell proliferation,aberrant ion flux,therapeutic resistance,cardiac muscle contraction
ENSG00000176463,SLCO3A1,constitutive expression,dysregulation of transport,oncogenic processes,cellular homeostasis modulation,tumor suppressor/tumor promoter potential,transporter interactions
ENSG00000119203,CPSF3,rna processing,cancer progression,tumor growth,proliferation,cell survival,metastasis
ENSG00000183166,CALN1,calcium-dependent signaling,cell proliferation,tumor growth,apoptosis regulation,cancer metastasis,calcium homeostasis
ENSG00000133020,MYH8,tumor progression,cell migration,oncogene overexpression,metastasis initiation,adhesion regulation,cytoskeleton remodeling
ENSG00000165060,FXN,mitochondrial dysfunction,oxidative stress protection,iron-sulfur cluster biosynthesis,frataxin deficiency,neurodegeneration,regulated cellular metabolism
ENSG00000180543,TSPYL5,chromatin remodeling,oncogenic protein,histone modification,cell proliferation,epigenetic regulation,tumor suppression
ENSG00000154144,TBRG1,t-box family member,tumor growth promotion,oncogenic mutation,cell migration enhancement,transcriptional regulation,therapeutic target
ENSG00000138083,SIX3,wnt/β-catenin signaling pathway,overexpression,epithelial-to-mesenchymal transition (emt),cell proliferation regulation,differentiation inhibition,apoloosis suppression
ENSG00000075151,EIF4G3,mtor pathway activation,constitutive activation,translational regulation,cell proliferation enhancement,oncogene overexpression,mrna stability modulation
ENSG00000135537,AFG1L,mitochondrial biogenesis,mitochondrial dynamics,regulatory protein interactions,cellular stress responses,tumor progression,therapeutic target
ENSG00000152578,GRIA4,amplified expression,neurotransmission regulation,synaptic plasticity modulation,cell proliferation enhancement,metastasis promotion,tumor growth facilitation
ENSG00000047230,CTPS2,nucleotide metabolism,cell proliferation,tumor progression,oncogenic potential,genetic mutations,antitumor target
ENSG00000104613,INTS10,transcriptional regulation,dysregulated gene expression,enhanced cell proliferation,oncogenic function,cellular processes regulation,genomic instability
ENSG00000198203,SULT1C2,sulfotransferase activity,ancillary detoxification,apoptosis regulation,cytoplasmic localization,metabolic reprogramming,oncogene activation/ suppression
ENSG00000181192,DHTKD1,glutamine metabolism,cell growth promotion,mitochondrial regulation,mtorc1 activation,tumor progression enhancement,therapeutic target
ENSG00000141519,CCDC40,pi3k/akt pathway regulation,tumor suppressor inhibition,epithelial-to-mesenchymal transition (emt),cell signaling modulation,cancer progression facilitation,metastasis promotion
ENSG00000173068,BNC2,transcriptional coactivation,cell cycle progression,dna replication modulation,chromatin remodeling,oncogene upregulation,protein-protein interaction
ENSG00000169976,SF3B5,aberrant splicing,cancer-specific phenotypes,dysregulation,oncogenic mutations,pre-mrna processing,splicing factor regulation
ENSG00000166295,ANAPC16,chromosome instability,constitutive activation,cell cycle dysregulation,tumor progression,genomic alterations,ubiquitination pathway
ENSG00000137760,ALKBH8,dna repair defects,tumor promoter,epigenetic regulation,cell growth promotion,oxidative stress response,genome instability
,ARSE,tissue specification,developmental regulation,transcriptional control,oncogenic potential,cell proliferation,metastatic progression
ENSG00000132286,TIMM10B,mitochondrial dysfunction,oxidative stress,altered cellular respiration,tumor progression,poor prognosis,downstream signaling
ENSG00000244187,TMEM141,transmembrane protein regulation,cellular homeostasis,signaling pathway modulation,ion transport regulation,tumor suppressor candidate,potential oncogenic driver
ENSG00000117228,GBP1,cellular proliferation,guanylate binding protein activity,immune response modulation,pi3k/akt pathway interaction,tumor progression enhancement,cancer-related overexpression
ENSG00000079931,MOXD1,oxidative stress modulation,cell cycle regulation,redox balance maintenance,tumor suppressor activity,antioxidant defense mechanism regulation,cancer cell proliferation
ENSG00000161791,FMNL3,cell migration,tumor growth,oncogenesis,metastasis,actin cytoskeleton regulation,signaling pathway activation
ENSG00000143258,USP21,oncogenic regulation,deubiquitinating enzyme activity,cell proliferation enhancement,apoptosis resistance,protein stability modulation,ubiquitin pathway regulation
ENSG00000171723,GPHN,glutamine synthesis,tumor growth promotion,energy metabolism regulation,cellular response modulation,protein-protein interaction,cancer progression driver
ENSG00000007062,PROM1,cell surface protein,progenitor cells marker,proliferation promotion,signaling interaction,poor prognosis indicator,hematopoietic system involvement
ENSG00000005436,GCFC2,alternative splicing regulator,cell cycle regulation,apoptosis modulation,dna repair regulation,tumor growth facilitation,therapeutic target candidate
ENSG00000175591,P2RY2,pi3k/akt pathway activation,g protein-coupled receptor function,cell proliferation enhancement,survival signaling pathway engagement,tumor progression facilitation,oncogene interaction
ENSG00000099822,HCN2,channel regulation,cell proliferation,signal transduction,oncogenic transformation,tumor progression,metabolic regulation
ENSG00000146678,IGFBP1,igf-mediated signaling pathway,tumor suppression,methylation-dependent regulation,cell growth inhibition,angiogenesis inhibition,cell cycle regulation
ENSG00000107159,CA9,tumor aggressiveness,hypoxia-induced angiogenesis,metabolic adaptation,ph regulation,transmembrane enzyme,therapeutic target
ENSG00000167216,KATNAL2,cell cycle regulation,mitotic spindle formation,chromosome segregation,microtubule dynamics,cell proliferation,tumor suppressor
ENSG00000164919,COX6C,mitochondrial function,electron transport chain,cellular metabolism,energy production,drug resistance,tumor microenvironment
ENSG00000137868,STRA6,ra signaling pathway disruption,growth regulation,cellular differentiation,retinol transport facilitation,tumor progression promotion,genomic instability induction
ENSG00000176136,MC5R,mc5r-dysregulation,skin integrity maintenance,cell growth regulation,constitutive activation,cancer metastasis,therapeutic target
ENSG00000122863,CHST3,tumor progression,metastasis facilitation,glycosaminoglycan regulation,cell migration modulation,therapeutic target potential,tissue integrity disruption
ENSG00000103121,CMC2,cell cycle regulation,chromosome segregation,genome stability maintenance,aurora kinase interaction,cyclin-dependent kinase modulation,tumor suppressor function
ENSG00000188620,HMX3,tumor suppressor dysregulation,oncogenic transcriptional regulator,cell proliferation enhancement,poor prognosis marker,wnt/β-catenin pathway interaction,embryonic development regulation
ENSG00000168653,NDUFS5,mitochondrial function,tumor progression,cellular metabolism,therapeutic target,reactive oxygen species regulation,complex i stability
ENSG00000130595,TNNT3,trk signaling pathway,oncogenic mutations,muscle-specific expression,cell proliferation regulation,therapeutic target for cancer,genomic amplifications
ENSG00000174917,MICOS13,mitochondrial biogenesis,metabolic reprogramming,oncogenic adaptation,mitochondrial morphology regulation,cell proliferation promotion,cancer metabolic adaptation
ENSG00000205683,DPF3,regulation of protein stability,oncogenic process,cell proliferation,apoptosis regulation,ubiquitination,therapeutic target
ENSG00000175606,TMEM70,mitochondrial regulation,oxidative phosphorylation,energy metabolism,cellular respiration,protein assembly,subunit integration
ENSG00000205981,DNAJC19,protein degradation regulation,cellular proliferation,tumor progression,oncogenesis,multifunctional role,cellular survival
ENSG00000087157,PGS1,oncogene activity,cell growth regulation,pentose phosphate pathway,nadph production,redox balance regulation,protein-protein interaction
ENSG00000163191,S100A11,calcium signaling,dysregulation,epithelial-to-mesenchymal transition,interaction with annexin a2,mitochondrial regulation,oncogenic function
ENSG00000145022,TCTA,immune system dysfunction,antigen recognition impairment,t-cell function loss,cancer immune evasion,genetic alterations,prognostic biomarker
ENSG00000137842,TMEM62,autophagy regulation,cellular homeostasis disruption,cancer progression facilitation,membrane remodeling,lipid metabolism regulation,genomic instability promotion
ENSG00000150540,HNMT,tumor progression,epigenetic regulation,methylation reaction,immune response modulation,therapeutic target,cancer metastasis
ENSG00000011405,PIK3C2A,pi3k/akt signaling,constitutive activation,gain of function mutations,oncogenic driver,cell survival enhancement,tumor suppressor regulation
ENSG00000198692,EIF1AY,mrna translational control,pseudogenic status,cellular proliferation pathway,regulatory function,translation initiation factor,tumor progression
ENSG00000170412,GPRC5C,calcium sensing regulation,tumor suppression,wnt/β-catenin pathway modulation,cell growth inhibition,apoptosis induction,genomic instability
ENSG00000179195,ZNF664,zinc finger protein,transcriptional regulator,oncogene,cell cycle progression,apoptosis regulation,tumor biomarker
ENSG00000166211,SPIC,tumor microenvironment modulation,immune checkpoint regulation,transcription factor activity,oncogenic potential,t-cell regulation,gene expression modulation
ENSG00000166902,MRPL16,mitochondrial translation regulation,ribosome assembly,cell growth promotion,apoptosis suppression,protein synthesis enhancement,tumor progression driver
ENSG00000092345,DAZL,pan-cancer relevance,oncogene function,cellular differentiation regulation,rna transport protein,germ cell development role,tumor progression marker
ENSG00000153707,PTPRD,tumor suppressor,rtk signaling pathway,dephosphorylation activity,cell growth regulation,angiogenesis inhibition,biomarker function
ENSG00000086200,IPO11,oncogene/tumor suppressor function,regulation of cell growth/differentiation,insulin-like signaling pathway involvement,transcriptional regulation/chromatin remodeling,cell proliferation/migration enhancement,apoptosis modulation
ENSG00000115556,PLCD4,pi3k/akt activation,cell proliferation,overexpression,tumor progression,signaling regulation,protein kinase activation
ENSG00000100228,RAB36,cellular trafficking regulation,oncogenic signaling pathway modulation,protein-protein interaction regulation,cell proliferation enhancement,tumor metastasis facilitation,genetic mutation association
ENSG00000134278,SPIRE1,polyamine synthesis,cell proliferation,tumorigenesis,oncogenesis,genomic instability,cell cycle regulation
ENSG00000127870,RNF6,regulation of emt,tumor suppressor function,ubiquitination activity,interaction with transcription factors,proteasomal degradation,maintenance of genome stability
ENSG00000166482,MFAP4,microfibril regulation,cell migration promotion,tumor progression enhancement,metastasis facilitation,cancer-related upregulation,poor prognosis indicator
ENSG00000140945,CDH13,tumor suppressor function,loss of adhesion,promoter hypermethylation,increased proliferation,poor prognosis marker,cell-cell interaction
ENSG00000074211,PPP2R2C,pi3k/akt/mtor pathway,regulatory subunit,dysregulation of pp2a,cell cycle disruption,oncogenic processes,therapeutic target
,MARC1,antigen presentation,tumor escape,oncogene function,cell survival,proliferation regulation,immune evasion
ENSG00000129993,CBFA2T3,chromatin remodeling,transcriptional regulation,cellular proliferation,metastatic potential,oncogenic driver,dna repair mechanism
ENSG00000138459,SLC35A5,glycosylation,constitutive expression,cell surface modification,tumor progression,oncogenic function,cell proliferation
ENSG00000106524,ANKMY2,ankmy2 interactions,oncogenic kinase stabilization,tumor progression,metastasis promotion,resistance to therapy,overexpression
ENSG00000151577,DRD3,g protein-coupled receptor,cell proliferation regulation,signaling pathway modulation,tumor progression facilitation,prognostic marker potential,brain-specific expression
ENSG00000047634,SCML1,genome stability maintenance,tumor suppressor regulation,dna repair mechanism interaction,cell cycle progression modulation,transcriptional regulation,oncogenic pathway inhibition
ENSG00000126653,NSRP1,spliceosome regulation,pre-mrna splicing,tumor suppressor regulation,oncogene modulation,nuclear rna binding,aberrant gene expression
ENSG00000075826,SEC31B,er-golgi transport regulation,gene amplification,tumor suppressor function,cell cycle modulation,autophagy regulation,protein folding disease
ENSG00000198604,BAZ1A,chromatin remodeling,transcriptional regulation,oncogene function,tumor growth promotion,metastasis facilitation,epigenetic modification
ENSG00000187689,AMTN,cell proliferation regulation,metalloprotease activity,signaling pathway activation,tumor growth promotion,oncogenic function,metastasis facilitation
ENSG00000129757,CDKN1C,cell cycle regulation,transcriptional regulation,nuclear localization,epigenetic regulation,oncogenic process,therapeutic target
ENSG00000135801,TAF5L,chromatin remodeling,transcriptional regulation,loss of function mutations,altered gene expression,cancer progression,cell proliferation
ENSG00000169684,CHRNA5,nicotinic receptor activation,cell proliferation regulation,oncogenic signaling pathway,neurotransmission regulation,metastasis promotion,biomarker potential
ENSG00000101846,STS,glycosylation regulation,cell surface modification,tumor progression,therapeutic target,signaling pathway modulation,protein-protein interaction
ENSG00000166803,PCLAF,pcna-binding,cell cycle regulation,dna replication,tumor growth promotion,oncogenic potential,genomic instability
ENSG00000152377,SPOCK1,cellular adhesion,epithelial-to-mesenchymal transition (emt),angiogenesis,tumor progression,matricellular protein,metastasis
ENSG00000125810,CD93,angiogenesis promotion,cell migration facilitation,immune evasion mechanism,metastatic progression enhancement,tumor-promoting signaling interaction,epithelial-to-mesenchymal transition modulation
ENSG00000021826,CPS1,metabolic regulation,oxidative stress regulation,antioxidant defense,cellular homeostasis,mitochondrial function,redox balance
ENSG00000070404,FSTL3,cellular interaction,tumor suppressor gene,paralogous relationship,energy homeostasis regulation,autophagy modulation,cell surface localization
ENSG00000198756,COLGALT2,fibrosis,cell adhesion,golgi apparatus localization,procollagen modification,collagen synthesis regulation,tumor progression
ENSG00000131899,LLGL1,cell polarity regulation,cell adhesion modulation,tumor invasion facilitation,oncogenic properties,genomic instability contribution,signaling pathway interaction
ENSG00000221944,TIGD1,tgf-beta signaling pathway,cell proliferation regulation,tumor suppression or oncogene,genomic instability,apoptosis modulation,clinical biomarker potential
ENSG00000071246,VASH1,tumor suppressor,transcription factor regulation,cell growth regulation,immune response modulation,apoptosis regulation,metastasis promotion
ENSG00000198934,MAGEE1,epigenetic regulation,histone methylation,chromatin modification,immune suppression,tumor invasion,cancer biomarker
ENSG00000173040,EVC2,hedgehog signaling pathway,abnormal ciliary function,oncogenic processes,cellular polarity,genetic instability,cilia formation and function
ENSG00000188643,S100A16,tumor metastasis,inflammation regulation,apoptosis modulation,cell proliferation,oncogene expression,cancer prognosis
ENSG00000137713,PPP2R1B,pi3k/akt pathway modulation,pp2a regulatory subunit,tumor growth promotion,therapeutic resistance modulation,oncogenic kinase regulation,cellular signaling network disruption
ENSG00000146426,TIAM2,rho gtpase activation,cancer progression,cell migration,metastasis promotion,tumor aggressiveness,gene expression regulation
ENSG00000112701,SENP6,desumoylation,epigenetic regulation,tumor suppressor protein regulation,cell cycle regulation,apoptosis regulation,post-translational modification regulator
ENSG00000196323,ZBTB44,tumor suppressor function,cell cycle regulation,apoptosis induction,genome stability maintenance,transcriptional regulation,chromatin remodeling interactions
ENSG00000197965,MPZL1,immune evasion,cell adhesion modulation,metastasis promotion,tumor microenvironment regulation,cytokine secretion modulation,protein-protein interaction
ENSG00000132359,RAP1GAP2,rap1 signaling modulation,gene amplification,promoter hypermethylation,cell proliferation enhancement,tumor progression facilitation,genetic instability promotion
ENSG00000112238,PRDM13,genomic instability,mutation hotspot,chromatin remodeling,apoptosis suppression,cell cycle dysregulation,histone modification
ENSG00000104915,STX10,regulation of vesicle transport,overexpression in tumors,promotion of cell migration,epithelial-to-mesenchymal transition (emt),interaction with oncogenic proteins,role in tumor progression
ENSG00000179761,PIPOX,dephosphorylation of pdh,mitochondrial dysfunction,energy metabolism reprogramming,glycolytic shift,oncogenic function,metabolic adaptation
ENSG00000132704,FCRL2,immune regulation,b-cell activation,oncogene overexpression,tumor cell survival,metastasis promotion,pi3k/akt pathway interaction
ENSG00000111875,ASF1A,chromatin regulation,apoptosis inhibition,cell cycle progression,genomic instability,oncogene activation,cell proliferation enhancement
ENSG00000095564,BTAF1,transcriptional regulation,chromatin remodeling,oncogenesis,tumorigenesis,genomic instability,dna damage response
ENSG00000213079,SCAF8,alternative polyadenylation regulation,cancer-related gene expression,cell proliferation driver,metastasis promoter,oncogenic function,mrna processing regulator
ENSG00000010539,ZNF200,chromatin regulation,tumor suppressor function,zinc finger protein,cellular differentiation,pi3k/akt pathway modulation,histone modification
ENSG00000182749,PAQR7,ppar signaling pathway,transcriptional regulation,lipid metabolism regulation,metabolic disorder,tumor progression modulation,therapeutic target
ENSG00000055163,CYFIP2,rho gtpase regulation,mrna stability modulation,cell growth promotion,oncogene activation,tumor suppressor protein interaction,cytoplasmic localization
ENSG00000095319,NUP188,npc assembly,chromatin remodeling,genomic instability,cellular transport disruption,apoptosis suppression,tumor aggressiveness
ENSG00000234370,GTF2H4,transcriptional regulation,gene expression modulation,tumor suppressor function,dna repair mechanisms,cell cycle progression modulation,cancer development association
ENSG00000260325,HSPB9,actin filament assembly,cell cycle regulation,microtubule stability,protein-protein interaction,tumor suppression,stress response
ENSG00000140157,NIPA2,mitochondrial dynamics,tumor suppressor function,genomic stability regulation,cellular survival enhancement,genomic integrity maintenance,p53-dependent pathway interaction
ENSG00000122729,ACO1,mitochondrial regulation,tumor metabolism,energy production regulation,oncogenesis facilitation,cellular growth promotion,gene expression modulation
ENSG00000107954,NEURL1,notch signaling pathway,tumor suppressor function,loss-of-function mutations,cell differentiation,oncogenic transformation,cell growth regulation
ENSG00000076650,GPATCH1,genomic instability,dna repair mechanism,tumor suppressor activity,nucleotide excision repair,genomic maintenance,transcriptional regulation
ENSG00000072042,RDH11,aldehyde detoxification,cellular redox regulation,dna repair modulation,gene expression regulation,oxidative stress prevention,transcription factor interaction
ENSG00000163655,GMPS,oncogenic protein stabilization,glutaminyl-peptide cyclotransferase activity,cell proliferation promotion,tumor progression,metastasis driver,protein stability regulation
ENSG00000023516,AKAP11,cellular regulation,camp-dependent protein kinase a (pka) activation,apoptosis inhibition,metastasis promotion,cell survival enhancement,subcellular localization modulation
ENSG00000063015,SEZ6,pi4p-binding protein,cancer aggressiveness,tumor progression,cell survival pathway,signaling molecule regulation,membrane trafficking
ENSG00000124466,LYPD3,cell adhesion modulation,tumor progression driver,protein-protein interactions,overexpression in cancer,cytoskeleton regulation,sulfation-dependent function
ENSG00000121775,TMEM39B,pi3k/akt pathway modulation,cell membrane dynamics regulation,lipid metabolism regulation,endoplasmic reticulum homeostasis,oncogenic signaling enhancement,cancer cell proliferation
ENSG00000070444,MNT,tumor suppressor function,genomic instability,apoptosis regulation,cell cycle regulation,transcriptional repression,dna repair pathways
ENSG00000163803,PLB1,phosphatidylcholine metabolism,oncogenic pathway activation,cell proliferation promotion,tumor growth facilitation,therapeutic target potential,genomic overexpression
ENSG00000101365,IDH3B,isocitrate dehydrogenase function,oncometabolite production,tumor progression,metabolic alteration,epigenetic regulation,genomic instability
ENSG00000164124,TMEM144,er membrane protein,tumor suppression,calcium ion transport,lipid metabolism regulation,cellular differentiation regulation,er stress response disruption
ENSG00000169118,CSNK1G1,cell cycle regulation,oncogene activation,g2/m phase transition,apoptosis inhibition,protein-protein interaction,kinase activity enhancement
ENSG00000205362,MT1A,mt1a expression,cellular defense mechanisms,oncogenic processes,epithelial-to-mesenchymal transition (emt),chemotherapy resistance,cancer cell proliferation
ENSG00000182450,KCNK4,cellular membrane regulation,tumor suppressor function,cell proliferation modulation,apoptosis induction,cell migration influence,pi3k/akt pathway interaction
ENSG00000274221,CCL3,immune response regulation,chemotaxis promotion,tumor angiogenesis,cell migration induction,cancer progression marker,inflammation mediator
ENSG00000135069,PSAT1,oncogene function,gain-of-function mutations,cell growth regulation,apoptosis resistance,amino acid biosynthesis,metabolic reprogramming
ENSG00000185730,ZNF696,regulation of gene expression,transcriptional regulation,cell proliferation,apoptosis inhibition,oncogenic potential,pi3k/akt signaling pathway modulation
ENSG00000198795,ZNF521,genetic regulation,tumor suppressor/oncogene role,transcriptional repressor function,cell growth regulation,proliferation control,molecular mechanism complexity
ENSG00000205923,CEMP1,cellular differentiation,epithelial-to-mesenchymal transition,oncogenic overexpression,cell proliferation,transcription factor activity,tumor progression
ENSG00000125746,EML2,aneuploidy,genomic instability,cancer driver gene,cell proliferation,protein-protein interaction,mitotic spindle assembly
ENSG00000198522,GPN1,lysosome regulation,autophagy pathway,trafficking and fusion,apoptosis modulation,lysosomal ph maintenance,protein-protein interactions
ENSG00000164828,SUN1,genomic instability,telomere maintenance,cellular anchoring,nuclear integrity,apoptosis induction,tumor suppression
ENSG00000198914,POU3F3,transcriptional regulation,cell differentiation,oncogenic mutation,cell cycle progression,apoptosis modulation,genomic instability
,NARS,chromatin regulation,histone modification,transcription regulation,oncogene activation,genomic instability,dna repair modulation
ENSG00000141744,PNMT,catecholamine regulation,tumor progression,prognostic marker,angiogenesis,immune modulation,therapeutic target
ENSG00000133028,SCO1,mitochondrial dysfunction,reactive oxygen species generation,electron transport chain disruption,dna damage response,cell cycle dysregulation,apoptosis evasion
ENSG00000162419,GMEB1,transcriptional regulation,cell proliferation modulation,tumor suppressor/oncogene duality,glucocorticoid responsiveness,dna binding specificity,post-transcriptional regulation control
ENSG00000008282,SYPL1,cell adhesion,metastasis promotion,tumor progression,cell migration regulation,signaling pathway involvement,vesicle trafficking
ENSG00000182158,CREB3L2,er stress response,transcriptional regulation,oncogenic function,cell proliferation,apoptosis suppression,protein folding regulation
ENSG00000288369,RBP5,epigenetic regulation,chromatin remodeling,oncogenic mutation,tumor progression,cell cycle regulation,genomic instability
ENSG00000138823,MTTP,lipid metabolism regulation,metabolic reprogramming,oncogenic processes promotion,cell proliferation enhancement,energy homeostasis modulation,therapeutic target identification
ENSG00000080546,SESN1,mtor pathway regulation,apoptosis modulation,tumor suppressor function,autophagy regulation,oncogenic pathway activation,cancer biomarker
ENSG00000112855,HARS2,histidine loading,trna synthetase function,aminoacylation pathway,protein translation regulation,cancer driver mutation,genetic instability 
ENSG00000069849,ATP1B3,ion channel regulation,tumor microenvironment modulation,cellular homeostasis maintenance,nuclear localization signal modification,cancer cell migration influence,protein-protein interaction alterations
ENSG00000143515,ATP8B2,lipid metabolism,cholesterol homeostasis,cell proliferation,tumor growth,aberrant cellular behavior,genomic instability
ENSG00000136695,IL36RN,immune modulation,inflammation regulation,tumor microenvironment,cell proliferation suppression,anti-tumor response inhibition,genetic variation impact
ENSG00000198399,ITSN2,cell migration,rho gtpase regulation,cytoskeletal organization,oncogene activation,tumor progression,signaling pathway modulation
ENSG00000149133,OR5F1,cell proliferation,oncogenesis,cell survival pathway,tumorigenesis,protein interaction,genomic alteration
ENSG00000198198,SZT2,histone demethylation,epigenetic regulation,transcriptional regulation,cell cycle progression,apoptosis modulation,oncogenic driver
ENSG00000188706,ZDHHC9,palmitoylation regulation,cell signaling modulation,oncogenic driver,post-translational modification,protein-protein interaction,tumor suppressor
ENSG00000162733,DDR2,cell adhesion,extracellular matrix interaction,tumor microenvironment modulation,oncogenic signaling pathways,cell migration and invasion,poor prognosis marker
ENSG00000117305,HMGCL,metabolic regulation,lipid metabolism,tumor progression,cell survival,energy production,pentose phosphate pathway
ENSG00000106113,CRHR2,crh system regulation,apoptosis modulation,angiogenesis promotion,cell proliferation regulation,tumor growth association,inflammation modulation
ENSG00000004776,HSPB6,heat shock protein regulation,cytoplasmic localization,cellular stress response,chaperone activity,microtubule dynamics regulation,tumor progression and metastasis
ENSG00000163798,SLC4A1AP,epigenetic regulation,cell membrane interaction,cellular ion balance,chloride transport regulation,cancer metastasis association,tumor progression enhancement
ENSG00000131143,COX4I1,mitochondrial localization,enhanced metabolic reprogramming,hypoxia-inducible factor stabilization,therapeutic target,electron transport chain regulation,glycolysis activation
ENSG00000153253,SCN3A,ion channel regulation,proliferation,electrical excitability,neuronal function disruption,tumor progression enhancement,genomic instability
ENSG00000148120,AOPEP,apoptosis regulation,mitochondrial outer membrane permeabilization,oncogenic processes,cell cycle progression,dna repair mechanisms,protein-protein interactions
ENSG00000164631,ZNF12,transcription regulation,oncogenic function,cell proliferation,apoptosis modulation,dna-binding interaction,transcriptional dysregulation
ENSG00000184857,TMEM186,cell growth regulation,transmembrane protein interaction,apoptosis modulation,proliferation regulation,tumorigenesis association,lipid metabolism involvement
ENSG00000187193,MT1X,mt family member,transcriptional regulator,cell survival promotion,apoptosis inhibition,cancer driver gene candidate,cell cycle regulation
ENSG00000196683,TOMM7,mitochondrial dynamics,tumor suppressor,gain of function mutations,metabolic adaptation,cell proliferation,genomic instability
ENSG00000100216,TOMM22,mitochondrial function,cellular metabolism alteration,apoptosis resistance,tumor progression promotion,energy homeostasis regulation,therapeutic target
ENSG00000122484,RPAP2,receptor processing,serine protease function,oncogenic signaling,cell growth regulation,metastatic potential,therapeutic resistance
ENSG00000170954,ZNF415,transcriptional regulation,cell cycle control,apoptosis modulation,cancer driver candidate,tumor suppressor potential,biomarker exploration
ENSG00000228090,MPIG6B,mitochondrial function,energy metabolism regulation,apoptosis evasion,cell proliferation enhancement,reactive oxygen species regulation,tumor progression facilitation
ENSG00000185551,NR2F2,tumor suppressor function,tumor progression inhibition,wnt/β-catenin pathway regulation,transcriptional repression,chromatin remodeling,prognostic marker
ENSG00000198553,KCNRG,oncogenic signaling,cell proliferation,potassium channel modulation,cellular migration,therapeutic target,tumor progression
ENSG00000121579,NAA50,cell cycle regulation,chromatin remodeling complex interaction,oncogenic mutations,protein acetylation regulation,swi/snf complex interaction,therapeutic target
ENSG00000182459,TEX19,oncogenic rna regulation,mitochondrial function disruption,protein-protein interactions,transcriptional modulation,tumor progression driver,overexpression in cancer
ENSG00000167703,SLC43A2,cell membrane transporter,amino acid regulation,cell proliferation,tumor progression,genomic instability,metabolic adaptation 
ENSG00000117593,DARS2,metabolic reprogramming,mitochondrial dysfunction,amino acid synthesis,tumor growth promotion,cellular homeostasis disruption,protein synthesis fidelity
ENSG00000120727,PAIP2,oncogene,overexpression,regulation of mrna stability,tumor progression,gene expression modulation,pabp interaction
ENSG00000174740,PABPC5,cell proliferation regulation,mrna stabilization,protein-protein interaction,tumor progression,cancer cell survival,gene expression regulation
ENSG00000110042,DTX4,histone-modifying activity,chromatin remodeling,oncogene activation,cancer cell proliferation,therapeutic target identification,epigenetic dysregulation
ENSG00000076826,CAMSAP3,actin filament regulation,oncogenic processes,cancer progression,tumor metastasis,calcium-regulated kinase,cell migration and invasion
ENSG00000109113,RAB34,rab family gtpase,cell migration regulation,pi3k/akt pathway interaction,endocytosis modulation,vesicle transport regulation,tumor progression promotion
ENSG00000150051,MKX,cancer-promoting,cell adhesion modulation,cytoplasmic targeting,metastasis facilitation,oncogenesis contribution,signaling pathway regulation
ENSG00000197217,ENTPD4,atp regulation,metastasis,cell proliferation,protein interaction,tumor progression,therapeutic target
ENSG00000100258,LMF2,oncogenic activity,transcriptional regulation,cell adhesion modulation,pi3k/akt pathway interaction,therapeutic target potential,cancer cell invasion promotion
ENSG00000136699,SMPD4,ceramide accumulation,altered cell signaling,oncogenic processes,cell proliferation enhancement,apoptosis inhibition,metastasis promotion
ENSG00000151304,SRFBP1,chromatin remodeling,epigenetic regulation,histone modification,oncogenic processes,pi3k/akt pathway interaction,transcriptional modulation
ENSG00000259571,BLID,cell cycle regulation,oncogenic driver,cell proliferation,tumor formation,cell survival,protein degradation
ENSG00000170265,ZNF282,transcriptional regulation,epithelial development,cell proliferation,oncogenic processes,apoptosis suppression,genomic instability
ENSG00000198848,CES1,chemo-resistance,pharmacokinetic regulation,drug metabolism,cancer progression,oncogenic potential,genomic instability
ENSG00000008513,ST3GAL1,altered glycosylation,cell adhesion modulation,epigenetic regulation,extracellular matrix remodeling,prognostic marker potential,tumor growth facilitation
ENSG00000146072,TNFRSF21,immune evasion,oncogene interaction,cell death regulation,tumor progression,therapeutic target,apoptosis induction
ENSG00000213977,TAX1BP3,nf-κb regulation,transcriptional regulation,cell growth promotion,oncogenic process,cancer cell survival,signal transduction
ENSG00000166589,CDH16,cell-cell adhesion,endothelial cell interaction,angiogenesis regulation,tumor progression facilitation,gene expression dysregulation,cell migration enhancement
ENSG00000131482,G6PC,gluconeogenesis,glucose metabolism,tumor growth promotion,warburg effect,wnt/β-catenin pathway modulation,cancer cell survival enhancement
ENSG00000196289,BECN2,autophagy regulation,oncogenic potential,cell proliferation enhancement,tumor suppressor function,autophagy induction,cell survival promotion
ENSG00000184524,CEND1,cell cycle regulation,tumor suppressor function,cell proliferation inhibition,oncogenic mutations,genomic instability,protein-protein interactions
ENSG00000171115,GIMAP8,gtpase activation,regulation of cell growth,rhoa/rac1 signaling pathway,lymphocyte homeostasis,autoimmune disease susceptibility,cell survival pathways
ENSG00000178685,PARP10,dna damage response,altered transcriptional regulation,chromatin remodeling,genome instability,cell cycle progression,oncogenic mutations
ENSG00000126733,DACH2,wnt/β-catenin signaling,oncogenic driver,cell proliferation regulator,tumor suppressor loss,epithelial-to-mesenchymal transition,metastatic potential
ENSG00000071189,SNX13,cell migration,endosomal sorting,enhanced proliferation,genomic instability,hypoxia adaptation,lipid metabolism regulation
ENSG00000157823,AP3S2,tumor suppressor function,aberrant protein sorting,trafficking regulation,lysosomal dysfunction,cellular homeostasis disruption,cancer driver mutation
ENSG00000122034,GTF3A,rna polymerase iii transcription,transcriptional dysregulation,cell proliferation enhancement,tumor progression promotion,genomic instability induction,therapeutic target identification
ENSG00000115761,NOL10,transcriptional regulation,stress response modulation,genomic stability disruption,oncogenic transcription program,chemoresistance induction,prognostic biomarker
ENSG00000162616,DNAJB4,mitochondrial localization,molecular chaperone function,apoptosis regulation,autophagy modulation,cell signaling interaction,oncomodulation
ENSG00000145817,YIPF5,membrane trafficking dysregulation,cancer cell proliferation,genomic instability,er stress response,protein-protein interaction,cellular membrane integrity
ENSG00000115365,LANCL1,metabolic regulation,cell survival,mapk signaling pathway,cell adhesion,oncogenic function,therapeutic target
ENSG00000158008,EXTL1,genomic instability,tumor suppressor,atr/chk1 pathway activation,homologous recombination,dna repair regulation,cell cycle checkpoint
ENSG00000122304,PRM2,protein processing,signaling pathway regulation,tumor progression,oncogenic protein regulation,poor prognosis biomarker,therapeutic target
ENSG00000130702,LAMA5,basement membrane integrity,cell adhesion,cell migration,integrin interaction,laminin structure,tumor progression
ENSG00000154518,ATP5MC3,mitochondrial metabolism,energy homeostasis,atp synthesis regulation,tumor progression,therapeutic target,genetic mutations
ENSG00000181965,NEUROG1,oncogene activation,cell proliferation promotion,transcriptional regulation,tumor metastasis enhancement,apoptosis suppression,pi3k/akt pathway interaction
ENSG00000147081,AKAP4,tumor progression,apoptosis regulation,cell cycle control,genomic stability maintenance,signaling molecule interaction,oncogene modulation
ENSG00000049283,EPN3,cellular regulation,oncogenic signaling,receptor internalization,signaling pathway modulation,tumor progression,therapeutic target
ENSG00000197555,SIPA1L1,constitutive activation,gain of function mutations,tumor progression,cell invasion,therapeutic target,rho gtpase activity
ENSG00000274488,LY6H,epigenetic regulation,oncogenic potential,cell signaling,tumor progression,immune evasion,metastasis driver
ENSG00000273397,NDUFA6,mitochondrial function,energy metabolism disruption,cellular respiration,apoptosis evasion,autophagy dysregulation,mitophagy modulation
ENSG00000179041,RRS1,translation regulation,cell proliferation,tumor promotion,protein synthesis,genomic instability,cancer driver gene
ENSG00000196542,SPTSSB,peptidyl-trna hydrolase activity,tumor growth promotion,cell migration enhancement,protein synthesis regulation,cellular stress response modulation,cancer cell proliferation
ENSG00000134698,AGO4,microrna regulation,gene silencing,post-transcriptional regulation,cell proliferation enhancement,tumor suppressor suppression,genome instability
ENSG00000119509,INVS,cell polarity disruption,ciliogenesis dysfunction,apoptosis suppression,cell proliferation enhancement,tumor suppressor inactivation,epithelial-to-mesenchymal transition modulation
ENSG00000042813,ZPBP,acrosome reaction-inducing zone,cell adhesion and migration,cancer driver gene,cell survival pathway,fertility-related protein,tumor progression and metastasis
ENSG00000188092,GPR89B,g protein-coupled receptor function,epithelial-to-mesenchymal transition,pi3k/akt/mtor pathway activation,chemotherapy resistance,oncogenic signaling,gpcr dysregulation
ENSG00000103546,SLC6A2,norepinephrine transport,neurotransmitter regulation,tumor growth promotion,angiogenesis stimulation,cell proliferation enhancement,sympathetic nervous system interaction
ENSG00000178764,ZHX2,transcriptional repressor,tumor suppressor interaction,cell growth regulation,apoptosis inhibition,oncogene modulation,genetic overexpression
ENSG00000154309,DISP1,notch signaling pathway,tumor promotion,metastasis facilitation,apoptosis suppression,therapeutic target,cell migration
ENSG00000157064,NMNAT2,cell survival,enhanced nad+ biosynthesis,oncogenic signaling pathway,therapeutic target,cell proliferation,nucleotide pool regulation
ENSG00000163157,TMOD4,tropomyosin regulation,actin filament dynamics,cell migration promotion,cytoskeleton modulation,poor prognosis association,aggressive tumor behavior
ENSG00000115128,SF3B6,alternative splicing,genomic instability,spliceosome dysfunction,rna processing,tumor suppressor function,pre-mrna regulation
ENSG00000205301,MGAT4D,genetic amplification,n-glycosylation pattern,cancer cell survival,glycoprotein modification,tumor progression,cancer driver gene
ENSG00000165917,RAPSN,cell adhesion,signal transduction,oncogenic processes,scaffold protein function,tumor cell proliferation,synaptogenesis dysfunction
ENSG00000162368,CMPK1,regulatory mechanism,cellular energy metabolism,metabolic adaptation,therapeutic target,onco-suppressor function,tumor aggressiveness
ENSG00000090238,YPEL3,pi3k/akt pathway interaction,constitutive activation,genomic instability,oncogenic dysregulation,cell growth regulation,tumor suppression bypass
ENSG00000125734,GPR108,gpcr signaling pathway,cytokine regulation,immune cell activation,pi3k/akt pathway modulation,tumor progression,oncogenic potential
ENSG00000231852,CYP21A2,steroid biosynthesis,cholesterol metabolism,cortisol regulation,aldosterone synthesis,enzyme dysfunction,hormone imbalance
ENSG00000159871,LYPD5,epithelial-to-mesenchymal transition,tumor progression,oncogenic function,cell signaling modulation,protein-protein interactions,cancer metastasis
ENSG00000139977,NAA30,n-terminal acetylation,histone modification,chromatin regulation,cell cycle progression,therapeutic target,oncogenic process
ENSG00000135040,NAA35,cell cycle progression,protein acetylation,tumorigenesis,cell migration,chromatin remodeling,therapeutic target
ENSG00000174705,SH3PXD2B,pi3k/akt pathway regulation,gene overexpression,cell membrane trafficking,endocytosis modulation,protein-protein interaction,oncogenic signaling
ENSG00000092871,RFFL,ubiquitination regulation,cancer progression,protein stability modulation,cell cycle regulation,dna repair disruption,therapeutic target
ENSG00000142025,DMRTC2,transcriptional regulation,chromatin remodeling,genomic instability,tumor suppressor function loss,nuclear localization,cellular proliferation promotion
ENSG00000129194,SOX15,transcription factor regulation,embryonic development,chromatin remodeling,leukemia association,tumor progression,multipotency regulator
ENSG00000158987,RAPGEF6,activation of rap gtpases,cell migration,cancer metastasis,growth regulation,metastatic potential,oncogenic signaling
ENSG00000150054,MPP7,oncogenic suppression,tumor suppressor,epithelial integrity regulation,cell-cell adhesion modulation,cytoplasmic microtubule network formation,adherens junction stability maintenance
ENSG00000164404,GDF9,ovarian follicle development,cell proliferation,apoptosis inhibition,tumor progression,downstream signaling pathways,protein-protein interactions
ENSG00000153037,SRP19,regulatory element disruption,tumor suppressor function,cellular stress response,protein homeostasis regulation,oncogenic pathway modulation,genetic instability
ENSG00000167468,GPX4,oxidative stress resistance,antioxidant function,cellular homeostasis regulation,ferroptosis induction,genomic stability maintenance,therapeutic target
ENSG00000141965,FEM1A,cell cycle regulation,tumor progression,protein-protein interaction,dna repair mechanisms,cancer cell proliferation,therapeutic target
ENSG00000075407,ZNF37A,genomic instability,transcriptional regulation,epigenetic modification,cell cycle progression,proliferation regulator,apoptosis suppressor
ENSG00000141905,NFIC,transcriptional regulation,dna repair mechanisms,cell growth regulation,genomic instability,oncogene regulation,tumor suppressor interactions
ENSG00000158805,ZNF276,cell cycle progression,apoptosis inhibition,chromatin remodeling,transcriptional regulation,microrna modulation,tumor growth promotion
ENSG00000090402,SI,regulatory function,immune modulation,tumor progression,prognostic marker,anti-tumor immunity,oncogenic pathway alterations
,HIST3H2A,histone modification,chromatin organization,gene regulation,cell growth regulation,oncogenesis,genomic instability
ENSG00000139219,COL2A1,cell migration,extracellular matrix remodeling,gene upregulation,metastasis promotion,oncogenic function,prognostic marker
ENSG00000114378,HYAL1,ha degradation,tumor suppressor function,cancer microenvironment modification,cell migration inhibition,metastasis suppression,therapeutic target candidate
ENSG00000089057,SLC23A2,cellular ph regulation,oncogenic mutations,loss of function mutations,genomic instability,tumor suppressor function,therapeutic target
ENSG00000005882,PDK2,metabolic regulation,warburg effect,tumor progression,therapeutic target,signaling pathway interaction,glycolysis promotion
ENSG00000196358,NTNG2,cell migration,metastasis promoter,extracellular matrix interaction,angiogenesis regulation,tumor progression,prognostic biomarker
ENSG00000262655,SPON1,tumor progression,extracellular matrix interaction,cell migration,epithelial-to-mesenchymal transition,cancer metastasis,biomarker for prognosis
ENSG00000102547,CAB39L,calcium homeostasis regulation,calcineurin/nfat pathway activation,oncogenic role,cell proliferation enhancement,tumor progression facilitation,autophagy regulation
ENSG00000115257,PCSK4,oncogenic function,cell proliferation,protein processing,apoptosis evasion,tumor progression,metastatic potential
ENSG00000157219,HTR5A,serotonin receptor regulation,cell proliferation,apoptosis modulation,tumor progression,g protein-coupled receptor function,neurotransmission modulation
ENSG00000130413,STK33,cell proliferation,serine/threonine kinase activity,oncogenic potential,genomic instability,biomarker significance,apoptosis regulation
ENSG00000132196,HSD17B7,dna damage response,steroid hormone biosynthesis,cell proliferation regulation,apoptosis modulation,genomic stability maintenance,therapeutic target
ENSG00000133742,CA1,carbonic anhydrase activity,tumor hypoxia adaptation,energy metabolism regulation,cell survival enhancement,angiogenesis facilitation,ph regulation in tumor microenvironment
ENSG00000006788,MYH13,cell migration,tumor progression,cytoskeletal organization,oncogenic driver,metastasis promotion,therapeutic target
ENSG00000113946,CLDN16,epithelial cell adhesion,tight junction regulation,tumor suppressor function,cell migration modulation,cancer cell invasion prevention,biological barrier maintenance
ENSG00000162512,SDC3,syndecan-3 overexpression,cell adhesion disruption,tumor progression,metastasis enhancement,growth factor interaction,emt regulation
ENSG00000196296,ATP2A1,calcium homeostasis,cell signaling,contractile regulation,tissue relaxation,cellular response modulation,ion exchange mechanism
ENSG00000034971,MYOC,glaucoma association,intraocular pressure regulation,leucine-rich repeat-containing protein family,cell proliferation promotion,signaling pathway interaction,upregulated expression in cancer
ENSG00000115457,IGFBP2,igf signaling pathway modulation,tumor suppression,oncogenic properties,cancer progression facilitation,cell proliferation inhibition,basement membrane degradation
ENSG00000184709,LRRC26,pi3k/akt pathway modulation,oncogene,transmembrane protein function,cell adhesion and migration facilitation,metastatic tumor formation promotion,tumor growth and metastasis regulation
ENSG00000198732,SMOC1,emt regulation,oncogene activation,pi3k/akt pathway modulation,wnt/β-catenin signaling interaction,transcription factor regulation,metastasis promotion
ENSG00000138760,SCARB2,tumor suppressor,pi3k/akt interaction,cell signaling regulation,cholesterol homeostasis,lipid metabolism regulation,immune response modulation
ENSG00000087842,PIR,jak/stat signaling inhibition,apoptosis regulation,proliferation control,tumor suppressor activity,immune response modulation,cytokine receptor interaction
ENSG00000163563,MNDA,cell cycle progression,apoptosis resistance,dna damage response inhibition,microrna regulation,tumor growth promotion,oncogene function
ENSG00000169740,ZNF32,tumor suppression,zinc finger motif,dna binding,transcriptional regulation,oncogenic transformation,apoptosis regulation
ENSG00000076248,UNG,dna repair mechanism,genomic instability,tumor suppressor function,oncogenic properties,ber pathway activation,dna damage response
ENSG00000137225,CAPN11,signaling pathway dysregulation,constitutive activation mutations,proteolytic activity,cell proliferation enhancement,tumor progression,genomic instability
ENSG00000227345,PARG,genomic instability,dna repair mechanism,tumor progression,oncogene maintenance,therapeutic target,protein-protein interaction
ENSG00000172273,HINFP,histone modification,chromatin regulation,transcriptional repression,dna damage response,cellular proliferation,cancer driver gene
ENSG00000187021,PNLIPRP1,lipid metabolism regulation,membrane trafficking,lipolytic processes,cellular growth regulation,metabolic reprogramming,potential oncogene
ENSG00000189159,JPT1,mitochondrial regulation,cellular metabolism,energy production,tca cycle,oxidative phosphorylation,genetic mutations
ENSG00000135744,AGT,ras pathway,cell proliferation,angiogenesis promotion,metastasis facilitation,epithelial-to-mesenchymal transition (emt),biomarker potential
ENSG00000171310,CHST11,glycosylation regulation,cell surface modification,oncogenic potential,genomic instability,cell adhesion disruption,apoptosis evasion
ENSG00000132749,TESMIN,tumor suppressor,cell proliferation regulation,chromosomal location 5q31,dna damage response,cell differentiation,therapeutic target
ENSG00000109572,CLCN3,chloride channel regulation,cellular homeostasis maintenance,neurological disorder association,proliferation regulation,differentiation modulation,apoptosis regulation
ENSG00000174292,TNK1,cell signaling pathways,constitutive expression,kinase activity,oncogenic driver,phosphorylation events,tumor promotion
ENSG00000106290,TAF6,transcription initiation factor,constitutive activation of transcription,mutations in pan-cancer,oncogenic drivers,cell proliferation regulation,interaction with p53 protein
ENSG00000130783,CCDC62,coiled-coil domain,cell signaling,cytoskeleton organization,pi3k/akt/mtor pathway,oncogenic driver,tumor progression
ENSG00000109472,CPE,protein processing,cell signaling,angiogenesis,cell migration,cell invasion,tumor progression
ENSG00000174165,ZDHHC24,oncogenic pathway regulation,aberrant expression,palmitoyltransferase enzyme,cell survival promotion,tumor progression driver,therapeutic target candidate
ENSG00000149308,NPAT,cell cycle regulation,histone chaperone activity,genomic stability maintenance,oncogenic processes,tumor cell proliferation,dna replication interaction
ENSG00000135643,KCNMB4,calcium-activated potassium channels,regulatory subunit,cell proliferation regulation,cell migration modulation,tumorigenesis association,channel activity modulation
ENSG00000145936,KCNMB1,sk channel regulation,cell proliferation,signaling pathway modulation,therapeutic target,apoptosis resistance,cancer progression
ENSG00000179915,NRXN1,notch signaling pathway alteration,tumor cell behavior modulation,neurexin-1 protein function dysregulation,gene expression profile changes,cell growth and survival promotion,metastatic progression facilitation 
ENSG00000145555,MYO10,cancer progression,cell adhesion regulation,cytoplasmic localization,dysregulation in tumors,metastasis promotion,prognostic marker
ENSG00000197530,MIB2,cell cycle regulation,genomic instability,mitotic checkpoint complex,oncogene overexpression,tumor suppressor inactivation,chromosomal separation
ENSG00000244005,NFS1,tumor suppression,genome stability maintenance,dna repair interactions,oxidative stress regulation,chemotherapy resistance,cellular proliferation enhancement
ENSG00000163746,PLSCR2,phospholipid scrambling,apoptosis resistance,angiogenesis promotion,immune evasion,pi3k/akt pathway modulation,cell signaling regulation
ENSG00000150551,LYPD1,cell-cell interactions,tumor progression,metastasis,epithelial-to-mesenchymal transition,pi3k/akt pathway signaling,immune suppression
ENSG00000180992,MRPL14,mitochondrial function,ribosome assembly,oncogenic mrna translation,tumor progression,therapeutic target,cancer prognosis
ENSG00000197134,ZNF257,transcriptional regulation,tumor suppressor function,cell cycle regulation,apoptosis induction,proliferation suppression,dna binding and transcription
ENSG00000128652,HOXD3,hoxd3,oncogenic potential,embryonic development,transcriptional regulation,apoptosis inhibition,epithelial-to-mesenchymal transition
ENSG00000182132,KCNIP1,apoptosis regulation,cell cycle control,tumor suppressor function,dna damage response,genomic instability,transcriptional modulation
ENSG00000029639,TFB1M,dna damage response,transcriptional regulation,genomic stability maintenance,homologous recombination repair,oncogenic transcription,apoptosis resistance
ENSG00000197213,ZSCAN5B,zinc finger protein regulation,chromatin structure modulation,transcriptional silencing disruption,pi3k/akt pathway interaction,oncogenic processes facilitation,therapeutic target identification
ENSG00000110888,CAPRIN2,cellular proliferation,gene expression regulation,mrna stabilization,translation initiation complex interaction,cap-binding complex interaction,therapeutic target
ENSG00000133030,MPRIP,rap1 signaling pathway,cell proliferation,tumor progression,negative regulator,protein-protein interactions,cell migration and adhesion
ENSG00000104953,TLE6,oncogene,tumor progression,wnt/β-catenin pathway interaction,enhanced cell growth,transcriptional regulator,poor prognosis indicator
ENSG00000198740,ZNF652,transcriptional regulation,cell cycle progression,apoptosis modulation,zinc finger motifs,co-activator/co-repressor interactions,genomic instability
ENSG00000241343,RPL36A,ribosomal function,cellular proliferation,translation regulation,tumor progression,oncogene potential,genomic overexpression
ENSG00000205138,SDHAF1,mitochondrial regulation,cellular respiration inhibition,succinate accumulation,oncogenic mutations,tumor formation,epigenetic modification suppression
ENSG00000278695,GSTT2B,glutathione conjugation,detoxification process,cellular stress response,oxidative damage protection,environmental toxin handling,genomic instability management
ENSG00000110436,SLC1A2,amino acid transporter,glutamate regulation,cell proliferation,oncogenic processes,tumor progression,protein interaction
ENSG00000139910,NOVA1,aberrant splicing regulation,oncogenic signaling pathway activation,tumor progression driver,prognostic marker,post-transcriptional gene expression modulation,cellular growth and differentiation regulator
ENSG00000102001,CACNA1F,calcium influx regulation,cellular differentiation,visual function maintenance,genetic interaction,photoreceptor modulation,signaling pathway modulation
ENSG00000138829,FBN2,disrupted elastic fibers,excessive extracellular matrix deposition,tissue remodeling,oncosuppressive effects,marfan syndrome-related mutations,extracellular matrix composition disruption
ENSG00000011347,SYT7,ca2+ homeostasis,cell migration,tumor progression,calcium-dependent vesicle fusion,dysregulated calcium signaling,mitochondrial regulation
ENSG00000010327,STAB1,pi3k/akt pathway,tumor progression,cell migration,lysosomal function regulation,cancer cell survival,apoptosis evasion
ENSG00000149782,PLCB3,constitutive activation,gain of function mutations,oncogenic signaling pathways,cell growth regulation,therapeutic target,protein kinase c interaction
ENSG00000129968,ABHD17A,lysophosphatidic acid regulation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000076716,GPC4,tumor progression,cell growth regulation,wnt signaling pathway,growth factor modulation,prognostic biomarker,cell migration enhancement
ENSG00000148824,MTG1,transcriptional regulation,tumor suppressor function,gene silencing,apoptosis promotion,oncogene inhibition,cancer prevention
ENSG00000130024,PHF10,chromatin remodeling,tumor suppressor function,loss of function mutations,cell cycle regulation,histone modification,dna damage response
ENSG00000100983,GSS,gdnf/gfrα1 complex,cell proliferation,angiogenesis promotion,mapk/erk pathway activation,tumor metastasis facilitation,autocrine growth factor
ENSG00000118246,FASTKD2,mitochondrial function regulation,apoptosis resistance,tumor suppressor activity,cell proliferation promotion,protein-protein interaction modulation,poor prognosis association
ENSG00000164398,ACSL6,fatty acid metabolism,lipid synthesis,cell membrane fluidity,oncogenic processes,tumor cell growth,proliferation regulation
ENSG00000230763,HLA-DPB1,antigen presentation,immune modulation,mhc class ii complex,t-cell activation,dendritic cell interaction,genetic polymorphism
ENSG00000144339,TMEFF2,tumor suppressor candidate,cellular signaling regulation,gene expression modulation,cell proliferation influence,protein-protein interaction,cancer progression involvement
ENSG00000162813,BPNT1,prolyl peptidase activity,cell proliferation,oncogene potential,nuclear localization,acylpeptidase function,tumor development
ENSG00000106723,SPIN1,chromatin remodeling,apoptosis regulation,genomic stability maintenance,cell proliferation modulation,transcriptional control,histone modification interaction
ENSG00000142515,KLK3,prostate gland development,serine protease activity,tumor progression,metastasis promotion,epigenetic regulation,oncogenic pathway activation
ENSG00000114026,OGG1,dna damage repair,genomic instability,increased activity,oncogenic potential,tumor progression,genome maintenance
ENSG00000144369,FAM171B,cell growth regulation,oncogene function,mutant gene expression,cell cycle control,tumor progression signaling,genomic instability
ENSG00000135097,MSI1,genomic instability,oncogene function,chromatin remodeling,transcriptional regulation,cell cycle progression,aggressive tumor growth
ENSG00000090539,CHRD,bmp signaling,cell proliferation regulation,tumor progression,extracellular protein modulation,oncogenesis,therapeutic target
ENSG00000105409,ATP1A3,na+/k+-atpase regulation,constitutive activation,gain of function mutations,tumor progression,cell migration,therapeutic target
ENSG00000130477,UNC13A,cancer stem cell maintenance,cell-cell fusion regulation,tumor aggressiveness promoter,metastasis facilitator,oncogenesis regulator,cell adhesion modulation
ENSG00000107331,ABCA2,lipid metabolism regulation,cellular response modulation,drug resistance enhancement,chemosensitization evasion,tumor progression facilitation,genomic instability
ENSG00000115155,OTOF,hair cell maintenance,sensory organ dysfunction,developmental disorder gene,cellular trafficking regulation,protein assembly disruption,genetic mutations
ENSG00000170989,S1PR1,sphingolipid signaling pathway,g-protein coupled receptor,cell migration regulation,tumor progression modulation,therapeutic target,signaling pathway interaction
ENSG00000156876,SASS6,microtubule dynamics regulation,genomic instability driver,cytokinesis disruption,cell proliferation enhancer,tumor progression contributor,mitotic checkpoint modulation
ENSG00000167114,SLC27A4,oncogenic role,lipid metabolism regulation,cell proliferation enhancement,tumor growth promotion,metastasis facilitation,therapeutic target
ENSG00000011021,CLCN6,tumor progression,cell proliferation,ion homeostasis disruption,therapeutic target,oncogenic potential,signaling pathway interaction
ENSG00000205744,DENND1C,tumor suppressor function,loss-of-function mutations,cellular membrane trafficking regulation,protein degradation pathway impairment,oncogenic protein accumulation,therapeutic target
ENSG00000135525,MAP7,microtubule dynamics regulation,oncogenic processes promotion,cell migration and invasion facilitation,tumor progression association,cancer prognosis impact,microtubule interaction modulation
ENSG00000093183,SEC22C,membrane trafficking,oncogenic processes,golgi apparatus regulation,protein secretion,aberrant protein expression,cellular homeostasis disruption
ENSG00000067177,PHKA1,tumor suppressor,glycolytic pathway regulation,oncogenesis prevention,cell growth inhibition,metabolic adaptation disruption,genomic instability association
ENSG00000108389,MTMR4,pi(3)p signaling pathway,cell proliferation,tumor progression,autophagy regulation,dephosphorylation activity,therapeutic target
ENSG00000089639,GMIP,oncogenic function,regulation of cellular proliferation,glycosylation pathway,cellular survival mechanism,metastasis promotion,immune evasion strategy
ENSG00000168216,LMBRD1,lysosomal transport,cellular metabolism regulation,protein degradation regulation,tumor progression driver,therapeutic target,genomic instability modulation
ENSG00000162407,PLPP3,magnesium homeostasis,cellular signaling,potential tumor suppressor,uncontrolled cell growth,cell growth regulation,apoptosis regulation
ENSG00000170458,CD14,tumor-associated macrophages,angiogenesis promotion,immunosuppression,metastasis facilitation,prognostic marker,pattern recognition receptor interaction
ENSG00000100373,UPK3A,cellular proliferation,deubiquitination regulation,gene upregulation,tumor cell invasion,multifunctional protein interactions,oncogenic signaling pathways
ENSG00000110077,MS4A6A,co-expression,oncogenic process,immune evasion,cell proliferation regulation,tumor progression association,therapeutic target candidate
ENSG00000213380,COG8,n-glycosylation,protein misfolding,cellular stress response,oligosaccharyltransferase activity,cancer driver mutation,aberrant protein modification
ENSG00000137413,TAF8,tfiia complex assembly,transcriptional activation,epigenetic regulation,oncogenic potential,cell cycle progression,apoptosis modulation
ENSG00000116852,KIF21B,genomic instability,cell division dysregulation,mitotic spindle formation,chromosome alignment regulation,protein-protein interaction,therapeutic target
ENSG00000148200,NR6A1,transcriptional regulation,cellular proliferation,apoptosis regulation,tumorigenesis,signaling pathway modulation,nuclear receptor activity
ENSG00000152670,DDX4,oncogenesis,promotes tumor progression,chromosomal instability,meiotic regulation,molecular interaction,genomic integrity maintenance
ENSG00000115592,PRKAG3,metabolic reprogramming,gain of function mutations,constitutive activation,tumor progression,energy homeostasis regulation,cellular metabolic adaptation
ENSG00000166454,ATMIN,genomic instability,dna damage response,apoptosis regulation,cell cycle checkpoint,oncogene/tumor suppressor,biomarker potential
ENSG00000136514,RTP4,tumor suppressor regulation,cell growth modulation,rna degradation,p53 pathway interaction,protein kinase activation,none
ENSG00000130649,CYP2E1,ros production,oxidative stress,dna damage,oncogenesis,tumor progression,biomarker
ENSG00000125652,ALKBH7,2og-dependent dioxygenase,dna repair,gene expression regulation,chromatin remodeling,cell proliferation promotion,stemness maintenance
ENSG00000184007,PTP4A2,dephosphorylation regulation,receptor activation,cell proliferation enhancement,oncogenic pathway modulation,signaling cascade interaction,therapeutic target
ENSG00000105289,TJP3,tumor progression,epithelial barrier function disruption,cell polarity loss,adherens junction regulation,cell migration facilitation,tight junction component
ENSG00000274334,VASN,oncogenic function,cell adhesion regulation,tumor progression facilitation,angiogenesis promotion,genetic mutation implication,therapeutic targeting
ENSG00000022567,SLC45A4,pi3k/akt pathway interaction,constitutive activation,loss of function variants,gain-of-function mutations,cell membrane transport disruption,tumor progression
ENSG00000120328,PCDHB12,cell adhesion,cell proliferation,oncogenesis,tumor cell survival,neuronal development,synapse formation
ENSG00000139684,ESD,epoxide hydrolysis,xenobiotic metabolism,cellular detoxification,genomic instability,reactive oxygen species regulation,cancer-related pathways modulation
ENSG00000151881,TMEM267,tumor growth promotion,cellular differentiation regulation,transmembrane protein function,cancer tissue overexpression,protein interaction signaling pathway,gene expression alteration
ENSG00000182150,ERCC6L2,dna repair,genomic instability,oncogenic driver,chromosomal rearrangements,enhanced cell proliferation,tumor suppression
ENSG00000162390,ACOT11,lipid biosynthesis regulation,cell proliferation promotion,tumorigenesis association,fatty acid metabolism dysregulation,protein interaction network,therapeutic target candidate
ENSG00000102910,LONP2,mitochondrial function,protein degradation,oncogenic processes,cellular metabolism,therapeutic target,genomic instability
ENSG00000080709,KCNN2,calcium-dependent signaling,oncogenic proliferation,ion transport regulation,channel activity enhancement,cellular excitability modulation,prognostic marker significance
ENSG00000182512,GLRX5,glutathione reduction,reactive oxygen species modulation,cellular redox balance,oncogenic process facilitation,tumor progression promotion,biomarker identification
ENSG00000119514,GALNT12,o-glycosylation initiation,cell proliferation enhancement,oncogenic potential,tumor progression promotion,glycosyltransferase activity,cancer cell growth facilitation
ENSG00000011454,RABGAP1,rab gtpase regulation,endocytic recycling control,autophagy modulation,cell trafficking dysregulation,tumor progression promotion,cancer cell invasiveness enhancement
ENSG00000161798,AQP5,water channel function,tumor cell migration,epithelial cell expression,cell signaling interaction,oncogenic driver gene,metastasis promotion
ENSG00000171786,NHLH1,tumor suppressor function,dna repair regulation,cellular proliferation inhibition,genomic integrity maintenance,transcriptional repression,oncogenesis prevention
ENSG00000101457,DNTTIP1,genomic regulation,epigenetic alterations,tumor progression,dna methylation,cellular proliferation,gene silencing
ENSG00000109956,B3GAT1,cellular remodeling,glycosaminoglycan biosynthesis,extracellular matrix regulation,tumor progression,proteoglycan modification,oncogene interaction
ENSG00000182154,MRPL41,mitochondrial ribosome function,oncogene activation,cell proliferation regulation,apoptosis suppression,autophagy modulation,tumor progression association
ENSG00000154133,ROBO4,vascular disruption,tumor progression,endothelial junction regulation,cell migration,angiogenic potential,signaling pathway modulation
ENSG00000158714,SLAMF8,tumor progression,immune evasion,cell surface receptor,oncogene overexpression,cell activation,cytokine production
ENSG00000243910,TUBA4B,microtubule regulation,genomic instability,tumor progression,apoptosis resistance,therapeutic target,cellular integrity
ENSG00000129518,EAPP,tumor suppressor function,cell cycle regulation,oncoprotein accumulation,apoptosis inhibition,signaling pathway modulation,protein stability regulation
ENSG00000131126,TEX101,dna replication,cell cycle regulation,oncogenic signaling,protein-protein interaction,genomic instability,poor prognosis marker
ENSG00000181418,DDN,cyclin dependent kinase inhibition,cell cycle progression regulation,genome stability maintenance,mitotic checkpoint control,oncogenic driver mutation,therapeutic target candidate
ENSG00000121101,TEX14,genomic instability,oncogenic process,meiotic regulation,chromosome segregation,cell cycle regulation,dna repair mechanism
ENSG00000065057,NTHL1,genomic instability,tumor suppressor,dna damage response,cell growth regulation,oncogenic potential,therapeutic target
ENSG00000169347,GP2,glycoprotein function,cell-cell adhesion,immune regulation,epithelial integrity,tissue structure maintenance,alteration in expression
ENSG00000124172,ATP5F1E,mitochondrial atp synthase,oxidative phosphorylation,cellular energy production,tumorigenesis regulation,metabolic reprogramming,cancer development pathways
ENSG00000148795,CYP17A1,tumor suppressor regulation,steroid biosynthesis,mitochondrial localization,cholesterol metabolism,genomic instability,hormone regulation
ENSG00000139620,KANSL2,krab domain,chromatin remodeling,tumor suppression,cell cycle regulation,dna damage response,p53 interaction
ENSG00000100982,PCIF1,chromatin remodeling,transcriptional regulation,histone modification,apoptosis regulation,cell cycle control,tumor suppressor
ENSG00000090263,MRPS33,mitochondrial function,altered metabolic activity,genomic instability,oncogenic mutations,proteome alteration,apoptosis evasion
ENSG00000164054,SHISA5,genomic instability,tumor suppression,hippo-yap pathway regulation,cell cycle regulation,cancer stem cell maintenance,emt regulation
ENSG00000126952,NXF5,nuclear rna export factor,tumor growth promotion,prognostic biomarker,resistance to therapy,cell migration regulation,oncogenic process regulation
ENSG00000204577,LILRB3,tumor evasion,immune suppression,oncogenic signaling,cell survival,antigen presentation,inhibitory receptor
ENSG00000065609,SNAP91,exocytic regulation,cell proliferation,metastasis promotion,tumor progression,upregulated expression,protein-protein interaction
ENSG00000145217,SLC26A1,cellular ion balance disruption,aberrant expression,tumor progression association,ion transport dysfunction,signaling pathway interaction,poor prognosis biomarker
ENSG00000127366,TAS2R5,tumor suppression,g-protein coupled receptor,cell cycle arrest,apoptosis induction,mapk/erk pathway inhibition,poor prognosis association
ENSG00000186049,KRT73,intermediate filament assembly,cytoskeleton stability,epithelial integrity loss,cell migration enhancement,tumor progression association,therapeutic target potential
ENSG00000205364,MT1M,cellular defense,zinc homeostasis regulation,cell growth modulation,apoptosis regulation,oncogene overexpression,protein interaction modulation
ENSG00000186967,KRTAP19-4,epithelial cell regulation,keratin-associated protein,hair follicle maintenance,cellular growth regulation,differentiation mechanism,proliferation pathway
ENSG00000164751,PEX2,peroxisomal dysfunction,cell proliferation,protein import,reactive oxygen species,aberrant lipid metabolism,biomarker potential
ENSG00000136521,NDUFB5,mitochondrial dysfunction,oncogenic process,electron transport chain,warburg effect,reactive oxygen species,dna damage
ENSG00000111897,SERINC1,er stress response,tumor suppressor,apoptosis induction,cell death pathway regulation,protein-protein interaction modulation,signaling cascade influence
ENSG00000116985,BMP8B,tumor suppression,tgf-beta signaling pathway,apoptosis regulation,proliferation inhibition,cancer progression prevention,tissue homeostasis maintenance
ENSG00000115020,PIKFYVE,pi3p metabolism,constitutive activation,gain of function mutations,tumor progression,therapeutic target,endosomal trafficking
ENSG00000278165,DUSP8,mapk signaling pathway,dephosphorylation activity,oncogene regulation,cell proliferation,cytokine response modulation,protein kinase inhibition
ENSG00000130176,CNN1,epithelial-to-mesenchymal transition,cell adhesion disruption,actin cytoskeleton regulation,oncogenic signaling pathway,tumor progression marker,therapeutic target
ENSG00000185565,LSAMP,cell adhesion,tumor growth,metastasis regulation,signaling pathway modulation,integrin interaction,apo-2 ligand interaction
ENSG00000183840,GPR39,constitutive activation,signaling pathway deregulation,cell proliferation enhancement,oncogenic process promotion,cancer cell growth facilitation,tumor microenvironment modulation
ENSG00000163738,MTHFD2L,one-carbon metabolism,gene expression regulation,epigenetic modifications,cell growth promotion,nucleotide synthesis,mutations contributing to cancer
ENSG00000204237,OXLD1,mitochondrial localization,oxidative stress regulation,transcription factor modulation,cell growth regulation,apoptosis modulation,xenobiotic metabolism
ENSG00000223547,ZNF844,cell cycle regulation,apoptosis modulation,transcriptional regulation,zinc finger protein interaction,chromatin remodeling,tumor suppressor modulation
ENSG00000105085,MED26,transcriptional regulation,cancer driver gene,tumor growth promotion,metastasis facilitation,rna polymerase ii recruitment,cdk7 kinase activation
ENSG00000189221,MAOA,cellular metabolism,oncogenesis,mitochondrial function,protein-protein interaction,signaling pathway modulation,transcriptional regulation
ENSG00000132688,NES,tumor progression,cell growth regulation,transcriptional coactivation,genetic mutations,cell differentiation,protein interaction
ENSG00000180660,MAB21L1,cell cycle regulation,epithelial-to-mesenchymal transition (emt) suppression,genomic instability,oncogene silencing,transcriptional regulation,tumor progression restriction
ENSG00000276615,KEL,amino acid metabolism,cytotoxic effects,dysregulation,enzyme interaction,metabolic regulation,transcriptional regulation
ENSG00000177125,ZBTB34,cell cycle regulation,tumor suppression,transcriptional repression,epigenetic silencing,mutational loss of function,dna damage response
ENSG00000126091,ST3GAL3,glycan biosynthesis,oncogenic properties,immune evasion,tumor aggressiveness,prognostic marker,therapeutic target
ENSG00000111331,OAS3,tumor suppressor function,antiviral defense,cell cycle regulation,apoptosis modulation,epigenetic regulation,stress response activation
ENSG00000166455,C16orf46,microtubule binding,spindle assembly regulation,oncogene potential,cell proliferation promotion,genomic instability induction,aneuploidy formation
ENSG00000109758,HGFAC,cellular proliferation,cell differentiation,oncogenesis,cell survival,signaling pathway regulation,tumor progression
ENSG00000176920,FUT2,tumor-associated antigen,glycosylation regulation,cell adhesion modulation,immune response modulation,tumor progression,prognostic marker
ENSG00000142512,SIGLEC10,immunoregulation,tumor suppression,mhc interaction,cell adhesion regulation,cancer immunotherapy target,proliferation regulation
ENSG00000091640,SPAG7,p53 inhibition,oncogenic activity,mitochondrial dysfunction,cancer stem cell maintenance,cell cycle progression regulation,apoptosis suppression
ENSG00000077684,JADE1,genomic instability,spindle assembly checkpoint,cell survival,mitotic fidelity,biomarker potential,tumor suppression
ENSG00000119915,ELOVL3,fatty acid elongation,vlcfa synthesis,cancer progression,tumor aggressiveness,chemotherapy resistance,lipid metabolism regulation
ENSG00000184185,KCNJ12,ion channel regulation,cell proliferation,oncogenic signaling,metastasis promotion,apoptosis inhibition,none
ENSG00000284039,KIR2DS3,enhanced cell proliferation,cellular homeostasis disruption,immune system dysregulation,oncogenic pathway activation,calcium influx modulation,potassium channel function
ENSG00000128512,DOCK4,oncogenic processes,tumor growth,metastasis,cell migration,guanylate nucleotide exchange,rho gtpase activation
ENSG00000166862,CACNG2,cellular excitability,calcium influx regulation,neurological disorders,synaptic transmission,signal pathway modulation,calcium channel regulation
ENSG00000166136,NDUFB8,mitochondrial function,cell survival,electron transport chain,reactive oxygen species regulation,tumor suppressor pathway modulation,autophagy regulation
ENSG00000175787,ZNF169,transcriptional regulation,tumor suppressor loss,oncogene role,cell proliferation enhancement,genomic instability contribution,apoptosis inhibition
ENSG00000079691,CARMIL1,cellular motility,gene regulation,actin dynamics,cytoskeleton organization,mitotic regulator,tumor progression
ENSG00000175348,TMEM9B,oncogene activation,cellular proliferation,transmembrane protein function,tumor progression,genomic amplification,signaling pathway interaction
ENSG00000181690,PLAG1,genomic instability,chromosomal translocations,oncogenic transcription factor,cell proliferation regulation,fusion protein formation,apoptosis inhibition
ENSG00000102384,CENPI,chromosome segregation,genomic stability,therapeutic target,tumor suppressor function,cell division regulation,kinetochore assembly
ENSG00000125637,PSD4,cell cycle regulation,cell proliferation control,signal transduction pathway,tumor suppressor function,cancer biomarker potential,protein-protein interaction modulation
ENSG00000027001,MIPEP,mitochondrial protein processing,metabolic regulation,cellular respiration,energy metabolism,protein kinase activation,genomic instability 
ENSG00000176715,ACSF3,apoptosis regulation,metabolic reprogramming,mitochondrial integrity,energy production regulation,cell proliferation enhancement,cell survival promotion
ENSG00000001036,FUCA2,tumor progression,oncogenic processes,cell proliferation,metastasis,immune modulation,glycoprotein modification
ENSG00000183077,AFMID,homologous recombination repair,genome instability,potential oncogene,dna crosslink repair,genomic stability regulation,interstrand crosslink repair
ENSG00000189046,ALKBH2,dna demethylation,genomic instability,tumor suppressor function,dna repair mechanism,cellular response regulation,epi-genetic alterations
ENSG00000171989,LDHAL6B,apoptosis,cell growth,dna repair,energy metabolism,lactate dehydrogenase regulation,oxidative stress regulation
ENSG00000140488,CELF6,rna-binding protein,alternative splicing regulator,tumor progression promoter,cancer gene,post-transcriptional regulator,cell growth regulator
ENSG00000148834,GSTO1,altered expression,detoxification processes,chemoresistance modulation,cellular stress responses,redox regulation,tumorigenesis promotion
ENSG00000142207,URB1,chromatin remodeling,tumor suppressor loss,akt pathway activation,cell proliferation regulation,cancer stem cell maintenance,prognostic marker
ENSG00000111863,ADTRP,adtrp protein interaction,cell growth regulation,oncogenic transformation,aggressive tumor behavior,pi3k/akt pathway modulation,prostate-specific expression
ENSG00000131400,NAPSA,chromatin remodeling,genome stability,epigenetic dysregulation,tumor suppressor interaction,p53 modulation,dna repair
ENSG00000121406,ZNF549,genomic regulation,tumor suppression,cell growth regulation,dna binding activity,nuclear localization,transcriptional modulation
ENSG00000064601,CTSA,tumor progression,metastasis resistance,lysosomal function,immune evasion,protein degradation,cell surface modification
ENSG00000051825,MPHOSPH9,genomic instability,mitotic regulation,tumor suppression,cell cycle control,chromosomal alterations,apoptosis induction
ENSG00000100271,TTLL1,microtubule regulation,cellular proliferation,centrosome localization,chromosomal instability,oncogenic process,therapeutic target
ENSG00000174579,MSL2,histone acetylation,chromatin remodeling,epigenetic regulation,genomic instability,tumor suppression,transcriptional deregulation
ENSG00000158545,ZC3H18,regulation of pre-mrna processing,overexpression in tumors,tumor progression,gene regulation,rna binding,cellular proliferation
ENSG00000148672,GLUD1,glutamate metabolism,amino acid synthesis,neurotransmitter regulation,tumor progression,energy production,metabolic reprogramming
ENSG00000232616,SKIV2L,dna repair,genomic stability,nucleotide excision repair (ner),cell cycle regulation,protein-protein interaction,tumorigenesis
ENSG00000100285,NEFH,microtubule regulation,cell migration,apoptosis modulation,cell cycle progression,protein phosphorylation,neuronal cytoskeleton stability
ENSG00000178234,GALNT11,galnac-t activity,wnt signaling pathway regulation,glycosylation modification,promotes tumorigenesis,oncogenic properties,cellular proliferation enhancement
ENSG00000127419,TMEM175,genomic stability maintenance,homologous recombination repair,chromosomal instability,dna double-strand break repair,nuclear membrane localization,genomic instability increase
ENSG00000110066,KMT5B,epigenetic regulation,histone methylation,chromatin remodeling,oncogenic driver,tumor suppressor modulation,cell proliferation enhancement
ENSG00000185053,SGCZ,tumor progression,cell migration,ion transport regulation,therapeutic target,dysregulation impact,hallmark of cancer
ENSG00000176024,ZNF613,tumor suppression,transcriptional regulation,cell differentiation,protein-protein interaction,apoptosis induction,oncogene inhibition
ENSG00000125304,TM9SF2,cellular migration,metastatic progression,cytoskeleton modulation,protein overexpression,oncogenic interaction,signaling pathway regulation
ENSG00000198569,SLC34A3,cell proliferation,gene amplification,tumor aggressiveness,prognostic marker,cancer metabolism,sodium-phosphate cotransport
ENSG00000147799,ARHGAP39,tumor suppressor,rho-gtpase activation,cytoskeleton organization,metastasis suppression,cell cycle regulation,gef interaction
ENSG00000273706,LHX1,transcriptional regulation,dysregulated expression,cell differentiation,protein-protein interaction,tumor suppressor dysfunction,oncogenic activity
ENSG00000143457,GOLPH3L,golgi apparatus regulation,oncogenic potential,cell growth promotion,tumor progression,protein processing regulation,overexpression association
ENSG00000159884,CCDC107,centrosome duplication,mitotic spindle formation,aneuploidy,chromatin remodeling,protein-protein interactions,microtubule organization
ENSG00000196368,NUDT11,dna damage response,genomic instability,tumor suppressor,cell cycle regulation,protein-protein interactions,genetic mutations
ENSG00000156076,WIF1,wnt pathway regulation,tumor suppression,cell proliferation inhibition,oncogene regulation,negative feedback mechanism,cell differentiation promotion
ENSG00000029993,HMGB3,chromatin architecture,proliferation regulation,cell survival pathway,inflammation response,post-translational modifications,tissue-specific expression
ENSG00000131495,NDUFA2,mitochondrial function,impaired respiratory chain,oxidative stress induction,mtor pathway activation,cell proliferation regulation,chemotherapy sensitivity alteration
ENSG00000132591,ERAL1,post-transcriptional regulation,mrna processing,oncogene regulation,tumor suppressor modulation,cellular proliferation,cancer therapy target
ENSG00000163634,THOC7,oncogene function,cellular export regulation,tumor growth promotion,anti-apoptotic mechanism,stress response modulation,mitochondrial interaction
ENSG00000276880,IFI27L1,ifn-γ signaling pathway,tumor suppressor function,apoptosis regulation,cell growth promotion,oncogenesis facilitation,genetic upregulation
ENSG00000178252,WDR6,oncogene activation,protein degradation regulation,scf complex interaction,cell proliferation enhancement,tumor suppressor degradation,therapeutic target
ENSG00000107669,ATE1,oncogenic potential,glycolytic pathway regulation,tumor growth promotion,aerobic glycolysis facilitation,cancer metabolism modulation,cell proliferation regulation
ENSG00000171819,ANGPTL7,lipid metabolism regulation,insulin resistance induction,tumor growth promotion,metastasis facilitation,energy supply modulation,poor prognosis marker
ENSG00000172380,GNG12,heterotrimeric g-protein signaling,constitutive activation,gain of function mutations,tumor progression,signaling pathway regulation,epigenetic modification
ENSG00000102100,SLC35A2,glycosylation regulation,cancer cell growth,oncogene activation,metabolic regulation,warburg effect promotion,poor prognosis biomarker
ENSG00000117620,SLC35A3,aberrant glycosylation,glycoprotein processing,golgi apparatus localization,nucleotide sugar transport,tumor progression,cell proliferation
ENSG00000072422,RHOBTB1,tumor suppression,inhibited rhoa signaling,loss of function mutations,cell cycle regulation,cytoskeleton organization,wnt signaling modulation
ENSG00000130158,DOCK6,cell migration regulation,rho gtpase activation,epithelial-to-mesenchymal transition,metastasis promotion,pi3k/akt pathway interaction,mapk/erk signaling modulation
ENSG00000175087,PDIK1L,pi3k/akt/mtor pathway,oncogenic potential,autophagy regulation,cellular metabolism,protein kinase function,genomic instability
ENSG00000136144,RCBTB1,chromatin regulation,oncogenic processes,epigenetic regulation,tumor suppressor modulation,cell proliferation enhancement,prognostic marker potential
ENSG00000072657,TRHDE,autophagy activation,oncogene potential,tumor growth promotion,protein degradation regulation,cell proliferation modulation,metabolic pathway dysregulation
ENSG00000131174,COX7B,mitochondrial function,antioxidant response,cellular respiration,electron transport chain,energy metabolism regulation,therapeutic target
ENSG00000137714,FDX1,mitochondrial electron transport chain disruption,energy metabolism alteration,oxidative stress induction,transcriptional regulation modulation,cellular redox balance disruption,cancer cell metabolic reprogramming
ENSG00000131055,COX4I2,mitochondrial function,energy production pathway,tumor progression,therapeutic resistance,metabolic regulation,oxidative phosphorylation
ENSG00000182732,RGS6,wnt/β-catenin pathway regulation,pi3k/akt inhibition,tumor suppressor function,gpcr signaling modulation,cell proliferation regulation,prognostic biomarker significance
ENSG00000155545,MIER3,cell proliferation regulation,apoptosis modulation,pi3k/akt pathway regulation,genomic stability maintenance,biomarker and therapeutic target potential,tumor progression association
ENSG00000151445,VIPAS39,autophagic flux regulation,endosomal sorting regulation,membrane trafficking facilitation,tumor cell proliferation promotion,cellular signaling pathway interaction,ubiquitinated protein degradation facilitation
ENSG00000105642,KCNN1,ion flow regulation,calcium influx modulation,oncogene activation,tumor progression enhancement,chemoresistance development,metastatic potential promotion
ENSG00000102109,PCSK1N,cell signaling,prohormone processing,oncogenic pathway activation,cell proliferation,apoptosis resistance,tumor progression
ENSG00000109610,SOD3,oxidative stress regulation,dna damage repair,mitochondrial function,cancer progression,cellular redox balance,tumor growth promotion
ENSG00000135315,CEP162,chromosomal instability,microtubule regulation,mitotic spindle formation,tumor progression,cellular proliferation,resistance to therapy
ENSG00000105997,HOXA3,oncogenic transcription factor,epigenetic regulation,cell migration and invasion,chromatin remodeling,transcriptional coactivation,tumor aggressiveness
ENSG00000141639,MAPK4,mitogen-activated protein kinase signaling pathway,gain of function mutations,cell proliferation enhancement,oncogenesis promotion,tumor progression facilitation,cancer prognosis association
ENSG00000135597,REPS1,pi3k/akt signaling pathway,oncogenic driver,cell proliferation regulator,mdm2 interaction,poor prognostic marker,angiogenesis promoter
ENSG00000138468,SENP7,desumoylation process,cell cycle regulation,oncogenic signaling,genome instability,nuclear localization,apoptosis modulation
ENSG00000182175,RGMA,oncogene activation,tumor progression,enhanced cell migration,constitutive activation,upregulated expression,cell-cell interactions
ENSG00000162654,GBP4,regulation of gtpase activity,immune response modulation,oncogenic driver gene,tumor progression facilitation,immune evasion promotion,epithelial-to-mesenchymal transition regulation
ENSG00000136286,MYO1G,cellular migration,endocytic pathway regulation,overexpression,tumor aggressiveness,membrane trafficking,protein expression
ENSG00000042980,ADAM28,tumor progression,mutation,cell signaling,protein-protein interaction,t-cell regulation,cancer cell proliferation
ENSG00000105926,MPP6,genomic instability,dna repair facilitation,oncogenic process promotion,cell cycle regulation,splicing regulation,rna metabolism
ENSG00000077232,DNAJC10,chaperone function,protein stability regulation,tumor progression,apoptosis evasion,oncogenic pathway activation,poor prognostic marker
ENSG00000164011,ZNF691,transcriptional regulation,cell growth regulation,dna-binding activity,zinc finger domains,cancer-related gene expression disruption,apoptosis regulation
ENSG00000138107,ACTR1A,nuclear receptor complex regulation,transcriptional activation,cell growth regulation,chromatin remodeling,apoptosis evasion,co-regulator protein interaction
ENSG00000101470,TNNC2,muscle contraction regulation,protein-protein interaction,cell migration enhancement,metastatic potential increase,cancer cell invasion facilitation,genomic amplification associated
ENSG00000113971,NPHP3,primary cilium formation,ciliopathy-associated,cell division regulation,sensory perception,oncogenic processes,tumor suppressor
ENSG00000182963,GJC1,gap junctions,cell-to-cell communication,oncogenic behavior,cell proliferation,apoptosis regulation,angiogenesis modulation
ENSG00000101187,SLCO4A1,chemotherapy resistance,aberrant expression,tumor growth,efflux transport,chemotherapeutic agent resistance,cancer progression
ENSG00000126353,CCR7,chemokine signaling,immunosuppression,metastasis promotion,tumor homing,chemotaxis facilitation,epithelial-to-mesenchymal transition
ENSG00000106436,MYL10,cancer-promoting effects,cell migration and invasion,oncogene activation,genomic instability,actin cytoskeleton regulation,therapeutic target
ENSG00000141349,G6PC3,glycogenolysis,gluconeogenesis,mtor pathway activation,tumor growth promotion,metabolic reprogramming,cellular proliferation enhancement
ENSG00000155906,RMND1,mitochondrial dna replication,loss of function mutation,tumor suppressor activity,dna replication regulation,metabolic reprogramming,transcriptional regulation
ENSG00000177045,SIX5,tumor suppressor function,loss of heterozygosity,cell cycle regulation,epithelial-to-mesenchymal transition,stem cell self-renewal,transcription factor activity
ENSG00000281818,MANSC1,autophagic dysregulation,cellular homeostasis disruption,endocytosis regulation,membrane trafficking modulation,oncogenic reprogramming,therapeutic target
ENSG00000182533,CAV3,cell migration,cell survival,vesicular transport,caveolae membranes,pi3k/akt pathway,signal transduction
,IMPAD1,protein degradation,ubiquitin-proteasome pathway,e3 ubiquitin ligase activity,cellular homeostasis regulation,oncogenic signaling regulation,tumor suppressor function
ENSG00000206487,C6orf136,tpr domain containing,uncharacterized protein function,regulation of cell cycle,protein-protein interaction regulation,potential tumorigenesis contribution,cellular process modulation
ENSG00000106333,PCOLCE,tumor microenvironment modulation,cell proliferation regulation,aggressive tumor phenotype,metastasis facilitation,cell adhesion interaction,therapeutic target
ENSG00000109674,NEIL3,genomic instability,dna repair mechanism,oxidative damage repair,mutagenesis prevention,8-oxoguanine excision,cancer susceptibility
ENSG00000124067,SLC12A4,nkcc1 protein function,ion transport regulation,cellular ph regulation,oncogenic processes,tumor progression,therapeutic target
ENSG00000171680,PLEKHG5,cellular membrane localization,cytoplasmic domain interactions,membrane trafficking regulation,oncogenic transformation promoter,pi3k/akt signaling pathway regulator,tumor suppressor dysfunction
ENSG00000077157,PPP1R12B,cell cycle regulation,tumor progression,cell proliferation,oncogene activation,signaling pathway regulation,protein phosphatase regulation
ENSG00000154655,L3MBTL4,chromatin remodeling,transcriptional repression,gene silencing,genomic instability,tumor suppressor function,histone modification
ENSG00000276747,PADI6,chromatin remodeling,cancer progression,tumor suppressor interaction,cytoskeletal regulation,apoptosis inhibition,cell proliferation promotion
ENSG00000105549,THEG,angiogenesis,cell adhesion,endothelial cell regulation,growth factor interaction,metastasis promotion,tumor progression
ENSG00000277443,MARCKS,cell signaling,constitutive phosphorylation,oncogenic behavior,protein kinase activity,tumor progression,biomarker/prognosis marker
,MARCH9,pi3k/akt pathway interaction,p53 degradation,oncogenic protein stabilization,cell proliferation regulation,tumor suppressor regulation,ubiquitin ligase activity
ENSG00000092377,TBL1Y,chromatin remodeling,genomic instability,homologous recombination deficiency,transcriptional regulation,brca1 interaction,dna damage repair
ENSG00000169594,BNC1,genomic instability,tumor suppressor function,dna repair mechanisms,homologous recombination,non-homologous end joining,genome maintenance
ENSG00000185133,INPP5J,ip4 5-kinase activation,tumor progression,cell growth regulation,therapeutic target,inositol phosphate metabolism,signaling pathway alteration
ENSG00000123360,PDE1B,aberrant expression,cgmp regulation,cell proliferation enhancement,oncogenic activation,pi3k/akt pathway modulation,therapeutic target potential
ENSG00000241863,RPP21,ribosomal dysfunction,protein synthesis regulation,cell proliferation,cancer progression,signaling pathway activation,genetic instability
ENSG00000100473,COCH,stereocilia maintenance,gene amplification,cell proliferation,tumor suppressor function,epigenetic regulation,mitotic activity
ENSG00000285501,AGBL2,microtubule stabilization,tumor growth,cell proliferation,therapeutic target,mitosis regulation,cancer development
ENSG00000196652,ZKSCAN5,cellular regulation,dna binding,oncogenesis,tumor suppression,tissue-specific expression,apoptosis modulation
ENSG00000109180,OCIAD1,cellular stress response,chromatin remodeling,transcriptional regulation,gene expression modulation,cancer biology involvement,cellular response modulation
ENSG00000172262,ZNF131,transcriptional regulation,apoptosis inhibition,cell cycle progression,dna repair mechanism,chromatin remodeling,tumor suppressor function
ENSG00000086102,NFX1,dna replication regulation,chromatin remodeling,genomic instability,cell proliferation promotion,nuclear matrix association,transcriptional regulation support
ENSG00000124357,NAGK,glutamine synthesis,nitrogen assimilation,anabolic metabolism,cell proliferation,tumor growth,protein kinase regulation
ENSG00000184659,FOXD4L4,neural crest development,transcriptional regulation,ectopic expression,mesenchymal transition,angiogenesis,immune evasion
ENSG00000196911,KPNA5,cell cycle regulation,chromatin remodeling,nuclear transport,oncogenesis,cell proliferation,protein-protein interactions
ENSG00000103174,NAGPA,asparaginase activity,tumor microenvironment,asparagine regulation,amino acid metabolism,enzymatic degradation,secreted enzyme
ENSG00000142677,IL22RA1,il-22 signaling pathway,tumor-promoting inflammation,immune evasion mechanisms,therapeutic target for immunotherapy,receptor-ligand interaction,immune response modulation
ENSG00000197894,ADH5,cellular redox balance,detoxification of ros,alcohol metabolism,genomic instability,oxidative stress,protein-protein interaction
ENSG00000221818,EBF2,transcriptional regulation,oncogene activity,tumor progression,cell proliferation,apoptosis evasion,signaling pathway interaction
ENSG00000172818,OVOL1,epithelial integrity maintenance,gene silencing,transcriptional regulation,tumor suppression,cell adhesion regulation,mesenchymal transition inhibition
ENSG00000256683,ZNF350,cell cycle regulation,dna repair mechanism,chromatin remodeling,tumor suppression,gene transcription regulation,nuclear localization
ENSG00000176294,OR4N2,olfactory receptor function,overexpression,biomarker potential,tumor progression,cell proliferation,poor prognosis
ENSG00000198765,SYCP1,meiosis regulation,dna repair,genomic stability,telomere maintenance,chromosome pairing,synapsis formation
ENSG00000165233,CARD19,immune evasion,antigen presentation,tumor microenvironment,lipid antigen processing,immune suppression,cancer immuneediting
ENSG00000130204,TOMM40,mitochondrial dynamics,oncogenic transformation,energy metabolism regulation,cell survival enhancement,apoptosis resistance,protein transport modulation 
ENSG00000283201,ZNF724,oncogenic function,tumor aggressiveness,transcriptional regulation,cell cycle progression,apoptosis evasion,chromatin remodeling
ENSG00000114859,CLCN2,emt regulatory,ion transport modulation,tumor progression driver,cell migration enhancement,protein interaction network,voltage-gated chloride channel
ENSG00000172113,NME6,ndk family,cell proliferation,dna repair,apoptosis regulation,genomic instability,tumor suppressor modulation
ENSG00000059915,PSD,postsynaptic density component,regulates synaptic transmission,modulates ampa receptor activity,involved in oncogenic processes,cell migration and invasion regulator,aberrant expression contributes to tumorigenesis
ENSG00000213901,SLC23A3,tumor progression,metabolic regulation,tumor microenvironment,epithelial-to-mesenchymal transition,chemotherapy resistance,radioresistance
ENSG00000176340,COX8A,mitochondrial function,tumor energy metabolism,cell survival,therapeutic target,genomic instability,electron transport chain
ENSG00000111144,LTA4H,leukotriene biosynthesis,cysteinyl leukotrienes production,inflammation promotion,tumor growth enhancement,angiogenesis stimulation,metastasis facilitation
ENSG00000069188,SDK2,chromatin remodeling,tumor progression,proliferation,survival,transcriptional regulation,histone deacetylation
ENSG00000182208,MOB2,aurora-a kinase interaction,cell cycle dysregulation,oncogenic function,scaffold protein,kinase activity regulation,cancer resistance
ENSG00000204710,SPDYC,microtubule dynamics,mitotic checkpoint control,aneuploidy,genomic instability,tumor progression,therapeutic target
ENSG00000136944,LMX1B,tumor suppressor function,transcriptional regulation,genomic instability,cancer cell proliferation,gene dysregulation,protein-protein interactions
ENSG00000173080,RXFP4,oncogenic role,cell proliferation,cell migration,tumor invasion,signaling pathway modulation,ligand interaction
ENSG00000129197,RPAIN,genomic instability,cell cycle checkpoint regulation,dna repair facilitation,oncogene promoter,genomic integrity maintenance,cell proliferation enhancer
ENSG00000170325,PRDM10,chromatin remodeling,transcriptional regulation,tumor suppressor activity,oncogene function,cell proliferation promotion,epigenetic modification regulation
ENSG00000156510,HKDC1,pi3k pathway alteration,cell proliferation enhancement,tumor aggressiveness increase,apoptosis resistance,dna repair mechanism modulation,protein kinase regulation
ENSG00000011376,LARS2,mitochondrial translation,charging trnas with amino acids,regulation of mitochondrial dynamics,aberrant translation process,contribution to oncogenic transformation,cellular energy metabolism
ENSG00000167074,TEF,transcriptional regulation,oncogene upregulation,chromatin remodeling,cell proliferation enhancement,metastasis promotion,therapeutic target
ENSG00000135452,TSPAN31,cell adhesion disruption,cell migration modulation,genetic mutations,immunomodulatory functions,oncogenesis driver,tumor progression enhancement
ENSG00000277725,KIR2DL2,ion channel regulation,cellular proliferation,dysregulated expression,cancer progression,therapeutic target,genomic amplification
ENSG00000146409,SLC18B1,neurotransmitter signaling,regulatory protein interactions,oncogenic potential,cellular proliferation,apoptosis regulation,transcriptional modulation
ENSG00000107593,PKD2L1,ion channel regulation,calcium homeostasis disruption,tumor progression,metastasis promotion,therapeutic target,genomic instability
ENSG00000271303,SRXN1,redox regulation,oxidative stress,genome stability,cell survival,tumorigenesis,metastasis promotion
ENSG00000163867,ZMYM6,oncogenic transformation,pi3k/akt pathway interaction,cell adhesion disruption,transcriptional regulation,cytoskeletal reorganization,metastatic potential
ENSG00000204548,DEFB121,epithelial protection,antimicrobial activity,immune regulation,tumor suppression,cell differentiation regulation,cell membrane interaction
ENSG00000015133,CCDC88C,tumor progression,pi3k/akt pathway modulation,oncogenic driver,epithelial-to-mesenchymal transition (emt) regulation,cell signaling enhancement,cancer aggressiveness marker
ENSG00000104112,SCG3,neurotransmitter regulation,gain of function mutations,therapeutic target,constitutive activation,tumor progression,genomic profiling
ENSG00000124107,SLPI,inflammation regulation,immune suppression,apoptosis inhibition,tumor progression,metastasis facilitation,protein-protein interaction
ENSG00000119946,CNNM1,cancer cell proliferation,oncogenic signaling pathway,protein kinase activation,cellular metabolism regulation,rna expression changes,tumor growth promotion
ENSG00000176635,HORMAD2,genome instability,synaptonemal complex formation,meiotic recombination,dna repair pathway,tumor suppressor function,genomic alteration
ENSG00000140807,NKD1,wnt/β-catenin pathway,tumor suppressor function,loss of function mutations,gene expression regulation,cell proliferation regulation,cancer association
ENSG00000261787,TCF24,wnt/β-catenin pathway,dysregulation,transcriptional regulator,cell proliferation,apoptosis regulation,oncogenic driver
ENSG00000160949,TONSL,chromosomal instability,aneuploidy,genomic instability,centrosome regulation,microtubule dynamics,biomarker potential
ENSG00000164691,TAGAP,t-cell regulation,immune suppression,cytokine production,cell signaling modulation,oncogenic driver,immune evasion
ENSG00000125850,OVOL2,tumor suppressor,epithelial-to-mesenchymal transition (emt) inhibition,cell cycle arrest promotion,proliferation inhibition,apo-1 death receptor interaction,dna repair regulation
ENSG00000170476,MZB1,cellular proliferation,genomic instability,oncogenic function,transcriptional regulation,co-regulatory interactions,dna replication
ENSG00000149451,ADAM33,angiogenesis facilitation,cell adhesion modulation,tumor growth promotion,cellular invasion enhancement,biomarker potential,cancer progression association
ENSG00000108799,EZH1,epigenetic regulation,histone modification,gene silencing,oncogenesis,tumor suppressor repression,therapeutic target
ENSG00000187546,AGMO,wnt signaling,constitutive activation,gain of function mutations,cellular homeostasis disruption,therapeutic target,genomic instability
ENSG00000172992,DCAKD,oncogenic signaling,protein-kinase activation,cell growth modulation,tumorigenesis promotion,genetic mutations,gene expression regulation
ENSG00000085788,DDHD2,lysophospholipase activity,phosphatidic acid production,cell membrane dynamics,lipid metabolism dysregulation,oncogenic signaling activation,therapeutic target identification
ENSG00000184634,MED12,chromatin remodeling,transcriptional regulation,cell proliferation,oncogene activation,signaling pathway modulation,tumorigenesis driver
ENSG00000177200,CHD9,chromatin remodeling,dna damage response,genomic instability,cell cycle progression,tumor progression,genome stability
ENSG00000136235,GPNMB,glycoprotein expression,osteoblast regulation,metastasis promotion,tumor progression,angiogenesis modulation,emt regulation
ENSG00000282813,ARMC10,oncogene,wnt signaling pathway,cell adhesion regulation,cytoskeleton organization,tumor growth promotion,metastasis facilitation
ENSG00000076555,ACACB,fatty acid synthesis,metabolic regulation,cell membrane biogenesis,therapeutic target,prognostic biomarker,pi3k/akt signaling
ENSG00000114757,PEX5L,peroxisomal import,cell proliferation,oncogenic processes,therapeutic target,genomic instability,protein regulation
ENSG00000112769,LAMA4,tumor progression,cell adhesion,extracellular matrix,integrin interaction,cancer metastasis,angiogenesis
ENSG00000250361,GYPB,gpi-anchored protein,tumor suppressor,glycophorin regulation,red blood cell membrane stability,hematopoietic system regulation,lysosomal function regulation
ENSG00000167771,RCOR2,chromatin remodeling,histone deacetylase interaction,transcriptional silencing,corepressor function loss,oncogenic pathway activation,tumor suppression
ENSG00000172915,NBEA,tumor progression,cellular proliferation,oncogene activation,protein-protein interactions,cell survival regulation,neurodevelopmental plasticity
ENSG00000122386,ZNF205,cell cycle regulation,chromatin modification,dna damage response,oncogenic transformation,tumor progression,transcriptional regulation
ENSG00000256797,KLRF2,kelch repeat domain,transcriptional regulation,pi3k/akt pathway,epithelial-to-mesenchymal transition,metastasis promoter,stat3 interaction
ENSG00000134287,ARF3,adp-ribosylation factor function,chromosomal instability,genomic stability regulation,microtubule dynamics regulation,oncogenic signaling pathway modulation,spindle assembly checkpoint regulation
ENSG00000095383,TBC1D2,tbc1d2 regulation,endosomal trafficking modulation,cellular proliferation promotion,tumor progression contribution,rho-like gtpase interaction,mutation implicated oncogenesis
ENSG00000099326,MZF1,tumor suppressor function,cell cycle regulation,apoptosis evasion prevention,metastasis suppression,genomic stability maintenance,transcriptional repression
ENSG00000205213,LGR4,wnt/β-catenin pathway,overexpression mutations,oncogene activation,cell proliferation regulation,therapeutic target,signaling pathway modulation
ENSG00000105612,DNASE2,genomic instability,dna damage response,oncogenic processes,chromosomal degradation,genome stability maintenance,parp1 interaction
ENSG00000101180,HRH3,histamine signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000172239,PAIP1,regulation of translation,oncogenic processes,cell proliferation,metastasis,poor prognosis,therapeutic resistance
ENSG00000204962,PCDHA8,cell-cell interaction disruption,epithelial-to-mesenchymal transition,cell migration facilitation,tumor progression,oncogenic potential,signaling pathway regulation
ENSG00000133636,NTS,g-protein coupled receptor signaling,oncogenic transformation,aberrant signaling pathways,cell proliferation and survival,therapeutic target,genomic instability
ENSG00000101188,NTSR1,neurotensin receptor activation,cell proliferation enhancement,mapk/erk pathway stimulation,pi3k/akt pathway involvement,g protein-coupled receptor function,tumor progression promotion
ENSG00000063241,ISOC2,idh1 enzymatic activity loss,2-hg oncometabolite production,histone demethylation inhibition,metabolic regulation alteration,tumor growth promotion,oncogenic driver mutation
ENSG00000131480,AOC2,cellular stress responses,detoxification mechanisms,epithelial-to-mesenchymal transition (emt),metabolic regulation,apoptosis modulation,cancer-related pathway interaction
ENSG00000198689,SLC9A6,autophagy regulation,cell migration promotion,ion homeostasis disruption,oncogene overexpression,prognosis correlation,therapeutic target candidate
ENSG00000164794,KCNV1,pi3k/akt signaling,constitutive activation,gain of function mutations,oncogenic driver,cellular proliferation,therapeutic target
ENSG00000148840,PPRC1,tumor suppressor function,regulates cell signaling,modulator of oncogenic proteins,pan-cancer mutations,enhances tumor progression,therapeutic target
ENSG00000130638,ATXN10,polyglutamine repeat expansion,oncogene activation,chromatin remodeling,genomic instability,tumor suppressor interaction,cell cycle regulation
ENSG00000155966,AFF2,rna processing regulation,gene expression modulation,chromatin remodeling interaction,cellular proliferation regulation,transcriptional regulation involvement,protein-protein interaction
ENSG00000167769,ACER1,tumor progression,pi3k/akt pathway interaction,cell proliferation,metastasis promotion,inflammation regulation,angiogenesis modulation
ENSG00000134324,LPIN1,triglyceride biosynthesis,lipid metabolism regulation,glycolipid synthesis,autophagy modulation,cell membrane component,oncogenic signaling pathway activation
ENSG00000149182,ARFGAP2,regulation of vesicular transport,cellular signaling pathway,endocytic pathway modulation,receptor internalization,genetic mutations,tumorigenesis
ENSG00000116539,ASH1L,histone methylation regulation,chromatin structure modulation,epigenetic regulator,tumor suppressor function,cell cycle progression control,genome stability maintenance
ENSG00000124615,MOCS1,molybdenum cofactor synthesis,genomic instability,cellular redox balance,dna damage repair,tumor suppression,apoptosis regulation
ENSG00000059588,TARBP1,gw182-tarbp2 complex,alternative splicing regulation,mirna processing,cellular proliferation promotion,oncogenic processes enhancement,tumor suppressor function modulation
ENSG00000188778,ADRB3,g-protein coupled signaling,adrenergic receptor overexpression,lipolysis regulation,metabolic dysregulation,tumor growth promotion,oncogenic pathway activation
ENSG00000143314,MRPL24,ribosomal function,overexpression,cell proliferation,tumor progression,protein-protein interaction,metabolic regulation
ENSG00000087008,ACOX3,fatty acid oxidation,redox regulation,oxidative stress,tumor progression,cell proliferation,genomic instability
ENSG00000175063,UBE2C,ubiquitin conjugation,tumor progression,proliferation regulation,apoptosis suppression,oncogene overexpression,ubiquitination pathway disruption
ENSG00000070731,ST6GALNAC2,o-glcnac transferase activity,cell surface modification,post-translational regulation,epigenetic regulation,cancer biomarker,therapeutic target
ENSG00000204624,DISP3,wnt/β-catenin pathway activation,metastasis promotion,cell adhesion disruption,tumor progression facilitation,protein function alteration,poor prognosis marker
ENSG00000203907,OOEP,cellular interaction regulation,tumor progression modulation,metastasis promotion,adhesion molecule disruption,signal transduction involvement,cancer-related protein interactions
ENSG00000060982,BCAT1,bcaa catabolism,cellular proliferation,mtor pathway regulation,oncogene overexpression,poor prognosis marker,energy metabolism regulation
ENSG00000169255,B3GALNT1,biosynthesis of proteoglycans,altered expression levels,impact on cellular functions,dysregulation of glycosylation,aberrant protein modification,increased risk of tumorigenesis
ENSG00000100403,ZC3H7B,spliceosomal interaction,alternative splicing regulation,transcriptional modulation,cellular proliferation,tumor progression,genomic instability
ENSG00000162761,LMX1A,cell proliferation,epithelial-to-mesenchymal transition (emt),neural crest-derived tissues,transcription factor regulation,chromatin remodeling,cell migration and invasion
ENSG00000122694,GLIPR2,epithelial-to-mesenchymal transition,cell adhesion regulation,metastatic potential,cancer prognosis,cell signaling pathways,tumor progression
ENSG00000196228,SULT1C3,metabolic regulation,estrogen conjugation,tumor suppression,genetic variations,hormone metabolism,protein interaction
ENSG00000163348,PYGO2,wnt/β-catenin pathway,co-activator function,gain of function mutations,tumor progression,cancer cell proliferation,metastasis
ENSG00000141446,ESCO1,genome stability,dna repair,double-strand break resolution,helicase activity,genomic instability,cell cycle regulation
ENSG00000182400,TRAPPC6B,protein transport regulation,tumor progression,aberrant expression,proliferation enhancement,metastasis facilitation,genomic alteration
ENSG00000169635,HIC2,transcriptional regulation,tumor suppressor function,cell growth inhibition,apoptosis modulation,co-repressor interaction,genome stability maintenance
ENSG00000100629,CEP128,chromosomal instability,cell division regulation,microtubule dynamics,aneuploidy prevention,tumor progression,therapeutic target
ENSG00000116096,SPR,proteolytic activity,tumor microenvironment modulation,cell invasion facilitation,oncogenic potential,apoptosis regulation,tissue remodeling
ENSG00000134109,EDEM1,erad pathway regulation,protein misfolding recognition,oncogene upregulation,cell survival enhancement,immune evasion,autophagy modulation
ENSG00000163017,ACTG2,actin cytoskeleton regulation,cell migration enhancement,cancer cell invasion,metastasis facilitation,oncogenic property induction,therapeutic target potential
ENSG00000164344,KLKB1,hemostasis regulation,tumor progression,proteolytic activity,fibrinolysis regulation,cell migration,inflammation modulation
ENSG00000244057,LCE3C,epithelial differentiation,stratum corneum formation,barrier function regulation,skin permeability modulation,protein structure maintenance,cell membrane integrity
ENSG00000100994,PYGB,glycogen phosphorylation,overexpression,glycolysis upregulation,cell proliferation enhancement,energy metabolism dysregulation,protein interaction alteration
ENSG00000164597,COG5,golgi apparatus dysfunction,altered protein glycosylation,lipid metabolism regulation,cell growth promotion,tumor progression facilitation,therapeutic target identification
ENSG00000136240,KDELR2,er stress response,misfolded protein accumulation,cell signaling pathway,protein quality control,oncogenic processes,endoplasmic reticulum homeostasis
ENSG00000166451,CENPN,aneuploidy,genomic instability,chromosome segregation,kinetochore complex,microtubule attachment,cell growth regulation
ENSG00000186198,SLC51B,bile acid transport,dysregulated lipid metabolism,cell proliferation enhancement,enhanced cell survival,prognostic marker,tumor microenvironment modulation
ENSG00000140326,CDAN1,cell adhesion regulation,cytoskeleton modulation,epithelial integrity maintenance,tumorigenesis prevention,cell migration inhibition,cancer progression association
ENSG00000089820,ARHGAP4,rhogtpase activation,rho signaling pathway,tumor suppression,gene expression regulation,cytoskeleton reorganization,cell migration inhibition
ENSG00000165434,PGM2L1,glycolytic pathway,overexpression,oncogenic role,metabolic regulation,tumor aggressiveness,therapeutic target
ENSG00000183723,CMTM4,tumor progression,cell adhesion regulation,signaling pathway interaction,oncogene activation,metastasis promotion,therapeutic target
ENSG00000134755,DSC2,cell-cell adhesion,cytoskeletal organization,signal transduction,oncogene overexpression,tumor progression,protein-protein interaction
ENSG00000075884,ARHGAP15,rhogtpase regulation,tumor progression,cell migration,metastasis promotion,oncogenic interaction,signaling pathway modulation
ENSG00000114923,SLC4A3,cellular ph regulation,tumor microenvironment modulation,prognostic marker candidate,chemoresistance associated,cell migration facilitation,antigen presentation regulation
ENSG00000187140,FOXD3,transcription factor regulation,cell cycle progression,apoptosis regulation,tumor suppressor activity,oncogene potential,stem cell maintenance
ENSG00000168303,MPLKIP,mapk pathway inhibition,genomic stability maintenance,cell survival promotion,apoptosis resistance,prognostic biomarker,therapeutic target
ENSG00000165506,DNAAF2,axonemal assembly,cell migration,chemoresistance,ciliogenesis,metastasis promotion,oncogenic potential
ENSG00000117154,IGSF21,epithelial-to-mesenchymal transition,cell migration,adhesion molecule function,cancer progression,metastasis facilitation,pi3k/akt pathway interaction
ENSG00000070540,WIPI1,autophagy regulation,tumor progression,cell survival enhancement,metabolic reprogramming,protein interaction,signaling pathway modulation
ENSG00000149256,TENM4,cell adhesion disruption,tumor progression,metastasis promotion,apoptosis evasion,pi3k/akt pathway interaction,cancer cell migration
ENSG00000162692,VCAM1,angiogenesis,cell adhesion molecule,immune suppression,metastasis,prognostic marker,tumor progression
ENSG00000175093,SPSB4,protein processing,cell signaling regulation,tumor suppression degradation,promotes oncogenesis,tumor progression facilitation,cancer biology implication
ENSG00000156427,FGF18,cell growth regulation,tumor progression driver,wnt/β-catenin pathway activation,emt promotion,metastasis facilitation,oncogene potential
ENSG00000123243,ITIH5,proteolytic regulation,extracellular matrix remodeling,tumor growth promotion,metastasis facilitation,cell migration enhancement,pi3k/akt pathway interaction
ENSG00000154227,CERS3,aberrant lipid metabolism,autophagy regulation,cancer stem cell maintenance,cell membrane fluidity,lipid raft formation,oncogenic signaling pathway
ENSG00000127463,EMC1,genomic instability,aneuploidy promotion,chromothripsis facilitation,mitotic regulation disruption,tumor progression enhancement,chromosome segregation error
ENSG00000129636,ITFG1,cellular regulation,oncogenic promotion,tumor suppression interaction,pi3k/akt pathway modulation,cell invasion facilitation,tissue homeostasis maintenance
ENSG00000183963,SMTN,microtubule regulation,mitosis meiosis regulation,cell proliferation driver,genomic instability factor,therapeutic resistance marker,tumor growth regulator
ENSG00000117000,RLF,tumor progression,cell migration,angiogenesis promotion,metastasis induction,epithelial-to-mesenchymal transition (emt),paracrine function
ENSG00000030419,IKZF2,transcriptional regulation,oncogene/tumor suppressor,t-cell development repression,notch1 receptor inhibition,cell growth/proliferation promotion,therapeutic target
ENSG00000205649,HTN3,transcription factor regulation,oncogene activation,tumor progression,cell proliferation,therapeutic target,genomic instability
ENSG00000136110,CNMD,cell cycle regulation,tumor suppressor regulation,calcium-dependent signaling,epithelial-to-mesenchymal transition,oncogenic transformation,tumor growth promotion
ENSG00000164944,VIRMA,viral replication,tumor progression,cell proliferation,retrovirus interaction,nuclear localization,oncogene activation
ENSG00000163673,DCLK3,microtubule dynamics,tumor progression,prognostic biomarker,wnt/β-catenin signaling,chemoresistance,dna damage repair
ENSG00000148143,ZNF462,chromatin remodeling,tumor suppressor function,c2h2-type zinc finger domains,dna repair,cell cycle regulation,antitumoral activity
ENSG00000089053,ANAPC5,genomic instability,cell cycle regulation,tumor suppression,mitotic checkpoint,chromosomal segregation,ancillary subunit
ENSG00000145423,SFRP2,wnt signaling inhibition,tumor suppressor,cell proliferation regulation,oncogenic activation,loss of expression,phosphorylation regulation
ENSG00000179528,LBX2,tumor suppressor function,regulation of muscle cell differentiation,inhibition of oncogenic processes,cell proliferation inhibition,metastasis suppression,signaling pathway regulation
ENSG00000187134,AKR1C1,cell proliferation,steroid hormone regulation,angiogenesis promotion,tumor progression enhancement,metabolic regulation,oncogene function
ENSG00000288118,GLUD2,glutamine metabolism,tumor growth,energy production,oncogenic processes,anabolic metabolism,tumor progression
ENSG00000054148,PHPT1,oncogene mutation,aberrant protein phosphatase regulation,tumor progression driver,cell cycle dysregulation,apoptosis evasion mechanism,tumor growth promotion
ENSG00000234514,LST1,chromatin remodeling,transcriptional regulation,oncogenesis,genome instability,epigenetic modifications,tumor suppression
ENSG00000186280,KDM4D,tumor promoter,histone modification,chromatin remodeling,dna damage response,transcriptional regulation,oncogenic driver
ENSG00000275052,PPP4R3B,protein phosphatase regulation,cell cycle regulation,epithelial-to-mesenchymal transition (emt),signaling pathway modulation,tumor progression driver,cancer therapeutic target
ENSG00000166473,PKD1L2,cellular homeostasis disruption,cancer driver mutations,mtor pathway activation,pi3k/akt signaling cascade,calcium channel regulation,tumor progression facilitation
ENSG00000160124,CCDC58,tumor progression,cell proliferation,apoptosis regulation,ciliary complex maintenance,biomarker identification,co-expression with oncogenes
ENSG00000005483,KMT2E,histone methylation regulation,tumorigenesis,gene expression control,oncogenic process,cell cycle regulation,genomic stability maintenance
ENSG00000183309,ZNF623,transcriptional regulation,tumor suppressor function,chromatin remodeling,cell cycle regulation,anti-apoptotic activity,genomic instability
ENSG00000092421,SEMA6A,angiogenesis inhibition,notch signaling interaction,tumor suppression function,cell migration regulation,cancer stem cell modulation,gene expression downregulation
ENSG00000196387,ZNF140,cellular differentiation,tissue specificity,transcriptional repression,krab domain,dna damage response,wnt signaling pathway regulation
ENSG00000167508,MVD,angiogenesis promotion,dihydrofolate reductase activity,vegf signaling regulation,tumor growth enhancement,cell proliferation increase,oncogenic driver
ENSG00000024422,EHD2,endocytic recycling pathway,cell migration and invasion,oncogenic driver mutations,tumor aggressiveness,protein trafficking regulation,membrane dynamics modulation
ENSG00000197584,KCNMB2,cellular signaling modulation,protein-protein interactions,cancer cell proliferation,epithelial-to-mesenchymal transition,apoptosis resistance,chromatin remodeling
,HARS,histidine loading,protein synthesis regulation,cancer driver potential,mutation or altered expression,cell growth and proliferation regulation,signaling pathway interaction
ENSG00000104450,SPAG1,chromosomal instability,aneuploidy,cancer predisposition,biomarker candidate,cell cycle regulation,dna damage response
ENSG00000205277,MUC12,mucin expression,epithelial-to-mesenchymal transition (emt),oncogenic processes,cell adhesion modulation,overexpression in cancer,signaling molecule interaction 
,GPR21,oncogene,cell proliferation,pi3k/akt/mtor pathway activation,metastasis promotion,estrogen receptor interaction,epigenetic regulation
ENSG00000144962,SPATA16,dna repair,cell cycle regulation,tumor suppressor function,genomic instability,oncogenesis,biomarker potential
ENSG00000277481,PKD1L3,oncogenic signaling,gain of function mutations,cellular transport regulation,ion channel activity,protein-protein interaction,genomic instability
ENSG00000158296,SLC13A3,cellular metabolism,citrate transport,increased glucose uptake,lipid biosynthesis,metabolic regulation,nucleotide synthesis
ENSG00000182795,C1orf116,cellular proliferation,signaling pathway interaction,gene overexpression,tumor growth promotion,metabolic regulation,potential oncogene
ENSG00000146729,NIPSNAP2,vesicle fusion,cellular homeostasis regulation,tumorigenesis association,autophagy modulation,cancer driver potential,membrane trafficking regulation
ENSG00000153820,SPHKAP,sphingolipid metabolism regulation,cancer cell apoptosis,pi3k/akt pathway modulation,oncogenic transformation,tumor suppression,cell cycle regulation
ENSG00000142484,TM4SF5,cell adhesion modulation,focal complex formation,microvilli regulation,oncogene function,transmembrane protein,metastasis promotion
ENSG00000148408,CACNA1B,calcium channel regulation,dysregulated function,neurotransmitter release dysfunction,aberrant calcium signaling,synaptic plasticity disruption,cerebral degeneration
ENSG00000135297,MTO1,mitochondrial localization,oncogene/tumor suppressor,cellular metabolism regulation,metabolic adaptation,tumor growth/survival modulation,protein-protein interaction
ENSG00000275482,EPHB6,receptor dimerization,tumor suppressor function,mutations in expression,cellular adhesion regulation,signaling pathway modulation,epithelial-to-mesenchymal transition
ENSG00000276582,ABCB11,multidrug resistance,drug efflux,cellular transport,cholestasis,prognostic marker,cancer biology
ENSG00000119922,IFIT2,tumor suppressor function,jak/stat pathway regulation,immune response modulation,viral replication inhibition,cell growth regulation,apoptosis promotion
ENSG00000159256,MORC3,telomere maintenance,genomic instability,dna damage response,cell cycle regulation,chromatin remodeling,protein-protein interactions
ENSG00000182687,GALR2,oncogene potential,proliferation enhancement,survival promotion,tumor microenvironment modulation,g-protein coupled receptor activity,cell growth regulation
ENSG00000164128,NPY1R,oncogenic processes,cell proliferation,metastasis promotion,therapeutic target,signaling pathway activation,gpcr interaction
ENSG00000275717,KIR3DL1,nk cell activation,immunoregulation,mhc-i recognition,tumor surveillance,gene expression variation,cancer susceptibility
ENSG00000185739,SRL,proteolytic regulation,tumor suppressor,cysteine cathepsin inhibition,cellular homeostasis,oncogene activity,prognostic biomarker
ENSG00000169031,COL4A3,basement membrane integrity,cell adhesion disruption,epithelial-to-mesenchymal transition,tumor progression facilitation,oncogenesis promotion,biomarker potential
ENSG00000102385,DRP2,mitochondrial dynamics,apoptosis regulation,cell metabolism enhancement,oncogenic processes,therapeutic target,genetic alterations
ENSG00000181631,P2RY13,purinergic signaling,g-protein coupled receptor,cell proliferation,tumor progression,immune evasion,therapeutic target
ENSG00000141469,SLC14A1,urea transport,tumor growth regulation,cellular metabolism modulation,cancer aggressiveness marker,poor patient outcomes,biomarker potential
ENSG00000100625,SIX4,transcription factor activation,tumor suppressor function loss,cell proliferation regulation,embryonic development gene,oncogene involvement,genetic mutation impact
ENSG00000109911,ELP4,genomic instability,constitutive expression,aberrant transcription,dna repair defect,cell cycle progression,tumor progression
ENSG00000088367,EPB41L1,tumor suppressor,cell adhesion regulation,cytoskeletal organization,apoptosis regulation,genomic instability,mitotic checkpoint
ENSG00000180185,FAHD1,oncogenic metabolism,altered lipid profile,genetic instability,dna damage repair,cell proliferation enhancement,aberrant expression
,HIST1H1T,chromatin structure modification,epigenetic regulation,histone post-translational modifications,transcriptional regulation,oncogenesis,tumor suppression
ENSG00000100596,SPTLC2,sphingolipid biosynthesis,oncogenic effects,cell signaling pathway,tumor progression,therapeutic target,genomic instability
ENSG00000114374,USP9Y,deubiquitination,oncogene activation,pi3k/akt pathway regulation,chromatin remodeling,tumor growth promotion,protein stabilization
ENSG00000170608,FOXA3,transcriptional regulation,oncogenic activity,cellular proliferation,apoptosis modulation,genetic mutations,tumor progression
ENSG00000117643,MAN1C1,protein maturation,endoplasmic reticulum localization,cell-cell adhesion regulation,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway interaction,glycosylation regulation
ENSG00000145868,FBXO38,cell cycle regulation,dna damage response,oncogenic protein degradation,tumor suppressor function,protein ubiquitination,genomic instability
ENSG00000153303,FRMD1,cell cycle regulation,oncogene function,mitosis regulator,cell proliferation driver,dna damage response modifier,tumor suppressor interaction
ENSG00000176978,DPP7,protein degradation,altered expression in cancer,nf-κb signaling regulation,cellular process regulation,enzyme-protein interaction,cell proliferation and apoptosis modulation
ENSG00000151640,DPYSL4,microtubule regulation,tumor progression,oncogene potential,cytoskeletal dynamics,metastasis promotion,chemoresistance enhancement
ENSG00000159374,M1AP,pi3k/akt signaling,apoptosis regulation,cell cycle progression,protein-protein interactions,autophagy regulation,tumor progression
ENSG00000144320,LNPK,interaction with g-proteins and signaling molecules,contribution to oncogenic processes,overexpression in various tumor types,lnpk's role in maintaining ntp/ndp balance,impact on cellular proliferation and survival,association with poor prognosis
ENSG00000171051,FPR1,cell migration,g protein-coupled receptor,metastasis promotion,oncogenic potential,phagocytosis regulation,tumor progression
ENSG00000049656,CLPTM1L,dna repair regulation,apoptosis induction,cell cycle control,transcriptional regulation,genomic instability prevention,tumor suppressor function
ENSG00000180245,RRH,mitotic spindle checkpoint,genomic instability,automatic expression,cellular interaction,tumor suppressor regulation,prognostic marker
ENSG00000171302,CANT1,lysosomal function,chemoresistance mechanism,unfolded protein response,cellular stress regulation,cancer progression marker,protein-protein interaction
ENSG00000163975,MELTF,oncogenic potential,apoptosis regulation,tumor suppressor function,transcriptional regulation,cell cycle progression,cancer-related transcription factor
ENSG00000274205,MAPK15,mitogen-activated protein kinases,oncogenic activation,cell proliferation,apoptosis resistance,tumor progression,genetic amplification
ENSG00000174236,REP15,cell cycle regulation,dna replication facilitation,oncogene interaction,therapeutic target potential,chromatin remodeling,genomic instability prevention
ENSG00000156218,ADAMTSL3,cell migration regulation,epithelial-to-mesenchymal transition promotion,integrin interaction,protein kinase activation,mapk signaling pathway,upregulated expression levels
ENSG00000134389,CFHR5,complement regulation,tumor microenvironment modulation,immune evasion,tumorigenesis promotion,cell survival regulation,proliferation enhancement
ENSG00000166596,CFAP52,ciliary dysfunction,tumor suppressor function,dysregulated cell division,aberrant cellular proliferation,cancer-related mutations,genomic instability
ENSG00000122592,HOXA7,oncogenic transcription factor,tumor progression,cell proliferation,migration invasion,epigenetic regulation,signaling pathway modulation
ENSG00000125772,GPCPD1,pe metabolism regulation,pi3k/akt pathway modulation,tumor suppressor potential,gene expression regulation,metabolic stress adaptation,oncogenic properties
ENSG00000119616,FCF1,telomere maintenance,dna repair,genomic instability,chromosomal breakage,cancer suppressor,oncogenic pathway
ENSG00000274803,BDP1,oncogenic coactivator,transcriptional regulation,cell growth promotion,apoptosis evasion,chromatin remodeling,poor prognosis marker
ENSG00000168461,RAB31,aberrant activation,cell migration enhancement,membrane protrusion formation,metastatic establishment support,oncogenic process driving,rab gtpase regulation
ENSG00000178038,ALS2CL,cellular adhesion disruption,oncogenic processes,cell growth regulation,metastasis promotion,epithelial integrity maintenance,cell polarity regulation
ENSG00000160183,TMPRSS3,proteolytic processing,cellular invasion,oncogenesis,tumor aggressiveness,therapeutic target,epithelial-mesenchymal transition
ENSG00000205758,CRYZL1,cell cycle regulation,oncogene overexpression,dna repair,tumor suppressor interaction,proliferation promotion,survival enhancement
ENSG00000073737,DHRS9,angiogenesis promotion,epithelial-to-mesenchymal transition,invasiveness enhancement,metabolic reprogramming,oncogenic signaling,therapeutic target
ENSG00000103021,CCDC113,cilia formation disruption,centriole regulation,cellular morphology alteration,oncogenic cell proliferation,therapeutic target,pi3k/akt signaling pathway
ENSG00000175318,GRAMD2A,oncogenic signaling pathway,cellular metabolism modulation,kinase regulation,tumor growth promotion,protein interaction,metabolic reprogramming
ENSG00000167699,GLOD4,glycosylation,protein modification,cell growth regulation,cancer progression,mutations,diagnostic marker
ENSG00000152082,MZT2B,histone modification regulation,cellular homeostasis,genetic reprogramming,gene expression regulation,chromatin structure alteration,malignant transformation
ENSG00000124104,SNX21,endosomal regulation,protein trafficking,cellular signaling,tumor progression,oncogene regulator,gene expression alteration
ENSG00000165684,SNAPC4,snare complex regulation,vesicular trafficking,cell proliferation,membrane dynamics,oncogenesis,genomic instability
ENSG00000126768,TIMM17B,mitochondrial protein import,energy metabolism,cellular respiration regulation,warburg effect association,mitochondrial dna maintenance,protein folding and assembly
ENSG00000061987,MON2,golgi apparatus maintenance,cellular homeostasis regulation,protein-protein interactions,lipid metabolism modulation,oncogenic processes promotion,tumorigenesis involvement
ENSG00000197140,ADAM32,tumor growth,cell migration,proteolytic activity,therapeutic target,cancer progression,cell adhesion
ENSG00000143498,TAF1A,tfiia complex,transcriptional regulation,chromatin remodeling,gene expression modulation,histone modifications,therapeutic target
ENSG00000163900,TMEM41A,aberrant lipid metabolism,loss-of-function mutations,tumor cell survival,ectopic expression,er stress response pathway disruption,mitochondrial dysfunction
ENSG00000266338,NBPF15,nucleus,non-homologous end joining (nhej),dna repair,genome stability,oncogenic mutations,genomic instability
ENSG00000179364,PACS2,vesicular trafficking regulation,cell proliferation enhancement,metastasis promotion,signaling pathway activation,golgi apparatus localization,protein sorting modulation
ENSG00000141161,UNC45B,tumor progression,constitutive activation,gain of function mutations,microtubule dynamics regulation,cell signaling pathway interaction,therapeutic target
ENSG00000007001,UPP2,nucleotide degradation,p53 regulation,tumor growth,cell proliferation,mtor activation,beta-alanine accumulation
ENSG00000122707,RECK,tumor suppressor,inhibits invasion,cellular migration regulation,extracellular matrix regulation,cancer metastasis promotion,therapeutic target
ENSG00000170703,TTLL6,microtubule regulation,oncogene activation,tyrosination modification,cell proliferation promotion,cytoskeleton organization,mitosis regulation
ENSG00000164674,SYTL3,lysosome regulation,gene overexpression,cell proliferation,oncometabolism,lysosomal membrane fusion,kinase substrate
ENSG00000241697,TMEFF1,cell adhesion regulation,tumor progression promotion,epithelial-to-mesenchymal transition,protein-protein interaction,cell migration modulation,transmembrane protein function
ENSG00000114767,RRP9,ribosomal assembly,translation regulation,mrna processing,tumor suppression,cancer prognosis,therapeutic target
ENSG00000006695,COX10,heme a biosynthesis,mitochondrial function disruption,loss-of-function mutations,aerobic glycolysis dependency,tumor cell metabolic adaptation,atp production impairment
ENSG00000170113,NIPA1,tumor suppressor function,genomic instability,apoptosis regulation,cell growth modulation,protein interaction network,pan-cancer involvement
ENSG00000171954,CYP4F22,overexpression,oxidative stress,therapeutic target,cellular proliferation,lipid metabolism regulation,protein-protein interaction
ENSG00000066056,TIE1,tumor angiogenesis,receptor tyrosine kinase activity,angiopoietin-1 binding,vascular integrity regulation,ligand-receptor interactions,cell survival promotion
ENSG00000128342,LIF,oncogenic signaling,pleiotropic cytokine,embryonic development,stat activation,tumor progression,chemoresistance
ENSG00000178343,SHISA3,wnt/β-catenin pathway disruption,tumor suppressor function,cell surface molecule,transmembrane protein signaling,ectopic expression,genetic alterations
ENSG00000148935,GAS2,apoptosis regulation,cell cycle control,microtubule interaction,tumor suppressor function,pi3k/akt pathway modulation,epigenetic regulation
ENSG00000137801,THBS1,angiogenesis inhibition,endothelial cell regulation,cell adhesion molecule,protease activity modulation,signal transduction pathway interaction,cancer metastasis suppression
ENSG00000074582,BCS1L,mitochondrial metabolism regulation,tumor suppressor function,cellular redox balance,mitochondrial dysfunction association,oncogenic metabolic reprogramming,complex iii assembly
ENSG00000178177,LCORL,regulation of cholesterol homeostasis,aberrant expression in cancer,cellular stress and inflammation,enhanced cell proliferation,potential biomarker for diagnosis,targeted therapeutic strategy
ENSG00000274780,PHRF1,cellular proliferation,oncogene or tumor suppressor,histone modification regulation,chromatin remodeling,protein degradation interaction,gene expression repression
ENSG00000284228,TMEM102,immune evasion,tumor microenvironment,cell survival,metastasis,macrophage regulation,oncogenesis
ENSG00000185022,MAFF,transcriptional regulation,oncogenesis,cell cycle progression,apoptosis evasion,oxidative stress response,inflammatory response modulation
ENSG00000134490,TMEM241,cell membrane regulation,transmembrane protein interaction,cell signaling pathway,oncogenic processes,apoptosis resistance,tumor progression
ENSG00000094914,AAAS,er stress response,tumor progression,oncogenic transformation,therapeutic resistance,mitochondrial dysfunction,protein misfolding
ENSG00000106415,GLCCI1,gstp1 regulation,tumor suppression,cellular detoxification,oxidative stress protection,redox balance maintenance,chemosensitivity modulation
ENSG00000069345,DNAJA2,protein stability modulation,cell cycle regulation,apoptosis inhibition,metastatic progression,oncogenic protein interaction,chaperone function
ENSG00000140403,DNAJA4,cellular chaperone function,tumor suppression,apoptosis induction,cell cycle regulation,oncogene downregulation,hsc70 interaction
ENSG00000213626,LBH,pi3k/akt pathway modulation,chromatin remodeling,cell proliferation enhancement,transcriptional regulation,protein-protein interactions,oncogenic processes promotion
ENSG00000158042,MRPL17,ribosomal function,gene expression regulation,cell growth promotion,oncogene enhancement,tumor progression,metastasis facilitation
ENSG00000123500,COL10A1,cartilage degradation,tumor progression,cell migration,epithelial-to-mesenchymal transition,angiogenesis promotion,poor prognosis marker
ENSG00000184792,OSBP2,lipid metabolism regulation,oncogenic signaling,cellular transformation,tumor progression,cell survival promotion,protein-protein interactions
ENSG00000158050,DUSP2,erk activation,mapk pathway disruption,oncogenic transformation,cellular proliferation regulation,phosphatase activity,therapeutic resistance
ENSG00000129596,CDO1,cell-cell adhesion,cancer progression,tumor metastasis,immune evasion,signal transduction,overexpression
ENSG00000197594,ENPP1,nucleotide metabolism regulation,tumor suppressor function,genomic instability prevention,oncogenic pathway modulation,cellular homeostasis maintenance,therapeutic target identification
ENSG00000130962,PRRG1,cellular regulation,transcription factor regulation,epithelial-to-mesenchymal transition,cell growth control,dna repair regulation,protein-protein interaction
ENSG00000115339,GALNT3,oncogene,protein modification,tumor progression,cell growth regulation,glycosylation pathway,poor prognosis marker
ENSG00000176222,ZNF404,transcriptional regulation,oncogenic function,cell cycle progression,apoptosis regulation,nuclear localization,tumor suppressor gene interaction
ENSG00000174576,NPAS4,cell cycle regulation,tumor suppressor,transcriptional regulation,circadian rhythm modulation,antiproliferative effects,tissue specificity
ENSG00000175073,VCPIP1,aberrant cell signaling,chaperone complex interaction,cellular transformation,oncogenic driver mutation,protein processing regulation,serine protease activity
ENSG00000013588,GPRC5A,g protein coupled receptor regulation,akt/pi3k pathway modulation,cell survival enhancement,differentiation inhibition,oncogenic driver mutations,retinoic acid signaling
ENSG00000138166,DUSP5,mapk signaling pathway,erk1/2 regulation,cell proliferation,tumorigenesis modulation,apoptosis regulation,genetic instability
ENSG00000134996,OSTF1,tumor suppressor,cell cycle regulation,apoptosis suppression,mirna regulation,chromatin remodeling,genomic instability
ENSG00000185670,ZBTB3,tumor suppressor function,cellular growth regulation,apoptosis induction,dna replication control,chromatin remodeling,transcriptional repression
ENSG00000116260,QSOX1,therapeutic target,growth factor regulation,cell adhesion modulation,dna repair regulation,tumor microenvironment modulation,rna stabilization
ENSG00000187257,RSBN1L,chromatin regulation,tumor suppression,gene expression regulation,transcription factor modulation,oncogenic pathway regulation,genomic instability prevention
ENSG00000196876,SCN8A,neuronal excitability,voltage-gated sodium channels,tumorigenesis,neurological disorders,epileptic encephalopathies,developmental delay
ENSG00000169218,RSPO1,wnt/β-catenin signaling pathway,cellular proliferation,genetic mutations,aberrant expression,oncogenic outcomes,tumor progression
ENSG00000187801,ZFP69B,transcription factor activity,oncogenic function,cell proliferation enhancement,tumor suppressor suppression,epigenetic regulation,gene expression modulation
ENSG00000132677,RHBG,apoptosis regulation,cell growth promotion,gene expression modulation,oncogene potential,protein-protein interaction,retinoid transport
ENSG00000133401,PDZD2,wnt/β-catenin pathway,cell adhesion regulation,dysregulation in tumorigenesis,oncogenic function,signaling pathway modulation,protein-protein interaction
ENSG00000006453,BAIAP2L1,pi3k/akt pathway interaction,gain of function mutations,oncogenic signaling,tumor progression,therapeutic target,genomic instability
ENSG00000180739,S1PR5,sphingosine-1-phosphate signaling pathway,g-protein coupled receptor activation,epithelial-to-mesenchymal transition,tumor progression facilitation,cell migration regulation,apoptosis inhibition
ENSG00000170624,SGCD,disrupted cellular signaling,cell adhesion disruption,sarcolemma maintenance,oncogene potential,mutations in cancer,cell surface receptor interaction
ENSG00000168757,TSPY2,oncogene,pseudogene expression,cell proliferation,p53 interaction,apoptosis regulation,overexpression in cancer
ENSG00000005302,MSL3,histone modification,chromatin remodeling,dosage compensation,cell proliferation,x-chromosome regulation,tumor suppression
ENSG00000273859,RASSF7,tumor suppressor activity,epigenetic silencing,microtubule dynamics regulation,cell cycle progression inhibition,apoptosis induction,oncogenesis promotion
ENSG00000138303,ASCC1,genetic instability,gene expression regulation,transcriptional co-activation,cell cycle progression,oncogenic pathway modulation,tumor aggressiveness
ENSG00000180902,D2HGDH,mitochondrial enzyme,tumor suppressor function,alpha-ketoglutarate dehydrogenase complex,cellular metabolism regulation,cancer cell energy production,gene expression dysregulation
ENSG00000134186,PRPF38B,spliceosome regulation,tumor suppressor function,haploinsufficiency,aberrant splicing patterns,transcription factor modulation,cell growth regulation
ENSG00000183648,NDUFB1,mitochondrial function impairment,genomic instability,dna damage,cellular transformation,therapeutic target,energy metabolism
ENSG00000187672,ERC2,dna repair defects,genomic instability,homologous recombination,genetic mutation hotspots,oncogenic potential,cell cycle regulation
ENSG00000135409,AMHR2,aberrant expression,cell proliferation,tumorigenesis,resistance to therapy,wnt/β-catenin signaling inhibition,transcriptional repression
ENSG00000280094,OR1B1,olfactory receptor signaling,cancer metastasis,upregulated expression,cell migration,transcriptional regulation,tumor progression
ENSG00000107651,SEC23IP,tumor progression,metastatic potential,tumorigenesis driver,protein trafficking regulation,cell migration enhancement,anti-apoptotic signaling
ENSG00000124225,PMEPA1,transcriptional regulation,genetic instability,epigenetic modifications,signal transduction,cell cycle progression,therapeutic target
ENSG00000172031,EPHX4,oncogenesis,cell proliferation,reactive oxygen species regulation,therapeutic resistance,epoxide hydrolase activity,cancer cell survival
ENSG00000253831,ETV3L,dna damage response,transcription factor activity,cell differentiation regulation,oncogene activation,proliferation promotion,apoptosis inhibition
ENSG00000153779,TGIF2LX,transcriptional regulator,cell proliferation,signaling pathway modulation,oncogene overexpression,dna damage response,cell cycle regulation
ENSG00000232258,TMEM114,er-resident protein,calcium signaling regulation,mitochondrial function modulation,apoptosis regulation,cancer driver potential,cellular stress response
ENSG00000196867,ZFP28,transcriptional regulation,dna binding,zinc finger protein,c2h2-type zinc finger family,cell growth regulation,apoptosis regulation
ENSG00000163814,CDCP1,cell migration,epithelial-to-mesenchymal transition,glycoprotein function,tumor progression,cell adhesion regulation,biomarker expression
ENSG00000138411,HECW2,ubiquitination regulation,protein degradation pathway,apoptosis modulation,cell cycle control,tumor suppressor role,oncogenic regulator
ENSG00000091010,POU4F3,cellular differentiation,transcriptional regulation,cell proliferation,oncogenesis,cellular identity,regulatory element
ENSG00000008300,CELSR3,notch signaling pathway,gain-of-function mutations,constitutive activation,cell polarity loss,tumor progression,therapeutic target
ENSG00000156471,PTDSS1,metabolic reprogramming,oncogene function,cellular metabolism regulation,tumor growth promotion,therapeutic target,genomic amplification
ENSG00000164068,RNF123,e3 ubiquitin ligase activity,cell cycle regulation,tumor suppressor function,apoptosis modulation,oncogenic processes,genetic instability
ENSG00000059378,PARP12,apoptosis regulation,chromatin remodeling,dna repair regulation,gene expression modulation,genomic instability maintenance,oncogenesis promotion
ENSG00000183513,COA5,mitochondrial dysfunction,apoptosis regulation,oxidative phosphorylation,energy metabolism alteration,glycolytic shift,electron transport chain disruption
ENSG00000099864,PALM,protein-protein interactions,cell adhesion regulation,tumor suppressor function,gtpase activation,cytoskeleton dynamics regulation,cell migration facilitation
ENSG00000221995,TIAF1,transcriptional regulation,oncogene activation,cell growth control,signaling pathway modulation,apoptosis influence,genomic instability
ENSG00000161533,ACOX1,metabolic reprogramming,peroxisomal function,fatty acid oxidation,cellular energy homeostasis,tumor metabolic profiles,cancer cell survival
ENSG00000163833,FBXO40,e3 ubiquitin ligase activity,tumor suppressor/oncogene dichotomy,p53 binding,notch signaling regulation,brca1 interaction,cancer cell cycle regulation
ENSG00000182508,LHFPL1,overexpression,cell-cell adhesion disruption,epithelial-to-mesenchymal transition facilitation,tumor growth promotion,metastasis enhancement,pi3k/akt pathway interaction
ENSG00000198885,ITPRIPL1,pi3k/akt/mtor signaling pathway modification,oncogene activation,cell proliferation regulation,tumor progression association,protein-protein interaction,genetic instability promotion
ENSG00000129625,REEP5,genomic instability,therapeutic target,endoplasmic reticulum localization,cellular regulation disruption,pi3k/akt pathway interaction,mitochondrial dynamics modulation
ENSG00000120318,ARAP3,rhoa/rap1 signaling,cell migration enhancement,tumor growth promotion,therapeutic target,gtpase activation regulation,endocytosis regulation
ENSG00000188037,CLCN1,chloride channel activity,constitutive activation,cell proliferation,epithelial-to-mesenchymal transition,tumor progression,aberrant regulation
ENSG00000067704,IARS2,iron-regulation,cell proliferation,oncogenesis,iron metabolism,ferroptosis modulation,hypoxia response
ENSG00000203485,INF2,actin dynamics regulation,rhoa inhibition,cytoskeletal organization,cell motility alteration,oncogenic mutation,tumor progression
ENSG00000181061,HIGD1A,mitochondrial dynamics,dna damage,ros production,tumor suppressor,cell proliferation,metabolic reprogramming
ENSG00000148019,CEP78,centrosome regulation,cell cycle progression,oncogenic driver,cell proliferation enhancement,microtubule stabilization,signaling pathway activation
ENSG00000206237,HLA-DQB1,immune evasion,mhc class ii antigen presentation,antigen processing,t-cell recognition,cancer immunity,genetic variation
ENSG00000116176,TPSG1,chromosomal instability,mitotic spindle assembly,tumor suppressor function,microtubule dynamics regulation,cell cycle progression regulation,aneuploidy induction
ENSG00000175470,PPP2R2D,protein phosphatase regulation,cancer cell proliferation,substrate dephosphorylation,oncogenic signaling,cell cycle progression,genetic instability 
ENSG00000152700,SAR1B,copii complex,cell trafficking regulation,protein secretion regulation,oncogenic process,therapeutic target,poor prognosis marker
ENSG00000135392,DNAJC14,cellular chaperoning,genomic stability regulation,molecular interaction network,cell cycle progression,oncogenesis association,protein folding regulation
ENSG00000197119,SLC25A29,mitochondrial carrier protein,metabolic reprogramming,fatty acid transport,cellular respiration,tumor metabolism,energy homeostasis
ENSG00000073067,CYP2W1,pi3k/akt pathway,cellular regulation,detoxification mechanism,oncogenic potential,therapeutic target,tumor progression
ENSG00000133111,RFXAP,transcriptional regulation,regulatory complex formation,gene expression modulation,tumor suppressor interaction,cellular process regulation,dna damage response
ENSG00000116205,TCEANC2,transcriptional regulation,chromatin remodeling,cell cycle control,genomic instability,dna replication,tumor suppressor activity
ENSG00000144161,ZC3H8,chromatin remodeling,genomic stability,cell cycle progression,transcriptional control,dna damage response,tumor progression
ENSG00000144681,STAC,cellular adhesion modulation,cancer cell migration,metastatic process facilitation,tumor suppressor interaction disruption,proliferative signaling pathway activation,oncogenic process promotion
ENSG00000141447,OSBPL1A,cell membrane modulation,cholesterol regulation,tumor progression,cell proliferation enhancement,signal transduction,protein-protein interaction
ENSG00000138660,AP1AR,cyclin d1 regulation,constitutive activation,oncogenic signaling,cell cycle progression,transcriptional regulation,protein-protein interactions
ENSG00000149124,GLYAT,aberrant aminoacylation,cell growth promotion,mischarging event,oncogenic mutations,protein synthesis regulation,tumor suppressor activity
ENSG00000103067,ESRP2,alternative splicing regulation,tumor progression,oncogenic phenotypes,rna processing,aberrant protein isoforms,cancer prognosis
ENSG00000140395,WDR61,cell cycle regulation,dna damage response,oncogene role,genomic stability maintenance,protein-protein interaction,ubiquitin ligase activity
ENSG00000128590,DNAJB9,cellular survival,proteostasis regulation,apoptosis regulation,gain of function mutations,therapeutic target,tumor progression
ENSG00000104904,OAZ1,ubiquitin ligase activity,transcription factor regulation,genomic stability maintenance,cell cycle control,apoptosis modulation,tumor suppression
ENSG00000139629,GALNT6,oncogene,tumor progression,cell proliferation,signaling pathway regulation,glycosylation process,metastasis
ENSG00000070214,SLC44A1,altered sphingolipid metabolism,pi3k/akt pathway activation,tumor growth and invasion,metastasis promotion,cellular membrane composition changes,therapeutic target
ENSG00000175538,KCNE3,voltage-gated potassium channel subunit,cardiac repolarization,gain of function mutations,ablation of normal cardiac rhythm,abnormal heart rhythms,long qt syndrome
ENSG00000153291,SLC25A27,mitochondrial carrier protein,metabolic reprogramming,energy homeostasis regulation,cellular adaptation mechanism,transport of adp,cellular energy supply
ENSG00000166503,HDGFL3,genomic instability,cell proliferation,scaffold protein,dna repair,protein-protein interaction,tumor suppressor potential
ENSG00000147588,PMP2,epithelial integrity disruption,metastasis facilitation,tumor cell migration,cell survival regulation,angiogenesis modulation,tumor suppressor function
ENSG00000179520,SLC17A8,glutamate metabolism,vesicular transport,neurotransmission regulation,tumor progression,genomic alteration,biomarker potential
ENSG00000010438,PRSS3,prss3 serine protease activity,tumor progression,pro-inflammatory signaling,microenvironment modulation,cell growth regulation,apoptosis evasion
ENSG00000137124,ALDH1B1,detoxification mechanism,redox regulation,cellular metabolism,protein stabilization,oxidative stress resistance,tumor progression
ENSG00000082996,RNF13,cell cycle regulation,apoptosis,ubiquitination,genomic stability,e3 ubiquitin ligase activity,protein degradation
ENSG00000135124,P2RX4,atp-gated ion channel,epithelial-to-mesenchymal transition (emt),immunosuppression mechanism,ion channel regulation,metastasis promotion,oncogenic signaling
ENSG00000086232,EIF2AK1,protein synthesis inhibition,tumor progression,oncogenic adaptation,cellular stress response,autophosphorylation activation,double-stranded rna binding
ENSG00000158089,GALNT14,o-galnac glycosylation,protein modification,wnt/β-catenin pathway,pi3k/akt activation,cell proliferation,tumor progression
ENSG00000163788,SNRK,pi3k/akt signaling pathway,oncogene,tumor progression,cell proliferation,angiogenesis,epithelial-to-mesenchymal transition (emt)
ENSG00000115380,EFEMP1,tumor progression,cell adhesion disruption,angiogenesis promotion,oncogenic potential,therapeutic target,genomic instability
ENSG00000105879,CBLL1,cell cycle regulation,tumor progression,oncogene,pi3k/akt signaling,ubiquitination,e3 ligase function
ENSG00000075336,TIMM21,mitochondrial localization,regulation of tumor suppressor genes,interaction with tom20/tom22,pi3k/akt pathway modulation,tumor cell metabolism,oncogene overexpression
ENSG00000162729,IGSF8,cell adhesion disruption,immune response modulation,protein-protein interactions,tumor progression facilitation,signaling pathway involvement,oncogenic role definition
ENSG00000116698,SMG7,genetic instability,mrna quality control,oncogenesis,cancer driver mutation,genomic maintenance,cellular stress response
ENSG00000156486,KCNS2,ion channel regulation,tumor progression,pi3k/akt pathway interaction,oncogenic processes,cellular stress response,therapeutic target
ENSG00000070785,EIF2B3,pi3k/akt signaling,stress response activation,glioma initiation,cell survival enhancement,protein synthesis regulation,tumor progression
ENSG00000125363,AMELX,melanocytic differentiation,mutation associated,transcriptional regulation,cellular growth regulation,tumor suppressor activity,pigmentation pathway disruption
ENSG00000140795,MYLK3,cell migration,protein interaction,tumorigenesis promotion,oncogene involvement,cell proliferation regulation,kinase activity enhancement
ENSG00000032219,ARID4A,chromatin remodeling,tumor suppressor function,cell cycle regulation,dna repair mechanisms,transcriptional control disruptions,oncogenic processes alterations
ENSG00000164663,USP49,oncogene stabilization,protein degradation regulation,cell signaling modulation,tumor progression driver,genomic instability regulator,cell growth promoter
ENSG00000143390,RFX5,enhanced cell proliferation,regulated gene expression,cell cycle progression,transcriptional activation,oncogenic transformation,apoptosis resistance
ENSG00000109790,KLHL5,cullin 3 regulation,tumor growth promotion,oncogenic process driver,ubiquitin ligase complex component,cell cycle regulation,transcriptional repression
ENSG00000122122,SASH3,tumor suppressor,cell growth regulation,apoptosis induction,autophagy modulation,signaling pathway interaction,cellular stress response
ENSG00000137857,DUOX1,excessive ros production,oxidative stress,dna damage,chromosomal instability,cell proliferation,signaling pathway activation
ENSG00000137474,MYO7A,actin cytoskeleton regulation,cell migration promotion,cytoskeletal remodeling,gene amplification,metastatic potential,oncogenic driver
ENSG00000116745,RPE65,visual cycle regulation,cellular metabolism,oncogene overexpression,metabolic reprogramming,tumor progression,genetic instability
ENSG00000158793,NIT1,apoptosis regulation,cell cycle progression,dna repair regulation,oncogene activation,transcriptional modulation,nuclear factor function
ENSG00000147687,TATDN1,telomerase regulation,genomic instability,telomere maintenance,nuclear protein function,chromosome stability,oncogene involvement
ENSG00000125459,MSTO1,cellular growth regulation,tumor progression,hippo signaling pathway activation,transcriptional modulation,apoptosis inhibition,oncogenic transformation
ENSG00000066279,ASPM,genomic instability,aneuploidy,cell proliferation,microtubule dynamics,anti-apoptotic function,dysregulated microtubule assembly
ENSG00000156831,NSMCE2,proteasome assembly,mutation-induced activation,cell cycle regulation,genomic instability,oncogenic pathway interaction,ubiquitination impairment
ENSG00000131050,BPIFA2,lipid metabolism regulation,cell membrane integrity,tumor progression,immunosuppression,oncogene function,cell migration and invasion
ENSG00000168389,MFSD2A,lipid metabolism regulation,tumor growth promotion,lipid uptake facilitation,oncogenic process support,tumor progression association,therapeutic target potential
ENSG00000196705,ZNF431,dna binding activity,zinc finger domains,cell growth regulation,transcriptional regulation,genomic instability,none
ENSG00000127081,ZNF484,chromatin remodeling,oncogene activation,cell proliferation,gene expression regulation,tumor progression,genomic instability
ENSG00000110880,CORO1C,actin cytoskeleton remodeling,endocytic trafficking regulation,membrane trafficking modulation,tumor cell migration enhancement,protein-protein interaction dynamics,cellular homeostasis disruption
ENSG00000130270,ATP8B3,phospholipid transport,cellular signaling pathway,lipid metabolism regulation,protein-protein interactions,tumor progression,therapeutic target
ENSG00000144476,ACKR3,adhesion gpcr family member,chemokine signaling modulation,immune system regulation,tumor microenvironment involvement,cell migration modulation,signaling pathway complexity
ENSG00000197360,ZNF98,cell proliferation,tumor growth,transcription factor,apoptosis suppression,zinc finger motif,oncogenic driver
ENSG00000284068,KPNA7,nuclear import,cell proliferation,oncogenic progression,genomic instability,microtubule regulation,prognostic marker
ENSG00000250510,GPR162,signaling pathway modulation,constitutive activation,cell proliferation regulation,metabolic regulation,protein interaction,g protein-coupled receptor function
ENSG00000205336,ADGRG1,pi3k/akt/mtor pathway modulation,oncogene function,cell migration facilitation,tumor growth promotion,metastasis enhancer,signaling pathway regulation
ENSG00000182674,KCNB2,wnt/β-catenin pathway regulation,gene amplification,oncogenic effects,cell proliferation enhancement,signaling pathway modulation,ion channel regulation
ENSG00000248487,ABHD14A,lipid regulation,cancer progression,signaling pathway modulation,tumor microenvironment,protein interaction,endoplasmic reticulum localization
ENSG00000183549,ACSM5,lipid biosynthesis,oncogenic metabolic reprogramming,fatty acid activation,tumor growth promotion,therapeutic vulnerability,metabolic adaptation
ENSG00000136634,IL10,tumor-promoting effects,immune suppression,angiogenesis promotion,gene regulation,cancer progression,therapeutic target
ENSG00000104093,DMXL2,desmosomal adhesion,oncogenic mutations,epithelial-to-mesenchymal transition (emt),cell migration,chemoresistance,metastasis promotion
ENSG00000108582,CPD,genomic instability,gain of function mutations,dna repair mechanism,nucleotide excision repair,post-translational modifications,uv-induced dna damage
ENSG00000152229,PSTPIP2,cell adhesion disruption,immune response modulation,tumor microenvironment regulation,oncogenic driver,proliferation enhancement,migration promotion
ENSG00000198839,ZNF277,krab domain-containing transcription factor,tumor suppressor function,cell cycle regulation,apoptosis inhibition,metastasis regulation,embryonic development
ENSG00000172889,EGFL7,pro-angiogenic factor,endothelial cell migration,vascular development,tumor vasculature establishment,oncogenic process,poor prognosis indicator
ENSG00000198417,MT1F,zinc regulation,oxidative stress response,antioxidant defense mechanisms,cell survival enhancement,dna repair facilitation,tumor progression promotion
ENSG00000136274,NACAD,cytochrome b5 reduction,electron transport chain,cellular respiration,tumor progression,metabolic reprogramming,oncogenic processes
ENSG00000039523,RIPOR1,autophagy regulation,lysosome maintenance,endosomal sorting,tumor suppressor function loss,cell death inhibition,protein-protein interaction alteration
ENSG00000154620,TMSB4Y,chromatin remodeling,oncogenesis promoter,cell proliferation enhancer,transcriptional regulator,centromere function modulator,mitotic spindle assembly
ENSG00000141316,SPACA3,oncogenic protein,aberrant expression,cell survival and growth,metastasis regulation,protein-protein interaction,stress response signaling
ENSG00000188372,ZP3,tumor progression,cell adhesion regulation,oncogenic signaling,glycosylation alteration,cancer cell invasion,metastasis promotion
ENSG00000077935,SMC1B,chromosomal instability,genome maintenance,dna repair mechanisms,cohesin complex formation,epigenetic regulation,tumor progression
ENSG00000157350,ST3GAL2,glycosylation regulation,cell surface modification,ganglioside biosynthesis,oncogene overexpression,immune evasion mechanism,signaling pathway interaction
ENSG00000213424,KRT222,keratin filament formation,cell growth regulation,epithelial cell maintenance,apoptosis inhibition,emt activation,poor prognosis marker
ENSG00000108828,VAT1,v-atpase assembly,acidic environment,cellular ph regulation,ion transport modulation,cancer cell metabolism,tumor progression acceleration
ENSG00000172661,WASHC2C,actin dynamics regulation,cell migration enhancement,cell proliferation promotion,ciliogenesis disruption,primary cilia dysfunction,therapeutic target
ENSG00000106178,CCL24,tumor microenvironment modulation,immune suppression,angiogenesis promotion,metastasis facilitation,cell migration regulation,pro-inflammatory cytokine signaling
ENSG00000161544,CYGB,cellular differentiation,constitutive activation,electron transfer chain,ferricyanide reduction,metabolic reprogramming,tumorigenesis
ENSG00000125965,GDF5,gdf5 overexpression,tumor progression,emt regulation,angiogenesis promotion,cell migration enhancement,oncogene interaction
ENSG00000213445,SIPA1,rho gtpase regulation,constitutive activation,aberrant expression,cell migration promotion,tumor progression driver,genomic instability
ENSG00000185885,IFITM1,oncogenic potential,overexpression,cell proliferation enhancement,immune evasion mechanism,tumor aggressiveness marker,cancer stem cell maintenance
ENSG00000277494,GPIHBP1,cellular lipid metabolism,oncogenic properties,growth factor regulation,lipid uptake facilitation,proliferative signaling,tumor progression
ENSG00000164961,WASHC5,cellular homeostasis,endosomal sorting,regulatory complex,aberrant protein accumulation,impaired cellular signaling,post-translational modifications
ENSG00000143126,CELSR2,cell adhesion disruption,signaling pathway modulation,protein expression alterations,mitogenic activity enhancement,tumor microenvironment interaction,wnt signaling activation
ENSG00000110931,CAMKK2,ampk activation,energy homeostasis regulation,histone modification regulation,cell proliferation enhancement,therapeutic target identification,tumor suppressor function
ENSG00000135973,GPR45,tumor progression,promotes oncogenesis,cell proliferation enhancement,signaling pathway activation,gene expression regulation,metastasis facilitation
ENSG00000274348,TRPV5,calcium signaling,oncogenesis,cell proliferation,tumorigenesis,channel activation,transcriptional regulation
ENSG00000101443,WFDC2,oncogene,pi3k/akt signaling activation,cell survival promotion,tumor progression facilitation,epithelial-to-mesenchymal transition regulation,protein stabilization through disulfide bond formation
ENSG00000066855,MTFR1,mitochondrial biogenesis,oncogenic processes,enhanced metabolic activity,cellular proliferation,tumorigenesis,prognostic marker
ENSG00000140386,SCAPER,genomic instability,chromosomal missegregation,centrosome dysfunction,protein kinase activation,cancer prognosis,cell polarity disruption
ENSG00000101417,PXMP4,cellular homeostasis disruption,lipid bilayer regulation,membrane trafficking,autophagy modulation,p4-atpase activity,cancer driver potential
ENSG00000196184,OR10J1,olfactory receptor function,tumor progression,cell proliferation,survival and migration,upregulation in cancer,metastasis promotion
ENSG00000118432,CNR1,endocannabinoid system regulation,cancer cell proliferation,chemotherapy resistance,oncogenic signaling,tumor growth promotion,cell survival enhancement
ENSG00000165188,RNF183,ubiquitination regulation,tumor suppressor protein degradation,oncogenic transformation,cell cycle regulation,apoptosis modulation,protein-protein interactions
ENSG00000169026,SLC49A3,phosphate transporter function,cell proliferation enhancement,metastasis promotion,inorganic phosphate regulation,cell survival pathways,tumor growth facilitation
ENSG00000105583,WDR83OS,oncogenic regulation,cancer-associated lncrna,competitive endogenous rna (cerna),cellular pathway regulation,enhanced cell survival,tumor progression
ENSG00000124212,PTGIS,angiogenesis,prostaglandin synthesis,vasodilation,tumor progression,anti-inflammatory response,genomic instability
ENSG00000186470,BTN3A2,epigenetic regulation,chromatin remodeling,transcriptional regulation,tumor suppressor function,apoptosis modulation,protein-protein interactions
ENSG00000004059,ARF5,endocytosis,cellular homeostasis,autophagy regulation,mitophagy modulation,tumor progression,cancer genetics
ENSG00000178372,CALML5,cell migration,calcium-dependent signaling pathway,metastasis regulation,prognostic biomarker,oncogene activation,cell cycle progression
ENSG00000166685,COG1,mitochondrial function,electron transport chain,metabolic reprogramming,gain of function mutations,cellular respiration,energy metabolism
,LOR,ribosome biogenesis,mrna stability,translation regulation,protein synthesis impairment,cellular growth regulation,metabolic reprogramming
ENSG00000213930,GALT,metabolic regulation,cancer metabolism,tumor progression,cell growth modulation,ancillary pathway interaction,genetic disorder association
ENSG00000135749,PCNX2,genomic instability,chromosomal instability,dna repair regulation,cell cycle regulation,oncogenic process promoter,tumor progression facilitator
ENSG00000087250,MT3,cancer cell survival,zinc binding domain,metal detoxification,cell growth regulation,apoptosis evasion,therapeutic resistance
ENSG00000100884,CPNE6,microtubule stabilization,cell proliferation promotion,calcium-binding protein function,tumor aggressiveness association,pi3k/akt pathway interaction,erk signaling activation
ENSG00000108510,MED13,transcriptional regulation,oncogene activation,cancer driver gene,cell cycle progression,apoptosis dysregulation,genomic instability
ENSG00000283706,PRSS50,pi3k/akt pathway regulation,oncogene,tumor progression,cellular signaling modulation,protein degradation regulation,serine protease activity
ENSG00000075188,NUP37,npc dysfunction,altered nuclear transport,genomic instability,tumorigenesis,cell cycle disruption,apoptosis resistance
ENSG00000168386,FILIP1L,filip1l-filamin a interaction,pi3k/akt pathway activation,oncogenic signaling,cell migration and invasion,cytoskeleton regulation,biomarker and therapeutic target potential
ENSG00000140285,FGF7,fgf/fgfr interaction,oncogenic growth,angiogenesis promotion,cell migration enhancement,apoptosis resistance,mapk/erk pathway modulation
ENSG00000269405,NXF2,mrna export regulator,tumor suppressor function,nuclear rna export,loss-of-function mutations,gene expression regulation,oncogenic driver
ENSG00000269437,NXF2B,cellular transport regulation,oncogenic potential,genome instability maintenance,apoptosis evasion,therapeutic target consideration,gene expression modulation
ENSG00000182902,SLC25A18,mitochondrial transport,aspartate transport,energy metabolism regulation,glycolytic enzyme upregulation,metabolic reprogramming,tumor growth promotion
ENSG00000133488,SEC14L4,cellular proliferation,oncogenic potential,lipid droplet formation,endocytosis regulation,golgi function modulation,prognostic marker
ENSG00000156219,ART3,mtor signaling pathway,cellular proliferation,metabolic reprogramming,arginine regulation,tumor progression,metastasis driver
ENSG00000166938,DIS3L,nonsense-mediated mrna decay (nmd),regulation of tumor suppressor genes,oncogene regulation,rna processing and degradation,cell growth modulation,pi3k/akt pathway interaction
ENSG00000154719,MRPL39,mitochondrial ribosome assembly,energy metabolism regulation,cellular growth promotion,cancer driver gene potential,therapeutic target for intervention,metabolic reprogramming involvement
ENSG00000225830,ERCC6,genomic instability,dna repair,nucleotide excision repair,tumor suppression,cell cycle regulation,transcriptional activation
ENSG00000124233,SEMG1,actin cytoskeleton regulation,cell migration,protein kinase activation,tumor progression,biomarker potential,cancer aggressiveness
ENSG00000182050,MGAT4C,cell adhesion disruption,glycosylation dysregulation,metastasis promotion,tumor growth enhancement,signaling pathway modulation,prognostic biomarker potential
ENSG00000285112,SLC52A2,altered expression levels,cellular metabolism regulation,dna repair mechanism alteration,cell proliferation influence,nutrient uptake regulation,tumor growth association
ENSG00000115286,NDUFS7,mitochondrial complex i upregulation,energy metabolism alteration,oncogenic transformation,cellular respiration modulation,therapeutic target identification,radiation therapy resistance
ENSG00000070193,FGF10,fgf10 signaling,oncogenesis promotion,proliferation enhancement,angiogenesis facilitation,epithelial-to-mesenchymal transition (emt) regulation,receptor activation
ENSG00000082126,MPP4,cell polarity regulation,adhesion junction maintenance,tumor growth promotion,metastasis facilitation,prognostic marker potential,kinase regulator activity
ENSG00000173145,NOC3L,ribosome biogenesis,nucleolar complex protein,cell proliferation,tumor progression,oncogenic potential,genomic amplification
ENSG00000239305,RNF103,genomic instability,chromatin remodeling,protein degradation,cell cycle progression,apoptosis regulation,therapeutic target
ENSG00000136531,SCN2A,voltage-gated sodium channels,neuronal excitability,epilepsy susceptibility,seizure induction,ion channel regulation,neurological disorders
ENSG00000172379,ARNT2,transcriptional regulation,environmental toxin response,xenobiotic-induced gene expression,oncogene overexpression,cell proliferation enhancement,metastatic potential increase
ENSG00000104805,NUCB1,neuromodulation,stress response regulation,immune suppression induction,angiogenesis promotion,metastasis facilitation,oncogene role
ENSG00000124587,PEX6,peroxisome biogenesis,protein importation,genetic disorder,x-linked dominant,peroxisome function,cancer cell metabolism
ENSG00000159199,ATP5MC1,mitochondrial energy metabolism,increased atp production,oncogenic driver gene,apoptosis resistance,tumor growth promotion,therapeutic target
ENSG00000187416,LHFPL3,lipid phosphate phosphohistidine-specific phosphatase domain,oncogenic potential,cellular proliferation,tumor progression,metastasis promotion,signaling pathway modulation
ENSG00000163637,PRICKLE2,cellular adhesion,cytoarchitecture disruption,planar cell polarity pathway,tumor progression,oncogenic driver,cell migration enhancement
ENSG00000010295,IFFO1,interferon signaling pathway,cell survival regulation,tumor progression,immune evasion mechanisms,cancer driver gene,cell cycle modulation
ENSG00000152642,GPD1L,metabolic reprogramming,tumor progression,oncogenic signaling,cellular redox balance,energy metabolism regulation,therapeutic target
ENSG00000160209,PDXK,pyridoxal kinase activity,vitamin b6 biosynthesis,cellular metabolism regulation,tumor growth modulation,cancer cell interaction,protein kinase activity
ENSG00000182793,GSTA5,detoxification mechanism,conjugation process,oxidative stress protection,cell growth regulation,apoptosis modulation,therapeutic target
ENSG00000170049,KCNAB3,ion channel regulation,dysregulated ion flow,aberrant cell proliferation,cellular electrical homeostasis,signaling pathway modulation,apoptosis regulation
ENSG00000166532,RIMKLB,mtorc1 regulation,ribosome biogenesis,translation initiation,oncogenic signaling,aberrant protein synthesis,therapeutic target
ENSG00000180535,BHLHA15,bhlh family transcription factors,transcriptional regulation,cell cycle regulation,apoptosis modulation,chromatin remodeling,emt process
ENSG00000164038,SLC9B2,ion transport,ph regulation,cell migration,tumor growth,metastasis,therapeutic target
ENSG00000117400,MPL,jak/stat activation,oncogenic transformation,tumor suppressor function,cell proliferation inhibition,apoptosis promotion,megakaryocyte development regulation
ENSG00000248483,POU5F2,oncogene,embryonic development regulator,stem cell maintenance,transcriptional regulation,epithelial-to-mesenchymal transition (emt),cancer stem cell self-renewal
ENSG00000180964,TCEAL8,tumor suppressor activity,apoptosis regulation,cell cycle inhibition,pi3k/akt pathway interaction,transcriptional regulation,protein-protein interactions
ENSG00000123983,ACSL3,metabolic reprogramming,lipid metabolism regulation,dysregulated expression,pan-cancer target,cancer cell growth modulation,therapeutic potential
ENSG00000183092,BEGAIN,tumor suppressor function,cell cycle regulation,dna repair mechanism,apoptosis promotion,loss-of-function mutations,genetic instability
ENSG00000143994,ABHD1,pi3k/akt signaling pathway,lipid metabolism regulation,oncogenic driver mutation,tumor cell proliferation,signaling pathway modulation,therapeutic target
ENSG00000156110,ADK,atp homeostasis,energy metabolism regulation,glycolysis enhancement,tumor growth promotion,cell proliferation increase,protein interaction modulation
ENSG00000128039,SRD5A3,steroid hormone metabolism,cellular stress response,oncogenic processes,tumor progression,unfolded protein response (upr),cell proliferation
ENSG00000142347,MYO1F,metastasis promotion,cell invasion facilitation,cytoskeleton regulation,signaling pathway modulation,tumor aggressiveness enhancement,therapeutic target
ENSG00000140548,ZNF710,altered gene expression,chromatin remodeling,dna binding activity,oncogenic mutations,transcriptional regulation,zinc finger domain
ENSG00000103888,CEMIP,cell migration,cell adhesion,apoptosis regulation,cytoskeleton reorganization,tumor progression,therapeutic target
ENSG00000174574,AKIRIN1,cell proliferation,epithelial-to-mesenchymal transition,immune suppression,tumor growth promotion,cytokine regulation,transcriptional regulation
ENSG00000118702,GHRH,growth promotion,cell proliferation,metabolic regulation,hormonal signaling pathway,tumor progression,receptor overexpression
ENSG00000177646,ACAD9,mitochondrial dysfunction,energy metabolism dysregulation,fatty acid oxidation disruption,tumor suppressor function,oncogenic mutations,genomic instability
ENSG00000182348,ZNF804B,transcriptional regulation,amplicon formation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000173825,TIGD3,transcriptional regulation,cell cycle progression,t2g domain protein,genetic dysregulation,oncogene activation,signaling pathway interaction
ENSG00000182541,LIMK2,actin cytoskeleton regulation,cell migration facilitation,constitutive activation,oncogenic process promotion,cell survival enhancement,tumor progression driver
ENSG00000081052,COL4A4,basement membranes,genomic instability,tumor progression,cell adhesion,extracellular matrix remodeling,tissue architecture disruption
ENSG00000105679,GAPDHS,cell growth promotion,glucose metabolism regulation,oncogenic protein interaction,tumor aggressiveness enhancement,poor prognosis association,therapeutic target potential
ENSG00000198205,ZXDA,tumor suppressor,transcriptional regulation,chromatin remodeling,cell cycle regulation,gene expression,oncogenesis
ENSG00000139287,TPH2,tph2 regulation,serotonin biosynthesis,oncogenic processes,cell proliferation,metastasis promotion,pi3k/akt pathway interaction
ENSG00000196850,PPTC7,transcriptional regulation,dysregulation,cell growth regulation,tumor progression,apoptosis modulation,genomic instability
ENSG00000147457,CHMP7,escrt-iii complex,ubiquitinated protein degradation,chromatin remodeling,cellular stress response,gene expression regulation,protein-protein interactions
ENSG00000242802,AP5Z1,ap-3 complex,abnormal protein sorting,cellular trafficking,pi3k/akt pathway interaction,protein expression regulation,oncogenic processes
ENSG00000131148,EMC8,chromatin remodeling,tumorigenesis,nucleosome assembly,epigenetic regulation,gene expression modulation,cell cycle regulation
ENSG00000159788,RGS12,tumor suppressor activity,loss of function mutations,pi3k/akt signaling dysregulation,cell migration regulation,gtpase-activating protein function,oncogenic process modulation
ENSG00000108688,CCL7,angiogenesis facilitation,inflammatory recruitment,tumor growth promotion,macrophage activation,immune cell migration,cell signaling regulation
ENSG00000137502,RAB30,rab gtpase signaling,cell proliferation,tumor progression,membrane trafficking regulation,protein transport modulation,therapeutic target
ENSG00000140398,NEIL1,base excision repair,dna glycosylase,genomic stability,oxidative stress,tumor suppressor gene potential,oncogene potential
ENSG00000188425,NANOS2,apoptosis inhibition,cell proliferation,gene regulation,mrna stability,pi3k/akt pathway,protein-rna interaction
ENSG00000179593,ALOX15B,tumor microenvironment,lipid mediator regulation,angiogenesis promotion,chemotherapy resistance,cell proliferation enhancement,oncogenic transformation
ENSG00000174844,DNAH12,dynein assembly,cilia formation,cell cycle regulation,tumor progression,genomic instability,signaling modulation
ENSG00000278322,MBOAT7,cellular lipid homeostasis,cell membrane modification,oncogenic function,tumor progression,lipid metabolism regulation,protein-protein interaction
ENSG00000099954,CECR2,regulation of cell cycle,dna damage response,tumorigenesis promoter,interaction with oncogenic pathways,apoptosis inhibitor,cell growth regulator
ENSG00000198160,MIER1,oncogenic regulation,cell proliferation,transcription factor function,chromatin remodeling,apoptosis evasion,cell cycle progression
ENSG00000141431,ASXL3,histone modification,chromatin remodeling,transcriptional regulation,genomic instability,oncogenic signaling,epigenetic repression
ENSG00000136108,CKAP2,oncogene,cell proliferation,epithelial-to-mesenchymal transition,cytoskeletal regulation,microtubule interaction,aneuploidy prevention
ENSG00000113430,IRX4,cell proliferation,transcription factor activity,tumor progression,metastasis,embryonic development,regulatory element interaction
ENSG00000152467,ZSCAN1,p53 pathway regulation,tumor suppressor function,dna damage response,cell cycle control,transcriptional regulation,chromatin remodeling
ENSG00000198758,EPS8L3,actin cytoskeleton regulation,cell migration,metastasis driver,rac gtpase activation,tumor invasion,cancer cell motility
,MARCH8,regulation of protein degradation,modulation of signaling pathways,cell surface receptor interaction,oncogenic potential,tumor progression,metastasis regulation
ENSG00000281500,SLC37A4,sulfate metabolism,tumor progression,cellular proliferation,apoptosis resistance,therapeutic target,metabolic regulation
ENSG00000163812,ZDHHC3,palmitoylation regulation,cell signaling alteration,oncogenic driver,protein modification pathway,tumor cell proliferation,signaling pathway disruption
ENSG00000164219,PGGT1B,chromatin structure modification,transcriptional regulation,metabolic reprogramming,epigenetic modification,protein-protein interaction,cell proliferation promotion
ENSG00000006007,GDE1,cellular proliferation,tumor growth,lipid biosynthesis,apoptosis regulation,gde1-pi3k/akt interaction,genomic amplification
ENSG00000151655,ITIH2,tumor metastasis,regulation of trypsin activity,cell adhesion and migration,extracellular matrix remodeling,tumor aggressiveness,prognostic biomarker
ENSG00000171649,ZIK1,cell cycle regulation,chromatin remodeling,oncogenesis,transcriptional activation,pi3k/akt signaling,overexpression
ENSG00000162704,ARPC5,actin cytoskeleton remodeling,gene amplification,cell migration regulation,tumor invasion promotion,protein-protein interaction alteration,genomic instability
ENSG00000160539,PLPP7,oncogenic potential,lipid metabolism regulation,cell proliferation enhancement,metabolic reprogramming,glycolysis modulation,tumor progression acceleration
ENSG00000143768,LEFTY2,loss of function mutations,tumor suppressor,cell fate regulation,aberrant cell proliferation,wnt/β-catenin pathway interaction,embryonic development
ENSG00000111058,ACSS3,mitochondrial regulation,anabolic glycolysis,warburg effect,cellular metabolism,protein-protein interaction,cancer cell fitness
ENSG00000281216,KIF26B,microtubule-based transport,overexpression/mutation,cytoskeletal reorganization,tumor progression,genomic instability,therapeutic target
ENSG00000014919,COX15,cytochrome c oxidase assembly,mitochondrial dysfunction,enhanced glycolysis,altered cellular metabolism,heme biosynthesis regulation,protein-protein interactions
ENSG00000198380,GFPT1,hexosamine biosynthesis pathway,metabolic regulation,cellular proliferation,glycoprotein synthesis,protein kinase activation,tumor progression
ENSG00000162706,CADM3,altered expression,cellular polarity,downregulation in cancer,epithelial-to-mesenchymal transition (emt),increased oncogene expression,loss of cell-cell adhesion
ENSG00000114857,NKTR,tumor progression,aberrant activation,cell proliferation,immune evasion,inflammatory responses,signaling pathway
ENSG00000186918,ZNF395,tumor suppressor function,cell cycle regulation,apoptosis induction,dna repair enhancement,mutation-driven oncogenesis,transcriptional regulation
ENSG00000179603,GRM8,aberrant expression,cell proliferation,immune modulation,metastasis,neurotransmission regulation,tumor growth
ENSG00000282185,PTPRN2,oncogenic signaling,tumor suppressor function,loss of function mutations,cell adhesion disruption,metastasis and progression,genomic instability
ENSG00000180537,RNF182,ubiquitination regulation,ring-type e3 ubiquitin ligase activity,cell cycle progression modulation,dna repair mechanism interaction,oncoprotein stabilization,proteasome regulation
ENSG00000185527,PDE6G,photoreceptor signaling,cyclic gmp regulation,enzyme activity modulation,visual disorder association,less clear oncogenic role,phosphodiesterase function
ENSG00000108947,EFNB3,angiogenesis promotion,cell migration regulation,ephrin receptor function,metastasis enhancement,signaling pathway modulation,tumor progression facilitation
ENSG00000178522,AMBN,oncogenic potential,overexpression,cell proliferation,disrupted cell adhesion,apoptosis suppression,tumor progression
ENSG00000198670,LPA,atherogenic,angiogenesis promotion,cardiovascular disease association,inflammation regulation,oncogenic process modulation,pro-inflammatory mediator
ENSG00000138031,ADCY3,camp signaling pathway,constitutive activation,tumor progression,oncogenic processes,therapeutic target,genomic instability
ENSG00000147488,ST18,emt program modulation,transcription factor function,oncogenic potential,wnt/β-catenin pathway interaction,cellular transformation,metastatic progression
ENSG00000204604,ZNF468,transcriptional regulation,tumor progression,cell growth enhancement,overexpression in cancer cells,genomic instability,protein-protein interaction
ENSG00000171540,OTP,emt regulation,transcriptional regulation,cellular differentiation disruption,tumor progression facilitation,stem cell-like properties acquisition,oncogenic transcription factor activity
ENSG00000101474,APMAP,glycoprotein modification,tumor cell migration,immune evasion,angiogenesis,lysosomal function,cancer cell survival
ENSG00000102904,TSNAXIP1,tgf-β signaling pathway,cellular transformation,smad protein regulation,protein-protein interaction,cell proliferation enhancement,oncogenic potential
ENSG00000185070,FLRT2,oncogenic function,aberrant expression,cell adhesion regulation,wnt/β-catenin signaling,fgfr interaction,tumor progression
ENSG00000204130,RUFY2,genomic instability,chromosomal instability,dna repair regulation,cell cycle progression,apoptosis regulation,tumor suppressor function
ENSG00000173976,RAX2,transcription factor regulation,cell differentiation,oncogene/tumor suppressor potential,wnt/β-catenin pathway involvement,neurogenesis and organogenesis,embryonic development regulation
ENSG00000172006,ZNF554,tumor suppressor function,cellular transcription regulation,kruppel c2h2-type zinc finger protein family,dna repair mechanism,apoptosis induction,cell cycle regulation
ENSG00000215454,KRTAP10-4,ectopic expression,histone modification regulation,intermediate filament component,epigenetic target gene,cellular proliferation modulation,skin cell specificity
ENSG00000144671,SLC22A14,organic cation transport,cellular proliferation,chemoresistance,cancer progression,oncogenic signaling,therapeutic target
ENSG00000171532,NEUROD2,regulation of cell cycle,apoptosis suppression,tumor progression,transcriptional regulation,cell proliferation enhancement,oncogenic driver status
ENSG00000101868,POLA1,genomic instability,dna replication,polymerase activity,oncogenesis,cell cycle regulation,tumor suppressor dysfunction
ENSG00000213366,GSTM2,detoxification mechanism,conjugation reactions,oxidative stress reduction,dna repair pathway,cell survival facilitation,environmental exposure interaction
ENSG00000178662,CSRNP3,transcriptional regulation,cellular proliferation,tumor progression,chromatin remodeling,cancer development,therapeutic target
ENSG00000162188,GNG3,gtp exchange regulator,tumor progression driver,cell signaling pathway,cell proliferation enhancer,survival pathway activator,genomic alteration hotspot
ENSG00000255150,EID3,oncogenic function,transcriptional regulation,tumor growth promotion,cell proliferation enhancement,apoptosis suppression,metastasis facilitation
ENSG00000118162,KPTN,microtubule regulation,tumor progression,cell division dysregulation,dna repair disruption,protein degradation modulation,therapeutic resistance
ENSG00000172782,FADS6,fatty acid biosynthesis,lipid metabolism alteration,omega-6/omega-3 fatty acid balance,pro-inflammatory eicosanoid production,cancer cell proliferation modulation,biomarker candidate
ENSG00000134317,GRHL1,transcriptional regulation,epithelial cell development,oncogenic transformation,cell proliferation,tumor invasion,epithelial-to-mesenchymal transition
ENSG00000173992,CCS,mitochondrial regulation,electron transport chain dysfunction,metabolic reprogramming,cellular respiration impairment,tumor progression facilitation,therapeutic target
ENSG00000204060,FOXO6,tumor suppressor,dna repair regulation,cell proliferation promotion,genomic instability maintenance,transcription factor activity,cancer progression association
ENSG00000068912,ERLEC1,tumor progression,er stress response,upr signaling pathways,protein misfolding,cell adaptation,cancer aggressiveness
ENSG00000197622,CDC42SE1,apoptosis regulation,cellular transformation,cytoskeletal organization,gtpase activity,metastasis promotion,mitotic progression
ENSG00000185269,NOTUM,tumor suppressor function,oncogene activity,cell growth regulation,cell polarity disruption,wnt/pcp pathway modulation,therapeutic target
ENSG00000196660,SLC30A10,zinc homeostasis dysregulation,oncogenic activity promotion,tumor cell proliferation,increased tumor growth,apoptosis inhibition,zinc-dependent signaling pathway interaction
ENSG00000131725,WDR44,genomic instability,dna repair pathway,tumor suppressor gene,chromosomal instability,cell cycle regulation,apoptosis regulation
ENSG00000046653,GPM6B,cell signaling,amplification,oncogenesis,cell adhesion,vesicle transport,cell proliferation
ENSG00000136867,SLC31A2,zinc transport regulation,oncogenic transformation,cancer progression,apoptosis evasion,cell proliferation enhancement,genomic instability induction
ENSG00000280549,PADI3,cancer progression,dna repair enhancement,tumor growth promotion,cell cycle regulation,protein modification enzyme,angiogenesis facilitation
ENSG00000226430,USP17L7,oncogene,cell cycle regulation,protein stability modulation,tumor aggressiveness promotion,metastasis facilitation,apoptosis inhibition
ENSG00000156925,ZIC3,oncogene,transcription factor activity,cell proliferation regulation,tumor growth promotion,cell cycle regulation,gene expression modulation
ENSG00000169918,OTUD7A,nf-κb pathway modulation,chromatin remodeling,deubiquitinating enzyme activity,cell cycle regulation,ubiquitin-dependent pathways,tumor progression
ENSG00000116497,S100PBP,cellular regulation,calcium signaling,cell proliferation,oncogenic processes,transcriptional activation,protein interaction
ENSG00000151532,VTI1A,cellular regulation,endocytosis,autophagy modulation,apoptosis inhibition,cell proliferation regulation,glycolysis regulation
ENSG00000183655,KLHL25,apc regulation,cell cycle progression,tumor suppression,oncogenic mutations,pi3k/akt pathway interaction,mitotic checkpoint regulation
ENSG00000066813,ACSM2B,metabolic regulation,mitochondrial function,oncogenic mutations,lipid droplet formation,therapeutic target,cellular homeostasis
ENSG00000168779,SHOX2,oncogenic transcription factor,pi3k/akt/mtor pathway activation,cell proliferation enhancement,tumor progression promotion,metastasis facilitation,angiogenesis regulation
ENSG00000104951,IL4I1,oncogenic pathway modulation,cell proliferation regulation,tumor microenvironment modification,protein-protein interaction,genetic mutation contribution,co-expression with cancer drivers
ENSG00000112218,GPR63,g-protein coupled receptor,constitutive activation,inflammation regulation,tumor progression,metastasis promotion,oncogenic signaling
ENSG00000196511,TPK1,aberrant signaling,constitutive activation,dysregulated apoptosis,enhanced cell growth,oncogenic processes,tumor progression
ENSG00000178814,OPLAH,metabolic reprogramming,transmembrane transport,cellular homeostasis disruption,oncogenic potential,nutrient efflux regulation,tumor metabolism alteration
ENSG00000171408,PDE7B,camp hydrolysis,cell proliferation,therapeutic target,oncogenic processes,tumor development,resistance to therapy
ENSG00000276231,PIK3R6,pi3k/akt/mtor pathway,dysregulation,tumor progression,therapeutic target,genomic instability,cellular proliferation
ENSG00000198753,PLXNB3,cell adhesion disruption,metastasis promotion,actin cytoskeleton regulation,focal adhesion modulation,pi3k/akt pathway interaction,tumor aggressiveness enhancement
ENSG00000119723,COQ6,mitochondrial dysfunction,oxidative stress,genomic instability,reactive oxygen species,dna damage,cellular energy production
ENSG00000168675,LDLRAD4,genomic stability,dna repair mechanisms,transcriptional regulation,chromatin remodeling,genomic instability,oncogenic processes
ENSG00000135919,SERPINE2,tumor progression,apoptosis inhibition,proteolysis regulation,cell migration control,oncogenic process,cancer driver gene
ENSG00000143847,PPFIA4,wnt/β-catenin signaling pathway,cell migration,tumor progression,therapeutic target,protein-protein interaction,gene amplification
ENSG00000159409,CELF3,cellular regulation,post-transcriptional control,rna-binding protein activity,proliferation promotion,apoptosis inhibition,tumor suppressor function
ENSG00000100342,APOL1,lysosomal function,lipid metabolism regulation,podocyte expression,cellular defense mechanism,membrane trafficking regulation,immune response modulation
ENSG00000147955,SIGMAR1,angiogenesis,cell survival,chemoresistance,chaperone function,dysregulation,oncogenic function
ENSG00000144821,MYH15,cellular homeostasis regulation,tumor aggressiveness enhancement,cell adhesion modulation,tumor progression facilitation,oncogenic process contribution,therapeutic target identification
ENSG00000104723,TUSC3,ribosome biogenesis,translation initiation,tumor suppressor function,dna damage repair,cellular stress response,genomic instability
ENSG00000164252,AGGF1,angiogenic factor,vegf pathway activation,oncogenic driver,tumor growth promotion,metastasis facilitation,therapeutic target
ENSG00000100078,PLA2G3,inflammation modulation,tumor progression,cell proliferation regulation,signaling pathway interaction,oncogene expression,cancer cell migration
ENSG00000144182,LIPT1,lipid metabolism regulation,pi3k/akt pathway modulation,cell growth promotion,tumor survival enhancement,oncogene activation,cancer susceptibility gene
ENSG00000120832,MTERF2,mitochondrial rna processing,genomic instability,apoptosis dysregulation,tumor progression,oxidative stress induction,p53 pathway modulation
ENSG00000002586,CD99,apoptosis regulation,cell migration,gene overexpression,immune evasion,signal transduction,tumor progression
ENSG00000137871,ZNF280D,cellular regulation,transcriptional regulation,zinc finger domain,oncogenic role,tumor progression,genomic amplification
ENSG00000178537,SLC25A20,mitochondrial carrier,electrogenic transport,energy metabolism regulation,cell growth promotion,tca cycle modulation,therapeutic target
ENSG00000153936,HS2ST1,chromatin regulation,methylation of histone h4,epigenetic modifications,dna repair,cell cycle regulation,tumor suppressor or oncogene role
ENSG00000166869,CHP2,escrt-iii complex dysfunction,tumor growth promotion,loss of function mutations,endosomal sorting regulation,multi-vesicular body formation,therapeutic target
ENSG00000164300,SERINC5,tumor suppressor,cell-cell fusion regulation,protein kinase c modulation,pi3k pathway interaction,nedd4l and tp53 interaction,dna damage response regulation
ENSG00000249115,HAUS5,genomic instability,oncogenic signaling,cellular stress response,dna repair regulation,aneuploidy induction,cellular proliferation
ENSG00000275824,CCL4,immunosuppressive microenvironment,angiogenesis promotion,tumor cell migration,chemokine signaling pathway,oncogenic potential,immune evasion
ENSG00000173175,ADCY5,adenylyl cyclase activity,camp regulation,cell proliferation,oncogene function,tumor progression,signaling pathway activation
ENSG00000198121,LPAR1,constitutive activation,cell proliferation,therapeutic target,oncogenesis,g-protein coupled receptor,cell migration
ENSG00000116793,PHTF1,histone modification,transcriptional regulation,oncogene suppression,cell cycle arrest,chromatin remodeling,tumor suppressor function
ENSG00000253958,CLDN23,tumor suppressor function,epithelial cell adhesion,cell-cell junctions,altered expression profile,tight junction maintenance,pan-cancer involvement
ENSG00000140043,PTGR2,antioxidant function,cell proliferation,tumor progression,apoptosis resistance,redox balance regulation,cancer biomarker
ENSG00000120533,ENY2,fatty acid elongation,cell proliferation,lipid metabolism regulation,tumor progression,oncogenic driver,therapeutic target
ENSG00000152683,SLC30A6,zinc homeostasis regulation,cell proliferation enhancement,oncogenic process contribution,cancer progression association,therapeutic target potential,tumor resistance development
ENSG00000145740,SLC30A5,zinc transport regulation,oncogene function,cellular proliferation enhancement,apoptosis modulation,autophagy regulation,protein-protein interaction
ENSG00000147789,ZNF7,transcriptional regulation,tumor suppressor gene regulation,oncoprotein regulation,gene expression modulation,cell proliferation promotion,chromatin modification
ENSG00000100106,TRIOBP,apoptosis regulation,cytoplasmic structure maintenance,tumor suppressor function,rho gtpase interaction,mitogenic signaling modulation,cytoskeletal reorganization
ENSG00000164172,MOCS2,cellular metabolism,molybdenum cofactor biosynthesis,oxidative stress response,cancer cell survival,tumor proliferation,metabolic regulation
ENSG00000163297,ANTXR2,angiogenesis promotion,cell adhesion regulation,genetic amplification,metastasis facilitation,oncogene involvement,tumor progression enhancement
ENSG00000236637,IFNA4,tumor suppressor,immune modulation,cell proliferation inhibition,apoptosis induction,antiviral response,epigenetic regulation
ENSG00000135916,ITM2C,metalloprotease activity,aberrant protein processing,cancer progression,cell proliferation,protein degradation,tumor aggressiveness
ENSG00000175766,EIF4E1B,oncogenic mrna translation,gain of function mutations,tumor progression,therapeutic target,protein synthesis regulation,cap-dependent translation modulation
ENSG00000197044,ZNF441,zinc finger protein,transcriptional regulation,cell growth modulation,apoptosis regulation,cell differentiation control,genome-wide association studies
ENSG00000072182,ASIC4,cellular survival,ion channel regulation,tumor microenvironment,acidic conditions,pro-oncogenic function,signaling pathway interaction
ENSG00000147117,ZNF157,tumor suppression,dna damage response,epigenetic regulation,transcriptional repression,histone modification,genomic instability
ENSG00000116133,DHCR24,cholesterol biosynthesis,cell growth regulation,tumor progression,mtor pathway interaction,biomarker significance,genomic instability
ENSG00000130787,HIP1R,oncogenic processes,disrupted endocytic pathway,cell proliferation regulation,apoptosis resistance,therapeutic target,pi3k/akt pathway interaction
ENSG00000118473,SGIP1,rho gtpase regulation,oncogenic signaling,cell migration promotion,tumor progression facilitation,signaling pathway regulation,gene amplification
ENSG00000164010,ERMAP,er membrane association,oncogenic signaling,cell proliferation regulation,tumor progression,gene expression modulation,protein-protein interaction
ENSG00000183035,CYLC1,cellular metabolism,reactive oxygen species regulation,mitochondrial localization,electron transport chain modulation,tumor growth promotion,oncogene activation
ENSG00000106636,YKT6,vesicle docking,protein sorting,golgi apparatus regulation,cellular morphology changes,tumor progression,secretory pathway alteration
ENSG00000132464,ENAM,amelogenesis imperfecta,abnormal tooth enamel,cell-cell interactions,tumor microenvironment changes,protein-protein interactions,extracellular matrix deposition
ENSG00000007216,SLC13A2,tumor growth enhancement,metastatic potential,glycolytic metabolism,glutamine dependency,cell membrane transport,oncofetal expression
ENSG00000176597,B3GNT5,glycoprotein biosynthesis,overexpression,aberrant glycosylation,tumor progression,pro-tumorigenic microenvironment,cellular signaling
ENSG00000140297,GCNT3,aberrant glycosylation,cancer stem cell maintenance,cell signaling modulation,glycosyltransferase enzyme,oncogenic processes promotion,pi3k/akt pathway regulation
ENSG00000115252,PDE1A,cancer driver,signaling pathway regulation,oncogenesis,cellular proliferation,therapeutic target,genomic instability
ENSG00000148334,PTGES2,prostaglandin e synthesis,oncogenic properties,tumor microenvironment modulation,cell proliferation regulation,therapeutic target,pro-inflammatory mediator
ENSG00000197181,PIWIL2,regulation of gene expression,epigenetic processes,oncogene potential,cell survival and proliferation,stem cell regulation,metastatic potential
ENSG00000103037,SETD6,chromatin regulation,oncogenic activity,histone methylation,tumor suppressor degradation,gene expression modulation,epigenetic control
ENSG00000127663,KDM4B,histone demethylase activity,tumor suppressor function,lysine residue modification,epigenetic regulation,cell growth promotion,cancer driver gene
ENSG00000142784,WDTC1,cell cycle regulation,tumor suppression,g2/m checkpoint modulation,dna damage response modulation,protein-protein interactions,oncogenic potential
ENSG00000158161,EYA3,transcriptional regulation,cell proliferation,apoptosis inhibition,oncogenic transformation,tumor progression,constitutive activation
ENSG00000197123,ZNF679,oncogenic potential,transcriptional regulation,cell proliferation enhancement,tumor progression,therapeutic target,dna damage response
ENSG00000177156,TALDO1,metabolic reprogramming,glycolytic shift,nadph generation,pentose phosphate pathway activation,cancer cell metabolism,therapeutic target
ENSG00000119681,LTBP2,tgf-β pathway,angiogenesis,cell migration,apoptosis regulation,extracellular matrix production,latent complex formation
ENSG00000102595,UGGT2,er-associated protein degradation pathway,cellular stress response modulation,glycoprotein quality control,protein folding regulation,cell growth and proliferation regulation,apoptosis suppression
ENSG00000144029,MRPS5,mitochondrial translation,enhanced cell growth,upregulated expression,cellular energy metabolism,mitochondrial biogenesis,stress response regulation
ENSG00000166435,XRRA1,dna damage response,genomic instability,homologous recombination,cell cycle regulation,tumor suppressor function,genetic mutation prevention
ENSG00000134216,CHIA,chromatin remodeling,tumor suppression,oncogenic interaction,dna repair regulation,cell cycle progression modulation,nuclear protein function
ENSG00000077254,USP33,pi3k/akt pathway regulation,tumor cell proliferation,immune response inhibition,cell cycle regulation,apoptosis suppression,emt induction
ENSG00000196611,MMP1,tumor metastasis,ecm degradation,cell invasion,angiogenesis,inflammation regulation,tissue remodeling
ENSG00000170619,COMMD5,protein degradation regulation,signaling pathway modulation,cell proliferation promotion,tumor progression facilitation,ubiquitination regulation,cell migration enhancement
ENSG00000103316,CRYM,mitochondrial protection,protein folding regulation,redox balance maintenance,oxidative stress induction,tumor progression promotion,therapeutic target potential
ENSG00000080618,CPB2,cell adhesion modulation,protein processing regulation,tumor growth promotion,metastasis facilitation,oncogenic modification,proteolytic activity
ENSG00000137251,TINAG,pi3k/akt pathway interaction,oncogenic potential,apoptosis regulation,cell proliferation modulation,metastasis promotion,therapeutic target
ENSG00000171421,MRPL36,ribosomal function,constitutive activation,altered translation efficiency,mtor pathway regulation,cellular homeostasis disruption,oncogenic transformation
ENSG00000120093,HOXB3,transcription factor regulation,epithelial-to-mesenchymal transition,cell proliferation,oncogenesis,signal transduction modulation,wnt/β-catenin pathway interaction
,H1FOO,histone modification,chromatin condensation,cell cycle regulation,apoptosis modulation,gene expression regulation,embryonic development
ENSG00000142556,ZNF614,transcriptional regulation,oncogene activation,cell proliferation,apoptosis inhibition,metastatic potential enhancement,tumor suppressor interaction
ENSG00000131871,SELENOS,genomic instability,dna repair regulation,oncogenesis,cellular interaction,apoptosis regulation,tumor suppression
ENSG00000165300,SLITRK5,tumor suppressor function,cell proliferation inhibition,pi3k/akt pathway inhibition,metastasis regulation,poor prognosis association,apoptosis induction
ENSG00000178700,DHFR2,tumor metabolism,cell proliferation,dna synthesis,therapeutic target,metabolic reprogramming,one-carbon metabolism
ENSG00000083544,TDRD3,tumor suppressor activity,rna metabolism regulation,genomic stability maintenance,cell proliferation inhibition,oncogene downregulation,ribonucleoprotein granule formation
ENSG00000277363,SRCIN1,oncogenic transformation,metastatic potential,cell migration,therapeutic target,phosphorylation regulation,protein kinase activation
ENSG00000149972,CNTN5,cell adhesion disruption,metastasis promotion,cell migration regulation,tumor progression facilitation,signaling pathway interaction,genomic instability association
ENSG00000126500,FLRT1,wnt/β-catenin pathway regulation,cell signaling modulation,axon guidance and migration regulation,tumor progression and metastasis association,cancer cell proliferation enhancement,cell adhesion molecule interaction
ENSG00000197616,MYH6,oncogenic potential,overexpression,cell proliferation,metastasis,muscle contraction regulation,signaling pathway activation
ENSG00000055211,GINM1,chromosomal instability,cell cycle regulation,oncogene activation,mitosis regulation,genomic instability,poor prognosis indicator
ENSG00000013306,SLC25A39,mitochondrial carrier,metabolic regulation,apoptosis suppression,cell metabolism,nutrient uptake,tumor growth support
ENSG00000169116,PARM1,apoptosis regulator,cell cycle progression,dna damage response,oncogene interaction,tumor suppressor regulation,cytoskeleton organization
ENSG00000205659,LIN52,telomerase regulation,tumor suppressor function,cell proliferation regulation,shelterin complex interaction,cancer cell survival factor,pi3k/akt pathway modulation
ENSG00000198554,WDHD1,g2/m checkpoint modulation,cell cycle regulation,genomic instability facilitation,apoptosis evasion,transcriptional regulation,chromatin remodeling
ENSG00000105732,ZNF574,transcription factor activity,epigenetic regulation,cancer driver gene,cell cycle regulation,apoptosis inhibition,emt induction
ENSG00000119614,VSX2,oncogenic transcription factor,epithelial-to-mesenchymal transition,wnt/β-catenin pathway activation,chemo-resistance,cell proliferation regulation,tumor growth promotion
ENSG00000144218,AFF3,transcriptional regulation,oncogene activation,tumorigenesis promotion,cell cycle progression,apoptosis inhibition,chromatin modification
ENSG00000102387,TAF7L,genomic instability,homologous recombination repair,cell cycle regulation,transcriptional regulation,dna damage response,genome maintenance
ENSG00000176102,CSTF3,rna-binding protein,constitutive activation,splice site recognition,cell proliferation,apoptosis resistance,tumor metastasis
ENSG00000001561,ENPP4,nucleotide sugar regulation,sirtuin activity modulation,tumor cell survival promotion,metabolic reprogramming,cell signaling pathway interaction,oncogenic protein overexpression
ENSG00000159322,ADPGK,hexokinase 2 interaction,glycogen metabolism,altered glucose uptake,metabolic reprogramming,tumor adaptation,oncogenic mutations
,TWISTNB,cancer stem cells,cell migration,epithelial-to-mesenchymal transition,transcription factor regulation,oncogenic reactivation,tumor progression
ENSG00000133424,LARGE1,pi3k/akt pathway,tumor growth,cell migration,apoptosis resistance,oncogene potential,extracellular matrix regulation
ENSG00000141429,GALNT1,tumor progression,oncogenic driver,altered glycosylation patterns,metastasis promoter,cell adhesion regulator,glycoprotein modification
ENSG00000152495,CAMK4,cell cycle regulation,aberrant expression,apoptosis inhibition,dna repair modulation,phosphorylation activation,pi3k/akt pathway interaction
ENSG00000112394,SLC16A10,tumor metabolism,lactate transport,warburg effect,anaerobic glycolysis,cell proliferation,metabolic adaptation
ENSG00000197106,SLC6A17,neurotransmitter transport,transmembrane protein,cellular signaling pathways,transport regulation,cellular membrane,protein expression
ENSG00000176399,DMRTA1,regulation of emt,epithelial-to-mesenchymal transition,cancer stem cell maintenance,wnt/β-catenin signaling pathway modulation,oncogenic transcription factor regulation,cell proliferation regulation
ENSG00000160445,ZER1,mirna regulation,apoptosis regulation,cell cycle progression,transcriptional regulation,protein stability,cancer biomarker
ENSG00000135763,URB2,cellular regulation,dysregulated ubiquitination,enhanced cell proliferation,oncogenic processes,cell survival modulation,metastatic influence
ENSG00000162892,IL24,tumor suppression,apoptosis induction,cell proliferation inhibition,anti-tumor activity,signaling pathway modulation,immune response regulation
ENSG00000134153,EMC7,er stress response,regulation of protein synthesis,cellular homeostasis,altered expression levels,metabolic regulation,translation initiation
ENSG00000125675,GRIA3,neurotransmitter regulation,tumor progression,cellular metabolism alteration,gene expression dysregulation,protein-protein interaction,oncogene activation
ENSG00000136378,ADAMTS7,tumor progression,angiogenesis regulation,tumor growth promotion,metastasis facilitation,proliferation regulation,extracellular matrix remodeling
ENSG00000114450,GNB4,heterotrimeric g-protein complex,gβ4 subunit,signal transduction,cell proliferation,cell survival,metastasis promotion
ENSG00000153721,CNKSR3,pi3k/akt pathway regulation,tumor growth promotion,cancer cell survival enhancement,apoptosis inhibition,cell cycle progression regulation,cytokinesis modulation
ENSG00000116786,PLEKHM2,endosomal trafficking regulation,autophagy regulation,lysosome function regulation,cell proliferation promotion,tumor cell survival enhancement,cancer progression association
ENSG00000116747,RO60,apoptosis regulation,tumor suppressor function,pro-apoptotic activity,dna repair regulation,transcriptional modulation,cell cycle progression
ENSG00000129990,SYT5,oncogenic signaling,pi3k/akt pathway interaction,overexpression in cancer,membrane trafficking regulation,calcium-dependent function,tumor progression promotion
ENSG00000197150,ABCB8,multidrug resistance,cellular detoxification,drug efflux mechanism,tumor progression,apoptosis regulation,autophagy modulation
ENSG00000047597,XK,nuclear transport,cellular import,protein-rna interaction,cell cycle regulation,genome stability,transcriptional control
ENSG00000135519,KCNH3,oncogenic potential,voltage-gated potassium channel regulation,cell proliferation,tumor invasion,metastasis promotion,poor prognosis indicator
ENSG00000160781,PAQR6,transcriptional regulation,cell growth promotion,oncogenic behavior promotion,apoptosis inhibition,cell cycle regulation,nuclear receptor function
ENSG00000169251,NMD3,ribosome biogenesis,tumor progression,dysregulation of ribosome synthesis,cell survival and proliferation,genomic instability,therapeutic target
ENSG00000173918,C1QTNF1,complement activation,immune regulation,cell adhesion,tumor progression,oncogenesis,genomic instability
ENSG00000133466,C1QTNF6,metabolic regulation,gene expression alteration,tumor progression,tissue metastasis,protein-protein interaction,lipid metabolism
ENSG00000122585,NPY,angiogenesis,immune evasion,inflammation,neurotransmission,tumor growth,vasodilation
ENSG00000176209,SMIM19,mitochondrial localization,oxidative phosphorylation regulation,apoptosis regulation,cellular metabolism modulation,tumor suppressor activity,overexpression in cancers
ENSG00000188991,SLC15A5,cellular proliferation,peptide transport,nutrient uptake,tumor progression,therapeutic target,gene expression regulation
ENSG00000161904,LEMD2,pi3k/akt pathway interaction,transmembrane protein function,cancer progression influence,epithelial-to-mesenchymal transition regulation,angiogenesis modulation,oncogene potential
ENSG00000103449,SALL1,tumor suppressor function,transcriptional regulation,cellular differentiation,apoptosis regulation,chromatin remodeling,embryonic development
ENSG00000102393,GLA,galactose-containing lipid accumulation,tumor progression,cancer cell survival,oxidative stress,cell membrane dynamics,genomic instability
ENSG00000066827,ZFAT,transcriptional regulation,cell cycle control,apoptosis regulation,tumor suppression,oncogenesis facilitation,genetic instability
ENSG00000117477,CCDC181,coiled-coil domain,oncogene,cell proliferation,protein-protein interactions,tumor suppressor regulation,cancer metastasis
ENSG00000156521,TYSND1,tumor suppressor dysfunction,genomic instability,cellular reprogramming,oncogenic driver mutation,protein-protein interaction dysregulation,transcriptional regulation alteration
ENSG00000147912,FBXO10,cell cycle regulation,cancer driver mutation,growth factor signaling,protein degradation pathway,tumor suppressor dysregulation,cell proliferation enhancement
ENSG00000129151,BBOX1,chromatin remodeling,tumor suppressor function,cell cycle regulation,dna repair mechanism,transcriptional regulation,oncogenic protein
ENSG00000148219,ASTN2,adhesion molecule,metastasis promoter,cell migration enhancer,tumor progression factor,pancreatic cancer driver,therapeutic target
ENSG00000182983,ZNF662,gene regulation,transcriptional repressor,cell proliferation,tumor suppressor,dna binding,signal transduction
ENSG00000130558,OLFM1,epithelial-to-mesenchymal transition (emt),cell adhesion disruption,loss of tumor suppressor function,regulation of cellular migration,protein-protein interaction partner,gene expression modulation
ENSG00000132681,ATP1A4,na+/k+ transport,oncogenic transformation,tumor progression,cell signaling disruption,gene expression alteration,therapeutic target
ENSG00000126545,CSN1S1,ubiquitin-proteasome pathway,protein modification,cell cycle regulation,tumor suppressor degradation,cancer therapy target,gene expression regulation
ENSG00000018625,ATP1A2,ion channel regulation,tumor progression,cellular homeostasis disruption,proliferation and survival modulation,sodium-potassium pump dysfunction,cancer-associated mutations
ENSG00000163923,RPL39L,mitochondrial ribosomal protein,enhanced cellular proliferation,potential oncogene,poor prognosis marker,reduced overall survival,cellular growth regulation
ENSG00000126217,MCF2L,cellular regulation,tumor progression,oncogenic driver,signaling pathway modulation,genomic mutation hotspot,protein-protein interaction
ENSG00000160991,ORAI2,calcium channel regulation,dysregulated expression,oncogenic properties,cell proliferation enhancement,ca++ influx modulation,therapeutic target
ENSG00000141873,SLC39A3,zinc transporter,tumor progression,genome stability maintenance,apoptosis regulation,cellular metabolism modulation,therapeutic target candidate
ENSG00000168944,CEP120,microtubule regulation,mitotic spindle assembly,centrosomal protein interaction,cell cycle checkpoint disruption,genomic instability induction,oncogenic potential
ENSG00000105136,ZNF419,transcriptional regulation,zinc finger protein,oncogene function,cell proliferation enhancement,dna damage response,genomic instability
ENSG00000067533,RRP15,ribosome biogenesis regulation,tumor progression,oncogenic driver,cell survival promotion,apoptosis suppression,tumor microenvironment modulation
ENSG00000129128,SPCS3,proteasome regulation,cellular stress response,aberrant protein accumulation,oncogenic protein stabilization,therapeutic target,cancer aggressiveness
ENSG00000145075,CCDC39,centriole regulation,cilia formation,genomic instability,microtubule dynamics,mitotic progression,oncogenic transformation
ENSG00000172766,NAA16,chromatin remodeling,transcriptional regulation,histone acetylation,oncogene,tumor progression,chromatin modification
ENSG00000182759,MAFA,tumor suppressor,cell cycle regulation,dna damage response,transcriptional regulation,apoptosis induction,pancreas development
ENSG00000128394,APOBEC3F,dna deamination,genomic instability,tumor suppressor mutation,oncogenic activation,tumor microenvironment,immune evasion
ENSG00000066926,FECH,iron homeostasis alteration,heme biosynthesis dysregulation,erythropoietic protoporphyria association,oxidative stress regulation,cell metabolism alteration,genetic mutation implication
ENSG00000156531,PHF6,chromatin remodeling,transcriptional regulation,tumor suppression,prc2 interaction,histone modifications,cell growth modulation
ENSG00000164742,ADCY1,oncogenic transformation,signal transduction pathway,cell proliferation regulation,second messenger camp,pka activation,tumorigenesis association
ENSG00000198092,TMPRSS11F,tumor-promoting microenvironment,immune response modulation,protease activity regulation,cell signaling pathway activation,oncogenic process driving,epithelial cell expression
ENSG00000183576,SETD3,histone methylation,chromatin regulation,oncogene overexpression,tumorigenesis promotion,transcriptional regulation,apoptosis suppression
ENSG00000130881,LRP3,wnt/β-catenin pathway,constitutive activation,tumor progression,inflammatory response regulation,glycoprotein function,transmembrane receptor
ENSG00000186684,CYP27C1,cholesterol regulation,anti-tumor activity,lipid metabolism,redox balance,oxidative stress,drug resistance
ENSG00000205358,MT1H,cellular stress response,apoptosis regulation,cancer development,tumor suppressor,oncogene interaction,dna damage repair
ENSG00000134825,TMEM258,cell-cell interaction disruption,tumor progression,metastasis facilitation,protein-protein interaction,gene expression dysregulation,cancer prognosis impact
ENSG00000112294,ALDH5A1,mitochondrial localization,oxidation of short-chain aldehydes,aldehyde detoxification,chemoresistance mechanism,tumor progression association,metabolic regulation interaction
ENSG00000056291,NPFFR2,oncogene activation,cell proliferation enhancement,metastasis promotion,tumor progression facilitation,receptor overexpression,pain modulation dysregulation
ENSG00000130700,GATA5,genetic instability,transcriptional dysregulation,cell proliferation,tumor growth,apoptosis evasion,dna repair impairment
ENSG00000148498,PARD3,tumor progression,cell polarity regulation,wnt/β-catenin pathway activation,oncogenic protein interaction,cancer cell proliferation,epithelial-to-mesenchymal transition
ENSG00000166557,TMED3,erad pathway regulation,cellular proteostasis modulation,oncogenic protein trafficking,cell proliferation enhancement,protein secretion regulation,tumor suppressor function
ENSG00000198924,DCLRE1A,genomic instability,mutation frequency,tumor suppressor,non-homologous end joining (nhej),dna repair,chromosomal rearrangements
ENSG00000253710,ALG11,dysregulated glycosylation,aberrant glycan structures,tumor progression,therapeutic target,cell migration,glycoprotein modification
ENSG00000129038,LOXL1,elastin cross-linking,lysyl oxidase activity,extracellular matrix remodeling,cell adhesion disruption,tumor growth promotion,epigenetic regulation
ENSG00000143536,CRNN,calpain activity,oncogenic signaling pathway,cell proliferation regulation,tumor invasion,metastasis facilitation,proteolytic activity
ENSG00000261456,TUBB8,microtubule dynamics,cell division,axonal transport,neurofilament bundling,oncogenic processes,tumor progression
ENSG00000168802,CHTF8,genomic instability,dna replication,cell cycle regulation,chromatin remodeling,oncogenic processes,tumorigenesis
ENSG00000110841,PPFIBP1,pi3k/pten pathway regulation,tumor progression,cell survival enhancement,metastasis facilitation,signaling pathway activation,cell cycle regulation
ENSG00000112053,SLC26A8,loss of function mutations,growth factor signaling,cellular ph regulation,tumor progression,tissue invasion,genomic instability
ENSG00000175832,ETV4,oncogene,transcriptional regulation,cell proliferation,epithelial-to-mesenchymal transition,therapeutic target,signaling pathway modulation
ENSG00000101638,ST8SIA5,psa synthesis,cell surface modification,glycosylation regulation,epithelial-to-mesenchymal transition (emt),prognostic marker,pi3k/akt signaling interaction
ENSG00000111199,TRPV4,mechanosensitive ion channel,calcium influx regulation,promotes cell proliferation,tumor progression,enhances metastasis,therapeutic target
ENSG00000198829,SUCNR1,angiogenesis regulation,constitutive activation,dysregulated expression,g protein-coupled receptor function,modulation of vegf expression,tumor progression driver
ENSG00000214872,SMTNL1,microtubule stability,cell division regulation,oncogenic driver,kinase-phosphatase interaction,tumor progression,microtubule dynamics regulator
ENSG00000168734,PKIG,pkig signaling,oncogenic activity,cell proliferation,signaling pathway regulation,cell survival promotion,therapeutic target
ENSG00000188290,HES4,transcriptional repression,cell cycle progression,cellular proliferation,apoptosis suppression,gene expression modulation,epigenetic regulation
ENSG00000141200,KIF2B,microtubule dynamics,mitosis regulation,tumor progression,genomic instability,cell proliferation,chromatin remodeling
ENSG00000181019,NQO1,antioxidant defense,detoxification of carcinogens,cell signaling regulation,apoptosis regulation,tumor aggressiveness,chemotherapy resistance
ENSG00000161671,EMC10,erad dysfunction,cell cycle regulation,dna repair defects,mitochondrial dysfunction,cancer driver mutation,tumor suppressor gene
ENSG00000255529,POLR2M,transcriptional regulation,gene expression dysregulation,chromatin remodeling,cell proliferation enhancement,tumor development facilitation,therapeutic resistance promotion
ENSG00000183773,AIFM3,genomic instability,oncogenesis,apoptosis regulation,cellular redox balance,dna repair mechanisms,mitochondrial function
ENSG00000002726,AOC1,cellular invasion,cell migration,oxidative stress response,tumor progression,protein-protein interactions,redox regulation
ENSG00000197721,CR1L,complement system modulation,immune evasion mechanisms,tumor progression enhancement,cell proliferation promotion,protein interaction regulation,signaling pathway modulation
ENSG00000114805,PLCH1,pi3k/akt pathway activation,cell signaling regulation,calcium homeostasis disruption,tumor suppression role,pro-survival gene upregulation,oncogenic process promotion
ENSG00000196214,ZNF766,tumor suppressor/oncogene,cellular regulation,gene expression regulation,wnt/β-catenin signaling pathway,apoptosis modulation,biomarker potential
ENSG00000196967,ZNF585A,chromatin remodeling,oncogene activation,dna-binding activity,tumor progression,cell cycle regulation,gene expression modulation
ENSG00000123594,ATXN3L,transcriptional regulation,cell cycle progression,chromatin remodeling,apoptosis regulation,protein-protein interactions,cellular mechanisms
ENSG00000198551,ZNF627,transcriptional regulation,gene expression modulation,oncogenic properties,cell proliferation promotion,apoptosis inhibition,zinc finger protein interaction
ENSG00000151151,IPMK,constitutive activation,gain of function mutations,enhanced cell survival,promotion of oncogenesis,tumor progression,regulation of cellular homeostasis
ENSG00000107815,TWNK,mitochondrial dysfunction,genomic instability,apoptosis evasion,cellular stress response,oncogenic mutation,autophagy dysregulation
ENSG00000142279,WTIP,chromatin remodeling,transcription regulation,cell growth regulation,tumor suppressor function,mutation hotspot,oncogene activation
ENSG00000230797,YY2,cell cycle regulation,genomic stability maintenance,dna repair modulation,tumor progression promoter,transcriptional regulator,oncogenic driver
ENSG00000255974,CYP2A6,cancer susceptibility,xenobiotic metabolism,nicotine detoxification,genetic variation,cancer risk modifier,therapeutic target
ENSG00000158435,CNOT11,pi3k/akt signaling,apoptosis regulation,cell cycle progression,mrna degradation regulation,tumor progression,transcriptional regulation
ENSG00000163394,CCKAR,g protein-coupled receptor activation,cell proliferation promotion,tumor growth facilitation,metastasis enhancement,mapk/erk pathway activation,appetite regulation disruption
ENSG00000160602,NEK8,mitotic checkpoint,centrosome regulation,cell cycle regulation,genome stability maintenance,tumor suppressor function,protein kinase activation
ENSG00000135974,C2orf49,cellular regulation,tumor progression,gene amplification,oncogenic processes,prognostic marker,aggressive tumor behavior
ENSG00000183044,ABAT,tumor progression,immunosuppression,cellular catabolism,amino acid depletion,kynurenine pathway,enzyme activity
ENSG00000176153,GPX2,glutathione peroxidase activity,epithelial cell expression,oxidative stress modulation,cell survival and proliferation,tumor progression marker,redox balance regulation
ENSG00000032444,PNPLA6,lipid metabolism regulation,autophagy dysregulation,oncogene function,cell signaling modulation,tumor progression,lipid droplet formation
ENSG00000140835,CHST4,cell signaling pathway,chondroitin sulfate biosynthesis,tumor suppressor/oncogene,cell proliferation regulation,apoptosis modulation,mutation biomarker
ENSG00000196090,PTPRT,cellular adhesion regulation,tumor suppressor activity,receptor-type protein tyrosine phosphatase,signal transduction modulation,protein interaction with integrins,gene expression dysregulation
ENSG00000166743,ACSM1,enhanced lipid metabolism,fatty acid oxidation,cellular energy production,cell proliferation,tumor progression,metabolic reprogramming
ENSG00000100852,ARHGAP5,rho gtpase regulation,tumor suppressor function,cell migration regulation,metastasis promotion,signaling pathway modulation,cancer prognosis marker
ENSG00000116014,KISS1R,tumor progression,oncogenic potential,hormonal regulation disruption,reproductive axis dysregulation,cell proliferation promotion,cancer stem cell maintenance
ENSG00000123505,AMD1,histone modification,chromatin relaxation,gene expression regulation,therapeutic target,cancer progression,prognostic biomarker
ENSG00000104313,EYA1,oncogene activation,transcriptional regulation,cellular proliferation,tumor progression,wnt/β-catenin signaling,growth factor regulation
ENSG00000228628,ATF6B,endoplasmic reticulum stress,transcription factor activation,cell survival regulation,oncogenesis promotion,tumor suppressor function,autoregulatory feedback loop
ENSG00000186517,ARHGAP30,gtpase activation,cell migration,cytoskeleton regulation,tumor progression,epithelial-to-mesenchymal transition,pi3k/akt pathway interaction
ENSG00000110921,MVK,mevalonate pathway,oncogenic regulation,gain of function mutations,cancer stem cell maintenance,epithelial-to-mesenchymal transition (emt),prenylation modification
ENSG00000048740,CELF2,tumor promoter,cell survival regulation,post-transcriptional regulation,oncogene function,cancer metastasis facilitation,splicing regulation
ENSG00000146192,FGD2,rho gtpase activation,gef activity,oncogenic function,cell migration regulation,cancer progression,adhesion and motility
ENSG00000053747,LAMA3,basal lamina formation,cell adhesion and migration,integrin interaction,tumor progression and metastasis,pi3k/akt pathway activation,extracellular matrix modulation
ENSG00000163207,IVL,cellular adhesion,tumor suppression,epidermal barrier formation,protein cross-linking,keratin filament assembly,genetic mutation
ENSG00000275718,CCL15,immune suppression,tumor microenvironment,cell migration,adhesion molecule,chemokine signaling,inflammation regulation
ENSG00000167862,MRPL58,mitochondrial translation regulation,oncogenic overexpression,cellular metabolism enhancement,tumor growth promotion,metastasis facilitation,genomic instability induction
ENSG00000158623,COPG2,ubiquitination regulation,proteasomal degradation inhibition,oncogene stabilization,cell cycle progression,transcription factor activation,tumor suppressor downregulation
ENSG00000011426,ANLN,mitosis regulation,cytokinesis dysregulation,genomic instability,cell proliferation driver,cancer progression,mitotic spindle formation
ENSG00000143341,HMCN1,cell migration,cell proliferation,tumor microenvironment,extracellular matrix regulation,glycosaminoglycan binding,oncogenic process
ENSG00000181619,GPR135,g protein-coupled signaling pathway,cellular chemotaxis regulation,src kinase interaction,pi3k activation pathway,tumor microenvironment remodeling,oncogenic driver mutation
ENSG00000185085,INTS5,transcriptional regulation,tumor progression,genomic instability,cell proliferation,dna damage response,gene expression regulation
ENSG00000077147,TM9SF3,tm9sf3 mutations,cell signaling pathways,oncogenic behaviors,protein localization,endocytosis regulation,therapeutic target
ENSG00000143494,VASH2,tumor progression,immune evasion,cell adhesion regulation,cancer immunology,immune checkpoint regulation,genetic variation analysis
ENSG00000162998,FRZB,wnt signaling inhibition,tumor progression facilitation,cell migration enhancement,glycoprotein function,microenvironment modulation,canonical pathway disruption
ENSG00000111046,MYF6,tumor suppressor inhibition,cell cycle regulation disruption,transcriptional repression,proliferation promotion,metastasis facilitation,prognostic marker
ENSG00000058063,ATP11B,ion transport,multidrug resistance,apoptosis modulation,copper ion homeostasis,efflux pump regulation,cell cycle control
ENSG00000113196,HAND1,regulation of cell differentiation,transcriptional regulation,interaction with transcription factors,oncogenic roles,tumor progression,chromosomal location
ENSG00000143252,SDHC,mitochondrial function,metabolic reprogramming,reactive oxygen species (ros),tumorigenesis,cellular metabolism regulation,energetic imbalance
ENSG00000130529,TRPM4,trpm4 channel regulation,calcium influx modulation,cell proliferation enhancement,oncogenic signaling pathway activation,tumorigenesis association,apoptosis inhibition
ENSG00000102230,PCYT1B,cellular membrane structure,phosphatidylcholine synthesis,bile salt metabolism,detoxification process,cell growth regulation,oncogenic driver
ENSG00000005206,SPPL2B,notch signaling,cell proliferation,oncogenic processes,therapeutic target,secretory protein,cell fate decisions
ENSG00000177666,PNPLA2,lipid metabolism regulation,altered lipid droplet formation,cellular energy homeostasis disruption,biomarker potential,therapeutic target possibility,tumor microenvironment modulation
ENSG00000071859,FAM50A,homologous recombination,tumor suppressor function,pre-mrna processing regulation,genome integrity maintenance,cellular proliferation regulation,transcriptional regulation
ENSG00000128242,GAL3ST1,metabolic reprogramming,oncogenic driver,galactose metabolism regulation,cellular stress response,enhanced cell growth,cancer cell survival
ENSG00000262860,LSM14A,spliceosome regulation,tumor progression,mutation hotspot,genetic instability,rna processing,pre-mrna splicing
ENSG00000074603,DPP8,proteolytic activity,cell proliferation,oncogenic processes,metastasis,tumor growth,pi3k/akt signaling
ENSG00000181072,CHRM2,g-protein coupled receptor activation,cholinergic signaling pathway,cell proliferation regulation,tumor progression modulation,apoptosis modulation,oncogenic potential
ENSG00000149021,SCGB1A1,altered expression,cell survival modulation,cell cycle regulation,dna damage response,oncogenic adaptation,stress response regulation
ENSG00000160326,SLC2A6,enhanced glycolysis,glucose transporter function,oncogenic process,metastasis promotion,aggressive phenotype,warburg effect
ENSG00000171865,RNASEH1,genomic instability,dna repair mechanism,ber pathway dysfunction,tumor suppressor role,oncogenic potential,cellular metabolism
ENSG00000143157,POGK,genomic instability,homologous recombination,dna damage response,genome maintenance,oncogenic mutations,tumor suppression
ENSG00000170615,SLC26A5,slc26a5 regulation,cellular ph modulation,tumor progression,ion balance disruption,therapeutic target,prognostic biomarker
ENSG00000166847,DCTN5,microtubule regulation,dynactin complex,genomic instability,tumorigenesis,cell migration,cancer cell survival
ENSG00000043355,ZIC2,oncogenic transcription factor,transcription regulation,cell proliferation,epithelial-to-mesenchymal transition (emt),tumorigenesis,developmental gene expression regulator
ENSG00000181652,ATG9B,autophagic flux modulation,cellular homeostasis regulation,oncogenic protein overexpression,cancer cell survival enhancement,therapeutic target identification,genomic profiling in cancer biology
ENSG00000163914,RHO,cell migration,oncogenic process,metastasis promotion,cytoskeleton regulation,apoptosis inhibition,tumor progression
ENSG00000168538,TRAPPC11,trapp complex regulation,pro-survival signaling,mutations in pan-cancer,cellular proliferation,vesicular transport,therapeutic target
ENSG00000111319,SCNN1A,ion transport dysregulation,epithelial-to-mesenchymal transition,tumor progression,increased cell proliferation,altered microenvironment modulation,therapeutic resistance
ENSG00000163995,ABLIM2,microtubule stabilization,actin filament dynamics,tumor progression,metastasis promotion,epithelial-to-mesenchymal transition (emt) regulation,cell adhesion modulation
ENSG00000136051,WASHC4,endocytic regulation,oncogenic effects,cell growth promotion,clathrin-coated vesicle formation,tumor progression,therapeutic target
ENSG00000140263,SORD,metabolic reprogramming,glycolytic enhancement,oxidative stress regulation,tumor progression,cell survival modulation,warburg effect promotion
ENSG00000152439,ZNF773,gene regulation,dna binding,cell proliferation,tumor suppression,transcriptional modulation,oncogene regulation
ENSG00000129951,PLPPR3,pi3k/akt pathway,dephosphorylation activity,oncogenic transformation,enhanced cell proliferation,metabolic reprogramming,cell cycle regulation
ENSG00000179751,SYCN,synaptic regulation,cell survival promotion,oncogenic mutations,tumor migration facilitation,neuronal activity modulation,genetic instability induction
ENSG00000187714,SLC18A3,neurotransmitter transport,cell proliferation,therapeutic target,oncogene overexpression,signaling pathway regulation,cancer cell survival
ENSG00000165383,LRRC18,cellular migration,protein-protein interactions,cell adhesion,enhanced invasiveness,cancer progression,tumor morphology
ENSG00000049246,PER3,transcriptional regulation,circadian rhythm disruption,cell cycle regulation,dna damage response,genomic instability,protein-protein interactions
ENSG00000129657,SEC14L1,phospholipid metabolism,pi3k/akt signaling,tumor progression,oncogenic driver,therapeutic resistance,metastasis regulation
ENSG00000275013,PRAME,tumor antigen,cell surface expression,pi3k/akt pathway regulation,oncogene/tumor suppressor duality,immunotherapy target,genomic profiling alteration
ENSG00000130643,CALY,cell cycle regulation,kinase activity,phosphorylation,oncogenic transformation,genomic instability,cell proliferation
ENSG00000031003,FAM13B,genomic instability,cell cycle regulation,chromosomal segregation,cytokinesis,protein-protein interaction,cell proliferation
ENSG00000110675,ELMOD1,regulation of endocytosis,constitutive activation,tumor progression,biomarker potential,pi3k/akt pathway modulation,ras/raf/mek/mapk signaling interaction
ENSG00000148600,CDHR1,cell adhesion molecule,overexpressed in tumors,epithelial-to-mesenchymal transition,cell migration regulator,invasion suppressor,cancer metastasis promoter
ENSG00000082515,MRPL22,mitochondrial ribosome biogenesis,constitutive activation,gain of function mutations,tumor progression,therapeutic target,biomarker expression
ENSG00000282891,STATH,microtubule regulation,cancer cell proliferation,anti-apoptotic function,cell cycle progression,prognostic marker,tumor invasiveness
ENSG00000076258,FMO4,redox regulation,metabolic regulation,xenobiotic metabolism,cellular signaling,dna damage prevention,tumor suppression
ENSG00000197565,COL4A6,tissue integrity,genetic alterations,cell adhesion disruptions,metastasis promotion,therapeutic target potential,structural component role
ENSG00000133247,KMT5C,epigenetic regulation,histone methylation,tumor suppressor,dna repair,cell cycle progression,genome stability
ENSG00000177106,EPS8L2,egfr signaling,tumor progression,oncogenic pathway,cell proliferation,metastasis,ras/raf/mapk pathway
ENSG00000157734,SNX22,regulation of cell growth,endosomal trafficking,membrane budding,pdz domain interactions,small gtpase regulation,tumor suppression
ENSG00000162630,B3GALT2,oncogenic potential,cell proliferation enhancement,tumor progression facilitation,wnt/β-catenin pathway interaction,glycosaminoglycan biosynthesis involvement,proteoglycan modification role
ENSG00000128710,HOXD10,transcriptional regulation,tumor suppressor function,cell differentiation,oncogenesis promotion,cell proliferation inhibition,genomic instability
ENSG00000105808,RASA4,gain of function mutations,cell proliferation,signaling pathway regulation,loss of function mutations,tumor progression,rasgap domain
ENSG00000173436,MICOS10,mitochondrial dynamics,tumor growth promotion,fatty acid metabolism regulation,cellular energy production modulation,cancer progression association,biomarker potential
ENSG00000168564,CDKN2AIP,cell cycle regulation,g1 phase progression inhibition,cdk4/6 interaction,tumor suppressor function loss,oncogenic activity enhancement,cell proliferation promotion
ENSG00000151474,FRMD4A,rock regulatory protein,gain-of-function mutations,constitutive activation,tumor progression,metastasis enhancement,rho gtpase interaction
ENSG00000134313,KIDINS220,cellular proliferation,regulation of pi3k/akt signaling,serine/threonine kinase activity,tumor progression,protein-protein interaction,oncogenic transformation
ENSG00000136715,SAP130,prc1 complex,epigenetic regulation,cell cycle progression,tumor suppressor gene silencing,genomic stability disruption,therapeutic target
ENSG00000130821,SLC6A8,energy metabolism regulation,glycolysis modulation,potassium transporter function,sodium symporter activity,mct1 expression alteration,cancer metabolic reprogramming
ENSG00000167588,GPD1,glycerol-3-phosphate dehydrogenase,lipid metabolism regulation,cell proliferation promotion,antioxidant activity,therapeutic target identification,metabolic regulation alteration
ENSG00000166676,TVP23A,genomic instability,dna replication facilitation,cell proliferation promotion,apoptosis resistance,oncogenic pathway activation,pi3k/akt signaling interaction
ENSG00000134644,PUM1,post-transcriptional regulation,tumor suppressor function,mirna-mediated gene silencing,cell cycle regulation,oncogenic pathway interaction,protein-protein interactions
ENSG00000139151,PLCZ1,constitutive activation,pi3k/akt pathway,oncogene function,protein kinase activation,signaling pathway modulation,cell proliferation enhancement
ENSG00000111254,AKAP3,cellular proliferation,signaling pathway regulation,protein kinase anchoring,tumor progression,metastasis promotion,therapeutic target
ENSG00000005471,ABCB4,drug efflux,multidrug resistance,oncogene activation,bile acid transport regulation,cell survival enhancement,tumor progression facilitation
ENSG00000048405,ZNF800,oncogene function,cell proliferation promotion,transcriptional regulation,dna binding activity,tumor metastasis facilitation,nuclear localization
ENSG00000165566,AMER2,cell cycle regulation,overexpression,tumor suppressor dysfunction,cell proliferation enhancement,oncogene activation,genetic instability
ENSG00000138801,PAPSS1,sulfate conjugation,detoxification pathways,cellular proliferation,metabolic regulation,xenobiotic metabolism,immune response modulation
ENSG00000236177,HLA-DPA1,antigen presentation,immune evasion,cancer risk association,cell-mediated immunity,tumor antigens,mhc class i protein
ENSG00000242114,MTFP1,cellular stress response,transcriptional regulation,dna damage repair,oncogenesis,cell proliferation,metal ion sensing
ENSG00000103150,MLYCD,apoptosis inhibition,cell cycle progression,chromatin regulation,lipid metabolism,metabolic adaptation,tumor growth promotion
ENSG00000180613,GSX2,cellular differentiation,epithelial-to-mesenchymal transition,transcriptional regulation,homeobox transcription factor,tumor progression,metastasis
ENSG00000172586,CHCHD1,mitochondrial function,apoptosis regulation,energy metabolism,tumor progression,cell proliferation,oncogenic potential
ENSG00000203926,SPANXA2,p53 regulation,tumor suppression,apoptosis inhibition,cell proliferation enhancement,oncogenic potential,promoter methylation
ENSG00000198021,SPANXA1,protein-protein interaction,cell cycle regulation,tumor suppressor protein interaction,cancer progression,biomarker potential,phospholipase a2 activity
ENSG00000284938,FAM180B,dna damage response,genome instability,nucleotide excision repair,oncogenic mutations,tumor suppressor function,cancer predisposition
ENSG00000165733,BMS1,oncogenic mutation,dna damage response,cell cycle regulation,rna processing,genomic instability,protein scaffolding
ENSG00000176165,FOXG1,neural cell differentiation,transcription factor activity,cell proliferation regulation,wnt/β-catenin pathway activation,notch signaling modulation,epithelial-to-mesenchymal transition
ENSG00000171201,SMR3B,swi/snf chromatin remodeling,tumor suppressor function,chromatin regulation,dna repair mechanisms,apoptosis induction,cell cycle regulation
ENSG00000179774,ATOH7,genomic instability,regulation of cell cycle,oncogenic processes,therapeutic target,epithelial integrity,cell fate determination
ENSG00000196604,POTEF,tumor suppressor regulation,cell proliferation,oncogene expression,prognostic marker,therapeutic target,cancer cell survival
ENSG00000205927,OLIG2,cell proliferation,transcription factor activity,aberrant activation,oncogenic processes,tumor progression,therapeutic target
ENSG00000026751,SLAMF7,tumor microenvironment modulation,immune evasion,oncogenic function,cell signaling regulation,t-cell activation modulation,biomarker potential
ENSG00000175768,TOMM5,mitochondrial dynamics,cellular metabolism regulation,transmembrane protein function,antioxidant defense mechanism modulation,tumor progression promotion,gene expression regulation alteration
ENSG00000112041,TULP1,tumor maintenance,tissue specificity,gene regulation,signaling pathway modulation,mitochondrial function regulation,cell adhesion disruption
ENSG00000197562,RAB40C,ras superfamily member,tumor-promoting mutations,regulation of membrane trafficking,cellular signaling pathway dysregulation,gef/gap interactions,oncogenic process enhancement
ENSG00000161036,LRWD1,mitotic progression,genomic instability,tumor suppressor,loss of function mutation,microtubule stability,cellular architecture
ENSG00000116254,CHD5,genomic stability,apoptosis induction,tumor suppressor,chromatin remodeling,cell cycle regulation,dna damage response
ENSG00000147251,DOCK11,rac gtpase activation,cancer cell migration,cell adhesion regulation,tumor metastasis,cell invasion enhancement,oncogenic driver status
ENSG00000176076,KCNE5,cellular growth regulation,cellular migration modulation,kv channel complex interaction,potassium channel regulation,tumor progression,voltage-gated potassium channel modification
ENSG00000084090,STARD7,pi3k/akt signaling pathway disruption,cholesterol metabolism regulation,oncogene overexpression,tumor progression facilitation,therapeutic target modulation,cell cycle control alterations
,HIST1H2BO,histone regulation,chromatin remodeling,epigenetic regulation,genome stability,transcriptional control,protein conservation
ENSG00000130313,PGLS,glucose metabolism,cancer-associated glycosylation,dysregulated gene expression,tumor cell proliferation,enzyme catalysis,glycogen synthesis
ENSG00000063601,MTMR1,regulates cell proliferation,dephosphorylates protein kinase c,interacts with pi3k/akt/mtor pathway,tumor suppressor function,inhibits metastasis,regulates apoptosis
ENSG00000035928,RFC1,dna replication,genomic instability,cell proliferation,tumor progression,replication complex assembly,dna synthesis initiation
ENSG00000149970,CNKSR2,regulation of apoptosis,modulation of cell signaling,oncogenic processes,cell proliferation,tumor growth,genomic instability
ENSG00000171606,ZNF274,transcriptional repressor,chromatin modification,cell cycle regulation,apoptosis inhibition,epigenetic regulation,tumor growth promotion
ENSG00000112679,DUSP22,phosphatase activity,mapk signaling pathway,cellular stress response,regulatory mechanism,tumor suppressor function,genomic instability
ENSG00000138346,DNA2,genomic instability,genetic alterations,tumor progression,antitumor activity,dna repair machinery,biology of cancer
ENSG00000143486,EIF2D,tumor suppressor,cellular homeostasis regulation,protein translation inhibition,oncogene regulation,cell growth suppression,cancer prevention
ENSG00000180263,FGD6,pi3k/akt/mtor pathway regulation,rhoa activation,cell migration and invasion,oncogenic potential,guanine nucleotide exchange factor,cancer cell proliferation
ENSG00000124784,RIOK1,chromatin remodeling,tumor growth promotion,dna damage response,cell cycle regulation,kinase activation,genomic instability
ENSG00000073536,NLE1,rna export regulation,cell cycle progression,oncogenic potential,aberrant localization,cellular proliferation,gene expression control
ENSG00000183426,NPIPA1,nucleocytoplasmic transport regulation,oncogene activation,cell proliferation enhancement,tumor progression influence,signaling pathway modulation,genomic instability association
ENSG00000182903,ZNF721,oncogenic potential,transcriptional regulation,cell proliferation,apoptosis modulation,nucleus localization,dna binding activity
ENSG00000175426,PCSK1,prohormone processing,hormone regulation,energy homeostasis,metabolic regulation,cell growth modulation,therapeutic target
ENSG00000274671,MARVELD2,erad regulation,protein quality control,cellular stress response,proteostasis maintenance,misfolded protein degradation,cancer biology relevance
ENSG00000016391,CHDH,chromatin remodeling,genomic instability,epigenetic regulation,transcriptional activation,cell cycle progression,oncogenesis
ENSG00000177076,ACER2,overexpression,oncogene,cellular regulation,cell proliferation,growth regulation,protein interaction
ENSG00000156642,NPTN,cell migration,metastasis promotion,tumor progression,angiogenesis support,poor prognosis marker,transmembrane receptor
ENSG00000138161,CUZD1,cell growth regulation,adhesion disruption,tumor suppressor function,metastatic suppression,pi3k/akt inhibition,protein-protein interaction
ENSG00000132702,HAPLN2,hyaluronan regulation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000064933,PMS1,mismatch repair,microsatellite instability,genetic instability,tumor suppressor function,dna replication errors,mutation hotspots
ENSG00000130517,PGPEP1,tumor suppressor function,protein degradation regulation,cell cycle progression regulation,apoptosis regulation,genomic instability contribution,senescence regulation
ENSG00000054796,SPO11,genomic instability,chromosomal rearrangements,dna repair deficiency,meiotic recombination,homologous recombination,tumor progression
ENSG00000185024,BRF1,dna damage response,cell cycle regulation,transcriptional regulation,tumor suppressor function,genomic instability,protein-protein interactions
ENSG00000159450,TCHH,chromatin remodeling,dna repair,oncogenic driver,transcriptional regulation,gene expression modulation,chromatin assembly
ENSG00000196188,CTSE,protein degradation,tumor invasion,cell signaling pathway,antigen presentation,tumor progression,metastasis regulation
ENSG00000275313,CCL4L2,immune cell recruitment,angiogenesis promotion,immunosuppression,tumor microenvironment modulation,cancer progression contributor,chemokine signaling pathway interaction
ENSG00000278259,MYO19,cytoplasmic protein,cellular trafficking,actin filament interaction,cytoskeletal dynamics,intracellular transport,endocytic pathway
ENSG00000136213,CHST12,glycosylation regulation,tumor aggressiveness,overexpression,sulfation pathway,cell adhesion disruption,poor prognosis marker
ENSG00000103047,TANGO6,rab gtpase regulation,cellular trafficking disruption,tumorigenesis driver,autophagy modulation,endocytosis regulator,membrane homeostasis
ENSG00000174233,ADCY6,camp regulation,constitutive activation,gain of function mutations,oncogenic signaling,tumor progression,metabolic dysregulation
ENSG00000114547,ROPN1B,ribosome biogenesis,cell cycle regulation,oncogene activation,therapeutic target,apoptosis inhibition,ribosomal protein interaction
ENSG00000204899,MZT1,histone modification,cellular proliferation,transcriptional repression,chromatin remodeling,oncogene regulation,therapeutic target
ENSG00000151726,ACSL1,metabolic regulation,oncogenic activation,lipid metabolism,cell proliferation,energy provision,tumor progression
ENSG00000135778,NTPCR,purinergic signaling,nucleotide metabolism regulation,genomic stability maintenance,cellular energy modulation,oncogenic driver,protein interaction partner
ENSG00000110844,PRPF40B,rna splicing regulation,nuclear function,pre-mrna maturation,gene expression modulation,protein-coding regulation,cellular signaling pathway interaction
ENSG00000168827,GFM1,altered glucose metabolism,warburg effect,tumor progression,glucose transport regulation,metabolic shift,cancer cell adaptation
ENSG00000205835,GMNC,altered metabolism,chromatin remodeling,cell proliferation,oncogenic signaling,therapeutic target,gene expression regulation
ENSG00000090266,NDUFB2,mitochondrial dysfunction,electron transport chain,cellular respiration,energy metabolism,altered nutrient uptake,interactions with regulatory factors
ENSG00000126550,HTN1,telomerase activation,immortalization,telomere maintenance,genomic instability,cellular proliferation,cancer progression
ENSG00000123454,DBH,tyrosine hydroxylation,dopamine biosynthesis,norepinephrine production,sympathetic neuron expression,angiogenic modulation,immune system interaction
ENSG00000122299,ZC3H7A,oncogene function,cell proliferation enhancement,mir-145 regulation,epigenetic regulation,chromatin remodeling interaction,gene expression modulation
ENSG00000145757,SPATA9,mitotic spindle regulation,genomic integrity maintenance,chromosome segregation,cell division checkpoint,dna repair regulation,cancer genomic instability
ENSG00000117226,GBP3,tumor suppressor function,antiviral response,interferon signaling pathway,cell proliferation inhibition,apoptosis induction,genomic instability
ENSG00000114480,GBE1,lysosomal degradation pathway,sphingolipid metabolism regulation,tumor progression influence,cellular clearance modulation,oncogenic process involvement,metabolic disorder association
ENSG00000173253,DMRT2,genetic regulation,epithelial-to-mesenchymal transition,metastasis,cell cycle progression,oncogenic potential,germ cell specification
ENSG00000154646,TMPRSS15,oncogenic process,tumor progression,cell proliferation,proteolytic activity,cell invasion,metastasis
ENSG00000236221,TNXB,cell migration,adhesion molecule interaction,metastasis promotion,poor prognosis,biomarker expression,cancer progression
ENSG00000161381,PLXDC1,endocytosis regulation,cell membrane repair,vesicle-mediated transport,autophagy modulation,tumor suppressor function,therapeutic target
ENSG00000102996,MMP15,tumor progression,proteolytic activity,cell invasion,extracellular matrix degradation,prognostic marker,therapeutic target
ENSG00000149196,HIKESHI,chromatin regulation,cell cycle progression,genomic instability,oncogenic transformation,chromosome segregation,mitotic checkpoint
ENSG00000071909,MYO3B,myosin motor protein,cell membrane integrity,cell migration,adhesion regulation,oncogenesis driver,cell proliferation modulation
ENSG00000138688,KIAA1109,chromatin remodeling,cell cycle regulation,dna repair mechanism,genomic stability maintenance,tumorigenesis initiation,cancer biology involvement
ENSG00000274276,CBSL,pi3k/akt pathway activation,cbsl overexpression,mutation,oncogene potential,tumor progression,therapeutic target
ENSG00000115318,LOXL3,ecm remodeling,tumor progression,metastasis,angiogenesis promotion,fibrosis prevention,cancer stem cell regulation
ENSG00000138772,ANXA3,cellular membrane regulation,cancer progression,apoptosis resistance,protein-protein interaction,calcium signaling pathway,metastasis promotion
ENSG00000143473,KCNH1,oncogene,pi3k/akt signaling pathway,cellular ion balance regulation,tumor growth promotion,metastasis facilitation,cancer cell proliferation
ENSG00000134240,HMGCS2,ketogenesis regulation,cholesterol biosynthesis,cell proliferation,oncogenic driver,energy homeostasis regulation,lipid metabolism modulation
ENSG00000065320,NTN1,cell adhesion,cell migration,cell invasion,tumor progression,metastasis,neurodevelopmental pathway
ENSG00000162490,DRAXIN,tumor suppressor,cell proliferation inhibition,axonal outgrowth inhibition,neuronal migration regulation,microtubule-associated protein interaction,glioblastoma metastasis suppression
ENSG00000156502,SUPV3L1,genomic instability,aberrant dna replication,cancer predisposition,dna helicase function,cell cycle regulation,tumor suppressor
ENSG00000135838,NPL,nuclear transport regulation,chromatin remodeling,oncogenic signaling pathway activation,genetic rearrangement,transcriptional regulation,cell cycle progression
ENSG00000176842,IRX5,transcription factor regulation,cell cycle control,apoptosis modulation,tumor suppressor function,hematopoiesis regulation,self-renewal capability
ENSG00000103485,QPRT,nucleotide metabolism,cell cycle regulation,oncogenic potential,metabolic reprogramming,cell proliferation enhancement,dna repair modulation
ENSG00000078618,NRDC,chromatin remodeling,gene expression regulation,adaptor molecule function,tumor progression,poor prognosis marker,oncogenic processes
ENSG00000188820,CALHM6,calcium channel regulation,immune response modulation,neuronal excitability enhancement,tumor progression promotion,cellular proliferation facilitation,cancer-associated overexpression
ENSG00000122420,PTGFR,tumor progression,therapeutic target,cell proliferation,angiogenesis,metastasis,signaling pathway modulation
ENSG00000139651,ZNF740,transcriptional regulation,oncogene activation,cell cycle progression,apoptosis inhibition,genomic instability,chromatin remodeling
ENSG00000242252,BGLAP,calcium signaling,tumor suppressor,cell proliferation inhibition,apoptosis induction,cancer stem cell regulation,bone mineralization regulation
ENSG00000163453,IGFBP7,igf-binding inhibition,tumor suppression loss,cell cycle regulation,apoptosis evasion,angiogenesis promotion,protein-protein interaction
ENSG00000187048,CYP4A11,metabolic regulation,cell growth modulation,hydroxylation activity,signaling pathway interaction,apoptosis regulation,tissue expression
ENSG00000116731,PRDM2,tumor suppressor function,histone modification,chromatin remodeling,transcriptional repression,genomic instability,cell proliferation regulation
ENSG00000138777,PPA2,metabolic reprogramming,enhanced glycolysis,oncogenic metabolism,cell proliferation,therapeutic target,energy production
ENSG00000122042,UBL3,ubiquitination pathway,protein degradation,cellular homeostasis,dna repair,cell cycle regulation,tumor suppressor function
ENSG00000171611,PTCRA,immune evasion,t-cell suppression,antigen recognition,cell signaling,cancer immunology,genomic instability
ENSG00000188997,KCTD21,potassium channel regulation,oncogene function,ion channel modulation,tumor cell proliferation,cell signaling regulation,genomic amplification
ENSG00000148835,TAF5,chromatin remodeling,transcription initiation,histone modification,oncogenesis,cell proliferation,genetic regulation
ENSG00000188921,HACD4,fatty acid biosynthesis,lipid metabolism regulation,energy production modulation,oncogene or tumor suppressor,phospholipid modification,cellular homeostasis disruption
ENSG00000176953,NFATC2IP,nfatc2 regulation,cell proliferation regulation,disease association,tumor suppressor function,molecular interaction,cytoplasmic localization
ENSG00000134255,CEPT1,centrosomal protein,microtubule dynamics regulation,genomic instability driver,oncogenic mutation,cell cycle progression,mitotic checkpoint regulation
ENSG00000177283,FZD8,wnt/β-catenin pathway,aberrant activation,cell proliferation,survival,enhanced oncogenic process,dysregulation
ENSG00000112031,MTRF1L,mitochondrial translation regulation,cellular metabolism adaptation,hypoxia-induced response,ribosomal protein function,genomic instability,tumor cell energy metabolism
ENSG00000140367,UBE2Q2,oncogenic protein regulation,ubiquitin-proteasome system dysregulation,aberrant protein accumulation,tumor suppressor degradation,genome instability promotion,cancer cell survival enhancement
ENSG00000125492,BARHL1,transcription factor,tumor suppressor,cellular homeostasis,cell fate decisions,embryonic development,cancer prevention
ENSG00000198355,PIM3,phosphorylation regulation,cell proliferation,apoptosis resistance,metabolic regulation,tumor progression,therapeutic target
ENSG00000197841,ZNF181,chromatin remodeling,tumor progression,transcriptional regulation,oncogenic transformation,apoptosis suppression,epigenetic modification
ENSG00000133789,SWAP70,nf-κb activation,non-canonical signaling,protein-protein interaction,immune response modulation,cell proliferation regulation,oncogenic pathway dysregulation
ENSG00000136720,HS6ST1,tumor progression,cell proliferation,glycosaminoglycan sulfation,angiogenesis promotion,metastasis facilitation,microenvironment modification
ENSG00000187775,DNAH17,ciliary dysfunction,cell cycle dysregulation,apoptosis resistance,tumor progression,genomic instability,mitotic spindle organization
ENSG00000146233,CYP39A1,cancer-related lipid metabolism,nuclear receptor interaction,tumor progression,therapeutic target,genomic instability,enzymatic activity
ENSG00000131238,PPT1,tumor suppressor function,lysosomal enzyme activity,protein degradation regulation,genomic stability maintenance,cellular stress response modulation,toxic peptide accumulation
ENSG00000242389,RBMY1E,cell cycle regulation,dysregulation,apoptosis modulation,proliferation control,signaling pathway interaction,tumorigenesis
ENSG00000120254,MTHFD1L,dna synthesis impairment,tetrahydrofolate regulation,one-carbon metabolism disruption,homocysteine methylation reduction,purine and pyrimidine synthesis defect,cancer risk association
ENSG00000116221,MRPL37,mitochondrial translation regulation,oncogene overexpression,cell proliferation enhancement,apoptosis suppression,protein synthesis modulation,tumor growth promotion
ENSG00000132958,TPTE2,loss-of-function mutations,hyperactivation of protein kinases,cell growth regulation,cell cycle regulation,protein kinase inhibition,dephosphorylation activity
ENSG00000170802,FOXN2,transcriptional regulation,oncogenic function,tumor progression,apoptosis inhibition,genomic instability,immune evasion
ENSG00000144136,SLC20A1,angiogenesis,epithelial-to-mesenchymal transition (emt),cell proliferation,phosphate homeostasis regulation,signaling pathway interaction,metastatic potential
ENSG00000145494,NDUFS6,mitochondrial dysfunction,electron transport chain disruption,hypoxia-inducible factor activation,glycolysis regulation,oncogenesis promotion,apoptosis inhibition
ENSG00000168874,ATOH8,tumor-initiation,stem-like properties,transcriptional regulation,oncogenic signaling,metastatic potential,cellular differentiation
ENSG00000242612,DECR2,mitochondrial function,aerobic glycolysis,glycolytic shift,energy metabolism regulation,cellular respiration modulation,tumor progression facilitation
ENSG00000114812,VIPR1,pi3k/akt signaling,tumor progression,cell migration,immune response regulation,protein-protein interaction,angiogenesis promotion
ENSG00000225614,ZNF469,epigenetic regulation,chromatin remodeling,transcriptional regulation,cell growth promotion,genomic instability,pi3k/akt signaling interaction
ENSG00000171189,GRIK1,constitutive activation,gain of function mutations,aberrant signaling,cell proliferation,metastasis,tumor progression
ENSG00000146399,TAAR1,pi3k/akt signaling pathway,tumor cell growth,constitutive activation,oncogenic pathway modulation,therapeutic target,biomarker candidate
ENSG00000105447,GRWD1,genomic stability,chromatin remodeling,dna damage response,cell cycle regulation,tumor suppression,cancer predisposition
ENSG00000173653,RCE1,protein folding regulation,disulfide bond formation,cancer driver gene,pi3k/akt pathway interaction,endoplasmic reticulum-associated degradation,multifunctional enzyme
ENSG00000163104,SMARCAD1,chromatin remodeling,dna damage repair,genomic stability maintenance,histone modification regulation,oncogenic transcriptional regulation,transcription factor interaction
ENSG00000073614,KDM5A,oncogenic epigenetic regulation,histone demethylation,gene expression modulation,cell proliferation enhancement,therapeutic target discovery,aberrant protein-protein interactions
ENSG00000198300,PEG3,tumor suppressor function,chromatin remodeling,apoptosis regulation,oncogenic signaling inhibition,genomic instability association,cell growth regulation
ENSG00000220201,ZGLP1,glypican-3 regulation,tumor progression,biomarker candidate,signaling pathway activation,cell proliferation regulation,metastasis promotion
ENSG00000258315,C17orf49,protein modification,ubiquitin-proteasome pathway,epigenetic regulation,chromatin structure,aberrant protein accumulation,tumorigenesis
ENSG00000102401,ARMCX3,chromatin remodeling,histone modification,cell proliferation,tumor suppressor,genomic instability,epigenetic regulation
ENSG00000136908,DPM2,n-glycosylation pathway,aberrant glycosylation patterns,cell surface receptor signaling,dysregulated protein modification,oncogenic processes,tumorigenesis
ENSG00000069122,ADGRF5,cell adhesion,oncogenic signaling,tumor progression,cell migration,invasion facilitation,adhesion gpcr family
ENSG00000087269,NOP14,oncogenic function,nucleolar localization,cellular proliferation,genomic instability,mitotic regulation,rna processing
ENSG00000166920,C15orf48,cell cycle regulation,genetic instability,tumor suppression,genome stability,oncogenic mutations,anti-proliferative signaling
ENSG00000196632,WNK3,pi4kb pathway dysregulation,oncogenic driver,cellular homeostasis disruption,lipid metabolism alteration,therapeutic target,protein kinase activation
ENSG00000185842,DNAH14,cilia structure disruption,cell survival promotion,oncogenic function,cell proliferation enhancement,genetic variation association,tumor development
ENSG00000188153,COL4A5,type iv collagen assembly,basement membrane disruption,angiogenesis promotion,cell adhesion modulation,extracellular matrix remodeling,tumor cell migration
ENSG00000148339,SLC25A25,mitochondrial transport,fatty acid oxidation,cellular respiration,oncogenic mutations,metabolic reprogramming,apoptosis resistance
ENSG00000060558,GNA15,cell cycle regulation,apoptosis modulation,signal transduction,genomic instability,therapeutic target,tumor progression
ENSG00000140474,ULK3,autophagy regulation,pi3k/akt/mtor pathway,mtor complex 1 regulation,cell growth and proliferation,nutrient sensing,metabolic homeostasis
ENSG00000150403,TMCO3,protein trafficking regulation,er membrane localization,chaperone-mediated protein folding,cellular homeostasis maintenance,tumor suppressor or oncogene,apoptosis pathway interaction
ENSG00000198858,R3HDM4,chromatin remodeling,transcriptional repression,histone modification,dna repair,tumor suppressor,cell cycle regulation
ENSG00000115902,SLC1A4,glutamine transport,metabolic regulation,tumor cell growth,chemotherapy resistance,cellular uptake,protein interaction
ENSG00000081803,CADPS2,calcium-dependent regulation,exocytosis and endocytosis regulation,tumor development association,cellular signaling pathway modulation,prognostic marker potential,regulated by transcription factors
ENSG00000138078,PREPL,pi3k/akt interaction,cell proliferation promotion,prolyl endopeptidase activity,tumor progression contribution,angiogenesis regulation,gene expression elevation
ENSG00000104888,SLC17A7,nucleotide regulation,neurotransmitter function,cell proliferation,metabolic regulation,genomic stability,protein transport
ENSG00000118997,DNAH7,dynein heavy chain function,cilia motility regulation,cell proliferation regulation,tumor suppressor role,genetic disorder association,protein expression alteration
ENSG00000186897,C1QL4,oncogene,immune modulation,tumor progression,metastasis,cancer cell signaling,protein regulation
ENSG00000131620,ANO1,calcium-activated chloride channel,tumor progression,metastasis regulation,ion transport regulation,calcium homeostasis dysregulation,protein-protein interaction
ENSG00000185610,DBX2,tumor suppressor function,transcriptional regulation,cellular quiescence promotion,oncogenic target repression,genetic inactivation leading to tumorigenesis,chromatin modification interaction
ENSG00000174695,TMEM167A,cellular signaling pathway regulation,immune response modulation,tumor progression association,metastasis facilitation,oncogene potential,cancer development involvement
ENSG00000121446,RGSL1,nucleocytoplasmic transport,cell cycle regulation,g2/m phase transition,mitotic progression,tumor progression,prognostic marker
ENSG00000021461,CYP3A43,tumor metabolism,chemotherapy resistance,metabolic regulation,cytochrome p450 activity,cancer-specific expression,drug interaction
ENSG00000235194,PPP1R3E,pp1 holoenzyme regulation,tumor progression,cell cycle regulation,apoptosis modulation,dna repair mechanism dysregulation,signaling pathway disruption
ENSG00000151014,NOCT,cell cycle regulation,tumor suppression,transcriptional regulation,apoptosis modulation,nuclear receptor function,corepressor activity
ENSG00000115652,UXS1,gag biosynthesis alteration,cell migration regulation,tumor microenvironment modification,metastasis facilitation,biomarker potential,glycosylation pathway modulation
ENSG00000177303,CASKIN2,cell-cell adhesion,adherens junctions,cytoskeletal organization,cell migration,tumor progression,therapeutic target
ENSG00000159733,ZFYVE28,endocytic trafficking,regulation of vesicular transport,early endosome localization,cell growth regulation,protein-protein interaction,tumor progression
ENSG00000116147,TNR,dna repair mechanisms,cellular responses,tumor suppressor activity,oncogene function,cell growth regulation,trinucleotide repeat expansions
ENSG00000139155,SLCO1C1,altered expression,drug disposition,organic anion transport,tumor drug resistance,bile acid transport,xenobiotic movement
ENSG00000066032,CTNNA2,cell-cell adhesion disruption,constitutive activation of wnt/β-catenin pathway,gain of function mutations,tumor suppressor inactivation,wnt signaling pathway regulation,protein-protein interaction
ENSG00000260314,MRC1,metabolic regulation,cell proliferation,adhesion modulation,tumor progression,metastasis promotion,cancer prognosis marker
ENSG00000188487,INSC,purine biosynthesis,increased expression,cell growth promotion,chemotherapy resistance,tumor progression,cell cycle regulation
ENSG00000130921,C12orf65,genomic instability,gene expression regulation,transcriptional elongation factor regulation,dna damage response pathway interaction,tumor suppressor activity,oncogenic process promotion
ENSG00000097096,SYDE2,cellular structure regulation,tumor suppressor function,cytoskeletal dynamics,neurodevelopmental disorders association,oncogenic signaling pathway,cancer driver mutation
ENSG00000196268,ZNF493,transcriptional regulation,cell proliferation,chromatin remodeling,oncogene/tumor suppressor,genomic instability,therapeutic target
ENSG00000114349,GNAT1,g-protein coupled receptor signaling,cellular growth regulation,signal transduction modulation,protein interaction,oncogenic processes contribution,tumorigenesis association
ENSG00000175970,UNC119B,rho gtpase activation,oncogenic function,tumor progression,protein trafficking regulation,cell migration enhancement,cytoskeleton dynamics modulation
ENSG00000095574,IKZF5,genomic stability,tumor suppressor function,transcriptional regulation,chromatin remodeling,proliferation control,dysregulation in cancer
ENSG00000154845,PPP4R1,oncogene,cell proliferation,tumor progression,protein phosphatase regulation,transcriptional regulation,post-translational modification
,SARS,viral replication,viral transcription,rna packaging,translation initiation,cellular interaction,host-virus interface
ENSG00000151023,ENKUR,cell adhesion,cell motility,tumor growth,epithelial-to-mesenchymal transition (emt),signaling pathway interaction,cancer cell proliferation
ENSG00000186971,KRTAP13-4,keratin-associated protein,cell adhesion regulation,epithelial-to-mesenchymal transition,tissue architecture maintenance,cancer cell behavior modulation,cellular differentiation regulation
ENSG00000163870,TPRA1,epigenetic regulator,chromatin remodeling,tumor suppressor modulation,oncogenic potential,cell proliferation enhancement,stem cell maintenance
ENSG00000154079,SDHAF4,sdh dysregulation,mitochondrial function disruption,pseudohypoxic response activation,cellular metabolism increase,tumor growth promotion,oncogenic driver status
ENSG00000188994,ZNF292,transcriptional repression,oncogene function,cell proliferation regulation,krab domain-containing protein,genomic amplification,histone modification interaction
ENSG00000196620,UGT2B15,metabolic regulation,glucuronidation process,detoxification pathway,cellular sensitivity modulation,tumor suppressor function,cancer-related metabolism
ENSG00000074964,ARHGEF10L,rho gtpase activation,tumor progression,cancer cell migration,cellular signaling regulation,protein interaction network,genomic amplification
ENSG00000172724,CCL19,immune evasion,tumor microenvironment,chemokine signaling,lymph node homing,cell migration,metastasis promotion
ENSG00000172830,SSH3,rho gtpase regulation,cytoskeleton reorganization,cell migration,tumor progression,metastasis,therapeutic target
ENSG00000162104,ADCY9,camp signaling pathway,gain of function mutations,cellular proliferation,g-protein coupled receptors,oncogenic processes,therapeutic target
ENSG00000167130,DOLPP1,ribosome biogenesis,cell proliferation,tumor growth,protein processing,pre-rrna maturation,oncogenic signaling
ENSG00000171794,UTF1,cell proliferation,resistance to apoptosis,tumor growth,angiogenesis,transcription regulation,epigenetic modifications
ENSG00000103160,HSDL1,fatty acid metabolism,lipid biosynthesis,tumor cell survival,lipid-derived molecules,cancer prognosis,enzyme interaction
ENSG00000175646,PRM1,transcriptional regulation,cell cycle progression,signal transduction pathway,oncogenic properties,enhanced cell proliferation,metastasis promotion
,ADSSL1,actin dynamics regulation,cell migration promotion,oncogenic transformation potential,cytoskeletal component interaction,signaling pathway modulation,tumor progression contribution
ENSG00000092758,COL9A3,heterotrimer formation,cellular adhesion,migration regulation,overexpression mutations,tumor progression,cancer driver gene
ENSG00000132819,RBM38,p53 pathway modulation,rna processing regulation,cellular transformation,tumor suppressor function,genomic instability,oncogenic potential
ENSG00000166592,RRAD,cellular transformation,vesicle transport regulation,endocytosis/exocytosis modulation,cancer cell proliferation,oncogenic signaling pathways interaction,multifaceted tumor progression
ENSG00000119685,TTLL5,microtubule regulation,oncogenic mutations,cell proliferation,tumor suppressor regulation,protein degradation,clinical correlation
ENSG00000037042,TUBG2,microtubule stabilization,cell cycle progression,mitotic spindle assembly,tumor cell migration,cancer driver gene,therapeutic target
ENSG00000138073,PREB,oncogenic protein,apoptosis resistance,cell proliferation enhancement,metastatic potential increase,therapeutic target,tumor formation and progression
ENSG00000081307,UBA5,nedd8 activation,cell cycle regulation,protein modification,apoptosis resistance,oncogenic process,ubiquitination machinery
ENSG00000105737,GRIK5,glutamate-gated ion channels,cell proliferation,mutation or expression alteration,tumor progression,neurological system interaction,oncogene regulation
ENSG00000092096,SLC22A17,transporter activity,overexpression in cancer,drug resistance,organic compound transport,proliferation regulation,survival pathway modulation
ENSG00000102218,RP2,microtubule regulation,cellular homeostasis,x-linked inheritance,photoreceptor degeneration,apoptosis resistance,kinesin motor interaction
ENSG00000197177,ADGRA1,angiogenesis promotion,cell-cell interaction regulation,pi3k/akt pathway activation,tumor progression facilitation,genomic amplification,protein-protein interaction modulation
ENSG00000161091,MFSD12,lipid transport,cell membrane dynamics,pi3k/akt pathway,tumor cell growth,metastasis regulation,therapeutic target
ENSG00000127954,STEAP4,iron metabolism regulation,metal reduction activity,oxidative stress response,angiogenesis promotion,apoptosis suppression,tumor progression driver
ENSG00000081014,AP4E1,cell surface regulation,oncogenic processes,therapeutic target,dysregulation,tumor progression,genetic mutations
ENSG00000167772,ANGPTL4,lipid metabolism inhibition,tumor growth promotion,angiogenesis regulation,glucose metabolism modulation,adiposity enhancement,prognostic marker
ENSG00000163507,CIP2A,apoptosis regulation,cell cycle progression,tumor suppression inhibition,p53 degradation,oncometabolism,oncogenic transformation
ENSG00000176890,TYMS,genomic stability disruption,thymidylate metabolism alteration,dna synthesis enhancement,cell proliferation increase,tumor aggressiveness facilitation,chemotherapy resistance promotion
ENSG00000177508,IRX3,pi3k/akt/mtor pathway regulation,tumor progression,transcriptional regulation,proliferation promotion,apoptosis inhibition,chromatin remodeling
ENSG00000170340,B3GNT2,tumor suppressor dysfunction,aberrant glycosylation,cell adhesion disruption,metastasis promotion,therapeutic target,genomic instability
ENSG00000177191,B3GNT8,o-glycosylation,initiation of tumorigenesis,aberrant glycosylation,cell adhesion modulation,immune evasion,protein stability regulation
ENSG00000263309,KRT23,altered expression,cell proliferation,epithelial integrity,oncogenic processes,tumor progression,therapeutic target
ENSG00000140479,PCSK6,notch signaling pathway,pro-tumorigenic factor activation,tumor progression,proteolytic processing,cell growth regulation,cancer cell survival
ENSG00000173200,PARP15,genomic instability,dna repair,homologous recombination,apoptosis resistance,cell proliferation,oncogenic properties
ENSG00000108474,PIGL,gpi-anchored protein biosynthesis,oncogene role,tumor progression promotion,cell survival enhancement,signaling pathway activation,gene expression dysregulation
ENSG00000138615,CILP,anti-apoptotic function,cell proliferation,tumor progression,biomarker potential,oncogenic signaling pathway,protein expression regulation
ENSG00000078124,ACER3,ceramide metabolism,tumor-suppressive/pro-oncogenic function,cell proliferation regulation,apoptosis modulation,stress response pathway,biomarker potential
ENSG00000175161,CADM2,epithelial integrity regulation,tumor suppressor function,cell migration inhibition,metastasis suppression,emt regulation,apoptosis promotion
ENSG00000103274,NUBP1,chromatin remodeling,tumor suppressor function,genomic stability maintenance,dna repair mechanism,cell cycle regulation,nuclear protein interaction
ENSG00000162572,SCNN1D,enac subunit function,sodium transport regulation,ion balance modulation,cellular proliferation influence,tumor microenvironment interaction,epithelial cell response
ENSG00000156875,MFSD14A,lysosomal membrane trafficking,oncogenic function,protein recycling,autophagy regulation,lipid metabolism regulation,cell surface modification
ENSG00000064687,ABCA7,cellular efflux,dysregulation of lipid metabolism,enhanced tumor growth,involvement in pi3k/akt pathway,oncogenic function,therapeutic target for lipid transport
ENSG00000241360,PDXP,energy metabolism disruption,alpha-ketoglutarate regulation,mitochondrial dysfunction,cellular survival pathways,tumor suppressor function,oxidative stress response
ENSG00000173762,CD7,t-cell development,cell surface protein,immunoglobulin superfamily member,therapeutic target,cell signaling modulation,oncogenic process regulation
ENSG00000147481,SNTG1,pi3k/akt pathway,oncogene activation,overexpression/amplification,tumor progression,cell proliferation,cell migration
ENSG00000188937,NYX,circadian rhythm regulation,cellular proliferation,genetic mutations,tumorigenesis,congenital blindness,therapeutic target
ENSG00000119411,BSPRY,tumor suppressor function,transcriptional regulation,apoptosis induction,oncogenic pathway regulation,cell cycle control,genomic instability modulation
ENSG00000168010,ATG16L2,autophagy pathway,oncogenic mutations,tumor progression,metabolic adaptation,protein-protein interaction,gene expression alteration
ENSG00000103310,ZP2,cellular adhesion disruption,tumor progression,pi3k/akt pathway interaction,metastasis promotion,genomic instability,oncogenic potential
ENSG00000280641,CDH4,cell adhesion,oncogenic behavior,signaling pathway modulation,tumor progression,prognostic marker,genomic instability
ENSG00000254415,SIGLEC14,cell surface molecule,immune response modulation,tumor-immune cell interaction,glycoconjugate binding,inflammation regulation,myeloid cell expression 
ENSG00000263014,ATP6V1G3,v-atpase regulation,ph homeostasis maintenance,cellular transport modulation,tumor progression facilitation,oncogenesis promotion,acid-base balance disruption
ENSG00000105516,DBP,cell cycle regulation,tumor suppression,genomic stability maintenance,p53 interaction,oncogene regulation,transcriptional regulation
ENSG00000145384,FABP2,lipid metabolism regulation,tumor growth promotion,metabolic reprogramming,oncogenic protein interaction,cell proliferation facilitation,energy production modulation
ENSG00000256060,TRAPPC2B,trapp complex regulation,cellular transport modulation,vesicle formation regulation,tumor cell maintenance,protein-protein interaction,membrane dynamics regulation
ENSG00000128694,OSGEPL1,cell growth regulation,endoplasmic reticulum stress modulation,stress response pathway modulation,cell survival enhancement,protein interaction,transcriptional regulation
ENSG00000137877,SPTBN5,genomic amplification,epithelial-to-mesenchymal transition,cell migration,cell adhesion regulation,cytoskeletal organization,protein kinase interaction
ENSG00000127920,GNG11,g protein signaling,oncogenic pathway activation,cell proliferation regulation,tumor progression association,prognostic marker candidate,genetic alteration hotspot
ENSG00000164715,LMTK2,cell polarity regulation,catalytic activation,constitutive activation,tumor progression,mutation hotspot,therapeutic target
ENSG00000102897,LYRM1,mitochondrial function,cell metabolism regulation,electron transport chain interaction,tumor suppression activity,oxidative stress modulation,protein-protein interaction
ENSG00000083814,ZNF671,gene regulation,genomic stability disruption,transcriptional modulation,tumor progression promotion,apoptosis inhibition,immune system modulation
ENSG00000188690,UROS,heme biosynthesis pathway,gain of function mutations,porphyrin accumulation,enzyme deficiency,oncogenesis,metabolic regulation
ENSG00000160868,CYP3A4,biotransformation,drug metabolism,oxidation reaction,pharmacokinetics regulation,liver expression,polymorphic variation
ENSG00000138131,LOXL4,ecm remodeling,copper-dependent amine oxidase activity,pro-tumorigenic properties,tumor cell invasion,signaling pathway interaction,metastatic potential enhancement
ENSG00000118707,TGIF2,transcription factor activation,oncogene role,cell cycle regulation,wnt/β-catenin signaling pathway,apoptosis inhibition,genomic instability
ENSG00000112333,NR2E1,oncogene/tumor suppressor,transcriptional regulation,cell proliferation,aberrant signaling pathways,wnt/β-catenin pathway,notch-dll4 axis
ENSG00000205707,ETFRF1,genomic instability,cellular proliferation,transcriptional regulation,apoptosis modulation,chromosomal aberrations,cell cycle progression
ENSG00000282003,TUBGCP3,microtubule assembly,genomic instability,cellular proliferation,oncogenic processes,protein-protein interactions,chromosomal segregation
ENSG00000146216,TTBK1,microtubule dynamics,pi3k/akt signaling,kinase activity,cell proliferation,genomic instability,mitosis regulation
ENSG00000171763,SPATA5L1,microtubule assembly,oncogenic processes,cell cycle progression,genome stability,mitotic regulation,protein-protein interaction
ENSG00000129103,SUMF2,altered gene expression,cancer progression,enzyme regulation,glycosaminoglycan metabolism,protein interaction,sulfatase activation
ENSG00000110245,APOC3,apoc3 mutations,antagonistic regulation,lipid metabolic disruption,tumor growth promotion,inflammatory response modulation,angiogenic pathway interaction
ENSG00000186912,P2RY4,cell migration,g-protein coupled receptor,cell proliferation,angiogenesis promotion,tumor progression,potential therapeutic target
ENSG00000185340,GAS2L1,cellular apoptosis,chromatin remodeling,dna damage response,histone binding,oncogenic processes,tumor suppression
ENSG00000183153,GJD3,cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt),tumor progression,metastasis facilitation,immune evasion,overexpression
ENSG00000138821,SLC39A8,zinc transporter,dysregulated expression,genomic instability,cell signaling modulation,pan-cancer driver,metal ion metabolism
ENSG00000140497,SCAMP2,pancreatic cancer prognosis,cellular morphology alteration,secretory pathway regulation,vesicle trafficking modulation,tumor progression marker,poor prognosis correlation
ENSG00000137731,FXYD2,ion transport regulation,na+/k+-atpase pump regulation,cellular homeostasis,cardiovascular disease association,tumorigenesis modulation,oncogene potential
ENSG00000075790,BCAP29,b-cell activation,scaffold protein function,tumor metastasis,proliferation regulation,cell signaling pathway,immune system modulation
ENSG00000138271,GPR87,g protein-coupled receptor,angiogenesis regulation,tumor progression marker,overexpressed in cancer,cell proliferation modulation,molecular target
ENSG00000163607,GTPBP8,gtp hydrolysis regulation,cell signaling pathway,oncogene mutation,tumor progression,cancer cell proliferation,genomic instability
ENSG00000132330,SCLY,tumor invasion,matrix metalloproteinase regulation,cell migration,angiogenesis promotion,oncogenic process,prognostic marker
ENSG00000153487,ING1,histone modification,dna repair mechanisms,tumor suppressor function,cell cycle regulation,apoptosis modulation,genomic instability
ENSG00000063761,ADCK1,mitochondrial function,regulation of autophagy,cellular metabolism,protein degradation,ubiquitin-proteasome system regulation,lipid metabolism
ENSG00000142892,PIGK,oncogenic pathway activation,cell membrane lipidation,increased cell proliferation,lipid metabolism regulation,genetic overexpression,protein-protein interaction
ENSG00000006576,PHTF2,transcriptional regulation,cell cycle repression,loss of function mutations,tumor suppression,chromatin remodeling,genomic instability
ENSG00000155463,OXA1L,mitochondrial assembly,mitochondrial dysfunction,energy metabolism disruption,tumor growth promotion,cellular respiration regulation,reactive oxygen species production
ENSG00000006534,ALDH3B1,cellular detoxification,tumor progression,enhanced enzymatic activity,apoptosis resistance,redox balance regulation,oxidation reaction catalysis
ENSG00000120094,HOXB1,hox gene family,cellular proliferation,epithelial-to-mesenchymal transition (emt),transcriptional regulation,overexpression,oncogenesis
ENSG00000130052,STARD8,cholesterol efflux,apoptosis suppression,autophagic regulation,cellular metabolism,oncogenic processes,therapeutic target
ENSG00000178732,GP5,glutamate regulation,metalloprotease activity,neurotransmitter processing,neurodegenerative disease,synaptic plasticity,glutamatergic signaling
ENSG00000159713,TPPP3,microtubule dynamics regulation,genomic instability association,cell cycle regulation interaction,oncoprotein overexpression,cell survival promotion,tumor progression association
ENSG00000139323,POC1B,cell cycle regulation,centrosome function,dna damage response,mitotic spindle formation,oncogenic transformation,tumor progression
ENSG00000117697,NSL1,histone modification,tumor suppressor suppression,transcription elongation regulation,chromatin remodeling,genome instability promotion,cancer cell proliferation enhancement
ENSG00000172590,MRPL52,ribosome biogenesis,cellular proliferation,tumorigenesis,protein synthesis regulation,oncogenic mutations,genomic instability
ENSG00000067842,ATP2B3,calcium signaling pathway,dysregulation of calcium homeostasis,cellular proliferation,cell survival,protein-protein interactions,signaling modulation
ENSG00000179772,FOXS1,cellular proliferation,transcriptional regulation,immune evasion,cell cycle dysregulation,oncogene activation,chromatin remodeling
ENSG00000086712,TXLNG,nuclear protein,transcriptional regulation,cell growth promotion,oncogene potential,overexpression in cancer,apoptosis inhibition
ENSG00000104447,TRPS1,cell growth regulation,transcriptional regulation,tumor suppressor function,dna binding activity,protein-protein interactions,genomic instability prevention
ENSG00000127980,PEX1,cellular metabolism,peroxisome biogenesis,zellweger spectrum disorder,oncogenic process,tumor suppressor function,protein-protein interaction
ENSG00000138722,MMRN1,mitochondrial regulation,tumor suppressor activity,oncogenic promotion,metabolic reprogramming,prognostic biomarker,cellular metabolism modulation
ENSG00000182180,MRPS16,mitochondrial dysfunction,tumor suppressor function,energy metabolism regulation,cell proliferation modulation,ribosome biogenesis impairment,loss of function mutation
ENSG00000176383,B3GNT4,n-glycosylation regulation,cellular growth modulation,protein modification,tumor progression regulation,cancer-related protein interaction,oncogenic process contribution
ENSG00000181722,ZBTB20,transcriptional regulation,tumor suppressor/oncogene function,cell proliferation enhancement,apoptosis suppression,genomic instability contribution,dna sequence binding
ENSG00000139508,SLC46A3,nucleoside transport regulation,oncogenic proliferation,dna repair mechanism influence,nucleotide pool modulation,genomic stability disruption,therapeutic target opportunity
ENSG00000176428,VPS37D,autophagy regulation,endosomal sorting disruption,oncogenic process contribution,cell growth enhancement,therapeutic target potential,genomic instability association
ENSG00000102125,TAZ,hippo signaling pathway activation,phosphorylation regulation,cell growth promotion,tumor progression driver,therapeutic target,genomic instability
ENSG00000127990,SGCE,sarcoglycan function,dystrophin-associated glycoprotein complex,neurodegenerative disease,muscle cell integrity,protein aggregation,cellular trafficking regulation
ENSG00000102302,FGD1,gef activity for rho gtpase,cell proliferation,migratory signaling pathway,tumor metastasis,rho gef function,protein-protein interactions
ENSG00000187118,CMC1,regulation of cell growth,wd40 repeat family member,pi3k/akt pathway regulation,tumor progression driver,immune response modulation,oncogene function
ENSG00000009335,UBE3C,ubiquitin-protein ligase,apoptosis inhibition,cell survival promotion,dna repair regulation,genomic instability,tumor progression driver
ENSG00000234906,APOC2,cell membrane regulation,lipid metabolism modulation,protein-lipid interaction,tumor growth modulation,cancer cell proliferation,cellular growth regulation
ENSG00000180447,GAS1,tumor suppressor function,cell proliferation inhibition,apoptosis induction,cellular stress response modulation,loss of heterozygosity,biomarker potential
ENSG00000178403,NEUROG2,neural development,transcription factor function,cellular proliferation,self-renewal properties,tumorigenesis,stem cell regulation
ENSG00000117054,ACADM,mitochondrial dysfunction,fatty acid oxidation,beta-oxidation pathway,cellular energy production,metabolic reprogramming,tumor suppressor function
ENSG00000137414,FAM8A1,tumor progression,cell cycle regulation,protein degradation,ubiquitination pathway,oncogene overexpression,cancer cell proliferation
ENSG00000140391,TSPAN3,cell adhesion modulation,oncogenic signaling,epithelial-to-mesenchymal transition,integrin interaction,pi3k/akt pathway activation,tumor progression promotion
ENSG00000163359,COL6A3,cellular adhesion regulation,tumor progression facilitation,collagen assembly involvement,matrix metalloproteinase interaction,poor prognosis biomarker,signal transduction modulation
ENSG00000005381,MPO,inflammation,angiogenesis,tumor progression,reactive oxygen species production,cell proliferation,protein-protein interaction
ENSG00000109065,NAT9,cellular proliferation,signaling pathway modulation,dna damage response,oncogenesis,gene expression regulation,protein-protein interaction
ENSG00000152580,IGSF10,immunoglobulin superfamily,tumor progression,cell adhesion,immune modulation,malignant transformation,cancer metastasis
ENSG00000006071,ABCC8,channel regulation,gain of function mutations,cellular metabolism alteration,tumor growth influence,insulin secretion modulation,anti-apoptotic effect
ENSG00000275111,ZNF2,transcriptional regulation,epigenetic modification,chromatin remodeling,tumor suppression,oncogenesis,genomic instability
ENSG00000016602,CLCA4,calcium-activated signaling,cell proliferation,adenylate cyclase activation,calmodulin interaction,camp-mediated pka activation,tumor progression
ENSG00000151834,GABRA2,receptor regulation,altered expression levels,neurological disorder association,cellular proliferation modulation,cancer cell behavior modification,channel function alteration
ENSG00000254004,ZNF260,transcriptional regulation,apoptosis modulation,cell growth regulation,protein-protein interactions,dna binding specificity,chromosome localization
ENSG00000275385,CCL18,angiogenesis promotion,immunosuppression induction,tumor growth facilitation,metastasis enhancement,poor prognosis association,biomarker potential
ENSG00000171130,ATP6V0E2,v-atpase activation,constitutive expression,glycolytic reprogramming,cell survival enhancement,tumor progression promotion,therapeutic target
ENSG00000145214,DGKQ,pi3k/akt pathway,cell proliferation,phosphoinositide metabolism,dgk family member,oncogenic transformation,survival signaling
ENSG00000140937,CDH11,adhesion loss,cell migration,epithelial-to-mesenchymal transition (emt),metastatic suppression,oncogene/tumor suppressor function,signaling pathway modulation
ENSG00000140284,SLC27A2,fatty acid transport,long-chain fatty acids,cellular lipid metabolism,oncogenic processes,therapeutic target,pi3k/akt/mtor pathway
ENSG00000102195,GPR50,g protein-coupled receptor function,cell proliferation promotion,oncogenic potential,cell migration modulation,wnt signaling interaction,brain-specific expression
ENSG00000183856,IQGAP3,regulation of cell adhesion,modulation of rho gtpase activity,oncogenic potential,cell migration regulation,interaction with cytoskeletal proteins,signaling pathway modulation
,TMEM246,dna damage response,oncogenic transformation,genetic instability,cell cycle regulation,protein interaction modulation,tumorigenic predisposition
ENSG00000203747,FCGR3A,immune evasion,altered gene expression,tumor growth,immunotherapy target,innate immunity modulation,genetic polymorphisms
ENSG00000188266,HYKK,oncogene activation,cell proliferation enhancement,apoptosis inhibition,centrosome duplication regulation,serine/threonine kinase activity,cell cycle progression regulation
ENSG00000165609,NUDT5,genomic stability,dna repair,mutations,oxidative stress,tumor suppressor,cellular senescence
ENSG00000059377,TBXAS1,oncogenic function,overexpression association,cell proliferation regulation,pi3k/akt pathway activation,angiogenesis modulation,metabolic regulation
ENSG00000119013,NDUFB3,mitochondrial respiratory chain dysfunction,oncogenic transformation potential,genomic instability induction,energetic metabolism reprogramming,cellular energy balance disruption,epigenetic regulation alterations
ENSG00000086205,FOLH1,folate metabolism regulation,cellular growth promotion,oncogenic process involvement,tumor progression association,chemotherapy resistance contribution,pi3k/akt pathway interaction
,TSTA3,genomic instability,tumor suppressor function,cellular proliferation regulation,transcriptional activation modulation,oncogenic processes promotion,therapeutic resistance association
ENSG00000145736,GTF2H2,transcriptional regulation,tumor suppressor function,dna damage repair,cell cycle control,cancer predisposition,genomic instability
ENSG00000100678,SLC8A3,calcium homeostasis,cellular signaling,cell proliferation,apoptosis resistance,tumor progression,mutation implicated
ENSG00000240303,ACAD11,fatty acid metabolism,mitochondrial function,cell survival,cell proliferation,metabolic reprogramming,apoptosis prevention
ENSG00000054983,GALC,demyelination,galactolipid catabolism,myelin maintenance,neurodegenerative disorder,toxic metabolite accumulation,enzyme deficiency
ENSG00000288399,KCTD11,tumor suppressor function,protein stability regulation,cell cycle progression modulation,apoptosis induction,dna damage response,oncogenic processes involvement
ENSG00000126391,FRMD8,rhoa signaling pathway,actin cytoskeleton regulation,tumor progression,oncogenic driver,therapeutic target,cancer cell invasion
ENSG00000284752,GMPR2,cellular proliferation,tumor suppressor downregulation,pi3k/akt pathway interaction,g-protein coupled receptor interaction,genetic heterogeneity,apoptosis resistance
ENSG00000144895,EIF2A,translation initiation factor regulation,oncogene activation,tumor progression,cellular adaptation,protein synthesis regulation,hypoxia resistance
ENSG00000148634,HERC4,genomic instability,protein degradation pathway,cell cycle regulation,oncogenesis driver,ubiquitination regulation,dna repair mechanism
ENSG00000182362,YBEY,rna degradation,cellular proliferation,tumor progression,protein-protein interaction,cancer prognosis,gene expression regulation
ENSG00000197724,PHF2,tumor suppressor dysfunction,chromatin remodeling,histone modification disruption,oncogene activation,genome instability promotion,prognostic marker candidate
ENSG00000103066,PLA2G15,phospholipid hydrolysis,tumor progression,genomic instability,cell migration,angiogenesis promotion,oncogene interaction
ENSG00000244274,DBNDD2,microtubule dynamics regulation,cancer cell proliferation,oncogenic kinase activity,cell migration promotion,tumor suppressor dysfunction,genomic instability
ENSG00000088881,EBF4,oncogenic processes,cell growth promotion,overexpression,tumor progression,transcriptional regulation,cell survival enhancement
ENSG00000185480,PARPBP,parp protein binding,dna repair regulation,tumor suppressor function,epigenetic regulation,genomic stability maintenance,oncogene potential
ENSG00000240021,TEX35,pre-mrna splicing,aberrant gene expression,spliceosome regulation,cancer genomics,tumor heterogeneity,molecular diagnostics
ENSG00000157388,CACNA1D,voltage-gated calcium channels,genomic instability,calcium influx regulation,cell proliferation promotion,oncogenic signaling pathway interaction,epigenetic alteration
ENSG00000256223,ZNF10,transcriptional regulation,chromatin remodeling,tumor progression,ept interaction,epithelial-to-mesenchymal transition,histone modification
ENSG00000134575,ACP2,energy metabolism regulation,oxidative stress modulation,glycolytic activity promotion,therapeutic target identification,warburg effect facilitation,protein kinase activation regulation
ENSG00000013563,DNASE1L1,dna degradation,tumor immune evasion,immune suppression,antigen presentation,endonuclease activity,dna repair
ENSG00000101958,GLRA2,inhibitory neurotransmission,cell proliferation,oncogenesis,synaptic transmission,apoptosis regulation,chromosomal location
ENSG00000167522,ANKRD11,genomic instability,tumor suppressor function,dna repair,chromatin remodeling,cell cycle regulation,apoptosis modulation
ENSG00000157869,RAB28,cell migration,vesicular transport regulation,aberrant signaling,endocytic recycling pathway,tumor progression,protein localization
ENSG00000134716,CYP2J2,cell proliferation,tumor progression,metabolic regulation,protein kinase activation,angiogenesis,epoxyeicosatrienoic acids (eets)
ENSG00000137563,GGH,cellular proliferation,signaling pathway activation,phosphorylation activity,oncogenic function,tumor suppressor interaction,apoptosis resistance
ENSG00000172172,MRPL13,mitochondrial function,cellular proliferation,protein synthesis regulation,tumor progression,dysregulated expression,therapeutic target
ENSG00000152782,PANK1,coa biosynthesis disruption,metabolic reprogramming,oxidative stress regulation,therapeutic target,cellular metabolism dysregulation,protein-protein interactions
ENSG00000198918,RPL39,ribosome biogenesis,cell proliferation,protein synthesis regulation,mtor pathway interaction,oncogene potential,genomic instability
ENSG00000184005,ST6GALNAC3,galnac transferase activity,glycosylation regulation,metastatic progression,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway interaction,wnt/β-catenin signaling modulation
ENSG00000131096,PYY,tumor suppression,angiogenesis inhibition,cell proliferation regulation,glucose metabolism modulation,neuropeptide hormone function,gastrointestinal system involvement
,HIST1H2BJ,histone modification,anti-apoptotic effects,dna repair,cell cycle regulation,genomic instability,epi-genetic alterations
ENSG00000170275,CRTAP,extracellular matrix remodeling,collagen modification,tumor progression,fibrosis,osteogenesis imperfecta,oncogenic mechanism
ENSG00000174840,PDE12,cancer progression,cell growth regulation,signaling pathway modulation,apoptosis suppression,cell cycle progression,protein interaction
ENSG00000163508,EOMES,tumor suppressor,epithelial-to-mesenchymal transition regulation,immune evasion,apoptosis promotion,cell cycle arrest,transcription factor
ENSG00000169490,TM2D2,tumor suppressor function,cell proliferation regulation,wnt/β-catenin pathway interaction,genomic stability maintenance,metastasis promotion,therapeutic target
ENSG00000109158,GABRA4,ion regulation,chloride channels,neurotransmission modulation,tumor progression,cell proliferation enhancement,metastasis facilitation
ENSG00000107020,PLGRKT,mhc class i presentation,immune evasion strategies,tumor suppressor function,cancer immunity landscape,peptide processing mechanisms,cellular antigen presentation
ENSG00000176720,BOK,apoptosis regulation,pro-apoptotic function,tumor suppression,cell proliferation inhibition,tumorigenesis association,genomic instability
ENSG00000006377,DLX6,cell proliferation,transcriptional regulation,oncogene activation,epithelial-to-mesenchymal transition,apoptosis inhibition,cancer stem cell maintenance
ENSG00000215045,GRID2IP,ion channel regulation,tumor progression,overexpression in cancer,poor prognosis marker,synaptic plasticity modulation,cellular excitability
ENSG00000143443,C1orf56,mitochondrial dynamics,glycolytic shift,mitochondrial function alterations,cellular metabolism regulation,tumor progression,proteostasis imbalance
ENSG00000135870,RC3H1,apoptosis regulation,mitochondrial outer membrane permeabilization,tumor suppressor function,dna damage response,caspase activation,cellular stress signaling
ENSG00000160746,ANO10,genomic instability,aneuploidy drivers,cell membrane dynamics,calcium regulation,metastasis enhancer,therapeutic target
ENSG00000250722,SELENOP,antioxidant defenses,oxidative stress regulation,tumor suppressor/oncogene,cell survival promotion,protein-protein interactions,selenium homeostasis regulation
ENSG00000237693,IRGM,autophagy regulation,tumor suppression,cellular clearance,immune modulation,pro-inflammatory cytokine regulation,mapk/erk pathway interaction
ENSG00000179431,FJX1,ubiquitination regulation,oncogene activation,cell cycle progression,apoptosis modulation,prognostic marker,metastasis promotion
ENSG00000104901,DKKL1,wnt signaling regulation,inhibitory protein function,tumor suppression,oncogenic role ambiguity,cell proliferation modulation,protein-protein interactions
ENSG00000125414,MYH2,actomyosin regulation,cell migration,cytoskeleton remodeling,dna damage response,metastasis promotion,prognostic biomarker
ENSG00000112486,CCR6,tumor microenvironment,immune evasion,cell migration,angiogenesis promotion,ligand-receptor interaction,dysregulated expression
ENSG00000183778,B3GALT5,tumor progression,cell surface glycosylation,oncogenesis,cell adhesion,cellular signaling regulation,glycan biosynthesis
ENSG00000198342,ZNF442,cellular regulation,transcriptional modulation,tumor suppressor pathway dysregulation,oncogenic process driver,prognostic biomarker potential,gene expression regulator
ENSG00000165496,RPL10L,ribosome biogenesis,nucleolar localization,cellular stress,oncogenic processes,impaired cell growth,apoptosis regulation
ENSG00000095596,CYP26A1,retinoic acid regulation,apoptosis suppression,cell proliferation enhancement,cancer progression,tumor suppressor degradation,differentiation inhibition
ENSG00000173848,NET1,nucleosome remodeling,chromatin regulation,cell proliferation,therapeutic target,overexpression,cell cycle regulation
ENSG00000158604,TMED4,cellular regulation,protein modification,chaperone function,cell survival promotion,tumor progression,genomic instability
ENSG00000108306,FBXL20,ubiquitin ligase activity,cell cycle regulation,prb interaction,tumor suppressor dysfunction,g2/m checkpoint modulation,apoptosis suppression
ENSG00000140534,TICRR,cell adhesion disruption,oncogenic transformation,signaling pathway modulation,tumor progression,biomarker potential,downstream pathway regulation
ENSG00000105672,ETV2,transcriptional regulation,gain of function mutations,tumor progression,oncogenic pathway activation,cell proliferation,therapeutic target
ENSG00000147408,CSGALNACT1,oncogenic signaling pathway,constitutive activation,tumor progression,protein modification,cell growth regulation,metastasis promotion
ENSG00000277354,CRIM1,tumor suppressor,cell polarity regulation,disrupted cell-cell adhesion,gain of function mutations,tissue architecture maintenance,signaling pathway disruption
ENSG00000265203,RBP3,disrupted retinoid signaling,cell survival enhancement,tumor progression,therapeutic target,cytoplasmic localization,vitamin a transport
ENSG00000166111,SVOP,cell cycle regulation,dysregulated expression,genomic instability,oncogene activation,apoptosis evasion,tumor progression
ENSG00000124767,GLO1,glycosylation end-products,tumor suppressor function,methylglyoxal detoxification,cell growth regulation,oxidative stress response,redox balance maintenance
ENSG00000103460,TOX3,constitutive activation,overexpression in breast cancer,transcriptional regulation,cell cycle dysregulation,apoptosis evasion,prognostic biomarker
ENSG00000075673,ATP12A,cellular calcium regulation,ca2+-dependent signaling,tumor progression,protein-protein interactions,magnesium-dependent atpase activity,calcium channel regulation
ENSG00000176533,GNG7,altered gene expression,cell signaling regulation,downstream pathway activation,g-protein coupled receptor interaction,mutation association,tumor progression
ENSG00000104368,PLAT,cell surface receptor recycling,receptor endocytosis regulation,signal transduction modulation,tumor suppressor function,protein-protein interaction,oncogenic signaling pathway disruption
ENSG00000136856,SLC2A8,glucose uptake,metabolic reprogramming,cell proliferation,oncogenic process,tumor growth,therapeutic target
ENSG00000273494,PANK4,loss-of-function mutations,metabolic shift,cell proliferation,fatty acid metabolism,coenzyme a biosynthesis,tumor progression
ENSG00000166272,WBP1L,oncogenic transformation,cell proliferation,tumorigenesis,protein-protein interaction,cell survival,signaling pathway regulation
ENSG00000162520,SYNC,oncofetal protein,overexpression,aggressive tumor behavior,signaling pathway modulation,cellular membrane dynamics,cytoskeletal regulation
ENSG00000141540,TTYH2,pi3k/akt signaling pathway,constitutive activation of pathway,oncogenic potential,tyrosine kinase activity,cell proliferation regulation,protein interaction and modulation
ENSG00000180090,OR3A1,olfactory receptor function,cancer correlation,cell growth regulation,signaling pathway interaction,tumor progression,genetic modification
ENSG00000100997,ABHD12,cellular metabolism,lipid regulation,calcium signaling pathway,neurological disorder association,cancer cell survival,genetic mutations
ENSG00000184903,IMMP2L,constitutive activation,genomic instability,oncogenic mutations,protein-protein interaction,pi3k/akt pathway involvement,tumor progression
ENSG00000070669,ASNS,tumor growth support,hypoxia adaptation,amino acid metabolism regulation,cellular homeostasis maintenance,therapeutic target,oncogenic process promotion
ENSG00000122482,ZNF644,tumor suppressor function loss,cancer driver gene,oncogenic potential,transcription factor activity,overexpression associated,cellular proliferation promotion
ENSG00000131373,HACL1,lipid metabolic regulation,apoptosis regulation,dna damage response,cellular homeostasis,tumor suppressor function,genetic instability
ENSG00000113805,CNTN3,cell proliferation,epithelial-to-mesenchymal transition,protein-protein interaction,transmembrane glycoprotein,upregulated expression,cell migration
ENSG00000089050,RBBP9,histone modification regulation,genome stability maintenance,dna damage response facilitation,tumor suppressor function,chromatin-associated protein,oncogenic process involvement
ENSG00000203797,DDO,angiogenesis regulation,catecholamine biosynthesis,tumor growth promotion,oncogene function,cell migration enhancement,vascular endothelial growth factor signaling
ENSG00000072840,EVC,ciliary maintenance,intraflagellar transport,genetic interactions,cellular signaling pathway,developmental disorder,proliferation regulation
ENSG00000170468,RIOX1,ribosome biogenesis,oncogene,overexpression,cell growth regulation,aberrant regulation,tumorigenesis
ENSG00000130294,KIF1A,microtubule destabilization,mitochondrial trafficking disruption,oncogenic process involvement,cellular transport regulation,microtubule dynamics modulation,axonal transport dysfunction
ENSG00000123213,NLN,microtubule dynamics,cell division regulation,tumor progression,therapeutic target,kinase activation,cancer driver gene
ENSG00000205863,C1QTNF9B,cell adhesion modulation,tumor microenvironment modification,metastatic progression promotion,immune response regulation,cancer diagnostic biomarker,protein-protein interaction
,ELMSAN1,cdk7-containing complex,g2/m phase transition,cell proliferation regulation,tumor progression,genomic instability,biomarker potential
ENSG00000135164,DMTF1,transcriptional regulation,oncogene activation,epigenetic dysregulation,cellular proliferation,metastatic potential,chromatin remodeling
ENSG00000065613,SLK,oncogenic signaling,overexpression,apoptosis regulation,cell cycle progression,kinase activation,protein interaction
,HIST1H2AA,chromatin remodeling,histone modification,genomic instability,cell cycle regulation,apoptosis modulation,none
ENSG00000119844,AFTPH,pi3k/akt signaling pathway modulation,oncogenic protein interaction,cell cycle regulation,apoptosis evasion,tumor progression facilitation,prognostic biomarker potential
ENSG00000126773,PCNX4,telomere regulation,genomic instability,tumor suppression,cell proliferation,genome maintenance,oncogenic process
ENSG00000160182,TFF1,epithelial integrity,cell survival,egfr signaling pathway,pi3k/akt activation,emt induction,metastatic potential
ENSG00000121904,CSMD2,wnt signaling pathway disruption,loss of function mutations,cell proliferation enhancement,apoptosis regulation dysfunction,tumor progression facilitation,therapeutic target candidacy
ENSG00000187240,DYNC2H1,microtubule dynamics,tumor progression,mitotic spindle regulation,cancer cell migration,proliferation enhancement,therapeutic target
ENSG00000214021,TTLL3,microtubule stabilization,oncogenic process,tumor suppressor dysfunction,cell proliferation enhancement,genomic instability promotion,protein kinase activation
ENSG00000108576,SLC6A4,serotonin transporter regulation,epigenetic modulation,tumor progression,metastasis facilitation,therapeutic target,prognostic marker
ENSG00000167549,CORO6,actin cytoskeleton regulation,oncogenic signaling,cell migration promotion,protein-protein interaction,gene expression regulation,cell cycle progression enhancement
ENSG00000186310,NAP1L3,histone modification,chromatin remodeling,transcriptional regulation,cellular proliferation,apoptosis inhibition,metabolic dysregulation
ENSG00000100626,GALNT16,glycosylation regulation,tumor progression,metastasis facilitation,cell proliferation enhancement,signaling pathway modulation,o-galnac modification
ENSG00000166716,ZNF592,chromatin remodeling,transcriptional regulation,dna binding activity,cell growth modulation,histone modification,genomic instability
ENSG00000184428,TOP1MT,dna replication maintenance,chromosomal instability,genomic rearrangements,therapeutic target,dna damage response,oncogenic gene expression
ENSG00000142973,CYP4B1,arachidonic acid metabolism,oxidation reactions,cell proliferation,tumorigenesis,prostaglandin synthesis,metabolic regulation
ENSG00000197629,MPEG1,cellular proliferation,mannose-containing glycoproteins synthesis,cell migration enhancement,tumor progression facilitation,poor prognosis marker,genomic instability promotion
ENSG00000278767,SERPINA10,cellular regulation,pi3k/akt pathway interaction,protease inhibitor function,apoptosis modulation,angiogenesis regulation,cancer cell proliferation
ENSG00000084636,COL16A1,tumor progression,cell adhesion,growth factor interaction,metastasis enhancement,pi3k/akt pathway activation,cell proliferation increase
ENSG00000122674,CCZ1,genomic instability,cell cycle regulation,oncogenic process,transcriptional regulation,tumor cell proliferation,tumor aggressiveness
ENSG00000174669,SLC29A2,nucleoside transport,apoptosis resistance,tumor growth,metastasis promotion,chemotherapy resistance,energy metabolism regulation
ENSG00000144026,ZNF514,oncogenic potential,transcriptional repression,cell cycle regulation,apoptosis modulation,tumor suppressor interaction,gene overexpression
ENSG00000135390,ATP5MC2,mitochondrial function,energy metabolism dysregulation,warburg effect,oncogenesis promotion,tumor growth facilitation,apoptosis resistance
ENSG00000147862,NFIB,wnt/β-catenin signaling pathway,oncogenic potential,dual functional nature,transcriptional regulation,cell proliferation and migration,tumor suppressor or oncogene
ENSG00000188338,SLC38A3,glutamine metabolism,ammonia production,amino acid transport,oncogenic potential,metabolic regulation,cellular growth modulation
ENSG00000144231,POLR2D,altered gene expression,constitutive activation,genomic amplification,mutational hotspot,oncogenic pathway,transcriptional regulation
ENSG00000164308,ERAP2,erap2 function,antigen processing and presentation,cancer immunotherapy target,immune evasion mechanism,tumor antigen regulation,proteolytic activity
ENSG00000213047,DENND1B,cellular growth,endocytic regulation,oncogenesis,cell signaling,protein interaction,tumorigenesis
ENSG00000219438,TAFA5,transcriptional regulation,cell cycle progression,dna damage response,chromatin modification,genome stability,epigenetic regulation
ENSG00000168393,DTYMK,dna synthesis,oncogenic process,cell growth regulation,nucleotide biosynthesis,enzyme dysregulation,cancer therapy target
ENSG00000174177,CTU2,chromatin regulation,dna replication repair,genomic instability,cancer development,cell cycle regulation,apoptosis suppression
ENSG00000123612,ACVR1C,aberrant activation,tumor progression,epithelial-to-mesenchymal transition (emt),oncogenic processes,cell growth regulation,therapeutic target
ENSG00000131446,MGAT1,aberrant glycosylation,n-glycan biosynthesis,tumor progression,cell proliferation,metastasis,prognostic marker
ENSG00000257446,ZNF878,transcriptional regulation,cell growth regulation,dna binding specificity,nuclear localization,epigenetic influence,regulatory complexity
ENSG00000076706,MCAM,cell-cell adhesion disruption,immune evasion,metastatic progression,tumor heterogeneity,therapeutic target,genetic amplification
ENSG00000180113,TDRD6,mirna regulation,tumor suppression,cell proliferation,cancer metastasis,protein-rna interaction,rna degradation
ENSG00000178201,VN1R1,receptor function,cellular signaling,olfactory detection,protein structure,odorant binding,molecular recognition
ENSG00000174915,PTDSS2,pyruvoyl-trna synthetase function,tumorigenic potential,metabolic regulation disruption,cellular metabolism alteration,oncogene activation,cancer-related metabolic reprogramming 
ENSG00000182141,ZNF708,transcriptional regulation,chromatin remodeling,zinc finger domain,cellular differentiation,histone modification,genomic binding sites
ENSG00000278608,MAMDC2,pi3k/akt pathway activation,cell proliferation enhancement,mapk/erk signaling modulation,epithelial-to-mesenchymal transition regulation,protein-protein interaction,genomic instability promotion
ENSG00000164299,SPZ1,transcriptional regulation,oncogenic process,altered chromatin structure,gene expression alteration,cell growth promotion,chromatin remodeling
ENSG00000154240,CEP112,cell cycle regulation,microtubule organization,centrosome function,genomic instability,tumor progression,oncogene or tumor suppressor
ENSG00000122574,WIPF3,cytoskeleton regulation,actin polymerization,cell migration,oncogenic driver,therapeutic target,tumorigenesis
ENSG00000187446,CHP1,histone modification,chromatin regulation,cell cycle progression,dna damage response,apoptosis regulation,genomic instability
ENSG00000138756,BMP2K,oncogene regulation,cellular proliferation,bmp/mapk pathway modulation,protein kinase activation,tumor suppression dysregulation,cancer cell survival enhancement
ENSG00000106331,PAX4,enhanced proliferation,aberrant gene expression,transcriptional regulation,oncogenic potential,pancreatic development,tumorigenesis
ENSG00000085721,RRN3,ribosome biogenesis,oncogenic function,cell proliferation,nuclear protein,rna processing,tumorigenesis
ENSG00000108242,CYP2C18,drug metabolism,tumor progression,cell cycle regulation,metabolic reprogramming,oncogenic function,dysregulation
ENSG00000159164,SV2A,neurotransmitter release regulation,calcium-dependent modulation,synaptic vesicle docking,cell proliferation regulation,tumor microenvironment interaction,metastatic potential
ENSG00000105552,BCAT2,bcka production,mtor pathway activation,bcaa regulation,cell proliferation,insulin signaling modulation,protein synthesis regulation
ENSG00000205307,SAP25,apoptosis regulation,cellular trafficking,cargo protein sorting,oncogenic signaling,clathrin-coated vesicles,adaptor complex ap-3
ENSG00000152595,MEPE,phosphate regulation,calcification regulation,mineralization disorders,ectodermal dysplasias,bone mineralization,cell signaling
ENSG00000167930,FAM234A,cell cycle regulation,tumor aggressiveness,cell growth modulation,oncogene/tumor suppressor,signaling pathway interaction,mutational association with cancer
ENSG00000101825,MXRA5,max transcription factor,microrna regulation,cell proliferation,apoptosis regulation,transcriptional modulation,protein-protein interaction
ENSG00000137672,TRPC6,oncogene,cell proliferation,metastasis,therapeutic target,store-operated calcium entry,calcium channel activation
ENSG00000166821,PEX11A,peroxisome regulation,oncogenic mutations,cell proliferation,metabolic dysregulation,genetic disorder,signaling pathway modulation
ENSG00000151892,GFRA1,wnt signaling pathway modulation,gain of function mutations,oncogenic signaling,tumor progression,immune evasion,cell proliferation regulation
ENSG00000166401,SERPINB8,protease inhibition,tumor suppression pathway inhibition,oncogene activity,apoptosis regulation,cell proliferation promotion,angiogenesis regulation
ENSG00000275181,GPR20,gpcr signaling pathway,cell proliferation regulation,tissue expression heterogeneity,camp/pka pathway modulation,oncogenic process promotion potential,signaling pathway modulation
ENSG00000177225,GATD1,cellular metabolism,transcriptional regulation,oncogenic potential,translation regulation,metabolic reprogramming,epigenetic modifications
ENSG00000168300,PCMTD1,protein structure regulation,tumor suppressor function,oncogenic signaling pathway activation,apoptosis regulation,dna repair modulation,cell growth control
ENSG00000147257,GPC3,wnt/β-catenin pathway,tumor progression,cell proliferation,therapeutic target,overexpression biomarker,oncofetal protein
ENSG00000162931,TRIM17,cell growth regulation,oncogenic function,apoptosis modulation,cell cycle progression,protein-protein interactions,ring finger domain
ENSG00000177951,BET1L,genetic alterations,cellular trafficking,oncogenesis,cell growth regulation,apoptosis inhibition,protein-protein interaction
ENSG00000146904,EPHA1,receptor tyrosine kinase activity,cell migration regulation,epithelial-to-mesenchymal transition (emt),cancer stem cell maintenance,angiogenesis promotion,vascular endothelial growth factor (vegf) signaling
ENSG00000106617,PRKAG2,cellular metabolism regulation,glycogen synthesis modulation,lipolysis activation,pka signaling pathway,cellular energy homeostasis,genetic mutations consequence
ENSG00000006283,CACNA1G,calcium channel regulation,cell proliferation promotion,genomic instability,p/q-type voltage-gated calcium channels,signaling pathway modulation,tumor growth enhancement
ENSG00000120500,ARR3,camp signaling,cell growth promotion,oncogene activation,adenylate cyclase regulation,pka activation,growth factor signaling
,GUCA1A,signal transduction,cgmp regulation,retinal disease association,smooth muscle relaxation,photoreceptor function,cellular proliferation
ENSG00000019505,SYT13,upregulated expression,prognostic significance,cellular proliferation,pi3k/akt pathway regulation,apoptosis modulation,autophagy regulation
ENSG00000155287,SLC25A28,mitochondrial carrier protein,energy metabolism regulation,tumor growth promotion,oncogenic signaling activation,reactive oxygen species production,cellular stress response modulation
ENSG00000136643,RPS6KC1,cell proliferation,kinase activity,oncogenic signaling,metabolic adaptation,tumor progression,mrna translation
ENSG00000139725,RHOF,rho/rac/cdc42 pathway,gain of function mutations,tumor progression,cell migration,actin cytoskeleton dynamics,protein-protein interaction
ENSG00000170364,SETMAR,genomic instability,dna cleavage activity,chromosomal rearrangements,oncogenic mutations,tumor progression,dna repair mechanisms
ENSG00000204963,PCDHA7,cell adhesion disruption,pi3k/akt signaling pathway interaction,cell survival enhancement,tumor progression,gene expression dysregulation,epithelial-to-mesenchymal transition (emt)
ENSG00000172269,DPAGT1,glycosylation pathway,gain of function mutations,tumor progression,protein misfolding,cellular stress response,cancer initiation
ENSG00000139083,ETV6,transcription factor activation,chromatin remodeling,oncogenic transcription,genetic recombination,leukemia associated gene,tumor suppressor regulation
ENSG00000095752,IL11,pi3k/akt pathway activation,cell proliferation enhancement,angiogenesis promotion,tumor progression support,oncogenic role,prognostic biomarker
ENSG00000112110,MRPL18,40s ribosomal subunit component,translation initiation complex,cell cycle progression,oncogenic transformation,mtor pathway interaction,protein synthesis regulation
ENSG00000169418,NPR1,natriuretic peptide-binding,guanylyl cyclase activity,tumor progression,metastasis suppression,wnt/β-catenin pathway interaction,cell growth regulation
ENSG00000105258,POLR2I,oncogenic mutations,constitutive activation,genomic instability,transcriptional regulation,tumor progression,therapeutic target
ENSG00000048544,MRPS10,mitochondrial ribosome function,cellular metabolism disruption,tumor suppressor potential,apoptosis regulation,protein-protein interaction,energy production alteration
ENSG00000115607,IL18RAP,constitutive activation,nf-kb pathway regulation,immune evasion,oncogenic signaling,cell proliferation,inflammation response
ENSG00000183878,UTY,genomic instability,transcriptional regulation,tumor suppression,dna repair mechanisms,histone modification,chromatin remodeling
ENSG00000160957,RECQL4,genomic instability,tumor suppressor function,gain-of-function mutations,dna repair mechanisms,helicase activity,sister chromatid exchanges
ENSG00000111241,FGF6,fgf signaling pathway,gain of function mutations,cell proliferation enhancement,tumor progression facilitation,therapeutic target,signaling pathway interaction
ENSG00000153107,ANAPC1,cell cycle regulation,genomic instability,mitotic checkpoint,tumor suppressor function,proteasome degradation,genetic predisposition
ENSG00000196284,SUPT3H,transcriptional regulation,chromatin remodeling,cell cycle progression,genetic expression,epigenetic modification,protein-protein interaction
ENSG00000136492,BRIP1,genomic instability,tumor suppressor function,dna repair mechanism,homologous recombination,fanconi anemia pathway,oncogenesis
ENSG00000168487,BMP1,cellular processes regulation,extracellular matrix degradation,tumor progression facilitation,protease activation,cell proliferation enhancement,metastasis promotion
ENSG00000144827,ABHD10,lpc hydrolysis,fatty acid production,cell proliferation enhancement,tumor progression promotion,oncogenic transformation,lipid metabolism regulation
ENSG00000120242,IFNA8,tumor suppression,immunomodulation,cell cycle regulation,apoptosis induction,angiogenesis inhibition,anti-viral defense
ENSG00000113600,C9,transcriptional regulation,rna-binding motifs,cellular toxicity,neurodegenerative disease,genetic mutations,chromatin remodeling
,HIST1H2BK,histone regulation,chromatin assembly,gene expression regulation,nucleosome formation,transcriptional control,dna packaging
ENSG00000233816,IFNA13,interferon signaling pathway,tumor suppressor function,apoptosis induction,immune evasion mechanism,cellular proliferation regulation,genetic instability modulation
ENSG00000197919,IFNA1,tumor-promoting effects,tumor-suppressing effects,antiviral response,jak/stat pathway activation,apoptosis induction,immunosuppressive environment modulation
ENSG00000075213,SEMA3A,tumor suppressor,angiogenesis regulation,cell migration inhibition,plexin interaction,apoptosis induction,prognostic biomarker
ENSG00000167186,COQ7,mitochondrial dysfunction,energy metabolism reprogramming,tumor progression driver,therapeutic target,oxidative stress induction,cell proliferation enhancement
ENSG00000104976,SNAPC2,ribosome biogenesis,cell proliferation,tumor progression,poor prognosis marker,aggressive tumor behavior,chemotherapy resistance modulation
ENSG00000036828,CASR,calcium homeostasis regulation,tumor growth promotion,cell proliferation enhancement,metastasis facilitation,signaling pathway activation,protein-protein interaction alteration
ENSG00000204086,RPA4,cell cycle regulation,dna repair mechanism,genomic instability,oncogenesis driver,protein interaction network,tumor progression
ENSG00000110200,ANAPC15,cell cycle regulation,deregulation,oncogenesis,proteolytic degradation,cell proliferation,genomic instability
ENSG00000145839,IL9,oncogene,angiogenesis,immune regulation,cell proliferation,apoptosis resistance,signaling pathway
ENSG00000124334,IL9R,tumor progression,antigen presentation,immune suppression,cell proliferation,signaling pathway activation,angiogenesis
ENSG00000102678,FGF9,fgf signaling pathway,cell proliferation,angiogenesis promotion,metastasis enhancement,tumor growth promotion,oncogenic potential
ENSG00000129055,ANAPC13,chromosomal instability,genomic stability regulation,sister chromatid cohesion,tumor suppressor function,mitotic checkpoint disruption,apoptosis regulation
ENSG00000147873,IFNA5,immune response modulation,apoptosis induction,tumor suppression,inflammation regulation,cell growth inhibition,viral defense mechanism
ENSG00000171855,IFNB1,immunomodulation,interferon response,viral resistance,cell surface regulation,tumor immune evasion,cytokine signaling
ENSG00000186895,FGF3,angiogenesis promotion,cellular proliferation enhancement,fgf/fgfr interaction,oncogenic overexpression,tumor progression facilitation,genomic amplification
ENSG00000114861,FOXP1,oncogene,epithelial-to-mesenchymal transition (emt),wnt/β-catenin pathway activation,transcription factor activity,cell proliferation regulation,metastasis promotion
ENSG00000081026,MAGI3,epithelial cancer,cell adhesion disruption,tumor suppressor function,cell migration enhancement,proliferation regulation,signaling pathway modulation
ENSG00000105287,PRKD2,protein kinase activation,cell signaling pathway,oncogenic signaling,tumor progression,cell proliferation,protein-protein interaction
ENSG00000119973,PRLHR,g protein-coupled receptor,cell proliferation regulation,tumor development modulation,hypothalamic-pituitary axis regulation,apoptosis regulation,dna repair pathway interaction
ENSG00000144596,GRIP2,regulation of gene expression,cell adhesion modulation,tumor progression promotion,metastasis enhancement,oncogene potential,signaling pathway interaction
ENSG00000069020,MAST4,pi3k/akt pathway interaction,cell migration regulation,kinase activation facilitation,actin cytoskeleton reorganization,oncogenesis promotion,prognostic marker status
ENSG00000183479,TREX2,transcriptional regulation,chromatin remodeling,oncogenic processes,cell proliferation,survival signaling,genomic instability
ENSG00000175175,PPM1E,cell cycle regulation,gene silencing mutations,tumor suppressor function,genome stability maintenance,anti-proliferative effects,protein dephosphorylation
ENSG00000144455,SUMF1,epithelial-to-mesenchymal transition,cell signaling regulation,sulfatase activity,growth factor modulation,oncogenic transformation,apoptosis suppression
ENSG00000198964,SGMS1,cell membrane trafficking,apoptosis regulation,oncogenic signaling,tumor growth promotion,metastasis facilitation,prognostic marker
ENSG00000261150,EPPK1,cell growth,tumor suppressor,nuclear localization,cell proliferation,therapeutic target,apoptosis regulation
ENSG00000125844,RRBP1,post-transcriptional regulation,mrna stability and translation,pro-survival gene expression,oncogenic transformation,tumor growth and resistance,angiogenesis modulation
ENSG00000144407,PTH2R,cellular regulation,receptor activation,metabolic regulation,tumor progression,therapeutic target,genomic profiling
ENSG00000113396,SLC27A6,fatty acid metabolism,cell membrane incorporation,cell growth and proliferation,pi3k/akt pathway activation,warburg effect modulation,biomarker potential
ENSG00000185238,PRMT3,tumor suppressor regulation,methyltransferase activity,cell proliferation pathways,oncogenic function,therapeutic target,epigenetic modification
ENSG00000183291,SELENOF,tumor suppressor function,antioxidant enzyme activity,redox reaction regulation,oxidative stress mitigation,cell growth regulation,apoptosis induction
ENSG00000144048,DUSP11,mapk signaling pathway suppression,oncogenic transformation,tumor progression promoter,cell survival enhancement,cancer cell proliferation,therapeutic target
ENSG00000079393,DUSP13,cellular regulation,dephosphorylation activity,mapk signaling pathway,oncogenesis promotion,protein-protein interaction,tumorigenesis involvement
ENSG00000284835,DEFA3,antimicrobial defense,immune response modulation,tumor progression,angiogenesis regulation,cell differentiation,inflammation mediation
ENSG00000130640,TUBGCP2,microtubule dynamics,oncogenic driver,mitotic spindle formation,genome instability,cell division regulation,aberrant stabilization
ENSG00000183638,RP1L1,cell migration,microtubule stability,cytoplasmic localization,protein interaction,rab gtpase family member,cancer metastasis
ENSG00000130234,ACE2,tumor growth,angiogenesis regulation,cell migration promotion,viral entry facilitation,ras pathway involvement,zinc-metalloprotease activity
ENSG00000266200,PNLIPRP2,lipid metabolism regulation,tumor progression association,cellular lipid homeostasis,genomic alteration,oncogenesis involvement,pancreatic tissue expression
ENSG00000114113,RBP2,chromatin remodeling,tumor suppressor interaction,oncogenic transcription,transcriptional regulation,cell cycle progression,tumorigenesis driver
ENSG00000121207,LRAT,retinol metabolism,visual cycle regulation,lipid transferase activity,photoreceptor function,cell membrane modulation,none
ENSG00000171864,PRND,signaling pathway modulation,cellular proliferation regulation,tumor growth promotion,protein-protein interaction,metastasis facilitation,cancer progression
ENSG00000183395,PMCH,pi3k/akt pathway regulation,tumor suppressor activity,calcium signaling inhibition,osteoclast differentiation regulation,cell proliferation regulation,bone metastasis prevention
ENSG00000125851,PCSK2,constitutive activation,upregulation of expression,growth factor processing,cellular signaling regulation,tumorigenesis contribution,genetic amplification/mutation
ENSG00000130635,COL5A1,tumor progression,ecm remodeling,cell migration,adhesion molecule regulation,therapeutic target,extracellular matrix component
ENSG00000170743,SYT9,calcium-dependent signaling,apoptosis regulation,tumor suppressor activity,er localization,vesicle docking and fusion,cell death pathways
ENSG00000168952,STXBP6,autophagy modulation,cell cycle regulation,cancer driver gene,metabolic reprogramming,neurotransmitter release,oncogenic pathway interaction
ENSG00000021852,C8B,immune regulation,complement cascade,innate immunity,cell lysis,microenvironment modulation,immunosurveillance
ENSG00000266964,FXYD1,ion transport regulation,oncogenic function,tumor growth promotion,cell proliferation enhancement,metastasis facilitation,drug resistance development
ENSG00000203710,CR1,immune evasion,apoptotic cell clearance,tumor progression,complement regulation,cell signaling modulation,metastasis facilitation
ENSG00000204983,PRSS1,pancreatitis,inflammation,proteolytic activity,cancer progression,tissue damage,growth factor regulation
ENSG00000088926,F11,coagulation cascade,serine protease activity,tumor progression,thrombin generation,cell adhesion,hemostatic regulation
ENSG00000106624,AEBP1,transcriptional regulation,epithelial-to-mesenchymal transition (emt),apoptosis suppression,oncogene activation,gene expression modulation,tumor progression
ENSG00000070748,CHAT,acetylcholine synthesis,apoptosis regulation,cellular stress response,hypoxia adaptation,metabolic reprogramming,neurotransmitter function
ENSG00000128791,TWSG1,signaling pathway dysregulation,epithelial-to-mesenchymal transition promotion,transcription factor activation,cell survival enhancement,tumor progression facilitation,therapeutic target potentialization
ENSG00000159723,AGRP,cellular proliferation,tumor progression,oncogenic role,neuroendocrine regulation,signaling pathway modulation,energy balance disruption
ENSG00000165195,PIGA,glycosylphosphatidylinositol (gpi) anchor,mutation hotspot,immune evasion,cell membrane integrity,protein anchoring,tumor growth and invasion
ENSG00000100564,PIGH,angiogenesis enhancer,tumor progression promoter,poor prognostic marker,protein-protein interaction,cell growth regulator,metastasis facilitator
ENSG00000127129,EDN2,angiogenesis promotion,cell proliferation enhancement,metastasis facilitation,receptor interaction,tumor progression marker,vasoconstrictor function
ENSG00000092009,CMA1,cellular homeostasis disruption,autophagic pathway deregulation,protein aggregation,oncogenic process promotion,tumor progression facilitation,cellular stress response alteration
ENSG00000132561,MATN2,tumor progression,cell adhesion regulation,epithelial-to-mesenchymal transition (emt) regulation,cell migration regulation,complex roles in cancer biology,potential oncogene/tumor suppressor
ENSG00000167103,PIP5KL1,pi3k/akt pathway activation,oncogene activity,cell proliferation enhancement,metastasis promotion,therapeutic target,phospholipid metabolism regulation
ENSG00000134247,PTGFRN,pi3k/akt signaling pathway regulation,tumor progression and metastasis,ion transport regulation,cellular proliferation and survival,oncogene function,signaling pathway interaction
ENSG00000134489,HRH4,histamine receptor regulation,immune evasion,metastasis promotion,tumor angiogenesis,g protein coupling,oncogenic interaction
ENSG00000150681,RGS18,cellular regulation,tumor suppressor/oncogene dualism,g-protein signaling modulation,oncogenic pathway activation,signaling pathway crosstalk,protein interaction and regulation
ENSG00000107518,ATRNL1,tumor suppressor function,cell cycle regulation,apoptosis regulation,dna damage response,genomic stability maintenance,cancer driver gene candidate
ENSG00000117322,CR2,complement system regulation,immunoglobulin binding,phagocytosis promotion,b cell activation,c3b fragment interaction,antigen presentation
ENSG00000036473,OTC,urea cycle regulation,cell proliferation,mitochondrial localization,amino acid metabolism,hyperammonemia,therapeutic target
ENSG00000129910,CDH15,tumor suppressor function,loss of cell adhesion,homophilic binding,cell migration inhibition,epithelial integrity maintenance,cancer initiation
ENSG00000204262,COL5A2,tumor microenvironment disruption,ecm composition alteration,cell adhesion regulation failure,protein-protein interaction dysregulation,oncogenesis promotion,genetic mutation association
ENSG00000003436,TFPI,cellular regulation,anti-inflammatory response,cancer metastasis,tumor suppressor function,cell migration inhibition,angiogenesis suppression 
ENSG00000139610,CELA1,lipid metabolism,tumor progression,cell survival,signaling pathway activation,mutations implicated,pancreatic cancer association
ENSG00000124159,MATN4,overexpression,tumor progression,cell proliferation,adhesion modulation,oncogene activation,prognostic marker
ENSG00000132031,MATN3,cellular adhesion,tumor invasion,angiogenesis promotion,metastasis enhancement,apoptosis resistance,enzymatic activity alteration
ENSG00000108963,DPH1,mapk pathway regulation,gain of function mutations,dysregulated signal transduction,cell proliferation enhancement,tumor suppression loss,phosphatase activity
ENSG00000004468,CD38,cell adhesion,calcium signaling,oncogenic transformation,immune response modulation,tumor growth promotion,metastasis facilitation
ENSG00000127311,HELB,transcriptional regulation,oncogenic function,cell proliferation,genetic instability,tumorigenesis,epigenetic modulation
ENSG00000135074,ADAM19,cell adhesion regulation,notch signaling pathway modulation,tumor progression facilitation,metastasis promotion,therapeutic target candidate,gene overexpression
ENSG00000172238,ATOH1,overexpression,wnt/β-catenin pathway interaction,cell cycle regulation,transcriptional activation,tumor suppressor/oncogene function,self-renewal/differentiation balance
ENSG00000101680,LAMA1,hemidesmosome formation,cell adhesion,integrin interaction,tumor progression,metastasis promotion,prognostic marker
ENSG00000242441,GTF2A1L,disrupted transcriptional regulation,aberrant expression patterns,mutations contributing to cancer,interaction with oncogenic pathways,critical role in pre-initiation complex formation,nuclear localization and rna polymerase ii recruitment
ENSG00000113100,CDH9,cell-cell adhesion disruption,oncogene function,tumor progression,pi3k/akt signaling pathway interaction,metastatic capabilities enhancement,epithelial tissue expression
ENSG00000223496,EXOSC6,cellular metabolism,constitutive activation,glycolysis regulation,rna degradation,therapeutic target,oncogenic process
ENSG00000146938,NLGN4X,synaptic function,cell signaling pathway interaction,neurological disorder association,oncogenesis contribution,tumor progression influence,x-linked intellectual disability linkage
ENSG00000211896,IGHG1,immunoglobulin production,antibody formation,b-cell development,germinal center formation,lymphoproliferation,humoral immunity
ENSG00000176406,RIMS2,cell cycle regulation,mitotic progression,cytokinesis regulation,cell division,oncogenesis,cancer progression
ENSG00000073849,ST6GAL1,tumor progression,aberrant glycosylation,oncogenic function,immune evasion,therapeutic target,genomic instability
ENSG00000081138,CDH7,cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt),oncogenic signaling,protein-protein interaction,tumor progression,metastasis regulation
ENSG00000113361,CDH6,tumor suppressor function,epithelial-to-mesenchymal transition inhibition,cell-cell adhesion regulation,aberrant signaling pathway activation,poor prognosis correlation,wnt/β-catenin pathway interaction
ENSG00000023839,ABCC2,multidrug resistance,tumor progression,phosphorylation-dependent transport,efflux transporter,xenobiotic efflux,drug sensitivity modulation
ENSG00000185252,ZNF74,cellular regulation,transcriptional regulation,oncogene regulation,tumor suppressor regulation,cell proliferation,apoptosis suppression
ENSG00000143196,DPT,oncogene,overexpression,tumor progression,cell signaling pathway,metastasis,cancer stem cell maintenance
ENSG00000198785,GRIN3A,glutamatergic neurotransmission,tumor progression,cell survival and growth,genomic instability,epigenetic alterations,synaptic plasticity
ENSG00000131183,SLC34A1,tumor progression,cell proliferation,growth factor regulation,angiogenesis promotion,genetic alterations,cancer metastasis
ENSG00000161513,FDXR,cancer driver gene,redox regulation,tumor progression,dna repair facilitation,cellular stress response modulation,protein disulfide reduction
ENSG00000197467,COL13A1,tumor progression,cell migration,metastasis facilitation,angiogenesis regulation,drug resistance,cell adhesion modulation
ENSG00000122367,LDB3,chromatin remodeling,gene expression regulation,transcriptional control,oncogenic processes,apoptosis modulation,cell cycle progression
ENSG00000196371,FUT4,tumor metastasis,oncogene,cell surface localization,glycosylation regulation,immune evasion,apoptosis resistance
ENSG00000142185,TRPM2,cancer progression,oncogenesis driver,tumor growth regulator,calcium influx mediator,cell death modulator,genomic instability contributor
ENSG00000164574,GALNT10,galnac-transferase activity,o-linked glycosylation,tumor progression,cell adhesion disruption,protein expression regulation,signaling pathway modulation
ENSG00000087237,CETP,lipid metabolism,angiogenesis,lipid profiles,tumor growth,overexpression,atherosclerosis
ENSG00000205916,DAZ4,genomic instability,dna repair regulation,tumor suppressor function,oncogene activation,cellular proliferation,genetic predisposition
ENSG00000112234,FBXL4,tumor suppression,cell cycle regulation,ubiquitin ligase complex,protein degradation pathway,genomic stability maintenance,cancer cell response modulation
ENSG00000040731,CDH10,epithelial-to-mesenchymal transition,cancer progression,cell adhesion disruption,tumor suppressor role,metastatic spread,prognostic marker
ENSG00000167642,SPINT2,inhibitor function,tumor suppression,regulatory protein interactions,cell migration regulation,epithelial-to-mesenchymal transition (emt),proteolytic pathway modulation
ENSG00000114270,COL7A1,type vii collagen expression,extracellular matrix disruption,cell migration promotion,tumor progression facilitation,angiogenesis enhancement,metastasis increase
ENSG00000148702,HABP2,dna repair mechanism,apoptosis regulation,cell survival promotion,oncogenic function,parp1 interaction,cancer association
ENSG00000134760,DSG1,cell adhesion disruption,tumor suppressor loss,adhesion molecule downregulation,epithelial-to-mesenchymal transition,autoimmune disease association,proliferation and invasion enhancement
ENSG00000099769,IGFALS,igf signaling pathway,cell proliferation,growth factor regulation,insulin-like growth factors,tumorigenesis driver,therapeutic target
ENSG00000186340,THBS2,angiogenic regulation,tumor progression promoter,cell adhesion facilitation,extracellular matrix modulation,signaling pathway interaction,prognostic marker
ENSG00000010818,HIVEP2,oncogene-induced senescence suppression,genomic instability,immune response regulation,tumor progression,protein-dna interaction,chromatin remodeling
ENSG00000159496,RGL4,gpcr signaling pathway,gain of function mutations,oncogene activation,tumor progression,metastasis regulation,epithelial-to-mesenchymal transition
ENSG00000100060,MFNG,melanogenesis regulation,oncogenic function,cell migration modulation,adhesion molecule interaction,proliferation enhancement,survival pathway involvement
ENSG00000106003,LFNG,notch signaling,cellular adhesion disruption,tumor progression driver,signaling pathway modulation,glycosyltransferase activity,oncogenic process regulation
ENSG00000130988,RGN,rab protein regulation,gtpase activation,cell trafficking dysregulation,tumor promotion,signaling pathway interaction,biomarker and therapeutic target
,FAM57A,pi3k/akt/mtor pathway activation,oncogene,cell proliferation enhancement,gtp-binding activity,protein-protein interaction,tumorigenesis promotion
ENSG00000010072,SPRTN,genomic instability,dna repair pathways,oncogenic mutations,tumor progression,increased proliferation,genome maintenance
ENSG00000182240,BACE2,amyloid precursor protein regulation,cell growth modulation,neuroprotection,pi3k/akt pathway interaction,protein processing regulation,tumor suppressor function
ENSG00000111785,RIC8B,g-protein activation,cancer progression,tumor aggressiveness,cell proliferation,gef regulation,protein kinase interaction
ENSG00000103495,MAZ,apoptosis suppression,cell proliferation enhancement,chromatin remodeling,dna binding activity,epigenetic regulation,gene expression modulation
ENSG00000149575,SCN2B,hyperexcitability,oncogenic potential,cell proliferation,metastasis promotion,prognostic marker,signaling pathway interaction
ENSG00000166947,EPB42,rho gtpase signaling pathway,cell adhesion regulation,oncogenic transformation,metastatic potential,anchorage-independent growth,cytoskeletal remodeling
ENSG00000120903,CHRNA2,nicotinic acetylcholine receptor activation,cell proliferation,tumor progression,therapeutic target,ion channel regulation,gene expression modulation
ENSG00000221946,FXYD7,ion transport regulation,oncogene function,cell proliferation promotion,na+/k+-atpase interaction,sodium pump modulation,therapeutic target potential
ENSG00000282049,PRSS2,tumor suppressor function loss,loss of function mutations,protein processing regulation,cellular homeostasis disruption,tumor growth promotion,metastasis facilitation
ENSG00000196526,AFAP1,actin cytoskeleton regulation,tumor growth promotion,metastasis facilitation,oncogene overexpression,pi3k/akt pathway activation,transcription factor regulation
ENSG00000197614,MFAP5,tumor progression,metastasis enhancement,cell adhesion regulation,epithelial tissue expression,protein-protein interactions,upregulated expression levels
ENSG00000058085,LAMC2,cell adhesion,tumor progression,extracellular matrix formation,oncogenic processes,angiogenesis promotion,prognostic biomarker
ENSG00000048028,USP28,genomic instability,dna repair mechanism,cell survival pathways,transcriptional regulation,nf-κb signaling,deubiquitinating enzyme
ENSG00000126746,ZNF384,cell cycle regulation,oncogenic transcription factor,tumor suppressor disruption,apoptosis evasion,genomic instability driver,therapeutic target potential
ENSG00000177103,DSCAML1,immune modulation,cell-cell interactions,transmembrane protein,adhesion regulation,tumor growth influence,immunotherapy target
ENSG00000116962,NID1,overexpression,basement membrane formation,cell migration and invasion,protein-protein interaction,signal transduction regulation,tumor aggressiveness
ENSG00000146276,GABRR1,neurotransmitter regulation,gaba receptor subunit,chloride channel function,neuronal excitability,synaptic plasticity,genetic variation
ENSG00000186583,SPATC1,genomic instability,cell cycle regulation,tumor suppressor function,dna damage response,centrosome duplication,oncogenic transformation
ENSG00000204084,INPP5B,cell membrane regulation,inositol phosphate homeostasis,dephosphorylation of irs1,insulin/igf-1 signaling pathway,oncogenic potential,tumor progression
ENSG00000108830,RND2,cell migration,actin cytoskeleton reorganization,oncogenic potential,tumor progression,cell invasion,metastasis
ENSG00000042832,TG,cancer-promoting activity,tumor progression facilitation,cell adhesion regulation,polyamination-dependent protein modification,cross-linking enzyme function,pi3k/akt/mtor pathway interaction
ENSG00000107789,MINPP1,phosphoinositide regulation,tumor suppressor function,genomic stability maintenance,cell survival promotion,dna damage response regulation,therapeutic target identification
ENSG00000277445,CPEB1,cytoplasmic polyadenylation,rna-binding protein,translation regulation,oncogenic pathway activation,tumor growth promotion,metastasis enhancement
ENSG00000197375,SLC22A5,chemotherapy resistance,xenobiotic transport,organic cation uptake,liver-specific expression,drug transport modulation,chemotherapeutic agent interaction
ENSG00000197208,SLC22A4,oncogenic function,cell proliferation regulation,metabolic support,tumor growth facilitation,pi3k/akt pathway interaction,protein-protein interaction
ENSG00000084453,SLCO1A2,chemoresistance,drug transport regulation,cellular metabolism modulation,oncogenic signaling interaction,therapeutic target modulation,genomic stability maintenance
ENSG00000064205,CCN5,cellular adhesion,angiogenesis promotion,tumor progression,epithelial-to-mesenchymal transition,apoptosis regulation,metastasis facilitation
ENSG00000160349,LCN1,iron metabolism regulator,host defense peptide binder,pi3k/akt pathway modulator,oncogene upregulation,cellular proliferation enhancer,tumor aggressiveness marker
ENSG00000090382,LYZ,cell proliferation,prognostic marker,tumor progression,antimicrobial activity,pi3k/akt pathway interaction,oncogenesis
ENSG00000100031,GGT1,glutathione metabolism,detoxification process,cellular proliferation,drug resistance,redox balance,dna damage repair
ENSG00000077984,CST7,cellular degradation,lysosomal function,extracellular matrix remodeling,tumor progression,metastasis driver,therapeutic target
ENSG00000196104,SPOCK3,wnt/β-catenin pathway,extracellular matrix association,cell migration promotion,tumor progression facilitation,integrin interaction,angiogenesis regulation
ENSG00000107742,SPOCK2,cellular adhesion modulation,extracellular matrix interaction,glycosaminoglycan binding,lrr domain protein,oncogenic progression,tumor cell migration 
ENSG00000160963,COL26A1,high molecular weight complexes,cellular adhesion disruption,tumor invasion promotion,epithelial barrier function loss,cell signaling pathway dysregulation,mucin family interaction
ENSG00000186998,EMID1,mitotic spindle regulation,chromosomal stability,oncogene function,cell proliferation driver,chemotherapy resistance,cell cycle regulation
ENSG00000126562,WNK4,regulation of ion transport,tumor progression,cell growth promotion,electrolyte balance disruption,serine/threonine kinase activity,genomic instability
ENSG00000070915,SLC12A3,ion channel regulation,electrolyte balance modulation,cellular proliferation regulation,tumor microenvironment interaction,cancer cell survival enhancement,genomic instability promotion
ENSG00000050438,SLC4A8,anion exchange,cell migration,gain of function mutations,interacts with wnt/β-catenin,promotes cell proliferation,tumor microenvironment modulation
ENSG00000109861,CTSC,tumor progression,cell migration,invasion,signaling pathway modulation,protease activity,dysregulation
ENSG00000115386,REG1A,oncogene activation,transcription factor regulation,cell proliferation promotion,apoptosis inhibition,tumor growth enhancement,metastasis facilitation
ENSG00000172016,REG3A,cellular differentiation,epithelial-to-mesenchymal transition,oncogenic function,protein-protein interaction,tumor progression,cell migration
ENSG00000179403,VWA1,vwa-integrin interaction,cancer cell adhesion,scaffold protein function,tumor metastasis,oncogenic phenotype,biomarker potential
ENSG00000148926,ADM,cell survival,tumor progression,apoptosis regulation,stress response,angiogenesis promotion,therapeutic target
ENSG00000078401,EDN1,vasoconstriction,angiogenesis promotion,cell proliferation enhancement,tumor progression facilitation,endothelial cell interaction,metastatic potential increase
ENSG00000173171,MTX1,cellular interaction modulation,tumor progression facilitation,metastasis promotion,adhesion and detachment regulation,migration and invasion enablement,upregulated expression in cancer cells
ENSG00000145730,PAM,cellular growth regulation,oncogenesis involvement,tumor development,cell proliferation,gene expression regulation,salivary gland tumor association
ENSG00000121236,TRIM6,tumor suppression,apoptosis regulation,cell cycle control,protein ubiquitination,nuclear localization,cellular growth regulation
ENSG00000125834,STK35,genomic instability,oncogenic driver,dna repair regulation,sister chromatid cohesion,chromosomal instability,therapeutic target
ENSG00000104415,CCN4,angiogenic factor,cell adhesion molecule,integrin interaction,signaling pathway modulation,tumor microenvironment regulation,prognostic marker
ENSG00000142156,COL6A1,tumor progression,metastasis promotion,cell migration regulation,oncogenic signaling pathway,therapeutic target,extracellular matrix remodeling
ENSG00000162510,MATN1,oncogenic suppression,cell-cell adhesion,tumor suppressor function,cell migration regulation,gene expression regulation,protein-protein interaction
ENSG00000030304,MUSK,pi3k/akt pathway modulation,oncogenic driver,cell growth regulation,protein-protein interaction,signaling pathway regulation,tumorigenesis promoter
ENSG00000170498,KISS1,metastatic suppression,tumor growth inhibition,apoptosis regulation,cell differentiation modulation,signaling pathway interaction,tumor suppressor function
ENSG00000105880,DLX5,transcriptional regulation,oncogenesis promotion,cell proliferation enhancement,tumor progression facilitation,genomic instability contribution,therapeutic target potential
ENSG00000128872,TMOD2,cytoskeleton regulation,actin filament modulation,cell migration promotion,tumor progression enhancement,metastasis facilitation,potential therapeutic target
ENSG00000171199,OPRPN,opioid peptide receptor family,cell signaling regulation,mapk/erk pathway activation,tumor progression promotion,cell proliferation modulation,epigenetic regulation influence
ENSG00000121552,CSTA,epithelial-to-mesenchymal transition,oncogene overexpression,pi3k/akt pathway activation,tumor progression facilitation,cell adhesion modulation,signaling pathway interaction
ENSG00000140465,CYP1A1,tumor promoter,genomic instability,metabolic activation,reactive oxygen species formation,cancer susceptibility,xenobiotic metabolism
ENSG00000171533,MAP6,genomic instability,microtubule regulation,cell migration,oncogene activity,dna repair mechanisms,mitotic spindle stabilization
ENSG00000145864,GABRB2,gaba receptor function,immune microenvironment modulation,neurotransmission regulation,cell proliferation modulation,apoptosis influence,tumor growth suppression
ENSG00000115993,TRAK2,microtubule dynamics,cell trafficking regulation,cytoskeleton regulation,apoptosis regulation,autophagy regulation,therapeutic target
ENSG00000182256,GABRG3,altered signaling pathways,cellular homeostasis,indirect influence on cancer progression,neuronal development regulation,roles in cellular stress response,ion channel subunit function
ENSG00000131089,ARHGEF9,rho/rock pathway,oncogenic signaling,gtpase activation,cell migration,invasion and metastasis,cell cycle progression
ENSG00000187955,COL14A1,overexpression,prognostic marker,ecm modulation,cancer cell adhesion,metastasis promotion,cell migration regulation
ENSG00000196767,POU3F4,transcriptional regulation,tumor suppressor function,neuronal differentiation,histone modification,chromatin remodeling,oncogenic repression
ENSG00000157152,SYN2,microrna regulation,tumor progression,metastasis,protein kinase activation,synaptic plasticity,neurotransmitter release
ENSG00000185666,SYN3,overexpression,metastasis regulation,epithelial-to-mesenchymal transition (emt),biomarker,cellular adhesion modulation,synaptic neurexin-iii function
ENSG00000159197,KCNE2,potassium channel regulation,ion flux imbalance,cardiac arrhythmia susceptibility,voltage-gated potassium channels,cell membrane ion transport,genetic mutation association
ENSG00000188783,PRELP,cell adhesion regulation,tumor progression inhibition,metastasis suppression,epithelial integrity maintenance,prognostic biomarker potential,extracellular matrix interaction
ENSG00000151704,KCNJ1,cellular excitability,electrical properties modulation,ion channel regulation,oncogenesis promotion,tumor growth facilitation,drug resistance association
ENSG00000054967,RELT,cell adhesion signaling,integrin binding,pi3k/akt activation,cell migration regulation,oncogenic processes,therapeutic target
ENSG00000198502,HLA-DRB5,antigen presentation,tumor immunosurveillance,immune evasion,adaptive immune response,mhc class ii molecule,immunogenic peptide presentation
ENSG00000167635,ZNF146,tumor suppressor function,krab domain-mediated repression,transcriptional regulation,cellular homeostasis,apoptosis induction,cancer-related gene expression
ENSG00000080573,COL5A3,type v collagen production,ecm remodeling,cancer metastasis,cell adhesion modulation,therapeutic target,tissue stiffness regulation
ENSG00000109471,IL2,t-cell activation,gene expression regulation,immune response modulation,cancer immunotherapy target,proliferation and differentiation regulation,tumor-infiltrating lymphocyte stimulation
ENSG00000087494,PTHLH,tumor progression,cell survival inhibition,angiogenesis promotion,oncogenic signaling,cell growth regulation,prognostic marker
ENSG00000027644,INSRR,tumor growth promotion,pi3k/akt/mtor pathway activation,cell proliferation enhancement,survival pathway regulation,angiogenesis modulation,apoptosis inhibition
ENSG00000132692,BCAN,epithelial-to-mesenchymal transition,cell adhesion regulation,metastasis promotion,cancer cell migration,therapeutic target identification,prognostic biomarker
ENSG00000263290,SCAMP3,lysosomal trafficking dysregulation,tumor growth promotion,cell proliferation enhancement,protein-protein interaction,genomic amplification,oncogenic driver
ENSG00000171209,CSN3,ubiquitin-proteasome pathway regulation,deubiquitination,protein stabilization,oncoprotein accumulation,tumorigenesis promotion,signal transduction modulation
ENSG00000169676,DRD5,epigenetic regulation,g protein-coupled receptor signaling,cell proliferation enhancement,oncogene function,tumor microenvironment modulation,dopamine receptor activation
ENSG00000099866,MADCAM1,cell adhesion,tumor progression,metastasis,immune responses,constitutive expression,cell migration
ENSG00000261701,HPR,tumor suppressor,e3 ubiquitin ligase activity,cell cycle regulation,apoptosis regulation,pi3k/akt pathway regulation,prognostic marker
ENSG00000088320,REM1,tumor immune evasion,antigen presentation regulation,immunosuppressive tumor microenvironment,major histocompatibility complex class i family,cd4+ t-cell interaction,nk cell interaction
ENSG00000143590,EFNA3,enhanced cell proliferation,oncogenic properties,aberrant activation,tumor growth,metastasis,cell migration
ENSG00000159640,ACE,angiogenesis,blood pressure regulation,electrolyte balance,inflammation promotion,tissue remodeling,ras pathway modulation
ENSG00000120708,TGFBI,epithelial integrity regulation,cell adhesion modulation,signaling pathway interaction,cancer progression role,genomic instability link,protein-protein interaction
ENSG00000163141,BNIPL,apoptosis regulator,cell cycle progression,dna repair mechanism,genomic instability,nuclear protein,tumor suppressor function
ENSG00000104537,ANXA13,enhanced cell motility,tumor cell invasion,oncogene overexpression,cell membrane trafficking,apoptosis resistance,metastasis promotion
ENSG00000175564,UCP3,mitochondrial carrier protein,fatty acid oxidation,cellular respiration,tumor suppression,cancer metabolism regulation,energy homeostasis
,C1orf61,long non-coding rna,cellular proliferation,epigenetic regulation,transcriptional modulation,chromatin remodeling,oncogenic function
ENSG00000041982,TNC,tumor progression,cell migration,cell adhesion,angiogenesis promotion,epithelial-to-mesenchymal transition,oncogenic effects
ENSG00000164588,HCN1,cellular excitability,oncogenic process,therapeutic resistance,apoptosis evasion,cell cycle progression,protein-protein interaction
ENSG00000123066,MED13L,oncogene activity,transcriptional regulation,gene expression modulation,cell proliferation enhancement,tumor growth promotion,chromatin remodeling involvement
ENSG00000176909,MAMSTR,cell migration,oncogenic function,tumor metastasis,cell proliferation,signaling pathway regulation,cytoplasmic localization
ENSG00000187688,TRPV2,trp channel activation,apoptosis inhibition,cell proliferation,oncogenesis,pain signaling,channel function
ENSG00000196689,TRPV1,pain modulation,overexpression,inflammatory response regulation,cell growth promotion,survival pathway activation,signaling pathway interaction
ENSG00000164117,FBXO8,aberrant protein accumulation,cell cycle regulation disruption,oncogene activation,proteasomal degradation impairment,tumor suppressor function loss,ubiquitination pathway alteration
ENSG00000141665,FBXO15,wnt/β-catenin pathway,cell cycle progression,proteasomal degradation,genomic instability,tumor aggressiveness,amplification
ENSG00000147255,IGSF1,immunoglobulin superfamily member,cell-cell interaction regulation,tumor suppression hypothesis,cancer cell adhesion modulation,potential therapeutic target,immune response regulation
ENSG00000156671,SAMD8,protein degradation regulation,ubiquitin-proteasome pathway modulation,co-amplification with oncogenes,tumor growth promotion,cancer cell survival enhancement,biological pathway disruption
ENSG00000206073,SERPINB4,proteolytic regulation,tumor progression,apoptosis modulation,cancer subtype variability,cell survival enhancement,tissue remodeling
ENSG00000163131,CTSS,proteolytic activity,antigen presentation,growth factor activation,tumor progression,metastasis,immune evasion
ENSG00000126838,PZP,oncogenic mutations,growth factor regulation,cell migration,immune modulation,tumor microenvironment,secreted glycoprotein
ENSG00000182742,HOXB4,hoxb4 overexpression,transcriptional regulation,embryonic development,cellular self-renewal,angiogenesis,therapeutic target
ENSG00000285121,MTCH2,mitochondrial dysfunction,tumor suppressor function,apoptosis regulation,metabolic reprogramming,cell survival enhancement,autophagy modulation
ENSG00000272398,CD24,tumor progression,emt induction,epithelial-to-mesenchymal transition,cell adhesion disruption,metastatic potential,prognostic marker
ENSG00000177879,AP3S1,ap-3 trafficking,autophagy regulation,apoptosis modulation,mitochondrial function,lysosomal sorting,cellular trafficking
ENSG00000105376,ICAM5,metastasis,cell adhesion modulation,pro-tumorigenic microenvironment,cell migration enhancement,tumor progression promotion,cancer cell dissemination facilitation
ENSG00000112280,COL9A1,tumor progression,metastasis promotion,prognostic marker,cell migration facilitation,extracellular matrix degradation,signaling pathway regulation
ENSG00000160013,PTGIR,prostaglandin receptor regulation,tumor progression,metastasis promotion,oncogenic activity,angiogenesis induction,gene overexpression
ENSG00000276613,MUC4,egfr interaction,oncogenesis,cell proliferation,tumor progression,immunotherapeutic target,epithelial barrier function
ENSG00000073754,CD5L,cellular lipid metabolism,phosphatidylserine transport,tumor growth promotion,apoptosis regulation,signaling pathway modulation,cell surface protein interaction
ENSG00000136381,IREB2,iron metabolism regulation,tumor progression promoter,cellular iron homeostasis disruption,protein interaction network,therapeutic target candidate,oncogene upregulation
ENSG00000178473,UCN3,tumor progression,cell proliferation,protein expression regulation,signaling pathway modulation,stress response regulation,oncogenic driver status
ENSG00000198252,STYX,microtubule regulation,genomic instability,oncogenic transformation,cell division disruption,mitotic checkpoint control,spindle assembly modulation
ENSG00000126759,CFP,calcium homeostasis,hormone regulation,bone metabolism,osteoclast activity,tumor biomarker potential,genetic regulation
ENSG00000082258,CCNT2,microtubule stabilization,cell cycle regulation,tumor progression,multinucleation,chromosomal instability,dna damage response
ENSG00000169131,ZNF354A,genomic instability,tumor suppressor function,cell cycle regulation,dna repair mechanism,transcriptional regulation,oncogenesis
ENSG00000134765,DSC1,lipid metabolism disruption,membrane repair impairment,protein trafficking dysfunction,sarcolemma protein insertion defect,calcium signaling alteration,muscle cell degeneration
ENSG00000138769,CDKL2,genomic instability,cell cycle progression,tumor growth,protein kinase activation,dna repair regulation,serine/threonine phosphorylation
ENSG00000116353,MECR,dna repair,genomic integrity,methylated cytosine maintenance,oxidative damage correction,epigenetic regulation,base excision repair
ENSG00000152208,GRID2,calcium signaling,oncogene function,nmda receptor subunit,tumor progression,cell proliferation,protein-protein interactions
ENSG00000105929,ATP6V0A4,tumor growth,cell migration,lysosomal function,proton pumping activity,metastasis promotion,acidic microenvironment
ENSG00000105825,TFPI2,cell migration,angiogenesis,tumor progression,apoptosis inhibition,fibrinolysis regulation,cancer metastasis
ENSG00000187848,P2RX2,ion channel activation,tumor progression,angiogenesis promotion,immune modulation,chemotherapy resistance,ligand-gated signaling
ENSG00000179142,CYP11B2,mineralocorticoid biosynthesis,glucocorticoid production,tumor growth promotion,cell proliferation enhancement,metastatic potential increase,apoptosis suppression
ENSG00000241484,ARHGAP8,rhogtpase regulation,tumor suppressor function,cell migration modulation,oncogenic signaling inhibition,metastasis promotion,rhoa interaction
ENSG00000100234,TIMP3,genetic regulation,tumor suppression,inhibitory protein,cell migration inhibition,anti-angiogenic effects,dna damage response
ENSG00000116183,PAPPA2,extracellular matrix degradation,cell migration,tumor invasion,angiogenesis promotion,growth factor regulation,signaling pathway modulation
ENSG00000117122,MFAP2,microfibril formation,tumor growth promotion,extracellular matrix interaction,cell migration regulation,glycoprotein secretion,metastasis facilitation
ENSG00000166402,TUB,microtubule dynamics,tumor progression,aneuploidy,genomic instability,mitotic alterations,cancer therapy target
ENSG00000182752,PAPPA,igf-binding regulation,tumor progression,metastasis promotion,therapeutic resistance,angiogenesis facilitation,cell proliferation enhancement
ENSG00000169213,RAB3B,rab3b overexpression,regulation of vesicle trafficking,neurotransmitter release,cell proliferation enhancement,tumor suppressor p53 interaction,autophagy regulation
ENSG00000280706,REXO4,nucleolar localization,rna degradation,ribonuclease activity,rrna processing,tumorigenic potential,cellular proliferation regulator
ENSG00000116117,PARD3B,cell polarity disruption,disrupted epithelial integrity,tumor progression,gene mutation,protein-protein interaction,pi3k/akt pathway modulation
ENSG00000144355,DLX1,transcriptional regulation,cell proliferation,oncogenic transformation,tissue patterning,embryogenesis,cancer progression
ENSG00000103811,CTSH,aberrant expression,altered cell cycle regulation,cancer progression,cellular homeostasis disruption,oncogenic processes,proteolytic activity regulation
ENSG00000168539,CHRM1,cholinergic system regulation,oncogenic potential,g protein-coupled receptor function,cell proliferation modulation,apoptosis induction,tumor suppressor activity
ENSG00000185668,POU3F1,transcription factor regulation,oncogenic pathway activation,cell proliferation modulation,chromatin remodeling,apoptosis suppression,pan-cancer involvement
ENSG00000170430,MGMT,dna repair mechanism,chemotherapy resistance,tumor progression marker,genomic instability,epigenetic regulation,cancer stem cell maintenance
ENSG00000111783,RFX4,transcriptional regulation,cell growth control,chromatin remodeling,oncogenic function,cell proliferation,metastasis promotion
ENSG00000105695,MAG,tumor suppressor dysfunction,cell adhesion disruption,signal transduction alteration,growth factor regulation,cell migration enhancement,myelin maintenance compromise
ENSG00000138496,PARP9,oncogenesis,epigenetic regulation,dna repair dysfunction,chromatin remodeling,immune evasion mechanism,apoptosis suppression
ENSG00000112599,GUCA1B,cgmp-dependent protein kinase activation,constitutive activation,gain of function mutations,oncogenic driver,cell proliferation,cellular homeostasis
ENSG00000203668,CHML,cell adhesion,hematopoietic regulation,cell signaling,protein interaction,oncogene activation,lymphocyte maturation
ENSG00000108961,RANGRF,pi3k/akt pathway activation,growth factor signaling,cell proliferation enhancement,tumor progression facilitation,epithelial-to-mesenchymal transition regulation,cancer diagnosis biomarker
ENSG00000166816,LDHD,metabolic regulation,tumor metabolism,hypoxia response,angiogenesis promotion,poor prognosis marker,cell survival enhancement
ENSG00000100979,PLTP,overexpression,tumor cell proliferation,oncogenesis,lipid metabolism regulation,immune modulation,therapeutic target
ENSG00000141086,CTRL,rna degradation pathway,nmd complex component,3'-5' helicase-dependent degradation,mrna surveillance,cellular stress response,none
ENSG00000105371,ICAM4,platelet-erythrocyte interaction,cell adhesion,tumor progression,hematopoiesis regulation,prognostic biomarker,therapeutic target
ENSG00000213918,DNASE1,genomic instability,telomere destabilization,chromatin remodeling,apoptosis regulation,cell proliferation,oncogene potential
ENSG00000187244,BCAM,metastasis marker,cell migration,tumor progression,angiogenesis promotion,epithelial-to-mesenchymal transition,oncogenic signaling
ENSG00000135622,SEMA4F,tumor suppressor function,cell migration regulation,angiogenesis inhibition,metastasis suppression,cell adhesion modulation,cancer prognosis impact
ENSG00000174611,KY,microtubule dynamics,oncogenic function,amplification and overexpression,cell proliferation,signaling pathway activation,tumor progression
ENSG00000274619,CFD,complement activation,immune evasion,tumor immunity suppression,oncogenic inflammation,tissue damage,prognostic marker
ENSG00000185313,SCN10A,voltage-gated sodium channel,oncogenic signaling,tumor growth promotion,chemotherapy resistance,cellular excitability regulation,ion channel interaction
ENSG00000155897,ADCY8,camp signaling,oncogenic process,cell proliferation,metabolic regulation,gene expression,protein kinase activation
ENSG00000072315,TRPC5,calcium influx regulation,tumor progression,cell proliferation,signaling pathway modulation,protein interaction,ion channel function
ENSG00000240771,ARHGEF25,rho gtpase activation,cell migration and invasion,tumor progression,metastasis formation,signaling pathway modulation,gef activity regulation
ENSG00000104880,ARHGEF18,rho gtpase activation,guanine nucleotide exchange factor,cdc42 activation,metastasis driver,cell migration regulation,tumor progression
ENSG00000145681,HAPLN1,cell proliferation,tumor progression,oncogene potential,extracellular matrix interaction,proteoglycan regulation,cell adhesion modulation
ENSG00000163888,CAMK2N2,camkii pathway,dysregulated expression,genomic instability,oncogenic processes,protein kinase regulation,tumor progression
ENSG00000168263,KCNV2,ion channel function,oncogenic activation,cellular excitability,tumor progression,therapeutic resistance,genetic mutations
ENSG00000062598,ELMO2,cell migration,oncogene activation,rac1/cdc42 pathway,actin cytoskeleton reorganization,tumor progression,metastasis resistance
ENSG00000069424,KCNAB2,disrupted cellular signaling,overexpressed in tumors,tumor progression,cell cycle dysregulation,oncogenic processes,signaling pathway interaction
ENSG00000169282,KCNAB1,ion channel regulation,cellular excitability disruption,oncogenic potential,tumor progression facilitation,protein interaction modulation,gene expression alteration
ENSG00000170890,PLA2G1B,oncogenic function,pro-inflammatory mediator generation,tumor growth promotion,metastasis facilitation,angiogenesis modulation,cell signaling pathway regulation
ENSG00000173432,SAA1,acute phase response,inflammation regulation,immune modulation,tumor growth promotion,metastasis facilitation,chronic inflammation association
ENSG00000137872,SEMA6D,tumor suppressor function,loss of expression,increased cell migration,cell adhesion modulation,integrin interaction,metastatic potential
ENSG00000114554,PLXNA1,tumor progression,cell migration,therapeutic target,signaling pathway regulation,epithelial-to-mesenchymal transition (emt),angiogenesis
ENSG00000118263,KLF7,tumor suppressor function,loss of expression,cell proliferation regulation,epithelial integrity maintenance,wnt/β-catenin pathway modulation,cancer prognosis correlation
ENSG00000123843,C4BPB,complement regulation,tumor progression,immune evasion,cell proliferation,metastasis regulation,protein binding
ENSG00000005243,COPZ2,protein quality control,heat shock protein regulation,cellular homeostasis,tumorigenesis driver,apoptosis modulation,cancer cell proliferation
ENSG00000131771,PPP1R1B,dysregulation of pp1 activity,tumor growth and proliferation,mutations in cancer,regulation of cell migration,interactions with key oncogenes,
ENSG00000285456,LTB4R,leukotriene signaling pathway,nf-κb activation,inflammation-mediated growth,immune cell recruitment,pro-tumorigenic microenvironment,tumor angiogenesis
ENSG00000198049,AVPR1B,cellular growth regulation,signaling pathway activation,oncogenic potential,gene expression regulation,cellular stress response,therapeutic target
ENSG00000165462,PHOX2A,tumor progression,constitutive activation,oncogenic process,deregulation of gene expression,transcriptional regulation,proliferation and invasion
ENSG00000103145,HCFC1R1,transcriptional regulation,chromatin remodeling,cell proliferation,gene expression modulation,protein-protein interaction,cancer cell survival
ENSG00000196517,SLC6A9,neurotransmitter transport,cell growth regulation,altered expression levels,tumor progression,biomarker potential,genetic variability
ENSG00000111886,GABRR2,pi3k/akt pathway interaction,receptor dysfunction,inhibitory neurotransmission,cell survival enhancement,neuronal excitability regulation,tumorigenesis facilitation
ENSG00000188419,CHM,retinal maintenance,photoreceptor degeneration,vision loss,transport regulation,protein-protein interaction,none
ENSG00000158985,CDC42SE2,gef activity,gtpase regulation,cancer metastasis,prognostic biomarker,cell adhesion disruption,tumor progression driver
ENSG00000137103,TMEM8B,calcium signaling regulation,constitutive activation,calcium channel modulation,tumor progression,cellular growth regulation,genomic instability
,GRASP,pi3k/akt signaling pathway,overexpression,oncogenic properties,cell growth regulation,survival promotion,therapeutic target
ENSG00000186795,KCNK18,neuronal excitability modulation,tumor progression driver,ion channel regulation,cellular signaling pathway alteration,potential therapeutic target,genomic instability susceptibility
ENSG00000182771,GRID1,nmda receptor signaling,tumor progression,cell proliferation,oncogenic processes,therapeutic target,genomic profiling
ENSG00000114646,CSPG5,tumor progression,cell adhesion regulation,metastasis promoter,signaling pathway modulation,cell migration enhancement,angiogenesis regulator
ENSG00000134184,GSTM1,cancer susceptibility,detoxification pathway,epigenetic regulation,metabolic regulation,oxidative stress resistance,silenced expression
ENSG00000129214,SHBG,hormone regulation,tumor progression,protein-protein interaction,dysregulation,oncogenesis,cellular availability
ENSG00000167749,KLK4,serine protease function,cellular proliferation regulation,tumor progression driver,oncogenic properties,signaling pathway modulation,proteolytic activity
ENSG00000145526,CDH18,cell-cell adhesion,epithelial-to-mesenchymal transition (emt),tumor suppressor function,glycoprotein interactions,wnt/β-catenin signaling pathway,transcriptional regulation
ENSG00000071991,CDH19,disrupted adhesion,epithelial-to-mesenchymal transition (emt),oncogenic signaling pathways,cell migration and invasion,aberrant expression patterns,cellular proliferation
ENSG00000063438,AHRR,cellular homeostasis,oxidative stress regulation,ahr signaling pathway,metabolic regulation,immune response modulation,therapeutic target
ENSG00000110697,PITPNM1,ps flippase regulation,constitutive activation,oncogenic potential,pi3k/akt pathway modulation,cell membrane asymmetry maintenance,overexpression or mutation leading to tumorigenesis
ENSG00000285346,CTRB1,oncogenic signaling pathway,aberrant expression,cell invasion,metastasis facilitation,proteolytic activity,tumor progression
ENSG00000164418,GRIK2,tumor progression,neuronal excitability,synaptic plasticity,glutamate receptor function,ion channel regulation,signal transduction pathway interaction
ENSG00000005421,PON1,oxidative stress regulation,detoxification,cell proliferation inhibition,angiogenesis promotion,antioxidant defense,lipid metabolism
ENSG00000134757,DSG3,epithelial-to-mesenchymal transition,loss of cell-cell adhesion,altered expression patterns,cadherin superfamily member,tumor progression,cell migration
ENSG00000141298,SSH2,genomic instability,chromosomal instability,tumor suppressor function,deubiquitinating enzyme activity,dna repair regulation,cell cycle control maintenance
ENSG00000162461,SLC25A34,mitochondrial carrier function,nucleoside transport regulation,cellular metabolism regulation,energy metabolism alteration,tumor suppressor potential,cancer-related gene expression alterations
ENSG00000175920,DOK7,egfr activation,cell migration,pro-survival signals,tumor progression,oncogenic driver,metastasis promoter
ENSG00000124102,PI3,pi3k/akt pathway,regulatory subunit,gain of function mutations,tumor progression,therapeutic target,cell survival enhancement
ENSG00000187682,ERAS,e3 ubiquitin ligase activation,cell cycle regulation,oncogene regulation,tumor progression,therapeutic target,genomic instability
ENSG00000113249,HAVCR1,apoptotic cell recognition,immune evasion mechanisms,tumor associated antigen,phagocytic receptor function,immune suppression pathways,cancer immunotherapy target
ENSG00000154330,PGM5,enhanced glucose uptake,altered metabolism,aerobic glycolysis,cell proliferation,oncogenic processes,glycolytic pathway regulation
ENSG00000164816,DEFA5,antimicrobial activity,immune system regulation,pathogen disruption,tissue protection,inflammation modulation,microbial membrane interaction
ENSG00000171303,KCNK3,apoptosis regulation,cellular metabolism regulation,voltage-gated potassium channel,tumor progression,cell survival promotion,genomic instability
ENSG00000166035,LIPC,fatty acid metabolism,tumor progression,lipid regulation,metabolic reprogramming,cellular proliferation,oncogenesis
ENSG00000150281,CTF1,genomic instability,dna methyltransferase,tumor suppressor function,gene silencing,oncogene activation,genomic stability maintenance
ENSG00000158815,FGF17,fgf signaling pathway,tumor growth,gene amplification,oncogenesis,cell proliferation,metastasis
ENSG00000182871,COL18A1,tumor progression,cell adhesion modulation,angiogenesis regulation,extracellular matrix remodeling,tumor growth promotion,metastasis facilitation
ENSG00000170502,NUDT9,genomic stability,cellular response to dna damage,apoptosis regulation,tumor suppressor function,mutation sensitivity,genetic instability
ENSG00000154080,CHST9,proteoglycan sulfation,cell proliferation,apoptosis regulation,tumor progression,metastasis promotion,extracellular matrix remodeling
ENSG00000145777,TSLP,immune system modulation,tumor growth promotion,dysregulated expression,oncogenic pathway activation,epithelial cell-derived cytokine,type 2 immune response induction
ENSG00000054179,ENTPD2,tumor microenvironment modulation,cell proliferation regulation,apoptosis regulation,extracellular nucleotide hydrolysis,cancer cell growth promotion,oncogenic process facilitation
ENSG00000006652,IFRD1,apoptosis regulation,tumor progression,cell proliferation,immune response modulation,dna repair regulation,genetic instability
ENSG00000162747,FCGR3B,fc-gamma receptor 3b,phagocytosis regulation,tumor progression factor,immune evasion mechanism,cancer-related dysregulation,cell surface receptor expression
ENSG00000112936,C7,complement system dysregulation,tumor progression,cell survival,metastasis promotion,immune evasion,genomic instability
ENSG00000169836,TACR3,cell proliferation,dysregulated signaling pathways,immune evasion,mapk/erk activation,promoter hypermethylation,therapeutic target
ENSG00000168056,LTBP3,enhances cell migration,tgf-beta signaling regulation,oncogenic processes promotion,cellular growth control disruption,metastasis facilitation,extracellular matrix association
ENSG00000169385,RNASE2,antisense rna degradation,cellular localization,genomic instability,immune response modulation,microrna regulation,ribonuclease activity
ENSG00000138435,CHRNA1,nicotinic acetylcholine receptor signaling,aberrant expression,cancer cell migration,tumor growth regulation,therapeutic target,genomic instability
ENSG00000164619,BMPER,tumor promoter,angiogenic pathway regulation,cell proliferation inhibition,metastasis enhancement,endothelial cell regulation,signaling molecule interaction
ENSG00000014824,SLC30A9,regulation of zinc homeostasis,golgi apparatus localization,tumor progression,cell survival modulation,metabolic regulation,pi3k/akt pathway interaction
ENSG00000124157,SEMG2,cell proliferation,transcriptional regulation,apoptosis inhibition,tumor progression,therapeutic target,muscle development
ENSG00000146477,SLC22A3,drug efflux pump,chemoresistance,substrate transport,oncogenic properties,cellular survival pathways,organic cation transporter
ENSG00000154734,ADAMTS1,tumor suppressor,cell adhesion regulation,metastasis inhibition,proteolytic activity,cancer cell migration,extracellular matrix interaction
ENSG00000038295,TLL1,hedgehog pathway activation,cell proliferation,therapeutic target,gli transcription factor interaction,mutations leading to oncogenesis,developmental regulator
ENSG00000111341,MGP,angiogenesis inhibition,tumor suppressor function,calcification regulation,metastatic progression,protease activity regulation,arterial wall calcification
ENSG00000163536,SERPINI1,tumor suppressor/tumor promoter,epithelial-to-mesenchymal transition,cell migration/invasion,apoptosis regulation,cancer stem cell maintenance,protease inhibition
ENSG00000095303,PTGS1,prostaglandin synthesis,cyclooxygenase activity,tumor progression,angiogenesis promotion,apoptosis suppression,metastasis facilitation
ENSG00000106031,HOXA13,tumor suppressor dysfunction,oncogene activation,constitutive activation,gain of function mutations,transcriptional regulation,cellular proliferation
ENSG00000128714,HOXD13,homeobox transcription factor,tumor development,cell proliferation,apoptosis regulation,metastasis promotion,prognostic marker
,MARCH4,e3 ubiquitin ligase activity,tumor suppression,cancer cell regulation,ubiquitination pathway disruption,apoptosis modulation,cell cycle control
ENSG00000183696,UPP1,mitochondrial metabolism,pyrimidine salvage pathway,oncogenic mechanism,cell proliferation enhancement,nucleotide metabolism regulation,protein modification 
ENSG00000118520,ARG1,nitrogen metabolism regulation,oncogenic processes,glycolysis enhancement,metabolic reprogramming,tumor progression,cellular amino acid regulation
ENSG00000155858,LSM11,pre-mrna splicing,genomic stability regulation,rna helicase interaction,alternative splicing modulation,nuclear export regulation,cancer prognostic marker
ENSG00000176020,AMIGO3,cell adhesion disruption,tumor progression,metastasis facilitation,cytoplasmic reorganization,cell motility enhancement,oncogene overexpression
ENSG00000127533,F2RL3,tumor progression,angiogenesis promotion,protease activation,cell adhesion modulation,cancer metastasis,coagulation regulation
ENSG00000171587,DSCAM,cell adhesion,cell migration,signaling pathway,tumor progression,cancer cell proliferation,mutations leading to oncogenesis
ENSG00000184588,PDE4B,camp regulation,tumor growth,metastasis promotion,cell proliferation enhancement,apoptosis inhibition,signaling pathway modulation
ENSG00000169306,IL1RAPL1,il-1r complex interaction,epithelial-to-mesenchymal transition,cell proliferation enhancement,inflammation modulation,signaling pathway regulation,cancer cell survival
ENSG00000163064,EN1,transcriptional regulation,cell cycle progression,apoptosis modulation,neural patterning,oncogenic potential,tumor growth promotion
ENSG00000135845,PIGC,cellular signaling,constitutive activation,gain of function mutations,tumor progression,protein-protein interactions,lipid metabolism
ENSG00000102924,CBLN1,eph receptor interaction,cell adhesion modulation,tumor progression association,synaptic plasticity regulation,metastasis facilitation,emt process influence
ENSG00000139899,CBLN3,cell-to-cell communication,signaling pathway regulation,tumor growth regulation,oncogenic processes,protein-protein interactions,dysregulation or mutations
ENSG00000047457,CP,tumor progression,cellular signaling pathway,proteolytic activity,metastasis promotion,extracellular matrix degradation,oncogenic process
ENSG00000110756,HPS5,hops complex,lysosome-related organelles,membrane trafficking impairment,platelet-dense granule formation,oculocutaneous albinism,genetic mutations
ENSG00000179862,CITED4,transcriptional coactivator function,protein-protein interaction,cell growth regulation,angiogenesis promotion,tumor progression enhancement,poor prognosis marker
ENSG00000175189,INHBC,cellular differentiation regulation,epithelial-to-mesenchymal transition promotion,oncogenic potential,tumor progression contribution,therapeutic target,poor prognosis correlation
ENSG00000185972,CCIN,genomic instability,cell cycle regulation,protein-protein interactions,cell proliferation,onco-suppressor function,loss of function mutations
ENSG00000184156,KCNQ3,hypoxia adaptation,ion flux regulation,cell migration enhancement,metabolic reprogramming,therapeutic target,voltage-gated potassium channel
ENSG00000117013,KCNQ4,cell membrane regulation,gene mutation,oncogene role,tumor progression,therapeutic target,genomic profiling
ENSG00000126266,FFAR1,metabolic reprogramming,oncogenic process,g protein-coupled receptor (gpcr),cell proliferation,glucose and lipid metabolism,energy production
ENSG00000136816,TOR1B,tbk1 regulation,mtor signaling pathway,oncogenic process,cellular growth promotion,autophagy inhibition,apoptosis evasion
ENSG00000168878,SFTPB,altered gene expression,tumor suppression,chronic inflammation,lung disease association,cellular stress response,dysregulated surfactant function
ENSG00000160613,PCSK7,angiogenesis regulation,cell signaling modulation,extracellular matrix remodeling,post-translational modification,protein processing activation,tumor progression enhancement
ENSG00000168065,SLC22A11,transport mechanism,tumor suppressor function,cellular response regulation,platinum drug resistance,cancer therapy target,genetic instability regulation
ENSG00000001617,SEMA3F,loss of function mutations,tumor suppressor role,reduced expression,cell migration inhibition,metastasis suppression,biomarker potential
ENSG00000164889,SLC4A2,acid-base balance regulation,bicarbonate-chloride exchange,cell growth promotion,cell migration facilitation,tumor progression association,metastasis enhancement
ENSG00000169902,TPST1,protein disulfide isomerase activity,cell growth modulation,oncogenic processes,tumor metastasis,cell signaling pathway regulation,protein folding facilitation
ENSG00000174600,CMKLR1,tumor progression,metabolic regulation,lipid metabolism,pi3k/akt pathway,cell proliferation,oncogenic processes
ENSG00000128294,TPST2,protein modification,cell growth regulation,tumor progression,oncogenic signaling,therapeutic target,genomic amplification
ENSG00000156103,MMP16,tumor invasion,extracellular matrix degradation,metastasis promotion,proteolytic activity,cell migration enhancement,angiogenesis facilitation
ENSG00000143669,LYST,lysosomal assembly,genetic mutations,tumor development,cellular signaling,protein-protein interactions,gene expression regulation
ENSG00000254550,OMP,mitochondrial serine protease,tumor suppressor function,mitochondrial dynamics regulation,protein folding degradation,cancer-related stress response,cellular stress adaptation
ENSG00000175336,APOF,lipid metabolism regulation,biomarker,protein secretion,hdl cholesterol regulation,cell proliferation promotion,tumor marker
ENSG00000282291,SLC39A11,zinc transporter function,gain of function mutations,cellular proliferation,therapeutic target,genomic profiling,metal ion homeostasis
ENSG00000276858,FCAR,complement activation,immune complex clearance,tumor promotion,genetic regulation,protein interaction,cancer progression
ENSG00000278533,OSCAR,tumor progression,osteoclast activation,immune response modulation,signaling pathway interaction,pi3k/akt pathway involvement,bone metastasis promotion
ENSG00000160882,CYP11B1,steroid hormone regulation,gain of function mutations,metabolic dysregulation,oncogenic signaling pathways,therapeutic target,tumor progression
ENSG00000119669,IRF2BPL,tumor suppressor function,transcriptional regulation,cell cycle progression,apoptosis promotion,oncogene inhibition,tissue-specific expression
ENSG00000151164,RAD9B,dna damage repair,genomic instability,homologous recombination repair (hrr),cell cycle regulation,checkpoint activation,tumor suppressor function
,CARS,oxidative stress modulation,tumor progression marker,cellular metabolism regulation,protein kinase inhibition,antioxidant response,detoxification mechanism
ENSG00000166206,GABRB3,gaba receptor modulation,cell proliferation enhancement,oncogenic role,synaptic plasticity regulation,tumor growth promotion,signaling pathway interaction
ENSG00000203722,RAET1G,inflammasome activation,immunomodulation,tumor progression,apoptosis regulation,inflammatory response,immune evasion
ENSG00000111981,ULBP1,immunosuppressive environment,tumor antigen presentation,nk cell activation,tumor evasion,overexpression,ligand-receptor interaction
ENSG00000077327,SPAG6,genomic instability,mitotic spindle regulation,centrosome amplification,microtubule dynamics,chromosome segregation,oncogene activation
ENSG00000125910,S1PR4,immune modulation,tumor progression,oncogenic potential,g-protein coupled receptor,cell migration regulation,sphingosine-1-phosphate signaling
ENSG00000148154,UGCG,galactose metabolism,cellular homeostasis,altered glycosylation,metabolic rewiring,tumor growth,immune evasion
ENSG00000083807,SLC27A5,fatty acid transport,cellular membrane synthesis,tumor progression,anabolic processes,oncogenic signaling,genetic amplification
ENSG00000121743,GJA3,gap junction formation,intercellular communication disruption,tumor progression contribution,chemotherapy resistance link,metastasis facilitation,cellular proliferation regulation
ENSG00000119888,EPCAM,epithelial cell adhesion,disrupted cell-cell interaction,tumor progression,cancer stem cell marker,immunotherapeutic target,cell polarity maintenance
ENSG00000121764,HCRTR1,cell proliferation,g protein-coupled receptor,hypocretin regulation,oncogenic properties,tumor growth,neurological disorders
ENSG00000111537,IFNG,immune modulation,dysregulation in tumor growth,anti-tumor activity,pro-inflammatory response,cell differentiation,apoptosis induction
ENSG00000099953,MMP11,extracellular matrix remodeling,tumor progression,stromal cell interaction,cancer cell invasion,proteolytic activity,tumor aggressiveness
ENSG00000163431,LMOD1,mitotic regulation,microtubule dynamics,oncogenesis,cell cycle progression,tumor growth,therapeutic target
ENSG00000143162,CREG1,tumor progression,metastasis regulation,cell invasion,extracellular matrix interaction,pi3k/akt pathway modulation,post-transcriptional regulation
ENSG00000196878,LAMB3,basement membrane assembly,cell migration,epithelial-to-mesenchymal transition,overexpression,prognostic marker,angiogenesis regulation
ENSG00000163794,UCN,tumor microenvironment modulation,oncogenic signaling pathways activation,tumor progression promoter,angiogenesis induction,immune response modulation,cancer prognosis indicator
ENSG00000125966,MMP24,extracellular matrix degradation,tumor progression,cell migration,proteolytic activity,oncogenesis,therapeutic target
ENSG00000106086,PLEKHA8,pi3k/akt signaling,oncogene activation,tumor progression,cell proliferation,pleckstrin homology domain,cancer driver gene
ENSG00000115159,GPD2,metabolic reprogramming,glycolytic flux regulation,cellular proliferation,oxidative stress response,mitochondrial function,cancer metabolism
ENSG00000162437,RAVER2,transcriptional regulation,mrna translation regulation,ribonucleoprotein complex assembly,rna recognition motif (rrm),pi3k/akt pathway interaction,microrna expression regulation
ENSG00000160321,ZNF208,transcriptional regulation,oncogenic activity,cell cycle progression,apoptosis modulation,genomic stability maintenance,epigenetic modification
ENSG00000022355,GABRA1,gaba receptor regulation,tumor progression,cell cycle modulation,apoptosis resistance,neurotransmission disruption,genetic predisposition
ENSG00000179546,HTR1D,serotonin receptor 1d,cell proliferation,tumor growth promotion,metastasis regulation,apoptosis resistance,therapeutic target
ENSG00000165215,CLDN3,disrupted tight junctions,cell migration,increased invasion,altered cell adhesion,oncogene upregulation,aberrant expression patterns
ENSG00000164284,GRPEL2,aberrant expression,cellular proliferation,pro-survival signaling,oncogenic processes,tumorigenesis,g-protein coupled receptor
ENSG00000170367,CST5,cell growth regulation,metalloprotease activity,bioactive peptide processing,tumor progression,cell survival modulation,oncogene involvement
ENSG00000274542,CHRNA7,nicotinic signaling pathway,gain of function mutations,cell survival,cell proliferation,therapeutic target,genomic instability
ENSG00000124570,SERPINB6,apoptosis regulation,angiogenesis promotion,cell cycle modulation,oncogene/tumor suppressor function,protease inhibition,tumor progression
ENSG00000050767,COL23A1,collagen binding,cell adhesion molecule,epithelial-to-mesenchymal transition,tumor progression,metastasis promotion,pi3k/akt pathway activation
ENSG00000116996,ZP4,zona pellucida formation,oocyte development,glycoprotein layer structure,cell signaling interactions,proliferation regulation,none
ENSG00000101246,ARFRP1,aberrant membrane trafficking,arf6 regulation,cell proliferation enhancement,dysregulated endocytic pathways,increased cell survival,membrane trafficking regulator
ENSG00000144278,GALNT13,o-linked glycosylation,tumor progression,cell growth regulation,apoptosis resistance,metastasis enhancement,glycoprotein modification
ENSG00000139574,NPFF,tumor progression,cell proliferation,metastasis promotion,pain modulation disruption,stress response dysregulation,genetic alterations
ENSG00000073711,PPP2R3A,dephosphorylation inhibition,tumor progression,cell cycle regulation,pi3k/akt pathway modulation,apoptosis suppression,protein phosphatase regulation
ENSG00000139220,PPFIA2,tumor progression,pro-oncogenic signaling,cell proliferation,metastasis,adaptor protein function,signaling complex assembly
ENSG00000196277,GRM7,receptor activation,g protein coupling,cell proliferation,tumor progression,signaling pathway regulation,overexpression
ENSG00000124493,GRM4,tumor progression,pro-oncogenic function,cell migration,g-protein activation,metastasis promotion,synaptic transmission regulation
ENSG00000113262,GRM6,metabolic regulation,g protein-coupled receptor signaling,cell proliferation,tumor progression,oncogenic pathway activation,protein-protein interaction
ENSG00000185974,GRK1,phosphorylation,g protein-coupled receptor kinase activity,cell migration,tumor progression,therapeutic target,signaling pathway disruption
ENSG00000038002,AGA,epigenetic regulation,chromatin remodeling,transcriptional regulation,cell growth regulation,cancer predisposition,histone modification
ENSG00000092929,UNC13D,immune evasion,tumor progression,viral association,gene reactivation,cellular communication dysfunction,cancer driver gene
ENSG00000163286,ALPG,altered lipid metabolism,bile acid synthesis regulation,cell growth modulation,energy demand increase,genomic instability contribution,metabolic reprogramming
ENSG00000135740,SLC9A5,nuclear localization,sodium-hydrogen exchange activity,tumorigenesis association,metastasis promotion,cell adhesion modulation,proton-dependent transport
ENSG00000136160,EDNRB,oncogene activation,prognostic marker,tumor progression,cell migration,cell proliferation,signaling pathway interaction
ENSG00000158528,PPP1R9A,pi3k/akt signaling,regulatory subunit,tumorigenesis,pro-survival pathways,cell cycle regulation,metabolic regulation
ENSG00000272636,DOC2B,calcium-binding protein,tumor modulator,oncogenic regulator,membrane trafficking regulation,cell growth modulation,signaling pathway interaction
ENSG00000187961,KLHL17,protein stability regulation,tumor growth promotion,cell proliferation regulation,oncogenesis contribution,ubiquitination complex formation,pan-cancer involvement
ENSG00000162139,NEU3,ceramide signaling,apoptosis modulation,cell growth regulation,oncogenesis driver,sphingomyelin breakdown,signaling lipid metabolism
ENSG00000182346,DAOA,redox regulation,d-amino acid catabolism,cellular metabolism,protein stability modulation,tumor suppressor function,oxidative stress regulation
ENSG00000167346,MMP26,ecm degradation,tumor progression,cell migration,invasion promotion,overexpression,angiogenesis regulation
ENSG00000274129,TSEN34,translation regulation,cell proliferation,oncogenic process,cell survival,protein synthesis,mrna splicing
ENSG00000213199,ASIC3,proton-gated sodium channel,ph regulation,cell survival,tumor progression,metabolic regulation,signaling pathway modulation
ENSG00000276068,NAIP,apoptosis inhibition,innate immunity activation,inflammasome regulation,immune evasion mechanism,cancer cell survival,genotoxic stress response
ENSG00000169992,NLGN2,neural cell adhesion,cancer progression,cell proliferation,synaptic transmission regulation,epithelial-to-mesenchymal transition,therapeutic target
ENSG00000116774,OLFML3,tumor progression,cell adhesion disruption,transmembrane glycoprotein,oncogene/tumor suppressor,cell migration enhancement,extracellular matrix interaction
ENSG00000100883,SRP54,protein synthesis regulation,tumor progression,cell growth promotion,cancer biomarker,transmembrane signaling,chromosomal location
ENSG00000122224,LY9,t-cell activation,proliferation regulation,leukocyte receptor interaction,oncogenic processes,hematological malignancies,tumor cell survival
ENSG00000131269,ABCB7,mitochondrial iron transport,oncofetal expression,tumor aggressiveness,dysregulated metabolism,oxidative stress,therapeutic target
ENSG00000116032,GRIN3B,apoptosis disruption,cell proliferation,metastasis facilitation,oncogenesis promotion,synaptic plasticity,tumor progression
ENSG00000133937,GSC,granulin precursor protein,tumor aggressiveness,cell growth regulation,apoptosis inhibition,angiogenesis promotion,stat3 activation
ENSG00000100359,SGSM3,mtorc2 signaling pathway,oncogenic activity,autophagy regulation,scaffolding function,cellular proliferation,metastasis promotion
ENSG00000137709,POU2F3,transcriptional regulation,tumor suppressor function,immune response modulation,cellular differentiation,oncogene downregulation,genomic instability
ENSG00000124568,SLC17A1,nucleotide transport,cellular metabolism,tumor progression,dna synthesis regulation,cell proliferation modulation,energy balance disruption
ENSG00000213402,PTPRCAP,enhanced cell proliferation,tumor progression,metastasis,cellular regulation disruption,prognostic biomarker,signaling pathway modulation
ENSG00000132205,EMILIN2,loss of function mutations,tumor progression,extracellular matrix remodeling,cell adhesion modulation,angiogenesis promotion,metastasis enhancement
ENSG00000159212,CLIC6,pi3k/akt pathway modulation,cell cycle regulation,oncogene function,tumorigenesis association,apoptosis resistance,cell proliferation enhancement
ENSG00000122735,DNAI1,aneuploidy,chromosomal instability,ciliogenesis defect,genomic rearrangement,microtubule regulation,oncogenic driver
ENSG00000197632,SERPINB2,tumor suppressor activity,apoptosis inhibition,proteolytic regulation,cell survival enhancement,mapk pathway interaction,pi3k/akt pathway modulation
ENSG00000169575,VPREB1,cellular proliferation,genomic instability,nf-κb activation,oncogenic driver,pi3k/akt pathway interaction,immune evasion
ENSG00000163581,SLC2A2,glut2 overexpression,pi3k/akt pathway activation,metabolic adaptation,oncogenic signaling,cell proliferation enhancement,therapeutic target
ENSG00000079335,CDC14A,genomic instability,cell cycle regulation,polo-like kinase 1 activation,mitotic exit regulation,ubiquitination modification,tumor progression
ENSG00000115616,SLC9A2,pi3k/akt pathway regulation,sodium-hydrogen exchange,cell proliferation enhancement,tumor growth promotion,chemotherapy resistance,metastasis facilitation
ENSG00000171126,KCNG3,wnt/β-catenin pathway regulation,cell survival enhancement,tumor progression,therapeutic target,cancer stem cell maintenance,potassium channel regulation
ENSG00000049089,COL9A2,cartilage matrix formation,oncogene activity,tumor progression,metastatic potential,cell migration,aggressive behavior
ENSG00000115596,WNT6,wnt signaling,oncogenic driver,cell proliferation,tumor initiation,signaling pathway,secreted protein
ENSG00000168418,KCNG4,ion channel regulation,cancer cell migration,cellular stress response,oncogenic processes,tumor suppressor function,epigenetic regulation
ENSG00000108684,ASIC2,acid-sensing ion channel,cell migration,cell invasion,tumor progression,metastasis promotion,pi3k/akt signaling interaction
ENSG00000086848,ALG9,glycosylation process,protein modification,tumor progression,metastasis association,cell proliferation enhancement,therapeutic target
ENSG00000146070,PLA2G7,inflammation induction,tumor microenvironment modulation,cell proliferation enhancement,apoptosis suppression,lipid metabolism dysregulation,chronic inflammation promotion
ENSG00000198691,ABCA4,cellular homeostasis maintenance,transmembrane transport,retinoid metabolism,visual pigment regeneration,cellular response regulation,protein kinase activation
ENSG00000122176,FMOD,tumor microenvironment regulation,cancer progression,cell adhesion modulation,tumor growth promotion,extracellular matrix interaction,angiogenesis promotion
ENSG00000143869,GDF7,cellular proliferation,tumor progression,epithelial-to-mesenchymal transition (emt),apoptosis regulation,growth factor signaling,protein expression modulation
ENSG00000105668,UPK1A,urothelial integrity,cellular adhesion disruption,loss of polarity,cell proliferation enhancement,tumor progression contribution,gene expression alteration
ENSG00000115112,TFCP2L1,tumor suppressor function,epithelial-to-mesenchymal transition regulation,transcriptional regulation,chromatin remodeling interaction,cancer risk association,loss of function mutation
ENSG00000144837,PLA1A,pi3k/akt pathway activation,tumor progression enhancement,pro-inflammatory eicosanoid production,cell proliferation facilitation,metabolic regulation alteration,apoptosis modulation
ENSG00000103723,AP3B2,lysosomal membrane proteins,sorting defects,protein trafficking abnormalities,cellular transport regulation,oncogenic potential,genetic alterations
ENSG00000135617,PRADC1,atr/chk1 pathway activation,genomic instability,oncogenic potential,cell proliferation enhancement,dna damage response regulation,tumor suppressor function
ENSG00000196954,CASP4,apoptosis regulation,tumor suppressor function,cellular stress response,caspase activation,dna damage response,proteolytic cleavage
ENSG00000095397,WHRN,sensory hair cell maintenance,stereocilia stability,mutations leading to disease,mechanoreceptor regulation,therapeutic target,genomic profiling
ENSG00000185437,SH3BGR,sh2/sh3 domain interaction,protein-protein interaction,scaffolding adaptor function,cell growth regulation,differentiation modulation,survival signaling pathway
ENSG00000153246,PLA2R1,tumor progression,cell proliferation,immune modulation,signaling pathway activation,cancer metastasis,protein overexpression
ENSG00000169340,PDILT,er quality control,mutations in cancer,protein trafficking,disulfide bond formation,tumor growth promotion,oncogenic protein folding
ENSG00000142173,COL6A2,extracellular matrix formation,cell attachment and migration,oncogenic progression,angiogenesis promotion,metastasis facilitation,integrin interaction
ENSG00000165970,SLC6A5,taurine import,cns disorders,cellular stress,neuronal damage,cell growth regulation,cell migration modulation
ENSG00000164953,TMEM67,ciliogenesis disruption,wnt/pcp pathway dysregulation,cell migration abnormalities,tumor initiation potential,epithelial polarity loss,cellular signaling disruption
ENSG00000163285,GABRG1,gabaergic neurotransmission,inhibitory signaling pathway,tumor progression,cell proliferation regulation,metastasis modulation,protein-protein interactions
ENSG00000152932,RAB3C,cell proliferation,protein-protein interaction,membrane trafficking,vesicle transport,apoptosis evasion,tumor suppressor inactivation
ENSG00000157150,TIMP4,tumor suppression,matrix metalloproteinase inhibition,cell proliferation regulation,apoptosis induction,proteolytic activity modulation,genomic profiling
ENSG00000064666,CNN2,cellular migration,actin filament regulation,tumor invasion,protein-protein interaction,cancer metastasis,cell proliferation
ENSG00000120068,HOXB8,tumor progression,transcription factor activity,cell proliferation,constitutive activation,genomic instability,oncogenic transformation
ENSG00000106341,PPP1R17,pp1 regulation,cell cycle progression,apoptosis modulation,tumor growth modulation,emt regulation,phosphatase activity
ENSG00000060718,COL11A1,extracellular matrix remodeling,tumor progression,cell adhesion disruption,metastasis facilitation,signaling pathway regulation,genetic mutation association
ENSG00000179914,ITLN1,tumor microenvironment modulation,cell proliferation enhancement,apoptosis suppression,poor prognosis indicator,tissue homeostasis disruption,immune response regulation
ENSG00000124257,NEURL2,tumor suppressor,cellular homeostasis regulation,transcriptional repressor function,genomic instability induction,oncogenic pathway modulation,cancer cell proliferation enhancement
ENSG00000150394,CDH8,epithelial-to-mesenchymal transition,cell-cell adhesion disruption,tumor microenvironment modulation,immune evasion mechanisms,molecular alterations,cancer stem cell maintenance
ENSG00000105996,HOXA2,apoptosis evasion,cell proliferation,dna damage repair regulation,genomic instability induction,glycolytic shift promotion,homeobox transcription factor activity
ENSG00000005073,HOXA11,hox gene regulation,transcriptional activation,cell differentiation,tumor progression,metastasis,apoptosis regulation
ENSG00000264424,MYH4,cell motility,pi3k/akt signaling,non-muscle myosin activity,cytoskeleton regulation,gene expression modulation,tumor progression
ENSG00000133454,MYO18B,cell division regulation,pi3k/akt pathway involvement,tumor progression factor,metastasis enhancement,cytoskeleton regulation,gene amplification
ENSG00000109424,UCP1,metabolic reprogramming,cellular energy metabolism,lipid oxidation,glycolytic capacity,cell proliferation,oncogenic signaling
ENSG00000123838,C4BPA,tumor progression,immunosuppression,immune tolerance disruption,complement cascade regulation,antibody binding,protease modulation
ENSG00000166033,HTRA1,apoptosis regulation,cellular degradation,oncogene activation,tumor growth promotion,metastasis facilitation,proteolytic activity enhancement
ENSG00000170425,ADORA2B,pi3k/akt pathway regulation,constitutive activation,oncogene function,cell proliferation enhancement,metastatic potential,adenosine receptor signaling
ENSG00000125798,FOXA2,transcriptional regulation,dual role in cancer,cell growth and differentiation,chromatin remodeling,genomic instability,tumor suppressor activity
ENSG00000164778,EN2,tumor suppression,cell cycle regulation,transcriptional regulation,cellular differentiation,embryonic development,gene expression modulation
ENSG00000081842,PCDHA6,oncogenic properties,cell-cell interaction disruption,tumor progression facilitation,neuronal cell adhesion regulation,cytoplasmic signaling pathway alteration,genomic instability induction
ENSG00000104899,AMH,cellular context,apoptosis induction,estrogen receptor signaling,tumor suppressor,cell growth inhibition,metastasis association
ENSG00000163382,NAXE,nucleic acid regulation,tumor growth,cell cycle modulation,apoptosis suppression,signaling pathway modulation,oncogenic potential
ENSG00000112293,GPLD1,gpi-anchored protein release,oncogenic protein activation,cell proliferation,angiogenesis promotion,biomarker for diagnosis,prognostic factor
ENSG00000147437,GNRH1,gnrh signaling,oncogene,tumor progression,cell proliferation,apoptosis modulation,gonadotropin regulation
ENSG00000134443,GRP,angiogenesis promotion,anti-apoptotic properties,constitutive activation,growth factor activity,oncogenic signaling pathway modulation,tumor progression enhancement
,ELOA3,regulation of mrna stability,ubiquitin-proteasome pathway,cell cycle progression,dna repair mechanisms,anti-apoptotic function,protein degradation regulation
ENSG00000104918,RETN,tumor microenvironment modulation,inflammatory response regulation,cell growth modulation,lipid metabolism alteration,insulin sensitivity disruption,glycemic control compromise
ENSG00000164061,BSN,cancer progression,cell adhesion disruption,metastasis promotion,tumor cell migration,cytoplasmic structure regulation,synaptic plasticity regulation
ENSG00000134265,NAPG,mitochondrial enzyme function,amino acid metabolism regulation,cellular homeostasis maintenance,tumor growth promotion,energy production regulation,acetylglutamate biosynthesis
ENSG00000135902,CHRND,ion channel formation,tumor growth,metastasis promotion,cell adhesion alteration,synaptic transmission disruption,neuronal excitability modulation
ENSG00000129744,ART1,ahr pathway activation,oncogenic function,xenobiotic metabolism,cell proliferation,apoptosis resistance,transcriptional regulation
ENSG00000280477,RASA3,genomic instability,chromosomal instability,tumor suppressor function,ras signaling regulation,gene regulation,cellular regulation
ENSG00000127472,PLA2G5,lysophospholipid signaling,gain of function mutations,apoptosis regulation,necroptosis modulation,cancer association,pan-cancer involvement
ENSG00000114200,BCHE,cell signaling regulation,serine hydrolase activity,neurotransmission modulation,tumor progression association,cancer cell proliferation,acetylcholine pathway regulation
ENSG00000281151,KCNQ2,tumor suppressor function,cell cycle regulation,dna repair mechanism,apoptosis regulation,neuronal excitability regulation,epigenetic silencing
ENSG00000278444,CDC42EP5,cell migration and invasion,oncogenic process facilitation,tumor progression,metastasis,pi3k/akt pathway interaction,therapeutic target potential
ENSG00000111186,WNT5B,wnt/β-catenin pathway activation,epithelial-to-mesenchymal transition (emt),cell proliferation regulation,oncogenic signaling,therapeutic target potential,genomic upregulation
ENSG00000116703,PDC,apoptosis regulation,tumor suppressor/oncogene function,mitochondrial pathway involvement,cellular stress response,dna damage repair,protein-protein interactions
ENSG00000128713,HOXD11,oncogenic potential,cell proliferation,overexpression,transcriptional regulation,emt markers,axial patterning
ENSG00000102854,MSLN,oncogenic signaling,molecular adhesion,cancer progression,tumor metastasis,immune evasion,therapeutic target
ENSG00000177098,SCN4B,altered expression,cell migration,cell proliferation,electrical activity regulation,ion channel interactions,oncogenic potential
ENSG00000168267,PTF1A,transcriptional regulation,developmental biology,pancreatic islet cell development,congenital diabetes mellitus,oncogene function,cell growth regulation
ENSG00000197891,SLC22A12,multidrug transport,chemotherapy resistance,xenobiotic transport,cellular membrane regulation,pharmacokinetic modulation,oncogenic function
ENSG00000079482,OPHN1,actin cytoskeleton regulation,rho-gtpase activating protein function,cell migration regulation,metastasis promotion,tumor progression driver,x-linked intellectual disability gene
ENSG00000173702,MUC13,tumor progression,gain of function mutations,epithelial integrity loss,cell migration promotion,signaling pathway interaction,therapeutic target
ENSG00000132424,PNISR,p53 pathway disruption,tumor suppressor function,cell cycle regulation,genomic instability,apoptosis modulation,protein-protein interaction
ENSG00000177946,CENPBD1,centromere function,kinetochore assembly,genomic instability,aneuploidy,dysregulation of cell cycle,tumorigenesis
ENSG00000115425,PECR,centrosome maturation,chromosomal instability,cell cycle regulation,tumor progression,aneuploidy,autophosphorylation
ENSG00000112541,PDE10A,cellular proliferation,genetic instability,tumor progression,metabolic regulation,signaling pathway modulation,enzymatic activity dysregulation
ENSG00000189180,ZNF33A,transcriptional regulation,chromatin remodeling,tumor suppressor activity,elevated expression levels,aberrant cell cycle control,prognostic marker potential
ENSG00000125861,GFRA4,cell surface receptor,receptor activation,gdnf signaling pathway,tumor progression,cell proliferation,cell migration
ENSG00000125650,PSPN,protease activity,tumor progression,immune modulation,extracellular matrix degradation,cell invasion,cancer metastasis
ENSG00000184956,MUC6,epithelial barrier function,cellular adhesion,enhanced cell proliferation,mucin secretion pathway,tumor progression,oncogenic transformation
ENSG00000138356,AOX1,aox1 overexpression,cellular metabolism regulation,mitochondrial dysfunction,reactive oxygen species production,poor prognosis,tumor progression
ENSG00000169231,THBS3,angiogenesis promotion,emt regulation,extracellular matrix remodeling,growth factor interaction,metastasis enhancement,protease inhibition
ENSG00000154478,GPR26,regulation of cell proliferation,dysregulation of gene expression,modulation of pi3k/akt pathway,constitutive activation of downstream targets,cell growth and survival pathways,cancer driver gene candidate
ENSG00000012174,MBTPS2,tumor suppression,transcriptional regulation,loss-of-function mutations,oncogenic processes,apoptosis modulation,cancer risk modulation
ENSG00000185760,KCNQ5,oncogenic activity,overexpression,cell proliferation,ion channel function,pi3k/akt pathway interaction,mutation leading to tumorigenesis
ENSG00000137975,CLCA2,calcium-activated chloride channel function,wnt/β-catenin pathway interaction,epithelial-to-mesenchymal transition,tumor progression and metastasis,genomic instability,dna damage response
ENSG00000171812,COL8A2,tumor progression,cell adhesion modulation,basement membrane component,angiogenesis promotion,metastasis facilitation,cellular interaction regulation
ENSG00000086189,DIMT1,pi3k/akt pathway,constitutive activation,dna methylation regulation,tumor suppressor gene silencing,cancer cell proliferation,chromatin remodeling
ENSG00000086062,B4GALT1,glycosylation regulation,cell-cell adhesion,tumor progression,oncogenic transformation,glycoprotein biosynthesis,cell signaling
ENSG00000169427,KCNK9,cellular proliferation,ion channel regulation,protein interaction,tumor progression,signaling pathway modulation,cellular excitability
ENSG00000148965,SAA4,oncogenic protein,tumor metastasis,inflammatory response modulation,cell adhesion regulation,immune evasion mechanism,acute phase response protein
ENSG00000115665,SLC5A7,monocarboxylate transport,metabolic regulation,cell proliferation,energy source regulation,microbiome interaction,tumor progression
ENSG00000160951,PTGER1,tumor promotion,angiogenesis,cell proliferation,oncogenic signaling,g-protein coupled receptor activation,prostaglandin e2 binding
ENSG00000198598,MMP17,tumor progression,cell migration,extracellular matrix degradation,angiogenesis,growth factor regulation,proteolytic processing
ENSG00000143199,ADCY10,camp signaling,oncogenic transformation,cell proliferation,g-protein coupled receptor interaction,poor prognosis marker,tumor progression
ENSG00000179097,HTR1F,serotonin receptor signaling,vasoconstriction and vasodilation regulation,angiogenesis modulation,tumor growth promotion,g-protein coupled mechanisms,cancer progression involvement
ENSG00000134438,RAX,cellular plasticity,oncogene activation,prognostic biomarker,tumor initiation,stemness maintenance,apoptosis evasion
ENSG00000101346,POFUT1,glycosylation regulation,cell adhesion disruption,oncogenic transformation,tumor progression driver,prognostic marker potential,therapeutic target candidate
ENSG00000188517,COL25A1,wnt/β-catenin signaling,cell adhesion disruption,tumor progression,oncogene potential,poor prognosis association,wnt pathway regulation
ENSG00000167748,KLK1,tumor progression,apoptosis evasion,angiogenesis promotion,proteolytic cascades activation,oncogenic signaling modulation,metastasis facilitation
ENSG00000109743,BST1,tumor progression,angiogenesis promotion,immune suppression,adenosine regulation,oncogenic mutation,cell surface enzyme
ENSG00000101938,CHRDL1,wnt signaling pathway,tumor suppressor function,loss of expression,oncogenic process,cell proliferation,transcriptional regulation
ENSG00000121281,ADCY7,camp signaling pathway,gain of function mutations,cell proliferation enhancement,oncogenic driver,adenylate cyclase activity,g-protein interaction
ENSG00000197093,GAL3ST4,cell surface interactions,glycosaminoglycan sulfation,cell proliferation regulation,tumor progression driver,therapeutic target potential,cancer metastasis promotion
ENSG00000175785,PRIMA1,apoptosis regulation,tumor suppressor function,cell growth inhibition,p53 interaction,genomic stability maintenance,dna damage response
ENSG00000101190,TCFL5,wnt/β-catenin pathway,epigenetic reprogramming,overexpression oncogene,cell cycle regulation,tumor progression driver,chromatin remodeling
ENSG00000168743,NPNT,cell migration,metastasis,protein-protein interaction,signaling pathway modulation,tumor aggressiveness,glycoprotein binding
ENSG00000137221,TJAP1,cell adhesion disruption,enhanced migration capability,epithelial-to-mesenchymal transition,protein-protein interaction,metastatic progression,tumor suppressor regulation
ENSG00000116675,DNAJC6,chaperone regulation,cell cycle arrest,apoptosis regulation,oncogene potential,heat shock protein interaction,tumor suppression modulation
ENSG00000154162,CDH12,cell adhesion disruption,wnt/β-catenin pathway activation,tumor progression promotion,oncogene downregulation,epithelial cell expression,adhesion molecule complex formation
ENSG00000187017,ESPN,cellular stress responses,oxidative stress protection,dna repair regulation,cell cycle progression,antioxidant defense,protein folding regulation
ENSG00000139269,INHBE,inhibin regulation,fsh feedback loop,reproductive homeostasis,tissue differentiation,growth modulation,cancer association
ENSG00000126231,PROZ,cellular response regulation,molecular interaction,adhesion molecule function,coagulation process,serine protease inhibitor,cancer-related signaling pathway
ENSG00000179091,CYC1,mitochondrial function,cellular respiration,metabolic regulation,oxidative stress modulation,apoptosis pathway interaction,energy metabolism alteration
ENSG00000100665,SERPINA4,oncogenic potential,cell proliferation,proteolytic regulation,signaling pathway interaction,apoptosis inhibition,overexpression association
ENSG00000177511,ST8SIA3,tumor progression,glycosylation regulation,immune suppression,cell proliferation,cancer metastasis,gene overexpression
ENSG00000113532,ST8SIA4,aberrant expression,sialylation pathway,tumor progression,metastasis promotion,immune evasion,therapeutic target
ENSG00000140557,ST8SIA2,glycosylation regulation,tumor progression,potential oncogene,cell-cell interactions,metastatic potential,signaling pathway modulation
ENSG00000162545,CAMK2N1,cellular regulation,apoptosis modulation,cancer progression,cell cycle control,protein kinase regulation,neuronal signaling
ENSG00000184302,SIX6,wnt/β-catenin signaling,transcriptional regulation,mitotic proliferation,oncogenic driver,molecular interaction,dna binding motif
ENSG00000110080,ST3GAL4,cell surface glycosylation,sialic acid metabolism,tumor microenvironment,oncogenic signaling pathways,epigenetic regulation,glycoprotein modification
ENSG00000125813,PAX1,proliferation regulation,transcription factor activity,embryonic development,oncogene activation,tumor progression,cell differentiation
ENSG00000163785,RYK,receptor tyrosine kinase,cell adhesion and migration,tumor growth and invasion,signaling pathway activation,oncogene overexpression,aberrant cell signaling
ENSG00000135678,CPM,genomic instability,tumor development,cell cycle regulation,mitotic checkpoint complex,chromosomal segregation,spindle checkpoint activation
ENSG00000185033,SEMA4B,tumor suppressor,downregulated expression,plexin interaction,angiogenesis regulation,cell migration modulation,cell adhesion disruption
ENSG00000182580,EPHB3,ephb3-ephrin interaction,angiogenesis inhibition,tumor suppressor function,cell migration regulation,metastasis suppression,loss-of-function mutation
ENSG00000141574,SECTM1,tumor progression,cytoskeletal regulation,cell adhesion disruption,metastasis promotion,protein-protein interactions,cell migration enhancement
ENSG00000112249,ASCC3,gene expression regulation,cellular proliferation enhancement,protein complex assembly,transcriptional activation,apoptosis inhibition,tumor progression support
ENSG00000127074,RGS13,gpcr signaling modulation,small gtpase regulation,cell migration regulation,mitogenic signaling,oncogenesis promotion,therapeutic response modulation
ENSG00000180875,GREM2,bmp signaling inhibition,tumor suppression,cell proliferation regulation,smad phosphorylation inhibition,embryonic development modulation,cell differentiation regulation
ENSG00000114982,KANSL3,chromatin modification,histone h2a ubiquitination,tumor suppression,oncogenic transformation,dna repair regulation,transcriptional repression
ENSG00000169313,P2RY12,platelet aggregation,adp binding,tumor growth promotion,angiogenesis regulation,poor prognosis marker,therapeutic target candidate
ENSG00000172009,THOP1,genomic instability,oncogene activation,cell proliferation,threonine oxidation,apoptosis regulation,pi3k/akt pathway interaction
ENSG00000104921,FCER2,fc epsilon receptor 2 regulation,antibody-dependent cellular cytotoxicity,immune complex handling,cytokine production,tumor marker,therapeutic target
ENSG00000205810,KLRC3,activating receptor,anti-tumor immunity,immune checkpoint regulator,nk cell activation,tumor recognition,immune-related gene interaction
ENSG00000133116,KL,mitochondrial transport,kinesin motor protein,tumor suppressor activity,cell proliferation regulation,cell survival enhancement,microtubule interaction
ENSG00000096006,CRISP3,crispr-mediated defense,cellular proliferation,pro-inflammatory response,wound healing regulation,oncogenesis,tumor progression
ENSG00000186074,CD300LF,immunosuppression,tumor immune evasion,cell surface receptor,immune regulation,nk cell activation,apoptosis inhibition
ENSG00000275099,GGNBP2,genomic instability,dna repair,homologous recombination,tumor suppressor function,cancer cell survival,therapeutic target
ENSG00000172794,RAB37,rab37 endocytic trafficking,dysregulation,cell proliferation,endosomal recycling,tumor progression,oncogenic processes
ENSG00000152266,PTH,pth/pth1r signaling,oncogenic proliferation,calcium regulation,tumor metastasis,cell migration,immunosuppression
ENSG00000127124,HIVEP3,transcription factor activation,tumor progression,oncogenic function,immune evasion,cell proliferation,epigenetic regulation
ENSG00000164035,EMCN,tumor progression,cancer driver gene,cell adhesion,angiogenesis regulation,metastasis promotion,therapeutic target
ENSG00000114631,PODXL2,tumor progression,immunosuppression,cell adhesion,metastasis promotion,angiogenesis regulation,oncogenic function
ENSG00000105472,CLEC11A,antigen presentation,immune evasion,cell signaling,tumor progression,prognostic marker,biomolecular interaction
ENSG00000101890,GUCY2F,signaling pathway regulation,guanosine monophosphate production,cell proliferation enhancement,tumor metastasis promotion,cell survival modulation,protein interaction partner
ENSG00000158887,MPZ,blood-brain barrier disruption,myelination regulation,vascularization enhancement,axonal maintenance disruption,transcriptional regulation,post-translational modification
ENSG00000244486,SCARF2,aberrant signaling pathway,cell proliferation,cancer metastasis,fak/src pathway activation,integrin-mediated signaling,oncogenic processes
ENSG00000134258,VTCN1,immunosuppression,tumor suppressor,immune evasion,cell proliferation inhibition,protein-protein interaction,t-cell regulation
ENSG00000088827,SIGLEC1,siglec-cd33 interaction,tumor progression,cell adhesion regulation,immune response modulation,surface antigen expression,cancer metastasis
ENSG00000119523,ALG2,o-glycosylation,protein processing,glycoprotein transport,tumor aggressiveness,cell surface antigen regulation,n-glycan glucosylation
ENSG00000170175,CHRNB1,nicotinic acetylcholine receptor,constitutive activation,gain of function mutations,tumor progression,therapeutic target,ion channel regulation
ENSG00000104755,ADAM2,cell surface interaction,proteolysis activation,growth factor release,metastasis promotion,angiogenesis facilitation,tumor invasion enhancement
ENSG00000074803,SLC12A1,ion transport regulation,metastasis promotion,cell proliferation enhancement,chemoresistance,tumor growth facilitation,gene expression modulation
ENSG00000139998,RAB15,rho gtpase activation,cell migration,epithelial-to-mesenchymal transition (emt),oncogenic protein interaction,prognostic biomarker,endocytosis regulation
ENSG00000105697,HAMP,iron regulation,tumor progression,angiogenesis promotion,warburg effect association,protein binding,rna expression regulation
ENSG00000109991,P2RX3,purinergic signaling,ion channel activation,tumor progression,immune response modulation,pro-inflammatory cytokine release,chronic pain association
ENSG00000141527,CARD14,inflammatory signaling pathway,immune response modulation,adaptor molecule function,keratinocyte expression,caspase recruitment domain,inflammasome activation
ENSG00000134762,DSC3,desmosomal adhesion,epithelial-to-mesenchymal transition,tumor progression,cell-cell interaction,cancer cell invasion,metastasis
ENSG00000160111,CPAMD8,cancer overexpression,cell proliferation regulation,protein-protein interaction,apoptosis inhibition,cell migration facilitation,tumorigenesis promotion
ENSG00000187094,CCK,oncogenesis,cell proliferation,proliferation regulation,wnt/β-catenin pathway interaction,metastasis promotion,tumor growth enhancement
ENSG00000185149,NPY2R,npy/npy2r interaction,angiogenesis promotion,metastasis facilitation,cell proliferation enhancement,g protein coupled receptor activation,tumor growth support
ENSG00000075223,SEMA3C,tumor progression,angiogenesis regulation,receptor interaction,cellular migration,oncogenic process modulation,biomarker potential
ENSG00000165949,IFI27,apoptosis inhibition,cellular survival,antiviral response modulation,oncogene activation,tumor suppressor function,viral oncogenesis
ENSG00000115705,TPO,thyroid hormone synthesis,cell survival,tumor growth,oncogenic pathway,protein-protein interaction,iodine metabolism
ENSG00000161298,ZNF382,chromatin remodeling,transcriptional regulation,tumor suppressor function,genome stability maintenance,pi3k/akt pathway interaction,wnt/β-catenin pathway modulation
ENSG00000164509,IL31RA,immune response modulation,inflammatory pathway regulation,cell proliferation,signaling pathway interaction,gene expression patterns,protein-protein interactions
ENSG00000091536,MYO15A,dysregulation,genetic mutations,cellular integrity maintenance,hair cell development,stereocilia formation,vestibular dysfunction
ENSG00000166825,ANPEP,protein metabolism regulation,tumor progression,cellular invasion,ubiquitin-proteasome pathway,peptidase activity,amino acid processing
ENSG00000183607,GKN2,gelatinase activation,cell invasion,metastasis promotion,tumor progression,angiogenesis regulation,signaling pathway modulation
ENSG00000125820,NKX2-2,tumor suppressor function,oncogenic potential,transcriptional regulation,cell fate decisions,morphogenesis regulation,thyroid gland development
ENSG00000136982,DSCC1,tumor progression,cell adhesion,receptor tyrosine kinase activity,extracellular matrix interaction,oncogenic properties,signaling pathway activation
ENSG00000122678,POLM,dna repair,genomic instability,non-homologous end joining,nhej pathway activation,enzymatic activity,ligation step
ENSG00000183671,GPR1,g-protein coupled receptor,cell proliferation regulation,tumor suppressor/ oncogene,mapk/erk signaling pathway activation,pi3k/akt/mtor pathway regulation,g-protein interaction
ENSG00000116785,CFHR3,complement regulation,immune evasion,apoptosis induction,tumor microenvironment modulation,cancer progression facilitation,genetic silencing
ENSG00000138771,SHROOM3,microtubule dynamics,cell morphology regulation,epithelial-to-mesenchymal transition (emt),cancer stem cell regulation,therapeutic target,cell signaling pathway modulation
ENSG00000128322,IGLL1,genomic instability,chromosomal rearrangements,dna repair dysfunction,tumor driver mutations,cancer genomic profiling,immunoglobulin function disruption
ENSG00000108091,CCDC6,pi3k/akt pathway,tumor suppressor function,cell cycle regulation,dna damage response,oncogenic pathways,therapeutic target
ENSG00000008516,MMP25,tumor invasion,extracellular matrix degradation,proteolytic activity,therapeutic target,cancer progression,cell migration
ENSG00000139132,FGD4,constitutive activation,gain of function mutations,cell proliferation,therapeutic target,cancer progression,protein regulation
ENSG00000164266,SPINK1,tumor progression,cell survival enhancement,oncogenic pathway modulation,apoptosis suppression,protease inhibition disruption,pancreatic secretions regulation
ENSG00000147647,DPYS,polyamine metabolism,dysregulated expression,tumor proliferation,cell survival regulation,polyamine derivatives accumulation,biomarker potential
ENSG00000197696,NMB,neuropeptide signaling,constitutive activation,growth factor regulation,cell proliferation,metastasis promotion,therapeutic target
ENSG00000179943,FIZ1,cellular proliferation,aberrant expression,embryonic development,tissue homeostasis,apoptosis modulation,protein-protein interaction
ENSG00000006116,CACNG3,calcium channel regulation,tumorigenesis association,proliferation promotion,migration enhancement,pi3k/akt pathway interaction,therapeutic target candidate
ENSG00000185559,DLK1,notch signaling pathway,constitutive activation,tumor suppressor function,cell proliferation inhibition,apoptosis induction,angiogenesis regulation
ENSG00000168702,LRP1B,loss-of-function mutations,tumor suppressor function,cellular lipid metabolism,lipid accumulation,cell proliferation enhancement,reduced apoptosis
ENSG00000238289,MICB,immune regulation,peptide presentation,tumor cell survival,prognostic value,immune evasion,cell proliferation
ENSG00000136457,CHAD,regulation of hif activity,tumor cell proliferation,metastasis promotion,cell migration regulation,angiogenesis facilitation,proton exchange regulation
ENSG00000243480,AMY2A,cellular metabolism,tissue specificity,glycemic regulation,digestion,enzymatic activity,biological pathway modulation
ENSG00000021355,SERPINB1,protease inhibition,tumor progression,cell invasion,metastasis promotion,apoptosis regulation,angiogenesis regulation
ENSG00000054803,CBLN4,cell adhesion disruption,tumor progression association,axon guidance dysregulation,cytoskeletal modulation,protein-protein interaction,immunoglobulin superfamily member
ENSG00000026559,KCNG1,neuronal excitability,cancer-testis antigen,elevated expression,cell signaling modulation,pi3k/akt pathway interaction,tumorigenesis regulation
ENSG00000178342,KCNG2,cell proliferation,enhanced tumorigenesis,ion flux regulation,tumor progression,tissue invasion,poor prognosis
ENSG00000177981,ASB8,signaling pathway regulation,oncogenic processes,protein-protein interactions,cell growth modulation,cancer progression,therapeutic target
ENSG00000100312,ACR,proliferation promotion,invasion facilitation,migration enhancement,tumor progression,extracellular matrix degradation,cellular transformation
ENSG00000257594,GALNT4,o-glycosylation pathway,cell proliferation regulation,tumor suppressor function,epithelial-to-mesenchymal transition (emt),apoptosis modulation,glycosyltransferase activity
ENSG00000108556,CHRNE,aberrant signaling pathway,cell proliferation,metastasis promotion,tumor progression,neurotransmitter regulation,muscle fiber interaction
ENSG00000138792,ENPEP,tumor progression,cell survival,protein degradation,cell proliferation,signal transduction,cancer metabolism
ENSG00000112246,SIM1,transcriptional regulation,cellular proliferation,genomic instability,tumor progression,neurodevelopmental disorder,apoptosis suppression
ENSG00000139178,C1RL,cellular regulation,tumor progression,complement activation inhibition,protein-protein interaction,metastasis promotion,proliferation enhancement
ENSG00000110721,CHKA,phospholipid synthesis,metabolic reprogramming,cell proliferation,therapeutic target,oncogenic function,glycolytic shift
ENSG00000124205,EDN3,oncogenic properties,angiogenesis promotion,cell proliferation enhancement,tumor metastasis facilitation,poor prognosis indicator,endothelin signaling involvement
ENSG00000112619,PRPH2,epithelial-to-mesenchymal transition,cell adhesion regulation,tumor progression,metastasis driver,oncogene potential,signaling pathway modulation
ENSG00000149403,GRIK4,glutamate receptor function,neuronal plasticity regulation,synaptic transmission modulation,oncogenic pathway interaction,cancer-related signaling alteration,neuronal excitability control
ENSG00000159307,SCUBE1,wnt/β-catenin signaling,oncogenic driver,cell proliferation enhancement,metastasis promotion,angiogenesis facilitation,poor prognosis indicator
ENSG00000175356,SCUBE2,angiogenesis promoter,cell adhesion protein,growth factor receptor,metastasis enhancer,protein-protein interaction,tumor progression regulator
ENSG00000156853,ZNF689,chromatin remodeling,epigenetic regulation,oncogenic processes,transcriptional modulation,apoptosis regulation,cell cycle control
ENSG00000118733,OLFM3,epithelial-to-mesenchymal transition (emt),cell adhesion disruption,loss of tumor suppressor function,pancreatic cancer association,egfr interaction,pi3k/akt pathway involvement
ENSG00000188613,NANOS1,microrna regulation,gene expression modulation,tumor progression,cell survival enhancement,metastatic potential modulation,oncogene interaction
,DAZ3,tumor suppressor function,genomic instability,cell cycle regulation,histone modification,chromatin remodeling,meiotic progression
ENSG00000171246,NPTX1,signaling pathway regulation,calcium-dependent proteolytic activity,oncogenic mutations,tumor progression,metastasis promotion,therapeutic target
ENSG00000124374,PAIP2B,mrna processing,p53 degradation,oncogenic process,cell survival,therapeutic target,dna damage response
ENSG00000159184,HOXB13,chromatin remodeling,oncogene regulation,metastasis promotion,cell proliferation enhancement,epigenetic reprogramming,transcriptional modulation
ENSG00000241563,CORT,regulation of inflammation,immune response modulation,g-protein coupled receptor activity,tumor microenvironment modulation,cell survival enhancement,cytokine regulation
ENSG00000183067,IGSF5,insulin-like signaling,cell proliferation,tumor progression,receptor binding,growth factor regulation,survival pathways
ENSG00000028203,VEZT,vezt mutations,loss of function,tumor suppression,vesicular trafficking regulation,cell signaling modulation,pi3k/akt pathway inhibition
ENSG00000132465,JCHAIN,mucosal immunity,immunoglobulin a assembly,epithelial transport,mucus barrier function,immune microenvironment modulation,indirect tumorigenesis link
ENSG00000158488,CD1E,lipid antigen presentation,immune modulation,tumor microenvironment alteration,oncogenesis,immune cell regulation,adaptive immunity activation
ENSG00000115598,IL1RL2,tumor progression,inflammatory regulation,immune suppression,oncogenic interaction,signaling modulation,tumor microenvironment
ENSG00000140015,KCNH5,pi3k/akt signaling pathway,altered electrical properties,ion transport regulation,tumor cell aggressiveness,cancer progression marker,potassium ion flow modulation
ENSG00000102539,MLNR,cell proliferation regulation,protein-protein interaction,centrosome separation,cell cycle regulation,prognostic marker,therapeutic target
ENSG00000106128,GHRHR,growth hormone-releasing hormone (ghrh),cell proliferation,tumor progression,constitutive activation,cell survival,protein structure mutation 
ENSG00000136487,GH2,cell proliferation,insulin-like growth factor 1 (igf-1) production,genomic instability,chromosomal alterations,tumor aggressiveness,therapeutic target
ENSG00000136697,IL1F10,il-1 family cytokine,immune regulation,tumor progression,angiogenesis inhibition,pro-inflammatory response modulation,anti-tumor activity
ENSG00000227357,HLA-DRB4,immune system regulation,antigen presentation,tumor antigen recognition,immune checkpoint blockade target,cancer immunotherapy target,genetic diversity
ENSG00000176919,C8G,cysteine protease,cell signaling regulation,transcriptional regulation,oncogenic processes,cell survival pathways,none
ENSG00000137252,HCRTR2,hypocretin/orexin regulation,g protein-coupled receptor function,cell proliferation modulation,pi3k/akt/mtor pathway interaction,tumor progression involvement,oncogene activation
ENSG00000244414,CFHR1,complement regulation,immune evasion,genomic instability,tumor progression,cellular interaction,apoptosis regulation
ENSG00000154736,ADAMTS5,tumor progression,metastasis facilitation,extracellular matrix remodeling,proteoglycan degradation,growth factor modulation,cell migration enhancement
ENSG00000185518,SV2B,tumor growth,cellular proliferation,metastasis,oncogenic pathway,synaptic transmission regulation,calcium-binding protein activity
ENSG00000102349,KLF8,tumor suppressor activity,dual function transcription factor,oncogenic potential,transcriptional regulation,wnt/β-catenin pathway interaction,nf-κb pathway modulation
ENSG00000184470,TXNRD2,oncogene function,redox regulation,cell survival pathway,thiol-disulfide exchange,antioxidant defense mechanism,post-translational modification
ENSG00000162267,ITIH3,cellular survival,oncogenic potential,immune modulation,complement regulation,inflammatory response,stress response
ENSG00000177311,ZBTB38,chromatin regulation,tumor suppressor/oncogene,gene expression modulation,cellular proliferation regulation,chromatin modification,cellular survival promotion
ENSG00000077498,TYR,melanin biosynthesis,cancer progression,cell proliferation,protein-protein interactions,dysregulated expression,oncogenic signaling
ENSG00000126709,IFI6,chronic inflammation,immune evasion,tumor progression,apoptosis inhibition,cell signaling regulation,pro-inflammatory cytokine production
ENSG00000155903,RASA2,mapk signaling inhibition,tumor suppressor function,loss of function mutations,cell growth regulation,oncogenic process suppression,genomic instability
ENSG00000167157,PRRX2,cell proliferation,pi3k/akt activation,oncogenic potential,e3 ubiquitin ligase activity,epithelial-to-mesenchymal transition (emt),tumor suppression loss
ENSG00000172840,PDP2,dephosphorylation regulation,protein-lipid interactions,cell growth modulation,apoptosis regulation,metastasis promotion,therapeutic target candidate
ENSG00000174080,CTSF,tumor progression,proteolytic activity,cellular degradation,oncogenic driver,cancer metastasis,therapeutic target
ENSG00000181826,RELL1,tumor suppressor,oncogenic mutation,dna repair regulation,cell growth modulation,pi3k/akt pathway interaction,synaptic plasticity disruption
ENSG00000141384,TAF4B,transcription regulation,cell cycle progression,tumor suppressor function,oncogene interaction,proto-oncogene activation,apoptosis evasion
ENSG00000242950,ERVW-1,genomic instability,transcriptional regulation,oncogenic function,cell proliferation,metastasis promotion,genomic integration
ENSG00000164776,PHKG1,glycogen metabolism,energy production,cell proliferation,metabolic reprogramming,tumor metabolism,therapeutic target
ENSG00000126861,OMG,mitochondrial stability,apoptosis resistance,pro-survival interactions,tumorigenesis regulation,oncogenic signaling modulation,cellular metabolism regulation
ENSG00000185924,RTN4RL1,apoptosis regulation,cell survival pathways,tumor progression modulation,oncogenic signaling,transmembrane protein function,cancer cell behavior
ENSG00000111729,CLEC4A,immune recognition,molecular interactions,antigen presentation,dysregulated expression,tumor progression,somatic mutations
ENSG00000135709,KIAA0513,cell cycle regulation,genomic instability,mitotic checkpoint regulation,post-translational modification,tumor suppressor activity,cancer therapeutic target
ENSG00000186326,RGS9BP,g-protein coupled receptor signaling,regulator of g-protein activation,rgs interaction,tumor progression,therapeutic target,genomic profiling
ENSG00000103226,NOMO3,kinetochore assembly,chromosomal instability,cell division regulator,tumor aggressiveness,spindle assembly checkpoint,mitosis regulator
ENSG00000101425,BPI,tumor progression,inflammation regulation,immune system modulation,protein binding activity,cell recruitment,cytokine signaling
ENSG00000163590,PPM1L,phosphatase activity,genomic stability regulation,cell cycle progression regulation,apoptosis regulation,tumor suppressor function,protein-protein interaction modulation
ENSG00000276836,ARHGAP27,rhogtpase regulation,tumor suppressor function,cancer-related pathways,pi3k/akt/mtor pathway interaction,cell proliferation and survival signals,actin cytoskeleton modulation
ENSG00000140545,MFGE8,annexin a2 binding,cell migration,extracellular vesicle uptake,membrane dynamics regulation,pi3k/akt pathway modulation,tumor progression facilitation
ENSG00000164532,TBX20,oncogenic transcription factor,promotes cell proliferation,enhances tumor growth,regulates cardiac development,cardiac tissue differentiation,metastatic potential
ENSG00000064225,ST3GAL6,sialylation machinery,tumor progression,immune evasion,cancer stem cell regulation,glycosylation pattern modulation,cell surface modification
ENSG00000178199,ZC3H12D,tumor suppressor,mrna stability,cell proliferation,metastasis,nf-kappa b pathway,pi3k/akt signaling
ENSG00000156232,WHAMM,microtubule regulation,cell division,cell migration,protein-protein interaction,tumor progression,oncogenic function
ENSG00000141756,FKBP10,p53 inhibition,apoptosis inhibition,cell cycle regulation,oncogene activation,tumor suppression modulation,biomarker potential
ENSG00000221866,PLXNA4,cell migration,therapeutic target,angiogenesis promoter,tumor progression,oncogenic process regulation,semaphorin interaction
ENSG00000168282,MGAT2,n-glycosylation process,glycan transferase activity,cancer stem cells maintenance,tumor growth promotion,cell adhesion modulation,immune evasion mechanism
ENSG00000048342,CC2D2A,wnt signaling pathway,overexpression,tumor suppressor function,loss of heterozygosity,cellular proliferation regulation,cancer genome alterations
ENSG00000125744,RTN2,constitutive activation,gain of function mutations,tumor progression,cellular stress regulation,autophagy modulation,angiogenesis promotion
ENSG00000182264,IZUMO1,cancer stem cell marker,cell adhesion regulator,metastatic promoter,tumor progression factor,sperm-egg interaction protein,epithelial-to-mesenchymal transition regulator
ENSG00000129749,CHRNA10,neurotransmitter regulation,oncogenic activity,cell proliferation regulation,amplification/overexpression,signaling pathway modulation,epithelial cell differentiation
ENSG00000174343,CHRNA9,nicotinic receptor function,altered expression,ion channel regulation,cell growth regulation,neurotransmission modulation,tumor suppressor potential
ENSG00000152127,MGAT5,oncogene,overexpression,tumor growth,metastasis,immune suppression,glycosylation
ENSG00000052795,FNIP2,mtor inhibition,cellular growth regulation,genomic stability maintenance,tumor suppression,pathway activation,protein synthesis regulation
ENSG00000122012,SV2C,regulates cell proliferation,interacts with receptor tyrosine kinases,modulates pi3k/akt/mtor pathway,involved in oncogenic processes,upregulated in tumor tissues,regulates neurotransmitter release
ENSG00000158158,CNNM4,cellular metabolism regulation,gene mutation impact,tumor growth modulation,nad+ sensing,energy homeostasis regulation,sirtuin pathway interaction
ENSG00000162836,ACP6,calcium homeostasis regulation,metabolic regulation,tumor microenvironment disruption,cell proliferation promotion,protein interaction with oncogenes,upregulated expression in cancer cells
ENSG00000167210,LOXHD1,dna repair mechanism,tumor suppressor function,genomic instability,dna damage response,chromosomal abnormalities,mutation hotspot
ENSG00000126267,COX6B1,mitochondrial function,electron transport chain,cellular respiration,atp production,gain of function mutations,cancer cell metabolism
ENSG00000236279,CLEC2L,immune evasion,cell adhesion modulation,tumor growth promotion,metastasis facilitation,protein interaction,cell surface expression
ENSG00000213934,HBG1,oxygen transport,dysregulated expression,cellular metabolism,tumor adaptation,protein complex formation,signaling pathway interaction
ENSG00000183734,ASCL2,oncogene activity,transcriptional regulation,cell proliferation promotion,tumor aggressiveness association,epithelial-to-mesenchymal transition induction,co-activator complex recruitment
ENSG00000237123,CDSN,tetraspanin family,cell adhesion regulation,protein-protein interactions,membrane organization regulation,cancer progression modulation,tumor suppressor function
ENSG00000135272,MDFIC,mtf-1 activation,chemo-resistance,oxidative stress resistance,transcription regulation,cell survival pathways,p53 interaction
ENSG00000263324,HCN3,hyperpolarization-activated ion channel,oncogenic potential,tumor progression,cell proliferation,electrical regulation,signaling pathway interaction
ENSG00000184571,PIWIL3,pirna pathway,epigenetic silencing,genomic instability,meiotic sex chromosome inactivation,tumor suppressor,chromatin remodeling
ENSG00000167531,LALBA,lactation regulator,milk synthesis modulator,cellular signaling pathway modifier,metastasis associated protein,poor prognosis marker,genomic locus 4q21-22
ENSG00000166006,KCNC2,electrical signaling regulation,cell proliferation modulation,tumor progression association,pi3k/akt pathway interaction,cell migration influence,voltage-gated potassium channel function
ENSG00000151657,KIN,cell cycle dysregulation,centrosome maturation,chromosomal instability,genomic alterations,mitotic spindle checkpoint disruption,oncogenic driver
ENSG00000171940,ZNF217,transcription factor regulation,oncogenic processes promotion,cell proliferation enhancement,gene expression modulation,constitutive activation,amplification or mutation
ENSG00000108231,LGI1,tumor suppressor function,regulation of cell growth,implicated in pan-cancer,glioblastoma mutations,neurotransmission regulation,synaptic plasticity modulation
ENSG00000165059,PRKACG,histone modification,epigenetic regulation,cell proliferation,oncogenesis,apoptosis suppression,protein kinase activation
ENSG00000214415,GNAT3,adenylyl cyclase activity,camp-dependent signaling,oncogenic processes,tumor progression,protein kinase activation,nutrient sensing and energy homeostasis regulation
ENSG00000069018,TRPC7,trp channel function,calcium signaling,oncogenic properties,cell proliferation,cell migration,pi3k/akt/mtor pathway activation
ENSG00000185808,PIGP,gpi-anchored proteins,cell proliferation,cell survival,therapeutic target,cell migration,signaling pathways
ENSG00000171759,PAH,cellular metabolism regulation,genomic instability contribution,therapeutic target opportunity,hyperphenylalaninemia association,protein synthesis regulation,tumor progression contribution
ENSG00000143627,PKLR,glycolytic enzyme,energy metabolism regulation,warburg effect contribution,tumor growth promotion,cell proliferation enhancement,metabolic reprogramming
ENSG00000141012,GALNS,glycosyltransferase activity,glycan biosynthesis,lysosomal expression,mucopolysaccharidosis iv,cellular signaling,tumor progression
ENSG00000105499,PLA2G4C,cellular regulation,phospholipid hydrolysis,arachidonic acid production,tumor progression,signaling molecule,therapeutic target
ENSG00000132141,CCT6B,protein folding regulation,tumor progression,cell proliferation,protein stabilization,ubiquitin-proteasome pathway regulation,chaperone-mediated protein degradation
ENSG00000144285,SCN1A,voltage-gated sodium channels,regulation of action potentials,cellular proliferation,neuronal excitability,synaptic transmission regulation,tumor growth promotion
ENSG00000169857,AVEN,cell cycle regulation,apoptosis inhibition,transcriptional coactivation,oncogenesis promotion,tumor progression,therapeutic target
ENSG00000117983,MUC5B,mucin expression,tumor microenvironment,cell proliferation enhancement,metastasis facilitation,angiogenesis promotion,signaling pathway interaction
ENSG00000152382,TADA1,chromatin remodeling,oncogenic pathway activation,epigenetic regulation,histone modification,dna repair mechanism,genomic instability
ENSG00000119760,SUPT7L,chromatin remodeling,nucleosome positioning,histone modification,dna repair mechanism,transcriptional regulation,cell cycle progression
ENSG00000104325,DECR1,long-chain acylcarnitine degradation,tumor progression,cell growth promotion,mitochondrial energy regulation,oxidative stress modulation,therapeutic outcome influence
ENSG00000168781,PPIP5K1,cellular differentiation,cytoskeletal regulation,phosphoinositide phosphorylation,signal transduction pathway,cell migration,protein kinase activation
ENSG00000136295,TTYH3,regulation of protein transport,aberrant signaling pathways,cellular processes disruption,oncogenic signaling,tumorigenesis promotion,cellular function maintenance
ENSG00000164197,RNF180,ubiquitination regulation,oncogenic processes,tumor suppressor modulation,cell cycle control,apoptosis regulation,prognostic marker
ENSG00000140455,USP3,deubiquitination activity,nf-κb pathway regulation,oncogenic protein stabilization,cell proliferation promotion,cancer cell survival enhancement,apoptosis resistance
ENSG00000066923,STAG3,genomic instability,aneuploidy,cell cycle regulation,tumor aggressiveness,cohesin complex disruption,transcriptional dysregulation
ENSG00000164091,WDR82,genomic instability,homologous recombination,cell proliferation,dna repair mechanism,cancer predisposition,regulatory interaction
ENSG00000143867,OSR1,pdk1/akt signaling,tumor progression,cell cycle regulation,metabolic reprogramming,oncogenic driver,therapeutic target
ENSG00000198168,SVIP,altered expression,cell migration regulation,dysregulation of pi3k/akt pathway,neurotransmitter release modulation,regulation of cell proliferation,synaptic transmission disruption
ENSG00000121440,PDZRN3,p53 regulation,cell growth promotion,pi3k/akt pathway regulation,tumor suppressor protein interaction,cell survival enhancement,oncogenic process activation
ENSG00000196177,ACADSB,fatty acid oxidation,mitochondrial enzyme,energy production,lipid metabolism,muscle weakness,cardiac complications
ENSG00000055483,USP36,protein regulation,cell cycle progression,apoptosis regulation,deubiquitinating enzyme activity,tumor suppressor modulation,genetic instability
ENSG00000239900,ADSL,nucleotide sugar metabolism,glycogen synthesis,cell signaling pathways,glycosylation regulation,oncogenesis,proliferation and survival
ENSG00000135913,USP37,p53 stabilization,genome instability,cell survival promotion,dna damage accumulation,tumor suppressor regulation,ubiquitin modification
ENSG00000136014,USP44,deubiquitinating enzyme,genome stability regulator,cell cycle progression,tumor suppressor interaction,oncogenic signaling pathway activator,genomic amplification marker
ENSG00000178445,GLDC,mitochondrial function,dysregulated glutamine metabolism,oncogenic mutations,glutamate synthesis,glycolytic activity enhancement,tumor growth promotion
ENSG00000141404,GNAL,aberrant signaling,g-protein regulation,oncogenic mutations,cell proliferation,metabolic reprogramming,immune evasion
ENSG00000140986,RPL3L,ribosome biogenesis,oncogene function,cell cycle regulation,tumor suppressor pathway modulation,protein translation efficiency,biomarker for aggressive disease
ENSG00000223443,USP17L2,deubiquitination,protein stability modulation,oncogenic signaling pathway activation,tumor suppressor degradation,cell proliferation promotion,metastasis facilitation
ENSG00000186866,POFUT2,glycosylation pathway,oncogene overexpression,tumor progression,metastasis promotion,cell proliferation enhancement,protein function modification
ENSG00000109016,DHRS7B,lipid metabolism regulation,cell growth modulation,chemoresistance association,cancer risk enhancer,therapeutic target potential,stress response regulator
ENSG00000005100,DHX33,cellular rna processing,helix-destabilizing activity,oncogenic function,transcriptional regulation,microrna-mediated gene silencing,tumor aggressiveness
,FAM129B,rna-binding protein,oncogene activation,cell proliferation regulation,apoptosis evasion,cell cycle modulation,genetic dysregulation
ENSG00000115368,WDR75,dna repair mechanism,cell cycle regulation,genomic instability,aneuploidy,replication fork stability,therapeutic target
ENSG00000183605,SFXN4,fe-s cluster biogenesis,mitochondrial localization,apoptosis regulation,tumor suppressor function,dna repair pathway,cell cycle regulation
ENSG00000163584,RPL22L1,ribosome biogenesis,oncogenic function,cellular proliferation,protein synthesis regulation,tumorigenesis involvement,genomic instability
ENSG00000165097,KDM1B,histone modification,tumor suppressor,cell proliferation regulation,apoptosis inhibition,chromatin remodeling,therapeutic target
ENSG00000187772,LIN28B,microrna regulation,cellular self-renewal,oncogenic transformation,tumor progression,stem cell maintenance,gene expression regulation
ENSG00000143493,INTS7,transcriptional regulation,genomic instability,tumor progression,cell proliferation,epigenetic regulation,chromatin structure
ENSG00000111231,GPN3,genomic instability,dna repair regulation,transcriptional modulation,cell cycle control,tumor suppressor activity,cancer risk association
ENSG00000182521,TBPL2,transcriptional regulation,epigenetic modification,dna repair pathways,cellular proliferation,metabolic reprogramming,therapeutic target
ENSG00000112992,NNT,mitochondrial localization,redox balance regulation,energy metabolism regulation,cell survival promotion,antioxidant defense mechanism,overexpression association
ENSG00000156011,PSD3,chromatin remodeling,tumor suppressor function,pi3k/akt pathway interaction,constitutive activation of oncogenic pathways,gene expression regulation,cell cycle progression control
ENSG00000198690,FAN1,genomic instability,tumor suppressor,dna repair mechanisms,replication-associated damage,cell cycle regulation,apoptosis modulation
ENSG00000188322,SBK1,pi3k/akt signaling,gain-of-function mutations,tumor progression,metabolic regulation,protein kinase activation,cellular proliferation
ENSG00000155115,GTF3C6,general transcription factor,rna polymerase iii-dependent transcription,tumor suppressor function,loss of heterozygosity,cell proliferation,increased survival
ENSG00000241476,SSX2,chromatin remodeling,tumor suppressor function,transcriptional regulation,cellular proliferation,apoptosis modulation,histone modification
ENSG00000268447,SSX2B,chromatin remodeling,cell proliferation,oncogenic function,transcription factor activity,tumor expression,protein interaction
ENSG00000119547,ONECUT2,transcription factor activation,cell proliferation driver,tumor suppressor loss,epithelial-to-mesenchymal transition (emt),apoptosis evasion,wnt/β-catenin pathway interaction
ENSG00000115827,DCAF17,cancer-driver mutation,oncoprotein stabilization,ubiquitination regulation,transcription factor degradation,cell cycle progression,protein stability modulation
ENSG00000180233,ZNRF2,wnt signaling inhibition,tumor suppressor function,cell proliferation regulation,protein turnover modulation,oncogenic pathway disruption,genomic instability prevention
ENSG00000258659,TRIM34,protein degradation regulation,apoptosis induction,tumor suppressor activity,cell signaling modulation,gene expression regulation,viral response mechanism
ENSG00000163564,PYHIN1,dna damage response,innate immune activation,cytoplasmic dna sensing,apoptosis regulation,pi3k/akt pathway modulation,oncogenic transformation
ENSG00000125703,ATG4C,autophagy regulation,deubiquitinating enzyme function,cell survival pathway modulation,tumor growth promotion,metastasis facilitation,protein degradation regulation
ENSG00000099814,CEP170B,gain of function mutations,tumor progression,cell proliferation,microtubule stability,centrosomal protein,oncogenic pathway activation
ENSG00000162396,PARS2,genomic stability,dna repair mechanisms,homologous recombination,tumor progression,genetic instability,therapeutic target
ENSG00000066084,DIP2B,chromatin remodeling,dysregulated gene expression,oncogenic pathway activation,cell proliferation enhancement,apoptosis evasion,epithelial-to-mesenchymal transition (emt)
ENSG00000189195,BTBD8,apoptosis regulation,cell cycle regulation,dna damage response,g2/m checkpoint inhibition,tumor suppressor activity,protein-protein interaction
ENSG00000105662,CRTC1,constitutive activation,cellular proliferation,genomic amplification,metabolic reprogramming,transcriptional regulation,energy homeostasis disruption
ENSG00000175121,WFDC5,wap family protein,cell growth regulation,epithelial-to-mesenchymal transition,apoptosis inhibition,cell migration and invasion,oncoprotein overexpression
ENSG00000111704,NANOG,pluripotency maintenance,tumor initiating cell,self-renewal promotion,epigenetic regulation,apoptosis evasion,stem cell reprogramming
ENSG00000267680,ZNF224,tumor suppressor function,transcriptional regulation,gene expression modulation,cell cycle control,chromatin remodeling,dna damage response
ENSG00000124459,ZNF45,apoptosis regulation,cell growth modulation,dna damage response,gene expression control,transcription factor activity,tumor suppression loss
ENSG00000167380,ZNF226,epigenetic regulation,transcriptional regulation,cellular differentiation,chromatin remodeling,tumor suppression,cancer driver gene
ENSG00000146757,ZNF92,cell cycle regulation,chromatin remodeling,dna damage response,transcriptional repression,tumor suppressor function,tumor-promoting activity
ENSG00000235109,ZSCAN31,apoptosis regulation,chromatin remodeling,cell cycle modulation,cancer driver mutation,dna binding activity,gene expression regulation
ENSG00000135638,EMX1,homeobox-containing transcription factor,tumor suppressor/oncogene,cellular differentiation regulation,developmental pathway disruption,oncogenic transformation promoter,tumor microenvironment modulation
ENSG00000128645,HOXD1,tumor progression,transcription factor function,epithelial-to-mesenchymal transition (emt),oncogene activity,apoptosis suppression,cell migration promotion
ENSG00000169989,TIGD4,immune receptor signaling,oncogenesis,apoptosis inhibition,metastasis facilitation,cell cycle regulation alteration,prognostic marker
ENSG00000165583,SSX5,genomic instability,tumor progression,dna repair suppression,oncogene expression,chromatin remodeling,transcriptional regulation
ENSG00000115421,PAPOLG,dna damage response,genomic instability,tumor progression,apoptosis resistance,oncogenic pathway activation,dna repair interaction
ENSG00000005801,ZNF195,transcriptional regulation,cell proliferation,oncogenic driver,tumor progression,prognostic marker,genomic amplification
ENSG00000151240,DIP2C,dip2c overexpression,chromatin remodeling,gain-of-function mutations,oncogene potential,histone modification regulation,cell survival enhancement
ENSG00000160352,ZNF714,zinc finger protein interaction,transcriptional regulation,chromatin remodeling,cell growth regulation,apoptosis modulation,genomic stability
ENSG00000215421,ZNF407,zinc finger transcription factor,chromatin remodeling regulator,transcriptional modulation,apoptosis regulation,cellular proliferation control,tumor suppressor activity
ENSG00000198039,ZNF273,tumor suppressor modulation,gene expression regulation,krab domain interaction,cell cycle regulation,transcriptional control,oncogene modulation
ENSG00000164651,SP8,cell cycle regulation,oncogene function,transcriptional modulation,cell proliferation enhancement,prognostic marker,genomic instability
ENSG00000172000,ZNF556,chromatin remodeling,transcriptional regulation,aberrant expression,zinc finger domain,oncogene activity,tumor suppressor function
ENSG00000175322,ZNF519,epigenetic regulation,transcriptional regulation,tumor suppressor function,cell proliferation control,metastasis promotion,cancer aggressiveness
ENSG00000171467,ZNF318,krab-containing zinc finger protein,tumor suppressor,cell cycle regulation,gene expression regulation,oncogenic process,chromatin modification
ENSG00000185669,SNAI3,epithelial-to-mesenchymal transition,constitutive activation,transcription factor activity,cell migration and invasion,tumor progression and metastasis,transcriptional regulation
ENSG00000081665,ZNF506,transcriptional repression,chromatin remodeling,tumor suppressor function,cell cycle regulation,apoptosis modulation,dna repair mechanism
ENSG00000111639,MRPL51,ribosomal function alteration,cellular metabolism reprogramming,tumor growth promotion,potential biomarker identification,therapeutic target consideration,genomic instability contribution
,H2BFM,epigenetic regulation,chromatin remodeling,genome stability maintenance,histone modifications,nucleosome assembly,tumorigenesis contribution
ENSG00000176387,HSD11B2,glucocorticoid receptor signaling,mineralocorticoid activity,inflammatory responses,angiogenesis promotion,metabolic regulation,cortisol conversion
ENSG00000204335,SP5,transcriptional regulation,constitutive activation,overexpression,oncogenic process,epithelial-to-mesenchymal transition,therapeutic target
ENSG00000269058,CALR3,dna repair,apoptosis regulation,cell cycle progression,genetic instability prevention,mitotic spindle assembly,tumor suppression interaction
ENSG00000167136,ENDOG,angiogenesis,cell migration,tumor growth,pi3k/akt activation,metastasis promotion,therapeutic target
ENSG00000188786,MTF1,metal ion homeostasis,oxidative stress response,tumor progression,therapeutic target,transcriptional regulation,gene expression modulation
ENSG00000101493,ZNF516,zinc finger protein,oncogene activation,tumor suppressor interaction,cell proliferation modulation,genomic integrity regulation,cancer driver mutation
ENSG00000108423,TUBD1,microtubule dynamics,gene expression regulation,cellular behavior modulation,tumor suppressor function,genomic instability,protein-protein interactions
ENSG00000145476,CYP4V2,lipid metabolism regulation,tumor progression,oncogene role,apoptosis resistance,therapeutic target,redox status modulation
ENSG00000125520,SLC2A4RG,glucose transport regulation,tumor suppressor/oncogene switch,cellular adaptation,insulin signaling pathway,glucose homeostasis regulation,transcriptional coactivation
ENSG00000153391,INO80C,chromatin remodeling,tumor suppressor,genome stability,dna repair,transcriptional regulation,nucleosome reorganization
ENSG00000283510,INO80D,chromatin remodeling,genomic instability,dna repair,cell cycle regulation,transcriptional control,tumor initiation
ENSG00000100601,ALKBH1,dna repair,tumor suppression,alkylation resistance,genomic stability,chemotherapy sensitivity,telomere maintenance
ENSG00000130997,POLN,dna replication,mismatch repair,genomic instability,dna damage response,oncogene potential,cancer predisposition
ENSG00000118245,TNP1,chromatin regulation,cell proliferation,genomic instability,tumor suppressor interaction,dna repair modulation,nuclear localization
ENSG00000100162,CENPM,aneuploidy,genomic instability,histone deposition,kinetochores assembly,chromosome segregation,tumor suppressor dysfunction
,HIST1H2AD,chromatin remodeling,tumor suppressor function,epigenetic regulation,gene transcription,oncogene potential,chromatin structure
ENSG00000130304,SLC27A1,fatty acid metabolism,lipid biosynthesis,tumor growth,therapeutic target,cellular proliferation,metabolic regulation
ENSG00000155307,SAMSN1,cellular proliferation,tumor progression,scaffold protein function,pathway regulation disruption,therapeutic target,genomic profiling
ENSG00000147180,ZNF711,tumor suppressor repression,oncogenic potential,cell growth regulation,transcriptional repressor function,dna binding activity,genetic instability
ENSG00000184735,DDX53,rna processing,cell cycle regulation,aberrant mrna metabolism,tumor suppressor function,ribosome biogenesis regulation,cancer progression enhancement
ENSG00000187821,HELT,genomic instability,tumor progression,dna repair mechanism,protein stability regulation,cell proliferation enhancement,oncogenic process promotion
ENSG00000184058,TBX1,oncogene activity,transcriptional regulation,cell proliferation,genomic instability,tumorigenesis driver,apoptosis modulation
ENSG00000050030,NEXMIF,cytoplasmic localization,cell adhesion regulation,oncogenic behavior promotion,tumor progression driver,therapeutic target,protein function alteration
ENSG00000263141,PAXBP1,regulation of transcriptional activity,oncogenic pathway activation,cell proliferation regulation,apoptosis evasion modulation,gene expression profile alteration,tumor aggressiveness promotion
ENSG00000284869,EEFSEC,apoptosis modulation,cell growth regulation,dna repair interaction,eukaryotic translation elongation factor 2 regulation,protein synthesis control,tumor initiation
ENSG00000008311,AASS,lysine biosynthesis,amino acid metabolism,enzyme activity,genetic disorder,metabolic regulation,protein-protein interaction
ENSG00000176623,RMDN1,mitotic regulation,chromosomal instability,aneuploidy promotion,microtubule interaction,oncogenic function,cell cycle modulation
ENSG00000168297,PXK,protein tyrosine kinase,pi3k/akt signaling pathway,cell proliferation,tumor progression,therapeutic target,cancer initiation
ENSG00000154493,C10orf90,apoptosis regulation,cancer pathogenesis,cell cycle progression,cell proliferation,oncogenic pathway interaction,overexpression
ENSG00000125246,CLYBL,tumor progression,metabolic regulation,cell survival enhancement,oncogene overexpression,resistance to chemotherapy,beta-ketoacyl-coa derivative production
ENSG00000103855,CD276,immunosuppressive microenvironment,tumor progression,overexpression,therapeutic target,angiogenesis promotion,metastasis facilitation
ENSG00000075275,CELSR1,tumor progression,cell adhesion disruption,loss-of-function mutations,prognostic biomarker,wnt/pcp signaling pathway interaction,therapeutic target
ENSG00000150893,FREM2,cell-cell adhesion disruption,invasive growth promotion,cell migration regulation,signaling pathway modulation,oncogenic interaction,tumorigenesis involvement
ENSG00000148842,CNNM2,cgmp degradation,cell proliferation,energy metabolism regulation,oncogenic mutations,prognostic marker,therapeutic target
ENSG00000196159,FAT4,wnt/β-catenin signaling inhibition,cell adhesion regulation,tumor suppressor function,epithelial-to-mesenchymal transition inhibition,cell polarity regulation,asymmetric cell division modulation
ENSG00000166341,DCHS1,disrupted cell adhesion,tumor progression,oncogenic driver,cell migration,metastatic potential,epithelial integrity disruption
ENSG00000169851,PCDH7,neural development regulation,cell-cell adhesion disruption,epigenetic regulation,signaling pathway modulation,oncogene/tumor suppressor function,histone modification influence
ENSG00000280165,PCDH20,pi3k/akt pathway disruption,tumor suppressor function,epithelial-to-mesenchymal transition,cell adhesion loss,metastasis promotion,cancer progression
ENSG00000253873,PCDHGA11,cell-cell adhesion,adherens junctions,cadherin superfamily member,homophilic interactions,tissue structure maintenance,cancer progression
ENSG00000165323,FAT3,tumor progression,gain of function mutations,cancer driver gene,cell-cell adhesion disruption,oncogenic protein,pi3k/akt pathway interaction
ENSG00000203972,GLYATL3,metabolic regulation,tumor progression,rna-binding protein interaction,cell proliferation,reactive oxygen species modulation,oncogenic pathway involvement
ENSG00000263243,KRT12,cellular adhesion,epithelial-to-mesenchymal transition,type i cytokeratin family,cell migration,proliferation regulation,cancer-related mutations
ENSG00000072778,ACADVL,mitochondrial dysfunction,metabolic reprogramming,lipid metabolism disruption,cell death promotion,tumor growth facilitation,genomic instability
ENSG00000136010,ALDH1L2,dna damage response,genomic integrity maintenance,cellular redox balance regulation,oxidative stress mitigation,tumorigenesis contributor,genome stability preservation
ENSG00000157184,CPT2,fatty acid oxidation,metabolic regulator,cellular stress response,tumor progression,therapeutic target,mitochondrial function
ENSG00000069998,HDHD5,protein phosphatase regulation,cell cycle regulation,overexpression,protein interaction,tumor suppression defect,cell proliferation
ENSG00000182810,DDX28,genomic instability,oncogene regulation,transcriptional regulation,apoptosis evasion,cell proliferation enhancement,rna helicase activity
ENSG00000132463,GRSF1,spliceosome regulation,gene expression modulation,alternative splicing,protein-protein interaction,tumor progression modulation,rna transport regulation
ENSG00000100294,MCAT,oncogenic transcription factor,promotes cell proliferation,regulation of pi3k/akt pathway,wnt/β-catenin signaling activation,notch signaling modulation,tumor metastasis driver
ENSG00000114686,MRPL3,mitochondrial ribosome component,regulation of mitochondrial biogenesis,altered energy metabolism,cellular respiration modulation,tumor suppressor function,apoptosis regulation
ENSG00000106591,MRPL32,mitochondrial ribosomal function,dysregulation of translation process,tumor progression,mitochondrial dysfunction,cellular metabolism enhancement,prognostic significance
ENSG00000136897,MRPL50,mitochondrial translation,cell growth regulation,cell proliferation,oncogene potential,metabolic reprogramming,apoptosis evasion
ENSG00000183617,MRPL54,protein synthesis regulation,aberrant protein production,cellular response dysregulation,oncogenic processes contribution,cell survival enhancement,therapeutic target potential
ENSG00000162910,MRPL55,mitochondrial translation regulation,protein synthesis disruption,tumor progression enhancement,cell growth promotion,energy metabolism dysregulation,oncogenic mutation
ENSG00000122140,MRPS2,mitochondrial dysfunction,cancer initiation,energy metabolism alteration,oncogenic signaling,tumor progression driver,genomic instability
ENSG00000112996,MRPS30,mitochondrial ribosome biogenesis,altered cellular metabolism,enhanced protein synthesis,tumor progression,cellular energy production,oncogenic processes
ENSG00000177192,PUS1,pseudouridine synthesis regulation,rna stabilization,trna modification,genomic instability suppression,tumor suppressor activity,epigenetic regulation
ENSG00000143374,TARS2,threonine charging,dna repair,apoptosis resistance,cell proliferation,metastasis promotion,oncogene activation
ENSG00000112941,TENT4A,telomerase activation,chromosomal instability,gene amplification,dna damage response,genomic instability,tumor suppressor dysfunction
,MARCH1,apoptosis regulation,cellular protein degradation,immune response modulation,nf-κb signaling pathway interaction,tumor suppressor regulation,ubiquitin ligase function
ENSG00000108479,GALK1,glycolysis enhancement,glucose metabolism dysregulation,warburg effect association,cellular energy production,tumor growth promotion,cancer cell survival
ENSG00000180855,ZNF443,cell growth regulation,transcriptional regulation,c2h2-type zinc finger proteins,dna binding interactions,oncogene suppression,tumor suppressor function
ENSG00000007174,DNAH9,cilia assembly,dynein heavy chain function,motility regulation,cell signaling regulation,genetic disorder association,axonemal structure maintenance
ENSG00000141696,P3H4,collagen remodeling,proline hydroxylation,extracellular matrix integrity,cell adhesion modulation,tissue architecture maintenance,metastasis regulation
ENSG00000185432,METTL7A,m6a writer enzyme,rna stability regulation,post-transcriptional regulation,tumor suppressor loss,cell proliferation enhancement,metabolic reprogramming
ENSG00000065518,NDUFB4,mitochondrial dysfunction,electron transport chain disruption,metabolic reprogramming,genomic instability,ros-mediated dna damage,tumor metabolic adaptation
ENSG00000155962,CLIC2,chloride ion transport,cell signaling modulation,tumor progression promotion,apoptosis evasion,pi3k/akt pathway interaction,oncogene expression
ENSG00000114124,GRK7,gpcr regulation,signal transduction,oncogenic processes,cell proliferation,therapeutic target,g protein modulation
ENSG00000204977,TRIM13,tumor suppressor function,gain of function mutations,cell cycle regulation,anti-tumorigenic properties,cancer prognosis marker,ubiquitination pathway modulation
ENSG00000120008,WDR11,chromatin remodeling,transcription regulation,tumor suppression,dna repair,cell cycle progression,genomic stability
ENSG00000284807,DHRS4,regulation of cholesterol homeostasis,enhanced tumor progression,cell signaling regulation,tumor metastasis,prognosis indicator,rapid cell growth
ENSG00000168546,GFRA2,gdnf/gfra2 pathway,cell proliferation,tumor progression,neural crest development,biomarker potential,pi3k/akt/mtor signaling
ENSG00000211448,DIO2,thyroid hormone regulation,metabolic regulation,cell proliferation,tumor progression,gene expression profiling,therapeutic target
ENSG00000181873,IBA57,protein folding regulation,hsp90 complex subunit,autophagy modulation,tumorigenesis promotion,cell survival enhancement,oncogenic signaling pathway activation
ENSG00000100226,GTPBP1,oncogenic process,cell proliferation,gtpase regulation,protein-protein interaction,signaling pathway modulation,cancer metastasis
ENSG00000123684,LPGAT1,lipid metabolism,phospholipid synthesis,cellular proliferation,tumorigenesis,oncogenic process,signaling pathways
ENSG00000197563,PIGN,pi-glycosylation,cell signaling,oncogenic transformation,cell adhesion,tumor progression,therapeutic target
ENSG00000196458,ZNF605,transcriptional regulation,chromatin remodeling,tumor progression,cell proliferation,oncogenic pathway interaction,subcellular localization
ENSG00000213221,DNLZ,nf-κb pathway activation,oncogenic potential,tumor proliferation,metastasis promotion,protein kinase activation,inflammatory response mediation
ENSG00000130309,COLGALT1,cellular glycosylation,oncogenic processes,tumor progression,therapeutic target,protein-protein interactions,glycoprotein biosynthesis
ENSG00000053438,NNAT,oncogene overexpression,phosphatidylinositol 3-kinase (pi3k) pathway activation,sialic acid biosynthesis regulation,cell proliferation enhancement,epigenetic modification involvement,tumor suppressor interaction disruption
ENSG00000166796,LDHC,lactate production,metabolic rewiring,cell proliferation enhancement,tumor microenvironment alteration,prognostic marker,cancer metabolism dysfunction
ENSG00000106038,EVX1,transcription factor activation,pro-tumorigenic gene expression,cell survival promotion,tumor progression facilitation,genomic instability mediation,biomarker potentialization
ENSG00000186017,ZNF566,chromatin remodeling,cell growth regulation,tumor suppressor function,cancer driver mutation,genomic instability prevention,transcriptional regulation
ENSG00000083812,ZNF324,wnt/β-catenin pathway,transcriptional regulation,oncogenic driver,cell proliferation,metastasis promotion,chromatin remodeling
ENSG00000159917,ZNF235,krab domain-containing transcription factor,tumor suppressor function,cell cycle regulation,apoptosis modulation,genome stability maintenance,oncogenic effects in cancer
ENSG00000137573,SULF1,tumor progression,tumor microenvironment modulation,growth factor signaling regulation,cell adhesion modulation,oncogene activity,angiogenesis promotion
ENSG00000138336,TET1,tet1-mediated dna demethylation,epigenetic regulation,cancer cell reprogramming,tumor suppressor gene suppression,cpg dinucleotide targeting,stem cell pluripotency
ENSG00000263310,SALL3,tumor suppressor,transcription factor,cell proliferation inhibition,apoptosis promotion,epigenetic regulation,dna damage response
ENSG00000163872,YEATS2,epigenetic regulation,chromatin remodeling,transcriptional control,histone modification,oncogene activation,tumor suppression
,H2AFJ,chromatin modification,histone regulation,gene expression control,cell cycle regulation,genomic instability,transcriptional repression
ENSG00000178449,COX14,mitochondrial function,oncogenic mutations,electron transport chain,reactive oxygen species,genomic instability,tumor progression
ENSG00000051596,THOC3,pre-mrna processing,transcriptional regulation,oncogenic mrna export,epithelial-to-mesenchymal transition,cellular proliferation,prognostic biomarker
ENSG00000234438,KBTBD13,e3 ubiquitin ligase complex,tumor suppressor function,cell cycle regulation,apoptosis modulation,cancer gene mutation,genomic instability modification
,H2AFB1,chromatin remodeling,histone modification,cell cycle regulation,genomic instability,tumor suppressor function,nucleosome compaction
ENSG00000112699,GMDS,microtubule stability regulation,cytoskeleton modulation,cell division enhancement,oncogenic transformation driver,poor prognosis indicator,pi3k/akt pathway interaction
ENSG00000153933,DGKE,oncogenic signaling,phosphatidic acid production,protein kinase c activation,cell proliferation enhancement,tumor progression promotion,metastatic potential
ENSG00000058866,DGKG,genomic instability,cell growth promotion,dna repair mechanisms,p53 interaction,oncogenic potential,tumor suppressor function
ENSG00000091704,CPA1,peptide processing,metalloprotease activity,tumor progression,angiogenesis,cell invasion,biomarker potential
ENSG00000180138,CSNK1A1L,pi3k/akt pathway activation,cell proliferation regulation,tumor suppressor/oncogene,protein kinase activity,apoptosis regulation,cell cycle progression modulation
ENSG00000066422,ZBTB11,wnt/β-catenin pathway,transcriptional coactivator,loss of function mutations,cell proliferation,therapeutic target,genomic instability
ENSG00000288503,DDX51,deah-box helicase activity,oncogenic process promotion,dna repair regulation,telomere maintenance,cell proliferation enhancement,therapeutic resistance
ENSG00000138380,CARF,chromatin remodeling,transcriptional regulation,cell cycle progression,apoptosis dysregulation,oncogene mutation,genomic instability
ENSG00000112695,COX7A2,metabolic reprogramming,oxidative phosphorylation,cellular respiration,tumor aggressiveness,cell survival,apoptosis resistance
ENSG00000169515,CCDC8,cell cycle regulation,ciliogenesis regulation,dna damage response,transcriptional regulation,tumor suppressor function,genomic instability
ENSG00000101003,GINS1,genomic instability,proliferation enhancement,dna replication regulation,cell cycle progression,metastasis promotion,chemotherapy resistance
ENSG00000124479,NDP,dna repair mechanism,cell cycle regulation,p53 modulation,genomic instability,apoptosis evasion,tumor suppressor function
ENSG00000141314,RHBDL3,notch signaling pathway,cancer association,intramembrane protease activity,cellular homeostasis regulation,oncogenic process promotion,protein interaction modulation
ENSG00000196275,GTF2IRD2,transcriptional regulation,tumor suppressor regulation,oncogene modulation,cell cycle progression,apoptosis regulation,zinc finger dna binding
ENSG00000075461,CACNG4,cac channel regulation,ca2+ signaling dysregulation,tumor progression,cell proliferation enhancement,neuronal excitability modulation,oncogene function alteration
ENSG00000133256,PDE6B,visual transduction pathway,tumor suppressor loss,photoreceptor degeneration,cell cycle dysregulation,signal transduction alterations,genetic mutation associated
ENSG00000181588,MEX3D,tumor suppressor,cell growth regulation,post-transcriptional control,rna binding protein interaction,microrna modulation,oncogene regulation
ENSG00000180011,ZADH2,genome stability,brca1/brcan pathway interaction,oxidative dna damage repair,tumor suppressor function,epigenetic regulation,base excision repair
ENSG00000175193,PARL,mitochondrial dynamics,apoptosis regulation,oncogenic mutation,tumor progression,metabolic reprogramming,stress response modification
ENSG00000180901,KCTD2,ion channel regulation,transcriptional control,potassium channel interaction,oncogenic processes,cell proliferation,cancer cell survival
ENSG00000112078,KCTD20,regulatory protein interactions,cell proliferation regulation,protein-protein interaction modulation,transcriptional regulation involvement,apoptosis regulation alteration,tumorigenesis association
ENSG00000102271,KLHL4,cell cycle regulation,chromosomal stability maintenance,cancer driver gene,tumor suppressor function,mitotic checkpoint regulation,protein degradation facilitation
ENSG00000155729,KCTD18,apoptosis regulation,cell cycle disruption,oncogene interaction,protein-protein interaction regulation,tumor suppressor modulation,transcriptional regulation
ENSG00000137200,CMTR1,mitochondrial function regulation,calcium signaling modulation,protein interaction activation,tumor progression enhancement,metastasis promotion,cell cycle regulation disruption
ENSG00000197345,MRPL21,mitochondrial ribosomal function,oncogene activation,pi3k/akt/mtor pathway modulation,cell proliferation enhancement,tumor progression promotion,poor prognosis biomarker
ENSG00000258366,RTEL1,telomere maintenance,telomerase regulation,dna repair pathway,genomic instability,chromosomal stability,replication fork stabilization
ENSG00000121940,CLCC1,tight junction regulation,cell polarity maintenance,epithelial barrier function,cell adhesion dysregulation,cancer invasion facilitation,signal transduction pathway modulation
ENSG00000131043,AAR2,neddylation regulation,gain of function mutations,cell proliferation enhancement,apoptosis resistance,dna damage response modulation,cancer initiation
ENSG00000112584,FAM120B,cell growth regulation,scaffold protein function,apoptosis modulation,leukemia development,protein interaction network,oncogenic processes
ENSG00000131459,GFPT2,glycolysis promotion,constitutive activation,metabolic dysregulation,cellular metabolism enhancement,warburg effect induction,tumor growth promotion
ENSG00000134744,TUT4,rna modification,tumor suppressor function,post-transcriptional regulation,cell growth regulation,apoptosis modulation,translation initiation modification
ENSG00000138413,IDH1,histone modification,epigenetic regulation,cellular metabolism,gain-of-function mutations,2-hydroxyglutarate accumulation,redox imbalance
ENSG00000253506,NACA2,nucleosome assembly,apoptosis regulation,chromatin remodeling,tumor growth promotion,biomarker function,transcriptional control
ENSG00000153093,ACOXL,fatty acid oxidation,warburg effect,cell growth,chemotherapy resistance,lipid metabolism,cancer stem cell maintenance
ENSG00000140876,NUDT7,genomic instability,dna damage repair,cell proliferation regulation,tumor suppressor function,genetic mutation regulation,apoptosis modulation
ENSG00000130584,ZBTB46,transcriptional regulation,cell cycle arrest,tumor suppressor function,dna damage response,chromatin remodeling,apoptosis induction
ENSG00000165487,MICU2,mitochondrial function,calcium regulation,energy metabolism,cell survival,oncometabolism,biomarker potential
ENSG00000188573,FBLL1,protein processing regulation,apoptosis suppression,cell growth promotion,genomic instability,dna repair disruption,tumor microenvironment modulation
ENSG00000126249,PDCD2L,apoptosis regulation,cell cycle control,protein interaction network,adaptor protein function,genomic stability maintenance,cancer susceptibility
ENSG00000180098,TRNAU1AP,trna processing,genetic instability,oncogenesis,proteostasis imbalance,metabolic reprogramming,cell transformation
ENSG00000172469,MANEA,transcriptional regulation,epigenetic alterations,oncogenic processes,cellular proliferation,therapeutic target,signaling pathway dysregulation
ENSG00000119655,NPC2,cholesterol transport,lysosomal efflux,lipid metabolism regulation,cellular survival promotion,cancer association,therapeutic target
ENSG00000156282,CLDN17,metastasis,epithelial-to-mesenchymal transition,tight junction disruption,oncogenic potential,prognostic marker,cancer aggressiveness
ENSG00000257008,GPR142,regulation of glucose metabolism,pancreatic beta-cell dysfunction,impaired insulin secretion,cancer cell metabolism,tumor growth promotion,therapeutic target
ENSG00000047648,ARHGAP6,rho gtpase regulation,tumor progression,cell migration and invasion,therapeutic target,cytoskeletal dynamics regulation,signaling pathway interaction
ENSG00000263238,CTSO,proteolytic activity,tumor progression,immune evasion,metastasis,angiogenesis,cell proliferation
ENSG00000186479,RGS7BP,g-protein signaling,regulatory mechanism,cell signaling modulation,tumor suppression,oncogenesis implication,cellular regulation
ENSG00000203780,FANK1,ferm domain-containing protein,cell-cell adhesion disruption,oncogenic signaling pathway activation,cell proliferation enhancement,metastasis promotion,biomarker expression
ENSG00000198216,CACNA1E,calcium channel regulation,cancer cell proliferation,cell cycle progression,apoptosis evasion,tumor progression,therapeutic target
ENSG00000142910,TINAGL1,cell adhesion disruption,emt induction,metastatic progression,pi3k/akt pathway modulation,wnt/β-catenin pathway interaction,therapeutic target
ENSG00000125831,CST11,cell cycle regulation,apoptosis evasion,angiogenesis promotion,tumor growth facilitation,peptidase activity modulation,natriuretic peptide conversion
ENSG00000152454,ZNF256,genomic instability,transcriptional regulation,tumor suppressor function,cell growth regulation,oncogenic pathway modulation,chromatin remodeling
ENSG00000112379,ARFGEF3,golgi apparatus regulation,gef activity activation,cell proliferation enhancement,oncogenic process promotion,pi3k/akt pathway interaction,tumor suppressor/tumor promoter dual role
ENSG00000170255,MRGPRX1,gpcr activation,cell proliferation,tumor progression,oncogene activation,pi3k/akt pathway interaction,mutation-driven tumorigenesis
ENSG00000114796,KLHL24,loss-of-function mutations,cul4 complex component,ubiquitination regulation,cell growth regulation,p53 interaction,oncogenic driver
ENSG00000142634,EFHD2,cell cycle regulation,tumor suppressor protein interaction,ca²⁺ signaling pathway,apoptosis modulation,dna repair regulation,overexpression in cancer
ENSG00000188158,NHS,chromatin remodeling,histone modification regulation,transcriptional activation,cell cycle progression,apoptosis regulation,genetic instability
ENSG00000152784,PRDM8,tumor suppression,genomic stability maintenance,histone methylation regulation,dna repair modulation,cell cycle regulation influence,apoptosis promotion
ENSG00000119125,GDA,mitochondrial biogenesis,cell survival promotion,energy metabolism regulation,tumorigenesis driver,oncogenic process modulation,stress response regulation
ENSG00000169154,GOT1L1,tumor suppressor,glutamate transport regulation,cancer driver mutation,gene expression dysregulation,cell proliferation enhancement,genomic instability promotion
ENSG00000025708,TYMP,nucleotide metabolism,angiogenic activity,tumor progression,vascular endothelial growth factor production,cell proliferation modulation,dna synthesis regulation
ENSG00000255346,NOX5,ros generation,pro-tumorigenic microenvironment,genomic instability,oncogenic signaling pathway,cellular differentiation,anti-apoptotic function
ENSG00000173626,TRAPPC3L,er transport regulation,cell survival promotion,tumorigenesis driver,protein-protein interactions,pi3k/akt pathway modulation,cancer prognosis marker
ENSG00000128159,TUBGCP6,microtubule nucleation,genomic instability,cell division regulation,cancer cell proliferation,therapeutic target,mitotic process
ENSG00000175854,SWI5,genomic instability,dna replication regulation,chromatin remodeling,transcriptional activation,s-phase progression maintenance,cancer driver candidate
ENSG00000127084,FGD3,arf gtpase regulation,guanine nucleotide exchange factor activity,cell migration facilitation,membrane trafficking regulation,oncogenic process promotion,tumorigenesis association
ENSG00000108784,NAGLU,lysosomal storage,glycosaminoglycan degradation,cellular accumulation,tumor microenvironment modulation,inflammation induction,oxidative stress generation
ENSG00000137509,PRCP,cell surface regulation,e3 ubiquitin ligase activity,modulation of protein turnover,tumor suppressor or oncogene,regulator of proteolysis and signaling,protein trafficking and degradation
ENSG00000116406,EDEM3,er quality control,misfolded protein degradation,cell proliferation,autophagy regulation,tumor progression,cancer adaptation
ENSG00000181523,SGSH,tumor aggressiveness,cell surface modification,lysosomal dysfunction,oncogene activation,signaling pathway modulation,protein degradation
ENSG00000164039,BDH2,warburg effect,metabolic reprogramming,cellular energy regulation,fatty acid breakdown,glycolytic shift,tumor metabolic adaptation
ENSG00000170088,TMEM192,cell signaling regulation,plasma membrane localization,tumor type association,oncogenic potential,cell growth regulation,protein-protein interaction
ENSG00000198171,DDRGK1,dual specificity phosphatase,p38 map kinase regulation,tumor progression driver,cellular signaling modulation,oncogenic pathway activation,genomic instability promoter
ENSG00000100802,C14orf93,oncogene potential,tumor progression,cell proliferation,promoter activity regulation,transcriptional control,chromatin remodeling
ENSG00000165046,LETM2,mitochondrial regulation,oncogenic signaling pathway,cell proliferation facilitation,calcium homeostasis disruption,metastatic potential enhancement,therapeutic target identification
ENSG00000185404,SP140L,chromatin modification,transcription regulation,histone modification,cell growth regulation,apoptosis inhibition,tumor progression
ENSG00000140522,RLBP1,regulation of cell growth,genomic instability,increased protein stability,oncogenic function,pi3k/akt signaling interaction,cellular differentiation
,C22orf46,cellular regulation,dysregulation in cancer,gene expression modulation,long non-coding rna,potential oncogene,tumorigenesis involvement
ENSG00000137491,SLCO2B1,organic anion transport,hepatic detoxification,bilirubin glucuronide transport,liver function regulation,detoxification process,redox balance maintenance
ENSG00000247626,MARS2,peptide release,cellular stress,genomic instability,oncogenic potential,protein synthesis regulation,ribosomal interaction
ENSG00000121316,PLBD1,genomic instability,chromosomal abnormalities,dna repair dysfunction,homologous recombination repair,cell cycle regulation,protein-protein interactions
ENSG00000100889,PCK2,gluconeogenesis regulation,metabolic reprogramming,glycolysis facilitation,warburg effect association,therapeutic target,genomic instability
ENSG00000111536,IL26,jak/stat pathway,oncogene,immune evasion,angiogenesis promotion,cell proliferation enhancement,poor prognosis marker
ENSG00000110002,VWA5A,genomic instability,dna damage response,cell proliferation,overexpression,proliferation enhancement,centrosome regulation
ENSG00000134183,GNAT2,camp/pka signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cellular proliferation
ENSG00000132840,BHMT2,methionine cycle regulation,dna methylation,cellular metabolism regulation,proliferation modulation,oncogenic potential,genomic stability maintenance
ENSG00000163377,TAFA4,cell cycle regulation,oncogenic potential,transcriptional activity,gene expression modulation,tumorigenesis promotion,protein interaction
ENSG00000174370,C11orf45,cell cycle regulation,gene expression modulation,dna replication maintenance,tumor suppression,pan-cancer association,brca1 interaction
ENSG00000163378,EOGT,o-glcnac transferase activity,post-translational modification,cell cycle regulation,dna repair mechanisms,transcriptional control,tumor progression marker
ENSG00000117308,GALE,ga-like lectin family,glycosylation regulation,tumor progression,cancer stem cell maintenance,proliferation and migration,immune evasion
ENSG00000116874,WARS2,oncogene,protein synthesis regulation,cell proliferation enhancement,tumor progression facilitation,genetic instability contribution,metabolic reprogramming involvement
ENSG00000141580,WDR45B,cellular degradation,cell proliferation regulation,genomic instability,p53 interaction,protein degradation complex,ubiquitination pathway
ENSG00000114956,DGUOK,mitochondrial integrity,dna replication,oxidative stress,cellular homeostasis,genomic instability,tumor suppressor
ENSG00000103707,MTFMT,one-carbon metabolism,cellular energy production,impaired mitochondrial function,tumorigenesis,genetic instability,dna damage repair
ENSG00000042445,RETSAT,transcriptional regulation,myc/e2f pathway modulation,cellular growth regulation,differentiation control,tumor suppressor function,genomic instability
ENSG00000282074,MPV17L,mitochondrial integrity,tumor progression,cell survival,dna repair regulation,apoptosis resistance,protein overexpression
ENSG00000144647,POMGNT2,o-glcnacylation,oncogenesis,cell proliferation,tumor progression,pi3k/akt pathway,dysregulation
ENSG00000285136,DEFA6,antimicrobial activity,cell proliferation,angiogenesis promotion,inflammation regulation,pancreatic function regulation,therapeutic target
ENSG00000122335,SERAC1,cholesterol synthesis,lipid homeostasis regulation,fatty acid elongation,cell proliferation,tumor growth,metastasis promotion
ENSG00000158270,COLEC12,tumor-associated antigen,immune system modulation,cancer biomarker potential,innate immunity regulation,cellular homeostasis maintenance,protein-carbohydrate interactions
ENSG00000152611,CAPSL,transcriptional regulation,histone modification,cellular growth,tumor suppressor,therapeutic target,gene expression modulation
ENSG00000073605,GSDMB,pyroptosis induction,apoptosis regulation,tumor progression,inflammatory signaling,cell proliferation regulation,metastasis promotion
ENSG00000101074,R3HDML,ubiquitin ligase activity,cellular stress response regulation,transcriptional regulation,dna binding,cancer driver mutation,therapeutic target candidate
ENSG00000106537,TSPAN13,cell-cell adhesion disruption,tumor progression facilitation,oncogenic processes contribution,plasma membrane localization,cell migration promotion,therapeutic target potential
ENSG00000124232,RBPJL,notch signaling pathway,aberrant activation,oncogenic driver,cell proliferation,genetic mutations,therapeutic target
ENSG00000139914,FITM1,ferroptosis regulator,iron homeostasis regulation,tumor growth promotion,cell death dysregulation,therapeutic target opportunity,redox balance disruption
ENSG00000124449,IRGC,cellular metabolism,dna repair regulation,oncogenesis promotion,tumor cell proliferation,cell cycle modulation,nucleotide pool regulation
ENSG00000163521,GLB1L,glycogen regulation,oncogenic metabolism,glycolysis promotion,lipid biosynthesis,cell proliferation enhancement,therapeutic target
ENSG00000177830,CHID1,genomic instability,dna damage response,cell cycle regulation,apoptosis induction,tumor suppressor function,brca2 interaction
ENSG00000006625,GGCT,amino acid metabolism,tumor growth,cellular regulation,dysregulation,potential oncogenic impact,unresolved role in cancer
ENSG00000169738,DCXR,multidrug resistance,cell membrane transport,oncogenic potential,tumor progression,metabolic regulation,transmembrane protein
ENSG00000173464,RNASE11,oncogenic roles,rna degradation regulation,cell survival enhancement,genomic instability,therapeutic target,pi3k/akt pathway interaction
ENSG00000080910,CFHR2,complement regulation,tumor progression,biomarker identification,immune evasion,metastasis promotion,genetic predisposition
ENSG00000119899,SLC17A5,glutamate transport,neurotransmitter release,cell proliferation,oncogene regulation,synaptic vesicle function,tumorigenesis
ENSG00000129480,DTD2,chromosomal instability,genomic instability,dna repair pathway,cell cycle progression,genome integrity maintenance,protein-protein interaction
ENSG00000144815,NXPE3,genomic instability,constitutive activation,gain of function mutations,epigenetic regulation,tumor progression,nucleocytoplasmic transport
ENSG00000106384,MOGAT3,lipid metabolism,tumor growth promotion,oncogene activation,cell proliferation facilitation,metastasis regulation,therapeutic target
ENSG00000197406,DIO3,thyroid hormone metabolism,oncogenic transformation,p53 inhibition,cell proliferation,epigenetic regulation,tumor metastasis
ENSG00000143919,CAMKMT,calcium signaling regulation,cell cycle progression,cell proliferation,apoptosis modulation,oncogenic pathway involvement,genomic instability
ENSG00000150656,CNDP1,redox imbalance,oxidative stress,genomic instability,cellular detoxification,transcriptional regulation,apoptosis suppression
ENSG00000166049,PASD1,phosphatase activity,tyrosine phosphorylation regulation,cell signaling modulation,oncogenic protein interaction,cancer mutation association,tumor progression promotion
ENSG00000101327,PDYN,tumor progression,cell migration,dysregulated expression,immune evasion,angiogenesis promotion,epithelial-to-mesenchymal transition
ENSG00000154122,ANKH,bone mineralization,cell adhesion disruption,craniotabes association,hyperostosis causation,osteoarthritis link,pyrophosphate export regulation
ENSG00000186283,TOR3A,aaa+ atpase family,cellular stress response,intracellular protein trafficking,mitochondrial function regulation,protein folding disorder,torsin a dysfunction
ENSG00000127540,UQCR11,mitochondrial dysfunction,genomic instability,cellular respiration,oncogenic transformation,metabolic reprogramming,reactive oxygen species
ENSG00000136522,MRPL47,mitochondrial biogenesis,cellular metabolism,ribosomal function regulation,tumor progression,oncogenic pathway interaction,metabolic regulation
ENSG00000139168,ZCRB1,cellular proliferation,transcriptional regulation,chromatin remodeling,oncogene function,apoptosis resistance,tumor suppressor activity
ENSG00000128524,ATP6V1F,acidic extracellular environment,cancer cell survival,cellular ph regulation,h+atpase activity,metastasis promotion,tumor microenvironment
ENSG00000103335,PIEZO1,mechanically activated ion channel,mechanotransduction,cellular homeostasis regulation,tumor progression,biomarker potential,chromosomal location 20q13.33
ENSG00000116580,GON4L,cell cycle regulation,microtubule stability,protein-protein interaction,cell proliferation,tumorigenesis,cellular growth
ENSG00000104774,MAN2B1,glycosylation pattern,aberrant enzyme activity,tumor progression,cell adhesion modulation,unfolded protein response regulation,glycan modification
ENSG00000152620,NADK2,cell growth promotion,cell survival enhancement,energy metabolism regulation,kinase activation modulation,pi3k/akt pathway interaction,oncogenic process contribution
ENSG00000131171,SH3BGRL,signaling pathway regulation,oncogenic protein interaction,cell proliferation modulation,therapeutic target potential,biomarker candidate,genomic amplification
ENSG00000128311,TST,immune regulation,antigen recognition,cell signaling pathways,apoptosis regulation,tumor progression,therapeutic target
ENSG00000104889,RNASEH2A,chromatin remodeling,genomic instability,loss of function mutations,apoptosis regulation,cell cycle control,dna replication repair
ENSG00000172922,RNASEH2C,rnase h2 activity,loss of function mutations,genomic instability,chromosomal rearrangement,dna repair deficiency,cancer predisposition
ENSG00000136104,RNASEH2B,genomic instability,loss of function mutations,dna repair pathway,abasic site processing,tumor suppressor,protein-protein interaction
ENSG00000122965,RBM19,rna-binding protein,cell cycle regulation,apoptosis inhibition,metastasis promotion,gene expression dysregulation,poor prognosis marker
ENSG00000171202,TMEM126A,mitochondrial regulation,tumor progression,apoptosis evasion,energy metabolism regulation,cell survival enhancement,oncogenic driver
ENSG00000174982,OR4S2,olfactory receptor signaling,cell membrane expression,protein-protein interactions,epithelial cell expression,cancer-associated genes,tumor tissue expression
ENSG00000091009,RBM27,regulation of pre-mrna splicing,transcriptional regulation,gene expression profiling,oncogenic mutations,nuclear localization,rna-protein interactions
ENSG00000165661,QSOX2,transcriptional regulation,protein modification,cell growth promotion,tumor progression,resistance to apoptosis,signaling pathway modulation
ENSG00000115204,MPV17,mitochondrial dna maintenance,oncogenic function,genomic instability,cell survival enhancement,tumor progression,cellular proliferation
ENSG00000206256,PPT2,oncogene,cell proliferation,protein dephosphorylation,cell signaling pathways,tumor progression,therapeutic target
ENSG00000151176,PLBD2,cancer driver,tumor progression,cell migration,signaling pathway activation,protein interaction,cell adhesion regulation
ENSG00000090686,USP48,deubiquitination activity,oncogenic processes,cell proliferation enhancement,tumor suppressor protein regulation,protein homeostasis regulation,cancer progression promotion
ENSG00000144120,TMEM177,ion transport regulation,plasma membrane localization,cellular homeostasis,transmembrane protein interaction,oncogenic potential,signaling pathway modulation
ENSG00000184076,UQCR10,mitochondrial electron transport chain,electron transfer complex,ubiquinol-cytochrome c reductase,atp synthesis,cellular respiration,oncogenesis
ENSG00000166704,ZNF606,chromatin modification,transcriptional regulation,tumor suppressor activity,gene repression,krab domain-containing family,cell proliferation inhibition
ENSG00000132915,PDE6A,pi3k/akt pathway interaction,cgmp phosphodiesterase activity,cell signaling regulation,genetic disorder association,photoreceptor function,visual transduction pathway
ENSG00000178187,ZNF454,tumor suppression,genomic instability,transcriptional regulation,cell cycle control,apoptosis modulation,dna repair interaction
ENSG00000085449,WDFY1,ubiquitination regulation,sumoylation modification,cellular signaling modulation,tumor progression driver,genomic instability mediator,protein-protein interaction network
ENSG00000283085,TPBG,cellular proliferation,tumor suppressor activity,oncogene,cell cycle regulation,epithelial development,cell survival
ENSG00000135776,ABCB10,abc transporter,iron metabolism regulation,tumor progression driver,chemotherapy resistance mediator,genetic instability contributor,heme export function
ENSG00000198729,PPP1R14C,pp2a inhibition,oncogene activation,cell proliferation enhancement,apoptosis suppression,hyperphosphorylation,mutation-driven overexpression
ENSG00000100558,PLEK2,cell migration,plekhin domain,metastasis promotion,tumor progression,pi3k interaction,cancer prognosis
ENSG00000184227,ACOT1,lipid metabolism modulation,pi3k/akt/mtor signaling,fatty acid synthesis regulation,cell growth promotion,therapeutic target identification,cancer cell metabolic adaptation
ENSG00000115944,COX7A2L,mitochondrial dynamics,antisense regulation,electron transport chain disruption,glycolytic shift,apoptosis modulation,metabolic rewiring
ENSG00000112893,MAN2A1,glycosylation regulation,cell surface protein recognition,cell growth modulation,protein processing mechanism,n-glycan maturation,metabolic pathway manipulation
ENSG00000277656,GSTT1,dna damage response,genomic instability,oxidative stress protection,cancer predisposition,cell growth regulation,detoxification pathway modulation
ENSG00000254685,FPGT,amino acid catabolism,metabolic regulation,cellular growth,toxic intermediate accumulation,phenylketone excretion,enzyme dysfunction
ENSG00000148719,DNAJB12,cellular protein quality control,oncogenic interaction,tumor suppressor activity,protein misfolding regulation,apoptosis inhibition,cancer cell survival
ENSG00000196449,YRDC,gain of function mutations,pi3k/akt signaling pathway interaction,tumor progression promotion,cell proliferation regulation,apoptosis inhibition,therapeutic target potential
ENSG00000101079,NDRG3,tumor suppressor,cellular differentiation regulation,transcriptional regulation,dna repair mechanism,cell cycle progression inhibition,epigenetic modification target
ENSG00000204764,RANBP17,ran gtpase regulation,tumor development,aberrant cell cycle progression,oncogene potential,nucleocytoplasmic transport,mitotic spindle assembly
ENSG00000127080,IPPK,transcriptional regulation,chromatin remodeling,epigenetic modifications,histone interactions,gene expression control,protein-protein interactions
ENSG00000101337,TM9SF4,aberrant membrane trafficking,cell migration and invasion,chromatin remodeling,epigenetic modifications,metastatic potential,oncogenic protein accumulation
ENSG00000173905,GOLIM4,mrna regulation,aberrant expression,altered cell processes,cellular proliferation,nuclear transport interactions,oncogenic potential
ENSG00000099974,DDTL,pi3k/akt pathway,oncogene,tumor progression,cell proliferation,chromatin remodeling,transcriptional regulation
ENSG00000205903,ZNF316,transcriptional regulation,tumor suppressor function,cell proliferation control,apoptosis induction,dna binding protein,cancer prognosis marker
ENSG00000125877,ITPA,genomic instability,mutagenesis prevention,dna replication regulation,mutant alleles,genetic alterations,cellular mutagenesis
ENSG00000169299,PGM2,glycolysis,tumor growth,cell proliferation,metabolic adaptation,prognostic marker,therapeutic target
ENSG00000134056,MRPS36,mitochondrial function,oncogenic process,altered metabolism,cellular respiration,protein synthesis regulation,tumor progression
ENSG00000160785,SLC25A44,mitochondrial carrier protein,metabolic regulation,cell growth promotion,tumor progression,therapeutic target,metabolic adaptation
ENSG00000106853,PTGR1,prostaglandin synthesis,constitutive activation,oncogene overexpression,metastasis promotion,chemoresistance induction,inflammation regulation
ENSG00000155850,SLC26A2,anabolic metabolism,cell invasion,energy demand regulation,metastasis facilitation,prognostic marker,tumor progression
ENSG00000166800,LDHAL6A,warburg effect,cellular metabolism regulation,glycolytic flux enhancement,tumor growth promotion,hypoxia response,metabolic reprogramming
ENSG00000153956,CACNA2D1,calcium channel regulation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000117143,UAP1,ubiquitination regulation,oncogene activation,cell proliferation enhancement,protein stability modulation,cancer progression driver,post-translational modification regulation
ENSG00000205544,TMEM256,cellular adhesion,cell migration,cancer progression,stress response regulation,tumor suppressor function,genomic instability
ENSG00000166965,RCCD1,cell cycle regulation,genomic instability,telomere length maintenance,chromatin remodeling,epigenetic alterations,mitotic checkpoint control
ENSG00000178802,MPI,microtubule regulation,tumor growth,cell division,metastasis,cytoskeletal organization,genomic instability
ENSG00000173262,SLC2A14,altered glucose metabolism,facilitated glucose uptake,warburg effect,tumorigenesis,cell growth and survival,metabolic regulation
,PALM2,phosphatidylserine modification,mitochondrial localization,oncogenic process,cellular differentiation,phospholipid metabolism,tumor progression
ENSG00000198478,SH3BGRL2,pi3k/akt pathway regulation,protein-protein interaction,cell cycle modulation,scaffolding function,phosphatase activity,tumorigenesis
ENSG00000164933,SLC25A32,mitochondrial carrier protein,metabolic regulation,cell growth promotion,tumor progression correlation,prognostic biomarker,energy metabolism modulation
ENSG00000185414,MRPL30,ribosomal assembly,mitochondrial function disruption,oncogene potential,tumor growth promotion,therapeutic target,cell cycle regulation alteration
ENSG00000072756,TRNT1,translation regulation,genomic instability,tumor progression,cellular proliferation,therapeutic target,protein synthesis
ENSG00000163389,POGLUT1,o-glcnac transferase activity,cellular proliferation,apoptosis regulation,protein stability modulation,transcriptional regulation,subcellular localization control
ENSG00000213965,NUDT19,dna repair mechanism,nucleus-localized protein,genomic instability driver,tumor suppressor function,epigenetic regulation,chromatin remodeling interaction
ENSG00000113273,ARSB,lysosomal function disruption,glycosaminoglycan accumulation,oxidative stress induction,cellular damage promotion,cancer progression enhancement,metabolic dysregulation
ENSG00000054793,ATP9A,cellular ion transport regulation,oncogenic function,apoptosis modulation,growth factor signaling,cellular metabolism alteration,tumorigenesis association
ENSG00000157014,TATDN2,dna repair,genome stability,ubiquitin-protein conjugates,chromatin regulation,cell cycle control,transcriptional modulation
ENSG00000044459,CNTLN,microtubule regulation,calmodulin interaction,centrosome separation,cell migration promotion,genomic instability induction,protein-protein interaction modulation
ENSG00000122687,MRM2,oxidative stress reduction,gene dysregulation,cell survival promotion,protein homeostasis maintenance,epigenetic regulation,cellular stress response
ENSG00000116127,ALMS1,cancer association,tumor suppressor,cell proliferation regulation,cilia dysfunction,genomic instability,metastasis
ENSG00000163319,MRPS18C,mitochondrial translation,energy production regulation,oncogenic transformation,tumor growth promotion,cell proliferation regulation,genomic instability
ENSG00000243147,MRPL33,genomic instability,constitutive activation,enhanced protein synthesis,cell proliferation,oncogenic processes,genetic interactions
ENSG00000275004,ZNF280B,transcription factor,constitutive activation,genomic instability,oncogenic pathway activation,cellular growth regulation,epigenetic modulation
ENSG00000198453,ZNF568,zinc finger protein,dna binding,transcriptional regulation,cell cycle progression,apoptosis modulation,oncogenic pathway activation
ENSG00000257591,ZNF625,epigenetic regulation,transcriptional repression,genomic instability,cell cycle control,apoptosis modulation,oncogenic process
ENSG00000196437,ZNF569,chromatin remodeling,transcriptional regulation,dna repair,cell cycle progression,tumor suppressor function,genomic instability
ENSG00000249471,ZNF324B,chromatin regulation,dysregulated transcription,cellular proliferation,transcriptional modulation,zinc finger domain disruption,tumorigenic pathway modification
ENSG00000245680,ZNF585B,oncogene expression,genomic repression,tumor progression,gene regulation,chromatin remodeling,zinc finger domain
ENSG00000181007,ZFP82,transcriptional regulation,cellular proliferation,tumor suppressor/oncogene,dual role in cancer,dna binding motif,nuclear localization
ENSG00000275723,NAPEPLD,regulation of endocannabinoid metabolism,promotion of cell survival and growth,metabolic reprogramming,tumor aggressiveness,cell proliferation,pro-survival gene expression
ENSG00000182111,ZNF716,transcriptional regulator,tumor progression,cell differentiation,apoptosis regulation,metastasis promotion,dysregulated expression
ENSG00000274195,ZNF705G,gene expression regulation,chromatin remodeling,transcriptional regulation,oncogenic activity,epigenetic regulation,cell proliferation
ENSG00000170920,OR7G3,tumor progression,oncogenesis,cell proliferation,signal transduction pathway,cell survival mechanism,tissue specificity
ENSG00000185013,NT5C1B,purinergic signaling,cell proliferation,increased apoptosis resistance,oncogenic process,therapeutic target,metabolic regulation
ENSG00000145194,ECE2,vascular regulation,endothelin activation,metalloprotease activity,blood pressure modulation,pulmonary artery expression,cardiovascular disease risk
ENSG00000137976,DNASE2B,extracellular dna degradation,cell migration enhancement,pi3k/akt pathway interaction,emt regulation,immune system modulation,therapeutic target
ENSG00000169814,BTD,genomic instability,metabolic adaptation,energy metabolism,dna synthesis,protein activity,reduced biotin levels
ENSG00000196344,ADH7,adh7 expression alteration,cellular metabolism disruption,genomic instability induction,oncogenic signaling activation,tumor progression promotion,therapeutic target modulation
ENSG00000148513,ANKRD30A,tumor suppressor,cell cycle regulation,chromatin structure regulation,dna repair mechanism,transcriptional control,genomic instability prevention
ENSG00000219481,NBPF1,amplification,cell growth regulation,chromatin remodeling,oncogenic signaling,prognostic marker,tumor progression
ENSG00000100578,KIAA0586,mitotic spindle checkpoint regulation,chromosomal instability,genomic stability maintenance,microtubule dynamics regulation,cell division regulation,aneuploidy induction
ENSG00000128059,PPAT,metabolic reprogramming,fatty acid synthesis,tumor metabolism,genetic alterations,therapeutic target,cellular proliferation
ENSG00000172663,TMEM134,er stress response modulation,cellular integrity maintenance,tumor development regulation,apoptosis modulation,autophagy regulation,biomarker potential
ENSG00000165490,DDIAS,pyrimidine biosynthesis,carcinogenesis involvement,cell cycle regulation,dna repair mechanisms,redox balance disruption,tumor progression association
ENSG00000243749,TMEM35B,cellular responses,protein homeostasis,tumor progression,potential therapeutic target,pi3k/akt pathway interaction,cellular growth regulation
ENSG00000124780,KCNK17,pi3k/akt pathway regulation,cell proliferation enhancement,constitutive activation,tumor progression facilitation,therapeutic target,tissue electrical excitability
ENSG00000156453,PCDH1,loss of cell adhesion,epithelial-to-mesenchymal transition (emt),apoptosis inhibition,autophagy disruption,tumor progression,wnt/β-catenin pathway interaction
ENSG00000242110,AMACR,metabolic adaptation,oncogenic function,cellular proliferation,therapeutic target,mitochondrial localization,metabolic regulator
ENSG00000101323,HAO1,tumor suppressor,antioxidant defense,cell survival,therapeutic target,oxidative stress regulation,cell growth regulation
ENSG00000116882,HAO2,mitochondrial localization,tumor progression,reactive oxygen species generation,cell proliferation,angiogenesis stimulation,metabolic reprogramming
ENSG00000148832,PAOX,peroxisomal function,tumor growth regulation,cellular metabolic adaptation,mitochondrial biogenesis regulation,nuclear receptor activity,energy metabolism modulation
ENSG00000177465,ACOT4,fatty acid metabolism regulation,tumor progression,cell growth promotion,metabolic adaptation,warburg effect modulation,oncogene upregulation
ENSG00000118454,ANKRD13C,gene regulation,transcriptional modulation,ankyrin repeat domain protein,apoptosis regulation,cell cycle progression,protein-protein interaction
ENSG00000137948,BRDT,chromatin regulation,cancer driver target,transcriptional activation,cell proliferation enhancer,apoptosis suppressor,genomic instability contributor
ENSG00000172594,SMPDL3A,sphingosine-1-phosphate signaling,tumor growth promotion,immune evasion,metastasis facilitation,cell migration regulation,angiogenesis modulation
,IGHG2,antibody structure,immunoglobulin heavy chain,gamma 2 constant region,b-cell specificity,tumor microenvironment modulation,immune evasion mechanisms
ENSG00000100288,CHKB,phospholipid metabolism,cell proliferation,tumor progression,genetic alterations,oncogenic transformation,protein kinase regulation
ENSG00000055957,ITIH1,tumor progression,protein-protein interaction,overexpression,promotes angiogenesis,regulates cellular proliferation,cellular migration and invasion
ENSG00000168907,PLA2G4F,extracellular remodeling,tumor progression,pro-inflammatory mediator,metastasis facilitation,secretory enzyme activity,phospholipid degradation
ENSG00000198336,MYL4,cell migration,overexpression,tumor progression,metastatic potential,biomarker,epithelial-to-mesenchymal transition (emt)
ENSG00000103489,XYLT1,proteoglycan biosynthesis,cell proliferation,tumor progression,angiogenesis,resistance to chemotherapy,poor prognosis
ENSG00000178878,APOLD1,tumor progression,genomic instability,cell cycle regulation,oncogenic potential,apoptosis resistance,pi3k/akt pathway interaction
ENSG00000128918,ALDH1A2,aldh/retinoic acid signaling,cell survival and proliferation,oncogenic activation,detoxification and metabolic regulation,tumor microenvironment modulation,cancer stem cell maintenance
ENSG00000153558,FBXL2,scf ubiquitin ligase complex,cell cycle regulation,substrate receptor component,ubiquitination,protein degradation,therapeutic target
ENSG00000172476,RAB40A,endosomal trafficking regulation,gtpase activity,mitochondrial interaction,proliferation enhancement,tumor progression facilitation,cancer cell migration promotion
ENSG00000119682,AREL1,gene regulation,cell growth promotion,alternative polyadenylation,oncogene regulation,tumor progression,rna binding protein
ENSG00000196109,ZNF676,oncogene,krab domain-containing protein,transcriptional repressor,cell proliferation regulator,tumor suppressor overexpression,zinc finger protein
ENSG00000125821,DTD1,cell cycle regulation,genomic instability,growth promotion,tumor suppression loss,cell proliferation increase,dna damage response
ENSG00000282966,CYP2D6,genetic variation,drug metabolism,pharmacokinetics regulation,therapeutic agent modulation,individualized medicine,clinical outcome impact
ENSG00000139160,ETFBKMT,histone modification,chromatin remodeling,transcriptional regulation,oncogene activation,tumor suppressor suppression,methylation activity
ENSG00000123427,EEF1AKMT3,translation regulation,amplification in cancer,mutation-induced oncogenesis,protein-protein interaction,cell growth modulation,translational initiation complex assembly
ENSG00000181038,METTL23,rna methylation,cell proliferation,methyltransferase activity,tumor progression,oncogene function,rna-binding protein interaction
ENSG00000128915,ICE2,cell proliferation,apoptosis resistance,pi3k/akt pathway regulation,cell survival enhancement,oncogenic potential,tumor progression facilitation
ENSG00000237172,B3GNT9,glucuronyltransferase 2 activity,glycosaminoglycan synthesis,cancer progression,oncogenic pathways,cell adhesion molecule regulation,tumor metastasis
ENSG00000166930,MS4A5,immunomodulation,tumor progression,cell signaling regulation,oncogenic transformation,genomic alterations,cancer prognosis
ENSG00000198157,HMGN5,chromatin regulation,oncogene overexpression,cell proliferation promotion,dna damage response modulation,chromatin compaction modulation,cell survival enhancement
ENSG00000120322,PCDHB8,cell adhesion,cancer progression,signal transduction,tumor development,oncogenesis,genomic clustering
ENSG00000033011,ALG1,n-glycosylation,tumor growth,cell adhesion,metastasis,cell proliferation,protein stability
ENSG00000171551,ECEL1,erap2 activity,antigen presentation,tumor microenvironment modulation,immunotherapy target,protein degradation pathways,cellular stress responses
ENSG00000228474,OST4,osteolysis,tumor microenvironment modulation,metastasis facilitation,cell proliferation regulation,wnt/β-catenin pathway interaction,pre-metastatic niche development
ENSG00000068650,ATP11A,phospholipid transport,p-type atpase activity,cellular homeostasis disruption,tumor growth promotion,metastasis induction,emt regulation
ENSG00000101974,ATP11C,lipid metabolism regulation,cell membrane dynamics,oncogenic expression,aggressive tumor behavior,therapeutic resistance modulation,cellular stress response interaction
ENSG00000103227,LMF1,transcriptional regulator,tumor suppressor function,metabolic reprogramming,lipid synthesis regulation,cellular differentiation modulation,oncogene repression
ENSG00000147256,ARHGAP36,rho gtpase activation,cellular proliferation,tumor suppression,oncogenic signaling pathway modulation,growth factor regulation,cytoskeletal organization
ENSG00000072786,STK10,cellular regulation,tumor suppressor function,genomic stability,p53 pathway disruption,oncogenic process promotion,therapeutic target
ENSG00000161929,SCIMP,tumor immune evasion,immune cell regulation,cell proliferation,apoptosis suppression,pi3k/akt pathway interaction,adaptor protein function
ENSG00000140254,DUOXA1,er homeostasis,ros production,protein folding regulation,tumor progression,cellular redox balance,oncogene activation
ENSG00000258484,SPESP1,acrosomal formation,oncogenic potential,cell proliferation regulation,signaling pathway modulation,genomic instability,therapeutic target
ENSG00000113088,GZMK,apoptosis induction,cancer progression,tumor suppression,serine protease activity,caspase cleavage,immune regulation
ENSG00000254709,IGLL5,immunoglobulin production,tumor progression,immunoregulation,b-cell development,therapeutic target,gene expression
ENSG00000170099,SERPINA6,tumor microenvironment regulation,cell proliferation modulation,serine protease inhibition,inflammation regulation,coagulation pathway disruption,tissue repair regulation
ENSG00000123561,SERPINA7,aberrant regulation,apoptosis suppression,constitutive expression,inflammation regulation,metastasis promotion,protease inhibition disruption
ENSG00000120539,MASTL,cell cycle regulation,chromosomal instability,aneuploidy,tumor progression,kinase activation,genomic destabilization
ENSG00000176371,ZSCAN2,tumor suppressor function,transcriptional regulation,cell cycle regulation,dna damage response,apoptosis induction,genomic stability maintenance
ENSG00000288504,YBX2,tumor suppressor/oncogene,cellular regulation,transcriptional regulation,dna/rna binding,cell cycle regulation,genomic instability
ENSG00000227642,AGPAT1,cell membrane composition,lipid biosynthesis regulation,oncogenic processes promotion,cell signaling modulation,metastasis enhancement,protein-protein interaction
ENSG00000198610,AKR1C4,steroid hormone metabolism,tumor progression,prostaglandin biosynthesis,cell growth regulation,androgen conversion,akt/pi3k pathway activation
,APOPT1,apoptosis regulation,tumor suppressor function,dual pro-apoptotic/anti-apoptotic properties,programmed cell death,bcl2 family member,cancer driver gene
ENSG00000147145,LPAR4,pi3k/akt pathway,g protein-coupled receptor,tumor progression,oncogenic process,therapeutic target,signal transduction
ENSG00000174156,GSTA3,cellular survival,metabolic regulation,cancer progression,therapeutic target,detoxification processes,genetic instability
ENSG00000060642,PIGV,molecular alterations,cell surface modifications,gpi anchor biosynthesis,protein glycosylation,cell signaling disruptions,cancer susceptibility
ENSG00000169906,S100G,calcium-binding protein,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition,tumor progression,protein-protein interaction,upregulation in cancer
ENSG00000184602,SNN,polyamine biosynthesis,cellular growth regulation,tumor progression,metabolic regulation,regulatory mechanisms,apoptosis modulation
ENSG00000136840,ST6GALNAC4,epithelial-to-mesenchymal transition,tumor progression,metastasis promoter,sialyltransferase activity,glycosylation regulation,cancer stemness
ENSG00000130300,PLVAP,tumor microenvironment modulation,angiogenesis regulation,cell adhesion molecule function,protein-protein interactions,oncogenic potential contributor,cancer cell invasion facilitation
ENSG00000178828,RNF186,oncogenic regulation,ubiquitin ligase activity,tumor suppressor degradation,cell cycle control,protein stability modulation,cancer progression
ENSG00000196151,WDSUB1,genomic instability,chromosome segregation,mitotic checkpoint regulation,oncogenic driver,tumor progression,dna repair interaction
ENSG00000174502,SLC26A9,ion transport regulation,cellular homeostasis disruption,oncogenic potential speculation,ph regulation alteration,epithelial function modulation,genomic instability link
ENSG00000166788,SAAL1,apoptosis regulation,cell cycle progression,gene transcription regulation,protein interaction,transcriptional modulation,tumorigenesis
ENSG00000130193,THEM6,sphingolipid metabolism,oncogenic signaling pathway modulation,cell membrane dynamics regulation,tumor progression facilitation,therapeutic target potential,genomic instability association
ENSG00000142197,DOP1B,cellular signaling,phosphatase regulation,oncogenesis,aberrant signaling,protein-protein interactions,cancer progression
ENSG00000158669,GPAT4,lipid metabolism,glycerophospholipid synthesis,cell proliferation,cancer stem cell maintenance,tumor growth promotion,potential therapeutic target
ENSG00000050555,LAMC3,angiogenesis promotion,cell adhesion disruption,epithelial-to-mesenchymal transition,gain of function mutations,laminin receptor interaction,metastasis facilitation
ENSG00000117479,SLC19A2,folate transporter function,tumor cell proliferation,oncogene potential,nucleotide metabolism regulation,enhanced growth and survival,dna synthesis dependency
ENSG00000140107,SLC25A47,mitochondrial transport,metabolic regulation,energy homeostasis,tumorigenesis,cancer association,cellular metabolism
ENSG00000159423,ALDH4A1,oncogene,chemoresistance,radioresistance,cell proliferation,metabolic regulation,reactive oxygen species modulation
ENSG00000178301,AQP11,cellular invasion,oncogene activation,tumor progression,metabolic regulation,protein interaction,water transport
ENSG00000182858,ALG12,cellular interaction regulation,n-glycosylation process,glycoprotein synthesis,endoplasmic reticulum localization,cellular function maintenance,tumor progression modulation
ENSG00000113492,AGXT2,metabolic regulation,redox homeostasis maintenance,toxic compound detoxification,tumor suppressor/oncogene function,genomic stability maintenance,cellular oxidative stress management
ENSG00000197859,ADAMTSL2,tumor progression,cell signaling regulation,metastasis promotion,angiogenesis modulation,adhesion molecule interaction,apoptosis evasion
ENSG00000187758,ADH1A,alcohol metabolism,detoxification process,cell proliferation,oxidative stress,dna damage,pro-carcinogenic effects
ENSG00000091262,ABCC6,dysregulation of transport function,cellular membrane trafficking,genetic disorders,pseudoxanthoma elasticum (pxe),metabolic regulation,cancer association unknown
ENSG00000085465,OVGP1,cellular survival,tumor invasion,cell migration,protein interaction,signaling pathway modulation,cell adhesion modification
ENSG00000114770,ABCC5,multidrug resistance,chemosensitivity regulation,oncogenic pathway activation,cell proliferation enhancement,tumor progression facilitation,therapeutic target identification
ENSG00000171766,GATM,glutamine synthetase regulation,warburg effect associated,metabolic reprogramming,oxidative stress modulation,nitrogen metabolism regulation,therapeutic target
ENSG00000111713,GYS2,warburg effect,glucose metabolism regulation,glycogenesis activation,enhanced glycolysis,therapeutic target,metabolic reprogramming
ENSG00000119711,ALDH6A1,oxidative stress regulation,cellular detoxification,metabolic enzyme activity,mitochondrial localization,aldehyde metabolism regulation,potential tumorigenesis involvement
ENSG00000135929,CYP27A1,cholesterol catabolism,mitochondrial localization,cellular oxidative stress regulation,heme oxygenase modulation,bile acid synthesis regulation,redox balance disruption
ENSG00000154265,ABCA5,tumor progression,multidrug resistance,lipid metabolism regulation,cell differentiation,chemoresistance,protein-protein interactions
ENSG00000197417,SHPK,tumor suppressor,pi3k/akt signaling regulation,stat3 inhibition,cell proliferation regulation,dephosphorylation activity,protein-protein interaction
ENSG00000166741,NNMT,metabolic reprogramming,glycolytic shift,oncogenic driver,cellular metabolism,tumor growth promotion,biomarker potential
ENSG00000086544,ITPKC,cell cycle regulation,calcium homeostasis disruption,oncogenic pathway activation,biomarker potential,phosphoinositide metabolism,lipid signaling modulation
ENSG00000167676,PLIN4,metabolic regulation,adipocyte differentiation,cell proliferation,tumor growth,metastasis,lipid metabolism
ENSG00000170949,ZNF160,tumor suppressor/oncogene,transcriptional regulation,cell cycle progression,apoptosis,dna-binding activity,leucine zipper motif
ENSG00000182327,GLTPD2,lipid biosynthesis,increased glycerol-3-phosphate levels,energy metabolism regulation,tumor growth promotion,cell survival enhancement,altered cellular redox balance
ENSG00000070526,ST6GALNAC1,cell adhesion modulation,glycosylation pathway,oncogenic function,tumor progression,immune response modulation,signaling pathway regulation
ENSG00000153976,HS3ST3A1,glycosylation regulation,cell surface modification,metastasis promotion,angiogenesis regulation,biomarker potential,signaling pathway modulation
ENSG00000176022,B3GALT6,tumor progression,cell adhesion modulation,glycosyltransferase activity,extracellular matrix regulation,metastasis promotion,poor prognosis marker
ENSG00000198715,GLMP,protein processing,cell-cell communication,golgi apparatus function,oncogenic processes,tumor progression,genomic instability
ENSG00000181666,ZNF875,krab domain-containing protein,transcriptional regulator,cell proliferation inhibition,tumor suppressor downregulation,apoptosis modulation,chromatin modification
ENSG00000185947,ZNF267,tumor suppression,nuclear localization,transcriptional regulation,apoptosis induction,cell cycle regulation,oncogene inhibition
ENSG00000100490,CDKL1,oncogenic mutation,cell cycle regulation,protein kinase activation,tumor growth promotion,g2/m checkpoint dysregulation,apoptosis resistance
ENSG00000168661,ZNF30,oncogenic transcriptional regulator,nuclear localization,dna binding activity,cell proliferation enhancer,apoptosis suppression,tumor suppressor dysfunction
ENSG00000007038,PRSS21,tumor progression,therapeutic target,serine protease activity,protein processing,cell signaling,oncogenesis
ENSG00000109323,MANBA,glycoprotein processing,cell adhesion,cell migration,signaling pathway regulation,pi3k/akt pathway interaction,gene expression regulation
ENSG00000143324,XPR1,transporter function,cellular homeostasis regulation,aberrant expression implicated,signaling pathway modulation,tumor microenvironment regulation,cancer cell proliferation
ENSG00000166004,CEP295,chromatin regulation,microtubule organization,centrosomal protein function,spindle assembly,mitotic progression,cytokinesis disruption
ENSG00000162039,MEIOB,pi3k/akt signaling,constitutive activation,gain of function mutations,tumor progression,cell cycle regulation,oncogenic potential
ENSG00000136868,SLC31A1,zinc homeostasis,cellular proliferation,gene expression regulation,apoptosis modulation,tumor progression,genomic instability
ENSG00000167914,GSDMA,nf-κb pathway modulation,inflammation regulation,immune response dysregulation,epithelial-to-mesenchymal transition,tumor progression,protein-protein interaction
ENSG00000148218,ALAD,heme biosynthesis disruption,oncogenic process,metabolic regulation,cellular proliferation,enzymatic deficiency,genetic predisposition
ENSG00000147471,PLPBP,tumor progression,metastasis promotion,poor prognosis association,oncogenic pathway interaction,cell migration modulation,adhesion regulation
ENSG00000065833,ME1,metabolic reprogramming,glycolytic shift,tumor progression,oncogenic driver,therapeutic target,mitochondrial localization
ENSG00000142002,DPP9,cell cycle regulation,prolyl peptidase activity,rb stabilization,tumor suppressor regulation,e3 ubiquitin ligase interaction,poor prognosis marker
ENSG00000122642,FKBP9,phosphoprotein interaction,cell cycle progression,oncogenic potential,apoptosis regulation,chemoresistance,pro-survival signaling
ENSG00000172037,LAMB2,tumor suppressor function,disrupted cell adhesion,metastatic potential,epithelial integrity loss,cell migration disruption,basement membrane instability
ENSG00000111344,RASAL1,cell division,oncogenesis,constitutive activation,protein-protein interaction,signaling pathway regulation,apoptosis
ENSG00000121064,SCPEP1,pi3k/akt pathway,oncogenic processes,matrix metalloproteinase regulation,secreted protein function,tumor progression,therapeutic target
ENSG00000088899,LZTS3,tumor suppressor function,cell cycle regulation,apoptosis induction,cdk4/cdk6 inhibition,mitotic checkpoint maintenance,protein ubiquitination
ENSG00000206557,TRIM71,cell cycle regulation,tumor suppressor function,apoptosis regulation,cyclin-dependent kinase inhibition,transcriptional control,proliferation suppression
ENSG00000119698,PPP4R4,pi3k/akt signaling,phosphatase regulation,tumor promotion,cell cycle modulation,oncogenic activation,protein phosphorylation
ENSG00000274391,TPTE,tumor progression,metastatic potential,cell adhesion,extracellular matrix degradation,cell migration,protein interaction
ENSG00000015520,NPC1L1,cholesterol metabolism,cell proliferation,signaling pathway modulation,tumor growth promotion,metastasis facilitation,cancer prognosis
ENSG00000107443,CCNJ,cell cycle regulation,g1 phase progression,transcriptional control,cell proliferation,oncogenic process,tumor growth
ENSG00000185736,ADARB2,rna editing,genomic integrity,oncogenic driver,therapeutic target,tumor progression,alternative splicing
ENSG00000149657,LSM14B,rna stabilization,cell cycle regulation,malignant transformation,tumor progression,oncogenic role,genomic instability
ENSG00000197483,ZNF628,oncogene,transcription factor function,cell proliferation,apoptosis inhibition,epigenetic regulation,tumorigenesis
ENSG00000123728,RAP2C,cellular regulation,signaling pathway activation,tumor progression,metabolic regulation,oncogene function,cellular interaction
ENSG00000276130,SLC22A18,transport regulation,chemotherapeutic uptake,tumor progression,cellular response modulation,oat/oct interaction,genomic instability
ENSG00000167644,C19orf33,pi3k/akt signaling pathway,genetic alterations,cell cycle regulation,apoptosis regulation,dna repair mechanisms,tumor suppressor function
ENSG00000148411,NACC2,microtubule dynamics regulation,cell proliferation regulation,apoptosis modulation,cdk interaction,tumor progression,genetic interaction with tp53
ENSG00000176160,HSF5,heat shock response regulation,oncogene activation,aberrant transcriptional control,tumor progression driver,therapeutic target identification,cellular stress adaptation
ENSG00000143194,MAEL,cellular differentiation,tumor progression,transcriptional regulation,signal transduction pathway,protein-protein interactions,cancer metastasis
ENSG00000005379,TSPOAP1,mitochondrial function,apoptosis regulation,cell survival,oxidative stress response,tumor progression,therapeutic target
ENSG00000151322,NPAS3,cancer driver,transcription factor activity,oncogene activation,cell cycle regulation,apoptosis evasion,pi3k/akt pathway interaction
ENSG00000167889,MGAT5B,glycosylation pathway,altered expression,n-glycan biosynthesis,glycoprotein modification,oncogenic processes,cellular regulation
ENSG00000153266,FEZF2,oncogenic activity,constitutive activation,amplification events,epithelial-to-mesenchymal transition (emt),transcription factor regulation,immune evasion mechanisms
ENSG00000111911,HINT3,chromatin assembly,genome stability,histone modification,transcriptional regulation,cell cycle progression,genetic instability
ENSG00000110237,ARHGEF17,rho gtpase activation,oncogenic signaling,cytoplasmic localization,cell migration regulation,tumor invasion,metastasis promotion
ENSG00000156414,TDRD9,mirna regulation,oncogene regulation,cell proliferation,tumor suppressor function,germ granule binding,mirna-124 targeting
ENSG00000110871,COQ5,mitochondrial dysfunction,electron transport chain disruption,ros production,genomic instability,cellular proliferation,metabolic reprogramming
ENSG00000167113,COQ4,mitochondrial assembly,electron transport chain disruption,oncogenic mutations,cellular metabolism regulation,energy production dysregulation,genomic instability
ENSG00000136960,ENPP2,nucleotide regulation,cell proliferation,tumor progression,metastasis promotion,therapeutic target,cell signaling regulation
ENSG00000100027,YPEL1,cell cycle regulation,dna replication facilitation,tumor growth promotion,biomarker potential,genomic instability contribution,oncogenic role in cell proliferation
ENSG00000178295,GEN1,genomic instability,replication stress resolution,homologous recombination repair,dna damage response,cell cycle regulation,cancer predisposition
ENSG00000169894,MUC3A,mucin expression,cell adhesion,tumor progression,immunosuppression,aberrant signaling pathway,metastatic potential
ENSG00000167895,TMC8,trna processing regulation,gene mutation,metabolic alterations,protein misfolding,therapeutic target,genomic instability
ENSG00000243284,VSIG8,immune checkpoint regulation,t-cell activation suppression,oncogenic function,tumor progression,immune evasion,cancer immunology
ENSG00000267673,FDX2,mitochondrial function,redox regulation,tumor suppression,energy metabolism,oncogenesis,genomic instability
ENSG00000141376,BCAS3,cell cycle regulation,oncogenic mutations,tumor progression,dna replication,protein interaction,apoptosis suppression
ENSG00000215455,KRTAP10-1,epithelial-to-mesenchymal transition,protein interaction,cell signaling regulation,tumor progression,structural integrity,keratin-associated protein
ENSG00000126460,PRRG2,epithelial-to-mesenchymal transition,transmembrane protein interaction,cell adhesion regulation,pi3k/akt pathway modulation,oncogenic mutations,tumor progression enhancement
ENSG00000141391,PRELID3A,pi3k/akt activation,oncogenic function,tumor progression,therapeutic resistance,genomic instability,cellular proliferation
ENSG00000160767,FAM189B,cell proliferation,transcriptional regulation,nuclear localization,dna repair,oncogenic function,poor prognosis
ENSG00000198390,KRTAP13-1,cellular differentiation,epithelial cell regulation,keratin-associated protein function,oncogenic potential,protein interaction networks,cell growth modulation
ENSG00000196378,ZNF34,tumor suppressor,transcriptional regulation,dna binding activity,cell cycle regulation,apoptosis induction,metastasis suppression
ENSG00000205476,CCDC85C,pka regulatory subunit,cell proliferation regulation,oncogene activation,tumor progression promotion,protein kinase modulation,cell cycle regulation
ENSG00000196263,ZNF471,chromatin remodeling,transcriptional regulation,apoptosis evasion,gene expression modulation,cell cycle disruption,zinc finger domain interaction
ENSG00000154889,MPPE1,metallopeptidase activity,oncogenic potential,cell migration and invasion,tumor progression,enzymatic regulation,cancer cell growth inhibition
ENSG00000120451,SNX19,endocytic trafficking modulation,pi3k/akt pathway regulation,tumor progression facilitation,metastasis promotion,cell migration enhancement,membrane dynamics regulation
ENSG00000143452,HORMAD1,meiotic regulation,mitotic disruption,chromosomal instability,oncogene overexpression,cell cycle modulation,dna repair interaction
ENSG00000109132,PHOX2B,neurotransmitter regulation,transcriptional regulation,oncogenic driver,tumor progression,cell proliferation,cell survival
ENSG00000105877,DNAH11,dynein heavy chain,microtubule stability regulation,tumor growth promotion,cell cycle disruption,apoptosis suppression,mitotic spindle formation
ENSG00000188766,SPRED3,ras/mapk pathway inhibition,tumor suppressor function,cell proliferation regulation,mapk signaling activation,cell differentiation control,oncogenesis association
ENSG00000124541,RRP36,ribosome biogenesis,genomic instability,cellular proliferation,protein synthesis regulation,tumor progression,pi3k/akt signaling interaction
ENSG00000113593,PPWD1,cell cycle progression,proteasomal degradation,genomic instability,dna repair mechanisms,protein accumulation,therapeutic target
ENSG00000124608,AARS2,mitochondrial localization,translational regulation,aminoacyl-trna synthetase activity,cellular proliferation,genomic instability,tumorigenesis
ENSG00000149212,SESN3,cellular proliferation,oncogene activation,mtor pathway dysregulation,ampk pathway modulation,cell cycle regulation,apoptosis resistance
ENSG00000132581,SDF2,pi4p regulation,lipid biosynthesis regulation,cellular homeostasis modulation,aberrant akt pathway activation,oncogenic processes contribution,synaptic function regulation
ENSG00000185127,C6orf120,genomic instability,cell cycle regulation,apoptosis dysregulation,dna repair interaction,tumor progression,protein-protein interaction
ENSG00000087301,TXNDC16,redox regulation,protein chaperone function,thiol:disulfide oxidoreductase activity,cell growth regulation,chaperone-assisted protein folding,oncogenic signaling pathway interaction
ENSG00000134882,UBAC2,mitochondrial function regulation,ubiquitination pathway disruption,glycolytic shift,cellular proliferation enhancement,tumor suppressor dysregulation,oncogenic metabolic reprogramming
ENSG00000128463,EMC4,er membrane protein complex,protein folding regulation,genomic stability maintenance,oncogenic mutations,dna repair mechanisms disruption,cellular stress response modulation
ENSG00000197056,ZMYM1,genomic instability,chromatin remodeling,transcriptional regulation,apoptosis modulation,tumor suppression,cell cycle control
ENSG00000169715,MT1E,oxidative stress regulation,zinc homeostasis modulation,cell survival promotion,cancer-related dysregulation,cellular signaling pathway interaction,redox regulation enhancement
ENSG00000177558,FAM187B,regulation of cell growth,pi3k/akt signaling interaction,epigenetic regulation,tumorigenesis driver,cell cycle progression,poor prognosis marker
ENSG00000100263,RHBDD3,mitochondrial function,apoptosis suppression,cell survival promotion,protein processing regulation,tumor progression modulation,oncogenic transformation facilitation
ENSG00000168830,HTR1E,cell cycle regulation,apoptosis inhibition,tumor growth promotion,metastasis facilitation,signaling pathway modulation,transcriptional regulation
ENSG00000121577,POPDC2,hippo/yap signaling pathway,regulation of cell growth,tumor progression,cell migration and invasion,transcriptional regulation,chromatin remodeling
ENSG00000177119,ANO6,calcium signaling,cell proliferation,ion transport regulation,plasma membrane integrity,cell survival,dna repair
ENSG00000146828,SLC12A9,ion transport regulation,cancer metastasis,cell proliferation,sodium-dependent cotransporter,chloride ion efflux,genomic amplification
ENSG00000197136,PCNX3,cell cycle regulation,cyclin-dependent kinase activity,g1/s phase transition,proliferation promotion,tumor progression contribution,apoptosis inhibition
ENSG00000169762,TAPT1,histone modification,regulatory complex formation,chromatin remodeling,transcriptional regulation,tumor suppressor function,epigenetic alterations
ENSG00000087502,ERGIC2,protein transport,oncogene overexpression,cancer stem cell maintenance,cellular stress response modulation,amplification event in cancer,epithelial-to-mesenchymal transition
ENSG00000004866,ST7,metastasis suppression,epigenetic regulation,cell cycle regulation,apoptosis induction,microtubule stability,tumor suppressor function
ENSG00000124532,MRS2,mitochondrial biogenesis,overexpression,pi3k/akt interaction,oncogenic process,tumor growth,therapeutic target
ENSG00000103550,KNOP1,centrosome regulation,microtubule stability,cell cycle control,genomic integrity,tumor progression,protein-protein interactions
ENSG00000187792,ZNF70,transcriptional regulation,krab domain-containing,zinc finger protein,transcription factor,dna binding,oncogenesis
ENSG00000179965,ZNF771,transcriptional regulation,cell cycle control,apoptosis evasion,tumor progression,gene expression dysregulation,chromatin modification
ENSG00000101247,NDUFAF5,mitochondrial assembly,mitochondrial dysfunction,proliferation,cell survival,glycolytic reprogramming,oxidative phosphorylation
ENSG00000198146,ZNF770,chromatin remodeling,epigenetic regulation,transcription factor activity,gene expression modulation,cell growth promotion,signal transduction pathway interaction
ENSG00000282608,ADORA3,oncogene,angiogenesis promotion,cell proliferation enhancement,metastasis facilitation,immune response modulation,tumor growth promotion
ENSG00000284400,TBC1D9B,pi(3)p regulation,endocytic pathway regulation,cell membrane trafficking,tumor progression,cancer biology,protein interaction
ENSG00000260916,CCPG1,chromatin remodeling,dna repair mechanisms,cellular proliferation,epigenetic regulation,tumor suppressor function,genomic instability
ENSG00000184277,TM2D3,nf-κb signaling,tumor suppressor,apoptosis regulation,genomic stability maintenance,metastasis suppression,inflammatory response modulation
ENSG00000169230,PRELID1,redox regulation,iron homeostasis,cytoskeleton dynamics,oxidative stress response,genomic stability maintenance,tumorigenesis driver
ENSG00000243130,PSG11,tumorigenesis,cell proliferation,immune regulation,calcium-binding protein,signaling pathway modulation,oncogenic driver
ENSG00000243137,PSG4,dual function,pi3k/akt signaling pathway interaction,tumor promoter or suppressor,cell growth and proliferation regulation,epithelial-to-mesenchymal transition (emt) modulation,protein-protein interactions
ENSG00000114902,SPCS1,pi3k/akt signaling,dysregulated expression,tumor progression,protein kinase regulation,cell survival modulation,signaling pathway interaction
ENSG00000141219,C17orf80,cell proliferation,tumor growth,immune responses,adaptor molecule,signaling pathway,dysregulation
ENSG00000198482,ZNF808,tumor suppressor function,cell cycle regulation,apoptosis induction,proliferation inhibition,transcriptional regulation,krab domain-containing protein
ENSG00000197566,ZNF624,transcriptional regulation,oncogenic processes,krab zinc finger protein family,cell growth modulation,dna sequence binding,tumorigenesis
ENSG00000177150,FAM210A,genomic instability,oncogenic mutations,dna repair regulation,cell cycle regulation,tumor progression,replication fork stability
ENSG00000133983,COX16,mitochondrial dysfunction,cellular metabolism regulation,oxidative stress and dna damage,apoptosis resistance,chromatin remodeling and gene expression modulation,protein-protein interaction in cell cycle regulation
ENSG00000156535,CD109,tgf-beta signaling regulation,cell proliferation modulation,oncogene activity,cancer type association,protein interaction modification,cell growth regulation
ENSG00000155275,TRMT44,mitochondrial protein regulation,sec biosynthesis dysregulation,oncogenic potential,cell survival enhancement,genomic instability induction,ros production
ENSG00000232629,HLA-DQB2,antigen presentation,immune evasion,major histocompatibility complex (mhc),cell surface expression,t-cell recognition,antigen processing
ENSG00000163864,NMNAT3,cellular metabolism regulation,tumor growth promotion,oncogenic protein interaction,genetic instability contribution,energy metabolism reprogramming,nad biosynthesis enhancement
ENSG00000141627,DYM,membrane trafficking,cellular proliferation,oncogenic processes,apoptosis regulation,genomic amplifications,protein-protein interactions
ENSG00000102763,VWA8,cell adhesion,integrin interaction,metastasis promotion,tumor progression,therapeutic target,cell migration
ENSG00000148377,IDI2,dna repair mechanisms,genetic instability,cell cycle regulation,apoptosis modulation,reactive oxygen species regulation,tumor suppression
ENSG00000262664,OVCA2,pi3k/akt signaling,constitutive activation,gain of function mutations,cellular regulation,cell proliferation,genomic profiling
ENSG00000130032,PRRG3,transcriptional regulation,oncogenesis,chromatin remodeling,dna repair,tumor suppressor protein regulation,cell proliferation enhancement
ENSG00000163162,RNF149,genetic instability,cell cycle regulation,dna damage response,oncoprotein regulation,ubiquitination processes,protein-protein interactions
ENSG00000173451,THAP2,transcriptional regulation,chromatin modification,cell cycle progression,genomic stability,apoptosis suppression,tumor progression
ENSG00000176988,FMR1NB,regulatory role,translation regulation,protein-protein interactions,mrna stability,cellular homeostasis,genetic instability
ENSG00000119777,TMEM214,oncogenic function,autophagy modulation,cell survival enhancement,metabolic adaptation,dysregulation of homeostasis,therapeutic target
ENSG00000164073,MFSD8,lipid metabolism regulation,tumor suppressor function,mutated or altered,cellular lipid accumulation,oncogenic potential,poor prognosis
ENSG00000121210,TMEM131L,pi3k/akt pathway regulation,oncogenic process promotion,tumor progression facilitation,metastasis enhancer,cell migration regulator,multidomain protein structure
ENSG00000171208,NETO2,cell cycle regulation,microtubule stabilization,oncogenesis,cell proliferation,tumorigenesis,therapeutic target
ENSG00000122912,SLC25A16,mitochondrial function modification,oncogenic metabolic reprogramming,anabolic metabolism enhancement,tumor progression facilitation,therapeutic target potential,cellular energy regulation disruption
ENSG00000106714,CNTNAP3,cell adhesion molecule,neuronal communication,synaptic plasticity,transmembrane glycoprotein,cell migration,dysregulation of adhesion molecules
ENSG00000126243,LRFN3,tumor aggressiveness,cell adhesion disruption,signaling molecule interaction,metastasis promotion,cancer progression,angiogenesis enhancement
ENSG00000167757,KLK11,proteolytic activity,cell migration and invasion,tumor progression,poor prognosis marker,serine protease function,enzymatic regulation
ENSG00000138759,FRAS1,pi3k/akt signaling pathway regulation,cell surface polarity disruption,tumor progression driver,genomic instability contributor,tumor suppressor function,cell migration regulation
ENSG00000182575,NXPH3,actin cytoskeleton dynamics,cell migration,invasive growth,oncogenic processes,tumor progression,cancer metastasis
ENSG00000083067,TRPM3,calcium influx,cell proliferation,stress response activation,tumor progression driver,oncogenic signaling pathway,genomic instability
ENSG00000144642,RBMS3,rna stabilization,translation regulation,oncogene function,mrna binding,cancer-related mrnas,tumor growth promotion
ENSG00000181240,SLC25A41,mitochondrial transport,cellular respiration,metabolic regulation,energy production,protein interaction,cancer progression
ENSG00000137513,NARS2,mitochondrial translation,tumor cell survival,warburg effect,cancer cell proliferation,cellular energy metabolism,protein structure mutation
ENSG00000131378,RFTN1,altered expression,cell membrane trafficking regulation,genetic mutations,oncogenic processes involvement,tumor progression facilitation,therapeutic target potential
ENSG00000177054,ZDHHC13,palmitoylation regulation,endocytosis regulation,protein modification enzyme,oncogenic driver,cell signaling modulation,cancer progression marker
ENSG00000001630,CYP51A1,cholesterol biosynthesis,oncogene function,cell membrane integrity,oxidative stress resistance,tumor growth promotion,fungal metabolism regulation
ENSG00000120697,ALG5,glycoprotein synthesis,oncogene potential,cell signaling regulation,cell growth modulation,protein interaction,glycosylation pathway
ENSG00000164081,TEX264,genomic integrity,transcriptional regulation,dna damage response,tumor progression,oncogenesis,therapeutic target
ENSG00000164535,DAGLB,pkc activation,oncogenic role,lipolytic activity,cell proliferation,cell survival,protein kinase regulation
ENSG00000128203,ASPHD2,genomic instability,tumor suppressor function,cell cycle regulation,mitotic progression,chromatin remodeling,protein degradation
ENSG00000167775,CD320,vitamin b12 regulation,genomic instability,dna repair defect,methylation pathway alteration,receptor dysfunction,cell proliferation enhancement
ENSG00000119537,KDSR,glycosylation enzyme,keratan sulfate biosynthesis,cell signaling regulation,cellular interaction modulation,glycoprotein modification,enzymatic activity
ENSG00000099904,ZDHHC8,palmitoylation,cell signaling pathway regulation,protein modification,oncogenesis,tumor progression,gene mutation
ENSG00000156599,ZDHHC5,palmitoylation regulation,protein modification,tumor growth promotion,oncogenic process modulation,cellular regulation disruption,post-translational modification
ENSG00000121578,B4GALT4,tumor progression,aberrant glycosylation,cell surface molecule regulation,cell adhesion modulation,glycoconjugate biosynthesis,cancer development association
ENSG00000132026,RTBDN,oncogene,tumor suppressor loss,cell cycle progression,e3 ubiquitin ligase activity,transcriptional regulation,protein-protein interactions
ENSG00000186787,SPIN2B,cell cycle regulation,apc/c activator,genetic instability,tumor suppressor function,protein-protein interaction,chromosome segregation
ENSG00000168813,ZNF507,transcriptional regulation,oncogene function,zinc finger protein,cell proliferation,apoptosis regulation,genomic instability
ENSG00000248496,ZBED9,chromatin remodeling,epigenetic modifications,cell differentiation,transcription factor activity,tumor suppressor dysfunction,genomic instability
ENSG00000170324,FRMPD2,wnt/β-catenin pathway,constitutive activation,cell adhesion and migration,tumor invasion and metastasis,oncogenic signaling,protein-protein interactions
ENSG00000157637,SLC38A10,glutamine transport,tumor progression,metabolic adaptation,oncogenic process,cancer metabolism,therapeutic target
ENSG00000164465,DCBLD1,cell adhesion regulation,epithelial-to-mesenchymal transition,tumor aggressiveness marker,tumorigenesis regulator,cancer progression facilitator,emt process modulator
ENSG00000106692,FKTN,α-dystroglycan glycosylation,muscle cell integrity,neuronal function regulation,glycosylation pathway modulation,cell adhesion modulation,tumorigenesis association
ENSG00000131019,ULBP3,immune activation,nkg2d receptor interaction,tumor immune evasion,cancer immunosurveillance,nk cell cytotoxicity,soluble mica binding
ENSG00000125430,HS3ST3B1,tumor suppressor function,cell proliferation regulation,extracellular matrix modification,heparan sulfate biosynthesis,growth factor regulation,therapeutic target
ENSG00000131873,CHSY1,o-linked n-acetylglucosamine modification,glycosylation pathway,cell growth regulation,dysregulated expression,aberrant protein modification,cancer progression hallmark
ENSG00000102743,SLC25A15,mitochondrial carrier protein,succinate transport,citric acid cycle regulation,metabolic reprogramming,tumorigenesis driver,therapeutic target
ENSG00000138678,GPAT3,lipid metabolism regulation,cellular proliferation enhancement,cancer cell survival promotion,oncogenic process involvement,therapeutic target potentiality,genomic amplification marker
ENSG00000188883,KLRG2,immune checkpoint regulation,cell surface expression,tumor evasion,polymorphic variation,mutation hotspot,cancer progression
ENSG00000181027,FKRP,alpha-dystroglycan glycosylation,glycosyltransferase function,muscular dystrophy association,cellular migration promotion,protein quality control disruption,glycosylation defects in cancer
ENSG00000158470,B4GALT5,epithelial-to-mesenchymal transition (emt),glycosylation pathway,glycoproteins and proteoglycans,cell-cell interactions,increased metastatic potential,resistance to apoptosis
ENSG00000161682,FAM171A2,genomic instability,dna repair,tumor suppressor,genetic alterations,oncogenesis,genome maintenance
ENSG00000114487,MORC1,genome stability maintenance,chromatin remodeling,transcriptional regulation,histone modification,tumor suppression,oncogenic pathway inhibition
ENSG00000145861,C1QTNF2,cell migration,inflammation regulation,metastasis promotion,tumor progression,prognostic marker,angiogenesis enhancement
ENSG00000166321,NUDT13,dna damage response,tumor suppressor function,loss-of-function mutations,genomic instability,oncogenic driver,chemotherapy sensitivity
ENSG00000120256,LRP11,wnt/β-catenin signaling pathway,overexpression mutations,oncogenic drivers,cell proliferation enhancement,tumor progression facilitation,therapeutic target potentialization
ENSG00000170571,EMB,chromatin remodeling,tissue development regulation,transcriptional regulation,potential oncogenic role,cellular proliferation modulation,genomic interaction
ENSG00000084444,FAM234B,pi3k/akt pathway regulation,oncogenic properties,genomic overexpression,cellular proliferation enhancement,signaling pathway modulation,tumor progression promotion
ENSG00000164169,PRMT9,asymmetric dimethylation,chromatin remodeling,dna methylation,epigenetic regulation,oncogenic transcription factors,tumor suppressor gene regulation
ENSG00000007402,CACNA2D2,calcium channel regulation,auxiliary subunit function,oncogenic transcription factor activation,tumor cell proliferation,cell survival and migration,neuronal excitability modulation
ENSG00000109586,GALNT7,oncogenic properties,tumor-promoting activity,egfr signaling regulation,cell adhesion modulation,glycosylation process involvement,cancer cell survival enhancement
ENSG00000166507,NDST2,cell proliferation,oncogenic signaling,cell migration,heparan sulfate biosynthesis,angiogenesis,metastasis
ENSG00000070614,NDST1,angiogenesis,cell migration,heparan sulfate biosynthesis,tumor progression,prognostic marker,glycosylation regulation
ENSG00000187676,B3GLCT,oncogenic regulation,glycosylation process,cell proliferation,protein modification,signaling pathway modulation,therapeutic target
ENSG00000139263,LRIG3,tumor suppressor,rtk signaling inhibition,receptor tyrosine kinase regulation,egfr/erbb2 interaction,metastasis promotion,therapeutic target
ENSG00000063180,CA11,ca11 overexpression,tumor cell proliferation,metastasis promotion,ancillary role in angiogenesis,proliferation regulation,tumorigenesis facilitation
ENSG00000186446,ZNF501,transcriptional regulation,zinc finger protein function,cell cycle regulation,dna-binding activity,protein-protein interactions,gene expression modulation
ENSG00000147869,CER1,apoptosis regulation,ceramide signaling pathway,dysregulation in oncogenesis,mitochondrial membrane permeability regulation,cell survival modulation,pro-apoptotic protein interaction
ENSG00000184613,NELL2,cell migration,cell survival,pi3k/akt pathway interaction,tumor progression,therapeutic target,cell adhesion
ENSG00000165644,COMTD1,oxidative stress modulation,steroid hydroxylation,cellular metabolism regulation,tumorigenesis association,genomic instability driver,protein interaction network
ENSG00000180488,MIGA1,cellular proliferation,gene amplification,mutation hotspot,pi3k/akt pathway regulation,tumor progression driver,oncogene overexpression
ENSG00000139278,GLIPR1,oncogenic function,tumor growth,cell proliferation,apoptosis regulation,signaling pathway modulation,prognostic marker
ENSG00000103544,VPS35L,endosomal transport,pten degradation,oncogenic process,cell proliferation,autophagy regulation,tumor suppression
ENSG00000174928,C3orf33,cellular proliferation,genomic instability,protein interaction network,signaling pathway modulation,cell migration,oncogenesis
ENSG00000138399,FASTKD1,mitochondrial regulation,apoptosis modulation,cell survival pathway,akt signaling activation,tumor progression association,oxidative phosphorylation regulation
ENSG00000103356,EARS2,nuclear pore complex regulation,rna binding protein,tumor progression,cell growth regulation,post-transcriptional regulation,nuclear architecture maintenance
ENSG00000174032,SLC25A30,mitochondrial function,metabolic regulation,cell proliferation,energy metabolism,warburg effect,prognostic biomarker
ENSG00000136444,RSAD1,genomic instability,apoptosis regulation,cellular response to oxidative stress,loss-of-function mutations,tumor suppressor function,dna damage repair
ENSG00000105696,TMEM59L,tumor suppressor function,downregulation in cancer,cell cycle regulation,apoptosis inhibition,cell proliferation enhancement,homeostasis maintenance
ENSG00000135454,B4GALNT1,overexpression,oncogenic transformation,glycosylation dysregulation,cell signaling modulation,metastasis enhancement,tumor microenvironment modification
ENSG00000104497,SNX16,endosomal sorting,oncogenic potential,cell surface receptor regulation,tumor progression,trafficking regulation,protein-protein interactions
ENSG00000144227,NXPH2,oncogenic potential,tumor progression,biomarker candidate,cell migration regulation,cell adhesion modulation,constitutive activation
ENSG00000280969,RPS4Y2,ribosomal protein function,cellular proliferation,apoptosis suppression,oncogenic driver,genomic instability,tumor growth promotion
ENSG00000174749,FAM241A,cell proliferation,genomic instability,centrosome separation,aberrant mitosis,microtubule stability,tumor progression
ENSG00000157570,TSPAN18,cell-cell interaction,tumor progression,metastasis,cell adhesion,signaling pathway modulation,transmembrane protein function
ENSG00000168785,TSPAN5,epithelial-to-mesenchymal transition,tumor progression,cell migration,chemoresistance,apoptosis regulation,adhesion molecule interactions
ENSG00000103978,TMEM87A,altered expression,cell proliferation regulation,lipid metabolism modulation,signaling pathway interaction,oncogenic process contribution,tumor cell growth promotion
ENSG00000153982,GDPD1,mitochondrial localization,lipid metabolism regulation,energy production modulation,glycerol-3-phosphate synthesis,pyruvate dehydrogenase interaction,oncogenic potential
ENSG00000003989,SLC7A2,metabolic regulation,tumor proliferation,cellular uptake,glutamine accumulation,chemotherapy resistance,cancer metabolism
ENSG00000109929,SC5D,lipid biosynthesis,oncogenic processes,cell membrane composition,fatty acid synthesis,cell proliferation enhancement,signaling pathway interaction
ENSG00000023041,ZDHHC6,protein palmitoylation,cellular regulation,post-translational modification,cell signaling pathways,gene expression,cell survival
ENSG00000175106,TVP23C,alternative splicing regulation,pre-mrna processing,cell proliferation modulation,spliceosome assembly interaction,oncogenic transformation potential,tumor progression contribution
ENSG00000215704,CELA2B,tumor growth promotion,chemotherapy resistance,cell proliferation enhancement,metastasis facilitation,poor prognosis indicator,lipid metabolism dysregulation
ENSG00000150625,GPM6A,cellular proliferation,oncogenic potential,calcium signaling,tumor progression,metastasis,cell differentiation
ENSG00000204160,ZDHHC18,cellular trafficking,signaling pathway modulation,palmitoylation regulation,receptor tyrosine kinase activation,tumorigenesis promotion,therapeutic target
ENSG00000185090,MANEAL,cell cycle regulation,oncogenic driver,genomic instability,dna damage response,cell proliferation promotion,atm kinase activation
ENSG00000258102,MAP1LC3B2,autophagic pathway,dysregulated expression,tumor cell survival,therapeutic target,cellular homeostasis,protein-protein interaction
ENSG00000102128,RAB40AL,autophagy dysregulation,cell proliferation increase,gtpase activity regulation,increased metastasis,novel cancer-related gene,signaling pathway interaction
ENSG00000285281,SGPP1,sphingolipid metabolism regulation,constitutive activation,oncogenic signaling,cell proliferation,immunosuppression,angiogenesis promotion
ENSG00000214113,LYRM4,mitochondrial function,cellular metabolism regulation,antioxidant defense mechanism,redox balance maintenance,oncogenic process modulation,genomic stability preservation
ENSG00000177000,MTHFR,methylation regulation,homocysteine accumulation,folate metabolism disruption,dna instability,genomic alterations,epigenetic changes
ENSG00000130508,PXDN,pi3k/akt pathway enhancement,oncogenic process promotion,tumor progression driver,therapeutic target,lipid metabolism alteration,cell proliferation facilitation
ENSG00000137269,LRRC1,cell adhesion regulation,gene amplification,pi3k/akt pathway activation,tumor growth promotion,oncogene function,mutation hotspot detection
ENSG00000282830,CALB2,calcium-dependent signaling,cell growth regulation,cellular localization regulation,cytosolic protein interaction,intracellular calcium signaling,oncogenic process
ENSG00000053770,AP5M1,ap-4 complex regulation,oncogenic signaling pathway,tumor progression,cell membrane trafficking,protein sorting and transport,adaptor-associated protein function
ENSG00000143502,SUSD4,epithelial-to-mesenchymal transition (emt),apoptosis suppression,cancer progression driver,immune evasion mechanism,cell adhesion regulation,metastasis promotion
ENSG00000169629,RGPD8,genomic instability,dna repair mechanism regulation,oncogenesis promotion,genotoxic stress response,atm interaction,brca1 association
ENSG00000112276,BVES,angiogenesis facilitation,cell adhesion dysfunction,multifunctional protein,oncogenic potential,tumor progression promotion,vegf interaction
ENSG00000151366,NDUFC2,mitochondrial complex i dysfunction,electron transport chain regulation,energy metabolism dysregulation,tumor growth promotion,hypoxia-inducible factor stabilization,therapeutic target
ENSG00000101452,DHX35,tumor suppressor function,genomic instability,dna repair mechanisms,cell cycle progression,chromatin remodeling,rna metabolism disruption
ENSG00000125827,TMX4,genomic instability,chromatin remodeling,oncogene activation,cell proliferation,protein-protein interaction,tumor progression
ENSG00000129244,ATP1B2,na+/k+-atpase regulation,oncogenic processes,cell proliferation enhancement,apoptosis resistance,genomic instability,metabolic reprogramming
ENSG00000180730,SHISA2,wnt/β-catenin pathway inhibition,tumor suppressor function,cell proliferation regulation,apoptosis induction,genomic instability regulation,metastasis suppression
ENSG00000282739,SLC25A26,mitochondrial carrier protein,cellular respiration regulation,tumor metabolic adaptation,oncogenic metabolic switch,therapeutic target,cell survival regulation
ENSG00000165115,KIF27,spindle assembly,tumor suppressor dysfunction,cell division regulation,cancer predisposition,mitotic process alteration,aneuploidy induction
ENSG00000278565,CEACAM21,tumor progression,cell-cell adhesion disruption,cancer antigen expression,immune evasion mechanisms,metastasis promotion,adhesion molecule function
ENSG00000170426,SDR9C7,pi3k/akt pathway interaction,oncogenic function,dna repair regulation,cell proliferation regulation,protein-protein interaction,mutational activation
ENSG00000148090,AUH,m(6)a demethylase activity,rna methylation regulation,tumorigenesis promotion,genomic instability induction,dna damage response regulation,therapeutic target potentialization
ENSG00000244444,EGFL8,tumor progression,angiogenic processes,cell adhesion,gain of function mutations,pi3k/akt pathway interaction,oncogenic behaviors
ENSG00000164898,FMC1,chromosome segregation,mitotic checkpoint control,spindle assembly checkpoint,chromosomal instability,genomic maintenance,cell division regulation 
ENSG00000139324,TMTC3,notch receptor modification,cellular proliferation,tumor progression,therapeutic target,genomic instability,cancer cell survival
ENSG00000125247,TMTC4,notch signaling pathway,overexpression,cell proliferation,tumor progression,genetic alterations,therapeutic target
ENSG00000137216,TMEM63B,cell polarity dysregulation,wnt/pcp pathway activation,tumor aggressiveness,metastatic potential,therapeutic target,genomic instability
ENSG00000146433,TMEM181,genomic instability,chromatin remodeling,dna repair mechanism,transcriptional regulation,cell cycle regulation,protein-protein interaction
ENSG00000157600,TMEM164,er stress modulation,upr activation,ire1α interaction,tumor suppression,cancer predisposition,cell survival enhancement
ENSG00000106809,OGN,tumor progression,oncogene,cell survival,gene expression profiling,extracellular matrix interaction,adhesion and migration regulation
ENSG00000064763,FAR2,actin cytoskeleton regulation,cell migration promotion,cancer metastasis facilitation,oncogene overexpression,tumor progression enhancement,therapeutic target identification
,MARC2,mitochondrial function,cellular stress response,ros regulation,oxidative phosphorylation,dysregulation in cancer,tumor progression marker
ENSG00000179598,PLD6,cellular signaling,oncogenic properties,phospholipid metabolism,cell proliferation,tumor progression,protein-protein interaction
ENSG00000147119,CHST7,cell proliferation,glycosaminoglycan modification,apoptosis regulation,tumor progression,angiogenesis promotion,proteoglycan sulfation
ENSG00000116273,PHF13,histone modification regulation,tumor suppressor interaction,genomic instability driver,chromatin remodeling enzyme,cell cycle regulator,prognostic marker
ENSG00000183032,SLC25A21,mitochondrial carrier function,cellular energy metabolism regulation,oncogenic signaling pathway modulation,tumor progression facilitation,anabolic process promotion,redox balance alteration
ENSG00000113583,C5orf15,oncogenic function,poor prognosis marker,cell growth regulation,dna damage response pathway,transcriptional regulation,unknown biological function
ENSG00000037749,MFAP3,tumor progression,metastatic marker,extracellular matrix remodeling,cell migration facilitation,fibronectin interaction,prognostic indicator
ENSG00000084110,HAL,regulation of cell growth,apoptosis regulation,interactions with ras pathway,tumor progression,ras signaling modulation,cancer associated mutations
ENSG00000198276,UCKL1,pyrimidine biosynthesis,dna synthesis,tumor proliferation,cell growth promotion,nucleotide metabolism,salvage pathway activation
ENSG00000183066,WBP2NL,cell cycle regulation,tumor growth,protein stabilization,nucleolar localization,ubiquitin-proteasome interaction,genetic instability
ENSG00000186075,ZPBP2,cell proliferation regulation,survival signaling,oncogene potential,zona pellucida interaction,tumorigenesis association,genomic overexpression
ENSG00000104760,FGL1,fibrinogen-like protein regulation,immune evasion mechanisms,cell proliferation modulation,angiogenesis promotion,tumor metastasis facilitation,prognostic biomarker
ENSG00000113391,FAM172A,pi3k/akt pathway,constitutive activation,gain of function mutations,oncogenic driver,cell proliferation regulation,golgi apparatus localization
ENSG00000110811,P3H3,aberrant protein aggregation,cell cycle dysregulation,chaperone interactions,protein homeostasis disruption,therapeutic target potential,tumor progression mechanism
ENSG00000133612,AGAP3,cell growth regulation,gtpase activation,membrane trafficking,oncogenesis promotion,cell proliferation enhancement,arf-gap domain function
ENSG00000122787,AKR1D1,akr1d1,lipid metabolism,steroid synthesis,tumor growth promotion,androgen signaling regulation,metastasis facilitation
ENSG00000135898,GPR55,g protein-coupled receptor family,constitutive activation,gain of function mutations,tumor progression,therapeutic target,angiogenesis regulation
ENSG00000158764,ITLN2,bacteriolytic activity,epithelial expression,immune response modulation,innate immunity component,peptidoglycan cleavage,tumor microenvironment interaction
ENSG00000055732,MCOLN3,lysosomal function,oncogenic driver,cell survival pathway,tumor progression factor,therapeutic target,genomic instability
ENSG00000135317,SNX14,endocytic pathway,cell survival,tumor progression,phagosome formation,apoptosis regulation,proliferation enhancement
ENSG00000106603,COA1,energy metabolism regulation,mitochondrial function alteration,cellular respiration disruption,therapeutic target identification,pi3k/akt pathway interaction,metabolic reprogramming
ENSG00000153898,MCOLN2,lysosomal function,cellular calcium signaling,autophagy regulation,oncogenic pathways,therapeutic target,genomic instability
ENSG00000156162,DPY19L4,ubiquitin-proteasome pathway,cellular response modulation,oncogenic process regulation,tumorigenesis driver,apoptosis regulation,pan-cancer association
ENSG00000007341,ST7L,tumor suppressor,cellular apoptosis,cell cycle regulation,epigenetic regulation,prognostic marker,genomic instability
ENSG00000278889,OR2S2,olfactory receptor,g-protein coupled receptor,cell signaling,aberrant expression,oncogenic potential,cellular proliferation
ENSG00000121377,TAS2R7,taste receptor function,bitter taste perception,genetic variation,cellular responses,signaling pathways,gastrointestinal health
ENSG00000157111,TMEM171,tumor progression,epithelial-to-mesenchymal transition,cell surface receptor interaction,oncogenic mutations,cancer invasion,metastasis regulation
ENSG00000244617,ASPRV1,tumor progression,cell proliferation,dna damage response,genomic instability,serine protease activation,cancer cell survival
ENSG00000172061,LRRC15,oncogenic protein,tumor promotion,cell proliferation enhancement,cell adhesion regulation,metastasis facilitation,therapeutic target
ENSG00000164318,EGFLAM,cell migration,tumor progression,angiogenesis,promiscuous signaling,adhesion complex formation,endmt regulation
ENSG00000183098,GPC6,endothelial cell adhesion,angiogenesis regulation,vascular stability disruption,tumor growth promotion,cell migration enhancement,metastasis facilitation
ENSG00000054690,PLEKHH1,cell division regulation,tumor suppressor function,genomic instability,cytokinesis regulation,mitotic progression,chromosome segregation
ENSG00000126259,KIRREL2,cell adhesion regulation,integrin-mediated signaling,protein kinase c activation,metastasis promotion,tumor invasion facilitation,genomic instability link
ENSG00000165828,PRAP1,pi3k/akt signaling,gain of function mutations,tumor progression,scaffolding protein function,cell survival regulation,oncogenesis
ENSG00000162769,FLVCR1,iron regulation,tumor progression,cell signaling,overexpression,metastasis promotion,prognostic marker
ENSG00000072041,SLC6A15,transporter function,tumor progression,cellular proliferation,metabolic regulation,protein-protein interaction,therapeutic target
ENSG00000147100,SLC16A2,monocarboxylate transporter,cellular metabolism regulation,energy production enhancement,glycolysis promotion,tumorigenesis support,transporter interaction
ENSG00000176142,TMEM39A,cholesterol regulation,er homeostasis disruption,oncogenic process,cell proliferation enhancement,metastasis promotion,lipid metabolism interaction
ENSG00000125434,SLC25A35,mitochondrial carrier protein,cellular respiration modulation,bioenergetic metabolism alteration,tumor growth promotion,apoptosis inhibition,cell cycle regulation interaction
ENSG00000164291,ARSK,genomic instability,transcriptional regulation,protein-protein interactions,tumorigenesis,apoptosis,dna repair
ENSG00000184374,COLEC10,innate immune response,tumor suppressor,pathogen recognition,fungal infections,lung tissue expression,prognostic marker
ENSG00000025423,HSD17B6,steroid hormone regulation,antioxidant activity,metabolic enzyme function,nadph-dependent reduction,cytoplasmic localization,tumor suppressor potential
ENSG00000171936,OR10H3,cell proliferation,tumor progression,oncogenic processes,cell migration,upregulation in cancer,signaling pathway interaction
ENSG00000151093,OXSM,apoptosis regulation,cell cycle progression,genomic instability,oncogenic transformation,tumor suppressor function,oxidative stress response
ENSG00000175065,DSG4,cell adhesion disruption,oncogene overexpression,cancer cell migration,signaling pathway activation,protein kinase substrate,tumor progression promotion
ENSG00000184635,ZNF93,tumor suppressor/oncogene,transcription factor activity,dna binding,epigenetic regulation,chromatin remodeling,cell proliferation/survival
ENSG00000118620,ZNF430,transcriptional regulation,zinc finger protein,dna-binding properties,cell growth regulation,proliferation control,tumor suppressor or oncogene potential
ENSG00000136877,FPGS,one-carbon metabolism,methylation regulation,cellular proliferation,folate resistance,antifolate drug resistance,gene expression regulation
ENSG00000095981,KCNK16,cell proliferation,aberrant channel function,oncogenic processes,cell survival,signaling pathway interaction,genomic instability
ENSG00000173621,LRFN4,emt regulation,metastasis promoter,cell migration regulator,prognostic biomarker,cancer driver gene,adhesion protein
ENSG00000143061,IGSF3,cell adhesion,tumor progression,therapeutic target,protein interaction,cell migration,metastasis
ENSG00000138617,PARP16,cancer-promoting factor,cell proliferation regulator,chromatin remodeling protein,dna damage response mediator,histone modification enzyme,tumor suppressor loss
ENSG00000115539,PDCL3,apoptosis,cellular growth modulation,cell cycle regulation,cellular signaling pathway,gene expression regulation,genomic instability
ENSG00000161395,PGAP3,protein glycosylation regulation,tumor growth promotion,metastasis facilitation,aberrant protein degradation,cell survival modulation,genetic mutation implication
ENSG00000213413,PVRIG,t-cell regulation,immunosuppression,oncogenesis,immune evasion,therapeutic target,genomic instability
ENSG00000116138,DNAJC16,regulation of proteostasis,modulation of upr,inhibition of apoptosis,promotion of cell growth,interaction with rpn2,cellular homeostasis
ENSG00000185561,TLCD2,cell cycle regulation,protein-protein interactions,gene transcription regulation,cyclin-dependent kinase modulation,nuclear localization,chromatin remodeling
ENSG00000120594,PLXDC2,aberrant lipid metabolism,cell membrane alteration,endocytic trafficking disruption,lipid transport regulation,oncogenic process contribution,tumor growth promotion
ENSG00000070413,DGCR2,dysregulation of mirna processing,aberrant mirna expression,oncogenic potential,tumor progression,genomic instability,epigenetic regulation
ENSG00000048140,TSPAN17,tetraspanin web,cell adhesion,cell migration,oncogenic process,integrin interaction,receptor tyrosine kinase activation
ENSG00000019102,VSIG2,tumor microenvironment,immune regulation,cell proliferation,overexpression,enhanced metastatic potential,immune surveillance disruption
ENSG00000171004,HS6ST2,aberrant sulfation,bifunctional enzyme activity,gag biosynthesis regulation,cell signaling modulation,heparan sulfate interaction,tumorigenesis promotion
ENSG00000178904,DPY19L3,telomerase activation,genomic instability,tumor progression,dna damage response,proliferation regulation,telomere elongation
ENSG00000177034,MTX3,oncometastatase,extracellular matrix degradation,tumor progression,immune modulation,cell migration and invasion,therapeutic target
ENSG00000106560,GIMAP2,gtp-binding protein regulation,immune cell development,cellular proliferation,cell differentiation,regulatory mechanism,signal transduction
,KIAA0391,overexpression,cell proliferation promotion,chromatin remodeling,cancer aggressiveness,aaa family protein,dna repair pathway involvement
ENSG00000284120,KIR2DS1,immune response modulation,apoptosis regulation,potassium ion channel regulation,t-cell activation,pan-cancer involvement,sodium-potassium balance
ENSG00000133317,LGALS12,tumor microenvironment modulation,cell migration and invasion,epithelial-to-mesenchymal transition (emt) promotion,oncoprotein interaction and signaling modulation,pro-inflammatory cytokine induction,poor prognosis association
ENSG00000172551,MUCL1,microtubule stabilization,oncogenic potential,cell proliferation enhancement,cancer progression promotion,genomic alteration association,protein-protein interaction role
ENSG00000174944,P2RY14,g protein-coupled receptor,purinergic signaling,immune cell regulation,tumor immunity modulation,cancer immunotherapy target,receptor-ligand interaction
ENSG00000198108,CHSY3,chondroitin sulfate synthesis,cell proliferation,tumor invasion,extracellular matrix regulation,glycosaminoglycan production,oncogenic potential
ENSG00000111885,MAN1A1,glycoprotein processing,tumor progression,cellular adhesion,angiogenesis,gene expression regulation,protein maturation
ENSG00000183798,EMILIN3,emilin3-mediated angiogenesis,ecm remodeling,integrin binding,oncogenic transformation,tumor microenvironment modulation,cell migration enhancement
ENSG00000145882,PCYOX1L,heme degradation,tumor microenvironment modulation,immune response regulation,oxidative stress prevention,inflammation modulation,angiogenesis regulation
ENSG00000149577,SIDT2,nucleotide metabolism,dna damage response,oncogenic role,tumor progression,genotoxic stress regulation,protein-protein interaction
ENSG00000198743,SLC5A3,ph regulation,oncogenesis facilitation,chemoresistance association,tumor growth promotion,sodium-dependent transport,bicarbonate transport modulation
ENSG00000117069,ST6GALNAC5,tumor progression,cell surface modification,metastasis facilitation,glycosylation regulation,sialyltransferase activity,oncogenic potential
ENSG00000102078,SLC25A14,mitochondrial carrier function,metabolic regulation,aspartate transport,cell proliferation,redox balance,cancer progression
ENSG00000111801,BTN3A3,immune evasion,tumor progression,oncogene potential,apoptosis regulation,cell cycle modulation,protein processing
ENSG00000026950,BTN3A1,tumor cell proliferation,oncogenic processes,immune evasion,genetic regulation,protein-protein interactions,inflammatory response
ENSG00000240654,C1QTNF9,tumor growth,cell survival,immune evasion,angiogenesis,promoter of oncogenes,metastasis-associated protein
ENSG00000118298,CA14,ph regulation,cell migration,tumor progression,metastasis,prognosis marker,signaling pathway interaction
ENSG00000128274,A4GALT,carbohydrate biosynthesis,glycosyltransferase function,cell surface antigen modulation,cell adhesion regulation,metastasis promotion,altered glycosylation pattern
ENSG00000166997,CNPY4,cell migration,apoptosis regulation,oncogene activation,pi3k/akt pathway modulation,cell proliferation enhancement,tumor invasion facilitation
ENSG00000256453,DND1,genomic instability,aneuploidy,cell proliferation,centrosome separation,oncogenesis,cancer prognosis
ENSG00000141933,TPGS1,oncogene activation,tumor microenvironment modulation,metastasis promotion,angiogenesis regulation,cell-to-cell communication,therapeutic target
ENSG00000137821,LRRC49,autophagy regulation,mitochondrial dysfunction,gtpase activity,oncogenic mutations,cell survival promotion,tumor progression facilitation
ENSG00000172339,ALG14,biosynthesis pathway,tumor cell proliferation,glycosylation dysregulation,lipid metabolism,oncogenic process,cancer biomarker
ENSG00000005059,MCUB,immune regulation,protein ubiquitination,cell proliferation,signal transduction,cellular degradation,therapeutic target
ENSG00000248144,ADH1C,alcohol metabolism,enzyme activity,microenvironment modulation,detoxification pathway,cancer progression,tumor microenvironment modification
ENSG00000102287,GABRE,gabaergic regulation,altered expression patterns,cell proliferation regulation,neurotransmitter modulation,cancer-related dysregulation,synaptic transmission disruption
ENSG00000137198,GMPR,glutamate regulation,tumor progression,enzymatic activity,cell signaling modulation,metallopeptidase function,cell growth influence
ENSG00000169508,GPR183,pi3k/akt activation,g protein-coupled receptor function,cell proliferation regulation,cholesterol homeostasis modulation,tumor progression enhancement,cancer cell survival promotion
ENSG00000203737,GPR52,pi3k/akt pathway interaction,cell survival regulation,mutation associated,signaling pathway modulation,g-protein coupled receptor function,tumor progression role
ENSG00000135912,TTLL4,microtubule polymerization,oncogene function,mt stability regulation,cell division regulation,tumor progression driver,chemotherapy resistance
ENSG00000165799,RNASE7,tumor suppression,immune regulation,nucleic acid degradation,innate immunity,genome stability,epithelial marker
ENSG00000179913,B3GNT3,glycosylation process,tumorigenesis,immune evasion,cell adhesion regulation,apoptosis modulation,therapeutic target
ENSG00000106526,ACTR3C,cellular regulation,dysregulated expression,transcriptional activation,proliferation promotion,metabolic modulation,protein interaction
ENSG00000164048,ZNF589,cellular differentiation,chromatin regulation,dna binding activity,gene expression modulation,oncogenesis suppression,transcriptional regulation
ENSG00000090612,ZNF268,tumor suppression,transcriptional regulation,epigenetic modulation,protein-protein interactions,cell cycle regulation,apoptosis regulation
ENSG00000169258,GPRIN1,rgs activity,promotes oncogenesis,constitutive activation,cell proliferation regulation,g-protein modulation,tumor progression driver
ENSG00000103241,FOXF1,transcriptional regulation,cell growth modulation,oncogenic processes,tumorigenesis involvement,metastasis promotion,developmental regulation
ENSG00000076351,SLC46A1,folate transport,tumor growth promotion,cell proliferation support,biomarker significance,metabolic adaptation,genomic instability
ENSG00000143612,C1orf43,mitotic kinase regulation,microtubule organization,cell proliferation enhancement,genomic instability,apoptosis resistance,tumor progression
ENSG00000162600,OMA1,mitochondrial function,apoptosis regulation,degradation of opa1,cancer progression,biomarker potential,therapeutic target
ENSG00000275600,PIGW,gpi anchor synthesis,cell signaling pathway modulation,tumor progression facilitation,prognostic marker potential,chromosome 5q31 alteration,epigenetic regulation dysregulation
ENSG00000141437,SLC25A52,mitochondrial transport,cell proliferation,amplification,oncogenic driver,poor prognosis,tumor resistance
ENSG00000283034,ZNF445,cellular regulation,dna binding,gene expression,oncogene/tumor suppressor,transcriptional regulation,tumorigenesis
ENSG00000161905,ALOX15,oxylipin synthesis,inflammation regulation,angiogenesis promotion,tumor growth enhancement,metastasis facilitation,epigenetic modulation
ENSG00000166396,SERPINB7,tumor suppressor,loss of function mutations,protease inhibition,epithelial cell expression,apoptosis regulation,cell growth control
ENSG00000118017,A4GNT,glycosylation regulation,tumor progression,cell surface modification,protein stability modulation,oncogenic signaling,therapeutic target
ENSG00000198792,TMEM184B,enhanced egfr activity,cell proliferation regulation,pi3k/akt pathway modulation,tumor progression enhancement,cancer prognosis correlation,protein-protein interaction role
ENSG00000111684,LPCAT3,cell migration,cell signaling,enzymatic activity,increased membrane fluidity,lipid metabolism regulation,oncogenic pathway activation
ENSG00000167332,OR51E2,odorant detection,tumor suppressor function,cell proliferation,molecular alteration,oncogenic process,gene expression regulation
ENSG00000164180,TMEM161B,er stress regulation,ca2+ homeostasis disruption,tumor cell survival enhancement,promoter of metastasis,tumor aggressiveness increaser,chemosensitivity resistance enhancer
ENSG00000139624,CERS5,ceramide biosynthesis,oncogenic transformation,lipid metabolism regulation,apoptosis inhibition,signaling pathway modulation,cellular membrane composition
ENSG00000181396,OGFOD3,oncogene/tumor suppressor,cell cycle regulation,apoptosis modulation,protein stability/localization,substrate specificity,post-translational modifications
ENSG00000149582,TMEM25,mechanotransduction,cellular morphology,cellular polarity,tumor progression,cytoskeletal remodeling,extracellular matrix interaction
ENSG00000176454,LPCAT4,lipid remodeling,cell survival,mtor activation,unsaturated lipid increase,tumor progression,metabolic regulation
ENSG00000197586,ENTPD6,tumor suppressor function,loss of function mutations,regulation of immune responses,modulation of nucleotide levels,inflammation regulation,cell survival pathways interaction
ENSG00000178752,ERFE,cellular regulation,oncogenic function,protein synthesis regulation,tumor progression,therapeutic target,translational control
ENSG00000170801,HTRA3,tumor progression,growth factor regulation,apoptosis suppression,cell cycle modulation,angiogenesis promotion,therapeutic target
ENSG00000185621,LMLN,cellular interaction,chromatin regulation,apoptosis regulation,protein modification,cell cycle regulation,genomic stability
ENSG00000120820,GLT8D2,glutamine dependency,gene mutation,cellular proliferation,metabolic rewiring,oncogenic activation,tumor adaptation
ENSG00000173852,DPY19L1,genomic instability,chromosomal alterations,cell cycle progression,apoptosis suppression,dna repair regulation,mitotic spindle assembly
ENSG00000164976,MYORG,pi3k/akt pathway activation,tumor progression,cell proliferation,genomic instability,therapeutic target,signaling pathway interaction
ENSG00000144959,NCEH1,apoptosis regulation,lipid metabolism alteration,cellular signaling pathway modulation,oncogenic process promotion,protein interaction dysregulation,therapeutic target
ENSG00000106771,TMEM245,pi3k/akt/mtor pathway activation,transmembrane protein function,oncogenic signaling,cell surface interaction,cancer biomarker,mutational hotspot
ENSG00000169379,ARL13B,arl13b,ciliogenesis,aurora kinase a interaction,genomic instability,pi3k/akt pathway regulation,tumor aggressiveness
ENSG00000182162,P2RY8,cellular proliferation,glycolysis regulation,glucose metabolism,g-protein coupled receptor,oncogenic signaling,tumor growth promotion
ENSG00000133657,ATP13A3,cancer-associated,metabolic regulation,cellular ion homeostasis,mitochondrial function,oncogenic potential,protein-protein interactions
ENSG00000115828,QPCT,glutamyl aminopeptidase dysfunction,loss of function mutations,tumor suppressor role,cell proliferation regulation,cancer association,metabolic regulation
ENSG00000198018,ENTPD7,upregulation,purinergic signaling regulation,cell proliferation enhancement,metastasis promotion,pkb/akt pathway activation,tumor growth facilitation
,TMEM8A,wnt pathway modulation,co-receptor function,cell proliferation regulation,canonical signaling cascade,g-protein coupled receptor,epithelial cell expression
ENSG00000146282,RARS2,splicing regulation,alternative splicing,gu-rich sequence recognition,cell survival promotion,gene expression modulation,tumor progression
ENSG00000069943,PIGB,enhanced glycolysis,glycolipid synthesis,cell growth regulation,oncogenic potential,tumor aggressiveness,poor prognostic marker
ENSG00000163755,HPS3,hps complex regulation,dysregulated lros,oncogenic signaling pathways,cell survival alterations,therapeutic target potential,lysosome-related organelle maturation
ENSG00000111728,ST8SIA1,cell surface glycosylation,glycosyltransferase activity,tumor progression,metastasis,signaling pathway interaction,cell membrane dynamics
ENSG00000269556,TMEM185A,genomic instability,homologous recombination repair,dna damage response,transmembrane protein,cancer predisposition,genome maintenance
ENSG00000226479,TMEM185B,cell signaling modulation,oncogenic processes promotion,tumor progression facilitation,immune response regulation disruption,epithelial integrity maintenance impairment,chemoresistance induction
ENSG00000143653,SCCPDH,dna damage recognition,tumor suppression,genomic instability,transcriptional regulation,chromatin remodeling,dna repair mechanisms
ENSG00000115488,NEU2,cellular regulation,tumor progression,apoptosis resistance,glycoprotein modification,cell growth enhancement,signaling pathway modulation
ENSG00000196950,SLC39A10,tumor progression,oncogenic pathway activation,zinc homeostasis regulation,cell proliferation enhancement,survival signaling modulation,therapeutic target
ENSG00000112195,TREML2,immune evasion,tumor suppressor function,constitutive activation mutations,oncogene potential,proliferation regulation,signaling pathway modulation
ENSG00000153214,TMEM87B,cellular trafficking,oncogenic signaling,tumor progression,metastasis promotion,therapeutic resistance,autophagy regulation
ENSG00000086696,HSD17B2,steroid hormone synthesis,overexpression in tumors,cell proliferation,apoptosis regulation,tumor progression,immune modulation
ENSG00000090530,P3H2,post-translational modification,proline hydroxylation,collagen stability,ecm regulation,molecular interaction,tumor microenvironment
ENSG00000206072,SERPINB11,pi3k/akt signaling,tumor suppressor function,apoptosis regulation,proteolytic inhibition,cancer progression inhibition,cell cycle regulation
ENSG00000152749,GPR180,g protein-coupled receptor signaling,angiogenesis promotion,metastatic progression,tumor growth facilitation,immune response modulation,cancer biomarker
ENSG00000115525,ST3GAL5,tumor progression,glycosylation regulation,cell migration enhancement,immune evasion facilitation,oncogenic process involvement,signaling pathway interaction
ENSG00000243449,C4orf48,regulatory lncrna,oncogenic function,cell growth promotion,apoptosis suppression,pi3k/akt pathway modulation,transcription factor regulation
ENSG00000169884,WNT10B,constitutive activation,wnt/β-catenin pathway,enhanced cell proliferation,cell survival and metastasis,cell differentiation regulation,tgf-β signaling interaction
ENSG00000070718,AP3M2,lysosomal trafficking,cell metabolism regulation,tumor growth promotion,immune evasion,metastasis facilitation,subcellular localization alteration
,FUK,muscle membrane integrity,glycosyltransferase function,cell proliferation regulation,cell survival pathways,dystroglycan modification,oncogenesis modulation
ENSG00000145309,CABS1,cancer-related instability,centrosome regulation,tumor suppressor dysfunction,mitotic catastrophe,cellular polarity disruption,cytokinesis impairment
ENSG00000122778,KIAA1549,mitotic checkpoint complex,cell division regulation,genomic instability,chromosomal aneuploidy,protein-protein interactions,hedgehog signaling pathway
ENSG00000110975,SYT10,apoptosis dysregulation,cell proliferation increase,genomic amplification,interactions with pi3k/akt pathway,oncogenic driver,synaptotagmin function disruption
ENSG00000184330,S100A7A,tumor progression,cell proliferation,protein interaction,calcium regulation,immune response modulation,epigenetic regulation
ENSG00000172888,ZNF621,transcription factor activity,cell proliferation,apoptosis inhibition,signal transduction pathway,mapk/erk signaling,poor prognosis marker
ENSG00000149328,GLB1L2,prognostic marker,glycosylation regulation,cell surface modification,nuclear localization,tumorigenesis,therapeutic target
ENSG00000169105,CHST14,cell migration,tumor progression,epithelial-to-mesenchymal transition,proteoglycan modification,biomarker potential,angiogenesis regulation
ENSG00000196562,SULF2,cell proliferation,oncogenic signaling,tumor progression,cell surface modification,wnt/β-catenin pathway,proteoglycan regulation
ENSG00000088812,ATRN,dna damage response,cell proliferation,pi3k/akt activation,protein synthesis regulation,tumor suppressor function,cancer biomarker and therapeutic target
ENSG00000144357,UBR3,loss of function mutations,tumor suppressor role,cell cycle regulation,apoptosis modulation,genome instability,protein degradation dysfunction
ENSG00000106868,SUSD1,epithelial-to-mesenchymal transition (emt),matrix metalloproteinase inhibition,cell adhesion regulation,tumor suppressor function,cancer metastasis suppression,immune response modulation
ENSG00000146833,TRIM4,tumor suppressor function,ubiquitination regulation,cell cycle regulation,apoptosis modulation,oncogene regulation,cancer predisposition
ENSG00000100276,RASL10A,gain of function mutations,tumor progression,pi3k/akt pathway activation,constitutive activation,protein-protein interactions,genomic profiling
ENSG00000168528,SERINC2,lipid metabolism regulation,oncogene inhibition,tumor growth promotion,cell death modulation,apoptosis induction,therapeutic target candidacy
ENSG00000110013,SIAE,adhesion molecule regulation,cell migration suppression,metastasis promotion,immune evasion enhancement,tumor progression facilitation,stem cell enrichment
ENSG00000138744,NAAA,metalloprotease activity,neurotrophic factor processing,cell proliferation regulation,tumor progression,apoptosis inhibition,protein degradation
ENSG00000013288,MAN2B2,glycosphingolipid metabolism,aberrant glycosylation patterns,oncogenic process,tumor microenvironment modulation,immune response evasion,therapeutic target
ENSG00000140993,TIGD7,mitochondrial dysfunction,lipid metabolism regulation,insulin signaling disruption,tumor growth promotion,metastasis facilitation,oncogenic role
ENSG00000147432,CHRNB3,nicotinic acetylcholine receptor,cell proliferation,apoptosis regulation,tumor progression,signaling pathway activation,dysregulation of oncogenes
ENSG00000174428,GTF2IRD2B,oncogenic transcription factor,overexpressed or amplified,cell cycle progression,apoptosis suppression,dna repair dysregulation,poor prognosis indicator
ENSG00000112761,CCN6,tumor progression,cell migration,prognostic biomarker,angiogenesis regulation,immune evasion,cell adhesion
ENSG00000167261,DPEP2,antioxidant regulation,redox signaling pathway,glutathione metabolism,tumor microenvironment modulation,oxidative stress response,cancer progression driver
ENSG00000033100,CHPF2,epigenetic regulation,cell proliferation,chromatin remodeling,oncogenic protein interaction,wnt/β-catenin signaling pathway degradation,ubiquitination and proteasomal degradation
ENSG00000168569,TMEM223,pi3k/akt signaling,mutation-driven oncogenesis,cell membrane regulation,tumor progression,angiogenesis modulation,signal transduction pathway interaction
ENSG00000145990,GFOD1,increased glucose metabolism,oncogenic driver,pi3k/akt/mtor interaction,glycolytic enzyme regulation,cell proliferation enhancement,biomarker candidacy 
ENSG00000141098,GFOD2,glutaryl-coa dehydrogenation,mitochondrial dysfunction,bcaa catabolism regulation,mtorc1 activation,cell proliferation enhancement,tumor progression
ENSG00000162694,EXTL2,genomic instability,tumor suppression,microtubule regulation,heparan sulfate biosynthesis,mitotic spindle assembly,cancer driver gene
ENSG00000139572,GPR84,g-protein coupled receptor,constitutive activation,tumor growth promotion,pi3k/akt pathway modulation,immune response regulation,therapeutic target
ENSG00000188095,MESP2,tumor progression,transcriptional regulation,cell proliferation,embryonic development,oncogene interaction,cellular differentiation
ENSG00000157617,C2CD2,cell cycle regulation,apoptosis modulation,tumor suppressor,protein-protein interaction,gene expression regulation,cancer prognosis
ENSG00000095203,EPB41L4B,chromatin remodeling,amplicon formation,cell proliferation,apoptosis inhibition,tumorigenesis promotion,transcriptional regulation
ENSG00000161714,PLCD3,calcium mobilization,constitutive activation,cell proliferation,oncogenic transformation,tumor progression,therapeutic target
ENSG00000288508,ISLR,immune regulation,cell adhesion,tumorigenesis,metastasis,oncogene,genomic instability
ENSG00000170848,PSG6,cell growth regulation,tumor progression,stress response,oncogenesis,progestin-binding protein family,altered expression levels
ENSG00000204941,PSG5,tumor progression,cell adhesion disruption,extracellular matrix interaction,metastasis promotion,immune evasion,cancer cell migration
ENSG00000221826,PSG3,cell adhesion,tissue repair,wound healing,transmembrane protein,glycosaminoglycan chains,epithelial expression
ENSG00000129667,RHBDF2,apoptosis evasion,cell proliferation,genetic mutations,retinoid metabolism,reticulon domain interaction,tumor progression
ENSG00000139344,AMDHD1,mitochondrial regulation,cellular metabolism modulation,tumor microenvironment influence,oncogenesis involvement,metabolic pathway alteration,mitophagy regulation
ENSG00000159579,RSPRY1,cellular regulation,tumor suppression,cyclin-dependent kinase inhibition,chromatin remodeling,transcriptional repression,protein-protein interaction
ENSG00000187054,TMPRSS11A,cell surface proteolysis,protein activation,tumor progression,metastasis,biomarker potential,cancer cell invasion
ENSG00000166682,TMPRSS5,protein activation,cell proliferation,constitutive activation,oncogenic signaling,therapeutic target,signal transduction
ENSG00000134779,TPGS2,cellular redox balance,oncogene,apoptosis resistance,dna repair regulation,epithelial-to-mesenchymal transition (emt),signaling pathway modulation
ENSG00000186919,ZACN,tumor immunosurveillance,lipid metabolism regulation,adipocyte function modulation,cell growth regulation,differentiation regulation,immune response modulation
ENSG00000149150,SLC43A1,bcaa metabolism,cell growth regulation,metabolic adaptation,cell proliferation enhancement,oncogenic processes promotion,genomic alterations association
ENSG00000171466,ZNF562,transcriptional regulation,tumor progression,cell proliferation,krab domain-containing zinc finger protein,cell cycle regulation,gene expression repression
ENSG00000171469,ZNF561,krab-domain containing protein,transcriptional regulator,cell cycle control,apoptosis modulation,oncogenic processes,epigenetic modification target
ENSG00000167981,ZNF597,chromatin remodeling,oncogenic properties,transcriptional repression,cell cycle regulation,prognostic marker,genomic instability
ENSG00000124302,CHST8,oncogene activation,cell proliferation enhancement,metastasis promotion,pi3k/akt pathway interaction,carbohydrate sulfotransferase function,glycoprotein modification
ENSG00000087299,L2HGDH,metabolic regulation,tumor progression,oncogenic processes,stress response activation,ros accumulation,enzymatic activity disruption
ENSG00000276175,LILRA3,immunomodulation,immune evasion,tumor microenvironment,antigen presentation,immune suppression,biomarker potential
ENSG00000277398,LILRA1,regulatory immune response,inhibitory receptor activity,tumor immunity modulation,autoimmune disease association,immunoglobulin binding,immune checkpoint regulation
ENSG00000149054,ZNF215,transcriptional regulation,oncogene function,chromatin remodeling,cell proliferation,metastasis promotion,amplification event
ENSG00000166979,EVA1C,cell growth regulation,oncogenic mutation,ribosome biogenesis,cell proliferation regulation,gene amplification,tumorigenesis promotion
ENSG00000125355,TMEM255A,cellular interaction,regulatory function,cell proliferation,signaling pathway disruption,cancer development,protein localization
ENSG00000115226,FNDC4,tumor progression,epithelial-to-mesenchymal transition,cell migration,matrix metalloproteinase activation,wnt/β-catenin pathway regulation,pi3k/akt/mtor signaling modulation
ENSG00000122986,HVCN1,heterogeneous expression levels,cellular ion regulation,apoptosis modulation,metabolic reprogramming,prognostic marker,tumor microenvironment remodeling
ENSG00000118242,MREG,chromatin remodeling,transcriptional regulation,oncogenic processes,tumor progression,metastasis,chemoresistance
ENSG00000177181,RIMKLA,oncogenic signaling,cell proliferation,tumor aggressiveness,g-protein coupled receptors,protein interaction,cancer development
ENSG00000188352,FOCAD,focad mutations,loss of function mutations,tissue architecture disruption,cell-cell interaction regulation,epithelial integrity loss,downstream signaling pathway activation
ENSG00000072954,TMEM38A,er stress regulation,tumor suppressor function,cell migration promotion,oncogenic mutation,therapeutic target,signaling pathway modulation
ENSG00000151806,GUF1,oncogenic function,cell migration,microtubule dynamics,organelle trafficking,protein degradation regulation,dynactin complex subunit
ENSG00000188175,HEPACAM2,cell-cell adhesion disruption,protein-protein interaction,tumor progression marker,pi3k/akt pathway interaction,cellular integrity disruption,cancer stem cell maintenance
ENSG00000068137,PLEKHH3,endocytosis regulation,oncogenic function,cell migration enhancement,cancer progression,overexpression,cytoskeleton dynamics regulation
ENSG00000168671,UGT3A2,pharmacokinetic regulation,drug metabolism,glucuronidation process,cellular detoxification,enzyme expression modulation,oncosuppressive function
ENSG00000163898,LIPH,lysophosphatidic acid acyltransferase,constitutive activation,genetic alteration,tumor progression,bioactive lipid signaling,cell membrane lipid composition
ENSG00000087116,ADAMTS2,aberrant expression,extracellular matrix remodeling,metalloprotease activity,oncogenic potential,protein-protein interaction,tumor progression
ENSG00000214456,PLIN5,lipid metabolism,adipocyte differentiation,tumor progression,insulin sensitivity,energy homeostasis,signaling pathway interaction
ENSG00000100344,PNPLA3,lipid metabolism regulator,hepatic triglyceride regulation,nafld risk modifier,lipolytic enzyme activity,cellular energy metabolism,metabolic disease association
ENSG00000139974,SLC38A6,cellular uptake,oncogenic signaling,mtorc1 pathway activation,protein synthesis regulation,tumor progression facilitation,amino acid metabolism interaction
ENSG00000281919,SLC45A2,protein-protein interaction,cell adhesion,extracellular matrix deposition,tumor growth,epithelial-to-mesenchymal transition,metabolic regulation
ENSG00000140675,SLC5A2,glucose metabolism,sodium-glucose cotransporter function,cancer cell metabolism,overexpression in cancer,glycolysis activation,cellular growth and proliferation
ENSG00000113296,THBS4,angiogenesis regulation,tumor microenvironment modulation,cell proliferation inhibition,apoptosis induction,signaling pathway interaction,endothelial cell regulation
ENSG00000205268,PDE7A,cgmp regulation,tumor growth promotion,signaling pathway modulation,cell proliferation enhancement,metastasis facilitation,prognostic marker candidate
ENSG00000188782,CATSPER4,sperm motility regulation,aberrant expression,x-chromosome localization,cell growth regulation,signaling pathway alteration,tumor progression marker
ENSG00000170464,DNAJC18,protein folding regulation,cell cycle regulation,dna replication interaction,therapeutic target,genome stability maintenance,oncogenesis involvement
ENSG00000103196,CRISPLD2,tumor suppressor function,cell proliferation regulation,signaling pathway modulation,mutations associated with tumorigenesis,altered expression levels in cancer,protein-protein interactions
ENSG00000164176,EDIL3,disrupted cell adhesion,oncogenic mutations,tumor progression,cell migration regulation,epithelial integrity disruption,adherens junction formation
ENSG00000136883,KIF12,microtubule-based transport,chromosomal instability,cell cycle regulation,therapeutic target potential,mitotic spindle assembly,aneuploidy induction
ENSG00000146006,LRRTM2,tumor progression,mutation loss,cell adhesion disruption,stem cell-like properties,protein interaction regulation,signaling pathway activation
ENSG00000198754,OXCT2,mitochondrial enzyme,metabolic reprogramming,hypoxia adaptation,tumor growth support,therapeutic target,biomarker expression
ENSG00000094975,SUCO,hedgehog pathway inhibition,loss-of-function mutations,tumor suppressor function,cell proliferation regulation,apoptosis resistance,chemotherapy resistance
ENSG00000163053,SLC16A14,metabolic reprogramming,glycolysis upregulation,warburg effect activation,tumor progression facilitation,therapeutic target identification,lactate production enhancement
ENSG00000138111,MFSD13A,tumor progression,apoptosis regulation,cell proliferation,lipid metabolism regulation,epithelial-to-mesenchymal transition (emt),metastasis facilitation
ENSG00000186377,CYP4X1,lipid oxidation,cell proliferation,lipid metabolism regulation,metastasis promotion,energy homeostasis modulation,signaling pathway interaction
ENSG00000196636,SDHAF3,mitochondrial function,electron transport chain,energy metabolism,succinate regulation,hypoxic signaling,tumor progression
ENSG00000276114,CCL23,protein-protein interaction,angiogenesis promotion,immune evasion,chemokine signaling pathway,lymphangiogenesis induction,tumor progression
ENSG00000173638,SLC19A1,folate transport,enhanced nucleotide synthesis,therapeutic target,tumorigenesis driver,cell proliferation regulator,chemotherapy resistance
ENSG00000148950,IMMP1L,telomere maintenance,cell cycle regulation,genomic stability,pi3k/akt pathway regulation,tumorigenesis driver,oncogene function
ENSG00000248099,INSL3,tumor suppression,cell proliferation inhibition,receptor interaction,apoptosis induction,genetic alterations,hormone regulation
ENSG00000150045,KLRF1,tumor progression,immune evasion,oncogenic signaling,cell adhesion,metastasis,migration
ENSG00000206150,RNASE13,tumor suppressor downregulation,rna degradation pathway,cell proliferation regulation,oncogene regulation,cancer cell interaction,translational control
ENSG00000177202,SPACA4,overexpression,tumor growth promotion,apoptosis suppression,poor prognosis marker,sperm-associated protein function,cancer stem cell maintenance
ENSG00000134905,CARS2,redox regulation,oxidative stress resistance,glutathione metabolism,therapeutic target,cellular protection,sulfur amino acid metabolism
ENSG00000164494,PDSS2,preneylation pathway disruption,oncogenic protein activation,cell growth dysregulation,tumorigenesis association,protein modification regulation,gtpase interaction
ENSG00000204140,CLPSL1,tumor progression,cell signaling,immune response modulation,inflammation regulation,cell proliferation enhancement,crisp family protein
ENSG00000188811,NHLRC3,genomic instability,tumor suppression,dna double-strand break repair,non-homologous end joining,genome maintenance,cancer susceptibility
ENSG00000228083,IFNA14,immune regulation,antiproliferative effects,immunogenic cell death,damps release,jak-stat signaling pathway,cell cycle arrest
ENSG00000234829,IFNA17,immune modulation,apoptosis induction,tumor microenvironment modification,jak/stat signaling pathway involvement,t-cell regulation,antiviral response activation
ENSG00000138308,PLA2G12B,tumor progression,cancer metastasis,lipid metabolism regulation,calcium-independent activity,inflammation modulation,cell proliferation enhancement
ENSG00000263961,RHEX,cell cycle regulation,oncogene activation,transcriptional regulation,tumor growth promotion,metastasis facilitation,epithelial-to-mesenchymal transition (emt)
ENSG00000173947,PIFO,cell cycle progression,dna replication,genomic instability,chromatin remodeling,transcriptional regulation,oncogenic driver
ENSG00000109762,SNX25,endosomal sorting,receptor tyrosine kinase regulation,cell surface protein composition,cell growth promotion,mitosis regulation,polyubiquitination modification
ENSG00000090975,PITPNM2,tumor progression,phosphatidylinositol-tmphosphatase activity,oncogene activation,cell proliferation regulation,genomic instability,protein-protein interaction
ENSG00000148343,MIGA2,transcription regulation,histone modification,chromatin remodeling,tumor progression,cell proliferation,dna repair regulation
ENSG00000205111,CDKL4,cell cycle regulation,transcriptional control,oncogenic activity,tumor progression,dna repair mechanism,cancer predisposition
ENSG00000185838,GNB1L,g-protein complex,heterotrimeric subunit,cell signaling regulation,tumor progression,metastasis facilitation,angiogenesis promotion
ENSG00000176204,LRRTM4,metastasis promotion,tumor growth facilitation,cell adhesion regulation,signaling pathway modulation,oncogenic driver,prognostic biomarker
ENSG00000139044,B4GALNT3,n-glycan synthesis,constitutive activation,driver mutation,tumor aggressiveness,protein regulation,cell signaling
ENSG00000182272,B4GALNT4,tumor progression,glycosphingolipid synthesis,glycoprotein modification,cell-cell interactions,oncogenesis,metastasis promoter
ENSG00000198799,LRIG2,rtk signaling pathway regulation,tumor progression enhancement,constitutive activation of rtks,oncogenic processes promotion,tumor suppressor function,genomic instability induction
ENSG00000146530,VWDE,wnt/β-catenin signaling pathway,oncogenic potential,gain of function mutations,cell proliferation regulation,transcriptional regulation,developmental processes
ENSG00000119900,OGFRL1,oncogene,tumor progression,cell growth regulation,signal transduction pathway,therapeutic target,protein interaction
ENSG00000113119,TMCO6,mitochondrial dynamics,apoptosis regulation,oncogenic pathway interaction,energy metabolism modulation,tumorigenesis association,therapeutic target
ENSG00000171595,DNAI2,aberrant motor protein activity,cell cycle regulation dysfunction,genomic instability,motor protein regulation impairment,tumorigenesis contribution,cellular machinery disruption
ENSG00000101448,EPPIN,cell adhesion inhibition,proteolytic regulation dysfunction,tumor progression facilitation,cancer cell migration enhancement,therapeutic target potential,genomic instability association
ENSG00000249139,EPPIN-WFDC6,epithelial cell adhesion regulation,tumor suppressor function,matrix metalloproteinase inhibition,cell invasion suppression,proteolytic activity regulation,biomarker potential
ENSG00000187800,PEAR1,protease-activated receptor,tumor growth promotion,immune evasion,metastasis facilitation,endothelial cell recruitment,cancer cell adhesion
ENSG00000180626,ZNF594,krab-related domain,transcription factor regulation,gene expression modulation,cellular proliferation,apoptosis inhibition,tumor metastasis
ENSG00000154415,PPP1R3A,phosphatase regulation,cell metabolism modulation,oncogenic signaling pathway activation,tumor suppressor interaction,biomarker for diagnosis,protein-protein interaction regulation
ENSG00000139292,LGR5,wnt/β-catenin signaling pathway,cell fate decision,cancer stem cell marker,tumor progression,epithelial-to-mesenchymal transition,oncogene activation
ENSG00000173114,LRRN3,tumor suppressor,cell cycle regulation,apoptosis modulation,pi3k/akt pathway interaction,cell growth regulation,protein-protein interaction
ENSG00000182168,UNC5C,tumor suppressor,cell migration inhibitor,metastasis suppressor,dna damage inducer,apoptosis regulator,axon guidance receptor
ENSG00000148468,FAM171A1,genomic instability,oncogenic processes,cell proliferation,therapeutic target,dna damage repair,tumor suppressor interaction
ENSG00000152767,FARP1,rho-gap activity,cell migration,signaling pathway interaction,gene expression regulation,tumor progression,oncogenic driver
ENSG00000224940,PRRT4,protein kinase activation,cell adhesion regulation,tumor aggressiveness enhancement,metastasis promotion,signaling pathway regulation,cancer biomarker potential
ENSG00000113205,PCDHB3,cell-cell interaction,gene regulation,signaling pathway modulation,oncogenic phenotype disruption,neural circuit specificity,synaptic transmission regulation
ENSG00000117114,ADGRL2,oncogenic,overexpression,signaling modulation,cell proliferation,angiogenesis promotion,tumor progression
ENSG00000081760,AACS,metabolic reprogramming,tumor growth support,cellular energy metabolism regulation,amino acid decarboxylation,oncogenic environment promotion,mitochondrial enzyme function
ENSG00000108846,ABCC3,multidrug resistance,drug efflux transporter,ion homeostasis regulation,lipid metabolism regulation,tumor cell survival,cancer drug target
ENSG00000112812,PRSS16,serine protease activity,cell signaling pathway,protein processing,enzymatic function,substrate binding site,catalytic triad
ENSG00000151005,TKTL2,purine biosynthesis,glycolytic shift,glutamine dependence,cellular energy homeostasis,metabolic reprogramming,cancer metabolic adaptation
ENSG00000170950,PGK2,glycolysis regulation,energy metabolism upregulation,mtor pathway activation,pi3k/akt signaling enhancement,tumor progression association,oncogenic potential
ENSG00000164434,FABP7,cell proliferation,lipid metabolism,transcription factor interaction,cancer aggressiveness,nuclear localization,protein-protein interactions
ENSG00000047365,ARAP2,arf6 activation,cell migration,endocytosis regulation,gef activity,oncogene interaction,protein trafficking dysfunction
ENSG00000143891,GALM,glycoprotein synthesis,galactose metabolism,cell proliferation,wnt/β-catenin pathway,transcriptional regulation,cancer progression
ENSG00000101311,FERMT1,cell adhesion disruption,constitutive pathway activation,cell migration and invasion regulation,poor prognosis biomarker,oncogenic signaling cascade modulation,protein-protein interaction dysregulation
ENSG00000100033,PRODH,mitochondrial localization,tumor suppressor function,oncogenic metabolism,cell proliferation regulation,genomic instability prevention,therapeutic target
ENSG00000253626,EIF5AL1,oncogene activation,cell proliferation enhancement,pro-survival signaling pathway activation,tumor progression promotion,genomic instability induction,protein-protein interaction facilitation
ENSG00000134398,ERN2,er stress response,cellular homeostasis regulation,unfolded protein response modulation,oncogenic potential,tumor progression facilitation,cellular survival enhancement
ENSG00000156958,GALK2,metabolic reprogramming,pi3k/akt/mtor pathway interaction,cell proliferation enhancement,oncogenic signaling promotion,apoptosis resistance increase,tumor progression facilitation
ENSG00000183208,GDPGP1,gpi anchor biosynthesis,tumor progression,cell survival,apoptosis evasion,malignant transformation,prognostic marker
ENSG00000196475,GK2,fatty acid oxidation,cellular metabolism,tumor progression,gene expression regulation,oncogenesis,protein interaction
ENSG00000099984,GSTT2,gstt2 activity,cellular detoxification,oxidative stress regulation,glutathione conjugation,cancer susceptibility,genomic variations
ENSG00000107902,LHPP,warburg effect,metabolic reprogramming,tumor growth,prognostic marker,fatty acid metabolism,energy production
ENSG00000198951,NAGA,glycoprotein modification,cell growth regulation,oncogene activation,cancer therapy resistance,tumor progression,metabolic dysregulation
ENSG00000185792,NLRP9,inflammatory pathway regulation,tumor growth promotion,metastasis induction,cell death modulation,tumor microenvironment modulation,immunogenicity enhancement
ENSG00000215440,NPEPL1,apoptosis regulation,cell proliferation,peptidase activity,protein modification,tumor progression,overexpression
ENSG00000157045,NTAN1,genomic instability,microtubule stabilization,cell cycle regulation,dna repair dysfunction,tumor progression enhancement,apoptosis suppression
ENSG00000218823,PAPOLB,cell-cell adhesion,tumor suppression,metastasis enhancement,epithelial integrity disruption,cancer progression,gene expression regulation
ENSG00000127125,PPCS,oncogenic activation,prolyl peptidase activity,cell proliferation,tumor metastasis,genomic amplification,therapeutic target
ENSG00000185164,NOMO2,genetic instability,tumor growth,inflammation regulation,promiscuous interactions,dna damage response modulation,ancillary cell survival
ENSG00000013583,HEBP1,cellular homeostasis,cholesterol biosynthesis regulation,dysregulation in tumorigenesis,altered expression levels,cell growth regulation,genomic instability modulation
ENSG00000145284,SCD5,lipid metabolism,oncogenesis,cell proliferation,tumorigenesis,cellular membrane fluidity,apoptosis inhibition
ENSG00000100092,SH3BP1,akt pathway inhibition,tumor suppressor activity,cell survival regulation,multiple protein interactions,negative regulator role,akt signaling modulation
ENSG00000171612,SLC25A33,mitochondrial carrier protein,metabolic regulation,tumor suppressor function,oncogenic mutations,apoptosis regulation,cellular metabolism alterations
ENSG00000114779,ABHD14B,lysophospholipid metabolism,cancer driver gene,cell proliferation promoter,signaling pathway regulator,hydrolytic enzyme activity,lpa receptor activation
ENSG00000109667,SLC2A9,glucose transport,urate reabsorption,cellular energy production,metabolic regulation,plasma membrane localization,transcriptional regulation
ENSG00000142871,CCN1,tumor progression,epithelial-to-mesenchymal transition,cell migration and proliferation,angiogenesis,oncogene activation,signaling pathway modulation
ENSG00000167962,ZNF598,tumor suppression,transcriptional regulation,epigenetic modification,recognition of dna sequences,interaction with proteins,cell growth inhibition
ENSG00000214338,SOGA3,histone modification regulation,dysregulated expression,chromatin remodeling,epigenetic alterations,tumor suppressor function,genomic instability
ENSG00000176393,RNPEP,arginine methylation regulation,cellular senescence modulation,chromatin modification influence,dna damage response interaction,oncogenic pathway activation,therapeutic target potential
ENSG00000105778,AVL9,genomic instability,chromatin regulation,cell proliferation,oncogenic process,metastasis regulator,epigenetic modifier
ENSG00000254656,RTL1,regulation of membrane trafficking,rab gtpase family member,oncogenic processes involved,tumor growth and invasion associated,cell proliferation and survival enhanced,cancer stem cell regulation implicated
ENSG00000172318,B3GALT1,cell adhesion modulation,dysregulated expression,glycosaminoglycan synthesis,oncogenic transformation,tumor progression,cell signaling regulation
ENSG00000172733,PURG,homologous recombination,genomic stability,oncogenic process,cell proliferation,apoptosis regulation,therapeutic target
ENSG00000106034,CPED1,cellular proliferation,transcriptional regulation,dna repair mechanisms,tumor growth promotion,metastasis facilitation,apoptosis inhibition
ENSG00000154165,GPR15,immune system modulation,oncogenic potential,chemokine signaling,tumor microenvironment modification,epithelial-to-mesenchymal transition,cancer stem cell maintenance
ENSG00000181827,RFX7,genome stability,transcriptional regulation,chromatin remodeling,cell cycle progression,dna repair mechanisms,genomic instability
ENSG00000121075,TBX4,tumor progression,transcription factor activity,oncogene function,cell proliferation enhancement,apoptosis resistance,metastasis promotion
ENSG00000248905,FMN1,genomic stability,cellular redox balance,oxidative stress response,dna repair regulation,biomarker potential,redox enzyme function
ENSG00000160094,ZNF362,transcriptional regulation,oncogenesis,tumor progression,cell growth modulation,krab-domain containing,p53 interaction
ENSG00000156787,TBC1D31,rab gtpase regulation,membrane trafficking,oncogenic behavior,cell proliferation,invadopodia formation,amplification mutations
ENSG00000104983,CCDC61,myc pathway interaction,co-chaperone function,protein stabilization,cell division regulation,transcriptional enhancement,oncogenic overexpression
ENSG00000277848,MEGF11,cell-cell adhesion disruption,tumor progression,transmembrane protein function,cell migration enhancement,egf-like domain interaction,therapeutic target potential
ENSG00000143971,ETAA1,alternative splicing regulation,tumor progression,enhanced cell proliferation,modulator of isoform composition,cellular signaling pathway alteration,oncogene dysregulation
ENSG00000196074,SYCP2,chromosomal instability,genomic integrity maintenance,meiotic drive contribution,dna damage response interaction,synaptonemal complex formation,prophase i regulation
ENSG00000263002,ZNF234,histone modification,regulation of transcription,cell proliferation,apoptosis regulation,oncogenic transformation,chromatin remodeling
ENSG00000186020,ZNF529,regulation of gene expression,tumor suppressor activity,oncogenic properties,cell differentiation,apoptosis regulation,therapeutic target
ENSG00000204611,ZNF616,transcriptional regulation,oncogene activation,cell proliferation,tumor progression,epigenetic modification,gene expression disruption
ENSG00000244588,RAD21L1,genomic instability,sister chromatid cohesion,oncogenic process,tumor progression,cell proliferation,therapeutic target
,FOPNL,transcriptional regulation,oncogenic transformation,cell proliferation,dna binding,ap-1 family member,tumorigenesis
ENSG00000169607,CKAP2L,akt signaling pathway regulation,cancer cell interaction facilitation,cell signaling dysregulation,cell proliferation promotion,gene expression upregulation,protein-protein interaction involvement
ENSG00000133739,LRRCC1,microtubule regulation,dysregulation of centrosome,chromosomal instability,gene overexpression,cellular morphology,protein-protein interaction
ENSG00000169359,SLC33A1,calcium-dependent glycosylphosphatidylinositol anchor biosynthesis,gpi-anchored protein regulation,cell signaling disruption,oncogenic mutation driver,cellular homeostasis dysregulation,lipid metabolism modulation
ENSG00000006831,ADIPOR2,metabolic regulation,tumor progression,signaling pathway activation,insulin sensitivity enhancement,inflammation reduction,glucose uptake promotion
ENSG00000138018,SELENOI,antioxidant defense,redox regulation,nuclear localization,selenium-dependent enzyme,protein-protein interactions,oxidative stress response
ENSG00000164168,TMEM184C,cellular regulation,tumor progression,transmembrane protein function,pi3k/akt signaling interaction,overexpression,plasma membrane localization
ENSG00000146842,TMEM209,cell signaling pathway modification,tumor progression,cell proliferation enhancement,prognostic marker,cell migration promotion,overexpression in cancer
ENSG00000166471,TMEM41B,autophagy regulation,gain of function mutations,lysosomal dysfunction,tumor progression,cancer driver gene,autophagosome formation
ENSG00000175274,TP53I11,tumor suppressor function,cell cycle regulation,genomic stability maintenance,dna repair mechanism,apoptosis induction,epigenetic regulation disruption
ENSG00000139636,LMBR1L,overexpression,tumor progression,cell proliferation,signaling pathway regulation,oncogenic mutations,protein-protein interaction
ENSG00000143797,MBOAT2,lysophospholipid modification,oncogenic signaling pathway activation,cell membrane trafficking regulation,tumor progression promotion,biomarker potential,prognostic significance
ENSG00000111860,CEP85L,microtubule regulation,mitotic spindle integrity,cell cycle progression,genomic instability,centrosomal protein function,oncogenic mutations
ENSG00000170390,DCLK2,microtubule dynamics,oncogenic stemness,tumor progression,chemoresistance,genomic instability,protein interaction network
ENSG00000100147,CCDC134,microtubule dynamics,cell division regulation,mitotic progression modulation,oncogenic process involvement,genetic aberration association,paralogous gene interaction
ENSG00000158966,CACHD1,calcium-dependent signaling,oncogenesis,cell proliferation,kinase activation,metastasis promotion,nf-κb pathway regulation
ENSG00000148358,GPR107,oncogene function,tumor-promoting signaling,immune evasion mechanisms,epigenetic regulation,prognostic biomarker potential,receptor-ligand interactions
ENSG00000176018,LYSMD3,innate immune response regulation,cytoplasmic expression,immune pathway modulation,viral/bacterial recognition,oncogene dysregulation,cell proliferation regulation
ENSG00000124786,SLC35B3,glycosylation pathway,transporter activity,overexpression in cancer,cell growth regulation,tumor progression,glycoprotein biosynthesis
ENSG00000131389,SLC6A6,short-chain fatty acid transport,tumor progression,cellular proliferation,intracellular ph regulation,gut microbiome modulation,protein-protein interaction
ENSG00000149483,TMEM138,dna damage response,cell cycle regulation,transmembrane protein function,oncogenic mutations,genomic instability,cancer cell survival
ENSG00000180776,ZDHHC20,cell signaling pathway alteration,tumor progression facilitation,metastatic enhancement,cancer cell survival promotion,palmitoyltransferase activity,membrane protein modification
ENSG00000163704,PRRT3,cell migration,prognostic marker,tumor progression,cell invasion,transmembrane protein function,aggressive disease phenotype
ENSG00000173930,SLCO4C1,oncogenesis,poor prognosis,transport regulation,cellular membrane localization,organic anion transport,bile acid metabolism
ENSG00000187049,TMEM216,mitochondrial regulation,genomic instability,tumor suppressor function,cellular metabolism,mitochondrial dynamics,atp production
ENSG00000116396,KCNC4,calcium channel regulation,cell proliferation,ion channel dysfunction,cell migration,cancer progression,therapeutic target
ENSG00000103061,SLC7A6OS,amino acid export,oncogenic signaling,metabolic regulation,tumor progression,cellular transport,nutrient uptake
ENSG00000164403,SHROOM1,genomic stability,cell proliferation,chromosomal instability,tumor suppression,aneuploidy regulation,actin cytoskeleton regulation
ENSG00000100124,ANKRD54,chromatin remodeling,transcriptional regulation,oncogenesis,cell proliferation,protein-protein interactions,gene expression dysregulation
ENSG00000114541,FRMD4B,cellular organization,microtubule stabilization,oncogenic driver,aberrant expression,genomic instability,tumor suppression
,KIAA0556,genomic instability,oncogene activation,cell proliferation regulation,pi3k/akt pathway involvement,dna repair mechanisms disruption,gene expression modulation
ENSG00000148459,PDSS1,mitochondrial function,cancer cell survival,oncogenesis,energy metabolism,dysregulation,signaling pathway
ENSG00000019186,CYP24A1,vitamin d metabolism,oncogenesis,antiproliferative effects,overexpression,biomarker,therapeutic target
ENSG00000174886,NDUFA11,mitochondrial biogenesis,energy metabolism,electron transport chain,complex i subunit,ros generation,cellular respiration
ENSG00000110074,FOXRED1,mitoribosome assembly,mitochondrial dysfunction,oxidative stress induction,dna damage response,cell proliferation regulation,genetic instability promotion
ENSG00000144406,UNC80,tumor cell survival,cell proliferation,oncogene overexpression,potassium channel activation,therapeutic resistance,tumor growth promotion
ENSG00000164296,TIGD6,mitochondrial regulation,p53 inhibition,cell survival promotion,apoptosis resistance,therapeutic target,stress response modulation
ENSG00000004848,ARX,cellular differentiation,tumor suppressor activity,transcriptional regulation,gain of function mutations,oncogenic potential,apoptosis suppression
ENSG00000172197,MBOAT1,sphingomyelin acylation,gene amplification,oncogenic properties,lipid metabolism regulation,tumor progression,cell signaling pathway modulation
ENSG00000171487,NLRP5,aberrant nf-κb activation,autophagy regulation dysfunction,inflammasome assembly,cellular autophagic flux disruption,protein-protein interaction,tumor progression and metastasis promotion
ENSG00000183340,JRKL,pi3k/akt pathway,apoptosis regulation,cell cycle control,tumor suppressor degradation,oncogenic interaction,therapeutic target
ENSG00000167701,GPT,metabolic reprogramming,tumor metabolic shift,cellular energy production,nutrient availability,glycolysis regulation,biomarker identification
ENSG00000131848,ZSCAN5A,chromatin remodeling,transcriptional regulation,dna damage response,cell proliferation,tumor suppressor interaction,oncogenic reprogramming
ENSG00000113248,PCDHB15,cell adhesion regulation,tumor suppressor function,oncogenic mutations,synaptic maintenance,calcium-dependent processes,signal transduction pathways
ENSG00000166548,TK2,cell proliferation,genomic instability,dna synthesis,oncogene,tumor progression,therapeutic target
ENSG00000274538,PHLDA2,akt signaling inhibition,tumor suppressor activity,cell cycle regulation,apoptosis regulation,epigenetic regulation,oncogenic transformation
ENSG00000005889,ZFX,x chromosome regulation,transcription factor function,gene dosage compensation,rna binding protein interaction,x-linked gene silencing,x-chromosome inactivation
ENSG00000164099,PRSS12,cellular signal transduction,epithelial-to-mesenchymal transition (emt),growth factor regulation,tumor angiogenesis,tumor progression,poor prognosis marker
ENSG00000275568,ARHGAP11A,tumor growth promotion,rho gtpase regulation,cell migration and invasion,growth factor-independent survival signaling,genomic instability driver,therapeutic target candidate
ENSG00000138640,FAM13A,rho gtpase regulation,glycolysis reprogramming,tumor progression driver,oncogene overexpression,cancer cell metabolism alterations,protein-protein interaction
ENSG00000173083,HPSE,heparan sulfate degradation,cell migration and invasion,tumor progression and metastasis,extracellular matrix remodeling,protein-protein interactions,pi3k/akt pathway modulation
ENSG00000134802,SLC43A3,lipid metabolism reprogramming,fatty acid transport,cellular homeostasis,oncogenesis,metabolic regulation,tumor progression
ENSG00000111696,NT5DC3,nucleotide metabolism enhancement,tumor progression driver,purine pyrimidine metabolism,apoptosis inhibition,survival advantage,rapid cell proliferation
ENSG00000056586,RC3H2,cell cycle regulation,ubiquitin-proteasome system interaction,calcium signaling modulation,tumor suppressor function,genome stability maintenance,oncogenic promotion
ENSG00000074657,ZNF532,transcriptional regulation,tumorigenesis,cell proliferation,metastasis,histone modification,pi3k/akt pathway interaction
ENSG00000024526,DEPDC1,mtor pathway activation,g-protein coupled receptor regulation,cell proliferation enhancement,tumor progression promotion,genomic mutations associated,signaling pathway dysregulation
ENSG00000125454,SLC25A19,mitochondrial carrier,cellular respiration regulation,energy metabolism modulation,tumorigenesis facilitation,diagnostic marker potential,therapeutic target opportunity
ENSG00000134343,ANO3,calcium-activated chloride channel,constitutive activation,enhanced cell proliferation,interaction with signaling molecules,potential therapeutic target,oncogenic process modulation
ENSG00000123600,METTL8,methyltransferase activity,trna methylation,cellular metabolism regulation,cancer cell growth promotion,therapeutic target potential,epithelial-to-mesenchymal transition influence
ENSG00000091622,PITPNM3,pi3k/akt signaling pathway activation,pitp regulation disruption,oncogene potential,tumor growth promotion,cell proliferation enhancement,metastasis facilitation
ENSG00000204991,SPIRE2,oncogenic transformation,cell surface receptor signaling,escrt complex regulation,endosomal sorting and degradation,tumorigenesis promotion,apoptosis inhibition
ENSG00000186001,LRCH3,genome stability,chromatin remodeling,cell signaling pathway,transcriptional regulation,protein-protein interaction,tumorigenesis driver
ENSG00000213799,ZNF845,chromatin remodeling,gene regulation,transcriptional modulation,krab domain-containing,zinc finger protein function,tumor suppressor/ oncogene potential
ENSG00000017483,SLC38A5,glutamine metabolism,cellular proliferation,protein interaction,mtor pathway regulation,tumor growth promotion,amino acid transport
ENSG00000203705,TATDN3,dna replication regulation,genomic instability facilitation,cell cycle progression,tumor antigen-derived protein,dna damage response pathway interaction,chromosomal stability influence
ENSG00000123165,ACTRT1,oncogenic transformation,wnt/β-catenin pathway activation,transcriptional regulation,cell cycle progression promotion,tumor aggressiveness enhancement,metastatic potential increase
ENSG00000180346,TIGD2,mitochondrial function,apoptosis regulation,cell growth promotion,oncogenic processes,tumor suppressor interaction,transcriptional regulation
ENSG00000173681,BCLAF3,transcriptional regulation,apoptosis regulation,cell cycle progression,tumor suppressor interaction,proliferation promotion,growth factor regulation
ENSG00000277972,CISD3,mitochondrial function regulation,tumor suppressor function,cellular metabolism enhancement,proliferation promotion,cell growth regulation,iron-sulfur domain interaction
ENSG00000185189,NRBP2,rna-binding protein regulation,tumor progression,oncogene overexpression,cell proliferation,immune response modulation,signal transduction pathway interaction
ENSG00000257315,ZBED6,transcriptional repression,telomerase regulation,oncogene potential,cell cycle regulation,protein-protein interaction,cancer progression
ENSG00000070601,FRMPD1,cell surface receptor regulation,receptor tyrosine kinase interaction,pi3k/akt pathway activation,oncogenic process promotion,cell migration facilitation,adhesion modulation
ENSG00000163623,NKX6-1,cell cycle regulation,tumor suppressor function,transcriptional regulation,apoptosis induction,genomic stability maintenance,dna repair regulation
ENSG00000104967,NOVA2,splicing regulation,rna-binding protein interaction,tumor progression,metastasis driver,cellular proliferation,gene expression modulation
ENSG00000184677,ZBTB40,tumor suppression,cell growth regulation,transcriptional repression,apoptosis induction,genomic stability maintenance,epigenetic regulation
ENSG00000251493,FOXD1,transcriptional regulation,oncogenic driver,cellular proliferation,tumor progression,metastatic potential,genetic amplification
ENSG00000178919,FOXE1,transcriptional regulation,oncogene activation,epithelial-to-mesenchymal transition,cell proliferation,apoptosis suppression,biomarker potential
ENSG00000186766,FOXI2,oncogenic function,tumor growth promotion,transcriptional activation,cell cycle regulation,dna repair pathway,embryonic development
ENSG00000179981,TSHZ1,chromatin regulation,transcriptional activation,cell proliferation,oncogene overexpression,signal transduction,genomic instability
ENSG00000176678,FOXL1,oncogenic transformation,transcriptional regulation,cell survival pathways,growth factor signaling,molecular regulator,tumor suppressor dysfunction
ENSG00000164379,FOXQ1,cellular transformation,transcriptional regulation,ectopic expression,metastatic potential,stem cell self-renewal,tumor suppressor function
ENSG00000267728,KRTAP9-9,epithelial cell marker,keratin filament stabilization,oncogenic potential,protein-protein interaction,tumor aggressiveness,poor prognosis
ENSG00000180386,KRTAP9-7,altered keratin filament structures,cell adhesion disruption,cancer cell proliferation,epithelial integrity loss,overexpression patterns,oncogenic properties
ENSG00000240542,KRTAP9-1,pan-cancer association,keratin-associated protein function,cell adhesion disruption,tumorigenesis contribution,proliferation influence,dysregulation involvement
ENSG00000162782,TDRD5,tumor suppression,mrna stability regulation,argonaute protein interaction,poor prognosis indicator,metabolic reprogramming,cellular proliferation modulation
ENSG00000227140,USP17L5,tumor progression,oncoprotein stabilization,cell growth regulation,ubiquitin-proteasome pathway modulation,deubiquitination activity,aggressive tumor behavior
ENSG00000230549,USP17L1,ubiquitin-proteasome pathway modulation,tumor progression facilitation,oncogenic pathway activation,cell cycle regulation disruption,apoptosis inhibition,immune response gene regulation
ENSG00000144659,SLC25A38,mitochondrial carrier function,tumor growth promotion,metabolic reprogramming,tricarboxylate transport,energy production enhancement,oncogenic potential
ENSG00000188452,CERKL,ceramide metabolism,oncogene activation,cell proliferation,signal transduction,protein kinase activation,lipid mediator regulation
ENSG00000176567,OR4X1,cellular regulation,olfactory receptor family member,apoptosis regulation,metastasis involvement,protein interaction partner,chromosomal location
ENSG00000214435,AS3MT,methylarsonate formation,epigenetic regulation,dna methylation,arsenic resistance,cell survival enhancement,therapeutic target
ENSG00000196917,HCAR1,immune system regulation,tumor microenvironment modulation,natural killer cell activity,chemokine signaling,apoptosis evasion,angiogenesis regulation
ENSG00000184347,SLIT3,slit-robo signaling pathway disruption,tumor suppression,cell migration regulation,epigenetic silencing,oncogenic processes promotion,therapeutic target potential
ENSG00000165973,NELL1,transcriptional regulator,emt program regulation,tumor suppressor activity,cell adhesion modulation,protein-protein interaction,epithelial-to-mesenchymal transition
ENSG00000171714,ANO5,cellular stress response,dna damage response,oncogenic signaling pathways,epithelial-to-mesenchymal transition (emt),metastasis,tumor microenvironment modulation
ENSG00000170613,FAM71B,cellular proliferation,signaling pathway regulation,tumor progression,oncogenic mutations,plasma membrane localization,calcium signaling modulation
ENSG00000261221,ZNF865,cell cycle regulation,transcriptional repressor,chromatin remodeling,histone modification,apoptosis dysregulation,oncogene activation
ENSG00000139800,ZIC5,transcription factor activity,cellular differentiation,overexpression in tumors,epithelial-to-mesenchymal transition,cell proliferation regulation,cancer progression driver
ENSG00000224877,NDUFAF8,mitochondrial dysfunction,energy metabolism regulation,electron transport chain disruption,tumor growth promotion,oncogenic transformation,metabolic adaptation
ENSG00000240857,RDH14,cellular regulation,growth factor signaling,apoptosis resistance,oncogenic transformation,visual cycle disruption,tumor progression
ENSG00000101166,PRELID3B,cellular regulation,cancer driver gene,tumor suppressor function,protein ubiquitination,apoptosis regulation,dna repair pathway
ENSG00000127184,COX7C,dysregulated energy metabolism,cell proliferation and survival,mitochondrial biogenesis and dynamics,enhanced aggressive tumor behavior,critical role in cellular respiration,oncogenic transformation and progression
ENSG00000240230,COX19,mitochondrial function,tumor progression,metabolic adaptation,oxidative stress,apoptosis resistance,autophagy regulation
ENSG00000123815,COQ8B,mitochondrial dysfunction,energetic adaptation,oncogenic reprogramming,reactive oxygen species generation,metabolic rewiring,coenzyme q assembly
ENSG00000135469,COQ10A,mitochondrial function,oncogenic signaling pathway,disrupted energy metabolism,oxidative stress,tumorigenesis,cancer therapy target
ENSG00000173085,COQ2,coenzyme q10 biosynthesis,mitochondrial respiration,reactive oxygen species production,cellular energy metabolism regulation,genetic instability promotion,therapeutic target potential
ENSG00000167799,NUDT8,genomic instability,reactive oxygen species regulation,dna damage repair,cell proliferation promotion,apoptosis modulation,autophagy regulation
ENSG00000165443,PHYHIPL,genomic instability,tumor suppressor function,pi3k/akt signaling,cell cycle regulation,dna damage response,apoptosis regulation
ENSG00000115520,COQ10B,mitochondrial function,mitochondrial membrane potential,oxidative stress regulation,cell proliferation,energy metabolism regulation,tumor suppressor dysfunction
ENSG00000185973,TMLHE,regulatory protein,tumor progression,serine hydrolase activity,cancer development,cell proliferation regulation,genomic instability
ENSG00000006282,SPATA20,mitochondrial dynamics regulation,oncogene or tumor suppressor,cell growth promotion,metabolic reprogramming,therapeutic target potential,cancer metabolism alterations
ENSG00000146250,PRSS35,proteolytic activation,tumor growth,metastasis promoter,cell proliferation,angiogenesis,cancer development
ENSG00000184831,APOO,lipid regulation,tumor suppressor function,metabolic disorders,signal transduction pathway interaction,growth regulation,cell survival modulation
ENSG00000144481,TRPM8,cold-activated channel,cell proliferation,calcium influx,oncogenic signaling,therapeutic target,tumor aggressiveness
ENSG00000198771,RCSD1,rhoa inhibition,tumor suppressor,cell migration regulation,metastasis promotion,gtpase regulation,prognostic marker
ENSG00000276776,TC2N,genome stability,tumor suppressor activity,cell cycle regulation,dna repair mechanisms,cancer predisposition,protein interaction
ENSG00000163608,NEPRO,nuclear pore complex assembly,cell proliferation,oncogenic pathway interaction,tumorigenesis driver,aggressive tumor behavior,transcriptional regulation modulation
ENSG00000174990,CA5A,angiogenesis,anti-cancer target,cancer progression,cell membrane transport,enzymatic activity,metastasis
ENSG00000167800,TBX10,emt regulation,oncogenic transcription factor,cell proliferation enhancement,metastasis promotion,biomarker potential,tumor aggressiveness
ENSG00000235608,NKX1-1,transcriptional regulation,neural crest development,cell proliferation,tumor suppressor activity,gene expression regulation,pancreatic organogenesis
ENSG00000131845,ZNF304,tumor suppressor function,transcriptional regulation,zinc finger motifs,cell cycle progression,apoptosis inhibition,genomic stability maintenance
ENSG00000105467,SYNGR4,calcium-dependent signaling pathway,cancer progression,cell growth regulation,cell adhesion molecules,synaptic vesicle formation,apoptosis regulation
ENSG00000213853,EMP2,oncogene,cell adhesion regulation,tumor progression,adherens junction disruption,signaling pathway interaction,poor prognosis
ENSG00000132294,EFR3A,apoptosis regulation,cell cycle progression,cancer development,oncogenic process,tumor growth,therapeutic target
ENSG00000165757,JCAD,notch signaling,cell adhesion molecule,tumor progression,metastasis promoter,cell migration regulation,signaling pathway modulation
ENSG00000165959,CLMN,cellular adhesion,cellular proliferation,cellular survival,cell migration,pi3k/akt interaction,loss-of-function mutation
ENSG00000115459,ELMOD3,cell migration,pi3k/akt signaling,actin polymerization,oncogene function,rac1 gtpase interaction,tumor progression
ENSG00000166897,ELFN2,nuclear transport regulation,epithelial-to-mesenchymal transition,microrna regulation,apoptosis inhibition,cell cycle dysregulation,tumor progression
ENSG00000288318,PALM3,cell migration,cytoplasmic organization,metastasis promotion,microtubule stabilization,oncogenic driver,tumor progression
ENSG00000215252,GOLGA8B,golgi apparatus disruption,protein trafficking dysregulation,oncogenic signaling activation,cell proliferation enhancement,metastasis promotion,therapeutic target potential
ENSG00000116157,GPX7,redox regulation,oxidative stress reduction,cellular protection,antioxidant function,cancer-related interaction,signaling pathway modulation
ENSG00000212657,KRTAP16-1,cell adhesion disruption,aggressive tumor behavior,tumor progression,cancer aggressiveness,metastasis facilitation,epithelial cell interaction
ENSG00000170667,RASA4B,ras/mapk pathway regulation,tumor suppressor function,signaling pathway inhibition,cell proliferation control,oncogenic pathway activation,poor prognosis indicator
ENSG00000284965,OR2F2,genomic instability,signaling modulation,cancer-associated fragile sites,cell adhesion regulation,fragile site-related mutations,protein-protein interaction
ENSG00000130368,MAS1,amplification,oncogene,cell proliferation,cell survival,angiogenesis,transcription regulation
ENSG00000154678,PDE1C,regulation of cyclic nucleotides,hydrolysis of cgmp,interaction with pi3k/akt pathway,metabolic regulation,tumorigenesis,cellular signaling
ENSG00000188107,EYS,cell cycle regulation,ciliary function disruption,cell survival pathway modulation,tumor growth promotion,photoreceptor development involvement,genomic instability contribution
ENSG00000172824,CES4A,cell proliferation regulation,drug metabolism alteration,apoptosis modulation,inflammatory response regulation,therapeutic target candidate,genomic instability prevention
ENSG00000214595,EML6,transcription elongation,chromatin remodeling,oncogenic driver,protein-protein interactions,tumor progression,transcriptional regulation
ENSG00000238243,OR2W3,g-protein coupled receptor,oncogene activation,tumor progression,cell proliferation,signaling pathway interaction,genomic aberration
,PRSS42,extracellular matrix degradation,tumor progression,metastasis,serine protease activity,protease regulation,prognostic marker
126231,ZNF573,tumor suppressor function,chromatin remodeling,genomic instability,aneuploidy,dna repair regulation,epigenetic regulation
ENSG00000102043,MTMR8,regulation of pi(3)p,modulator of akt pathway,cell survival and growth,oncogenesis and tumorigenesis,phosphatase activity and regulation,loss-of-function mutations
ENSG00000189108,IL1RAPL2,protein-protein interaction,inflammation regulation,immune response modulation,tumor microenvironment modification,cancer progression facilitation,cell proliferation enhancement
ENSG00000254245,PCDHGA3,adhesion molecule,cellular signaling,metastasis promotion,cancer progression,tumor suppressor function loss,mutational hotspot
ENSG00000174948,GPR149,constitutive activation,tumor progression,cell signaling regulation,pi3k/akt pathway modulation,genetic mutations,therapeutic target
ENSG00000167065,DUSP18,mapk pathway modulation,cellular regulation,tumor suppressor function,oncogenic potential,phosphatase activity,cell survival regulation
ENSG00000156194,PPEF2,pp2a activation,cell cycle regulation,tumor progression,protein kinase inhibition,gene expression alterations,mitotic control
ENSG00000203867,RBM20,aberrant splicing,cellular homeostasis disruption,oncogenesis contribution,tumor progression promotion,alternative splicing regulation,cardiac muscle gene expression
ENSG00000167861,HID1,cellular regulation,tumor suppression,kinase modulation,senescence regulation,apoptosis induction,proliferation inhibition
ENSG00000198585,NUDT16,reactive oxygen species regulation,dna damage response,antioxidant activity,oncogenic process promotion,tumor progression enhancement,genomic integrity maintenance
ENSG00000213973,ZNF99,krab domain-containing,zinc finger protein,transcriptional regulation,tumor suppressor function,apoptosis induction,cell growth inhibition
ENSG00000263464,PPIAL4C,cellular regulation,oncogenic processes,ppai enzyme inhibition,pi3k/akt/mtor signaling pathway,tumorigenesis,cancer metabolism
ENSG00000137080,IFNA21,tumor microenvironment regulation,anti-tumor immunity modulation,angiogenesis inhibition,tumor suppressor function,immune response regulation,antiviral defense activation
ENSG00000174482,LINGO2,cell adhesion disruption,immune evasion,apoptosis inhibition,tumor progression,angiogenesis promotion,signaling pathway modulation
ENSG00000197479,PCDHB11,protocadherin function,cell-to-cell adhesion,wnt/β-catenin pathway interaction,neuronal development regulation,tumor microenvironment impact,oncogenic cell proliferation
ENSG00000250120,PCDHA10,adhesion molecule,transmembrane protein,cell-cell interaction,epithelial-to-mesenchymal transition (emt),loss of heterozygosity (loh),oncogenic driver gene
ENSG00000211679,IGLC3,antibody function,immunoglobulin interaction,antigen recognition,b cell activation,immune evasion,cancer immunology
ENSG00000253910,PCDHGB2,cadherin signaling,tumor aggressiveness,cell-cell adhesion,metastasis,poor prognosis,wnt/β-catenin pathway
ENSG00000254221,PCDHGB1,cell-cell adhesion disruption,epigenetic modification,signaling pathway activation,tumor progression,metastasis promotion,prognostic marker
ENSG00000248383,PCDHAC1,adhesive function,cell-cell adhesion,cell migration,tumor suppression,adherens junction regulation,invasion suppression
ENSG00000198077,CYP2A7,carcinogen metabolism,tumor initiation,xenobiotic biotransformation,oxidative stress regulation,detoxification mechanisms,genotoxicity prevention
ENSG00000186190,BPIFB3,oncogene,cell proliferation,angiogenesis regulation,pi3k/mapk pathway interaction,apoptosis resistance,genetic mutation hotspot
ENSG00000165246,NLGN4Y,neural adhesion molecules,tumor microenvironment modulation,synaptic plasticity regulation,immune response activation,cell growth suppression,gene fusion events
ENSG00000236334,PPIAL4G,protein stability modulation,cell cycle regulation disruption,apoptosis evasion,tumor suppressor downregulation,genetic instability induction,signaling pathway dysregulation
ENSG00000131398,KCNC3,constitutive activation,gain of function mutations,potassium channel modulation,cell proliferation regulation,apoptosis inhibition,therapeutic target
ENSG00000272674,PCDHB16,cellular adhesion,signaling pathway modulation,tumor progression,metastasis promotion,oncogene overexpression,synaptic transmission regulation
ENSG00000251664,PCDHA12,cadherin superfamily member,cell-cell adhesion dysfunction,tumor progression facilitation,epithelial-to-mesenchymal transition regulation,wnt/β-catenin pathway activation,oncogenic protein interaction
,IGLC2,b cell proliferation,somatic hypermutation,constitutive activation,genomic instability,cell survival enhancement,oncogenic signaling
ENSG00000187372,PCDHB13,cell-cell adhesion,tumor progression,gene expression regulation,neuronal development,cancer therapy target,protein-protein interaction
ENSG00000255408,PCDHA3,cell adhesion disruption,tumor invasion,metastasis promotion,signaling pathway modulation,oncomorphic mutations,tumor progression
ENSG00000162365,CYP4A22,fatty acid hydroxylation,inflammatory regulation,cell proliferation,apoptosis modulation,therapeutic target,metabolic regulation
ENSG00000239389,PCDHA13,tumor suppression,cell-cell adhesion,epithelial cell disruption,cancer initiation,gene deletion,metastasis promotion
ENSG00000204961,PCDHA9,cell adhesion disruption,tumor aggressiveness,wnt/pcp pathway interaction,biomarker potential,loss of cell polarity,neurological disorder association
ENSG00000160870,CYP3A7,xenobiotic metabolism,tissue specificity,dual-function regulation,pregnane x receptor activation,drug resistance modulation,constitutive androstane receptor interaction
ENSG00000186526,CYP4F8,cell proliferation,mutation associated overexpression,lipid metabolism regulation,endoplasmic reticulum localization,heme-dependent enzymatic activity,tumor microenvironment modulation
ENSG00000276547,PCDHGB5,cadherin superfamily member,cell-cell adhesion modulation,candidate tumor suppressor,tumor progression inhibition,oncogenic pathway regulation,glycosylation and anchoring function
ENSG00000253953,PCDHGB4,cell adhesion regulation,synaptic plasticity modulation,oncogene or tumor suppressor potential,tumor progression contribution,genomic instability influence,signaling pathway regulation
ENSG00000166173,LARP6,overexpression,oncogene,cell proliferation,pi3k/akt pathway,rna processing,gene regulation
ENSG00000284810,CTRB2,proteolytic regulation,cellular migration modulation,gastrointestinal system regulation,sequence similarity with trypsinogen genes,potential tumorigenesis link,limited oncogenic role in cancer
ENSG00000100012,SEC14L3,pi transfer protein,regulates pi4kiiα activity,impaired cell cycle regulation,increased proliferation,phosphoinositide metabolism,tumor progression
ENSG00000253485,PCDHGA5,cadherin superfamily interaction,cell-cell adhesion disruption,dysregulation in tumor progression,metastasis and invasion promotion,resistance to apoptosis,signaling pathway modulation
ENSG00000197838,CYP2A13,altered expression,metabolic reprogramming,xenobiotic metabolism,drug sensitivity,protein-protein interaction,cell proliferation regulation
ENSG00000105889,STEAP1B,iron transport regulation,upregulated expression,cellular signaling modulation,tumor growth promotion,poor prognosis indicator,cancer cell iron uptake enhancement
ENSG00000051128,HOMER3,pan-cancer driver,pi3k/akt pathway interaction,oncogenic signaling regulation,cell survival and proliferation enhancement,tumor progression facilitation,genomic instability promotion
ENSG00000262209,PCDHGB3,cell adhesion,tumor suppression,cell migration,metastasis,prognostic marker,cancer biomarker
ENSG00000214042,IFNA7,type i interferon signaling,apoptosis induction,immune response modulation,tumor growth inhibition,chronic inflammation,epigenetic regulation
ENSG00000243709,LEFTY1,tgf-β signaling pathway,constitutive activation,loss-of-function mutations,oncogenesis,cell proliferation,cell migration
ENSG00000124467,PSG8,antimicrobial peptide regulation,cell proliferation,tumor progression,diagnostic biomarker,therapeutic target,cellular defense mechanisms
ENSG00000071073,MGAT4A,glycoprotein modification,tumor progression,n-glycosylation pathway,oncogenic protein activation,cell adhesion disruption,therapeutic target
ENSG00000130751,NPAS1,circadian rhythm regulation,cell cycle modulation,transcriptional regulation,metabolic reprogramming,tumor suppressor dysfunction,genomic instability
ENSG00000095587,TLL2,tumor progression,oncogene overexpression,cell proliferation promotion,protease activity,oncogenic pathway regulation,cancer metastasis
ENSG00000163295,ALPI,alp regulation,phosphate metabolism regulation,cell survival and growth enhancement,epithelial tissue involvement,placental expression during embryonic development,enzymatic function in tumor progression
ENSG00000059691,GATB,cellular adhesion,focal adhesions regulation,cytoskeletal organization,cell migration facilitation,tumor suppressor function,genomic instability prevention
ENSG00000004809,SLC22A16,dna repair regulation,cellular homeostasis,genomic instability,transport mechanism alteration,oncogenic process contribution,tumor progression facilitation
ENSG00000113212,PCDHB7,cell migration,tumor progression,metastasis promotion,cell-cell adhesion disruption,protein-protein interaction,signaling pathway modulation
ENSG00000204970,PCDHA1,cellular response modulation,excitatory synaptic transmission regulation,signaling pathway interaction,oncogenic process contribution,tumor progression facilitation,genomic instability promotion
ENSG00000131409,LRRC4B,cell surface receptor,epithelial-to-mesenchymal transition,tumor progression marker,increased cell migration,cell adhesion regulation,oncogene expression
ENSG00000198131,ZNF544,tumor suppressor function,regulation of cell cycle,modulator of transcription factors,involvement in dna damage response,apoptosis promotion,cancer biomarker
ENSG00000186297,GABRA5,ion channel regulation,neurotransmitter signaling,synaptic transmission,tumor microenvironment interaction,gaba_a receptor assembly,neuronal excitability
ENSG00000174348,PODN,cell migration,podosome formation,cortactin interaction,tumor progression,extracellular matrix degradation,cell invasiveness
ENSG00000189184,PCDH18,cell-cell adhesion disruption,oncogenic potential,amplification in pan-cancer,widespread expression across cancer types,signaling pathway dysregulation,tumor progression
ENSG00000242419,PCDHGC4,tumor suppressor function,cell-cell adhesion disruption,epithelial-to-mesenchymal transition inhibition,metastasis suppression,pi3k/akt pathway modulation,wnt/β-catenin pathway regulation
ENSG00000100003,SEC14L2,genomic instability,pi3k signaling,oncogenic kinase activation,tumor progression,lipid metabolism alterations,apoptosis modulation
ENSG00000112852,PCDHB2,protocadherin function,cell-cell adhesion,tumor progression,epithelial-to-mesenchymal transition (emt),signal transduction pathway,adhesion property
ENSG00000111799,COL12A1,cell adhesion alterations,ecm regulation,collagen family member,tumor progression driver,metastasis suppression,prognostic marker
ENSG00000213512,GBP7,tumor progression,cell migration,immune evasion,oncogenic driver,guanylate-binding protein function,pi3k/akt pathway modulation
ENSG00000228278,ORM2,lipid regulation,oncogenic transformation,metabolic reprogramming,cell proliferation enhancement,phosphorylation signaling,signaling pathway modulation
ENSG00000185674,LYG2,tumor microenvironment modulation,immune evasion mechanism,oncogenesis promotion,cell survival enhancement,genetic alterations association,apoptosis regulation disruption
ENSG00000134249,ADAM30,cell adhesion disruption,invasion promotion,metastasis facilitation,angiogenesis modulation,proteolytic processing,biomarker potential
ENSG00000015413,DPEP1,glutamine metabolism,oncogenic driver,metabolic regulation,protein-protein interaction,post-translational modification,cell signaling pathway
ENSG00000139200,PIANP,genomic instability,mitotic spindle assembly,cell cycle regulation,chromosome segregation,tumor suppressor function,oncogenic transformation
ENSG00000141096,DPEP3,dipeptide transport regulation,cell proliferation enhancement,tumor metastasis promotion,oncogene activation,signaling pathway modulation,prognostic marker alteration
ENSG00000113211,PCDHB6,dysregulated expression,transmembrane protein,cell-cell adhesion modulation,oncogenic driver,tumor progression facilitation,epithelial-to-mesenchymal transition regulation
ENSG00000138650,PCDH10,cell adhesion disruption,neuronal differentiation inhibition,tumor suppression activity,epithelial-to-mesenchymal transition,apoptosis promotion,glioblastoma progression
ENSG00000118946,PCDH17,loss of adhesion,cell migration,tumor progression,oncogenesis,epigenetic regulation,metastasis
ENSG00000167740,CYB5D2,electron transfer reactions,redox balance modulation,tumor suppressor function,oxidative stress response,cellular metabolic regulation,protein-protein interaction network
ENSG00000158467,AHCYL2,adp-ribosylation,nad+ regulation,oncogenic processes,tumor progression,dna repair mechanisms,cell signaling pathways
ENSG00000074935,TUBE1,microtubule stability,genomic instability,mitotic checkpoint regulation,cancer driver gene,cell proliferation,genomic profiling
ENSG00000165105,RASEF,gef activity,rac1 activation,cell migration,tumor progression,therapeutic target,signaling pathway modulation
ENSG00000221968,FADS3,lipid metabolism,oncogene potential,tumor microenvironment modulation,cell growth regulation,unsaturated fatty acid production,phosphatidylinositol 3-kinase (pi3k) signaling pathway
ENSG00000136478,TEX2,rna splicing dysfunction,spliceosome regulation,tumor aggressiveness,genomic instability,cell proliferation enhancement,rna processing aberration
ENSG00000170373,CST1,cancer metastasis,cathepsin s activation,extracellular matrix degradation,antigen presentation,tumor progression,protein processing
ENSG00000101441,CST4,cell survival,protein folding regulation,endoplasmic reticulum chaperone,unfolded protein response,genetic mutations,oncogenic potential
ENSG00000057704,TMCC3,chromatin remodeling,transcriptional regulation,cellular growth,apoptosis regulation,protein-protein interaction,genomic instability
ENSG00000179104,TMTC2,cell surface receptor interactions,epithelial-to-mesenchymal transition,cell adhesion and migration,tumor aggressiveness and metastasis,poor prognosis marker,overexpression associated with tumor progression
ENSG00000166450,PRTG,tumor suppressor function,cell cycle regulation,dna damage response,apoptosis modulation,genomic instability,protein phosphatase activity
ENSG00000113555,PCDH12,cadherin superfamily member,cell-cell adhesion regulation,epithelial-to-mesenchymal transition (emt),metastasis promotion,calcium signaling modulation,signal transduction pathway involvement
ENSG00000198538,ZNF28,transcriptional regulation,oncogene activation,cell growth modulation,tumorigenesis promotion,metastasis facilitation,prognostic marker
ENSG00000253537,PCDHGA7,cadherin signaling,cell-cell adhesion disruption,metastasis promotion,tumor progression,oncogene/tumor suppressor roles,adhesive protein interaction
ENSG00000168515,SCGB1D1,tumor progression,epithelial expression,cell adhesion regulation,metastasis promoter,inflammatory response modulation,biomarker function
ENSG00000162877,PM20D1,protein degradation pathways,tumor progression,cell proliferation regulation,ubiquitin-proteasome system interaction,androgen receptor target gene,apoptosis regulation
ENSG00000167904,TMEM68,cancer driver,cell signaling regulation,cell proliferation,calcium homeostasis regulation,tumorigenesis promotion,chemotherapy resistance
ENSG00000103742,IGDCC4,innate immune response modulation,autophagy regulation,immune surveillance evasion,therapeutic target or biomarker potential,cellular signaling pathway modulation,interferon-stimulated genes activity
ENSG00000165023,DIRAS2,ras family gtpase,cell proliferation regulation,tumor suppressor/ oncogene,metabolic regulation,protein-protein interaction,glycolysis modulation
ENSG00000185909,KLHDC8B,chromatin regulation,epigenetic silencing,genome instability,oncogenic processes,tumor suppressor function,cell proliferation control
ENSG00000177047,IFNW1,tumor progression,cellular signaling,apoptosis modulation,proliferation regulation,immune response regulation,metastasis promotion
ENSG00000134533,RERG,ras/mapk signaling,tumor suppressor function,negative regulator,oncogenic transformation,cell proliferation inhibition,genomic downregulation
ENSG00000127418,FGFRL1,decoy receptor function,fibroblast growth factor inhibition,cell proliferation regulation,angiogenesis modulation,oncogenic potential,tumor suppressor loss
ENSG00000156150,ALX3,wnt/β-catenin signaling activation,cell proliferation regulation,tumor progression enhancement,oncogenic protein interaction,metastatic potential increase,transcriptional modulation
ENSG00000139330,KERA,tumor suppressor function,cell adhesion regulation,extracellular matrix modulation,oncogenic potential,metastatic facilitation,tissue organization maintenance
ENSG00000274349,ZNF658,transcription factor regulation,signaling pathway modulation,cell cycle control,chromatin remodeling,tumor suppressor gene suppression,therapeutic target
ENSG00000178163,ZNF518B,transcriptional regulation,cell cycle regulation,oncogene overexpression,tumor suppressor interaction,apoptosis resistance,genomic instability
ENSG00000175697,GPR156,g protein coupled receptor,cell migration,cell proliferation,protein-protein interactions,cell survival regulation,signaling pathway modulation
ENSG00000221890,NPTXR,calcium signaling disruption,oncogenic processes,cell proliferation enhancement,tumor growth promotion,therapeutic target,signal transduction modulation
ENSG00000159618,ADGRG5,cell-cell interaction disruption,tumor progression,epithelial-to-mesenchymal transition,increased cell proliferation,signaling pathway modulation,oncogenesis
ENSG00000172878,METAP1D,methionine metabolism,cellular proliferation,dna synthesis,apoptosis regulation,oncogenic mutations,tumor progression
ENSG00000136169,SETDB2,histone methylation,oncogenic function,epigenetic regulation,heterochromatin formation,tumor suppressor silencing,genomic instability
ENSG00000174326,SLC16A11,glut3 expression,tumor-promoting function,glycolytic reprogramming,prognostic biomarker,lactate production,glucose metabolism
ENSG00000062370,ZNF112,transcription regulation,oncogene/tumor suppressor function,gene expression changes,subcellular localization,protein-protein interactions,cell growth modulation
ENSG00000197363,ZNF517,krab domain repressor,transcriptional regulation,apoptosis modulation,cell cycle control,protein-protein interaction,zinc finger dna-binding
ENSG00000198759,EGFL6,metastasis-promoting factor,angiogenesis regulator,epithelial-to-mesenchymal transition,cell invasion facilitator,adhesion molecule regulator,tumor aggressiveness enhancer
ENSG00000278216,UGT2A3,altered expression,drug resistance,detoxification process,metabolic regulation,enzyme overexpression,tumorigenesis
ENSG00000173227,SYT12,vesicle fusion,cellular stress response,constitutive activation,apoptosis regulation,tumor progression,genomic instability
ENSG00000173391,OLR1,g protein-coupled receptor function,tumor progression,metastasis promotion,prognostic marker,therapeutic target,cellular signaling modulation
ENSG00000160161,CILP2,cancer-promoting effects,oncogenic properties,cell proliferation regulation,tumor growth enhancement,prognostic biomarker candidate,signaling pathway modulation
ENSG00000166535,A2ML1,tumor progression,cellular regulation,protease inhibition,cell migration,immune evasion,cell survival
ENSG00000122254,HS3ST2,heparan sulfate modification,cell proliferation enhancement,angiogenesis promotion,prognostic marker,tumor progression facilitation,growth factor signaling activation
ENSG00000149742,SLC22A9,transport of organic cations,tumor progression,upregulated expression,potential therapeutic target,metastasis contribution,chemotherapeutic agent transport
ENSG00000164451,CALHM4,calcium-dependent signaling pathway,plasma membrane expression,cell proliferation enhancement,synaptic transmission modulation,oncogenic processes involvement,epithelial cell expression
ENSG00000170044,ZPLD1,chromatin remodeling,oncogenic transformation,dna repair mechanisms,histone modification,transcriptional regulation,apoptosis inhibition
ENSG00000140511,HAPLN3,extracellular matrix regulation,cell adhesion modulation,protein-protein interaction,glycosaminoglycan regulation,cell migration facilitation,tumorigenesis association
ENSG00000168903,BTNL3,immune modulation,tumor immunity,antigen presentation,t-cell activation,cytokine regulation,transmembrane protein
ENSG00000149218,ENDOD1,tumor suppression,transcriptional regulation,embryonic development,differentiation pathway,cellular proliferation,protein interaction
ENSG00000100416,TRMU,mitochondrial trna modification,glycolytic shift,warburg effect,chemoresistance,tissue-specific expression,oxidative stress regulation
ENSG00000167992,VWCE,e3 ubiquitin ligase activity,protein degradation regulation,cell cycle progression,overexpression in cancers,tumorigenesis promotion,ubiquitination pathway interaction
ENSG00000075429,CACNG5,calcium channel regulation,neurotransmitter release modulation,cell signaling dysregulation,tumor progression involvement,genomic instability association,oncogenic process contribution
ENSG00000110900,TSPAN11,pi3k/akt pathway,tumor progression,emt induction,cancer metastasis,cell adhesion regulation,prognostic marker
ENSG00000120519,SLC10A7,bile salt transport,tumor suppressor function,cell membrane transport,oncogenic regulation,genomic instability,therapeutic target
ENSG00000205359,SLCO6A1,chemotherapy resistance,overexpression,cell growth regulation,tumor metastasis,bile acid transport,endogenous compound recognition
ENSG00000145863,GABRA6,gaba_a receptor complex regulation,cellular signaling modulation,inhibitory neurotransmission,apoptosis regulation,tumor metastasis promotion,epithelial-to-mesenchymal transition
ENSG00000185664,PMEL,melanocyte differentiation,transmembrane glycoprotein,melanosome biogenesis,mitf regulation,oncogenic transformation,therapeutic target
ENSG00000122711,SPINK4,wnt/beta-catenin pathway,oncogenic potential,apoptosis inhibition,angiogenesis promotion,tumor progression,biomarker candidate
ENSG00000164411,GJB7,cell-cell communication,gap junction formation,tumor suppression hypothesis,proliferation enhancement,apoptosis modulation,signaling molecule exchange
ENSG00000119004,CYP20A1,cytochrome p450 activity,steroid hydroxylation,cell proliferation,oncogenic potential,metabolic regulation,protein interaction
ENSG00000180432,CYP8B1,cellular signaling,enzymatic activity,metabolic regulation,tumor growth promotion,oncogenic process modulation,lipid metabolism interaction
ENSG00000163626,COX18,mitochondrial function impairment,oncogenic potential,apoptosis evasion,cellular stress response activation,tumor suppressor/pro-oncogene activity,electron transport chain disruption
ENSG00000197020,ZNF100,transcriptional regulation,apoptosis modulation,dna repair pathway,cell proliferation control,chromatin remodeling,ubiquitin-proteasome interaction
ENSG00000065308,TRAM2,protein targeting,transmembrane trafficking,er membrane localization,oncogenic processes,cellular growth regulation,metabolic reprogramming
ENSG00000112337,SLC17A2,glutamate release,synaptic vesicle function,neurotransmitter transport,tumor progression,angiogenesis,metastasis
ENSG00000157693,TMEM268,altered expression levels,cell adhesion modulation,cell migration regulation,cellular differentiation influence,plasma membrane localization,prognostic marker
ENSG00000117151,CTBS,cellular proliferation,genetic alterations,tumor progression,dysregulated interaction,signaling pathway modulation,oncogenesis
ENSG00000139540,SLC39A5,iron regulation,cellular proliferation,metal ion transport,apoptosis evasion,oxidative stress,cell cycle progression
ENSG00000167280,ENGASE,epithelial sodium channel assembly,gamma subunit function,phosphorylation regulation,sodium ion transport,protein kinase c interaction,hypertension pathogenesis
ENSG00000172828,CES3,nuclear receptor regulation,metabolic regulator,detoxification enzyme,xenobiotic metabolism,oncogenic process,tumor suppressor interaction
ENSG00000095713,CRTAC1,cell cycle regulation,chromatin remodeling,histone modification,rna polymerase ii transcription,transcriptional regulation,protein complex formation
ENSG00000148482,SLC39A12,zinc transport,tumor progression,overexpression,prognostic marker,therapeutic target,regulation of cellular homeostasis
ENSG00000134193,REG4,wnt/β-catenin pathway regulation,cell proliferation promotion,angiogenesis stimulation,tumor metastasis enhancement,pancreatic cancer association,colorectal cancer involvement
ENSG00000124785,NRN1,cellular regulation,neurodevelopmental factor,tgf-β pathway interaction,cancer therapeutic target,genetic regulation,proliferation modulation
ENSG00000164520,RAET1E,type i interferon signaling,cell survival,oncogenic driver,immune evasion,tumor progression,protein-protein interaction
ENSG00000103260,METRN,genomic instability,cell cycle regulation,spindle assembly checkpoint,mitotic progression,chromosomal stability,microtubule stabilization
ENSG00000198797,BRINP2,chromatin remodeling,oncogene function,transcriptional regulation,wnt/β-catenin signaling,histone modification,epigenetic regulation
ENSG00000162670,BRINP3,oncogenic transcriptional regulation,transcriptional coactivator function,tumor progression promotion,resistance to therapy,cell proliferation enhancement,apoptosis inhibition
ENSG00000182986,ZNF320,tumor suppressor function loss,cell cycle dysregulation,dna binding activity,chromatin remodeling regulation,apoptosis inhibition,genomic instability
ENSG00000232143,GNL1,cell proliferation,apoptosis regulation,metabolic regulation,protein-protein interactions,overexpression,cell survival
ENSG00000186777,ZNF732,oncogenic transformation,tumor suppressor regulation,chromatin remodeling,transcriptional repression,apoptosis resistance,protein-dna interaction
ENSG00000165953,SERPINA12,proteolytic regulation,tumor microenvironment modulation,angiogenesis inhibition,immune response suppression,cell proliferation enhancement,metastasis promotion
ENSG00000162687,KCNT2,channel subunit regulation,tumor progression,dysregulation,transcriptional activity,cell cycle regulation,mitochondrial localization
ENSG00000162086,ZNF75A,transcriptional regulation,cell cycle progression,apologetic function,chromatin remodeling,cancer biomarker,oncogenic transformation
ENSG00000162944,RFTN2,apoptosis regulation,calcium signaling,er membrane dynamics,microtubule organization,cell survival pathway,tumor progression
ENSG00000186803,IFNA10,apoptosis induction,tumor progression,antitumor activity,jak-stat signaling,interferon receptor activation,angiogenesis inhibition
ENSG00000185873,TMPRSS11B,cell growth promotion,angiogenesis facilitation,tumor progression driver,proteolytic activity regulation,cancer cell migration enhancer,egfr/fgfr2 interaction partner
ENSG00000183196,CHST6,epigenetic regulation,chondroitin sulfate modification,tumor progression,cell adhesion,protein-protein interaction,gene expression modulation
ENSG00000243232,PCDHAC2,tumor suppressor,cell adhesion molecule,cell-cell interactions regulation,wnt/β-catenin pathway modulation,epithelial cell surface expression,tissue-specific function
ENSG00000162496,DHRS3,biomarker potential,cell differentiation regulation,cell survival modulation,enzymatic activity,gene expression alteration,pi3k/akt pathway involvement
ENSG00000178502,KLHL11,cancer driver,cell cycle regulation,tumor suppressor function,cell division regulation,ubiquitination pathway modulation,dna repair mechanism
ENSG00000145103,ILDR1,immune recognition,innate immunity dysregulation,tumor suppressor function,aberrant immune responses,pathogen internalization,cellular protection
ENSG00000253767,PCDHGA8,tumor suppressor function,cell-cell adhesion regulation,neural system expression,apoptosis regulation,proliferation control,metastasis facilitation
ENSG00000180423,HARBI1,cellular regulation,oncogenic function,rna-binding protein,genomic instability,chromatin remodeling,pi3k/akt pathway interaction
ENSG00000133069,TMCC2,cellular transformation,gtpase regulation,small gtpases,tumor progression,cell proliferation,metastasis
ENSG00000183979,NPB,pro-tumorigenic microenvironment,angiogenesis promotion,pi3k/akt pathway interaction,vasodilation and natriuresis regulation,cell survival and proliferation enhancement,poor prognosis biomarker
ENSG00000160233,LRRC3,cell migration,cell proliferation,tumor progression,poor prognosis,overexpression,oncogenic pathway
ENSG00000146453,PNLDC1,protein degradation regulation,aberrant expression,tumor progression,cellular stress response,apoptosis regulation,cancer resistance
ENSG00000186452,TMPRSS12,mapk/erk signaling,tumor progression,cell proliferation,oncogenic pathways,serine protease activity,growth factor activation
,IGHA2,tumor microenvironment regulation,immune evasion,antibody production,cell proliferation,metastasis promotion,oncogene interaction
ENSG00000197745,SCGB1D4,tumor microenvironment modification,metastasis regulation,immune response modulation,cell growth regulation,biomarker potential,therapeutic target candidate
ENSG00000141337,ARSG,genomic instability,cell proliferation,dna repair mechanism,cancer driver mutation,tumor suppressor function,cell cycle regulation
ENSG00000182612,TSPAN10,emt regulator,cell adhesion modulation,signaling pathway interaction,tumor progression facilitator,metastasis promoter,gene expression regulation
ENSG00000170382,LRRN2,wnt/β-catenin pathway regulation,cytoskeleton dynamics regulation,cell proliferation enhancement,oncogenic effects promotion,protein-protein interaction facilitation,ubiquitin ligase complex formation
ENSG00000101203,COL20A1,type ii transmembrane collagen,cell adhesion regulation,metastasis promotion,oncogene potential,therapeutic target,epithelial-to-mesenchymal transition
ENSG00000283934,IGSF6,cell adhesion modulation,oncogenic signaling,tumor progression,glycoprotein function,protein-protein interaction,metastasis promotion
ENSG00000162951,LRRTM1,cell adhesion regulation,axon guidance protein,oncogenic driver,cell migration enhancer,tumor progression factor,wnt/β-catenin pathway modulator
ENSG00000133597,ADCK2,mitochondrial function regulation,oncogene activation,cell signaling pathway modulation,cancer progression promotion,cellular energy production regulation,ros accumulation
ENSG00000171462,DLK2,dlk2 expression,oncogene activation,phospholipid metabolism,cell differentiation suppression,protein kinase regulation,cell survival promotion
ENSG00000203697,CAPN8,emt process,proteolytic activity,cell migration,apoptosis regulation,cancer aggressiveness,substrate cleavage
ENSG00000150967,ABCB9,multidrug resistance,apoptosis evasion,cell cycle regulation,cancer chemoresistance,protein transport function,tumor suppression impairment
ENSG00000166118,SPATA19,mitochondrial dynamics regulation,oncogenic function,tumor suppressor loss,cell survival enhancement,proliferation promotion,genomic instability induction
ENSG00000126010,GRPR,bombesin-like peptide activation,cell proliferation,g-protein coupled receptor function,invasion and metastasis,oncogene overexpression,therapeutic target
ENSG00000137507,LRRC32,cell adhesion,epithelial-to-mesenchymal transition,tumor progression,metastasis promotion,cancer aggressiveness,cytoplasmic structure modification
ENSG00000169955,ZNF747,p53 regulation,antitumor activity,apoptosis induction,cytosine methylation regulation,dna binding domain,tumor suppression
ENSG00000151033,LYZL2,tumor promotion,cell adhesion disruption,gene expression regulation,metastasis facilitation,cell migration enhancement,signaling pathway interaction
ENSG00000115084,SLC35F5,glycosylation regulation,nucleotide sugar transporter,cell signaling modulation,tumor microenvironment interaction,molecular chaperone function,genetic association studies
ENSG00000146411,SLC2A12,cellular metabolism,aerobic glycolysis,tumor progression,glucose uptake,plasma membrane localization,hypoxic adaptation
ENSG00000135407,AVIL,tumor growth,metastasis promotion,cell migration regulation,epithelial tumor origin,biomarker candidate,tissue adhesion disruption
ENSG00000253159,PCDHGA12,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,oncogenic potential,tumor suppressor function,loss-of-function mutations,metastasis facilitation
ENSG00000137968,SLC44A5,cellular proliferation,phospholipid metabolism,pi3k/akt pathway modulation,tumor growth promotion,apoptosis suppression,lipid trafficking regulation
ENSG00000135697,BCO1,acidic ph regulation,cellular metabolism,tumor progression,prognostic marker,genetic upregulation,metabolic reprogramming
,C12orf49,mitotic spindle assembly,tumor suppressor function,genomic stability maintenance,chromosomal segregation regulation,cell division checkpoint regulation,prognostic marker
ENSG00000157214,STEAP2,iron homeostasis regulation,oxidative stress induction,genetic instability driver,prognostic biomarker,therapeutic target,iron transport protein
,KIAA1324L,genomic instability,cell proliferation,oncogene,mitotic spindle formation,chromosome segregation,microtubule dynamics
ENSG00000077713,SLC25A43,metabolic reprogramming,tumor growth promotion,mitochondrial biogenesis,energy production alteration,ancient gene mutation,ancillary protein function
ENSG00000050165,DKK3,wnt signaling pathway,dual role in cancer,tumor suppressor function,oncogene activation,cell growth regulation,biomarker potential
ENSG00000137869,CYP19A1,estrogen biosynthesis,aromatase overexpression,tumor growth promotion,hormone-dependent tumor,therapeutic target,gene amplification
ENSG00000204524,ZNF805,chromatin remodeling,transcriptional regulation,zinc finger protein,cellular proliferation,genetic alterations,epigenetic modifications
ENSG00000197408,CYP2B6,drug metabolism,carcinogen activation,tumor microenvironment,oncogenic potential,therapeutic resistance,signal transduction
ENSG00000164484,TMEM200A,genomic instability,tumor suppressor function,cellular interaction,oncogenic mutations,therapeutic target,metastatic progression
ENSG00000164855,TMEM184A,membrane trafficking regulation,oncogenic processes,tumor progression,pi3k/akt pathway interaction,cell proliferation enhancement,therapeutic target
ENSG00000016402,IL20RA,il-22 signaling pathway,tumor-promoting effects,cell proliferation regulation,angiogenesis induction,immune evasion mechanism,genetic predisposition
ENSG00000184254,ALDH1A3,epithelial-to-mesenchymal transition,redox regulation,therapeutic target,tumor progression,metastasis resistance,cellular differentiation
ENSG00000177932,ZNF354C,transcriptional regulation,oncogene activation,cell proliferation promotion,apoptosis inhibition,epigenetic modulation,cell cycle progression regulation
ENSG00000121417,ZNF211,chromatin remodeling,dna binding,transcriptional regulation,tumor progression,cell proliferation,gene expression modulation
ENSG00000160097,FNDC5,genomic instability,cell proliferation,therapeutic target,tumor progression,signaling pathway regulation,protein interaction
ENSG00000155970,MICU3,mitochondrial regulation,calcium transport regulation,oncogenic mutations,tumor progression promotion,cellular proliferation enhancement,protein interaction modulation
ENSG00000174951,FUT1,fucosylation,oncogenic cooperation,tumor progression,metastasis facilitation,extracellular matrix interaction,biomarker potential
ENSG00000186026,ZNF284,apoptosis regulation,cell differentiation,dna binding activity,genomic stability,gene expression modulation,oncogenic potential
ENSG00000091490,SEL1L3,erad pathway,oncogenic driver,protein degradation regulation,cell growth modulation,apoptosis regulation,ubiquitination control
ENSG00000184599,TAFA3,transcriptional regulation,nuclear protein,rna polymerase ii interaction,chromatin modification,gene expression modulation,cellular stress response
ENSG00000157315,TMED6,er protein quality control,oncogene function,growth factor regulation,protein trafficking,apoptosis evasion,angiogenesis promotion
ENSG00000180257,ZNF816,cell growth regulation,transcriptional suppression,krab domain-containing protein,oncogene activation,tumor progression driver,cell proliferation pathway
ENSG00000174514,MFSD4A,lipid transport,overexpression,cellular metabolism,lysosomal function,autophagy regulation,cancer biomarker
ENSG00000106328,FSCN3,oncogene,cellular migration,actin-bundling protein,genomic amplification,tumor progression,cancer prognosis
ENSG00000149050,ZNF214,krab domain containing,tumor suppressor function,apoptosis induction,cell cycle regulation,dna repair modulation,gene expression regulation
ENSG00000139985,ADAM21,notch signaling pathway,cell-to-cell interactions,metastasis promotion,tumor progression,angiogenesis regulation,protein-protein interaction
ENSG00000166509,CLEC3A,carbohydrate binding,tumor progression,immune modulation,cell adhesion,phagocytosis regulation,prognostic marker
ENSG00000189050,RNFT1,regulation of transcription,cellular responses modulation,mrna processing and transport,nuclear rna-binding protein function,oncogenic pathway modulation,tumour suppressor activity
ENSG00000187037,GPR141,cell proliferation,oncogenesis,protein interaction,signaling pathway regulation,tumor progression,g protein-coupled receptor
ENSG00000105852,PON3,lipid peroxidation,cell proliferation,detoxification pathway,oxidative stress regulation,tumor progression,therapeutic target
ENSG00000165194,PCDH19,oncogenic potential,overexpression,cell-cell adhesion,synaptic plasticity,epithelial-to-mesenchymal transition (emt),neurological disorders
ENSG00000124574,ABCC10,multidrug resistance,transporter activity,cellular efflux,chemotherapy resistance,tumor progression,abc transporter function
ENSG00000174842,GLMN,pi3k/akt signaling,constitutive activation,oncogenic driver,glucose metabolism regulation,cell proliferation enhancement,tumor growth promotion
ENSG00000218336,TENM3,tumor progression,oncogene activation,cell adhesion disruption,signaling pathway regulation,angiogenesis promotion,mutation association
ENSG00000198346,ZNF813,tumor suppressor function,transcriptional regulation,zinc finger motifs,dna binding,cell cycle control,apoptosis regulation
ENSG00000213096,ZNF254,tumor suppressor,cell cycle regulation,apoptosis modulation,dna repair mechanism,proliferation enhancement,genomic instability
ENSG00000165475,CRYL1,cellular regulation,dna repair,cell cycle modulation,oncogenic mutations,tumor suppressor,protein-protein interaction
ENSG00000162078,ZG16B,apoptosis regulation,cancer development,cellular interaction,gene expression regulation,oncogene/tumor suppressor,transcriptional modulation
ENSG00000183569,SERHL2,spliceosome function,alternative splicing regulation,gene expression modulation,oncogenic processes driver,cellular stress response modification,pi3k/akt pathway interaction
ENSG00000135953,MFSD9,iron regulation,oncogene function,cell proliferation,tumor progression,therapeutic target,genomic amplification
ENSG00000175928,LRRN1,cellular response modulation,oncogene activation,apoptosis regulation,mitotic progression regulation,p53 interaction,dna damage response modulation
ENSG00000172687,ZNF738,transcriptional regulation,tumor aggressiveness,dna repair modulation,cell cycle progression,epigenetic modification,genome instability
ENSG00000144045,DQX1,mirna processing,oncogenic mirna pathways,cell proliferation,apoptosis regulation,genome stability maintenance,cancer driver gene
ENSG00000120563,LYZL1,protein maturation,chromatin modification,dna damage repair,cell cycle regulation,tumor suppression,apoptosis regulation
ENSG00000125900,SIRPD,immune response modulation,tumor microenvironment suppression,cell adhesion and migration regulation,signaling pathway interaction,therapeutic target identification,genomic profiling for biomarkers
ENSG00000182489,XKRX,genomic stability,proliferation regulation,dna repair mechanisms,cell cycle control,tumor suppressor,oncogenic mutation
ENSG00000005189,REXO5,genomic instability,tumor suppressor function,rna metabolism regulation,exoribonuclease activity,cell cycle progression,aberrant rna degradation
ENSG00000146066,HIGD2A,mitochondrial respiration,oncogenic driver,regulatory dysfunction,energy metabolism,reactive oxygen species,cell survival signaling
ENSG00000174109,C16orf91,ubiquitin ligase activity,genomic instability,cell cycle regulation,tumor suppressor dysfunction,protein degradation pathway,oncogenic mutations
ENSG00000273111,LYPD4,tumor-promoting,immune evasion,cell adhesion modulation,metastatic potential,apoptosis resistance,prognostic marker
ENSG00000172940,SLC22A13,transport regulation,cell proliferation,resistance to treatment,drug interaction,organic anion transport,tumorigenesis
ENSG00000169758,TMEM266,cell signaling dysregulation,overexpressed tumor suppressor,cell growth enhancement,apoptosis resistance,tumor progression facilitation,genetic amplification
ENSG00000113108,APBB3,wnt/β-catenin signaling pathway,cellular adaptation,phosphorylation regulation,substrate for gsk-3β,oncogenic pathway activation,tumor progression
ENSG00000107362,ABHD17B,cell membrane remodeling,lipid metabolism regulation,oncogenic signaling modulation,protein-protein interaction,cancer cell membrane fluidity modification,tumor suppressor function
ENSG00000237814,SFTA2,cellular compartmentalization,extracellular matrix assembly,cell signaling disruption,tumor microenvironment manipulation,oncoprotein interaction,gene expression regulation
ENSG00000157837,SPPL3,cell signaling disruption,apoptosis resistance,multifunctional protein,tumor progression driver,therapeutic target candidate,protein trafficking regulation
ENSG00000275031,METRNL,alternative splicing regulation,cellular response to stress,gene expression regulation,rna processing and export,spliceosome complex component,unconventional rna binding
ENSG00000136237,RAPGEF5,rap gtpase activation,guanine nucleotide exchange factor,cell migration regulation,cancer progression,prognostic marker,cytoskeleton organization
ENSG00000105088,OLFM2,cell adhesion,cancer progression,signaling pathway modulation,tumor growth promotion,oncogene overexpression,biomarker candidate
ENSG00000166575,TMEM135,cellular stress responses,endoplasmic reticulum stress regulation,autophagy modulation,tumor suppressor function,loss-of-function mutations,oncogenesis promotion
ENSG00000182534,MXRA7,gain of myc-driven transcriptional activity,regulation of cell cycle and differentiation,loss of function leading to oncogenesis,frequent mutation or deletion in tumors,impaired mxd1/max complex formation,tumor progression
ENSG00000119686,FLVCR2,tumor suppressor,cell cycle regulation,iron homeostasis regulation,heme biosynthesis regulation,protein-protein interaction,transcriptional regulation
ENSG00000188467,SLC24A5,transmembrane protein,cell signaling pathway,cell membrane transport,gene expression regulation,cellular growth regulation,protein-protein interaction
ENSG00000158516,CPA2,cancer-promoting mutations,cell proliferation,oncogene activity,tumor growth regulation,peptide hormone regulation,enzymatic activity
ENSG00000163959,SLC51A,regulation of bile acid transport,cellular metabolism regulation,tumor progression modulation,protein-protein interaction,biomarker for treatment outcome,metabolic reprogramming
ENSG00000128040,SPINK2,apoptosis regulation,cell proliferation,inflammatory response,oncogenesis,overexpression,therapeutic target
ENSG00000083454,P2RX5,atp-mediated signaling,purinergic receptor activation,tumor progression,cell proliferation regulation,dysregulation in cancer,oncogenic potential
ENSG00000205669,ACOT6,tumor progression,gain of function mutations,oncogenic processes,cell growth regulation,metabolic regulation,protein modification
ENSG00000180479,ZNF571,transcriptional regulation,oncogenic activity,chromatin remodeling,gene expression modulation,cell growth promotion,protein-dna interaction
ENSG00000173875,ZNF791,tumor suppressor function,chromatin remodeling,transcriptional regulation,cell cycle regulation,apoptosis inhibition,genomic instability
ENSG00000159905,ZNF221,wnt/β-catenin signaling,transcriptional regulation,chromatin remodeling,genomic instability,dna repair mechanisms,cellular proliferation
ENSG00000256294,ZNF225,transcriptional repressor,zinc finger domain,dna recognition,histone modification complex,cell proliferation regulation,tumor suppressor gene regulation
ENSG00000163328,GPR155,transmembrane receptor,signaling pathway activation,cell proliferation regulation,tumor growth promotion,therapeutic target identification,metastasis regulation
ENSG00000173950,XXYLT1,glycosylation regulation,cell adhesion disruption,tissue integrity loss,aberrant enzyme activity,cancer microenvironment modulation,protein modification alteration
ENSG00000124935,SCGB1D2,tumor progression,oncogenic function,cell proliferation,metastasis,cancer cell survival,genomic instability
ENSG00000235589,ZNF311,krab domain-containing zinc finger protein,transcriptional regulation,genomic instability,apoptosis evasion,cell proliferation enhancement,tumor suppressor dysfunction
ENSG00000145451,GLRA3,ion channel regulation,neurotransmission modulation,epilepsy-related mutation,tumor suppressor potential,cell growth inhibition,neuronal development role
ENSG00000141449,GREB1L,nuclear localization,cell proliferation regulation,dna repair interaction,oncogenic process involvement,genome instability promotion,cancer-related mutation
ENSG00000144043,TEX261,centriole regulation,cilia formation,polo-like kinase 4 interaction,gtpase activity regulation,centrosomal abnormalities,cellular transformation
ENSG00000172817,CYP7B1,cholesterol metabolism,dysregulation of bile acid production,lipid digestion and absorption,tissue-specific expression,transcriptional regulation,protein-lipid interactions
ENSG00000151948,GLT1D1,apoptosis regulation,cell cycle progression,dna repair mechanisms,gt-nh2 domain-containing protein,oncogene function,transcriptional regulation
ENSG00000104499,GML,microtubule dynamics,mitotic spindle assembly,chromosomal segregation,centrosome duplication,cytokinesis regulation,genomic instability
ENSG00000269743,SLC25A53,mitochondrial transport,tumor suppressor function,metabolic reprogramming,apoptosis regulation,genomic instability,therapeutic target
ENSG00000139433,GLTP,glutathione conjugation,antioxidant defense,cellular detoxification,tumor growth promotion,chemoresistance,oxidative stress regulation
ENSG00000172986,GXYLT2,glycoprotein biosynthesis,n-glycosylation pathway,oncogenic processes,tumor growth promotion,immune evasion mechanisms,therapeutic target
ENSG00000151233,GXYLT1,glycosaminoglycan biosynthesis,cellular differentiation,apoptosis modulation,cell proliferation regulation,proteoglycan modification,signaling pathway involvement
ENSG00000099998,GGT5,golgi apparatus integrity,cell proliferation regulation,metabolic regulation,oncogenic processes promotion,cell survival enhancement,pi3k/akt pathway interaction
ENSG00000124490,CRISP2,apoptosis regulation,cell death modulation,cancer-associated protein,tumor progression factor,oncogenic transformation promoter,secreted protein family member
ENSG00000099999,RNF215,e3 ubiquitin ligase activity,cell cycle regulation,dna repair mechanism,oncogenic process,tumor progression marker,protein stability modulation
ENSG00000158156,XKR8,tetratricopeptide repeat domains,cell cycle progression,protein-protein interactions,oncogene potential,dna repair pathways,cell proliferation
ENSG00000115649,CNPPD1,hypoxia adaptation,acid-base regulation,tumor microenvironment modification,oncogenic transformation,cell migration promotion,metastatic potential enhancer
ENSG00000163710,PCOLCE2,cell proliferation,tumor growth,metastasis promotion,pi3k/akt pathway interaction,cell survival regulation,glycosylation process
ENSG00000103355,PRSS33,cellular degradation,metastasis,tumor progression,promoter of,proteolytic activity,remodeling tissue
ENSG00000131781,FMO5,metabolic regulation,detoxification process,xenobiotic metabolism,therapeutic target,prognostic marker,cancer association 
ENSG00000131044,TTLL9,microtubule stability regulation,metastasis promotion,cell division regulation,tumor progression,therapeutic target,signaling pathway modulation
ENSG00000124251,TP53TG5,apoptosis regulation,cell cycle arrest,tumor suppression,p53 interaction,dna damage response,oncogenic stress modulation
ENSG00000167562,ZNF701,tumor suppressor activity,genomic instability,dna binding specificity,co-repressor recruitment,cell cycle regulation,apoptosis induction
ENSG00000169397,RNASE3,rna degradation,tumor suppressor,oncogene potential,cellular homeostasis regulation,rna processing regulation,poor prognosis association
ENSG00000080166,DCT,dysregulation,cell proliferation,genomic instability,tumor progression,microtubule stability,motor activity
ENSG00000213085,CFAP45,centriole duplication,genomic instability,aneuploidy,dysregulated protein interactions,post-translational modification,cell proliferation regulation
ENSG00000184995,IFNE,innate immunity,interferon-gamma pathway,anti-viral activity,tumor suppression,immune regulation,cytokine signaling
ENSG00000078795,PKD2L2,cellular signaling,regulatory function,transmembrane protein,cell growth modulation,oncogenesis interaction,genomic alteration
ENSG00000176782,DEFB104A,antimicrobial activity,cationic peptide function,innate immunity regulation,immune cell modulation,tumor microenvironment interaction,dna damage response
ENSG00000277006,DEFB104B,antimicrobial activity,immune regulation,epithelial cell expression,innate immunity,cell differentiation,tumor suppression
ENSG00000101670,LIPG,lipid hydrolysis,metabolic regulation,lysosomal storage disease,lipid accumulation,cellular environment modification,tissue pathology
ENSG00000125458,NT5C,adenosine regulation,tumor progression,biomarker potential,dysregulated expression,cell surface modulation,signal transduction
ENSG00000143297,FCRL5,immune cell regulation,tumor immune evasion,cancer cell survival,cell proliferation modulation,anti-tumor immunity suppression,pro-inflammatory cytokine production
ENSG00000007350,TKTL1,pentose phosphate pathway dysregulation,tumor metabolism,glycolytic shift,cancer stem cell maintenance,cell proliferation driver,metabolic enzyme overexpression
ENSG00000165076,PRSS37,constitutive activation,epithelial-to-mesenchymal transition,oncogenic transformation,proteolytic activity,tumor progression,cancer cell invasion
ENSG00000118276,B4GALT6,aberrant glycosylation,tumor progression,glycoprotein synthesis,cell adhesion disruption,proteoglycan formation,metastasis facilitation
ENSG00000183709,IFNL2,tumor suppression,immune regulation,epithelial expression,antiviral response,cytokine induction,tumor microenvironment modulation
ENSG00000104804,TULP2,chromosomal instability,aneuploidy,ploidy changes,enhanced cell proliferation,survival and migration,none
ENSG00000134538,SLCO1B1,drug transport,liver-specific expression,bile acid conjugation,organic anion-transporting polypeptide,chemotherapy resistance,cancer prognosis
ENSG00000117009,KMO,kynurenine pathway,pro-inflammatory metabolites,cell proliferation,angiogenesis promotion,therapeutic target,tumor progression
ENSG00000167543,TP53I13,p53 family interaction,dna damage response,cell cycle regulation,apoptosis modulation,tumor suppressor function,genomic instability
ENSG00000198812,LRRC10,cellular proliferation,chromatin remodeling,oncogenic transformation,tumor suppressor loss,genomic instability,mitotic regulation
ENSG00000142694,EVA1B,genomic instability,dna repair pathway,tumor progression,therapeutic target,cell cycle checkpoint,apoptosis regulation
ENSG00000186334,SLC36A3,tumor progression,cell proliferation,enhanced metabolic regulation,oncogenic mutations,therapeutic target,amino acid uptake
ENSG00000109576,AADAT,decarboxylation,dopamine metabolism,enzymatic activity,neurotransmitter biosynthesis,signaling pathway regulation,neuronal function
ENSG00000145879,SPINK7,cellular regulation,oncogene function,protein-protein interaction,tumor progression,cancer cell survival,cell signaling pathway
ENSG00000138463,SLC49A4,calcium ion transport,cell proliferation regulation,apoptosis modulation,angiogenesis promotion,pi3k/akt pathway interaction,tumor growth enhancement
ENSG00000166250,CLMP,cell migration,tumor progression,cancer cell adhesion,genetic regulation,apoptosis suppression,biomarker candidate
ENSG00000144908,ALDH1L1,detoxification pathway,cell proliferation,apoptosis inhibition,tumor progression,cancer biomarker,pi3k/akt interaction
ENSG00000158865,SLC5A11,metabolic reprogramming,cell proliferation,anabolic processes,glycolytic shift,lactate uptake,nutrient transport
ENSG00000172728,FUT10,oncogene,tumor cell adhesion,cell surface glycosylation modification,signaling pathway interaction,tumor growth promotion,chemotherapy resistance
ENSG00000002745,WNT16,wnt/β-catenin signaling,tumor suppressor,cell proliferation regulation,canonical pathway activation,tissue homeostasis regulation,oncogenic driver
ENSG00000004846,ABCB5,chemo resistance,cancer stem cell properties,mitotic regulation,cell cycle progression,therapeutic target,drug efflux mechanism
ENSG00000167536,DHRS13,oncogenesis,proliferation,survival,cell growth,inflammation,metabolic regulation
ENSG00000155893,PXYLP1,cellular regulation,dysregulated expression,tumor suppression,transcriptional regulation,apoptosis inhibition,growth factor modulation
ENSG00000174562,KLK15,cell proliferation,extracellular matrix degradation,protease activation,oncogene role,tumor microenvironment modulation,poor prognosis marker
ENSG00000254402,LRRC24,cell adhesion,leucine-rich repeats,tumor growth,signaling pathway interaction,metastasis promotion,wnt/β-catenin regulation
ENSG00000168890,TMEM150A,oncogenic activity,cell growth regulation,lipid metabolism regulation,chemotherapy resistance modulation,tumor cell migration promotion,mapk/erk signaling pathway interaction
ENSG00000179954,SSC5D,pi3k/akt pathway interaction,dna damage response regulation,oncogene potential,tumor suppressor function,cancer driver gene candidate,cellular stress response modulation
ENSG00000205221,VIT,vitamin k metabolism,warfarin sensitivity,blood coagulation regulation,post-translational modification,hepatic expression,genetic variation impact
ENSG00000134285,FKBP11,cell cycle regulation,transcriptional modulation,protein-protein interaction,apoptosis induction,oncogene or tumor suppressor,growth inhibition
ENSG00000157800,SLC37A3,sulfate transport,genomic instability,oncogene,cell proliferation,chemotherapeutic resistance,pi3k/akt/mtor activation
ENSG00000149564,ESAM,angiogenesis promotion,endothelial cell interaction,tumor growth enhancement,vascular permeability increase,gene upregulation in cancer,protein-protein interaction
ENSG00000156574,NODAL,tgf-?-family member,cancer progression,epithelial-to-mesenchymal transition (emt),cell proliferation,wnt/?-catenin signaling pathway,oncogenic potential
ENSG00000016864,GLT8D1,glutamate transport,mtor signaling activation,cell proliferation regulation,tumor microenvironment modulation,therapeutic target identification,prognostic marker expression
ENSG00000167941,SOST,osteoblast activity,wnt/β-catenin pathway inhibition,bone formation regulation,tumor microenvironment modulation,oncosuppressor/tumorigenic context dependence,tissue-type specificity
ENSG00000083817,ZNF416,cellular proliferation,transcriptional regulation,dna binding,oncogenic transformation,metastatic progression,gene expression modulation
ENSG00000158525,CPA5,peptide processing,cell growth regulation,oncogenic process,cell proliferation enhancement,apoptosis regulation,signaling pathway interaction
ENSG00000217555,CKLF,angiogenesis,cell adhesion and migration,oncogenic signaling pathways,tumor progression,metastasis,prognosis
ENSG00000169239,CA5B,tumor metabolism,cellular ph regulation,prognostic marker,therapeutic target,hypoxia adaptation,tumor cell adaptation
ENSG00000198663,C6orf89,cell growth regulation,tumor progression marker,protein-protein interactions,cancer prognostic indicator,cell cycle regulation,uncharacterized domain of unknown function (duf) 3420
ENSG00000171161,ZNF672,cell cycle regulation,chromatin modification,dual-function protein,gene expression regulation,tumor suppression potential,oncogenic pathway activation
ENSG00000214128,TMEM213,autophagy regulation,oncogenic process,tumor biology modulation,therapeutic target,biomarker potential,cell survival regulation
ENSG00000167311,ART5,tumor progression,cell proliferation,immune response modulation,antimicrobial activity,inflammatory processes,peptidoglycan recognition
ENSG00000183876,ARSI,ribosome biogenesis regulation,dysregulation in cancer,enhanced protein synthesis,aberrant cellular proliferation,prognostic marker,genomic instability
ENSG00000280568,ZNF780A,transcriptional repression,genomic instability,histone modification,co-repressor recruitment,protein-dna interaction,epigenetic regulation
ENSG00000224290,APOM,apoptosis regulation,cell signaling alteration,high-density lipoprotein interaction,lipid metabolism regulation,oncogenic process contribution,protein-protein interaction
ENSG00000117010,ZNF684,regulation of transcription,dna-binding motifs,epigenetic regulation,chromatin remodeling,tumor suppressor function,oncogenic pathways
ENSG00000094963,FMO2,metabolic regulation,phase i biotransformation,enzyme activity,xenobiotic metabolism,cell signaling,detoxification processes
ENSG00000105767,CADM4,cell adhesion modulation,tumor suppressor function,epithelial-to-mesenchymal transition inhibition,wnt/β-catenin pathway regulation,prognostic marker,metastasis suppression
ENSG00000186765,FSCN2,cell migration,cytoplasmic actin remodeling,epithelial-to-mesenchymal transition,focal adhesion regulation,invasion,metastasis promotion
ENSG00000118094,TREH,chromatin remodeling,epigenetic regulation,tumor progression,cell proliferation,transcriptional regulation,genomic instability
ENSG00000078579,FGF20,cell surface interaction,oncogenic pathway activation,tumor progression,aberrant expression,biomarker potential,pi3k/akt signaling pathway activation
ENSG00000254858,MPV17L2,mitochondrial function,metabolic regulation,cellular metabolism,glycolytic shift,protein-protein interaction,tumor suppressor
ENSG00000256087,ZNF432,chromatin remodeling,transcriptional regulation,oncogenic potential,cell growth promotion,dna repair mechanisms,tumor progression
ENSG00000204922,UQCC3,mitochondrial function,electron transport chain regulation,oxidative phosphorylation,atp production,energy metabolism,tumor growth
ENSG00000140873,ADAMTS18,tumor progression,extracellular matrix remodeling,cellular invasion,protease activation,angiogenesis regulation,emt induction
ENSG00000146360,GPR6,signaling modulation,oncogenic pathway activation,cell proliferation enhancement,tumor progression promotion,biomarker potential,upregulated expression levels
ENSG00000173264,GPR137,tumor suppressor function,loss of expression,reduced cell proliferation,cell survival regulation,signaling pathway interaction,regulatory mechanisms
ENSG00000197110,IFNL3,immune modulation,tumor suppression,antiviral response,cell differentiation,apoptosis regulation,inflammation modulation
ENSG00000143552,NUP210L,nuclear transport regulation,tumor progression,chromatin organization alteration,oncogenic signaling pathway activation,cell cycle regulation disruption,nucleoporin function aberration
ENSG00000164088,PPM1M,cellular regulation,phosphatase activity,serine/threonine dephosphorylation,tumor suppressor candidate,protein-protein interactions,signal transduction pathway
ENSG00000120057,SFRP5,wnt signaling pathway,downregulation,tumor suppressor function,loss-of-function mutations,wnt/β-catenin signaling inhibition,cellular growth regulation
ENSG00000118557,PMFBP1,transcriptional regulation,cell proliferation,oncogenic function,tumor suppressor function,transcription factor interaction,cell cycle regulation
ENSG00000213088,ACKR1,angiogenesis promotion,cell migration facilitation,immunosuppression induction,metastasis enhancement,tumor progression facilitation,chemokine modulation
ENSG00000100632,ERH,cellular proliferation,transcriptional regulation,genomic instability,nucleolar organization,pre-rrna processing,rbdna transcription
ENSG00000198573,SPANXC,aneuploidy,chromosome segregation,cell division regulation,kinase activation,tumor progression,dysregulation
ENSG00000155254,MARVELD1,tumor progression,immune evasion,loss-of-function mutations,cell signaling regulation,membrane trafficking regulation,transmembrane protein
ENSG00000215695,RSC1A1,chromatin remodeling,transcriptional regulation,gene expression,cell proliferation,oncogenic transformation,genomic instability
ENSG00000174136,RGMB,rgma binding,cell invasion,metastasis promotion,tumor progression,immune evasion,epithelial-to-mesenchymal transition
ENSG00000131686,CA6,enzymatic activity,tumor microenvironment,cell signaling pathways,pancreatic cancer progression,proton secretion,angiogenesis regulation
ENSG00000125999,BPIFB1,lipid metabolism regulation,oncogenic processes enhancement,tumor progression modulation,pi3k/akt pathway interaction,cellular homeostasis disruption,bpi fold domain involvement
ENSG00000121270,ABCC11,cellular transport,odorant regulation,gene expression modulation,tumor interaction,constitutive activation,mutation impact
ENSG00000198113,TOR4A,cellular regulation,tumor suppression,pi3k/akt pathway modulation,gene expression regulation,tata box-binding protein interaction,cancer development inhibition
ENSG00000088726,TMEM40,er morphology regulation,cell proliferation enhancement,oncogenic function,tumor progression facilitation,apoptosis resistance,metastatic potential
ENSG00000134851,TMEM165,cellular regulation,pi3k/akt pathway,constitutive activation,oncogenic transformation,tumor progression,therapeutic target
ENSG00000108018,SORCS1,endocytosis regulation,cell migration inhibition,oncogenic signaling,lipid metabolism regulation,tumor progression association,therapeutic target
ENSG00000183128,CALHM3,calcium influx regulation,calcium channel complex,neurotransmitter release modulation,tumor microenvironment influence,oncogene potential,cell signaling pathway involvement
ENSG00000174332,GLIS1,oncogenesis,promotes cell survival,tumor progression,wnt/β-catenin signaling pathway,transcriptional regulation,genetic mutations
ENSG00000137449,CPEB2,cell proliferation,regulation of mrna translation,dysregulation leads to oncogenesis,epithelial-to-mesenchymal transition (emt),oncogenic activity enhancement,regulatory role in cell survival
ENSG00000174885,NLRP6,inflammasome regulation,tumor suppressor function,nf-kb inhibition,immune response modulation,pro-inflammatory cytokine regulation,cancer immunotherapy target
ENSG00000169469,SPRR1B,tumor progression,cell migration,epithelial-to-mesenchymal transition (emt),protein-protein interactions,cell proliferation,poor prognosis
ENSG00000181450,ZNF678,transcriptional regulation,dna binding activity,tumor suppressor function,epigenetic regulation,cell growth modulation,apoptosis regulation
ENSG00000130035,GALNT8,aberrant glycosylation,oncogenic function,tumor progression,therapeutic target,cell proliferation inhibition,apoptosis induction
ENSG00000180592,SKIDA1,cell cycle regulation,dysregulation in cancer,phosphorylation by cdks,g2/m phase transition,interaction with cdc2 and tp53,potential biomarker
ENSG00000203785,SPRR2E,cell-cell interaction,epithelial integrity,desmosomal adhesion,epithelial-to-mesenchymal transition,biomarker potential,tumor aggressiveness
ENSG00000166143,PPP1R14D,cellular regulation,apoptosis evasion,metastasis promotion,cancer progression,tumor initiation,signal transduction
ENSG00000105738,SIPA1L3,genomic instability,cancer metastasis,cell migration,dna damage response,cytoskeleton organization,septin family member
ENSG00000134758,RNF138,ubiquitination regulation,cell cycle modulation,dna repair mechanism,oncogenic potential,tumor suppressor function,gene amplification
ENSG00000175764,TTLL11,microtubule dynamics,tubulin modification,cell division regulation,genomic instability,oncogenic signaling,tumor progression
ENSG00000196169,KIF19,chromosomal instability,genomic duplication,mitotic regulation,oncogenic properties,spindle assembly,dna damage response
ENSG00000018869,ZNF582,oncogene,transcription factor activity,cell proliferation regulation,anti-apoptotic signaling pathway,post-translational modification,microrna regulation
ENSG00000141946,ZIM3,cellular differentiation,transcriptional regulation,dna binding,apoptosis inhibition,tumor progression,metastasis promotion
ENSG00000267041,ZNF850,transcriptional regulation,chromatin remodeling,oncogenic process,cell cycle control,genomic instability,metastasis
ENSG00000204519,ZNF551,tumor suppressor function,cell growth regulation,transcriptional regulation,nuclear localization,apoptosis promotion,chromatin remodeling interaction
ENSG00000281448,ZNF502,epigenetic regulation,tumor progression,oncogenic transformation,genomic instability,transcriptional control,cell cycle dysregulation
ENSG00000181315,ZNF322,chromatin remodeling,tumor progression,oncogenic potential,transcriptional regulation,dna repair pathways,nuclear localization
ENSG00000167637,ZNF283,transcription factor regulation,tumor suppressor function,zinc finger domain,multiple gene expression,cell cycle regulation,anti-proliferative activity
ENSG00000136866,ZFP37,apoptosis regulation,cell growth regulation,dna binding,gene expression regulation,genomic stability maintenance,transcriptional control
ENSG00000250571,GLI4,hedgehog pathway,transcriptional regulator,cell proliferation,tumor maintenance,cancer stem cell regulation,oncogenic driver
ENSG00000146839,ZAN,chromatin remodeling,tumor suppressor,genome instability,cancer predisposition,apoptosis regulation,cell cycle progression
ENSG00000221880,KRTAP1-3,cell proliferation regulation,tumor growth promotion,dysregulation in cancer,epigenetic modification target,intermediate filament formation,keratin interaction protein
ENSG00000102181,CD99L2,oncogenic function,tumor progression,cell adhesion disruption,metastasis promotion,signaling pathway modulation,genomic amplification
ENSG00000117480,FAAH,endocannabinoid regulation,tumor progression,cellular proliferation,pain modulation,mood regulation,lipid metabolism
ENSG00000215186,GOLGA6B,golgi apparatus function,protein modification regulation,apoptosis inhibition,cell growth promotion,tumor progression association,oncogenic potential
ENSG00000228049,POLR2J2,transcription initiation,oncogenic processes,genomic instability,cell cycle progression,rna synthesis regulation,subunit of pol ii complex
ENSG00000206306,HLA-DRB1,immune evasion,tumor antigen presentation,class ii mhc protein,antigen processing and presentation,protein interaction,immunogenicity
ENSG00000070388,FGF22,cell proliferation regulation,gene expression modulation,angiogenesis promotion,cell survival enhancement,biological pathway regulation,tumor progression facilitation
ENSG00000176239,OR51B6,odorant detection,tumor expression,gpcr signaling,cell differentiation,environmental sensing,cancer association
ENSG00000112139,MDGA1,aberrant expression,oncogene activity,tumor progression,cell migration,adhesion molecule function,signaling pathway modulation
ENSG00000161610,HCRT,wnt/β-catenin signaling,cell proliferation,tumor microenvironment,oncogene regulation,immune evasion,growth factor regulation
ENSG00000109390,NDUFC1,mitochondrial dysfunction,metabolic regulation,reactive oxygen species production,complex i assembly,energy metabolism alteration,tumor growth facilitation
ENSG00000178235,SLITRK1,oncogene,tumor progression,cell signaling regulation,proliferation regulation,metastasis association,therapeutic target
ENSG00000165379,LRFN5,cell adhesion regulation,tumor progression driver,extracellular matrix interaction,axon guidance regulator,signaling pathway modulation,cancer cell migration promoter
ENSG00000157766,ACAN,aggrecan expression,tumor aggressiveness,wnt/β-catenin pathway,epithelial-to-mesenchymal transition (emt),cell migration and invasion,poor prognosis
ENSG00000112562,SMOC2,cell adhesion disruption,tumor progression facilitation,emt regulation,signaling pathway interaction,oncogenic overexpression,angiogenesis promotion
ENSG00000136488,CSH1,cartilage regulation,differentiation inhibition,tgf-beta pathway interaction,osteoarthritis association,cartilage proliferation modulation,synovial inflammation promotion
ENSG00000179399,GPC5,cell surface localization,growth factor interaction,heparan sulfate proteoglycan,molecular attachment site,pi3k/akt/mtor pathway regulation,transcriptional modulation
ENSG00000197054,ZNF763,genomic instability,transcriptional regulation,chromatin modification,oncogenic transcription factor,therapeutic target,cellular differentiation
ENSG00000150275,PCDH15,cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt) involvement,prognostic biomarker potential,pancreatic and breast cancer association,usher syndrome type 1f link,adherens junction modulation
ENSG00000110427,KIAA1549L,wnt/β-catenin signaling,oncogene,cell proliferation enhancement,tumor progression,gene amplification,poor prognosis
ENSG00000213420,GPC2,cell surface modulation,cell proliferation regulation,epithelial-to-mesenchymal transition,growth factor interaction,heparan sulfate proteoglycan function,tumor progression promotion
ENSG00000112414,ADGRG6,emt process,cell migration,signaling pathway dysregulation,oncogene overexpression,metastasis driver,cell-cell interaction
ENSG00000276053,LAIR1,immunoregulation,transmembrane receptor,inhibitory signaling,leukocyte activation,tumor immune evasion,immunomodulatory target
ENSG00000134256,CD101,cell adhesion disruption,immunosuppression,tumor microenvironment modulation,epigenetic regulation,prognostic biomarker,transmembrane glycoprotein
ENSG00000182035,ADIG,cellular regulation,oncogenic pathway promotion,signaling molecule interaction,tumor cell growth enhancement,metabolic regulation facilitation,adaptor protein function
ENSG00000163273,NPPC,oncogenic signaling,vasodilation promotion,angiogenesis facilitation,apoptosis inhibition,cancer progression driver,genomic profiling target
ENSG00000196209,SIRPB2,immune regulation,tumor microenvironment,cell signaling modulation,phagocytosis inhibition,cancer progression,therapeutic target
ENSG00000154269,ENPP3,oncogenic mutation,tumor growth promotion,immune evasion,adenosine regulation,ectonucleotide degradation,cell proliferation regulation
ENSG00000145850,TIMD4,apoptosis regulation,pi3k/akt pathway interaction,tumor microenvironment modulation,immune cell regulation,therapeutic target potentiality,cellular signaling pathway modulation
ENSG00000158292,GPR153,gpcr activity,signaling pathway activation,cell growth modulation,epithelial-to-mesenchymal transition,ligand binding interaction,tumor progression
ENSG00000140287,HDC,histamine regulation,angiogenesis promotion,tumor progression facilitation,metastasis enhancement,immune evasion role,cancer cell proliferation
ENSG00000183117,CSMD1,tumor suppressor function,apoptosis regulation,cell adhesion modulation,immune response regulation,metastasis inhibition,epithelial-to-mesenchymal transition (emt) regulation
ENSG00000180828,BHLHE22,cellular regulation,transcriptional regulation,oncogenic transformation,tumor suppressor pathway,apoptosis modulation,cell cycle progression
ENSG00000169618,PROKR1,receptor activation,cell signaling pathway,tumor growth promotion,angiogenesis regulation,therapeutic target,prognostic marker









ENSG00000167191,GPRC5B,g protein-coupled receptor activity,protein kinase activator activity,positive regulation of protein tyrosine kinase activity,canonical wnt signaling pathway,negative regulation of canonical nf-kappab signal transduction,plasma membrane localization
ENSG00000166923,GREM1,**

negative regulation of bmp signaling pathway,negative regulation of cell growth,inhibition of chondrocyte differentiation,regulation of focal adhesion assembly,promotion of angiogenesis,involvement in endothelial cell migration

**
ENSG00000175745,NR2F1,rna polymerase ii-specific sequence binding,dna-binding transcription factor activity,zinc ion binding,nuclear receptor activity,sequence-specific double-stranded dna binding,regulation of dna-templated transcription
ENSG00000204370,SDHD,**
electron transfer activity,ubiquinone binding,protein binding,heme binding,succinate dehydrogenase (quinone) activity,metal ion binding
ENSG00000154743,TSEN2,trna splicing activity,nucleic acid binding,endonucleolytic cleavage activity,centrosome organization,mrna processing,tissue culture adaptation
ENSG00000134548,SPX,neuropeptide hormone activity,hormone binding,signal transduction,regulation of appetite,systemic arterial blood pressure regulation,negative regulation of heart rate
ENSG00000178928,TPRX1,transcriptional regulation,rna polymerase ii-specific activity,dna-binding transcription factor activity,regulation of dna-templated transcription,nucleus localization,none
,MARCH6,ubiquitin ligase activity,erad pathway regulation,cell surface receptor modulation,tumor microenvironment regulation,oncogenic signaling promotion,inflammation and immune suppression
ENSG00000181467,RAP2B,g protein activity,gtp binding,platelet aggregation,rap protein signal transduction,signal transduction,protein domain specific binding
ENSG00000136193,SCRN1,cysteine-type exopeptidase activity,exocytosis regulation,proteolysis regulation,neurotransmitter processing,synaptic vesicle cycle regulation,cytoplasmic localization
ENSG00000175395,ZNF25,regulation of dna-templated transcription,rna polymerase ii-specific sequence binding,metal ion binding,nucleus localization,dna-binding transcription factor activity,protein binding
ENSG00000084234,APLP2,aplp2 binding activity,dna binding activity,metal ion binding activity,transition metal ion binding activity,serine-type endopeptidase inhibitor activity,g protein-coupled receptor signaling pathway
ENSG00000164929,BAALC,histone modification activity,chromatin remodeling,igf2 signaling pathway,cytosolic localization,membrane raft association,synaptic transmission regulation
ENSG00000111218,PRMT8,histone methyltransferase activity,protein-arginine n-methyltransferase activity,protein arginine methylation,s-adenosylmethionine-dependent methyltransferase activity,histone modification,chromatin remodeling
ENSG00000162144,CYB561A3,**

transmembrane ascorbate ferrireductase activity,oxidoreductase activity,metal ion binding,protein binding,transmembrane transport,intracellular iron ion homeostasis

**
ENSG00000188379,IFNA2,type i interferon receptor binding,cytokine activity,cell surface receptor signaling pathway,defense response to virus,negative regulation of dna-templated transcription,adaptive immune response
ENSG00000134602,STK26,**

non-specific serine/threonine kinase activity,histone h3t6 kinase activity,chromatin remodeling,apoptotic process regulation,cellular response to starvation,intracellular signal transduction
ENSG00000169752,NRG4,growth factor activity,signaling receptor binding,protein binding,erbb4-erbb4 signaling pathway,signal transduction,plasma membrane localization
ENSG00000135917,SLC19A3,thiamine transmembrane transporter activity,vitamin transmembrane transport,thiamine diphosphate biosynthetic process,pyridoxine transport,thiamine transport,plasma membrane localization
ENSG00000165915,SLC39A13,metal ion transmembrane transporter activity,zinc ion transmembrane transporter activity,intracellular zinc ion homeostasis,metal ion transport,cellular growth regulation,endoplasmic reticulum localization
ENSG00000110375,UPK2,protein binding,epithelial cell differentiation,plasma membrane localization,extracellular exosome association,apical plasma membrane involvement,none
ENSG00000166452,AKIP1,protein binding,nf-kappab signaling,non-canonical nf-kappab signal transduction,substrate adhesion-dependent cell spreading,nucleoplasm localization,nuclear regulation
ENSG00000113504,SLC12A7,chloride:monoatomic cation symporter activity,symporter activity,potassium:chloride symporter activity,protein kinase binding,chloride transmembrane transport,cellular response to glucose stimulus
ENSG00000158186,MRAS,gtp-dependent protein binding,gtpase activity,protein phosphatase type 1 complex interaction,plasma membrane localization,ras protein signal transduction,actin cytoskeleton organization
ENSG00000203879,GDI1,small gtpase regulation,vesicle-mediated transport,signal transduction,protein transport,rab gdp-dissociation inhibitor activity,gdp-dissociation inhibitor activity
ENSG00000007171,NOS2,nitric oxide synthase activity,cytokine regulation,inflammatory response,cellular redox homeostasis,plasma membrane localization,nitric oxide biosynthetic process
ENSG00000280830,ADI1,methionine metabolic process,l-methionine salvage from methylthioadenosine,metal ion binding,iron ion binding,oxidoreductase activity,acireductone dioxygenase activity
ENSG00000160460,SPTBN4,phosphatase binding,cytoskeletal protein-membrane anchor activity,actin filament capping,axonogenesis,spectrin binding,phospholipid binding
ENSG00000179085,DPM3,dolichol-phosphate mannosyltransferase subunit activity,glycosylation via 2'-alpha-mannosyl-l-tryptophan,regulation of protein stability,protein o-linked mannosylation,carbohydrate metabolic process,dolichol metabolic process
ENSG00000105821,DNAJC2,rna binding activity,ubiquitin-modified histone reader activity,atpase activator activity,chromatin organization,regulation of translational fidelity,'de novo' cotranslational protein folding
ENSG00000010256,UQCRC1,electron transport activity,ubiquinol-cytochrome c reductase activity,aerobic respiration,oxidative phosphorylation,mitochondrial inner membrane localization,response to alkaloid
,FAM84B,transcriptional regulation,cellular signaling pathway,dna repair,chromatin remodeling,cell cycle control,cancer-specific signaling
ENSG00000089225,TBX5,**
transcription factor activity,cardiac muscle cell differentiation,regulation of transcription by rna polymerase ii,embryonic limb morphogenesis,lung development,negative regulation of epithelial to mesenchymal transition
**
ENSG00000100425,BRD1,histone acetyltransferase activity,histone reader activity,chromatin organization,regulation of developmental process,erythrocyte maturation,hemopoiesis
ENSG00000254986,DPP3,aminopeptidase activity,metallopeptidase activity,zinc ion binding,protein catabolic process,proteolysis,cytosol localization
ENSG00000130332,LSM7,u6 snrna binding,rna binding,protein binding,mrna splicing,mrna processing,nuclear-transcribed mrna catabolic process
ENSG00000165175,MID1IP1,microtubule regulation,lipid biosynthesis,protein-protein interactions,cellular stability,energy metabolism,positive regulation of fatty acid synthesis
ENSG00000213022,KLK9,serine-type endopeptidase activity,hydrolase activity,protein maturation,proteolysis,secretory granule localization,extracellular space presence
ENSG00000135338,LCA5,intraciliary transport,photoreceptor cell maintenance,protein binding activity,cilium integrity regulation,central complex formation,photoreceptor connecting cilium maintenance
ENSG00000005194,CIAPIN1,electron transfer activity,iron ion binding,protein binding,iron-sulfur cluster assembly,apoptotic process regulation,mitochondrial localization
,MMD2,monocyte to macrophage differentiation factor 2 activity,protein kinase activity,ras protein signal transduction regulation,neuron differentiation regulation,cellular trafficking regulation,golgi apparatus localization
ENSG00000272047,GTF2H5,protein binding,dna repair,nucleotide-excision repair,transcription elongation by rna polymerase i,cytoplasmic localization,nuclear localization
ENSG00000112425,EPM2A,glycogen metabolic process,protein dephosphorylation,histone phosphatase activity,plasma membrane localization,negative regulation of gene expression,autophagy regulation
ENSG00000187566,NHLRC1,ubiquitin-protein transferase activity,ubiquitin protein ligase activity,protein binding,regulation of gene expression,glycogen metabolic process,autophagy
ENSG00000183145,RIPPLY3,protein binding activity,cell population proliferation regulation,transcriptional regulation,embryonic pattern specification,heart development,negative regulation of transcription
ENSG00000114115,RBP1,lipid binding,retinol binding,protein binding,fatty acid transport,lipid homeostasis,vitamin a metabolic process
ENSG00000099992,TBC1D10A,rab-gtpase activating activity,gtpase activator activity,guanyl-nucleotide exchange factor activity,cadherin binding,retrograde transport regulation,cilium assembly regulation
ENSG00000005812,FBXL3,ubiquitin-protein transferase activity,protein binding,rhythmic process regulation,circadian rhythm entrainment,scf-dependent proteasomal ubiquitin-dependent protein catabolic process,protein destabilization
ENSG00000057593,F7,signaling receptor binding,ca2+ ion binding,serine-type peptidase activity,blood coagulation regulation,cell migration promotion,hormone response modulation
ENSG00000243135,UGT1A3,udp-glucuronosyltransferase activity,glycosyltransferase activity,glucuronidation,lipid metabolic process,xenobiotic detoxification,vitamin d3 metabolic process
ENSG00000148158,SNX30,phosphatidylinositol binding activity,protein binding activity,endocytic recycling regulation,autophagy regulation,piecemeal microautophagy of the nucleus,positive regulation of autophagosome assembly
ENSG00000114209,PDCD10,angiogenesis regulation,cancer cell migration regulation,apoptosis modulation,protein kinase binding,intracellular signal transduction,golgi apparatus localization
ENSG00000122970,IFT81,protein binding,tubulin binding,intraciliary transport,cell differentiation,sperm flagellum assembly,centrosome localization
ENSG00000167720,SRR,l-serine ammonia-lyase activity,amino acid metabolic process,response to lipopolysaccharide,pyruvate biosynthetic process,d-serine metabolic process,cytosolic localization
ENSG00000153495,TEX29,protein binding,membrane localization,none,none,none,none
ENSG00000168172,HOOK3,microtubule binding,dynein light intermediate chain binding,dynactin binding,protein transport,microtubule anchoring at centrosome,cytoplasmic microtubule organization
ENSG00000006712,PAF1,rna polymerase ii-associated factor 1 homolog,rna polymerase ii complex binding,chromatin binding,transcription elongation by rna polymerase ii,mrna 3'-end processing,negative regulation of myeloid cell differentiation
ENSG00000196376,SLC35F1,transmembrane transporter activity,protein binding,transmembrane transport,synaptic vesicle localization,neuronal signaling,cellular communication
ENSG00000183828,NUDT14,hydrolase activity,phosphorus-containing anhydrides acting on acid anhydrides,uridine diphosphate glucose pyrophosphatase activity,metal ion binding,nucleoside phosphate metabolic process,adp-ribose diphosphatase activity
ENSG00000170873,MTSS1,signaling receptor binding,actin binding,phospholipid binding,epithelial cell proliferation regulation,renal tubule morphogenesis,plasma membrane organization
ENSG00000080822,CLDND1,protein binding,cell surface localization,apical plasma membrane,membrane regulation,tight junction maintenance,adherens junction regulation
ENSG00000108511,HOXB6,rna-binding transcription factor activity,dna-binding transcription factor activity,anterior/posterior pattern specification,embryonic skeletal system morphogenesis,erythrocyte homeostasis,regulation of dna-templated transcription
ENSG00000140718,FTO,mrna n6-methyladenosine dioxygenase activity,trna demethylase activity,dna alkylation repair,rna repair,regulation of respiratory system process,brown fat cell differentiation
ENSG00000137492,THAP12,dna binding activity,metal ion binding activity,transcriptional regulation,cellular proliferation,negative regulation of cell population,signal transduction
ENSG00000148985,PGAP2,gpi anchor biosynthetic process,protein binding,endoplasmic reticulum localization,golgi apparatus involvement,membrane association,cell surface protein maturation
ENSG00000196141,SPATS2L,rna binding,post-transcriptional regulation,cell growth regulation,dna replication influence,nucleoplasm localization,nucleus interaction
ENSG00000038358,EDC4,protein binding,deadenylation-independent decapping of nuclear-transcribed mrna,cytoplasmic p-body localization,cytosol and nucleus involvement,mrna stability regulation,cellular homeostasis maintenance
ENSG00000184887,BTBD6,cytosol localization,cytoplasmic localization,biological regulation of gene expression,cellular signaling pathway regulation,neurogenesis,protein-protein interactions
ENSG00000169067,ACTBL2,**
structural constituent of postsynaptic actin cytoskeleton,atp binding,protein kinase binding,cell motility,postsynaptic actin cytoskeleton organization,axonogenesis
**
ENSG00000147394,ZNF185,zinc ion binding,protein binding,metal ion binding,cytoskeleton localization,anchoring junction interaction,focal adhesion regulation
ENSG00000170423,KRT78,keratinization,intermediate filament organization,structural constituent of skin epidermis,protein binding,epithelial-to-mesenchymal transition (emt),cytoskeletal network regulation
ENSG00000159377,PSMB4,protein binding,lipopolysaccharide binding,negative regulation of inflammatory response to antigenic stimulus,proteolysis involved in protein catabolic process,proteasome-mediated ubiquitin-dependent protein catabolic process,mitochondrial localization
ENSG00000134769,DTNA,pdz domain binding,protein binding,metal ion binding,cell-cell adhesion,signal transduction,chemical synaptic transmission
ENSG00000135245,HILPDA,signaling receptor binding,protein binding,autocrine signaling,lipid storage,cytokine production,cellular response to hypoxia
ENSG00000091583,APOH,lipoprotein lipase activator activity,triglyceride transport,blood coagulation regulation,fibrinolysis regulation,cell surface localization,lipid binding
ENSG00000090971,NAT14,n-acetyltransferase activity,acylation regulation,dna-templated transcription initiation,positive regulation of dna-templated transcription,nuclear localization,membrane-bound acetylation
ENSG00000198768,APCDD1L,wnt-protein binding,protein binding,negative regulation of wnt signaling pathway,plasma membrane localization,tumor suppressor function,cellular process regulation
ENSG00000184205,TSPYL2,histone-binding activity,chromatin organization,protein kinase activity regulation,nucleosome assembly,rdna binding,chromatin localization
ENSG00000223609,HBD,hemoglobin alpha binding,oxygen carrier activity,peroxidase activity,heme binding,metal ion binding,oxygen transport
ENSG00000183049,CAMK1D,calcium/calmodulin-dependent protein kinase activity,signal transduction,nervous system development,inflammatory response,cell survival regulation,protein serine/threonine kinase activity
ENSG00000198586,TLK1,histone kinase activity,chromatin remodeling,intracellular signal transduction,protein phosphorylation,dna damage response,chromosome segregation
ENSG00000123064,DDX54,rna helicase activity,rna binding,nucleic acid binding,atp-dependent h2az histone chaperone activity,chromatin remodeling,rna processing
ENSG00000170486,KRT72,keratin structure formation,protein binding,intermediate filament assembly,keratinization,cellular structural integrity,cytoskeleton maintenance
ENSG00000132911,NMUR2,gtp binding,intracellularly calcium-gated chloride channel activity,g protein-coupled receptor activity,cell-cell signaling,positive regulation of calcium-mediated signaling,plasma membrane localization
ENSG00000168917,SLC35G2,protein binding,nucleotide sugar transport,glycosylation process,cell surface modification,cellular trafficking,plasma membrane localization
ENSG00000182504,CEP97,molecular function: mrna splicing via spliceosome complex,u2 snrna binding,calmodulin binding
biological process: centrosome organization,mitotic spindle assembly regulation,cilium formation
cellular component: centrosome,centriole
ENSG00000185069,KRT76,intermediate filament organization,structural constituent of skin epidermis,protein binding,keratinization,pigmentation,cytoskeleton organization
ENSG00000078596,ITM2A,amyloid-binding activity,protein binding,plasma cell differentiation,negative regulation of amyloid precursor protein biosynthetic process,plasma membrane localization,golgi apparatus localization
ENSG00000112667,DNPH1,purine nucleotide catabolism,nucleoside metabolic process,deoxyribonucleoside monophosphate catabolic process,hydrolyzing n-glycosyl compounds,cellular localization to nucleus and cytoplasm,protein-protein interaction regulation
ENSG00000155313,USP25,ubiquitin-like protein peptidase activity,cysteine-type peptidase activity,deubiquitinase activity,protein deubiquitination regulation,proteasome-mediated ubiquitin-dependent protein catabolic process,negative regulation of response to oxidative stress
ENSG00000189299,FOXR2,sequence-specific double-stranded dna binding,rna polymerase ii-specific transcription factor activity,dna-binding transcription factor activity,regulation of dna-templated transcription,nucleus localization,transcriptional regulation by rna polymerase ii
ENSG00000163719,MTMR14,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,phosphatidylinositol-3-phosphate phosphatase activity,protein serine/threonine phosphatase activity,phosphatidylinositol biosynthetic process,macroautophagy
ENSG00000171564,FGB,platelet aggregation,hemostasis regulation,fibrin clot formation,cell-matrix adhesion,protein polymerization,endothelial cell interaction
ENSG00000143224,PPOX,heme biosynthetic pathway,oxidoreductase activity,menaquinone-dependent protoporphyrinogen oxidase activity,oxygen-dependent protoporphyrinogen oxidase activity,mitochondrial membrane localization,heme a biosynthesis
ENSG00000126001,CEP250,centriole-centriole cohesion,microtubule organization,centrosomal protein binding,cilium assembly,mitotic cell cycle regulation,protein localization to centrosome
ENSG00000155265,GOLGA7B,enzyme binding,protein targeting,plasma membrane localization,golgi apparatus interaction,palmitoyltransferase complex involvement,protein trafficking regulation
ENSG00000113318,MSH3,mismatch repair activity,single-stranded dna binding,molecular recognition of dna damage,somatic recombination regulation,dna mismatch correction,nucleus localization
ENSG00000119689,DLST,transferase activity,acyltransferase activity,protein binding,dihydrolipoyllysine-residue succinyltransferase activity,generation of precursor metabolites and energy,succinyl-coa metabolic process
ENSG00000144580,CNOT9,**
negative regulation of intracellular estrogen receptor signaling pathway,epidermal growth factor receptor binding,nuclear receptor coactivator activity,protein binding,kinase binding,cytokine-mediated signaling pathway

**
ENSG00000151835,SACS,protein folding regulation,negative regulation of inclusion body assembly,low-density lipoprotein particle receptor binding,hsp70 protein interaction,proteasome association,cytoplasmic and mitochondrial localization
ENSG00000130762,ARHGEF16,rho gtpase regulation,cadherin binding,cell chemotaxis,actin cytoskeleton organization,guanine nucleotide exchange factor activity,receptor tyrosine kinase interaction
ENSG00000213023,SYT3,**

calcium-dependent phospholipid binding,calcium ion sensor activity,protein binding,snare binding,metal ion binding,regulation of calcium ion-dependent exocytosis

**
ENSG00000213967,ZNF726,dna binding,rna polymerase ii-specific dna-binding transcription factor activity,regulation of transcription by rna polymerase ii,metal ion binding,nucleus localization,dna-templated transcription
ENSG00000068394,GPKOW,nucleic acid binding,protein binding,rna binding,mrna splicing,mrna processing,nuclear localization
ENSG00000115183,TANC1,protein binding function,myoblast fusion regulation,dendritic spine maintenance,postsynaptic density organization,neuronal localization,synaptic transmission
ENSG00000134897,BIVM,basic transcription factor function,protein binding,cellular localization to cytoplasm,nucleus,extracellular space,none
ENSG00000179922,ZNF784,zinc finger protein activity,rna polymerase ii-specific sequence-binding,sequence-specific dna binding,dna-binding transcription activator activity,nucleus localization,hematopoietic progenitor cell differentiation
ENSG00000178021,TSPYL6,histone binding activity,chromatin structure regulation,nucleosome assembly,epigenetic regulation,protein-nucleic acid interaction,chromatin remodeling
ENSG00000116031,CD207,d-mannose binding,carbohydrate binding,pattern recognition receptor activity,protein binding,immune response,plasma membrane localization
ENSG00000132768,DPH2,histidyl modification,protein binding,iron-sulfur cluster binding,cytosol localization,metal ion binding,post-translational modification
ENSG00000117298,ECE1,metallopeptidase activity,zinc ion binding,regulation of systemic arterial blood pressure by endothelin,endothelin maturation,vasoconstriction regulation,hormone catabolic process
ENSG00000002919,SNX11,phosphatidylinositol phosphate binding,lipid binding,protein binding,intracellular protein transport,vesicle organization,plasma membrane localization
ENSG00000143740,SNAP47,exocytosis,synaptic vesicle priming,long-term synaptic potentiation,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,synaptic vesicle fusion to presynaptic active zone membrane,snap receptor activity
ENSG00000089902,RCOR1,transcription corepressor activity,chromatin binding,protein binding,negative regulation of dna-templated transcription,chromatin organization,regulation of transcription by rna polymerase ii
ENSG00000167397,VKORC1,vitamin k epoxide reductase activity,oxidoreductase activity,blood coagulation regulation,xenobiotic metabolism,vitamin k recycling,quinone binding
ENSG00000085644,ZNF213,dna-templated transcription regulation,rna polymerase ii interaction,metal ion binding,dna-binding activity,transcriptional regulation,gene expression modulation
ENSG00000122008,POLK,dna polymerase activity,dna-directed dna polymerase activity,error-prone translesion synthesis,nucleotide-excision repair,cellular response to uv,dna damage response
ENSG00000141433,ADCYAP1,neuropeptide hormone activity,pituitary adenylate cyclase activating polypeptide activity,hormone regulation,insulin secretion,g-protein coupled receptor signaling,extracellular region localization
ENSG00000100095,SEZ6L,synapse maturation,protein kinase c signaling,endoplasmic reticulum membrane localization,negative regulation of protein expression,synaptic plasticity regulation,tumor adaptation
ENSG00000197008,ZNF138,regulation of dna-templated transcription,sequence-specific dna binding,dna-binding transcription factor activity,metal ion binding,rna polymerase ii cis-regulatory region sequence-specific dna binding,protein binding
ENSG00000170881,RNF139,ubiquitin-protein transferase activity,zinc ion binding,protein binding,erad pathway regulation,endoplasmic reticulum localization,negative regulation of translation
ENSG00000101294,HM13,intramembrane cleaving activity,membrane protein proteolysis,aspartic endopeptidase activity,cytoplasmic side of er membrane localization,endoplasmic reticulum involvement,protein binding
ENSG00000171236,LRG1,epithelial-to-mesenchymal transition,wound healing,angiogenesis,tgf-β receptor interaction,endothelial cell proliferation,keratinocyte migration
ENSG00000143416,SELENBP1,oxidoreductase activity,selenium binding,methanethiol oxidase activity,protein transport,cellular redox state regulation,nucleus localization
ENSG00000035664,DAPK2,histone kinase activity,protein serine/threonine kinase activity,regulation of autophagy,chromatin remodeling,apo-1 death receptor binding,intracellular signal transduction
ENSG00000121851,POLR3GL,transcription regulation,ribosomal rna synthesis,protein binding,nucleus localization,cytosol localization,genomic stability maintenance
ENSG00000223572,CKMT1A,phosphocreatine biosynthetic process,creatine kinase activity,kinase activity,atp binding,protein binding,mitochondrion localization
ENSG00000237289,CKMT1B,phosphocreatine biosynthetic process,kinase activity,atp binding,creatine kinase activity,mitochondrial localization,none
ENSG00000068885,IFT80,cilia assembly and maintenance,keratinocyte proliferation,fibroblast growth factor receptor signaling pathway,bone development,osteoblast differentiation,cellular polarity
ENSG00000218891,ZNF579,rna polymerase ii-specific,rna binding,dna-binding transcription factor activity,metal ion binding,nuclear localization,regulation of transcription
ENSG00000168484,SFTPC,protein binding,identical protein binding,respiratory gaseous exchange,pulmonary surfactant formation,extracellular region localization,alveolar lamellar body presence
ENSG00000112494,UNC93A,transmembrane protein function,modulation of tlr signaling pathways,regulation of endosomal trafficking,maintenance of epithelial cell integrity,recognition of viral nucleic acids,plasma membrane localization
ENSG00000063587,ZNF275,rna polymerase ii-specific dna binding,dna-binding transcription factor activity,protein binding,metal ion binding,nucleus localization,transcriptional regulation
ENSG00000142684,ZNF593,dna-binding activity,zinc ion binding,transcriptional regulation,ribosome biogenesis,nucleic acid binding,nucleus localization
ENSG00000132824,SERINC3,l-serine transmembrane transporter activity,protein binding,detection of virus,innate immune response,viral defense,l-serine biosynthetic process
ENSG00000080298,RFX3,sequence-specific dna binding,rna polymerase ii-specific transcription factor activity,dna-binding transcription factor activity,cell differentiation regulation,regulation of insulin secretion,nucleus localization
ENSG00000214160,ALG3,dolichol-linked oligosaccharide biosynthetic process,protein n-linked glycosylation,mannosyltransferase activity,dol-p-man:man(5)glcnac(2)-pp-dol alpha-1,3-mannosyltransferase activity,glycosyltransferase activity
ENSG00000170369,CST2,cysteine-type endopeptidase inhibitor activity,protein binding,detection of chemical stimulus,cellular localization in cytoplasm and extracellular spaces,tumor suppressor role,cathepsin activity regulation
ENSG00000186471,AKAP14,protein kinase a regulatory subunit binding,cytoplasmic localization,camp-dependent protein kinase complex association,cellular regulation,proliferation modulation,survival pathway regulation
ENSG00000173805,HAP1,**

autophagosome localization,endoplasmic reticulum interaction,cytosol binding,signaling receptor activity,brain-derived neurotrophic factor binding,protein targeting regulation
**
ENSG00000111328,CDK2AP1,dna replication regulation,dna polymerase binding,protein phosphorylation regulation,cyclin dependent kinase 2 interaction,nuclear localization,transcriptional regulation
ENSG00000167767,KRT80,keratinization,intermediate filament organization,cytoskeletal function,protein binding,cellular structural integrity,mechanical stress response
ENSG00000229346,TRIM10,ubiquitin protein ligase activity,metal ion binding,zinc ion binding,protein binding,negative regulation of viral entry into host cell,innate immune response
ENSG00000169180,XPO6,small gtpase binding,nuclear export signal receptor activity,protein binding,nucleocytoplasmic transport,macromolecule localization,plasma membrane localization
ENSG00000117222,RBBP5,histone binding,transcription cis-regulatory region binding,chromatin organization,dna damage response,protein binding,nucleus localization
ENSG00000108813,DLX4,transcriptional regulation,dna-binding transcription repressor activity,sequence-specific double-stranded dna binding,rna polymerase ii cis-regulatory region sequence-specific dna binding,cellular differentiation,chromatin remodeling
ENSG00000130518,IQCN,protein binding activity,mitochondrial localization,nuclear interaction,spermatid development regulation,cancer cell survival regulation,energy metabolism modulation
ENSG00000239474,KLHL41,ubiquitin-like ligase-substrate adaptor activity,protein binding,regulation of skeletal muscle cell differentiation,skeletal muscle contraction regulation,proteasome-mediated ubiquitin-dependent protein catabolic process,pseudopodium assembly
ENSG00000112118,MCM3,dna replication licensing,dna unwinding involved in dna replication,molecular chaperone activity,atp binding,dna replication initiation,chromatin remodeling
ENSG00000135374,ELF5,dna-binding transcription factor activity,sequence-specific dna binding,rna polymerase ii-specific,rna polymerase ii regulation,chromatin localization,nucleus residency
ENSG00000053702,NRIP2,aspartic-type endopeptidase activity,notch signaling pathway,negative regulation of transcription,proteolysis,cytoplasm localization,nuclear localization
ENSG00000168883,USP39,protein deubiquitination activity,rna splicing process,spikeosomal complex assembly,zinc ion binding,nucleoplasm localization,cell division regulation
ENSG00000078328,RBFOX1,rna splicing activity,rna binding activity,nervous system development regulation,alternative mrna splicing regulation,mrna processing regulation,nucleus localization
ENSG00000167977,KCTD5,proteasome-mediated ubiquitin-dependent protein catabolic process,cullin family protein binding,identical protein binding,protein-containing complex binding,protein regulation,ubiquitin ligase complex interaction
ENSG00000106682,EIF4H,translation factor activity,translational initiation,protein binding,rna binding,regulation of translational initiation,cytoplasm localization
ENSG00000107731,UNC5B,**
netrin receptor activity,protein binding,anterior/posterior axon guidance,negative regulation of extrinsic apoptotic signaling pathway,angiogenesis,cell survival
**
ENSG00000067141,NEO1,transmembrane protein localization,trans-synaptic signaling,bmp receptor binding,regulation of axon guidance,intracellular iron ion homeostasis,cell adhesion
ENSG00000105427,CNFN,keratinization process,protein binding function,cornified envelope formation,skin barrier integrity,epithelial-to-mesenchymal transition (emt),cell adhesion and migration
ENSG00000072682,P4HA2,dioxygenase activity,iron ion binding,electron transfer activity,l-ascorbic acid binding,procollagen-proline 4-dioxygenase activity,metal ion binding
ENSG00000056277,ZNF280C,rna polymerase ii interaction,dna binding,metal ion binding,nucleus localization,regulation of transcription by rna polymerase ii,regulation of dna-templated transcription
